Citrus Sinensis ID: 001566

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870-------880-------890-------900-------910-------920-------930-------940-------950-------960-------970-------980-------990------1000------1010------1020------1030------1040------1050--
Protein Sequence
MLNVTCLFSVSRRKLYFAAKMKNLVCLLVVCSTFMLSGGANAESVPTTDSASLLSFKASISRDPSNLLATWNSSTDHCTWHGVTCDHFTGRVTALRITGKATPWPSKSSVISGTLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPHLQHLDCIAFKGNKYLASCPDTNATAPEKPPVQLDEKLQNGKRSKVFIIAVVTSASAVLLIFLVIIFVILRRRKFGRIASLRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQLK
Secondary Structure (PSIPRED)
ccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccHHHHHHHHHHHHccccccccccccccccccccccEEEEcccccccEEEEEccccccccccccccccEEccccccccccccEEEccccccEEcccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEccccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccHHHHccccccEEEcccccccccccccccccccccEEEccccccccccccccccccccEEcccHHHHccccccEEcccccccEEEccccccccccccEEEccccEEEEEccccccccccccEEEccccEEEEccccccccccccEEEccccccEEcccccccccccccccccccccccccccccccccccccEEEccccccEEEcccccccccccccccccccEEEccccccccccccccccccccccccEEEcccccccccccHHHHHccccccEEEcccccccccccHHHHccccccEEEccccccccccHHHHHccccccccccccccccccccHHHHccccccEEEcccccccccccHHHHccccccccccccccccccccccccccccccEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccHHHHHHHHcccccccEEEEcccccEEEEEEccccEEEEEEEcccccccHHHHHHHHHHHccccccccccEEEEEEcccEEEEEEcccccccHHHHccccccccccHHHHHHHHHHHHHHHcccccccccccEEcccccccccccccccEEcccccccccccccccEEEEccccccccccccccccccccccccccHHHHHHHHHHHcccccccccccccccccHHHHHHHHHHccccccccccccccccHHHHHHHHHHHHHccccccccccccHHHHHHHHHHcc
Secondary Structure Prediction (SSPRO)
cccHHHHHHEEccccccccHHHHHHHHHHHHHHHHHHHHHHHHccccHHHHHHHHHHHHHccccccccccccccccccccEEEEEcccccEEEEEEEcccccEcccccccccccccHHHccccccEEEEcccccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHcccccccEEEccccEEEEEccHHHcccHHccEEEEccccccccccHHHcccHcccEEEEccccccccccHHHccHHHHcEEEEEcccccccccHHHcccccccccccHHHcccccccEEEcccccccccccHHHcccccccEEEcccccccccccHHHHcccccEEEEEccccccccccHHccccccEEEEEccccccccccHHHccccccEEEEEccccccccccHHHcccccEEEEEEccccccccccHHHHccHHHcccccccEEEEEccccccccccHHHHHcccccEEEEEEEccccccccccHHHHcccccccEEEcccccccccccHHccccccccEEEccccccEEcccHHHHHcccccEEEccccEEEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHccccccEEEccccccEccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccHHHHHHHHccccHHcEEEcccccEEEEEEcccccEEEEEEcccccccccHHHHHHHHHHHHcccHHHHHHHEEEcccccEEEEEEccccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHHHccccccccccHHHEEEcccccEEEcccccccEcccHHHHccccccccHHHccHHHHHHccccHHHHHHHHHHHHHHHHccccccccccccccccccHHHHHHHHHHccccHHHccccHcccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHcc
Coil and Loop (DISEMBL)
mlnvtclfsvSRRKLYFAAKMKNLVCLLVVCSTfmlsgganaesvpttdsaslLSFKasisrdpsnllatwnsstdhctwhgvtcdhfTGRVTALRitgkatpwpskssviSGTLSASIAKLTelrtlsvphnsfsgeipagvgELRLLEVLELqgnnfsgkipyqmsnLERLRVLNLSfnsfsgevprgligngeLSVIDMssnrlsgglaidsssecefLTYLKlsdnfltesipkeigkcrnlknllldgnilegsipkeigtiselKVLDVsrnsltdripveladcsKLSVLVLTNIdasldldnsrgefsafdggvpYELLLSRSLEVlwapranlggrlpdnwsescSLKVLNLGqnslkgavpkslgmcrnltYLDLSlnnlegylpmqlpvpcmvYFNVsqnnitgvlprfenvscdnhfgfqdlqyanvpvmgsisdenFVIIHDfsgnkflgslplfaigdgflaakykphyrlllnnnmfngsvpgeriskcndlqsFSVNLSANLLSGMSYEAFLLDCVQLVEFEaannqisgsiAAGVGKLMKLQRldlrgnrvsgslpdelgkLKFLKWILLggnnltgeipsqFGHLISLVVLDlshnaltgsipasltKATKLESLFLAHNrlsgeipvsfSTLVNLSALdlsfnnlsghiphlqhldciafkgnkylascpdtnatapekppvqldeklqngkrSKVFIIAVVTSASAVLLIFLVIIFVILRRRKFGRIASLRGQVMvtfadtpaeltydnvvratgnfsirnligtggfgstykaelVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLsggnletfihkksgkKIQWSVIHKIAIDIAQALAYLHYscvprivhrdikpsnilLDEELNAYLSDFGLARLLEVsethattdvagtfgyvapeyattcrvsdkadvySFGVVLLELISgkrsldpsfseygngfNIVSWAKLLIKEgrsselflpelweagpqeNLLGMMRlastctvetlstrpSVKQVLIKLKQLK
Flexible Loop (DISEMBL)
mlnvtclfsvsRRKLYFAAKMKNLVCLLVVCSTFMLSGGANAESVPTTDSASLLSFKASISRDPSNLLATWNSSTDHCTWHGVTCDHFTGRVTALRitgkatpwpskssviSGTLSASIAKLTElrtlsvphnsfsGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTdripveladcsklsVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRgnrvsgslpdelgKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPHLQHLDCIAFKGNKYLASCPDTnatapekppvqlDEKLQNGKRSKVFIIAVVTSASAVLLIFLVIIFVILRRRKFGriaslrgqvmvtfadtpaeltyDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAeigtlgrirHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTctvetlstrpsvkqVLIKLKQLK
Low Complexity Region (SEG)
MLNVTCLFSVSRRKLYFAAKMKNLVCLLVVCSTFMLSGGANAESVPTTDSASLLSFKASISRDPSNLLATWNSSTDHCTWHGVTCDHFTGRVTALRITGKATPWPSKSSVISGTLSASIAKLTELRTLSVPHNSFSGEIPAgvgelrllevlelQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPHLQHLDCIAFKGNKYLASCPDTNATAPEKPPVQLDEKLQNGKRSKVFIIAVVTSASAvlliflviifvilrrrKFGRIASLRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSvkqvliklkqlk
Disordered region (IsUnstruct)
**NVTCLFSVSRRKLYFAAKMKNLVCLLVVCSTFMLSGGA*************************NLLATWNSSTDHCTWHGVTCDHFTGRVTALRITGKATPWPSKSSVISGTLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPHLQHLDCIAFKGNKYLASC************************SKVFIIAVVTSASAVLLIFLVIIFVILRRRKFGRIASLRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTR**VKQVLI******
Disordered Region (DISOPRED)
**************LYFAAKMKNLVCLLVVCSTFMLSGGANA***PTTDSASLLSFKASISR*PS*LLATWNSSTDHCTWHGVTCDHFTGRVTALRITGKATPWPSKSSVISGTLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPHLQHLDCIAFKGNKYLASCPDT*************************IIAVVTSASAVLLIFLVIIFVI*********************DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRF*GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQLK
Disordered Region (DISEMBL)
MLNVTCLFSVSRRKLYFAAKMKNLVCLLVVCSTFMLSGGANAESVPTTDSASLLSFKASISRDPSNLLATWNSSTDHCTWHGVTCDHFTGRVTALRITGKATPWPSKSSVISGTLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPHLQHLDCIAFKGNKYLASCPDTNATAPEKPPVQLDEKLQNGKRSKVFIIAVVTSASAVLLIFLVIIFVILRRRKFGRIASLRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQLK
Disordered Region (DISPRO)
MLNVTCLFSVSRRKLYFAAKMKNLVCLLVVCSTFMLSGGANAESVPTTDSASLLSFKASISRDPSNLLATWNSSTDHCTWHGVTCDHFTGRVTALRITGKATPWPSKSSVISGTLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPHLQHLDCIAFKGNKYLASCPDTNATAPE************GKRSKVFIIAVVTSASAVLLIFLVIIFVILRRRK**********VMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQLK
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MLNVTCLFSVSRRKLYFAAKMKNLVCLLVVCSTFMLSGGANAESVPTTDSASLLSFKASISRDPSNLLATWNSSTDHCTWHGVTCDHFTGRVTALRITGKATPWPSKSSVISGTLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPHLQHLDCIAFKGNKYLASCPDTNATAPEKPPVQLDEKLQNGKRSKVFIIAVVTSASAVLLIFLVIIFVILRRRKFGRIASLRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQLK
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	1052	2.2.26 [Sep-21-2011]
Q9S7I6	1151	LRR receptor-like serine/	yes	no	0.973	0.889	0.429	0.0
Q9SHI2	1101	Leucine-rich repeat recep	no	no	0.932	0.891	0.324	1e-133
Q9M2Z1	1002	Leucine-rich repeat recep	no	no	0.876	0.920	0.332	1e-128
Q9LYN8	1192	Leucine-rich repeat recep	no	no	0.853	0.753	0.339	1e-126
Q9LVP0	1102	Probable leucine-rich rep	no	no	0.904	0.863	0.330	1e-125
O49545	1003	Leucine-rich repeat recep	no	no	0.884	0.928	0.322	1e-122
Q9ZVR7	1008	Phytosulfokine receptor 1	no	no	0.903	0.942	0.316	1e-119
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.872	0.734	0.314	1e-119
O49318	1124	Probable leucine-rich rep	no	no	0.934	0.874	0.305	1e-118
Q9LJF3	1164	Receptor-like protein kin	no	no	0.899	0.812	0.326	1e-117

>sp|Q9S7I6|RPK2_ARATH LRR receptor-like serine/threonine-protein kinase RPK2 OS=Arabidopsis thaliana GN=RPK2 PE=1 SV=1

 Score =  816 bits (2109), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 493/1148 (42%), Positives = 662/1148 (57%), Gaps = 124/1148 (10%)

Query: 16   YFAAKMKNLVC--LLVVCSTFMLSGGANAESVPTTDSASLLSFKASISRDPSNLLATW-N 72
            +F  +M + V   L ++C    L+G      +  +D + LL FK ++S DP ++LA+W  
Sbjct: 13   FFRRQMPSDVVFSLCLLCFASCLAGKITV--LADSDKSVLLRFKKTVS-DPGSILASWVE 69

Query: 73   SSTDHCTWHGVTCDHFTGRVTAL-------------RIT-GKATPWP-----------SK 107
             S D+C+W GV+CD  + RV AL             R T G    +P             
Sbjct: 70   ESEDYCSWFGVSCDS-SSRVMALNISGSGSSEISRNRFTCGDIGKFPLYGFGVRRDCTGN 128

Query: 108  SSVISGTLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQM 167
               ++G L + I  LT LR LS+P NSFSGEIP G+  +  LEVL+L+GN  +G +P Q 
Sbjct: 129  HGALAGNLPSVIMSLTGLRVLSLPFNSFSGEIPVGIWGMEKLEVLDLEGNLMTGSLPDQF 188

Query: 168  SNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSG------------------ 209
            + L  LRV+NL FN  SGE+P  L    +L ++++  N+L+G                  
Sbjct: 189  TGLRNLRVMNLGFNRVSGEIPNSLQNLTKLEILNLGGNKLNGTVPGFVGRFRVLHLPLNW 248

Query: 210  ---GLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGT 266
                L  D    C  L +L LS NFLT  IP+ +GKC  L++LLL  N LE +IP E G+
Sbjct: 249  LQGSLPKDIGDSCGKLEHLDLSGNFLTGRIPESLGKCAGLRSLLLYMNTLEETIPLEFGS 308

Query: 267  ISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNI-DASLDLDNSRGE----------- 314
            + +L+VLDVSRN+L+  +PVEL +CS LSVLVL+N+ +   D+++ RGE           
Sbjct: 309  LQKLEVLDVSRNTLSGPLPVELGNCSSLSVLVLSNLYNVYEDINSVRGEADLPPGADLTS 368

Query: 315  ----FSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAV 370
                F+ + GG+P E+     L++LW PRA L GR P +W    +L+++NLGQN  KG +
Sbjct: 369  MTEDFNFYQGGIPEEITRLPKLKILWVPRATLEGRFPGDWGSCQNLEMVNLGQNFFKGEI 428

Query: 371  PKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNITGVLPRFENVSCDN--- 427
            P  L  C+NL  LDLS N L G L  ++ VPCM  F+V  N+++GV+P F N +  +   
Sbjct: 429  PVGLSKCKNLRLLDLSSNRLTGELLKEISVPCMSVFDVGGNSLSGVIPDFLNNTTSHCPP 488

Query: 428  --HFG-----------------FQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLF 468
              +F                  F +       ++   SD    + H+F+ N F G+L   
Sbjct: 489  VVYFDRFSIESYSDPSSVYLSFFTEKAQVGTSLIDLGSDGGPAVFHNFADNNFTGTLKSI 548

Query: 469  AIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFL 528
             +    L  +    Y      N   G  PG     C++L++  VN+S N LSG   +   
Sbjct: 549  PLAQERLGKRVS--YIFSAGGNRLYGQFPGNLFDNCDELKAVYVNVSFNKLSGRIPQGLN 606

Query: 529  LDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGK-LKFLKWILL 587
              C  L   +A+ NQI G I   +G L  L  L+L  N++ G +P  LGK +  L ++ +
Sbjct: 607  NMCTSLKILDASVNQIFGPIPTSLGDLASLVALNLSWNQLQGQIPGSLGKKMAALTYLSI 666

Query: 588  GGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVS 647
              NNLTG+IP  FG L SL VLDLS N L+G IP        L  L L +N LSG IP  
Sbjct: 667  ANNNLTGQIPQSFGQLHSLDVLDLSSNHLSGGIPHDFVNLKNLTVLLLNNNNLSGPIPSG 726

Query: 648  FSTLVNLSALDLSFNNLSGHIPHLQHL-DCIAFKGNKYLASCPDTNATAP---------- 696
            F+T    +  ++S NNLSG +P    L  C    GN YL  C   + T P          
Sbjct: 727  FATF---AVFNVSSNNLSGPVPSTNGLTKCSTVSGNPYLRPCHVFSLTTPSSDSRDSTGD 783

Query: 697  -----------EKPPVQLDEKLQNGKRSKVFIIAVVTSASAVLLIFLVIIFVILRR-RKF 744
                       E  P Q   K   G  S         SA   +LI LVI+F   R+    
Sbjct: 784  SITQDYASSPVENAPSQSPGK--GGFNSLEIASIASASAIVSVLIALVILFFYTRKWHPK 841

Query: 745  GRIASLRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAV 804
             +I +   + +  F D    +T+DNVVRATGNF+  NLIG GGFG+TYKAE+    +VA+
Sbjct: 842  SKIMATTKREVTMFMDIGVPITFDNVVRATGNFNASNLIGNGGFGATYKAEISQDVVVAI 901

Query: 805  KKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHK 864
            K+LSIGRFQG+QQF AEI TLGR+RH NLVTLIGY+  E EMFLVYN+L GGNLE FI +
Sbjct: 902  KRLSIGRFQGVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLVYNYLPGGNLEKFIQE 961

Query: 865  KSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR 924
            +S +   W V+HKIA+DIA+ALAYLH  CVPR++HRD+KPSNILLD++ NAYLSDFGLAR
Sbjct: 962  RSTR--DWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDCNAYLSDFGLAR 1019

Query: 925  LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEY 984
            LL  SETHATT VAGTFGYVAPEYA TCRVSDKADVYS+GVVLLEL+S K++LDPSF  Y
Sbjct: 1020 LLGTSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFVSY 1079

Query: 985  GNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQV 1044
            GNGFNIV WA +L+++GR+ E F   LW+AGP ++L+ ++ LA  CTV++LSTRP++KQV
Sbjct: 1080 GNGFNIVQWACMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSLSTRPTMKQV 1139

Query: 1045 LIKLKQLK 1052
            + +LKQL+
Sbjct: 1140 VRRLKQLQ 1147

Key regulator of anther development (e.g. lignification pattern), including tapetum degradation during pollen maturation (e.g. germination capacity). Together with RPK1, required for pattern formation along the radial axis (e.g. the apical embryonic domain cell types that generate cotyledon primordia), and the apical-basal axis (e.g. differentiation of the basal pole during early embryogenesis).
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2

 Score =  476 bits (1225), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 366/1127 (32%), Positives = 566/1127 (50%), Gaps = 146/1127 (12%)

Query: 21   MKNLVCLL---VVCS-TFMLSGGANAESVPTTDSASLLSFKASISRDPSNLLATWNS-ST 75
            M+  +C L   ++CS +F+L    N E         LL FKA ++ D +  LA+WN   +
Sbjct: 1    MRGRICFLAIVILCSFSFILVRSLNEEG------RVLLEFKAFLN-DSNGYLASWNQLDS 53

Query: 76   DHCTWHGVTCDHFTGRVTALRITGKATPWPSKSSVISGTLSASIAKLTELRTLSVPHNSF 135
            + C W G+ C H    VT++ + G           +SGTLS  I KL  LR L+V  N  
Sbjct: 54   NPCNWTGIACTHLR-TVTSVDLNGMN---------LSGTLSPLICKLHGLRKLNVSTNFI 103

Query: 136  SGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNG 195
            SG IP  +   R LEVL+L  N F G IP Q++ +  L+ L L  N   G +PR +    
Sbjct: 104  SGPIPQDLSLCRSLEVLDLCTNRFHGVIPIQLTMIITLKKLYLCENYLFGSIPRQIGNLS 163

Query: 196  ELSVIDMSSNRLSG-----------------------GLAIDSSSECEFLTYLKLSDNFL 232
             L  + + SN L+G                       G+     S CE L  L L++N L
Sbjct: 164  SLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGRNGFSGVIPSEISGCESLKVLGLAENLL 223

Query: 233  TESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCS 292
              S+PK++ K +NL +L+L  N L G IP  +G IS L+VL +  N  T  IP E+   +
Sbjct: 224  EGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVGNISRLEVLALHENYFTGSIPREIGKLT 283

Query: 293  KLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYEL-LLSRSLEVLWAPRANLGGRLPDNWS 351
            K+  L L                +   G +P E+  L  + E+ ++    L G +P  + 
Sbjct: 284  KMKRLYLYT--------------NQLTGEIPREIGNLIDAAEIDFS-ENQLTGFIPKEFG 328

Query: 352  ESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLP-VPCMVYFNVSQ 410
               +LK+L+L +N L G +P+ LG    L  LDLS+N L G +P +L  +P +V   +  
Sbjct: 329  HILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFLPYLVDLQLFD 388

Query: 411  NNITGVLPRFENVSCDNHFGFQDLQYANV--PVMGSISDENFVIIHDFSGNKFLGSLPL- 467
            N + G +P    +   ++F   D+   ++  P+         +I+     NK  G++P  
Sbjct: 389  NQLEGKIPPL--IGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKLSGNIPRD 446

Query: 468  ---------FAIGDGFLA-------------------------------AKYKPHYRLLL 487
                       +GD  L                                 K K   RL L
Sbjct: 447  LKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNLERLRL 506

Query: 488  NNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGS 547
             NN F G +P E I     +  F  N+S+N L+G   +  L  CV +   + + N+ SG 
Sbjct: 507  ANNNFTGEIPPE-IGNLTKIVGF--NISSNQLTGHIPKE-LGSCVTIQRLDLSGNKFSGY 562

Query: 548  IAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISL- 606
            IA  +G+L+ L+ L L  NR++G +P   G L  L  + LGGN L+  IP + G L SL 
Sbjct: 563  IAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQ 622

Query: 607  VVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSG 666
            + L++SHN L+G+IP SL     LE L+L  N+LSGEIP S   L++L   ++S NNL G
Sbjct: 623  ISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVG 682

Query: 667  HIPH---LQHLDCIAFKGNKYLASCPDTNATAPEKP--PVQLDEKLQNGKRSKVFIIAVV 721
             +P     Q +D   F GN  L +   ++   P  P    +L+  +   +R K+  I  +
Sbjct: 683  TVPDTAVFQRMDSSNFAGNHGLCNSQRSHC-QPLVPHSDSKLNWLINGSQRQKILTITCI 741

Query: 722  TSASAVLLIFLVIIFVILRRRKFGRIA---SLRGQVMVTFADTPAELTYDNVVRATGNFS 778
               S  L+ FL + + I +RR+   +A     +  VM ++       TY  +V AT NFS
Sbjct: 742  VIGSVFLITFLGLCWTI-KRREPAFVALEDQTKPDVMDSYYFPKKGFTYQGLVDATRNFS 800

Query: 779  IRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVT 835
               ++G G  G+ YKAE+  G ++AVKKL+  R +G      F AEI TLG+IRH+N+V 
Sbjct: 801  EDVVLGRGACGTVYKAEMSGGEVIAVKKLN-SRGEGASSDNSFRAEISTLGKIRHRNIVK 859

Query: 836  LIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
            L G+   +    L+Y ++S G+L E     +    + W+  ++IA+  A+ L YLH+ C 
Sbjct: 860  LYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHDCR 919

Query: 895  PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV 954
            P+IVHRDIK +NILLDE   A++ DFGLA+L+++S + + + VAG++GY+APEYA T +V
Sbjct: 920  PQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSYGYIAPEYAYTMKV 979

Query: 955  SDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP--ELW 1012
            ++K D+YSFGVVLLELI+GK  + P       G ++V+W +      RS    +P  E++
Sbjct: 980  TEKCDIYSFGVVLLELITGKPPVQP----LEQGGDLVNWVR------RSIRNMIPTIEMF 1029

Query: 1013 EAGPQEN-------LLGMMRLASTCTVETLSTRPSVKQVLIKLKQLK 1052
            +A    N       +  ++++A  CT  + ++RP++++V+  + + +
Sbjct: 1030 DARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMITEAR 1076

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1

 Score =  461 bits (1187), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 341/1025 (33%), Positives = 513/1025 (50%), Gaps = 103/1025 (10%)

Query: 46   PTTDSASLLSFKASISRDP-SNLLATWNSSTDHCTWHGVTCDHFTGRVTALRITGKATPW 104
            P T+  +LLS K+S + D  S LL +WN ST  C+W GVTCD     VT+L ++G     
Sbjct: 24   PITELHALLSLKSSFTIDEHSPLLTSWNLSTTFCSWTGVTCDVSLRHVTSLDLSGLN--- 80

Query: 105  PSKSSVISGTLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIP 164
                  +SGTLS+ +A L  L+ LS+  N  SG IP  +  L  L  L L  N F+G  P
Sbjct: 81   ------LSGTLSSDVAHLPLLQNLSLAANQISGPIPPQISNLYELRHLNLSNNVFNGSFP 134

Query: 165  YQMSN-LERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLT 223
             ++S+ L  LRVL+L  N+ +G++P  L    +L  + +  N  SG +   +      L 
Sbjct: 135  DELSSGLVNLRVLDLYNNNLTGDLPVSLTNLTQLRHLHLGGNYFSGKIPA-TYGTWPVLE 193

Query: 224  YLKLSDNFLTESIPKEIGKCRNLKNLLLD-GNILEGSIPKEIGTISELKVLDVSRNSLTD 282
            YL +S N LT  IP EIG    L+ L +   N  E  +P EIG +SEL   D +   LT 
Sbjct: 194  YLAVSGNELTGKIPPEIGNLTTLRELYIGYYNAFENGLPPEIGNLSELVRFDAANCGLTG 253

Query: 283  RIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANL 342
             IP E+    KL  L L              + +AF G +  EL L  SL+ +       
Sbjct: 254  EIPPEIGKLQKLDTLFL--------------QVNAFTGTITQELGLISSLKSMDLSNNMF 299

Query: 343  GGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPC 402
             G +P ++S+  +L +LNL +N L GA+P+ +G    L  L L  NN  G +P +L    
Sbjct: 300  TGEIPTSFSQLKNLTLLNLFRNKLYGAIPEFIGEMPELEVLQLWENNFTGSIPQKLGENG 359

Query: 403  -MVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKF 461
             +V  ++S N +TG LP   N+   N             +M  I+  NF+          
Sbjct: 360  RLVILDLSSNKLTGTLP--PNMCSGNR------------LMTLITLGNFL---------- 395

Query: 462  LGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSG 521
             GS+P     D     K +   R+ +  N  NGS+P E        Q   V L  N L+G
Sbjct: 396  FGSIP-----DSL--GKCESLTRIRMGENFLNGSIPKELFGLPKLSQ---VELQDNYLTG 445

Query: 522  MSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKF 581
                +       L +   +NNQ+SGS+ A +G L  +Q+L L GN+ SGS+P E+G+L+ 
Sbjct: 446  ELPISGGGVSGDLGQISLSNNQLSGSLPAAIGNLSGVQKLLLDGNKFSGSIPPEIGRLQQ 505

Query: 582  LKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLS 641
            L  +    N  +G I  +      L  +DLS N L+G IP  LT    L  L L+ N L 
Sbjct: 506  LSKLDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGMKILNYLNLSRNHLV 565

Query: 642  GEIPVSFSTLVNLSALDLSFNNLSGHIP---HLQHLDCIAFKGNK-----YLASCPDTNA 693
            G IPV+ +++ +L+++D S+NNLSG +P      + +  +F GN      YL  C     
Sbjct: 566  GSIPVTIASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVGNSHLCGPYLGPCGKGTH 625

Query: 694  TAPEKPPVQLDEKLQNGKRSKVFIIAVVTSASAVLLIFLVIIF---VILRRRKFGRIASL 750
             +  KP                 + A       + L+F  ++F    I++ R     +  
Sbjct: 626  QSHVKP-----------------LSATTKLLLVLGLLFCSMVFAIVAIIKARSLRNASEA 668

Query: 751  RGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIG 810
            +   +  F     + T D+V+ +       N+IG GG G  YK  +  G LVAVK+L+  
Sbjct: 669  KAWRLTAFQR--LDFTCDDVLDS---LKEDNIIGKGGAGIVYKGTMPKGDLVAVKRLATM 723

Query: 811  RFQGIQQ--FDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGK 868
                     F+AEI TLGRIRH+++V L+G+        LVY ++  G+L   +H K G 
Sbjct: 724  SHGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGG 783

Query: 869  KIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV 928
             + W+  +KIA++ A+ L YLH+ C P IVHRD+K +NILLD    A+++DFGLA+ L+ 
Sbjct: 784  HLHWNTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQD 843

Query: 929  SET-HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNG 987
            S T    + +AG++GY+APEYA T +V +K+DVYSFGVVLLELI+GK+ +     E+G+G
Sbjct: 844  SGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGKKPV----GEFGDG 899

Query: 988  FNIVSWAKLLIKEGRSSELFLPEL-WEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046
             +IV W + +    +   L + +L   + P   +  +  +A  C  E    RP++++V+ 
Sbjct: 900  VDIVQWVRSMTDSNKDCVLKVIDLRLSSVPVHEVTHVFYVALLCVEEQAVERPTMREVVQ 959

Query: 1047 KLKQL 1051
             L ++
Sbjct: 960  ILTEI 964

Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1

 Score =  452 bits (1163), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 348/1024 (33%), Positives = 517/1024 (50%), Gaps = 126/1024 (12%)

Query: 106  SKSSVISGTLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPY 165
            + S   +G L   I+KL  L  L + +N     IP   GEL  L +L L      G IP 
Sbjct: 217  APSCFFNGPLPKEISKLKHLAKLDLSYNPLKCSIPKSFGELHNLSILNLVSAELIGLIPP 276

Query: 166  QMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSS--NRLSGGLAIDSSSECEFLT 223
            ++ N + L+ L LSFNS SG +P  L    E+ ++  S+  N+LSG L      + + L 
Sbjct: 277  ELGNCKSLKSLMLSFNSLSGPLPLEL---SEIPLLTFSAERNQLSGSLP-SWMGKWKVLD 332

Query: 224  YLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDR 283
             L L++N  +  IP EI  C  LK+L L  N+L GSIP+E+     L+ +D+S N L+  
Sbjct: 333  SLLLANNRFSGEIPHEIEDCPMLKHLSLASNLLSGSIPRELCGSGSLEAIDLSGNLLSGT 392

Query: 284  IPVELADCSKLSVLVLTN--IDAS------------LDLD--NSRGE------------- 314
            I      CS L  L+LTN  I+ S            LDLD  N  GE             
Sbjct: 393  IEEVFDGCSSLGELLLTNNQINGSIPEDLWKLPLMALDLDSNNFTGEIPKSLWKSTNLME 452

Query: 315  ----FSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAV 370
                ++  +G +P E+  + SL+ L      L G +P    +  SL VLNL  N  +G +
Sbjct: 453  FTASYNRLEGYLPAEIGNAASLKRLVLSDNQLTGEIPREIGKLTSLSVLNLNANMFQGKI 512

Query: 371  PKSLGMCRNLTYLDLSLNNLEGYLPMQL----PVPCMVYFNVSQNNITGVLPRFENVSCD 426
            P  LG C +LT LDL  NNL+G +P ++     + C+V   +S NN++G +P        
Sbjct: 513  PVELGDCTSLTTLDLGSNNLQGQIPDKITALAQLQCLV---LSYNNLSGSIPS------- 562

Query: 427  NHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLL 486
                 +   Y +   M  +S      I D S N+  G +P   +G+  +  +        
Sbjct: 563  -----KPSAYFHQIEMPDLSFLQHHGIFDLSYNRLSGPIP-EELGECLVLVEIS------ 610

Query: 487  LNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISG 546
            L+NN  +G +P   +S+  +L    ++LS N L+G S    + + ++L     ANNQ++G
Sbjct: 611  LSNNHLSGEIPAS-LSRLTNLTI--LDLSGNALTG-SIPKEMGNSLKLQGLNLANNQLNG 666

Query: 547  SIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISL 606
             I    G L  L +L+L  N++ G +P  LG LK L  + L  NNL+GE+ S+   +  L
Sbjct: 667  HIPESFGLLGSLVKLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSELSTMEKL 726

Query: 607  VVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSG 666
            V L +  N  TG IP+ L   T+LE L ++ N LSGEIP     L NL  L+L+ NNL G
Sbjct: 727  VGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLAKNNLRG 786

Query: 667  HIPH---LQHLDCIAFKGNKYLASCPDTNATAPEKPPVQLDEKLQNGKRSKVFIIAVVTS 723
             +P     Q        GNK L  C            V  D K++  K    + IA    
Sbjct: 787  EVPSDGVCQDPSKALLSGNKEL--CGRV---------VGSDCKIEGTKLRSAWGIA---- 831

Query: 724  ASAVLLIFLVIIFVI---LRRRKFGRI------------ASLRGQV-------------- 754
               ++L F +I+FV    LRR    +             + L+G V              
Sbjct: 832  --GLMLGFTIIVFVFVFSLRRWAMTKRVKQRDDPERMEESRLKGFVDQNLYFLSGSRSRE 889

Query: 755  -----MVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSI 809
                 +  F     ++   ++V AT +FS +N+IG GGFG+ YKA L     VAVKKLS 
Sbjct: 890  PLSINIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSE 949

Query: 810  GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSG-- 867
             + QG ++F AE+ TLG+++H NLV+L+GY     E  LVY ++  G+L+ ++  ++G  
Sbjct: 950  AKTQGNREFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGML 1009

Query: 868  KKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE 927
            + + WS   KIA+  A+ LA+LH+  +P I+HRDIK SNILLD +    ++DFGLARL+ 
Sbjct: 1010 EVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLIS 1069

Query: 928  VSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNG 987
              E+H +T +AGTFGY+ PEY  + R + K DVYSFGV+LLEL++GK    P F E   G
Sbjct: 1070 ACESHVSTVIAGTFGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPTGPDFKE-SEG 1128

Query: 988  FNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047
             N+V WA   I +G++ ++  P L     + + L ++++A  C  ET + RP++  VL  
Sbjct: 1129 GNLVGWAIQKINQGKAVDVIDPLLVSVALKNSQLRLLQIAMLCLAETPAKRPNMLDVLKA 1188

Query: 1048 LKQL 1051
            LK++
Sbjct: 1189 LKEI 1192

Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1

 Score =  451 bits (1159), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 354/1070 (33%), Positives = 536/1070 (50%), Gaps = 118/1070 (11%)

Query: 63   DPSNLLATWNSSTD-HCTWHGVTCDHFTGRVTALRITGKATPWPSKSSVISGTLSASIAK 121
            D    L  WNS+    C W GV C +++     L +          S V+SG LS SI  
Sbjct: 43   DAKQNLRNWNSNDSVPCGWTGVMCSNYSSDPEVLSLN-------LSSMVLSGKLSPSIGG 95

Query: 122  LTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMS---NLERLRVLN- 177
            L  L+ L + +N  SG+IP  +G    LE+L+L  N F G+IP ++    +LE L + N 
Sbjct: 96   LVHLKQLDLSYNGLSGKIPKEIGNCSSLEILKLNNNQFDGEIPVEIGKLVSLENLIIYNN 155

Query: 178  -------------LSF-------NSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSS 217
                         LS        N+ SG++PR +     L+      N +SG L  +   
Sbjct: 156  RISGSLPVEIGNLLSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQNMISGSLPSEIGG 215

Query: 218  ECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSR 277
             CE L  L L+ N L+  +PKEIG  + L  ++L  N   G IP+EI   + L+ L + +
Sbjct: 216  -CESLVMLGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPREISNCTSLETLALYK 274

Query: 278  NSLTDRIPVELADCSKLSVLVLT-------------NIDASLDLDNSRGEFSAFDGGVPY 324
            N L   IP EL D   L  L L              N+  ++++D S    +A  G +P 
Sbjct: 275  NQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSE---NALTGEIPL 331

Query: 325  ELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLG---------------------- 362
            EL     LE+L+     L G +P   S   +L  L+L                       
Sbjct: 332  ELGNIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQ 391

Query: 363  --QNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPC-MVYFNVSQNNITGVLPR 419
              QNSL G +P  LG   +L  LD+S N+L G +P  L +   M+  N+  NN++G +P 
Sbjct: 392  LFQNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPT 451

Query: 420  FENVSCDNHFGFQDLQYANVPVMG----SISDENFVIIHDFSGNKFLGSLPLFAIGDGFL 475
                +C        L+ A   ++G    ++  +  V   +   N+F GS+P   +G+   
Sbjct: 452  -GITTCKT---LVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPR-EVGN--- 503

Query: 476  AAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLV 535
                    RL L +N F G +P E I   + L +  +N+S+N L+G    + + +C  L 
Sbjct: 504  ---CSALQRLQLADNGFTGELPRE-IGMLSQLGT--LNISSNKLTG-EVPSEIFNCKMLQ 556

Query: 536  EFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGE 595
              +   N  SG++ + VG L +L+ L L  N +SG++P  LG L  L  + +GGN   G 
Sbjct: 557  RLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGS 616

Query: 596  IPSQFGHLISL-VVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNL 654
            IP + G L  L + L+LS+N LTG IP  L+    LE L L +N LSGEIP SF+ L +L
Sbjct: 617  IPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSL 676

Query: 655  SALDLSFNNLSGHIPHLQHLDCIAFKGNKYLASCPDTNATAPEKP--PVQLDEKLQNGKR 712
               + S+N+L+G IP L+++   +F GN+ L   P  N     +P  P Q   K    + 
Sbjct: 677  LGYNFSYNSLTGPIPLLRNISMSSFIGNEGLCG-PPLNQCIQTQPFAPSQSTGKPGGMRS 735

Query: 713  SKVFIIAVVTSASAVLLIFLVIIFVILRRRKFGRIAS--LRGQVMVTFADT---PAE-LT 766
            SK  IIA+  +    + + L+ + V L RR    +AS    GQ      D    P E  T
Sbjct: 736  SK--IIAITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEGFT 793

Query: 767  YDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQG-----IQQFDAE 821
            + ++V AT NF    ++G G  G+ YKA L  GY +AVKKL+     G        F AE
Sbjct: 794  FQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAE 853

Query: 822  IGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAID 881
            I TLG IRH+N+V L G+   +    L+Y ++  G+L   +H  S   + WS   KIA+ 
Sbjct: 854  ILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHDPSCN-LDWSKRFKIALG 912

Query: 882  IAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF 941
             AQ LAYLH+ C PRI HRDIK +NILLD++  A++ DFGLA+++++  + + + +AG++
Sbjct: 913  AAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSY 972

Query: 942  GYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEG 1001
            GY+APEYA T +V++K+D+YS+GVVLLEL++GK  + P       G ++V+W +  I+  
Sbjct: 973  GYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQP----IDQGGDVVNWVRSYIRRD 1028

Query: 1002 RSSELFLPE---LWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKL 1048
              S   L     L +     ++L ++++A  CT  +   RPS++QV++ L
Sbjct: 1029 ALSSGVLDARLTLEDERIVSHMLTVLKIALLCTSVSPVARPSMRQVVLML 1078

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1

 Score =  439 bits (1128), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 331/1026 (32%), Positives = 503/1026 (49%), Gaps = 95/1026 (9%)

Query: 44   SVPTTDSASLLSFKASIS---RDPSNLLATWNSSTDHCTWHGVTCDHFTGRVTALRITGK 100
            S P ++  +LLS K S++    D ++ L++W  ST  CTW GVTCD     VT+L ++G 
Sbjct: 20   SRPISEFRALLSLKTSLTGAGDDKNSPLSSWKVSTSFCTWIGVTCDVSRRHVTSLDLSGL 79

Query: 101  ATPWPSKSSVISGTLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFS 160
                      +SGTLS  ++ L  L+ LS+  N  SG IP  +  L  L  L L  N F+
Sbjct: 80   N---------LSGTLSPDVSHLRLLQNLSLAENLISGPIPPEISSLSGLRHLNLSNNVFN 130

Query: 161  GKIPYQMSN-LERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSEC 219
            G  P ++S+ L  LRVL++  N+ +G++P  +    +L  + +  N  +G +   S    
Sbjct: 131  GSFPDEISSGLVNLRVLDVYNNNLTGDLPVSVTNLTQLRHLHLGGNYFAGKIP-PSYGSW 189

Query: 220  EFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDG-NILEGSIPKEIGTISELKVLDVSRN 278
              + YL +S N L   IP EIG    L+ L +   N  E  +P EIG +SEL   D +  
Sbjct: 190  PVIEYLAVSGNELVGKIPPEIGNLTTLRELYIGYYNAFEDGLPPEIGNLSELVRFDGANC 249

Query: 279  SLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAP 338
             LT  IP E+    KL  L L              + + F G + +EL    SL+ +   
Sbjct: 250  GLTGEIPPEIGKLQKLDTLFL--------------QVNVFSGPLTWELGTLSSLKSMDLS 295

Query: 339  RANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQL 398
                 G +P +++E  +L +LNL +N L G +P+ +G    L  L L  NN  G +P +L
Sbjct: 296  NNMFTGEIPASFAELKNLTLLNLFRNKLHGEIPEFIGDLPELEVLQLWENNFTGSIPQKL 355

Query: 399  PVPCMVYF-NVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFS 457
                 +   ++S N +TG LP   N+   N                    E  + +    
Sbjct: 356  GENGKLNLVDLSSNKLTGTLP--PNMCSGNKL------------------ETLITL---- 391

Query: 458  GNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSAN 517
            GN   GS+P     D     K +   R+ +  N  NGS+P          Q   V L  N
Sbjct: 392  GNFLFGSIP-----DSL--GKCESLTRIRMGENFLNGSIPKGLFGLPKLTQ---VELQDN 441

Query: 518  LLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELG 577
             LSG    A  +  V L +   +NNQ+SG +   +G    +Q+L L GN+  G +P E+G
Sbjct: 442  YLSGELPVAGGVS-VNLGQISLSNNQLSGPLPPAIGNFTGVQKLLLDGNKFQGPIPSEVG 500

Query: 578  KLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAH 637
            KL+ L  I    N  +G I  +      L  +DLS N L+G IP  +T    L  L L+ 
Sbjct: 501  KLQQLSKIDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGEIPNEITAMKILNYLNLSR 560

Query: 638  NRLSGEIPVSFSTLVNLSALDLSFNNLSGHIP---HLQHLDCIAFKGNK-----YLASCP 689
            N L G IP S S++ +L++LD S+NNLSG +P      + +  +F GN      YL  C 
Sbjct: 561  NHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQFSYFNYTSFLGNPDLCGPYLGPCK 620

Query: 690  DTNATAPEKPPVQLDEKLQNGKRSKVFIIAVVTSASAVLLIFLVIIFVILRRRKFGRIAS 749
            D  A           +    G  S    + +V       + F V+   I++ R   + + 
Sbjct: 621  DGVAKGGH-------QSHSKGPLSASMKLLLVLGLLVCSIAFAVV--AIIKARSLKKASE 671

Query: 750  LRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLS- 808
             R   +  F     + T D+V+ +       N+IG GG G  YK  +  G LVAVK+L+ 
Sbjct: 672  SRAWRLTAFQRL--DFTCDDVLDS---LKEDNIIGKGGAGIVYKGVMPNGDLVAVKRLAA 726

Query: 809  IGRFQGIQQ-FDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSG 867
            + R       F+AEI TLGRIRH+++V L+G+        LVY ++  G+L   +H K G
Sbjct: 727  MSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKG 786

Query: 868  KKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE 927
              + W   +KIA++ A+ L YLH+ C P IVHRD+K +NILLD    A+++DFGLA+ L+
Sbjct: 787  GHLHWDTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQ 846

Query: 928  VSET-HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGN 986
             S T    + +AG++GY+APEYA T +V +K+DVYSFGVVLLEL++G++ +     E+G+
Sbjct: 847  DSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELVTGRKPV----GEFGD 902

Query: 987  GFNIVSWAKLLIKEGRSSEL-FLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVL 1045
            G +IV W + +    + S L  L     + P   +  +  +A  C  E    RP++++V+
Sbjct: 903  GVDIVQWVRKMTDSNKDSVLKVLDPRLSSIPIHEVTHVFYVAMLCVEEQAVERPTMREVV 962

Query: 1046 IKLKQL 1051
              L ++
Sbjct: 963  QILTEI 968

Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZVR7|PSKR1_ARATH Phytosulfokine receptor 1 OS=Arabidopsis thaliana GN=PSKR1 PE=2 SV=4

 Score =  431 bits (1109), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 337/1066 (31%), Positives = 535/1066 (50%), Gaps = 116/1066 (10%)

Query: 26   CLLVVCSTFMLSGGANAESVPTT-----DSASLLSFKASISRDPSNLLATWNSSTDHCTW 80
            C++V+  T +L    ++ES  T+     D  +L  F A +   P   + + +SSTD C W
Sbjct: 7    CVIVIFLTELLCFFYSSESQTTSRCHPHDLEALRDFIAHLEPKPDGWINS-SSSTDCCNW 65

Query: 81   HGVTCD-HFTGRVTALRITGKATPWPSKSSVISGTLSASIAKLTELRTLSVPHNSFSGEI 139
             G+TC+ + TGRV  L +  K          +SG LS S+ KL E+R L++  N     I
Sbjct: 66   TGITCNSNNTGRVIRLELGNKK---------LSGKLSESLGKLDEIRVLNLSRNFIKDSI 116

Query: 140  PAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNG-ELS 198
            P  +  L+ L+ L+L  N+ SG IP  + NL  L+  +LS N F+G +P  +  N  ++ 
Sbjct: 117  PLSIFNLKNLQTLDLSSNDLSGGIPTSI-NLPALQSFDLSSNKFNGSLPSHICHNSTQIR 175

Query: 199  VIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEG 258
            V+ ++ N  +G        +C  L +L L  N LT +IP+++   + L  L +  N L G
Sbjct: 176  VVKLAVNYFAGNFT-SGFGKCVLLEHLCLGMNDLTGNIPEDLFHLKRLNLLGIQENRLSG 234

Query: 259  SIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAF 318
            S+ +EI  +S L  LDVS N  +  IP    +  +L   +              G+ + F
Sbjct: 235  SLSREIRNLSSLVRLDVSWNLFSGEIPDVFDELPQLKFFL--------------GQTNGF 280

Query: 319  DGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCR 378
             GG+P  L  S SL +L     +L GRL  N +   +L  L+LG N   G +P++L  C+
Sbjct: 281  IGGIPKSLANSPSLNLLNLRNNSLSGRLMLNCTAMIALNSLDLGTNRFNGRLPENLPDCK 340

Query: 379  NLTYLDLSLNNLEGYLPMQLP-VPCMVYFNVSQNNIT------GVLPRFENVSCDNHFGF 431
             L  ++L+ N   G +P        + YF++S +++       G+L   +N++       
Sbjct: 341  RLKNVNLARNTFHGQVPESFKNFESLSYFSLSNSSLANISSALGILQHCKNLT------- 393

Query: 432  QDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNM 491
                               V+  +F G     +LP     D  L   ++    L++ N  
Sbjct: 394  -----------------TLVLTLNFHGE----ALP----DDSSL--HFEKLKVLVVANCR 426

Query: 492  FNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAG 551
              GS+P   +S  N+LQ   ++LS N L+G +  +++ D   L   + +NN  +G I   
Sbjct: 427  LTGSMP-RWLSSSNELQL--LDLSWNRLTG-AIPSWIGDFKALFYLDLSNNSFTGEIPKS 482

Query: 552  VGKLMKLQRLDLRGNRVSGSLPDELGK------------LKFLKWILLGGNNLTGEIPSQ 599
            + KL  L   ++  N  S   P  + +              F   I LG NNL+G I  +
Sbjct: 483  LTKLESLTSRNISVNEPSPDFPFFMKRNESARALQYNQIFGFPPTIELGHNNLSGPIWEE 542

Query: 600  FGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDL 659
            FG+L  L V DL  NAL+GSIP+SL+  T LE+L L++NRLSG IPVS   L  LS   +
Sbjct: 543  FGNLKKLHVFDLKWNALSGSIPSSLSGMTSLEALDLSNNRLSGSIPVSLQQLSFLSKFSV 602

Query: 660  SFNNLSGHIP---HLQHLDCIAFKGNKYLASCPDTNATAPEKPPVQLDEKLQNGKRSKVF 716
            ++NNLSG IP     Q     +F+ N          +   E   ++   + + G      
Sbjct: 603  AYNNLSGVIPSGGQFQTFPNSSFESNHLCGEHRFPCSEGTESALIKRSRRSRGGD----I 658

Query: 717  IIAVVTSASAVLLIFLVIIFVILRRRKFGRI---------------ASLRGQVMVTFADT 761
             +A+  +  +V L+ L+ + V+  RR+ G +                 +  +++V F   
Sbjct: 659  GMAIGIAFGSVFLLTLLSLIVLRARRRSGEVDPEIEESESMNRKELGEIGSKLVVLFQSN 718

Query: 762  PAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAE 821
              EL+YD+++ +T +F   N+IG GGFG  YKA L  G  VA+KKLS    Q  ++F+AE
Sbjct: 719  DKELSYDDLLDSTNSFDQANIIGCGGFGMVYKATLPDGKKVAIKKLSGDCGQIEREFEAE 778

Query: 822  IGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK--IQWSVIHKIA 879
            + TL R +H NLV L G+   + +  L+Y+++  G+L+ ++H+++     ++W    +IA
Sbjct: 779  VETLSRAQHPNLVLLRGFCFYKNDRLLIYSYMENGSLDYWLHERNDGPALLKWKTRLRIA 838

Query: 880  IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG 939
               A+ L YLH  C P I+HRDIK SNILLDE  N++L+DFGLARL+   ETH +TD+ G
Sbjct: 839  QGAAKGLLYLHEGCDPHILHRDIKSSNILLDENFNSHLADFGLARLMSPYETHVSTDLVG 898

Query: 940  TFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIK 999
            T GY+ PEY      + K DVYSFGVVLLEL++ KR +D    +     +++SW   +  
Sbjct: 899  TLGYIPPEYGQASVATYKGDVYSFGVVLLELLTDKRPVD--MCKPKGCRDLISWVVKMKH 956

Query: 1000 EGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVL 1045
            E R+SE+F P ++     + +  ++ +A  C  E    RP+ +Q++
Sbjct: 957  ESRASEVFDPLIYSKENDKEMFRVLEIACLCLSENPKQRPTTQQLV 1002

Phytosulfokine receptor with a serine/threonine-protein kinase activity. Regulates, in response to phytosulfokine binding, a signaling cascade involved in plant cell differentiation, organogenesis, somatic embryogenesis, cellular proliferation and plant growth. Not involved in PSY perception.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  430 bits (1106), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 327/1039 (31%), Positives = 521/1039 (50%), Gaps = 121/1039 (11%)

Query: 102  TPWPSKSSVISGTLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSG 161
            T + +  ++++GT+ A + +L  L  L++ +NS +GEIP+ +GE+  L+ L L  N   G
Sbjct: 218  TVFTAAENMLNGTIPAELGRLENLEILNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQG 277

Query: 162  KIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEF 221
             IP  +++L  L+ L+LS N+ +GE+P       +L  + +++N LSG L     S    
Sbjct: 278  LIPKSLADLGNLQTLDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTN 337

Query: 222  LTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPK------------------- 262
            L  L LS   L+  IP E+ KC++LK L L  N L GSIP+                   
Sbjct: 338  LEQLVLSGTQLSGEIPVELSKCQSLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLE 397

Query: 263  -----EIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSA 317
                  I  ++ L+ L +  N+L  ++P E++   KL VL L     S ++    G  ++
Sbjct: 398  GTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTS 457

Query: 318  ----------FDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLK 367
                      F+G +P  +   + L +L   +  L G LP +      L +L+L  N L 
Sbjct: 458  LKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLS 517

Query: 368  GAVPKSLGMCRNLTYLDLSLNNLEGYLPMQL-PVPCMVYFNVSQNNITGVLPRFENVSCD 426
            G++P S G  + L  L L  N+L+G LP  L  +  +   N+S N + G +      S  
Sbjct: 518  GSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSY 577

Query: 427  NHF-----GFQD---LQYAN-----------------VP-VMGSISDENFVIIHDFSGNK 460
              F     GF+D   L+  N                 +P  +G I + + +   D S N 
Sbjct: 578  LSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLL---DMSSNA 634

Query: 461  FLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPG--ERISKCNDLQSFSVNLSAN- 517
              G++PL       +  K   H  L  NNN  +G +P    ++S+  +L+     LS+N 
Sbjct: 635  LTGTIPL-----QLVLCKKLTHIDL--NNNFLSGPIPPWLGKLSQLGELK-----LSSNQ 682

Query: 518  LLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELG 577
             +  +  E F  +C +L+      N ++GSI   +G L  L  L+L  N+ SGSLP  +G
Sbjct: 683  FVESLPTELF--NCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMG 740

Query: 578  KLKFLKWILLGGNNLTGEIPSQFGHLISL-VVLDLSHNALTGSIPASLTKATKLESLFLA 636
            KL  L  + L  N+LTGEIP + G L  L   LDLS+N  TG IP+++   +KLE+L L+
Sbjct: 741  KLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLS 800

Query: 637  HNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIP-HLQHLDCIAFKGNKYLASCPDTNATA 695
            HN+L+GE+P S   + +L  L++SFNNL G +          +F GN  L   P +    
Sbjct: 801  HNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQFSRWPADSFLGNTGLCGSPLSRCNR 860

Query: 696  PEKPPVQLDEKLQNGKRSKVFIIAVVTSASAVLLIFLVIIFVILRRRKF------GRIAS 749
                 V+ + K Q      V II+ +++ +A+ L+ LVI     +R  F      G  A 
Sbjct: 861  -----VRSNNKQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAY 915

Query: 750  LRGQVMVTFADTP--------AELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYL 801
                        P        +++ +++++ AT N S   +IG+GG G  YKAEL  G  
Sbjct: 916  TSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGET 975

Query: 802  VAVKK-LSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAE--MFLVYNFLSGGNL 858
            VAVKK L        + F  E+ TLGRIRH++LV L+GY   ++E    L+Y ++  G++
Sbjct: 976  VAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSI 1035

Query: 859  ETFIHK------KSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEE 912
              ++H+      K  K + W    +IA+ +AQ + YLH+ CVP IVHRDIK SN+LLD  
Sbjct: 1036 WDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSN 1095

Query: 913  LNAYLSDFGLARLLEV---SETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLE 969
            + A+L DFGLA++L     + T + T  A ++GY+APEYA + + ++K+DVYS G+VL+E
Sbjct: 1096 MEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLME 1155

Query: 970  LISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSS--ELFLPELWEAGP--QENLLGMMR 1025
            +++GK    P+ S +G   ++V W +  ++   S+  +L  P+L    P  ++    ++ 
Sbjct: 1156 IVTGKM---PTDSVFGAEMDMVRWVETHLEVAGSARDKLIDPKLKPLLPFEEDAACQVLE 1212

Query: 1026 LASTCTVETLSTRPSVKQV 1044
            +A  CT  +   RPS +Q 
Sbjct: 1213 IALQCTKTSPQERPSSRQA 1231

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1

 Score =  428 bits (1100), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 331/1083 (30%), Positives = 533/1083 (49%), Gaps = 100/1083 (9%)

Query: 48   TDSASLLSFKASISRDPSNLLATWNSSTDH-CTWHGVTCDHFTGRVTALRITGKATPWPS 106
            +D   LL  K    +D  N L  WN   +  C W GV C       ++  +    T    
Sbjct: 35   SDGQFLLELKNRGFQDSLNRLHNWNGIDETPCNWIGVNCSSQGSSSSSNSLV--VTSLDL 92

Query: 107  KSSVISGTLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQ 166
             S  +SG +S SI  L  L  L++ +N+ +G+IP  +G    LEV+ L  N F G IP +
Sbjct: 93   SSMNLSGIVSPSIGGLVNLVYLNLAYNALTGDIPREIGNCSKLEVMFLNNNQFGGSIPVE 152

Query: 167  MSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLK 226
            ++ L +LR  N+  N  SG +P  +     L  +   +N L+G L   S      LT  +
Sbjct: 153  INKLSQLRSFNICNNKLSGPLPEEIGDLYNLEELVAYTNNLTGPLP-RSLGNLNKLTTFR 211

Query: 227  LSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPV 286
               N  + +IP EIGKC NLK L L  N + G +PKEIG + +L+ + + +N  +  IP 
Sbjct: 212  AGQNDFSGNIPTEIGKCLNLKLLGLAQNFISGELPKEIGMLVKLQEVILWQNKFSGFIPK 271

Query: 287  ELADCSKLSVLVLTNIDASLDLDNSRGEFSA----------FDGGVPYEL-LLSRSLEVL 335
            ++ + + L  L L        + +  G   +           +G +P EL  LS+ +E+ 
Sbjct: 272  DIGNLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLNGTIPKELGKLSKVMEID 331

Query: 336  WAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLP 395
            ++    L G +P   S+   L++L L QN L G +P  L   RNL  LDLS+N+L G +P
Sbjct: 332  FSENL-LSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPIP 390

Query: 396  MQLP-VPCMVYFNVSQNNITGVLPRFENV-SCDNHFGFQDLQYA-NVPVMGSISDENFVI 452
                 +  M    +  N+++GV+P+   + S      F + Q +  +P    I  ++ +I
Sbjct: 391  PGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSENQLSGKIPPF--ICQQSNLI 448

Query: 453  IHDFSGNKFLGSLP-----------LFAIGDGFLAAKYKPHYRLL------LNNNMFNGS 495
            + +   N+  G++P           L  +G+           +L+      L+ N F+G 
Sbjct: 449  LLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGP 508

Query: 496  VPGERISKCNDLQ-------SFSVNL---------------SANLLSGMSYEAFLLDCVQ 533
            +P E I  C  LQ        FS NL               S+N L+G    + + +C  
Sbjct: 509  LPPE-IGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTG-PIPSEIANCKM 566

Query: 534  LVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLT 593
            L   + + N   GS+   +G L +L+ L L  NR SG++P  +G L  L  + +GGN  +
Sbjct: 567  LQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFS 626

Query: 594  GEIPSQFGHLISL-VVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLV 652
            G IP Q G L SL + ++LS+N  +G IP  +     L  L L +N LSGEIP +F  L 
Sbjct: 627  GSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLS 686

Query: 653  NLSALDLSFNNLSGHIPH---LQHLDCIAFKGNK-----YLASCPDTNATAPEKPPVQLD 704
            +L   + S+NNL+G +PH    Q++   +F GNK     +L SC  ++++ P    +   
Sbjct: 687  SLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGGHLRSCDPSHSSWPHISSL--- 743

Query: 705  EKLQNGKRSKVFIIAVVTSASAVLLIFLVIIFVILRRRKFGRIASLRGQVMVTFADT--- 761
             K  + +R ++ II         LL+  +++  +  R      A         F ++   
Sbjct: 744  -KAGSARRGRIIIIVSSVIGGISLLLIAIVVHFL--RNPVEPTAPYVHDKEPFFQESDIY 800

Query: 762  --PAE-LTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLS-------IGR 811
              P E  T  +++ AT  F    ++G G  G+ YKA +  G  +AVKKL           
Sbjct: 801  FVPKERFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNS 860

Query: 812  FQGIQQFDAEIGTLGRIRHKNLVTLIG--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKK 869
                  F AEI TLG+IRH+N+V L    Y+ G     L+Y ++S G+L   +H      
Sbjct: 861  NNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHGGKSHS 920

Query: 870  IQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS 929
            + W     IA+  A+ LAYLH+ C PRI+HRDIK +NIL+DE   A++ DFGLA+++++ 
Sbjct: 921  MDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDMP 980

Query: 930  ETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFN 989
             + + + VAG++GY+APEYA T +V++K D+YSFGVVLLEL++GK  + P       G +
Sbjct: 981  LSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQP----LEQGGD 1036

Query: 990  IVSWAKLLIKEGR-SSELFLPELWEAGPQ---ENLLGMMRLASTCTVETLSTRPSVKQVL 1045
            + +W +  I++   +SE+  P L +        +++ + ++A  CT  + S RP++++V+
Sbjct: 1037 LATWTRNHIRDHSLTSEILDPYLTKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMREVV 1096

Query: 1046 IKL 1048
            + L
Sbjct: 1097 LML 1099

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LJF3|BRL3_ARATH Receptor-like protein kinase BRI1-like 3 OS=Arabidopsis thaliana GN=BRL3 PE=1 SV=1

 Score =  423 bits (1088), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 379/1160 (32%), Positives = 547/1160 (47%), Gaps = 214/1160 (18%)

Query: 49   DSASLLSFK-ASISRDPSNLLATWN--SSTDHCTWHGVTCDHFTGRVTALRITGKATPWP 105
            D+A L +FK  SI  DP+N L  W   S  D CTW GV+C    GRV  L +        
Sbjct: 33   DTALLTAFKQTSIKSDPTNFLGNWRYGSGRDPCTWRGVSCSS-DGRVIGLDL-------- 83

Query: 106  SKSSVISGTLS-ASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGN------- 157
             ++  ++GTL+  ++  L+ LR+L +  N+FS    +       LEVL+L  N       
Sbjct: 84   -RNGGLTGTLNLNNLTALSNLRSLYLQGNNFSSGD-SSSSSGCSLEVLDLSSNSLTDSSI 141

Query: 158  --------------NFS-----GKIPYQMS-NLERLRVLNLSFNSFSGEVPRGLI----- 192
                          NFS     GK+    S + +R+  ++LS N FS E+P   I     
Sbjct: 142  VDYVFSTCLNLVSVNFSHNKLAGKLKSSPSASNKRITTVDLSNNRFSDEIPETFIADFPN 201

Query: 193  --------GNG--------------ELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDN 230
                    GN                L+V  +S N +SG     S S C+ L  L LS N
Sbjct: 202  SLKHLDLSGNNVTGDFSRLSFGLCENLTVFSLSQNSISGDRFPVSLSNCKLLETLNLSRN 261

Query: 231  FLTESIPKE--IGKCRNLKNLLLDGNILEGSIPKEIGTISE-LKVLDVSRNSLTDRIPVE 287
             L   IP +   G  +NL+ L L  N+  G IP E+  +   L+VLD+S NSLT ++P  
Sbjct: 262  SLIGKIPGDDYWGNFQNLRQLSLAHNLYSGEIPPELSLLCRTLEVLDLSGNSLTGQLPQS 321

Query: 288  LADCSKLSVLVLTNIDASLD-----------LDNSRGEFSAFDGGVPYELLLSRSLEVLW 336
               C  L  L L N   S D           + N    F+   G VP  L    +L VL 
Sbjct: 322  FTSCGSLQSLNLGNNKLSGDFLSTVVSKLSRITNLYLPFNNISGSVPISLTNCSNLRVLD 381

Query: 337  APRANLGGRLPDNW---SESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGY 393
                   G +P  +     S  L+ L +  N L G VP  LG C++L  +DLS N L G 
Sbjct: 382  LSSNEFTGEVPSGFCSLQSSSVLEKLLIANNYLSGTVPVELGKCKSLKTIDLSFNALTGL 441

Query: 394  LPMQL-PVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDE---- 448
            +P ++  +P +    +  NN+TG +P  E++ C +    + L   N  + GS+ +     
Sbjct: 442  IPKEIWTLPKLSDLVMWANNLTGGIP--ESI-CVDGGNLETLILNNNLLTGSLPESISKC 498

Query: 449  -NFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDL 507
             N + I   S N   G +P+  IG      K +    L L NN   G++P E +  C +L
Sbjct: 499  TNMLWI-SLSSNLLTGEIPV-GIG------KLEKLAILQLGNNSLTGNIPSE-LGNCKNL 549

Query: 508  QSF---SVNLSANLLSGMSYEAFLL-------------------DCV---QLVEFEAANN 542
                  S NL+ NL   ++ +A L+                   DC     LVEFE    
Sbjct: 550  IWLDLNSNNLTGNLPGELASQAGLVMPGSVSGKQFAFVRNEGGTDCRGAGGLVEFEGIRA 609

Query: 543  Q-----------ISGSIAAGVGKLM-----KLQRLDLRGNRVSGSLPDELGKLKFLKWIL 586
            +               I +G+   M      +  LDL  N VSGS+P   G + +L+ + 
Sbjct: 610  ERLEHFPMVHSCPKTRIYSGMTMYMFSSNGSMIYLDLSYNAVSGSIPLGYGAMGYLQVLN 669

Query: 587  LGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPV 646
            LG N LTG IP  FG L ++ VLDLSHN L G +P SL                     +
Sbjct: 670  LGHNLLTGTIPDSFGGLKAIGVLDLSHNDLQGFLPGSLGG-------------------L 710

Query: 647  SFSTLVNLSALDLSFNNLSGHIP---HLQHLDCIAFKGNKYLASCPDTNATAPEKPPVQL 703
            SF     LS LD+S NNL+G IP    L       +  N  L   P    ++  +P    
Sbjct: 711  SF-----LSDLDVSNNNLTGPIPFGGQLTTFPLTRYANNSGLCGVPLPPCSSGSRP---- 761

Query: 704  DEKLQNGKRSKVFIIAVVTSASAV--LLIFLVIIFVILRRRKFGRIASLRGQVM------ 755
                ++    K   IA   SA  V   +  +++I  + R RK  +    R + +      
Sbjct: 762  ---TRSHAHPKKQSIATGMSAGIVFSFMCIVMLIMALYRARKVQKKEKQREKYIESLPTS 818

Query: 756  ------------------VTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV 797
                               TF     +LT+ +++ AT  FS  ++IG+GGFG  YKA+L 
Sbjct: 819  GSSSWKLSSVHEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGDVYKAKLA 878

Query: 798  PGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGN 857
             G +VA+KKL     QG ++F AE+ T+G+I+H+NLV L+GY     E  LVY ++  G+
Sbjct: 879  DGSVVAIKKLIQVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKYGS 938

Query: 858  LETFIH---KKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELN 914
            LET +H   KK G  + WS   KIAI  A+ LA+LH+SC+P I+HRD+K SN+LLD++  
Sbjct: 939  LETVLHEKTKKGGIFLDWSARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFV 998

Query: 915  AYLSDFGLARLLEVSETH-ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
            A +SDFG+ARL+   +TH + + +AGT GYV PEY  + R + K DVYS+GV+LLEL+SG
Sbjct: 999  ARVSDFGMARLVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSG 1058

Query: 974  KRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW--EAGPQENLLGMMRLASTCT 1031
            K+ +DP   E+G   N+V WAK L +E R +E+  PEL   ++G  E LL  +++AS C 
Sbjct: 1059 KKPIDP--EEFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVE-LLHYLKIASQCL 1115

Query: 1032 VETLSTRPSVKQVLIKLKQL 1051
             +    RP++ QV+   K+L
Sbjct: 1116 DDRPFKRPTMIQVMTMFKEL 1135

Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Binds brassinolide. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. May be involved in cell growth and vascular differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	1052
225451631	1066	PREDICTED: LRR receptor-like serine/thre	0.975	0.962	0.672	0.0
255543519	1050	ATP binding protein, putative [Ricinus c	0.956	0.958	0.650	0.0
224131420	1065	predicted protein [Populus trichocarpa]	0.967	0.955	0.645	0.0
356560424	1022	PREDICTED: LRR receptor-like serine/thre	0.949	0.977	0.626	0.0
357508455	1131	Receptor-like-kinase [Medicago truncatul	0.952	0.885	0.598	0.0
449452034	1041	PREDICTED: LRR receptor-like serine/thre	0.953	0.963	0.629	0.0
449527533	1041	PREDICTED: LOW QUALITY PROTEIN: LRR rece	0.953	0.963	0.628	0.0
104294990	1053	leucine-rich repeat-containing protein k	0.929	0.928	0.580	0.0
339790481	1125	leucine rich repeat receptor protein kin	0.972	0.909	0.448	0.0
356523630	1120	PREDICTED: LRR receptor-like serine/thre	0.964	0.906	0.445	0.0

>gi|225451631|ref|XP_002276030.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase RPK2 [Vitis vinifera] gi|147802220|emb|CAN68268.1| hypothetical protein VITISV_029909 [Vitis vinifera]

 Score = 1381 bits (3574), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 717/1066 (67%), Positives = 843/1066 (79%), Gaps = 40/1066 (3%)

Query: 24   LVCLLVVCSTFMLSGGANAESVPTTDSASLLSFKASISRDPSNLLATWNSSTDHCTWHGV 83
            ++ +LV   +F  S   +A +  + D+  LLSFK+SIS DP++LL+ WN ST+HC W+GV
Sbjct: 3    VLWILVFSLSFAFS---HAVASVSRDAMLLLSFKSSISLDPASLLSDWNLSTNHCHWYGV 59

Query: 84   TCDHFTGRVTALRITGKATP---------WPSKSSVISGTLSASIAKLTELRTLSVPHNS 134
            TCD F+GRV AL ITG  +          +  K SV+ GTLSASI  L+ELR LS+PHN 
Sbjct: 60   TCDRFSGRVVALSITGSMSSSGLPELGYNFTGKDSVLVGTLSASIGGLSELRILSIPHNV 119

Query: 135  FSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGN 194
            FSGEIPA V +L  LE+L+LQGNNFSG+IP Q+S+L  LR+LNLS+N  SG++P  LIG+
Sbjct: 120  FSGEIPADVAKLHKLEILQLQGNNFSGRIPDQISSLLSLRMLNLSYNVVSGQIPDKLIGS 179

Query: 195  GELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGN 254
            G+L VID+S+N+LSG + +D  SECEFL +LKLS NFLT++IP EIGKC NL+ LLLD N
Sbjct: 180  GKLRVIDLSNNQLSGEIGVDRFSECEFLVHLKLSHNFLTDNIPAEIGKCWNLRTLLLDSN 239

Query: 255  ILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNID----ASLDL-D 309
            I EG IP EIG IS+L+VLDVSRNSLTD IP ELA+C +LSV+VLTN+D    A  +L D
Sbjct: 240  IFEGRIPAEIGRISQLRVLDVSRNSLTDGIPKELANCRELSVIVLTNLDDFSSAEDNLAD 299

Query: 310  NSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGA 369
            +S GEF+AF GGVPYELLL   L++ WAPRANLGGRLP NWS+SCSL+ LNLGQN +  A
Sbjct: 300  SSSGEFNAFMGGVPYELLLLPKLQIFWAPRANLGGRLPSNWSDSCSLRALNLGQNYISAA 359

Query: 370  VPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNITGVLPRFENVSCDN-- 427
            VP+S+G C+NLT+LDLS N LEGYLP Q   PCMVYFN+S+N +TGVLPRF   SC +  
Sbjct: 360  VPESMGKCKNLTFLDLSSNVLEGYLPFQWLFPCMVYFNISRNMLTGVLPRFGKESCHSIM 419

Query: 428  --------HFGFQDLQ--YANVPV--------MGSISDENFVIIHDFSGNKFLGSLPLFA 469
                        +D+Q  Y+N+PV         GS+ DEN V IHDFS N+F+G +P F+
Sbjct: 420  VSYGQAPIFLDVEDIQNAYSNIPVWGYQMSTIFGSLVDENLVFIHDFSWNRFIGPIPSFS 479

Query: 470  IGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLL 529
            IG  FLA  +KP Y+L LNNN  NGS+PGE +S CNDLQ+FSVNLS N +SG  Y   LL
Sbjct: 480  IGGDFLATNHKPSYKLFLNNNALNGSLPGELVSNCNDLQTFSVNLSTNQISGGIYPGLLL 539

Query: 530  DCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGG 589
            DC+QL EFEAA+NQISGSI    G L  LQRLDLRGNR+SGSLP +LG LK LKWILLGG
Sbjct: 540  DCLQLKEFEAAHNQISGSIGPAFGNLKMLQRLDLRGNRLSGSLPGQLGMLKDLKWILLGG 599

Query: 590  NNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFS 649
            NNLTGEIPSQ G L SL+VLDLS N LTGSIP +LT AT LE + L HNRL GEIP SFS
Sbjct: 600  NNLTGEIPSQLGQLTSLIVLDLSRNGLTGSIPENLTNATNLEIVLLNHNRLVGEIPSSFS 659

Query: 650  TLVNLSALDLSFNNLSGHIPHLQHL-DCIAFKGNKYLASCPDTNATAPEKPPVQLD-EKL 707
            TL +L+ LD+SFNNLSGHIP LQHL +C  FKGN+YL  C D  +  P++ P  L+  K 
Sbjct: 660  TLSSLTELDVSFNNLSGHIPQLQHLSNCDFFKGNQYLHPCLDPYSAPPDRLPDLLEVHKE 719

Query: 708  QNGKRSKVFIIAVVTSASAVLLIFLVIIFVILR-RRKFGRIASLRGQVMVTFADTPAELT 766
                + K F+IA+V SAS +L I LV++ V++  RRK  R+ SLR +V+VTFAD P E+ 
Sbjct: 720  YRQSKLKSFVIAMVASASFILFILLVMVLVLILGRRKISRLTSLRRKVVVTFADAPTEVN 779

Query: 767  YDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLG 826
            YDNVVRATGNFSIRNLIGTGGFGSTYKAELVPG+LVAVK+LSIGRFQG+QQFDAEI TLG
Sbjct: 780  YDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGFLVAVKRLSIGRFQGLQQFDAEIKTLG 839

Query: 827  RIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQAL 886
            RIRHKNLVTLIGY+VGE EMFL+YNFLSGGNLETFIH +SGK +QW VIHKIA+ IAQAL
Sbjct: 840  RIRHKNLVTLIGYHVGETEMFLIYNFLSGGNLETFIHDRSGKNVQWPVIHKIALHIAQAL 899

Query: 887  AYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAP 946
            AYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAP
Sbjct: 900  AYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAP 959

Query: 947  EYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSEL 1006
            EYATTCRVSDKADVYSFGVVLLEL+SGK+SLDPSFSEYGNGFNIV+WAKLLIKE RSSEL
Sbjct: 960  EYATTCRVSDKADVYSFGVVLLELMSGKKSLDPSFSEYGNGFNIVAWAKLLIKERRSSEL 1019

Query: 1007 FLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQLK 1052
            F PELWE GP+ENLLGM++LASTCTVE++S RPS++QV+ KLKQL+
Sbjct: 1020 FSPELWEVGPKENLLGMLKLASTCTVESISIRPSMRQVVEKLKQLR 1065

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255543519|ref|XP_002512822.1| ATP binding protein, putative [Ricinus communis] gi|223547833|gb|EEF49325.1| ATP binding protein, putative [Ricinus communis]

 Score = 1323 bits (3425), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 680/1045 (65%), Positives = 828/1045 (79%), Gaps = 39/1045 (3%)

Query: 37   SGGANAESVPTTDSASLLSFKASISRDPSNLLATWNSSTDHCTWHGVTCDHFTGRVTALR 96
            S    AE +   D+A+LL F+ S+SRDPSNLLA W  ++D+C+W+GVTC+  + RV AL 
Sbjct: 15   SSWTKAEPLVLNDTAALLDFRKSVSRDPSNLLAGWTPNSDYCSWYGVTCNEVSKRVVALN 74

Query: 97   ITGKATPWPSKSSVISGTLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQG 156
             T +     S +S ++GTL  S+  LTELR L +P N+FSG+IP  +G LR LEVLELQG
Sbjct: 75   FTSR-----SLTSFLAGTLPDSVGNLTELRALVIPQNAFSGDIPVTIGNLRFLEVLELQG 129

Query: 157  NNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSS 216
            NNFSGKIP Q+SNLE L +LNLSFNSF+GE+P  LIG G+L VID+S+N+L+GG+ +D+S
Sbjct: 130  NNFSGKIPDQISNLESLSLLNLSFNSFTGEIPDSLIGYGKLKVIDLSNNQLTGGIKVDNS 189

Query: 217  SECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVS 276
            S+C FL +LKLS+NFL ESIPKEIGKC+ L+ LLLDGNIL+G +P EIG ISEL++LDVS
Sbjct: 190  SQCSFLRHLKLSNNFLKESIPKEIGKCKYLRTLLLDGNILQGPLPAEIGQISELRILDVS 249

Query: 277  RNSLTDRIPVELADCSKLSVLVLTN-------IDASLDLDNSRGEFSAFDGGVPYELLLS 329
             NS +++IP ELA+C KLSV VLTN       I+  L  D SR +F+AF+GG+P+E+L+ 
Sbjct: 250  TNSFSEKIPKELANCRKLSVFVLTNSSNFVGNINGDLS-DRSRLDFNAFEGGIPFEVLML 308

Query: 330  RSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNN 389
             SL++LWAPRANLGGRLP +W + CSL+V++LG N  KG VPK LGMC+NLT+LDLS N 
Sbjct: 309  PSLQILWAPRANLGGRLPSSWGDLCSLRVVHLGFNFFKGVVPKGLGMCKNLTFLDLSSNY 368

Query: 390  LEGYLPMQLPVPCMVYFNVSQNNITGVLPRFENVSCDNH---FG----FQDLQ-----YA 437
            L GYLPMQL VPCMVYFNVSQNN++  LP F+  SCD     FG    F D++     ++
Sbjct: 369  LVGYLPMQLQVPCMVYFNVSQNNMSRALPSFQKGSCDASMILFGQDHSFLDMEDVRIAFS 428

Query: 438  NVPV--------MGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNN 489
            ++PV        +GS+ +E+FVI+HDFS N+F+GSLPLF++GD FLA K KP YRLLLN 
Sbjct: 429  SIPVWGPQMVTSLGSMGEEDFVIVHDFSWNQFVGSLPLFSVGDEFLATKNKPTYRLLLNE 488

Query: 490  NMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIA 549
            NMFNGS+P E +S CN LQSFSVNLSAN +SG   E+ L+ C Q+++FEAA NQI GS+ 
Sbjct: 489  NMFNGSLPSELVSNCNHLQSFSVNLSANYMSGKIPESLLVSCPQMIQFEAAYNQIGGSLP 548

Query: 550  AGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVL 609
              +G LM LQ  D+RGN +SGSLP++LG L  LK +LLG NN+ G IPSQ   L SLVVL
Sbjct: 549  PSIGNLMMLQYFDIRGNTLSGSLPNQLGNLTLLKSLLLGMNNVLGNIPSQLDQLTSLVVL 608

Query: 610  DLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIP 669
            DLSHNA+TGSIPASL  A  LE + L +NRLSGEIP SFSTL NL+  D+SFNNLSGH+P
Sbjct: 609  DLSHNAVTGSIPASLPNAKNLEVVLLNNNRLSGEIPSSFSTLTNLTVFDVSFNNLSGHLP 668

Query: 670  HLQHLD-CIAFKGNKYLASCPDTNATAPEKPPVQLDEKLQNGKRSKVFIIAVVTSASAVL 728
              QHL  C  F+GN +L  CP + ++         D K    +  K  I+A+  SA AV 
Sbjct: 669  QFQHLSSCDWFRGNTFLEPCPSSKSSTDSNG----DGKWHRHRNEKPLILALSVSAFAVF 724

Query: 729  LIFLV-IIFVILRRRKFGRIASLRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGG 787
             +FLV ++  I  +RK  R++SLRG+V+VTFAD PAEL+YD VVRATG+FSIRNLIGTGG
Sbjct: 725  CLFLVGVVIFIHWKRKLNRLSSLRGKVVVTFADAPAELSYDAVVRATGHFSIRNLIGTGG 784

Query: 788  FGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMF 847
            FGSTYKAEL PGY VAVK+LS+GRFQGIQQFDAEI TLGRIRHK LVTLIGYYVG++EMF
Sbjct: 785  FGSTYKAELAPGYFVAVKRLSLGRFQGIQQFDAEIRTLGRIRHKKLVTLIGYYVGDSEMF 844

Query: 848  LVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNI 907
            L+YN+LSGGNLETFIH++S KK+QWSVI+KIA+DIAQALAYLHYSCVPRI+HRDIKPSNI
Sbjct: 845  LIYNYLSGGNLETFIHERSIKKVQWSVIYKIALDIAQALAYLHYSCVPRILHRDIKPSNI 904

Query: 908  LLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVL 967
            LLDEELNAYLSDFGLARLLEVS+THATTDVAGTFGYVAPEYATTCRVSDK+DVYSFGVVL
Sbjct: 905  LLDEELNAYLSDFGLARLLEVSQTHATTDVAGTFGYVAPEYATTCRVSDKSDVYSFGVVL 964

Query: 968  LELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLA 1027
            LEL+SGK+SLDPSFS+YGNGFNIV+WAKLLIKEGRS ELF  +LWE+GP+ENLLGM++LA
Sbjct: 965  LELMSGKKSLDPSFSDYGNGFNIVAWAKLLIKEGRSPELFSVKLWESGPKENLLGMLKLA 1024

Query: 1028 STCTVETLSTRPSVKQVLIKLKQLK 1052
            ++CTVE+LS RPS+KQVL KLKQLK
Sbjct: 1025 ASCTVESLSVRPSMKQVLEKLKQLK 1049

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224131420|ref|XP_002321080.1| predicted protein [Populus trichocarpa] gi|222861853|gb|EEE99395.1| predicted protein [Populus trichocarpa]

 Score = 1283 bits (3320), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 691/1071 (64%), Positives = 827/1071 (77%), Gaps = 53/1071 (4%)

Query: 27   LLVVCSTFMLSGG------ANAESVPTTDSASLLSFKASISRDPSNLLATWNSST--DHC 78
            ++V  + F+  GG      A A S   + S +LLSFK S+  DPSNLL++WN +T  D+C
Sbjct: 2    VVVAAAWFLFVGGLAATFSAEALSFNDSTSGTLLSFKNSVLGDPSNLLSSWNLTTNPDYC 61

Query: 79   TWHGVTCDHFTGRVT-----ALRITGKATPWPSKSSVISGTLSASIAKLTELRTLSVPHN 133
            TW+GVTC   +   T     AL  +G +T      + +SGTL  SI  L  LRTL + HN
Sbjct: 62   TWYGVTCQKPSNTTTEVVVIALNFSGTST------TRLSGTLPESIQNLPYLRTLVLSHN 115

Query: 134  SFSGEIPAG-VGELRLLEVLELQGNNFSGKIPYQMS-NLERLRVLNLSFNSFSGEVPRGL 191
             FSGEIPAG + +L  LEVLELQGNNFSGKIP Q+S +L  LR LNLSFNSF+G++P  L
Sbjct: 116  CFSGEIPAGSIAKLSFLEVLELQGNNFSGKIPQQISTDLHSLRFLNLSFNSFTGDIPATL 175

Query: 192  IGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLL 251
            IG G+L VID+S+NRL+GG+ + S S+C FL +LKLS+N L  +IPK+IG C+NL+ LLL
Sbjct: 176  IGFGKLRVIDLSNNRLTGGMQLVSLSKCLFLRHLKLSNNLLENNIPKDIGHCKNLRTLLL 235

Query: 252  DGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASL----- 306
            DGNIL+G IP EIG I EL+VLDVS NSLT  IP EL  C KLSVLVLTN    +     
Sbjct: 236  DGNILQGPIPAEIGQIPELRVLDVSTNSLTQTIPKELGYCRKLSVLVLTNSSNFVGDNGG 295

Query: 307  ---DLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQ 363
               +LD  R EF+AF+GGVP E+L+  SL++LWAPRANL GRLPDNWS+SCSL+VL+LGQ
Sbjct: 296  TGGNLDGFRLEFNAFEGGVPQEVLMLPSLQILWAPRANLDGRLPDNWSDSCSLRVLHLGQ 355

Query: 364  NSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNITGVLPRFENV 423
            NSL+G VPK L MC+NLT+LDLS N L G LPMQL VPCM+YFNVSQNNI+G +P F   
Sbjct: 356  NSLRGVVPKGLVMCKNLTFLDLSSNYLTGDLPMQLQVPCMMYFNVSQNNISGAVPTFGKG 415

Query: 424  SCD----------NHFGFQDLQ--YANVPV------MGSISDENFVIIHDFSGNKFLGSL 465
            SCD          N F  +D+Q  YAN+PV      +GS++  +FVI+HDFS N F+GSL
Sbjct: 416  SCDTSIISYGQDPNFFYVEDIQIAYANIPVWGSHTLLGSMAGADFVIVHDFSWNHFVGSL 475

Query: 466  PLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYE 525
            P F++G+ FL +K +  YRLLL++N F GS+PG+ +S CNDL SFSVNLSAN +SG    
Sbjct: 476  PSFSVGEEFLVSKNRTSYRLLLSSNGFTGSLPGKLVSNCNDLLSFSVNLSANHISG-EIP 534

Query: 526  AFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWI 585
              LL+C+ + EFEAA+N+ISG +A  +G L  L+RLDLR NR+SGSLP+ELG L+FL+ +
Sbjct: 535  DMLLNCLPIREFEAADNEISGFLAPSIGNLRMLRRLDLRRNRLSGSLPNELGNLRFLRSV 594

Query: 586  LLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIP 645
            LLG NNLTGEIPS+FG L SL VLDLSHNA+TGSIP SLT A  LE + L +N LSG IP
Sbjct: 595  LLGMNNLTGEIPSEFGQLSSLTVLDLSHNAVTGSIPVSLTSAKNLEIVLLNNNDLSGAIP 654

Query: 646  VSFSTLVNLSALDLSFNNLSGHIPHLQH-LDCIAFKGNKYLASCPDTNATAP--EKPPVQ 702
              FS + +L  L++SFNNLSGHIPHLQH +DC  F+GN +L  C D ++  P  E     
Sbjct: 655  PPFSNISSLVVLNVSFNNLSGHIPHLQHPIDCDWFRGNFFLDKCLDQSSNTPPGEVQQSH 714

Query: 703  LDEKLQNGKRSKVFIIAVVTSASAVLLIFLVII-FVILRRRKFGRIASLRGQVMVTFADT 761
             D K +N  R K F+IAVVTSAS VL + LV++ F    ++K  R++ LRG+V+VTFAD 
Sbjct: 715  GDRKWRN-HRKKSFLIAVVTSASVVLCVSLVVVLFSFYGKKKSWRLSILRGKVVVTFADA 773

Query: 762  PAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAE 821
            PAELTYD+VVRATGNFS+RNLIGTGGFGSTYKAELVPGY +AVK+LSIGRFQGIQQFDAE
Sbjct: 774  PAELTYDSVVRATGNFSMRNLIGTGGFGSTYKAELVPGYFIAVKRLSIGRFQGIQQFDAE 833

Query: 822  IGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAID 881
            I TLGRIRHKNLVTLIGYYV EAEMFL+YN+LSGGNLETFIH +    +QW VIHKIA+D
Sbjct: 834  IRTLGRIRHKNLVTLIGYYVAEAEMFLIYNYLSGGNLETFIHDRPDTNVQWPVIHKIALD 893

Query: 882  IAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF 941
            IAQALAYLHYSC PRI+HRDIKPSNILLDEELNAYLSDFGLA+LLEVS+THATTDVAGTF
Sbjct: 894  IAQALAYLHYSCAPRILHRDIKPSNILLDEELNAYLSDFGLAKLLEVSQTHATTDVAGTF 953

Query: 942  GYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEG 1001
            GYVAPEYATTCRVSDK+DVYSFGVVLLEL+SGK+SLDPSFSEYGNGFNIV+WAKLLIKE 
Sbjct: 954  GYVAPEYATTCRVSDKSDVYSFGVVLLELMSGKKSLDPSFSEYGNGFNIVAWAKLLIKER 1013

Query: 1002 RSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQLK 1052
            RSSELF PELWEAGP ENLLGM++LAS+CTV++LS RPS+KQVL KLKQLK
Sbjct: 1014 RSSELFAPELWEAGPNENLLGMLKLASSCTVDSLSVRPSMKQVLEKLKQLK 1064

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356560424|ref|XP_003548492.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase RPK2-like, partial [Glycine max]

 Score = 1217 bits (3150), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 648/1035 (62%), Positives = 782/1035 (75%), Gaps = 36/1035 (3%)

Query: 40   ANA-ESVPTTDSASLLSFKASISRDPSNLLATWNSST--DHCTWHGVTCDHFTGRVTALR 96
            ANA ++    D+ SLLSFK  +S DPSNLLA W++ T  + C W  V C    GRVT L 
Sbjct: 1    ANALDATIPRDALSLLSFKRFVSSDPSNLLAAWSNRTSPNLCRWRAVACG-VAGRVTVLN 59

Query: 97   ITGKATPWPSKSSVISGTLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQG 156
            +TG          +  G LS S+  ++ELR LS+  N FSGEIP  +  L+ LEVLELQG
Sbjct: 60   VTG----------LRGGELSPSVGDMSELRVLSLAGNMFSGEIPVTLVNLQFLEVLELQG 109

Query: 157  NNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSS 216
            NNFSGKIP QMS    L+V+NLS N+FSG +P  +IG+G + ++D+S+N+ SG + ++ S
Sbjct: 110  NNFSGKIPTQMS-FTFLQVVNLSGNAFSGSIPSEIIGSGNVKIVDLSNNQFSGVIPVNGS 168

Query: 217  SECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVS 276
              C+ L +L+LS NFLT  IP +IG+CRNL+ LL+DGNILEG IP EIG I EL+VLDVS
Sbjct: 169  --CDSLKHLRLSLNFLTGEIPPQIGECRNLRTLLVDGNILEGRIPSEIGHIVELRVLDVS 226

Query: 277  RNSLTDRIPVELADCSKLSVLVLTNIDASLDL----DNSRGEFSAFDGGVPYELLLSRSL 332
            RNSLT R+P ELA+C KLSVLVLT++    D     D  RGEF+AF G +P+++LL  SL
Sbjct: 227  RNSLTGRVPKELANCVKLSVLVLTDLFEDRDEGGLEDGFRGEFNAFVGNIPHQVLLLSSL 286

Query: 333  EVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEG 392
             VLWAPRANLGGRLP  WS+ CSL+VLNL QN + G VP+SLGMCRNL++LDLS N L G
Sbjct: 287  RVLWAPRANLGGRLPSGWSDLCSLRVLNLAQNYVAGVVPESLGMCRNLSFLDLSSNILVG 346

Query: 393  YLP-MQLPVPCMVYFNVSQNNITGVLPRFENVSC-----DNHF----GFQDLQYANVPVM 442
            YLP +QL VPCM+YFN+S+NNI+G L  F N SC     D  F    GF   ++    ++
Sbjct: 347  YLPSLQLRVPCMMYFNISRNNISGTLQGFRNESCGASALDASFLELNGFNVWRFQKNALI 406

Query: 443  GSISDEN--FVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGER 500
            GS  +E    V+ HDFS N F GSLPLF++GD    A     Y L LNNN FNG++  + 
Sbjct: 407  GSGFEETNTVVVSHDFSWNSFSGSLPLFSLGDNLSGANRNVSYTLSLNNNKFNGTLLYQL 466

Query: 501  ISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQR 560
            +S CNDL++ SVNLS N LS  +++A    C +L++FEAA NQI GSI  G+G LM LQR
Sbjct: 467  VSNCNDLKTLSVNLSLNQLSSGNFQASFWGCRKLIDFEAAYNQIDGSIGPGIGDLMMLQR 526

Query: 561  LDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSI 620
            LDL GN++SGSLP +LG L+ +KW+LLGGNNLTGEIPSQ G L SL VL+LS NAL G+I
Sbjct: 527  LDLSGNKLSGSLPSQLGNLQNMKWMLLGGNNLTGEIPSQLGLLTSLAVLNLSRNALVGTI 586

Query: 621  PASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPHLQHLD-CIAF 679
            P SL+ A  LE+L L HN LSGEIP++FSTL NL+ LD+SFNNLSGHIPHLQH   C ++
Sbjct: 587  PVSLSNAKNLETLLLDHNNLSGEIPLTFSTLANLAQLDVSFNNLSGHIPHLQHPSVCDSY 646

Query: 680  KGNKYLASCPDTNATAPEKPPVQLD-EKLQNGKRSKVFIIAVVTSASAVLLIFLVIIFVI 738
            KGN +L SCPD  + +P   P  L+ ++     + +  +IAVVTSAS  L   LVI+ VI
Sbjct: 647  KGNAHLHSCPDPYSDSPASLPFPLEIQRTHKRWKLRTMVIAVVTSASVTLCTLLVIVLVI 706

Query: 739  LRRR-KFGRIASLRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV 797
              RR KFGR++S+R + +VTF D P EL YD VV ATGNFSIR LIGTGGFGSTYKAEL 
Sbjct: 707  FSRRSKFGRLSSIRRRQVVTFQDVPTELNYDTVVTATGNFSIRYLIGTGGFGSTYKAELS 766

Query: 798  PGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGN 857
            PG+LVA+K+LSIGRFQGIQQF+ EI TLGRIRHKNLVTL+GYYVG+AEMFL+YN+LSGGN
Sbjct: 767  PGFLVAIKRLSIGRFQGIQQFETEIRTLGRIRHKNLVTLVGYYVGKAEMFLIYNYLSGGN 826

Query: 858  LETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYL 917
            LE FIH +SGK +QW VI+KIA DIA+ALAYLHYSCVPRIVHRDIKPSNILLDE+LNAYL
Sbjct: 827  LEAFIHDRSGKNVQWPVIYKIAKDIAEALAYLHYSCVPRIVHRDIKPSNILLDEDLNAYL 886

Query: 918  SDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSL 977
            SDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLEL+SG++SL
Sbjct: 887  SDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELMSGRKSL 946

Query: 978  DPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLST 1037
            DPSFSEYGNGFNIV WA+LL+ E R SELF+  LWEAGP+E LLG+++LA TCT ETLS 
Sbjct: 947  DPSFSEYGNGFNIVPWAELLMTERRCSELFVSTLWEAGPKEKLLGLLKLALTCTEETLSI 1006

Query: 1038 RPSVKQVLIKLKQLK 1052
            RPS+K VL KLKQLK
Sbjct: 1007 RPSMKHVLEKLKQLK 1021

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357508455|ref|XP_003624516.1| Receptor-like-kinase [Medicago truncatula] gi|355499531|gb|AES80734.1| Receptor-like-kinase [Medicago truncatula]

 Score = 1197 bits (3097), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 631/1055 (59%), Positives = 767/1055 (72%), Gaps = 53/1055 (5%)

Query: 40   ANA--ESVPTTDSASLLSFKASISRDPSNLLATWN--SSTDHCTWHGVTCDHFTGRVTAL 95
            ANA   S+P  D+ SLL+FK  +S DPSNLL+ W+  SS   C WHGVTC    GRVT L
Sbjct: 87   ANAFNPSIPN-DALSLLTFKRFVSSDPSNLLSGWSHRSSLKFCNWHGVTCGGGDGRVTEL 145

Query: 96   RITGKATPWPSKSSVISGTLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQ 155
             +TG          +  G L + I  L+ELR LS+  N FSGEIP  +  LR LE+LELQ
Sbjct: 146  NVTG----------LRGGELLSDIGNLSELRILSLSGNMFSGEIPVSLVNLRGLEILELQ 195

Query: 156  GNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDS 215
            GNNFSGK+P+QMS  E + ++NLS N+FSGE+P GL+ +  + ++D+S+N+ SG + ++ 
Sbjct: 196  GNNFSGKLPFQMSYFESVFLVNLSGNAFSGEIPNGLVFSRNVEIVDLSNNQFSGSIPLNG 255

Query: 216  SSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDV 275
            S  C+ L +LKLS NFLT  IP +IGKCRNL+ LL+DGNIL+G IP EIG   EL+VLDV
Sbjct: 256  SGSCDSLKHLKLSHNFLTGEIPHQIGKCRNLRTLLVDGNILDGEIPHEIGDAVELRVLDV 315

Query: 276  SRNSLTDRIPVELADCSKLSVLVLTNI--------DASLDLDNS-RGEFSAFDGGVPYEL 326
            SRNSLT RIP EL +C KLSVLVLT++        D SL  D+  RGEF+AF G +PY++
Sbjct: 316  SRNSLTGRIPNELGNCLKLSVLVLTDLYEDHGGSNDGSLLEDSRFRGEFNAFVGNIPYKV 375

Query: 327  LLSRSLEVLWAPRANLGGRLPD-NWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDL 385
            LL   L VLWAPRANLGGRLP   WS+SCSLKVLNL QN + G VP+SLGMCRNLT+LDL
Sbjct: 376  LLLSGLRVLWAPRANLGGRLPAAGWSDSCSLKVLNLAQNYVTGVVPESLGMCRNLTFLDL 435

Query: 386  SLNNLEGYLPMQ-LPVPCMVYFNVSQNNITGVLPRFENVSC------------------- 425
            S NNL G+LP+Q L VPCM YFNVS+NNI+G LP F    C                   
Sbjct: 436  SSNNLVGHLPLQHLRVPCMTYFNVSRNNISGTLPGFMKERCRSSSTLAALEPAFLELEGL 495

Query: 426  -DNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPH-- 482
             D +F  +  +      +GS  +E  V+ HDFS N F+G LPLF +GD         +  
Sbjct: 496  NDAYFNIRSWRSQENAFIGSGFEETVVVSHDFSSNSFVGPLPLFFVGDNLFTENENRNIS 555

Query: 483  YRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANN 542
            Y L LNNN FNG++P   +S CNDL++ SVNLS N L G   +A  L+C++L++FEA+ N
Sbjct: 556  YMLSLNNNKFNGTLPYRLVSNCNDLKTLSVNLSVNQLCGEISQALFLNCLKLMDFEASYN 615

Query: 543  QISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGH 602
            QI GSI  G+ +L  L+RLDL GN++   LP++LG LK +KW+LLGGNNLTGEIP Q G 
Sbjct: 616  QIGGSIQPGIEELALLRRLDLTGNKLLRELPNQLGNLKNMKWMLLGGNNLTGEIPYQLGR 675

Query: 603  LISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFN 662
            L SLVVL++SHN+L G+IP SL+ AT LE L L HN LSGEIP+    L +L  LD+SFN
Sbjct: 676  LTSLVVLNVSHNSLIGTIPPSLSNATGLEILLLDHNNLSGEIPLLVCALSDLVQLDVSFN 735

Query: 663  NLSGHIPHLQHL-DCIAFKGNKYLASCPDTNATAPEK---PPVQLDEKLQNGKRSKVFII 718
            NLSGHIP LQH+ DC ++KGN++L  CPD    +P     PPV  +   +  K+ +  +I
Sbjct: 736  NLSGHIPPLQHMSDCDSYKGNQHLHPCPDPYFDSPASLLAPPVVKNSHRRRWKKVRTVVI 795

Query: 719  AVVTSASAVLLIFLVIIFVIL-RRRKFGRIASLRGQVMVTFADTPAELTYDNVVRATGNF 777
             V  SA   L   L I+ VI  R+ K  R +S+R + +VTF   P EL+YD+VV  TGNF
Sbjct: 796  TVSASALVGLCALLGIVLVICCRKGKLTRHSSIRRREVVTFQVVPIELSYDSVVTTTGNF 855

Query: 778  SIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLI 837
            SIR LIGTGGFGSTYKAEL PG+LVA+K+LSIGRFQG+QQF+ EI TLGRIRHKNLVTLI
Sbjct: 856  SIRYLIGTGGFGSTYKAELSPGFLVAIKRLSIGRFQGMQQFETEIRTLGRIRHKNLVTLI 915

Query: 838  GYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
            GYYVG+AEM L+YN+LSGGNLE FIH +SGK +QW VI+KIA DIA+AL+YLHYSCVPRI
Sbjct: 916  GYYVGKAEMLLIYNYLSGGNLEAFIHDRSGKNVQWPVIYKIAKDIAEALSYLHYSCVPRI 975

Query: 898  VHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDK 957
            VHRDIKPSNILLDE+LNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDK
Sbjct: 976  VHRDIKPSNILLDEDLNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDK 1035

Query: 958  ADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQ 1017
            ADVYS+GVVLLELISG+RSLDPSFS+YGNGFNIV WA+LL+ EGR SELF   LWE GP+
Sbjct: 1036 ADVYSYGVVLLELISGRRSLDPSFSDYGNGFNIVPWAELLMTEGRCSELFSSALWEVGPK 1095

Query: 1018 ENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQLK 1052
            E LLG++++A TCT ETLS RPS+K VL KLKQLK
Sbjct: 1096 EKLLGLLKIALTCTEETLSIRPSMKHVLDKLKQLK 1130

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449452034|ref|XP_004143765.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase RPK2-like [Cucumis sativus]

 Score = 1191 bits (3080), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 641/1019 (62%), Positives = 779/1019 (76%), Gaps = 16/1019 (1%)

Query: 47   TTDSASLLSFKASISRDPSNLLATWNSSTDHCTWHGVTCDHF-TGRVTALRITGKATPWP 105
            + D+ SLL FK+SIS   S++L +WN S  HC W GVTC +  T RV AL I+G      
Sbjct: 25   SDDAMSLLMFKSSISFGASHVLRSWNLSVSHCDWFGVTCGNGGTDRVVALNISGGIIGGV 84

Query: 106  -SKSSVISGTLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIP 164
             ++ S ++GTL+ SI  L +LR LS+P+N   GEIP  VG+L+ LE+LELQGNNFSG+IP
Sbjct: 85   LAEGSFLAGTLNPSIGNLVQLRVLSLPNNLMYGEIPGTVGKLQSLEILELQGNNFSGEIP 144

Query: 165  YQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTY 224
             Q+S+L  LR+LNLS NS SG VP  LIG+G+L VID+S N+LSG + +   + C  L +
Sbjct: 145  NQISSLPSLRLLNLSDNSVSGWVPSKLIGSGKLEVIDLSYNQLSGNIQV-VDNRCGALNH 203

Query: 225  LKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRI 284
            L+LS NFLT +IP EIG+C  L+ LLLDGNILEG IP EIG ISEL++LDVSRNSLTD I
Sbjct: 204  LRLSHNFLTGNIPAEIGQCWKLRTLLLDGNILEGKIPAEIGQISELRILDVSRNSLTDSI 263

Query: 285  PVELADCSKLSVLVLTNI-DASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLG 343
            P EL +C KLS +VLTN+ D + D D+ RGEF+AF+GG+P  LLL  SL+VLWAPR N  
Sbjct: 264  PKELGNCRKLSQIVLTNLNDINPDNDSLRGEFNAFNGGIPSGLLLLPSLQVLWAPRGNFN 323

Query: 344  GRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCM 403
            GRLP NW+  CSLKVLNLGQN + G +P+S+  C NLTYLDLS N L+G LP QL V CM
Sbjct: 324  GRLPTNWNSLCSLKVLNLGQNYITGTIPESIRKCANLTYLDLSSNKLQGNLPSQLRVSCM 383

Query: 404  VYFNVSQNNITGVLPRFENVS-CDNHFGFQDLQ------YANVPVMGSIS-DENFVIIHD 455
             YFNVSQN I+GVLPRFE  S C N       Q      Y N PV      ++N +I HD
Sbjct: 384  AYFNVSQNKISGVLPRFEKDSFCTNLIPMLSDQEDDWNSYLNFPVWDFTRLNDNLLIAHD 443

Query: 456  FSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLS 515
            FS N+F GSL    +G+  LA   K  Y+LLLN+N FNG +P + IS CND++   VNLS
Sbjct: 444  FSWNRFSGSLASVKVGEELLANGIKFSYKLLLNSNKFNGPLPIDLISHCNDMKGVLVNLS 503

Query: 516  ANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDE 575
            +NL+SG   +AF L C QL+EFEAA+N++  SI + +G+L  L+RLDLRGNR+ G LPD+
Sbjct: 504  SNLVSGEISDAFFLHCRQLIEFEAASNELDNSIGSRIGELQMLRRLDLRGNRLCGVLPDQ 563

Query: 576  LGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFL 635
            LG L+ LKW+LLGGNNLTGEIPS+   L SL+ LDLS N  TG IP SL+ A++LE L L
Sbjct: 564  LGNLQTLKWMLLGGNNLTGEIPSRLSQLTSLLSLDLSRNLFTGFIPDSLSYASRLEILLL 623

Query: 636  AHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPHLQH-LDCIAFKGNKYLASCPDTNAT 694
             HNRL+GEIP SFS L +L+ LD+SFNNLSGHIPHL H  DCI F GNK+L  CPD+ + 
Sbjct: 624  DHNRLTGEIPESFSALSHLTKLDVSFNNLSGHIPHLHHTFDCIYFGGNKFLHPCPDSYSD 683

Query: 695  APEKPPVQLD-EKLQNGKRSKVFIIAVVTSASAVLLIFLVIIFVILRRRKFGRIASLRGQ 753
            +P   PV LD EK +  ++    +IAV  S++ + L+ ++ + +I++RR  G+   L+ +
Sbjct: 684  SPAGLPVPLDVEKWKRRRKFMSMVIAVAASSTLICLLLMIAVIIIVKRR-LGKQNRLKKK 742

Query: 754  VMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQ 813
             +VTF+D P++L YDNVVRAT NFS+R LIGTGGFGSTYKAEL  G+LVAVK+LSIGRFQ
Sbjct: 743  QVVTFSDAPSDLNYDNVVRATENFSLRYLIGTGGFGSTYKAELPSGFLVAVKRLSIGRFQ 802

Query: 814  G-IQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQW 872
            G IQQFDAEI TLGRIRHKNLVTL+GYYVGEAEMFLVYN+LSGGNLETFIH+KS K ++ 
Sbjct: 803  GGIQQFDAEIRTLGRIRHKNLVTLLGYYVGEAEMFLVYNYLSGGNLETFIHEKSCKHVKH 862

Query: 873  SVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH 932
            SVIHKIA+DIA+ALAYLHYSC PRIVHRDIKPSNILLDE+ N Y+SDFGLARLLEVSETH
Sbjct: 863  SVIHKIALDIARALAYLHYSCDPRIVHRDIKPSNILLDEDHNTYISDFGLARLLEVSETH 922

Query: 933  ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVS 992
            ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLEL+SGKRSLD SFS++GNGFNIV+
Sbjct: 923  ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELLSGKRSLDRSFSDFGNGFNIVT 982

Query: 993  WAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051
            WA +LIKEGRSSELF PEL E GP+E+LLGM++LAS CTVETL+ RPS+KQV+  LKQL
Sbjct: 983  WANMLIKEGRSSELFTPELREMGPKEHLLGMLKLASNCTVETLALRPSMKQVVETLKQL 1041

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449527533|ref|XP_004170765.1| PREDICTED: LOW QUALITY PROTEIN: LRR receptor-like serine/threonine-protein kinase RPK2-like [Cucumis sativus]

 Score = 1187 bits (3072), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 640/1019 (62%), Positives = 778/1019 (76%), Gaps = 16/1019 (1%)

Query: 47   TTDSASLLSFKASISRDPSNLLATWNSSTDHCTWHGVTCDHF-TGRVTALRITGKATPWP 105
            + D+ SLL FK+SIS   S++L +WN S  HC W GVTC +  T RV AL I+G      
Sbjct: 25   SDDAMSLLMFKSSISFGASHVLRSWNLSVSHCDWFGVTCGNGGTDRVVALNISGGIIGGV 84

Query: 106  -SKSSVISGTLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIP 164
             ++ S ++GTL+ SI  L +LR LS+P+N   GEIP  VG+L+ LE+LELQGNNFSG+IP
Sbjct: 85   LAEGSFLAGTLNPSIGNLVQLRVLSLPNNLMYGEIPGTVGKLQSLEILELQGNNFSGEIP 144

Query: 165  YQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTY 224
             Q+S+L  LR+LNLS NS SG VP  LIG+G+L VID+S N+LSG + +   + C  L +
Sbjct: 145  NQISSLPSLRLLNLSDNSVSGWVPSKLIGSGKLEVIDLSYNQLSGNIQV-VDNRCGALNH 203

Query: 225  LKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRI 284
            L+LS NFLT +IP EIG+C  L+ LLLDGNILEG IP EIG ISEL++LDVSRNSLTD I
Sbjct: 204  LRLSHNFLTGNIPAEIGQCWKLRTLLLDGNILEGKIPAEIGQISELRILDVSRNSLTDSI 263

Query: 285  PVELADCSKLSVLVLTNI-DASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLG 343
            P EL +C KLS +VLTN+ D + D D+ RGEF+AF+GG+P  LLL  SL+VLWAPR N  
Sbjct: 264  PKELGNCRKLSQIVLTNLNDINPDNDSLRGEFNAFNGGIPSGLLLLPSLQVLWAPRGNFN 323

Query: 344  GRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCM 403
            GRLP NW+  CSLKVLNLGQN + G +P+S+  C NLTYLDLS N L+G LP QL V CM
Sbjct: 324  GRLPTNWNSLCSLKVLNLGQNYITGTIPESIRKCANLTYLDLSSNKLQGNLPSQLRVSCM 383

Query: 404  VYFNVSQNNITGVLPRFENVS-CDNHFGFQDLQ------YANVPVMGSIS-DENFVIIHD 455
             YFNVSQN I+GVLPRFE  S C N       Q      Y N PV      ++N +I HD
Sbjct: 384  AYFNVSQNKISGVLPRFEKDSFCTNLIPMLSDQEDDWNSYLNFPVWDFTRLNDNLLIAHD 443

Query: 456  FSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLS 515
            FS N+F GSL    +G+  LA   K  Y+LLLN+N FNG +P + IS CND++   VNLS
Sbjct: 444  FSWNRFSGSLASVKVGEELLANGIKFSYKLLLNSNKFNGPLPVDLISHCNDMKGVLVNLS 503

Query: 516  ANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDE 575
            +NL+SG   +AF L C QL+EFEAA+N++  SI + +G+L  L+RLDLRGNR+ G LPD+
Sbjct: 504  SNLVSGEIPDAFFLHCRQLIEFEAASNELDNSIGSRIGELQMLRRLDLRGNRLCGVLPDQ 563

Query: 576  LGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFL 635
            LG L+ LKW+LLG NNLTGEIPS+   L SL+ LDLS N  TG IP SL+ A++LE L L
Sbjct: 564  LGNLQTLKWMLLGXNNLTGEIPSRLSRLTSLLSLDLSRNLFTGFIPDSLSYASRLEILLL 623

Query: 636  AHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPHLQH-LDCIAFKGNKYLASCPDTNAT 694
             HNRL+GEIP SFS L +L+ LD+SFNNLSGHIPHL H  DCI F GNK+L  CPD+ + 
Sbjct: 624  DHNRLTGEIPESFSALSHLTKLDVSFNNLSGHIPHLHHTFDCIYFGGNKFLHPCPDSYSD 683

Query: 695  APEKPPVQLD-EKLQNGKRSKVFIIAVVTSASAVLLIFLVIIFVILRRRKFGRIASLRGQ 753
            +P   PV LD EK +  ++    +IAV  S++ + L+ ++ + +I++RR  G+   L+ +
Sbjct: 684  SPAGLPVPLDVEKWKRRRKFMSMVIAVAASSTLICLLLMIAVIIIVKRR-LGKQNRLKKK 742

Query: 754  VMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQ 813
             +VTF+D P++L YDNVVRAT NFS+R LIGTGGFGSTYKAEL  G+LVAVK+LSIGRFQ
Sbjct: 743  QVVTFSDAPSDLNYDNVVRATENFSLRYLIGTGGFGSTYKAELPSGFLVAVKRLSIGRFQ 802

Query: 814  G-IQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQW 872
            G IQQFDAEI TLGRIRHKNLVTL+GYYVGEAEMFLVYN+LSGGNLETFIH+KS K ++ 
Sbjct: 803  GGIQQFDAEIRTLGRIRHKNLVTLLGYYVGEAEMFLVYNYLSGGNLETFIHEKSCKHVKH 862

Query: 873  SVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH 932
            SVIHKIA+DIA+ALAYLHYSC PRIVHRDIKPSNILLDE+ N Y+SDFGLARLLEVSETH
Sbjct: 863  SVIHKIALDIARALAYLHYSCDPRIVHRDIKPSNILLDEDHNTYISDFGLARLLEVSETH 922

Query: 933  ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVS 992
            ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLEL+SGKRSLD SFS++GNGFNIV+
Sbjct: 923  ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELLSGKRSLDRSFSDFGNGFNIVT 982

Query: 993  WAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051
            WA +LIKEGRSSELF PEL E GP+E+LLGM++LAS CTVETL+ RPS+KQV+  LKQL
Sbjct: 983  WANMLIKEGRSSELFTPELREMGPKEHLLGMLKLASNCTVETLALRPSMKQVVETLKQL 1041

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|104294990|gb|ABF72006.1| leucine-rich repeat-containing protein kinase family protein [Musa acuminata]

 Score = 1093 bits (2827), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 599/1032 (58%), Positives = 740/1032 (71%), Gaps = 54/1032 (5%)

Query: 48   TDSASLLSFKASISRDPSNLLATWNS-STDHCTWHGVTCDHFTGRVTALRITGKATPWPS 106
            TD A+LL+FK+S++ DP++LL+ W+  +  HCTW GVTCD  +GRVTAL +TG  TP   
Sbjct: 26   TDQAALLAFKSSVALDPASLLSGWSPVARRHCTWRGVTCDAVSGRVTALNLTG--TP--- 80

Query: 107  KSSVISGTLSASIAKLTELRTLSVPHNSFSGEIPAG-VGELRLLEVLELQGNNFSGKIPY 165
             SS +SG L+A++  LTELR LS+PHN+FSG+IPA  +G L  LEVL+L+ NNFSGKIP 
Sbjct: 81   -SSPLSGRLAAALGNLTELRVLSLPHNAFSGDIPAAAIGSLCRLEVLDLRRNNFSGKIPD 139

Query: 166  QMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYL 225
            ++S L  L VL+LS NS SG +P  LIG+  L  +D+S N+LSG + +D    C  LT+L
Sbjct: 140  EISRLPSLSVLDLSHNSLSGAIPESLIGSSNLQSVDLSFNQLSGKITVDPLGSCSCLTHL 199

Query: 226  KLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIP 285
            +LS N L   IP  IG+C  ++ LLLD NILEG IP  IG + +L+VLDVSRNSLTDRIP
Sbjct: 200  RLSSNLLVGRIPPAIGRCTKIQTLLLDRNILEGRIPAAIGQLLDLRVLDVSRNSLTDRIP 259

Query: 286  VELADCSKLSVLVLTNIDASLDLDNSRG-----EFSAFDGGVPYELLLSRSLEVLWAPRA 340
             ELA C KLSVL LTN+   +D D++ G     EF+AF G +P E+    SLE+LWAPRA
Sbjct: 260  RELALCQKLSVLRLTNL---MDFDSTGGSSNVEEFNAFIGSMPAEIFSIPSLEILWAPRA 316

Query: 341  NLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPV 400
            NL G LPD+ + SCSL +LNLGQN + G +P+ LG CRNL++LDLS N L+G LP  L +
Sbjct: 317  NLDGSLPDSRNGSCSLGILNLGQNYIAGVIPEWLGTCRNLSFLDLSSNYLQGLLPASLGI 376

Query: 401  PCMVYFNVSQNNITGVLPRFENVSCDNHFG----------------------FQDLQYAN 438
            PCM YFN+SQN++TG LP F ++ C  +                         Q  Q  N
Sbjct: 377  PCMAYFNISQNSVTGSLPGFLDLDCSYNLASLSKSGDLLVEDNLLIAYSADLLQSTQRDN 436

Query: 439  VPVMGSISDENFVIIHDFSGNKFLGSLPLFA--IGDGFLAAKYKPHYRLLLNNNMFNGSV 496
               +  + D +FV++HDFS N+F+G LP F   + D F        Y L LNNN FNGS+
Sbjct: 437  PFAL--VLDNSFVVLHDFSQNRFIGPLPSFVMPLDDSF-------PYGLSLNNNGFNGSI 487

Query: 497  PGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLM 556
             G+    C     F+VNL+ N +SG      L DC  L  FEAANN++ GSI + +  L 
Sbjct: 488  SGKLFGSCQVGSGFAVNLTVNKMSG-GVNDILTDCWLLKSFEAANNRLHGSIPSEIRNLN 546

Query: 557  KLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNAL 616
             L+ LDLR N  +GS PD+L  LK L  +LLGGNN +G IP+QF  L SL VLDLS N+ 
Sbjct: 547  LLRHLDLRNNYFNGSTPDKLRGLKSLGQVLLGGNNFSGGIPTQFDGLSSLTVLDLSRNSF 606

Query: 617  TGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPHLQH-LD 675
            TGSIP SL  AT LE L L +N+LSG IP SFS L  L  LD+SFNNLSG IPHL+H  D
Sbjct: 607  TGSIPPSLANATNLEVLLLNNNQLSGTIPPSFSALHRLIELDVSFNNLSGDIPHLEHSTD 666

Query: 676  CIAFKGNKYLASCPDTNATAPEKPPVQLDEKLQNGKRS--KVFIIAVVTSASAVLLIFLV 733
            C  F GN +L  C D + +AP   P + +   Q  ++S  K F IA V SAS ++ + LV
Sbjct: 667  CKFFLGNSFLKPCQDPSMSAPSGIPFKTEIPDQGHRKSRLKYFTIAAVASASVLVSVLLV 726

Query: 734  IIFVILR-RRKFGRIASLRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTY 792
            + FV++  RRKF RI SLR +++VTF D PAELTY+NVVRATGNFSI+NLIGTGGFG+TY
Sbjct: 727  LTFVLVSGRRKFVRITSLRKKLVVTFTDVPAELTYENVVRATGNFSIQNLIGTGGFGATY 786

Query: 793  KAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF 852
            K ELVPG+LVAVK+LSIGRFQG+QQFDAEI TLGR+RHKNLVTLIGY++GE + FL+YN+
Sbjct: 787  KGELVPGFLVAVKRLSIGRFQGLQQFDAEIRTLGRVRHKNLVTLIGYHMGEIDTFLIYNY 846

Query: 853  LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEE 912
            LSGGNLETFI   S + + W  +HKIA+D+AQAL+YLHYSCVPRIVHRDIKPSNILLDE+
Sbjct: 847  LSGGNLETFIRHMSNRNVTWYEVHKIALDVAQALSYLHYSCVPRIVHRDIKPSNILLDEK 906

Query: 913  LNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
            LNAYLSDFGLARLLEVS+THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLEL+S
Sbjct: 907  LNAYLSDFGLARLLEVSQTHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELMS 966

Query: 973  GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTV 1032
            GKRSLDPSFSEYGNGF IV+W +LLI+E R+ ELF   LWE GP++ L+ M++LA +CTV
Sbjct: 967  GKRSLDPSFSEYGNGFTIVAWGRLLIQENRAGELFSQLLWENGPKDKLVSMLKLALSCTV 1026

Query: 1033 ETLSTRPSVKQV 1044
            E+LS RPS+KQ 
Sbjct: 1027 ESLSVRPSMKQT 1038

Source: Musa acuminata

Species: Musa acuminata

Genus: Musa

Family: Musaceae

Order: Zingiberales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|339790481|dbj|BAK52397.1| leucine rich repeat receptor protein kinase 2 [Solanum pennellii]

 Score =  883 bits (2281), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 498/1111 (44%), Positives = 683/1111 (61%), Gaps = 88/1111 (7%)

Query: 24   LVCLLVVCSTFMLSGGANAESVPTTDSASLLSFKASISRDPSNLLATWNSSTDHCTWHGV 83
            L   L++C  F++ G A +     +D ++LL  KAS+S     + +  + + DHC+W GV
Sbjct: 17   LKVFLILCVFFLVHGYALSSD---SDKSALLELKASLSDSSGVISSWSSRNNDHCSWFGV 73

Query: 84   TCDHFTGRVTALRITG---------KATPWP-----------SKSSVISGTLSASIAKLT 123
            +CD    RV AL ITG         K   +P           + S  + G +  +I+KLT
Sbjct: 74   SCDS-DSRVVALNITGGNLGSLSCAKIAQFPLYGFGITRVCANNSVKLVGKVPLAISKLT 132

Query: 124  ELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSF 183
            ELR LS+P N   G+IP G+ ++  LEVL+LQGN  +G +P +   L +LRVLNL FN  
Sbjct: 133  ELRVLSLPFNELRGDIPLGIWDMDKLEVLDLQGNLITGSLPLEFKGLRKLRVLNLGFNQI 192

Query: 184  SGEVPRGLI------------------------GNGELSVIDMSSNRLSGGLAIDSSSEC 219
             G +P  L                         G G+L  I +S N+LSG +  +    C
Sbjct: 193  VGAIPNSLSNCLALQIFNLAGNRVNGTIPAFIGGFGDLRGIYLSFNQLSGSIPGEIGRSC 252

Query: 220  EFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNS 279
            E L  L+++ N L   IPK +G C  L++L+L  N+LE +IP E+G ++ELK+LD+SRNS
Sbjct: 253  EKLQSLEMAGNILGGVIPKSLGNCTRLQSLVLYSNLLEEAIPAELGQLTELKILDLSRNS 312

Query: 280  LTDRIPVELADCSKLSVLVLTNIDASL----DLDNSRGEFSAFDGGVPYELLLSRSLEVL 335
            L+ R+P EL +CSKLS+LVL+++   L    D  ++  EF+ F+G +P E+    SL ++
Sbjct: 313  LSGRLPSELGNCSKLSILVLSSLWDPLPNVSDSAHTTDEFNFFEGTIPSEITRLPSLRMI 372

Query: 336  WAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLP 395
            WAPR+ L G+ P +W    +L+++NL QN   G + + LG C+ L +LDLS N L G L 
Sbjct: 373  WAPRSTLSGKFPGSWGACDNLEIVNLAQNYYTGVISEELGSCQKLHFLDLSSNRLTGQLV 432

Query: 396  MQLPVPCMVYFNVSQNNITGVLPRFENVSC-------DNHFGFQDLQYANVPVMGSIS-- 446
             +LPVPCM  F+VS N ++G +PRF N SC        + FG  D   A +    S S  
Sbjct: 433  EKLPVPCMFVFDVSGNYLSGSIPRFSNYSCAHVVSSGGDPFGPYDTSSAYLAHFTSRSVL 492

Query: 447  -------DENFVIIHDFSGNKFLGSLPL-FAIGDGFLAAKYKPHYRLLLNNNMFNGSVPG 498
                   D N  + H+F GN F G+LP    I    L  +    Y  L  +N F G   G
Sbjct: 493  DTTLFAGDGNHAVFHNFGGNNFTGNLPPSMLIAPEMLVKQIV--YAFLAGSNRFTGPFAG 550

Query: 499  ERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKL 558
                KC+D++   VN+S N LSG   E     C  L   + + NQI G++   +G L+ L
Sbjct: 551  NLFEKCHDMKGMIVNVSNNALSGQIPEDIGAICGSLRLLDGSKNQIGGTVPPSLGSLVSL 610

Query: 559  QRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTG 618
              L+L  N + G +P  LG++K L ++ L GNNL G IPS FG L SL  L+LS N+L+G
Sbjct: 611  VALNLSWNHLRGQIPSSLGQIKDLSYLSLAGNNLVGSIPSSFGQLHSLETLELSSNSLSG 670

Query: 619  SIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPHLQHL-DCI 677
             IP +L     L SL L +N LSG+IP   + +  L+A ++SFNNLSG +P  + L  C 
Sbjct: 671  EIPNNLVNLRNLTSLLLNNNNLSGKIPSGLANVTTLAAFNVSFNNLSGPLPLNKDLMKCN 730

Query: 678  AFKGNKYLASC-------PDTNATA----PEKPPVQLDEKLQNGKRSKV--FIIAVVTSA 724
            + +GN +L SC       P T+        +          Q G  S      IA +TSA
Sbjct: 731  SVQGNPFLQSCHVFSLSTPSTDQQGRIGDSQDSAASPSGSTQKGGSSGFNSIEIASITSA 790

Query: 725  SAVLLIFLVIIFVILRRRKF---GRIASLRGQVMVTFADTPAELTYDNVVRATGNFSIRN 781
            +A++ + L +I +    RK+    R+A    + +  F + P  LT++NVVRATG+F+  N
Sbjct: 791  AAIVSVLLALIVLFFYTRKWNPRSRVAGSTRKEVTVFTEVPVPLTFENVVRATGSFNASN 850

Query: 782  LIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV 841
             IG+GGFG+TYKAE+ PG+LVAVK+L++GRFQGIQQFDAEI TLGR+RH NLVTLIGY+ 
Sbjct: 851  CIGSGGFGATYKAEIAPGFLVAVKRLAVGRFQGIQQFDAEIRTLGRLRHPNLVTLIGYHN 910

Query: 842  GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
             E EMFL+YN+L GGNLE FI ++S + + W V+HKIA+D+A+ALAYLH  CVPR++HRD
Sbjct: 911  SETEMFLIYNYLPGGNLEKFIQERSTRAVDWRVLHKIALDVARALAYLHDQCVPRVLHRD 970

Query: 902  IKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVY 961
            +KPSNILLDEE NAYLSDFGLARLL  SETHATT VAGTFGYVAPEYA TCRVSDKADVY
Sbjct: 971  VKPSNILLDEEYNAYLSDFGLARLLGTSETHATTGVAGTFGYVAPEYAMTCRVSDKADVY 1030

Query: 962  SFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLL 1021
            S+GVVLLELIS K++LDPSFS YGNGFNIV+WA +L+++GR+ E F   LW++GP ++L+
Sbjct: 1031 SYGVVLLELISDKKALDPSFSSYGNGFNIVAWACMLLRQGRAKEFFTAGLWDSGPHDDLV 1090

Query: 1022 GMMRLASTCTVETLSTRPSVKQVLIKLKQLK 1052
             ++ LA  CTV++LSTRP++KQV+ +LKQL+
Sbjct: 1091 EVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 1121

Source: Solanum pennellii

Species: Solanum pennellii

Genus: Solanum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356523630|ref|XP_003530440.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase RPK2-like [Glycine max]

 Score =  879 bits (2272), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 503/1128 (44%), Positives = 681/1128 (60%), Gaps = 113/1128 (10%)

Query: 24   LVCLLVVCSTFMLSGGANAESVPTTDSASLLSFKASISRDPSNLLATWNSSTDHCTWHGV 83
            LV L  + S  MLS   N      +D + LL  K S+S DPS LLATW  S DHC W GV
Sbjct: 3    LVRLFTLASLLMLS--LNDVVSSDSDKSVLLELKHSLS-DPSGLLATWQGS-DHCAWSGV 58

Query: 84   TCDHFTGR-VTALRITG----KATPWPSKS-------------------SVISGTLSASI 119
             CD    R V A+ +TG    +  P P                        + G LS  +
Sbjct: 59   LCDSAARRRVVAINVTGNGGNRKPPSPCSDYAQFPFYGFGIRRSCDGFRGALFGKLSPKL 118

Query: 120  AKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLS 179
            ++L ELR LS+P N   GEIP  +  +  LEVL+L+GN  SG +P + + L+ LRVLNL 
Sbjct: 119  SELAELRVLSLPFNGLEGEIPEEIWGMEKLEVLDLEGNLISGVLPIRFNGLKNLRVLNLG 178

Query: 180  FNSFSGEVPRGL-----------IGNG----------ELSVIDMSSNRLSGGLAIDSSSE 218
            FN F GE+P  L            GNG           L  + +S N L G +  +    
Sbjct: 179  FNRFVGEIPSSLSNVKSLEVLNLAGNGINGSVSGFVGRLRGVYLSYNLLGGAIPEEIGEH 238

Query: 219  CEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRN 278
            C  L +L LS N L + IP  +G C  L+ +LL  NILE  IP E+G + +L+VLDVSRN
Sbjct: 239  CGQLEHLDLSGNLLMQGIPGSLGNCSELRTVLLHSNILEDVIPAELGRLRKLEVLDVSRN 298

Query: 279  SLTDRIPVELADCSKLSVLVLTNIDASL-DLDNSRG-------------EFSAFDGGVPY 324
            +L  ++P+EL +C++LSVL+L+N+ +S+ D++ + G             EF+ F+G VP 
Sbjct: 299  TLGGQVPMELGNCTELSVLLLSNLFSSVPDVNGTLGDSGVEQMVAMNIDEFNYFEGPVPV 358

Query: 325  ELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLD 384
            E++    L +LWAPRANL G    +W +  SL++LNL QN   G  P  LG C+NL +LD
Sbjct: 359  EIMNLPKLRLLWAPRANLEGSFMSSWGKCDSLEMLNLAQNDFTGDFPNQLGGCKNLHFLD 418

Query: 385  LSLNNLEGYLPMQLPVPCMVYFNVSQNNITGVLPRFENVSC-------DNHFGFQD--LQ 435
            LS NNL G L  +LPVPCM  F+VS N ++G +P+F    C        N F   D  L 
Sbjct: 419  LSANNLTGVLAEELPVPCMTVFDVSGNVLSGPIPQFSVGKCASVPSWSGNLFETDDRALP 478

Query: 436  YANV--------PVMGSISDENFVIIHDFSGNKFLG--SLPLF--AIGDGFLAAKYKPHY 483
            Y +         P++ S+ +    + H+F  N F+   SLP+    +G G +       Y
Sbjct: 479  YKSFFASKILGGPILASLGEVGRSVFHNFGQNNFVSMESLPIARDKLGKGLV-------Y 531

Query: 484  RLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQ 543
             +L+  N   G  P     KC+ L +  +N+S N+LSG     F   C  L   +A+ NQ
Sbjct: 532  AILVGENKLAGPFPTNLFEKCDGLNALLLNVSYNMLSGQIPSKFGRMCRSLKFLDASGNQ 591

Query: 544  ISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHL 603
            I+G I  G+G ++ L  L+L  NR+ G +   +G+LK LK++ L  NN+ G IP+  G L
Sbjct: 592  ITGPIPVGLGDMVSLVSLNLSRNRLQGQILVSIGQLKHLKFLSLADNNIGGSIPTSLGRL 651

Query: 604  ISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNN 663
             SL VLDLS N+LTG IP  +     L  + L +N+LSG+IP   + +  LSA ++SFNN
Sbjct: 652  YSLEVLDLSSNSLTGEIPKGIENLRNLTDVLLNNNKLSGQIPAGLANVSTLSAFNVSFNN 711

Query: 664  LSGHIP-HLQHLDCIAFKGNKYLASCPDTNATAPEK--------------PPVQLDEKLQ 708
            LSG  P +   + C    GN +L SC + +   P                PP    +K  
Sbjct: 712  LSGSFPSNGNSIKCSNAVGNPFLRSCNEVSLAVPSADQGQVDNSSSYTAAPPEVTGKKGG 771

Query: 709  NGKRSKVFIIAVVTSASAVLLIFLVIIFVILRRRKFGR----IASLRGQVMVTFADTPAE 764
            NG  S    IA +TSASA++ + L +I + +  +K+      + S+R +V V F D    
Sbjct: 772  NGFNS--IEIASITSASAIVSVLLALIVLFIYTQKWNPRSRVVGSMRKEVTV-FTDIGVP 828

Query: 765  LTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGT 824
            LT++NVVRATGNF+  N IG GGFG+TYKAE+VPG LVA+K+L++GRFQG+QQF AEI T
Sbjct: 829  LTFENVVRATGNFNASNCIGNGGFGATYKAEIVPGNLVAIKRLAVGRFQGVQQFHAEIKT 888

Query: 825  LGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQ 884
            LGR+RH NLVTLIGY+  E EMFL+YN+L GGNLE FI ++S + + W ++HKIA+DIA+
Sbjct: 889  LGRLRHPNLVTLIGYHASETEMFLIYNYLPGGNLEKFIQERSTRAVDWRILHKIALDIAR 948

Query: 885  ALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYV 944
            ALAYLH  CVPR++HRD+KPSNILLD++ NAYLSDFGLARLL  SETHATT VAGTFGYV
Sbjct: 949  ALAYLHDQCVPRVLHRDVKPSNILLDDDYNAYLSDFGLARLLGTSETHATTGVAGTFGYV 1008

Query: 945  APEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSS 1004
            APEYA TCRVSDKADVYS+GVVLLEL+S K++LDPSFS YGNGFNIV+WA +L+++G++ 
Sbjct: 1009 APEYAMTCRVSDKADVYSYGVVLLELLSDKKALDPSFSSYGNGFNIVAWACMLLRQGQAK 1068

Query: 1005 ELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQLK 1052
            E F   LW+AGP+++L+ ++ LA  CTV++LSTRPS+K V+ +LKQL+
Sbjct: 1069 EFFAAGLWDAGPEDDLVEVLHLAVVCTVDSLSTRPSMKHVVRRLKQLQ 1116

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	1052
TAIR|locus:2182870	1192	EMS1 "EXCESS MICROSPOROCYTES1"	0.561	0.495	0.321	8.8e-117
TAIR|locus:2160791	1102	AT5G63930 [Arabidopsis thalian	0.847	0.809	0.340	1e-116
TAIR|locus:2046525	1124	AT2G33170 [Arabidopsis thalian	0.666	0.623	0.296	1.6e-113
TAIR|locus:2020417	1101	AT1G17230 [Arabidopsis thalian	0.843	0.805	0.339	8.4e-113
UNIPROTKB|Q8RZV7	1294	P0413C03.22 "Putative extra sp	0.269	0.219	0.424	1.5e-110
TAIR|locus:2032697	1123	PEPR1 "PEP1 receptor 1" [Arabi	0.862	0.807	0.314	3e-108
TAIR|locus:2120362	1249	GSO1 "GASSHO1" [Arabidopsis th	0.694	0.585	0.307	1.8e-74
UNIPROTKB|P93194	1109	INRPK1 "Receptor-like protein	0.859	0.815	0.314	7.5e-105
TAIR|locus:2092810	1164	BRL3 "BRI1-like 3" [Arabidopsi	0.268	0.242	0.464	3.9e-103
TAIR|locus:2020457	1166	BRL1 "BRI1 like" [Arabidopsis	0.268	0.241	0.462	1.4e-102

TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)]

 Score = 623 (224.4 bits), Expect = 8.8e-117, Sum P(2) = 8.8e-117
 Identities = 210/654 (32%), Positives = 307/654 (46%)

Query:    47 TTDSASLLSFKASISRDPSNLLATWN--SSTDHCTWHGVTCDHFTGRVTALRITGKATPW 104
             ++++ SL+SFK S+  +PS LL++WN  SS  HC W GVTC    GRV +L +       
Sbjct:    24 SSETTSLISFKRSLE-NPS-LLSSWNVSSSASHCDWVGVTC--LLGRVNSLSL------- 72

Query:   105 PSKSSVISGTLSASIAKLTELRTLSVPHNSFSGEIPAXXXXXXXXXXXXXQGNNFSGKIP 164
             PS S  + G +   I+ L  LR L +  N FSG+IP               GN+ +G +P
Sbjct:    73 PSLS--LRGQIPKEISSLKNLRELCLAGNQFSGKIPPEIWNLKHLQTLDLSGNSLTGLLP 130

Query:   165 YQMSNLERLRVLNLSFNSFSGEVPRGL-IGNGELSVIDMSSNRLSGGLAIDSSSECEFLT 223
               +S L +L  L+LS N FSG +P    I    LS +D+S+N LSG +  +   +   L+
Sbjct:   131 RLLSELPQLLYLDLSDNHFSGSLPPSFFISLPALSSLDVSNNSLSGEIPPEIG-KLSNLS 189

Query:   224 YLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDR 283
              L +  N  +  IP EIG    LKN         G +PKEI  +  L  LD+S N L   
Sbjct:   190 NLYMGLNSFSGQIPSEIGNISLLKNFAAPSCFFNGPLPKEISKLKHLAKLDLSYNPLKCS 249

Query:   284 IPVELADCSKLSVLVLTNIDA-SL---DLDNSRG------EFSAFDGGVPYELLLSRSLE 333
             IP    +   LS+L L + +   L   +L N +        F++  G +P EL     L 
Sbjct:   250 IPKSFGELHNLSILNLVSAELIGLIPPELGNCKSLKSLMLSFNSLSGPLPLELS-EIPLL 308

Query:   334 VLWAPRANLGGRLPDNWSESCS-LKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEG 392
                A R  L G LP +W      L  L L  N   G +P  +  C  L +L L+ N L G
Sbjct:   309 TFSAERNQLSGSLP-SWMGKWKVLDSLLLANNRFSGEIPHEIEDCPMLKHLSLASNLLSG 367

Query:   393 YLPMQL-PVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENF- 450
              +P +L     +   ++S N ++G +   E V  D      +L   N  + GSI ++ + 
Sbjct:   368 SIPRELCGSGSLEAIDLSGNLLSGTI---EEVF-DGCSSLGELLLTNNQINGSIPEDLWK 423

Query:   451 --VIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQ 508
               ++  D   N F G +P  ++       ++   Y      N   G +P E I     L+
Sbjct:   424 LPLMALDLDSNNFTGEIPK-SLWKSTNLMEFTASY------NRLEGYLPAE-IGNAASLK 475

Query:   509 SFSVNLSANLLSG-MSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNR 567
                  LS N L+G +  E   L  + ++   A  N   G I   +G    L  LDL  N 
Sbjct:   476 RLV--LSDNQLTGEIPREIGKLTSLSVLNLNA--NMFQGKIPVELGDCTSLTTLDLGSNN 531

Query:   568 VSGSLPDELGKLKFLKWILLGGNNLTGEIPSQ---FGHLISLV---------VLDLSHNA 615
             + G +PD++  L  L+ ++L  NNL+G IPS+   + H I +          + DLS+N 
Sbjct:   532 LQGQIPDKITALAQLQCLVLSYNNLSGSIPSKPSAYFHQIEMPDLSFLQHHGIFDLSYNR 591

Query:   616 LTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIP 669
             L+G IP  L +   L  + L++N LSGEIP S S L NL+ LDLS N L+G IP
Sbjct:   592 LSGPIPEELGECLVLVEISLSNNHLSGEIPASLSRLTNLTILDLSGNALTGSIP 645

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009556 "microsporogenesis" evidence=IMP

GO:0010234 "tapetal cell fate specification" evidence=IMP

GO:0016020 "membrane" evidence=IDA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)]

 Score = 1150 (409.9 bits), Expect = 1.0e-116, P = 1.0e-116
 Identities = 324/952 (34%), Positives = 488/952 (51%)

Query:   111 ISGTLSASIAKLTELRTLSVPHNSFSGEIPAXXXXXXXXXXXXXQGNNFSGKIPYQMSNL 170
             ISG+L   I  L  L  L    N+ SG++P                N  SG +P ++   
Sbjct:   157 ISGSLPVEIGNLLSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQNMISGSLPSEIGGC 216

Query:   171 ERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDN 230
             E L +L L+ N  SGE+P+ +    +LS + +  N  SG +  + S+ C  L  L L  N
Sbjct:   217 ESLVMLGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPREISN-CTSLETLALYKN 275

Query:   231 FLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELAD 290
              L   IPKE+G  ++L+ L L  N L G+IP+EIG +S    +D S N+LT  IP+EL +
Sbjct:   276 QLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELGN 335

Query:   291 CSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNW 350
                L +L L         +N         G +P EL   ++L  L      L G +P  +
Sbjct:   336 IEGLELLYL--------FENQ------LTGTIPVELSTLKNLSKLDLSINALTGPIPLGF 381

Query:   351 SESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPC-MVYFNVS 409
                  L +L L QNSL G +P  LG   +L  LD+S N+L G +P  L +   M+  N+ 
Sbjct:   382 QYLRGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLG 441

Query:   410 QNNITGVLPRFENVSCDNHFGFQDLQYANVPVMG----SISDENFVIIHDFSGNKFLGSL 465
              NN++G +P     +C        L+ A   ++G    ++  +  V   +   N+F GS+
Sbjct:   442 TNNLSGNIPT-GITTCKT---LVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSI 497

Query:   466 PLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYE 525
             P   +G+   +A      RL L +N F G +P E I   + L +  +N+S+N L+G    
Sbjct:   498 PR-EVGN--CSALQ----RLQLADNGFTGELPRE-IGMLSQLGT--LNISSNKLTG-EVP 546

Query:   526 AFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWI 585
             + + +C  L   +   N  SG++ + VG L +L+ L L  N +SG++P  LG L  L  +
Sbjct:   547 SEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTEL 606

Query:   586 LLGGNNLTGEIPSQFGHLISL-VVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEI 644
              +GGN   G IP + G L  L + L+LS+N LTG IP  L+    LE L L +N LSGEI
Sbjct:   607 QMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEI 666

Query:   645 PVSFSTLVNLSALDLSFNNLSGHIPHLQHLDCIAFKGNKYLASCPDTNATAPEKP--PVQ 702
             P SF+ L +L   + S+N+L+G IP L+++   +F GN+ L   P  N     +P  P Q
Sbjct:   667 PSSFANLSSLLGYNFSYNSLTGPIPLLRNISMSSFIGNEGLCG-PPLNQCIQTQPFAPSQ 725

Query:   703 LDEKLQNGKRSKVFIIAVVTSASAXXXXXXXXXXXXXXXXKFGRIASLR--GQVMVTFAD 760
                K   G RS   IIA+  +                       +AS    GQ      D
Sbjct:   726 STGK-PGGMRSSK-IIAITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLD 783

Query:   761 T---PAE-LTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSI----GRF 812
                 P E  T+ ++V AT NF    ++G G  G+ YKA L  GY +AVKKL+     G  
Sbjct:   784 IYFPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNN 843

Query:   813 QGIQQ-FDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQ 871
               +   F AEI TLG IRH+N+V L G+   +    L+Y ++  G+L   +H  S   + 
Sbjct:   844 NNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHDPSCN-LD 902

Query:   872 WSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET 931
             WS   KIA+  AQ LAYLH+ C PRI HRDIK +NILLD++  A++ DFGLA+++++  +
Sbjct:   903 WSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHS 962

Query:   932 HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIV 991
              + + +AG++GY+APEYA T +V++K+D+YS+GVVLLEL++GK  + P       G ++V
Sbjct:   963 KSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQP----IDQGGDVV 1018

Query:   992 SWAKLLIKEGRSSELFLPE---LWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
             +W +  I+    S   L     L +     ++L ++++A  CT  +   RPS
Sbjct:  1019 NWVRSYIRRDALSSGVLDARLTLEDERIVSHMLTVLKIALLCTSVSPVARPS 1070

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)]

 Score = 693 (249.0 bits), Expect = 1.6e-113, Sum P(2) = 1.6e-113
 Identities = 228/768 (29%), Positives = 359/768 (46%)

Query:   113 GTLSASIAKLTELRTLSVPHNSFSGEIPAXXXXXXXXXXXXXQGNNFSGKIPYQMSNLER 172
             G++   I KL++LR+ ++ +N  SG +P                NN +G +P  + NL +
Sbjct:   147 GSIPVEINKLSQLRSFNICNNKLSGPLPEEIGDLYNLEELVAYTNNLTGPLPRSLGNLNK 206

Query:   173 LRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFL 232
             L       N FSG +P  +     L ++ ++ N +SG L  +     + L  + L  N  
Sbjct:   207 LTTFRAGQNDFSGNIPTEIGKCLNLKLLGLAQNFISGELPKEIGMLVK-LQEVILWQNKF 265

Query:   233 TESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCS 292
             +  IPK+IG   +L+ L L GN L G IP EIG +  LK L + +N L   IP EL   S
Sbjct:   266 SGFIPKDIGNLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLNGTIPKELGKLS 325

Query:   293 KLSVLVLTN--IDASLDLDNSR-GEF-------SAFDGGVPYELLLSRSLEVLWAPRANL 342
             K+  +  +   +   + ++ S+  E        +   G +P EL   R+L  L     +L
Sbjct:   326 KVMEIDFSENLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSL 385

Query:   343 GGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPC 402
              G +P  +    S++ L L  NSL G +P+ LG+   L  +D S N L G +P   P  C
Sbjct:   386 TGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSENQLSGKIP---PFIC 442

Query:   403 ----MVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIH---- 454
                 ++  N+  N I G +P    + C +      L+     + G    E   +++    
Sbjct:   443 QQSNLILLNLGSNRIFGNIPPGV-LRCKS---LLQLRVVGNRLTGQFPTELCKLVNLSAI 498

Query:   455 DFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNL 514
             +   N+F G LP   IG      K +   RL L  N F+ ++P E ISK ++L +F  N+
Sbjct:   499 ELDQNRFSGPLPP-EIGT---CQKLQ---RLHLAANQFSSNLPNE-ISKLSNLVTF--NV 548

Query:   515 SANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPD 574
             S+N L+G    + + +C  L   + + N   GS+   +G L +L+ L L  NR SG++P 
Sbjct:   549 SSNSLTG-PIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPF 607

Query:   575 ELGKLKFLKWILLGGNNLTGEIPSQFGHLISL-VVLDLSHNALTGSIPASLTKATKLESL 633
              +G L  L  + +GGN  +G IP Q G L SL + ++LS+N  +G IP  +     L  L
Sbjct:   608 TIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYL 667

Query:   634 FLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPH---LQHLDCIAFKGNK-----YL 685
              L +N LSGEIP +F  L +L   + S+NNL+G +PH    Q++   +F GNK     +L
Sbjct:   668 SLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGGHL 727

Query:   686 ASCPDTNATAPEKPPVQLDEKLQNGKRSKVFIIAVVTSASAXXXXXXXXXXXXXXXXKFG 745
              SC  ++++ P    +    K  + +R ++ II  V+S                      
Sbjct:   728 RSCDPSHSSWPHISSL----KAGSARRGRIIII--VSSVIGGISLLLIAIVVHFLRNPVE 781

Query:   746 RIASLRGQVMVTFADT-----PAE-LTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPG 799
               A         F ++     P E  T  +++ AT  F    ++G G  G+ YKA +  G
Sbjct:   782 PTAPYVHDKEPFFQESDIYFVPKERFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSG 841

Query:   800 YLVAVKKLSIGRFQGIQQ--------FDAEIGTLGRIRHKNLVTLIGY 839
               +AVKKL   R +G           F AEI TLG+IRH+N+V L  +
Sbjct:   842 KTIAVKKLESNR-EGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSF 888

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006486 "protein glycosylation" evidence=RCA

TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)]

 Score = 1113 (396.9 bits), Expect = 8.4e-113, P = 8.4e-113
 Identities = 324/953 (33%), Positives = 486/953 (50%)

Query:   113 GTLSASIAKLTELRTLSVPHNSFSGEIPAXXXXXXXXXXXXXQGNNFSGKIPYQMSNLER 172
             G++   I  L+ L+ L +  N+ +G IP                N FSG IP ++S  E 
Sbjct:   153 GSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGRNGFSGVIPSEISGCES 212

Query:   173 LRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFL 232
             L+VL L+ N   G +P+ L     L+ + +  NRLSG +   S      L  L L +N+ 
Sbjct:   213 LKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNRLSGEIP-PSVGNISRLEVLALHENYF 271

Query:   233 TESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCS 292
             T SIP+EIGK   +K L L  N L G IP+EIG + +   +D S N LT  IP E     
Sbjct:   272 TGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTGFIPKEFGHIL 331

Query:   293 KLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSE 352
              L +L L         +N         G +P EL     LE L      L G +P     
Sbjct:   332 NLKLLHL--------FEN------ILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQF 377

Query:   353 SCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQL-PVPCMVYFNVSQN 411
                L  L L  N L+G +P  +G   N + LD+S N+L G +P        ++  ++  N
Sbjct:   378 LPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSN 437

Query:   412 NITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIG 471
              ++G +PR +  +C +      L   +  + GS+  E F + +       L +L L    
Sbjct:   438 KLSGNIPR-DLKTCKS---LTKLMLGDNQLTGSLPIELFNLQN-------LTALELHQNW 486

Query:   472 -DGFLAA---KYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAF 527
               G ++A   K K   RL L NN F G +P E I     +  F  N+S+N L+G   +  
Sbjct:   487 LSGNISADLGKLKNLERLRLANNNFTGEIPPE-IGNLTKIVGF--NISSNQLTGHIPKE- 542

Query:   528 LLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILL 587
             L  CV +   + + N+ SG IA  +G+L+ L+ L L  NR++G +P   G L  L  + L
Sbjct:   543 LGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQL 602

Query:   588 GGNNLTGEIPSQFGHLISLVV-LDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPV 646
             GGN L+  IP + G L SL + L++SHN L+G+IP SL     LE L+L  N+LSGEIP 
Sbjct:   603 GGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPA 662

Query:   647 SFSTLVNLSALDLSFNNLSGHIPH---LQHLDCIAFKGNKYLASCPDTNATAPEKPPVQL 703
             S   L++L   ++S NNL G +P     Q +D   F GN  L +   ++   P  P    
Sbjct:   663 SIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQ-PLVP--HS 719

Query:   704 DEKLQ---NG-KRSKVFIIAVVTSASAXXXXXXXXXXXXXXXXK-FGRIAS-LRGQVMVT 757
             D KL    NG +R K+  I  +   S                   F  +    +  VM +
Sbjct:   720 DSKLNWLINGSQRQKILTITCIVIGSVFLITFLGLCWTIKRREPAFVALEDQTKPDVMDS 779

Query:   758 FADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQ 817
             +       TY  +V AT NFS   ++G G  G+ YKAE+  G ++AVKKL+  R +G   
Sbjct:   780 YYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLN-SRGEGASS 838

Query:   818 ---FDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK---IQ 871
                F AEI TLG+IRH+N+V L G+   +    L+Y ++S G+L   + +  G+K   + 
Sbjct:   839 DNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQR--GEKNCLLD 896

Query:   872 WSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET 931
             W+  ++IA+  A+ L YLH+ C P+IVHRDIK +NILLDE   A++ DFGLA+L+++S +
Sbjct:   897 WNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYS 956

Query:   932 HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIV 991
              + + VAG++GY+APEYA T +V++K D+YSFGVVLLELI+GK  + P   E G   ++V
Sbjct:   957 KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPL--EQGG--DLV 1012

Query:   992 SWAKLLIKEGRSS-ELFLPELWEAGPQENLLGM---MRLASTCTVETLSTRPS 1040
             +W +  I+    + E+F   L +   +  +  M   +++A  CT  + ++RP+
Sbjct:  1013 NWVRRSIRNMIPTIEMFDARL-DTNDKRTVHEMSLVLKIALFCTSNSPASRPT 1064

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

UNIPROTKB|Q8RZV7 P0413C03.22 "Putative extra sporogenous cells" [Oryza sativa Japonica Group (taxid:39947)]

 Score = 601 (216.6 bits), Expect = 1.5e-110, Sum P(2) = 1.5e-110
 Identities = 123/290 (42%), Positives = 184/290 (63%)

Query:   755 MVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIG-RFQ 813
             + TF      +T D++++AT NFS  ++IG GGFG+ YKA L  G  VA+K+L  G +FQ
Sbjct:   980 LATFEHALLRVTADDILKATENFSKVHIIGDGGFGTVYKAALPEGRRVAIKRLHGGHQFQ 1039

Query:   814 GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSG--KKIQ 871
             G ++F AE+ T+G+++H NLV L+GY V   E FL+Y ++  G+LE ++  ++   + + 
Sbjct:  1040 GDREFLAEMETIGKVKHPNLVPLLGYCVCGDERFLIYEYMENGSLEMWLRNRADALEALG 1099

Query:   872 WSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET 931
             W    KI +  A+ LA+LH+  VP I+HRD+K SNILLDE     +SDFGLAR++   ET
Sbjct:  1100 WPDRLKICLGSARGLAFLHHGFVPHIIHRDMKSSNILLDENFEPRVSDFGLARIISACET 1159

Query:   932 HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIV 991
             H +TD+AGTFGY+ PEY  T + + K DVYSFGVV+LEL++G+        E   G N+V
Sbjct:  1160 HVSTDIAGTFGYIPPEYGLTMKSTTKGDVYSFGVVMLELLTGRPPTGQE--EVQGGGNLV 1217

Query:   992 SWAKLLIKEGRSSELFLPELWEAGP-QENLLGMMRLASTCTVETLSTRPS 1040
              W + +I  G+ +ELF P L  +   +E +  ++ +A  CT +    RP+
Sbjct:  1218 GWVRWMIARGKQNELFDPCLPVSSVWREQMARVLAIARDCTADEPFKRPT 1267

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0009554 "megasporogenesis" evidence=IMP

GO:0009556 "microsporogenesis" evidence=IMP

GO:0048658 "tapetal layer development" evidence=IMP

TAIR|locus:2032697 PEPR1 "PEP1 receptor 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1070 (381.7 bits), Expect = 3.0e-108, P = 3.0e-108
 Identities = 303/964 (31%), Positives = 481/964 (49%)

Query:   111 ISGTLSASIAKLTELRTLSVPHNSFSGEIPAXXXXXXXXXXXXXQGNNFSGKIPYQMSNL 170
             ++G L  S+ ++ +L+ L + +N+ +G IP                N FSG IP  + N 
Sbjct:   159 LTGELPESLFRIPKLQVLYLDYNNLTGPIPQSIGDAKELVELSMYANQFSGNIPESIGNS 218

Query:   171 ERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDN 230
               L++L L  N   G +P  L   G L+ + + +N L G +   S + C+ L  L LS N
Sbjct:   219 SSLQILYLHRNKLVGSLPESLNLLGNLTTLFVGNNSLQGPVRFGSPN-CKNLLTLDLSYN 277

Query:   231 FLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELAD 290
                  +P  +G C +L  L++    L G+IP  +G +  L +L++S N L+  IP EL +
Sbjct:   278 EFEGGVPPALGNCSSLDALVIVSGNLSGTIPSSLGMLKNLTILNLSENRLSGSIPAELGN 337

Query:   291 CSKLSVLVLTNIDASLDLDNSRGEF----------SAFDGGVPYELLLSRSLEVLWAPRA 340
             CS L++L L +      + ++ G+           + F G +P E+  S+SL  L   + 
Sbjct:   338 CSSLNLLKLNDNQLVGGIPSALGKLRKLESLELFENRFSGEIPIEIWKSQSLTQLLVYQN 397

Query:   341 NLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPV 400
             NL G LP   +E   LK+  L  NS  GA+P  LG+  +L  +D   N L G +P  L  
Sbjct:   398 NLTGELPVEMTEMKKLKIATLFNNSFYGAIPPGLGVNSSLEEVDFIGNKLTGEIPPNLCH 457

Query:   401 PCMV-YFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVP-VMGSISDENFVIIHDFSG 458
                +   N+  N + G +P      C     F  L+  N+  ++   S ++ +   DF+ 
Sbjct:   458 GRKLRILNLGSNLLHGTIPASIG-HCKTIRRFI-LRENNLSGLLPEFSQDHSLSFLDFNS 515

Query:   459 NKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFS-VNLSAN 517
             N F G +P      G L +  K    + L+ N F G +P +      +LQ+   +NLS N
Sbjct:   516 NNFEGPIP------GSLGS-CKNLSSINLSRNRFTGQIPPQ----LGNLQNLGYMNLSRN 564

Query:   518 LLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELG 577
             LL G S  A L +CV L  F+   N ++GS+ +       L  L L  NR SG +P  L 
Sbjct:   565 LLEG-SLPAQLSNCVSLERFDVGFNSLNGSVPSNFSNWKGLTTLVLSENRFSGGIPQFLP 623

Query:   578 KLKFLKWILLGGNNLTGEIPSQFGHLISLVV-LDLSHNALTGSIPASLTKATKLESLFLA 636
             +LK L  + +  N   GEIPS  G +  L+  LDLS N LTG IPA L    KL  L ++
Sbjct:   624 ELKKLSTLQIARNAFGGEIPSSIGLIEDLIYDLDLSGNGLTGEIPAKLGDLIKLTRLNIS 683

Query:   637 HNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIP-HLQ-HL--DCIAFKGNKYLASCPDTN 692
             +N L+G + V    L +L  +D+S N  +G IP +L+  L  +  +F GN  L      +
Sbjct:   684 NNNLTGSLSV-LKGLTSLLHVDVSNNQFTGPIPDNLEGQLLSEPSSFSGNPNLCIPHSFS 742

Query:   693 ATAPEKPPVQLDEKLQNGKRSKVF---IIAVVTSASAXXXXXXXXXXXXXXXXKFGRIAS 749
             A+   +  ++  +     ++S +    I+ +   +S                 + GR   
Sbjct:   743 ASNNSRSALKYCKDQSKSRKSGLSTWQIVLIAVLSSLLVLVVVLALVFICLRRRKGRPE- 801

Query:   750 LRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSI 809
              +   + T  + P+ L  + V+ AT N + +  IG G  G  Y+A L  G + AVK+L  
Sbjct:   802 -KDAYVFTQEEGPS-LLLNKVLAATDNLNEKYTIGRGAHGIVYRASLGSGKVYAVKRLVF 859

Query:   810 G-RFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGK 868
                 +  Q    EI T+G++RH+NL+ L G+++ + +  ++Y ++  G+L   +H  S K
Sbjct:   860 ASHIRANQSMMREIDTIGKVRHRNLIKLEGFWLRKDDGLMLYRYMPKGSLYDVLHGVSPK 919

Query:   869 K--IQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL 926
             +  + WS  + +A+ +A  LAYLHY C P IVHRDIKP NIL+D +L  ++ DFGLARLL
Sbjct:   920 ENVLDWSARYNVALGVAHGLAYLHYDCHPPIVHRDIKPENILMDSDLEPHIGDFGLARLL 979

Query:   927 EVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGN 986
             + S T +T  V GT GY+APE A       ++DVYS+GVVLLEL++ KR++D SF E   
Sbjct:   980 DDS-TVSTATVTGTTGYIAPENAFKTVRGRESDVYSYGVVLLELVTRKRAVDKSFPE--- 1035

Query:   987 GFNIVSWAKLLIKEGRSS----------ELFLPELWEAGPQENLLGMMRLASTCTVETLS 1036
               +IVSW +  +    ++           + + EL ++  +E ++ +  LA +CT +  +
Sbjct:  1036 STDIVSWVRSALSSSNNNVEDMVTTIVDPILVDELLDSSLREQVMQVTELALSCTQQDPA 1095

Query:  1037 TRPS 1040
              RP+
Sbjct:  1096 MRPT 1099

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0001653 "peptide receptor activity" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0045087 "innate immune response" evidence=TAS

GO:0009611 "response to wounding" evidence=IEP

GO:0009753 "response to jasmonic acid stimulus" evidence=IEP

GO:0004383 "guanylate cyclase activity" evidence=IDA

GO:0006955 "immune response" evidence=IMP

GO:0009506 "plasmodesma" evidence=IDA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0052542 "defense response by callose deposition" evidence=RCA

TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)]

 Score = 759 (272.2 bits), Expect = 1.8e-74, P = 1.8e-74
 Identities = 243/790 (30%), Positives = 377/790 (47%)

Query:   111 ISGTLSASIAKLTELRTLSVPHNSFSGEIPAXXXXXXXXXXXXXQGNNFSGKIPYQM-SN 169
             + G +  S+A L  L+TL +  N+ +GEIP                N+ SG +P  + SN
Sbjct:   275 LQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSN 334

Query:   170 LERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSD 229
                L  L LS    SGE+P  L     L  +D+S+N L+G +  ++  E   LT L L +
Sbjct:   335 NTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSNNSLAGSIP-EALFELVELTDLYLHN 393

Query:   230 NFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELA 289
             N L  ++   I    NL+ L+L  N LEG +PKEI  + +L+VL +  N  +  IP E+ 
Sbjct:   394 NTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIG 453

Query:   290 DCSKLSVLVLTNIDASLDLDNSRGEFSAFD----------GGVPYELLLSRSLEVLWAPR 339
             +C+ L ++ +       ++  S G     +          GG+P  L     L +L    
Sbjct:   454 NCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQLNILDLAD 513

Query:   340 ANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLP 399
               L G +P ++     L+ L L  NSL+G +P SL   RNLT ++LS N L G +     
Sbjct:   514 NQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCG 573

Query:   400 VPCMVYFNVSQNNITGVLPRFENVSCDN----HFGFQDLQYANVP-VMGSISDENFVIIH 454
                 + F+V+ N     +P  E  +  N      G   L    +P  +G I + + +   
Sbjct:   574 SSSYLSFDVTNNGFEDEIP-LELGNSQNLDRLRLGKNQLT-GKIPWTLGKIRELSLL--- 628

Query:   455 DFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNL 514
             D S N   G++PL  +       K   H  + LNNN  +G +P   + K + L    + L
Sbjct:   629 DMSSNALTGTIPLQLV-----LCKKLTH--IDLNNNFLSGPIP-PWLGKLSQLGE--LKL 678

Query:   515 SAN-LLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLP 573
             S+N  +  +  E F  +C +L+      N ++GSI   +G L  L  L+L  N+ SGSLP
Sbjct:   679 SSNQFVESLPTELF--NCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLP 736

Query:   574 DELGKLKFLKWILLGGNNLTGEIPSQFGHLISLV-VLDLSHNALTGSIPASLTKATKLES 632
               +GKL  L  + L  N+LTGEIP + G L  L   LDLS+N  TG IP+++   +KLE+
Sbjct:   737 QAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLET 796

Query:   633 LFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIP-HLQHLDCIAFKGNKYLASCPDT 691
             L L+HN+L+GE+P S   + +L  L++SFNNL G +          +F GN  L   P +
Sbjct:   797 LDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQFSRWPADSFLGNTGLCGSPLS 856

Query:   692 NATAPEKPPVQLDEKLQNGKRSKVFIIAVVTSASAXXXXXXXXXXXXXXXXKF------G 745
                      V+ + K Q      V II+ +++ +A                 F      G
Sbjct:   857 RCNR-----VRSNNKQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVGHG 911

Query:   746 RIA--SLRGQVMVT----FAD--TPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV 797
               A  S       T    F +  + +++ +++++ AT N S   +IG+GG G  YKAEL 
Sbjct:   912 STAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELE 971

Query:   798 PGYLVAVKK-LSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAE--MFLVYNFLS 854
              G  VAVKK L        + F  E+ TLGRIRH++LV L+GY   ++E    L+Y ++ 
Sbjct:   972 NGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMK 1031

Query:   855 GGNLETFIHK 864
              G++  ++H+
Sbjct:  1032 NGSIWDWLHE 1041

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

UNIPROTKB|P93194 INRPK1 "Receptor-like protein kinase" [Ipomoea nil (taxid:35883)]

 Score = 1038 (370.5 bits), Expect = 7.5e-105, P = 7.5e-105
 Identities = 303/964 (31%), Positives = 475/964 (49%)

Query:   108 SSVISGTLSASIAKLTELRTLSVPHNSFSGEIPAXXXXXXXXXXXXXQGNNFSGKIPYQM 167
             +S+I G    S+  +  L T+    N  +G IP+               N FSG +P  +
Sbjct:   150 NSLI-GPFPESLLSIPHLETVYFTGNGLNGSIPSNIGNMSELTTLWLDDNQFSGPVPSSL 208

Query:   168 SNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKL 227
              N+  L+ L L+ N+  G +P  L     L  +D+ +N L G + +D  S C+ +  + L
Sbjct:   209 GNITTLQELYLNDNNLVGTLPVTLNNLENLVYLDVRNNSLVGAIPLDFVS-CKQIDTISL 267

Query:   228 SDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVE 287
             S+N  T  +P  +G C +L+        L G IP   G +++L  L ++ N  + RIP E
Sbjct:   268 SNNQFTGGLPPGLGNCTSLREFGAFSCALSGPIPSCFGQLTKLDTLYLAGNHFSGRIPPE 327

Query:   288 LADCSKLSVLVLTNIDASLDLDNSRGEFSAFD----------GGVPYELLLSRSLEVLWA 337
             L  C  +  L L       ++    G  S             G VP  +   +SL+ L  
Sbjct:   328 LGKCKSMIDLQLQQNQLEGEIPGELGMLSQLQYLHLYTNNLSGEVPLSIWKIQSLQSLQL 387

Query:   338 PRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQ 397
              + NL G LP + +E   L  L L +N   G +P+ LG   +L  LDL+ N   G++P  
Sbjct:   388 YQNNLSGELPVDMTELKQLVSLALYENHFTGVIPQDLGANSSLEVLDLTRNMFTGHIPPN 447

Query:   398 L-PVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISD---ENFVII 453
             L     +    +  N + G +P  +   C      + L      + G + D   +  ++ 
Sbjct:   448 LCSQKKLKRLLLGYNYLEGSVPS-DLGGCST---LERLILEENNLRGGLPDFVEKQNLLF 503

Query:   454 HDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVN 513
              D SGN F G +P  ++G+       K    + L++N  +GS+P E +     L+   +N
Sbjct:   504 FDLSGNNFTGPIPP-SLGN------LKNVTAIYLSSNQLSGSIPPE-LGSLVKLEH--LN 553

Query:   514 LSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLP 573
             LS N+L G+   + L +C +L E +A++N ++GSI + +G L +L +L L  N  SG +P
Sbjct:   554 LSHNILKGI-LPSELSNCHKLSELDASHNLLNGSIPSTLGSLTELTKLSLGENSFSGGIP 612

Query:   574 DELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESL 633
               L +   L  + LGGN L G+IP   G L +L  L+LS N L G +P  L K   LE L
Sbjct:   613 TSLFQSNKLLNLQLGGNLLAGDIPP-VGALQALRSLNLSSNKLNGQLPIDLGKLKMLEEL 671

Query:   634 FLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPH--LQHLDC--IAFKGNKYLA-SC 688
              ++HN LSG + V  ST+ +L+ +++S N  SG +P    + L+    +F GN  L  +C
Sbjct:   672 DVSHNNLSGTLRV-LSTIQSLTFINISHNLFSGPVPPSLTKFLNSSPTSFSGNSDLCINC 730

Query:   689 PDTNATAPEKP---PVQLDEKLQNGKRSKVFIIAVVTSASAXXXXXXXXXXXXXXXXKFG 745
             P      PE     P  +      G  S + I  +V  A                  K  
Sbjct:   731 PADGLACPESSILRPCNMQSNTGKGGLSTLGIAMIVLGALLFIICLFLFSAFLFLHCK-- 788

Query:   746 RIASLRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVK 805
                S++ ++ ++  +    L  + V+ AT N + + +IG G  G+ YKA L P  + AVK
Sbjct:   789 --KSVQ-EIAISAQEGDGSLL-NKVLEATENLNDKYVIGKGAHGTIYKATLSPDKVYAVK 844

Query:   806 KLSI-GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHK 864
             KL   G   G      EI T+G++RH+NL+ L  +++ +    ++Y ++  G+L   +H+
Sbjct:   845 KLVFTGIKNGSVSMVREIETIGKVRHRNLIKLEEFWLRKEYGLILYTYMENGSLHDILHE 904

Query:   865 KSGKK-IQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLA 923
              +  K + WS  H IA+  A  LAYLH+ C P IVHRDIKP NILLD +L  ++SDFG+A
Sbjct:   905 TNPPKPLDWSTRHNIAVGTAHGLAYLHFDCDPAIVHRDIKPMNILLDSDLEPHISDFGIA 964

Query:   924 RLLEVSETHATTD-VAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFS 982
             +LL+ S T   ++ V GT GY+APE A T   S ++DVYS+GVVLLELI+ K++LDPSF 
Sbjct:   965 KLLDQSATSIPSNTVQGTIGYMAPENAFTTVKSRESDVYSYGVVLLELITRKKALDPSF- 1023

Query:   983 EYGNG-FNIVSWAKLL-IKEGRSSEL----FLPELWEAGPQENLLGMMRLASTCTVETLS 1036
                NG  +IV W + +  + G   ++     L EL ++   E +   + LA  C  + + 
Sbjct:  1024 ---NGETDIVGWVRSVWTQTGEIQKIVDPSLLDELIDSSVMEQVTEALSLALRCAEKEVD 1080

Query:  1037 TRPS 1040
              RP+
Sbjct:  1081 KRPT 1084

GO:0005524 "ATP binding" evidence=NAS

GO:0005576 "extracellular region" evidence=NAS

GO:0005886 "plasma membrane" evidence=NAS

GO:0006468 "protein phosphorylation" evidence=NAS

GO:0019199 "transmembrane receptor protein kinase activity" evidence=NAS

TAIR|locus:2092810 BRL3 "BRI1-like 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 642 (231.1 bits), Expect = 3.9e-103, Sum P(2) = 3.9e-103
 Identities = 136/293 (46%), Positives = 197/293 (67%)

Query:   755 MVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQG 814
             + TF     +LT+ +++ AT  FS  ++IG+GGFG  YKA+L  G +VA+KKL     QG
Sbjct:   836 VATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGDVYKAKLADGSVVAIKKLIQVTGQG 895

Query:   815 IQQFDAEIGTLGRIRHKNLVTLIGYY-VGEAEMFLVYNFLSGGNLETFIH---KKSGKKI 870
              ++F AE+ T+G+I+H+NLV L+GY  +GE E  LVY ++  G+LET +H   KK G  +
Sbjct:   896 DREFMAEMETIGKIKHRNLVPLLGYCKIGE-ERLLVYEYMKYGSLETVLHEKTKKGGIFL 954

Query:   871 QWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE 930
              WS   KIAI  A+ LA+LH+SC+P I+HRD+K SN+LLD++  A +SDFG+ARL+   +
Sbjct:   955 DWSARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVARVSDFGMARLVSALD 1014

Query:   931 TH-ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFN 989
             TH + + +AGT GYV PEY  + R + K DVYS+GV+LLEL+SGK+ +DP   E+G   N
Sbjct:  1015 THLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDPE--EFGEDNN 1072

Query:   990 IVSWAKLLIKEGRSSELFLPELW--EAGPQENLLGMMRLASTCTVETLSTRPS 1040
             +V WAK L +E R +E+  PEL   ++G  E LL  +++AS C  +    RP+
Sbjct:  1073 LVGWAKQLYREKRGAEILDPELVTDKSGDVE-LLHYLKIASQCLDDRPFKRPT 1124

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006888 "ER to Golgi vesicle-mediated transport" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0043090 "amino acid import" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2020457 BRL1 "BRI1 like" [Arabidopsis thaliana (taxid:3702)]

 Score = 648 (233.2 bits), Expect = 1.4e-102, Sum P(2) = 1.4e-102
 Identities = 136/294 (46%), Positives = 197/294 (67%)

Query:   755 MVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQG 814
             + TF     +LT+ +++ AT  FS   ++G+GGFG  YKA+L  G +VA+KKL     QG
Sbjct:   837 VATFEKPLRKLTFAHLLEATNGFSAETMVGSGGFGEVYKAQLRDGSVVAIKKLIRITGQG 896

Query:   815 IQQFDAEIGTLGRIRHKNLVTLIGYY-VGEAEMFLVYNFLSGGNLETFIHKKSGKK---- 869
              ++F AE+ T+G+I+H+NLV L+GY  VGE E  LVY ++  G+LET +H+KS KK    
Sbjct:   897 DREFMAEMETIGKIKHRNLVPLLGYCKVGE-ERLLVYEYMKWGSLETVLHEKSSKKGGIY 955

Query:   870 IQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS 929
             + W+   KIAI  A+ LA+LH+SC+P I+HRD+K SN+LLDE+  A +SDFG+ARL+   
Sbjct:   956 LNWAARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDEDFEARVSDFGMARLVSAL 1015

Query:   930 ETH-ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGF 988
             +TH + + +AGT GYV PEY  + R + K DVYS+GV+LLEL+SGK+ +DP   E+G   
Sbjct:  1016 DTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDPG--EFGEDN 1073

Query:   989 NIVSWAKLLIKEGRSSELFLPELW--EAGPQENLLGMMRLASTCTVETLSTRPS 1040
             N+V WAK L +E R +E+  PEL   ++G  E L   +++AS C  +    RP+
Sbjct:  1074 NLVGWAKQLYREKRGAEILDPELVTDKSGDVE-LFHYLKIASQCLDDRPFKRPT 1126

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0009691 "cytokinin biosynthetic process" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9S7I6	RPK2_ARATH	2, ., 7, ., 1, 1, ., 1	0.4294	0.9733	0.8896	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.914
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	1052
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-104
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-48
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-48
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-42
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-40
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-39
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-38
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	7e-37
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-34
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-33
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-33
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-32
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-32
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	6e-31
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-30
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-29
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	8e-29
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-28
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-28
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-26
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-26
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-26
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	6e-26
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	8e-26
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-25
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-25
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	4e-25
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	4e-24
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-24
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-23
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-23
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-23
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-23
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-23
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-22
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-22
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-22
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-22
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-22
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-22
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-22
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-22
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-22
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-21
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-21
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-21
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-21
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-21
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-21
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	6e-21
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	9e-21
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	9e-21
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-20
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-20
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-20
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-20
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-20
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-20
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-20
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-20
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-20
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-20
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-20
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-20
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	6e-20
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	8e-20
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	9e-20
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-19
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-19
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-19
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-19
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-19
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-19
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-19
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-19
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	7e-19
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	8e-19
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	9e-19
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-18
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-18
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-18
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-18
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-18
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-18
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-18
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-18
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-18
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-18
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-18
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	6e-18
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	6e-18
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	7e-18
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	9e-18
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-17
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-17
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-17
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-17
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-17
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-17
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-17
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-17
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-17
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-17
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-17
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-17
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-17
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	6e-17
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	8e-17
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	9e-17
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	9e-17
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-16
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-16
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-16
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-16
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-16
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-16
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-16
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-16
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-16
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-16
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-16
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-16
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-16
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-16
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	5e-16
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	7e-16
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	8e-16
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	8e-16
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	8e-16
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	8e-16
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	9e-16
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-15
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-15
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-15
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-15
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-15
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-15
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-15
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-15
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-15
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	6e-15
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	7e-15
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	7e-15
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	9e-15
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	9e-15
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	9e-15
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-14
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-14
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-14
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-14
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-14
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-14
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-14
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-14
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-14
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-14
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-14
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-14
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-14
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-14
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	6e-14
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	9e-14
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-13
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-13
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-13
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-13
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	6e-13
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	6e-13
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	8e-13
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	8e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-12
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-12
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-12
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-12
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-12
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-12
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-12
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-12
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-12
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-12
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-12
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-12
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-12
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-12
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-12
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-12
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	4e-12
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-12
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-12
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-12
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	6e-12
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	6e-12
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-12
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	7e-12
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	9e-12
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	9e-12
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	9e-12
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-11
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-11
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-11
pfam08263	42	pfam08263, LRRNT_2, Leucine rich repeat N-terminal	1e-11
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-11
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-11
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-11
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-11
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-11
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-11
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-11
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-11
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-11
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-11
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	5e-11
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	6e-11
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	6e-11
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	6e-11
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	7e-11
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-10
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-10
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-10
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-10
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-10
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-10
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-10
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-10
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-10
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-10
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-10
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-10
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-10
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-10
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	5e-10
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	8e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-09
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-09
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-09
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-09
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	2e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-09
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-09
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-09
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-09
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	4e-09
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-09
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	5e-09
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	8e-09
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	8e-09
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	9e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	9e-09
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-08
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-08
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-08
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-08
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-08
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-08
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-08
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	6e-08
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	6e-08
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	6e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	8e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	8e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	9e-08
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-07
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-07
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-07
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	4e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-07
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	6e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	6e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	9e-07
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-06
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-06
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-06
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	3e-06
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	6e-06
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	6e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	4e-05
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	4e-05
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	6e-05
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	8e-05
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	9e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-04
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	2e-04
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-04
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	5e-04
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	7e-04
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	7e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.001
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	0.002
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.002
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.002

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  349 bits (897), Expect = e-104
 Identities = 311/1029 (30%), Positives = 482/1029 (46%), Gaps = 145/1029 (14%)

Query: 53   LLSFKASISRDPSNLLATWNSSTDHCTWHGVTCDHFTGRVTALRITGKATPWPSKSSVIS 112
            LLSFK+SI+ DP   L+ WNSS D C W G+TC++ + RV ++ ++GK          IS
Sbjct: 34   LLSFKSSIN-DPLKYLSNWNSSADVCLWQGITCNNSS-RVVSIDLSGKN---------IS 82

Query: 113  GTLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRL-LEVLELQGNNFSGKIPY-QMSNL 170
            G +S++I +L  ++T+++ +N  SG IP  +      L  L L  NNF+G IP   + NL
Sbjct: 83   GKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNL 142

Query: 171  ERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGL--AIDSSSECEFLTYLKLS 228
            E    L+LS N  SGE+P  +     L V+D+  N L G +  ++ + +  EFLT   L+
Sbjct: 143  E---TLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLT---LA 196

Query: 229  DNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVEL 288
             N L   IP+E+G+ ++LK + L  N L G IP EIG ++ L  LD+  N+LT  IP  L
Sbjct: 197  SNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSL 256

Query: 289  ADCSKL----------------SVLVLTNIDASLDL-DNSRGEFSAFDGGVPYELLLSRS 331
             +   L                S+  L  +  SLDL DNS        G +P  ++  ++
Sbjct: 257  GNLKNLQYLFLYQNKLSGPIPPSIFSLQKL-ISLDLSDNS------LSGEIPELVIQLQN 309

Query: 332  LEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLE 391
            LE+L     N  G++P   +    L+VL L  N   G +PK+LG   NLT LDLS     
Sbjct: 310  LEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLS----- 364

Query: 392  GYLPMQLPVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFV 451
                               NN+TG +P      C +   F+ + ++N     S+  E   
Sbjct: 365  ------------------TNNLTGEIP---EGLCSSGNLFKLILFSN-----SLEGE--- 395

Query: 452  IIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFS 511
            I       + L                     R+ L +N F+G +P E  +K   L  F 
Sbjct: 396  IPKSLGACRSL--------------------RRVRLQDNSFSGELPSE-FTKL-PLVYF- 432

Query: 512  VNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGS 571
            +++S N L G    +   D   L     A N+  G +    G   +L+ LDL  N+ SG+
Sbjct: 433  LDISNNNLQG-RINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGA 490

Query: 572  LPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLE 631
            +P +LG L  L  + L  N L+GEIP +      LV LDLSHN L+G IPAS ++   L 
Sbjct: 491  VPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLS 550

Query: 632  SLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPHLQHLDCI---AFKGNKYLASC 688
             L L+ N+LSGEIP +   + +L  +++S N+L G +P       I   A  GN  L   
Sbjct: 551  QLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGG 610

Query: 689  PDTNATAPEKPPVQLDEKLQNGKRSKVFIIAVVTSASAVLLIFLV-IIFVILRRRK---F 744
              T+   P K            +++  +   +  +  A L++ LV   FV +R R     
Sbjct: 611  DTTSGLPPCK----------RVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLEL 660

Query: 745  GRIASLRGQVMVTFADTPA--ELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLV 802
             R+ +  G   + F D+     +T ++++ +       N+I  G  G++YK + +   + 
Sbjct: 661  KRVENEDGTWELQFFDSKVSKSITINDILSSLKE---ENVISRGKKGASYKGKSIKNGMQ 717

Query: 803  AVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFI 862
             V K  I     I    +EI  +G+++H N+V LIG    E   +L++ ++ G NL   +
Sbjct: 718  FVVK-EINDVNSIPS--SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL 774

Query: 863  HKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGL 922
               S     W    KIAI IA+AL +LH  C P +V  ++ P  I++D +   +L    L
Sbjct: 775  RNLS-----WERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSL 828

Query: 923  ARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFS 982
              LL        +       YVAPE   T  +++K+D+Y FG++L+EL++GK   D  F 
Sbjct: 829  PGLLCTDTKCFISS-----AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG 883

Query: 983  EYGNGFNIVSWAKLLIKEGRSSELFLPELWE--AGPQENLLGMMRLASTCTVETLSTRPS 1040
             +G   +IV WA+    +        P +    +  Q  ++ +M LA  CT    + RP 
Sbjct: 884  VHG---SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPC 940

Query: 1041 VKQVLIKLK 1049
               VL  L+
Sbjct: 941  ANDVLKTLE 949

Length = 968

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  173 bits (441), Expect = 1e-48
 Identities = 69/200 (34%), Positives = 103/200 (51%), Gaps = 9/200 (4%)

Query: 777 FSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLV 834
           + I   +G G FG  Y A +   G LVA+K +   + +   ++   EI  L +++H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
            L   +  E +++LV  +  GG+L   + K+   ++           I  AL YLH    
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR--GRLSEDEARFYLRQILSALEYLHSK-- 116

Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV 954
             IVHRD+KP NILLDE+ +  L+DFGLAR L+       T   GT  Y+APE       
Sbjct: 117 -GIVHRDLKPENILLDEDGHVKLADFGLARQLD--PGEKLTTFVGTPEYMAPEVLLGKGY 173

Query: 955 SDKADVYSFGVVLLELISGK 974
               D++S GV+L EL++GK
Sbjct: 174 GKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  171 bits (435), Expect = 2e-48
 Identities = 70/192 (36%), Positives = 105/192 (54%), Gaps = 9/192 (4%)

Query: 783 IGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
           +G GGFG+ Y A     G  VA+K +       + ++   EI  L ++ H N+V L G +
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
             E  ++LV  +  GG+L+  + +  G K+    I +I + I + L YLH S    I+HR
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEG-KLSEDEILRILLQILEGLEYLH-SN--GIIHR 116

Query: 901 DIKPSNILLDE-ELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE-YATTCRVSDKA 958
           D+KP NILLD       L+DFGL++LL   ++   T V GT  Y+APE        S+K+
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSEKS 175

Query: 959 DVYSFGVVLLEL 970
           D++S GV+L EL
Sbjct: 176 DIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  155 bits (395), Expect = 2e-42
 Identities = 75/197 (38%), Positives = 108/197 (54%), Gaps = 12/197 (6%)

Query: 783 IGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFD---AEIGTLGRIRHKNLVTLIG 838
           +G+G FG+ YKA+    G +VAVK L   R +  ++      EI  L R+ H N+V LI 
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKK-RSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +  +  ++LV  +  GG+L  ++ +     +      KIA+ I + L YLH S    I+
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYLSRG--GPLSEDEAKKIALQILRGLEYLH-SN--GII 120

Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE-YATTCRVSDK 957
           HRD+KP NILLDE     ++DFGLA+ L  S +  TT   GT  Y+APE          K
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPWYMAPEVLLGGNGYGPK 179

Query: 958 ADVYSFGVVLLELISGK 974
            DV+S GV+L EL++GK
Sbjct: 180 VDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  148 bits (377), Expect = 4e-40
 Identities = 73/219 (33%), Positives = 111/219 (50%), Gaps = 19/219 (8%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKN 832
            ++   L+G G FGS Y A     G L+AVK + +     + ++  + EI  L  ++H N
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 833 LVTLIGYYVGEAEMFLVYN----FLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
           +V   G    E +     N    ++SGG+L + +  K   K+   VI K    I + LAY
Sbjct: 61  IVRYYGSERDEEKNT--LNIFLEYVSGGSLSSLL--KKFGKLPEPVIRKYTRQILEGLAY 116

Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL-EVSETHATTDVAGTFGYVAPE 947
           LH +    IVHRDIK +NIL+D +    L+DFG A+ L ++     T  V GT  ++APE
Sbjct: 117 LHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173

Query: 948 YATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGN 986
                     AD++S G  ++E+ +GK    P +SE GN
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATGK----PPWSELGN 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  145 bits (369), Expect = 5e-39
 Identities = 61/196 (31%), Positives = 98/196 (50%), Gaps = 9/196 (4%)

Query: 783 IGTGGFGSTYKAELVPG-----YLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNLVTL 836
           +G G FG  YK  L          VAVK L      Q I++F  E   + ++ H N+V L
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66

Query: 837 IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPR 896
           +G    E  + +V  ++ GG+L  ++ K   K++  S +   A+ IA+ + YL  S    
Sbjct: 67  LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE-SK--N 123

Query: 897 IVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD 956
            +HRD+   N L+ E L   +SDFGL+R L   + +          ++APE     + + 
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTS 183

Query: 957 KADVYSFGVVLLELIS 972
           K+DV+SFGV+L E+ +
Sbjct: 184 KSDVWSFGVLLWEIFT 199

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  143 bits (364), Expect = 2e-38
 Identities = 61/196 (31%), Positives = 102/196 (52%), Gaps = 10/196 (5%)

Query: 783 IGTGGFGSTYKAELVP-----GYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNLVTL 836
           +G G FG  YK +L          VAVK L      Q I++F  E   + ++ H N+V L
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66

Query: 837 IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPR 896
           +G    E  +++V  ++ GG+L +++ +K+  K+  S +   A+ IA+ + YL  S    
Sbjct: 67  LGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYLE-SK--N 122

Query: 897 IVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD 956
            +HRD+   N L+ E L   +SDFGL+R L   + +          ++APE     + + 
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTS 182

Query: 957 KADVYSFGVVLLELIS 972
           K+DV+SFGV+L E+ +
Sbjct: 183 KSDVWSFGVLLWEIFT 198

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  139 bits (353), Expect = 7e-37
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 19/202 (9%)

Query: 783 IGTGGFGSTYKAELVP-----GYLVAVKKLSIG-RFQGIQQFDAEIGTLGRIRHKNLVTL 836
           +G G FG  YK  L          VAVK L  G   +  ++F  E   + ++ H N+V L
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 837 IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPR 896
           +G       +++V  ++ GG+L  F+ K  G+K+    + ++A+ IA+ + YL       
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFLRKH-GEKLTLKDLLQMALQIAKGMEYLESK---N 122

Query: 897 IVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYV-----APEYATT 951
            VHRD+   N L+ E L   +SDFGL+R +   + +         G +     APE    
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY----RKRGGGKLPIKWMAPESLKD 178

Query: 952 CRVSDKADVYSFGVVLLELISG 973
            + + K+DV+SFGV+L E+ + 
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTL 200

Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  131 bits (333), Expect = 3e-34
 Identities = 72/210 (34%), Positives = 112/210 (53%), Gaps = 11/210 (5%)

Query: 777 FSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
           F I   IG GGFG  YKA     G  VA+K + +   +  ++   EI  L + +H N+V 
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
             G Y+ + E+++V  F SGG+L+  + K + + +  S I  +  ++ + L YLH +   
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKDLL-KSTNQTLTESQIAYVCKELLKGLEYLHSN--- 117

Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVS 955
            I+HRDIK +NILL  +    L DFGL+   ++S+T A   + GT  ++APE        
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSA--QLSDTKARNTMVGTPYWMAPEVINGKPYD 175

Query: 956 DKADVYSFGVVLLELISGKRSLDPSFSEYG 985
            KAD++S G+  +EL  GK    P +SE  
Sbjct: 176 YKADIWSLGITAIELAEGK----PPYSELP 201

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  129 bits (328), Expect = 1e-33
 Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 18/206 (8%)

Query: 781 NLIGTGGFGSTYKAELVPG----YLVAVKKL-SIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
             +G G FG  YK +L         VAVK L      +  + F  E   + ++ H N+V 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKK-------SGKKIQWSVIHKIAIDIAQALAY 888
           L+G    E  ++LV  ++ GG+L  ++ K            +    +   AI IA+ + Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF--GYVAP 946
           L  S   + VHRD+   N L+ E+L   +SDFGL+R +   + +      G     ++AP
Sbjct: 121 LA-SK--KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD-YYRKKTGGKLPIRWMAP 176

Query: 947 EYATTCRVSDKADVYSFGVVLLELIS 972
           E       + K+DV+SFGV+L E+ +
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFT 202

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  129 bits (327), Expect = 2e-33
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 9/205 (4%)

Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDA--EIGTLGRIRHKN 832
            + I   IG G FG  Y       G L  +K++ +      ++ DA  E+  L ++ H N
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIH--KKSGKKIQWSVIHKIAIDIAQALAYLH 890
           ++     +  + ++ +V  +  GG+L   I   KK GK      I    + +  AL YLH
Sbjct: 61  IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120

Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
                +I+HRDIKP NI L       L DFG++++L  +   A T V GT  Y++PE   
Sbjct: 121 SR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT-VVGTPYYLSPELCQ 176

Query: 951 TCRVSDKADVYSFGVVLLELISGKR 975
               + K+D++S G VL EL + K 
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTLKH 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  126 bits (319), Expect = 2e-32
 Identities = 77/281 (27%), Positives = 125/281 (44%), Gaps = 34/281 (12%)

Query: 777  FSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKNL 833
            + +   IG G FG+  K      G ++  K++  G    +  QQ  +E+  L  ++H N+
Sbjct: 2    YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61

Query: 834  VTLIGYYVGEAE--MFLVYNFLSGGNLETFIHK--KSGKKIQWSVIHKIAIDIAQALAYL 889
            V      +  +   +++V  +  GG+L   I K  K  K I+   I +I   +  AL   
Sbjct: 62   VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYEC 121

Query: 890  HYSCVP--RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE 947
            H    P   ++HRD+KP+NI LD   N  L DFGLA++L    + A T V GT  Y++PE
Sbjct: 122  HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPE 180

Query: 948  YATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSEL- 1006
                    +K+D++S G ++ EL +      P F       N +  A   IKEG+   + 
Sbjct: 181  QLNHMSYDEKSDIWSLGCLIYELCALS----PPF----TARNQLQLAS-KIKEGKFRRIP 231

Query: 1007 --FLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVL 1045
              +  EL E            +  +        RPS +++L
Sbjct: 232  YRYSSELNE------------VIKSMLNVDPDKRPSTEELL 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  129 bits (324), Expect = 4e-32
 Identities = 81/284 (28%), Positives = 119/284 (41%), Gaps = 25/284 (8%)

Query: 776  NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRF---QGIQQFDAEIGTLGRIRH-K 831
            ++ I   +G G FG  Y A      LVA+K L+       + +++F  EI  L  + H  
Sbjct: 1    SYRILRKLGEGSFGEVYLARDRK--LVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 832  NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHK-KSGKKIQWSVIHKIAIDIAQALAYLH 890
            N+V L  ++  E  ++LV  ++ GG+LE  + K      +  S    I   I  AL YLH
Sbjct: 59   NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 891  YSCVPRIVHRDIKPSNILLDEELN-AYLSDFGLARLL-----EVSETHATTDVAGTFGYV 944
                  I+HRDIKP NILLD +     L DFGLA+LL       S     +   GT GY+
Sbjct: 119  SK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 945  APEYAT---TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEG 1001
            APE          S  +D++S G+ L EL++G     P   E  +     +   +L    
Sbjct: 176  APEVLLGLSLAYASSSSDIWSLGITLYELLTGLP---PFEGEKNSSATSQTLKIILELP- 231

Query: 1002 RSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVL 1045
              +      L  + P+        L      +    R S    L
Sbjct: 232  --TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273

Length = 384

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  122 bits (308), Expect = 6e-31
 Identities = 78/221 (35%), Positives = 111/221 (50%), Gaps = 18/221 (8%)

Query: 780 RNLIGTGGFGSTYKA-ELVPGYLVAVKKLSI--GRFQGIQQFDAEIGTLGRIRHKNLVTL 836
            N IG G FG  Y A  L  G L+AVK++ I     + I++   E+  L  ++H NLV  
Sbjct: 5   GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64

Query: 837 IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPR 896
            G  V   ++++   + SGG LE  +    G+ +   VI    + + + LAYLH      
Sbjct: 65  YGVEVHREKVYIFMEYCSGGTLEELLE--HGRILDEHVIRVYTLQLLEGLAYLHSH---G 119

Query: 897 IVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFG---YVAPEYATTCR 953
           IVHRDIKP+NI LD      L DFG A  L+ + T    +V    G   Y+APE  T  +
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179

Query: 954 VSDK---ADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIV 991
                  AD++S G V+LE+ +GKR     +SE  N F I+
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKR----PWSELDNEFQIM 216

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  121 bits (306), Expect = 1e-30
 Identities = 66/201 (32%), Positives = 103/201 (51%), Gaps = 7/201 (3%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSI-GRFQGIQQFDAEIGTLGRIRHKNL 833
           +     ++G G  G  YK    P G + A+KK+ + G  +  +Q   E+ TL       +
Sbjct: 2   DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYV 61

Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
           V   G +  E E+ +V  ++ GG+L   +  K   KI   V+  IA  I + L YLH   
Sbjct: 62  VKCYGAFYKEGEISIVLEYMDGGSLADLL--KKVGKIPEPVLAYIARQILKGLDYLHT-- 117

Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCR 953
              I+HRDIKPSN+L++ +    ++DFG++++LE +     T V GT  Y++PE      
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGES 176

Query: 954 VSDKADVYSFGVVLLELISGK 974
            S  AD++S G+ LLE   GK
Sbjct: 177 YSYAADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  118 bits (298), Expect = 1e-29
 Identities = 63/202 (31%), Positives = 103/202 (50%), Gaps = 9/202 (4%)

Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKN 832
           N+ + +LIG G FG  YK   L  G  VA+K++S+ +   + ++    EI  L  ++H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V  IG       ++++  +   G+L   I KK G     S++      + Q LAYLH  
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQII-KKFGP-FPESLVAVYVYQVLQGLAYLHEQ 118

Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
               ++HRDIK +NIL  ++    L+DFG+A  L    +     V GT  ++APE     
Sbjct: 119 ---GVIHRDIKAANILTTKDGVVKLADFGVATKLN-DVSKDDASVVGTPYWMAPEVIEMS 174

Query: 953 RVSDKADVYSFGVVLLELISGK 974
             S  +D++S G  ++EL++G 
Sbjct: 175 GASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  116 bits (292), Expect = 8e-29
 Identities = 65/207 (31%), Positives = 94/207 (45%), Gaps = 17/207 (8%)

Query: 776 NFSIRNLIGTGGFGSTYKAE-------LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRI 828
           +F +  +IG G FG     +           Y+   K +  G  + +     E   L  +
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLN---ERRILQEL 57

Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
            H  LV L   +  E  M+LV + L GG+L   + +K   K     +     +I  AL Y
Sbjct: 58  NHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEY 115

Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
           LH      I+HRDIKP NILLDE+ + +++DF +A  +       TT  +GT GY+APE 
Sbjct: 116 LHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL--TTSTSGTPGYMAPEV 170

Query: 949 ATTCRVSDKADVYSFGVVLLELISGKR 975
                 S   D +S GV   E + GKR
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  115 bits (291), Expect = 2e-28
 Identities = 65/212 (30%), Positives = 96/212 (45%), Gaps = 17/212 (8%)

Query: 781 NLIGTGGFGSTYKAELVP-----GYLVAVKKLSI-GRFQGIQQFDAEIGTLGRIRHKNLV 834
             +G G FG        P     G  VAVK L+  G  Q    F+ EI  L  + H+N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 835 TLIG--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
              G     G   + L+  +L  G+L  ++ +    +I    +   +  I + + YL   
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQ 128

Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
              R +HRD+   NIL++ E    +SDFGLA++L   + +      G    F Y APE  
Sbjct: 129 ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECL 184

Query: 950 TTCRVSDKADVYSFGVVLLELIS-GKRSLDPS 980
            T + S  +DV+SFGV L EL + G  S  P 
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFTYGDPSQSPP 216

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  114 bits (288), Expect = 3e-28
 Identities = 62/198 (31%), Positives = 97/198 (48%), Gaps = 13/198 (6%)

Query: 780 RNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGY 839
              IG G FG     +   G  VAVK L        Q F AE   +  +RH NLV L+G 
Sbjct: 11  GATIGKGEFGDVMLGDYR-GQKVAVKCLK-DDSTAAQAFLAEASVMTTLRHPNLVQLLGV 68

Query: 840 YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
            +    +++V  +++ G+L  ++  +    I  +     A+D+ + + YL        VH
Sbjct: 69  VLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVH 125

Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF--GYVAPEYATTCRVSDK 957
           RD+   N+L+ E+L A +SDFGLA+  E S+   +    G     + APE     + S K
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGLAK--EASQGQDS----GKLPVKWTAPEALREKKFSTK 179

Query: 958 ADVYSFGVVLLELISGKR 975
           +DV+SFG++L E+ S  R
Sbjct: 180 SDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  110 bits (278), Expect = 1e-26
 Identities = 65/203 (32%), Positives = 107/203 (52%), Gaps = 12/203 (5%)

Query: 777 FSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ-GIQQFDA--EIGTLGRIRHKN 832
           +     +G G +G  YKA +   G +VA+KK+ +   + GI    A  EI  L  ++H N
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPS-TALREISLLKELKHPN 59

Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V L+     E +++LV+ +    +L+ ++ K+ G  +  ++I  I   + + LAY H  
Sbjct: 60  IVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGP-LSPNLIKSIMYQLLRGLAYCHSH 117

Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
              RI+HRD+KP NIL++ +    L+DFGLAR   +     T +V  T  Y APE     
Sbjct: 118 ---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLGS 173

Query: 953 RVSDKA-DVYSFGVVLLELISGK 974
           +    A D++S G +  E+I+GK
Sbjct: 174 KHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  108 bits (273), Expect = 5e-26
 Identities = 66/219 (30%), Positives = 109/219 (49%), Gaps = 19/219 (8%)

Query: 756 VTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQG 814
           V+  D P EL Y N+ +          IG G  G  YKA +   G  VA+KK+ + + Q 
Sbjct: 12  VSEGD-PREL-YKNLEK----------IGEGASGEVYKATDRATGKEVAIKKMRLRK-QN 58

Query: 815 IQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSV 874
            +    EI  +   +H N+V     Y+   E+++V  ++ GG+L T I  ++  ++    
Sbjct: 59  KELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSL-TDIITQNFVRMNEPQ 117

Query: 875 IHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT 934
           I  +  ++ Q L YLH      ++HRDIK  NILL ++ +  L+DFG A  L   ++   
Sbjct: 118 IAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN 174

Query: 935 TDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
           + V GT  ++APE         K D++S G++ +E+  G
Sbjct: 175 SVV-GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  107 bits (270), Expect = 5e-26
 Identities = 58/206 (28%), Positives = 103/206 (50%), Gaps = 7/206 (3%)

Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDA--EIGTLGRIRHKN 832
           +F I N IG G FG  +K        + A+K++ + +    ++ +A  E   L ++    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           ++     ++ + ++ +V  +   G+L   +  + G+ +    + +  I I   LA+LH  
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120

Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
              +I+HRDIK  N+ LD   N  + D G+A+LL  +   A T V GT  Y++PE     
Sbjct: 121 ---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPELCEDK 176

Query: 953 RVSDKADVYSFGVVLLELISGKRSLD 978
             ++K+DV++ GVVL E  +GK   D
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFD 202

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  107 bits (270), Expect = 6e-26
 Identities = 79/270 (29%), Positives = 126/270 (46%), Gaps = 24/270 (8%)

Query: 777  FSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
            F I   +G G +GS YKA     G +VA+K + +   + +Q+   EI  L +     +V 
Sbjct: 5    FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVK 62

Query: 836  LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
              G Y    ++++V  +   G++   + K + K +    I  I     + L YLH +   
Sbjct: 63   YYGSYFKNTDLWIVMEYCGAGSVSDIM-KITNKTLTEEEIAAILYQTLKGLEYLHSN--- 118

Query: 896  RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVS 955
            + +HRDIK  NILL+EE  A L+DFG++  L  +     T V GT  ++APE       +
Sbjct: 119  KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQEIGYN 177

Query: 956  DKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAG 1015
            +KAD++S G+  +E+  GK    P +S+     + +  A  +I       L  PE W   
Sbjct: 178  NKADIWSLGITAIEMAEGK----PPYSD----IHPMR-AIFMIPNKPPPTLSDPEKWS-- 226

Query: 1016 PQENLLGMMRLASTCTVETLSTRPSVKQVL 1045
            P+ N          C V+    RPS  Q+L
Sbjct: 227  PEFN-----DFVKKCLVKDPEERPSAIQLL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  108 bits (271), Expect = 8e-26
 Identities = 55/223 (24%), Positives = 98/223 (43%), Gaps = 29/223 (13%)

Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLS---IGRFQGIQQFDAEIGTLGRI-RH 830
           +F    +IG G F +   A E       A+K L    + + + ++    E   L R+  H
Sbjct: 2   DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61

Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
             ++ L   +  E  ++ V  +   G L  +I K      + +     A +I  AL YLH
Sbjct: 62  PGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF--YAAEILLALEYLH 119

Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL----------EVSETHATTDVA-- 938
            S    I+HRD+KP NILLD++++  ++DFG A++L            +    +      
Sbjct: 120 -SK--GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176

Query: 939 -------GTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
                  GT  YV+PE          +D+++ G ++ ++++GK
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  106 bits (268), Expect = 1e-25
 Identities = 65/196 (33%), Positives = 96/196 (48%), Gaps = 10/196 (5%)

Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLS---IGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +G G FG      +   G L A+K L    I + + ++    E   L RI H  +V L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +  E +++LV  +  GG L + + K+   +         A +I  AL YLH      I+
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSL---GII 115

Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP NILLD + +  L+DFGLA+ L  SE   T    GT  Y+APE           
Sbjct: 116 YRDLKPENILLDADGHIKLTDFGLAKEL-SSEGSRTNTFCGTPEYLAPEVLLGKGYGKAV 174

Query: 959 DVYSFGVVLLELISGK 974
           D +S GV+L E+++GK
Sbjct: 175 DWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  105 bits (264), Expect = 3e-25
 Identities = 57/196 (29%), Positives = 105/196 (53%), Gaps = 4/196 (2%)

Query: 777 FSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTL 836
           F++   +G+G FG  ++        VA+K L        Q F  E+  L R+RHK+L++L
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 837 IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPR 896
                    ++++   +  G+L  F+    G+ +  + +  +A  +A+ +AYL       
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---N 124

Query: 897 IVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD 956
            +HRD+   NIL+ E+L   ++DFGLARL++  + + ++D    + + APE A+    S 
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIK-EDVYLSSDKKIPYKWTAPEAASHGTFST 183

Query: 957 KADVYSFGVVLLELIS 972
           K+DV+SFG++L E+ +
Sbjct: 184 KSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  105 bits (264), Expect = 4e-25
 Identities = 63/190 (33%), Positives = 97/190 (51%), Gaps = 4/190 (2%)

Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  +         VAVK L  G     + F  E   + ++RH  LV L      
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS-PEAFLQEAQIMKKLRHDKLVQLYAVCSE 72

Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           E  +++V  ++S G+L  F+    GKK++   +  +A  IA+ +AYL        +HRD+
Sbjct: 73  EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDL 129

Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
              NIL+ E L   ++DFGLARL+E  E  A         + APE A   R + K+DV+S
Sbjct: 130 AARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWS 189

Query: 963 FGVVLLELIS 972
           FG++L E+++
Sbjct: 190 FGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  103 bits (258), Expect = 4e-24
 Identities = 60/196 (30%), Positives = 96/196 (48%), Gaps = 10/196 (5%)

Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDA--EIGTLGRIRHKNLVTLIGY 839
           IG G +G  YKA + + G +VA+KK+ +          A  EI  L  + H N++ L+  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 840 YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
           +  + +++LV+ F+   +L   I K   + +  S+I      + Q LA+ H      I+H
Sbjct: 67  FRHKGDLYLVFEFMDT-DLYKLI-KDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILH 121

Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA- 958
           RD+KP N+L++ E    L+DFGLAR         T  V  T  Y APE     +      
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-TRWYRAPELLLGDKGYSTPV 180

Query: 959 DVYSFGVVLLELISGK 974
           D++S G +  EL+S +
Sbjct: 181 DIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  102 bits (256), Expect = 5e-24
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 8/208 (3%)

Query: 783 IGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQ-QFDAEIGTLGRIRHKNLVTLIGYY 840
           +G G  G   K    P G ++AVK + +   + IQ Q   E+  L +     +V   G +
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
               ++ +   ++ GG+L+  + K+   +I   ++ KIA+ + + L YLH     +I+HR
Sbjct: 69  YNNGDISICMEYMDGGSLDKIL-KEVQGRIPERILGKIAVAVLKGLTYLHE--KHKIIHR 125

Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADV 960
           D+KPSNIL++      L DFG++   ++  + A T V GT  Y+APE       S K+D+
Sbjct: 126 DVKPSNILVNSRGQIKLCDFGVSG--QLVNSLAKTFV-GTSSYMAPERIQGNDYSVKSDI 182

Query: 961 YSFGVVLLELISGKRSLDPSFSEYGNGF 988
           +S G+ L+EL +G+    P        F
Sbjct: 183 WSLGLSLIELATGRFPYPPENDPPDGIF 210

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  101 bits (253), Expect = 1e-23
 Identities = 55/193 (28%), Positives = 96/193 (49%), Gaps = 10/193 (5%)

Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  ++        VAVK L  G     + F AE   + ++RH  L+ L      
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCTL 72

Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL---HYSCVPRIVH 899
           E  +++V   +  G+L  ++   +G+ ++   +  +A  +A  +AYL   +Y      +H
Sbjct: 73  EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY------IH 126

Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKAD 959
           RD+   N+L+ E     ++DFGLAR+++     A         + APE A   R S K+D
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186

Query: 960 VYSFGVVLLELIS 972
           V+SFG++L E+++
Sbjct: 187 VWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  101 bits (254), Expect = 2e-23
 Identities = 62/204 (30%), Positives = 91/204 (44%), Gaps = 23/204 (11%)

Query: 783 IGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDA----EIGTLGRIRHKNLVTLI 837
           IG G +G  YKA     G LVA+KK+ +      + F      EI  L ++RH N+V L 
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRM--ENEKEGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 838 GYYVGEA--EMFLVYNF----LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
                +    +++V+ +    L+G      +      K   S I      + + L YLH 
Sbjct: 65  EIVTSKGKGSIYMVFEYMDHDLTG------LLDSPEVKFTESQIKCYMKQLLEGLQYLHS 118

Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT 951
           +    I+HRDIK SNIL++ +    L+DFGLAR      +   T+   T  Y  PE    
Sbjct: 119 N---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLG 175

Query: 952 CRVSDKA-DVYSFGVVLLELISGK 974
                   D++S G +L EL  GK
Sbjct: 176 ATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  101 bits (252), Expect = 2e-23
 Identities = 72/219 (32%), Positives = 110/219 (50%), Gaps = 10/219 (4%)

Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFDA-EIGTLGRIRHKN 832
           NF     IG G +G  YKA   + G +VA+KK+ +    +G+      EI  L  + H N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V L+     E +++LV+ FL   +L+ F+       I   +I      + Q LA+ H  
Sbjct: 61  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119

Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
              R++HRD+KP N+L++ E    L+DFGLAR   V     T +V  T  Y APE    C
Sbjct: 120 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGC 175

Query: 953 RV-SDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
           +  S   D++S G +  E+++ +R+L P  SE    F I
Sbjct: 176 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 213

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  100 bits (250), Expect = 2e-23
 Identities = 66/195 (33%), Positives = 103/195 (52%), Gaps = 9/195 (4%)

Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  +         VA+K L  G     + F  E   + ++RH+ LV L    V 
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV-VS 71

Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI--VHR 900
           E  +++V  ++S G+L  F+  + GK ++   +  +A  IA  +AY     V R+  VHR
Sbjct: 72  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY-----VERMNYVHR 126

Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADV 960
           D++ +NIL+ E L   ++DFGLARL+E +E  A         + APE A   R + K+DV
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 961 YSFGVVLLELISGKR 975
           +SFG++L EL +  R
Sbjct: 187 WSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score =  100 bits (249), Expect = 3e-23
 Identities = 62/193 (32%), Positives = 100/193 (51%), Gaps = 5/193 (2%)

Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  +         VA+K L  G     + F  E   + ++RH  LV L    V 
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAV-VS 71

Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           E  +++V  F+  G+L  F+ +  GK ++   +  +A  IA  +AY+        +HRD+
Sbjct: 72  EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDL 128

Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
           + +NIL+ + L   ++DFGLARL+E +E  A         + APE A   R + K+DV+S
Sbjct: 129 RAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188

Query: 963 FGVVLLELISGKR 975
           FG++L EL++  R
Sbjct: 189 FGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 98.1 bits (244), Expect = 1e-22
 Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 11/200 (5%)

Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           IG G FG+  + E   G  VAVK +        Q F  E   + ++ HKNLV L+G  + 
Sbjct: 14  IGEGEFGAVLQGEYT-GQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILH 70

Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
              +++V   +S GNL  F+  +    +    + + ++D+A+ + YL      ++VHRD+
Sbjct: 71  NG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDL 126

Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
              NIL+ E+  A +SDFGLAR+     +    +      + APE     + S K+DV+S
Sbjct: 127 AARNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWS 182

Query: 963 FGVVLLELISGKRSLDPSFS 982
           +GV+L E+ S  R+  P  S
Sbjct: 183 YGVLLWEVFSYGRAPYPKMS 202

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 98.2 bits (245), Expect = 1e-22
 Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 17/208 (8%)

Query: 778 SIRNLIGTGGFGSTYKAEL----VPGYLVAVKKLSIGRFQGIQQFD--AEIGTLGRIRHK 831
           +I  +IG G FG   +  L         VA+K L  G     Q+ D   E   +G+  H 
Sbjct: 7   TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG-SSDKQRLDFLTEASIMGQFDHP 65

Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
           N++ L G       + ++  ++  G+L+ F+ +  GK      +  +   IA  + YL  
Sbjct: 66  NIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK-FTVGQLVGMLRGIASGMKYLSE 124

Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEY 948
                 VHRD+   NIL++  L   +SDFGL+R LE SE  AT    G      + APE 
Sbjct: 125 MNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE--ATYTTKGGKIPIRWTAPEA 179

Query: 949 ATTCRVSDKADVYSFGVVLLELIS-GKR 975
               + +  +DV+SFG+V+ E++S G+R
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMSYGER 207

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 98.5 bits (246), Expect = 2e-22
 Identities = 63/222 (28%), Positives = 96/222 (43%), Gaps = 28/222 (12%)

Query: 775 GNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDA-------EIGTLG 826
             + +  ++G G +G   K      G +VA+KK     F+  +  +        E+  L 
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKK-----FKESEDDEDVKKTALREVKVLR 55

Query: 827 RIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQAL 886
           ++RH+N+V L   +  +  ++LV+ ++    LE       G       +      + QA+
Sbjct: 56  QLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPD--AVRSYIWQLLQAI 113

Query: 887 AYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAP 946
           AY H      I+HRDIKP NIL+ E     L DFG AR L        TD   T  Y AP
Sbjct: 114 AYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAP 170

Query: 947 EYATTCRVSDK-----ADVYSFGVVLLELISGKRSLDPSFSE 983
           E      V D       DV++ G ++ EL+ G   L P  S+
Sbjct: 171 ELL----VGDTNYGKPVDVWAIGCIMAELLDG-EPLFPGDSD 207

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 97.8 bits (243), Expect = 2e-22
 Identities = 61/193 (31%), Positives = 100/193 (51%), Gaps = 5/193 (2%)

Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  +         VAVK L  G     + F  E   + ++RH  LV L    V 
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP-ESFLEEAQIMKKLRHDKLVQLYAV-VS 71

Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           E  +++V  ++S G+L  F+    G+ ++   +  +A  +A  +AY+        +HRD+
Sbjct: 72  EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDL 128

Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
           + +NIL+ + L   ++DFGLARL+E +E  A         + APE A   R + K+DV+S
Sbjct: 129 RSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188

Query: 963 FGVVLLELISGKR 975
           FG++L EL++  R
Sbjct: 189 FGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 97.9 bits (244), Expect = 2e-22
 Identities = 70/225 (31%), Positives = 107/225 (47%), Gaps = 16/225 (7%)

Query: 774 TGNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFD---AEIGTLGRIR 829
            GNF I   IG G F   YKA  L+ G +VA+KK+ I      +       EI  L ++ 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIH--KKSGKKIQWSVIHKIAIDIAQALA 887
           H N++  +  ++   E+ +V      G+L   I   KK  + I    I K  + +  AL 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE 947
           ++H     RI+HRDIKP+N+ +       L D GL R    S+T A   + GT  Y++PE
Sbjct: 121 HMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPE 176

Query: 948 YATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVS 992
                  + K+D++S G +L E+     +L   F  YG+  N+ S
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMA----ALQSPF--YGDKMNLYS 215

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 97.9 bits (244), Expect = 2e-22
 Identities = 56/208 (26%), Positives = 105/208 (50%), Gaps = 19/208 (9%)

Query: 782 LIGTGGFGSTYKA-ELVPGYLVAVKKL-----SIGRFQGIQQ-----FDAEIGTLGRIRH 830
           LIG G +G  Y A  +  G ++AVK++       GR    Q+       +EI TL  + H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            N+V  +G+   E  + +   ++ GG++ + +      + +  ++      + + LAYLH
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLH 125

Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE-VSETHATTDVAGTFGYVAPEYA 949
                 I+HRD+K  N+L+D +    +SDFG+++  + + +      + G+  ++APE  
Sbjct: 126 SK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182

Query: 950 TTCR--VSDKADVYSFGVVLLELISGKR 975
            +     S K D++S G V+LE+ +G+R
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 97.4 bits (243), Expect = 2e-22
 Identities = 66/201 (32%), Positives = 108/201 (53%), Gaps = 15/201 (7%)

Query: 777 FSIRNLIGTGGFGSTYKA-ELVPGYLVAVK--KLSIGR-FQGIQQFDAEIGTLGRIRHKN 832
           + +   IG+G +G  YKA ++  G LVA+K  KL  G  F+ IQQ   EI  L   RH N
Sbjct: 5   YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQ---EISMLKECRHPN 61

Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V   G Y+   ++++V  +  GG+L+  I++ +   +    I  +  +  + LAYLH +
Sbjct: 62  IVAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAYLHET 120

Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
                +HRDIK +NILL E+ +  L+DFG++  L  +     + + GT  ++APE A   
Sbjct: 121 ---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVE 176

Query: 953 RVSD---KADVYSFGVVLLEL 970
           R      K D+++ G+  +EL
Sbjct: 177 RKGGYDGKCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 97.1 bits (242), Expect = 3e-22
 Identities = 66/210 (31%), Positives = 103/210 (49%), Gaps = 18/210 (8%)

Query: 782 LIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRF-----QGIQQFDAEIGTLGRIRHKNLVT 835
           L+G+G FGS Y+   L  G   AVK++S+        + ++Q + EI  L +++H N+V 
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
            +G    E  +++    + GG+L   + KK G      VI      I   L YLH     
Sbjct: 67  YLGTEREEDNLYIFLELVPGGSLAK-LLKKYGS-FPEPVIRLYTRQILLGLEYLHDR--- 121

Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVS 955
             VHRDIK +NIL+D      L+DFG+A+  +V E        G+  ++APE        
Sbjct: 122 NTVHRDIKGANILVDTNGVVKLADFGMAK--QVVEFSFAKSFKGSPYWMAPEVIAQQGGY 179

Query: 956 D-KADVYSFGVVLLELISGKRSLDPSFSEY 984
              AD++S G  +LE+ +GK    P +S+ 
Sbjct: 180 GLAADIWSLGCTVLEMATGK----PPWSQL 205

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 96.7 bits (241), Expect = 4e-22
 Identities = 59/201 (29%), Positives = 87/201 (43%), Gaps = 17/201 (8%)

Query: 782 LIGTGGFGSTYKAE-------LVPGYLVAVKKLSIGRFQGIQQ-FDAEIGTLGRIRHKNL 833
            +G G FG   + E       ++P   VAVK L   +   I   F  E   +  + H+NL
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIP---VAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENL 58

Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
           + L G  V    + +V      G+L   + K +      S +   A+ IA  + YL    
Sbjct: 59  IRLYGV-VLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK- 116

Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAPEYATT 951
             R +HRD+   NILL  +    + DFGL R L  +E H   +      F + APE   T
Sbjct: 117 --RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174

Query: 952 CRVSDKADVYSFGVVLLELIS 972
              S  +DV+ FGV L E+ +
Sbjct: 175 RTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 95.9 bits (239), Expect = 1e-21
 Identities = 59/215 (27%), Positives = 104/215 (48%), Gaps = 14/215 (6%)

Query: 777 FSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQ-GIQQFDAEIGTLGRIRHKNLV 834
           + +  +IG G     Y A  +P    VA+K++ + + Q  + +   E+  + +  H N+V
Sbjct: 3   YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVV 62

Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFI-HKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
                +V   E++LV  +LSGG+L   +        +  ++I  +  ++ + L YLH + 
Sbjct: 63  KYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN- 121

Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE---VSETHATTDVAGTFGYVAPEYAT 950
               +HRDIK  NILL E+ +  ++DFG++  L               GT  ++APE   
Sbjct: 122 --GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179

Query: 951 TCRVSD-KADVYSFGVVLLELISGKRSLDPSFSEY 984
                D KAD++SFG+  +EL +G       +S+Y
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGA----APYSKY 210

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 96.0 bits (239), Expect = 1e-21
 Identities = 66/208 (31%), Positives = 96/208 (46%), Gaps = 29/208 (13%)

Query: 782 LIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTL 836
            +G G FGS       P     G +VAVKKL     + ++ F+ EI  L  ++H N+V  
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70

Query: 837 IG--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY------ 888
            G  Y  G   + LV  +L  G+L  ++ K           H+  +D  + L Y      
Sbjct: 71  KGVCYSAGRRNLRLVMEYLPYGSLRDYLQK-----------HRERLDHRKLLLYASQICK 119

Query: 889 -LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYV 944
            + Y    R VHRD+   NIL++ E    + DFGL ++L   + +      G    F Y 
Sbjct: 120 GMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY- 178

Query: 945 APEYATTCRVSDKADVYSFGVVLLELIS 972
           APE  T  + S  +DV+SFGVVL EL +
Sbjct: 179 APESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 94.3 bits (234), Expect = 3e-21
 Identities = 63/201 (31%), Positives = 101/201 (50%), Gaps = 11/201 (5%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
              +   IG G FG     +   G  VAVK   I      Q F AE   + ++RH NLV 
Sbjct: 7   ELKLLQTIGKGEFGDVMLGDY-RGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQ 63

Query: 836 LIGYYVGE-AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
           L+G  V E   +++V  +++ G+L  ++  +    +    + K ++D+ +A+ YL  +  
Sbjct: 64  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN-- 121

Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV 954
              VHRD+   N+L+ E+  A +SDFGL +  E S T  T  +     + APE     + 
Sbjct: 122 -NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKF 176

Query: 955 SDKADVYSFGVVLLELISGKR 975
           S K+DV+SFG++L E+ S  R
Sbjct: 177 STKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 94.3 bits (234), Expect = 3e-21
 Identities = 54/190 (28%), Positives = 95/190 (50%), Gaps = 4/190 (2%)

Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  +         VAVK L  G    +Q F  E   +  ++H  LV L      
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVVTK 72

Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           E  ++++  +++ G+L  F+    G K+    +   +  IA+ +AY+        +HRD+
Sbjct: 73  EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDL 129

Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
           + +N+L+ E L   ++DFGLAR++E +E  A         + APE       + K+DV+S
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 189

Query: 963 FGVVLLELIS 972
           FG++L E+++
Sbjct: 190 FGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 94.1 bits (234), Expect = 3e-21
 Identities = 56/193 (29%), Positives = 99/193 (51%), Gaps = 5/193 (2%)

Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  +         VA+K L  G     + F AE   + +++H  LV L    V 
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYAV-VT 71

Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           +  ++++  ++  G+L  F+    G K+  + +  +A  IA+ +A++        +HRD+
Sbjct: 72  QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDL 128

Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
           + +NIL+ E L   ++DFGLARL+E +E  A         + APE       + K+DV+S
Sbjct: 129 RAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 188

Query: 963 FGVVLLELISGKR 975
           FG++L E+++  R
Sbjct: 189 FGILLTEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 93.9 bits (233), Expect = 4e-21
 Identities = 78/284 (27%), Positives = 126/284 (44%), Gaps = 27/284 (9%)

Query: 776  NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRF---QGIQQFDAEIGTLGRIRHK 831
            NF I   IG G F   Y+A  L+    VA+KK+ I      +  Q    EI  L ++ H 
Sbjct: 3    NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 832  NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIH--KKSGKKIQWSVIHKIAIDIAQALAYL 889
            N++  +  ++ + E+ +V      G+L   I   KK  + I    + K  + +  A+ ++
Sbjct: 63   NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 890  HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
            H     R++HRDIKP+N+ +       L D GL R    S+T A   + GT  Y++PE  
Sbjct: 123  HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERI 178

Query: 950  TTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009
                 + K+D++S G +L E+     +L   F  YG+  N+ S  +      +  +   P
Sbjct: 179  HENGYNFKSDIWSLGCLLYEMA----ALQSPF--YGDKMNLFSLCQ------KIEQCDYP 226

Query: 1010 ELWEAGPQENLLGMMR-LASTCTVETLSTRPSVKQVLIKLKQLK 1052
             L    P E+    +R L S C       RP +  V    KQ+ 
Sbjct: 227  PL----PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 94.2 bits (235), Expect = 6e-21
 Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 29/214 (13%)

Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQ---FDA--EIGTLGRIR 829
            +     +G G +   YKA     G +VA+KK+ +G  +  +    F A  EI  L  ++
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHK--IAIDIAQALA 887
           H N++ L+  +  ++ + LV+ F+   +LE  I  KS   I  +        +   + L 
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFMET-DLEKVIKDKS---IVLTPADIKSYMLMTLRGLE 116

Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE 947
           YLH +    I+HRD+KP+N+L+  +    L+DFGLAR         T  V  T  Y APE
Sbjct: 117 YLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPE 172

Query: 948 -------YATTCRVSDKADVYSFGVVLLELISGK 974
                  Y          D++S G +  EL+   
Sbjct: 173 LLFGARHYGVGV------DMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 93.3 bits (232), Expect = 9e-21
 Identities = 59/195 (30%), Positives = 97/195 (49%), Gaps = 13/195 (6%)

Query: 783 IGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV 841
           +G G FG  YKA+    G   A K + I   + ++ F  EI  L   +H N+V L   Y 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 842 GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
            E +++++  F  GG L++ I  +  + +    I  +   + +AL +LH     +++HRD
Sbjct: 73  YENKLWILIEFCDGGALDS-IMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRD 128

Query: 902 IKPSNILLDEELNAYLSDFGL-ARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD---- 956
           +K  NILL  + +  L+DFG+ A+     +   T    GT  ++APE        D    
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKDNPYD 186

Query: 957 -KADVYSFGVVLLEL 970
            KAD++S G+ L+EL
Sbjct: 187 YKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 92.9 bits (231), Expect = 9e-21
 Identities = 68/272 (25%), Positives = 128/272 (47%), Gaps = 30/272 (11%)

Query: 779  IRNLIGTGGFGSTY---KAELVPGYLVAVKKLSIGRFQGIQQFDA--EIGTLGRIRHKNL 833
            IR ++G G FG      + E     LV  K++++ R    ++ DA  EI  L  ++H N+
Sbjct: 5    IR-VLGKGAFGEATLYRRTE--DDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61

Query: 834  VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
            +    +++ +  + +   + +GG L   I ++ G+  +  ++      I  A++Y+H + 
Sbjct: 62   IAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA- 120

Query: 894  VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCR 953
               I+HRDIK  NI L +     L DFG++++L    + A T V GT  Y++PE     +
Sbjct: 121  --GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQGVK 177

Query: 954  VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWE 1013
             + K+D+++ G VL EL++ KR+ D +     N  N+V   K++              + 
Sbjct: 178  YNFKSDIWALGCVLYELLTLKRTFDAT-----NPLNLVV--KIVQGN-----------YT 219

Query: 1014 AGPQENLLGMMRLASTCTVETLSTRPSVKQVL 1045
                     ++ L  +   +    RP+  +VL
Sbjct: 220  PVVSVYSSELISLVHSLLQQDPEKRPTADEVL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 93.0 bits (231), Expect = 1e-20
 Identities = 62/221 (28%), Positives = 107/221 (48%), Gaps = 23/221 (10%)

Query: 776 NFSIRNLIGTGGFGSTYKAEL--VPGYLVAVKKLSIGRF---QGIQQFDAEIGTL----- 825
            +++   +G+G FG  YK         L+A+K++++      +  ++ D  IG +     
Sbjct: 1   EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60

Query: 826 ---GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIH-KKSGKKIQWSVIHKIAI 880
               ++RH N+V     ++    +++V + + G  L E F   K+  ++     I  I +
Sbjct: 61  IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120

Query: 881 DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT 940
            +  AL YLH     RIVHRD+ P+NI+L E+    ++DFGLA+  +       T V GT
Sbjct: 121 QMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGT 176

Query: 941 FGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSF 981
             Y  PE        +KADV++FG +L ++     +L P F
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQMC----TLQPPF 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 91.9 bits (228), Expect = 2e-20
 Identities = 54/190 (28%), Positives = 96/190 (50%), Gaps = 5/190 (2%)

Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           IG+G FG  +    +    VA+K +  G     + F  E   + ++ H  LV L G    
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70

Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
            + + LV+ F+  G L  ++  + GK  Q +++  + +D+ + +AYL  S V   +HRD+
Sbjct: 71  RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLL-GMCLDVCEGMAYLESSNV---IHRDL 126

Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
              N L+ E     +SDFG+ R +   +  ++T       + +PE  +  + S K+DV+S
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWS 186

Query: 963 FGVVLLELIS 972
           FGV++ E+ S
Sbjct: 187 FGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 92.2 bits (229), Expect = 2e-20
 Identities = 59/210 (28%), Positives = 105/210 (50%), Gaps = 28/210 (13%)

Query: 782 LIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGIQQFDA------EIGTLGRIRHKNLV 834
            +GTG F S Y+A  V  G L+AVK+++  R    +Q +       EI  + R+ H +++
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
            ++G    ++   L   +++GG++   + K      + +VI      + + L+YLH +  
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA--FKEAVIINYTEQLLRGLSYLHEN-- 122

Query: 895 PRIVHRDIKPSNILLDEE-LNAYLSDFGLARLLEVSETHA---TTDVAGTFGYVAPE--- 947
            +I+HRD+K +N+L+D       ++DFG A  L    T A      + GT  ++APE   
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181

Query: 948 ---YATTCRVSDKADVYSFGVVLLELISGK 974
              Y  +C      DV+S G V++E+ + K
Sbjct: 182 GEQYGRSC------DVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 92.7 bits (231), Expect = 2e-20
 Identities = 72/225 (32%), Positives = 109/225 (48%), Gaps = 40/225 (17%)

Query: 781 NLIGTGGFGSTYKA-ELVPGYLVAVKKLSI-GRFQGIQQFDA-EIGTLGRIR---HKNLV 834
             IG G +G+ YKA +L  G  VA+KK+ +    +GI      EI  L ++    H N+V
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64

Query: 835 TLI----GYYVG-EAEMFLVYNFLSGGNLETFIHK--KSG---KKIQWSVIHKIAIDIAQ 884
            L+    G     E ++ LV+  +   +L T++ K  K G   + I+  ++ ++     +
Sbjct: 65  RLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKD-LMRQLL----R 118

Query: 885 ALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYV 944
            + +LH     RIVHRD+KP NIL+  +    ++DFGLAR+   S   A T V  T  Y 
Sbjct: 119 GVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIY--SFEMALTSVVVTLWYR 173

Query: 945 APE------YATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSE 983
           APE      YAT        D++S G +  EL   +R L    SE
Sbjct: 174 APEVLLQSSYATPV------DMWSVGCIFAELFR-RRPLFRGTSE 211

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 91.8 bits (228), Expect = 2e-20
 Identities = 59/217 (27%), Positives = 106/217 (48%), Gaps = 17/217 (7%)

Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRF-----QGIQQFDAEIGTLGRIR 829
           N+    L+G G FG  Y   ++  G  +AVK++          + +   + EI  L  ++
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62

Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           H+ +V   G    +  + +   ++ GG+++  +  K+   +  +V  K    I + + YL
Sbjct: 63  HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQILEGVEYL 120

Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT--TDVAGTFGYVAPE 947
           H +    IVHRDIK +NIL D   N  L DFG ++ L+   +  T    V GT  +++PE
Sbjct: 121 HSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177

Query: 948 YATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEY 984
             +      KADV+S G  ++E+++ K    P ++E+
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLTEK----PPWAEF 210

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 92.1 bits (229), Expect = 2e-20
 Identities = 63/201 (31%), Positives = 107/201 (53%), Gaps = 19/201 (9%)

Query: 782 LIGTGGFGSTYKAELVP-GYLVAVKKLSIG----RFQGIQQFDAEIGTLGRIRH---KNL 833
           LIG G +G+ Y+ + VP G +VA+K +++         IQ+   E+  L ++R     N+
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQR---EVALLSQLRQSQPPNI 64

Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
               G Y+    ++++  +  GG++ T +  K+G  I    I  I  ++  AL Y+H   
Sbjct: 65  TKYYGSYLKGPRLWIIMEYAEGGSVRTLM--KAGP-IAEKYISVIIREVLVALKYIHKV- 120

Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCR 953
              ++HRDIK +NIL+    N  L DFG+A LL  + +  +T   GT  ++APE  T  +
Sbjct: 121 --GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAPEVITEGK 177

Query: 954 VSD-KADVYSFGVVLLELISG 973
             D KAD++S G+ + E+ +G
Sbjct: 178 YYDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 92.0 bits (228), Expect = 2e-20
 Identities = 67/227 (29%), Positives = 106/227 (46%), Gaps = 16/227 (7%)

Query: 775 GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRF---QGIQQFDAEIGTLGRIRH 830
            NF I   IG G F   Y+A  L+ G  VA+KK+ I      +       EI  L ++ H
Sbjct: 2   ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61

Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIH--KKSGKKIQWSVIHKIAIDIAQALAY 888
            N++     ++ + E+ +V      G+L   I   KK  + I    + K  + +  AL +
Sbjct: 62  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121

Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
           +H     R++HRDIKP+N+ +       L D GL R    S+T A   + GT  Y++PE 
Sbjct: 122 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPER 177

Query: 949 ATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAK 995
                 + K+D++S G +L E+     +L   F  YG+  N+ S  K
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMA----ALQSPF--YGDKMNLYSLCK 218

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 91.0 bits (226), Expect = 3e-20
 Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 14/198 (7%)

Query: 782 LIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
            IG G FG  YK  L     VAVK         + ++F  E   L +  H N+V LIG  
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
           V +  +++V   + GG+L TF+ KK  +     ++  +++D A  + YL        +HR
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQ-MSLDAAAGMEYLESKNC---IHR 117

Query: 901 DIKPSNILLDEELNAYLSDFGLAR-----LLEVSETHATTDVAGTFGYVAPEYATTCRVS 955
           D+   N L+ E     +SDFG++R     +  VS+      +  T    APE     R +
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWT----APEALNYGRYT 173

Query: 956 DKADVYSFGVVLLELISG 973
            ++DV+S+G++L E  S 
Sbjct: 174 SESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 91.5 bits (228), Expect = 4e-20
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 19/213 (8%)

Query: 777 FSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKL----SIGRFQGIQQFDAEIGTLGRIRHK 831
           F++   IG G FG  YKA +     +VA+K +    +    + IQQ   EI  L + R  
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQ---EIQFLSQCRSP 59

Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
            +    G ++  ++++++  +  GG+    +  K GK +  + I  I  ++   L YLH 
Sbjct: 60  YITKYYGSFLKGSKLWIIMEYCGGGSCLDLL--KPGK-LDETYIAFILREVLLGLEYLHE 116

Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT 951
                 +HRDIK +NILL EE +  L+DFG++  L  + +   T V GT  ++APE    
Sbjct: 117 E---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQ 172

Query: 952 CRVSDKADVYSFGVVLLELISGKRSLDPSFSEY 984
               +KAD++S G+  +EL  G+    P  S+ 
Sbjct: 173 SGYDEKADIWSLGITAIELAKGE----PPLSDL 201

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 91.4 bits (227), Expect = 4e-20
 Identities = 60/196 (30%), Positives = 94/196 (47%), Gaps = 9/196 (4%)

Query: 783 IGTGGFGSTYKAEL-VPGYLVAVKKLSIGRF---QGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +G GGFG     ++   G + A KKL   R    +G Q    E   L ++  + +V+L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +  + ++ LV   ++GG+L+  I+         +     A  I   L +LH     RIV
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIV 117

Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+LLD+  N  +SD GLA  +E+         AGT GY+APE           
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSV 175

Query: 959 DVYSFGVVLLELISGK 974
           D ++ G  L E+I+G+
Sbjct: 176 DWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 90.9 bits (225), Expect = 4e-20
 Identities = 57/200 (28%), Positives = 99/200 (49%), Gaps = 5/200 (2%)

Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  + A       VAVK +  G    ++ F AE   +  ++H  LV L      
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVTK 72

Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           E  ++++  F++ G+L  F+    G K     +   +  IA+ +A++        +HRD+
Sbjct: 73  EP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDL 128

Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
           + +NIL+   L   ++DFGLAR++E +E  A         + APE       + K+DV+S
Sbjct: 129 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 188

Query: 963 FGVVLLELISGKRSLDPSFS 982
           FG++L+E+++  R   P  S
Sbjct: 189 FGILLMEIVTYGRIPYPGMS 208

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 90.5 bits (225), Expect = 5e-20
 Identities = 63/197 (31%), Positives = 92/197 (46%), Gaps = 13/197 (6%)

Query: 783 IGTGGFGST----YKAELVPGYLVAVKKLSIGRFQ-GIQQFDAEIGTLGRIRHKNLVTLI 837
           +G G FGS     Y  +      VAVK L       G ++F  E   + ++ H  +V LI
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 838 GYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
           G   GE  M LV      G L  ++ K+   +I  S + ++A  +A  +AYL        
Sbjct: 63  GVCKGEPLM-LVMELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESK---HF 116

Query: 898 VHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF--GYVAPEYATTCRVS 955
           VHRD+   N+LL     A +SDFG++R L     +     AG +   + APE     + S
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFS 176

Query: 956 DKADVYSFGVVLLELIS 972
            K+DV+S+GV L E  S
Sbjct: 177 SKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 91.2 bits (227), Expect = 6e-20
 Identities = 55/195 (28%), Positives = 95/195 (48%), Gaps = 9/195 (4%)

Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGR-FQGIQ-QFDAEIGTLGRIRHKNLVTLIGY 839
           IG G  G  +KA +   G  VA+KK+++ R   GI  Q   EI  L   +H  +V L+  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 840 YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
           +   +   LV  ++   +L   +  +  + +  + +      + + +AY+H +    I+H
Sbjct: 68  FPHGSGFVLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHAN---GIMH 122

Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA- 958
           RD+KP+N+L+  +    ++DFGLARL    E    +    T  Y APE     R  D   
Sbjct: 123 RDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGV 182

Query: 959 DVYSFGVVLLELISG 973
           D+++ G +  EL++G
Sbjct: 183 DLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 90.3 bits (224), Expect = 8e-20
 Identities = 66/213 (30%), Positives = 106/213 (49%), Gaps = 22/213 (10%)

Query: 776 NFSIRNLIGTGGFGSTYKAEL-VPG---YLVAVKKLSIGRFQGIQQ-FDAEIGTLGRIRH 830
              I  +IG G FG      L +PG     VA+K L  G  +  ++ F +E   +G+  H
Sbjct: 5   CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH 64

Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALAY 888
            N++ L G       + +V  ++  G+L+ F+ K  G   Q++VI  + +   IA  + Y
Sbjct: 65  PNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDG---QFTVIQLVGMLRGIASGMKY 121

Query: 889 LH---YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFG--Y 943
           L    Y      VHRD+   NIL++  L   +SDFGL+R+LE     A T   G     +
Sbjct: 122 LSDMGY------VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 175

Query: 944 VAPEYATTCRVSDKADVYSFGVVLLELIS-GKR 975
            APE     + +  +DV+S+G+V+ E++S G+R
Sbjct: 176 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 90.6 bits (225), Expect = 9e-20
 Identities = 66/194 (34%), Positives = 108/194 (55%), Gaps = 9/194 (4%)

Query: 783 IGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQ-QFDAEIGTLGRIRHKNLVTLIGYY 840
           +G G  GS  K + +P G ++A K + IG    ++ Q   E+  +   R   +V+  G +
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
           + E  + +   F+  G+L+  I+KK G  I   ++ KIA+ + + L YL+   V RI+HR
Sbjct: 73  LNENNICMCMEFMDCGSLDR-IYKKGGP-IPVEILGKIAVAVVEGLTYLYN--VHRIMHR 128

Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADV 960
           DIKPSNIL++      L DFG++   E+  + A T V GT  Y++PE     + + K+DV
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVSG--ELINSIADTFV-GTSTYMSPERIQGGKYTVKSDV 185

Query: 961 YSFGVVLLELISGK 974
           +S G+ ++EL  GK
Sbjct: 186 WSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 90.0 bits (223), Expect = 1e-19
 Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 16/206 (7%)

Query: 780 RNLIGTGGFGSTYKAEL-VPG---YLVAVKKLSIGRFQGIQQ-FDAEIGTLGRIRHKNLV 834
           + +IG G FG  ++  L +PG     VA+K L  G  +  +Q F +E   +G+  H N++
Sbjct: 10  QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69

Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALAYLHYS 892
            L G         ++  ++  G L+ ++    G   ++S    + +   IA  + YL   
Sbjct: 70  RLEGVVTKFKPAMIITEYMENGALDKYLRDHDG---EFSSYQLVGMLRGIAAGMKYLSDM 126

Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE--VSETHATTDVAGTFGYVAPEYAT 950
                VHRD+   NIL++  L   +SDFGL+R+LE     T+ T+       + APE   
Sbjct: 127 ---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIA 183

Query: 951 TCRVSDKADVYSFGVVLLELIS-GKR 975
             + +  +DV+SFG+V+ E++S G+R
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMSFGER 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 89.7 bits (223), Expect = 2e-19
 Identities = 69/218 (31%), Positives = 106/218 (48%), Gaps = 22/218 (10%)

Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDA--------EIGTLGRIRHKNL 833
           IG G +G  YKA + + G +VA+KK+ +      +  D         EI  L  + H N+
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRL------ETEDEGVPSTAIREISLLKELNHPNI 60

Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
           V L+     E +++LV+ FL   +L+ ++       +   +I      + Q +AY H   
Sbjct: 61  VRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH- 118

Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCR 953
             R++HRD+KP N+L+D E    L+DFGLAR   V     T +V  T  Y APE     R
Sbjct: 119 --RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGSR 175

Query: 954 -VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
             S   D++S G +  E+++ +R L P  SE    F I
Sbjct: 176 QYSTPVDIWSIGCIFAEMVN-RRPLFPGDSEIDQLFRI 212

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 90.3 bits (224), Expect = 2e-19
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 15/203 (7%)

Query: 776 NFSIRNLIGTGGFGSTYKAEL-VPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
           +F +   +GTG FG    A+    G   A+K   K  I + + +Q    E   L  + H 
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78

Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
            +V ++  +  E  ++ +  F+ GG  E F H +   +    V      ++  A  YLH 
Sbjct: 79  FIVNMMCSFQDENRVYFLLEFVVGG--ELFTHLRKAGRFPNDVAKFYHAELVLAFEYLH- 135

Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT 951
           S    I++RD+KP N+LLD + +  ++DFG A+ +       T  + GT  Y+APE   +
Sbjct: 136 SK--DIIYRDLKPENLLLDNKGHVKVTDFGFAKKV----PDRTFTLCGTPEYLAPEVIQS 189

Query: 952 CRVSDKA-DVYSFGVVLLELISG 973
            +   KA D ++ GV+L E I+G
Sbjct: 190 -KGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 88.4 bits (219), Expect = 4e-19
 Identities = 64/209 (30%), Positives = 107/209 (51%), Gaps = 18/209 (8%)

Query: 779 IRNLIGTGGFGSTYKAEL-VPG---YLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNL 833
           I  +IG G FG   +  L +PG     VA+K L  G   +  + F +E   +G+  H N+
Sbjct: 8   IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67

Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALAYLHY 891
           + L G       + ++  F+  G L++F+ +  G   Q++VI  + +   IA  + YL  
Sbjct: 68  IHLEGVVTKSRPVMIITEFMENGALDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLSE 124

Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE--VSETHATTDVAGTFG--YVAPE 947
                 VHRD+   NIL++  L   +SDFGL+R LE   S+   T+ + G     + APE
Sbjct: 125 M---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181

Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKR 975
                + +  +DV+S+G+V+ E++S G+R
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGER 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 88.5 bits (220), Expect = 4e-19
 Identities = 76/288 (26%), Positives = 123/288 (42%), Gaps = 36/288 (12%)

Query: 773  ATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGIQQFDAEIGTLGRI-RH 830
             TG F +  +IG G +G  YKA     G LVA+K + I      ++   E   L +   H
Sbjct: 4    PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDI-IEDEEEEIKEEYNILRKYSNH 62

Query: 831  KNLVTLIGYY------VGEAEMFLVYNFLSGGNLETFIH--KKSGKKIQWSVIHKIAIDI 882
             N+ T  G +        + +++LV     GG++   +   +K GK+++   I  I  + 
Sbjct: 63   PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRET 122

Query: 883  AQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFG 942
             + LAYLH +   +++HRDIK  NILL +     L DFG++  L+ S         GT  
Sbjct: 123  LRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD-STLGRRNTFIGTPY 178

Query: 943  YVAPE-----YATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLL 997
            ++APE              ++DV+S G+  +EL  GK    P   +          A   
Sbjct: 179  WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK----PPLCDMHP-----MRALFK 229

Query: 998  IKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVL 1045
            I       L  PE W     + +       S C ++    RP ++++L
Sbjct: 230  IPRNPPPTLKSPENWSKKFNDFI-------SECLIKNYEQRPFMEELL 270

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 89.5 bits (223), Expect = 4e-19
 Identities = 65/215 (30%), Positives = 100/215 (46%), Gaps = 29/215 (13%)

Query: 777 FSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGR-FQGIQQFDA-----EIGTLGRIR 829
           + +   IG+G +G    A     G  VA+KK  I   F      DA     EI  L  +R
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKK--ISNVFD--DLIDAKRILREIKLLRHLR 57

Query: 830 HKNLVTLI-----GYYVGEAEMFLVYNFLSGGNLETFIHK--KSGKKIQWSVIHKIAIDI 882
           H+N++ L+            ++++V   +     ET +HK  KS + +    I      I
Sbjct: 58  HENIIGLLDILRPPSPEDFNDVYIVTELM-----ETDLHKVIKSPQPLTDDHIQYFLYQI 112

Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT--TDVAGT 940
            + L YLH S    ++HRD+KPSNIL++   +  + DFGLAR ++  E      T+   T
Sbjct: 113 LRGLKYLH-SA--NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVT 169

Query: 941 FGYVAPEYATTCRVSDKA-DVYSFGVVLLELISGK 974
             Y APE   +     KA D++S G +  EL++ K
Sbjct: 170 RWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 88.6 bits (220), Expect = 5e-19
 Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 20/210 (9%)

Query: 775 GNFSIRNLIGTGGFGSTYKAELVPGYLV-AVKKLSIGRFQGIQ-QFDAEIGTLGRIRHKN 832
                 + +G G  GS  K  L    ++ A+K ++      +Q Q   E+      +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 833 LVTLIGYYVGEAE--MFLVYNFLSGGNLETFIHK--KSGKKIQWSVIHKIAIDIAQALAY 888
           +V   G ++ E+   + +   +  GG+L++   K  K G +I   V+ KIA  + + L+Y
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120

Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFG----YV 944
           LH     +I+HRDIKPSNILL  +    L DFG      VS       +AGTF     Y+
Sbjct: 121 LHSR---KIIHRDIKPSNILLTRKGQVKLCDFG------VS-GELVNSLAGTFTGTSFYM 170

Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGK 974
           APE       S  +DV+S G+ LLE+   +
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 87.3 bits (216), Expect = 5e-19
 Identities = 65/239 (27%), Positives = 110/239 (46%), Gaps = 23/239 (9%)

Query: 776  NFSIRNLIGTGGFGSTYKAELV----PGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRH 830
             +++  ++G G FG   +A LV         A+K++ + +    ++    E   L +++H
Sbjct: 1    QYNVLRVVGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKH 57

Query: 831  KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
             N+V     +  +  +++V  +  GG+L   I  + GK      I +  + +   + ++H
Sbjct: 58   PNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH 117

Query: 891  YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
                 R++HRDIK  NI L +     L DFG ARLL     +A T V GT  YV PE   
Sbjct: 118  EK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWE 173

Query: 951  TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009
                ++K+D++S G +L EL + K             F   SW  L++K  + S   LP
Sbjct: 174  NMPYNNKSDIWSLGCILYELCTLKHP-----------FQANSWKNLILKVCQGSYKPLP 221

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 87.2 bits (216), Expect = 7e-19
 Identities = 72/266 (27%), Positives = 127/266 (47%), Gaps = 28/266 (10%)

Query: 783  IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
            +GTG FG     +    Y VA+K +  G      +F  E   + ++ H+ LV L G    
Sbjct: 12   LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMKLSHEKLVQLYGVCTK 70

Query: 843  EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
            +  +++V  ++S G L  ++ ++ GK+ Q S + ++  D+ + +AYL      + +HRD+
Sbjct: 71   QRPIYIVTEYMSNGCLLNYL-REHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDL 126

Query: 903  KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF--GYVAPEYATTCRVSDKADV 960
               N L+D++    +SDFGL+R   V +   T+ V   F   +  PE     + S K+DV
Sbjct: 127  AARNCLVDDQGCVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDV 184

Query: 961  YSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQEN 1019
            ++FGV++ E+ S GK   +     + N     S     + +G    L+ P L      E 
Sbjct: 185  WAFGVLMWEVYSLGKMPYE----RFNN-----SETVEKVSQGL--RLYRPHL----ASEK 229

Query: 1020 LLGMMRLASTCTVETLSTRPSVKQVL 1045
            +  +M    +C  E    RP+ +Q+L
Sbjct: 230  VYAIM---YSCWHEKAEERPTFQQLL 252

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 87.3 bits (216), Expect = 8e-19
 Identities = 72/282 (25%), Positives = 121/282 (42%), Gaps = 44/282 (15%)

Query: 781  NLIGTGGFGSTYKAELVPGYLVAVKKLSIG---------RFQGIQQFDAEIGTLGRIRHK 831
             ++G G +G+ Y      G L+AVK++ +           ++ +Q+   E+  L  ++H 
Sbjct: 6    EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQE---EVDLLKSLKHV 62

Query: 832  NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
            N+V  +G  + +  + +   F+ GG++ + +  + G   +  V  K    I   +AYLH 
Sbjct: 63   NIVQYLGTCLDDNTISIFMEFVPGGSISSIL-NRFGPLPE-PVFCKYTKQILDGVAYLHN 120

Query: 892  SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT-----TDVAGTFGYVAP 946
            +CV   VHRDIK +N++L       L DFG AR L     H T       + GT  ++AP
Sbjct: 121  NCV---VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177

Query: 947  EYATTCRVSDKADVYSFGVVLLELISGK---RSLDPSFSEYGNGFNIVSWAKLLIKEGRS 1003
            E         K+D++S G  + E+ +GK    S+D               A   I   R 
Sbjct: 178  EVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA------------AMFYIGAHRG 225

Query: 1004 SELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVL 1045
                LP+ + A   +         ++C       RPS  Q+L
Sbjct: 226  LMPRLPDSFSAAAID-------FVTSCLTRDQHERPSALQLL 260

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 87.3 bits (217), Expect = 9e-19
 Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 18/203 (8%)

Query: 783 IGTGGFGSTYKAE-LVPGYLVAVKKLS----IGRFQGIQQFDAEIGTLGRIRHKNLVTLI 837
           I  G +G  + A+    G + A+K +     I + Q + Q   E   L + +   +V L 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQ-VDQVLTERDILSQAQSPYVVKLY 59

Query: 838 GYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
             + G+  ++LV  +L GG+L + +   +   +   V      +I  AL YLH S    I
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDLASLLE--NVGSLDEDVARIYIAEIVLALEYLH-SN--GI 114

Query: 898 VHRDIKPSNILLDEELNAYLSDFGLAR-------LLEVSETHATTDVAGTFGYVAPEYAT 950
           +HRD+KP NIL+D   +  L+DFGL++       +    +      + GT  Y+APE   
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174

Query: 951 TCRVSDKADVYSFGVVLLELISG 973
               S   D +S G +L E + G
Sbjct: 175 GQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 87.7 bits (217), Expect = 1e-18
 Identities = 55/193 (28%), Positives = 103/193 (53%), Gaps = 8/193 (4%)

Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV 841
           IG G  G+ Y A ++  G  VA+K++++ +    +    EI  +   +H N+V  +  Y+
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86

Query: 842 GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
              E+++V  +L+GG+L   + +     +    I  +  +  QAL +LH +   +++HRD
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSN---QVIHRD 140

Query: 902 IKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVY 961
           IK  NILL  + +  L+DFG    +   ++  +T V GT  ++APE  T      K D++
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 199

Query: 962 SFGVVLLELISGK 974
           S G++ +E++ G+
Sbjct: 200 SLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 86.6 bits (214), Expect = 1e-18
 Identities = 61/204 (29%), Positives = 101/204 (49%), Gaps = 10/204 (4%)

Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDA---EIGTLGRIRHK 831
            + I   IG G FG  Y A+         +K++ + +   +++ +A   E+  L +++H 
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP-VKEKEASKKEVILLAKMKHP 59

Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
           N+VT    +     +F+V  +  GG+L   I+++ G       I    + I+  L ++H 
Sbjct: 60  NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119

Query: 892 SCVPRIVHRDIKPSNILLDEE-LNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
               +I+HRDIK  NI L +  + A L DFG+AR L  S   A T   GT  Y++PE   
Sbjct: 120 R---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT-CVGTPYYLSPEICQ 175

Query: 951 TCRVSDKADVYSFGVVLLELISGK 974
               ++K D++S G VL EL + K
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 86.8 bits (215), Expect = 1e-18
 Identities = 69/249 (27%), Positives = 118/249 (47%), Gaps = 23/249 (9%)

Query: 782  LIGTGGFGSTYKA-ELVPGYLVAVKK--LSIGRFQG-------IQQFDAEIGTLGRIRHK 831
            LIG+G FGS Y       G L+AVK+  L              +     EI  L  ++H+
Sbjct: 7    LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 832  NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
            N+V  +G  +    + +   ++ GG++   ++       + +++      I + L YLH 
Sbjct: 67   NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA--FEETLVRNFVRQILKGLNYLHN 124

Query: 892  SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVA-----GTFGYVAP 946
                 I+HRDIK +NIL+D +    +SDFG+++ LE +     T+ A     G+  ++AP
Sbjct: 125  R---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181

Query: 947  EYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSEL 1006
            E       + KAD++S G +++E+++GK    P  ++    F I   A   I    SSE 
Sbjct: 182  EVVKQTSYTRKADIWSLGCLVVEMLTGKHPF-PDCTQLQAIFKIGENASPEIPSNISSEA 240

Query: 1007 --FLPELWE 1013
              FL + +E
Sbjct: 241  IDFLEKTFE 249

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 86.4 bits (214), Expect = 1e-18
 Identities = 54/194 (27%), Positives = 98/194 (50%), Gaps = 5/194 (2%)

Query: 778 SIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTL 836
           ++++ +G G +G  Y+         VAVK L     + +++F  E   +  I+H NLV L
Sbjct: 9   TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQL 67

Query: 837 IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPR 896
           +G    E   +++  F++ GNL  ++ + + +++   V+  +A  I+ A+ YL       
Sbjct: 68  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---N 124

Query: 897 IVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD 956
            +HRD+   N L+ E     ++DFGL+RL+      A         + APE     + S 
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 184

Query: 957 KADVYSFGVVLLEL 970
           K+DV++FGV+L E+
Sbjct: 185 KSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 87.0 bits (215), Expect = 2e-18
 Identities = 83/291 (28%), Positives = 134/291 (46%), Gaps = 46/291 (15%)

Query: 783  IGTGGFGSTYKAEL-VPGY----LVAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVTL 836
            +G   FG  YK  L +PG     LVA+K L  I   Q   +F  E   +  + H N+V L
Sbjct: 13   LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 837  IGYYVGEAEMFLVYNFLSGGNLETFI-----HKKSG------KKIQWSVIH----KIAID 881
            +G    E  + +++ +L+ G+L  F+     H   G        ++ S+ H     IAI 
Sbjct: 73   LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 882  IAQALAYL--HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH-ATTDVA 938
            IA  + YL  H+      VH+D+   NIL+ E+L+  +SD GL+R +  ++ +       
Sbjct: 133  IAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187

Query: 939  GTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLI 998
                ++ PE     + S  +D++SFGVVL E+ S    L P +     GF+     + +I
Sbjct: 188  LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS--FGLQPYY-----GFS----NQEVI 236

Query: 999  KEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLK 1049
            +  R  +L LP   +  P+     M  L + C  E  S RP  K +  +L+
Sbjct: 237  EMVRKRQL-LPCSEDCPPR-----MYSLMTECWQEGPSRRPRFKDIHTRLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 86.3 bits (213), Expect = 3e-18
 Identities = 53/193 (27%), Positives = 105/193 (54%), Gaps = 8/193 (4%)

Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV 841
           IG G  G+ + A ++  G  VA+K++++ +    +    EI  +  +++ N+V  +  ++
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86

Query: 842 GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
              E+F+V  +L+GG+L   + +    + Q   I  +  +  QAL +LH +   +++HRD
Sbjct: 87  VGDELFVVMEYLAGGSLTDVVTETCMDEAQ---IAAVCRECLQALEFLHAN---QVIHRD 140

Query: 902 IKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVY 961
           IK  N+LL  + +  L+DFG    +   ++  +T V GT  ++APE  T      K D++
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 199

Query: 962 SFGVVLLELISGK 974
           S G++ +E++ G+
Sbjct: 200 SLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 85.2 bits (211), Expect = 3e-18
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 11/203 (5%)

Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G+G FG  +  +      VA+K +  G       F  E   + ++ H NLV L G    
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE-DDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGK-KIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
           +  +F+V  +++ G L  ++ ++ GK   +W  +  +  D+ +A+ YL  +     +HRD
Sbjct: 71  QRPIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYLESNGF---IHRD 125

Query: 902 IKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF--GYVAPEYATTCRVSDKAD 959
           +   N L+ E+    +SDFGLAR   V +   T+     F   +  PE     R S K+D
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARY--VLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSD 183

Query: 960 VYSFGVVLLELISGKRSLDPSFS 982
           V+SFGV++ E+ S  +     FS
Sbjct: 184 VWSFGVLMWEVFSEGKMPYERFS 206

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 86.1 bits (214), Expect = 3e-18
 Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 17/204 (8%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVPGY-LVAVKKLS---IGRFQGIQQFDAEIGTLGRIRHK 831
           +F     +GTG FG              A+K LS   I + + ++    E   L  IRH 
Sbjct: 2   DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHP 61

Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGK-KIQWSVIHKIAIDIAQALAYLH 890
            LV L G +  ++ ++LV  ++ GG L +   +KSG+     +  +  A  +  AL YLH
Sbjct: 62  FLVNLYGSFQDDSNLYLVMEYVPGGELFSH-LRKSGRFPEPVARFY--AAQVVLALEYLH 118

Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
            S    IV+RD+KP N+LLD +    ++DFG A+ +   +    T + GT  Y+APE   
Sbjct: 119 -SL--DIVYRDLKPENLLLDSDGYIKITDFGFAKRV---KGRTYT-LCGTPEYLAPE-II 170

Query: 951 TCRVSDKA-DVYSFGVVLLELISG 973
             +   KA D ++ G+++ E+++G
Sbjct: 171 LSKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 84.9 bits (210), Expect = 4e-18
 Identities = 63/215 (29%), Positives = 108/215 (50%), Gaps = 18/215 (8%)

Query: 783 IGTGGFGSTYKAELVP----GYLVAVKKLSIGRFQGIQQFDA--EIGTLGRIRHKNLVTL 836
           IG G FG   KA LV     G    +K+++I +    ++ ++  E+  L  ++H N+V  
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64

Query: 837 IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPR 896
              +     +++V ++  GG+L   I+ + G       I    + I  AL ++H     +
Sbjct: 65  QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---K 121

Query: 897 IVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD 956
           I+HRDIK  NI L ++    L DFG+AR+L  +   A T + GT  Y++PE       ++
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEICENRPYNN 180

Query: 957 KADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIV 991
           K+D+++ G VL E+ + K +      E GN  N+V
Sbjct: 181 KSDIWALGCVLYEMCTLKHAF-----EAGNMKNLV 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 85.7 bits (213), Expect = 4e-18
 Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 42/212 (19%)

Query: 783 IGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGIQQFDA--------EIGTLGRI-RHKN 832
           +G G FGS Y A     G LVA+KK+        ++F +        E+ +L ++  H N
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHPN 59

Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH-- 890
           +V L   +    E++ V+ ++ G NL   +  + GK    SVI  I   I Q LA++H  
Sbjct: 60  IVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH 118

Query: 891 -YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE-- 947
            +       HRD+KP N+L+       ++DFGLAR  E+      TD   T  Y APE  
Sbjct: 119 GF------FHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTRWYRAPEIL 170

Query: 948 -----YATTCRVSDKADVYSFGVVLLELISGK 974
                Y      S   D+++ G ++ EL + +
Sbjct: 171 LRSTSY------SSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 84.8 bits (210), Expect = 5e-18
 Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 11/204 (5%)

Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDA--EIGTLGRIRHKN 832
           +F +   +G G +GS YK + L      A+K++ +G     ++ DA  EI  L  + H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHK--KSGKKIQWSVIHKIAIDIAQALAYLH 890
           +++    ++   ++ +V  +   G+L   I K  K  K I    I +I I + + L  LH
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
                +I+HRD+K +NILL       + D G++++L   +  A T + GT  Y+APE   
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVL--KKNMAKTQI-GTPHYMAPEVWK 174

Query: 951 TCRVSDKADVYSFGVVLLELISGK 974
               S K+D++S G +L E+ +  
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFA 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 85.2 bits (211), Expect = 6e-18
 Identities = 52/215 (24%), Positives = 97/215 (45%), Gaps = 25/215 (11%)

Query: 775 GNFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKL--SIGRFQGIQQFDAEIGTLGR 827
                  ++G+G FG+ YK   +P        VA+K L       +  ++   E   +  
Sbjct: 7   TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSP-KANKEILDEAYVMAS 65

Query: 828 IRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGK-----KIQWSVIHKIAIDI 882
           + H ++V L+G  +   ++ L+   +  G L  ++            + W V       I
Sbjct: 66  VDHPHVVRLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCV------QI 118

Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT-F 941
           A+ ++YL      R+VHRD+   N+L+    +  ++DFGLA+LL+V E     +      
Sbjct: 119 AKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPI 175

Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKR 975
            ++A E       + K+DV+S+GV + EL++ G +
Sbjct: 176 KWMALESILHRIYTHKSDVWSYGVTVWELMTFGAK 210

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 84.9 bits (210), Expect = 6e-18
 Identities = 59/197 (29%), Positives = 104/197 (52%), Gaps = 14/197 (7%)

Query: 780 RNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQ-QFDAEIGTLGRIRHKNLVTLI 837
           + ++G G  G+ YKA  +    ++AVK + +     +Q Q  +E+  L +     ++   
Sbjct: 6   QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65

Query: 838 GYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
           G +  E  + +   F+ GG+L+ +      +KI   V+ +IA+ + + L YL +S   +I
Sbjct: 66  GAFFVENRISICTEFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYL-WSL--KI 116

Query: 898 VHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDK 957
           +HRD+KPSN+L++      L DFG++  L  S   A T V GT  Y+APE  +  +    
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--AKTYV-GTNAYMAPERISGEQYGIH 173

Query: 958 ADVYSFGVVLLELISGK 974
           +DV+S G+  +EL  G+
Sbjct: 174 SDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 84.9 bits (210), Expect = 7e-18
 Identities = 58/198 (29%), Positives = 96/198 (48%), Gaps = 10/198 (5%)

Query: 783 IGTGGFGSTYKAEL-VPGYLVAVKKLSIGRF---QGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +G GGFG     ++   G L A KKL+  R    +G +    E   L ++  + +V+L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKI--AIDIAQALAYLHYSCVPR 896
            +  + ++ LV   ++GG+L   I+    +   +           I   L +LH     R
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---R 117

Query: 897 IVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD 956
           I++RD+KP N+LLD + N  +SD GLA  L+  ++  T   AGT G++APE         
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEEYDF 176

Query: 957 KADVYSFGVVLLELISGK 974
             D ++ GV L E+I+ +
Sbjct: 177 SVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 83.8 bits (207), Expect = 9e-18
 Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 15/204 (7%)

Query: 782 LIGTGGFGSTY------KAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
           ++G G FG  +        +LV    + V++++       Q    E   L  + H N++ 
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQN---ECQVLKLLSHPNIIE 63

Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
               ++ +  + +V  +  GG L  +I K+    +    I    + I  AL ++H     
Sbjct: 64  YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK--- 120

Query: 896 RIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV 954
            I+HRD+K  NILLD+      + DFG++++L  S++ A T V GT  Y++PE       
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKIL-SSKSKAYT-VVGTPCYISPELCEGKPY 178

Query: 955 SDKADVYSFGVVLLELISGKRSLD 978
           + K+D+++ G VL EL S KR+ +
Sbjct: 179 NQKSDIWALGCVLYELASLKRAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 84.2 bits (208), Expect = 1e-17
 Identities = 57/196 (29%), Positives = 98/196 (50%), Gaps = 9/196 (4%)

Query: 783 IGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQ---GIQQFDAEIGTLGRIRHKNLVTLIG 838
           +G GGFG     ++   G + A KKL   R +   G +    E   L ++    +V L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +  +  + LV + ++GG+L+  I+    + ++   +   +  I   + +LH      IV
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIV 117

Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+LLD++ N  LSD GLA  +E+ +    T  AGT GY+APE       S   
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILKEEPYSYPV 175

Query: 959 DVYSFGVVLLELISGK 974
           D ++ G  + E+++G+
Sbjct: 176 DWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 84.7 bits (210), Expect = 1e-17
 Identities = 70/232 (30%), Positives = 103/232 (44%), Gaps = 37/232 (15%)

Query: 770 VVRATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDA-------E 821
             R+   F   N IG G +G  Y+A +   G +VA+KK+   R     + D        E
Sbjct: 2   RCRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKV---RMD--NERDGIPISSLRE 56

Query: 822 IGTLGRIRHKNLVTLIGYYVGEA--EMFLVYNF-------LSGGNLETFIHKKSGKKIQW 872
           I  L  +RH N+V L    VG+    +FLV  +       L       F           
Sbjct: 57  ITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSE--------- 107

Query: 873 SVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH 932
           S +  + + + + L YLH +    I+HRD+K SN+LL ++    ++DFGLAR   +    
Sbjct: 108 SQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP 164

Query: 933 ATTDVAGTFGYVAPEYATTCRVSDKA-DVYSFGVVLLELISGKRSLDPSFSE 983
            T  V  T  Y APE    C     A D+++ G +L EL++ K  L P  SE
Sbjct: 165 MTPKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK-PLLPGKSE 214

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 85.3 bits (212), Expect = 1e-17
 Identities = 71/216 (32%), Positives = 105/216 (48%), Gaps = 32/216 (14%)

Query: 777 FSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDA-----EIGTLGRIR- 829
           + I   +G G +G  +KA +     +VA+KK+    F+     DA     EI  L  +  
Sbjct: 9   YEILQKLGKGAYGIVWKAIDRRTKEVVALKKI-FDAFR--NATDAQRTFREIMFLQELGD 65

Query: 830 HKNLVTLIGYYVGEAE----MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHK--IAIDIA 883
           H N+V L+   V +AE    ++LV+ ++     ET +H      I    +HK  I   + 
Sbjct: 66  HPNIVKLLN--VIKAENDKDIYLVFEYM-----ETDLHAVIRANILED-VHKRYIMYQLL 117

Query: 884 QALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL----EVSETHATTDVAG 939
           +AL Y+H      ++HRD+KPSNILL+ +    L+DFGLAR L    E  E    TD   
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174

Query: 940 TFGYVAPEYATTCRVSDKA-DVYSFGVVLLELISGK 974
           T  Y APE         K  D++S G +L E++ GK
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 84.4 bits (209), Expect = 1e-17
 Identities = 54/203 (26%), Positives = 99/203 (48%), Gaps = 13/203 (6%)

Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIG---RFQGIQQFDAEIGTLGRIRHK 831
           +      +GTG FG  +   + +  +  A+K ++I    R +  Q    E   L  + H 
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61

Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
            ++ L      +  ++++  ++ GG  E F + ++  +   S     A +I  AL YLH 
Sbjct: 62  FIIRLFWTEHDQRFLYMLMEYVPGG--ELFSYLRNSGRFSNSTGLFYASEIVCALEYLHS 119

Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT 951
                IV+RD+KP NILLD+E +  L+DFG A+  ++ +   T  + GT  Y+APE   +
Sbjct: 120 K---EIVYRDLKPENILLDKEGHIKLTDFGFAK--KLRDR--TWTLCGTPEYLAPEVIQS 172

Query: 952 CRVSDKADVYSFGVVLLELISGK 974
              +   D ++ G+++ E++ G 
Sbjct: 173 KGHNKAVDWWALGILIYEMLVGY 195

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 83.3 bits (206), Expect = 2e-17
 Identities = 69/227 (30%), Positives = 104/227 (45%), Gaps = 43/227 (18%)

Query: 780 RNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           R ++G G +G  Y A +L     +A+K++     + +Q    EI     ++H+N+V  +G
Sbjct: 13  RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLG 72

Query: 839 YYVGEAEMFLVY-NFLSGGNLETFIHKKSGK-KIQWSVIHKIAIDIAQALAYLHYSCVPR 896
               E   F ++   + GG+L   +  K G  K     I      I + L YLH +   +
Sbjct: 73  S-DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---Q 128

Query: 897 IVHRDIKPSNILLDEELNAY-----LSDFG----LARLLEVSETHATTDVAGTFGYVAPE 947
           IVHRDIK  N+L    +N Y     +SDFG    LA +   +ET       GT  Y+APE
Sbjct: 129 IVHRDIKGDNVL----VNTYSGVVKISDFGTSKRLAGINPCTET-----FTGTLQYMAPE 179

Query: 948 YATTCRVSDK--------ADVYSFGVVLLELISGKRSLDPSFSEYGN 986
                 V DK        AD++S G  ++E+ +GK    P F E G 
Sbjct: 180 ------VIDKGPRGYGAPADIWSLGCTIVEMATGK----PPFIELGE 216

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 83.7 bits (207), Expect = 2e-17
 Identities = 64/196 (32%), Positives = 95/196 (48%), Gaps = 19/196 (9%)

Query: 783 IGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGIQQFD---AEIGTLGRIRHKNLVTLIG 838
           IG G FG+ Y A  V    +VA+KK+S    Q  +++     E+  L ++RH N +   G
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82

Query: 839 YYVGEAEMFLVYNFLSGGNLETF-IHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
            Y+ E   +LV  +  G   +   +HKK  ++++   I  I     Q LAYLH       
Sbjct: 83  CYLREHTAWLVMEYCLGSASDILEVHKKPLQEVE---IAAICHGALQGLAYLHSHER--- 136

Query: 898 VHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC---RV 954
           +HRDIK  NILL E     L+DFG A L+  + +       GT  ++APE        + 
Sbjct: 137 IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS-----FVGTPYWMAPEVILAMDEGQY 191

Query: 955 SDKADVYSFGVVLLEL 970
             K DV+S G+  +EL
Sbjct: 192 DGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 83.6 bits (207), Expect = 2e-17
 Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 20/205 (9%)

Query: 782 LIGTGGFGSTYKAELVP-GYLVAVKKLSI---GRFQGIQQFDAEIGTLGRIRHKNLVTLI 837
            IG G FG+  K    P G ++AVK++      + Q  ++   ++  +  +R  +   ++
Sbjct: 11  EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQ--KRLLMDLDVV--MRSSDCPYIV 66

Query: 838 GYY-----VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
            +Y      G+  + +    +S      ++++     I   ++ KIA+   +AL YL   
Sbjct: 67  KFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE 126

Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
              +I+HRD+KPSNILLD   N  L DFG++  L   ++ A T  AG   Y+APE     
Sbjct: 127 L--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV--DSIAKTRDAGCRPYMAPERIDPS 182

Query: 953 RVSD---KADVYSFGVVLLELISGK 974
                  ++DV+S G+ L E+ +GK
Sbjct: 183 ARDGYDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 83.3 bits (206), Expect = 2e-17
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 16/209 (7%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVPGY----LVAVKKLS----IGRFQGIQQFDAEIGTLGR 827
           NF +  ++GTG +G  +    V G+    L A+K L     + + +  +    E   L  
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 828 IRHKN-LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQAL 886
           +R    LVTL   +  + ++ L+ ++++GG  E F H    +    S +     +I  AL
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLHLILDYVNGG--ELFTHLYQREHFTESEVRVYIAEIVLAL 118

Query: 887 AYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAP 946
            +LH      I++RDIK  NILLD E +  L+DFGL++     E        GT  Y+AP
Sbjct: 119 DHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175

Query: 947 EYATT-CRVSDKA-DVYSFGVVLLELISG 973
           E         DKA D +S GV+  EL++G
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 82.9 bits (205), Expect = 3e-17
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 31/215 (14%)

Query: 783 IGTGGFGSTYKAELV------PGYLVAVKKLSIGRFQGIQQ-FDAEIGTLGRIRHKNLVT 835
           +G G FG  YK EL           VA+K L       +QQ F  E   +  ++H N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKS-------------GKKIQW--SVIHKIAI 880
           L+G    E    +++ +L+ G+L  F+ + S              K        +H IAI
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH-IAI 131

Query: 881 DIAQALAYL--HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVA 938
            IA  + YL  H+      VHRD+   N L+ E L   +SDFGL+R +  ++ +     +
Sbjct: 132 QIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186

Query: 939 G-TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
                ++ PE     + + ++D++SFGVVL E+ S
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 82.0 bits (202), Expect = 3e-17
 Identities = 59/196 (30%), Positives = 94/196 (47%), Gaps = 13/196 (6%)

Query: 782 LIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQ-QFDAEIGTLGRIRHKNLVTLIGYY 840
           L+G G FG  +K  L     VAVK       Q ++ +F +E   L +  H N+V LIG  
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
                +++V   + GG+  +F+ KK   +++   + K A+D A  +AYL        +HR
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESK---NCIHR 117

Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG----TFGYVAPEYATTCRVSD 956
           D+   N L+ E     +SDFG++R     E       +G       + APE     R S 
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR----QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSS 173

Query: 957 KADVYSFGVVLLELIS 972
           ++DV+S+G++L E  S
Sbjct: 174 ESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 86.0 bits (213), Expect = 4e-17
 Identities = 38/87 (43%), Positives = 53/87 (60%)

Query: 561 LDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSI 620
           L L    + G +P+++ KL+ L+ I L GN++ G IP   G + SL VLDLS+N+  GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 621 PASLTKATKLESLFLAHNRLSGEIPVS 647
           P SL + T L  L L  N LSG +P +
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAA 509

Length = 623

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 82.4 bits (203), Expect = 4e-17
 Identities = 62/202 (30%), Positives = 97/202 (48%), Gaps = 9/202 (4%)

Query: 777 FSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLS---IGRFQGIQQFDAEIGTLGRIRHKN 832
           F    ++G GGFG     ++   G + A KKL    I + +G      E   L ++  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V+L   Y  +  + LV   ++GG+L+  I+       +       A +I   L  LH  
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121

Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
              RIV+RD+KP NILLD+  +  +SD GLA  + V E        GT GY+APE     
Sbjct: 122 ---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKNE 176

Query: 953 RVSDKADVYSFGVVLLELISGK 974
           R +   D ++ G +L E+I+G+
Sbjct: 177 RYTFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 82.4 bits (203), Expect = 5e-17
 Identities = 85/309 (27%), Positives = 124/309 (40%), Gaps = 49/309 (15%)

Query: 758  FADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYK-AELVPGYLVAVKKLSIGRFQGIQ 816
            F    + L  +++   T  + I   IG G +G  YK      G L AVK L       I 
Sbjct: 5    FPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-----PIS 59

Query: 817  QFDAEIGTLGRI-----RHKNLVTLIG------YYVGEAEMFLVYNFLSGGNLETFIHK- 864
              D EI     I      H N+V   G        VG  +++LV    +GG++   +   
Sbjct: 60   DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG-GQLWLVLELCNGGSVTELVKGL 118

Query: 865  -KSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLA 923
               G+++  ++I  I       L +LH +   RI+HRD+K +NILL  E    L DFG++
Sbjct: 119  LICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVS 175

Query: 924  RLLEVSETHATTDVAGTFGYVAPEYATTCRVSD-----KADVYSFGVVLLELISGKRSLD 978
              L  +     T V GT  ++APE     +  D     + DV+S G+  +EL  G    D
Sbjct: 176  AQLTSTRLRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG----D 230

Query: 979  PSFSEYGNGFNIVSWAKLLIKEGR--SSELFLPELWEAGPQENLLGMMRLASTCTVETLS 1036
            P   +       +   K L K  R     L  PE W               S C ++   
Sbjct: 231  PPLFD-------MHPVKTLFKIPRNPPPTLLHPEKW-------CRSFNHFISQCLIKDFE 276

Query: 1037 TRPSVKQVL 1045
             RPSV  +L
Sbjct: 277  ARPSVTHLL 285

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 83.0 bits (205), Expect = 6e-17
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 16/210 (7%)

Query: 770 VVRATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTL 825
           V   T  +     +G G FG    A + + G  VA+KK+ +  F      ++   E+  L
Sbjct: 5   VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI-MKPFSTPVLAKRTYRELKLL 63

Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
             +RH+N+++L   ++   E       L G +L   +   + + ++   I      I + 
Sbjct: 64  KHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLL---TSRPLEKQFIQYFLYQILRG 120

Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
           L Y+H + V   VHRD+KPSNIL++E  +  + DFGLAR+ +       T    T  Y A
Sbjct: 121 LKYVHSAGV---VHRDLKPSNILINENCDLKICDFGLARIQD----PQMTGYVSTRYYRA 173

Query: 946 PEYATTCRVSD-KADVYSFGVVLLELISGK 974
           PE   T +  D + D++S G +  E++ GK
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 82.9 bits (205), Expect = 8e-17
 Identities = 66/208 (31%), Positives = 101/208 (48%), Gaps = 31/208 (14%)

Query: 781 NLIGTGGFGSTYKAELVP-GYLVAVKKL------SIGRFQGIQQFDAEIGTLGRIRHKNL 833
           N IG+G  G+ YK    P G L A+K +      ++ R     Q   EI  L  + H N+
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR-----QICREIEILRDVNHPNV 134

Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKI-QWSVIHKIAIDIAQALAYLHYS 892
           V     +    E+ ++  F+ GG+LE       G  I     +  +A  I   +AYLH  
Sbjct: 135 VKCHDMFDHNGEIQVLLEFMDGGSLE-------GTHIADEQFLADVARQILSGIAYLHRR 187

Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
               IVHRDIKPSN+L++   N  ++DFG++R+L  +     + V GT  Y++PE   T 
Sbjct: 188 ---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINT- 242

Query: 953 RVSDKA------DVYSFGVVLLELISGK 974
            ++  A      D++S GV +LE   G+
Sbjct: 243 DLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 82.0 bits (202), Expect = 9e-17
 Identities = 58/202 (28%), Positives = 101/202 (50%), Gaps = 11/202 (5%)

Query: 783 IGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV 841
           IG G  G    A +   G LVAVKK+ + + Q  +    E+  +   +H+N+V +   Y+
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 842 GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
              E+++V  FL GG L   +   +  ++    I  + + + +AL+ LH   V   +HRD
Sbjct: 88  VGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLKALSVLHAQGV---IHRD 141

Query: 902 IKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVY 961
           IK  +ILL  +    LSDFG    +   E      + GT  ++APE  +      + D++
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKSLVGTPYWMAPELISRLPYGPEVDIW 200

Query: 962 SFGVVLLELISGKRSLDPSFSE 983
           S G++++E++ G+    P F+E
Sbjct: 201 SLGIMVIEMVDGE---PPYFNE 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 81.7 bits (202), Expect = 9e-17
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 11/213 (5%)

Query: 783 IGTGGFGSTYKAE-LVPGYLVAVKKLSI-GRFQGIQQFDA-EIGTLGRIRHKNLVTLIGY 839
           IG G +G  YK      G +VA+KK+ +    +G+      EI  L  ++H N+V L   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 840 YVGEAEMFLVYNFLSGGNLETFIHK-KSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            + E+ ++L++ FLS  +L+ ++     G+ +   ++      I Q + + H     R++
Sbjct: 68  LMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVL 123

Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT-TCRVSDK 957
           HRD+KP N+L+D +    L+DFGLAR   +     T +V  T  Y APE    + R S  
Sbjct: 124 HRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-TLWYRAPEVLLGSPRYSTP 182

Query: 958 ADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
            D++S G +  E+ + K+ L    SE    F I
Sbjct: 183 VDIWSIGTIFAEMAT-KKPLFHGDSEIDQLFRI 214

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 82.1 bits (202), Expect = 1e-16
 Identities = 66/209 (31%), Positives = 102/209 (48%), Gaps = 19/209 (9%)

Query: 777 FSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFD---AEIGTLGRIRHKN 832
           F+    IG G FG+ Y A ++    +VA+KK+S    Q  +++     E+  L RI+H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETF-IHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
            +   G Y+ E   +LV  +  G   +   +HKK  ++++ + I   A+   Q LAYLH 
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGAL---QGLAYLHS 143

Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT 951
                ++HRDIK  NILL E     L+DFG A +   + +       GT  ++APE    
Sbjct: 144 H---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS-----FVGTPYWMAPEVILA 195

Query: 952 C---RVSDKADVYSFGVVLLELISGKRSL 977
               +   K DV+S G+  +EL   K  L
Sbjct: 196 MDEGQYDGKVDVWSLGITCIELAERKPPL 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 81.7 bits (201), Expect = 1e-16
 Identities = 55/193 (28%), Positives = 104/193 (53%), Gaps = 8/193 (4%)

Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV 841
           IG G  G+ Y A ++  G  VA+K++++ +    +    EI  +   ++ N+V  +  Y+
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86

Query: 842 GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
              E+++V  +L+GG+L   + +    + Q   I  +  +  QAL +LH +   +++HRD
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTETCMDEGQ---IAAVCRECLQALDFLHSN---QVIHRD 140

Query: 902 IKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVY 961
           IK  NILL  + +  L+DFG    +   ++  +T V GT  ++APE  T      K D++
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 199

Query: 962 SFGVVLLELISGK 974
           S G++ +E++ G+
Sbjct: 200 SLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 81.2 bits (200), Expect = 1e-16
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 18/216 (8%)

Query: 775 GNFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFDAEIGTLGRI-RHKN 832
           G F +  ++G G +G  YK   V  G L A+K + +   +  ++   EI  L +   H+N
Sbjct: 16  GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRN 74

Query: 833 LVTLIGYYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQAL 886
           + T  G ++ ++      +++LV  F   G++   +    G  ++   I  I  +I + L
Sbjct: 75  IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGL 134

Query: 887 AYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAP 946
           A+LH     +++HRDIK  N+LL E     L DFG++  L+ +     T + GT  ++AP
Sbjct: 135 AHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAP 190

Query: 947 EYATTCRVSD-----KADVYSFGVVLLELISGKRSL 977
           E        D     ++D++S G+  +E+  G   L
Sbjct: 191 EVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 81.3 bits (200), Expect = 1e-16
 Identities = 54/193 (27%), Positives = 102/193 (52%), Gaps = 8/193 (4%)

Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV 841
           IG G  G+ Y A ++  G  VA++++++ +    +    EI  +   ++ N+V  +  Y+
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 842 GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
              E+++V  +L+GG+L   + +    + Q   I  +  +  QAL +LH +   +++HRD
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCMDEGQ---IAAVCRECLQALEFLHSN---QVIHRD 141

Query: 902 IKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVY 961
           IK  NILL  + +  L+DFG    +   E    + + GT  ++APE  T      K D++
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200

Query: 962 SFGVVLLELISGK 974
           S G++ +E+I G+
Sbjct: 201 SLGIMAIEMIEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 80.9 bits (199), Expect = 1e-16
 Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 13/209 (6%)

Query: 777 FSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQG-IQQFDAEIGTLGRIRHKNLV 834
           F+    IG G FG  YK  +     +VA+K + +   +  I+    EI  L +     + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
              G Y+   +++++  +L GG+    +  K G  ++ + I  I  +I + L YLH    
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLL--KPGP-LEETYIATILREILKGLDYLHSE-- 120

Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV 954
            R +HRDIK +N+LL E+ +  L+DFG+A  L  ++    T V   F ++APE       
Sbjct: 121 -RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVIKQSAY 178

Query: 955 SDKADVYSFGVVLLELISGKRSLDPSFSE 983
             KAD++S G+  +EL  G    +P  S+
Sbjct: 179 DFKADIWSLGITAIELAKG----EPPNSD 203

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 80.2 bits (198), Expect = 2e-16
 Identities = 52/198 (26%), Positives = 84/198 (42%), Gaps = 15/198 (7%)

Query: 783 IGTGGFGSTYKAE-LVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK-NLVTLI 837
           I  G FGS Y A+    G   A+K   K  +     +    AE   +        +  L 
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 838 GYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
             +  +  ++LV  +L+GG+  + I    G    W    +   ++   +  LH      I
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDW--AKQYIAEVVLGVEDLHQR---GI 118

Query: 898 VHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDK 957
           +HRDIKP N+L+D+  +  L+DFGL+R    ++        GT  Y+APE          
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK-----KFVGTPDYLAPETILGVGDDKM 173

Query: 958 ADVYSFGVVLLELISGKR 975
           +D +S G V+ E + G  
Sbjct: 174 SDWWSLGCVIFEFLFGYP 191

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 80.5 bits (198), Expect = 2e-16
 Identities = 60/216 (27%), Positives = 103/216 (47%), Gaps = 18/216 (8%)

Query: 775 GNFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFDAEIGTLGRI-RHKN 832
           G F +  L+G G +G  YK   V  G L A+K + +   +  ++   EI  L +   H+N
Sbjct: 6   GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRN 64

Query: 833 LVTLIGYYVG------EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQAL 886
           + T  G ++       + +++LV  F   G++   I    G  ++   I  I  +I + L
Sbjct: 65  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 124

Query: 887 AYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAP 946
           ++LH     +++HRDIK  N+LL E     L DFG++  L+ +     T + GT  ++AP
Sbjct: 125 SHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAP 180

Query: 947 EYATTCRVSD-----KADVYSFGVVLLELISGKRSL 977
           E        D     K+D++S G+  +E+  G   L
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 80.5 bits (199), Expect = 2e-16
 Identities = 65/207 (31%), Positives = 106/207 (51%), Gaps = 27/207 (13%)

Query: 782 LIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHK-----NLVT 835
            IG+G  G  YK      G+++AVK++   R  G ++ +  I     +  K      +V 
Sbjct: 22  EIGSGTCGQVYKMRFKKTGHVMAVKQM---RRTGNKEENKRILMDLDVVLKSHDCPYIVK 78

Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL---HYS 892
             GY++ ++++F+    L    L+  + K+    I   ++ K+ + I +AL YL   H  
Sbjct: 79  CYGYFITDSDVFICME-LMSTCLDKLL-KRIQGPIPEDILGKMTVAIVKALHYLKEKH-- 134

Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLA-RLLEVSETHATTDVAGTFGYVAPEYATT 951
               ++HRD+KPSNILLD   N  L DFG++ RL+   ++ A T  AG   Y+APE    
Sbjct: 135 ---GVIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKTRSAGCAAYMAPERIDP 188

Query: 952 CRVSDK----ADVYSFGVVLLELISGK 974
              + K    ADV+S G+ L+EL +G+
Sbjct: 189 PDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 80.4 bits (198), Expect = 2e-16
 Identities = 62/209 (29%), Positives = 102/209 (48%), Gaps = 16/209 (7%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVPGY----LVAVKKLS----IGRFQGIQQFDAEIGTLGR 827
           NF +  ++GTG +G  +    V G+    L A+K L     + + +  +    E   L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 828 IRHKN-LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQAL 886
           IR    LVTL   +  + ++ L+ ++++GG  E F H    ++ +   +   + +I  AL
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGG--ELFTHLSQRERFKEQEVQIYSGEIVLAL 118

Query: 887 AYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAP 946
            +LH      I++RDIK  NILLD   +  L+DFGL++     E        GT  Y+AP
Sbjct: 119 EHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAP 175

Query: 947 EYATTCRVS-DKA-DVYSFGVVLLELISG 973
           +         DKA D +S GV++ EL++G
Sbjct: 176 DIVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 80.5 bits (198), Expect = 3e-16
 Identities = 55/194 (28%), Positives = 95/194 (48%), Gaps = 11/194 (5%)

Query: 783 IGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV 841
           +G G FG  YKA+    G L A K +     + ++ +  EI  L    H  +V L+G + 
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 842 GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
            + +++++  F  GG ++  I  +  + +    I  I   + +AL YLH     +I+HRD
Sbjct: 80  WDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRD 135

Query: 902 IKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD----- 956
           +K  N+LL  + +  L+DFG++    V          GT  ++APE      + D     
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVSA-KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDY 194

Query: 957 KADVYSFGVVLLEL 970
           KAD++S G+ L+E+
Sbjct: 195 KADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 81.2 bits (200), Expect = 3e-16
 Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 18/205 (8%)

Query: 776 NFSIRNLIGTGGFG----STYKAELVPGYLVAVKKLSIGRFQGIQQFD---AEIGTLGRI 828
           +F+    +GTG FG    +TYK E  P   VA+K+    +    +Q D   +E   L  I
Sbjct: 31  DFNFIRTLGTGSFGRVILATYKNEDFPP--VAIKRFEKSKIIKQKQVDHVFSERKILNYI 88

Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
            H   V L G +  E+ ++LV  F+ GG   TF+ +   K+    V    A  I     Y
Sbjct: 89  NHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEY 146

Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
           L       IV+RD+KP N+LLD++    ++DFG A++++      T  + GT  Y+APE 
Sbjct: 147 LQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TYTLCGTPEYIAPEI 199

Query: 949 ATTCRVSDKADVYSFGVVLLELISG 973
                    AD ++ G+ + E++ G
Sbjct: 200 LLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 80.5 bits (198), Expect = 4e-16
 Identities = 65/203 (32%), Positives = 98/203 (48%), Gaps = 19/203 (9%)

Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFD---AEIGTLGRIRHKNLVTLIG 838
           IG G FG+ Y A       +VAVKK+S    Q  +++     E+  L +++H N +   G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 839 YYVGEAEMFLVYNFLSGGNLETF-IHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
            Y+ E   +LV  +  G   +   +HKK  ++++ + I   A+   Q LAYLH      +
Sbjct: 89  CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGAL---QGLAYLHSHN---M 142

Query: 898 VHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC---RV 954
           +HRDIK  NILL E     L+DFG A     S++       GT  ++APE        + 
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSA-----SKSSPANSFVGTPYWMAPEVILAMDEGQY 197

Query: 955 SDKADVYSFGVVLLELISGKRSL 977
             K DV+S G+  +EL   K  L
Sbjct: 198 DGKVDVWSLGITCIELAERKPPL 220

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 79.9 bits (197), Expect = 4e-16
 Identities = 68/221 (30%), Positives = 105/221 (47%), Gaps = 27/221 (12%)

Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDA--------EIGTLGRIRHKNL 833
           IG G +G  YKA + V    +A+KK+ +      +Q D         EI  L  ++H N+
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRL------EQEDEGVPSTAIREISLLKEMQHGNI 63

Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS--VIHKIAIDIAQALAYLHY 891
           V L      E  ++LV+ +L   +L+   H  S      +  +I      I + +AY H 
Sbjct: 64  VRLQDVVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS 120

Query: 892 SCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
               R++HRD+KP N+L+D   NA  L+DFGLAR   +     T +V  T  Y APE   
Sbjct: 121 H---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEILL 176

Query: 951 -TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
            +   S   D++S G +  E+++ ++ L P  SE    F I
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVN-QKPLFPGDSEIDELFKI 216

Length = 294

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 79.4 bits (196), Expect = 5e-16
 Identities = 56/202 (27%), Positives = 100/202 (49%), Gaps = 11/202 (5%)

Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV 841
           IG G  G    A +   G  VAVKK+ + + Q  +    E+  +   +H N+V +   Y+
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86

Query: 842 GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
              E+++V  FL GG L   +   +  ++    I  + + + +AL++LH      ++HRD
Sbjct: 87  VGDELWVVMEFLEGGALTDIV---THTRMNEEQIATVCLAVLKALSFLHAQ---GVIHRD 140

Query: 902 IKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVY 961
           IK  +ILL  +    LSDFG    +   E      + GT  ++APE  +      + D++
Sbjct: 141 IKSDSILLTSDGRVKLSDFGFCAQVS-KEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIW 199

Query: 962 SFGVVLLELISGKRSLDPSFSE 983
           S G++++E++ G+    P F+E
Sbjct: 200 SLGIMVIEMVDGE---PPYFNE 218

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 79.7 bits (196), Expect = 5e-16
 Identities = 60/202 (29%), Positives = 100/202 (49%), Gaps = 11/202 (5%)

Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV 841
           IG G  G    A E   G  VAVKK+ + + Q  +    E+  +    H+N+V +   Y+
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 842 GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
              E+++V  FL GG L   +   +  ++    I  + + + +AL+YLH   V   +HRD
Sbjct: 90  VGDELWVVMEFLEGGALTDIV---THTRMNEEQIATVCLSVLRALSYLHNQGV---IHRD 143

Query: 902 IKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVY 961
           IK  +ILL  +    LSDFG    +   E      + GT  ++APE  +      + D++
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQVS-KEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIW 202

Query: 962 SFGVVLLELISGKRSLDPSFSE 983
           S G++++E+I G+    P F+E
Sbjct: 203 SLGIMVIEMIDGE---PPYFNE 221

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 79.1 bits (195), Expect = 7e-16
 Identities = 64/204 (31%), Positives = 100/204 (49%), Gaps = 13/204 (6%)

Query: 777 FSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLS---IGRFQGIQQFDAEIGTLGRIRHKN 832
           F    ++G GGFG     ++   G + A KKL    I + +G      E   L ++  + 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHK--KSGKKIQWSVIHKIAIDIAQALAYLH 890
           +V+L   Y  +  + LV   ++GG+L+  I+     G   + +V +  A +I   L  LH
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFY--AAEITCGLEDLH 119

Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
                RIV+RD+KP NILLD+  +  +SD GLA  +E+ E        GT GY+APE   
Sbjct: 120 RE---RIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRVGTVGYMAPEVVK 174

Query: 951 TCRVSDKADVYSFGVVLLELISGK 974
             R +   D +  G ++ E+I GK
Sbjct: 175 NERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 79.6 bits (196), Expect = 8e-16
 Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 15/208 (7%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVPGY----LVAVKKLS----IGRFQGIQQFDAEIGTLGR 827
           NF +  ++GTG +G  +    V G+    L A+K L     + + + ++    E   L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 828 IRHKN-LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQAL 886
           +R    LVTL   +  EA++ L+ +++SGG  E F H           +   + +I  AL
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGG--EMFTHLYQRDNFSEDEVRFYSGEIILAL 118

Query: 887 AYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAP 946
            +LH      IV+RDIK  NILLD E +  L+DFGL++     E   T    GT  Y+AP
Sbjct: 119 EHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAP 175

Query: 947 EYATTCRVSDKA-DVYSFGVVLLELISG 973
           E         KA D +S G+++ EL++G
Sbjct: 176 EIIRGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 78.8 bits (194), Expect = 8e-16
 Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 21/207 (10%)

Query: 779 IRNLIGTGGFGSTYKAELV--------PGYLVAVKKLSIG-RFQGIQQFDAEIGTLGRIR 829
           IR+L G G FG   K EL          G  VAVK L        I     EI  L  + 
Sbjct: 9   IRDL-GEGHFG---KVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 64

Query: 830 HKNLVTLIGYYV--GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALA 887
           H+N+V   G     G   + L+  FL  G+L+ ++  ++  KI      K A+ I + + 
Sbjct: 65  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGMD 123

Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT--DVAGTFGYVA 945
           YL      + VHRD+   N+L++ E    + DFGL + +E  + + T   D+     + A
Sbjct: 124 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYA 180

Query: 946 PEYATTCRVSDKADVYSFGVVLLELIS 972
           PE     +    +DV+SFGV L EL++
Sbjct: 181 PECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 79.3 bits (195), Expect = 8e-16
 Identities = 62/203 (30%), Positives = 99/203 (48%), Gaps = 19/203 (9%)

Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFD---AEIGTLGRIRHKNLVTLIG 838
           IG G FG+ Y A ++    +VA+KK+S    Q  +++     E+  L ++RH N +   G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 839 YYVGEAEMFLVYNFLSGGNLETF-IHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
            Y+ E   +LV  +  G   +   +HKK  ++++ + +   A+   Q LAYLH      +
Sbjct: 83  CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGAL---QGLAYLHSH---NM 136

Query: 898 VHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC---RV 954
           +HRD+K  NILL E     L DFG A ++  +         GT  ++APE        + 
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-----FVGTPYWMAPEVILAMDEGQY 191

Query: 955 SDKADVYSFGVVLLELISGKRSL 977
             K DV+S G+  +EL   K  L
Sbjct: 192 DGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 79.7 bits (196), Expect = 8e-16
 Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 9/199 (4%)

Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGI--QQFDAEIGTLGRIRHKNLVTLIGYY 840
           +G G  G   K +  P  L+  +KL     +     Q   E+  L       +V   G +
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
             + E+ +    + GG+L+  +  K  K+I   ++ K++I + + LAYL      +I+HR
Sbjct: 73  YSDGEISICMEHMDGGSLDQVL--KEAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHR 128

Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADV 960
           D+KPSNIL++      L DFG++  L  S  ++     GT  Y++PE       S ++D+
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTHYSVQSDI 185

Query: 961 YSFGVVLLELISGKRSLDP 979
           +S G+ L+EL  G+  + P
Sbjct: 186 WSMGLSLVELAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 78.6 bits (194), Expect = 9e-16
 Identities = 60/220 (27%), Positives = 97/220 (44%), Gaps = 36/220 (16%)

Query: 783 IGTGGFGSTYKAE---LVPG---YLVAVKKLSIGRFQGIQQ-FDAEIGTLGRIRHKNLVT 835
           +G G FG  +  E   L P     LVAVK L        ++ F+ E   L   +H+N+V 
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIH------------KKSGKKIQWSVIHKIAIDIA 883
             G         +V+ ++  G+L  F+                  ++  S + +IA+ IA
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 884 QALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD---VAGT 940
             + YL        VHRD+   N L+  +L   + DFG++R +       TTD   V G 
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDV------YTTDYYRVGGH 183

Query: 941 ----FGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKR 975
                 ++ PE     + + ++DV+SFGVVL E+ + GK+
Sbjct: 184 TMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQ 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 78.4 bits (193), Expect = 1e-15
 Identities = 77/289 (26%), Positives = 121/289 (41%), Gaps = 32/289 (11%)

Query: 779  IRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQ-FDAEIGTLGRIRHKN 832
            IR L G G FG        P     G +VAVK L     Q     +  EI  L  + H+N
Sbjct: 9    IRVL-GEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHEN 67

Query: 833  LVTLIG--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +V   G     G   + L+  ++  G+L  ++ K    K+  + +   A  I + +AYLH
Sbjct: 68   IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLH 124

Query: 891  YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
                   +HRD+   N+LLD +    + DFGLA+ +     +      G    F Y A E
Sbjct: 125  SQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVE 180

Query: 948  YATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELF 1007
                 + S  +DV+SFGV L EL++     D   S       ++       K+G+ + + 
Sbjct: 181  CLKENKFSYASDVWSFGVTLYELLT---HCDSKQSPPKKFEEMIG-----PKQGQMTVVR 232

Query: 1008 LPELWEAG-----PQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051
            L EL E G     P+     +  L   C       RP+ + ++  LK++
Sbjct: 233  LIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 77.7 bits (192), Expect = 1e-15
 Identities = 58/222 (26%), Positives = 90/222 (40%), Gaps = 49/222 (22%)

Query: 783 IGTGGFGSTYKAELVPG----YLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +G GGFG     ++        L  VKK  I      +   +E   L    H  +V L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI---DIAQ--------ALA 887
            +  +  ++++  +  GG L             W+++    +     A+        A  
Sbjct: 61  TFKDKKYIYMLMEYCLGGEL-------------WTILRDRGLFDEYTARFYIACVVLAFE 107

Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE 947
           YLH      I++RD+KP N+LLD      L DFG A+ L+  +   T    GT  YVAPE
Sbjct: 108 YLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK--TWTFCGTPEYVAPE 162

Query: 948 ------YATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSE 983
                 Y  +       D +S G++L EL++G+    P F E
Sbjct: 163 IILNKGYDFS------VDYWSLGILLYELLTGR----PPFGE 194

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 78.0 bits (192), Expect = 2e-15
 Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 31/218 (14%)

Query: 783 IGTGGFGSTYKAE---LVPG---YLVAVKKLSIGRFQGIQ-QFDAEIGTLGRIRHKNLVT 835
           IG G FG  ++A    L+P     +VAVK L       +Q  F  E   +    H N+V 
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKS------------------GKKIQWSVIHK 877
           L+G       M L++ +++ G+L  F+  +S                     +  S   +
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 878 IAI--DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH-AT 934
           + I   +A  +AYL      + VHRD+   N L+ E +   ++DFGL+R +  ++ + A+
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 935 TDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
            + A    ++ PE     R + ++DV+++GVVL E+ S
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 77.4 bits (191), Expect = 2e-15
 Identities = 82/283 (28%), Positives = 128/283 (45%), Gaps = 28/283 (9%)

Query: 782  LIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDA--EIGTLGRIRHKNLVTLIG 838
            L+G G +G   K +    G +VA+KK        + +  A  EI  L ++RH+NLV LI 
Sbjct: 8    LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 839  YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
             +  +  ++LV+ F+    L+      +G  +  S + K    I + + + H      I+
Sbjct: 68   VFRRKKRLYLVFEFVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFCHSH---NII 122

Query: 899  HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
            HRDIKP NIL+ +     L DFG AR L  +     TD   T  Y APE         +A
Sbjct: 123  HRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYTDYVATRWYRAPELLVGDTKYGRA 181

Query: 959  -DVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELF---------- 1007
             D+++ G ++ E+++G+  L P  S+    ++I+     LI   R  E+F          
Sbjct: 182  VDIWAVGCLVTEMLTGE-PLFPGDSDIDQLYHIIKCLGNLIP--RHQEIFQKNPLFAGMR 238

Query: 1008 LPELWEAGPQENLLG-----MMRLASTCTVETLSTRPSVKQVL 1045
            LPE+ E  P E         ++ LA  C       RPS  Q+L
Sbjct: 239  LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLL 281

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 76.8 bits (189), Expect = 2e-15
 Identities = 51/211 (24%), Positives = 99/211 (46%), Gaps = 17/211 (8%)

Query: 762 PAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAE 821
           P+ELT+           ++ L G+G FG  +  +      VA+K ++ G     + F  E
Sbjct: 3   PSELTF-----------MKEL-GSGQFGVVHLGKWRAQIKVAIKAINEGAMSE-EDFIEE 49

Query: 822 IGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAID 881
              + ++ H  LV L G    +  +++V  F+  G L  ++ ++ GK +   ++  +  D
Sbjct: 50  AKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGK-LSKDMLLSMCQD 108

Query: 882 IAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF 941
           + + + YL  +     +HRD+   N L+       +SDFG+ R +   E  +++      
Sbjct: 109 VCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPV 165

Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
            +  PE     + S K+DV+SFGV++ E+ +
Sbjct: 166 KWSPPEVFNFSKYSSKSDVWSFGVLMWEVFT 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 77.4 bits (190), Expect = 2e-15
 Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 9/200 (4%)

Query: 777 FSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQG-IQQFDAEIGTLGRIRHKNLV 834
           F+    IG G FG  +K  +     +VA+K + +   +  I+    EI  L +     + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
              G Y+   +++++  +L GG+    +      + Q + + K   +I + L YLH    
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKGLDYLHSE-- 120

Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV 954
            + +HRDIK +N+LL E+ +  L+DFG+A  L  ++    T V   F ++APE       
Sbjct: 121 -KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVIQQSAY 178

Query: 955 SDKADVYSFGVVLLELISGK 974
             KAD++S G+  +EL  G+
Sbjct: 179 DSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 77.7 bits (192), Expect = 3e-15
 Identities = 64/216 (29%), Positives = 100/216 (46%), Gaps = 45/216 (20%)

Query: 781 NLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR-FQGIQQFDA-----EIGTLGRIRHKNL 833
           + +G+G +G    A     G  VA+KKLS  R FQ      A     E+  L  + H+N+
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRKVAIKKLS--RPFQSAI--HAKRTYRELRLLKHMDHENV 76

Query: 834 VTLIGYYVGEAE------MFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQA 885
           + L+  +   +       ++LV + + G +L   +   K S   IQ+     +   I + 
Sbjct: 77  IGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQF-----LVYQILRG 130

Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
           L Y+H S    I+HRD+KPSNI ++E+    + DFGLAR  +       T    T  Y A
Sbjct: 131 LKYIH-SA--GIIHRDLKPSNIAVNEDCELKILDFGLARHTD----DEMTGYVATRWYRA 183

Query: 946 PE-------YATTCRVSDKADVYSFGVVLLELISGK 974
           PE       Y  T       D++S G ++ EL++GK
Sbjct: 184 PEIMLNWMHYNQT------VDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 76.9 bits (189), Expect = 3e-15
 Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 9/202 (4%)

Query: 777 FSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLS---IGRFQGIQQFDAEIGTLGRIRHKN 832
           F    ++G GGFG     ++   G + A K+L    I + +G      E   L ++  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V L   Y  +  + LV   ++GG+L+  I+       +       A +I   L  LH  
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121

Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
                V+RD+KP NILLD+  +  +SD GLA  +++ E  +     GT GY+APE     
Sbjct: 122 ---NTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLNNQ 176

Query: 953 RVSDKADVYSFGVVLLELISGK 974
           R +   D +  G ++ E+I G+
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 77.0 bits (189), Expect = 5e-15
 Identities = 61/203 (30%), Positives = 100/203 (49%), Gaps = 13/203 (6%)

Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLI-GYY 840
           IG G  G    A E   G  VAVK + + + Q  +    E+  +   +H+N+V +   Y 
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
           VGE E++++  FL GG L   +   S  ++    I  +   + QAL YLH   V   +HR
Sbjct: 89  VGE-ELWVLMEFLQGGALTDIV---SQTRLNEEQIATVCESVLQALCYLHSQGV---IHR 141

Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADV 960
           DIK  +ILL  +    LSDFG    +   +      + GT  ++APE  +      + D+
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQIS-KDVPKRKSLVGTPYWMAPEVISRTPYGTEVDI 200

Query: 961 YSFGVVLLELISGKRSLDPSFSE 983
           +S G++++E++ G+    P FS+
Sbjct: 201 WSLGIMVIEMVDGE---PPYFSD 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 76.8 bits (189), Expect = 6e-15
 Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 16/206 (7%)

Query: 783 IGTGGFGSTYKAE-LVPGYLVAVK---KLSIGRFQGIQQFDAEIGTL-GRIRHKNLVTLI 837
           IG G FG    A+    G   AVK   K +I + +  +   AE   L   ++H  LV L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 838 GYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
             +    +++ V ++++GG  E F H +  +          A +IA AL YLH      I
Sbjct: 63  YSFQTADKLYFVLDYVNGG--ELFFHLQRERSFPEPRARFYAAEIASALGYLHSL---NI 117

Query: 898 VHRDIKPSNILLDEELNAYLSDFGLARL-LEVSETHATTDVAGTFGYVAPEYATTCRVSD 956
           ++RD+KP NILLD + +  L+DFGL +  +E S+T  T+   GT  Y+APE         
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLRKQPYDR 175

Query: 957 KADVYSFGVVLLELISGKRSLDPSFS 982
             D +  G VL E++ G   L P +S
Sbjct: 176 TVDWWCLGAVLYEMLYG---LPPFYS 198

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 75.9 bits (187), Expect = 7e-15
 Identities = 52/196 (26%), Positives = 87/196 (44%), Gaps = 10/196 (5%)

Query: 782 LIGTGGFGSTYKAELV----PGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTL 836
            IG G FG  Y+   +        VAVK         + ++F  E   + +  H ++V L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 837 IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPR 896
           IG  + E  +++V      G L +++       +  + +   +  ++ ALAYL      R
Sbjct: 73  IGV-ITENPVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESK---R 127

Query: 897 IVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD 956
            VHRDI   N+L+       L DFGL+R LE    +  +       ++APE     R + 
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTS 187

Query: 957 KADVYSFGVVLLELIS 972
            +DV+ FGV + E++ 
Sbjct: 188 ASDVWMFGVCMWEILM 203

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 75.9 bits (186), Expect = 7e-15
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 18/203 (8%)

Query: 776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVK--KLSIGR-FQGIQQFDAEIGTLGRIRHK 831
           +F +   IG+G +G  YKA  V  G L A+K  KL  G  F  +QQ   EI  +   +H 
Sbjct: 10  DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQ---EIIMMKDCKHS 66

Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
           N+V   G Y+   ++++   F  GG+L+   H      +  S I  ++ +  Q L YLH 
Sbjct: 67  NIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHS 124

Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT-TDVAGTFGYVAPEYAT 950
                 +HRDIK +NILL +  +  L+DFG++   +++ T A      GT  ++APE A 
Sbjct: 125 KGK---MHRDIKGANILLTDNGHVKLADFGVSA--QITATIAKRKSFIGTPYWMAPEVAA 179

Query: 951 TCR---VSDKADVYSFGVVLLEL 970
             R    +   D+++ G+  +EL
Sbjct: 180 VERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 75.1 bits (184), Expect = 9e-15
 Identities = 61/241 (25%), Positives = 104/241 (43%), Gaps = 9/241 (3%)

Query: 783  IGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQ-QFDAEIGTLGRIRHKNLVTLIGYY 840
            IG G FG  +   L      VAVK         ++ +F  E   L +  H N+V LIG  
Sbjct: 3    IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 841  VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
              +  +++V   + GG+  TF+ +  G +++   + ++  + A  + YL        +HR
Sbjct: 63   TQKQPIYIVMELVQGGDFLTFL-RTEGPRLKVKELIQMVENAAAGMEYLESKHC---IHR 118

Query: 901  DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT-FGYVAPEYATTCRVSDKAD 959
            D+   N L+ E+    +SDFG++R  E     +T  +      + APE     R S ++D
Sbjct: 119  DLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESD 178

Query: 960  VYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELF--LPELWEAGPQ 1017
            V+SFG++L E  S       + S       I    +L   E     ++  +   WE  P 
Sbjct: 179  VWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPG 238

Query: 1018 E 1018
            +
Sbjct: 239  Q 239

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 75.5 bits (185), Expect = 9e-15
 Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 18/203 (8%)

Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK--KLSIGR-FQGIQQFDAEIGTLGRIRHK 831
           ++ +   +G+G +G  YKA  L  G L AVK  KL  G  F  IQQ   EI  +   +H 
Sbjct: 10  DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQ---EIFMVKECKHC 66

Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
           N+V   G Y+   ++++   +  GG+L+   H  +G   +  + + +  +  Q LAYLH 
Sbjct: 67  NIVAYFGSYLSREKLWICMEYCGGGSLQDIYHV-TGPLSELQIAY-VCRETLQGLAYLHS 124

Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT-TDVAGTFGYVAPEYAT 950
                 +HRDIK +NILL +  +  L+DFG+A   +++ T A      GT  ++APE A 
Sbjct: 125 KGK---MHRDIKGANILLTDNGDVKLADFGVAA--KITATIAKRKSFIGTPYWMAPEVAA 179

Query: 951 TCR---VSDKADVYSFGVVLLEL 970
             +    +   D+++ G+  +EL
Sbjct: 180 VEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 76.2 bits (187), Expect = 9e-15
 Identities = 62/197 (31%), Positives = 95/197 (48%), Gaps = 11/197 (5%)

Query: 782 LIGTGGFGSTYKAEL-VPGYLVAVK----KLSIGRFQGIQQFDAEIGTLGRIRHKNLVTL 836
           +IG G FG    A+  + G   AVK    K+ + R +           L  ++H  LV L
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 837 IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPR 896
              +    +++ V +F++GG  E F H +  +          A +IA AL YLH      
Sbjct: 62  HYSFQTTEKLYFVLDFVNGG--ELFFHLQRERSFPEPRARFYAAEIASALGYLHSI---N 116

Query: 897 IVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD 956
           IV+RD+KP NILLD + +  L+DFGL +   ++++  TT   GT  Y+APE        +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175

Query: 957 KADVYSFGVVLLELISG 973
             D +  G VL E++ G
Sbjct: 176 TVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 75.0 bits (184), Expect = 1e-14
 Identities = 64/230 (27%), Positives = 110/230 (47%), Gaps = 27/230 (11%)

Query: 819  DAEIGTLGRIRHKNLVTLIGYYVGE-AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHK 877
            + E   L +++H N+V     + GE   +++V  F  GG+L   + ++ GK +  + + +
Sbjct: 47   EQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVE 106

Query: 878  IAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDV 937
              + IA AL YLH      I+HRD+K  N+ L       + D G+AR+LE     A+T +
Sbjct: 107  WFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST-L 162

Query: 938  AGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLL 997
             GT  Y++PE  +    + K+DV++ G  + E+ + K +           FN      L+
Sbjct: 163  IGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHA-----------FNAKDMNSLV 211

Query: 998  --IKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVL 1045
              I EG+     LP +    P++    +  L +T   +    RPSVK +L
Sbjct: 212  YRIIEGK-----LPPM----PKDYSPELGELIATMLSKRPEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 75.1 bits (184), Expect = 1e-14
 Identities = 61/213 (28%), Positives = 104/213 (48%), Gaps = 19/213 (8%)

Query: 782 LIGTGGFGSTYKA-ELVPGYLVAVKKL-----SIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
           L+G G FG  Y   ++  G  +A K++     S    + +   + EI  L  ++H+ +V 
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 836 LIGYYV--GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
             G      E  + +   ++ GG+++  +  K+   +  SV  K    I + ++YLH + 
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTRKYTRQILEGMSYLHSN- 125

Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT--TDVAGTFGYVAPEYATT 951
              IVHRDIK +NIL D   N  L DFG ++ L+      T    V GT  +++PE  + 
Sbjct: 126 --MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG 183

Query: 952 CRVSDKADVYSFGVVLLELISGKRSLDPSFSEY 984
                KADV+S G  ++E+++ K    P ++EY
Sbjct: 184 EGYGRKADVWSLGCTVVEMLTEK----PPWAEY 212

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 75.2 bits (185), Expect = 1e-14
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 13/201 (6%)

Query: 781 NLIGTGGFGSTYKAELVPG----YLVAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
            +IG G FG  Y   L+         AVK L+ I   + ++QF  E   +    H N+++
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 836 LIGYYV-GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
           L+G  +  E    +V  ++  G+L  FI  ++       +I    + +A+ + YL     
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLI-GFGLQVAKGMEYL---AS 116

Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLL---EVSETHATTDVAGTFGYVAPEYATT 951
            + VHRD+   N +LDE     ++DFGLAR +   E    H  T       ++A E   T
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT 176

Query: 952 CRVSDKADVYSFGVVLLELIS 972
            + + K+DV+SFGV+L EL++
Sbjct: 177 QKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 75.4 bits (185), Expect = 1e-14
 Identities = 56/199 (28%), Positives = 98/199 (49%), Gaps = 21/199 (10%)

Query: 783 IGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV 841
           +G G FG  YKA+    G L A K +     + ++ +  EI  L    H N+V L+  + 
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 842 GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
            E  ++++  F +GG ++  + +   + +    I  +     +AL YLH +   +I+HRD
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRD 128

Query: 902 IKPSNILLDEELNAYLSDFGLA----RLLEVSETHATTDVAGTFGYVAPEYATTCRVSD- 956
           +K  NIL   + +  L+DFG++    R ++  ++       GT  ++APE    C  S  
Sbjct: 129 LKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-----FIGTPYWMAPE-VVMCETSKD 182

Query: 957 -----KADVYSFGVVLLEL 970
                KADV+S G+ L+E+
Sbjct: 183 RPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 76.0 bits (187), Expect = 1e-14
 Identities = 62/212 (29%), Positives = 107/212 (50%), Gaps = 20/212 (9%)

Query: 780 RNLIGTGGFGSTYKAELV----PGYLVAVK---KLSIGRFQ-GIQQFDAEIGTLGRIRHK 831
             ++G GG+G  ++   V     G + A+K   K +I R Q       AE   L  ++H 
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIH-KKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +V LI  +    +++L+  +LSGG  E F+H ++ G  ++ +    ++ +I+ AL +LH
Sbjct: 61  FIVDLIYAFQTGGKLYLILEYLSGG--ELFMHLEREGIFMEDTACFYLS-EISLALEHLH 117

Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
                 I++RD+KP NILLD + +  L+DFGL +   + E   T    GT  Y+APE   
Sbjct: 118 QQ---GIIYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEGTVTHTFCGTIEYMAPEILM 173

Query: 951 TCRVSDKADVYSFGVVLLELISGKRSLDPSFS 982
                   D +S G ++ ++++G     P F+
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTGA----PPFT 201

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 75.5 bits (186), Expect = 1e-14
 Identities = 76/290 (26%), Positives = 127/290 (43%), Gaps = 49/290 (16%)

Query: 782  LIGTGGFGSTYKAELV----PGY--LVAVKKLSIGRF-QGIQQFDAEIGTLGRI-RHKNL 833
             +G G FG   KAE V    P     VAVK L      + +    +E+  +  I +HKN+
Sbjct: 19   PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 834  VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKK--------------SGKKIQWSVIHKIA 879
            + L+G    E  +++V  + + GNL  F+  +                + +    +   A
Sbjct: 79   INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 880  IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDVA 938
              +A+ + +L      + +HRD+   N+L+ E+    ++DFGLAR +  +     TT+  
Sbjct: 139  YQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195

Query: 939  GTFGYVAPEYATTCRV-SDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKL- 996
                ++APE A   RV + ++DV+SFGV+L E+ +   S  P           +   +L 
Sbjct: 196  LPVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG----------IPVEELF 244

Query: 997  -LIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVL 1045
             L+KEG   E          PQ     +  L   C  E  S RP+ KQ++
Sbjct: 245  KLLKEGYRME---------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLV 285

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 75.6 bits (186), Expect = 1e-14
 Identities = 62/201 (30%), Positives = 105/201 (52%), Gaps = 18/201 (8%)

Query: 782 LIGTGGFGSTYKAELVPG------YLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
           ++G G FG  +    + G      Y + V K +  + +   +   E   L  + H  +V 
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62

Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS---VIHKIAIDIAQALAYLHYS 892
           L   +  E +++L+ +FL GG+L T    +  K++ ++   V   +A ++A AL +LH  
Sbjct: 63  LHYAFQTEGKLYLILDFLRGGDLFT----RLSKEVMFTEEDVKFYLA-ELALALDHLHSL 117

Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
               I++RD+KP NILLDEE +  L+DFGL++     E  A +   GT  Y+APE     
Sbjct: 118 ---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPEVVNRR 173

Query: 953 RVSDKADVYSFGVVLLELISG 973
             +  AD +SFGV++ E+++G
Sbjct: 174 GHTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 75.0 bits (184), Expect = 2e-14
 Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 13/199 (6%)

Query: 782 LIGTGGFGSTYKAEL-VPGYLVAVKKLS---IGRFQGIQQFDAEIGTLGRIRHKNLVTLI 837
           ++G GGFG     ++   G + A KKL    I + +G      E   L ++  + +V+L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66

Query: 838 GYYVGEAEMFLVYNFLSGGNLETFIHK--KSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
             Y  +  + LV   ++GG+L+  I+     G   Q ++ +  A ++   L  L      
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFY--AAELCCGLEDLQRE--- 121

Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVS 955
           RIV+RD+KP NILLD+  +  +SD GLA  +++ E        GT GY+APE     + +
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGRVGTVGYMAPEVINNEKYT 179

Query: 956 DKADVYSFGVVLLELISGK 974
              D +  G ++ E+I G+
Sbjct: 180 FSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 75.1 bits (185), Expect = 2e-14
 Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 38/209 (18%)

Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFD---------AEIGTLGRIRHKN 832
           IG G +G  +K      G +VA+KK        ++  D          EI  L +++H N
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKF-------VESEDDPVIKKIALREIRMLKQLKHPN 61

Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHK--KSGKKIQWSVIHKIAIDIAQALAYLH 890
           LV LI  +  + ++ LV+ +       T +++  K+ + +   +I KI     QA+ + H
Sbjct: 62  LVNLIEVFRRKRKLHLVFEYCD----HTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH 117

Query: 891 -YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
            ++C+    HRD+KP NIL+ ++    L DFG AR+L       T  VA T  Y APE  
Sbjct: 118 KHNCI----HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA-TRWYRAPELL 172

Query: 950 TTCRVSDKA-----DVYSFGVVLLELISG 973
               V D       DV++ G V  EL++G
Sbjct: 173 ----VGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 75.4 bits (186), Expect = 2e-14
 Identities = 62/226 (27%), Positives = 95/226 (42%), Gaps = 39/226 (17%)

Query: 782 LIGTGGFGSTYKAEL-VPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLI 837
           L+G G  G  +   L   G L A+K   K  + +   +++   E   L  + H  L TL 
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL- 66

Query: 838 GYYVGEAEMF--LVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
            Y   + E +  LV ++  GG L   + ++ GK +   V    A ++  AL YLH   + 
Sbjct: 67  -YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LL 122

Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLA----------------------RLLEVSETHA 933
            IV+RD+KP NILL E  +  LSDF L+                           SET +
Sbjct: 123 GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFS 182

Query: 934 TTDVA------GTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
                      GT  Y+APE  +        D ++ G++L E++ G
Sbjct: 183 EEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 74.8 bits (184), Expect = 2e-14
 Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 21/208 (10%)

Query: 779 IRNLIGTGGFGSTYKAELVP-GYLVAVKKL-----SIGRFQGIQQFDAEIGTLGRIRHKN 832
           I  L G G +G   K   VP G ++AVK++     S  + + +   D  + +   +    
Sbjct: 6   IEEL-GRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRS---VDCPY 61

Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHK--KSGKKIQWSVIHKIAIDIAQALAYLH 890
            VT  G    E ++++    +   +L+ F  K    G  I   ++ KIA+ I +AL YLH
Sbjct: 62  TVTFYGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH 120

Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY-- 948
                 ++HRD+KPSN+L++      L DFG++  L V     T D AG   Y+APE   
Sbjct: 121 SKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYL-VDSVAKTID-AGCKPYMAPERIN 176

Query: 949 -ATTCRVSD-KADVYSFGVVLLELISGK 974
                +  D K+DV+S G+ ++EL +G+
Sbjct: 177 PELNQKGYDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 74.3 bits (182), Expect = 2e-14
 Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 13/203 (6%)

Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQG-IQQFDAEIGTLGRIRHKNLVTLIGYY 840
           IG G FG  +K  +     +VA+K + +   +  I+    EI  L +     +    G Y
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
           + + +++++  +L GG+    +      + Q + I +   +I + L YLH     + +HR
Sbjct: 72  LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR---EILKGLDYLHSE---KKIHR 125

Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADV 960
           DIK +N+LL E     L+DFG+A  L  ++    T V   F ++APE         KAD+
Sbjct: 126 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVIKQSAYDSKADI 184

Query: 961 YSFGVVLLELISGKRSLDPSFSE 983
           +S G+  +EL  G    +P  SE
Sbjct: 185 WSLGITAIELAKG----EPPHSE 203

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 74.6 bits (184), Expect = 3e-14
 Identities = 66/223 (29%), Positives = 106/223 (47%), Gaps = 26/223 (11%)

Query: 777 FSIRNLIGTGGFGSTYKA---ELVPGYLVAVKKL--SIGRFQGIQQFDA-EIGTLGRIRH 830
           + I   IG G +G  YKA       G   A+KK      ++ GI Q    EI  L  ++H
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 831 KNLVTLIGYYVGEAEM--FLVYNFLSGGNLETFIHKKSGKK---IQWSVIHKIAIDIAQA 885
           +N+V+L+  ++  A+   +L++++ +  +L   I      K   I  S++  +   I   
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120

Query: 886 LAYLHYSCVPRIVHRDIKPSNILL----DEELNAYLSDFGLARLL-EVSETHATTD-VAG 939
           + YLH +    ++HRD+KP+NIL+     E     + D GLARL     +  A  D V  
Sbjct: 121 VHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV 177

Query: 940 TFGYVAPEYATTCRVSDKA-DVYSFGVVLLELISGKRSLDPSF 981
           T  Y APE     R   KA D+++ G +  EL+    +L+P F
Sbjct: 178 TIWYRAPELLLGARHYTKAIDIWAIGCIFAELL----TLEPIF 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 74.3 bits (182), Expect = 4e-14
 Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 9/199 (4%)

Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGI--QQFDAEIGTLGRIRHKNLVTLIGYY 840
           +G G  G  +K    P  L+  +KL     +     Q   E+  L       +V   G +
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
             + E+ +    + GG+L+  + KK+G+ I   ++ K++I + + L YL      +I+HR
Sbjct: 73  YSDGEISICMEHMDGGSLDQVL-KKAGR-IPEQILGKVSIAVIKGLTYLREK--HKIMHR 128

Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADV 960
           D+KPSNIL++      L DFG++  L  S  ++     GT  Y++PE       S ++D+
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTHYSVQSDI 185

Query: 961 YSFGVVLLELISGKRSLDP 979
           +S G+ L+E+  G+  + P
Sbjct: 186 WSMGLSLVEMAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 76.4 bits (188), Expect = 6e-14
 Identities = 56/192 (29%), Positives = 90/192 (46%), Gaps = 22/192 (11%)

Query: 799 GYLVAVKKLSIGRFQGIQQ---FDAEIGTLGRIRHKNLVTLIGYYVGEAE---MFLVYNF 852
           G+ VA+K L     +   Q   F  E     R+ H N+V L+    GEA    +F V+ +
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDS--GEAPPGLLFAVFEY 60

Query: 853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILL--- 909
           + G  L   +          +   ++ + +  ALA  H      IVHRD+KP NI++   
Sbjct: 61  VPGRTLREVLAADGALPAGETG--RLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQT 115

Query: 910 DEELNAYLSDFGLARLL----EVSETHAT--TDVAGTFGYVAPEYATTCRVSDKADVYSF 963
               +A + DFG+  LL    +      T  T+V GT  Y APE      V+  +D+Y++
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175

Query: 964 GVVLLELISGKR 975
           G++ LE ++G+R
Sbjct: 176 GLIFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 73.5 bits (181), Expect = 9e-14
 Identities = 62/224 (27%), Positives = 101/224 (45%), Gaps = 47/224 (20%)

Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDA---------EIGTL 825
            +   + IG G +G    A     G  VA+KK        I  F+          EI  L
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKK--------ISPFEHQTFCQRTLREIKIL 57

Query: 826 GRIRHKNLVTLI-----GYYVGEAEMFLVYNFLSGGNLETFIHKK------SGKKIQWSV 874
            R +H+N++ ++       +    ++++V   +     ET ++K       S   IQ+ +
Sbjct: 58  RRFKHENIIGILDIIRPPSFESFNDVYIVQELM-----ETDLYKLIKTQHLSNDHIQYFL 112

Query: 875 IHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA- 933
                  I + L Y+H + V   +HRD+KPSN+LL+   +  + DFGLAR+ +    H  
Sbjct: 113 YQ-----ILRGLKYIHSANV---LHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTG 164

Query: 934 --TTDVAGTFGYVAPEYATTCRVSDKA-DVYSFGVVLLELISGK 974
             T  VA T  Y APE     +   KA D++S G +L E++S +
Sbjct: 165 FLTEYVA-TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 72.3 bits (177), Expect = 1e-13
 Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 17/203 (8%)

Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDA--EIGTLGRIR---HKNLVTL 836
           IG G +G+ YKA +   G+ VA+K + +   +         E+  L R+    H N+V L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 837 IGYYVG-----EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
           +          E ++ LV+  +   +L T++ K     +    I  +     + L +LH 
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126

Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT 951
           +C   IVHRD+KP NIL+       L+DFGLAR+   S   A T V  T  Y APE    
Sbjct: 127 NC---IVHRDLKPENILVTSGGQVKLADFGLARIY--SCQMALTPVVVTLWYRAPEVLLQ 181

Query: 952 CRVSDKADVYSFGVVLLELISGK 974
              +   D++S G +  E+   K
Sbjct: 182 STYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 72.0 bits (176), Expect = 1e-13
 Identities = 61/219 (27%), Positives = 106/219 (48%), Gaps = 19/219 (8%)

Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKL-----SIGRFQGIQQFDAEIGTLGRIR 829
           N+ +  L+G G FG  Y   +   G  +AVK++     S    + +   + EI  L  +R
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 830 HKNLVTLIGYYVG--EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALA 887
           H  +V   G      E ++ +   ++ GG+++  +  K+   +  +V  +    I Q ++
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTRRYTRQILQGVS 120

Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT--TDVAGTFGYVA 945
           YLH +    IVHRDIK +NIL D   N  L DFG ++ ++      T    V GT  +++
Sbjct: 121 YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMS 177

Query: 946 PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEY 984
           PE  +      KADV+S    ++E+++ K    P ++EY
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEMLTEK----PPWAEY 212

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 72.3 bits (177), Expect = 2e-13
 Identities = 65/208 (31%), Positives = 100/208 (48%), Gaps = 16/208 (7%)

Query: 782 LIGTGGFGSTYKAEL-VPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGR-IRHKNLVTL 836
           +IG G FG    A+    G   AVK   K +I + +      AE   L + ++H  LV L
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 837 IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPR 896
              +    +++ V ++++GG  E F H +  +          A ++A A+ YLH      
Sbjct: 62  HYSFQTAEKLYFVLDYVNGG--ELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL---N 116

Query: 897 IVHRDIKPSNILLDEELNAYLSDFGLARL-LEVSETHATTDVAGTFGYVAPEYATTCRVS 955
           I++RD+KP NILLD + +  L+DFGL +  +E  ET  T+   GT  Y+APE        
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEVLRKEPYD 174

Query: 956 DKADVYSFGVVLLELISGKRSLDPSFSE 983
              D +  G VL E++ G   L P +S 
Sbjct: 175 RTVDWWCLGAVLYEMLYG---LPPFYSR 199

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 70.5 bits (173), Expect = 4e-13
 Identities = 54/207 (26%), Positives = 99/207 (47%), Gaps = 22/207 (10%)

Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSI-GRFQGIQQFDA-EIGTLGRIRHKNLVTLIGY 839
           IG G +G+ +KA       +VA+K++ +    +G+      EI  L  ++HKN+V L   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 840 YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
              + ++ LV+ +    +L+ +    +G  I   ++      + + LA+ H      ++H
Sbjct: 68  LHSDKKLTLVFEYCDQ-DLKKYFDSCNGD-IDPEIVKSFMFQLLKGLAFCHSH---NVLH 122

Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE-------YATTC 952
           RD+KP N+L+++     L+DFGLAR   +     + +V  T  Y  P+       Y+T+ 
Sbjct: 123 RDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTSI 181

Query: 953 RVSDKADVYSFGVVLLELISGKRSLDP 979
                 D++S G +  EL +  R L P
Sbjct: 182 ------DMWSAGCIFAELANAGRPLFP 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 72.6 bits (178), Expect = 5e-13
 Identities = 45/137 (32%), Positives = 70/137 (51%), Gaps = 8/137 (5%)

Query: 846 MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPS 905
           + LV ++ + G+L   I  ++ K  +    H+  +   Q L  +H+     ++HRDIK +
Sbjct: 114 IALVLDYANAGDLRQEIKSRA-KTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSA 172

Query: 906 NILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFG----YVAPEYATTCRVSDKADVY 961
           NILL       L DFG +++   +    + DV  TF     YVAPE       S KAD++
Sbjct: 173 NILLCSNGLVKLGDFGFSKMYAAT---VSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMF 229

Query: 962 SFGVVLLELISGKRSLD 978
           S GV+L EL++ KR  D
Sbjct: 230 SLGVLLYELLTLKRPFD 246

Length = 496

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 70.2 bits (172), Expect = 6e-13
 Identities = 57/213 (26%), Positives = 94/213 (44%), Gaps = 19/213 (8%)

Query: 776 NFSIRNLIGTGGFGSTYKAELV--PGYL----VAVKKL-SIGRFQGIQQFDAEIGTLGRI 828
           + ++   +G G FG  Y+       G      VAVK L      Q    F  E   + + 
Sbjct: 7   SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF 66

Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-----KIAIDIA 883
            H+N+V LIG        F++   ++GG+L++F+ +   +  + S +        A D+A
Sbjct: 67  NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126

Query: 884 QALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSETHATTDVAG- 939
           +   YL  +     +HRDI   N LL        A ++DFG+AR +  +  +     A  
Sbjct: 127 KGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAML 183

Query: 940 TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
              ++ PE       + K DV+SFGV+L E+ S
Sbjct: 184 PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 70.8 bits (174), Expect = 6e-13
 Identities = 66/242 (27%), Positives = 104/242 (42%), Gaps = 41/242 (16%)

Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDA---------EIGTL 825
            +     IG+G +G    A +   G  VA+KK+          FD          E+  L
Sbjct: 6   RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIP-------HAFDVPTLAKRTLRELKIL 58

Query: 826 GRIRHKNLVTLIGYYVGEAEMF----LVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAID 881
              +H N++ +          F    +V + L   +L   IH  S + +    I      
Sbjct: 59  RHFKHDNIIAIRDILRPPGADFKDVYVVMD-LMESDLHHIIH--SDQPLTEEHIRYFLYQ 115

Query: 882 IAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET----HATTDV 937
           + + L Y+H + V   +HRD+KPSN+L++E+    + DFG+AR L  S T      T  V
Sbjct: 116 LLRGLKYIHSANV---IHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172

Query: 938 AGTFGYVAPEYATTC-RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKL 996
           A T  Y APE   +    +   D++S G +  E++ G+R L P       G N V   KL
Sbjct: 173 A-TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFP-------GKNYVHQLKL 223

Query: 997 LI 998
           ++
Sbjct: 224 IL 225

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 70.1 bits (171), Expect = 8e-13
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 14/199 (7%)

Query: 782 LIGTGGFGSTYKAELVP-----GYLVAVKKL--SIGRFQGIQQFDAEIGTLGRIRHKNLV 834
           ++G+G FG+ YK   VP        VA+K L  + G    ++  D E   +  + H +LV
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMD-EALIMASMDHPHLV 72

Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
            L+G  +    + LV   +  G L  ++H+     I   ++    + IA+ + YL     
Sbjct: 73  RLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEER-- 128

Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT-FGYVAPEYATTCR 953
            R+VHRD+   N+L+    +  ++DFGLARLLE  E     D       ++A E     +
Sbjct: 129 -RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK 187

Query: 954 VSDKADVYSFGVVLLELIS 972
            + ++DV+S+GV + EL++
Sbjct: 188 FTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 69.7 bits (170), Expect = 8e-13
 Identities = 79/308 (25%), Positives = 125/308 (40%), Gaps = 47/308 (15%)

Query: 758  FADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQ 816
            F  +   + +D+    +  + I   IG G +G  +K      G   AVK L       I 
Sbjct: 1    FPLSGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILD-----PIH 55

Query: 817  QFDAEIGTLGRI-----RHKNLVTLIGYY-----VGEAEMFLVYNFLSGGNLETFIHK-- 864
              D EI     I      H N+V   G Y         +++LV    +GG++   +    
Sbjct: 56   DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFL 115

Query: 865  KSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR 924
            K G++++  +I  I  +    L +LH   V + +HRD+K +NILL  E    L DFG++ 
Sbjct: 116  KRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSA 172

Query: 925  LLEVSETHATTDVAGTFGYVAPEYATTCRVSD-----KADVYSFGVVLLELISGKRSLDP 979
             L  +     T V GT  ++APE     +  D     + DV+S G+  +EL  G    DP
Sbjct: 173  QLTSTRLRRNTSV-GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG----DP 227

Query: 980  SFSEYGNGFNIVSWAKLLIKEGRS--SELFLPELWEAGPQENLLGMMRLASTCTVETLST 1037
              ++       +   + L K  R+    L  PELW     +           C  +    
Sbjct: 228  PLAD-------LHPMRALFKIPRNPPPTLHQPELWSNEFND-------FIRKCLTKDYEK 273

Query: 1038 RPSVKQVL 1045
            RP+V  +L
Sbjct: 274  RPTVSDLL 281

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 69.8 bits (171), Expect = 1e-12
 Identities = 41/132 (31%), Positives = 72/132 (54%), Gaps = 6/132 (4%)

Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           +  +F V  +L+GG+L    H +S  +   +     A +I   L +LH      I++RD+
Sbjct: 68  KEHLFFVMEYLNGGDL--MFHIQSSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDL 122

Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
           K  N+LLD++ +  ++DFG+ +     E  A+T   GT  Y+APE     + ++  D +S
Sbjct: 123 KLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAPEILKGQKYNESVDWWS 181

Query: 963 FGVVLLELISGK 974
           FGV+L E++ G+
Sbjct: 182 FGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 70.0 bits (171), Expect = 1e-12
 Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 13/205 (6%)

Query: 783 IGTGGFGSTY---KAELVPGY-LVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           IG G FG      K +    Y L  ++K  I     +    AE   L ++    +V L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +    +++LV  F++GG  E F H +   +   S       ++  AL  LH   V   +
Sbjct: 61  SFQSPEKLYLVLAFINGG--ELFHHLQREGRFDLSRARFYTAELLCALENLHKFNV---I 115

Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP NILLD + +  L DFGL + L + +   T    GT  Y+APE       +   
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAV 174

Query: 959 DVYSFGVVLLELISGKRSLDPSFSE 983
           D ++ GV+L E+++G   L P + E
Sbjct: 175 DWWTLGVLLYEMLTG---LPPFYDE 196

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 70.0 bits (171), Expect = 1e-12
 Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 16/207 (7%)

Query: 782 LIGTGGFG----STYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGR-IRHKNLVTL 836
           +IG G FG    + +KAE     +  ++K +I + +  +   +E   L + ++H  LV L
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 837 IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPR 896
              +    +++ V ++++GG  E F H +  +          A +IA AL YLH      
Sbjct: 62  HFSFQTADKLYFVLDYINGG--ELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---N 116

Query: 897 IVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDV-AGTFGYVAPEYATTCRVS 955
           IV+RD+KP NILLD + +  L+DFGL +  E  E + TT    GT  Y+APE        
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQPYD 174

Query: 956 DKADVYSFGVVLLELISGKRSLDPSFS 982
              D +  G VL E++ G   L P +S
Sbjct: 175 RTVDWWCLGAVLYEMLYG---LPPFYS 198

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 69.3 bits (169), Expect = 1e-12
 Identities = 60/211 (28%), Positives = 91/211 (43%), Gaps = 32/211 (15%)

Query: 783 IGTGGFGSTYKAELVP--GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIR----------- 829
           IG G +G  +KA  +   G  VA+K++ +       Q   E   L  IR           
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRV-------QTGEEGMPLSTIREVAVLRHLETF 61

Query: 830 -HKNLVTL-----IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIA 883
            H N+V L     +     E ++ LV+  +   +L T++ K     +    I  +   + 
Sbjct: 62  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLL 120

Query: 884 QALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGY 943
           + L +LH     R+VHRD+KP NIL+       L+DFGLAR+   S   A T V  T  Y
Sbjct: 121 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWY 175

Query: 944 VAPEYATTCRVSDKADVYSFGVVLLELISGK 974
            APE       +   D++S G +  E+   K
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 69.8 bits (171), Expect = 1e-12
 Identities = 54/226 (23%), Positives = 91/226 (40%), Gaps = 41/226 (18%)

Query: 781 NLIGTGGFGSTYKAE-LVPGYLVAVKKLSI-----GRFQGIQQFDA---------EIGTL 825
             +G G +G   KA   + G +VA+KK+ I        +  Q             E+  +
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHK--IAIDIA 883
             I+H+N++ L+  YV    + LV + ++       + K   +KI+ +      I + I 
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIMASD-----LKKVVDRKIRLTESQVKCILLQIL 129

Query: 884 QALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-------------LLEVSE 930
             L  LH       +HRD+ P+NI ++ +    ++DFGLAR                +  
Sbjct: 130 NGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186

Query: 931 THATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
               T    T  Y APE             D++S G +  EL++GK
Sbjct: 187 REEMTSKVVTLWYRAPELLMGAEK-YHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 61/219 (27%), Positives = 105/219 (47%), Gaps = 19/219 (8%)

Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKL-----SIGRFQGIQQFDAEIGTLGRIR 829
           N+ +  L+G G FG  Y   +   G  +AVK++     S    + +   + EI  L  + 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 830 HKNLVTLIGYY--VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALA 887
           H+ +V   G      E  + +    + GG+++  +  KS   +  +V  K    I + ++
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTRKYTRQILEGVS 120

Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT--TDVAGTFGYVA 945
           YLH +    IVHRDIK +NIL D   N  L DFG ++ L+      T    V GT  +++
Sbjct: 121 YLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMS 177

Query: 946 PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEY 984
           PE  +      KAD++S G  ++E+++ K    P ++E+
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLTEK----PPWAEF 212

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 70.1 bits (171), Expect = 1e-12
 Identities = 63/213 (29%), Positives = 107/213 (50%), Gaps = 34/213 (15%)

Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 83

Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +          +++LV + L G +L   +   K +   +Q+ +       I + L Y+H
Sbjct: 84  VFTPARSLEEFNDVYLVTH-LMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 137

Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
            +    I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE
Sbjct: 138 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 187

Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                   +   D++S G ++ EL++G R+L P
Sbjct: 188 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 219

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 69.9 bits (171), Expect = 1e-12
 Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 32/208 (15%)

Query: 782 LIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGT---------LGRIRHK 831
            +G+G +GS   A +   G  VA+KKLS       + F +EI           L  ++H+
Sbjct: 22  QVGSGAYGSVCSAIDKRTGEKVAIKKLS-------RPFQSEIFAKRAYRELTLLKHMQHE 74

Query: 832 NLVTLIGYYVGEAEMFLVYNF-LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
           N++ L+  +          +F L    ++T + K  G  +    +  +   +   L Y+H
Sbjct: 75  NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIH 134

Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
            +    I+HRD+KP N+ ++E+    + DFGLAR       HA  ++ G   T  Y APE
Sbjct: 135 SA---GIIHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVTRWYRAPE 184

Query: 948 YATT-CRVSDKADVYSFGVVLLELISGK 974
                   +   D++S G ++ E+++GK
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 69.5 bits (170), Expect = 2e-12
 Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 20/212 (9%)

Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLS---IGRFQGIQQFDAEIGTLGRIRHK 831
           +F +++L+G G FG      E   G + A+K +    +   + +  F+ E   L      
Sbjct: 2   DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSP 61

Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH- 890
            +  L   +  +  ++LV  +  GG+L + +++   +     +      ++  A+  +H 
Sbjct: 62  WIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQ-FDEDMAQFYLAELVLAIHSVHQ 120

Query: 891 --YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
             Y      VHRDIKP N+L+D   +  L+DFG A  L  ++   +    GT  Y+APE 
Sbjct: 121 MGY------VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEV 174

Query: 949 ATTCRVSDKA------DVYSFGVVLLELISGK 974
            TT     K       D +S GV+  E+I G+
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 69.8 bits (171), Expect = 2e-12
 Identities = 35/95 (36%), Positives = 52/95 (54%), Gaps = 6/95 (6%)

Query: 882 IAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET-HATTDVAGT 940
           I + L YLH +    I+HRDIKP N+L++      + DFGLAR+ E  E+ H T +V   
Sbjct: 112 ILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168

Query: 941 FGYVAPEYATTCR-VSDKADVYSFGVVLLELISGK 974
           + Y APE     R  +   D++S G +  EL+  +
Sbjct: 169 Y-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 68.6 bits (167), Expect = 2e-12
 Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 30/223 (13%)

Query: 776 NFSIRNLIGTGGFGSTYKAE---LVP---GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIR 829
           N  ++  +G G FG  + AE   L P     LVAVK L        + F  E   L  ++
Sbjct: 6   NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65

Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKI------------QWSVIHK 877
           H+++V   G  V    + +V+ ++  G+L  F+       +            Q  ++H 
Sbjct: 66  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH- 124

Query: 878 IAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDV 937
           IA  IA  + YL        VHRD+   N L+ E L   + DFG++R +  ++ +    V
Sbjct: 125 IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYR---V 178

Query: 938 AG----TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKR 975
            G       ++ PE     + + ++DV+S GVVL E+ + GK+
Sbjct: 179 GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 221

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 68.6 bits (168), Expect = 2e-12
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 20/215 (9%)

Query: 783 IGTGGFGSTYKAELVPGYLVAVKKL-------SIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
           +G G  G   K    P  L+  +KL       +I       Q   E+  L       +V 
Sbjct: 9   LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAI-----RNQIIRELKVLHECNSPYIVG 63

Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
             G +  + E+ +    + GG+L+  +  K   +I  +++ KI+I + + L YL      
Sbjct: 64  FYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPENILGKISIAVLRGLTYLRE--KH 119

Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVS 955
           +I+HRD+KPSNIL++      L DFG++  L  S   A + V GT  Y++PE       +
Sbjct: 120 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFV-GTRSYMSPERLQGTHYT 176

Query: 956 DKADVYSFGVVLLELISGKRSLD-PSFSEYGNGFN 989
            ++D++S G+ L+E+  G+  +  P   E    F 
Sbjct: 177 VQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFG 211

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 68.3 bits (167), Expect = 3e-12
 Identities = 51/197 (25%), Positives = 100/197 (50%), Gaps = 11/197 (5%)

Query: 783 IGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDA-EIGTLGRIRHKNLVTLIGYY 840
           +G G + + YK      G +VA+K++ +   +G       EI  +  ++H+N+V L    
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 841 VGEAEMFLVYNFLSGGNLETF--IHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
             E ++ LV+ ++   +L+ +   H   G  +  + +      + + +A+ H +   R++
Sbjct: 68  HTENKLMLVFEYMDK-DLKKYMDTHGVRGA-LDPNTVKSFTYQLLKGIAFCHEN---RVL 122

Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV-SDK 957
           HRD+KP N+L+++     L+DFGLAR   +     + +V  T  Y AP+     R  S  
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSRTYSTS 181

Query: 958 ADVYSFGVVLLELISGK 974
            D++S G ++ E+I+G+
Sbjct: 182 IDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 67.9 bits (166), Expect = 3e-12
 Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 23/208 (11%)

Query: 782 LIGTGGFGSTYKA-----ELVPGY-LVAVKKLSIGRFQGIQQ-FDAEIGTLGRIRHKNLV 834
            +G G FG  + A     E   G  LV VK L   + + +Q  F  E+    ++ HKN+V
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 835 TLIGYYVGEAE---MFLVYNFLSGGNLETFIHKKSGKKIQW-----SVIHKIAI--DIAQ 884
            L+G    EAE   M L Y  L  G+L+ F+     K  +      S   K+A+   IA 
Sbjct: 72  RLLGL-CREAEPHYMILEYTDL--GDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIAL 128

Query: 885 ALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYV 944
            + +L  +   R VHRD+   N L+  +    +S   L++ +  SE +   +      ++
Sbjct: 129 GMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWL 185

Query: 945 APEYATTCRVSDKADVYSFGVVLLELIS 972
           APE       S K+DV+SFGV++ E+ +
Sbjct: 186 APEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 69.8 bits (171), Expect = 4e-12
 Identities = 59/180 (32%), Positives = 79/180 (43%), Gaps = 27/180 (15%)

Query: 583 KWIL--LGGNN--LTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHN 638
           KW +  LG +N  L G IP+    L  L  ++LS N++ G+IP SL   T LE L L++N
Sbjct: 417 KWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYN 476

Query: 639 RLSGEIPVSFSTLVNLSALDLSFNNLSGHIP-----HLQHLDCIAFKGNKYLASCPDTNA 693
             +G IP S   L +L  L+L+ N+LSG +P      L H     F  N  L   P   A
Sbjct: 477 SFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRA 536

Query: 694 TAPEKPPVQLDEKLQNGKRSKVFIIAVVTSASAVLLIFLVIIFVILRRRKFGRIASLRGQ 753
             P      +  K           I +    S   L FLVI  +   +R   R   LR Q
Sbjct: 537 CGPHLS---VGAK-----------IGIAFGVSVAFL-FLVICAMCWWKR---RQNILRAQ 578

Length = 623

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 68.1 bits (167), Expect = 4e-12
 Identities = 60/229 (26%), Positives = 98/229 (42%), Gaps = 37/229 (16%)

Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDA--EIGTLGRIR 829
              ++ I   +G G FG  YKA ++  G +VA+KK+ +   +      A  EI  L +++
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65

Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETF-------IHKKSGK------KIQWSVIH 876
           H N+V LI       +M +     S     +         H  SG       K+  S I 
Sbjct: 66  HPNVVPLI-------DMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIK 118

Query: 877 KIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE------ 930
              + + + + YLH +    I+HRDIK +NIL+D +    ++DFGLAR  +         
Sbjct: 119 CYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175

Query: 931 ----THATTDVAGTFGYVAPEY-ATTCRVSDKADVYSFGVVLLELISGK 974
               T   T++  T  Y  PE      R +   D++  G V  E+ + +
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 68.5 bits (167), Expect = 4e-12
 Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 27/205 (13%)

Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +      VAVKKLS   FQ +   ++   E+  L  ++H+N++ L+ 
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLS-RPFQSLIHARRTYRELRLLKHMKHENVIGLLD 81

Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +          E++LV N L G +L   +   K S + +Q+ +       + + L Y+H
Sbjct: 82  VFTPATSIENFNEVYLVTN-LMGADLNNIVKCQKLSDEHVQFLIYQ-----LLRGLKYIH 135

Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
            +    I+HRD+KPSN+ ++E+    + DFGLAR  +       T    T  Y APE   
Sbjct: 136 SA---GIIHRDLKPSNVAVNEDCELRILDFGLARQAD----DEMTGYVATRWYRAPEIML 188

Query: 951 T-CRVSDKADVYSFGVVLLELISGK 974
                +   D++S G ++ EL+ GK
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 67.7 bits (165), Expect = 4e-12
 Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 31/222 (13%)

Query: 779 IRNLIGTGGFGSTYKAE---LVP---GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKN 832
           ++  +G G FG  + AE   L P     LVAVK L        + F  E   L  ++H++
Sbjct: 9   LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68

Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIH--------------KKSGKKIQWSVIHKI 878
           +V   G       + +V+ ++  G+L  F+               +++  ++  S +  I
Sbjct: 69  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128

Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVA 938
           A  IA  + YL        VHRD+   N L+   L   + DFG++R +  ++ +    V 
Sbjct: 129 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR---VG 182

Query: 939 G----TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKR 975
           G       ++ PE     + + ++DV+SFGV+L E+ + GK+
Sbjct: 183 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 68.1 bits (166), Expect = 4e-12
 Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 19/202 (9%)

Query: 782 LIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGIQQFDAEIG-TLGRIR-------HKN 832
           ++G G FG  + AEL       A+K L     + +   D ++  T+   R       H  
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALK----KDVVLMDDDVECTMVEKRVLSLAWEHPF 57

Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           L  L   +  +  +F V  +L+GG+L    H +S  K         A +I   L +LH  
Sbjct: 58  LTHLYCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICGLQFLHSK 115

Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
               IV+RD+K  NILLD + +  ++DFG+ +   + +   T    GT  Y+APE     
Sbjct: 116 ---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-TCTFCGTPDYIAPEILLGQ 171

Query: 953 RVSDKADVYSFGVVLLELISGK 974
           + +   D +SFGV+L E++ G+
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 67.2 bits (164), Expect = 5e-12
 Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 28/214 (13%)

Query: 781 NLIGTGGFGSTY----KAELVPG---YLVAVKKLSIG-RFQGIQQFDAEIGTLGRIRHKN 832
           N +G+G FG  Y       L PG     VAVK L  G   Q  ++F  E   +    H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-----KIAIDIAQALA 887
           +V L+G  +     +++   + GG+L +++     ++    ++       I +D+A+   
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNA-----YLSDFGLARLLEVSETHATTDVAG--- 939
           YL        +HRD+   N L+ E+         + DFGLAR +  S+ +      G   
Sbjct: 121 YLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY---RKEGEGL 174

Query: 940 -TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
               ++APE     + + ++DV+SFGV++ E+++
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 66.9 bits (163), Expect = 5e-12
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 25/203 (12%)

Query: 783 IGTGGFGST----YKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHK----NLV 834
           +G+G FG      YK        VA+K L     + ++    E+     I H+     +V
Sbjct: 3   LGSGNFGCVKKGVYKMR-KKQIDVAIKVLKNENEKSVRD---EMMREAEIMHQLDNPYIV 58

Query: 835 TLIGYYVGEAE-MFLVYNFLSGGNLETFIHKKSGKKIQWSV--IHKIAIDIAQALAYLHY 891
            +IG  V EAE + LV    SGG L  F+   SGKK + +V  + ++   ++  + YL  
Sbjct: 59  RMIG--VCEAEALMLVMEMASGGPLNKFL---SGKKDEITVSNVVELMHQVSMGMKYLEG 113

Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF--GYVAPEYA 949
                 VHRD+   N+LL  +  A +SDFGL++ L   +++     AG +   + APE  
Sbjct: 114 K---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECI 170

Query: 950 TTCRVSDKADVYSFGVVLLELIS 972
              + S ++DV+S+G+ + E  S
Sbjct: 171 NFRKFSSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 69.5 bits (170), Expect = 6e-12
 Identities = 45/128 (35%), Positives = 62/128 (48%), Gaps = 12/128 (9%)

Query: 71  WNSSTDHCT-----WHGVTCDHFTGRVTALRITGKATPWPSKSSVISGTLSASIAKLTEL 125
           WN   D C      W G  C  F        I G        +  + G +   I+KL  L
Sbjct: 392 WNG--DPCVPQQHPWSGADC-QFDSTKGKWFIDGLGL----DNQGLRGFIPNDISKLRHL 444

Query: 126 RTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSG 185
           +++++  NS  G IP  +G +  LEVL+L  N+F+G IP  +  L  LR+LNL+ NS SG
Sbjct: 445 QSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSG 504

Query: 186 EVPRGLIG 193
            VP  L G
Sbjct: 505 RVPAALGG 512

Length = 623

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 67.8 bits (166), Expect = 6e-12
 Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 19/202 (9%)

Query: 782 LIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQFDAE-------IGTLGRIRHKNL 833
           ++G G FG    AEL     L AVK L       +Q  D E       +  L   +H  L
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVI--LQDDDVECTMTEKRVLALAG-KHPFL 58

Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
             L   +  +  +F V  +++GG+L    H +   +         A +I   L +LH   
Sbjct: 59  TQLHSCFQTKDRLFFVMEYVNGGDL--MFHIQRSGRFDEPRARFYAAEIVLGLQFLHER- 115

Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE-VSETHATTDVAGTFGYVAPEYATTC 952
              I++RD+K  N+LLD E +  ++DFG+ +  E +     T+   GT  Y+APE  +  
Sbjct: 116 --GIIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPDYIAPEILSYQ 171

Query: 953 RVSDKADVYSFGVVLLELISGK 974
                 D ++ GV+L E+++G+
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 67.8 bits (165), Expect = 6e-12
 Identities = 45/150 (30%), Positives = 78/150 (52%), Gaps = 8/150 (5%)

Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           H  LV L   +  E+ +F V  +++GG+L    H +  +K+        + +I+ AL YL
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYL 112

Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARL-LEVSETHATTDVAGTFGYVAPEY 948
           H      I++RD+K  N+LLD E +  L+D+G+ +  L   +T  T+   GT  Y+APE 
Sbjct: 113 HER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEI 167

Query: 949 ATTCRVSDKADVYSFGVVLLELISGKRSLD 978
                     D ++ GV++ E+++G+   D
Sbjct: 168 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 68.1 bits (167), Expect = 6e-12
 Identities = 69/280 (24%), Positives = 105/280 (37%), Gaps = 86/280 (30%)

Query: 775 GNFSIRNLIGTGGFGSTYKAELV----PGYLVAVKKLS----IGRFQGIQQFDAEIGTLG 826
            +F +  +IG G FG  +   LV     G + A+K L     I R Q I    AE   L 
Sbjct: 1   DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILA 56

Query: 827 RIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQ-- 884
                 +V L   +  E  ++LV  ++ GG+L   + +K               + A+  
Sbjct: 57  DADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK----------DVFPEETARFY 106

Query: 885 ------ALAYLH---YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLA--------RLLE 927
                 AL  +H   +      +HRDIKP NIL+D + +  L+DFGL         R   
Sbjct: 107 IAELVLALDSVHKLGF------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160

Query: 928 VSETHATTD--------------------VAGTFGYVAPE------YATTCRVSDKADVY 961
           ++++H                          GT  Y+APE      Y   C      D +
Sbjct: 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLEC------DWW 214

Query: 962 SFGVVLLELISGKRSLDPSFSEYGNG---FNIVSWAKLLI 998
           S GV+L E++ G     P F           I++W + L 
Sbjct: 215 SLGVILYEMLYG----FPPFYSDTLQETYNKIINWKESLR 250

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 67.6 bits (165), Expect = 7e-12
 Identities = 60/200 (30%), Positives = 91/200 (45%), Gaps = 17/200 (8%)

Query: 782 LIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQFDAE-------IGTLGRIRHKNL 833
           ++G G FG    A L   G L AVK L       +Q  D E       I +L R  H  L
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVI--LQDDDVECTMTEKRILSLAR-NHPFL 58

Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
             L   +     +F V  F++GG+L    H +  ++   +     A +I  AL +LH   
Sbjct: 59  TQLYCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEITSALMFLHDK- 115

Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCR 953
              I++RD+K  N+LLD E +  L+DFG+ +   +     T+   GT  Y+APE      
Sbjct: 116 --GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDYIAPEILQEML 172

Query: 954 VSDKADVYSFGVVLLELISG 973
                D ++ GV+L E++ G
Sbjct: 173 YGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 66.8 bits (163), Expect = 9e-12
 Identities = 69/254 (27%), Positives = 110/254 (43%), Gaps = 31/254 (12%)

Query: 783  IGTGGFGSTYKA-ELVPGYLVAVKK-LSIGRFQGIQQFD-AEIGTLGRIRHKN-LVTLIG 838
            IG G +G  YKA +   G LVA+KK       +GI      EI  L  +     +V L+ 
Sbjct: 9    IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68

Query: 839  YY-----VGEAEMFLVYNFLSGGNLETFI---HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
                    G+  ++LV+ +L   +L+ F+    +  G+ +    I      + + +A+ H
Sbjct: 69   VEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH 127

Query: 891  YSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
               V   +HRD+KP N+L+D++     ++D GL R   +     T ++  T  Y APE  
Sbjct: 128  KHGV---MHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TLWYRAPEVL 183

Query: 950  TTCR-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFL 1008
                  S   D++S G +  E+   K+ L P  SE     +I    KLL   G  +E   
Sbjct: 184  LGSTHYSTPVDIWSVGCIFAEMSR-KQPLFPGDSELQQLLHIF---KLL---GTPTEQVW 236

Query: 1009 PEL-----WEAGPQ 1017
            P +     W   PQ
Sbjct: 237  PGVSKLRDWHEFPQ 250

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 66.9 bits (163), Expect = 9e-12
 Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 34/221 (15%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL---VAVKKLSIGRFQGIQQ-FDAEIGTLGRI-RH 830
           +   +++IG G FG   KA +    L    A+K++     +   + F  E+  L ++  H
Sbjct: 8   DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 67

Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHK--------------KSGKKIQWSVIH 876
            N++ L+G       ++L   +   GNL  F+ K               +   +    + 
Sbjct: 68  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127

Query: 877 KIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD 936
             A D+A+ + YL      + +HRD+   NIL+ E   A ++DFGL+R  EV        
Sbjct: 128 HFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVY------- 177

Query: 937 VAGTFG-----YVAPEYATTCRVSDKADVYSFGVVLLELIS 972
           V  T G     ++A E       +  +DV+S+GV+L E++S
Sbjct: 178 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 66.6 bits (162), Expect = 9e-12
 Identities = 59/217 (27%), Positives = 92/217 (42%), Gaps = 9/217 (4%)

Query: 777 FSIRNLIGTGGFGSTYKAELVPGY-LVAVKKL--SIGRFQGIQQFDAEIGTLGRIRHKNL 833
           F +  ++G G +G   K        +VA+KK   S    +  +    E+  L  ++ +N+
Sbjct: 3   FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62

Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
           V L   +    +++LV+ ++    LE      +G         K+   I Q +  +H+  
Sbjct: 63  VELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNG-----VPPEKVRSYIYQLIKAIHWCH 117

Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCR 953
              IVHRDIKP N+L+       L DFG AR L        T+   T  Y +PE      
Sbjct: 118 KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177

Query: 954 VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
                D++S G +L EL  G+  L P  SE    F I
Sbjct: 178 YGKAVDMWSVGCILGELSDGQ-PLFPGESEIDQLFTI 213

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 67.0 bits (164), Expect = 1e-11
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 26/206 (12%)

Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDA--EIGTLGRIRHKNLVTLI-- 837
           IG G FG  +KA       +VA+KK+ +   +      A  EI  L  ++H+N+V LI  
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79

Query: 838 ------GYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS--VIHKIAIDIAQALAYL 889
                  Y   +   +LV+ F    +L   +   S K ++++   I K+   +   L Y+
Sbjct: 80  CRTKATPYNRYKGSFYLVFEFCEH-DLAGLL---SNKNVKFTLSEIKKVMKMLLNGLYYI 135

Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA----TTDVAGTFGYVA 945
           H +   +I+HRD+K +NIL+ ++    L+DFGLAR   +S+       T  V  T  Y  
Sbjct: 136 HRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-TLWYRP 191

Query: 946 PEYATTCRVSDKA-DVYSFGVVLLEL 970
           PE     R      D++  G ++ E+
Sbjct: 192 PELLLGERDYGPPIDMWGAGCIMAEM 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 66.6 bits (162), Expect = 1e-11
 Identities = 59/220 (26%), Positives = 100/220 (45%), Gaps = 36/220 (16%)

Query: 783 IGTGGFGSTYKAE---LVP---GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTL 836
           +G G FG  + AE   L+P     LVAVK L        Q F  E   L  ++H+++V  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 837 IGYYVGEAEMFLVYNFLSGGNLETFI--HKKSGK-----------KIQWSVIHKIAIDIA 883
            G       + +V+ ++  G+L  F+  H    K           ++    +  IA  IA
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 884 QALAYL---HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG- 939
             + YL   H+      VHRD+   N L+ + L   + DFG++R +  ++ +    V G 
Sbjct: 133 SGMVYLASLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR---VGGR 183

Query: 940 ---TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKR 975
                 ++ PE     + + ++D++SFGVVL E+ + GK+
Sbjct: 184 TMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 67.3 bits (164), Expect = 1e-11
 Identities = 55/208 (26%), Positives = 103/208 (49%), Gaps = 33/208 (15%)

Query: 783 IGTGGFGST-YKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +G+     +   G  VA+KKL    FQ     ++   E+  L  ++H+N++ L+ 
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLY-RPFQSELFAKRAYRELRLLKHMKHENVIGLLD 81

Query: 839 YYVGEAEM------FLVYNFLSGGNLETFI-HKKSGK-KIQWSVIHKIAIDIAQALAYLH 890
            +  +  +      +LV  F+ G +L   + H+K  + +IQ+ V       + + L Y+H
Sbjct: 82  VFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQ-----MLKGLKYIH 135

Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
            +    I+HRD+KP N+ ++E+    + DFGLAR          +++ G   T  Y APE
Sbjct: 136 AA---GIIHRDLKPGNLAVNEDCELKILDFGLAR-------QTDSEMTGYVVTRWYRAPE 185

Query: 948 YATT-CRVSDKADVYSFGVVLLELISGK 974
                   +   D++S G ++ E+++GK
Sbjct: 186 VILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain

 Score = 59.6 bits (145), Expect = 1e-11
 Identities = 21/40 (52%), Positives = 30/40 (75%), Gaps = 1/40 (2%)

Query: 48 TDSASLLSFKASISRDPSNLLATWNSS-TDHCTWHGVTCD 86
           D  +LL+FK+S++ DPS  L++WN S +D C+W GVTCD
Sbjct: 3  DDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42

Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 66.2 bits (161), Expect = 2e-11
 Identities = 56/221 (25%), Positives = 97/221 (43%), Gaps = 34/221 (15%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL---VAVKKL-SIGRFQGIQQFDAEIGTLGRI-RH 830
           +    ++IG G FG   +A +    L    A+K L         + F  E+  L ++  H
Sbjct: 3   DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHH 62

Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKK--------------SGKKIQWSVIH 876
            N++ L+G       +++   +   GNL  F+ K               +   +    + 
Sbjct: 63  PNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122

Query: 877 KIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD 936
           + A D+A  + YL      + +HRD+   N+L+ E L + ++DFGL+R  EV        
Sbjct: 123 QFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVY------- 172

Query: 937 VAGTFG-----YVAPEYATTCRVSDKADVYSFGVVLLELIS 972
           V  T G     ++A E       + K+DV+SFGV+L E++S
Sbjct: 173 VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 64.9 bits (158), Expect = 2e-11
 Identities = 61/191 (31%), Positives = 87/191 (45%), Gaps = 17/191 (8%)

Query: 832  NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
            N+V L  Y V E  +FLV     GG L + I K     I    + + A ++  AL  LH 
Sbjct: 46   NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL--NIPEECVKRWAAEMVVALDALHR 103

Query: 892  SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT 951
                 IV RD+ P+NILLD+  +  L+ F   R  EV ++     V     Y APE    
Sbjct: 104  E---GIVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDGEAVENM--YCAPEVGGI 156

Query: 952  CRVSDKADVYSFGVVLLELISGKRSLD--PSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009
               ++  D +S G +L EL++GK  ++  PS        NI  W   + +E RS    L 
Sbjct: 157  SEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEW---VSEEARS---LLQ 210

Query: 1010 ELWEAGPQENL 1020
            +L +  P E L
Sbjct: 211  QLLQFNPTERL 221

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 66.0 bits (161), Expect = 2e-11
 Identities = 69/220 (31%), Positives = 100/220 (45%), Gaps = 25/220 (11%)

Query: 772 RATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDA--EIGTLGRI 828
           R    F I   IG G +G  YKA +   G LVA+KK+ +   +      A  EI  L ++
Sbjct: 4   RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL 63

Query: 829 RHKNLVTL----------IGYYVGEAEMFLVYNFLSG---GNLETFIHKKSGKKIQWSVI 875
            H+N+V L          + +   +   +LV+ ++     G LE+         + +S  
Sbjct: 64  NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLES-------GLVHFSED 116

Query: 876 HKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT 935
           H I   + Q L  L+Y      +HRDIK SNILL+ +    L+DFGLARL    E+   T
Sbjct: 117 H-IKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175

Query: 936 DVAGTFGYVAPEYAT-TCRVSDKADVYSFGVVLLELISGK 974
           +   T  Y  PE      R     DV+S G +L EL + K
Sbjct: 176 NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 67.8 bits (165), Expect = 2e-11
 Identities = 68/221 (30%), Positives = 105/221 (47%), Gaps = 38/221 (17%)

Query: 817  QFDAEIGTLGRIRHKNLVTLIGYYVGEA--EMFLVYNFLSGGNLETFIHK--KSGKKIQW 872
            Q   E+  +  ++HKN+V  I  ++ +A  +++++  F   G+L   I K  K   KI+ 
Sbjct: 58   QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE 117

Query: 873  SVIHKIAIDIAQALAYLHY----SCVPRIVHRDIKPSNILLD-------------EELN- 914
              I  I   +  ALAY H         R++HRD+KP NI L                LN 
Sbjct: 118  HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177

Query: 915  ---AYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA--TTCRVSDKADVYSFGVVLLE 969
               A + DFGL++ + + E+ A + V GT  Y +PE     T    DK+D+++ G ++ E
Sbjct: 178  RPIAKIGDFGLSKNIGI-ESMAHSCV-GTPYYWSPELLLHETKSYDDKSDMWALGCIIYE 235

Query: 970  LISGKRSLDPSFSEYGNGFNIVSWAK----LLIKEGRSSEL 1006
            L SGK      F +  N   ++S  K    L IK G+S EL
Sbjct: 236  LCSGK----TPFHKANNFSQLISELKRGPDLPIK-GKSKEL 271

Length = 1021

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 13/202 (6%)

Query: 777 FSIRNLIGTGGFGSTY----KAELVPGYLVAVKKLSIGRFQGIQ--QFDAEIGTLGRIRH 830
           + ++  +G G FG+ Y    K  +    L  +K++ +G     +  Q + E   L ++ H
Sbjct: 2   YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61

Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIH--KKSGKKIQWSVIHKIAIDIAQALAY 888
             +V     ++      ++  +  G +L+  +   K +GK +  + + +  I +   + Y
Sbjct: 62  PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHY 121

Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
           +H     RI+HRD+K  NI L   L   + DFG++RLL  S   ATT   GT  Y++PE 
Sbjct: 122 MH---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT-FTGTPYYMSPEA 176

Query: 949 ATTCRVSDKADVYSFGVVLLEL 970
                   K+D++S G +L E+
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 65.7 bits (160), Expect = 2e-11
 Identities = 42/142 (29%), Positives = 73/142 (51%), Gaps = 6/142 (4%)

Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           L  L   +  +  +F V  FL+GG+L   I  K    +  +  +  A +I   L +LH  
Sbjct: 58  LTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFY--AAEIVCGLQFLHSK 115

Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
               I++RD+K  N++LD + +  ++DFG+ +     +  A+T   GT  Y+APE     
Sbjct: 116 ---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQGL 171

Query: 953 RVSDKADVYSFGVVLLELISGK 974
           + +   D +SFGV+L E++ G+
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 64.9 bits (158), Expect = 3e-11
 Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 14/206 (6%)

Query: 778 SIRNLIGTGGFGSTYKAEL-VPG---YLVAVKKLSIGRFQGIQQ-FDAEIGTLGRIRHKN 832
            I  ++GTG FG   +  L +P      VA+  L  G     ++ F AE  TLG+  H N
Sbjct: 8   KIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSN 67

Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALAYLH 890
           +V L G       M +V  ++S G L++F+ K  G   Q      + +   +A  + YL 
Sbjct: 68  IVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEG---QLVAGQLMGMLPGLASGMKYLS 124

Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
                  VH+ +    +L++ +L   +S F   +  +    + T        + APE   
Sbjct: 125 EM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQ 181

Query: 951 TCRVSDKADVYSFGVVLLELIS-GKR 975
               S  +DV+SFG+V+ E++S G+R
Sbjct: 182 YHHFSSASDVWSFGIVMWEVMSYGER 207

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 65.7 bits (160), Expect = 3e-11
 Identities = 80/278 (28%), Positives = 123/278 (44%), Gaps = 35/278 (12%)

Query: 783  IGTGGFGSTYKAELV-PGYLVAVKKLS---IGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
            IG G FG  Y+        + A+K LS   I   + +     E   L R        ++G
Sbjct: 1    IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 839  Y---YVGEAEMFLVYNFLSGGNLETFIH-KKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
                +  +++++LV +++SGG  E F H +K G+  +      IA ++  AL +LH    
Sbjct: 61   LKFSFQTDSDLYLVTDYMSGG--ELFWHLQKEGRFSEDRAKFYIA-ELVLALEHLHKY-- 115

Query: 895  PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV 954
              IV+RD+KP NILLD   +  L DFGL++   +++   T    GT  Y+APE     + 
Sbjct: 116  -DIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEVLLDEKG 173

Query: 955  SDK-ADVYSFGVVLLELISGKRSLDPSFSE-----YGN-GFNIVSWAK-LLIKEGRSSEL 1006
              K  D +S GV++ E+  G     P ++E     Y N  F  V + K +L  EGR    
Sbjct: 174  YTKHVDFWSLGVLVFEMCCG---WSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQ--- 227

Query: 1007 FLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQV 1044
            F+  L    PQ       RL +      L   P    +
Sbjct: 228  FVKGLLNRNPQH------RLGAHRDAVELKEHPFFADI 259

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 65.0 bits (158), Expect = 3e-11
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 38/211 (18%)

Query: 782 LIGTGGFGSTY---KAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +IG GGFG  Y   KA+   G + A+K L   R +  Q      G    +  + +++L+ 
Sbjct: 1   IIGRGGFGEVYGCRKAD--TGKMYAMKCLDKKRIKMKQ------GETLALNERIMLSLVS 52

Query: 839 -----YYVGEAEMF-------LVYNFLSGGNLETFIHKK---SGKKIQWSVIHKIAIDIA 883
                + V     F        + + ++GG+L   + +    S K++++      A +I 
Sbjct: 53  TGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-----YATEII 107

Query: 884 QALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGY 943
             L ++H   V   V+RD+KP+NILLDE  +  +SD GLA      + HA+    GT GY
Sbjct: 108 LGLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGY 161

Query: 944 VAPEYATTCRVSD-KADVYSFGVVLLELISG 973
           +APE        D  AD +S G +L +L+ G
Sbjct: 162 MAPEVLQKGTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 65.7 bits (160), Expect = 4e-11
 Identities = 43/164 (26%), Positives = 76/164 (46%), Gaps = 29/164 (17%)

Query: 825 LGRIRHKNLVTLIGYYV-GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIA 883
           L  + H +++ +    V G     ++ ++ S  +L T++ K+S             + I 
Sbjct: 111 LQNVNHPSVIRMKDTLVSGAITCMVLPHYSS--DLYTYLTKRSRP-----------LPID 157

Query: 884 QA----------LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA 933
           QA          L YLH     RI+HRD+K  NI +++     + D G A+   V+   A
Sbjct: 158 QALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--A 212

Query: 934 TTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSL 977
              +AGT    APE     + + KAD++S G+VL E+++   ++
Sbjct: 213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256

Length = 357

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 64.7 bits (157), Expect = 4e-11
 Identities = 53/211 (25%), Positives = 99/211 (46%), Gaps = 23/211 (10%)

Query: 783 IGTGGFGSTYKAEL---VPG---YLVAVKKLSIGRFQGI--QQFDAEIGTLGRIRHKNLV 834
           +G   FG  YK  L    PG     VA+K L   + +G   ++F  E     R++H N+V
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK-DKAEGPLREEFKHEAMMRSRLQHPNIV 71

Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFI-----HKKSGKKIQWSVIHKIAID-------I 882
            L+G    E  + +++++ S  +L  F+     H   G       + K  ++       +
Sbjct: 72  CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV-KSTLEPADFVHIV 130

Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT-DVAGTF 941
            Q  A + +     +VH+D+   N+L+ ++LN  +SD GL R +  ++ +    +     
Sbjct: 131 TQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPI 190

Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
            +++PE     + S  +D++S+GVVL E+ S
Sbjct: 191 RWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 65.0 bits (158), Expect = 4e-11
 Identities = 52/195 (26%), Positives = 97/195 (49%), Gaps = 9/195 (4%)

Query: 783 IGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQ-QFDAEIGTLGRIRHKNLVTLIGYY 840
           +G G + + YK    +   LVA+K++ +   +G       E+  L  ++H N+VTL    
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73

Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
             E  + LV+ +L   +L+ ++    G  I    +H + + + Q L  L+Y    +++HR
Sbjct: 74  HTEKSLTLVFEYLDK-DLKQYL-DDCGNSIN---MHNVKLFLFQLLRGLNYCHRRKVLHR 128

Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT-TCRVSDKAD 959
           D+KP N+L++E     L+DFGLAR   +     + +V  T  Y  P+    +   S + D
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYSTQID 187

Query: 960 VYSFGVVLLELISGK 974
           ++  G +  E+ +G+
Sbjct: 188 MWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 64.5 bits (157), Expect = 4e-11
 Identities = 52/214 (24%), Positives = 99/214 (46%), Gaps = 22/214 (10%)

Query: 777 FSIRNLIGTGGFGSTYKAEL-----VPGYLVAVK--KLSIGRFQGIQQFDAEIGTLGRIR 829
             +  ++G G FGS  + +L          VAVK  KL I  +  I++F +E   +    
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLK-VAVKTMKLDIHTYSEIEEFLSEAACMKDFD 59

Query: 830 HKNLVTLIGYYVGEAEM------FLVYNFLSGGNLETFIHKK----SGKKIQWSVIHKIA 879
           H N++ LIG     + +       ++  F+  G+L +F+         +K+    + K  
Sbjct: 60  HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119

Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG 939
           +DIA  + YL        +HRD+   N +L E++   ++DFGL++ +   + +    +A 
Sbjct: 120 VDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAK 176

Query: 940 T-FGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
               ++A E       + K+DV++FGV + E+ +
Sbjct: 177 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 65.1 bits (158), Expect = 5e-11
 Identities = 41/146 (28%), Positives = 74/146 (50%), Gaps = 6/146 (4%)

Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           LV L   +   + +FLV  +++GG+L    H +  +K+        A +I  AL +LH  
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNGGDL--MFHMQRQRKLPEEHARFYAAEICIALNFLHER 115

Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
               I++RD+K  N+LLD + +  L+D+G+ +   +     T+   GT  Y+APE     
Sbjct: 116 ---GIIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEILRGE 171

Query: 953 RVSDKADVYSFGVVLLELISGKRSLD 978
                 D ++ GV++ E+++G+   D
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 64.6 bits (157), Expect = 6e-11
 Identities = 73/294 (24%), Positives = 129/294 (43%), Gaps = 45/294 (15%)

Query: 783  IGTGGFGSTYKAELV------PGYL--VAVKKL-SIGRFQGIQQFDAEIGTLGRI-RHKN 832
            +G G FG    AE +      P  +  VAVK L S    + +    +E+  +  I +HKN
Sbjct: 26   LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 833  LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSV--------------IHKI 878
            ++ L+G    +  ++++  + S GNL  ++  +    +++                +   
Sbjct: 86   IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 879  AIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDV 937
            A  +A+ + YL      + +HRD+   N+L+ E+    ++DFGLAR +  +     TT+ 
Sbjct: 146  AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 938  AGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLL 997
                 ++APE       + ++DV+SFGV+L E+ +   S  P       G  +    KLL
Sbjct: 203  RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP-------GVPVEELFKLL 255

Query: 998  IKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051
             KEG   +        +     L  MMR    C     S RP+ KQ++  L ++
Sbjct: 256  -KEGHRMDK------PSNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 299

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 64.9 bits (158), Expect = 6e-11
 Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 23/204 (11%)

Query: 782 LIGTGGFGSTYKAELVPG---YLVAV-KKLSIGRFQGIQQFDAE-------IGTLGRIRH 830
           ++G G FG    AEL      Y + V KK  I     +Q  D +       I  L   +H
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI-----LQDDDVDCTMTEKRILALAA-KH 55

Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
             L  L   +  +  +F V  +++GG+L   I +   +K         A ++  AL +LH
Sbjct: 56  PFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQR--SRKFDEPRSRFYAAEVTLALMFLH 113

Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
              V   ++RD+K  NILLD E +  L+DFG+ +   +     TT   GT  Y+APE   
Sbjct: 114 RHGV---IYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIAPEILQ 169

Query: 951 TCRVSDKADVYSFGVVLLELISGK 974
                   D ++ GV++ E+++G+
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 64.6 bits (157), Expect = 6e-11
 Identities = 54/218 (24%), Positives = 105/218 (48%), Gaps = 42/218 (19%)

Query: 829  RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETF--------------IHKKSGKKIQWSV 874
            +HKN++ L+G    E  ++++  + + GNL  F              I K   +++ +  
Sbjct: 76   KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135

Query: 875  IHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHA 933
            +   A  +A+ + YL      R +HRD+   N+L+ E+    ++DFGLAR + ++     
Sbjct: 136  LVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKK 192

Query: 934  TTDVAGTFGYVAPEYATTCRV-SDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVS 992
            T++      ++APE A   RV + ++DV+SFG+++ E+          F+  G+ +  + 
Sbjct: 193  TSNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGILMWEI----------FTLGGSPYPGIP 241

Query: 993  WAKL--LIKEGR--------SSELF--LPELWEAGPQE 1018
              +L  L++EG         + EL+  + E W A P +
Sbjct: 242  VEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQ 279

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 63.8 bits (155), Expect = 7e-11
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 26/205 (12%)

Query: 782 LIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDA---EIGTLGRIRHKNL 833
           L+G+G FG+ +K   +P        VA+K  +I    G Q F      +  +G + H  +
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIK--TIQDRSGRQTFQEITDHMLAMGSLDHAYI 71

Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSG-----KKIQWSVIHKIAIDIAQALAY 888
           V L+G   G A + LV      G+L   + +        + + W V       IA+ + Y
Sbjct: 72  VRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCV------QIAKGMYY 124

Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET-HATTDVAGTFGYVAPE 947
           L       +VHR++   NILL  +    ++DFG+A LL   +  +  ++      ++A E
Sbjct: 125 LEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181

Query: 948 YATTCRVSDKADVYSFGVVLLELIS 972
                R + ++DV+S+GV + E++S
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 63.5 bits (154), Expect = 1e-10
 Identities = 55/204 (26%), Positives = 100/204 (49%), Gaps = 19/204 (9%)

Query: 783 IGTGGFGSTYKAELVPG---YLVAVK--KLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLI 837
           +G G FGS  + +L        VAVK  K++I     ++ F +E   +    H N++ LI
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 838 G--YYVGEAEMF----LVYNFLSGGNLETFI-HKKSGKKIQW---SVIHKIAIDIAQALA 887
           G      E+E +    ++  F+  G+L +F+ + + G   Q+    ++ K   DIA  + 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT-FGYVAP 946
           YL        +HRD+   N +L+E +N  ++DFGL++ +   + +    +A     ++A 
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 947 EYATTCRVSDKADVYSFGVVLLEL 970
           E       + K+DV+SFGV + E+
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEI 207

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 63.2 bits (153), Expect = 1e-10
 Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 34/216 (15%)

Query: 781 NLIGTGGFGSTYKAELVPGYL---VAVKKL-SIGRFQGIQQFDAEIGTLGRI-RHKNLVT 835
           ++IG G FG   KA +    L    A+K++         + F  E+  L ++  H N++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKK--------------SGKKIQWSVIHKIAID 881
           L+G       ++L   +   GNL  F+ K               +   +    +   A D
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 882 IAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF 941
           +A+ + YL      + +HRD+   NIL+ E   A ++DFGL+R  EV        V  T 
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-------VKKTM 170

Query: 942 G-----YVAPEYATTCRVSDKADVYSFGVVLLELIS 972
           G     ++A E       +  +DV+S+GV+L E++S
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 63.1 bits (154), Expect = 1e-10
 Identities = 50/210 (23%), Positives = 94/210 (44%), Gaps = 27/210 (12%)

Query: 783 IGTGGFGSTYK---AELVPGYL---VAVKKLSI-GRFQGIQQFDAEIGTLGRIRHKNLVT 835
           +G G FG  Y+     +V G     VA+K ++     +   +F  E   +      ++V 
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSV--------IHKIAIDIAQALA 887
           L+G         +V   ++ G+L++++  +  +                ++A +IA  +A
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFG----- 942
           YL      + VHRD+   N ++ E+L   + DFG+ R +  ++ +      G  G     
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK----GGKGLLPVR 186

Query: 943 YVAPEYATTCRVSDKADVYSFGVVLLELIS 972
           ++APE       + K+DV+SFGVVL E+ +
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 63.5 bits (154), Expect = 1e-10
 Identities = 54/195 (27%), Positives = 97/195 (49%), Gaps = 9/195 (4%)

Query: 783 IGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQ-QFDAEIGTLGRIRHKNLVTLIGYY 840
           +G G + + +K    +   LVA+K++ +   +G       E+  L  ++H N+VTL    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
             E  + LV+ +L   +L+ ++    G  +    +H + I + Q L  L Y    +I+HR
Sbjct: 73  HTERCLTLVFEYLDS-DLKQYL-DNCGNLMS---MHNVKIFMFQLLRGLSYCHKRKILHR 127

Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT-TCRVSDKAD 959
           D+KP N+L++E+    L+DFGLAR   V     + +V  T  Y  P+    +   S   D
Sbjct: 128 DLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYSTPID 186

Query: 960 VYSFGVVLLELISGK 974
           ++  G +L E+ +G+
Sbjct: 187 MWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 63.9 bits (155), Expect = 1e-10
 Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 21/201 (10%)

Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTLIG 838
           IG+G  G    A + V G  VAVKKLS   FQ     ++   E+  L  + HKN+++L+ 
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKLS-RPFQNQTHAKRAYRELVLLKCVNHKNIISLLN 87

Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
            +  +       +++LV   +   NL   IH +   +    +++++   I     +LH +
Sbjct: 88  VFTPQKSLEEFQDVYLVMELMDA-NLCQVIHMELDHERMSYLLYQMLCGIK----HLHSA 142

Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
               I+HRD+KPSNI++  +    + DFGLAR          T    T  Y APE     
Sbjct: 143 ---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAPEVILGM 197

Query: 953 RVSDKADVYSFGVVLLELISG 973
              +  D++S G ++ EL+ G
Sbjct: 198 GYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 63.5 bits (154), Expect = 1e-10
 Identities = 52/195 (26%), Positives = 96/195 (49%), Gaps = 9/195 (4%)

Query: 783 IGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQ-QFDAEIGTLGRIRHKNLVTLIGYY 840
           +G G + + +K    +   LVA+K++ +   +G       E+  L  ++H N+VTL    
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73

Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
             +  + LV+ +L   +L+ ++    G  +    +H + I + Q L  L Y    +++HR
Sbjct: 74  HTDKSLTLVFEYLDK-DLKQYM-DDCGNIMS---MHNVKIFLYQILRGLAYCHRRKVLHR 128

Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT-TCRVSDKAD 959
           D+KP N+L++E     L+DFGLAR   V     + +V  T  Y  P+    +   S + D
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYSTQID 187

Query: 960 VYSFGVVLLELISGK 974
           ++  G +  E+ SG+
Sbjct: 188 MWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 63.5 bits (154), Expect = 1e-10
 Identities = 72/294 (24%), Positives = 128/294 (43%), Gaps = 45/294 (15%)

Query: 783  IGTGGFGSTYKAELV--------PGYLVAVKKLSIGRFQ-GIQQFDAEIGTLGRI-RHKN 832
            +G G FG    AE +            VAVK L     +  +    +E+  +  I +HKN
Sbjct: 23   LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 833  LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSV-IHKIAID---------- 881
            ++ L+G    +  ++++  + S GNL  ++  +    +++S  I ++  +          
Sbjct: 83   IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 882  ---IAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDV 937
               +A+ + YL      + +HRD+   N+L+ E     ++DFGLAR +  +     TT+ 
Sbjct: 143  TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 938  AGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLL 997
                 ++APE       + ++DV+SFGV++ E+ +   S  P       G  +    KLL
Sbjct: 200  RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP-------GIPVEELFKLL 252

Query: 998  IKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051
             KEG   +        A     L  MMR    C     S RP+ KQ++  L ++
Sbjct: 253  -KEGHRMDK------PANCTNELYMMMR---DCWHAIPSHRPTFKQLVEDLDRI 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 63.6 bits (155), Expect = 1e-10
 Identities = 62/221 (28%), Positives = 94/221 (42%), Gaps = 36/221 (16%)

Query: 776 NFSIRNLIGTGGFG---STYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIR--- 829
            + +   +G G +G   S   AE      VA+KK++         F  +I     +R   
Sbjct: 1   RYELIKELGQGAYGIVCSARNAETSEEETVAIKKIT-------NVFSKKILAKRALRELK 53

Query: 830 -------HKNLVTL----IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKI 878
                  HKN+  L    I +     E++L Y  L   +L   I   SG+ +  +     
Sbjct: 54  LLRHFRGHKNITCLYDMDIVFPGNFNELYL-YEELMEADLHQIIR--SGQPLTDAHFQSF 110

Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL----EVSETHAT 934
              I   L Y+H + V   +HRD+KP N+L++ +    + DFGLAR        +    T
Sbjct: 111 IYQILCGLKYIHSANV---LHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMT 167

Query: 935 TDVAGTFGYVAPEYATTCRVSDKA-DVYSFGVVLLELISGK 974
             VA T  Y APE   + +   KA DV+S G +L EL+  K
Sbjct: 168 EYVA-TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 63.7 bits (155), Expect = 2e-10
 Identities = 55/180 (30%), Positives = 86/180 (47%), Gaps = 18/180 (10%)

Query: 802 VAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLV---YNFLSGGNL 858
           V VK ++ G+  G      EI  L  I H+ ++ LI  Y  ++ + +V   Y      +L
Sbjct: 122 VIVKAVTGGKTPG-----REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC----DL 172

Query: 859 ETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLS 918
            T++ +     ++ ++   I   + +ALAYLH      I+HRD+K  NI LDE  NA L 
Sbjct: 173 FTYVDRSGPLPLEQAIT--IQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLG 227

Query: 919 DFGLA-RLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSL 977
           DFG A +L    +T      +GT    +PE         K D++S G+VL E+     +L
Sbjct: 228 DFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 62.4 bits (152), Expect = 2e-10
 Identities = 42/155 (27%), Positives = 80/155 (51%), Gaps = 15/155 (9%)

Query: 828 IRHKNLVTLIGYYVGEAEM-FLVYNFLSGGNLETFIHKKSGKKIQWSVIHKI-------- 878
           + H+N++ ++   + + E  F++Y +++ GNL+ F+  +  +  + +    +        
Sbjct: 65  LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFL--QQCRLGEANNPQALSTQQLVHM 122

Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVA 938
           AI IA  ++YLH      ++H+DI   N ++DEEL   ++D  L+R L   + H   D  
Sbjct: 123 AIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNE 179

Query: 939 G-TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
                ++A E       S  +DV+SFGV+L EL++
Sbjct: 180 NRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 62.6 bits (152), Expect = 2e-10
 Identities = 38/96 (39%), Positives = 53/96 (55%), Gaps = 7/96 (7%)

Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVA 938
           A +I   L ++H   V   V+RD+KP+NILLDE  +  +SD GLA      + HA+    
Sbjct: 103 AAEIILGLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 156

Query: 939 GTFGYVAPEYATTCRVSD-KADVYSFGVVLLELISG 973
           GT GY+APE        D  AD +S G +L +L+ G
Sbjct: 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 62.5 bits (152), Expect = 3e-10
 Identities = 57/231 (24%), Positives = 101/231 (43%), Gaps = 24/231 (10%)

Query: 757 TFADTPAELTYDNVVR-ATGNFSIRNLIGTGGFGSTYKAELV------PGYLVAVKKL-S 808
            + D P +L YD        N S    +G G FG   +A             VAVK L  
Sbjct: 17  VYID-PTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKP 75

Query: 809 IGRFQGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSG 867
                  +   +E+  +  +  H+N+V L+G       + ++  +   G+L  F+ +K  
Sbjct: 76  TAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRE 135

Query: 868 KKIQWSVIHKIAIDIAQALAYLHY-SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL 926
             +    +   +  +A+ +A+L   +C+    HRD+   N+LL       + DFGLAR +
Sbjct: 136 SFLTLEDLLSFSYQVAKGMAFLASKNCI----HRDLAARNVLLTHGKIVKICDFGLARDI 191

Query: 927 E-----VSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
                 V + +A   V     ++APE    C  + ++DV+S+G++L E+ S
Sbjct: 192 MNDSNYVVKGNARLPVK----WMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 61.8 bits (150), Expect = 3e-10
 Identities = 53/209 (25%), Positives = 98/209 (46%), Gaps = 20/209 (9%)

Query: 783 IGTGGFGSTYKAELVP-GYLVAVKKLSI----GRFQGIQQFDAEIGTLGRIRHKNLVTLI 837
           +G G +GS YK    P G  +A+K++ +     +F  I     E+  L +     +V   
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIM---ELDILHKAVSPYIVDFY 65

Query: 838 GYYVGEAEMFLVYNFLSGGNLETFIHKKSG-KKIQWSVIHKIAIDIAQALAYLHYSCVPR 896
           G +  E  +++   ++  G+L+         + I   V+ +I   + + L +L       
Sbjct: 66  GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HN 123

Query: 897 IVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD 956
           I+HRD+KP+N+L++      L DFG++  L  S   A T++ G   Y+APE   +   + 
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--LAKTNI-GCQSYMAPERIKSGGPNQ 180

Query: 957 ------KADVYSFGVVLLELISGKRSLDP 979
                 ++DV+S G+ +LE+  G+    P
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGRYPYPP 209

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 62.4 bits (152), Expect = 3e-10
 Identities = 61/212 (28%), Positives = 90/212 (42%), Gaps = 30/212 (14%)

Query: 777 FSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFDAE--------IGTLGR 827
           F    ++G G FG    AE    G L A+K L  G    I + + E          T   
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDI--IARDEVESLMCEKRIFETANS 58

Query: 828 IRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKK--SGKKIQWSVIHKIAIDIAQA 885
            RH  LV L   +  E  +  V  + +GG+L   IH    S  +  +      A  +   
Sbjct: 59  ERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVF-----YAACVVLG 113

Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF---- 941
           L YLH +   +IV+RD+K  N+LLD E    ++DFGL +     E     D   TF    
Sbjct: 114 LQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK-----EGMGFGDRTSTFCGTP 165

Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
            ++APE  T    +   D +  GV++ E++ G
Sbjct: 166 EFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 63.3 bits (154), Expect = 4e-10
 Identities = 43/138 (31%), Positives = 64/138 (46%), Gaps = 29/138 (21%)

Query: 485 LLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQI 544
           L L+N    G +P + ISK   LQS  +NLS                          N I
Sbjct: 423 LGLDNQGLRGFIPND-ISKLRHLQS--INLS-------------------------GNSI 454

Query: 545 SGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFG-HL 603
            G+I   +G +  L+ LDL  N  +GS+P+ LG+L  L+ + L GN+L+G +P+  G  L
Sbjct: 455 RGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514

Query: 604 ISLVVLDLSHNALTGSIP 621
           +     + + NA    IP
Sbjct: 515 LHRASFNFTDNAGLCGIP 532

Length = 623

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 61.9 bits (151), Expect = 4e-10
 Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 28/217 (12%)

Query: 772 RATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDA----EIGTLG 826
           R+   +   N I  G +G  Y+A +   G +VA+KKL +   +  + F      EI  L 
Sbjct: 2   RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKM--EKEKEGFPITSLREINILL 59

Query: 827 RIRHKNLVTLIGYYVGEA--EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQ 884
           +++H N+VT+    VG    ++++V  ++   +L++ +       +Q S +  + + +  
Sbjct: 60  KLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQ-SEVKCLMLQLLS 117

Query: 885 ALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYV 944
            +A+LH +    I+HRD+K SN+LL+      + DFGLAR         T  V  T  Y 
Sbjct: 118 GVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYR 173

Query: 945 APE-------YATTCRVSDKADVYSFGVVLLELISGK 974
           APE       Y+T        D++S G +  EL++ K
Sbjct: 174 APELLLGAKEYSTAI------DMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 62.3 bits (151), Expect = 4e-10
 Identities = 67/271 (24%), Positives = 118/271 (43%), Gaps = 46/271 (16%)

Query: 783  IGTGGFGSTYKAELV--------PGYLVAVKKLSI-GRFQGIQQFDAEIGTLGRI-RHKN 832
            +G G FG    AE +            VAVK L      + +    +E+  +  I +HKN
Sbjct: 20   LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 833  LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSV--------------IHKI 878
            ++ L+G    +  ++++  + S GNL  ++  +    + +S               +   
Sbjct: 80   IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 879  AIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDV 937
            A  +A+ + YL      + +HRD+   N+L+ E+    ++DFGLAR +  +     TT+ 
Sbjct: 140  AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 938  AGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLL 997
                 ++APE       + ++DV+SFGV+L E+ +   S  P       G  +    KLL
Sbjct: 197  RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP-------GIPVEELFKLL 249

Query: 998  IKEGR--------SSELF--LPELWEAGPQE 1018
             KEG         + EL+  + E W A P +
Sbjct: 250  -KEGHRMDKPANCTHELYMIMRECWHAVPSQ 279

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 62.4 bits (151), Expect = 4e-10
 Identities = 60/223 (26%), Positives = 102/223 (45%), Gaps = 28/223 (12%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQ-----FDAEIGTLGRIRH 830
           +F I  +IG G FG     +L     V   K+ + +++ +++     F  E   L    +
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKI-LNKWEMLKRAETACFREERDVLVNGDN 60

Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQ-----WSVIHKIAIDIAQA 885
           + + TL   +  E  ++LV ++  GG+L T + K   +  +     +     IAID   +
Sbjct: 61  QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAID---S 117

Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
           +  LHY      VHRDIKP NIL+D   +  L+DFG    L    T  ++   GT  Y++
Sbjct: 118 VHQLHY------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 171

Query: 946 PEYATTC-----RVSDKADVYSFGVVLLELISGKRSLDPSFSE 983
           PE          +   + D +S GV + E++ G+    P ++E
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE---TPFYAE 211

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 62.1 bits (151), Expect = 4e-10
 Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 6/149 (4%)

Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           H  LV L   +  E+ +F V  F+SGG+L    H +  +K+        + +I+ AL +L
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEFVSGGDL--MFHMQRQRKLPEEHARFYSAEISLALNFL 112

Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
           H      I++RD+K  N+LLD E +  L+D+G+ +   +     T+   GT  Y+APE  
Sbjct: 113 HER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDTTSTFCGTPNYIAPEIL 168

Query: 950 TTCRVSDKADVYSFGVVLLELISGKRSLD 978
                    D ++ GV++ E+++G+   D
Sbjct: 169 RGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 62.4 bits (152), Expect = 4e-10
 Identities = 51/207 (24%), Positives = 96/207 (46%), Gaps = 21/207 (10%)

Query: 775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLS---IGRFQGIQQFDAEIGTLGRIRH 830
            +F I   +G GG+G  + A+    G +VA+K++    + +   ++    E   L   + 
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60

Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKK---SGKKIQWSVIHKI-AIDIAQAL 886
           + LV L+  +  +  ++L   ++ GG+  T ++     S    ++ +     A+D    L
Sbjct: 61  EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL 120

Query: 887 AYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAP 946
            Y         +HRD+KP N L+D   +  L+DFGL++ + V+  ++   V G+  Y+AP
Sbjct: 121 GY---------IHRDLKPENFLIDASGHIKLTDFGLSKGI-VTYANS---VVGSPDYMAP 167

Query: 947 EYATTCRVSDKADVYSFGVVLLELISG 973
           E           D +S G +L E + G
Sbjct: 168 EVLRGKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 61.1 bits (148), Expect = 5e-10
 Identities = 50/204 (24%), Positives = 86/204 (42%), Gaps = 20/204 (9%)

Query: 783 IGTGGFGSTYKAELVPGYLVA---VKKL-SIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           IG G FG     E   G   A   VK+L +         F  E+     + H N++  +G
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS---VIHKIAIDIAQALAYLHYSCVP 895
             +      LV  F   G+L+ ++    G   Q +   V+ ++A ++A  L +LH +   
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--- 119

Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFG--YVAPEYAT--- 950
             +H D+   N  L  +L+  + D+GLA L +  E +  T         ++APE      
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178

Query: 951 ----TCRVSDKADVYSFGVVLLEL 970
                   + K++++S GV + EL
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 60.4 bits (146), Expect = 8e-10
 Identities = 44/142 (30%), Positives = 69/142 (48%), Gaps = 8/142 (5%)

Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V +IG    E+ M LV      G L  F+ K   K +    I ++   ++  + YL  +
Sbjct: 58  IVRMIGICEAESWM-LVMELAELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEET 114

Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF--GYVAPEYAT 950
                VHRD+   N+LL  +  A +SDFGL++ L   E +      G +   + APE   
Sbjct: 115 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMN 171

Query: 951 TCRVSDKADVYSFGVVLLELIS 972
             + S K+DV+SFGV++ E  S
Sbjct: 172 YYKFSSKSDVWSFGVLMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 62.1 bits (151), Expect = 1e-09
 Identities = 33/85 (38%), Positives = 52/85 (61%), Gaps = 1/85 (1%)

Query: 541 NNQ-ISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQ 599
           +NQ + G I   + KL  LQ ++L GN + G++P  LG +  L+ + L  N+  G IP  
Sbjct: 426 DNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES 485

Query: 600 FGHLISLVVLDLSHNALTGSIPASL 624
            G L SL +L+L+ N+L+G +PA+L
Sbjct: 486 LGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 61.8 bits (150), Expect = 1e-09
 Identities = 33/88 (37%), Positives = 50/88 (56%)

Query: 212 AIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELK 271
             DS+    F+  L L +  L   IP +I K R+L+++ L GN + G+IP  +G+I+ L+
Sbjct: 410 QFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLE 469

Query: 272 VLDVSRNSLTDRIPVELADCSKLSVLVL 299
           VLD+S NS    IP  L   + L +L L
Sbjct: 470 VLDLSYNSFNGSIPESLGQLTSLRILNL 497

Length = 623

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 60.8 bits (147), Expect = 1e-09
 Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 15/210 (7%)

Query: 776 NFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQFDAEIGTLGR----IRH 830
           +F+   ++G G FG    AE      L A+K L   +   IQ  D E   + +    ++ 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILK--KDVVIQDDDVECTMVEKRVLALQD 58

Query: 831 KN--LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
           K   L  L   +     ++ V  +++GG+L   I +    K   +V +  A +I+  L +
Sbjct: 59  KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY--AAEISVGLFF 116

Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
           LH      I++RD+K  N++LD E +  ++DFG+ +   + +   T    GT  Y+APE 
Sbjct: 117 LHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-EHMVDGVTTRTFCGTPDYIAPEI 172

Query: 949 ATTCRVSDKADVYSFGVVLLELISGKRSLD 978
                     D +++GV+L E+++G+   D
Sbjct: 173 IAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 60.1 bits (145), Expect = 2e-09
 Identities = 53/195 (27%), Positives = 94/195 (48%), Gaps = 11/195 (5%)

Query: 783 IGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQFDA--EIGTLGRIRHKNLVTLIGY 839
           +G G + + YK +  V G LVA+K + +   +G   F A  E   L  ++H N+V L   
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHANIVLLHDI 71

Query: 840 YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
              +  + LV+ ++   +L  ++ K  G  +    +      + + L+Y+H      I+H
Sbjct: 72  IHTKETLTLVFEYVHT-DLCQYMDKHPGG-LHPENVKLFLFQLLRGLSYIHQR---YILH 126

Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT-TCRVSDKA 958
           RD+KP N+L+ +     L+DFGLAR   V  +H  ++   T  Y  P+    +   S   
Sbjct: 127 RDLKPQNLLISDTGELKLADFGLARAKSVP-SHTYSNEVVTLWYRPPDVLLGSTEYSTCL 185

Query: 959 DVYSFGVVLLELISG 973
           D++  G + +E+I G
Sbjct: 186 DMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 59.6 bits (144), Expect = 2e-09
 Identities = 52/213 (24%), Positives = 99/213 (46%), Gaps = 20/213 (9%)

Query: 777 FSIRNLIGTGGFGSTYKAELV----PGYLVAVK--KLSIGRFQGIQQFDAEIGTLGRIRH 830
           F++  ++G G FGS  +A+L         VAVK  K  I     I++F  E   +    H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 831 KNLVTLIGYYVGEAEM------FLVYNFLSGGNLETFI-HKKSGKK---IQWSVIHKIAI 880
            N++ LIG  +            ++  F+  G+L TF+   + G++   +    + +  I
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 881 DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG- 939
           DIA  + YL        +HRD+   N +L+E +   ++DFGL++ +   + +     +  
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 940 TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
              ++A E       +  +DV++FGV + E+++
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 60.4 bits (146), Expect = 2e-09
 Identities = 48/142 (33%), Positives = 77/142 (54%), Gaps = 6/142 (4%)

Query: 528 LLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILL 587
           L +   L   + + N +S  +   +  L  L  LDL GN++S  LP E+  L  L+ + L
Sbjct: 159 LRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDL 216

Query: 588 GGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVS 647
             N++  E+ S   +L +L  L+LS+N L   +P S+   + LE+L L++N++S     S
Sbjct: 217 SNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS--SISS 272

Query: 648 FSTLVNLSALDLSFNNLSGHIP 669
             +L NL  LDLS N+LS  +P
Sbjct: 273 LGSLTNLRELDLSGNSLSNALP 294

Length = 394

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 61.0 bits (148), Expect = 2e-09
 Identities = 70/291 (24%), Positives = 111/291 (38%), Gaps = 76/291 (26%)

Query: 776  NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
            +F +   +G G FG  YKA LV        K  + +    +    EI    R+R +    
Sbjct: 133  DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKK--ATEYGAVEIWMNERVR-RACPN 189

Query: 836  LIGYYVG----------EAEMFLVYNF-----LSG--------GNLETFIHKK-----SG 867
                +V           E E +LV+ +     L+          N+E ++  K      G
Sbjct: 190  SCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKG 249

Query: 868  KKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLL 926
             + +  +I  I   I  AL  LH +    IVHRD+KP NI+  E   ++ + D G A  L
Sbjct: 250  LERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNIIFSEGSGSFKIIDLGAAADL 306

Query: 927  EVSETHATTDVAGTFGYVAPE-YATTCR---------------------VSDKADVYSFG 964
             V   +   +      Y APE Y  + +                     + D+ D+YS G
Sbjct: 307  RVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 366

Query: 965  VVLLE-----------LISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSS 1004
            ++ L+           LI   R L        N +++V+W KL+  E R+S
Sbjct: 367  LIFLQMAFPNLRSDSNLIQFNRQLKR------NDYDLVAWRKLV--EPRAS 409

Length = 566

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 60.1 bits (145), Expect = 2e-09
 Identities = 49/207 (23%), Positives = 89/207 (42%), Gaps = 30/207 (14%)

Query: 782 LIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEI--------------GTLGR 827
           L+G G FG           ++ V++ + G++  ++    E+                L  
Sbjct: 2   LLGKGTFGK----------VILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKN 51

Query: 828 IRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALA 887
            RH  L +L   +  +  +  V  +++GG  E F H    +            +I  AL 
Sbjct: 52  TRHPFLTSLKYSFQTKDRLCFVMEYVNGG--ELFFHLSRERVFSEDRTRFYGAEIVSALD 109

Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE 947
           YLH     +IV+RD+K  N++LD++ +  ++DFGL +   +++        GT  Y+APE
Sbjct: 110 YLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEYLAPE 165

Query: 948 YATTCRVSDKADVYSFGVVLLELISGK 974
                      D +  GVV+ E++ G+
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 59.1 bits (144), Expect = 2e-09
 Identities = 43/163 (26%), Positives = 72/163 (44%), Gaps = 27/163 (16%)

Query: 830 HKNLVTLIGYYV--GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALA 887
           + N + L  YY         L+ +++  G+L   + K+   K+  + + KI   + +AL 
Sbjct: 68  NPNFIKL--YYSVTTLKGHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALN 123

Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELN-AYLSDFGLARLLEVSETHATTDVAGTFGYVAP 946
            LH      I+H DIK  N+L D   +  YL D+GL +++     +   D  GT  Y +P
Sbjct: 124 DLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY---D--GTLDYFSP 175

Query: 947 E------YATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSE 983
           E      Y  +       D ++ GV+  EL++GK        E
Sbjct: 176 EKIKGHNYDVS------FDWWAVGVLTYELLTGKHPFKEDEDE 212

Length = 267

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 59.8 bits (145), Expect = 3e-09
 Identities = 39/133 (29%), Positives = 69/133 (51%), Gaps = 6/133 (4%)

Query: 846 MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPS 905
           ++ V  +++GG+L   I +    K   +V +  A +IA  L +LH      I++RD+K  
Sbjct: 76  LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFY--AAEIAIGLFFLHSK---GIIYRDLKLD 130

Query: 906 NILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGV 965
           N++LD E +  ++DFG+ +   +     T    GT  Y+APE           D ++FGV
Sbjct: 131 NVMLDAEGHIKIADFGMCK-ENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGV 189

Query: 966 VLLELISGKRSLD 978
           +L E+++G+   D
Sbjct: 190 LLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 59.3 bits (144), Expect = 3e-09
 Identities = 46/203 (22%), Positives = 90/203 (44%), Gaps = 24/203 (11%)

Query: 786 GGFGSTYKAELVPGYLVAVKKLSI-----GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYY 840
                  K +     LVAVKK+++        + +QQ   EI T  +++H N++  +  +
Sbjct: 13  LMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQ---EIITSRQLQHPNILPYVTSF 68

Query: 841 VGEAEMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
           + ++E+++V   ++ G+ E  +  H   G  +    I  I  D+  AL Y+H       +
Sbjct: 69  IVDSELYVVSPLMAYGSCEDLLKTHFPEG--LPELAIAFILKDVLNALDYIHSK---GFI 123

Query: 899 HRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGTFG-----YVAPE--YAT 950
           HR +K S+ILL  +    LS    +  +++  +                 +++PE     
Sbjct: 124 HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQN 183

Query: 951 TCRVSDKADVYSFGVVLLELISG 973
               ++K+D+YS G+   EL +G
Sbjct: 184 LQGYNEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 58.8 bits (142), Expect = 3e-09
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 17/211 (8%)

Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDA--EIGTLGRIRHKNLVTLIGY 839
           +G G + + YK    + G LVA+K +S+   +G+  F A  E   L  ++H N+V L   
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLKHANIVLLHDI 71

Query: 840 YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
              +  +  V+ ++     +  I    G  +    +      + + LAY+H      I+H
Sbjct: 72  IHTKETLTFVFEYMHTDLAQYMIQHPGG--LHPYNVRLFMFQLLRGLAYIHGQ---HILH 126

Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEV-SETHATTDVAGTFGYVAPEYAT-TCRVSDK 957
           RD+KP N+L+       L+DFGLAR   + S+T+++  V  T  Y  P+        S  
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATDYSSA 184

Query: 958 ADVYSFGVVLLELISGKRSLDPSFSEYGNGF 988
            D++  G + +E++ G+    P+F    + F
Sbjct: 185 LDIWGAGCIFIEMLQGQ----PAFPGVSDVF 211

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 60.0 bits (145), Expect = 3e-09
 Identities = 51/181 (28%), Positives = 85/181 (46%), Gaps = 21/181 (11%)

Query: 820 AEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
           +E+  L    H  +V     +  + ++ L+  + SGG+L   I ++  + + +   +++ 
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQE-YEVG 172

Query: 880 I---DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD 936
           +    I  AL  +H      ++HRD+K +NI L       L DFG ++    S    + D
Sbjct: 173 LLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS---VSLD 226

Query: 937 VAGTFG----YVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLD-PSFSE------YG 985
           VA +F     Y+APE     R S KAD++S GV+L EL++  R    PS  E      YG
Sbjct: 227 VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG 286

Query: 986 N 986
            
Sbjct: 287 K 287

Length = 478

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 58.6 bits (142), Expect = 4e-09
 Identities = 55/255 (21%), Positives = 101/255 (39%), Gaps = 33/255 (12%)

Query: 805  KKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAE----MFLVYNFLSGGNLET 860
            KK   G    I   + EI  L RI   N++ + G+ +   +    + L+  + + G L  
Sbjct: 52   KKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLRE 111

Query: 861  FIHKKSGKKIQWSVIHKIAIDIAQALAYLH-YSCVPRIVHRDIKPSNILLDEELNAYLSD 919
             + K+  K + +     +AID  + L  L+ Y+  P   ++++   + L+ E     +  
Sbjct: 112  VLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKIIC 166

Query: 920  FGLARLLEVSETHATTDVAGTFGYVAPEYATTC--RVSDKADVYSFGVVLLELISGKRSL 977
             GL ++L          +     Y + +         + K D+YS GVVL E+ +GK   
Sbjct: 167  HGLEKILSSPPFKNVNFMV----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPF 222

Query: 978  DPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLST 1037
            +                 L+I +  ++ L LP      P E    +  +   CT      
Sbjct: 223  E--------NLTTKEIYDLIINK--NNSLKLP---LDCPLE----IKCIVEACTSHDSIK 265

Query: 1038 RPSVKQVLIKLKQLK 1052
            RP++K++L  L   K
Sbjct: 266  RPNIKEILYNLSLYK 280

Length = 283

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 58.5 bits (141), Expect = 4e-09
 Identities = 32/94 (34%), Positives = 55/94 (58%), Gaps = 4/94 (4%)

Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG 939
           + IA+ ++YL      R+VHRD+   N+L+    +  ++DFGLARLL++ ET    D   
Sbjct: 116 VQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGK 172

Query: 940 T-FGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
               ++A E     R + ++DV+S+GV + EL++
Sbjct: 173 VPIKWMALESILHRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 58.9 bits (142), Expect = 5e-09
 Identities = 38/133 (28%), Positives = 70/133 (52%), Gaps = 6/133 (4%)

Query: 846 MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPS 905
           ++ V  +++GG+L   I +    K   +V +  A +IA  L +LH      I++RD+K  
Sbjct: 76  LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFY--AAEIAIGLFFLHSK---GIIYRDLKLD 130

Query: 906 NILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGV 965
           N++LD E +  ++DFG+ +   + +   T    GT  Y+APE           D ++FGV
Sbjct: 131 NVMLDSEGHIKIADFGMCK-ENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGV 189

Query: 966 VLLELISGKRSLD 978
           +L E+++G+   +
Sbjct: 190 LLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 57.8 bits (140), Expect = 8e-09
 Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 25/202 (12%)

Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDA--EIGTLGRIRHKNLVTLIGY 839
           +G G + + YK    + G LVA+K++ +   +G   F A  E   L  ++H N+VTL   
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAP-FTAIREASLLKDLKHANIVTLHDI 71

Query: 840 YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
              +  + LV+ +L   +L+ ++    G  +    +      + + LAY H     R++H
Sbjct: 72  IHTKKTLTLVFEYLDT-DLKQYM-DDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLH 126

Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEV-SETHATTDVAGTFGYVAP-------EYATT 951
           RD+KP N+L+ E     L+DFGLAR   V S+T++   V  T  Y  P       EY+T+
Sbjct: 127 RDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWYRPPDVLLGSTEYSTS 184

Query: 952 CRVSDKADVYSFGVVLLELISG 973
                  D++  G +  E+ +G
Sbjct: 185 L------DMWGVGCIFYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 58.9 bits (142), Expect = 8e-09
 Identities = 67/244 (27%), Positives = 111/244 (45%), Gaps = 39/244 (15%)

Query: 760 DTPAELTYDNVVRATGNFSIR--NLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGIQ 816
           D   E   DN +  + N S +  N+IG G FG  Y+A  +     VA+KK+     Q  Q
Sbjct: 49  DEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV----LQDPQ 104

Query: 817 QFDAEIGTLGRIRHKNLVTLIGYYVGEA------EMFL--VYNFLSGGNLETFIHK---- 864
             + E+  +  + H N++ L  YY  E        +FL  V  F+        +HK    
Sbjct: 105 YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-----QTVHKYMKH 159

Query: 865 --KSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFG 921
             ++   +   ++   +  + +ALAY+H      I HRD+KP N+L+D   +   L DFG
Sbjct: 160 YARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216

Query: 922 LARLLEVSETHATTDVAGTFGYVAPEYAT-TCRVSDKADVYSFGVVLLELI------SGK 974
            A+ L ++   + + +   F Y APE        +   D++S G ++ E+I      SG+
Sbjct: 217 SAKNL-LAGQRSVSYICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQ 274

Query: 975 RSLD 978
            S+D
Sbjct: 275 SSVD 278

Length = 440

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 57.9 bits (140), Expect = 9e-09
 Identities = 43/150 (28%), Positives = 68/150 (45%), Gaps = 6/150 (4%)

Query: 825 LGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQ 884
           L   RH  L  L   +     +  V  + +GG  E F H    +            +I  
Sbjct: 49  LQNTRHPFLTALKYSFQTHDRLCFVMEYANGG--ELFFHLSRERVFSEDRARFYGAEIVS 106

Query: 885 ALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYV 944
           AL YLH SC   +V+RD+K  N++LD++ +  ++DFGL +   +S+        GT  Y+
Sbjct: 107 ALGYLH-SC--DVVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYL 162

Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGK 974
           APE           D +  GVV+ E++ G+
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 58.2 bits (141), Expect = 9e-09
 Identities = 34/90 (37%), Positives = 46/90 (51%), Gaps = 5/90 (5%)

Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
           L Y+H +    ++HRD+KPSN+LL+   +  + DFGLAR         T  V  T  Y A
Sbjct: 121 LKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRA 176

Query: 946 PEYATTCRVSDKA-DVYSFGVVLLELISGK 974
           PE    C     A DV+S G +  EL+  K
Sbjct: 177 PELLLNCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 57.7 bits (139), Expect = 1e-08
 Identities = 53/229 (23%), Positives = 97/229 (42%), Gaps = 37/229 (16%)

Query: 776 NFSIRNLIGTGGFGSTYKAELV-----PGYL-VAVKKLSIGRFQG-IQQFDAEIGTLGRI 828
           N  +   +G G FG   KA         GY  VAVK L        ++   +E   L ++
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60

Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHK----------KSGKKIQWSVIH-- 876
            H +++ L G    +  + L+  +   G+L +F+ +            G +    + +  
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 877 ----------KIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL 926
                       A  I++ + YL      ++VHRD+   N+L+ E     +SDFGL+R  
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSR-- 175

Query: 927 EVSETHATTDVAG---TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
           +V E  +    +       ++A E       + ++DV+SFGV+L E+++
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 57.7 bits (139), Expect = 1e-08
 Identities = 63/243 (25%), Positives = 100/243 (41%), Gaps = 57/243 (23%)

Query: 776 NFSIRNLIGTGGFGSTYKAELV----PGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRI 828
           +F    +IG G FG   +  LV     G++ A+K   K  +   + +    AE   L   
Sbjct: 2   DFESLKVIGRGAFG---EVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA 58

Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKK---SGKKIQWSVIHKI-AIDIAQ 884
               +V +   +  +  ++L+  FL GG++ T + KK   S +  Q+ +   + AID   
Sbjct: 59  DGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIH 118

Query: 885 ALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE--------TH---- 932
            L +         +HRDIKP N+LLD + +  LSDFGL   L+ +         TH    
Sbjct: 119 QLGF---------IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPS 169

Query: 933 ------------ATT----------DVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLEL 970
                       A T             GT  Y+APE       +   D +S GV++ E+
Sbjct: 170 DFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229

Query: 971 ISG 973
           + G
Sbjct: 230 LIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 56.5 bits (136), Expect = 2e-08
 Identities = 45/184 (24%), Positives = 85/184 (46%), Gaps = 15/184 (8%)

Query: 801 LVAVKKLSIGRFQGIQQ-FDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL- 858
           LVAVK L     +  +  F  EI  + R+++ N++ L+G  V +  + ++  ++  G+L 
Sbjct: 46  LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105

Query: 859 ---------ETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILL 909
                     TF H  +   +  + +  +A+ IA  + YL        VHRD+   N L+
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLV 162

Query: 910 DEELNAYLSDFGLARLLEVSETHATTDVAG-TFGYVAPEYATTCRVSDKADVYSFGVVLL 968
                  ++DFG++R L   + +     A     ++A E     + +  +DV++FGV L 
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLW 222

Query: 969 ELIS 972
           E+ +
Sbjct: 223 EMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 57.0 bits (137), Expect = 2e-08
 Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 30/214 (14%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDA-----EIGTLGRIRH 830
           ++ +  +IG G FG            V   KL + +F+ I++ D+     E   +     
Sbjct: 44  DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKL-LSKFEMIKRSDSAFFWEERDIMAFANS 102

Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
             +V L   +  +  +++V  ++ GG+L   +      + +W+  +    ++  AL  +H
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE-KWAKFY--TAEVVLALDAIH 159

Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLA-RLLEVSETHATTDVAGTFGYVAPE-- 947
                 ++HRD+KP N+LLD+  +  L+DFG   ++ E       T V GT  Y++PE  
Sbjct: 160 SM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVL 215

Query: 948 --------YATTCRVSDKADVYSFGVVLLELISG 973
                   Y   C      D +S GV L E++ G
Sbjct: 216 KSQGGDGYYGREC------DWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 56.6 bits (136), Expect = 3e-08
 Identities = 58/212 (27%), Positives = 103/212 (48%), Gaps = 27/212 (12%)

Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIGY 839
           +G G +G  YKA+   G     K+ ++ + +G         EI  L  ++H N++ L   
Sbjct: 9   VGRGTYGHVYKAKRKDGK--DEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKV 66

Query: 840 YVGEAE--MFLVYNFLSGGNLETFI--HK--KSGKK---IQWSVIHKIAIDIAQALAYLH 890
           ++  ++  ++L++++ +  +L   I  H+  K+ KK   +  S++  +   I   + YLH
Sbjct: 67  FLSHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125

Query: 891 YSCVPRIVHRDIKPSNILL----DEELNAYLSDFGLARLLEVSETHATTD---VAGTFGY 943
            + V   +HRD+KP+NIL+     E     ++D G ARL   S      D   V  TF Y
Sbjct: 126 ANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFN-SPLKPLADLDPVVVTFWY 181

Query: 944 VAPEYATTCRVSDKA-DVYSFGVVLLELISGK 974
            APE     R   KA D+++ G +  EL++ +
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 56.6 bits (136), Expect = 3e-08
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 27/212 (12%)

Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIGY 839
           +G G +G  YKA+   G     +  ++ + +G         EI  L  ++H N+++L   
Sbjct: 9   VGRGTYGHVYKAKRKDGK--DDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKV 66

Query: 840 YVGEAE--MFLVYNFLSGGNLETFIH-----KKSGKKIQW--SVIHKIAIDIAQALAYLH 890
           ++  A+  ++L++++ +  +L   I      K + K +Q    ++  +   I   + YLH
Sbjct: 67  FLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125

Query: 891 YSCVPRIVHRDIKPSNILL----DEELNAYLSDFGLARLLEVSETHATTD---VAGTFGY 943
            + V   +HRD+KP+NIL+     E     ++D G ARL   S      D   V  TF Y
Sbjct: 126 ANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFN-SPLKPLADLDPVVVTFWY 181

Query: 944 VAPEYATTCRVSDKA-DVYSFGVVLLELISGK 974
            APE     R   KA D+++ G +  EL++ +
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 56.1 bits (135), Expect = 3e-08
 Identities = 63/263 (23%), Positives = 109/263 (41%), Gaps = 31/263 (11%)

Query: 801  LVAVKKLSIGRFQGIQQ-FDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLE 859
            LVAVK L     +  +  F  E+  L R++  N++ L+G  V E  + ++  ++  G+L 
Sbjct: 48   LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107

Query: 860  TFIHKK-----------------SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
             F+                        I +S +  +A+ IA  + YL        VHRD+
Sbjct: 108  QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDL 164

Query: 903  KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG-TFGYVAPEYATTCRVSDKADVY 961
               N L+ E L   ++DFG++R L   + +     A     ++A E     + +  +DV+
Sbjct: 165  ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVW 224

Query: 962  SFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLL 1021
            +FGV L E++   +  +  + E  +   I +  +    +GR   LF P      PQ    
Sbjct: 225  AFGVTLWEILMLCK--EQPYGELTDEQVIENAGEFFRDQGRQVYLFRP---PPCPQ---- 275

Query: 1022 GMMRLASTCTVETLSTRPSVKQV 1044
            G+  L   C       RPS   +
Sbjct: 276  GLYELMLQCWSRDCRERPSFSDI 298

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 55.9 bits (135), Expect = 4e-08
 Identities = 43/149 (28%), Positives = 67/149 (44%), Gaps = 33/149 (22%)

Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH------KIAIDIAQALAYLHYSCVPR 896
           E  ++LV ++  GG+L T +  K   ++   +         +AID   ++  L Y     
Sbjct: 73  ENNLYLVMDYYVGGDLLTLL-SKFEDRLPEDMARFYLAEMVLAID---SVHQLGY----- 123

Query: 897 IVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE--------- 947
            VHRDIKP N+LLD+  +  L+DFG    L    T  +    GT  Y++PE         
Sbjct: 124 -VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGK 182

Query: 948 --YATTCRVSDKADVYSFGVVLLELISGK 974
             Y   C      D +S GV + E++ G+
Sbjct: 183 GRYGPEC------DWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 55.8 bits (134), Expect = 4e-08
 Identities = 51/207 (24%), Positives = 85/207 (41%), Gaps = 30/207 (14%)

Query: 782 LIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEI--------------GTLGR 827
           L+G G FG           ++ V++ + GR+  ++    E+                L  
Sbjct: 2   LLGKGTFGK----------VILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 51

Query: 828 IRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALA 887
            RH  L  L   +     +  V  + +GG  E F H    +            +I  AL 
Sbjct: 52  TRHPFLTALKYAFQTHDRLCFVMEYANGG--ELFFHLSRERVFTEERARFYGAEIVSALE 109

Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE 947
           YLH      +V+RDIK  N++LD++ +  ++DFGL +   +S+        GT  Y+APE
Sbjct: 110 YLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPE 165

Query: 948 YATTCRVSDKADVYSFGVVLLELISGK 974
                      D +  GVV+ E++ G+
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 55.4 bits (134), Expect = 4e-08
 Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 44/218 (20%)

Query: 783 IGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGIQQFDA--EIGTLGRIR-HKNLVTLIG 838
           IG G F    KA+    G   A+K +    F+ ++Q +   EI  L R+  H N++ LI 
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65

Query: 839 YYVGEAEMFLVYNFLSG----------GNLETFIHKK----SGKKIQWSVIHKIAIDIAQ 884
                    ++++  +G           NL   I  +      K+++  +       + +
Sbjct: 66  ---------VLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQ-----LLK 111

Query: 885 ALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYV 944
           +L ++H +    I HRDIKP NIL+ +++   L+DFG  R   +      T+   T  Y 
Sbjct: 112 SLDHMHRN---GIFHRDIKPENILIKDDI-LKLADFGSCR--GIYSKPPYTEYISTRWYR 165

Query: 945 APEYATTC-RVSDKADVYSFGVVLLELISGKRSLDPSF 981
           APE   T      K D+++ G V  E++    SL P F
Sbjct: 166 APECLLTDGYYGPKMDIWAVGCVFFEIL----SLFPLF 199

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 56.7 bits (137), Expect = 5e-08
 Identities = 29/82 (35%), Positives = 48/82 (58%)

Query: 128 LSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEV 187
           L + +    G IP  + +LR L+ + L GN+  G IP  + ++  L VL+LS+NSF+G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 188 PRGLIGNGELSVIDMSSNRLSG 209
           P  L     L +++++ N LSG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSG 504

Length = 623

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 55.7 bits (134), Expect = 6e-08
 Identities = 67/310 (21%), Positives = 106/310 (34%), Gaps = 27/310 (8%)

Query: 107 KSSVISGTLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQ 166
            SS     L +S+++L  L  LS    S        +  L  L  L+L  N     I   
Sbjct: 54  LSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLL-PLPSLDLNLNRLRSNISEL 112

Query: 167 M--SNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTY 224
           +  +NL  L + N +       +        EL + D     L   L          L  
Sbjct: 113 LELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLPSPLR-----NLPNLKN 167

Query: 225 LKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRI 284
           L LS N L++ +PK +    NL NL L GN +   +P EI  +S L+ LD+S NS+   +
Sbjct: 168 LDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-EL 224

Query: 285 PVELADCSKLSVL------------VLTNIDASLDLDNSRGEFSAFDGGVPY---ELLLS 329
              L++   LS L             + N+     LD S  + S+            L  
Sbjct: 225 LSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQISSISSLGSLTNLRELDL 284

Query: 330 RSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNN 389
               +  A        L      +  L +  L        +  ++ +    T    +L+ 
Sbjct: 285 SGNSLSNALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNI-LSNGETSSPEALSI 343

Query: 390 LEGYLPMQLP 399
           LE    +   
Sbjct: 344 LESLNNLWTL 353

Length = 394

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 55.8 bits (135), Expect = 6e-08
 Identities = 67/253 (26%), Positives = 105/253 (41%), Gaps = 79/253 (31%)

Query: 778 SIRNLIGTGGFGSTYKAELV----PGYLVAVKKLS----IGRFQGIQQFDAEIGTLGRIR 829
           SI+ +IG G FG   +  LV     G++ A+KKL     + + Q +    AE   L    
Sbjct: 5   SIK-VIGRGAFG---EVRLVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEAD 59

Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKK---SGKKIQWSVIHKI-AIDIAQA 885
           +  +V L   +  E  ++L+  +L GG++ T + KK   + ++ ++ +   I AID    
Sbjct: 60  NPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHK 119

Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD--------- 936
           L Y         +HRDIKP N+LLD + +  LSDFGL   L+  ++H T           
Sbjct: 120 LGY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLK--KSHRTEFYRILSHALP 168

Query: 937 ------------------------------VAGTFGYVAPE------YATTCRVSDKADV 960
                                           GT  Y+APE      Y   C      D 
Sbjct: 169 SNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKEC------DW 222

Query: 961 YSFGVVLLELISG 973
           +S GV++ E++ G
Sbjct: 223 WSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 55.8 bits (134), Expect = 6e-08
 Identities = 61/243 (25%), Positives = 100/243 (41%), Gaps = 57/243 (23%)

Query: 776 NFSIRNLIGTGGFGSTYKAELV----PGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRI 828
           +F    +IG G FG   +  LV     G++ A+K   K  +   + +    AE   L   
Sbjct: 2   DFESLKVIGRGAFG---EVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA 58

Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKK---SGKKIQWSVIHKI-AIDIAQ 884
               +V +   +  +  ++L+  FL GG++ T + KK   + ++ Q+ +   + AID   
Sbjct: 59  DSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIH 118

Query: 885 ALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV---------------- 928
            L +         +HRDIKP N+LLD + +  LSDFGL   L+                 
Sbjct: 119 QLGF---------IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169

Query: 929 --------SETHATT----------DVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLEL 970
                   S+  A T             GT  Y+APE       +   D +S GV++ E+
Sbjct: 170 DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229

Query: 971 ISG 973
           + G
Sbjct: 230 LIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 56.0 bits (135), Expect = 8e-08
 Identities = 27/78 (34%), Positives = 47/78 (60%), Gaps = 1/78 (1%)

Query: 342 LGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQL-PV 400
           L G +P++ S+   L+ +NL  NS++G +P SLG   +L  LDLS N+  G +P  L  +
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489

Query: 401 PCMVYFNVSQNNITGVLP 418
             +   N++ N+++G +P
Sbjct: 490 TSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 55.0 bits (132), Expect = 8e-08
 Identities = 53/208 (25%), Positives = 86/208 (41%), Gaps = 31/208 (14%)

Query: 782 LIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEI--------------GTLGR 827
           L+G G FG           ++ VK+ + GR+  ++    E+                L  
Sbjct: 2   LLGKGTFGK----------VILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 51

Query: 828 IRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALA 887
            RH  L  L   +     +  V  + +GG  E F H    +            +I  AL 
Sbjct: 52  SRHPFLTALKYSFQTHDRLCFVMEYANGG--ELFFHLSRERVFSEDRARFYGAEIVSALD 109

Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDV-AGTFGYVAP 946
           YLH      +V+RD+K  N++LD++ +  ++DFGL +  E  +  AT     GT  Y+AP
Sbjct: 110 YLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAP 165

Query: 947 EYATTCRVSDKADVYSFGVVLLELISGK 974
           E           D +  GVV+ E++ G+
Sbjct: 166 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 55.0 bits (132), Expect = 9e-08
 Identities = 55/221 (24%), Positives = 102/221 (46%), Gaps = 24/221 (10%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQ-----FDAEIGTLGRIRH 830
           +F I  +IG G FG     ++     +   K+ + +++ +++     F  E   L     
Sbjct: 2   DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKI-LNKWEMLKRAETACFREERNVLVNGDC 60

Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHK---KSGKKIQWSVIHKIAIDIAQALA 887
           + + TL   +  E  ++LV ++  GG+L T + K   +  + +    I ++ + I  ++ 
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAI-HSIH 119

Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE 947
            LHY      VHRDIKP N+LLD   +  L+DFG    +    T  ++   GT  Y++PE
Sbjct: 120 QLHY------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173

Query: 948 YATTC-----RVSDKADVYSFGVVLLELISGKRSLDPSFSE 983
                     +   + D +S GV + E++ G+    P ++E
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE---TPFYAE 211

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 54.7 bits (132), Expect = 1e-07
 Identities = 61/228 (26%), Positives = 104/228 (45%), Gaps = 35/228 (15%)

Query: 767 YDNVVRATGNFSI----RNL--IGTGGFGSTYKA-ELVPGYLVAVKKLSIGR-FQGI--- 815
           + +V      F++    +NL  IG+G  G    A + V G  VA+KKLS  R FQ +   
Sbjct: 2   FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLS--RPFQNVTHA 59

Query: 816 QQFDAEIGTLGRIRHKNLVTLIGYYVGE------AEMFLVYNFLSGGNLETFIHKKSGKK 869
           ++   E+  +  + HKN++ L+  +  +       +++LV   +   NL   I      +
Sbjct: 60  KRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMDLDHE 118

Query: 870 IQWSVIHKIAIDIAQALA---YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL 926
                  +++  + Q L    +LH +    I+HRD+KPSNI++  +    + DFGLAR  
Sbjct: 119 -------RMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR-- 166

Query: 927 EVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
               +   T    T  Y APE        +  D++S G ++ E+I G 
Sbjct: 167 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 54.0 bits (130), Expect = 1e-07
 Identities = 62/235 (26%), Positives = 99/235 (42%), Gaps = 59/235 (25%)

Query: 775 GNFSIRNLIGTGGFGSTYKAELVPGYLV---------AVKKLS----IGRFQGIQQFDAE 821
            +F    LI  G +G+ Y        LV         A+KK++    I R Q IQQ   E
Sbjct: 1   EDFETIKLISNGAYGAVY--------LVRHKETRQRFAMKKINKQNLILRNQ-IQQVFVE 51

Query: 822 IGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAID 881
              L    +  +V++   +  +  + +V  ++ GG+  T +            I  + +D
Sbjct: 52  RDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKN----------IGALPVD 101

Query: 882 IAQ--------ALAYLH-YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARL------L 926
           +A+        AL YLH Y     IVHRD+KP N+L+    +  L+DFGL+++       
Sbjct: 102 MARMYFAETVLALEYLHNYG----IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157

Query: 927 EVSETHATTD--------VAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
            + E H   D        V GT  Y+APE           D ++ G++L E + G
Sbjct: 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 54.0 bits (130), Expect = 2e-07
 Identities = 32/95 (33%), Positives = 49/95 (51%), Gaps = 7/95 (7%)

Query: 884 QALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR--LLEVSETHATTDVAGTF 941
           +AL Y+H + V    HRD+KP NIL + +    + DFGLAR    +       TD   T 
Sbjct: 114 RALKYIHTANV---FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 942 GYVAPEYATT--CRVSDKADVYSFGVVLLELISGK 974
            Y APE   +   + +   D++S G +  E+++GK
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 54.0 bits (130), Expect = 2e-07
 Identities = 59/222 (26%), Positives = 103/222 (46%), Gaps = 34/222 (15%)

Query: 776 NFSIRNLIGTGGFGSTYKAELV----PGYLVAVKKLSIGRFQGIQQFDAEIGTLGR--IR 829
           +F +  +IG G FG   + +LV       + A+K LS  +F+ I++ D+      R  + 
Sbjct: 44  DFDVIKVIGRGAFG---EVQLVRHKSSKQVYAMKLLS--KFEMIKRSDSAFFWEERDIMA 98

Query: 830 HKN---LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKI--QWSVIHKIAIDIAQ 884
           H N   +V L   +  +  +++V  ++ GG+L   +   S   I  +W+  +    ++  
Sbjct: 99  HANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM---SNYDIPEKWARFY--TAEVVL 153

Query: 885 ALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLA-RLLEVSETHATTDVAGTFGY 943
           AL  +H       +HRD+KP N+LLD+  +  L+DFG   ++         T V GT  Y
Sbjct: 154 ALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDY 209

Query: 944 VAPEYATTCRVSD----KADVYSFGVVLLELISGKRSLDPSF 981
           ++PE   +         + D +S GV L E++ G    D  F
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG----DTPF 247

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 47.5 bits (114), Expect = 4e-07
 Identities = 24/59 (40%), Positives = 29/59 (49%)

Query: 582 LKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRL 640
           LK + L  N LT      F  L +L VLDLS N LT   P + +    L SL L+ N L
Sbjct: 2   LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 52.3 bits (126), Expect = 5e-07
 Identities = 48/186 (25%), Positives = 86/186 (46%), Gaps = 20/186 (10%)

Query: 801 LVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLE 859
           LVAVK L         + F  E+  L R+   N+  L+G    +  + ++  ++  G+L 
Sbjct: 48  LVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLN 107

Query: 860 TFIHKK---------SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLD 910
            F+ K          + K + +S +  +A  IA  + YL        VHRD+   N L+ 
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVG 164

Query: 911 EELNAYLSDFGLARLLEVSETHATTDVAGT----FGYVAPEYATTCRVSDKADVYSFGVV 966
           +     ++DFG++R L  S+ +    V G       ++A E     + + K+DV++FGV 
Sbjct: 165 KNYTIKIADFGMSRNLYSSDYY---RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVT 221

Query: 967 LLELIS 972
           L E+++
Sbjct: 222 LWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 53.3 bits (128), Expect = 5e-07
 Identities = 48/155 (30%), Positives = 76/155 (49%), Gaps = 13/155 (8%)

Query: 777 FSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHKN 832
           F I   I  G FG  Y   +     L AVK   K  +     + Q  AE   L   +   
Sbjct: 6   FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF 65

Query: 833 LVTLIGYYVGEA--EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
           +V L  YY  ++   ++LV  +L GG++++ +H       + +V  K   ++A AL YLH
Sbjct: 66  IVHL--YYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAV--KYISEVALALDYLH 121

Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARL 925
                 I+HRD+KP N+L+  E +  L+DFGL+++
Sbjct: 122 RH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 47.2 bits (113), Expect = 6e-07
 Identities = 25/60 (41%), Positives = 34/60 (56%)

Query: 605 SLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNL 664
           +L  LDLS+N LT     +      L+ L L+ N L+   P +FS L +L +LDLS NNL
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 52.4 bits (125), Expect = 6e-07
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 27/205 (13%)

Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
           IG+G  G   + Y A L     VA+KKLS   FQ     ++   E+  +  + HKN+++L
Sbjct: 25  IGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISL 81

Query: 837 IGYYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAIDIAQALAYL 889
           +  +  +       +++LV   +     +          IQ  + H +++  + Q L  +
Sbjct: 82  LNVFTPQKSLEEFQDVYLVMELMDANLCQV---------IQMELDHERMSYLLYQMLCGI 132

Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
            +     I+HRD+KPSNI++  +    + DFGLAR      +   T    T  Y APE  
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVI 190

Query: 950 TTCRVSDKADVYSFGVVLLELISGK 974
                 +  D++S G ++ E++  K
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 51.4 bits (123), Expect = 9e-07
 Identities = 48/219 (21%), Positives = 91/219 (41%), Gaps = 25/219 (11%)

Query: 783 IGTGGFGSTYKAELVPGYLVA---VKKLSIGRFQGIQQFDAEIGTLGRI-RHKNLVTLIG 838
           IG G FG    +E+     VA   VK+L        Q    + G   RI +H N++  +G
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 839 YYVGEAEMFLVYNFLSGGNLETFI-----HKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
             V      LV+ +   G+L++++     H+++ + +    + ++A +IA  + ++H   
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLL---LQRMACEIAAGVTHMHKH- 118

Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD--VAGTFGYVAPEYAT- 950
               +H D+   N  L  +L   + D+G+       E +  T+        ++APE    
Sbjct: 119 --NFLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRWLAPELVGE 175

Query: 951 ------TCRVSDKADVYSFGVVLLELISGKRSLDPSFSE 983
                 T   +  ++V++ GV L EL           S+
Sbjct: 176 FHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD 214

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 52.0 bits (124), Expect = 1e-06
 Identities = 49/212 (23%), Positives = 90/212 (42%), Gaps = 26/212 (12%)

Query: 770 VVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIR 829
           +  +T     R  + +   G      L+   + A  + +I       Q + EI  LGR+ 
Sbjct: 169 LRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAI-------QLENEILALGRLN 221

Query: 830 HKNLVTLIGYYVGEAEMFLV---YNFLSGGNLETFIHKKSGKKIQWS------VIHKIAI 880
           H+N++ +      EA  +++   Y+F    +L +F++ ++     W           I  
Sbjct: 222 HENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEA---FDWKDRPLLKQTRAIMK 274

Query: 881 DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT 940
            +  A+ Y+H     +++HRDIK  NI L+ +    L DFG A   E           GT
Sbjct: 275 QLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGT 331

Query: 941 FGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
               +PE        +  D++S G++LL+++S
Sbjct: 332 VATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 51.4 bits (123), Expect = 1e-06
 Identities = 47/171 (27%), Positives = 78/171 (45%), Gaps = 22/171 (12%)

Query: 882  IAQALAYL-HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG- 939
            +A+ +++L   +C+    HRD+   NILL       + DFGLAR +     +     A  
Sbjct: 223  VAKGMSFLASKNCI----HRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL 278

Query: 940  TFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIK 999
               ++APE    C  + ++DV+S+G++L E+ S   S  P       G  + S    +IK
Sbjct: 279  PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYP-------GMPVDSKFYKMIK 331

Query: 1000 EGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQ 1050
            EG    +  PE     P E    M  +  +C       RP+ KQ++  ++Q
Sbjct: 332  EG--YRMLSPEC---APSE----MYDIMKSCWDADPLKRPTFKQIVQLIEQ 373

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 51.1 bits (122), Expect = 1e-06
 Identities = 46/198 (23%), Positives = 93/198 (46%), Gaps = 12/198 (6%)

Query: 782 LIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVT 835
           ++G+G FG+ YK   +P        VA+K+L      +  ++   E   +  + + ++  
Sbjct: 14  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 73

Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
           L+G  +    + L+   +  G L  ++ ++    I    +    + IA+ + YL      
Sbjct: 74  LLGICLTST-VQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYLEER--- 128

Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT-FGYVAPEYATTCRV 954
           R+VHRD+   N+L+    +  ++DFGLA+LL   E     +       ++A E       
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIY 188

Query: 955 SDKADVYSFGVVLLELIS 972
           + ++DV+S+GV + EL++
Sbjct: 189 THQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 51.1 bits (122), Expect = 2e-06
 Identities = 32/96 (33%), Positives = 46/96 (47%), Gaps = 3/96 (3%)

Query: 882 IAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF 941
           + +A+ YLH +   RI+HRDIK  NI ++   +  L DFG A        +     AGT 
Sbjct: 191 VLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTI 247

Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSL 977
              APE           D++S G+VL E+ +   SL
Sbjct: 248 ATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283

Length = 391

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 51.2 bits (122), Expect = 2e-06
 Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 23/203 (11%)

Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTLIG 838
           IG+G  G    A + +    VA+KKLS   FQ     ++   E+  +  + HKN++ L+ 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN 90

Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAIDIAQALAYLHY 891
            +  +       ++++V   +     +          IQ  + H +++  + Q L  + +
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLCQV---------IQMELDHERMSYLLYQMLCGIKH 141

Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT 951
                I+HRD+KPSNI++  +    + DFGLAR    S     T    T  Y APE    
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILG 199

Query: 952 CRVSDKADVYSFGVVLLELISGK 974
               +  D++S G ++ E+I G 
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 51.7 bits (124), Expect = 2e-06
 Identities = 30/112 (26%), Positives = 50/112 (44%), Gaps = 20/112 (17%)

Query: 878 IAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET------ 931
           I   I   + Y+H      ++HRD+KP NILL       + D+G A   ++ E       
Sbjct: 118 IFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDID 174

Query: 932 --------HATT---DVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
                    + T    + GT  Y+APE       S+  D+Y+ GV+L ++++
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 50.9 bits (122), Expect = 2e-06
 Identities = 50/200 (25%), Positives = 89/200 (44%), Gaps = 43/200 (21%)

Query: 802 VAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFL--SGGNLE 859
           VAVKK+ +   Q ++    EI  + R+ H N+V              VY  L  SG +L 
Sbjct: 33  VAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK-------------VYEVLGPSGSDLT 79

Query: 860 TFIHKKSGKKIQWSVIHKIAIDIA---------------------QALAYLHYSCVPRIV 898
             +   +     + V   +  D+A                     + L Y+H + V   +
Sbjct: 80  EDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANV---L 136

Query: 899 HRDIKPSNILLD-EELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVS 955
           HRD+KP+N+ ++ E+L   + DFGLAR+++   +H    ++   T  Y +P    +    
Sbjct: 137 HRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNY 196

Query: 956 DKA-DVYSFGVVLLELISGK 974
            KA D+++ G +  E+++GK
Sbjct: 197 TKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 49.9 bits (119), Expect = 3e-06
 Identities = 47/153 (30%), Positives = 73/153 (47%), Gaps = 19/153 (12%)

Query: 827 RIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGK-KIQWSVIHKIAIDIAQA 885
           ++ HK++V L G  V + E  +V  F+  G L+ F+H+KS      W    K+A  +A A
Sbjct: 60  QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKF--KVAKQLASA 117

Query: 886 LAYLHYSCVPRIVHRDIKPSNILL-----DEELNAY--LSDFGLARLLEVSETHATTDVA 938
           L+YL       +VH ++   NILL     D E   +  LSD G+  +  +S       + 
Sbjct: 118 LSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP-ITVLSRQECVERIP 173

Query: 939 GTFGYVAPEYATTCRV-SDKADVYSFGVVLLEL 970
               ++APE     +  S  AD +SFG  L E+
Sbjct: 174 ----WIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 49.9 bits (119), Expect = 3e-06
 Identities = 53/203 (26%), Positives = 87/203 (42%), Gaps = 18/203 (8%)

Query: 783 IGTGGFGSTYKAELVPGY---LVAVKKLSI-GRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           IG G FG     E+  GY    V VK+L +    Q   +F  E      ++H NL+  +G
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 839 YYVGEAEMFLVYNFLSGGNLETFIH---KKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
                    LV  F   G+L+ ++    K        + + ++A +IA  L +LH +   
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119

Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT-FGYVAPEYATTCR- 953
             +H D+   N LL  +L   + D+GL+      + + T D       ++APE       
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179

Query: 954 ---VSDK---ADVYSFGVVLLEL 970
              V D+   ++V+S GV + EL
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 49.2 bits (117), Expect = 6e-06
 Identities = 51/221 (23%), Positives = 96/221 (43%), Gaps = 44/221 (19%)

Query: 776 NFSIRNLIGTGGFGSTYKAELV----PGYLVAVKKLSIGRFQGIQQFDA-----EIGTLG 826
           ++ +  +IG G FG   + +LV       + A+K LS  +F+ I++ D+     E   + 
Sbjct: 44  DYEVVKVIGRGAFG---EVQLVRHKSTRKVYAMKLLS--KFEMIKRSDSAFFWEERDIMA 98

Query: 827 RIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHK----IAIDI 882
                 +V L   +  +  +++V  ++ GG+L   +      + +W+  +     +A+D 
Sbjct: 99  FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWARFYTAEVVLALDA 157

Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFG 942
             ++ +         +HRD+KP N+LLD+  +  L+DFG    +            GT  
Sbjct: 158 IHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 208

Query: 943 YVAPE----------YATTCRVSDKADVYSFGVVLLELISG 973
           Y++PE          Y   C      D +S GV L E++ G
Sbjct: 209 YISPEVLKSQGGDGYYGREC------DWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 48.9 bits (116), Expect = 6e-06
 Identities = 50/208 (24%), Positives = 96/208 (46%), Gaps = 27/208 (12%)

Query: 783 IGTGGFGSTYK--AELV----PGYLVAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
           +G G FG  Y+  A+ V    P   VA+K ++     +   +F  E   +      ++V 
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIH----KKSGKKIQ----WSVIHKIAIDIAQALA 887
           L+G         ++   ++ G+L++++     +     +Q       + ++A +IA  +A
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFG----- 942
           YL+ +   + VHRD+   N ++ E+    + DFG+ R  ++ ET       G  G     
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRK--GGKGLLPVR 186

Query: 943 YVAPEYATTCRVSDKADVYSFGVVLLEL 970
           +++PE       +  +DV+SFGVVL E+
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 43.3 bits (103), Expect = 1e-05
 Identities = 28/61 (45%), Positives = 33/61 (54%), Gaps = 2/61 (3%)

Query: 557 KLQRLDLRGNRVSGSLPDE-LGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNA 615
            L+ LDL  NR++  +PD     L  LK + L GNNLT   P  F  L SL  LDLS N 
Sbjct: 1   NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 616 L 616
           L
Sbjct: 60  L 60

Length = 60

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 48.7 bits (116), Expect = 1e-05
 Identities = 33/105 (31%), Positives = 56/105 (53%), Gaps = 14/105 (13%)

Query: 882 IAQALAYL-HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE-----VSETHATT 935
           +AQ + +L   +C+    HRD+   N+LL +   A + DFGLAR +      V + +A  
Sbjct: 221 VAQGMDFLASKNCI----HRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276

Query: 936 DVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPS 980
            V     ++APE    C  + ++DV+S+G++L E+ S  +S  P 
Sbjct: 277 PVK----WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG 317

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 48.3 bits (115), Expect = 1e-05
 Identities = 58/262 (22%), Positives = 92/262 (35%), Gaps = 83/262 (31%)

Query: 776 NFSIRNLIGTGGFGSTYKAELV----PGYLVAVKKL---SIGRFQGIQQFDAEIGTLGRI 828
           +F    +IG G FG   +  LV     G + A+K L    + +   +    AE   L   
Sbjct: 2   DFHTVKVIGKGAFG---EVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES 58

Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHK----------- 877
               +V+L   +     ++L+  FL GG+L T +       I++    +           
Sbjct: 59  DSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTML-------IKYDTFSEDVTRFYMAECV 111

Query: 878 IAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLA-------------R 924
           +AI+    L +         +HRDIKP NIL+D   +  LSDFGL+             +
Sbjct: 112 LAIEAVHKLGF---------IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQK 162

Query: 925 LLEVSETHATTD---------------------------------VAGTFGYVAPEYATT 951
           LL+        D                                   GT  Y+APE    
Sbjct: 163 LLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ 222

Query: 952 CRVSDKADVYSFGVVLLELISG 973
                + D +S G ++ E + G
Sbjct: 223 QGYGQECDWWSLGAIMFECLIG 244

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 47.1 bits (112), Expect = 4e-05
 Identities = 62/271 (22%), Positives = 103/271 (38%), Gaps = 72/271 (26%)

Query: 783 IGTGGFGSTYKAELV-PGYLVAVKKLS----IGRFQGIQQFDAEIGTLGRIRHKNLVTLI 837
           IG G FG       V    L A+K L     + R Q      AE   L    ++ +V L 
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQ-AAHVKAERDILAEADNEWVVKLY 67

Query: 838 GYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHK------IAIDIAQALAYLHY 891
             +  +  ++ V +++ GG++ + +       I+  +  +      IA ++  A+  +H 
Sbjct: 68  YSFQDKDNLYFVMDYIPGGDMMSLL-------IRLGIFEEDLARFYIA-ELTCAIESVHK 119

Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGL------------------ARL--LEVSET 931
                 +HRDIKP NIL+D + +  L+DFGL                   R   +E SE 
Sbjct: 120 M---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176

Query: 932 HATTDVA----------------------GTFGYVAPEYATTCRVSDKADVYSFGVVLLE 969
            +  D                        GT  Y+APE       +   D +S GV+L E
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236

Query: 970 LISGKRSLDPSF---SEYGNGFNIVSWAKLL 997
           ++ G+    P F   +       +++W   L
Sbjct: 237 MLVGQ----PPFLADTPAETQLKVINWETTL 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 46.5 bits (110), Expect = 4e-05
 Identities = 50/210 (23%), Positives = 94/210 (44%), Gaps = 27/210 (12%)

Query: 783 IGTGGFGSTYKA---ELVPGYL---VAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
           +G G FG  Y+    +++ G     VAVK ++     +   +F  E   +      ++V 
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFI-------HKKSGKKI-QWSVIHKIAIDIAQALA 887
           L+G         +V   ++ G+L++++           G+       + ++A +IA  +A
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFG----- 942
           YL+     + VHRD+   N ++  +    + DFG+ R  ++ ET       G  G     
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRK--GGKGLLPVR 186

Query: 943 YVAPEYATTCRVSDKADVYSFGVVLLELIS 972
           ++APE       +  +D++SFGVVL E+ S
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 45.7 bits (108), Expect = 6e-05
 Identities = 45/188 (23%), Positives = 80/188 (42%), Gaps = 24/188 (12%)

Query: 801 LVAVKKL-SIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLE 859
           LVAVK L           F  EI  + R++  N++ L+   +    + ++  ++  G+L 
Sbjct: 48  LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107

Query: 860 TFI---------HKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLD 910
            F+          K     I +S +  +A  IA  + YL        VHRD+   N L+ 
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVG 164

Query: 911 EELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAP------EYATTCRVSDKADVYSFG 964
           +     ++DFG++R L   + +     A     V P      E     + +  +DV++FG
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRA-----VLPIRWMSWESILLGKFTTASDVWAFG 219

Query: 965 VVLLELIS 972
           V L E+++
Sbjct: 220 VTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 43.9 bits (104), Expect = 6e-05
 Identities = 21/98 (21%), Positives = 40/98 (40%), Gaps = 10/98 (10%)

Query: 829 RHKNLV-TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALA 887
           R    V  ++     +   +L+  ++ G  L+    ++            IA  +A+ LA
Sbjct: 50  RKGLPVPKVLASGESDGWSYLLMEWIEGETLDEVSEEEKED---------IAEQLAELLA 100

Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARL 925
            LH   +  + H D+ P NIL+D+     + D+  A  
Sbjct: 101 KLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 45.2 bits (107), Expect = 8e-05
 Identities = 41/155 (26%), Positives = 75/155 (48%), Gaps = 12/155 (7%)

Query: 825 LGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHK-KSGKKIQWSVIHKIAIDIA 883
           + ++ HK+LV   G  V   E  +V  ++  G+L+T++ K K+   I W       +++A
Sbjct: 53  MSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK------LEVA 106

Query: 884 QALAY-LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE--VSETHATTDV-AG 939
           + LA+ LH+     + H ++   N+LL  E +    +    +L +  +S T    ++   
Sbjct: 107 KQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLE 166

Query: 940 TFGYVAPEYATTCR-VSDKADVYSFGVVLLELISG 973
              +V PE     + +S  AD +SFG  L E+ SG
Sbjct: 167 RIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 46.0 bits (109), Expect = 9e-05
 Identities = 36/127 (28%), Positives = 52/127 (40%), Gaps = 38/127 (29%)

Query: 249 LLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDL 308
           L LD   L G IP +I  +  L+ +++S NS+   IP  L   + L VL           
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVL----------- 471

Query: 309 DNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKG 368
           D S   F+                           G +P++  +  SL++LNL  NSL G
Sbjct: 472 DLSYNSFN---------------------------GSIPESLGQLTSLRILNLNGNSLSG 504

Query: 369 AVPKSLG 375
            VP +LG
Sbjct: 505 RVPAALG 511

Length = 623

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 45.0 bits (106), Expect = 2e-04
 Identities = 53/243 (21%), Positives = 93/243 (38%), Gaps = 57/243 (23%)

Query: 783 IGTGGFGSTYKAELV-PGYLVAVKKLS----IGRFQGIQQFDAEIGTLGRIRHKNLVTLI 837
           +G G FG    A  V    L A+K L     + R Q +    AE   L    ++ +V L 
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQ-VAHVKAERDILAEADNEWVVRLY 67

Query: 838 GYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
             +  +  ++ V +++ GG++ + + +         +      ++  A+  +H       
Sbjct: 68  YSFQDKDNLYFVMDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKM---GF 122

Query: 898 VHRDIKPSNILLDEELNAYLSDFGLA---RLLEVSETHATTD------------------ 936
           +HRDIKP NIL+D + +  L+DFGL    R    S+ + + D                  
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 937 -------------------------VAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELI 971
                                    + GT  Y+APE       +   D +S GV+L E++
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 972 SGK 974
            G+
Sbjct: 243 VGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 44.5 bits (105), Expect = 2e-04
 Identities = 27/76 (35%), Positives = 40/76 (52%), Gaps = 1/76 (1%)

Query: 898 VHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT-DVAGTFGYVAPEYATTCRVSD 956
           +HRD+   NILL E     + DFGLAR +     +    D      ++APE       + 
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTT 254

Query: 957 KADVYSFGVVLLELIS 972
           ++DV+SFGV+L E+ S
Sbjct: 255 QSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 44.5 bits (105), Expect = 2e-04
 Identities = 30/96 (31%), Positives = 46/96 (47%), Gaps = 4/96 (4%)

Query: 875 IHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS-ETHA 933
           +  +A  +  A+ Y+H      I+HRDIK  N+L++   +  L DFG A     S  T  
Sbjct: 262 VTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318

Query: 934 TTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLE 969
              +AGT    APE       +   D++S G+V+ E
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 44.2 bits (104), Expect = 2e-04
 Identities = 33/128 (25%), Positives = 53/128 (41%), Gaps = 13/128 (10%)

Query: 874 VIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA 933
           +I  I  D+   L Y+H      I H DIKP NI++D     Y+ D+G+A    +   H 
Sbjct: 127 LIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHI 183

Query: 934 TTDVA------GTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNG 987
                      GT  Y   +      V+ + D+ S G  +L+       L   +  +G+ 
Sbjct: 184 EYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKW--AGIKL--PWKGFGHN 239

Query: 988 FNIVSWAK 995
            N++  AK
Sbjct: 240 GNLIHAAK 247

Length = 294

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 44.2 bits (104), Expect = 3e-04
 Identities = 27/78 (34%), Positives = 41/78 (52%), Gaps = 1/78 (1%)

Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG-TFGYVAPEYATTCRV 954
           + +HRD+   NILL E     + DFGLAR +     +     A     ++APE       
Sbjct: 194 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVY 253

Query: 955 SDKADVYSFGVVLLELIS 972
           + ++DV+SFGV+L E+ S
Sbjct: 254 TTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 43.9 bits (103), Expect = 3e-04
 Identities = 27/78 (34%), Positives = 41/78 (52%), Gaps = 1/78 (1%)

Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT-DVAGTFGYVAPEYATTCRV 954
           + +HRD+   NILL E     + DFGLAR +     +    D      ++APE       
Sbjct: 199 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 258

Query: 955 SDKADVYSFGVVLLELIS 972
           + ++DV+SFGV+L E+ S
Sbjct: 259 TIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 43.5 bits (102), Expect = 5e-04
 Identities = 62/269 (23%), Positives = 104/269 (38%), Gaps = 64/269 (23%)

Query: 783 IGTGGFGSTYKAELV-PGYLVAVKKLS----IGRFQGIQQFDAEIGTLGRIRHKNLVTLI 837
           +G G FG    A  V    L A+K L     + R Q +    AE   L    ++ +V L 
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQ-VAHVKAERDILAEADNEWVVKLY 67

Query: 838 GYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
             +  +  ++ V +++ GG++ + +       I+  V  ++      A   L    V ++
Sbjct: 68  YSFQDKDNLYFVMDYIPGGDMMSLL-------IRMEVFPEVLARFYIAELTLAIESVHKM 120

Query: 898 --VHRDIKPSNILLDEELNAYLSDFGL--------------------------------- 922
             +HRDIKP NIL+D + +  L+DFGL                                 
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180

Query: 923 -----ARLLEVSETHATT--------DVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLE 969
                   L+  E  AT          + GT  Y+APE       +   D +S GV+L E
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240

Query: 970 LISGKRS-LDPSFSEYGNGFNIVSWAKLL 997
           ++ G+   L P+ +E      +++W   L
Sbjct: 241 MLVGQPPFLAPTPTE--TQLKVINWENTL 267

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 43.3 bits (102), Expect = 7e-04
 Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 6/97 (6%)

Query: 302 IDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNL 361
           ID  L LDN         G +P ++   R L+ +     ++ G +P +     SL+VL+L
Sbjct: 420 IDG-LGLDNQ-----GLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDL 473

Query: 362 GQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQL 398
             NS  G++P+SLG   +L  L+L+ N+L G +P  L
Sbjct: 474 SYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 42.1 bits (99), Expect = 7e-04
 Identities = 47/167 (28%), Positives = 76/167 (45%), Gaps = 23/167 (13%)

Query: 818 FDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHK-KSGKKIQWSVIH 876
           F      + ++ HK+LV L G  V + E  +V  ++  G L+ F+H+ K+   + W +  
Sbjct: 48  FFETASLMSQLSHKHLVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLD- 105

Query: 877 KIAIDIAQALAYLHYSCVPRIVHRDIKPSNILL-DEELN------AYLSDFGLAR-LLEV 928
            +A  +A AL YL      ++VH ++   NIL+    LN        LSD G+   +L  
Sbjct: 106 -VAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR 161

Query: 929 SETHATTDVAGTFGYVAPEY--ATTCRVSDKADVYSFGVVLLELISG 973
            E            ++APE        ++  AD +SFG  LLE+ S 
Sbjct: 162 EERVERIP------WIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.9 bits (89), Expect = 0.001
 Identities = 22/54 (40%), Positives = 30/54 (55%), Gaps = 7/54 (12%)

Query: 629 KLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSG-------HIPHLQHLD 675
            L+SL L++NRL+     +F  L NL  LDLS NNL+         +P L+ LD
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLD 54

Length = 60

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 41.5 bits (97), Expect = 0.002
 Identities = 41/167 (24%), Positives = 72/167 (43%), Gaps = 13/167 (7%)

Query: 511 SVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSG 570
           +++LS N +S       +     L E + +NN I   + + +  L  L  L+L  N++  
Sbjct: 190 NLDLSGNKIS--DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE- 245

Query: 571 SLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKL 630
            LP+ +G L  L+ + L  N ++    S  G L +L  LDLS N+L+ ++P         
Sbjct: 246 DLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALPLIA------ 297

Query: 631 ESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPHLQHLDCI 677
             L L    L   +    +  + L+++ L+ N LS           I
Sbjct: 298 -LLLLLLELLLNLLLTLKALELKLNSILLNNNILSNGETSSPEALSI 343

Length = 394

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.1 bits (87), Expect = 0.002
 Identities = 18/59 (30%), Positives = 27/59 (45%)

Query: 149 LEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRL 207
           L+ L+L  N  +         L  L+VL+LS N+ +   P    G   L  +D+S N L
Sbjct: 2   LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.1 bits (87), Expect = 0.002
 Identities = 20/60 (33%), Positives = 28/60 (46%), Gaps = 1/60 (1%)

Query: 355 SLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQL-PVPCMVYFNVSQNNI 413
           +LK L+L  N L      +     NL  LDLS NNL    P     +P +   ++S NN+
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	1052
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.98
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.98
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.98
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.98
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.98
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.98
PLN00009	294	cyclin-dependent kinase A; Provisional	99.98
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.98
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.98
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.98
PHA02882	294	putative serine/threonine kinase; Provisional	99.98
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.98
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.98
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.98
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.98
PHA03210	501	serine/threonine kinase US3; Provisional	99.98
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.98
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.97
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.97
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.97
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.97
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.97
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.97
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.97
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.97
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.97
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.97
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.97
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.97
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.97
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.97
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.97
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.97
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.97
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.97
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.97
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.97
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.97
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.97
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.97
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.97
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.97
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.97
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.97
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.97
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.97
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.97
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.97
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.97
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.97
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.97
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.97
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.97
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.97
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.97
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.97
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG0586	596	consensus Serine/threonine protein kinase [General	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.97
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.96
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.96
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.96
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.96
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.96
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.95
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.95
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.95
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.95
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.93
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.93
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.93
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.93
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.93
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.92
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.91
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.9
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.9
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.9
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.89
PLN00181	793	protein SPA1-RELATED; Provisional	99.89
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.88
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.88
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.88
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.87
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.86
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.86
PRK09188	365	serine/threonine protein kinase; Provisional	99.86
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.85
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.82
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.82
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.82
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.8
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.79
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.78
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.77
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.77
PRK12274	218	serine/threonine protein kinase; Provisional	99.76
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.75
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.75
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.74
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.74
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.72
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.72
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.71
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.7
PRK10345	210	hypothetical protein; Provisional	99.7
smart00090	237	RIO RIO-like kinase.	99.64
PRK14879	211	serine/threonine protein kinase; Provisional	99.62
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.61
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.6
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.6
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.6
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.58
PLN03150	623	hypothetical protein; Provisional	99.58
PLN03150	623	hypothetical protein; Provisional	99.52
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.5
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.48
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.46
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.43
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.34
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.3
KOG1243	690	consensus Protein kinase [General function predict	99.29
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.27
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.26
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.25
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.24
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.22
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.19
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.12
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.12
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.11
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.06
KOG3087	229	consensus Serine/threonine protein kinase [General	99.06
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.06
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.03
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.03
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.02
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.02
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	98.98
PF08263	43	LRRNT_2: Leucine rich repeat N-terminal domain; In	98.97
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	98.94
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.9
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	98.9
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.88
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	98.83
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.8
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.78
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.78
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.76
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.72
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.7
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.69
COG4248	637	Uncharacterized protein with protein kinase and he	98.66
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.64
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.59
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.51
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.5
PRK09902	216	hypothetical protein; Provisional	98.44
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.41
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.38
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.34
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.32

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.2e-107  Score=1051.60  Aligned_cols=912  Identities=31%  Similarity=0.514  Sum_probs=751.6

Q ss_pred             ChhhHHHHHHHHHhccCCCCCcccCCCCCCCCCCCCceEeecCCCceEEEEEccCCCCCCCCCcccccccchhhcCCCCC
Q 001566           46 PTTDSASLLSFKASISRDPSNLLATWNSSTDHCTWHGVTCDHFTGRVTALRITGKATPWPSKSSVISGTLSASIAKLTEL  125 (1052)
Q Consensus        46 ~~~d~~all~~k~~~~~~p~~~l~~W~~~~~~C~w~gV~C~~~~~~v~~l~l~~~~~~~~~~~~~l~g~l~~~l~~l~~L  125 (1052)
                      .++|+.||++||+++. ||.+.+++|+.+++||.|.||+|++ .++|+.+++.+..         ++|.+++++..+++|
T Consensus        27 ~~~~~~~l~~~~~~~~-~~~~~~~~w~~~~~~c~w~gv~c~~-~~~v~~L~L~~~~---------i~~~~~~~~~~l~~L   95 (968)
T PLN00113         27 HAEELELLLSFKSSIN-DPLKYLSNWNSSADVCLWQGITCNN-SSRVVSIDLSGKN---------ISGKISSAIFRLPYI   95 (968)
T ss_pred             CHHHHHHHHHHHHhCC-CCcccCCCCCCCCCCCcCcceecCC-CCcEEEEEecCCC---------ccccCChHHhCCCCC
Confidence            5689999999999995 7888899998888999999999986 5799999998754         888999999999999


Q ss_pred             CeeEecCCCceecCCCCcc-CCCCccEEEccCccccccCCccccCCCCCCeEecccccccccCCccccCCCCCcEEEccC
Q 001566          126 RTLSVPHNSFSGEIPAGVG-ELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSS  204 (1052)
Q Consensus       126 ~~L~L~~n~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  204 (1052)
                      +.|+|++|+++|.+|..+. .+++|++|+|++|++++.+|.  +.+++|++|+|++|.+++.+|..++++++|++|+|++
T Consensus        96 ~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~  173 (968)
T PLN00113         96 QTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGG  173 (968)
T ss_pred             CEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECcc
Confidence            9999999999999998765 999999999999999998886  5689999999999999999999999999999999999


Q ss_pred             CcccCccccCCCcccCCCCEEEccCCcCCCCCCcccCCCCCCCEEEcCCCccccccchhhcCCCCCCEEEccCCCCCCCC
Q 001566          205 NRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRI  284 (1052)
Q Consensus       205 N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  284 (1052)
                      |.+.+.+| ..+.++++|++|+|++|.+++.+|..++++++|++|++++|++++.+|..++++++|++|++++|++++.+
T Consensus       174 n~l~~~~p-~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~  252 (968)
T PLN00113        174 NVLVGKIP-NSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPI  252 (968)
T ss_pred             CcccccCC-hhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceecccc
Confidence            99988665 46788999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCCCCCceecccccccccCCCCCCccccccCCCchhhhcccCCcEEecCCCCCCccCCccccCCCCccEEeCCCC
Q 001566          285 PVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQN  364 (1052)
Q Consensus       285 p~~l~~l~~L~~L~L~~n~~~~~l~~~~~~~~~~~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~Ls~N  364 (1052)
                      |..++++++|+.|++++|.+              .+.+|..+..+++|+.|++++|.+.+.+|..+.++++|+.|++++|
T Consensus       253 p~~l~~l~~L~~L~L~~n~l--------------~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n  318 (968)
T PLN00113        253 PSSLGNLKNLQYLFLYQNKL--------------SGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSN  318 (968)
T ss_pred             ChhHhCCCCCCEEECcCCee--------------eccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCC
Confidence            99999999999999998654              4567888899999999999999999999999999999999999999


Q ss_pred             cccccCCccccccCCCCEEeCCCCcCcCCCCCCCC-CCCcceEecccCcccccCCCCCccccCcccCccccccccccccc
Q 001566          365 SLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLP-VPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMG  443 (1052)
Q Consensus       365 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~l~~~~~~~~~  443 (1052)
                      .+++.+|..++.+++|+.|+|++|++++.+|..+. +++|+.|++++|++++.+|..                       
T Consensus       319 ~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~-----------------------  375 (968)
T PLN00113        319 NFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEG-----------------------  375 (968)
T ss_pred             ccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChh-----------------------
Confidence            99999999999999999999999999999887664 789999999999999887752                       


Q ss_pred             cccccceeEEeeccCCccccccCcccccccccccccchhHHhhccCCcccCCCCCccccccCCCcceEEecCcccccCcc
Q 001566          444 SISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMS  523 (1052)
Q Consensus       444 ~~~~~~~l~~ldls~n~~~g~~p~~~~~~~~~~~~~~~~~~l~l~~n~~~~~~p~~~~~~~~~l~~~~l~l~~n~l~~~~  523 (1052)
                       +.....+..+++++|++.+.+|...       .....+..+.+.+|.+++.+|.. +..++.|+  .+++++|.+++..
T Consensus       376 -~~~~~~L~~L~l~~n~l~~~~p~~~-------~~~~~L~~L~L~~n~l~~~~p~~-~~~l~~L~--~L~Ls~N~l~~~~  444 (968)
T PLN00113        376 -LCSSGNLFKLILFSNSLEGEIPKSL-------GACRSLRRVRLQDNSFSGELPSE-FTKLPLVY--FLDISNNNLQGRI  444 (968)
T ss_pred             -HhCcCCCCEEECcCCEecccCCHHH-------hCCCCCCEEECcCCEeeeECChh-HhcCCCCC--EEECcCCcccCcc
Confidence             1122345678999999999888532       23445678889999999988764 56666666  5789999998876


Q ss_pred             hHHHHhcCcCccEEEccCcccccccccccCCCCCCCEEEccCCcCCCCCcccccCCccCcEEEcCCCccCCcCchhhcCC
Q 001566          524 YEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHL  603 (1052)
Q Consensus       524 ~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  603 (1052)
                      ...+ ..+++|++|++++|++.+.+|..+. .++|+.|+|++|++++..|..|.++++|+.|+|++|++++.+|..+.++
T Consensus       445 ~~~~-~~l~~L~~L~L~~n~~~~~~p~~~~-~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  522 (968)
T PLN00113        445 NSRK-WDMPSLQMLSLARNKFFGGLPDSFG-SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSC  522 (968)
T ss_pred             Chhh-ccCCCCcEEECcCceeeeecCcccc-cccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCc
Confidence            5544 5789999999999999999988764 5899999999999999999999999999999999999999999999999


Q ss_pred             CCCcEEEcCCCCCCCCCchhhhcccccceeeccCccCCCCCCcccccccccCceecccccccCCCCCcc---cccccccc
Q 001566          604 ISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPHLQ---HLDCIAFK  680 (1052)
Q Consensus       604 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~---~l~~~~~~  680 (1052)
                      ++|++|+|++|++++.+|..|..+++|+.|+|++|++++.+|..+..+++|+.|++++|+++|.+|...   .+....+.
T Consensus       523 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~  602 (968)
T PLN00113        523 KKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVA  602 (968)
T ss_pred             cCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhc
Confidence            999999999999999999999999999999999999999999999999999999999999999999654   45667889


Q ss_pred             CCccccCCCCCCCCCCCCCCccccccccCCCCccEEEeeeehhhHHHHHHHHHHHhhheeeccccccccc---ccceeee
Q 001566          681 GNKYLASCPDTNATAPEKPPVQLDEKLQNGKRSKVFIIAVVTSASAVLLIFLVIIFVILRRRKFGRIASL---RGQVMVT  757 (1052)
Q Consensus       681 ~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~liv~~~~~~~~~rrrk~~r~~~~---~~~~~~~  757 (1052)
                      |||..|..+.... .   ++...     ......+.+++++++++++++++++++++++|+++..+..+.   .+.....
T Consensus       603 ~n~~lc~~~~~~~-~---~~c~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  673 (968)
T PLN00113        603 GNIDLCGGDTTSG-L---PPCKR-----VRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQ  673 (968)
T ss_pred             CCccccCCccccC-C---CCCcc-----ccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhccccccccccccccccc
Confidence            9999965332211 1   11110     011112222222222222222222233333333322111111   1110000


Q ss_pred             -ec-CCCCccchhhHHHhhCCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCccccHHHHHHHHHHhhccCCCcee
Q 001566          758 -FA-DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV  834 (1052)
Q Consensus       758 -~~-~~~~~~~~~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv  834 (1052)
                       +. .....++++++   ...|...++||+|+||+||+|.. .++..||||++......    ..+|++.+++++||||+
T Consensus       674 ~~~~~~~~~~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv  746 (968)
T PLN00113        674 FFDSKVSKSITINDI---LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIV  746 (968)
T ss_pred             ccccccchhhhHHHH---HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcc
Confidence             00 01112233333   34577788999999999999976 57899999988643322    23568899999999999


Q ss_pred             eEEEEEecCCeeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc
Q 001566          835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELN  914 (1052)
Q Consensus       835 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~  914 (1052)
                      +++++|.++...++||||+++|+|.++++.     ++|.++.+++.|+++|++|||..+.++|+||||||+||+++.++.
T Consensus       747 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~  821 (968)
T PLN00113        747 KLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE  821 (968)
T ss_pred             eEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCc
Confidence            999999999999999999999999999953     789999999999999999999666669999999999999999988


Q ss_pred             EEEeeecccccccccCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHH
Q 001566          915 AYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWA  994 (1052)
Q Consensus       915 ~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  994 (1052)
                      .++. ||.+.....     .....+++.|+|||++.+..++.++|||||||++|||+||+.||+....   ......+|.
T Consensus       822 ~~~~-~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~---~~~~~~~~~  892 (968)
T PLN00113        822 PHLR-LSLPGLLCT-----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG---VHGSIVEWA  892 (968)
T ss_pred             eEEE-ecccccccc-----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC---CCCcHHHHH
Confidence            8875 665543221     1223678999999999999999999999999999999999999965433   345677777


Q ss_pred             HHHHHhCCccccccchhhcC--CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566          995 KLLIKEGRSSELFLPELWEA--GPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus       995 ~~~~~~~~~~~~~~~~l~~~--~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                      +...........+++.+...  .+.++..++.+++.+||+.||++||+|+|+++.|+++
T Consensus       893 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  951 (968)
T PLN00113        893 RYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA  951 (968)
T ss_pred             HHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence            76655554444555554332  3456677889999999999999999999999999875

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=4.2e-57  Score=582.37  Aligned_cols=515  Identities=32%  Similarity=0.498  Sum_probs=466.0

Q ss_pred             CCCCeeEecCCCceecCCCCccCCCCccEEEccCccccccCCcccc-CCCCCCeEecccccccccCCccccCCCCCcEEE
Q 001566          123 TELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMS-NLERLRVLNLSFNSFSGEVPRGLIGNGELSVID  201 (1052)
Q Consensus       123 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  201 (1052)
                      .+++.|+|++|+++|.+|..|..+++|++|+|++|+++|.+|..+. ++++|++|+|++|.+++.+|.  ..+++|++|+
T Consensus        69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~  146 (968)
T PLN00113         69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLD  146 (968)
T ss_pred             CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEE
Confidence            4688999999999999999999999999999999999999998765 999999999999999998886  4589999999


Q ss_pred             ccCCcccCccccCCCcccCCCCEEEccCCcCCCCCCcccCCCCCCCEEEcCCCccccccchhhcCCCCCCEEEccCCCCC
Q 001566          202 MSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLT  281 (1052)
Q Consensus       202 L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  281 (1052)
                      |++|.+++.+| ..++.+++|++|+|++|.+++.+|..++++++|++|++++|++.+.+|..++.+++|+.|+|++|+++
T Consensus       147 Ls~n~~~~~~p-~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~  225 (968)
T PLN00113        147 LSNNMLSGEIP-NDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLS  225 (968)
T ss_pred             CcCCcccccCC-hHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccC
Confidence            99999987555 45788999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCcccccCCCCCceecccccccccCCCCCCccccccCCCchhhhcccCCcEEecCCCCCCccCCccccCCCCccEEeC
Q 001566          282 DRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNL  361 (1052)
Q Consensus       282 ~~~p~~l~~l~~L~~L~L~~n~~~~~l~~~~~~~~~~~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L  361 (1052)
                      +.+|..++++++|+.|++++|.+              .+.+|..+..+++|+.|++++|.+.+.+|..+.++++|++|+|
T Consensus       226 ~~~p~~l~~l~~L~~L~L~~n~l--------------~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L  291 (968)
T PLN00113        226 GEIPYEIGGLTSLNHLDLVYNNL--------------TGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDL  291 (968)
T ss_pred             CcCChhHhcCCCCCEEECcCcee--------------ccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEEC
Confidence            99999999999999999998654              3567888999999999999999999999999999999999999


Q ss_pred             CCCcccccCCccccccCCCCEEeCCCCcCcCCCCCCC-CCCCcceEecccCcccccCCCCCccccCcccCcccccccccc
Q 001566          362 GQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQL-PVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVP  440 (1052)
Q Consensus       362 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~l~~~~~~  440 (1052)
                      ++|.+++.+|..+.++++|++|++++|++++.+|..+ .+++|+.|++++|++++.+|..                    
T Consensus       292 s~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~--------------------  351 (968)
T PLN00113        292 SDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKN--------------------  351 (968)
T ss_pred             cCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChH--------------------
Confidence            9999999999999999999999999999999988766 4899999999999999887742                    


Q ss_pred             ccccccccceeEEeeccCCccccccCcccccccccccccchhHHhhccCCcccCCCCCccccccCCCcceEEecCccccc
Q 001566          441 VMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLS  520 (1052)
Q Consensus       441 ~~~~~~~~~~l~~ldls~n~~~g~~p~~~~~~~~~~~~~~~~~~l~l~~n~~~~~~p~~~~~~~~~l~~~~l~l~~n~l~  520 (1052)
                          +.....+..+|+++|++.|.+|....       ....+..+.+.+|.+.+.+|.. ++.+.+|+  .+++++|.++
T Consensus       352 ----l~~~~~L~~L~Ls~n~l~~~~p~~~~-------~~~~L~~L~l~~n~l~~~~p~~-~~~~~~L~--~L~L~~n~l~  417 (968)
T PLN00113        352 ----LGKHNNLTVLDLSTNNLTGEIPEGLC-------SSGNLFKLILFSNSLEGEIPKS-LGACRSLR--RVRLQDNSFS  417 (968)
T ss_pred             ----HhCCCCCcEEECCCCeeEeeCChhHh-------CcCCCCEEECcCCEecccCCHH-HhCCCCCC--EEECcCCEee
Confidence                22234577899999999998885432       2344667899999999998864 56677777  4788999998


Q ss_pred             CcchHHHHhcCcCccEEEccCcccccccccccCCCCCCCEEEccCCcCCCCCcccccCCccCcEEEcCCCccCCcCchhh
Q 001566          521 GMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQF  600 (1052)
Q Consensus       521 ~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  600 (1052)
                      +..+..| ..++.|+.|++++|++++.+|..+..+++|+.|+|++|++.+.+|..+ ..++|+.|+|++|++++.+|..|
T Consensus       418 ~~~p~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~  495 (968)
T PLN00113        418 GELPSEF-TKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKL  495 (968)
T ss_pred             eECChhH-hcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhh
Confidence            7665554 689999999999999999999999999999999999999999888876 46899999999999999999999


Q ss_pred             cCCCCCcEEEcCCCCCCCCCchhhhcccccceeeccCccCCCCCCcccccccccCceecccccccCCCCC----cccccc
Q 001566          601 GHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPH----LQHLDC  676 (1052)
Q Consensus       601 ~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~----~~~l~~  676 (1052)
                      .++++|++|+|++|++++.+|..+.++++|++|+|++|++++.+|..|..+++|+.|+|++|+++|.+|.    +.+|..
T Consensus       496 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~  575 (968)
T PLN00113        496 GSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQ  575 (968)
T ss_pred             hhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCE
Confidence            9999999999999999999999999999999999999999999999999999999999999999998884    346888


Q ss_pred             ccccCCccccCCCC
Q 001566          677 IAFKGNKYLASCPD  690 (1052)
Q Consensus       677 ~~~~~n~~~~~~~~  690 (1052)
                      +++.+|++.+..|.
T Consensus       576 l~ls~N~l~~~~p~  589 (968)
T PLN00113        576 VNISHNHLHGSLPS  589 (968)
T ss_pred             EeccCCcceeeCCC
Confidence            99999999866554

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-47  Score=423.96  Aligned_cols=288  Identities=45%  Similarity=0.770  Sum_probs=254.4

Q ss_pred             CCCccchhhHHHhhCCCccceeeeccCceEEEEEEecCCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEE
Q 001566          761 TPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYY  840 (1052)
Q Consensus       761 ~~~~~~~~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~  840 (1052)
                      ....|+|+++..++++|.-..+||+|+||.||+|...+|+.||||++.....+...+|.+|++++.+++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            56678999999999999999999999999999999998899999988765543145699999999999999999999999


Q ss_pred             ecCC-eeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEee
Q 001566          841 VGEA-EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSD  919 (1052)
Q Consensus       841 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~D  919 (1052)
                      .+.+ +.++|||||++|+|.++++......++|.++.+||.++|+||+|||+.+.|.||||||||+|||+|+++++||+|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            9988 599999999999999999987533889999999999999999999999988999999999999999999999999


Q ss_pred             ecccccccccCccccccc-ccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHH
Q 001566          920 FGLARLLEVSETHATTDV-AGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLI  998 (1052)
Q Consensus       920 fgla~~~~~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  998 (1052)
                      ||+|+........ .... .||.+|+|||++..+..+.|+|||||||++.|++||++|.+...+.  ....+.+|++..+
T Consensus       221 FGLa~~~~~~~~~-~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~--~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  221 FGLAKLGPEGDTS-VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPR--GELSLVEWAKPLL  297 (361)
T ss_pred             ccCcccCCccccc-eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCc--ccccHHHHHHHHH
Confidence            9999755431111 1111 7999999999999999999999999999999999999998865422  3445899999999


Q ss_pred             HhCCccccccchhh-cCCCh-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566          999 KEGRSSELFLPELW-EAGPQ-ENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus       999 ~~~~~~~~~~~~l~-~~~~~-~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                      ..++..+.+|+.+. ..++. .+...+.+++.+|++.+|++||+|.||+++|+.+
T Consensus       298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~  352 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI  352 (361)
T ss_pred             HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence            99999999999987 55554 6888899999999999999999999999999764

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7e-46  Score=405.31  Aligned_cols=262  Identities=28%  Similarity=0.446  Sum_probs=227.7

Q ss_pred             hhHHHhhCCCccceeeeccCceEEEEEEecCCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeE
Q 001566          768 DNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMF  847 (1052)
Q Consensus       768 ~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  847 (1052)
                      +..+.....+++.+.||+|.||+||.|.+.....||+|.++..... .++|.+|+++|++++|++||+++|+|..++.+|
T Consensus       199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~-~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piy  277 (468)
T KOG0197|consen  199 DPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS-PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIY  277 (468)
T ss_pred             CCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC-hhHHHHHHHHHHhCcccCeEEEEEEEecCCceE
Confidence            3334444556778899999999999999998889999999876433 478899999999999999999999999988999


Q ss_pred             EEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccccc
Q 001566          848 LVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE  927 (1052)
Q Consensus       848 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~  927 (1052)
                      +|||||+.|+|.+||+...+..+...+.+.++.|||+||+||+++   ++|||||.++||||+++..|||+|||+|+...
T Consensus       278 IVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~  354 (468)
T KOG0197|consen  278 IVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIG  354 (468)
T ss_pred             EEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccC
Confidence            999999999999999987778899999999999999999999999   99999999999999999999999999999766


Q ss_pred             ccCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCcccc
Q 001566          928 VSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSEL 1006 (1052)
Q Consensus       928 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      .+.+.......-+..|+|||++..+.++.|||||||||+||||+| |+.|+.        ++...+..+.+.+..+..  
T Consensus       355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~--------~msn~ev~~~le~GyRlp--  424 (468)
T KOG0197|consen  355 DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP--------GMSNEEVLELLERGYRLP--  424 (468)
T ss_pred             CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCC--------CCCHHHHHHHHhccCcCC--
Confidence            666666666677889999999999999999999999999999999 666665        445556566555444332  


Q ss_pred             ccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1007 FLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1007 ~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                              .|..++..+.++|..||+.+|++|||++.+...++++
T Consensus       425 --------~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~  461 (468)
T KOG0197|consen  425 --------RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF  461 (468)
T ss_pred             --------CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence                    3667778899999999999999999999999988765

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-44  Score=392.87  Aligned_cols=256  Identities=34%  Similarity=0.566  Sum_probs=214.5

Q ss_pred             CCCccceeeeccCceEEEEEEecCCcEEEEEEeccCcccc--HHHHHHHHHHhhccCCCceeeEEEEEecCC-eeEEEEe
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQG--IQQFDAEIGTLGRIRHKNLVTLIGYYVGEA-EMFLVYN  851 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e  851 (1052)
                      ..+.+.+.||+|+||+||+|.++....||||++.......  .++|.+|+.++.+++|||||+++|+|.+.. ..++|||
T Consensus        41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE  120 (362)
T KOG0192|consen   41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE  120 (362)
T ss_pred             HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence            3455566799999999999999844449999997654333  458999999999999999999999999887 7999999


Q ss_pred             ecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCC-eeeCCCCCCCEEECCCC-cEEEeeeccccccccc
Q 001566          852 FLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPR-IVHRDIKPSNILLDEEL-NAYLSDFGLARLLEVS  929 (1052)
Q Consensus       852 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-iiHrDik~~Nill~~~~-~~kl~Dfgla~~~~~~  929 (1052)
                      |+++|+|.++++......+++..+.+++.|||+||+|||++   + |||||+||+|||++.++ ++||+|||+++.....
T Consensus       121 y~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  121 YMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             eCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            99999999999885457899999999999999999999999   7 99999999999999997 9999999999866533


Q ss_pred             CcccccccccccccccccccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccc
Q 001566          930 ETHATTDVAGTFGYVAPEYAT--TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELF 1007 (1052)
Q Consensus       930 ~~~~~~~~~g~~~y~aPE~~~--~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1052)
                      . .......||+.|||||++.  ...|+.|+||||||+++|||+||+.||....        ..+.+..+...+...   
T Consensus       198 ~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~--------~~~~~~~v~~~~~Rp---  265 (362)
T KOG0192|consen  198 K-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLA--------PVQVASAVVVGGLRP---  265 (362)
T ss_pred             c-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhcCCCC---
Confidence            2 2333468999999999999  5689999999999999999999999998432        233344444333322   


Q ss_pred             cchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1008 LPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1008 ~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                            ..|..++..+..++.+||+.||++||++.+++..|+.+
T Consensus       266 ------~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~  303 (362)
T KOG0192|consen  266 ------PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI  303 (362)
T ss_pred             ------CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence                  22333566799999999999999999999999999865

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-43  Score=369.60  Aligned_cols=252  Identities=29%  Similarity=0.468  Sum_probs=210.2

Q ss_pred             CCccceeeeccCceEEEEEEec-CCcEEEEEEeccC-ccccHHHHHHHHHHhhccCCCceeeEEEEEecCC-eeEEEEee
Q 001566          776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIG-RFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEA-EMFLVYNF  852 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~  852 (1052)
                      +.+..+.||+|..|+||++.++ +++.+|+|++... +....+++.+|++++++.+||+||.+||+|.... ..+++|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            4566789999999999999776 5888999999543 3344678999999999999999999999999988 59999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      |++|||++++...  +++++....+++.+|++||.|||+..  +||||||||+|||+...|++||||||.+..+-.+   
T Consensus       160 MDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---  232 (364)
T KOG0581|consen  160 MDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---  232 (364)
T ss_pred             cCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence            9999999999876  57999999999999999999999632  9999999999999999999999999999877544   


Q ss_pred             cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhh
Q 001566          933 ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012 (1052)
Q Consensus       933 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1012 (1052)
                      .....+||..|||||.+.+..|+.++||||||+.++|+++|+.||.+..+..   ....+....+..+ ..     |.+.
T Consensus       233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~---~~~~~Ll~~Iv~~-pp-----P~lP  303 (364)
T KOG0581|consen  233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY---LDIFELLCAIVDE-PP-----PRLP  303 (364)
T ss_pred             hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC---CCHHHHHHHHhcC-CC-----CCCC
Confidence            4456789999999999999999999999999999999999999998763332   2233322222221 11     1121


Q ss_pred             cCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1013 EAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1013 ~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ..   ....+++.++..|++.||.+||+++|+++
T Consensus       304 ~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  304 EG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             cc---cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            11   24556999999999999999999999875

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.4e-43  Score=403.57  Aligned_cols=259  Identities=29%  Similarity=0.443  Sum_probs=223.1

Q ss_pred             HhhCCCccceeeeccCceEEEEEEec------CCcEEEEEEeccCccc-cHHHHHHHHHHhhccCCCceeeEEEEEecCC
Q 001566          772 RATGNFSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSIGRFQ-GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEA  844 (1052)
Q Consensus       772 ~~~~~~~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  844 (1052)
                      ....+.+..+.||+|+||+||+|+..      +...||||.++..... ..++|++|++++..++|||||+++|+|.+++
T Consensus       483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~  562 (774)
T KOG1026|consen  483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD  562 (774)
T ss_pred             echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence            34456677789999999999999654      3467999999877665 6789999999999999999999999999999


Q ss_pred             eeEEEEeecCCCCHHHHHhhcc--------CCc----ccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC
Q 001566          845 EMFLVYNFLSGGNLETFIHKKS--------GKK----IQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEE  912 (1052)
Q Consensus       845 ~~~lv~e~~~~gsL~~~l~~~~--------~~~----l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~  912 (1052)
                      .+|+|+|||..|||.+||..+.        +..    ++..+.+.||.|||.||+||.++   .+|||||..+|+||.++
T Consensus       563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~  639 (774)
T KOG1026|consen  563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGEN  639 (774)
T ss_pred             eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccc
Confidence            9999999999999999997653        233    88999999999999999999999   99999999999999999


Q ss_pred             CcEEEeeecccccccccCccccc-ccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccH
Q 001566          913 LNAYLSDFGLARLLEVSETHATT-DVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNI  990 (1052)
Q Consensus       913 ~~~kl~Dfgla~~~~~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~  990 (1052)
                      ..|||+|||+++.+-..+++... .-.-+.+||+||.|..++|+.+||||||||++||+++ |+-||++-..        
T Consensus       640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn--------  711 (774)
T KOG1026|consen  640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN--------  711 (774)
T ss_pred             eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch--------
Confidence            99999999999988777777655 4456789999999999999999999999999999999 8888874322        


Q ss_pred             HHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566          991 VSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                      .+.++ .++.+...         ..|+.++.++.+||.+||+..|++||+++||-..|+.+
T Consensus       712 ~EVIe-~i~~g~lL---------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~  762 (774)
T KOG1026|consen  712 QEVIE-CIRAGQLL---------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW  762 (774)
T ss_pred             HHHHH-HHHcCCcc---------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence            23333 34444432         45778888999999999999999999999999988753

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-42  Score=360.55  Aligned_cols=200  Identities=30%  Similarity=0.548  Sum_probs=180.9

Q ss_pred             hCCCccceeeeccCceEEEEEEec-CCcEEEEEEeccC--ccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEE
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIG--RFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      .++|.+.+.||+|+||+||+|+++ ++..||||.+...  ..+..+-...|+.+++.++|||||++++++..++.+|+||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            457888999999999999999765 5799999999776  4445667789999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC------CcEEEeeecccc
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEE------LNAYLSDFGLAR  924 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~------~~~kl~Dfgla~  924 (1052)
                      |||.||+|.+|++++.  .+++..+..++.|+|.|+++||++   +||||||||+|||++..      ..+||+|||+|+
T Consensus        89 EyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             EeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            9999999999999874  799999999999999999999999   99999999999999865      468999999999


Q ss_pred             cccccCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 001566          925 LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPS  980 (1052)
Q Consensus       925 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~  980 (1052)
                      ...+  .......+|++-|||||+++..+|+.|+|+||+|+++|||++|++||+..
T Consensus       164 ~L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~  217 (429)
T KOG0595|consen  164 FLQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE  217 (429)
T ss_pred             hCCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence            8863  33345568999999999999999999999999999999999999999843

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.7e-43  Score=365.33  Aligned_cols=252  Identities=29%  Similarity=0.442  Sum_probs=209.7

Q ss_pred             hCCCccceeeeccCceEEEEE-EecCCcEEEEEEeccCccc-------cHHHHHHHHHHhhccCCCceeeEEEEEecCCe
Q 001566          774 TGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ-------GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAE  845 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  845 (1052)
                      .+.|.+.+.||+|+||.|-+| +.++|+.||||++......       ......+|+++|++++|||||+++++|...+.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            356888999999999999999 6678999999999654322       22346799999999999999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC---CcEEEeeecc
Q 001566          846 MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEE---LNAYLSDFGL  922 (1052)
Q Consensus       846 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~---~~~kl~Dfgl  922 (1052)
                      .|+||||++||+|.+++-.+  ..+.+.....+++|++.|+.|||++   ||+||||||+|||+..+   ..+||+|||+
T Consensus       251 ~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             eEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccch
Confidence            99999999999999999776  4688888899999999999999999   99999999999999766   6799999999


Q ss_pred             cccccccCcccccccccccccccccccCCCCCC---cchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHH
Q 001566          923 ARLLEVSETHATTDVAGTFGYVAPEYATTCRVS---DKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIK  999 (1052)
Q Consensus       923 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~---~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  999 (1052)
                      |+..+  +...+...+|||.|.|||++.+..+.   .+.|+||+||++|-+++|.+||.......        -....+.
T Consensus       326 AK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--------sl~eQI~  395 (475)
T KOG0615|consen  326 AKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--------SLKEQIL  395 (475)
T ss_pred             hhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--------cHHHHHh
Confidence            99776  44556678999999999999876533   47899999999999999999998654331        1333444


Q ss_pred             hCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1000 EGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1000 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      .|+..  +.|..|.    +..++..++|.+|+..||++|||++|+++
T Consensus       396 ~G~y~--f~p~~w~----~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  396 KGRYA--FGPLQWD----RISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             cCccc--ccChhhh----hhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            44443  3344443    34556899999999999999999999875

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-41  Score=374.56  Aligned_cols=247  Identities=26%  Similarity=0.403  Sum_probs=212.9

Q ss_pred             CCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccC---ccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIG---RFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      .+|...+.||+|||+.+|+++. .+|+.||+|++...   .....+...+|+++.++++|||||+++++|++...+|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5799999999999999999976 78999999999653   3344577889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccC
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~  930 (1052)
                      |+|+.++|..+++++  +.+++.++..+..||+.|+.|||+.   +|+|||||..|++++++.+|||+|||+|.......
T Consensus        98 ELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~  172 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG  172 (592)
T ss_pred             EecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCcc
Confidence            999999999999854  6899999999999999999999999   99999999999999999999999999999886433


Q ss_pred             cccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccch
Q 001566          931 THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010 (1052)
Q Consensus       931 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1052)
                       ......+|||.|.|||++....++..+||||+||++|-|+.|++||+.        ..+.+....+..... .      
T Consensus       173 -Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet--------k~vkety~~Ik~~~Y-~------  236 (592)
T KOG0575|consen  173 -ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET--------KTVKETYNKIKLNEY-S------  236 (592)
T ss_pred             -cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc--------chHHHHHHHHHhcCc-c------
Confidence             344557899999999999999999999999999999999999999983        223333333322221 1      


Q ss_pred             hhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1011 LWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1011 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                          .|........+||.++++.+|.+|||+++|+.
T Consensus       237 ----~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  237 ----MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             ----cccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                13344556889999999999999999999975

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-42  Score=345.03  Aligned_cols=253  Identities=28%  Similarity=0.457  Sum_probs=209.7

Q ss_pred             CCCccceeeeccCceEEEEE-EecCCcEEEEEEeccC--ccccHHHHHHHHHHhhccCCCceeeEEE-EEecCCe-eEEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIG--RFQGIQQFDAEIGTLGRIRHKNLVTLIG-YYVGEAE-MFLV  849 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~-~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~-~~~~~~~-~~lv  849 (1052)
                      .+|++.++||+|.||+||++ ...+|..+|.|.+.-.  +.+..++...|+.++++++|||||++++ .+.++.+ +++|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            45889999999999999999 4567999999988643  3344667889999999999999999999 4555555 8999


Q ss_pred             EeecCCCCHHHHHhhcc--CCcccHHHHHHHHHHHHHHHHHHHhcCCCC--eeeCCCCCCCEEECCCCcEEEeeeccccc
Q 001566          850 YNFLSGGNLETFIHKKS--GKKIQWSVIHKIAIDIAQALAYLHYSCVPR--IVHRDIKPSNILLDEELNAYLSDFGLARL  925 (1052)
Q Consensus       850 ~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--iiHrDik~~Nill~~~~~~kl~Dfgla~~  925 (1052)
                      ||++.+|+|.+.++..+  .+.+++..+++++.|++.|+.++|++. ++  |+||||||.||+++++|.||++|||+++.
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            99999999999987643  467999999999999999999999943 25  89999999999999999999999999998


Q ss_pred             ccccCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccc
Q 001566          926 LEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005 (1052)
Q Consensus       926 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1052)
                      +.. ........+|||.||+||.+.+..|+.+|||||+||++|||+.-.+||++.        ++.+..+.+ ..++...
T Consensus       178 l~s-~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--------n~~~L~~KI-~qgd~~~  247 (375)
T KOG0591|consen  178 LSS-KTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD--------NLLSLCKKI-EQGDYPP  247 (375)
T ss_pred             hcc-hhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--------cHHHHHHHH-HcCCCCC
Confidence            764 444556789999999999999999999999999999999999999999843        455544444 3443332


Q ss_pred             cccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1006 ~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ..        ..-...++..||..|+.+||+.||+...+++
T Consensus       248 ~p--------~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~  280 (375)
T KOG0591|consen  248 LP--------DEHYSTDLRELINMCIAVDPEQRPDTVPYVQ  280 (375)
T ss_pred             Cc--------HHHhhhHHHHHHHHHccCCcccCCCcchHHH
Confidence            21        1345667999999999999999998544443

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-42  Score=384.34  Aligned_cols=254  Identities=26%  Similarity=0.431  Sum_probs=218.1

Q ss_pred             CCccceeeeccCceEEEEEEecC----CcEEEEEEeccCcc-ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEE
Q 001566          776 NFSIRNLIGTGGFGSTYKAELVP----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      ...|.++||.|.||+||+|+++.    ...||||.++.... +...+|..|+.+|.++.||||+++.|+......+++|.
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT  709 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT  709 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence            35678999999999999997653    46799999987654 45678999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccC
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~  930 (1052)
                      |||++|+|+.||+.+++ ++++.++..+.++||.||.||.+.   ++||||+.++||||+.+..+|++|||+++.+....
T Consensus       710 EyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~  785 (996)
T KOG0196|consen  710 EYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  785 (996)
T ss_pred             hhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence            99999999999999874 599999999999999999999999   99999999999999999999999999999875433


Q ss_pred             --cccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCccccc
Q 001566          931 --THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELF 1007 (1052)
Q Consensus       931 --~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1052)
                        .+......-+.+|.|||++..++++.+|||||||++|||.++ |.+||...        +-++.++.+..+-+.    
T Consensus       786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm--------SNQdVIkaIe~gyRL----  853 (996)
T KOG0196|consen  786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM--------SNQDVIKAIEQGYRL----  853 (996)
T ss_pred             CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc--------chHHHHHHHHhccCC----
Confidence              222233345679999999999999999999999999999888 99998732        333444444333222    


Q ss_pred             cchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1008 LPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1008 ~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                            ..|++++..+.+|+.+||++|-.+||.+.|++..|+++
T Consensus       854 ------PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl  891 (996)
T KOG0196|consen  854 ------PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL  891 (996)
T ss_pred             ------CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence                  34678888899999999999999999999999999875

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=347.17  Aligned_cols=243  Identities=28%  Similarity=0.410  Sum_probs=206.4

Q ss_pred             hhCCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCc---cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEE
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFL  848 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  848 (1052)
                      ..++|++.++||+|+||+||.++. ++++.+|+|++++..   ..+.+...+|..++.+++||+||+++-.|++.+.+|+
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            346799999999999999999955 468999999986543   3346778899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccc
Q 001566          849 VYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV  928 (1052)
Q Consensus       849 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~  928 (1052)
                      |+||+.||.|..++++.  ..++++.+.-++..|+.||.|||++   ||||||+||+|||+|++|.++|+|||+++.-- 
T Consensus       103 Vld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~-  176 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL-  176 (357)
T ss_pred             EEeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc-
Confidence            99999999999999876  4799999999999999999999999   99999999999999999999999999998543 


Q ss_pred             cCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCcccccc
Q 001566          929 SETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFL 1008 (1052)
Q Consensus       929 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                      .....+...+||+.|||||++.+..|+.++|.||+|+++|||++|.+||...        +...+.+.+.......    
T Consensus       177 ~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~--------~~~~~~~~I~~~k~~~----  244 (357)
T KOG0598|consen  177 KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE--------DVKKMYDKILKGKLPL----  244 (357)
T ss_pred             cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc--------cHHHHHHHHhcCcCCC----
Confidence            2334455579999999999999999999999999999999999999999843        3445555544433111    


Q ss_pred             chhhcCCChHHHHHHHHHHHHccccCCCCCC
Q 001566         1009 PELWEAGPQENLLGMMRLASTCTVETLSTRP 1039 (1052)
Q Consensus      1009 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RP 1039 (1052)
                            .+.-...+.++++.+.+..||++|.
T Consensus       245 ------~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  245 ------PPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             ------CCccCCHHHHHHHHHHhccCHHHhc
Confidence                  1122334588999999999999996

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=1.6e-44  Score=374.32  Aligned_cols=478  Identities=27%  Similarity=0.369  Sum_probs=322.2

Q ss_pred             cchhhcCCCCCCeeEecCCCceecCCCCccCCCCccEEEccCccccccCCccccCCCCCCeEecccccccccCCccccCC
Q 001566          115 LSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGN  194 (1052)
Q Consensus       115 l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  194 (1052)
                      +.+.+.+|..|++|++++|+++ +.|++++.+..++.|+.++|+++ .+|.+++.+.+|+.|+.++|.+. ++|++++.+
T Consensus        60 l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~  136 (565)
T KOG0472|consen   60 LREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRL  136 (565)
T ss_pred             ccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHH
Confidence            3455666777777777777776 66667777777777777777776 66777777777777777777776 666666666


Q ss_pred             CCCcEEEccCCcccCccccCCCcccCCCCEEEccCCcCCCCCCcccCCCCCCCEEEcCCCccccccchhhcCCCCCCEEE
Q 001566          195 GELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLD  274 (1052)
Q Consensus       195 ~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  274 (1052)
                      ..|+.++..+|+++. .| ..+.++.+|..|++.+|+++...|..+. ++.|++|+...|.++ .+|..++.+.+|+.|+
T Consensus       137 ~~l~dl~~~~N~i~s-lp-~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~Ly  212 (565)
T KOG0472|consen  137 LDLEDLDATNNQISS-LP-EDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLY  212 (565)
T ss_pred             hhhhhhhcccccccc-Cc-hHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHH
Confidence            677777777777664 22 3344556666666666666654443333 666666666666665 6666666666666666


Q ss_pred             ccCCCCCCCCCcccccCCCCCceecccccccccCCCCCCccccccCCCchhhhcccCCcEEecCCCCCCccCCcc-ccCC
Q 001566          275 VSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDN-WSES  353 (1052)
Q Consensus       275 L~~N~l~~~~p~~l~~l~~L~~L~L~~n~~~~~l~~~~~~~~~~~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~-~~~~  353 (1052)
                      |.+|++. ..| +|+.++.|+.|+++.                                      |++. .+|+. .+.+
T Consensus       213 L~~Nki~-~lP-ef~gcs~L~Elh~g~--------------------------------------N~i~-~lpae~~~~L  251 (565)
T KOG0472|consen  213 LRRNKIR-FLP-EFPGCSLLKELHVGE--------------------------------------NQIE-MLPAEHLKHL  251 (565)
T ss_pred             hhhcccc-cCC-CCCccHHHHHHHhcc--------------------------------------cHHH-hhHHHHhccc
Confidence            6666666 344 566666666666554                                      4443 23433 4477


Q ss_pred             CCccEEeCCCCcccccCCccccccCCCCEEeCCCCcCcCCCCCCCCCCCcceEecccCcccccCCCCCccccCcccCccc
Q 001566          354 CSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQD  433 (1052)
Q Consensus       354 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~  433 (1052)
                      .+|.+|||..|+++ ..|+.++.+++|++||+|+|.+++.++....+ .|+.|-+.+|.+..+-.+  .+++.+.--++.
T Consensus       252 ~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNPlrTiRr~--ii~~gT~~vLKy  327 (565)
T KOG0472|consen  252 NSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNPLRTIRRE--IISKGTQEVLKY  327 (565)
T ss_pred             ccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCcccccc-eeeehhhcCCchHHHHHH--HHcccHHHHHHH
Confidence            77888888888887 67888888888888888888887665544444 777788888877643111  111211111111


Q ss_pred             cccccccccccccccceeEEeeccCCccccccCccccccccccccc--chhHHhhccCCcccCCCCCccccccCCCcceE
Q 001566          434 LQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKY--KPHYRLLLNNNMFNGSVPGERISKCNDLQSFS  511 (1052)
Q Consensus       434 l~~~~~~~~~~~~~~~~l~~ldls~n~~~g~~p~~~~~~~~~~~~~--~~~~~l~l~~n~~~~~~p~~~~~~~~~l~~~~  511 (1052)
                      +.-.-  .-..++..       =++-.-.++.|..     .+.+.+  .....+.++.-+++ .+|++.|....+-....
T Consensus       328 Lrs~~--~~dglS~s-------e~~~e~~~t~~~~-----~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~  392 (565)
T KOG0472|consen  328 LRSKI--KDDGLSQS-------EGGTETAMTLPSE-----SFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTS  392 (565)
T ss_pred             HHHhh--ccCCCCCC-------cccccccCCCCCC-----cccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEE
Confidence            10000  00000000       0000011111111     111111  12344555555554 68888888776655668


Q ss_pred             EecCcccccCcchHHHHhcCcC-ccEEEccCcccccccccccCCCCCCCEEEccCCcCCCCCcccccCCccCcEEEcCCC
Q 001566          512 VNLSANLLSGMSYEAFLLDCVQ-LVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGN  590 (1052)
Q Consensus       512 l~l~~n~l~~~~~~~~~~~~~~-L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N  590 (1052)
                      +++++|++.++|...-  .++. ++.+.+++|.++ .+|..++.+++|..|+|++|-+. .+|..++.+..|+.|++|.|
T Consensus       393 VnfskNqL~elPk~L~--~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~N  468 (565)
T KOG0472|consen  393 VNFSKNQLCELPKRLV--ELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFN  468 (565)
T ss_pred             EecccchHhhhhhhhH--HHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheeccccc
Confidence            9999999999997643  2333 345666666666 89999999999999999999998 89999999999999999999


Q ss_pred             ccCCcCchhhcCCCCCcEEEcCCCCCCCCCchhhhcccccceeeccCccCCCCCCcccccccccCceeccccccc
Q 001566          591 NLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLS  665 (1052)
Q Consensus       591 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  665 (1052)
                      ++. .+|..+..+..|+.+-.++|++....|..+.+|.+|+.|||.+|.|. .+|..+++|++|++|+++||+|+
T Consensus       469 rFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  469 RFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             ccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence            998 89998888888888888889999766677999999999999999999 78999999999999999999998

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-40  Score=390.41  Aligned_cols=257  Identities=26%  Similarity=0.414  Sum_probs=217.2

Q ss_pred             hCCCccceeeeccCceEEEEEEecC--C----cEEEEEEeccC-ccccHHHHHHHHHHhhccCCCceeeEEEEEecCCee
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELVP--G----YLVAVKKLSIG-RFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEM  846 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~~--~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  846 (1052)
                      ....+..+.||+|+||+||+|...+  +    ..||||.++.. +.++..+|.+|..+|+.++|||||+++|+|.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            4566778899999999999996653  3    34899988665 445678999999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhhcc-----CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeec
Q 001566          847 FLVYNFLSGGNLETFIHKKS-----GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFG  921 (1052)
Q Consensus       847 ~lv~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfg  921 (1052)
                      ++++|||++|+|..|+++.+     ...++..+...++.|||+|+.||+++   ++|||||.++|+|+++...|||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence            99999999999999998863     35688999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCccccccc-ccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHH
Q 001566          922 LARLLEVSETHATTDV-AGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIK  999 (1052)
Q Consensus       922 la~~~~~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  999 (1052)
                      +|+.+...+++..... .-+.+|||||.+..+.++.|+|||||||++||++| |..||. ..       +-.+....+..
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~-~~-------~n~~v~~~~~~  919 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYP-SR-------SNFEVLLDVLE  919 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCC-Cc-------chHHHHHHHHh
Confidence            9997766666655544 45579999999999999999999999999999999 555554 22       22344444555


Q ss_pred             hCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1000 EGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1000 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                      +++.          +.|..++..+.++|..||+.+|++||++..+++.+.++
T Consensus       920 ggRL----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i  961 (1025)
T KOG1095|consen  920 GGRL----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI  961 (1025)
T ss_pred             CCcc----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence            5522          23667778899999999999999999999999987764

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-39  Score=343.18  Aligned_cols=267  Identities=30%  Similarity=0.497  Sum_probs=210.5

Q ss_pred             hCCCccceeeeccCceEEEEEEecCCcEEEEEEeccCccccHHHHHHHHHHhhc--cCCCceeeEEEEEecCC----eeE
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGR--IRHKNLVTLIGYYVGEA----EMF  847 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~----~~~  847 (1052)
                      ....++.+++|+|+||.||+|.+. ++.||||++...+   .+.|.+|-.+++.  ++|+||++|+++-...+    +++
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhcc-CceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            345667789999999999999887 6899999997443   4566666666655  58999999999877655    899


Q ss_pred             EEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcC------CCCeeeCCCCCCCEEECCCCcEEEeeec
Q 001566          848 LVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC------VPRIVHRDIKPSNILLDEELNAYLSDFG  921 (1052)
Q Consensus       848 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------~~~iiHrDik~~Nill~~~~~~kl~Dfg  921 (1052)
                      +|+||.+.|+|.+||..+   .++|....+|+..+++||+|||+..      .|+|+|||||++||||.+|+++.|+|||
T Consensus       285 LVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG  361 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG  361 (534)
T ss_pred             EEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence            999999999999999886   5999999999999999999999764      3789999999999999999999999999


Q ss_pred             ccccccccCc-ccccccccccccccccccCCCCC-C-----cchhHHHHHHHHHHHHhCCCCCCC--------Ccc-cCC
Q 001566          922 LARLLEVSET-HATTDVAGTFGYVAPEYATTCRV-S-----DKADVYSFGVVLLELISGKRSLDP--------SFS-EYG  985 (1052)
Q Consensus       922 la~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~-~-----~~sDvwslG~il~elltg~~p~~~--------~~~-~~~  985 (1052)
                      +|..+.+... ......+||.+|||||++.+... .     .+.||||+|.++|||+++...+++        .++ +-+
T Consensus       362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG  441 (534)
T KOG3653|consen  362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG  441 (534)
T ss_pred             eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence            9998875543 33445789999999999987432 2     368999999999999998755542        111 223


Q ss_pred             CCccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566          986 NGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus       986 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                      ....+.++...+.++.....  .++.|...  ..+..+.+.+.+||..||+.|.|+.=+-+.+.++
T Consensus       442 ~hPt~e~mq~~VV~kK~RP~--~p~~W~~h--~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l  503 (534)
T KOG3653|consen  442 NHPTLEEMQELVVRKKQRPK--IPDAWRKH--AGMAVLCETIEECWDHDAEARLTAGCVEERMAEL  503 (534)
T ss_pred             CCCCHHHHHHHHHhhccCCC--ChhhhhcC--ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHH
Confidence            34445555555555544332  34445443  4466799999999999999999988877777654

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=6.4e-40  Score=329.15  Aligned_cols=262  Identities=24%  Similarity=0.342  Sum_probs=204.1

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCccc--cHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEe
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQ--GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYN  851 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  851 (1052)
                      +.|+...++|+|+||+||+++.+ +|+.||||++......  -.+-.++|++++++++|||+|.++++|......++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            46888899999999999999776 5999999999655432  23456899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCc
Q 001566          852 FLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET  931 (1052)
Q Consensus       852 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~  931 (1052)
                      |++. ++.+-++... ..++.+.+.+++.|++.|+.|+|++   +||||||||+||+++.++.+|+||||+|+.+.. ..
T Consensus        82 ~~dh-TvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pg  155 (396)
T KOG0593|consen   82 YCDH-TVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PG  155 (396)
T ss_pred             ecch-HHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-Cc
Confidence            9965 6666666665 5789999999999999999999999   999999999999999999999999999998863 23


Q ss_pred             ccccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHH----------HHHh
Q 001566          932 HATTDVAGTFGYVAPEYATT-CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKL----------LIKE 1000 (1052)
Q Consensus       932 ~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~----------~~~~ 1000 (1052)
                      ...+.++.|..|.|||.+.+ ..|+..+||||+||++.||++|.+.|.+.    .+..++....+.          ++..
T Consensus       156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~----SDiDQLy~I~ktLG~L~prhq~iF~~  231 (396)
T KOG0593|consen  156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGR----SDIDQLYLIRKTLGNLIPRHQSIFSS  231 (396)
T ss_pred             chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCc----chHHHHHHHHHHHcccCHHHHHHhcc
Confidence            34456788999999999988 67999999999999999999999777532    112222222211          1111


Q ss_pred             C-CccccccchhhcCCC-----hHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1001 G-RSSELFLPELWEAGP-----QENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1001 ~-~~~~~~~~~l~~~~~-----~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      + .....-.|......+     +.....+.++++.|++.||++|++-+|++.
T Consensus       232 N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  232 NPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             CCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            1 111111111111111     233446889999999999999999998864

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=7.2e-39  Score=316.80  Aligned_cols=260  Identities=25%  Similarity=0.365  Sum_probs=211.4

Q ss_pred             CCCccceeeeccCceEEEEE-EecCCcEEEEEEeccCcccc--HHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEe
Q 001566          775 GNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQG--IQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYN  851 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  851 (1052)
                      .+|...+++|+|.||.||+| +..+|+.||||+++..+..+  .....+|++.++.++|+||+.++++|...+.+.+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            46888899999999999999 56689999999998775543  3457899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCc
Q 001566          852 FLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET  931 (1052)
Q Consensus       852 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~  931 (1052)
                      ||+ .+|...++... ..++..++.+++.++++|++|+|++   .|+||||||.|+|++++|.+||+|||+|+.+.....
T Consensus        82 fm~-tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~  156 (318)
T KOG0659|consen   82 FMP-TDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR  156 (318)
T ss_pred             ecc-ccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence            995 69999998764 7899999999999999999999999   999999999999999999999999999998875444


Q ss_pred             ccccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccch
Q 001566          932 HATTDVAGTFGYVAPEYATT-CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010 (1052)
Q Consensus       932 ~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1052)
                      .... .+.|..|.|||.+.| +.|+...||||.|||+.||+.|.+-|.+       ..++.+.......-|...+...|+
T Consensus       157 ~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG-------~sDidQL~~If~~LGTP~~~~WP~  228 (318)
T KOG0659|consen  157 IQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPG-------DSDIDQLSKIFRALGTPTPDQWPE  228 (318)
T ss_pred             cccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCC-------CchHHHHHHHHHHcCCCCcccCcc
Confidence            3333 367899999999887 5589999999999999999988765542       223333334444444444444443


Q ss_pred             hhc--------CCC--------hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001566         1011 LWE--------AGP--------QENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus      1011 l~~--------~~~--------~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                      +..        ..|        +.+.....+++..|+..+|.+|+++.|++++
T Consensus       229 ~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  229 MTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             ccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            211        011        2344567999999999999999999999864

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-39  Score=344.90  Aligned_cols=253  Identities=32%  Similarity=0.515  Sum_probs=206.2

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCC--eeEEEEe
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEA--EMFLVYN  851 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e  851 (1052)
                      .+|...+.||+|+||.||++... +|+..|||.+...+....+.+.+|+.++++++|||||+.+|......  .+++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            45788899999999999999665 48999999987664444677899999999999999999999854444  6899999


Q ss_pred             ecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-CCcEEEeeecccccccc--
Q 001566          852 FLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDE-ELNAYLSDFGLARLLEV--  928 (1052)
Q Consensus       852 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~-~~~~kl~Dfgla~~~~~--  928 (1052)
                      |+++|+|.+++....+ .++++.+..++.||++|++|||++   |||||||||+|||++. ++.+||+|||.++....  
T Consensus        97 y~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             ccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            9999999999998876 899999999999999999999999   9999999999999999 79999999999987663  


Q ss_pred             cCcccccccccccccccccccCCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccc
Q 001566          929 SETHATTDVAGTFGYVAPEYATTCR-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELF 1007 (1052)
Q Consensus       929 ~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1052)
                      ..........||+.|||||++..+. ...++||||+||++.||+||++||...       ....+   .....+...  .
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-------~~~~~---~~~~ig~~~--~  240 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-------FEEAE---ALLLIGRED--S  240 (313)
T ss_pred             ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-------cchHH---HHHHHhccC--C
Confidence            2223345678999999999999633 345999999999999999999999742       11122   222222211  1


Q ss_pred             cchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001566         1008 LPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus      1008 ~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                      .|    ..|...+....+++.+|+..||++||||.++++.
T Consensus       241 ~P----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h  276 (313)
T KOG0198|consen  241 LP----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH  276 (313)
T ss_pred             CC----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence            12    2344455568999999999999999999999864

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-39  Score=361.37  Aligned_cols=256  Identities=27%  Similarity=0.394  Sum_probs=212.5

Q ss_pred             hhCCCccceeeeccCceEEEEEEecCC-----cEEEEEEeccC---ccccHHHHHHHHHHhhccCCCceeeEEEEEecCC
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAELVPG-----YLVAVKKLSIG---RFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEA  844 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~~~~~-----~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  844 (1052)
                      ..++..+.++||+|+||+||+|.+..+     ..||||..+..   ......+|.+|+++|+.++|||||+++|++..+.
T Consensus       155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~  234 (474)
T KOG0194|consen  155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE  234 (474)
T ss_pred             eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence            344566679999999999999966532     23899988752   2445788999999999999999999999999999


Q ss_pred             eeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccc
Q 001566          845 EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR  924 (1052)
Q Consensus       845 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~  924 (1052)
                      ++++|||+|.||+|.+||++.. ..++..+...++.++|+||+|||++   ++|||||.++|+|++.++.+||+|||+++
T Consensus       235 Pl~ivmEl~~gGsL~~~L~k~~-~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~  310 (474)
T KOG0194|consen  235 PLMLVMELCNGGSLDDYLKKNK-KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSR  310 (474)
T ss_pred             ccEEEEEecCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCcccccc
Confidence            9999999999999999999876 3699999999999999999999999   99999999999999999999999999987


Q ss_pred             cccccCccccc-ccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCC
Q 001566          925 LLEVSETHATT-DVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGR 1002 (1052)
Q Consensus       925 ~~~~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1052)
                      .-.  .+.... ...-+.+|+|||.+....|+.++|||||||++||+++ |..||.+.        ...+....+...+.
T Consensus       311 ~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~--------~~~~v~~kI~~~~~  380 (474)
T KOG0194|consen  311 AGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGM--------KNYEVKAKIVKNGY  380 (474)
T ss_pred             CCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCC--------CHHHHHHHHHhcCc
Confidence            543  111111 2245689999999999999999999999999999999 78888743        33344444445554


Q ss_pred             ccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1003 SSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1003 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                      ...         .+...+..+..++.+||..+|++||+|.++.+.++.+
T Consensus       381 r~~---------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~  420 (474)
T KOG0194|consen  381 RMP---------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEAL  420 (474)
T ss_pred             cCC---------CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHH
Confidence            442         2335566788999999999999999999999998865

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-39  Score=347.17  Aligned_cols=251  Identities=25%  Similarity=0.408  Sum_probs=209.5

Q ss_pred             HhhCCCccceeeeccCceEEEEE-EecCCcEEEEEEeccC---ccccHHHHHHHHHHhhcc-CCCceeeEEEEEecCCee
Q 001566          772 RATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIG---RFQGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEAEM  846 (1052)
Q Consensus       772 ~~~~~~~~~~~Lg~G~~g~V~~~-~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  846 (1052)
                      +...+|.+++.||+|+|++|++| +..+++.||||++.+.   +....+.+..|-..|.++ .||.|++++..|+++..+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            34567999999999999999999 4457999999988543   223345677899999999 899999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccc
Q 001566          847 FLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL  926 (1052)
Q Consensus       847 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~  926 (1052)
                      |+|+||+++|+|.+++++.  ..+++.....++.+|+.|++|||++   |||||||||+|||+|+++.++|+|||.|+.+
T Consensus       150 YFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l  224 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKIL  224 (604)
T ss_pred             EEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccC
Confidence            9999999999999999987  5799999999999999999999999   9999999999999999999999999999988


Q ss_pred             cccCcc---------c---ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHH
Q 001566          927 EVSETH---------A---TTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWA  994 (1052)
Q Consensus       927 ~~~~~~---------~---~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  994 (1052)
                      ++....         .   ....+||..|.+||++.+...++.+|+|+||||+|+|+.|.+||....+.       ....
T Consensus       225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney-------liFq  297 (604)
T KOG0592|consen  225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY-------LIFQ  297 (604)
T ss_pred             ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH-------HHHH
Confidence            643211         1   13478999999999999999999999999999999999999999843322       2222


Q ss_pred             HHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566          995 KLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus       995 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      +.+..+-            ..++..+..+.+|+++.+..||.+|+|+.+|.+
T Consensus       298 kI~~l~y------------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  298 KIQALDY------------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             HHHHhcc------------cCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence            2221111            123334456889999999999999999988865

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-39  Score=353.21  Aligned_cols=249  Identities=26%  Similarity=0.434  Sum_probs=213.8

Q ss_pred             CCCccceeeeccCceEEEEE-EecCCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeec
Q 001566          775 GNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFL  853 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  853 (1052)
                      ..|...+.||+|+.|.||.| +..+++.||||++........+-+.+|+.+|+..+|+|||++++.|...+..++|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            35777789999999999999 55678999999998777666677899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccc
Q 001566          854 SGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA  933 (1052)
Q Consensus       854 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  933 (1052)
                      +||+|.|.+....   +++.++..|+.++++||+|||.+   ||+|||||.+|||++.+|.+||+|||++..+..... .
T Consensus       353 ~ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-K  425 (550)
T KOG0578|consen  353 EGGSLTDVVTKTR---MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-K  425 (550)
T ss_pred             CCCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC-c
Confidence            9999999998754   99999999999999999999999   999999999999999999999999999998764443 4


Q ss_pred             ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhc
Q 001566          934 TTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWE 1013 (1052)
Q Consensus       934 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1013 (1052)
                      ....+|||.|||||++....|+++.||||||++++||+-|.+||-.+.+-       .  +...+......+.       
T Consensus       426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl-------r--AlyLIa~ng~P~l-------  489 (550)
T KOG0578|consen  426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-------R--ALYLIATNGTPKL-------  489 (550)
T ss_pred             cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH-------H--HHHHHhhcCCCCc-------
Confidence            56678999999999999999999999999999999999999999743322       1  2223333332222       


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1014 AGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1014 ~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ..+......+.+++.+|+..||++||++.|+++
T Consensus       490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            123344556999999999999999999999986

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-39  Score=347.40  Aligned_cols=263  Identities=24%  Similarity=0.366  Sum_probs=219.5

Q ss_pred             hCCCccceeeeccCceEEEEEEecCCcEEEEEEeccCcccc-HHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQG-IQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      .....+.++||+|.||+|..++...+..||||+++...... ..+|.+|+++|.+++||||++++|+|..++.+++|+||
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            44567889999999999999999888999999998765544 48899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      |++|+|.+|+.++......-....+|+.||+.|++||.+.   ++||||+.++|+|++.++++||+|||+++.+...+++
T Consensus       617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy  693 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY  693 (807)
T ss_pred             HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCce
Confidence            9999999999988655556677788999999999999999   9999999999999999999999999999977666655


Q ss_pred             ccc-ccccccccccccccCCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccc
Q 001566          933 ATT-DVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS--GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009 (1052)
Q Consensus       933 ~~~-~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                      ..+ ..+-+.+|||||.+.-++++.++|||+||+++||+++  ...||.....     .+.++-.......+...     
T Consensus       694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~-----e~vven~~~~~~~~~~~-----  763 (807)
T KOG1094|consen  694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD-----EQVVENAGEFFRDQGRQ-----  763 (807)
T ss_pred             eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH-----HHHHHhhhhhcCCCCcc-----
Confidence            443 4566789999999999999999999999999999877  5667753221     12333333333222211     


Q ss_pred             hhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 001566         1010 ELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQ 1050 (1052)
Q Consensus      1010 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~ 1050 (1052)
                       .....|.-++.++.+++.+||..|-++||+++++...|.+
T Consensus       764 -~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~  803 (807)
T KOG1094|consen  764 -VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE  803 (807)
T ss_pred             -eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence             2223467778889999999999999999999999888765

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-39  Score=345.20  Aligned_cols=260  Identities=25%  Similarity=0.345  Sum_probs=209.0

Q ss_pred             hhCCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCccccHHH--HHHHHHHhhccC-CCceeeEEEEEecCC-eeE
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQ--FDAEIGTLGRIR-HKNLVTLIGYYVGEA-EMF  847 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~  847 (1052)
                      ..++|.+.++||.|.||+||+|+. .+|..||||+++..-.. +++  -.+|++.++++. |||||++.+++.+.+ .+|
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            346899999999999999999954 56899999998755333 333  368999999998 999999999999888 999


Q ss_pred             EEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccccc
Q 001566          848 LVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE  927 (1052)
Q Consensus       848 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~  927 (1052)
                      +||||| ..+|++.++.+ ++.++++++..|+.||++||+|+|++   |+.|||+||+|||+.....+||+|||+|+...
T Consensus        87 fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   87 FVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             eeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccc
Confidence            999999 67999999988 68999999999999999999999999   99999999999999988899999999999776


Q ss_pred             ccCcccccccccccccccccccC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCcccc
Q 001566          928 VSETHATTDVAGTFGYVAPEYAT-TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSEL 1006 (1052)
Q Consensus       928 ~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      ....  .+.++.|..|.|||++. ..-|+.+.||||+|||++|+.+-++.|.+..       ...+..+...--|.....
T Consensus       162 SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s-------E~Dqi~KIc~VLGtP~~~  232 (538)
T KOG0661|consen  162 SKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS-------EIDQIYKICEVLGTPDKD  232 (538)
T ss_pred             cCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc-------HHHHHHHHHHHhCCCccc
Confidence            4433  34568899999999875 5678899999999999999999998876432       222333333333333222


Q ss_pred             ccch-------h---hcCC--------ChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001566         1007 FLPE-------L---WEAG--------PQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus      1007 ~~~~-------l---~~~~--------~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                      -++.       +   +...        -+.+..+..+++.+|+++||++||||.|+++.
T Consensus       233 ~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  233 SWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             cchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            2211       0   0000        12356678999999999999999999999863

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-38  Score=341.65  Aligned_cols=259  Identities=27%  Similarity=0.375  Sum_probs=208.6

Q ss_pred             CCCccceeeeccCceEEEEE-EecCCcEEEEEEeccCccc--cHHHHHHHHHHhhccCCCceeeEEEEEecC--CeeEEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQQFDAEIGTLGRIRHKNLVTLIGYYVGE--AEMFLV  849 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv  849 (1052)
                      +.|+..++||+|.||.||+| +..+|+.||+|++.....+  ......+|+.+|+++.||||+++.+...+.  ..+|+|
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            35778899999999999999 5567999999999776533  345567899999999999999999998876  689999


Q ss_pred             EeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccccccc
Q 001566          850 YNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS  929 (1052)
Q Consensus       850 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~  929 (1052)
                      +|||++ +|.-++... +-.+++.++..+++|+++|++|+|++   ||+|||||..|||+|.+|.+||+|||+|+.+...
T Consensus       197 FeYMdh-DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             Eecccc-hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            999954 888888764 36799999999999999999999999   9999999999999999999999999999988877


Q ss_pred             CcccccccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHh-CCccccc
Q 001566          930 ETHATTDVAGTFGYVAPEYATTC-RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE-GRSSELF 1007 (1052)
Q Consensus       930 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 1007 (1052)
                      .....+..+.|..|.|||.+.|. .|+.+.|+||.|||+.||++|++.|.+..+        ++-...+++. |...+.+
T Consensus       272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE--------veQl~kIfklcGSP~e~~  343 (560)
T KOG0600|consen  272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE--------VEQLHKIFKLCGSPTEDY  343 (560)
T ss_pred             CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH--------HHHHHHHHHHhCCCChhc
Confidence            76667788899999999998874 689999999999999999999998874322        1112222221 2222222


Q ss_pred             cc--hhh--------cCCC-------hHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1008 LP--ELW--------EAGP-------QENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1008 ~~--~l~--------~~~~-------~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      .+  ++.        ..+.       ...+....+|+..+++.||++|.||.++++
T Consensus       344 W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  344 WPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             cccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            22  110        0011       122345789999999999999999999875

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-38  Score=332.74  Aligned_cols=261  Identities=26%  Similarity=0.395  Sum_probs=210.1

Q ss_pred             hCCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCcccc-HHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEe
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQG-IQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYN  851 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  851 (1052)
                      .+.|++...||.|..++||+|.. ..++.||||++...+... .+.+.+|++.|+.++||||++++..|..+...|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            35799999999999999999965 458999999997665443 5788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCc
Q 001566          852 FLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET  931 (1052)
Q Consensus       852 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~  931 (1052)
                      ||.+||+.+.++..-...+++..+..|.+++++||.|||.+   |.||||||+.|||++++|.|||+|||.+..+.....
T Consensus       105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~  181 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD  181 (516)
T ss_pred             hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence            99999999999988778899999999999999999999999   999999999999999999999999998776644332


Q ss_pred             c---cccccccccccccccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCcccc
Q 001566          932 H---ATTDVAGTFGYVAPEYATT--CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSEL 1006 (1052)
Q Consensus       932 ~---~~~~~~g~~~y~aPE~~~~--~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      .   .....+|++.|||||++..  ..|+.|+||||||++..|+.+|..||....+-        .+.... -.+.....
T Consensus       182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm--------kvLl~t-Lqn~pp~~  252 (516)
T KOG0582|consen  182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM--------KVLLLT-LQNDPPTL  252 (516)
T ss_pred             eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH--------HHHHHH-hcCCCCCc
Confidence            1   1145689999999999543  56889999999999999999999999732211        111111 12222211


Q ss_pred             ccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1007 FLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1007 ~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ....+..+........+.+++..|+..||++|||++++++
T Consensus       253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            1111111112233346899999999999999999999875

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-39  Score=352.05  Aligned_cols=263  Identities=29%  Similarity=0.445  Sum_probs=211.6

Q ss_pred             hhHHHhhCCCccceeeeccCceEEEEEEecCCcEEEEEEeccCcc--ccHHHHHHHHHHhhccCCCceeeEEEEEecCCe
Q 001566          768 DNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAE  845 (1052)
Q Consensus       768 ~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  845 (1052)
                      +++....+++.+...||+|.||+||+|.|. | .||||++.....  +..+.|+.|+.++++-+|.||+-|+|+|..+..
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            344555567788899999999999999986 3 599999976543  346789999999999999999999999997766


Q ss_pred             eEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccc
Q 001566          846 MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARL  925 (1052)
Q Consensus       846 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~  925 (1052)
                       .+|+.+|+|.+|+.+++..+ ..++..+...||.||++||.|||.+   +|||||+|+.||++.+++.|||+|||++..
T Consensus       463 -AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatv  537 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATV  537 (678)
T ss_pred             -eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceee
Confidence             99999999999999998765 6789999999999999999999999   999999999999999999999999999975


Q ss_pred             cccc-CcccccccccccccccccccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhC
Q 001566          926 LEVS-ETHATTDVAGTFGYVAPEYATT---CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEG 1001 (1052)
Q Consensus       926 ~~~~-~~~~~~~~~g~~~y~aPE~~~~---~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1052)
                      ...- .........|..-|||||+++.   .+|+.++||||||+++|||+||..||.....+           +.++.-|
T Consensus       538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d-----------qIifmVG  606 (678)
T KOG0193|consen  538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD-----------QIIFMVG  606 (678)
T ss_pred             eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh-----------heEEEec
Confidence            4321 1122233457788999999975   45889999999999999999999999722211           1122222


Q ss_pred             CccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1002 RSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1002 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                      +..-..|..   .....++.++.+|+..||..++++||.+.+++..|+.+
T Consensus       607 rG~l~pd~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l  653 (678)
T KOG0193|consen  607 RGYLMPDLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEEL  653 (678)
T ss_pred             ccccCccch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHh
Confidence            221111111   12245566799999999999999999999999988765

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-38  Score=332.74  Aligned_cols=264  Identities=25%  Similarity=0.392  Sum_probs=203.5

Q ss_pred             hCCCccceeeeccCceEEEEEEecCCcEEEEEEeccCccccHHHHHHHHHHh--hccCCCceeeEEEEEecC----CeeE
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTL--GRIRHKNLVTLIGYYVGE----AEMF  847 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l--~~l~h~niv~l~~~~~~~----~~~~  847 (1052)
                      ..+..+.+.||+|.||+||+|+|+ |+.||||++...++.   .+.+|.+++  ..++|+||+.|++.-..+    ++++
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE~---SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw  285 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDER---SWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW  285 (513)
T ss_pred             hheeEEEEEecCccccceeecccc-CCceEEEEecccchh---hhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence            356888999999999999999998 899999999865544   334444444  456999999999987644    4689


Q ss_pred             EEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhc-----CCCCeeeCCCCCCCEEECCCCcEEEeeecc
Q 001566          848 LVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS-----CVPRIVHRDIKPSNILLDEELNAYLSDFGL  922 (1052)
Q Consensus       848 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~iiHrDik~~Nill~~~~~~kl~Dfgl  922 (1052)
                      +|++|.+.|||.|||.+.   .++.+...+++..+|.||++||..     ..|.|+|||||++||||+.++++.|+|+|+
T Consensus       286 LvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL  362 (513)
T KOG2052|consen  286 LVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  362 (513)
T ss_pred             EeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence            999999999999999875   599999999999999999999965     348899999999999999999999999999


Q ss_pred             cccccccC---cccccccccccccccccccCCCC----C--CcchhHHHHHHHHHHHHhC----------CCCCCCCccc
Q 001566          923 ARLLEVSE---THATTDVAGTFGYVAPEYATTCR----V--SDKADVYSFGVVLLELISG----------KRSLDPSFSE  983 (1052)
Q Consensus       923 a~~~~~~~---~~~~~~~~g~~~y~aPE~~~~~~----~--~~~sDvwslG~il~elltg----------~~p~~~~~~~  983 (1052)
                      |.......   .......+||.+|||||++....    +  -..+||||||.++||++.+          +.||++--+.
T Consensus       363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~  442 (513)
T KOG2052|consen  363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS  442 (513)
T ss_pred             eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence            98765432   12344578999999999987532    1  2368999999999999874          3666644333


Q ss_pred             CCCCccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566          984 YGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus       984 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                         +.+..++.+-+. ..+.... .|..|.  +..+...+.++|++||..+|..|.|+-.+.+.|.++
T Consensus       443 ---DPs~eeMrkVVC-v~~~RP~-ipnrW~--s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l  503 (513)
T KOG2052|consen  443 ---DPSFEEMRKVVC-VQKLRPN-IPNRWK--SDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL  503 (513)
T ss_pred             ---CCCHHHHhccee-ecccCCC-CCcccc--cCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence               222233222222 2222211 223333  346678899999999999999999999888888765

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-39  Score=347.39  Aligned_cols=242  Identities=29%  Similarity=0.446  Sum_probs=204.8

Q ss_pred             CccceeeeccCceEEEEEEecCCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecCCC
Q 001566          777 FSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGG  856 (1052)
Q Consensus       777 ~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  856 (1052)
                      ..-.+.||.|+.|.||.|++. ++.||||+++       +.-+.+++-|++++||||+.|.|+|.....+|+|||||..|
T Consensus       126 IsELeWlGSGaQGAVF~Grl~-netVAVKKV~-------elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G  197 (904)
T KOG4721|consen  126 ISELEWLGSGAQGAVFLGRLH-NETVAVKKVR-------ELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG  197 (904)
T ss_pred             hhhhhhhccCcccceeeeecc-CceehhHHHh-------hhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence            334578999999999999987 7889999875       22356899999999999999999999999999999999999


Q ss_pred             CHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcccccc
Q 001566          857 NLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD  936 (1052)
Q Consensus       857 sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~  936 (1052)
                      -|+..|+..  ..++....+.|.++||.||.|||.+   .|||||+|+-||||+.+..|||+|||.++.....  ...-.
T Consensus       198 qL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMS  270 (904)
T KOG4721|consen  198 QLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMS  270 (904)
T ss_pred             cHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhh
Confidence            999999875  5789999999999999999999999   9999999999999999999999999999876532  33345


Q ss_pred             cccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCCC
Q 001566          937 VAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGP 1016 (1052)
Q Consensus       937 ~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 1016 (1052)
                      +.||..|||||+++..+.+.|+|||||||++|||+||..||..-...             .+.-|-...    .+.-..|
T Consensus       271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss-------------AIIwGVGsN----sL~LpvP  333 (904)
T KOG4721|consen  271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS-------------AIIWGVGSN----SLHLPVP  333 (904)
T ss_pred             hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh-------------eeEEeccCC----cccccCc
Confidence            78999999999999999999999999999999999999998732211             111111111    1122346


Q ss_pred             hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 001566         1017 QENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQ 1050 (1052)
Q Consensus      1017 ~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~ 1050 (1052)
                      ..++..+.-|++.||+-.|..||++++++..++-
T Consensus       334 stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  334 STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence            6777889999999999999999999999988763

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-40  Score=354.51  Aligned_cols=402  Identities=22%  Similarity=0.213  Sum_probs=274.8

Q ss_pred             CCCCCCCCCceEeecCCCceEEEEEccCCCCCCCCCcccccccchhhcCCCCCCeeEecCCCceecCCCCccCCCCccEE
Q 001566           73 SSTDHCTWHGVTCDHFTGRVTALRITGKATPWPSKSSVISGTLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVL  152 (1052)
Q Consensus        73 ~~~~~C~w~gV~C~~~~~~v~~l~l~~~~~~~~~~~~~l~g~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L  152 (1052)
                      +.++.|.=.-..|+..  +.-+++-           ..+.|.+|+      +-+.||+++|.++..-+..|.++++|+.+
T Consensus        47 pa~c~c~~~lldcs~~--~lea~~~-----------~~l~g~lp~------~t~~LdlsnNkl~~id~~~f~nl~nLq~v  107 (873)
T KOG4194|consen   47 PATCPCNTRLLDCSDR--ELEAIDK-----------SRLKGFLPS------QTQTLDLSNNKLSHIDFEFFYNLPNLQEV  107 (873)
T ss_pred             CCcCCCCceeeecCcc--ccccccc-----------cccCCcCcc------ceeeeeccccccccCcHHHHhcCCcceee
Confidence            4445566555677642  2222211           235565653      45679999999998888889999999999


Q ss_pred             EccCccccccCCccccCCCCCCeEecccccccccCCccccCCCCCcEEEccCCcccCccccCCCcccCCCCEEEccCCcC
Q 001566          153 ELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFL  232 (1052)
Q Consensus       153 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l  232 (1052)
                      ++..|.++ .||...+...+|+.|+|.+|.|+..-...+..++.|+.||||.|.|+. ++...|..-.++++|+|++|.|
T Consensus       108 ~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~-i~~~sfp~~~ni~~L~La~N~I  185 (873)
T KOG4194|consen  108 NLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISE-IPKPSFPAKVNIKKLNLASNRI  185 (873)
T ss_pred             eeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhc-ccCCCCCCCCCceEEeeccccc
Confidence            99999999 889888888889999999999997777888888999999999999885 7777777777888888888888


Q ss_pred             CCCCCcccCCCCCCCEEEcCCCccccccchhhcCCCCCCEEEccCCCCCCCCCcccccCCCCCceecccccccccCCCCC
Q 001566          233 TESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSR  312 (1052)
Q Consensus       233 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~~~~~l~~~~  312 (1052)
                      +..--..|.++.+|..|.|+.|+++...+..|.++++|+.|+|..|+|.-.--..|.+|.+|+.|.|..           
T Consensus       186 t~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqr-----------  254 (873)
T KOG4194|consen  186 TTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQR-----------  254 (873)
T ss_pred             cccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhh-----------
Confidence            877777888888888888888888876777788888888888888888743344555665555555544           


Q ss_pred             CccccccCCCchhhhcccCCcEEecCCCCCCccCCccccCCCCccEEeCCCCcccccCCccccccCCCCEEeCCCCcCcC
Q 001566          313 GEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEG  392 (1052)
Q Consensus       313 ~~~~~~~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  392 (1052)
                                                 |++...-...|..+.++++|+|+.|+++..--.++-++++|+.||||+|.|..
T Consensus       255 ---------------------------N~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~r  307 (873)
T KOG4194|consen  255 ---------------------------NDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQR  307 (873)
T ss_pred             ---------------------------cCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhhe
Confidence                                       33333334456666666666666666665555666666666666666666653


Q ss_pred             CCCCCCCCCCcceEecccCcccccCCCCCccccCcccCccccccccccccccccccceeEEeeccCCccccccCcccccc
Q 001566          393 YLPMQLPVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGD  472 (1052)
Q Consensus       393 ~~p~~~~~~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~ldls~n~~~g~~p~~~~~~  472 (1052)
                      .-+..+                                                                          
T Consensus       308 ih~d~W--------------------------------------------------------------------------  313 (873)
T KOG4194|consen  308 IHIDSW--------------------------------------------------------------------------  313 (873)
T ss_pred             eecchh--------------------------------------------------------------------------
Confidence            322222                                                                          


Q ss_pred             cccccccchhHHhhccCCcccCCCCCccccccCCCcceEEecCcccccCcchHHHHhcCcCccEEEccCccccccccccc
Q 001566          473 GFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGV  552 (1052)
Q Consensus       473 ~~~~~~~~~~~~l~l~~n~~~~~~p~~~~~~~~~l~~~~l~l~~n~l~~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~  552 (1052)
                                                                              ..+++|++|+|++|+|+...+..|
T Consensus       314 --------------------------------------------------------sftqkL~~LdLs~N~i~~l~~~sf  337 (873)
T KOG4194|consen  314 --------------------------------------------------------SFTQKLKELDLSSNRITRLDEGSF  337 (873)
T ss_pred             --------------------------------------------------------hhcccceeEeccccccccCChhHH
Confidence                                                                    123455555555555555555555


Q ss_pred             CCCCCCCEEEccCCcCCCCCcccccCCccCcEEEcCCCccCCcCc---hhhcCCCCCcEEEcCCCCCCCCCchhhhcccc
Q 001566          553 GKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIP---SQFGHLISLVVLDLSHNALTGSIPASLTKATK  629 (1052)
Q Consensus       553 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~  629 (1052)
                      ..+..|++|+|+.|+|+..-...|.++++|+.|||++|.|+..+.   ..|.+|++|+.|+|.+|+|..+...+|.++.+
T Consensus       338 ~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~  417 (873)
T KOG4194|consen  338 RVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEA  417 (873)
T ss_pred             HHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcc
Confidence            666666666666666665555566666666666666666654433   23566666666666666666444456666666


Q ss_pred             cceeeccCccCCCCCCcccccccccCceecccccc
Q 001566          630 LESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNL  664 (1052)
Q Consensus       630 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l  664 (1052)
                      |+.|||.+|.|..+.|.+|..+ .|+.|-+..-.+
T Consensus       418 LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssf  451 (873)
T KOG4194|consen  418 LEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSF  451 (873)
T ss_pred             cceecCCCCcceeecccccccc-hhhhhhhcccce
Confidence            6666666666666666666666 666666554433

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-38  Score=344.26  Aligned_cols=263  Identities=25%  Similarity=0.425  Sum_probs=226.2

Q ss_pred             hhhHHHhhCCCccceeeeccCceEEEEEEecC-CcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCe
Q 001566          767 YDNVVRATGNFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAE  845 (1052)
Q Consensus       767 ~~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  845 (1052)
                      +++++-...+..+..+||-|.||+||.|.|+. .-.||||.++... -..++|..|+.+|+.++|||+|+++|+|..+..
T Consensus       259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP  337 (1157)
T KOG4278|consen  259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP  337 (1157)
T ss_pred             cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence            35566666678888999999999999998864 5679999987544 457899999999999999999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccc
Q 001566          846 MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARL  925 (1052)
Q Consensus       846 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~  925 (1052)
                      +|+|+|||..|+|.+||++.....++.-..+.+|.||..||+||..+   ++||||+.++|+||.++-.|||+|||+++.
T Consensus       338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRl  414 (1157)
T KOG4278|consen  338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRL  414 (1157)
T ss_pred             eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhh
Confidence            99999999999999999998777888888999999999999999999   999999999999999999999999999998


Q ss_pred             ccccCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCcc
Q 001566          926 LEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSS 1004 (1052)
Q Consensus       926 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1052)
                      +....+.......-++.|.|||.+....++.|+|||+|||++||+.| |..||.        +.++.+... +...+.  
T Consensus       415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYP--------GidlSqVY~-LLEkgy--  483 (1157)
T KOG4278|consen  415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYP--------GIDLSQVYG-LLEKGY--  483 (1157)
T ss_pred             hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCC--------CccHHHHHH-HHhccc--
Confidence            87666666666667789999999999999999999999999999999 777765        233333322 323332  


Q ss_pred             ccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1005 ELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1005 ~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                             .-+.|..|+..+.+||+.||++.|.+||+++|+-+.|+.|
T Consensus       484 -------RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm  523 (1157)
T KOG4278|consen  484 -------RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM  523 (1157)
T ss_pred             -------cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence                   2244677888899999999999999999999999998865

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-37  Score=312.15  Aligned_cols=237  Identities=25%  Similarity=0.396  Sum_probs=200.6

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCcc---ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF---QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      ++|++.+.||.|+||.|..++.+ +|..+|+|++...+.   +..+...+|..+++.+.||+++++.+.+.+.+..|+||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            46889999999999999999765 588999999976543   34566778999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccC
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~  930 (1052)
                      ||++||-|..++++.  ++++++.+.-+|.||+.|++|||+.   +|++||+||+|||+|.+|.+||+|||+|+...   
T Consensus       124 eyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~---  195 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVS---  195 (355)
T ss_pred             eccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEec---
Confidence            999999999999886  5799999999999999999999999   99999999999999999999999999999664   


Q ss_pred             cccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccch
Q 001566          931 THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010 (1052)
Q Consensus       931 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1052)
                       ..+...+|||.|+|||++....+..++|.|||||++|||+.|.+||....+        ....+.+ -+++..      
T Consensus       196 -~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--------~~iY~KI-~~~~v~------  259 (355)
T KOG0616|consen  196 -GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--------IQIYEKI-LEGKVK------  259 (355)
T ss_pred             -CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--------HHHHHHH-HhCccc------
Confidence             224556899999999999999999999999999999999999999985433        1112222 222211      


Q ss_pred             hhcCCChHHHHHHHHHHHHccccCCCCCC
Q 001566         1011 LWEAGPQENLLGMMRLASTCTVETLSTRP 1039 (1052)
Q Consensus      1011 l~~~~~~~~~~~l~~Li~~cl~~dP~~RP 1039 (1052)
                          .|......+.+|++..++.|-.+|-
T Consensus       260 ----fP~~fs~~~kdLl~~LL~vD~t~R~  284 (355)
T KOG0616|consen  260 ----FPSYFSSDAKDLLKKLLQVDLTKRF  284 (355)
T ss_pred             ----CCcccCHHHHHHHHHHHhhhhHhhh
Confidence                1222334488899999999999883

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=4.6e-38  Score=339.11  Aligned_cols=246  Identities=28%  Similarity=0.472  Sum_probs=210.1

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCc--cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEe
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR--FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYN  851 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  851 (1052)
                      ++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+..  .++...+.+|++++++++||||+.++++|+...++++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            57888899999999999999554 57899999886543  3345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCc
Q 001566          852 FLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET  931 (1052)
Q Consensus       852 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~  931 (1052)
                      |+.| +|..++...  ..++++.+..++.+++.|+.|||+.   +|+|||+||+||+++..+.+|+||||+|+.+.. ..
T Consensus        82 ~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t  154 (808)
T KOG0597|consen   82 YAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NT  154 (808)
T ss_pred             hhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-Cc
Confidence            9965 999999875  5799999999999999999999999   999999999999999999999999999997764 33


Q ss_pred             ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchh
Q 001566          932 HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPEL 1011 (1052)
Q Consensus       932 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1011 (1052)
                      .......|||-|||||...+..|+..+|+||+||++||+++|++||..        .++.+.++.+..+        +. 
T Consensus       155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a--------~si~~Lv~~I~~d--------~v-  217 (808)
T KOG0597|consen  155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA--------RSITQLVKSILKD--------PV-  217 (808)
T ss_pred             eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH--------HHHHHHHHHHhcC--------CC-
Confidence            445567899999999999999999999999999999999999999972        3344444444332        11 


Q ss_pred             hcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1012 WEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1012 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                        ..|......+..++...+..||.+|.+-.+++.
T Consensus       218 --~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  218 --KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             --CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence              123456677999999999999999999877653

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.5e-37  Score=350.43  Aligned_cols=259  Identities=24%  Similarity=0.381  Sum_probs=204.6

Q ss_pred             hhCCCccceeeeccCceEEEEEEe------cCCcEEEEEEeccCcc-ccHHHHHHHHHHhhcc-CCCceeeEEEEEecC-
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAEL------VPGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGE-  843 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-  843 (1052)
                      ..++|++.++||+|+||.||+|..      .+++.||||++..... .....+.+|+.+++++ +||||+++++++... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            456899999999999999999964      2356899999865432 3346788999999999 899999999988764 


Q ss_pred             CeeEEEEeecCCCCHHHHHhhcc---------------------------------------------------------
Q 001566          844 AEMFLVYNFLSGGNLETFIHKKS---------------------------------------------------------  866 (1052)
Q Consensus       844 ~~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------  866 (1052)
                      ...++||||+++|+|.+++....                                                         
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            46899999999999999997532                                                         


Q ss_pred             ---CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCc-ccccccccccc
Q 001566          867 ---GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET-HATTDVAGTFG  942 (1052)
Q Consensus       867 ---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~g~~~  942 (1052)
                         ...+++.++..++.|+++|++|||++   +|+||||||+||++++++.+||+|||+++....... .......+++.
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence               12477888999999999999999999   999999999999999999999999999986532222 12223345678


Q ss_pred             cccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCCChHHHH
Q 001566          943 YVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLL 1021 (1052)
Q Consensus       943 y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 1021 (1052)
                      |+|||++.+..++.++|||||||++|||++ |..||......       .... .....+...         ..+...+.
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-------~~~~-~~~~~~~~~---------~~~~~~~~  304 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-------EEFC-QRLKDGTRM---------RAPENATP  304 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-------HHHH-HHHhcCCCC---------CCCCCCCH
Confidence            999999999999999999999999999997 99998643211       1111 122222111         11223345


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1022 GMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1022 ~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                      .+.+++.+||+.||++|||+.|+++.|+++
T Consensus       305 ~l~~li~~cl~~dp~~RPs~~el~~~l~~~  334 (338)
T cd05102         305 EIYRIMLACWQGDPKERPTFSALVEILGDL  334 (338)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-37  Score=341.49  Aligned_cols=249  Identities=31%  Similarity=0.464  Sum_probs=207.5

Q ss_pred             HhhCCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccC----cc-ccHHHHHHHHHHhhccC-CCceeeEEEEEecCC
Q 001566          772 RATGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIG----RF-QGIQQFDAEIGTLGRIR-HKNLVTLIGYYVGEA  844 (1052)
Q Consensus       772 ~~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~  844 (1052)
                      ...+.|++.+.||+|.||.|+.|.. .+++.||+|++...    .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            3456899999999999999999954 56899999976553    11 23456778999999998 999999999999999


Q ss_pred             eeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC-CcEEEeeeccc
Q 001566          845 EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEE-LNAYLSDFGLA  923 (1052)
Q Consensus       845 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~-~~~kl~Dfgla  923 (1052)
                      ..|+||||+.+|+|.+++...  .++.+.++.+++.|++.|++|+|++   ||+||||||+||+++.+ +++||+|||++
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            999999999999999999883  5799999999999999999999999   99999999999999999 99999999999


Q ss_pred             ccccccCcccccccccccccccccccCCCC-CC-cchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhC
Q 001566          924 RLLEVSETHATTDVAGTFGYVAPEYATTCR-VS-DKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEG 1001 (1052)
Q Consensus       924 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1052)
                      .... ..........|++.|+|||++.+.. |+ .++||||+||++|.|++|+.||+..        +.....+. +..+
T Consensus       169 ~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~--------~~~~l~~k-i~~~  238 (370)
T KOG0583|consen  169 AISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS--------NVPNLYRK-IRKG  238 (370)
T ss_pred             cccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc--------cHHHHHHH-HhcC
Confidence            8764 2334455678999999999999977 75 7899999999999999999999852        22222222 2222


Q ss_pred             CccccccchhhcCCChHH-HHHHHHHHHHccccCCCCCCCHHHHH
Q 001566         1002 RSSELFLPELWEAGPQEN-LLGMMRLASTCTVETLSTRPSVKQVL 1045 (1052)
Q Consensus      1002 ~~~~~~~~~l~~~~~~~~-~~~l~~Li~~cl~~dP~~RPt~~eil 1045 (1052)
                      ...          .|... ..++..++++|+..||.+|+++.+++
T Consensus       239 ~~~----------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  239 EFK----------IPSYLLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             Ccc----------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            111          11122 45588999999999999999999998

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=5.9e-37  Score=332.28  Aligned_cols=252  Identities=23%  Similarity=0.346  Sum_probs=205.1

Q ss_pred             hhCCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCcc---ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEE
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRF---QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFL  848 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  848 (1052)
                      ..++|++.++||+|+||+||.|+- .+|+.+|+|++++...   .+.+.+++|-.+|....+|.||+++-.|++...+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            456899999999999999999954 5699999999976643   345677899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccc
Q 001566          849 VYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV  928 (1052)
Q Consensus       849 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~  928 (1052)
                      ||||++||++..+|.+.  ..++++.+..++.+++.|++.+|+.   |+|||||||+|+|||..|++||+|||++.-+..
T Consensus       219 iMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~  293 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK  293 (550)
T ss_pred             EEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhh
Confidence            99999999999999886  5899999999999999999999999   999999999999999999999999999964421


Q ss_pred             c----------------------Ccc-----c-------------------ccccccccccccccccCCCCCCcchhHHH
Q 001566          929 S----------------------ETH-----A-------------------TTDVAGTFGYVAPEYATTCRVSDKADVYS  962 (1052)
Q Consensus       929 ~----------------------~~~-----~-------------------~~~~~g~~~y~aPE~~~~~~~~~~sDvws  962 (1052)
                      .                      +..     .                   ....+|||.|||||++.+..|+..+|.||
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS  373 (550)
T KOG0605|consen  294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS  373 (550)
T ss_pred             hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence            0                      000     0                   01247999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCC--
Q 001566          963 FGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS-- 1040 (1052)
Q Consensus       963 lG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt-- 1040 (1052)
                      +|||+|||+.|.+||..+.+.. ....+..|...+..              ........+..+||.+|++ ||++|.-  
T Consensus       374 LG~ImyEmLvGyPPF~s~tp~~-T~rkI~nwr~~l~f--------------P~~~~~s~eA~DLI~rll~-d~~~RLG~~  437 (550)
T KOG0605|consen  374 LGCIMYEMLVGYPPFCSETPQE-TYRKIVNWRETLKF--------------PEEVDLSDEAKDLITRLLC-DPENRLGSK  437 (550)
T ss_pred             HHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhhhccC--------------CCcCcccHHHHHHHHHHhc-CHHHhcCcc
Confidence            9999999999999998654431 11222222221111              1112233568899999999 9999985  


Q ss_pred             -HHHHH
Q 001566         1041 -VKQVL 1045 (1052)
Q Consensus      1041 -~~eil 1045 (1052)
                       +.||.
T Consensus       438 G~~EIK  443 (550)
T KOG0605|consen  438 GAEEIK  443 (550)
T ss_pred             cHHHHh
Confidence             55543

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.5e-36  Score=334.29  Aligned_cols=246  Identities=22%  Similarity=0.325  Sum_probs=202.0

Q ss_pred             eeeeccCceEEEEEEecCCcEEEEEEeccCcccc---HHHHHHHHHHhhccCCCceeeEEEEEec----CCeeEEEEeec
Q 001566          781 NLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTLIGYYVG----EAEMFLVYNFL  853 (1052)
Q Consensus       781 ~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~  853 (1052)
                      ..||+|++|.||+|.+ +|+.||||+++......   .+.+.+|++++++++||||+++++++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            6799999999999987 58999999987654333   4678899999999999999999999876    34689999999


Q ss_pred             CCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccc
Q 001566          854 SGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA  933 (1052)
Q Consensus       854 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  933 (1052)
                      ++|+|.+++...  ..+++....+++.+++.|++|||+..  +++||||||+||++++++.+||+|||+++......   
T Consensus       105 ~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---  177 (283)
T PHA02988        105 TRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---  177 (283)
T ss_pred             CCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---
Confidence            999999999765  46889999999999999999999742  78899999999999999999999999998653221   


Q ss_pred             ccccccccccccccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchh
Q 001566          934 TTDVAGTFGYVAPEYATT--CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPEL 1011 (1052)
Q Consensus       934 ~~~~~g~~~y~aPE~~~~--~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1011 (1052)
                       ....++..|+|||.+.+  ..++.++|||||||++|||++|+.||....        ..++.......+...       
T Consensus       178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~--------~~~~~~~i~~~~~~~-------  241 (283)
T PHA02988        178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT--------TKEIYDLIINKNNSL-------  241 (283)
T ss_pred             -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhcCCCC-------
Confidence             23457889999999976  678999999999999999999999997431        223333333222111       


Q ss_pred             hcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccC
Q 001566         1012 WEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQLK 1052 (1052)
Q Consensus      1012 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~lk 1052 (1052)
                        ..+...+..+.+++.+||+.||++|||++|+++.|++++
T Consensus       242 --~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        242 --KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             --CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence              112234556999999999999999999999999999864

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3e-37  Score=340.24  Aligned_cols=247  Identities=26%  Similarity=0.365  Sum_probs=209.6

Q ss_pred             CCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCcc---ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRF---QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      +-|++++.||.|+.|.|-.|++ .+|+.+|||++.....   .....+++|+-+|+-+.||||++++++++...++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            5689999999999999999965 5799999999976522   22456889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccC
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~  930 (1052)
                      ||+++|-|.+|+-.+  .++++.++.+++.||+.|+.|+|..   +|+|||+||+|+|+|..+++||+|||+|..-.+  
T Consensus        92 Eyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~--  164 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP--  164 (786)
T ss_pred             EecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC--
Confidence            999999999999877  4799999999999999999999999   999999999999999999999999999986432  


Q ss_pred             cccccccccccccccccccCCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccc
Q 001566          931 THATTDVAGTFGYVAPEYATTCRVS-DKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009 (1052)
Q Consensus       931 ~~~~~~~~g~~~y~aPE~~~~~~~~-~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                      ...-...+|+|+|.|||++.|..|. .++||||+|||+|.++||+.||++        .+.......+.+ |..+     
T Consensus       165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD--------dNir~LLlKV~~-G~f~-----  230 (786)
T KOG0588|consen  165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD--------DNIRVLLLKVQR-GVFE-----  230 (786)
T ss_pred             CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC--------ccHHHHHHHHHc-Cccc-----
Confidence            2334456899999999999999884 789999999999999999999983        233333333322 2221     


Q ss_pred             hhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001566         1010 ELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus      1010 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                           .|...+.+.++|+.+|+..||++|.|++||.+.
T Consensus       231 -----MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  231 -----MPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             -----CCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence                 244555669999999999999999999999863

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-39  Score=346.26  Aligned_cols=393  Identities=23%  Similarity=0.244  Sum_probs=313.9

Q ss_pred             eeEecCCCceecCCCCccC-C-CCccEEEccCccccccCCccccCCCCCCeEecccccccccCCccccCCCCCcEEEccC
Q 001566          127 TLSVPHNSFSGEIPAGVGE-L-RLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSS  204 (1052)
Q Consensus       127 ~L~L~~n~l~~~~p~~~~~-l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  204 (1052)
                      .||.+++.+...--..+.. + +.-+.||+|+|+++..-+..|.++++|+.++|.+|.++ .+|........|+.|+|.+
T Consensus        56 lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~  134 (873)
T KOG4194|consen   56 LLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRH  134 (873)
T ss_pred             eeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeec
Confidence            4566666655211111111 1 23567999999999888888999999999999999998 8887776677789999999


Q ss_pred             CcccCccccCCCcccCCCCEEEccCCcCCCCCCcccCCCCCCCEEEcCCCccccccchhhcCCCCCCEEEccCCCCCCCC
Q 001566          205 NRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRI  284 (1052)
Q Consensus       205 N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  284 (1052)
                      |.|+. +..+.++.++.|+.||||.|.|+...-..|..-.++++|+|++|+|+..-...|.++.+|.+|.|+.|+++...
T Consensus       135 N~I~s-v~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp  213 (873)
T KOG4194|consen  135 NLISS-VTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLP  213 (873)
T ss_pred             ccccc-ccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccC
Confidence            98875 66667777888888889888888655566777678888888888888777888888888888888888888766


Q ss_pred             CcccccCCCCCceecccccccccCCCCCCccccccCCCchhhhcccCCcEEecCCCCCCccCCccccCCCCccEEeCCCC
Q 001566          285 PVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQN  364 (1052)
Q Consensus       285 p~~l~~l~~L~~L~L~~n~~~~~l~~~~~~~~~~~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~Ls~N  364 (1052)
                      +..|.+|++|+.|+|..|.+.                                      -.---.|.++.+|+.|.|..|
T Consensus       214 ~r~Fk~L~~L~~LdLnrN~ir--------------------------------------ive~ltFqgL~Sl~nlklqrN  255 (873)
T KOG4194|consen  214 QRSFKRLPKLESLDLNRNRIR--------------------------------------IVEGLTFQGLPSLQNLKLQRN  255 (873)
T ss_pred             HHHhhhcchhhhhhcccccee--------------------------------------eehhhhhcCchhhhhhhhhhc
Confidence            677777777777777654433                                      222234677777888888888


Q ss_pred             cccccCCccccccCCCCEEeCCCCcCcCCCCCCCCCCCcceEecccCcccccCCCCCccccCcccCcccccccccccccc
Q 001566          365 SLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGS  444 (1052)
Q Consensus       365 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~l~~~~~~~~~~  444 (1052)
                      .|...-...|..|.++++|+|+.|+++..-.                                                 
T Consensus       256 ~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~-------------------------------------------------  286 (873)
T KOG4194|consen  256 DISKLDDGAFYGLEKMEHLNLETNRLQAVNE-------------------------------------------------  286 (873)
T ss_pred             CcccccCcceeeecccceeecccchhhhhhc-------------------------------------------------
Confidence            8877777777777778888777777763210                                                 


Q ss_pred             ccccceeEEeeccCCccccccCcccccccccccccchhHHhhccCCcccCCCCCccccccCCCcceEEecCcccccCcch
Q 001566          445 ISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSY  524 (1052)
Q Consensus       445 ~~~~~~l~~ldls~n~~~g~~p~~~~~~~~~~~~~~~~~~l~l~~n~~~~~~p~~~~~~~~~l~~~~l~l~~n~l~~~~~  524 (1052)
                                                                                                      
T Consensus       287 --------------------------------------------------------------------------------  286 (873)
T KOG4194|consen  287 --------------------------------------------------------------------------------  286 (873)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             HHHHhcCcCccEEEccCcccccccccccCCCCCCCEEEccCCcCCCCCcccccCCccCcEEEcCCCccCCcCchhhcCCC
Q 001566          525 EAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLI  604 (1052)
Q Consensus       525 ~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  604 (1052)
                       .|..+++.|+.|++++|.|..+.++.+...++|++|+|++|+|+...+.+|..|..|++|+|++|.++..-...|..++
T Consensus       287 -g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~ls  365 (873)
T KOG4194|consen  287 -GWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLS  365 (873)
T ss_pred             -ccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhh
Confidence             0123577899999999999999999999999999999999999999999999999999999999999977788999999


Q ss_pred             CCcEEEcCCCCCCCCCc---hhhhcccccceeeccCccCCCCCCcccccccccCceecccccccCCCCC-cc--cccccc
Q 001566          605 SLVVLDLSHNALTGSIP---ASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPH-LQ--HLDCIA  678 (1052)
Q Consensus       605 ~L~~L~l~~N~l~~~~p---~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~--~l~~~~  678 (1052)
                      +|+.|||++|.|++.+-   ..|..|++|+.|+|.+|+|..+...+|.++++|+.|||.+|.|...=|. +.  .|..+.
T Consensus       366 sL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv  445 (873)
T KOG4194|consen  366 SLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELV  445 (873)
T ss_pred             hhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccchhhhhh
Confidence            99999999999986654   4588899999999999999977778999999999999999999753332 11  677888


Q ss_pred             ccCCccccCCC
Q 001566          679 FKGNKYLASCP  689 (1052)
Q Consensus       679 ~~~n~~~~~~~  689 (1052)
                      +..-.++|+|.
T Consensus       446 ~nSssflCDCq  456 (873)
T KOG4194|consen  446 MNSSSFLCDCQ  456 (873)
T ss_pred             hcccceEEecc
Confidence            88888899987

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=3.8e-41  Score=349.35  Aligned_cols=445  Identities=28%  Similarity=0.374  Sum_probs=335.0

Q ss_pred             cccchhhcCCCCCCeeEecCCCceecCCCCccCCCCccEEEccCccccccCCccccCCCCCCeEecccccccccCCcccc
Q 001566          113 GTLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLI  192 (1052)
Q Consensus       113 g~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  192 (1052)
                      ..+|++++++..++.|+.++|+++ ++|+.++.+.+|..|+.++|.+. .+|+.++.+..|..|+..+|+++ ..|.++.
T Consensus        81 ~~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~  157 (565)
T KOG0472|consen   81 SQLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMV  157 (565)
T ss_pred             hhCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHH
Confidence            357899999999999999999999 99999999999999999999999 88999999999999999999999 8999999


Q ss_pred             CCCCCcEEEccCCcccCccccCCCcccCCCCEEEccCCcCCCCCCcccCCCCCCCEEEcCCCccccccchhhcCCCCCCE
Q 001566          193 GNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKV  272 (1052)
Q Consensus       193 ~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  272 (1052)
                      .+.+|..+++.+|++.. .++.... ++.|++||...|.++ .+|..++.+.+|..|+|..|++. ..| +|.+++.|..
T Consensus       158 ~~~~l~~l~~~~n~l~~-l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~E  232 (565)
T KOG0472|consen  158 NLSKLSKLDLEGNKLKA-LPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKE  232 (565)
T ss_pred             HHHHHHHhhccccchhh-CCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHH
Confidence            99999999999999986 5555555 999999999999998 68999999999999999999998 777 8999999999


Q ss_pred             EEccCCCCCCCCCcccc-cCCCCCceecccccccccCCCCCCccccccCCCchhhhcccCCcEEecCCCCCCccCCcccc
Q 001566          273 LDVSRNSLTDRIPVELA-DCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWS  351 (1052)
Q Consensus       273 L~L~~N~l~~~~p~~l~-~l~~L~~L~L~~n~~~~~l~~~~~~~~~~~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~  351 (1052)
                      |+++.|++. .+|.+.. ++.++.+|||.+|++.               .+|.+++.+++|++|++++|.+++ +|..++
T Consensus       233 lh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk---------------e~Pde~clLrsL~rLDlSNN~is~-Lp~sLg  295 (565)
T KOG0472|consen  233 LHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK---------------EVPDEICLLRSLERLDLSNNDISS-LPYSLG  295 (565)
T ss_pred             HHhcccHHH-hhHHHHhcccccceeeeccccccc---------------cCchHHHHhhhhhhhcccCCcccc-CCcccc
Confidence            999999998 5776655 8999999999988776               466666777777777777666654 444566


Q ss_pred             CCCCccEEeCCCCcccccCCccccc------cCCCCE----EeCCCCc---------CcCCCCCCCCCCCcceEecccCc
Q 001566          352 ESCSLKVLNLGQNSLKGAVPKSLGM------CRNLTY----LDLSLNN---------LEGYLPMQLPVPCMVYFNVSQNN  412 (1052)
Q Consensus       352 ~~~~L~~L~Ls~N~l~~~~p~~~~~------l~~L~~----L~Ls~N~---------l~~~~p~~~~~~~L~~l~l~~N~  412 (1052)
                      ++ .|+.|-+.+|.+.. +-..+-+      ++.|+.    =-++.-.         ..+..|......+.+.|++++=+
T Consensus       296 nl-hL~~L~leGNPlrT-iRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~q  373 (565)
T KOG0472|consen  296 NL-HLKFLALEGNPLRT-IRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQ  373 (565)
T ss_pred             cc-eeeehhhcCCchHH-HHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccc
Confidence            66 66666677766652 2111111      111111    0011000         00001111112344555555555


Q ss_pred             ccccCCCCCccccCcccCccccccccccccccccccceeEEeeccCCccccccCcccccccccccccchhHHhhccCCcc
Q 001566          413 ITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMF  492 (1052)
Q Consensus       413 l~~~~p~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~ldls~n~~~g~~p~~~~~~~~~~~~~~~~~~l~l~~n~~  492 (1052)
                      ++.++.+                      +........+...+++.|++. .+|.-..       ..+.+..        
T Consensus       374 lt~VPdE----------------------Vfea~~~~~Vt~VnfskNqL~-elPk~L~-------~lkelvT--------  415 (565)
T KOG0472|consen  374 LTLVPDE----------------------VFEAAKSEIVTSVNFSKNQLC-ELPKRLV-------ELKELVT--------  415 (565)
T ss_pred             cccCCHH----------------------HHHHhhhcceEEEecccchHh-hhhhhhH-------HHHHHHH--------
Confidence            5443322                      122233344667788888875 2331100       0011111        


Q ss_pred             cCCCCCccccccCCCcceEEecCcccccCcchHHHHhcCcCccEEEccCcccccccccccCCCCCCCEEEccCCcCCCCC
Q 001566          493 NGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSL  572 (1052)
Q Consensus       493 ~~~~p~~~~~~~~~l~~~~l~l~~n~l~~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  572 (1052)
                                        .+.+++|.++-++  .+.+.+++|..|+|++|-+. .+|..++.+..|++|+++.|++. .+
T Consensus       416 ------------------~l~lsnn~isfv~--~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~l  473 (565)
T KOG0472|consen  416 ------------------DLVLSNNKISFVP--LELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-ML  473 (565)
T ss_pred             ------------------HHHhhcCccccch--HHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cc
Confidence                              1334444444433  23457789999999999988 78888999999999999999998 89


Q ss_pred             cccccCCccCcEEEcCCCccCCcCchhhcCCCCCcEEEcCCCCCCCCCchhhhcccccceeeccCccCCCCCCc
Q 001566          573 PDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPV  646 (1052)
Q Consensus       573 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  646 (1052)
                      |..+..+..|+.+-.++|++....|..+.+|.+|.+|||.+|.|. .+|..+++|++|++|+|++|+|+ .++.
T Consensus       474 P~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr-~Pr~  545 (565)
T KOG0472|consen  474 PECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR-QPRH  545 (565)
T ss_pred             hHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC-CCHH
Confidence            999999999999999999999666677999999999999999999 89999999999999999999998 4443

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-37  Score=336.74  Aligned_cols=260  Identities=27%  Similarity=0.419  Sum_probs=218.7

Q ss_pred             hHHHhhCCCccceeeeccCceEEEEEEecC---C--cEEEEEEeccC-ccccHHHHHHHHHHhhccCCCceeeEEEEEec
Q 001566          769 NVVRATGNFSIRNLIGTGGFGSTYKAELVP---G--YLVAVKKLSIG-RFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG  842 (1052)
Q Consensus       769 ~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~~---~--~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  842 (1052)
                      +++...+.....+.||+|.||.||+|...+   |  -.||||.-+.. .....+.|..|..+|+.++|||||+++|+|.+
T Consensus       383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e  462 (974)
T KOG4257|consen  383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE  462 (974)
T ss_pred             cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence            344455566778899999999999995432   3  45888987764 34457889999999999999999999999974


Q ss_pred             CCeeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecc
Q 001566          843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGL  922 (1052)
Q Consensus       843 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgl  922 (1052)
                       ...++|||.++-|-|..|++.+. ..++......++.||..|++|||+.   ++|||||.++||+|.+...||++|||+
T Consensus       463 -~P~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGL  537 (974)
T KOG4257|consen  463 -QPMWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGL  537 (974)
T ss_pred             -cceeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccch
Confidence             67899999999999999999876 6799999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhC
Q 001566          923 ARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEG 1001 (1052)
Q Consensus       923 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1052)
                      ++.+....++......-+..|||||.+.-++++.++|||.|||.+||++. |..||.+-...+...         .+..|
T Consensus       538 SR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~---------~iEnG  608 (974)
T KOG4257|consen  538 SRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG---------HIENG  608 (974)
T ss_pred             hhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE---------EecCC
Confidence            99998777777766667789999999999999999999999999999987 999997533221100         11111


Q ss_pred             CccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1002 RSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1002 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                      .         .-..|+.++..+..|+.+||.+||.+||++.|+...|+++
T Consensus       609 e---------RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv  649 (974)
T KOG4257|consen  609 E---------RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV  649 (974)
T ss_pred             C---------CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence            1         1245778888899999999999999999999999988764

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-38  Score=332.46  Aligned_cols=249  Identities=27%  Similarity=0.423  Sum_probs=209.1

Q ss_pred             CCCccceeeeccCceEEEEE-EecCCcEEEEEEeccCccc-cHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          775 GNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ-GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      ..|+..+.||+|.||.||+| +..+++.||+|++.....+ +.+++.+|+.++...+++||.++|+.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            45777799999999999999 4557899999999766544 467889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      +.||++.+.++..  ..+++..+.-+.++++.|+.|||.+   +.+|||||+.||++..+|.+|++|||.+.........
T Consensus        93 ~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r  167 (467)
T KOG0201|consen   93 CGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR  167 (467)
T ss_pred             hcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence            9999999999765  3458888889999999999999999   9999999999999999999999999999887654444


Q ss_pred             cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhh
Q 001566          933 ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012 (1052)
Q Consensus       933 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1012 (1052)
                      . ...+||+.|||||++....|+.|+||||+|++.+||++|.+|+....+..         +...+....     -|.+.
T Consensus       168 r-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr---------vlflIpk~~-----PP~L~  232 (467)
T KOG0201|consen  168 R-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR---------VLFLIPKSA-----PPRLD  232 (467)
T ss_pred             c-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce---------EEEeccCCC-----CCccc
Confidence            3 77899999999999999899999999999999999999999997443310         011111111     11222


Q ss_pred             cCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001566         1013 EAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus      1013 ~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                          ......+.+++..|+..+|+.||+|.++++.
T Consensus       233 ----~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  233 ----GDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             ----cccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence                2334459999999999999999999999863

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.6e-36  Score=328.73  Aligned_cols=256  Identities=24%  Similarity=0.359  Sum_probs=206.9

Q ss_pred             hCCCccceeeeccCceEEEEEEec----CCcEEEEEEeccCcc-ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEE
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELV----PGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFL  848 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  848 (1052)
                      .++|++.+.||+|+||.||+|.+.    .+..||+|.++.... .....+.+|+..+++++||||+++++++..++..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            356899999999999999999653    357899999876533 234578899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccc
Q 001566          849 VYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV  928 (1052)
Q Consensus       849 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~  928 (1052)
                      ||||+++|+|.+++.... ..+++.++..++.|++.|++|||++   +++||||||+||+++.++.++++|||.+.....
T Consensus        84 v~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          84 VTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             EEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            999999999999998753 4689999999999999999999999   999999999999999999999999998765432


Q ss_pred             cCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCccccc
Q 001566          929 SETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELF 1007 (1052)
Q Consensus       929 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1052)
                      ..........++..|+|||.+.+..++.++|||||||++||+++ |+.||.....        .+..+.. ..+...   
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~--------~~~~~~~-~~~~~~---  227 (266)
T cd05064         160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG--------QDVIKAV-EDGFRL---  227 (266)
T ss_pred             cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH--------HHHHHHH-HCCCCC---
Confidence            22122222345678999999999999999999999999999875 9999864321        1222222 222111   


Q ss_pred             cchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1008 LPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1008 ~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                            ..+..++..+.+++.+||+.+|++||+++|+.+.|+++
T Consensus       228 ------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         228 ------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             ------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                  12334456699999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.5e-37  Score=300.62  Aligned_cols=248  Identities=26%  Similarity=0.399  Sum_probs=211.7

Q ss_pred             hCCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCc---cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEE
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLV  849 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  849 (1052)
                      -++|++.+.||+|.||.||.|+. +++..||+|++.+.+   .+...++.+|+++-..++||||++++++|.+....|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            35799999999999999999965 457889999986553   23356889999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccccccc
Q 001566          850 YNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS  929 (1052)
Q Consensus       850 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~  929 (1052)
                      +||.++|.+...|+.....++++.....+..|+|.|+.|+|.+   +|+||||||+|+|++.++..||+|||.+...+  
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP--  175 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence            9999999999999987778899999999999999999999999   99999999999999999999999999998543  


Q ss_pred             CcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccc
Q 001566          930 ETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009 (1052)
Q Consensus       930 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                       .......+||..|.+||...+..++..+|+|++|++.||++.|.+||.....        .+-.+.+.+    .+.   
T Consensus       176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~--------~etYkrI~k----~~~---  239 (281)
T KOG0580|consen  176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH--------SETYKRIRK----VDL---  239 (281)
T ss_pred             -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh--------HHHHHHHHH----ccc---
Confidence             3445567899999999999999999999999999999999999999984321        111222211    111   


Q ss_pred             hhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1010 ELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1010 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                          ..|........++|.+|+..+|.+|.+..|+++
T Consensus       240 ----~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  240 ----KFPSTISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             ----cCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence                223445566899999999999999999999875

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.8e-36  Score=308.63  Aligned_cols=259  Identities=25%  Similarity=0.324  Sum_probs=208.1

Q ss_pred             CCCccceeeeccCceEEEEEE-ecCCcEEEEEEeccCcccc--HHHHHHHHHHhhccCCCceeeEEEEEec--CCeeEEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQG--IQQFDAEIGTLGRIRHKNLVTLIGYYVG--EAEMFLV  849 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv  849 (1052)
                      +.|++...|++|.||.||+|+ .++++.||+|+++......  .-...+|+.++.+.+|||||.+-.+...  -+.+|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            468899999999999999994 4578999999998765433  2345789999999999999999998764  3579999


Q ss_pred             EeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccccccc
Q 001566          850 YNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS  929 (1052)
Q Consensus       850 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~  929 (1052)
                      ||||+ -+|...++... +++...++.-+..|+++|++|||..   .|+|||+|++|+|+...|.+||+|||+|+.++..
T Consensus       156 Me~~E-hDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp  230 (419)
T KOG0663|consen  156 MEYVE-HDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP  230 (419)
T ss_pred             HHHHH-hhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence            99995 49999999886 7899999999999999999999999   9999999999999999999999999999988744


Q ss_pred             CcccccccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCcccccc
Q 001566          930 ETHATTDVAGTFGYVAPEYATTC-RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFL 1008 (1052)
Q Consensus       930 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                       ....+..+.|..|.|||.+.+. .|+.+.||||+|||+.||+++++.|.+..+       ..+..+....-|...+..+
T Consensus       231 -~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE-------~dQl~~If~llGtPte~iw  302 (419)
T KOG0663|consen  231 -LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE-------IDQLDKIFKLLGTPSEAIW  302 (419)
T ss_pred             -cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch-------HHHHHHHHHHhCCCccccC
Confidence             3445566789999999998875 588999999999999999999988864322       2233333333444444444


Q ss_pred             chhhc----------CCC--------hH--HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1009 PELWE----------AGP--------QE--NLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1009 ~~l~~----------~~~--------~~--~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      |.+..          ..+        ..  ....-.+++..++..||++|.||.|.++
T Consensus       303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence            43211          111        01  2245678999999999999999999875

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.7e-36  Score=327.94  Aligned_cols=250  Identities=33%  Similarity=0.532  Sum_probs=198.9

Q ss_pred             ccceeeeccCceEEEEEEec-----CCcEEEEEEeccCcc-ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEe
Q 001566          778 SIRNLIGTGGFGSTYKAELV-----PGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYN  851 (1052)
Q Consensus       778 ~~~~~Lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  851 (1052)
                      ++.+.||.|.||.||+|.+.     .+..|+||.++.... +..+.+.+|++.+++++||||++++|++...+..++|+|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e   81 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME   81 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence            35688999999999999877     357899999965433 346889999999999999999999999998888999999


Q ss_pred             ecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccC-
Q 001566          852 FLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE-  930 (1052)
Q Consensus       852 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~-  930 (1052)
                      |+++|+|.++++......+++.++..|+.||++|++|||++   +|+|+||+++||++++++.+||+|||++....... 
T Consensus        82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence            99999999999988557799999999999999999999999   99999999999999999999999999998763222 


Q ss_pred             cccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccc
Q 001566          931 THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009 (1052)
Q Consensus       931 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                      ............|+|||.+.+..++.++||||||+++||+++ |+.||...        ...++...+ ..+...     
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~--------~~~~~~~~~-~~~~~~-----  224 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY--------DNEEIIEKL-KQGQRL-----  224 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS--------CHHHHHHHH-HTTEET-----
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccc--------ccccccccc-cccccc-----
Confidence            223334457789999999999899999999999999999999 67777522        223333333 222221     


Q ss_pred             hhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 001566         1010 ELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKL 1048 (1052)
Q Consensus      1010 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L 1048 (1052)
                          ..+..++..+.+++.+||+.+|++||++.++++.|
T Consensus       225 ----~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  225 ----PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ----TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ----eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                11233455689999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=8.9e-36  Score=323.80  Aligned_cols=252  Identities=21%  Similarity=0.400  Sum_probs=205.9

Q ss_pred             CCCccceeeeccCceEEEEEEecCCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecC
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLS  854 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  854 (1052)
                      ++|++.+.||+|+||.||+|++.++..+|+|.+.... ...+++..|++++++++||||+++++++.+....++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            3588889999999999999998888899999876443 234678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcccc
Q 001566          855 GGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT  934 (1052)
Q Consensus       855 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  934 (1052)
                      +|+|.++++... ..+++..+..++.|++.|++|||+.   +|+||||+|+||++++++.+||+|||.+...........
T Consensus        83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~  158 (256)
T cd05114          83 NGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS  158 (256)
T ss_pred             CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence            999999997654 3588999999999999999999999   999999999999999999999999999986543322222


Q ss_pred             cccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhc
Q 001566          935 TDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWE 1013 (1052)
Q Consensus       935 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1013 (1052)
                      ....++..|+|||.+.+..++.++||||||+++|||++ |+.||....        ..+..+........   ..     
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~--------~~~~~~~i~~~~~~---~~-----  222 (256)
T cd05114         159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS--------NYEVVEMISRGFRL---YR-----  222 (256)
T ss_pred             CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC--------HHHHHHHHHCCCCC---CC-----
Confidence            23345678999999998889999999999999999999 888886322        12222222221111   11     


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 001566         1014 AGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLK 1049 (1052)
Q Consensus      1014 ~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~ 1049 (1052)
                        +...+..+.+++.+||+.+|++||+++|+++.|.
T Consensus       223 --~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         223 --PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             --CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence              1222346899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=6.2e-36  Score=333.74  Aligned_cols=263  Identities=24%  Similarity=0.400  Sum_probs=204.4

Q ss_pred             hCCCccceeeeccCceEEEEEEecC-----------------CcEEEEEEeccCcc-ccHHHHHHHHHHhhccCCCceee
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELVP-----------------GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVT  835 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~  835 (1052)
                      .++|++.+.||+|+||.||+|.+.+                 +..||+|.+..... ....++.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3578999999999999999996532                 34699999876433 23467899999999999999999


Q ss_pred             EEEEEecCCeeEEEEeecCCCCHHHHHhhcc-----------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 001566          836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKS-----------------GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV  898 (1052)
Q Consensus       836 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ii  898 (1052)
                      +++++.+.+..++||||+++|+|.+++....                 ...+++..+.+++.|++.|++|||+.   +|+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence            9999999999999999999999999986532                 12467888999999999999999999   999


Q ss_pred             eCCCCCCCEEECCCCcEEEeeecccccccccCc-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhC--CC
Q 001566          899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSET-HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG--KR  975 (1052)
Q Consensus       899 HrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg--~~  975 (1052)
                      ||||||+||++++++.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||+++  ..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            999999999999999999999999986543322 122234457899999999988899999999999999999974  45


Q ss_pred             CCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 001566          976 SLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQ 1050 (1052)
Q Consensus       976 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~ 1050 (1052)
                      ||....     ...................      ....++.++..+.+++.+||+.||++|||+.|+.+.|++
T Consensus       241 p~~~~~-----~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         241 PYGELT-----DEQVIENAGEFFRDQGRQV------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCCcCC-----HHHHHHHHHHHhhhccccc------cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            665321     1112222222222111110      111223445669999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=8.2e-36  Score=325.10  Aligned_cols=256  Identities=25%  Similarity=0.424  Sum_probs=210.7

Q ss_pred             hCCCccceeeeccCceEEEEEEecCCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeec
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFL  853 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  853 (1052)
                      .++|++.++||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|+|++++++++.+....+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            457899999999999999999888888999998765432 3578899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccc
Q 001566          854 SGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA  933 (1052)
Q Consensus       854 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  933 (1052)
                      ++++|.++++......+++.++..++.|+++|++|||+.   +++||||||+||++++++.++|+|||++..........
T Consensus        84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (261)
T cd05072          84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA  160 (261)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence            999999999876666789999999999999999999998   99999999999999999999999999998765332222


Q ss_pred             ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhh
Q 001566          934 TTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012 (1052)
Q Consensus       934 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1012 (1052)
                      .....++..|+|||.+.+..++.++||||||+++|||+| |+.||......        ..... ...+....       
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--------~~~~~-~~~~~~~~-------  224 (261)
T cd05072         161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--------DVMSA-LQRGYRMP-------  224 (261)
T ss_pred             cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--------HHHHH-HHcCCCCC-------
Confidence            233345678999999998889999999999999999998 88888632111        11111 11111110       


Q ss_pred             cCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1013 EAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1013 ~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                        .....+..+.+++.+|++.+|++||+++++.+.|+++
T Consensus       225 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         225 --RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             --CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence              1112344588999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=9.8e-36  Score=328.63  Aligned_cols=251  Identities=25%  Similarity=0.333  Sum_probs=202.2

Q ss_pred             CCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCcc---ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEe
Q 001566          776 NFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRF---QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYN  851 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  851 (1052)
                      .|+..+.||+|+||+||+|.. .+|+.||+|++.....   .....+.+|++++++++|++++++++++.+++..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            377889999999999999965 5689999998864432   223467889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCc
Q 001566          852 FLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET  931 (1052)
Q Consensus       852 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~  931 (1052)
                      |+++|+|.+++.......+++..+..++.|++.|++|||++   +|+||||||+||++++++.++|+|||++....... 
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-  156 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence            99999999988765545789999999999999999999999   99999999999999999999999999998653222 


Q ss_pred             ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchh
Q 001566          932 HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPEL 1011 (1052)
Q Consensus       932 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1011 (1052)
                       ......|+..|+|||++.+..++.++||||+||++|||++|+.||......     ...+.........  .       
T Consensus       157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~--~-------  221 (285)
T cd05631         157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER-----VKREEVDRRVKED--Q-------  221 (285)
T ss_pred             -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc-----hhHHHHHHHhhcc--c-------
Confidence             223456899999999999999999999999999999999999999743221     0111111111110  0       


Q ss_pred             hcCCChHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 001566         1012 WEAGPQENLLGMMRLASTCTVETLSTRPS-----VKQVLI 1046 (1052)
Q Consensus      1012 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPt-----~~eil~ 1046 (1052)
                       ...+......+.+++.+||+.||++||+     ++++++
T Consensus       222 -~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         222 -EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             -ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence             0112233456889999999999999997     788775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.4e-36  Score=325.91  Aligned_cols=257  Identities=25%  Similarity=0.407  Sum_probs=211.0

Q ss_pred             hhCCCccceeeeccCceEEEEEEecCCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      ..++|++.+.||+|+||.||+|...+++.||+|.++.... ..+++.+|++++++++|||++++++++...+..++||||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            3467999999999999999999877788899999875442 356789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      +++++|.+++....+..+++..+..++.|++.|+.|||+.   +|+||||||+||++++++.++|+|||++.........
T Consensus        83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05068          83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE  159 (261)
T ss_pred             ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence            9999999999876556789999999999999999999999   9999999999999999999999999999876533222


Q ss_pred             cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchh
Q 001566          933 ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPEL 1011 (1052)
Q Consensus       933 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1011 (1052)
                      .......+..|+|||.+.+..++.++||||||+++|||++ |+.||.....        .+..... ..+...       
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~-~~~~~~-------  223 (261)
T cd05068         160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--------AEVLQQV-DQGYRM-------  223 (261)
T ss_pred             ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHH-HcCCCC-------
Confidence            2222233468999999999899999999999999999999 8888863211        1111111 111110       


Q ss_pred             hcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1012 WEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1012 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                        ..+...+..+.+++.+|++.+|++||++.++++.|+.+
T Consensus       224 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         224 --PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             --CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence              11223445699999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-37  Score=300.20  Aligned_cols=266  Identities=24%  Similarity=0.381  Sum_probs=213.2

Q ss_pred             HHHhhCCCccceeeeccCceEEEEEE-ecCCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecC-----
Q 001566          770 VVRATGNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGE-----  843 (1052)
Q Consensus       770 ~~~~~~~~~~~~~Lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----  843 (1052)
                      +....++|++.+.||+|||+.||.++ ..+++.+|+|++.....++.+..++|++..++++|||+++++++...+     
T Consensus        16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~   95 (302)
T KOG2345|consen   16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK   95 (302)
T ss_pred             EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence            34456789999999999999999995 456889999999888777788999999999999999999999886533     


Q ss_pred             CeeEEEEeecCCCCHHHHHhhcc--CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeec
Q 001566          844 AEMFLVYNFLSGGNLETFIHKKS--GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFG  921 (1052)
Q Consensus       844 ~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfg  921 (1052)
                      .+.|++++|...|+|.+.++...  +..+++.++++|+.++++|+++||+. .+.++||||||.||++.+.+.+++.|||
T Consensus        96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~G  174 (302)
T KOG2345|consen   96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLG  174 (302)
T ss_pred             eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEecc
Confidence            45899999999999999998754  45799999999999999999999998 3359999999999999999999999999


Q ss_pred             ccccccccCc--------ccccccccccccccccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccH
Q 001566          922 LARLLEVSET--------HATTDVAGTFGYVAPEYAT---TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI  990 (1052)
Q Consensus       922 la~~~~~~~~--------~~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~  990 (1052)
                      .+....-...        ........|..|.|||.+.   +...+.++|||||||++|+|+.|..||+......+.- .+
T Consensus       175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl-aL  253 (302)
T KOG2345|consen  175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL-AL  253 (302)
T ss_pred             CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE-EE
Confidence            9986642211        1112235788999999885   4556889999999999999999999998654421110 00


Q ss_pred             HHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566          991 VSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                                    ......+.-......++.+.+++++|+++||.+||++.+++..++.+
T Consensus       254 --------------Av~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  254 --------------AVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             --------------eeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                          01111111111122566799999999999999999999999998765

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=6.8e-36  Score=325.76  Aligned_cols=258  Identities=26%  Similarity=0.445  Sum_probs=215.4

Q ss_pred             HhhCCCccceeeeccCceEEEEEEecCCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEe
Q 001566          772 RATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYN  851 (1052)
Q Consensus       772 ~~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  851 (1052)
                      +...+|++.++||.|+||.||+|...++..+|+|.+.........++.+|+++++.++|||++++++++.+....++|||
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            34557999999999999999999888899999999987666566789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCc
Q 001566          852 FLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET  931 (1052)
Q Consensus       852 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~  931 (1052)
                      |+++++|.+++....+..+++.++..++.|++.|++|||++   +|+||||+|+||++++++.+||+|||.+....... 
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~-  158 (261)
T cd05148          83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV-  158 (261)
T ss_pred             ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcc-
Confidence            99999999999876667789999999999999999999999   99999999999999999999999999998664322 


Q ss_pred             ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccch
Q 001566          932 HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010 (1052)
Q Consensus       932 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1052)
                      .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||....        ..+...... .+...      
T Consensus       159 ~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~--------~~~~~~~~~-~~~~~------  223 (261)
T cd05148         159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN--------NHEVYDQIT-AGYRM------  223 (261)
T ss_pred             ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC--------HHHHHHHHH-hCCcC------
Confidence            12223446678999999998889999999999999999998 888886432        112222221 11111      


Q ss_pred             hhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1011 LWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1011 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                         ..+..++..+.+++.+||+.||++|||++++++.|+.+
T Consensus       224 ---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         224 ---PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             ---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence               12234455689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.2e-36  Score=344.46  Aligned_cols=262  Identities=23%  Similarity=0.374  Sum_probs=206.4

Q ss_pred             HHHhhCCCccceeeeccCceEEEEEEec------CCcEEEEEEeccCcc-ccHHHHHHHHHHhhcc-CCCceeeEEEEEe
Q 001566          770 VVRATGNFSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRI-RHKNLVTLIGYYV  841 (1052)
Q Consensus       770 ~~~~~~~~~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  841 (1052)
                      +....++|++.+.||+|+||.||+|...      ++..||+|++..... ...+.+.+|+++++.+ +|+||+++++++.
T Consensus        33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~  112 (374)
T cd05106          33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT  112 (374)
T ss_pred             ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence            3445568999999999999999998642      235799999875432 3346688999999999 8999999999999


Q ss_pred             cCCeeEEEEeecCCCCHHHHHhhcc-------------------------------------------------------
Q 001566          842 GEAEMFLVYNFLSGGNLETFIHKKS-------------------------------------------------------  866 (1052)
Q Consensus       842 ~~~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------------------------  866 (1052)
                      .....++||||+++|+|.++++...                                                       
T Consensus       113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (374)
T cd05106         113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS  192 (374)
T ss_pred             CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence            9999999999999999999986431                                                       


Q ss_pred             -------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCc-c
Q 001566          867 -------------GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET-H  932 (1052)
Q Consensus       867 -------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~-~  932 (1052)
                                   ...+++.++.+++.|+++|++|||++   +|+||||||+||++++++.+||+|||+++....... .
T Consensus       193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~  269 (374)
T cd05106         193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV  269 (374)
T ss_pred             ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence                         12478889999999999999999999   999999999999999999999999999976543221 1


Q ss_pred             cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchh
Q 001566          933 ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPEL 1011 (1052)
Q Consensus       933 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1011 (1052)
                      ......++..|+|||++.+..++.++|||||||++|||++ |+.||......       .. .......+...       
T Consensus       270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~-------~~-~~~~~~~~~~~-------  334 (374)
T cd05106         270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN-------SK-FYKMVKRGYQM-------  334 (374)
T ss_pred             eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc-------HH-HHHHHHcccCc-------
Confidence            1222335678999999999899999999999999999997 99998643211       01 11111111111       


Q ss_pred             hcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1012 WEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1012 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                        ..+...+..+.+++.+||+.||++||++.++++.|+++
T Consensus       335 --~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         335 --SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             --cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence              01112245689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-37  Score=302.39  Aligned_cols=252  Identities=25%  Similarity=0.357  Sum_probs=208.0

Q ss_pred             hhCCCccceeeeccCceEEEEEE-ecCCcEEEEEEeccC--ccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEE
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG--RFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLV  849 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  849 (1052)
                      .++.|++.+.||+|.|+.||++. ..+|+.+|+|++...  ...+.+++.+|+.+-+.++||||+++.+.+.+.+..|+|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            34678999999999999999994 456889999987543  234578889999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---CCcEEEeeecccccc
Q 001566          850 YNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDE---ELNAYLSDFGLARLL  926 (1052)
Q Consensus       850 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~---~~~~kl~Dfgla~~~  926 (1052)
                      +|+|.|++|..-+-.+  ...++..+.....||++++.|+|.+   +|||||+||+|+++.+   ...+|++|||+|...
T Consensus        89 Fe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             EecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            9999999998766544  3578888999999999999999999   9999999999999953   345999999999977


Q ss_pred             cccCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCcccc
Q 001566          927 EVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSEL 1006 (1052)
Q Consensus       927 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      +  ........+|||+|||||+++..+|+..+|||+.||++|-++.|++||.++...        . ....+..+..  .
T Consensus       164 ~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~--------r-lye~I~~g~y--d  230 (355)
T KOG0033|consen  164 N--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--------R-LYEQIKAGAY--D  230 (355)
T ss_pred             C--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH--------H-HHHHHhcccc--C
Confidence            6  455566789999999999999999999999999999999999999999853222        1 1222223322  2


Q ss_pred             ccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1007 FLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1007 ~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      +++..|+...+    +..+|+++|+..||++|.|+.|.++
T Consensus       231 ~~~~~w~~is~----~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  231 YPSPEWDTVTP----EAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             CCCcccCcCCH----HHHHHHHHHhccChhhhccHHHHhC
Confidence            34444544444    4889999999999999999999874

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.5e-35  Score=323.34  Aligned_cols=255  Identities=25%  Similarity=0.418  Sum_probs=208.6

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeec
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFL  853 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  853 (1052)
                      .+|++.+.||+|+||.||+|... .++.||+|++... .....++.+|++++++++|||++++++++..+...++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            45888899999999999999654 5888999988644 334567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccc
Q 001566          854 SGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA  933 (1052)
Q Consensus       854 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  933 (1052)
                      ++++|.+++.......+++..+..++.|+++|++|||++   +++||||||+||++++++.+||+|||++..........
T Consensus        85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~  161 (263)
T cd05052          85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA  161 (263)
T ss_pred             CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence            999999999876556789999999999999999999999   99999999999999999999999999998664332222


Q ss_pred             ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhh
Q 001566          934 TTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012 (1052)
Q Consensus       934 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1012 (1052)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |..||....        ..+..+.. ..+..     +   
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~--------~~~~~~~~-~~~~~-----~---  224 (263)
T cd05052         162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--------LSQVYELL-EKGYR-----M---  224 (263)
T ss_pred             cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC--------HHHHHHHH-HCCCC-----C---
Confidence            222334568999999999999999999999999999998 888876321        12222222 11111     1   


Q ss_pred             cCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1013 EAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1013 ~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                       ..+...+..+.+++.+|++.+|++||++.+++++|+.+
T Consensus       225 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         225 -ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             -CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence             11233445699999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=9.9e-36  Score=340.83  Aligned_cols=259  Identities=24%  Similarity=0.387  Sum_probs=205.1

Q ss_pred             hhCCCccceeeeccCceEEEEEEe------cCCcEEEEEEeccCc-cccHHHHHHHHHHhhcc-CCCceeeEEEEEecCC
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAEL------VPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEA  844 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  844 (1052)
                      ..++|++.+.||+|+||.||+|.+      .++..||||+++... ....+.+.+|+++++.+ +||||+++++++.+.+
T Consensus        33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            345799999999999999999963      235689999986443 23346788999999999 8999999999999999


Q ss_pred             eeEEEEeecCCCCHHHHHhhcc----------------------------------------------------------
Q 001566          845 EMFLVYNFLSGGNLETFIHKKS----------------------------------------------------------  866 (1052)
Q Consensus       845 ~~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------  866 (1052)
                      ..++||||+++|+|.++++...                                                          
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            9999999999999999997532                                                          


Q ss_pred             ---------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCc
Q 001566          867 ---------------GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET  931 (1052)
Q Consensus       867 ---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~  931 (1052)
                                     ...++++.+.+++.||+.|++|||++   +|+||||||+||++++++.+||+|||+++.......
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  269 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN  269 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence                           12478889999999999999999999   999999999999999999999999999986543221


Q ss_pred             c-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccc
Q 001566          932 H-ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009 (1052)
Q Consensus       932 ~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                      . ......++..|+|||.+.+..++.++|||||||++|||++ |..||......       ....+ ....+...     
T Consensus       270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-------~~~~~-~~~~~~~~-----  336 (375)
T cd05104         270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-------SKFYK-MIKEGYRM-----  336 (375)
T ss_pred             ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-------HHHHH-HHHhCccC-----
Confidence            1 1222345678999999999999999999999999999998 78887632111       11111 22222111     


Q ss_pred             hhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1010 ELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1010 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                          ..+...+.++.+++.+||+.||++||++.|+++.|++.
T Consensus       337 ----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         337 ----LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             ----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence                01112234689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2e-36  Score=330.69  Aligned_cols=251  Identities=25%  Similarity=0.420  Sum_probs=216.4

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCccc--cHHHHHHHHHHhhccCCCceeeEEEEEecCCe-eEEEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQ--GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAE-MFLVY  850 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv~  850 (1052)
                      ++|...+++|+|+||.++.++++ ++..+++|++...+..  ..+....|+.++++++|||||.+.+.|.+++. .++||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            57889999999999999999665 5778999998765433  33467889999999999999999999999988 99999


Q ss_pred             eecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccC
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~  930 (1052)
                      +|++||++.+.+.+.++..++++.+.+|+.|++.|+.|||++   +|+|||||+.||+++.++.|||+|||+|+..++..
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            999999999999998888899999999999999999999998   99999999999999999999999999999887544


Q ss_pred             cccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccch
Q 001566          931 THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010 (1052)
Q Consensus       931 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1052)
                       .....++||+.||+||.+.+.+|..|+||||+||++|||++-+++|...        +....+..+.+..         
T Consensus       161 -~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~--------~m~~Li~ki~~~~---------  222 (426)
T KOG0589|consen  161 -SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS--------NMSELILKINRGL---------  222 (426)
T ss_pred             -hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc--------chHHHHHHHhhcc---------
Confidence             3455678999999999999999999999999999999999999999843        2333333333322         


Q ss_pred             hhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001566         1011 LWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus      1011 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                       ....|..+..++..+|+.|+..+|+.||++.+++..
T Consensus       223 -~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  223 -YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             -CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence             223355566679999999999999999999999864

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-35  Score=339.06  Aligned_cols=260  Identities=24%  Similarity=0.274  Sum_probs=199.4

Q ss_pred             hCCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      .++|++.+.||+|+||.||+|.. .+++.||+|+..      ...+.+|++++++++||||+++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            35799999999999999999954 568899999643      23567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      + .++|.+++...  ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+|+........
T Consensus       165 ~-~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~  238 (391)
T PHA03212        165 Y-KTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN  238 (391)
T ss_pred             C-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence            9 57899988765  4688999999999999999999999   9999999999999999999999999999754322222


Q ss_pred             cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccc-----
Q 001566          933 ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELF----- 1007 (1052)
Q Consensus       933 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 1007 (1052)
                      ......||+.|+|||++.+..++.++||||+||++|||++|+.||.......................+.....+     
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~  318 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ  318 (391)
T ss_pred             ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence            333457999999999999999999999999999999999999887643221111111111111111111100000     


Q ss_pred             -------------------cchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1008 -------------------LPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1008 -------------------~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                                         ....+. .....+.++.+++.+|++.||++|||++|+++
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        319 ANLDEIYIGLAKKSSRKPGSRPLWT-NLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHHHHHHHhccCCCCCCCCCHH-HHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence                               000000 00123557889999999999999999999985

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.1e-36  Score=313.53  Aligned_cols=247  Identities=22%  Similarity=0.393  Sum_probs=209.9

Q ss_pred             hCCCccceeeeccCceEEEEE-EecCCcEEEEEEeccCccc---cHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEE
Q 001566          774 TGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ---GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLV  849 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  849 (1052)
                      ..+|++.+.||+|.||.|-+| ++..|+.||||.++....+   +.-.+.+|+++|..++||||+.++.+|+..+...+|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            357899999999999999999 5578999999988765444   345578999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccccccc
Q 001566          850 YNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS  929 (1052)
Q Consensus       850 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~  929 (1052)
                      |||..+|.|+||+..+  +.+++.++..++.||+.|+.|+|..   +++|||+|.+|||+|+++++||+|||++-.+.  
T Consensus       132 MEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~--  204 (668)
T KOG0611|consen  132 MEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA--  204 (668)
T ss_pred             EEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc--
Confidence            9999999999999887  5799999999999999999999999   99999999999999999999999999998775  


Q ss_pred             CcccccccccccccccccccCCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCcccccc
Q 001566          930 ETHATTDVAGTFGYVAPEYATTCRVS-DKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFL 1008 (1052)
Q Consensus       930 ~~~~~~~~~g~~~y~aPE~~~~~~~~-~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                      +....+.++|++-|.+||++.|.+|. +..|.||+||++|-++.|.-||++.        +....++++.......    
T Consensus       205 ~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~--------Dhk~lvrQIs~GaYrE----  272 (668)
T KOG0611|consen  205 DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR--------DHKRLVRQISRGAYRE----  272 (668)
T ss_pred             cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc--------hHHHHHHHhhcccccC----
Confidence            33445667899999999999999885 7899999999999999999999843        3333444443322211    


Q ss_pred             chhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001566         1009 PELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus      1009 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                              ++.+....-||++|+..+|++|.|+.+|...
T Consensus       273 --------P~~PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  273 --------PETPSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             --------CCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence                    1122236679999999999999999998753

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-36  Score=339.30  Aligned_cols=253  Identities=24%  Similarity=0.399  Sum_probs=212.8

Q ss_pred             CCccceeeeccCceEEEEEEecC-----CcEEEEEEeccCcc-ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEE
Q 001566          776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLV  849 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  849 (1052)
                      ..+..++||.|+||+||+|.|-.     +.+||+|++..... +...++.+|+..|.++.|||+++++|+|..+. ..+|
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv  775 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV  775 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence            35667899999999999996643     35789998865433 34678999999999999999999999998765 8899


Q ss_pred             EeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccccccc
Q 001566          850 YNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS  929 (1052)
Q Consensus       850 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~  929 (1052)
                      ++||+.|+|.+|++.++ ..+..+..+.|..|||+||.|||++   +++||||.++||||++-..+||+|||+|+...+.
T Consensus       776 tq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  776 TQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            99999999999999876 6788999999999999999999999   9999999999999999999999999999988654


Q ss_pred             Cc-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCccccc
Q 001566          930 ET-HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELF 1007 (1052)
Q Consensus       930 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1052)
                      +. +......-++.|||-|.+....|+.++|||||||++||++| |..|++..        ...+ +....+.+...   
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi--------~~~e-I~dlle~geRL---  919 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGI--------PAEE-IPDLLEKGERL---  919 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCC--------CHHH-hhHHHhccccC---
Confidence            33 33334455679999999999999999999999999999999 88888732        2222 33344433322   


Q ss_pred             cchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1008 LPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1008 ~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                            ..|+.+..++.-++.+||..|++.||+++++..++.++
T Consensus       920 ------sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~  957 (1177)
T KOG1025|consen  920 ------SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM  957 (1177)
T ss_pred             ------CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence                  34777888899999999999999999999999988764

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-35  Score=329.52  Aligned_cols=244  Identities=25%  Similarity=0.326  Sum_probs=201.6

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCcc---ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF---QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      ++|++.+.||+|+||.||+|... +++.||+|++.....   +..+.+.+|++++++++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36889999999999999999664 689999999865332   23456888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccC
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~  930 (1052)
                      ||+++|+|.+++...  ..+++..+..++.|++.|++|||++   +|+||||||+||++++++.+||+|||++...... 
T Consensus        81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-  154 (291)
T cd05612          81 EYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-  154 (291)
T ss_pred             eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence            999999999999765  4689999999999999999999999   9999999999999999999999999999865421 


Q ss_pred             cccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccch
Q 001566          931 THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010 (1052)
Q Consensus       931 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1052)
                         .....|++.|+|||++.+..++.++||||+||++|||++|+.||....        ..+..+.... +..       
T Consensus       155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~--------~~~~~~~i~~-~~~-------  215 (291)
T cd05612         155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN--------PFGIYEKILA-GKL-------  215 (291)
T ss_pred             ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHh-CCc-------
Confidence               223468999999999999899999999999999999999999997432        1222222222 111       


Q ss_pred             hhcCCChHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 001566         1011 LWEAGPQENLLGMMRLASTCTVETLSTRPS-----VKQVLI 1046 (1052)
Q Consensus      1011 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt-----~~eil~ 1046 (1052)
                         ..+......+.+++++|++.||.+||+     +.|+++
T Consensus       216 ---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         216 ---EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             ---CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence               112222445889999999999999995     887764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-36  Score=344.96  Aligned_cols=259  Identities=26%  Similarity=0.377  Sum_probs=212.4

Q ss_pred             HHhhCCCccceeeeccCceEEEEEEecCC-cEEEEEEeccCccccHHHHHHHHHHhhccC-CCceeeEEEE-Eec-----
Q 001566          771 VRATGNFSIRNLIGTGGFGSTYKAELVPG-YLVAVKKLSIGRFQGIQQFDAEIGTLGRIR-HKNLVTLIGY-YVG-----  842 (1052)
Q Consensus       771 ~~~~~~~~~~~~Lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~-~~~-----  842 (1052)
                      .+...++++.++|.+|||+.||.|....+ ..||+|++...+....+...+|+++|++++ |+|||.+++. ...     
T Consensus        33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~  112 (738)
T KOG1989|consen   33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN  112 (738)
T ss_pred             EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence            34556788999999999999999976655 999999998888888899999999999996 9999999993 221     


Q ss_pred             -CCeeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeec
Q 001566          843 -EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFG  921 (1052)
Q Consensus       843 -~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfg  921 (1052)
                       ..++++.||||+||.|-|++..+-...+++.++++|+.++++|+++||.. .|.|||||||.+|||+..++..||||||
T Consensus       113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFG  191 (738)
T KOG1989|consen  113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFG  191 (738)
T ss_pred             ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccc
Confidence             24689999999999999999987767799999999999999999999986 5679999999999999999999999999


Q ss_pred             ccccccccCcc--------cccccccccccccccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccH
Q 001566          922 LARLLEVSETH--------ATTDVAGTFGYVAPEYAT---TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI  990 (1052)
Q Consensus       922 la~~~~~~~~~--------~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~  990 (1052)
                      .|.-.-.....        ..-....|+.|+|||++.   +...++|+|||++||+||-++....||+.....       
T Consensus       192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-------  264 (738)
T KOG1989|consen  192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-------  264 (738)
T ss_pred             ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-------
Confidence            98744222111        011235789999999874   677899999999999999999999999843211       


Q ss_pred             HHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566          991 VSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                            .+..+.+.        -...+.+...+.+||+.||+++|++||++.+++..+-+|
T Consensus       265 ------aIlng~Y~--------~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l  311 (738)
T KOG1989|consen  265 ------AILNGNYS--------FPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL  311 (738)
T ss_pred             ------eEEecccc--------CCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence                  01111111        112246677899999999999999999999999988765

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-36  Score=319.96  Aligned_cols=254  Identities=25%  Similarity=0.370  Sum_probs=199.3

Q ss_pred             HHhhCCCccceeeeccCceEEEEEE-ecCCcEEEEEEeccCccc--------------cHHHHHHHHHHhhccCCCceee
Q 001566          771 VRATGNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQ--------------GIQQFDAEIGTLGRIRHKNLVT  835 (1052)
Q Consensus       771 ~~~~~~~~~~~~Lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--------------~~~~~~~e~~~l~~l~h~niv~  835 (1052)
                      .+.-++|++.+.||+|.||.|-+|. ..+++.||||++.+....              ..+...+|+.+|++++|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            3445789999999999999999994 456899999998543211              1467889999999999999999


Q ss_pred             EEEEEec--CCeeEEEEeecCCCCHHHHHhhccCCc-ccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC
Q 001566          836 LIGYYVG--EAEMFLVYNFLSGGNLETFIHKKSGKK-IQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEE  912 (1052)
Q Consensus       836 l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~  912 (1052)
                      ++++..+  .+.+|+|+|||..|.+..   ....+. +++.++++++.+++.||+|||.+   |||||||||.|+|++++
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w---~p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~  246 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKW---CPPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSD  246 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCcccc---CCCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCC
Confidence            9999875  467999999998887643   223344 89999999999999999999999   99999999999999999


Q ss_pred             CcEEEeeecccccccccC----cccccccccccccccccccCCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCcccC
Q 001566          913 LNAYLSDFGLARLLEVSE----THATTDVAGTFGYVAPEYATTCR----VSDKADVYSFGVVLLELISGKRSLDPSFSEY  984 (1052)
Q Consensus       913 ~~~kl~Dfgla~~~~~~~----~~~~~~~~g~~~y~aPE~~~~~~----~~~~sDvwslG~il~elltg~~p~~~~~~~~  984 (1052)
                      |++||+|||.+..+..+.    .......+|||.|+|||...++.    .+.+.||||+||++|-|+.|+.||..++.. 
T Consensus       247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~-  325 (576)
T KOG0585|consen  247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL-  325 (576)
T ss_pred             CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH-
Confidence            999999999998774321    11223368999999999987733    246789999999999999999999754321 


Q ss_pred             CCCccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001566          985 GNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus       985 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                             +....+..         ..+.....+++...+.+||++++++||++|.+..+|...
T Consensus       326 -------~l~~KIvn---------~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H  372 (576)
T KOG0585|consen  326 -------ELFDKIVN---------DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH  372 (576)
T ss_pred             -------HHHHHHhc---------CcccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence                   11111111         111112223456779999999999999999999988643

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3e-35  Score=325.47  Aligned_cols=266  Identities=23%  Similarity=0.283  Sum_probs=201.7

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCcc--ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEe
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYN  851 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  851 (1052)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++.....  ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            36899999999999999999775 578999999865432  234677899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCc
Q 001566          852 FLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET  931 (1052)
Q Consensus       852 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~  931 (1052)
                      |++++.+..+.+.  ...++++.+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++........
T Consensus        81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  155 (287)
T cd07848          81 YVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN  155 (287)
T ss_pred             cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence            9988776655432  24689999999999999999999999   999999999999999999999999999987643333


Q ss_pred             ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccH--------HHHHHHHHHhCCc
Q 001566          932 HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI--------VSWAKLLIKEGRS 1003 (1052)
Q Consensus       932 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~--------~~~~~~~~~~~~~ 1003 (1052)
                      .......|++.|+|||++.+..++.++||||+||++|||++|+.||........ ....        .++.+........
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07848         156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ-LFTIQKVLGPLPAEQMKLFYSNPRF  234 (287)
T ss_pred             ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhCCCCHHHHHhhhccchh
Confidence            333445689999999999998899999999999999999999999974321100 0000        0000000000000


Q ss_pred             cccccchh------hcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1004 SELFLPEL------WEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1004 ~~~~~~~l------~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      .....+..      ........+..+.+++.+|++.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00000000      00111123456999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=331.26  Aligned_cols=243  Identities=24%  Similarity=0.359  Sum_probs=204.2

Q ss_pred             hhCCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCc---cccHHHHHHHHHHhhcc-CCCceeeEEEEEecCCeeE
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEAEMF  847 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  847 (1052)
                      .-++|.+.++||+|.||+|++|+.+ +++.+|||++++..   .++.+..+.|.+++... +||+++.++.+|+..+++|
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            3457999999999999999999776 57899999998764   34567778888888887 5999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccccc
Q 001566          848 LVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE  927 (1052)
Q Consensus       848 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~  927 (1052)
                      +||||+.||++..+.+   .+.+++..+.-+|..|+.||.|||++   +||+||+|.+|||+|.+|.+||+|||+++.--
T Consensus       446 fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m  519 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM  519 (694)
T ss_pred             EEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccC
Confidence            9999999999443333   35699999999999999999999999   99999999999999999999999999998432


Q ss_pred             ccCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccc
Q 001566          928 VSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELF 1007 (1052)
Q Consensus       928 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1052)
                       .....+....|||.|||||++.+..|+.++|.|||||++|||+.|..||.++.++        +....+..+.      
T Consensus       520 -~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe--------e~FdsI~~d~------  584 (694)
T KOG0694|consen  520 -GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE--------EVFDSIVNDE------  584 (694)
T ss_pred             -CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHhcCC------
Confidence             2334567789999999999999999999999999999999999999999865443        2222222111      


Q ss_pred             cchhhcCCChHHHHHHHHHHHHccccCCCCCCCH
Q 001566         1008 LPELWEAGPQENLLGMMRLASTCTVETLSTRPSV 1041 (1052)
Q Consensus      1008 ~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~ 1041 (1052)
                           ..+|.....+...++++++..+|++|.-+
T Consensus       585 -----~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  585 -----VRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             -----CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence                 12455666779999999999999999865

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4.9e-35  Score=317.80  Aligned_cols=252  Identities=25%  Similarity=0.413  Sum_probs=205.3

Q ss_pred             CCCccceeeeccCceEEEEEEecCCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecC
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLS  854 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  854 (1052)
                      ++|++.+.||+|+||.||.|++.++..+|+|.+..... ..+++.+|+.++++++||||+++++++.+....++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            45888899999999999999887777899998875432 34678999999999999999999999998889999999999


Q ss_pred             CCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcccc
Q 001566          855 GGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT  934 (1052)
Q Consensus       855 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  934 (1052)
                      +++|.+++.... ..+++.++.+++.|++.|++|||+.   +++|+||||+||++++++.+||+|||.++..........
T Consensus        83 ~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~  158 (256)
T cd05113          83 NGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS  158 (256)
T ss_pred             CCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence            999999997654 3689999999999999999999999   999999999999999999999999999886543322222


Q ss_pred             cccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhc
Q 001566          935 TDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWE 1013 (1052)
Q Consensus       935 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1013 (1052)
                      ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......        +...... .+...         
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~-~~~~~---------  220 (256)
T cd05113         159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--------ETVEKVS-QGLRL---------  220 (256)
T ss_pred             CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHh-cCCCC---------
Confidence            22345678999999998889999999999999999999 88888632211        1122221 11111         


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 001566         1014 AGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLK 1049 (1052)
Q Consensus      1014 ~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~ 1049 (1052)
                      ..+......+.+++.+||+.+|++||++.++++.++
T Consensus       221 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            011123456899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=5.6e-35  Score=318.30  Aligned_cols=255  Identities=27%  Similarity=0.438  Sum_probs=208.1

Q ss_pred             hCCCccceeeeccCceEEEEEEecCCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeec
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFL  853 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  853 (1052)
                      .++|++.+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|++++++++++. ....+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM   82 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence            457899999999999999999888888899999875443 3467899999999999999999999885 45689999999


Q ss_pred             CCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccc
Q 001566          854 SGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA  933 (1052)
Q Consensus       854 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  933 (1052)
                      ++++|.++++......++++++..++.|++.|++|||+.   +|+||||+|+||++++++.++|+|||.+..........
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05070          83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence            999999999876556689999999999999999999999   99999999999999999999999999998664333222


Q ss_pred             ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhh
Q 001566          934 TTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012 (1052)
Q Consensus       934 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1012 (1052)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |..||....        ..+...... .+...        
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~--------~~~~~~~~~-~~~~~--------  222 (260)
T cd05070         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN--------NREVLEQVE-RGYRM--------  222 (260)
T ss_pred             ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC--------HHHHHHHHH-cCCCC--------
Confidence            223345678999999998889999999999999999999 888886321        112222221 11111        


Q ss_pred             cCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1013 EAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1013 ~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                       ..+...+..+.+++.+|++.+|++|||++++.+.|+++
T Consensus       223 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  260 (260)
T cd05070         223 -PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLEDY  260 (260)
T ss_pred             -CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence             11223345699999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.2e-35  Score=325.90  Aligned_cols=256  Identities=27%  Similarity=0.436  Sum_probs=207.9

Q ss_pred             CCCccceeeeccCceEEEEEEecC------CcEEEEEEeccCcc-ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELVP------GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMF  847 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  847 (1052)
                      ++|++.+.||+|+||.||+|....      ...||+|.+..... ....++.+|++++++++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            468899999999999999996543      25799998865433 23467889999999999999999999999989999


Q ss_pred             EEEeecCCCCHHHHHhhccC--------------CcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC
Q 001566          848 LVYNFLSGGNLETFIHKKSG--------------KKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEEL  913 (1052)
Q Consensus       848 lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~  913 (1052)
                      ++|||+++++|.+++.....              ..+++.++..++.|++.|++|||++   +|+||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence            99999999999999976421              4578899999999999999999999   999999999999999999


Q ss_pred             cEEEeeecccccccccCc-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHH
Q 001566          914 NAYLSDFGLARLLEVSET-HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIV  991 (1052)
Q Consensus       914 ~~kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~  991 (1052)
                      .++|+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.....        .
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~--------~  233 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN--------Q  233 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH--------H
Confidence            999999999986543322 22333456788999999998899999999999999999998 9999874321        1


Q ss_pred             HHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566          992 SWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus       992 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                      +..+ .+..+...         ..+...+..+.+++.+||+.||++||++.|+++.|+.+
T Consensus       234 ~~~~-~i~~~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         234 EVIE-MIRSRQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             HHHH-HHHcCCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            2222 22222111         12334556799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.9e-35  Score=332.26  Aligned_cols=241  Identities=22%  Similarity=0.295  Sum_probs=196.8

Q ss_pred             eeeeccCceEEEEEEe-cCCcEEEEEEeccCc---cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecCCC
Q 001566          781 NLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGG  856 (1052)
Q Consensus       781 ~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  856 (1052)
                      +.||+|+||.||+|.. .+|+.||+|++....   ......+.+|++++++++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999965 468999999987532   223456788999999999999999999999999999999999999


Q ss_pred             CHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcccccc
Q 001566          857 NLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD  936 (1052)
Q Consensus       857 sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~  936 (1052)
                      +|.+++...  ..+++.++..++.||+.|++|||+.   +|+||||||+||+++.++.+||+|||+++.... .......
T Consensus        81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~-~~~~~~~  154 (323)
T cd05571          81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKT  154 (323)
T ss_pred             cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCccccc-CCCcccc
Confidence            999999765  4689999999999999999999999   999999999999999999999999999875321 1122334


Q ss_pred             cccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCCC
Q 001566          937 VAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGP 1016 (1052)
Q Consensus       937 ~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 1016 (1052)
                      ..|++.|+|||++.+..++.++||||+||++|||++|+.||.....        ........ .+..          ..+
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--------~~~~~~~~-~~~~----------~~p  215 (323)
T cd05571         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELIL-MEEI----------RFP  215 (323)
T ss_pred             eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH--------HHHHHHHH-cCCC----------CCC
Confidence            5689999999999999999999999999999999999999974211        11112111 1111          112


Q ss_pred             hHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 001566         1017 QENLLGMMRLASTCTVETLSTRP-----SVKQVLI 1046 (1052)
Q Consensus      1017 ~~~~~~l~~Li~~cl~~dP~~RP-----t~~eil~ 1046 (1052)
                      ......+.+++.+|++.||++||     ++.++++
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            23345688999999999999999     7888864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-35  Score=334.14  Aligned_cols=253  Identities=21%  Similarity=0.307  Sum_probs=204.3

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCc---cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      ++|++.+.||+|+||.||+|... +++.||+|++....   ......+..|+++++.++||||+++++++.+....|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36899999999999999999765 58899999986542   223456788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccC
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~  930 (1052)
                      ||+++|+|.+++...  ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++.....  
T Consensus        81 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--  153 (333)
T cd05600          81 EYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--  153 (333)
T ss_pred             eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence            999999999999765  4688999999999999999999999   999999999999999999999999999985542  


Q ss_pred             cccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccch
Q 001566          931 THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010 (1052)
Q Consensus       931 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1052)
                        ......|++.|+|||++.+..++.++||||+||++|||++|+.||.....        .+...........   +...
T Consensus       154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~~~~---~~~~  220 (333)
T cd05600         154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP--------NETWENLKYWKET---LQRP  220 (333)
T ss_pred             --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH--------HHHHHHHHhcccc---ccCC
Confidence              23345689999999999999999999999999999999999999974321        1111111111100   0000


Q ss_pred             hhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001566         1011 LWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus      1011 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                      ............+.+++.+|+..+|++||+++|+++.
T Consensus       221 ~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         221 VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            0000001234568899999999999999999999863

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=8.2e-35  Score=317.24  Aligned_cols=255  Identities=28%  Similarity=0.439  Sum_probs=207.1

Q ss_pred             hCCCccceeeeccCceEEEEEEecCCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeec
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFL  853 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  853 (1052)
                      .++|++.++||+|+||.||+|...++..||+|+++.... ..+++.+|++++++++|||++++++++. ....++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence            457999999999999999999877777899999875333 3467899999999999999999999875 45689999999


Q ss_pred             CCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccc
Q 001566          854 SGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA  933 (1052)
Q Consensus       854 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  933 (1052)
                      ++|+|.+++.......++++.+..++.|+++|++|+|+.   +|+||||||+||++++++.++|+|||.+..........
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~  159 (262)
T cd05071          83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  159 (262)
T ss_pred             CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence            999999999876555689999999999999999999999   99999999999999999999999999998665433322


Q ss_pred             ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhh
Q 001566          934 TTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012 (1052)
Q Consensus       934 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1012 (1052)
                      .....++..|+|||...+..++.++||||+|+++|||+| |..||......        +..... ..+...        
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~--------~~~~~~-~~~~~~--------  222 (262)
T cd05071         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--------EVLDQV-ERGYRM--------  222 (262)
T ss_pred             ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH--------HHHHHH-hcCCCC--------
Confidence            233456678999999998899999999999999999999 77777532111        111111 111100        


Q ss_pred             cCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1013 EAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1013 ~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                       ..+...+..+.+++.+|++.+|++||++.++++.|++.
T Consensus       223 -~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         223 -PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             -CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence             11234456689999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=9.8e-35  Score=327.66  Aligned_cols=199  Identities=28%  Similarity=0.458  Sum_probs=175.4

Q ss_pred             hCCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCcc-ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEe
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYN  851 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  851 (1052)
                      .++|++.+.||+|+||.||+|... ++..||+|.+..... ...+++.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            467999999999999999999665 588899998875432 234678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCc
Q 001566          852 FLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET  931 (1052)
Q Consensus       852 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~  931 (1052)
                      |+++++|.+++...  ..+++..+..++.|++.|+.|||+++  +|+||||||+||+++.++.+||+|||++......  
T Consensus        84 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  157 (331)
T cd06649          84 HMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (331)
T ss_pred             cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence            99999999999765  36889999999999999999999862  6999999999999999999999999998755322  


Q ss_pred             ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 001566          932 HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDP  979 (1052)
Q Consensus       932 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~  979 (1052)
                       ......|++.|+|||.+.+..++.++||||+||++|||++|+.||..
T Consensus       158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~  204 (331)
T cd06649         158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP  204 (331)
T ss_pred             -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence             22334689999999999999999999999999999999999999964

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=308.72  Aligned_cols=263  Identities=23%  Similarity=0.343  Sum_probs=201.0

Q ss_pred             hCCCccceeeeccCceEEEEEE-ecCCcEEEEEEecc--CccccHHHHHHHHHHhhccCCCceeeEEEEEec-----CCe
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSI--GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG-----EAE  845 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~-~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~  845 (1052)
                      ...|...+.||+|+||.|+.|. ..+|+.||||++..  ......++..+|+.+++.++|+||+.+.+++..     -..
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            3456667899999999999994 45789999999862  333445778899999999999999999999875     357


Q ss_pred             eEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccc
Q 001566          846 MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARL  925 (1052)
Q Consensus       846 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~  925 (1052)
                      +|+|+|+| +.+|.+.++..  +.++.+.+..+..|+++|+.|+|+.   +|+|||+||.|++++.+..+||+|||+|+.
T Consensus       101 vYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~  174 (359)
T KOG0660|consen  101 VYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARY  174 (359)
T ss_pred             eEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceee
Confidence            89999999 77999999875  4599999999999999999999999   999999999999999999999999999998


Q ss_pred             cccc-CcccccccccccccccccccC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccC----------CCCccHHH-
Q 001566          926 LEVS-ETHATTDVAGTFGYVAPEYAT-TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEY----------GNGFNIVS-  992 (1052)
Q Consensus       926 ~~~~-~~~~~~~~~g~~~y~aPE~~~-~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~----------~~~~~~~~-  992 (1052)
                      .... .....+..+.|..|.|||.+. ...|+.+.||||.|||+.||++|++-|.+...-.          +....... 
T Consensus       175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~  254 (359)
T KOG0660|consen  175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK  254 (359)
T ss_pred             ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence            7532 223346678899999999875 4678999999999999999999999886432110          00000000 


Q ss_pred             ----HHHHHHHhC-CccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566          993 ----WAKLLIKEG-RSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus       993 ----~~~~~~~~~-~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                          -++..+... .....-...+.    +.......+|+.+|+..||.+|+|++|+++
T Consensus       255 i~s~~ar~yi~slp~~p~~~f~~~f----p~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  255 IRSEKARPYIKSLPQIPKQPFSSIF----PNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             hccHHHHHHHHhCCCCCCCCHHHHc----CCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence                001111100 00000001111    233345889999999999999999999875

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=6.2e-35  Score=317.98  Aligned_cols=256  Identities=25%  Similarity=0.428  Sum_probs=209.8

Q ss_pred             hhCCCccceeeeccCceEEEEEEecCCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      ..++|++.++||+|+||.||+|...+++.||+|.+..... ..+++.+|++++++++|+|++++++++. +...+++|||
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY   81 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence            3467999999999999999999888889999999875443 3568899999999999999999999874 4578999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      +++++|.+++....+..+++.++..++.|++.|++|||+.   +++||||+|+||++++++.++|+|||.+.........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05067          82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence            9999999999876666789999999999999999999998   9999999999999999999999999999866533322


Q ss_pred             cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchh
Q 001566          933 ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPEL 1011 (1052)
Q Consensus       933 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1011 (1052)
                      ......++..|+|||.+.+..++.++||||||+++||+++ |+.||.....        .+..+.. ..+...       
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~-~~~~~~-------  222 (260)
T cd05067         159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN--------PEVIQNL-ERGYRM-------  222 (260)
T ss_pred             cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh--------HHHHHHH-HcCCCC-------
Confidence            2333445678999999998889999999999999999999 9999863221        1222222 111111       


Q ss_pred             hcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1012 WEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1012 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                        ..+...+..+.+++.+|++.+|++||+++++++.|+.+
T Consensus       223 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  260 (260)
T cd05067         223 --PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF  260 (260)
T ss_pred             --CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence              11222344699999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.1e-35  Score=332.58  Aligned_cols=244  Identities=25%  Similarity=0.363  Sum_probs=201.2

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCc---cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            46899999999999999999765 58899999986532   233466889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccC
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~  930 (1052)
                      ||+++|+|.+++...  ..++++.+..++.|++.|++|||++   +|+||||||+||++++++.+||+|||++...... 
T Consensus        98 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-  171 (329)
T PTZ00263         98 EFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-  171 (329)
T ss_pred             cCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence            999999999999765  4688999999999999999999999   9999999999999999999999999999865422 


Q ss_pred             cccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccch
Q 001566          931 THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010 (1052)
Q Consensus       931 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1052)
                         .....|++.|+|||++.+..++.++||||+||++|||++|+.||.....        .+..+.. ..+...      
T Consensus       172 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~i-~~~~~~------  233 (329)
T PTZ00263        172 ---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--------FRIYEKI-LAGRLK------  233 (329)
T ss_pred             ---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH--------HHHHHHH-hcCCcC------
Confidence               1234689999999999999999999999999999999999999964221        1222222 122111      


Q ss_pred             hhcCCChHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 001566         1011 LWEAGPQENLLGMMRLASTCTVETLSTRPS-----VKQVLI 1046 (1052)
Q Consensus      1011 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt-----~~eil~ 1046 (1052)
                          .+......+.+++.+||+.||++||+     ++|+++
T Consensus       234 ----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        234 ----FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             ----CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                11123345889999999999999997     677663

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=6.5e-35  Score=322.61  Aligned_cols=258  Identities=23%  Similarity=0.356  Sum_probs=199.1

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCcc-ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      ++|++.+.||+|+||.||+|... +++.||+|+++.... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            46999999999999999999654 688999999865432 2345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      ++ ++|.+++.... ..+++..+..++.|++.|++|||++   +|+||||||+||++++++.+||+|||+++...... .
T Consensus        85 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-~  158 (288)
T cd07871          85 LD-SDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-K  158 (288)
T ss_pred             CC-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC-c
Confidence            96 59999987653 4578999999999999999999999   99999999999999999999999999997553222 2


Q ss_pred             cccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHH-hCCccc-----
Q 001566          933 ATTDVAGTFGYVAPEYATT-CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIK-EGRSSE----- 1005 (1052)
Q Consensus       933 ~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~----- 1005 (1052)
                      ......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......        +....... .+....     
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~--------~~~~~~~~~~~~~~~~~~~~  230 (288)
T cd07871         159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK--------EELHLIFRLLGTPTEETWPG  230 (288)
T ss_pred             cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHHHhCCCChHHhhc
Confidence            2233467899999999875 56789999999999999999999999643211        11111110 000000     


Q ss_pred             -----cccchhhcC--------CChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1006 -----LFLPELWEA--------GPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1006 -----~~~~~l~~~--------~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                           .+.......        .......+..+++.+|++.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         231 ITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             cccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                 000000000        01122346889999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=7.6e-35  Score=334.04  Aligned_cols=262  Identities=22%  Similarity=0.329  Sum_probs=207.8

Q ss_pred             HHHhhCCCccceeeeccCceEEEEEEec------CCcEEEEEEeccCcc-ccHHHHHHHHHHhhccC-CCceeeEEEEEe
Q 001566          770 VVRATGNFSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR-HKNLVTLIGYYV  841 (1052)
Q Consensus       770 ~~~~~~~~~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~  841 (1052)
                      +....++|++.++||+|+||.||+|...      .+..||||++..... ...+.+.+|+++++++. ||||+++++++.
T Consensus        32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~  111 (400)
T cd05105          32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT  111 (400)
T ss_pred             eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence            3445678999999999999999999653      235799999865433 33467899999999996 999999999999


Q ss_pred             cCCeeEEEEeecCCCCHHHHHhhcc-------------------------------------------------------
Q 001566          842 GEAEMFLVYNFLSGGNLETFIHKKS-------------------------------------------------------  866 (1052)
Q Consensus       842 ~~~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------------------------  866 (1052)
                      +....|+||||+++|+|.++++...                                                       
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (400)
T cd05105         112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM  191 (400)
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence            9999999999999999999986531                                                       


Q ss_pred             ---------------------------------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCE
Q 001566          867 ---------------------------------------GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNI  907 (1052)
Q Consensus       867 ---------------------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Ni  907 (1052)
                                                             ...+++.++.+++.|+++|++|||+.   +|+||||||+||
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Ni  268 (400)
T cd05105         192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNV  268 (400)
T ss_pred             hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhE
Confidence                                                   12477888899999999999999999   999999999999


Q ss_pred             EECCCCcEEEeeecccccccccCc-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCC
Q 001566          908 LLDEELNAYLSDFGLARLLEVSET-HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYG  985 (1052)
Q Consensus       908 ll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~  985 (1052)
                      ++++++.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||......  
T Consensus       269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~--  346 (400)
T cd05105         269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD--  346 (400)
T ss_pred             EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh--
Confidence            999999999999999986543222 12223456788999999999899999999999999999997 88888632111  


Q ss_pred             CCccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566          986 NGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus       986 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                            .........+...         ..+...+..+.+++.+||+.||++||++.++.+.|+++
T Consensus       347 ------~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l  397 (400)
T cd05105         347 ------STFYNKIKSGYRM---------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL  397 (400)
T ss_pred             ------HHHHHHHhcCCCC---------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence                  1111122222111         11233455689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-36  Score=329.68  Aligned_cols=253  Identities=24%  Similarity=0.378  Sum_probs=211.1

Q ss_pred             hCCCccceeeeccCceEEEEEEecC--C--cEEEEEEeccCccc-cHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEE
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELVP--G--YLVAVKKLSIGRFQ-GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFL  848 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  848 (1052)
                      .++..+.+.||+|.||+|++|.|..  |  -.||||.++..... ...+|.+|+.+|.+++|||++++||++.+ ....+
T Consensus       109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM  187 (1039)
T KOG0199|consen  109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM  187 (1039)
T ss_pred             HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence            3456777899999999999998753  3  46899999766544 57899999999999999999999999987 78899


Q ss_pred             EEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccc
Q 001566          849 VYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV  928 (1052)
Q Consensus       849 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~  928 (1052)
                      |||.++.|+|.+.|++.....+-......++.|||.||.||.++   ++||||+.++|+++.....|||+|||+.+-++.
T Consensus       188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGE  264 (1039)
T ss_pred             HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCC
Confidence            99999999999999986557788899999999999999999999   999999999999999999999999999998865


Q ss_pred             cCccc--ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCccc
Q 001566          929 SETHA--TTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005 (1052)
Q Consensus       929 ~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1052)
                      .+.+.  .....-++.|+|||.+....++.++|||+|||++|||+| |..||-+..        -..+.+.+. ++.   
T Consensus       265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~--------g~qIL~~iD-~~e---  332 (1039)
T KOG0199|consen  265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR--------GIQILKNID-AGE---  332 (1039)
T ss_pred             CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC--------HHHHHHhcc-ccc---
Confidence            54332  233455679999999999999999999999999999999 677776332        223333222 111   


Q ss_pred             cccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 001566         1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKL 1048 (1052)
Q Consensus      1006 ~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L 1048 (1052)
                            .-.-|+.+++++.+++++||...|++|||+.++.+.+
T Consensus       333 ------rLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  333 ------RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             ------cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence                  1123667888899999999999999999999997543

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.1e-34  Score=317.28  Aligned_cols=259  Identities=25%  Similarity=0.376  Sum_probs=210.0

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCc---cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      ++|++.+.||+|+||.||+|... +++.||||.+....   .....++.+|+++++.++|||++++++++.+.+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            47899999999999999999654 68999999875432   233456889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcc--CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccc
Q 001566          851 NFLSGGNLETFIHKKS--GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV  928 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~  928 (1052)
                      ||+++++|.+++....  ...++++.+..++.|+++|++|||++   +|+||||+|+||+++.++.++|+|||.+.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999999886432  24578899999999999999999999   999999999999999999999999999886643


Q ss_pred             cCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCcccccc
Q 001566          929 SETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFL 1008 (1052)
Q Consensus       929 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                      .. .......+++.|+|||.+.+..++.++||||+|+++|||++|+.||.....      ...++.......+ ...   
T Consensus       159 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~------~~~~~~~~~~~~~-~~~---  227 (267)
T cd08228         159 KT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLFSLCQKIEQCD-YPP---  227 (267)
T ss_pred             hh-HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc------cHHHHHHHHhcCC-CCC---
Confidence            22 122234678899999999988899999999999999999999999864321      1222332222111 111   


Q ss_pred             chhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccC
Q 001566         1009 PELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQLK 1052 (1052)
Q Consensus      1009 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~lk 1052 (1052)
                           ..+...+..+.+++.+||+.+|++||++.++++.++++|
T Consensus       228 -----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         228 -----LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             -----CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence                 011234456899999999999999999999999999886

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.8e-35  Score=305.46  Aligned_cols=261  Identities=25%  Similarity=0.346  Sum_probs=204.8

Q ss_pred             CCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCccc--cHHHHHHHHHHhhccCCCc-eeeEEEEEecCC------
Q 001566          775 GNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQ--GIQQFDAEIGTLGRIRHKN-LVTLIGYYVGEA------  844 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~------  844 (1052)
                      ..|+..++||+|+||+||+|+. .+|+.||+|++.....+  ......+|+.++++++|+| |+++++++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            3567778899999999999954 46899999999766543  2345689999999999999 999999998877      


Q ss_pred             eeEEEEeecCCCCHHHHHhhccC--CcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecc
Q 001566          845 EMFLVYNFLSGGNLETFIHKKSG--KKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGL  922 (1052)
Q Consensus       845 ~~~lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgl  922 (1052)
                      ..++|+||+ .-+|..|+.....  ..++...+..++.|++.|++|||++   +|+||||||+||+++++|.+||+|||+
T Consensus        91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence            789999999 6799999988753  3577788999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCcccccccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhC
Q 001566          923 ARLLEVSETHATTDVAGTFGYVAPEYATTC-RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEG 1001 (1052)
Q Consensus       923 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1052)
                      |+.+.... ......++|..|.|||++.+. .|+...||||+|||+.||+++++-|.+..+       ..+..+....-|
T Consensus       167 Ara~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-------~~ql~~If~~lG  238 (323)
T KOG0594|consen  167 ARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-------IDQLFRIFRLLG  238 (323)
T ss_pred             HHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-------HHHHHHHHHHcC
Confidence            99665222 224456789999999999886 688999999999999999999988875432       222222222222


Q ss_pred             Cccccccchhh----------cCC-C-------hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001566         1002 RSSELFLPELW----------EAG-P-------QENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus      1002 ~~~~~~~~~l~----------~~~-~-------~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                      ...+...|...          ... +       +.......+++.+|++++|.+|.|++.+++.
T Consensus       239 tP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  239 TPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            22222222111          000 1       1111368899999999999999999999875

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=4.4e-35  Score=324.70  Aligned_cols=258  Identities=25%  Similarity=0.347  Sum_probs=196.4

Q ss_pred             CCCccceeeeccCceEEEEEEec--CCcEEEEEEeccCccc--cHHHHHHHHHHhhcc---CCCceeeEEEEEe-----c
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV--PGYLVAVKKLSIGRFQ--GIQQFDAEIGTLGRI---RHKNLVTLIGYYV-----G  842 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~h~niv~l~~~~~-----~  842 (1052)
                      .+|++.+.||+|+||+||+|+..  +++.||+|++......  ....+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36899999999999999999653  4688999988654322  234556677777665   6999999999985     2


Q ss_pred             CCeeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecc
Q 001566          843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGL  922 (1052)
Q Consensus       843 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgl  922 (1052)
                      ....++||||++ ++|.+++.......+++..+..++.|++.|++|||++   +|+||||||+||++++++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            456899999995 6999999876656789999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHh-C
Q 001566          923 ARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE-G 1001 (1052)
Q Consensus       923 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~ 1001 (1052)
                      +......  .......|++.|+|||.+.+..++.++||||+||++|||++|++||......        +........ +
T Consensus       157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~--------~~~~~i~~~~~  226 (290)
T cd07862         157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--------DQLGKILDVIG  226 (290)
T ss_pred             eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH--------HHHHHHHHHhC
Confidence            9865432  2233456899999999999888999999999999999999999999743221        111111110 0


Q ss_pred             Ccc------------ccccchh---hcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1002 RSS------------ELFLPEL---WEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1002 ~~~------------~~~~~~l---~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ...            ..+.+.-   .....+.....+.+++.+|++.||++|||+.|+++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         227 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             CCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            000            0000000   00001123455789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.6e-34  Score=314.68  Aligned_cols=255  Identities=27%  Similarity=0.434  Sum_probs=206.6

Q ss_pred             hCCCccceeeeccCceEEEEEEecCCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeec
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFL  853 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  853 (1052)
                      .++|++.+.||+|+||.||+|....+..+|+|++.... ...+.+.+|++++++++|+|++++++++. ....++||||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM   82 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence            35689999999999999999988777789999876443 23467889999999999999999999885 45688999999


Q ss_pred             CCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccc
Q 001566          854 SGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA  933 (1052)
Q Consensus       854 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  933 (1052)
                      ++++|.++++......+++..+..++.|++.|++|||+.   +|+||||+|+||++++++.++|+|||.+..........
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05069          83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence            999999999876556689999999999999999999999   99999999999999999999999999998664332222


Q ss_pred             ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhh
Q 001566          934 TTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012 (1052)
Q Consensus       934 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1012 (1052)
                      .....++..|+|||...+..++.++||||+|+++|||++ |+.||.....        .+..... ..+...        
T Consensus       160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~-~~~~~~--------  222 (260)
T cd05069         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN--------REVLEQV-ERGYRM--------  222 (260)
T ss_pred             cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHH-HcCCCC--------
Confidence            223345678999999998889999999999999999999 8888863221        1111111 111111        


Q ss_pred             cCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1013 EAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1013 ~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                       ..+...+..+.+++.+||+.+|++||+++++++.|+++
T Consensus       223 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  260 (260)
T cd05069         223 -PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLEDY  260 (260)
T ss_pred             -CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence             11233455699999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.1e-34  Score=342.04  Aligned_cols=250  Identities=23%  Similarity=0.303  Sum_probs=204.4

Q ss_pred             CCccceeeeccCceEEEEEEec-C-CcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeec
Q 001566          776 NFSIRNLIGTGGFGSTYKAELV-P-GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFL  853 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  853 (1052)
                      .|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+++++.++||||+++++++..++..|+||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4899999999999999999543 3 6788999876555555567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhc--cCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCc
Q 001566          854 SGGNLETFIHKK--SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET  931 (1052)
Q Consensus       854 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~  931 (1052)
                      ++|+|.++++..  ....+++.++..++.|++.||+|+|++   +|+||||||+||+++.++.+||+|||+++.+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999988653  234688999999999999999999999   999999999999999999999999999987643222


Q ss_pred             -ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccch
Q 001566          932 -HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010 (1052)
Q Consensus       932 -~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1052)
                       .......||+.|+|||++.+..++.++||||+||++|||++|+.||....        ..+........ ...      
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~--------~~~~~~~~~~~-~~~------  289 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS--------QREIMQQVLYG-KYD------  289 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhC-CCC------
Confidence             22334568999999999999999999999999999999999999996321        12222222221 111      


Q ss_pred             hhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1011 LWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1011 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                         ..+......+.+++.+|++.||++||++.++++
T Consensus       290 ---~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        290 ---PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             ---CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence               112233456899999999999999999999874

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-34  Score=315.13  Aligned_cols=250  Identities=25%  Similarity=0.406  Sum_probs=203.2

Q ss_pred             CCccceeeeccCceEEEEEEecCCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecCC
Q 001566          776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSG  855 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  855 (1052)
                      +|++.+.||+|+||.||+|.+.++..+|+|.+..... ...++.+|++++++++||||+++++++.+....++||||+++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            5788899999999999999887777899998864332 346788899999999999999999999999999999999999


Q ss_pred             CCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccccc
Q 001566          856 GNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT  935 (1052)
Q Consensus       856 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  935 (1052)
                      ++|.+++.... ..++++.+..++.|++.|++|||+.   +|+||||||+||++++++.+||+|||+++...........
T Consensus        84 ~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~  159 (256)
T cd05059          84 GCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ  159 (256)
T ss_pred             CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence            99999998654 3689999999999999999999999   9999999999999999999999999999765432222222


Q ss_pred             ccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcC
Q 001566          936 DVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEA 1014 (1052)
Q Consensus       936 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 1014 (1052)
                      ...++..|+|||.+.+..++.++||||||+++||+++ |+.||......        +..+.. ..+...         .
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~-~~~~~~---------~  221 (256)
T cd05059         160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--------EVVESV-SAGYRL---------Y  221 (256)
T ss_pred             CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--------HHHHHH-HcCCcC---------C
Confidence            2234568999999999899999999999999999999 78888632111        111111 111110         1


Q ss_pred             CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 001566         1015 GPQENLLGMMRLASTCTVETLSTRPSVKQVLIKL 1048 (1052)
Q Consensus      1015 ~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L 1048 (1052)
                      .+...+..+.+++.+||+.+|++||++.|+++.|
T Consensus       222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            1223455699999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4.1e-35  Score=330.79  Aligned_cols=245  Identities=26%  Similarity=0.367  Sum_probs=200.9

Q ss_pred             hCCCccceeeeccCceEEEEEEecC--CcEEEEEEeccCc---cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEE
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELVP--GYLVAVKKLSIGR---FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFL  848 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~~--~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  848 (1052)
                      .++|++.+.||+|+||.||+|....  +..||+|++....   ....+.+.+|+++++.++||||+++++++.+....++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            3569999999999999999996543  3689999886432   2334668889999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccc
Q 001566          849 VYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV  928 (1052)
Q Consensus       849 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~  928 (1052)
                      ||||+++|+|.+++...  ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||++.....
T Consensus       109 v~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            99999999999999765  4689999999999999999999999   999999999999999999999999999986542


Q ss_pred             cCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCcccccc
Q 001566          929 SETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFL 1008 (1052)
Q Consensus       929 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                      .    .....||+.|+|||++.+..++.++||||+||++|||++|+.||....+        ....+... .+..     
T Consensus       184 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--------~~~~~~i~-~~~~-----  245 (340)
T PTZ00426        184 R----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP--------LLIYQKIL-EGII-----  245 (340)
T ss_pred             C----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH--------HHHHHHHh-cCCC-----
Confidence            2    2335689999999999998899999999999999999999999974321        11112221 1111     


Q ss_pred             chhhcCCChHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 001566         1009 PELWEAGPQENLLGMMRLASTCTVETLSTRP-----SVKQVLI 1046 (1052)
Q Consensus      1009 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RP-----t~~eil~ 1046 (1052)
                           ..+......+.+++++|++.||++|+     +++|+++
T Consensus       246 -----~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        246 -----YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             -----CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence                 11222334578999999999999995     7888765

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-34  Score=315.71  Aligned_cols=255  Identities=27%  Similarity=0.440  Sum_probs=207.0

Q ss_pred             CCCccceeeeccCceEEEEEEecC----CcEEEEEEeccCcc-ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELVP----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLV  849 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  849 (1052)
                      ++|++.+.||+|+||.||+|.+..    ...||+|+++.... ....++.+|+.++++++||||+++++++.+.+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            568999999999999999997642    45799998865433 3346788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccccccc
Q 001566          850 YNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS  929 (1052)
Q Consensus       850 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~  929 (1052)
                      |||+++++|.+++.... ..+++.++.+++.|++.|++|||+.   +|+||||||+||++++++.++|+|||++......
T Consensus        84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          84 TEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             EEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            99999999999997754 4689999999999999999999998   9999999999999999999999999999876522


Q ss_pred             C-cccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCccccc
Q 001566          930 E-THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELF 1007 (1052)
Q Consensus       930 ~-~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1052)
                      . ........++..|+|||.+.+..++.++||||||+++|||++ |..||.....        .+..... ..+...   
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~--------~~~~~~~-~~~~~~---  227 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN--------QDVIKAV-EDGYRL---  227 (266)
T ss_pred             ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH--------HHHHHHH-HcCCCC---
Confidence            1 112222345678999999999899999999999999999998 9888853211        1112222 111111   


Q ss_pred             cchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1008 LPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1008 ~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                            ..+..++..+.+++.+|++.+|++||++.|+++.|+++
T Consensus       228 ------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         228 ------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                  11223445689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.6e-34  Score=322.13  Aligned_cols=260  Identities=23%  Similarity=0.348  Sum_probs=199.5

Q ss_pred             hCCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCccc-cHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEe
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQ-GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYN  851 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  851 (1052)
                      .++|++.+.||+|+||+||+|... +++.||+|++...... ....+.+|+.+++.++||||+++++++.++...++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            367999999999999999999765 6889999998754332 23467889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCc
Q 001566          852 FLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET  931 (1052)
Q Consensus       852 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~  931 (1052)
                      |+ .++|.+++.... ..++++.+..++.|++.|++|||++   +|+||||||+||++++++.+||+|||++...... .
T Consensus        84 ~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~  157 (303)
T cd07869          84 YV-HTDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP-S  157 (303)
T ss_pred             CC-CcCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC-C
Confidence            99 578888887653 5688999999999999999999999   9999999999999999999999999998754322 1


Q ss_pred             ccccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHh-CCcc-----
Q 001566          932 HATTDVAGTFGYVAPEYATT-CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE-GRSS----- 1004 (1052)
Q Consensus       932 ~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~----- 1004 (1052)
                      .......+++.|+|||++.+ ..++.++||||+||++|||++|+.||.....       ..+..+..... +...     
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~~~  230 (303)
T cd07869         158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD-------IQDQLERIFLVLGTPNEDTWP  230 (303)
T ss_pred             ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc-------HHHHHHHHHHHhCCCChhhcc
Confidence            22234567899999999875 4578899999999999999999999974321       11111111110 0000     


Q ss_pred             -----ccccchhhcC-CC---------hHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1005 -----ELFLPELWEA-GP---------QENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1005 -----~~~~~~l~~~-~~---------~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                           ..+++..... .+         ......+.+++.+|++.||++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         231 GVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             chhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence                 0011110000 00         011245789999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.2e-34  Score=319.61  Aligned_cols=255  Identities=24%  Similarity=0.410  Sum_probs=207.0

Q ss_pred             CCCccceeeeccCceEEEEEEecC------CcEEEEEEeccCccc-cHHHHHHHHHHhhccCCCceeeEEEEEecCCeeE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELVP------GYLVAVKKLSIGRFQ-GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMF  847 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  847 (1052)
                      ++|.+.+.||+|+||.||+|....      ++.||+|.++..... ..+.+.+|++++++++|+|++++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            468889999999999999996633      478999998765444 4578899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhhcc------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcE
Q 001566          848 LVYNFLSGGNLETFIHKKS------------GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNA  915 (1052)
Q Consensus       848 lv~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~  915 (1052)
                      +||||+++++|.++++...            ...+++.++..++.|++.|++|||++   +++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence            9999999999999997642            23578899999999999999999999   99999999999999999999


Q ss_pred             EEeeecccccccccCc-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHH
Q 001566          916 YLSDFGLARLLEVSET-HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSW  993 (1052)
Q Consensus       916 kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  993 (1052)
                      +|+|||++........ .......+++.|+|||++.+..++.++||||+|+++|||++ |..||......        +.
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~--------~~  233 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE--------EV  233 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--------HH
Confidence            9999999976533222 11223345788999999999999999999999999999999 99998633211        11


Q ss_pred             HHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 001566          994 AKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQ 1050 (1052)
Q Consensus       994 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~ 1050 (1052)
                      .... ..+...         ..+...+..+.+++.+||+.||++||++.|+++.|++
T Consensus       234 ~~~~-~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         234 IECI-TQGRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             HHHH-HcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            2221 122111         1122344568999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=7.4e-35  Score=327.27  Aligned_cols=241  Identities=23%  Similarity=0.298  Sum_probs=195.7

Q ss_pred             eeeeccCceEEEEEEe-cCCcEEEEEEeccCc---cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecCCC
Q 001566          781 NLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGG  856 (1052)
Q Consensus       781 ~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  856 (1052)
                      +.||+|+||.||+|.. .+|+.||+|++....   ......+.+|++++++++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4699999999999965 468999999986532   233456778999999999999999999999999999999999999


Q ss_pred             CHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcccccc
Q 001566          857 NLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD  936 (1052)
Q Consensus       857 sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~  936 (1052)
                      +|..++...  ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||++...... ......
T Consensus        81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~  154 (323)
T cd05595          81 ELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKT  154 (323)
T ss_pred             cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCcccc
Confidence            999988765  4689999999999999999999999   9999999999999999999999999998753221 122234


Q ss_pred             cccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCCC
Q 001566          937 VAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGP 1016 (1052)
Q Consensus       937 ~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 1016 (1052)
                      ..|++.|+|||.+.+..++.++||||+||++|||++|+.||.....        .+..+...... .          ..+
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--------~~~~~~~~~~~-~----------~~p  215 (323)
T cd05595         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILMEE-I----------RFP  215 (323)
T ss_pred             ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcCC-C----------CCC
Confidence            5689999999999999999999999999999999999999964221        11112221111 0          112


Q ss_pred             hHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 001566         1017 QENLLGMMRLASTCTVETLSTRP-----SVKQVLI 1046 (1052)
Q Consensus      1017 ~~~~~~l~~Li~~cl~~dP~~RP-----t~~eil~ 1046 (1052)
                      ......+.+++.+|++.||++||     ++.++++
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            23345588999999999999998     7888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-34  Score=314.74  Aligned_cols=257  Identities=28%  Similarity=0.431  Sum_probs=211.2

Q ss_pred             hhCCCccceeeeccCceEEEEEEecCCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      ..++|++.++||+|+||.||+|...++..||+|.+..... ..+++.+|+.++++++|+|++++++++......++||||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            4568999999999999999999888788899999875433 347789999999999999999999999988999999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      +++++|.+++....+..+++.++..++.|++.|++|||++   +|+|+||+|+||++++++.++++|||.+.........
T Consensus        83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~  159 (261)
T cd05034          83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT  159 (261)
T ss_pred             cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence            9999999999876666799999999999999999999999   9999999999999999999999999999866532222


Q ss_pred             cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchh
Q 001566          933 ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPEL 1011 (1052)
Q Consensus       933 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1011 (1052)
                      .......+..|+|||.+.+..++.++||||+|+++||+++ |+.||....        .....+... .+..        
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~--------~~~~~~~~~-~~~~--------  222 (261)
T cd05034         160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT--------NREVLEQVE-RGYR--------  222 (261)
T ss_pred             hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHH-cCCC--------
Confidence            2223335568999999999889999999999999999999 898885321        111112111 1110        


Q ss_pred             hcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1012 WEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1012 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                       ...+...+..+.+++.+|++.+|++||+++++.+.|+.+
T Consensus       223 -~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~  261 (261)
T cd05034         223 -MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY  261 (261)
T ss_pred             -CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence             011222345689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7e-35  Score=321.83  Aligned_cols=267  Identities=24%  Similarity=0.345  Sum_probs=202.9

Q ss_pred             CccceeeeccCceEEEEEEe-----cCCcEEEEEEeccCcc-ccHHHHHHHHHHhhccCCCceeeEEEEEecC--CeeEE
Q 001566          777 FSIRNLIGTGGFGSTYKAEL-----VPGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGE--AEMFL  848 (1052)
Q Consensus       777 ~~~~~~Lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  848 (1052)
                      |++.+.||+|+||+||++..     .++..||+|.+..... .....+.+|++++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            38889999999999988642     3578899999875533 2356788999999999999999999988653  46899


Q ss_pred             EEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccc
Q 001566          849 VYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV  928 (1052)
Q Consensus       849 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~  928 (1052)
                      ||||+++++|.+++...   .+++.++..++.|++.|++|||++   +|+||||||+||++++++.++|+|||++.....
T Consensus        86 v~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  159 (283)
T cd05080          86 IMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  159 (283)
T ss_pred             EecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCC
Confidence            99999999999999764   489999999999999999999999   999999999999999999999999999986643


Q ss_pred             cCcc--cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCcccc
Q 001566          929 SETH--ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSEL 1006 (1052)
Q Consensus       929 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      ....  ......++..|+|||.+.+..++.++||||||+++|||+||+.|+..........   ................
T Consensus       160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~  236 (283)
T cd05080         160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEM---IGPKQGQMTVVRLIEL  236 (283)
T ss_pred             cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhh---hcccccccchhhhhhh
Confidence            2211  1122345667999999998889999999999999999999999986432221000   0000000000000000


Q ss_pred             ccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccC
Q 001566         1007 FLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQLK 1052 (1052)
Q Consensus      1007 ~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~lk 1052 (1052)
                      .+.......+...+..+.+++.+||+.+|++||+++++++.|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            0011111123344567999999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.6e-34  Score=319.21  Aligned_cols=265  Identities=27%  Similarity=0.412  Sum_probs=205.4

Q ss_pred             CCCccceeeeccCceEEEEEEec-----CCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEec--CCeeE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-----PGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG--EAEMF  847 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~  847 (1052)
                      .+|++.+.||+|+||.||+|...     +++.||+|++........+.+.+|++++++++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            47889999999999999999642     578999999876666666788999999999999999999998754  34689


Q ss_pred             EEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccccc
Q 001566          848 LVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE  927 (1052)
Q Consensus       848 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~  927 (1052)
                      +|+||+++++|.+++.... ..+++..+..++.|++.|++|||++   +|+||||||+||++++++.+||+|||++....
T Consensus        84 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  159 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLP  159 (284)
T ss_pred             EEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccccc
Confidence            9999999999999997653 4589999999999999999999999   99999999999999999999999999998764


Q ss_pred             ccCcc--cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCC----CC---ccHHHHHHHHH
Q 001566          928 VSETH--ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYG----NG---FNIVSWAKLLI  998 (1052)
Q Consensus       928 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~----~~---~~~~~~~~~~~  998 (1052)
                      .....  ......++..|+|||.+.+..++.++||||+|+++|||++|..|+........    ..   ...........
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05081         160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL  239 (284)
T ss_pred             CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence            32221  11112334569999999988899999999999999999998876542211100    00   00000001111


Q ss_pred             HhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccC
Q 001566          999 KEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQLK 1052 (1052)
Q Consensus       999 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~lk 1052 (1052)
                      .....         ...+...+..+.+++.+||+.+|++|||+.|+++.|+++|
T Consensus       240 ~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~  284 (284)
T cd05081         240 KNNGR---------LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR  284 (284)
T ss_pred             hcCCc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence            11100         0112334456999999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-35  Score=327.14  Aligned_cols=239  Identities=23%  Similarity=0.320  Sum_probs=194.2

Q ss_pred             eeccCceEEEEEEec-CCcEEEEEEeccCc---cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecCCCCH
Q 001566          783 IGTGGFGSTYKAELV-PGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL  858 (1052)
Q Consensus       783 Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  858 (1052)
                      ||+|+||.||+|... +++.||+|++....   ......+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999664 57899999986432   23345678899999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcccccccc
Q 001566          859 ETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVA  938 (1052)
Q Consensus       859 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  938 (1052)
                      .+++...  ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++..... ........
T Consensus        81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~  154 (312)
T cd05585          81 FHHLQRE--GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-DDKTNTFC  154 (312)
T ss_pred             HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccC-CCcccccc
Confidence            9999764  4689999999999999999999999   9999999999999999999999999998754222 22233456


Q ss_pred             cccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCCChH
Q 001566          939 GTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQE 1018 (1052)
Q Consensus       939 g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 1018 (1052)
                      |++.|+|||.+.+..++.++||||+||++|||++|+.||....        ..+..+..... ..          ..+..
T Consensus       155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~--------~~~~~~~~~~~-~~----------~~~~~  215 (312)
T cd05585         155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN--------VNEMYRKILQE-PL----------RFPDG  215 (312)
T ss_pred             CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC--------HHHHHHHHHcC-CC----------CCCCc
Confidence            8999999999999999999999999999999999999997421        22222222211 10          11223


Q ss_pred             HHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 001566         1019 NLLGMMRLASTCTVETLSTRPS---VKQVLI 1046 (1052)
Q Consensus      1019 ~~~~l~~Li~~cl~~dP~~RPt---~~eil~ 1046 (1052)
                      ....+.+++.+||+.||++||+   +.|++.
T Consensus       216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            3456889999999999999985   555543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=9.1e-35  Score=328.01  Aligned_cols=259  Identities=24%  Similarity=0.366  Sum_probs=204.0

Q ss_pred             hhCCCccceeeeccCceEEEEEEec------CCcEEEEEEeccCcc-ccHHHHHHHHHHhhcc-CCCceeeEEEEEec-C
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRI-RHKNLVTLIGYYVG-E  843 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-~  843 (1052)
                      ..++|++.+.||+|+||.||+|...      +++.||+|++..... ...+.+..|+++++++ +|+||+++++++.. +
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            4467999999999999999999532      347899999875432 2345678899999999 89999999998864 4


Q ss_pred             CeeEEEEeecCCCCHHHHHhhccC--------------------------------------------------------
Q 001566          844 AEMFLVYNFLSGGNLETFIHKKSG--------------------------------------------------------  867 (1052)
Q Consensus       844 ~~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------  867 (1052)
                      ...++++||+++++|.+++.....                                                        
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            578899999999999999865321                                                        


Q ss_pred             ---CcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCc-cccccccccccc
Q 001566          868 ---KKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET-HATTDVAGTFGY  943 (1052)
Q Consensus       868 ---~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~g~~~y  943 (1052)
                         ..+++..+.+++.||+.|++|||++   +|+||||||+||++++++.++|+|||++..+..... .......++..|
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y  241 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  241 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence               2678999999999999999999999   999999999999999999999999999986643222 122334566789


Q ss_pred             ccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCCChHHHHH
Q 001566          944 VAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLG 1022 (1052)
Q Consensus       944 ~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 1022 (1052)
                      +|||++.+..++.++||||+||++|||++ |..||......        +........+...         ..+.....+
T Consensus       242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~---------~~~~~~~~~  304 (337)
T cd05054         242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID--------EEFCRRLKEGTRM---------RAPEYATPE  304 (337)
T ss_pred             cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc--------HHHHHHHhccCCC---------CCCccCCHH
Confidence            99999999999999999999999999998 99888642211        1111122221111         112223456


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1023 MMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1023 l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                      +.+++.+||+.+|++||++.|+++.|+++
T Consensus       305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~  333 (337)
T cd05054         305 IYSIMLDCWHNNPEDRPTFSELVEILGDL  333 (337)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            89999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.5e-34  Score=324.21  Aligned_cols=199  Identities=27%  Similarity=0.461  Sum_probs=174.6

Q ss_pred             hCCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCcc-ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEe
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYN  851 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  851 (1052)
                      .++|++.+.||+|+||.||+|... ++..+|+|.+..... ....++.+|++++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            468999999999999999999765 578899998865432 334678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCc
Q 001566          852 FLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET  931 (1052)
Q Consensus       852 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~  931 (1052)
                      |+++++|.+++...  ..+++..+..++.|++.|++|||+.+  +|+||||||+||++++++.+||+|||++......  
T Consensus        84 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--  157 (333)
T cd06650          84 HMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (333)
T ss_pred             cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence            99999999999765  45889999999999999999999752  7999999999999999999999999999755322  


Q ss_pred             ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 001566          932 HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDP  979 (1052)
Q Consensus       932 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~  979 (1052)
                       ......|+..|+|||.+.+..++.++||||+||++|||++|+.||..
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence             12234688999999999998899999999999999999999999974

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=8.6e-35  Score=327.33  Aligned_cols=241  Identities=23%  Similarity=0.320  Sum_probs=196.5

Q ss_pred             eeeeccCceEEEEEEe-cCCcEEEEEEeccCc---cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecCCC
Q 001566          781 NLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGG  856 (1052)
Q Consensus       781 ~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  856 (1052)
                      ++||+|+||.||+|.. .+++.||+|++....   ......+.+|+++++.++||||+++++++.+.+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4689999999999965 468999999986532   233467788999999999999999999999999999999999999


Q ss_pred             CHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcccccc
Q 001566          857 NLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD  936 (1052)
Q Consensus       857 sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~  936 (1052)
                      +|.+++...  ..+++.++..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++..... ......
T Consensus        81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~  154 (328)
T cd05593          81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKT  154 (328)
T ss_pred             CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCc-cccccc
Confidence            999998765  4689999999999999999999999   9999999999999999999999999998753221 122234


Q ss_pred             cccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCCC
Q 001566          937 VAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGP 1016 (1052)
Q Consensus       937 ~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 1016 (1052)
                      ..|++.|+|||.+.+..++.++||||+||++|||++|+.||.....        .+..+.... +..          ..+
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~--------~~~~~~~~~-~~~----------~~p  215 (328)
T cd05593         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELILM-EDI----------KFP  215 (328)
T ss_pred             ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH--------HHHHHHhcc-CCc----------cCC
Confidence            5689999999999998999999999999999999999999964211        122222111 110          112


Q ss_pred             hHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 001566         1017 QENLLGMMRLASTCTVETLSTRP-----SVKQVLI 1046 (1052)
Q Consensus      1017 ~~~~~~l~~Li~~cl~~dP~~RP-----t~~eil~ 1046 (1052)
                      ......+.+++.+|++.||++||     ++.|+++
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence            23345588999999999999997     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.1e-34  Score=327.83  Aligned_cols=251  Identities=26%  Similarity=0.342  Sum_probs=200.0

Q ss_pred             CCccceeeeccCceEEEEEEe----cCCcEEEEEEeccCc----cccHHHHHHHHHHhhcc-CCCceeeEEEEEecCCee
Q 001566          776 NFSIRNLIGTGGFGSTYKAEL----VPGYLVAVKKLSIGR----FQGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEAEM  846 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  846 (1052)
                      +|++.+.||+|+||.||+|+.    .+++.||+|++....    ....+.+..|+++++.+ +|++|+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            488899999999999999964    357899999986432    22345678899999999 599999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccc
Q 001566          847 FLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL  926 (1052)
Q Consensus       847 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~  926 (1052)
                      ++||||+++|+|.+++...  ..++++++..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++..
T Consensus        81 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~  155 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence            9999999999999999765  4689999999999999999999999   9999999999999999999999999999865


Q ss_pred             cccCcccccccccccccccccccCCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccc
Q 001566          927 EVSETHATTDVAGTFGYVAPEYATTCR-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005 (1052)
Q Consensus       927 ~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1052)
                      ............|++.|+|||++.+.. ++.++|||||||++|||+||+.||......    .......+.... .    
T Consensus       156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----~~~~~~~~~~~~-~----  226 (332)
T cd05614         156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER----NTQSEVSRRILK-C----  226 (332)
T ss_pred             cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCC----CCHHHHHHHHhc-C----
Confidence            433333334457899999999998754 788999999999999999999999743221    111122222211 1    


Q ss_pred             cccchhhcCCChHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 001566         1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRP-----SVKQVLI 1046 (1052)
Q Consensus      1006 ~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RP-----t~~eil~ 1046 (1052)
                        ++.    .+......+.+++.+|++.||++||     +++++++
T Consensus       227 --~~~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         227 --DPP----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             --CCC----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence              111    1223344588999999999999999     6777764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.1e-34  Score=318.76  Aligned_cols=256  Identities=25%  Similarity=0.412  Sum_probs=206.9

Q ss_pred             CCCccceeeeccCceEEEEEEec------CCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFL  848 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  848 (1052)
                      .+|.+.+.||+|+||.||++...      ++..+|+|.+..........+.+|++++++++|||++++++++......++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            46889999999999999999642      346689998876655556788999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhhcc-----------CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEE
Q 001566          849 VYNFLSGGNLETFIHKKS-----------GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYL  917 (1052)
Q Consensus       849 v~e~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl  917 (1052)
                      ||||+++++|.+++....           ...+++.++..++.|++.|++|||++   +++||||||+||++++++.++|
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEe
Confidence            999999999999997542           13489999999999999999999999   9999999999999999999999


Q ss_pred             eeecccccccccCc-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHH
Q 001566          918 SDFGLARLLEVSET-HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAK  995 (1052)
Q Consensus       918 ~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  995 (1052)
                      +|||++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||.....        .+..+
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~--------~~~~~  233 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--------NEVIE  233 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHH
Confidence            99999986543221 11223345678999999999899999999999999999999 8888863321        11112


Q ss_pred             HHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566          996 LLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                      . +..+....         .+...+..+.+++.+||+.+|.+|||+.|+.+.|+++
T Consensus       234 ~-i~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~  279 (288)
T cd05093         234 C-ITQGRVLQ---------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL  279 (288)
T ss_pred             H-HHcCCcCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence            2 22222111         1112334589999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.1e-34  Score=319.19  Aligned_cols=256  Identities=24%  Similarity=0.411  Sum_probs=208.2

Q ss_pred             CCCccceeeeccCceEEEEEEec------CCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFL  848 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  848 (1052)
                      ++|.+.+.||+|+||.||+|+..      ++..+++|.+........+.+.+|++.+++++|+||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            45888899999999999999643      345689999876665556778999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhhcc--------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc
Q 001566          849 VYNFLSGGNLETFIHKKS--------------GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELN  914 (1052)
Q Consensus       849 v~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~  914 (1052)
                      ||||+++++|.+++....              ...+++..+.+++.|++.|++|||++   +|+||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence            999999999999997642              23478999999999999999999999   9999999999999999999


Q ss_pred             EEEeeecccccccccCc-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHH
Q 001566          915 AYLSDFGLARLLEVSET-HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVS  992 (1052)
Q Consensus       915 ~kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~  992 (1052)
                      ++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|||+| |+.||......        +
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--------~  233 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT--------E  233 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------H
Confidence            99999999976543221 12233456788999999999999999999999999999999 99988643211        1


Q ss_pred             HHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566          993 WAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                      ..+ ....+....         .+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       234 ~~~-~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~  282 (291)
T cd05094         234 VIE-CITQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL  282 (291)
T ss_pred             HHH-HHhCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence            111 122222111         1222345689999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2e-34  Score=317.05  Aligned_cols=257  Identities=20%  Similarity=0.352  Sum_probs=204.1

Q ss_pred             hhCCCccceeeeccCceEEEEEEec------CCcEEEEEEeccCcc-ccHHHHHHHHHHhhccCCCceeeEEEEEecCCe
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAE  845 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  845 (1052)
                      ..++|++.+.||+|+||.||+|...      ++..||+|++..... ....++.+|+.+++.++||||+++++++.+...
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4567999999999999999999643      246799998854322 334568899999999999999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHhhccC--------CcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEE
Q 001566          846 MFLVYNFLSGGNLETFIHKKSG--------KKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYL  917 (1052)
Q Consensus       846 ~~lv~e~~~~gsL~~~l~~~~~--------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl  917 (1052)
                      .++||||+++++|.+++.....        ..+++..+..++.|+++|++|||+.   +++||||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence            9999999999999999976421        2357788999999999999999998   9999999999999999999999


Q ss_pred             eeecccccccccCcc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHH
Q 001566          918 SDFGLARLLEVSETH-ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAK  995 (1052)
Q Consensus       918 ~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  995 (1052)
                      +|||++......... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.....        .+..+
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~--------~~~~~  232 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--------EQVLR  232 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHH
Confidence            999998765433221 1122345778999999999889999999999999999999 6778763211        12222


Q ss_pred             HHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 001566          996 LLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQ 1050 (1052)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~ 1050 (1052)
                      .... +...         ..+...+..+.+++.+|++.+|++||++.|+++.|++
T Consensus       233 ~~~~-~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         233 FVME-GGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HHHc-CCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            2221 1111         1122334568999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2e-34  Score=323.29  Aligned_cols=254  Identities=22%  Similarity=0.410  Sum_probs=202.4

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCc----EEEEEEeccCcc-ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGY----LVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFL  848 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  848 (1052)
                      .+|++.+.||+|+||.||+|.+. +++    .||+|++..... ...+++.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            46899999999999999999754 333    489999865432 3456788999999999999999999999764 5789


Q ss_pred             EEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccc
Q 001566          849 VYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV  928 (1052)
Q Consensus       849 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~  928 (1052)
                      |+||+++|+|.+++.... ..+++..+..++.|++.||+|||++   +|+||||||+||++++++.+||+|||+++....
T Consensus        86 v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          86 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             eeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccC
Confidence            999999999999998754 4688999999999999999999999   999999999999999999999999999987653


Q ss_pred             cCcc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCcccc
Q 001566          929 SETH-ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSEL 1006 (1052)
Q Consensus       929 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      .... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||....        ..++. .....+...  
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~--------~~~~~-~~~~~~~~~--  230 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--------ASEIS-SILEKGERL--  230 (316)
T ss_pred             CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC--------HHHHH-HHHhCCCCC--
Confidence            3221 1122334678999999999999999999999999999998 999886321        11111 222221111  


Q ss_pred             ccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1007 FLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1007 ~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                             ..+..+...+.+++.+||+.+|++||++.++++.+.++
T Consensus       231 -------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~  268 (316)
T cd05108         231 -------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  268 (316)
T ss_pred             -------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                   11222345688999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.5e-34  Score=319.28  Aligned_cols=256  Identities=26%  Similarity=0.414  Sum_probs=204.7

Q ss_pred             CCCccceeeeccCceEEEEEEe-----cCCcEEEEEEeccCcc-ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAEL-----VPGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFL  848 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  848 (1052)
                      .+|++.+.||+|+||.||+|..     ..+..||+|.+..... +...++.+|++++++++||||+++++++......|+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4688889999999999999964     2467899999874332 334678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhhcc---------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC
Q 001566          849 VYNFLSGGNLETFIHKKS---------------GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEEL  913 (1052)
Q Consensus       849 v~e~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~  913 (1052)
                      ||||+++++|.+++....               ...+++.++..++.|++.|++|||++   +|+||||||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence            999999999999986432               13478889999999999999999999   999999999999999999


Q ss_pred             cEEEeeecccccccccCc-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHH
Q 001566          914 NAYLSDFGLARLLEVSET-HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIV  991 (1052)
Q Consensus       914 ~~kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~  991 (1052)
                      .+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||....        ..
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~--------~~  233 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS--------NQ  233 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC--------HH
Confidence            999999999986543221 22233345678999999998889999999999999999999 888886321        11


Q ss_pred             HHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566          992 SWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus       992 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                      +..+.. ......         ..+...+..+.+++.+||+.||++||++.++.+.|+.+
T Consensus       234 ~~~~~~-~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05090         234 EVIEMV-RKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRSW  283 (283)
T ss_pred             HHHHHH-HcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhcC
Confidence            222222 221111         11223345689999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-34  Score=317.76  Aligned_cols=251  Identities=26%  Similarity=0.351  Sum_probs=202.0

Q ss_pred             CCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCcc---ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEe
Q 001566          776 NFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRF---QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYN  851 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  851 (1052)
                      .|++.++||+|+||+||+|.. .+++.||+|++.....   .....+.+|++++++++||||+++++++.+++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            378889999999999999965 4689999999865332   223457789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCc
Q 001566          852 FLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET  931 (1052)
Q Consensus       852 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~  931 (1052)
                      |+++|+|.+++.......++++.+..++.|++.|++|||+.   +|+||||||+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-  156 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence            99999999998765445689999999999999999999999   99999999999999999999999999998654222 


Q ss_pred             ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchh
Q 001566          932 HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPEL 1011 (1052)
Q Consensus       932 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1011 (1052)
                       ......|++.|+|||.+.+..++.++||||+||++|||++|+.||......     ...+..........         
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~~---------  221 (285)
T cd05605         157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-----VKREEVERRVKEDQ---------  221 (285)
T ss_pred             -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-----hHHHHHHHHhhhcc---------
Confidence             122346889999999999988999999999999999999999999742211     11111111111111         


Q ss_pred             hcCCChHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 001566         1012 WEAGPQENLLGMMRLASTCTVETLSTRP-----SVKQVLI 1046 (1052)
Q Consensus      1012 ~~~~~~~~~~~l~~Li~~cl~~dP~~RP-----t~~eil~ 1046 (1052)
                       ...+...+..+.+++.+||+.||++||     +++++++
T Consensus       222 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         222 -EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             -cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence             112233445688999999999999999     8888865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=3.4e-34  Score=312.10  Aligned_cols=256  Identities=23%  Similarity=0.422  Sum_probs=208.9

Q ss_pred             hhCCCccceeeeccCceEEEEEEecCCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      ..++|++.+.||+|+||.||+|....+..+|+|.+.... ...+.+.+|++++++++|+|++++++++.+ ...+++|||
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            456899999999999999999987778889999886543 335678899999999999999999999887 778999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      +++++|.+++.......+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||.+.........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  158 (260)
T cd05073          82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT  158 (260)
T ss_pred             CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence            9999999999876656789999999999999999999998   9999999999999999999999999999866433322


Q ss_pred             cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchh
Q 001566          933 ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPEL 1011 (1052)
Q Consensus       933 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1011 (1052)
                      ......++..|+|||.+.+..++.++|+||||+++||++| |+.||.....        .... .....+...       
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--------~~~~-~~~~~~~~~-------  222 (260)
T cd05073         159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--------PEVI-RALERGYRM-------  222 (260)
T ss_pred             cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH--------HHHH-HHHhCCCCC-------
Confidence            2233345678999999998889999999999999999999 8888863211        1111 111222111       


Q ss_pred             hcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1012 WEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1012 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                        ..+...+..+.+++.+|++.+|++||++.++.+.|+++
T Consensus       223 --~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~  260 (260)
T cd05073         223 --PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  260 (260)
T ss_pred             --CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence              11123345689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.1e-34  Score=331.51  Aligned_cols=253  Identities=21%  Similarity=0.296  Sum_probs=202.1

Q ss_pred             hhCCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCc---cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEE
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFL  848 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  848 (1052)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+....++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3457999999999999999999664 58899999986432   2234557889999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccc
Q 001566          849 VYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV  928 (1052)
Q Consensus       849 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~  928 (1052)
                      ||||+++|+|.+++...   .+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+||+|||++.....
T Consensus       121 v~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~  194 (370)
T cd05596         121 VMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA  194 (370)
T ss_pred             EEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence            99999999999999764   478888999999999999999999   999999999999999999999999999986643


Q ss_pred             cCcccccccccccccccccccCCC----CCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCcc
Q 001566          929 SETHATTDVAGTFGYVAPEYATTC----RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSS 1004 (1052)
Q Consensus       929 ~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1052)
                      ..........|++.|+|||++.+.    .++.++||||+||++|||++|+.||.....        ............ .
T Consensus       195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~~~~-~  265 (370)
T cd05596         195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYSKIMDHKN-S  265 (370)
T ss_pred             CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH--------HHHHHHHHcCCC-c
Confidence            332233445799999999998653    378899999999999999999999974321        122222222111 1


Q ss_pred             ccccchhhcCCChHHHHHHHHHHHHccccCCCC--CCCHHHHHH
Q 001566         1005 ELFLPELWEAGPQENLLGMMRLASTCTVETLST--RPSVKQVLI 1046 (1052)
Q Consensus      1005 ~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~--RPt~~eil~ 1046 (1052)
                      ..+      ......+..+.+++.+|+..+|++  ||++.|+++
T Consensus       266 ~~~------~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         266 LTF------PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             CCC------CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence            000      011123456889999999999988  999999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.6e-34  Score=325.20  Aligned_cols=245  Identities=23%  Similarity=0.326  Sum_probs=194.0

Q ss_pred             eeeeccCceEEEEEEec-CCcEEEEEEeccCc---cccHHHHHHHHHHhhcc-CCCceeeEEEEEecCCeeEEEEeecCC
Q 001566          781 NLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEAEMFLVYNFLSG  855 (1052)
Q Consensus       781 ~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  855 (1052)
                      +.||+|+||.||+|... +++.||+|++....   ......+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999654 57899999987542   22345577888888776 799999999999999999999999999


Q ss_pred             CCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccccc
Q 001566          856 GNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT  935 (1052)
Q Consensus       856 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  935 (1052)
                      |+|.+++...  ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++..... .....
T Consensus        81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~~~  154 (329)
T cd05618          81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTS  154 (329)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCccc
Confidence            9999988764  4689999999999999999999999   9999999999999999999999999998753221 12223


Q ss_pred             ccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCC
Q 001566          936 DVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAG 1015 (1052)
Q Consensus       936 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 1015 (1052)
                      ...|++.|+|||++.+..++.++||||+||++|||++|+.||...............+....+.....          ..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----------~~  224 (329)
T cd05618         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------RI  224 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------CC
Confidence            45689999999999999999999999999999999999999964322221122222233222222211          11


Q ss_pred             ChHHHHHHHHHHHHccccCCCCCCCH
Q 001566         1016 PQENLLGMMRLASTCTVETLSTRPSV 1041 (1052)
Q Consensus      1016 ~~~~~~~l~~Li~~cl~~dP~~RPt~ 1041 (1052)
                      |......+.+++.+|++.||++||++
T Consensus       225 p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         225 PRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            22334558899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.8e-34  Score=324.98  Aligned_cols=250  Identities=23%  Similarity=0.317  Sum_probs=197.7

Q ss_pred             eeeeccCceEEEEEEec-CCcEEEEEEeccCc---cccHHHHHHHHHHhhcc-CCCceeeEEEEEecCCeeEEEEeecCC
Q 001566          781 NLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEAEMFLVYNFLSG  855 (1052)
Q Consensus       781 ~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  855 (1052)
                      ++||+|+||.||+|+.. +++.||+|+++...   ......+..|..+++++ +||||+++++++.+....|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999664 58899999997542   22345678899999888 799999999999999999999999999


Q ss_pred             CCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccccc
Q 001566          856 GNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT  935 (1052)
Q Consensus       856 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  935 (1052)
                      |+|.+++...  ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++.... ......
T Consensus        81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~-~~~~~~  154 (329)
T cd05588          81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR-PGDTTS  154 (329)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcccccccc-CCCccc
Confidence            9999998764  4699999999999999999999999   999999999999999999999999999874221 112223


Q ss_pred             ccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCC
Q 001566          936 DVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAG 1015 (1052)
Q Consensus       936 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 1015 (1052)
                      ...|++.|+|||++.+..++.++||||+||++|||++|+.||+.............++...........          .
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~  224 (329)
T cd05588         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR----------I  224 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC----------C
Confidence            456899999999999999999999999999999999999999743222111222223333333322211          1


Q ss_pred             ChHHHHHHHHHHHHccccCCCCCCC------HHHHHH
Q 001566         1016 PQENLLGMMRLASTCTVETLSTRPS------VKQVLI 1046 (1052)
Q Consensus      1016 ~~~~~~~l~~Li~~cl~~dP~~RPt------~~eil~ 1046 (1052)
                      |......+.+++.+|++.||++||+      ++|+++
T Consensus       225 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         225 PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            2223445889999999999999997      566653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.6e-35  Score=306.64  Aligned_cols=257  Identities=25%  Similarity=0.350  Sum_probs=196.1

Q ss_pred             CCccceeeeccCceEEEEEEec-CCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCC-----eeEEE
Q 001566          776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEA-----EMFLV  849 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~lv  849 (1052)
                      +|+-.+++|.|+||.||+|... +++.||||++-....    .-.+|+++|+++.|||||++.-+|....     ...+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            4667799999999999999665 468999998854332    2247999999999999999999987432     23689


Q ss_pred             EeecCCCCHHHHHhhc--cCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC-CcEEEeeecccccc
Q 001566          850 YNFLSGGNLETFIHKK--SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEE-LNAYLSDFGLARLL  926 (1052)
Q Consensus       850 ~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~-~~~kl~Dfgla~~~  926 (1052)
                      ||||+ -+|.++++..  .+..++.-.+.-+..||.+|++|||+.   +|+||||||+|+|+|.+ |.+||||||.|+..
T Consensus       101 leymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            99996 4999998753  245688888889999999999999998   99999999999999966 89999999999988


Q ss_pred             cccCcccccccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhC----
Q 001566          927 EVSETHATTDVAGTFGYVAPEYATTC-RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEG---- 1001 (1052)
Q Consensus       927 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 1001 (1052)
                      ..++..  ..+..|..|.|||.+.+. .|+.+.||||.||++.||+-|++-|.+..    ...++++.++..-...    
T Consensus       177 ~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s----~~dQL~eIik~lG~Pt~e~I  250 (364)
T KOG0658|consen  177 VKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS----SVDQLVEIIKVLGTPTREDI  250 (364)
T ss_pred             ccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC----HHHHHHHHHHHhCCCCHHHH
Confidence            655444  445678899999998875 58999999999999999999998887522    2233343333221111    


Q ss_pred             ---Ccc------ccccchhhcC-CChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1002 ---RSS------ELFLPELWEA-GPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1002 ---~~~------~~~~~~l~~~-~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                         ...      ..+.+..|.. .......+..+++.+++.++|.+|.++.|+++
T Consensus       251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence               000      1111111111 22344567999999999999999999999875

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=5.7e-35  Score=329.88  Aligned_cols=252  Identities=22%  Similarity=0.329  Sum_probs=203.0

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCcc---ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF---QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      ++|++.+.||+|+||+||+|... +++.||+|+++....   ...+.+.+|+.+++.++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            36899999999999999999654 689999999875432   23456888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccC
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~  930 (1052)
                      ||+++|+|.+++.... ..+++..+..++.|+++|++|||+.   +|+||||||+||+++.++.+||+|||++.......
T Consensus        81 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          81 EYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK  156 (330)
T ss_pred             CCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence            9999999999998763 4689999999999999999999999   99999999999999999999999999998765433


Q ss_pred             cccccccccccccccccccC------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCcc
Q 001566          931 THATTDVAGTFGYVAPEYAT------TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSS 1004 (1052)
Q Consensus       931 ~~~~~~~~g~~~y~aPE~~~------~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1052)
                      ........|++.|+|||++.      ...++.++||||+||++|||++|+.||.....        .+....+.......
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--------~~~~~~i~~~~~~~  228 (330)
T cd05601         157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS--------AKTYNNIMNFQRFL  228 (330)
T ss_pred             ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH--------HHHHHHHHcCCCcc
Confidence            33333456899999999986      45677899999999999999999999974321        12222222211111


Q ss_pred             ccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1005 ELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1005 ~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      . +      .........+.+++..|++ +|++||++.++++
T Consensus       229 ~-~------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         229 K-F------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             C-C------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            0 0      0112234558899999998 9999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2e-34  Score=324.00  Aligned_cols=241  Identities=24%  Similarity=0.365  Sum_probs=195.2

Q ss_pred             eeeeccCceEEEEEEe----cCCcEEEEEEeccCc----cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          781 NLIGTGGFGSTYKAEL----VPGYLVAVKKLSIGR----FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       781 ~~Lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      +.||+|+||.||+|+.    ..++.||+|+++...    ......+.+|+++++.++||||+++++++.+++..|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999964    357899999986532    12335678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      +++++|.+++...  ..+.+..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++...... .
T Consensus        82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~  155 (323)
T cd05584          82 LSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-T  155 (323)
T ss_pred             CCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-C
Confidence            9999999999765  4678889999999999999999999   99999999999999999999999999987543222 2


Q ss_pred             cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhh
Q 001566          933 ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012 (1052)
Q Consensus       933 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1012 (1052)
                      ......|++.|+|||.+.+..++.++||||+||++|||++|+.||.....        ......... +..         
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~--------~~~~~~~~~-~~~---------  217 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR--------KKTIDKILK-GKL---------  217 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH--------HHHHHHHHc-CCC---------
Confidence            22335689999999999998899999999999999999999999974321        122222221 111         


Q ss_pred             cCCChHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 001566         1013 EAGPQENLLGMMRLASTCTVETLSTRP-----SVKQVLI 1046 (1052)
Q Consensus      1013 ~~~~~~~~~~l~~Li~~cl~~dP~~RP-----t~~eil~ 1046 (1052)
                       ..+......+.+++.+|++.||++||     ++.++++
T Consensus       218 -~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         218 -NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             -CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence             11223345588999999999999999     7887765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.4e-34  Score=323.64  Aligned_cols=244  Identities=25%  Similarity=0.324  Sum_probs=194.5

Q ss_pred             CccceeeeccCceEEEEEEec-CCcEEEEEEeccCc---cccHHHHHHHHHHh---hccCCCceeeEEEEEecCCeeEEE
Q 001566          777 FSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR---FQGIQQFDAEIGTL---GRIRHKNLVTLIGYYVGEAEMFLV  849 (1052)
Q Consensus       777 ~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv  849 (1052)
                      |++.+.||+|+||.||+|... +++.||||+++...   ....+.+..|++++   +.++||||+++++++.+....|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            678899999999999999654 68999999986542   22234566665554   567899999999999999999999


Q ss_pred             EeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccccccc
Q 001566          850 YNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS  929 (1052)
Q Consensus       850 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~  929 (1052)
                      |||+++++|..+++.   ..+++..+..++.|++.|++|||++   +|+||||||+||++++++.+||+|||++......
T Consensus        81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05589          81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF  154 (324)
T ss_pred             EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence            999999999988865   3589999999999999999999999   9999999999999999999999999998743221


Q ss_pred             CcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccc
Q 001566          930 ETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009 (1052)
Q Consensus       930 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                       ........|++.|+|||.+.+..++.++|||||||++|||++|+.||.....        .+..........       
T Consensus       155 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~--------~~~~~~i~~~~~-------  218 (324)
T cd05589         155 -GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE--------EEVFDSIVNDEV-------  218 (324)
T ss_pred             -CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCC-------
Confidence             1223345689999999999999999999999999999999999999974321        122222222111       


Q ss_pred             hhhcCCChHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 001566         1010 ELWEAGPQENLLGMMRLASTCTVETLSTRP-----SVKQVLI 1046 (1052)
Q Consensus      1010 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RP-----t~~eil~ 1046 (1052)
                          ..+...+..+.+++.+|++.||++||     ++.++++
T Consensus       219 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         219 ----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             ----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence                11223345588999999999999999     4666654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.6e-34  Score=326.03  Aligned_cols=260  Identities=22%  Similarity=0.346  Sum_probs=195.1

Q ss_pred             CCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCc--cccHHHHHHHHHHhhccCCCceeeEEEEEecC-----CeeE
Q 001566          776 NFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGR--FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGE-----AEMF  847 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~  847 (1052)
                      +|++.++||+|+||.||+|.. .+++.||||++....  .....++.+|++++++++||||+++++++...     ...|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            588899999999999999965 468999999986432  23345688999999999999999999988643     2479


Q ss_pred             EEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccccc
Q 001566          848 LVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE  927 (1052)
Q Consensus       848 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~  927 (1052)
                      +||||+ +++|.+++...  ..+++..+..++.|+++|++|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus        81 lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~  154 (338)
T cd07859          81 VVFELM-ESDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAF  154 (338)
T ss_pred             EEEecC-CCCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence            999999 57999998765  4689999999999999999999999   99999999999999999999999999998553


Q ss_pred             ccCc--ccccccccccccccccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHH------
Q 001566          928 VSET--HATTDVAGTFGYVAPEYATT--CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLL------  997 (1052)
Q Consensus       928 ~~~~--~~~~~~~g~~~y~aPE~~~~--~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~------  997 (1052)
                      ....  .......|++.|+|||++.+  ..++.++||||+||++|||++|+.||......     .........      
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~-----~~~~~~~~~~~~~~~  229 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV-----HQLDLITDLLGTPSP  229 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH-----HHHHHHHHHhCCCCH
Confidence            2211  12234578999999999876  67889999999999999999999999643210     000000000      


Q ss_pred             -----HHhCCcccc---cc---chhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566          998 -----IKEGRSSEL---FL---PELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus       998 -----~~~~~~~~~---~~---~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                           +........   +.   +......-+.....+.+++.+|++.||++||+++|+++
T Consensus       230 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                 000000000   00   00000000112345789999999999999999999985

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.4e-34  Score=308.73  Aligned_cols=251  Identities=27%  Similarity=0.423  Sum_probs=207.8

Q ss_pred             hCCCccceeeeccCceEEEEEEecCCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeec
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFL  853 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  853 (1052)
                      .++|++.+.||+|+||.||+|... |+.||+|.+..... ..+++.+|+.++++++|+|++++++++.+....++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            357889999999999999999765 88999999876544 4578899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccc
Q 001566          854 SGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA  933 (1052)
Q Consensus       854 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  933 (1052)
                      ++++|.+++.......+++..+..++.|++.|+.|||++   +|+||||||+||++++++.++|+|||.++.......  
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--  157 (256)
T cd05039          83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--  157 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence            999999999876555789999999999999999999999   999999999999999999999999999986532211  


Q ss_pred             ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhh
Q 001566          934 TTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012 (1052)
Q Consensus       934 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1012 (1052)
                        ....+..|+|||.+.+..++.++||||||+++||+++ |..||.....        .+ .......+...        
T Consensus       158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~-~~~~~~~~~~~--------  218 (256)
T cd05039         158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KD-VVPHVEKGYRM--------  218 (256)
T ss_pred             --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--------HH-HHHHHhcCCCC--------
Confidence              2234568999999998889999999999999999997 9888863211        11 11111111111        


Q ss_pred             cCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1013 EAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1013 ~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                       ..+...+..+.+++.+|+..+|++||++.|++++|+++
T Consensus       219 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         219 -EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             -CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence             11223345689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-35  Score=331.52  Aligned_cols=251  Identities=24%  Similarity=0.338  Sum_probs=204.4

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCc---cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      ++|++.+.||+|+||+||+|... +++.||+|++....   ......+.+|+++++.++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            36899999999999999999665 68999999986542   233567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccC
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~  930 (1052)
                      ||+++++|.+++...  ..+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||++.......
T Consensus        81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  155 (350)
T cd05573          81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK  155 (350)
T ss_pred             cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence            999999999999876  5689999999999999999999998   99999999999999999999999999998664332


Q ss_pred             ----------------------------cccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcc
Q 001566          931 ----------------------------THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFS  982 (1052)
Q Consensus       931 ----------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~  982 (1052)
                                                  ........|++.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~  235 (350)
T cd05573         156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL  235 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence                                        1122345689999999999999999999999999999999999999974321


Q ss_pred             cCCCCccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 001566          983 EYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS-VKQVLI 1046 (1052)
Q Consensus       983 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt-~~eil~ 1046 (1052)
                              .+....+....... . .+     .....+..+.+++.+|++ ||++||+ ++|+++
T Consensus       236 --------~~~~~~i~~~~~~~-~-~p-----~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~  284 (350)
T cd05573         236 --------QETYNKIINWKESL-R-FP-----PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS  284 (350)
T ss_pred             --------HHHHHHHhccCCcc-c-CC-----CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence                    12222222110000 0 00     011134568899999997 9999999 999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=4.6e-34  Score=317.91  Aligned_cols=258  Identities=24%  Similarity=0.377  Sum_probs=207.0

Q ss_pred             hCCCccceeeeccCceEEEEEEec------CCcEEEEEEeccCc-cccHHHHHHHHHHhhcc-CCCceeeEEEEEecCCe
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEAE  845 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  845 (1052)
                      .++|++.+.||+|+||.||+|...      ++..||+|+++... ....+.+.+|+++++++ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            356899999999999999999642      34579999886543 23346788999999999 79999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccc
Q 001566          846 MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARL  925 (1052)
Q Consensus       846 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~  925 (1052)
                      .++||||+++|+|.++++......+++.++..++.|++.|++|||++   +|+|+||||+||+++.++.++++|||++..
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~  190 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARD  190 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccccc
Confidence            99999999999999999875544589999999999999999999999   999999999999999999999999999986


Q ss_pred             ccccCc-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCc
Q 001566          926 LEVSET-HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRS 1003 (1052)
Q Consensus       926 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1052)
                      ...... .......++..|+|||.+.+..++.++||||+||++|||++ |+.||......        +........+..
T Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~  262 (302)
T cd05055         191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD--------SKFYKLIKEGYR  262 (302)
T ss_pred             ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch--------HHHHHHHHcCCc
Confidence            543221 12222345678999999999999999999999999999998 89888643211        111122222211


Q ss_pred             cccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1004 SELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1004 ~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                      .         ..+...+..+.+++.+|++.+|++||++.|+++.|+++
T Consensus       263 ~---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         263 M---------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             C---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            1         01122344689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.4e-34  Score=337.75  Aligned_cols=254  Identities=24%  Similarity=0.321  Sum_probs=204.7

Q ss_pred             HhhCCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCc--cccHHHHHHHHHHhhccCCCceeeEEEEEecCC----
Q 001566          772 RATGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGR--FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEA----  844 (1052)
Q Consensus       772 ~~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----  844 (1052)
                      ...++|++.+.||+|+||+||+|.. .+|+.||||++....  ......+.+|+.++..++|+|++++++.+....    
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            3457899999999999999999964 468999999986543  233466788999999999999999988765332    


Q ss_pred             ----eeEEEEeecCCCCHHHHHhhcc--CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEe
Q 001566          845 ----EMFLVYNFLSGGNLETFIHKKS--GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLS  918 (1052)
Q Consensus       845 ----~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~  918 (1052)
                          ..++||||+++|+|.++++...  ...+++..+..++.|++.|+.|+|++   +|+||||||+||+++.++.+||+
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~  185 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLG  185 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEE
Confidence                3689999999999999997542  35689999999999999999999999   99999999999999999999999


Q ss_pred             eecccccccccC-cccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHH
Q 001566          919 DFGLARLLEVSE-THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLL  997 (1052)
Q Consensus       919 Dfgla~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  997 (1052)
                      |||+++.+.... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||...        ...+.....
T Consensus       186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~--------~~~~~~~~~  257 (496)
T PTZ00283        186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE--------NMEEVMHKT  257 (496)
T ss_pred             ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHH
Confidence            999998654322 12233456899999999999999999999999999999999999999742        222233322


Q ss_pred             HHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566          998 IKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus       998 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ... ...         ..+...+..+.+++.+||+.||++||++.++++
T Consensus       258 ~~~-~~~---------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        258 LAG-RYD---------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             hcC-CCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence            221 111         122334456899999999999999999999875

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.9e-34  Score=329.14  Aligned_cols=255  Identities=20%  Similarity=0.302  Sum_probs=200.9

Q ss_pred             HhhCCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCc---cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeE
Q 001566          772 RATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMF  847 (1052)
Q Consensus       772 ~~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  847 (1052)
                      ...++|++.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|+.+++.++||||+++++++.++...|
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            34568999999999999999999765 57899999986422   223456788999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccccc
Q 001566          848 LVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE  927 (1052)
Q Consensus       848 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~  927 (1052)
                      +||||+++|+|.+++...   .+++..+..++.|++.|++|||++   +|+||||||+||++++++.+||+|||++....
T Consensus       120 lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         120 MVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            999999999999999754   478899999999999999999999   99999999999999999999999999998764


Q ss_pred             ccCcccccccccccccccccccCCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCc
Q 001566          928 VSETHATTDVAGTFGYVAPEYATTCR----VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRS 1003 (1052)
Q Consensus       928 ~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1052)
                      ...........||+.|+|||++.+..    ++.++||||+||++|||++|+.||....        ..............
T Consensus       194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~--------~~~~~~~i~~~~~~  265 (370)
T cd05621         194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS--------LVGTYSKIMDHKNS  265 (370)
T ss_pred             cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCcc
Confidence            33332334567999999999987643    6789999999999999999999997432        11222222221111


Q ss_pred             cccccchhhcCCChHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 001566         1004 SELFLPELWEAGPQENLLGMMRLASTCTVETLST--RPSVKQVLIK 1047 (1052)
Q Consensus      1004 ~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~--RPt~~eil~~ 1047 (1052)
                      .. +      .........+.+++..|+..++.+  ||++.|+++.
T Consensus       266 ~~-~------p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         266 LN-F------PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             cC-C------CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            10 0      011223455788999999865544  8899998763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=5.4e-34  Score=311.92  Aligned_cols=258  Identities=28%  Similarity=0.423  Sum_probs=210.3

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCc---cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      ++|++.+.||+|+||.||+|... +|+.||+|.++...   ....+.+.+|++++++++|++++++++++.+++..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57999999999999999999766 78999999886432   233567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhc--cCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccc
Q 001566          851 NFLSGGNLETFIHKK--SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV  928 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~  928 (1052)
                      ||+++++|.+++...  ....++++++..++.+++.|++|||+.   +|+||||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999998653  234588999999999999999999999   999999999999999999999999999876542


Q ss_pred             cCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCcccccc
Q 001566          929 SETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFL 1008 (1052)
Q Consensus       929 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                      .. .......+++.|+|||.+.+..++.++||||+|+++|||++|+.||....      .+.......... +...    
T Consensus       159 ~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~-~~~~----  226 (267)
T cd08224         159 KT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLYSLCKKIEK-CDYP----  226 (267)
T ss_pred             CC-cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC------ccHHHHHhhhhc-CCCC----
Confidence            22 11223457889999999999889999999999999999999999986432      122222222111 1111    


Q ss_pred             chhhcCCC-hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccC
Q 001566         1009 PELWEAGP-QENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQLK 1052 (1052)
Q Consensus      1009 ~~l~~~~~-~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~lk 1052 (1052)
                           ..+ ...+..+.+++.+||+.+|++||++.++++++++++
T Consensus       227 -----~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         227 -----PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             -----CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                 111 134456899999999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=4.6e-34  Score=314.67  Aligned_cols=255  Identities=23%  Similarity=0.398  Sum_probs=205.5

Q ss_pred             CCCccceeeeccCceEEEEEEec------CCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFL  848 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  848 (1052)
                      .+|++.+.||+|+||.||+|...      ++..+|+|.+..........+.+|++.+++++|+||+++++++.+....++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            46788899999999999999532      356899998876666666789999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhhccC-------------CcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcE
Q 001566          849 VYNFLSGGNLETFIHKKSG-------------KKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNA  915 (1052)
Q Consensus       849 v~e~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~  915 (1052)
                      +|||+++++|.+++.....             ..+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence            9999999999999976531             3478999999999999999999999   99999999999999999999


Q ss_pred             EEeeecccccccccCc-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHH
Q 001566          916 YLSDFGLARLLEVSET-HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSW  993 (1052)
Q Consensus       916 kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  993 (1052)
                      ||+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||.....        .+.
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~  233 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN--------TEA  233 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH--------HHH
Confidence            9999999975543221 11222345678999999999999999999999999999998 8888863211        111


Q ss_pred             HHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 001566          994 AKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQ 1050 (1052)
Q Consensus       994 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~ 1050 (1052)
                      .... ..+...         ..+...+..+.+++.+||+.||++||+++|+++.|++
T Consensus       234 ~~~~-~~~~~~---------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         234 IECI-TQGREL---------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             HHHH-HcCccC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            1111 111111         1112234558899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5e-35  Score=289.10  Aligned_cols=252  Identities=26%  Similarity=0.403  Sum_probs=205.2

Q ss_pred             hhCCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCccc----c----HHHHHHHHHHhhcc-CCCceeeEEEEEec
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQ----G----IQQFDAEIGTLGRI-RHKNLVTLIGYYVG  842 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~----~----~~~~~~e~~~l~~l-~h~niv~l~~~~~~  842 (1052)
                      .-..|+-.+.+|+|..++|-++.+ .+|..+|+|++......    .    .+.-..|+.+++++ .||+|+.+.++|+.
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            345678889999999999999844 46888999988543221    1    23456799999998 69999999999999


Q ss_pred             CCeeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecc
Q 001566          843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGL  922 (1052)
Q Consensus       843 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgl  922 (1052)
                      +..+++|+|.|+.|-|.||+...  -.+++....+|+.|+.+|++|||.+   .|||||+||+||+++++.++||+|||+
T Consensus        95 ~sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGF  169 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGF  169 (411)
T ss_pred             cchhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccce
Confidence            99999999999999999999876  5799999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCcccccccccccccccccccC------CCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHH
Q 001566          923 ARLLEVSETHATTDVAGTFGYVAPEYAT------TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKL  996 (1052)
Q Consensus       923 a~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  996 (1052)
                      |+.+.++  ......+|||+|+|||.+.      ...|+...|+|++|||+|.++.|.+||.-.        .. ..+-.
T Consensus       170 a~~l~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR--------kQ-mlMLR  238 (411)
T KOG0599|consen  170 ACQLEPG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR--------KQ-MLMLR  238 (411)
T ss_pred             eeccCCc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH--------HH-HHHHH
Confidence            9988644  3445678999999999885      245778899999999999999999999721        11 12333


Q ss_pred             HHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566          997 LIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus       997 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      .+.+|+..  |...-|.    +......+||.+|++.||.+|.|++|+++
T Consensus       239 ~ImeGkyq--F~speWa----dis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  239 MIMEGKYQ--FRSPEWA----DISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             HHHhcccc--cCCcchh----hccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            44444433  2222233    23345889999999999999999999875

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4e-34  Score=319.11  Aligned_cols=251  Identities=27%  Similarity=0.362  Sum_probs=212.4

Q ss_pred             hhCCCccceeeeccCceEEEEEEecC-CcEEEEEEeccCccc---cHHHHHHHHHHhhccC-CCceeeEEEEEecCCeeE
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQ---GIQQFDAEIGTLGRIR-HKNLVTLIGYYVGEAEMF  847 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~  847 (1052)
                      ....|++.+.||+|.||.||++..+. |+.+|+|.+.+....   ..+.+.+|+.+|+++. |||||.++++|++...++
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            34578999999999999999996654 999999999766543   3468899999999998 999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC----CcEEEeeeccc
Q 001566          848 LVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEE----LNAYLSDFGLA  923 (1052)
Q Consensus       848 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~----~~~kl~Dfgla  923 (1052)
                      +|||++.||.|.+.+...   .+++.++..++.|++.++.|||+.   ||+|||+||+|+++...    +.+|++|||++
T Consensus       113 lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla  186 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLA  186 (382)
T ss_pred             EEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence            999999999999999876   399999999999999999999998   99999999999999643    47999999999


Q ss_pred             ccccccCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCc
Q 001566          924 RLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRS 1003 (1052)
Q Consensus       924 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1052)
                      .....  .......+||+.|+|||++....|+..+||||+||++|.|++|.+||......        .... .+..+..
T Consensus       187 ~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~--------~~~~-~i~~~~~  255 (382)
T KOG0032|consen  187 KFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF--------EIFL-AILRGDF  255 (382)
T ss_pred             eEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh--------HHHH-HHHcCCC
Confidence            98765  44566778999999999999999999999999999999999999999854332        1111 2222222


Q ss_pred             cccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1004 SELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1004 ~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                        .+....|...    ...+.++++.|+..||.+|+|+.++++
T Consensus       256 --~f~~~~w~~i----s~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  256 --DFTSEPWDDI----SESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             --CCCCCCcccc----CHHHHHHHHHhcccCcccCCCHHHHhc
Confidence              3344444443    445889999999999999999999986

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=5.3e-34  Score=309.67  Aligned_cols=250  Identities=24%  Similarity=0.393  Sum_probs=205.4

Q ss_pred             CCccceeeeccCceEEEEEEec-CCcEEEEEEeccCc-cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeec
Q 001566          776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFL  853 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  853 (1052)
                      +|++.+.||+|+||.||++... ++..+|+|.+.... ....+.+.+|+.+++.++|+|++++++++.+++..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4788999999999999999654 68899999886433 334567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccc
Q 001566          854 SGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA  933 (1052)
Q Consensus       854 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  933 (1052)
                      ++++|.+++....+..++++.+..++.|++.|+.|||++   +|+|+||||+||++++++.++++|||.+....... ..
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~  156 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-AY  156 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc-cc
Confidence            999999999776556789999999999999999999999   99999999999999999999999999997654222 12


Q ss_pred             ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhc
Q 001566          934 TTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWE 1013 (1052)
Q Consensus       934 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1013 (1052)
                      .....+++.|+|||++.+..++.++|+||+|+++|+|++|+.||....        ......... .+...         
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~--------~~~~~~~~~-~~~~~---------  218 (255)
T cd08219         157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS--------WKNLILKVC-QGSYK---------  218 (255)
T ss_pred             cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC--------HHHHHHHHh-cCCCC---------
Confidence            233568889999999999889999999999999999999999997421        112222221 11111         


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001566         1014 AGPQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus      1014 ~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                      ..+......+.+++.+||+.||++||++.|++..
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         219 PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            1122234458899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=5.6e-34  Score=326.59  Aligned_cols=262  Identities=22%  Similarity=0.338  Sum_probs=206.6

Q ss_pred             HHHhhCCCccceeeeccCceEEEEEEec------CCcEEEEEEeccCccc-cHHHHHHHHHHhhccC-CCceeeEEEEEe
Q 001566          770 VVRATGNFSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSIGRFQ-GIQQFDAEIGTLGRIR-HKNLVTLIGYYV  841 (1052)
Q Consensus       770 ~~~~~~~~~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~l~~~~~  841 (1052)
                      .....++|.+.+.||+|+||.||+|.+.      .+..||+|++...... ..+.+..|++++.++. ||||+++++++.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            4445567889999999999999999753      2468999999754332 2456889999999997 999999999999


Q ss_pred             cCCeeEEEEeecCCCCHHHHHhhccC------------------------------------------------------
Q 001566          842 GEAEMFLVYNFLSGGNLETFIHKKSG------------------------------------------------------  867 (1052)
Q Consensus       842 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------  867 (1052)
                      ..+..++|+||+++|+|.++++....                                                      
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            99999999999999999999975421                                                      


Q ss_pred             ------------------------------------------CcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCC
Q 001566          868 ------------------------------------------KKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPS  905 (1052)
Q Consensus       868 ------------------------------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~  905 (1052)
                                                                ..+++..+.+++.|++.|++|||+.   +|+||||||+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~  268 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR  268 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence                                                      2356778899999999999999998   9999999999


Q ss_pred             CEEECCCCcEEEeeecccccccccCc-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCccc
Q 001566          906 NILLDEELNAYLSDFGLARLLEVSET-HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSE  983 (1052)
Q Consensus       906 Nill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~  983 (1052)
                      ||++++++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... 
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~-  347 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM-  347 (401)
T ss_pred             eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc-
Confidence            99999999999999999986532211 11223356788999999998889999999999999999998 8888753211 


Q ss_pred             CCCCccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566          984 YGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus       984 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                             .+........+...         ..+......+.+++.+||+.+|++||+++|+++.|+++
T Consensus       348 -------~~~~~~~~~~~~~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         348 -------NEQFYNAIKRGYRM---------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             -------hHHHHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                   11111222222111         11223345699999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=7e-34  Score=308.90  Aligned_cols=249  Identities=27%  Similarity=0.438  Sum_probs=202.7

Q ss_pred             CCCccceeeeccCceEEEEEEecCCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEe-cCCeeEEEEeec
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV-GEAEMFLVYNFL  853 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~  853 (1052)
                      .+|++.+.||+|+||.||+|... |..||+|.++...  ..+.+.+|+.++++++|+|++++++++. .+...++|+||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            46889999999999999999765 7889999886433  3467889999999999999999999764 456789999999


Q ss_pred             CCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccc
Q 001566          854 SGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA  933 (1052)
Q Consensus       854 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  933 (1052)
                      ++++|.+++.......+++..+..++.|++.|++|||++   +|+||||||+||++++++.+|++|||++.......   
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---  156 (256)
T cd05082          83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  156 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence            999999999876655689999999999999999999999   99999999999999999999999999987543211   


Q ss_pred             ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhh
Q 001566          934 TTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012 (1052)
Q Consensus       934 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1012 (1052)
                       ....++..|+|||++.+..++.++||||||+++|||++ |+.||...        ...+..... ..+...        
T Consensus       157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~--------~~~~~~~~~-~~~~~~--------  218 (256)
T cd05082         157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--------PLKDVVPRV-EKGYKM--------  218 (256)
T ss_pred             -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHH-hcCCCC--------
Confidence             22334568999999999889999999999999999998 88887522        112222222 111111        


Q ss_pred             cCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1013 EAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1013 ~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                       ..+...+..+.+++.+|++.+|++|||+.++++.|+++
T Consensus       219 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         219 -DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             -CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence             11223345689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3.5e-34  Score=318.05  Aligned_cols=259  Identities=27%  Similarity=0.442  Sum_probs=207.1

Q ss_pred             HhhCCCccceeeeccCceEEEEEEecC------CcEEEEEEeccCc-cccHHHHHHHHHHhhcc-CCCceeeEEEEEecC
Q 001566          772 RATGNFSIRNLIGTGGFGSTYKAELVP------GYLVAVKKLSIGR-FQGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGE  843 (1052)
Q Consensus       772 ~~~~~~~~~~~Lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  843 (1052)
                      ...++|++.+.||+|+||.||+|....      ...+|+|.+.... .+...++.+|+++++++ +|+||+++++++..+
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            445678999999999999999997542      3679999887543 23345688999999999 799999999999999


Q ss_pred             CeeEEEEeecCCCCHHHHHhhc--------------cCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE
Q 001566          844 AEMFLVYNFLSGGNLETFIHKK--------------SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILL  909 (1052)
Q Consensus       844 ~~~~lv~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill  909 (1052)
                      +..+++|||+++|+|.++++..              ....+++..+.+++.|++.|++|||+.   +|+||||||+||++
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~  165 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLV  165 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEE
Confidence            9999999999999999999753              235689999999999999999999999   99999999999999


Q ss_pred             CCCCcEEEeeecccccccccCcc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCC
Q 001566          910 DEELNAYLSDFGLARLLEVSETH-ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNG  987 (1052)
Q Consensus       910 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~  987 (1052)
                      ++++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++||+++ |..||....      
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------  239 (293)
T cd05053         166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP------  239 (293)
T ss_pred             cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC------
Confidence            99999999999999866533221 1222335678999999998899999999999999999998 888876321      


Q ss_pred             ccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566          988 FNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus       988 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                        ..+..+. ...+...         ..+......+.+++.+|++.+|++|||+.|+++.|+++
T Consensus       240 --~~~~~~~-~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         240 --VEELFKL-LKEGYRM---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             --HHHHHHH-HHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence              1111121 1111111         11223345689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-34  Score=330.04  Aligned_cols=251  Identities=24%  Similarity=0.330  Sum_probs=199.8

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCc---cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      ++|++.+.||+|+||+||+|+.. +++.||||++....   ......+.+|+++++.++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            36899999999999999999664 68999999996532   223456788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccC
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~  930 (1052)
                      ||+++|+|.+++...  ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.++|+|||++..+....
T Consensus        81 E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  155 (364)
T cd05599          81 EYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH  155 (364)
T ss_pred             CCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence            999999999999765  4689999999999999999999999   99999999999999999999999999987543211


Q ss_pred             cc-------------------------------------cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhC
Q 001566          931 TH-------------------------------------ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG  973 (1052)
Q Consensus       931 ~~-------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg  973 (1052)
                      ..                                     .....+||+.|+|||++.+..++.++||||+||++|||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence            00                                     01124689999999999999999999999999999999999


Q ss_pred             CCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 001566          974 KRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS---VKQVLI 1046 (1052)
Q Consensus       974 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt---~~eil~ 1046 (1052)
                      ..||.....        .+..+......... .+      .........+.+++.+|+. +|.+|++   ++|+++
T Consensus       236 ~~Pf~~~~~--------~~~~~~i~~~~~~~-~~------~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         236 YPPFCSDNP--------QETYRKIINWKETL-QF------PDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCCCCH--------HHHHHHHHcCCCcc-CC------CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            999974321        12222222111100 00      0011223457889999996 9999998   888765

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.4e-34  Score=326.29  Aligned_cols=248  Identities=29%  Similarity=0.414  Sum_probs=194.0

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCcc-ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      ++|+..+.||+|+||.||+|... +++.||||++..... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            45777889999999999999654 689999999865433 2346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      +++++|.+.      ...++..+..++.||+.|++|||++   +|+||||||+||++++++.+||+|||+++.+.... .
T Consensus       154 ~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~  223 (353)
T PLN00034        154 MDGGSLEGT------HIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-D  223 (353)
T ss_pred             CCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc-c
Confidence            999998653      2356778889999999999999999   99999999999999999999999999998664321 1


Q ss_pred             cccccccccccccccccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccc
Q 001566          933 ATTDVAGTFGYVAPEYATT-----CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELF 1007 (1052)
Q Consensus       933 ~~~~~~g~~~y~aPE~~~~-----~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1052)
                      ......|+..|+|||.+..     ...+.++|||||||++|||++|+.||.....     .   +|............  
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~-----~---~~~~~~~~~~~~~~--  293 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ-----G---DWASLMCAICMSQP--  293 (353)
T ss_pred             cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-----c---cHHHHHHHHhccCC--
Confidence            2234568999999998753     2334689999999999999999999973211     1   11111111110000  


Q ss_pred             cchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001566         1008 LPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus      1008 ~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                           ...+......+.+++.+||+.||++||++.|+++.
T Consensus       294 -----~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        294 -----PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             -----CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 01122334568999999999999999999999863

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.9e-34  Score=329.04  Aligned_cols=251  Identities=22%  Similarity=0.324  Sum_probs=196.0

Q ss_pred             CCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCc---cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEe
Q 001566          776 NFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYN  851 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  851 (1052)
                      .|++.+.||+|+||+||+|.. .+++.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            588899999999999999955 468899999986543   2334568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCc
Q 001566          852 FLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET  931 (1052)
Q Consensus       852 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~  931 (1052)
                      |+++|+|.+++...  ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++..+.....
T Consensus        82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~  156 (381)
T cd05626          82 YIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN  156 (381)
T ss_pred             cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence            99999999999765  4688999999999999999999999   999999999999999999999999999764311000


Q ss_pred             ----------------------------------------------ccccccccccccccccccCCCCCCcchhHHHHHH
Q 001566          932 ----------------------------------------------HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGV  965 (1052)
Q Consensus       932 ----------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~  965 (1052)
                                                                    .......||+.|+|||++.+..++.++||||+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~  236 (381)
T cd05626         157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV  236 (381)
T ss_pred             cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence                                                          0012346899999999999988999999999999


Q ss_pred             HHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHH--ccccCCCCCCCHHH
Q 001566          966 VLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLAST--CTVETLSTRPSVKQ 1043 (1052)
Q Consensus       966 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~--cl~~dP~~RPt~~e 1043 (1052)
                      ++|||++|+.||......        +.............  .+     .......++.+++.+  |+..+|..||+++|
T Consensus       237 il~elltG~~Pf~~~~~~--------~~~~~i~~~~~~~~--~~-----~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~  301 (381)
T cd05626         237 ILFEMLVGQPPFLAPTPT--------ETQLKVINWENTLH--IP-----PQVKLSPEAVDLITKLCCSAEERLGRNGADD  301 (381)
T ss_pred             HHHHHHhCCCCCcCCCHH--------HHHHHHHccccccC--CC-----CCCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence            999999999999743221        11111111110000  00     011223457788888  44556666999999


Q ss_pred             HHH
Q 001566         1044 VLI 1046 (1052)
Q Consensus      1044 il~ 1046 (1052)
                      +++
T Consensus       302 ~l~  304 (381)
T cd05626         302 IKA  304 (381)
T ss_pred             Hhc
Confidence            975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1e-33  Score=306.36  Aligned_cols=247  Identities=26%  Similarity=0.385  Sum_probs=200.3

Q ss_pred             eeeeccCceEEEEEEecCCcEEEEEEeccCccc-cHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecCCCCHH
Q 001566          781 NLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQ-GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLE  859 (1052)
Q Consensus       781 ~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  859 (1052)
                      ++||+|+||.||+|...++..||+|.+...... ....+.+|++++++++|||++++++++......++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            368999999999998888899999988654332 2346889999999999999999999999999999999999999999


Q ss_pred             HHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccccccccc
Q 001566          860 TFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG  939 (1052)
Q Consensus       860 ~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g  939 (1052)
                      +++.... ..+++..+..++.|++.|+.|+|+.   +++||||+|+||++++++.+|++|||++...............+
T Consensus        81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (250)
T cd05085          81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI  156 (250)
T ss_pred             HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence            9997654 4678999999999999999999999   99999999999999999999999999997544322222222344


Q ss_pred             ccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCCChH
Q 001566          940 TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQE 1018 (1052)
Q Consensus       940 ~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 1018 (1052)
                      +..|+|||++.+..++.++||||||+++||+++ |..||.....        ...... ...+...         ..+..
T Consensus       157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~--------~~~~~~-~~~~~~~---------~~~~~  218 (250)
T cd05085         157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN--------QQAREQ-VEKGYRM---------SCPQK  218 (250)
T ss_pred             cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH--------HHHHHH-HHcCCCC---------CCCCC
Confidence            668999999998889999999999999999998 8888863211        111111 1111111         11223


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 001566         1019 NLLGMMRLASTCTVETLSTRPSVKQVLIKLK 1049 (1052)
Q Consensus      1019 ~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~ 1049 (1052)
                      .+..+.+++.+|++.+|++||++.|+++.|.
T Consensus       219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            4556999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-34  Score=307.28  Aligned_cols=249  Identities=22%  Similarity=0.370  Sum_probs=210.0

Q ss_pred             hhCCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCcccc--HHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEE
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQG--IQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLV  849 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  849 (1052)
                      ..+-|.+.+.||+|.|++|-.|++ -+|.+||||++.+.....  ...+..|+++|+-++|||||++|++...+..+|+|
T Consensus        16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi   95 (864)
T KOG4717|consen   16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI   95 (864)
T ss_pred             eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence            345688999999999999999954 579999999997665443  46788899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC-CCCcEEEeeecccccccc
Q 001566          850 YNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLD-EELNAYLSDFGLARLLEV  928 (1052)
Q Consensus       850 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~-~~~~~kl~Dfgla~~~~~  928 (1052)
                      +|.=++|+|.+|+-++. ..+.++...+++.||+.|+.|+|+.   .+||||+||+||++- .-|-||++|||++-.+.+
T Consensus        96 LELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   96 LELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             EEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            99999999999998875 6799999999999999999999999   899999999999875 568899999999987765


Q ss_pred             cCcccccccccccccccccccCCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccc
Q 001566          929 SETHATTDVAGTFGYVAPEYATTCRVS-DKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELF 1007 (1052)
Q Consensus       929 ~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1052)
                      +..  ....+|+..|.|||++.|..|. ++.||||+|||+|-+++|++||.......+         ...+.+.++    
T Consensus       172 G~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---------LTmImDCKY----  236 (864)
T KOG4717|consen  172 GKK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---------LTMIMDCKY----  236 (864)
T ss_pred             cch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh---------hhhhhcccc----
Confidence            433  3445899999999999999886 678999999999999999999985433311         111222222    


Q ss_pred             cchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1008 LPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1008 ~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                            ..|.....+..+||..|+..||++|.+.+||+.
T Consensus       237 ------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  237 ------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             ------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence                  235566677899999999999999999999874

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=6.9e-34  Score=314.60  Aligned_cols=258  Identities=21%  Similarity=0.328  Sum_probs=203.9

Q ss_pred             HhhCCCccceeeeccCceEEEEEEec------CCcEEEEEEeccCcc-ccHHHHHHHHHHhhccCCCceeeEEEEEecCC
Q 001566          772 RATGNFSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEA  844 (1052)
Q Consensus       772 ~~~~~~~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  844 (1052)
                      ...++|++.+.||+|+||.||+|..+      .+..||+|.+..... .....+.+|+.++++++||||+++++++.+..
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            35678999999999999999999543      245799998764432 23456788999999999999999999999999


Q ss_pred             eeEEEEeecCCCCHHHHHhhcc--------CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEE
Q 001566          845 EMFLVYNFLSGGNLETFIHKKS--------GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY  916 (1052)
Q Consensus       845 ~~~lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~k  916 (1052)
                      ..++||||+++|+|.++++...        ....++..+.+++.|++.|++|||++   +|+||||||+||++++++.++
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEE
Confidence            9999999999999999997642        12346778899999999999999999   999999999999999999999


Q ss_pred             EeeecccccccccCcc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHH
Q 001566          917 LSDFGLARLLEVSETH-ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWA  994 (1052)
Q Consensus       917 l~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  994 (1052)
                      ++|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||....        ..++.
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~--------~~~~~  231 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS--------NEQVL  231 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC--------HHHHH
Confidence            9999999865432221 1122345678999999999899999999999999999999 677876321        11222


Q ss_pred             HHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 001566          995 KLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQ 1050 (1052)
Q Consensus       995 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~ 1050 (1052)
                      +.....+...          .+...+..+.+++.+|++.||++||++.|+++.+++
T Consensus       232 ~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~  277 (288)
T cd05061         232 KFVMDGGYLD----------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD  277 (288)
T ss_pred             HHHHcCCCCC----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            2222221111          112234569999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.7e-34  Score=311.00  Aligned_cols=254  Identities=23%  Similarity=0.408  Sum_probs=202.1

Q ss_pred             CccceeeeccCceEEEEEEecC----CcEEEEEEeccCcc--ccHHHHHHHHHHhhccCCCceeeEEEEEecCCe-----
Q 001566          777 FSIRNLIGTGGFGSTYKAELVP----GYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAE-----  845 (1052)
Q Consensus       777 ~~~~~~Lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----  845 (1052)
                      |++.+.||+|+||.||+|....    +..||+|+++....  .....+.+|++.++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678999999999999996542    36799999875432  334678999999999999999999998876544     


Q ss_pred             -eEEEEeecCCCCHHHHHhhcc----CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeee
Q 001566          846 -MFLVYNFLSGGNLETFIHKKS----GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDF  920 (1052)
Q Consensus       846 -~~lv~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Df  920 (1052)
                       .++++||+++|+|..++....    ...+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence             799999999999999986542    23689999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCccc-ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHH
Q 001566          921 GLARLLEVSETHA-TTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLI  998 (1052)
Q Consensus       921 gla~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  998 (1052)
                      |+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.....        .+..+...
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--------~~~~~~~~  229 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--------HEIYDYLR  229 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHH
Confidence            9998664333222 122334678999999998889999999999999999999 7788753211        12222222


Q ss_pred             HhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566          999 KEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus       999 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                      . +...         ..+...+..+.+++.+||+.||++||++.|+++.|+++
T Consensus       230 ~-~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         230 H-GNRL---------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             c-CCCC---------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1 1111         11233455699999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=6.1e-34  Score=313.82  Aligned_cols=258  Identities=24%  Similarity=0.354  Sum_probs=207.0

Q ss_pred             hhCCCccceeeeccCceEEEEEEecC-----CcEEEEEEeccCc-cccHHHHHHHHHHhhccCCCceeeEEEEEec-CCe
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG-EAE  845 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~  845 (1052)
                      ..++|++.+.||+|+||.||+|....     +..|++|++.... ....+.+.+|+.++++++|||++++++++.. ...
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            35679999999999999999997765     6889999886442 2335668899999999999999999998776 467


Q ss_pred             eEEEEeecCCCCHHHHHhhccC------CcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEee
Q 001566          846 MFLVYNFLSGGNLETFIHKKSG------KKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSD  919 (1052)
Q Consensus       846 ~~lv~e~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~D  919 (1052)
                      .++++||+++++|.+++.....      ..+++.++..++.|++.|++|||+.   +++||||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence            8999999999999999976532      4589999999999999999999999   999999999999999999999999


Q ss_pred             ecccccccccCccc-ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHH
Q 001566          920 FGLARLLEVSETHA-TTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLL  997 (1052)
Q Consensus       920 fgla~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  997 (1052)
                      ||+++.+....... .....++..|+|||.+.+..++.++||||||+++||+++ |+.||....+        .++....
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~  232 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--------FEMAAYL  232 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--------HHHHHHH
Confidence            99998664333221 122345678999999998889999999999999999999 9999864221        1222222


Q ss_pred             HHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566          998 IKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus       998 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                      . .+...         ..+..++..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       233 ~-~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~  276 (280)
T cd05043         233 K-DGYRL---------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF  276 (280)
T ss_pred             H-cCCCC---------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            1 11110         11122345689999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.2e-34  Score=321.68  Aligned_cols=236  Identities=25%  Similarity=0.362  Sum_probs=191.6

Q ss_pred             eeeeccCceEEEEEEec-CCcEEEEEEeccCc---cccHHHHHHHHHHhhcc-CCCceeeEEEEEecCCeeEEEEeecCC
Q 001566          781 NLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEAEMFLVYNFLSG  855 (1052)
Q Consensus       781 ~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  855 (1052)
                      +.||+|+||.||+|... +++.||+|++....   ....+.+..|..++... +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999999764 57899999986432   23345677888888876 699999999999999999999999999


Q ss_pred             CCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccccc
Q 001566          856 GNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT  935 (1052)
Q Consensus       856 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  935 (1052)
                      |+|.+++...  ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||++...... .....
T Consensus        81 g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~~~  154 (320)
T cd05590          81 GDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTTS  154 (320)
T ss_pred             chHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCccc
Confidence            9999998765  4689999999999999999999999   9999999999999999999999999998754221 12233


Q ss_pred             ccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCC
Q 001566          936 DVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAG 1015 (1052)
Q Consensus       936 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 1015 (1052)
                      ...|++.|+|||.+.+..++.++||||+||++|||++|+.||.....        .+..+.... +..          ..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--------~~~~~~i~~-~~~----------~~  215 (320)
T cd05590         155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE--------DDLFEAILN-DEV----------VY  215 (320)
T ss_pred             ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--------HHHHHHHhc-CCC----------CC
Confidence            45689999999999999999999999999999999999999974321        222222221 111          01


Q ss_pred             ChHHHHHHHHHHHHccccCCCCCCCH
Q 001566         1016 PQENLLGMMRLASTCTVETLSTRPSV 1041 (1052)
Q Consensus      1016 ~~~~~~~l~~Li~~cl~~dP~~RPt~ 1041 (1052)
                      +......+.+++.+|++.||++||++
T Consensus       216 ~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         216 PTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence            22234458899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=5.7e-34  Score=325.63  Aligned_cols=252  Identities=24%  Similarity=0.337  Sum_probs=195.7

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCc---cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      ++|++.+.||+|+||+||+|... +++.||+|++....   ......+.+|+.++.+++|++|+++++++.+....|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46899999999999999999654 58899999986532   223456788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccC
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~  930 (1052)
                      ||+++|+|.+++...  ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++......
T Consensus        81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~  155 (363)
T cd05628          81 EFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH  155 (363)
T ss_pred             cCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence            999999999999765  4689999999999999999999999   99999999999999999999999999987543211


Q ss_pred             c----------------------------------ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 001566          931 T----------------------------------HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRS  976 (1052)
Q Consensus       931 ~----------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p  976 (1052)
                      .                                  ......+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence            0                                  001234799999999999999999999999999999999999999


Q ss_pred             CCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccc--cCCCCCCCHHHHHH
Q 001566          977 LDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTV--ETLSTRPSVKQVLI 1046 (1052)
Q Consensus       977 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~--~dP~~RPt~~eil~ 1046 (1052)
                      |.....        .+..+.+.... ....+.+.      ......+.+++.+++.  .++..||+++|+++
T Consensus       236 f~~~~~--------~~~~~~i~~~~-~~~~~p~~------~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~  292 (363)
T cd05628         236 FCSETP--------QETYKKVMNWK-ETLIFPPE------VPISEKAKDLILRFCCEWEHRIGAPGVEEIKT  292 (363)
T ss_pred             CCCCCH--------HHHHHHHHcCc-CcccCCCc------CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhC
Confidence            974321        12222222111 11111110      1122346677777544  23345689999876

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.2e-34  Score=320.07  Aligned_cols=238  Identities=24%  Similarity=0.338  Sum_probs=190.2

Q ss_pred             eeeeccCceEEEEEEec-CCcEEEEEEeccCc---cccHHHHHHHHHHhhcc-CCCceeeEEEEEecCCeeEEEEeecCC
Q 001566          781 NLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEAEMFLVYNFLSG  855 (1052)
Q Consensus       781 ~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  855 (1052)
                      +.||+|+||+||+|... +++.||+|+++...   ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999764 57889999986532   22334455666666654 899999999999999999999999999


Q ss_pred             CCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccccc
Q 001566          856 GNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT  935 (1052)
Q Consensus       856 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  935 (1052)
                      |+|.+++...  ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||++....... ....
T Consensus        81 g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~  154 (316)
T cd05592          81 GDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAS  154 (316)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccc
Confidence            9999999765  4689999999999999999999999   99999999999999999999999999997543222 2233


Q ss_pred             ccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCC
Q 001566          936 DVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAG 1015 (1052)
Q Consensus       936 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 1015 (1052)
                      ...|++.|+|||.+.+..++.++||||+||++|||++|+.||.....        .+....+.. ..          ...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~-~~----------~~~  215 (316)
T cd05592         155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE--------DELFDSILN-DR----------PHF  215 (316)
T ss_pred             cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHc-CC----------CCC
Confidence            45689999999999998999999999999999999999999974321        122222211 11          011


Q ss_pred             ChHHHHHHHHHHHHccccCCCCCCCHHH
Q 001566         1016 PQENLLGMMRLASTCTVETLSTRPSVKQ 1043 (1052)
Q Consensus      1016 ~~~~~~~l~~Li~~cl~~dP~~RPt~~e 1043 (1052)
                      +......+.+++.+||+.||++||++.+
T Consensus       216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~  243 (316)
T cd05592         216 PRWISKEAKDCLSKLFERDPTKRLGVDG  243 (316)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCChH
Confidence            2233445889999999999999998754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=6e-34  Score=317.76  Aligned_cols=259  Identities=25%  Similarity=0.426  Sum_probs=207.1

Q ss_pred             HhhCCCccceeeeccCceEEEEEEec--------CCcEEEEEEeccCc-cccHHHHHHHHHHhhcc-CCCceeeEEEEEe
Q 001566          772 RATGNFSIRNLIGTGGFGSTYKAELV--------PGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRI-RHKNLVTLIGYYV  841 (1052)
Q Consensus       772 ~~~~~~~~~~~Lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  841 (1052)
                      ...++|++.+.||+|+||.||+|+..        ++..||+|.+.... .....++.+|+.+++.+ +||||+++++++.
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            34567889999999999999999642        24579999886432 23456788999999999 8999999999999


Q ss_pred             cCCeeEEEEeecCCCCHHHHHhhcc--------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCE
Q 001566          842 GEAEMFLVYNFLSGGNLETFIHKKS--------------GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNI  907 (1052)
Q Consensus       842 ~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Ni  907 (1052)
                      .....++||||+++|+|.+++....              ...+++.++..++.|+++|++|||++   +|+||||||+||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni  168 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV  168 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence            9999999999999999999997642              23578889999999999999999999   999999999999


Q ss_pred             EECCCCcEEEeeecccccccccCcc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCC
Q 001566          908 LLDEELNAYLSDFGLARLLEVSETH-ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYG  985 (1052)
Q Consensus       908 ll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~  985 (1052)
                      ++++++.+||+|||.++........ ......+++.|+|||++.+..++.++||||||+++|||++ |..||...     
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-----  243 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-----  243 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-----
Confidence            9999999999999999866432222 2222345678999999999889999999999999999998 77777522     


Q ss_pred             CCccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566          986 NGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus       986 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                         ...++.+.. ..+...         ..+..++..+.+++.+||+.+|++||++.|+++.|+++
T Consensus       244 ---~~~~~~~~~-~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~  296 (304)
T cd05101         244 ---PVEELFKLL-KEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI  296 (304)
T ss_pred             ---CHHHHHHHH-HcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence               122322322 222111         11223455689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.7e-34  Score=324.89  Aligned_cols=241  Identities=22%  Similarity=0.293  Sum_probs=195.2

Q ss_pred             eeeeccCceEEEEEEe-cCCcEEEEEEeccCc---cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecCCC
Q 001566          781 NLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGG  856 (1052)
Q Consensus       781 ~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  856 (1052)
                      +.||+|+||.||+|.. .+++.||+|++....   ......+..|+++++.++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999965 468999999986532   223456778999999999999999999999999999999999999


Q ss_pred             CHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHh-cCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccccc
Q 001566          857 NLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY-SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT  935 (1052)
Q Consensus       857 sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  935 (1052)
                      +|.+++...  ..+++..+..++.|++.|++|||+ .   +|+||||||+||++++++.+||+|||+++..... .....
T Consensus        81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~  154 (325)
T cd05594          81 ELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMK  154 (325)
T ss_pred             cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCC-Ccccc
Confidence            999988765  468999999999999999999997 6   9999999999999999999999999998753221 12223


Q ss_pred             ccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCC
Q 001566          936 DVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAG 1015 (1052)
Q Consensus       936 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 1015 (1052)
                      ...|++.|+|||++.+..++.++||||+||++|||++|+.||.....        .+..+.... ...          ..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~--------~~~~~~i~~-~~~----------~~  215 (325)
T cd05594         155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELILM-EEI----------RF  215 (325)
T ss_pred             cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH--------HHHHHHHhc-CCC----------CC
Confidence            35689999999999999999999999999999999999999964221        112222111 110          11


Q ss_pred             ChHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 001566         1016 PQENLLGMMRLASTCTVETLSTRP-----SVKQVLI 1046 (1052)
Q Consensus      1016 ~~~~~~~l~~Li~~cl~~dP~~RP-----t~~eil~ 1046 (1052)
                      +......+.+++.+|++.||++|+     ++.++++
T Consensus       216 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence            222344588999999999999997     8988875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=7.1e-34  Score=311.00  Aligned_cols=258  Identities=25%  Similarity=0.392  Sum_probs=208.6

Q ss_pred             CCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCc---cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      ++|++.+.||+|+||.||+|.. .+++.+|||.+....   .....++.+|+.+++.++|||++++++++.+++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4688899999999999999975 478999999876432   223467889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhc--cCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccc
Q 001566          851 NFLSGGNLETFIHKK--SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV  928 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~  928 (1052)
                      ||+++++|.+++...  ....+++..+..++.|+++|++|||++   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999998743  234689999999999999999999999   999999999999999999999999999876543


Q ss_pred             cCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCcccccc
Q 001566          929 SETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFL 1008 (1052)
Q Consensus       929 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                      .. .......++..|+|||.+.+..++.++||||||+++|||++|..||.....      ...+..+.......      
T Consensus       159 ~~-~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~------  225 (267)
T cd08229         159 KT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKKIEQCDY------  225 (267)
T ss_pred             CC-cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc------hHHHHhhhhhcCCC------
Confidence            22 122334678899999999998899999999999999999999999864321      11222222211110      


Q ss_pred             chhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1009 PELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1009 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                      +.   ..+......+.+++.+||+.+|++|||+.++++.++++
T Consensus       226 ~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         226 PP---LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             CC---CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            00   01123455699999999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.3e-34  Score=321.61  Aligned_cols=196  Identities=27%  Similarity=0.429  Sum_probs=172.9

Q ss_pred             CCccceeeeccCceEEEEE-EecCCcEEEEEEeccCccccHHHHHHHHHHhhccC-C-----CceeeEEEEEecCCeeEE
Q 001566          776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIR-H-----KNLVTLIGYYVGEAEMFL  848 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~~~l  848 (1052)
                      +|++.++||+|.||.|.+| +..+++.||||+++..... ..+...|+.+|..++ |     -|+|+++++|...++.|+
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f-~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF-LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH-HHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            7899999999999999999 6667999999999755432 356678999999996 4     389999999999999999


Q ss_pred             EEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC--cEEEeeecccccc
Q 001566          849 VYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEEL--NAYLSDFGLARLL  926 (1052)
Q Consensus       849 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~--~~kl~Dfgla~~~  926 (1052)
                      |+|.+ .-+|+++++.+....++...+..|+.||+.||..||+.   +|||+||||+|||+.+.+  .+||+|||.|+..
T Consensus       266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            99999 67999999999888999999999999999999999999   999999999999997543  6999999999865


Q ss_pred             cccCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 001566          927 EVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPS  980 (1052)
Q Consensus       927 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~  980 (1052)
                      ...-.    .++-+..|.|||++.|.+|+.+.||||||||++||++|.+.|.++
T Consensus       342 ~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~  391 (586)
T KOG0667|consen  342 SQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD  391 (586)
T ss_pred             CCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence            43222    456778899999999999999999999999999999998777543

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=9.5e-34  Score=311.87  Aligned_cols=254  Identities=23%  Similarity=0.367  Sum_probs=200.3

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCc----EEEEEEeccCcc-ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGY----LVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFL  848 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  848 (1052)
                      ++|++.+.||+|+||+||+|.+. +++    .+++|.+..... ....++..|+..++++.||||+++++++. ....++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            46888999999999999999764 343    477887754322 22456778888999999999999999886 456788


Q ss_pred             EEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccc
Q 001566          849 VYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV  928 (1052)
Q Consensus       849 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~  928 (1052)
                      ++||+++|+|.+++.... ..+++..+..++.|++.|++|||++   +++||||||+||++++++.+||+|||.++....
T Consensus        86 i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             EEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            999999999999997654 5689999999999999999999999   999999999999999999999999999986543


Q ss_pred             cCc-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCcccc
Q 001566          929 SET-HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSEL 1006 (1052)
Q Consensus       929 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      ... .......++..|+|||.+.+..++.++||||||+++||+++ |+.||......        . .......+.... 
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--------~-~~~~~~~~~~~~-  231 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--------E-VPDLLEKGERLA-  231 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--------H-HHHHHHCCCcCC-
Confidence            222 12233456778999999998899999999999999999998 99888643211        1 122222222111 


Q ss_pred             ccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1007 FLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1007 ~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                       .       +..+...+.+++.+||..+|++||++.|+++.|.++
T Consensus       232 -~-------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~  268 (279)
T cd05111         232 -Q-------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRM  268 (279)
T ss_pred             -C-------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence             1       112234578899999999999999999999998765

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-35  Score=320.63  Aligned_cols=245  Identities=27%  Similarity=0.396  Sum_probs=204.7

Q ss_pred             eeeeccCceEEEEEEec-CCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecCCCCHH
Q 001566          781 NLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLE  859 (1052)
Q Consensus       781 ~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  859 (1052)
                      -+||+|.||+||.|+.. +...+|||.+.....+..+.+.+|+...++++|.|||+++|.+.+++.+-+.||-++||+|.
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            37999999999999654 45679999998888777888999999999999999999999999999999999999999999


Q ss_pred             HHHhhccCCcc--cHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC-CCCcEEEeeecccccccccCcccccc
Q 001566          860 TFIHKKSGKKI--QWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLD-EELNAYLSDFGLARLLEVSETHATTD  936 (1052)
Q Consensus       860 ~~l~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~-~~~~~kl~Dfgla~~~~~~~~~~~~~  936 (1052)
                      +.++... .++  .+.++-.+.+||++|+.|||+.   .|||||||-+||+|. -.|.+||+|||.++.+.. -...+..
T Consensus       661 sLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TET  735 (1226)
T KOG4279|consen  661 SLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTET  735 (1226)
T ss_pred             HHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc-CCccccc
Confidence            9998876 345  6778888999999999999999   999999999999995 678999999999987642 2334556


Q ss_pred             cccccccccccccCCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcC
Q 001566          937 VAGTFGYVAPEYATTC--RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEA 1014 (1052)
Q Consensus       937 ~~g~~~y~aPE~~~~~--~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 1014 (1052)
                      ..||..|||||++..+  .|+.++|||||||++.||.||++||..-.++        +.+.  ++-|-.  .    ..+.
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp--------qAAM--FkVGmy--K----vHP~  799 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP--------QAAM--FKVGMY--K----VHPP  799 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh--------hHhh--hhhcce--e----cCCC
Confidence            7799999999999764  5889999999999999999999999854333        1111  111111  1    1234


Q ss_pred             CChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1015 GPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1015 ~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      .|.+...+...+|.+|+.+||.+||++.++++
T Consensus       800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            56777888999999999999999999999875

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=5.7e-34  Score=314.56  Aligned_cols=255  Identities=24%  Similarity=0.351  Sum_probs=204.0

Q ss_pred             CCccceeeeccCceEEEEEEec------CCcEEEEEEeccCccc-cHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEE
Q 001566          776 NFSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSIGRFQ-GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFL  848 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  848 (1052)
                      +|++.+.||+|+||.||+|...      .+..||+|++...... ..+.+.+|+.+++.++||||+++++++.+....++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            4778899999999999999653      2478999998755433 24668899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhhcc--------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc
Q 001566          849 VYNFLSGGNLETFIHKKS--------------GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELN  914 (1052)
Q Consensus       849 v~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~  914 (1052)
                      ++||+++++|.+++....              ...+++..+.+++.|++.|++|+|++   +|+||||||.||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence            999999999999985321              13478888999999999999999999   9999999999999999999


Q ss_pred             EEEeeecccccccccCc-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHH
Q 001566          915 AYLSDFGLARLLEVSET-HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVS  992 (1052)
Q Consensus       915 ~kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~  992 (1052)
                      +||+|||+++....... .......+++.|+|||.+.+..++.++||||+|+++|||++ |..||....        ..+
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--------~~~  234 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS--------NQD  234 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC--------HHH
Confidence            99999999886543221 12233446779999999988889999999999999999998 777776321        122


Q ss_pred             HHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566          993 WAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                      +...+.. +...         ..+..++..+.+++.+||+.+|++||+++++++.|+.+
T Consensus       235 ~~~~i~~-~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  283 (283)
T cd05091         235 VIEMIRN-RQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRTW  283 (283)
T ss_pred             HHHHHHc-CCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhCC
Confidence            2222222 2111         12234455689999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.1e-33  Score=307.54  Aligned_cols=252  Identities=25%  Similarity=0.442  Sum_probs=204.5

Q ss_pred             CCCccceeeeccCceEEEEEEecCCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecC
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLS  854 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  854 (1052)
                      .+|++.+.||+|+||.||+|.+..++.+|+|.+..... ...++.+|++++++++||+++++++++......++|+||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            36888899999999999999877788999998864433 34678999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcccc
Q 001566          855 GGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT  934 (1052)
Q Consensus       855 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  934 (1052)
                      +++|.+++.... ..++++.+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||.+...........
T Consensus        83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  158 (256)
T cd05112          83 HGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS  158 (256)
T ss_pred             CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence            999999997654 4578999999999999999999999   999999999999999999999999999876543322222


Q ss_pred             cccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhc
Q 001566          935 TDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWE 1013 (1052)
Q Consensus       935 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1013 (1052)
                      ....++.+|+|||.+.+..++.++||||+|+++|||++ |+.||.....        .+..+... .+.  ....+    
T Consensus       159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~-~~~--~~~~~----  223 (256)
T cd05112         159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN--------SEVVETIN-AGF--RLYKP----  223 (256)
T ss_pred             CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH--------HHHHHHHh-CCC--CCCCC----
Confidence            23345678999999998889999999999999999998 8888863221        12222221 111  11111    


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 001566         1014 AGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLK 1049 (1052)
Q Consensus      1014 ~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~ 1049 (1052)
                         ...+..+.+++.+||+.+|++||++.|+++.|.
T Consensus       224 ---~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         224 ---RLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             ---CCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence               123456999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=8.6e-34  Score=315.27  Aligned_cols=254  Identities=25%  Similarity=0.402  Sum_probs=200.6

Q ss_pred             CCCccceeeeccCceEEEEEEecC-C--cEEEEEEeccC-ccccHHHHHHHHHHhhcc-CCCceeeEEEEEecCCeeEEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELVP-G--YLVAVKKLSIG-RFQGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEAEMFLV  849 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  849 (1052)
                      ++|++.++||+|+||.||+|.... +  ..+++|.++.. .....+.+..|+++++++ +||||+++++++.+....++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578999999999999999996643 3  34788887643 233456788999999999 799999999999999999999


Q ss_pred             EeecCCCCHHHHHhhcc--------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcE
Q 001566          850 YNFLSGGNLETFIHKKS--------------GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNA  915 (1052)
Q Consensus       850 ~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~  915 (1052)
                      +||+++++|.+++....              ...+++..+..++.|++.|++|||++   +|+||||||+||++++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence            99999999999997542              13478899999999999999999998   99999999999999999999


Q ss_pred             EEeeecccccccccCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHH
Q 001566          916 YLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWA  994 (1052)
Q Consensus       916 kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  994 (1052)
                      ||+|||++......  ........+..|+|||.+.+..++.++|||||||++|||++ |..||.....        .+..
T Consensus       159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~--------~~~~  228 (297)
T cd05089         159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC--------AELY  228 (297)
T ss_pred             EECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HHHH
Confidence            99999998643211  11111223557999999998889999999999999999998 9999863321        1222


Q ss_pred             HHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566          995 KLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus       995 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                      .... .+...         ..+...+..+.+++.+|++.+|.+||+++++++.|+++
T Consensus       229 ~~~~-~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  275 (297)
T cd05089         229 EKLP-QGYRM---------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM  275 (297)
T ss_pred             HHHh-cCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            2211 11110         11223345689999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=7.7e-34  Score=312.14  Aligned_cols=247  Identities=24%  Similarity=0.347  Sum_probs=195.4

Q ss_pred             eeccCceEEEEEEec-CCcEEEEEEeccCcc---ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecCCCCH
Q 001566          783 IGTGGFGSTYKAELV-PGYLVAVKKLSIGRF---QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL  858 (1052)
Q Consensus       783 Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  858 (1052)
                      ||+|+||.||+++.. +|+.||+|++.....   .....+..|++++++++||||+++++++.++...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999654 589999999864322   1234456799999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcccccccc
Q 001566          859 ETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVA  938 (1052)
Q Consensus       859 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  938 (1052)
                      .+++.......+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||++.......  ......
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~  155 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA  155 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence            9998776556789999999999999999999999   99999999999999999999999999987654322  222346


Q ss_pred             cccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCCChH
Q 001566          939 GTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQE 1018 (1052)
Q Consensus       939 g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 1018 (1052)
                      |+..|+|||++.+..++.++||||+||++|||++|+.||......    ....++.+.... ....  .       ....
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~----~~~~~~~~~~~~-~~~~--~-------~~~~  221 (277)
T cd05607         156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK----VAKEELKRRTLE-DEVK--F-------EHQN  221 (277)
T ss_pred             CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch----hhHHHHHHHhhc-cccc--c-------cccc
Confidence            889999999999988999999999999999999999998643221    111111111111 1100  0       0112


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 001566         1019 NLLGMMRLASTCTVETLSTRPSVKQVLIKL 1048 (1052)
Q Consensus      1019 ~~~~l~~Li~~cl~~dP~~RPt~~eil~~L 1048 (1052)
                      ....+.+++.+|++.||++||+++|+++..
T Consensus       222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         222 FTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             CCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            344589999999999999999997766443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=5.7e-34  Score=320.56  Aligned_cols=241  Identities=23%  Similarity=0.318  Sum_probs=194.0

Q ss_pred             CCccceeeeccCceEEEEEEec-CCcEEEEEEeccCc---cccHHHHHHHHHHhhccCC-CceeeEEEEEecCCeeEEEE
Q 001566          776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRIRH-KNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~  850 (1052)
                      +|++.+.||+|+||.||+|... +++.||+|++....   ....+.+..|.++++.++| ++|+++++++.+.+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4888999999999999999654 57889999986532   2345667889999999976 46888999999999999999


Q ss_pred             eecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccC
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~  930 (1052)
                      ||+++|+|.+++...  ..+++..+..++.|++.|++|||++   +|+||||||+||++++++.+||+|||++...... 
T Consensus        81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~-  154 (324)
T cd05587          81 EYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-  154 (324)
T ss_pred             cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC-
Confidence            999999999999765  4688999999999999999999999   9999999999999999999999999998743211 


Q ss_pred             cccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccch
Q 001566          931 THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010 (1052)
Q Consensus       931 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1052)
                      ........|++.|+|||++.+..++.++||||+||++|||+||+.||.....        .+..+.... ...       
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~~~i~~-~~~-------  218 (324)
T cd05587         155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--------DELFQSIME-HNV-------  218 (324)
T ss_pred             CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHc-CCC-------
Confidence            1222345689999999999999999999999999999999999999974321        111222211 110       


Q ss_pred             hhcCCChHHHHHHHHHHHHccccCCCCCCCH
Q 001566         1011 LWEAGPQENLLGMMRLASTCTVETLSTRPSV 1041 (1052)
Q Consensus      1011 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~ 1041 (1052)
                         ..+......+.+++.+|++.||++|++.
T Consensus       219 ---~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         219 ---SYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             ---CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence               1122234458899999999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.2e-33  Score=310.11  Aligned_cols=254  Identities=24%  Similarity=0.408  Sum_probs=199.0

Q ss_pred             CccceeeeccCceEEEEEEecCC---cEEEEEEeccCc--cccHHHHHHHHHHhhccCCCceeeEEEEEecC------Ce
Q 001566          777 FSIRNLIGTGGFGSTYKAELVPG---YLVAVKKLSIGR--FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGE------AE  845 (1052)
Q Consensus       777 ~~~~~~Lg~G~~g~V~~~~~~~~---~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~  845 (1052)
                      |.+.++||+|+||.||+|.....   ..||+|.++...  ....+.+..|+++++.++|+||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            35678999999999999976543   268999886542  33456788999999999999999999987532      24


Q ss_pred             eEEEEeecCCCCHHHHHhhcc----CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeec
Q 001566          846 MFLVYNFLSGGNLETFIHKKS----GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFG  921 (1052)
Q Consensus       846 ~~lv~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfg  921 (1052)
                      .++++||+++|+|.+++....    ...+++..+..++.|++.|++|||++   +|+||||||+||++++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence            689999999999999885322    24578999999999999999999998   99999999999999999999999999


Q ss_pred             ccccccccCccc-ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHH
Q 001566          922 LARLLEVSETHA-TTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIK  999 (1052)
Q Consensus       922 la~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  999 (1052)
                      +++......... .....+++.|+|||...+..++.++||||||+++|||++ |+.||....        ..+.... ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--------~~~~~~~-~~  228 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE--------NSEIYDY-LR  228 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC--------HHHHHHH-HH
Confidence            998764332211 222345678999999999999999999999999999999 778875321        1122222 22


Q ss_pred             hCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1000 EGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1000 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                      .+....         .+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       229 ~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         229 QGNRLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             cCCCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            222111         1223345689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=4.6e-34  Score=309.56  Aligned_cols=248  Identities=26%  Similarity=0.371  Sum_probs=197.5

Q ss_pred             eeeeccCceEEEEEEec-CCcEEEEEEeccCcc-ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecCCCCH
Q 001566          781 NLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL  858 (1052)
Q Consensus       781 ~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  858 (1052)
                      +.||+|+||.||+|... +++.||+|.+..... .....+.+|++++++++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36899999999999664 688999998764432 3346789999999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcccc-ccc
Q 001566          859 ETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT-TDV  937 (1052)
Q Consensus       859 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~-~~~  937 (1052)
                      .+++.... ..+++.++..++.|+++|++|||++   +|+||||+|+||+++.++.+||+|||++........... ...
T Consensus        81 ~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  156 (252)
T cd05084          81 LTFLRTEG-PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK  156 (252)
T ss_pred             HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence            99997643 4688999999999999999999999   999999999999999999999999999875432211111 111


Q ss_pred             ccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCCC
Q 001566          938 AGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGP 1016 (1052)
Q Consensus       938 ~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 1016 (1052)
                      ..+..|+|||.+.+..++.++||||+|+++|||++ |..||......        . ...........         ..+
T Consensus       157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--------~-~~~~~~~~~~~---------~~~  218 (252)
T cd05084         157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--------Q-TREAIEQGVRL---------PCP  218 (252)
T ss_pred             CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--------H-HHHHHHcCCCC---------CCc
Confidence            23457999999999889999999999999999998 88887632111        1 11111111111         112


Q ss_pred             hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 001566         1017 QENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQ 1050 (1052)
Q Consensus      1017 ~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~ 1050 (1052)
                      ...+..+.+++.+|++.+|++||++.|+.++|++
T Consensus       219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  252 (252)
T cd05084         219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS  252 (252)
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence            2334568999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=8.6e-34  Score=312.01  Aligned_cols=257  Identities=25%  Similarity=0.375  Sum_probs=204.0

Q ss_pred             hhCCCccceeeeccCceEEEEEEec------CCcEEEEEEeccCcc-ccHHHHHHHHHHhhccCCCceeeEEEEEecCCe
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAE  845 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  845 (1052)
                      ..++|++.+.||+|+||.||+|.+.      .+..||+|.+..... .....+..|+.++++++|+||+++++++.+...
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            3467899999999999999999765      357789998764432 234568899999999999999999999999899


Q ss_pred             eEEEEeecCCCCHHHHHhhccC-----CcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC---cEEE
Q 001566          846 MFLVYNFLSGGNLETFIHKKSG-----KKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEEL---NAYL  917 (1052)
Q Consensus       846 ~~lv~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~---~~kl  917 (1052)
                      .++||||+++++|.++++....     ..+++.++.+++.||+.|++|||++   +++||||||+||+++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence            9999999999999999976531     2588999999999999999999999   999999999999998654   5999


Q ss_pred             eeecccccccccCcc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHH
Q 001566          918 SDFGLARLLEVSETH-ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAK  995 (1052)
Q Consensus       918 ~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  995 (1052)
                      +|||+++........ .......+..|+|||++.+..++.++|||||||++|||++ |..||.....        .+...
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~--------~~~~~  232 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN--------QEVME  232 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHH
Confidence            999999866322211 1112234568999999999899999999999999999997 8888863221        12222


Q ss_pred             HHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 001566          996 LLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQ 1050 (1052)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~ 1050 (1052)
                      ........          ..+...+..+.+++.+|++.+|++||++.++++.|.+
T Consensus       233 ~~~~~~~~----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         233 FVTGGGRL----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             HHHcCCcC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence            22221111          1123334568999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-33  Score=307.23  Aligned_cols=251  Identities=25%  Similarity=0.375  Sum_probs=202.6

Q ss_pred             CCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCcc-----ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRF-----QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFL  848 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  848 (1052)
                      ++|++.+.||+|++|.||+|.. .+++.||+|.+.....     .....+.+|++++++++||||+++++++.++...++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            4689999999999999999965 4689999998864322     123568889999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccc
Q 001566          849 VYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV  928 (1052)
Q Consensus       849 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~  928 (1052)
                      |+||+++++|.+++...  ..+++..+.+++.|++.|++|||+.   +|+||||+|+||++++++.++|+|||++.....
T Consensus        82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          82 FMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             EEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence            99999999999999765  3588999999999999999999999   999999999999999999999999999976543


Q ss_pred             cCcccc--cccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCcccc
Q 001566          929 SETHAT--TDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSEL 1006 (1052)
Q Consensus       929 ~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      ......  ....++..|+|||.+.+..++.++||||+|+++|||++|+.||.....        ........... ..  
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------~~~~~~~~~~~-~~--  225 (263)
T cd06625         157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA--------MAAIFKIATQP-TN--  225 (263)
T ss_pred             cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch--------HHHHHHHhccC-CC--
Confidence            221111  234577899999999998899999999999999999999999863211        11111111111 11  


Q ss_pred             ccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001566         1007 FLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus      1007 ~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                            ...+......+.+++.+||..+|++||++.|+++.
T Consensus       226 ------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         226 ------PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             ------CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                  11223344568999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.5e-34  Score=316.56  Aligned_cols=263  Identities=20%  Similarity=0.369  Sum_probs=201.9

Q ss_pred             hCCCccceeeeccCceEEEEEEecC---------------CcEEEEEEeccCcc-ccHHHHHHHHHHhhccCCCceeeEE
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELVP---------------GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLI  837 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~  837 (1052)
                      ..+|++.+.||+|+||.||+|....               ...||+|++..... ....++.+|++++++++|+|+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            3579999999999999999986532               23589998865432 2345789999999999999999999


Q ss_pred             EEEecCCeeEEEEeecCCCCHHHHHhhcc----------CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCE
Q 001566          838 GYYVGEAEMFLVYNFLSGGNLETFIHKKS----------GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNI  907 (1052)
Q Consensus       838 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Ni  907 (1052)
                      +++......++||||+++++|.+++....          ...+++..+..++.|++.|++|||+.   +++||||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence            99999999999999999999999996542          12368889999999999999999999   999999999999


Q ss_pred             EECCCCcEEEeeecccccccccCc-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCcccC
Q 001566          908 LLDEELNAYLSDFGLARLLEVSET-HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS--GKRSLDPSFSEY  984 (1052)
Q Consensus       908 ll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt--g~~p~~~~~~~~  984 (1052)
                      ++++++.+||+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++  |..||...... 
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~-  239 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE-  239 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH-
Confidence            999999999999999976543222 11223345678999999998889999999999999999998  55566532111 


Q ss_pred             CCCccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 001566          985 GNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQ 1050 (1052)
Q Consensus       985 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~ 1050 (1052)
                          ...............      ......+...+..+.+++.+||+.+|++||+++++++.|++
T Consensus       240 ----~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         240 ----QVIENTGEFFRNQGR------QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             ----HHHHHHHHhhhhccc------cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence                111111111111100      00111122334569999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.3e-33  Score=313.42  Aligned_cols=250  Identities=24%  Similarity=0.387  Sum_probs=205.4

Q ss_pred             hCCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      ..+|++.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+|++++++.+..+...++||||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            35789999999999999999964 46889999999876666667889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      +++++|.+++...   .+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||++....... .
T Consensus        99 ~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~-~  171 (296)
T cd06654          99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-S  171 (296)
T ss_pred             cCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccc-c
Confidence            9999999998653   478999999999999999999999   99999999999999999999999999987654222 1


Q ss_pred             cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhh
Q 001566          933 ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012 (1052)
Q Consensus       933 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1012 (1052)
                      ......+++.|+|||.+.+..++.++|||||||++|||++|+.||....+.        .............        
T Consensus       172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~--------~~~~~~~~~~~~~--------  235 (296)
T cd06654         172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--------RALYLIATNGTPE--------  235 (296)
T ss_pred             ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH--------HhHHHHhcCCCCC--------
Confidence            122346788999999999888999999999999999999999999743221        1111111111110        


Q ss_pred             cCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1013 EAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1013 ~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ...+......+.+++.+||..+|++||++.|+++
T Consensus       236 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            0112334456889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.5e-33  Score=306.23  Aligned_cols=250  Identities=25%  Similarity=0.408  Sum_probs=206.0

Q ss_pred             CCccceeeeccCceEEEEEEec-CCcEEEEEEeccC--ccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIG--RFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      +|++.+.||+|++|.||+|... +++.|++|.+...  .......+.+|++++++++|||++++++++.+....++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4778899999999999999664 5889999988643  234456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      +++++|.++++......+++..+.+++.|++.|+.|||+.   +|+||||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-  156 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-  156 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence            9999999999886556799999999999999999999999   999999999999999999999999999886653322 


Q ss_pred             cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhh
Q 001566          933 ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012 (1052)
Q Consensus       933 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1012 (1052)
                      ......+++.|+|||+..+..++.++|+||||+++|||++|+.||.....        .+..+.. ..+...        
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~-~~~~~~--------  219 (256)
T cd08529         157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--------GALILKI-IRGVFP--------  219 (256)
T ss_pred             hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHH-HcCCCC--------
Confidence            22334578899999999998899999999999999999999999974321        1111111 111111        


Q ss_pred             cCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001566         1013 EAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus      1013 ~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                       ..+...+..+.+++.+||+.+|++||++.++++.
T Consensus       220 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         220 -PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             -CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence             1122344569999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=4.7e-34  Score=316.36  Aligned_cols=255  Identities=24%  Similarity=0.379  Sum_probs=202.9

Q ss_pred             CCccceeeeccCceEEEEEEec------CCcEEEEEEeccCcc-ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEE
Q 001566          776 NFSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFL  848 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  848 (1052)
                      +|++.+.||+|+||.||+|...      ....+|+|.+..... ....++..|+.+++.++||||+++++.+..++..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4788899999999999999643      235688888765432 334678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhhcc----------------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCC
Q 001566          849 VYNFLSGGNLETFIHKKS----------------------GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSN  906 (1052)
Q Consensus       849 v~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~N  906 (1052)
                      ++||+++++|.+++....                      ...+++..+..++.|++.|++|||+.   +|+||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence            999999999999986532                      13478899999999999999999999   99999999999


Q ss_pred             EEECCCCcEEEeeecccccccccCcc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccC
Q 001566          907 ILLDEELNAYLSDFGLARLLEVSETH-ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEY  984 (1052)
Q Consensus       907 ill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~  984 (1052)
                      |++++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||....+  
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--  235 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP--  235 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence            99999999999999999865432221 1222345678999999998889999999999999999999 8888864321  


Q ss_pred             CCCccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566          985 GNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus       985 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                            .+... ........         ..+......+.+++.+|++.+|++||+++|+++.|+++
T Consensus       236 ------~~~~~-~~~~~~~~---------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~  286 (290)
T cd05045         236 ------ERLFN-LLKTGYRM---------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM  286 (290)
T ss_pred             ------HHHHH-HHhCCCCC---------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence                  11111 11111111         11223345688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.4e-33  Score=306.73  Aligned_cols=246  Identities=26%  Similarity=0.394  Sum_probs=197.2

Q ss_pred             eeeccCceEEEEEEec---CCcEEEEEEeccCcc--ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecCCC
Q 001566          782 LIGTGGFGSTYKAELV---PGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGG  856 (1052)
Q Consensus       782 ~Lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  856 (1052)
                      .||+|+||.||+|.++   ++..+|+|+++....  ...+++.+|+.++++++||||+++++++. ....++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            5899999999999643   578899998864432  23567889999999999999999999886 45678999999999


Q ss_pred             CHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc--cc
Q 001566          857 NLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH--AT  934 (1052)
Q Consensus       857 sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~--~~  934 (1052)
                      +|.+++...  ..++++.+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||++.........  ..
T Consensus        81 ~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  155 (257)
T cd05116          81 PLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK  155 (257)
T ss_pred             cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence            999999764  4689999999999999999999999   9999999999999999999999999999866433221  11


Q ss_pred             cccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhc
Q 001566          935 TDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWE 1013 (1052)
Q Consensus       935 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1013 (1052)
                      ....++..|+|||.+....++.++||||||+++|||++ |+.||.....        .++.+.+ ..+...         
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~i-~~~~~~---------  217 (257)
T cd05116         156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--------NEVTQMI-ESGERM---------  217 (257)
T ss_pred             CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHH-HCCCCC---------
Confidence            22234578999999988888999999999999999998 8999874211        1222222 222111         


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1014 AGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1014 ~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                      ..+...+..+.+++.+||+.||++||++++|++.|++.
T Consensus       218 ~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         218 ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            11223445689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=8.1e-34  Score=312.47  Aligned_cols=245  Identities=25%  Similarity=0.362  Sum_probs=194.9

Q ss_pred             eeccCceEEEEEEec-CCcEEEEEEeccCccc---cHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecCCCCH
Q 001566          783 IGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQ---GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL  858 (1052)
Q Consensus       783 Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  858 (1052)
                      ||+|+||+||+|... +++.||+|++......   ..+.+..|++++++++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999654 6889999998654322   235677899999999999999999999999999999999999999


Q ss_pred             HHHHhhc--cCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcccccc
Q 001566          859 ETFIHKK--SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD  936 (1052)
Q Consensus       859 ~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~  936 (1052)
                      .+++...  ....+++..+..++.|++.|++|||++   +|+||||||+||+++.++.++|+|||.+........ ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence            9888542  235689999999999999999999999   999999999999999999999999999976543222 2234


Q ss_pred             cccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCCC
Q 001566          937 VAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGP 1016 (1052)
Q Consensus       937 ~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 1016 (1052)
                      ..|++.|+|||.+.+..++.++||||+|+++|||++|+.||......    ....+....... .  .        ...+
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~----~~~~~~~~~~~~-~--~--------~~~~  221 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK----VENKELKQRILN-D--S--------VTYP  221 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcc----hhHHHHHHhhcc-c--C--------CCCc
Confidence            56889999999999999999999999999999999999999743221    011111111110 0  0        0122


Q ss_pred             hHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 001566         1017 QENLLGMMRLASTCTVETLSTRP-----SVKQVLI 1046 (1052)
Q Consensus      1017 ~~~~~~l~~Li~~cl~~dP~~RP-----t~~eil~ 1046 (1052)
                      ...+..+.+++.+|++.||++||     +++++++
T Consensus       222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            33455688999999999999999     6777764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1e-33  Score=340.24  Aligned_cols=257  Identities=22%  Similarity=0.286  Sum_probs=200.6

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCcc---ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF---QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      ++|++.++||+|+||.||+|... +++.||+|++.....   ...+++.+|++++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57999999999999999999654 589999999865322   22457889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhcc---------CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeec
Q 001566          851 NFLSGGNLETFIHKKS---------GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFG  921 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfg  921 (1052)
                      ||+++|+|.+++....         ....++..+.+++.||++|++|||++   +|+||||||+||+++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999987521         12356678899999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCc-----------------ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccC
Q 001566          922 LARLLEVSET-----------------HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEY  984 (1052)
Q Consensus       922 la~~~~~~~~-----------------~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~  984 (1052)
                      +++.......                 .......||+.|+|||.+.+..++.++||||+||++|||+||+.||...... 
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~-  237 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR-  237 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh-
Confidence            9986621110                 1112346899999999999999999999999999999999999999642111 


Q ss_pred             CCCccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhc
Q 001566          985 GNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRP-SVKQVLIKLKQ 1050 (1052)
Q Consensus       985 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RP-t~~eil~~L~~ 1050 (1052)
                             ...   .. ....   .+.-.. .....+..+.+++.+|++.||++|| +++++.+.|+.
T Consensus       238 -------ki~---~~-~~i~---~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~  289 (932)
T PRK13184        238 -------KIS---YR-DVIL---SPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP  289 (932)
T ss_pred             -------hhh---hh-hhcc---Chhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                   000   00 0000   000000 0112345588999999999999997 56666666654

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.2e-34  Score=301.06  Aligned_cols=252  Identities=27%  Similarity=0.363  Sum_probs=208.1

Q ss_pred             CCCccceeeeccCceEEEEEEecC-CcEEEEEEeccCcc---ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRF---QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      ..|++.+.||+|.-|+||+++.++ +..+|+|++.+...   +...+...|.++|+.+.||.+..+|+.++.+...|+||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            468888999999999999998764 58899999965432   33566788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccC
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~  930 (1052)
                      |||+||+|....+++.+..++++.+.-+|..++-||+|||..   |||.||+||+||||.++|.+-|+||.++.......
T Consensus       157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~P  233 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP  233 (459)
T ss_pred             ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence            999999999999999999999999999999999999999999   99999999999999999999999999986552100


Q ss_pred             ---------------------------------c----------------------ccccccccccccccccccCCCCCC
Q 001566          931 ---------------------------------T----------------------HATTDVAGTFGYVAPEYATTCRVS  955 (1052)
Q Consensus       931 ---------------------------------~----------------------~~~~~~~g~~~y~aPE~~~~~~~~  955 (1052)
                                                       .                      ......+||-.|.|||++.|...+
T Consensus       234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg  313 (459)
T KOG0610|consen  234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG  313 (459)
T ss_pred             eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence                                             0                      001124688999999999999999


Q ss_pred             cchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCC
Q 001566          956 DKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETL 1035 (1052)
Q Consensus       956 ~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP 1035 (1052)
                      .++|.|+|||++|||+.|..||.+.....        -...+..+.         +.-...+..+....+||++.+.+||
T Consensus       314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~--------Tl~NIv~~~---------l~Fp~~~~vs~~akDLIr~LLvKdP  376 (459)
T KOG0610|consen  314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKE--------TLRNIVGQP---------LKFPEEPEVSSAAKDLIRKLLVKDP  376 (459)
T ss_pred             chhhHHHHHHHHHHHHhCCCCcCCCCchh--------hHHHHhcCC---------CcCCCCCcchhHHHHHHHHHhccCh
Confidence            99999999999999999999998654331        122222111         1101122455678999999999999


Q ss_pred             CCCCC----HHHHHH
Q 001566         1036 STRPS----VKQVLI 1046 (1052)
Q Consensus      1036 ~~RPt----~~eil~ 1046 (1052)
                      .+|..    ++||.+
T Consensus       377 ~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  377 SKRLGSKRGAAEIKR  391 (459)
T ss_pred             hhhhccccchHHhhc
Confidence            99997    777653

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=8.4e-34  Score=330.70  Aligned_cols=257  Identities=23%  Similarity=0.355  Sum_probs=192.8

Q ss_pred             hhCCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecC--------
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGE--------  843 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------  843 (1052)
                      ..++|++.++||+|+||.||+|... +++.||||++....    ....+|+.+++.++||||+++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            3457999999999999999999664 68899999885332    2345799999999999999999886432        


Q ss_pred             CeeEEEEeecCCCCHHHHHhhc--cCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC-cEEEeee
Q 001566          844 AEMFLVYNFLSGGNLETFIHKK--SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEEL-NAYLSDF  920 (1052)
Q Consensus       844 ~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~-~~kl~Df  920 (1052)
                      ...++||||++ +++.+++...  ....+++..+..++.|++.||+|||++   +|+||||||+||+++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence            24678999996 5788777542  245689999999999999999999999   999999999999999664 6999999


Q ss_pred             cccccccccCcccccccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHH
Q 001566          921 GLARLLEVSETHATTDVAGTFGYVAPEYATTC-RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIK  999 (1052)
Q Consensus       921 gla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  999 (1052)
                      |+|+......  ......|++.|+|||++.+. .++.++||||+||++|||++|++||......    ..+..   ....
T Consensus       216 Gla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~----~~~~~---i~~~  286 (440)
T PTZ00036        216 GSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV----DQLVR---IIQV  286 (440)
T ss_pred             ccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH----HHHHH---HHHH
Confidence            9998664322  22335688999999998764 6899999999999999999999999743221    01111   1100


Q ss_pred             hCCc-----------------cccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1000 EGRS-----------------SELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1000 ~~~~-----------------~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      .+..                 .......+....+...+.++.+++.+||..||++|||+.|+++
T Consensus       287 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        287 LGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             hCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            0000                 0000011111122334457899999999999999999999874

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=5.5e-34  Score=325.65  Aligned_cols=259  Identities=19%  Similarity=0.283  Sum_probs=203.0

Q ss_pred             hhHHHhhCCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCc---cccHHHHHHHHHHhhccCCCceeeEEEEEecC
Q 001566          768 DNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGE  843 (1052)
Q Consensus       768 ~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  843 (1052)
                      .+.....++|++.+.||+|+||.||+|... +++.||+|++....   ......+.+|+.+++.++||||+++++++.++
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  115 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            344455678999999999999999999765 57899999986422   22345578899999999999999999999999


Q ss_pred             CeeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccc
Q 001566          844 AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLA  923 (1052)
Q Consensus       844 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla  923 (1052)
                      ...++||||+++|+|.+++...   .+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||++
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a  189 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC  189 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence            9999999999999999999764   478889999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccCcccccccccccccccccccCCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHH
Q 001566          924 RLLEVSETHATTDVAGTFGYVAPEYATTCR----VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIK  999 (1052)
Q Consensus       924 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  999 (1052)
                      ...............||+.|+|||++.+..    ++.++||||+||++|||++|+.||....        .....+.+..
T Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~i~~  261 (371)
T cd05622         190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS--------LVGTYSKIMN  261 (371)
T ss_pred             eEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC--------HHHHHHHHHc
Confidence            876543333334567999999999987543    7789999999999999999999997432        1222222222


Q ss_pred             hCCccccccchhhcCCChHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 001566         1000 EGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLST--RPSVKQVLIK 1047 (1052)
Q Consensus      1000 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~--RPt~~eil~~ 1047 (1052)
                      .......       .........+.+++..|+..++.+  ||++.|+++.
T Consensus       262 ~~~~~~~-------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         262 HKNSLTF-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             CCCcccC-------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            1111110       111233455889999999844433  7789888763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4.5e-34  Score=320.97  Aligned_cols=241  Identities=23%  Similarity=0.334  Sum_probs=194.2

Q ss_pred             eeeeccCceEEEEEEec-CCcEEEEEEeccCc---cccHHHHHHHHHHhhcc-CCCceeeEEEEEecCCeeEEEEeecCC
Q 001566          781 NLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEAEMFLVYNFLSG  855 (1052)
Q Consensus       781 ~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  855 (1052)
                      ++||+|+||.||+|+.. +++.||+|++....   ....+.+..|.+++..+ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46899999999999665 57899999986532   23345677888888866 799999999999999999999999999


Q ss_pred             CCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccccc
Q 001566          856 GNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT  935 (1052)
Q Consensus       856 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  935 (1052)
                      |+|.+++...  ..+++..+..++.|++.|++|||++   +|+||||||+||++++++.+||+|||++....... ....
T Consensus        81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~  154 (321)
T cd05591          81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTT  154 (321)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-cccc
Confidence            9999998765  4689999999999999999999999   99999999999999999999999999987543221 2233


Q ss_pred             ccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCC
Q 001566          936 DVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAG 1015 (1052)
Q Consensus       936 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 1015 (1052)
                      ...|++.|+|||++.+..++.++||||+||++|||++|+.||.....        .+..+.......           ..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~--------~~~~~~i~~~~~-----------~~  215 (321)
T cd05591         155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE--------DDLFESILHDDV-----------LY  215 (321)
T ss_pred             ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCC-----------CC
Confidence            45689999999999998999999999999999999999999974321        122222222111           01


Q ss_pred             ChHHHHHHHHHHHHccccCCCCCC-------CHHHHHH
Q 001566         1016 PQENLLGMMRLASTCTVETLSTRP-------SVKQVLI 1046 (1052)
Q Consensus      1016 ~~~~~~~l~~Li~~cl~~dP~~RP-------t~~eil~ 1046 (1052)
                      +......+.+++.+|++.||++||       ++.++++
T Consensus       216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence            122334588999999999999999       7777764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1e-33  Score=316.20  Aligned_cols=257  Identities=25%  Similarity=0.427  Sum_probs=204.7

Q ss_pred             hCCCccceeeeccCceEEEEEEec--------CCcEEEEEEeccCc-cccHHHHHHHHHHhhcc-CCCceeeEEEEEecC
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELV--------PGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGE  843 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  843 (1052)
                      .++|.+.+.||+|+||.||+|...        .+..+|+|.+.... .....++..|+.+++++ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            457999999999999999999653        23569999987543 23356788899999999 799999999999999


Q ss_pred             CeeEEEEeecCCCCHHHHHhhcc--------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE
Q 001566          844 AEMFLVYNFLSGGNLETFIHKKS--------------GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILL  909 (1052)
Q Consensus       844 ~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill  909 (1052)
                      +..++||||+++|+|.+++....              ...+++.++.+++.|++.|++|||+.   +++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence            99999999999999999997643              13578899999999999999999998   99999999999999


Q ss_pred             CCCCcEEEeeecccccccccCcc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCC
Q 001566          910 DEELNAYLSDFGLARLLEVSETH-ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNG  987 (1052)
Q Consensus       910 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~  987 (1052)
                      +.++.+||+|||.+......... ......+++.|+|||.+.+..++.++||||+||++|||++ |+.||....      
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~------  247 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------  247 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC------
Confidence            99999999999998765422211 1112234568999999999889999999999999999998 778875321      


Q ss_pred             ccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566          988 FNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus       988 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                        ..+..+. ...+...         ..+......+.+++.+|++.+|++||++.++++.|+++
T Consensus       248 --~~~~~~~-~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~  299 (307)
T cd05098         248 --VEELFKL-LKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  299 (307)
T ss_pred             --HHHHHHH-HHcCCCC---------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence              1122222 2222111         11223445688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.2e-33  Score=309.16  Aligned_cols=255  Identities=27%  Similarity=0.439  Sum_probs=204.8

Q ss_pred             CCCccceeeeccCceEEEEEEec----CCcEEEEEEeccCcc-ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV----PGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLV  849 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  849 (1052)
                      ++|++.+.||+|+||.||+|...    .+..+|+|.++.... ...+.+..|+.++++++||||+++++++.+++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46889999999999999999653    234799998865432 2346789999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccccccc
Q 001566          850 YNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS  929 (1052)
Q Consensus       850 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~  929 (1052)
                      |||+++++|.+++.... ..+++.++..++.|++.|++|||+.   +++||||||+||+++.++.++++|||++......
T Consensus        84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          84 TEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            99999999999997654 4689999999999999999999999   9999999999999999999999999999866433


Q ss_pred             Ccccc--cccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCcccc
Q 001566          930 ETHAT--TDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSEL 1006 (1052)
Q Consensus       930 ~~~~~--~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      .....  ....++..|+|||.+.+..++.++|+||||+++||+++ |..||......        +..... ..+...  
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--------~~~~~~-~~~~~~--  228 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--------DVIKAI-EEGYRL--  228 (267)
T ss_pred             cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--------HHHHHH-hCCCcC--
Confidence            22111  12223568999999999889999999999999999887 99998632111        111111 111110  


Q ss_pred             ccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1007 FLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1007 ~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                             ..+...+..+.+++.+|++.+|++||++.++++.|+++
T Consensus       229 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         229 -------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             -------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                   11223345689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=8.2e-34  Score=310.49  Aligned_cols=255  Identities=24%  Similarity=0.371  Sum_probs=202.6

Q ss_pred             hCCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++..........+.+|+.++++++|||++++++++..+...++|+||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            34799999999999999999975 46889999998766555556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      +++++|.++++..  ..+++..+..++.|+++|+.|||+.   +|+|||++|+||++++++.++|+|||++....... .
T Consensus        88 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~  161 (267)
T cd06646          88 CGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-A  161 (267)
T ss_pred             CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc-c
Confidence            9999999998754  4689999999999999999999999   99999999999999999999999999998654221 1


Q ss_pred             cccccccccccccccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccc
Q 001566          933 ATTDVAGTFGYVAPEYAT---TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009 (1052)
Q Consensus       933 ~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                      ......++..|+|||.+.   ...++.++||||+||++|||++|+.||....+...        .. ........   .+
T Consensus       162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--------~~-~~~~~~~~---~~  229 (267)
T cd06646         162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--------LF-LMSKSNFQ---PP  229 (267)
T ss_pred             ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--------he-eeecCCCC---CC
Confidence            223346788999999884   34577899999999999999999999863321100        00 00000000   00


Q ss_pred             hhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 001566         1010 ELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKL 1048 (1052)
Q Consensus      1010 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L 1048 (1052)
                      ...  .....+..+.+++.+||+.+|++||+++++++.+
T Consensus       230 ~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         230 KLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            110  1112345689999999999999999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=9.8e-34  Score=310.40  Aligned_cols=256  Identities=23%  Similarity=0.371  Sum_probs=204.8

Q ss_pred             hCCCccceeeeccCceEEEEEEecC----CcEEEEEEeccCc-cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEE
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELVP----GYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFL  848 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  848 (1052)
                      ..+|.+.+.||+|+||.||+|...+    ...||+|...... ....+.+.+|++++++++|||++++++++.+ ...++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            3468889999999999999996543    2468999886554 3445678999999999999999999999875 55789


Q ss_pred             EEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccc
Q 001566          849 VYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV  928 (1052)
Q Consensus       849 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~  928 (1052)
                      ||||+++++|.+++.... ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++++|||++.....
T Consensus        84 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          84 VMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeeccc
Confidence            999999999999997653 4689999999999999999999998   999999999999999999999999999986643


Q ss_pred             cCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCccccc
Q 001566          929 SETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELF 1007 (1052)
Q Consensus       929 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1052)
                      ..........++..|+|||.+.+..++.++||||||+++||+++ |..||......        +..... ..+...   
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--------~~~~~~-~~~~~~---  227 (270)
T cd05056         160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN--------DVIGRI-ENGERL---  227 (270)
T ss_pred             ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHH-HcCCcC---
Confidence            33222223345568999999988889999999999999999986 99998643211        111111 111111   


Q ss_pred             cchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccC
Q 001566         1008 LPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQLK 1052 (1052)
Q Consensus      1008 ~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~lk 1052 (1052)
                            ..+...+..+.+++.+|+..+|++|||+.++++.|++++
T Consensus       228 ------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~  266 (270)
T cd05056         228 ------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL  266 (270)
T ss_pred             ------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                  112334456999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=5.9e-34  Score=315.36  Aligned_cols=261  Identities=25%  Similarity=0.321  Sum_probs=195.6

Q ss_pred             CCccceeeeccCceEEEEEEec-CCcEEEEEEeccCccc--cHHHHHHHHHHhhcc---CCCceeeEEEEEec-----CC
Q 001566          776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQ--GIQQFDAEIGTLGRI---RHKNLVTLIGYYVG-----EA  844 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~~  844 (1052)
                      +|++.+.||+|+||+||+|... +++.||+|.++.....  ....+.+|+++++++   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5888999999999999999654 6889999988754322  223556677777665   69999999998864     34


Q ss_pred             eeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccc
Q 001566          845 EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR  924 (1052)
Q Consensus       845 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~  924 (1052)
                      ..++||||++ ++|.+++.......++++.+..++.|++.|++|||++   +|+||||||+||++++++.+||+|||++.
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccc
Confidence            5799999996 5899999876556689999999999999999999999   99999999999999999999999999998


Q ss_pred             cccccCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHH---HhC
Q 001566          925 LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLI---KEG 1001 (1052)
Q Consensus       925 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~ 1001 (1052)
                      .....  .......++..|+|||++.+..++.++||||+||++|||++|++||......    ...........   ...
T Consensus       157 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~----~~~~~~~~~~~~~~~~~  230 (288)
T cd07863         157 IYSCQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA----DQLGKIFDLIGLPPEDD  230 (288)
T ss_pred             cccCc--ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH----HHHHHHHHHhCCCChhh
Confidence            65422  2223346788999999999989999999999999999999999998643211    00111100000   000


Q ss_pred             Cc------cccccch---hhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1002 RS------SELFLPE---LWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1002 ~~------~~~~~~~---l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      +.      ...+.+.   ......+.....+.+++.+|++.||++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            00      0000000   000111233456889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.7e-33  Score=305.74  Aligned_cols=247  Identities=24%  Similarity=0.385  Sum_probs=196.7

Q ss_pred             eeeccCceEEEEEEec---CCcEEEEEEeccCccc-cHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecCCCC
Q 001566          782 LIGTGGFGSTYKAELV---PGYLVAVKKLSIGRFQ-GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGN  857 (1052)
Q Consensus       782 ~Lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  857 (1052)
                      .||+|+||.||+|.+.   .+..||+|++...... ..+.+.+|+.++++++||||+++++++. ....++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999999654   3557999988655332 3466889999999999999999999886 457899999999999


Q ss_pred             HHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccc--cc
Q 001566          858 LETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TT  935 (1052)
Q Consensus       858 L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~--~~  935 (1052)
                      |.+++.... ..+++..+.+++.|++.|++|||++   +++||||||+||+++.++.+||+|||++..........  ..
T Consensus        81 L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          81 LNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             HHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence            999997543 5689999999999999999999999   99999999999999999999999999997554322211  11


Q ss_pred             ccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcC
Q 001566          936 DVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEA 1014 (1052)
Q Consensus       936 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 1014 (1052)
                      ...++..|+|||.+.+..++.++||||||+++||+++ |..||.....        .++.... ..+...         .
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~-~~~~~~---------~  218 (257)
T cd05115         157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG--------PEVMSFI-EQGKRL---------D  218 (257)
T ss_pred             CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH--------HHHHHHH-HCCCCC---------C
Confidence            1223578999999988889999999999999999996 9999863311        1222222 222111         1


Q ss_pred             CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1015 GPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1015 ~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                      .+..++.++.+++.+||..+|++||++.++.+.|+.+
T Consensus       219 ~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         219 CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            2233456688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.6e-33  Score=308.37  Aligned_cols=255  Identities=26%  Similarity=0.435  Sum_probs=204.9

Q ss_pred             CCCccceeeeccCceEEEEEEec-CC---cEEEEEEeccCc-cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PG---YLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLV  849 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  849 (1052)
                      .+|+..+.||+|+||.||+|... ++   ..+|+|.+.... ....+++..|++++++++|||++++++++.+.+..++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            46788899999999999999764 23   379999886543 23356788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccccccc
Q 001566          850 YNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS  929 (1052)
Q Consensus       850 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~  929 (1052)
                      |||+++++|.+++.... ..+++.++..++.|++.|++|||+.   +++||||||+||++++++.+|++|||++......
T Consensus        85 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          85 TEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            99999999999997654 5689999999999999999999999   9999999999999999999999999999765432


Q ss_pred             Cccc--ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCcccc
Q 001566          930 ETHA--TTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSEL 1006 (1052)
Q Consensus       930 ~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      ....  ......+..|+|||.+.+..++.++||||||+++|||++ |+.||.....        .++.+.+.. +...  
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--------~~~~~~i~~-~~~~--  229 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--------HEVMKAIND-GFRL--  229 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--------HHHHHHHhc-CCCC--
Confidence            2111  111223457999999998889999999999999999998 9999863211        122222221 1111  


Q ss_pred             ccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1007 FLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1007 ~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                             ..+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       230 -------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         230 -------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             -------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                   11223345689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=9.5e-34  Score=317.07  Aligned_cols=240  Identities=25%  Similarity=0.342  Sum_probs=191.5

Q ss_pred             eeeeccCceEEEEEEec-CCcEEEEEEeccCc---cccHHHHHHHHHHhhcc-CCCceeeEEEEEecCCeeEEEEeecCC
Q 001566          781 NLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEAEMFLVYNFLSG  855 (1052)
Q Consensus       781 ~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  855 (1052)
                      +.||+|+||+||+|... +++.||+|+++...   ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999765 57899999986542   22345566777777764 899999999999999999999999999


Q ss_pred             CCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccccc
Q 001566          856 GNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT  935 (1052)
Q Consensus       856 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  935 (1052)
                      |+|.+++...  ..+++.++..++.|++.|++|||++   +|+||||||+||++++++.+||+|||++....... ....
T Consensus        81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~  154 (316)
T cd05619          81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTC  154 (316)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Ccee
Confidence            9999999764  4688999999999999999999999   99999999999999999999999999987432211 1223


Q ss_pred             ccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCC
Q 001566          936 DVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAG 1015 (1052)
Q Consensus       936 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 1015 (1052)
                      ...|++.|+|||++.+..++.++||||+||++|||++|+.||....        ..+..+.... ...      .    .
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~--------~~~~~~~i~~-~~~------~----~  215 (316)
T cd05619         155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD--------EEELFQSIRM-DNP------C----Y  215 (316)
T ss_pred             eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHh-CCC------C----C
Confidence            4568999999999999899999999999999999999999997422        1122222211 110      0    1


Q ss_pred             ChHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 001566         1016 PQENLLGMMRLASTCTVETLSTRPSVK-QVL 1045 (1052)
Q Consensus      1016 ~~~~~~~l~~Li~~cl~~dP~~RPt~~-eil 1045 (1052)
                      +......+.+++.+|++.||++||++. ++.
T Consensus       216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         216 PRWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             CccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence            122334588999999999999999997 553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=8.4e-34  Score=319.05  Aligned_cols=241  Identities=22%  Similarity=0.312  Sum_probs=194.5

Q ss_pred             CCccceeeeccCceEEEEEEec-CCcEEEEEEeccCc---cccHHHHHHHHHHhhcc-CCCceeeEEEEEecCCeeEEEE
Q 001566          776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      +|++.+.||+|+||.||+|... +++.||+|++....   ....+.+..|..++... +|++|+++++++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4788999999999999999665 57899999987542   22234566788888777 5899999999999999999999


Q ss_pred             eecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccC
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~  930 (1052)
                      ||+++|+|.+++...  ..+++.++..++.|++.|++|||++   +|+||||||+||++++++.+||+|||+++..... 
T Consensus        81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~-  154 (323)
T cd05616          81 EYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD-  154 (323)
T ss_pred             cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC-
Confidence            999999999998765  4689999999999999999999999   9999999999999999999999999998754321 


Q ss_pred             cccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccch
Q 001566          931 THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010 (1052)
Q Consensus       931 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1052)
                      ........|++.|+|||++.+..++.++||||+||++|||+||+.||.....        .+..+.... ...       
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--------~~~~~~i~~-~~~-------  218 (323)
T cd05616         155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIME-HNV-------  218 (323)
T ss_pred             CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH--------HHHHHHHHh-CCC-------
Confidence            1223345689999999999999999999999999999999999999974321        122222221 111       


Q ss_pred             hhcCCChHHHHHHHHHHHHccccCCCCCCCH
Q 001566         1011 LWEAGPQENLLGMMRLASTCTVETLSTRPSV 1041 (1052)
Q Consensus      1011 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~ 1041 (1052)
                         ..+......+.+++.+|++.||++|++.
T Consensus       219 ---~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         219 ---AYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             ---CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence               1122334568899999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.3e-33  Score=313.98  Aligned_cols=263  Identities=22%  Similarity=0.381  Sum_probs=204.9

Q ss_pred             hCCCccceeeeccCceEEEEEEecC-----------------CcEEEEEEeccCcc-ccHHHHHHHHHHhhccCCCceee
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELVP-----------------GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVT  835 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~  835 (1052)
                      .++|++.+.||+|+||.||+|....                 +..||+|++..... ...+++.+|++++++++|||+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4579999999999999999986542                 24689999875533 34567889999999999999999


Q ss_pred             EEEEEecCCeeEEEEeecCCCCHHHHHhhcc---------CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCC
Q 001566          836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKS---------GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSN  906 (1052)
Q Consensus       836 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~N  906 (1052)
                      +++++..++..++|+||+++++|.+++....         ...+++..+..++.|++.|++|||+.   +|+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence            9999999999999999999999999997653         12689999999999999999999999   99999999999


Q ss_pred             EEECCCCcEEEeeecccccccccCc-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCccc
Q 001566          907 ILLDEELNAYLSDFGLARLLEVSET-HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS--GKRSLDPSFSE  983 (1052)
Q Consensus       907 ill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt--g~~p~~~~~~~  983 (1052)
                      |+++.++.++|+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++  |..||....  
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~--  238 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT--  238 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--
Confidence            9999999999999999986543322 12233456778999999998889999999999999999998  566664211  


Q ss_pred             CCCCccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 001566          984 YGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQ 1050 (1052)
Q Consensus       984 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~ 1050 (1052)
                         ...................      ....+...+.++.+++.+|++.||++||++.|+++.|++
T Consensus       239 ---~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         239 ---DQQVIENAGHFFRDDGRQI------YLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             ---hHHHHHHHHhccccccccc------cCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence               1111111111111111110      011122334569999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1e-33  Score=314.67  Aligned_cols=263  Identities=21%  Similarity=0.365  Sum_probs=203.0

Q ss_pred             hCCCccceeeeccCceEEEEEEec-----------------CCcEEEEEEeccCcc-ccHHHHHHHHHHhhccCCCceee
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELV-----------------PGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVT  835 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~  835 (1052)
                      .++|++.+.||+|+||.||+|+..                 ++..||+|++..... ....++.+|++++++++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            357999999999999999998532                 234689998875432 33467899999999999999999


Q ss_pred             EEEEEecCCeeEEEEeecCCCCHHHHHhhccC---------CcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCC
Q 001566          836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSG---------KKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSN  906 (1052)
Q Consensus       836 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~N  906 (1052)
                      +++++..++..++||||+++++|.+++.....         ..+++.++..++.|++.|++|||+.   +|+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence            99999999999999999999999999976431         2467889999999999999999999   99999999999


Q ss_pred             EEECCCCcEEEeeecccccccccCcc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh--CCCCCCCCccc
Q 001566          907 ILLDEELNAYLSDFGLARLLEVSETH-ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS--GKRSLDPSFSE  983 (1052)
Q Consensus       907 ill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt--g~~p~~~~~~~  983 (1052)
                      |++++++.++|+|||++..+...... ......+++.|++||...++.++.++|||||||++|||++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            99999999999999999865432221 1222344678999999888889999999999999999998  66777532111


Q ss_pred             CCCCccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 001566          984 YGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQ 1050 (1052)
Q Consensus       984 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~ 1050 (1052)
                           ................. .     ...+..++..+.+++.+||+.||++||++.|+++.|++
T Consensus       241 -----~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         241 -----QVIENTGEFFRDQGRQV-Y-----LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             -----HHHHHHHHHHhhccccc-c-----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                 11111111111111000 0     01122344668999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.3e-33  Score=309.13  Aligned_cols=255  Identities=25%  Similarity=0.449  Sum_probs=203.7

Q ss_pred             CCCccceeeeccCceEEEEEEecC-C---cEEEEEEeccC-ccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELVP-G---YLVAVKKLSIG-RFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLV  849 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  849 (1052)
                      ..|++.+.||+|+||.||+|.... +   ..||+|.+... ......+|..|+.++++++||||+++++++.++...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            357889999999999999997643 3   36999998754 233456899999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccccccc
Q 001566          850 YNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS  929 (1052)
Q Consensus       850 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~  929 (1052)
                      |||+++++|.+++.... ..+++.++..++.|++.|++|||++   +++||||||+||+++.++.++++|||++......
T Consensus        84 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          84 TEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             EecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccC
Confidence            99999999999997654 4689999999999999999999999   9999999999999999999999999998765432


Q ss_pred             Cccc--cccc--ccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCcc
Q 001566          930 ETHA--TTDV--AGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSS 1004 (1052)
Q Consensus       930 ~~~~--~~~~--~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1052)
                      ....  ....  ..+..|+|||.+.+..++.++||||+|+++||+++ |..||.....        .+..+.. ......
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--------~~~~~~i-~~~~~~  230 (269)
T cd05065         160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--------QDVINAI-EQDYRL  230 (269)
T ss_pred             ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--------HHHHHHH-HcCCcC
Confidence            2111  1111  12457999999999999999999999999999987 9999863211        1112222 111110


Q ss_pred             ccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1005 ELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1005 ~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                               ..+.+.+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       231 ---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         231 ---------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ---------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                     11223345688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-34  Score=328.05  Aligned_cols=252  Identities=23%  Similarity=0.308  Sum_probs=197.2

Q ss_pred             CCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCc---cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      ++|++.+.||+|+||+||+|.. .+++.||+|++....   ....+.+.+|++++++++||||+++++++.+....|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            3688999999999999999955 468999999986432   223456788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccC
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~  930 (1052)
                      ||+++|+|.+++...  ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.+....
T Consensus        81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  155 (377)
T cd05629          81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH  155 (377)
T ss_pred             eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            999999999999764  4688999999999999999999999   99999999999999999999999999996432110


Q ss_pred             cc----------------------------------------------cccccccccccccccccCCCCCCcchhHHHHH
Q 001566          931 TH----------------------------------------------ATTDVAGTFGYVAPEYATTCRVSDKADVYSFG  964 (1052)
Q Consensus       931 ~~----------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG  964 (1052)
                      ..                                              ......||+.|+|||++.+..++.++||||+|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  235 (377)
T cd05629         156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG  235 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence            00                                              00124689999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCC---CCH
Q 001566          965 VVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTR---PSV 1041 (1052)
Q Consensus       965 ~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~R---Pt~ 1041 (1052)
                      |++|||++|+.||.....        .+..+..........  .+     ........+.+++.+|+. +|.+|   +++
T Consensus       236 vil~elltG~~Pf~~~~~--------~~~~~~i~~~~~~~~--~p-----~~~~~s~~~~dli~~lL~-~~~~r~~r~~~  299 (377)
T cd05629         236 AIMFECLIGWPPFCSENS--------HETYRKIINWRETLY--FP-----DDIHLSVEAEDLIRRLIT-NAENRLGRGGA  299 (377)
T ss_pred             hhhhhhhcCCCCCCCCCH--------HHHHHHHHccCCccC--CC-----CCCCCCHHHHHHHHHHhc-CHhhcCCCCCH
Confidence            999999999999974321        111222211111000  01     011223458899999997 66665   599


Q ss_pred             HHHHHH
Q 001566         1042 KQVLIK 1047 (1052)
Q Consensus      1042 ~eil~~ 1047 (1052)
                      .|+++.
T Consensus       300 ~~~l~h  305 (377)
T cd05629         300 HEIKSH  305 (377)
T ss_pred             HHHhcC
Confidence            988753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.8e-34  Score=323.86  Aligned_cols=238  Identities=27%  Similarity=0.369  Sum_probs=193.6

Q ss_pred             eeeeccCceEEEEEEe----cCCcEEEEEEeccCcc--ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecC
Q 001566          781 NLIGTGGFGSTYKAEL----VPGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLS  854 (1052)
Q Consensus       781 ~~Lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  854 (1052)
                      +.||+|+||.||+++.    .+|+.||+|++.....  .....+..|++++++++||||+++++++.+.+..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999854    3578999999875432  233556789999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcccc
Q 001566          855 GGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT  934 (1052)
Q Consensus       855 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  934 (1052)
                      +|+|.+++...  ..+++..+..++.|+++|++|||++   +|+||||||+||++++++.+||+|||++....... ...
T Consensus        82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~  155 (318)
T cd05582          82 GGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKA  155 (318)
T ss_pred             CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cce
Confidence            99999999764  4689999999999999999999999   99999999999999999999999999987653221 223


Q ss_pred             cccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcC
Q 001566          935 TDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEA 1014 (1052)
Q Consensus       935 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 1014 (1052)
                      ....|++.|+|||.+.+..++.++|||||||++|||++|+.||....        ..+......... .          .
T Consensus       156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~--------~~~~~~~i~~~~-~----------~  216 (318)
T cd05582         156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD--------RKETMTMILKAK-L----------G  216 (318)
T ss_pred             ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC--------HHHHHHHHHcCC-C----------C
Confidence            34568999999999999889999999999999999999999997421        112222222111 1          1


Q ss_pred             CChHHHHHHHHHHHHccccCCCCCCCHHH
Q 001566         1015 GPQENLLGMMRLASTCTVETLSTRPSVKQ 1043 (1052)
Q Consensus      1015 ~~~~~~~~l~~Li~~cl~~dP~~RPt~~e 1043 (1052)
                      .+......+.+++.+|++.||++||++.+
T Consensus       217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         217 MPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            12233455889999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-33  Score=311.04  Aligned_cols=256  Identities=22%  Similarity=0.364  Sum_probs=205.3

Q ss_pred             hCCCccceeeeccCceEEEEEEec------CCcEEEEEEeccCcc-ccHHHHHHHHHHhhccCCCceeeEEEEEecCCee
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEM  846 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  846 (1052)
                      .++|++.+.||+|+||.||+|...      .+..||+|.+..... .....+.+|+++++.++|||++++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            457889999999999999999654      246899999864432 3345788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhhcc--------CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEe
Q 001566          847 FLVYNFLSGGNLETFIHKKS--------GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLS  918 (1052)
Q Consensus       847 ~lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~  918 (1052)
                      ++||||+++++|.+++....        ...+++..+..++.|++.|+.|||+.   +|+||||||+||++++++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence            99999999999999997543        12468889999999999999999999   99999999999999999999999


Q ss_pred             eecccccccccCc-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHH
Q 001566          919 DFGLARLLEVSET-HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKL  996 (1052)
Q Consensus       919 Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  996 (1052)
                      |||+++....... .......++..|+|||.+.+..++.++||||||+++||+++ |..||....        ..+..+.
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~--------~~~~~~~  233 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS--------NEEVLKF  233 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC--------HHHHHHH
Confidence            9999986543322 12223446788999999998889999999999999999998 888885321        1222222


Q ss_pred             HHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 001566          997 LIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQ 1050 (1052)
Q Consensus       997 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~ 1050 (1052)
                      .. .+...         ..+...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus       234 ~~-~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         234 VI-DGGHL---------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             Hh-cCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            22 11111         1122235568999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=6.9e-34  Score=326.26  Aligned_cols=264  Identities=23%  Similarity=0.314  Sum_probs=198.4

Q ss_pred             CCccceeeeccCceEEEEEEe-cCCcEEEEEEeccC--ccccHHHHHHHHHHhhccCCCceeeEEEEEecCC-----eeE
Q 001566          776 NFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIG--RFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEA-----EMF  847 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~  847 (1052)
                      +|++.+.||+|+||.||+|.. .+++.||+|++...  ......++.+|+++++.++||||+++++++....     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478899999999999999965 46899999988643  2233467889999999999999999999998766     789


Q ss_pred             EEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccccc
Q 001566          848 LVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE  927 (1052)
Q Consensus       848 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~  927 (1052)
                      +|+||+. ++|.+++...  ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus        81 lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~  154 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEE  154 (372)
T ss_pred             EEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence            9999995 6888887654  4689999999999999999999999   99999999999999999999999999998654


Q ss_pred             ccCcccccccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCC--------CccHHH------
Q 001566          928 VSETHATTDVAGTFGYVAPEYATTC-RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGN--------GFNIVS------  992 (1052)
Q Consensus       928 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~--------~~~~~~------  992 (1052)
                      ...........+++.|+|||.+.+. .++.++||||+||++|||++|+.||....+....        ......      
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  234 (372)
T cd07853         155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE  234 (372)
T ss_pred             cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence            4333333445678899999998874 4788999999999999999999999743221000        000000      


Q ss_pred             HHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566          993 WAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ................+... .........+.+++.+|++.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         235 GARAHILRGPHKPPSLPVLY-TLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             HHHHHHHhCCCCCCchHHhc-ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence            00000000000000000000 111222456889999999999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-33  Score=318.87  Aligned_cols=254  Identities=23%  Similarity=0.315  Sum_probs=197.8

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCc---cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      ++|++.+.||+|+||+||+|... +++.||+|++....   ....+.+.+|+.+++.++|+||+++++++.++...|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46899999999999999999754 58899999986422   223456888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccC
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~  930 (1052)
                      ||+++|+|.+++.... ..+++..+..++.||+.|++|||++   +|+||||||+||+++.++.+||+|||++.......
T Consensus        81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             ecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence            9999999999997643 5689999999999999999999999   99999999999999999999999999987654333


Q ss_pred             cccccccccccccccccccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccc
Q 001566          931 THATTDVAGTFGYVAPEYATT-----CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005 (1052)
Q Consensus       931 ~~~~~~~~g~~~y~aPE~~~~-----~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1052)
                      ........|++.|+|||++..     ..++.++||||+||++|||++|+.||....        ..+............ 
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~--------~~~~~~~i~~~~~~~-  227 (331)
T cd05597         157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETYGKIMNHKEHF-  227 (331)
T ss_pred             CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC--------HHHHHHHHHcCCCcc-
Confidence            333333468999999999863     456789999999999999999999997321        222222222211111 


Q ss_pred             cccchhhcCCChHHHHHHHHHHHHccccCCCC--CCCHHHHHH
Q 001566         1006 LFLPELWEAGPQENLLGMMRLASTCTVETLST--RPSVKQVLI 1046 (1052)
Q Consensus      1006 ~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~--RPt~~eil~ 1046 (1052)
                      .+.     ......+..+.+++.+|++.++++  ||++.++++
T Consensus       228 ~~~-----~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~  265 (331)
T cd05597         228 QFP-----PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKD  265 (331)
T ss_pred             cCC-----CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            010     111123445788888887654443  789988875

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-33  Score=325.80  Aligned_cols=262  Identities=21%  Similarity=0.227  Sum_probs=198.4

Q ss_pred             hCCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      ...|.+.+.||+|+||.||+|... .++.||||...      ...+.+|++++++++|+||+++++++...+..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            457999999999999999999665 47889999642      13457899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCc-
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET-  931 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~-  931 (1052)
                      + .++|.+++.... ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++....... 
T Consensus       242 ~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~  316 (461)
T PHA03211        242 Y-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST  316 (461)
T ss_pred             c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence            9 579999987643 4689999999999999999999999   999999999999999999999999999986543221 


Q ss_pred             ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccc--
Q 001566          932 HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP-- 1009 (1052)
Q Consensus       932 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 1009 (1052)
                      .......||+.|+|||++.+..++.++|||||||++|||++|..|+..............+..+.+...+.....+.+  
T Consensus       317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~  396 (461)
T PHA03211        317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA  396 (461)
T ss_pred             ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence            122245689999999999999999999999999999999998876643221111111111111111111110000000  


Q ss_pred             ----------------------hhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001566         1010 ----------------------ELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus      1010 ----------------------~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                                            .-|..+ ......+.+++.+|++.||++|||+.|+++.
T Consensus       397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        397 GSRLVSQYRHRAARNRRPAYTRPAWTRY-YKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             chHHHHHHHhhhhcccCCccCCcchhhh-ccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                                  000000 0112357899999999999999999999864

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=8.3e-34  Score=318.18  Aligned_cols=241  Identities=23%  Similarity=0.328  Sum_probs=194.7

Q ss_pred             eeeeccCceEEEEEEec-CCcEEEEEEeccCc---cccHHHHHHHHHHhhcc-CCCceeeEEEEEecCCeeEEEEeecCC
Q 001566          781 NLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEAEMFLVYNFLSG  855 (1052)
Q Consensus       781 ~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  855 (1052)
                      +.||+|+||+||+|... +++.||+|+++...   ......+..|.++++.+ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999665 57899999987542   23345667888888887 799999999999999999999999999


Q ss_pred             CCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccccc
Q 001566          856 GNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT  935 (1052)
Q Consensus       856 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  935 (1052)
                      |+|.+++...  ..+++.++..++.|++.|++|||++   +|+||||||+||++++++.+||+|||++...... .....
T Consensus        81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~  154 (318)
T cd05570          81 GDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG-GVTTS  154 (318)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcC-CCccc
Confidence            9999998765  4689999999999999999999999   9999999999999999999999999998743211 12223


Q ss_pred             ccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCC
Q 001566          936 DVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAG 1015 (1052)
Q Consensus       936 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 1015 (1052)
                      ...|++.|+|||++.+..++.++||||+||++|||++|+.||....        ..+...... ....          ..
T Consensus       155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~--------~~~~~~~i~-~~~~----------~~  215 (318)
T cd05570         155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD--------EDELFQSIL-EDEV----------RY  215 (318)
T ss_pred             ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC--------HHHHHHHHH-cCCC----------CC
Confidence            3468999999999999999999999999999999999999997422        112222221 1111          11


Q ss_pred             ChHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 001566         1016 PQENLLGMMRLASTCTVETLSTRPSV-----KQVLI 1046 (1052)
Q Consensus      1016 ~~~~~~~l~~Li~~cl~~dP~~RPt~-----~eil~ 1046 (1052)
                      +...+..+.+++.+||+.||++||++     .++++
T Consensus       216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            22334568999999999999999999     77764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=6.8e-34  Score=313.85  Aligned_cols=250  Identities=27%  Similarity=0.364  Sum_probs=200.8

Q ss_pred             CccceeeeccCceEEEEEEec-CCcEEEEEEeccCccc---cHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          777 FSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQ---GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       777 ~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      |++.+.||+|+||.||+|... +++.||+|.+......   ....+..|+.++++++|++++++++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            677899999999999999654 6889999988654322   234577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      +++++|.+++.......+++..+..++.|++.|+.|||+.   +|+||||||+||++++++.++|+|||++.......  
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  156 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--  156 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence            9999999999766556789999999999999999999998   99999999999999999999999999987553222  


Q ss_pred             cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhh
Q 001566          933 ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012 (1052)
Q Consensus       933 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1012 (1052)
                      ......|+..|+|||++.+..++.++||||+|+++|||++|+.||......    .. .+.........          .
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~----~~-~~~~~~~~~~~----------~  221 (285)
T cd05630         157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK----IK-REEVERLVKEV----------Q  221 (285)
T ss_pred             cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCcc----ch-HHHHHhhhhhh----------h
Confidence            122346899999999999999999999999999999999999999743221    00 01111111100          0


Q ss_pred             cCCChHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 001566         1013 EAGPQENLLGMMRLASTCTVETLSTRPS-----VKQVLI 1046 (1052)
Q Consensus      1013 ~~~~~~~~~~l~~Li~~cl~~dP~~RPt-----~~eil~ 1046 (1052)
                      ...+......+.+++.+||+.||++||+     +.|+++
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         222 EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            1112223445889999999999999999     888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.3e-33  Score=312.45  Aligned_cols=256  Identities=27%  Similarity=0.400  Sum_probs=205.4

Q ss_pred             hCCCccceeeeccCceEEEEEEec------CCcEEEEEEeccCcc-ccHHHHHHHHHHhhccCCCceeeEEEEEecCCee
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEM  846 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  846 (1052)
                      .++|++.+.||+|+||.||+|...      ++..||+|++..... ....++.+|++++++++|||++++++++.++...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            457899999999999999999753      467899998875432 3346788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhhcc--------------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCC
Q 001566          847 FLVYNFLSGGNLETFIHKKS--------------------GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSN  906 (1052)
Q Consensus       847 ~lv~e~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~N  906 (1052)
                      ++|+||+++|+|.+++....                    ...+++.++..++.|++.|++|||++   +++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence            99999999999999997532                    12467888999999999999999999   99999999999


Q ss_pred             EEECCCCcEEEeeecccccccccCc-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccC
Q 001566          907 ILLDEELNAYLSDFGLARLLEVSET-HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEY  984 (1052)
Q Consensus       907 ill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~  984 (1052)
                      |++++++.++|+|||++........ ........+..|+|||.+.+..++.++|||||||++|||++ |..||....   
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~---  237 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA---  237 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC---
Confidence            9999999999999999876543221 11222345678999999998899999999999999999998 777875321   


Q ss_pred             CCCccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 001566          985 GNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQ 1050 (1052)
Q Consensus       985 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~ 1050 (1052)
                           ..++..... .+...         ..+...+..+.+++.+|++.+|++||++.|+++.|++
T Consensus       238 -----~~~~~~~~~-~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         238 -----HEEVIYYVR-DGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             -----HHHHHHHHh-cCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                 122222222 22111         1122344569999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=4e-34  Score=328.88  Aligned_cols=250  Identities=21%  Similarity=0.298  Sum_probs=196.6

Q ss_pred             CCccceeeeccCceEEEEEEec-CCcEEEEEEeccCc---cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEe
Q 001566          776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYN  851 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  851 (1052)
                      +|++.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|++++++++||||+++++.+.+++..|+|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            6899999999999999999654 58999999986432   1234567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccC-
Q 001566          852 FLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE-  930 (1052)
Q Consensus       852 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~-  930 (1052)
                      |+++|+|.+++...  ..+++..+..++.||+.|++|||++   +|+||||||+||+++.++.+||+|||+|..+.... 
T Consensus        82 ~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          82 YIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence            99999999999765  4688899999999999999999999   99999999999999999999999999975331000 


Q ss_pred             -----------------------------------------cccccccccccccccccccCCCCCCcchhHHHHHHHHHH
Q 001566          931 -----------------------------------------THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLE  969 (1052)
Q Consensus       931 -----------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~e  969 (1052)
                                                               ........||+.|+|||++.+..++.++||||+||++||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye  236 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  236 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence                                                     000123468999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCC---CHHHHHH
Q 001566          970 LISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRP---SVKQVLI 1046 (1052)
Q Consensus       970 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RP---t~~eil~ 1046 (1052)
                      |++|+.||......        +............  ..     .........+.+++.+|+ .+|.+|+   ++.|+++
T Consensus       237 ll~G~~Pf~~~~~~--------~~~~~i~~~~~~~--~~-----~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~  300 (376)
T cd05598         237 MLVGQPPFLADTPA--------ETQLKVINWETTL--HI-----PSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA  300 (376)
T ss_pred             hhhCCCCCCCCCHH--------HHHHHHhccCccc--cC-----CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence            99999999743221        2222211111000  00     011123345777888876 5999999   8888875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.4e-33  Score=304.92  Aligned_cols=249  Identities=27%  Similarity=0.405  Sum_probs=202.1

Q ss_pred             eeeeccCceEEEEEEecC--C--cEEEEEEeccCcc-ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecCC
Q 001566          781 NLIGTGGFGSTYKAELVP--G--YLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSG  855 (1052)
Q Consensus       781 ~~Lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  855 (1052)
                      +.||+|++|.||+|.+..  +  ..||+|.+..... ...+.+..|++.+++++|||++++++++.+ ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999997643  2  3699999977665 556788999999999999999999999988 889999999999


Q ss_pred             CCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc--c
Q 001566          856 GNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH--A  933 (1052)
Q Consensus       856 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~--~  933 (1052)
                      ++|.+++.......+++..+..++.|+++|++|||++   +++||||+|+||+++.++.+||+|||++.........  .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            9999999876435689999999999999999999999   9999999999999999999999999999876542221  1


Q ss_pred             ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhh
Q 001566          934 TTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012 (1052)
Q Consensus       934 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1012 (1052)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |+.||....        ..+..+.........        
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--------~~~~~~~~~~~~~~~--------  220 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS--------GSQILKKIDKEGERL--------  220 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHhcCCcC--------
Confidence            123456778999999999899999999999999999999 999986321        122222222211111        


Q ss_pred             cCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 001566         1013 EAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQ 1050 (1052)
Q Consensus      1013 ~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~ 1050 (1052)
                       ..+...+..+.+++.+|++.+|++||++.|+++.|.+
T Consensus       221 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  257 (257)
T cd05040         221 -ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE  257 (257)
T ss_pred             -CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence             1122334569999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.7e-33  Score=321.64  Aligned_cols=257  Identities=26%  Similarity=0.350  Sum_probs=195.9

Q ss_pred             hhCCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCc--cccHHHHHHHHHHhhccCCCceeeEEEEEecCC-----
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGR--FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEA-----  844 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  844 (1052)
                      ..++|++.+.||+|+||.||+|.. .+|..||+|++....  ......+.+|+.+++.++||||+++++++....     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            346899999999999999999965 458999999986432  233466788999999999999999999986443     


Q ss_pred             -eeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccc
Q 001566          845 -EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLA  923 (1052)
Q Consensus       845 -~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla  923 (1052)
                       ..|+||||++ +++.+++..    .+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        99 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876          99 QDVYLVMELMD-ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             ceeEEEEeCCC-cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCc
Confidence             4799999995 567776643    378899999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCc
Q 001566          924 RLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRS 1003 (1052)
Q Consensus       924 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1052)
                      +.....  .......+++.|+|||.+.+..++.++||||+||++|||++|+.||......       ..|.......+..
T Consensus       171 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~-------~~~~~~~~~~~~~  241 (359)
T cd07876         171 RTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI-------DQWNKVIEQLGTP  241 (359)
T ss_pred             cccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHHhcCCC
Confidence            754321  2223456889999999999999999999999999999999999999743211       1111111100000


Q ss_pred             c---------------------c--ccc---ch-hhc---CCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1004 S---------------------E--LFL---PE-LWE---AGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1004 ~---------------------~--~~~---~~-l~~---~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      .                     .  .+.   +. ...   ..+......+.+++.+|++.||++|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         242 SAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             cHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence            0                     0  000   00 000   001112346889999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=7e-34  Score=327.48  Aligned_cols=250  Identities=21%  Similarity=0.304  Sum_probs=195.0

Q ss_pred             CCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCc---cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEe
Q 001566          776 NFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYN  851 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  851 (1052)
                      .|++.++||+|+||+||+|.. .+++.||+|++....   ......+.+|++++++++||||+++++++.+....|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            588999999999999999965 468899999986542   2234578889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccC-
Q 001566          852 FLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE-  930 (1052)
Q Consensus       852 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~-  930 (1052)
                      |+++|+|.+++.+.  ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||++..+.... 
T Consensus        82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~  156 (382)
T cd05625          82 YIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (382)
T ss_pred             CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence            99999999999765  4688999999999999999999999   99999999999999999999999999975331100 


Q ss_pred             ---------------------------------------------cccccccccccccccccccCCCCCCcchhHHHHHH
Q 001566          931 ---------------------------------------------THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGV  965 (1052)
Q Consensus       931 ---------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~  965 (1052)
                                                                   ........||+.|+|||++.+..++.++||||+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv  236 (382)
T cd05625         157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV  236 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence                                                         00011246899999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCC---HH
Q 001566          966 VLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS---VK 1042 (1052)
Q Consensus       966 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt---~~ 1042 (1052)
                      ++|||++|+.||....+        .+.............  .+     ..........+++.+|+ .+|++|++   +.
T Consensus       237 il~elltG~~Pf~~~~~--------~~~~~~i~~~~~~~~--~p-----~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~  300 (382)
T cd05625         237 ILYEMLVGQPPFLAQTP--------LETQMKVINWQTSLH--IP-----PQAKLSPEASDLIIKLC-RGPEDRLGKNGAD  300 (382)
T ss_pred             HHHHHHhCCCCCCCCCH--------HHHHHHHHccCCCcC--CC-----CcccCCHHHHHHHHHHc-cCHhHcCCCCCHH
Confidence            99999999999974321        111112211111100  00     01122344677777765 59999997   77


Q ss_pred             HHHH
Q 001566         1043 QVLI 1046 (1052)
Q Consensus      1043 eil~ 1046 (1052)
                      |+++
T Consensus       301 ei~~  304 (382)
T cd05625         301 EIKA  304 (382)
T ss_pred             HHhc
Confidence            7654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.2e-33  Score=314.78  Aligned_cols=255  Identities=26%  Similarity=0.413  Sum_probs=200.3

Q ss_pred             hCCCccceeeeccCceEEEEEEec-CCc--EEEEEEeccCc-cccHHHHHHHHHHhhcc-CCCceeeEEEEEecCCeeEE
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELV-PGY--LVAVKKLSIGR-FQGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEAEMFL  848 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  848 (1052)
                      .++|++.+.||+|+||.||+|... ++.  .+|+|.++... .....++.+|++++.++ +||||+++++++.+++..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            357889999999999999999764 343  45777765432 23346788999999999 89999999999999999999


Q ss_pred             EEeecCCCCHHHHHhhcc--------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc
Q 001566          849 VYNFLSGGNLETFIHKKS--------------GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELN  914 (1052)
Q Consensus       849 v~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~  914 (1052)
                      ||||+++++|.++++...              ...+++.++..++.|++.|++|||++   +|+||||||+||++++++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence            999999999999997542              23578999999999999999999999   9999999999999999999


Q ss_pred             EEEeeecccccccccCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHH
Q 001566          915 AYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSW  993 (1052)
Q Consensus       915 ~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  993 (1052)
                      +||+|||++......  .......++..|+|||.+.+..++.++|||||||++|||+| |..||.....        .+.
T Consensus       163 ~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~  232 (303)
T cd05088         163 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AEL  232 (303)
T ss_pred             EEeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh--------HHH
Confidence            999999998633211  11111234568999999988889999999999999999998 9999863211        111


Q ss_pred             HHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566          994 AKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus       994 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                      .+.. ..+...         ..+...+..+.+++.+||+.+|++||++.++++.++++
T Consensus       233 ~~~~-~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~  280 (303)
T cd05088         233 YEKL-PQGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  280 (303)
T ss_pred             HHHH-hcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            2211 111100         11122344588999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2e-33  Score=310.25  Aligned_cols=262  Identities=24%  Similarity=0.393  Sum_probs=204.6

Q ss_pred             CCccceeeeccCceEEEEEEe-----cCCcEEEEEEeccCc-cccHHHHHHHHHHhhccCCCceeeEEEEEecC--CeeE
Q 001566          776 NFSIRNLIGTGGFGSTYKAEL-----VPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGE--AEMF  847 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~  847 (1052)
                      .|++.+.||+|+||.||.|..     .++..||+|.++... ......+.+|++++++++|||++++++++.+.  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            478889999999999999964     357889999986543 33346789999999999999999999998875  5689


Q ss_pred             EEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccccc
Q 001566          848 LVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE  927 (1052)
Q Consensus       848 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~  927 (1052)
                      +||||+++++|.+++.... ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.++|+|||++..+.
T Consensus        85 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  160 (284)
T ss_pred             EEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccccc
Confidence            9999999999999997653 4589999999999999999999999   99999999999999999999999999998664


Q ss_pred             ccCcc--cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccC-------CCCccHHHHHHHHH
Q 001566          928 VSETH--ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEY-------GNGFNIVSWAKLLI  998 (1052)
Q Consensus       928 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~-------~~~~~~~~~~~~~~  998 (1052)
                      .....  ......++..|+|||.+.+..++.++||||||+++|||+|++.|........       ..........+ ..
T Consensus       161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  239 (284)
T cd05079         161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR-VL  239 (284)
T ss_pred             cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH-HH
Confidence            32221  1223456678999999998889999999999999999999887654221110       00111111111 11


Q ss_pred             HhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566          999 KEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus       999 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                      ..+...         ..+...+..+.+++.+|++.+|++||++.++++.++++
T Consensus       240 ~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         240 EEGKRL---------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HcCccC---------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            111111         11223456799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.3e-33  Score=309.08  Aligned_cols=255  Identities=23%  Similarity=0.400  Sum_probs=202.2

Q ss_pred             hCCCccceeeeccCceEEEEEEec-CCc----EEEEEEeccCcc-ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeE
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELV-PGY----LVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMF  847 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  847 (1052)
                      ..+|++.++||+|+||+||+|.+. +++    .||+|++..... ....++.+|+.+++.++|||++++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence            356889999999999999999753 343    489998865433 335678899999999999999999999875 4578


Q ss_pred             EEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccccc
Q 001566          848 LVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE  927 (1052)
Q Consensus       848 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~  927 (1052)
                      +++||+++|+|.++++... ..+++..+..++.|++.|++|||++   +|+||||||+||++++++.+||+|||+++...
T Consensus        85 l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             EEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecc
Confidence            9999999999999997653 4689999999999999999999999   99999999999999999999999999998764


Q ss_pred             ccCcc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCccc
Q 001566          928 VSETH-ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005 (1052)
Q Consensus       928 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1052)
                      ..... ......+++.|+|||...+..++.++|||||||++|||++ |..||.....        .+ .......+....
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~-~~~~~~~~~~~~  231 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--------RE-IPDLLEKGERLP  231 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HH-HHHHHHCCCcCC
Confidence            32221 1122334678999999999899999999999999999998 8888863221        11 111222221111


Q ss_pred             cccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1006 ~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                               .+...+..+.+++.+||+.||++||++.|+++.++++
T Consensus       232 ---------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~  268 (279)
T cd05109         232 ---------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM  268 (279)
T ss_pred             ---------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence                     1122345688999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.9e-33  Score=315.09  Aligned_cols=258  Identities=24%  Similarity=0.426  Sum_probs=204.1

Q ss_pred             hhCCCccceeeeccCceEEEEEEec--------CCcEEEEEEeccCc-cccHHHHHHHHHHhhcc-CCCceeeEEEEEec
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAELV--------PGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRI-RHKNLVTLIGYYVG  842 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  842 (1052)
                      ..++|.+.+.||+|+||.||+|+..        ....||+|.+.... .....++..|+++++++ +||||+++++++.+
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            3457889999999999999999642        24578999887543 23356788999999999 69999999999999


Q ss_pred             CCeeEEEEeecCCCCHHHHHhhcc--------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEE
Q 001566          843 EAEMFLVYNFLSGGNLETFIHKKS--------------GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNIL  908 (1052)
Q Consensus       843 ~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nil  908 (1052)
                      ....++||||+++|+|.+++....              ...+++.++.+++.|++.|++|||++   ||+||||||+||+
T Consensus        90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil  166 (314)
T cd05099          90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVL  166 (314)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEE
Confidence            899999999999999999997642              24588999999999999999999999   9999999999999


Q ss_pred             ECCCCcEEEeeecccccccccCccc-ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCC
Q 001566          909 LDEELNAYLSDFGLARLLEVSETHA-TTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGN  986 (1052)
Q Consensus       909 l~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~  986 (1052)
                      +++++.+||+|||.++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||....     
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~-----  241 (314)
T cd05099         167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP-----  241 (314)
T ss_pred             EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC-----
Confidence            9999999999999998654322211 112234567999999999889999999999999999999 888875321     


Q ss_pred             CccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566          987 GFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus       987 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                         ..+.... ...+...         ..+..++..+.+++.+|++.+|++||++.|+++.|+++
T Consensus       242 ---~~~~~~~-~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~  293 (314)
T cd05099         242 ---VEELFKL-LREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV  293 (314)
T ss_pred             ---HHHHHHH-HHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence               1111222 2222111         11223344688999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.1e-33  Score=316.71  Aligned_cols=240  Identities=24%  Similarity=0.331  Sum_probs=191.7

Q ss_pred             eeeeccCceEEEEEEec-CCcEEEEEEeccCc---cccHHHHHHHHHHhhcc-CCCceeeEEEEEecCCeeEEEEeecCC
Q 001566          781 NLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEAEMFLVYNFLSG  855 (1052)
Q Consensus       781 ~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  855 (1052)
                      ++||+|+||.||+|+.. +|+.||+|+++...   ....+.+..|..++... +||+|+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999765 58899999986532   22345566777777754 899999999999999999999999999


Q ss_pred             CCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccccc
Q 001566          856 GNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT  935 (1052)
Q Consensus       856 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  935 (1052)
                      |+|.+++...  ..+++..+..++.|+++|++|||++   +|+||||||+||+++.++.++|+|||+++..... .....
T Consensus        81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~  154 (316)
T cd05620          81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRAS  154 (316)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCcee
Confidence            9999998764  4688999999999999999999999   9999999999999999999999999998743211 12233


Q ss_pred             ccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCC
Q 001566          936 DVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAG 1015 (1052)
Q Consensus       936 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 1015 (1052)
                      ...|++.|+|||++.+..++.++||||+||++|||++|+.||.....        .+..+... ...      +    ..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--------~~~~~~~~-~~~------~----~~  215 (316)
T cd05620         155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--------DELFESIR-VDT------P----HY  215 (316)
T ss_pred             ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHH-hCC------C----CC
Confidence            45689999999999999999999999999999999999999974321        12222221 111      1    11


Q ss_pred             ChHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 001566         1016 PQENLLGMMRLASTCTVETLSTRPSVK-QVL 1045 (1052)
Q Consensus      1016 ~~~~~~~l~~Li~~cl~~dP~~RPt~~-eil 1045 (1052)
                      +......+.+++.+|++.||++||++. ++.
T Consensus       216 ~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         216 PRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            222344588999999999999999985 444

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-33  Score=303.81  Aligned_cols=247  Identities=27%  Similarity=0.410  Sum_probs=198.2

Q ss_pred             eeeeccCceEEEEEEecC----CcEEEEEEeccCcc-ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecCC
Q 001566          781 NLIGTGGFGSTYKAELVP----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSG  855 (1052)
Q Consensus       781 ~~Lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  855 (1052)
                      +.||+|+||.||+|.+..    +..+|+|.+..... ...+++.+|+++++++.|||++++++++. ....++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            468999999999995432    26899999875544 24567889999999999999999999876 4568999999999


Q ss_pred             CCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcccc-
Q 001566          856 GNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT-  934 (1052)
Q Consensus       856 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~-  934 (1052)
                      ++|.+++....  .+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.++.......... 
T Consensus        80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~  154 (257)
T cd05060          80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA  154 (257)
T ss_pred             CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence            99999998753  689999999999999999999999   999999999999999999999999999986643332211 


Q ss_pred             -cccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhh
Q 001566          935 -TDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012 (1052)
Q Consensus       935 -~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1012 (1052)
                       ....++..|+|||.+.+..++.++||||||+++|||++ |+.||.....        .+..+.. ..+...        
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--------~~~~~~~-~~~~~~--------  217 (257)
T cd05060         155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--------AEVIAML-ESGERL--------  217 (257)
T ss_pred             ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHH-HcCCcC--------
Confidence             11223468999999999899999999999999999998 9999864311        1222222 222111        


Q ss_pred             cCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1013 EAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1013 ~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                       ..+...+..+.+++.+|++.+|++||++.++++.|+++
T Consensus       218 -~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         218 -PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             -CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence             12233445689999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.4e-33  Score=305.46  Aligned_cols=240  Identities=25%  Similarity=0.342  Sum_probs=189.6

Q ss_pred             eeeeccCceEEEEEEecC-------------CcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeE
Q 001566          781 NLIGTGGFGSTYKAELVP-------------GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMF  847 (1052)
Q Consensus       781 ~~Lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  847 (1052)
                      +.||+|+||.||+|.+.+             ...||+|.+..........+.+|+.+++.++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999996532             2358899876655555567888999999999999999999999989999


Q ss_pred             EEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc-------EEEeee
Q 001566          848 LVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELN-------AYLSDF  920 (1052)
Q Consensus       848 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~-------~kl~Df  920 (1052)
                      +||||+++++|..++.... ..+++..+.+++.||++|++|||++   +|+||||||+||+++.++.       ++++||
T Consensus        81 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             EEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            9999999999999987653 4689999999999999999999999   9999999999999987654       899999


Q ss_pred             cccccccccCcccccccccccccccccccC-CCCCCcchhHHHHHHHHHHHH-hCCCCCCCCcccCCCCccHHHHHHHHH
Q 001566          921 GLARLLEVSETHATTDVAGTFGYVAPEYAT-TCRVSDKADVYSFGVVLLELI-SGKRSLDPSFSEYGNGFNIVSWAKLLI  998 (1052)
Q Consensus       921 gla~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~sDvwslG~il~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~  998 (1052)
                      |++.....     .....++..|+|||.+. +..++.++|||||||++|||+ +|..||.....        .+..+ ..
T Consensus       157 g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------~~~~~-~~  222 (262)
T cd05077         157 GIPITVLS-----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL--------AEKER-FY  222 (262)
T ss_pred             CCCccccC-----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch--------hHHHH-HH
Confidence            99875432     12345778899999887 466888999999999999998 57777653211        11111 11


Q ss_pred             HhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 001566          999 KEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLK 1049 (1052)
Q Consensus       999 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~ 1049 (1052)
                      . +...      .    .......+.+++.+||+.||++||++.++++.++
T Consensus       223 ~-~~~~------~----~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         223 E-GQCM------L----VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             h-cCcc------C----CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            1 1100      0    1112345889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2e-33  Score=314.24  Aligned_cols=261  Identities=21%  Similarity=0.305  Sum_probs=198.1

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCccc-cHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQ-GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      ++|++.+.||+|+||.||+|... +++.||+|+++..... ....+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56899999999999999999654 5788999998654322 234677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      ++ ++|.+++.... ..+++..+..++.|++.|++|||++   +|+||||||+||++++++.+||+|||.+....... .
T Consensus        86 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~  159 (309)
T cd07872          86 LD-KDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT-K  159 (309)
T ss_pred             CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc-c
Confidence            96 58988887653 4588999999999999999999999   99999999999999999999999999997543221 2


Q ss_pred             cccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHH--------hCCc
Q 001566          933 ATTDVAGTFGYVAPEYATT-CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIK--------EGRS 1003 (1052)
Q Consensus       933 ~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~~ 1003 (1052)
                      ......+++.|+|||.+.+ ..++.++||||+|+++|||+||+.||......     +..+.......        ....
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~  234 (309)
T cd07872         160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE-----DELHLIFRLLGTPTEETWPGISS  234 (309)
T ss_pred             ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhCCCCHHHHhhhcc
Confidence            2233457889999998865 45788999999999999999999999743221     01100000000        0000


Q ss_pred             ccc-ccchh-------hcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1004 SEL-FLPEL-------WEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1004 ~~~-~~~~l-------~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ... .+...       ...........+.+++.+|++.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            000 00000       00011223456889999999999999999999886

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.3e-33  Score=320.02  Aligned_cols=259  Identities=26%  Similarity=0.375  Sum_probs=201.3

Q ss_pred             hhCCCccceeeeccCceEEEEEEe------cCCcEEEEEEeccCcc-ccHHHHHHHHHHhhcc-CCCceeeEEEEEecC-
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAEL------VPGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGE-  843 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-  843 (1052)
                      ..++|++.+.||+|+||.||+|..      .+++.||||+++.... .....+.+|+.++.++ +||||+++++++... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            346799999999999999999953      3468899999875432 2345688999999999 689999999988654 


Q ss_pred             CeeEEEEeecCCCCHHHHHhhccC--------------------------------------------------------
Q 001566          844 AEMFLVYNFLSGGNLETFIHKKSG--------------------------------------------------------  867 (1052)
Q Consensus       844 ~~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------  867 (1052)
                      ...++||||+++|+|.+++.....                                                        
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            567999999999999999865321                                                        


Q ss_pred             ---------CcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCc-cccccc
Q 001566          868 ---------KKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET-HATTDV  937 (1052)
Q Consensus       868 ---------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~  937 (1052)
                               ..+++.++..++.|+++|++|||++   +|+||||||+||++++++.+||+|||++........ ......
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence                     2367888899999999999999999   999999999999999999999999999986532221 122223


Q ss_pred             ccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCCC
Q 001566          938 AGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGP 1016 (1052)
Q Consensus       938 ~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 1016 (1052)
                      .++..|+|||.+.+..++.++||||||+++|||++ |..||......        .........+....         .+
T Consensus       242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~---------~~  304 (343)
T cd05103         242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--------EEFCRRLKEGTRMR---------AP  304 (343)
T ss_pred             CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--------HHHHHHHhccCCCC---------CC
Confidence            45678999999999899999999999999999997 88887632111        11111222221111         01


Q ss_pred             hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1017 QENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1017 ~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                      ......+.+++.+||+.+|++||++.|+++.|+++
T Consensus       305 ~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~  339 (343)
T cd05103         305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  339 (343)
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            11233588999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=6.8e-34  Score=319.79  Aligned_cols=237  Identities=26%  Similarity=0.353  Sum_probs=189.2

Q ss_pred             eeeeccCceEEEEEEec-CCcEEEEEEeccCcc---ccHHHHHHHHH-HhhccCCCceeeEEEEEecCCeeEEEEeecCC
Q 001566          781 NLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF---QGIQQFDAEIG-TLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSG  855 (1052)
Q Consensus       781 ~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  855 (1052)
                      +.||+|+||+||+|... +|+.||+|++.....   ....++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999664 689999999865322   22234444544 56788999999999999999999999999999


Q ss_pred             CCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccccc
Q 001566          856 GNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT  935 (1052)
Q Consensus       856 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  935 (1052)
                      |+|.+++...  ..+++..+..++.||++|++|||++   +|+||||||+||+++.++.+||+|||++..... ......
T Consensus        81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~-~~~~~~  154 (323)
T cd05575          81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE-HSKTTS  154 (323)
T ss_pred             CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCccccc-CCCccc
Confidence            9999999764  4688999999999999999999999   999999999999999999999999999874321 122233


Q ss_pred             ccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCC
Q 001566          936 DVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAG 1015 (1052)
Q Consensus       936 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 1015 (1052)
                      ...|++.|+|||.+.+..++.++|||||||++|||++|+.||....        ..+..+...... .      .    .
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~-~------~----~  215 (323)
T cd05575         155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--------TAEMYDNILNKP-L------R----L  215 (323)
T ss_pred             cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC--------HHHHHHHHHcCC-C------C----C
Confidence            4568999999999999999999999999999999999999997421        222222222111 0      1    1


Q ss_pred             ChHHHHHHHHHHHHccccCCCCCCCHH
Q 001566         1016 PQENLLGMMRLASTCTVETLSTRPSVK 1042 (1052)
Q Consensus      1016 ~~~~~~~l~~Li~~cl~~dP~~RPt~~ 1042 (1052)
                      +......+.+++.+|++.||++||+++
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         216 KPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            122345588999999999999999885

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.8e-33  Score=308.89  Aligned_cols=250  Identities=24%  Similarity=0.378  Sum_probs=200.5

Q ss_pred             CCccceeeeccCceEEEEEEec-CCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecC
Q 001566          776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLS  854 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  854 (1052)
                      .|++.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++|||++++++++..+...++|+||++
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            3678899999999999999665 478889999876665566788899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcccc
Q 001566          855 GGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT  934 (1052)
Q Consensus       855 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  934 (1052)
                      +++|..++.... ..+++..+..++.|+++|++|||+.   +|+||||||+||+++.++.++|+|||++...... ....
T Consensus        86 ~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~-~~~~  160 (282)
T cd06643          86 GGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRR  160 (282)
T ss_pred             CCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccc-cccc
Confidence            999999886543 4689999999999999999999999   9999999999999999999999999998754322 1222


Q ss_pred             cccccccccccccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccc
Q 001566          935 TDVAGTFGYVAPEYAT-----TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009 (1052)
Q Consensus       935 ~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                      ....+++.|+|||++.     +..++.++||||+||++|||++|++||.....        .+.............    
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--------~~~~~~~~~~~~~~~----  228 (282)
T cd06643         161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAKSEPPTL----  228 (282)
T ss_pred             ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH--------HHHHHHHhhcCCCCC----
Confidence            3346888999999984     34567899999999999999999999863211        111111111111110    


Q ss_pred             hhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1010 ELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1010 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                          ..+...+..+.+++.+||+.+|.+||++.++++
T Consensus       229 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         229 ----AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             ----CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                112223456899999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.1e-33  Score=308.22  Aligned_cols=253  Identities=26%  Similarity=0.469  Sum_probs=200.9

Q ss_pred             HhhCCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCccccHHHHHHHHHHhhcc-CCCceeeEEEEEecC------
Q 001566          772 RATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGE------  843 (1052)
Q Consensus       772 ~~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~------  843 (1052)
                      .+.+.|++.+.||+|+||.||+|... +++.||+|++.... .....+..|+.+++++ +|+|++++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            45678999999999999999999654 58899999986543 3346788899999998 799999999998753      


Q ss_pred             CeeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccc
Q 001566          844 AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLA  923 (1052)
Q Consensus       844 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla  923 (1052)
                      ...++||||+++++|.+++.......+++..+..++.|++.|++|||++   +|+||||+|+||++++++.++|+|||++
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCc
Confidence            4689999999999999999876556789999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccCcccccccccccccccccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHH
Q 001566          924 RLLEVSETHATTDVAGTFGYVAPEYAT-----TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLI  998 (1052)
Q Consensus       924 ~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  998 (1052)
                      ....... .......|++.|+|||++.     +..++.++||||+||++|||++|+.||......       ....  ..
T Consensus       159 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-------~~~~--~~  228 (272)
T cd06637         159 AQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-------RALF--LI  228 (272)
T ss_pred             eeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-------HHHH--HH
Confidence            8654221 2223456888999999986     345778999999999999999999998632111       1111  11


Q ss_pred             HhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566          999 KEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus       999 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ......     ..   .+...+..+.+++.+||..+|.+||++.|+++
T Consensus       229 ~~~~~~-----~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         229 PRNPAP-----RL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             hcCCCC-----CC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            111111     00   11123446899999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3.4e-33  Score=307.52  Aligned_cols=251  Identities=24%  Similarity=0.395  Sum_probs=199.1

Q ss_pred             CCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCc-cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          775 GNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      ++|++.++||+|+||.||+|.. .+++.||+|++.... .....++.+|++++++++|||++++++++..+...++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3688899999999999999954 568899999986542 23346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      +++++|..+.      .+++..+..++.|++.|++|||+.   +|+|+||||+||+++.++.++|+|||++......   
T Consensus        81 ~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---  148 (279)
T cd06619          81 MDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---  148 (279)
T ss_pred             CCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---
Confidence            9999997653      367888999999999999999999   9999999999999999999999999999765322   


Q ss_pred             cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhh
Q 001566          933 ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012 (1052)
Q Consensus       933 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1012 (1052)
                      ......++..|+|||.+.+..++.++||||+|+++|||++|+.||.......... ...++.+...... ..     .+.
T Consensus       149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~-~~-----~~~  221 (279)
T cd06619         149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-MPLQLLQCIVDED-PP-----VLP  221 (279)
T ss_pred             cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-chHHHHHHHhccC-CC-----CCC
Confidence            2233468899999999999899999999999999999999999997533221111 1111111111111 00     000


Q ss_pred             cCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001566         1013 EAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus      1013 ~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                         .......+.+++.+|++.+|++||+++|+++.
T Consensus       222 ---~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         222 ---VGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             ---CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence               11123458899999999999999999998763

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-35  Score=314.83  Aligned_cols=243  Identities=32%  Similarity=0.413  Sum_probs=203.5

Q ss_pred             CccceeeeccCceEEEEEE-ecCCcEEEEEEeccCccc---cHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          777 FSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQ---GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       777 ~~~~~~Lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      |+-.+-||.|+||.||.|+ ..+.+.||||++.-...+   .+.++..|+.++++++|||.|.+-|||..+...|+||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            5556789999999999994 456889999999654433   467899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      | -|+-.|.+.-+. +++.+.++..|..+.+.||+|||+.   +.||||||+.|||+++.|.||++|||.|.+..+    
T Consensus       108 C-lGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P----  178 (948)
T KOG0577|consen  108 C-LGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP----  178 (948)
T ss_pred             H-hccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc----
Confidence            9 678899888775 7899999999999999999999999   999999999999999999999999999986643    


Q ss_pred             cccccccccccccccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccc
Q 001566          933 ATTDVAGTFGYVAPEYAT---TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009 (1052)
Q Consensus       933 ~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                       ...++|||.|||||++.   .+.|+-++||||+|++..|+.-.++|+...        +... +-+-+..+..... - 
T Consensus       179 -AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM--------NAMS-ALYHIAQNesPtL-q-  246 (948)
T KOG0577|consen  179 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--------NAMS-ALYHIAQNESPTL-Q-  246 (948)
T ss_pred             -hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc--------hHHH-HHHHHHhcCCCCC-C-
Confidence             34578999999999985   467899999999999999999999997622        1111 2233333333321 1 


Q ss_pred             hhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1010 ELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1010 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                            ..+....|..++..|++.-|.+|||.+++++
T Consensus       247 ------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  247 ------SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             ------CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence                  3345566999999999999999999999875

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.1e-33  Score=308.67  Aligned_cols=250  Identities=24%  Similarity=0.322  Sum_probs=199.5

Q ss_pred             CccceeeeccCceEEEEEEe-cCCcEEEEEEeccCcc---ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          777 FSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRF---QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       777 ~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      |+..+.||+|+||+||+|.. .+++.||+|.+.....   .....+.+|++++++++|++++++++++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            67788999999999999965 4688999999865432   2234577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      +++++|.+++.......+++..+..++.|++.|+.|||+.   +|+||||||+||++++++.++|+|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--  156 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence            9999999998765545799999999999999999999999   99999999999999999999999999987553221  


Q ss_pred             cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhh
Q 001566          933 ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012 (1052)
Q Consensus       933 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1012 (1052)
                      ......|+..|+|||.+.+..++.++|+||+|+++|||++|+.||......    .....+ ........  .       
T Consensus       157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~----~~~~~~-~~~~~~~~--~-------  222 (285)
T cd05632         157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK----VKREEV-DRRVLETE--E-------  222 (285)
T ss_pred             cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH----HHHHHH-HHhhhccc--c-------
Confidence            123346899999999999989999999999999999999999999743211    001111 11111110  0       


Q ss_pred             cCCChHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 001566         1013 EAGPQENLLGMMRLASTCTVETLSTRPS-----VKQVLI 1046 (1052)
Q Consensus      1013 ~~~~~~~~~~l~~Li~~cl~~dP~~RPt-----~~eil~ 1046 (1052)
                       ..+...+..+.+++.+|++.||++||+     +.++++
T Consensus       223 -~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         223 -VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             -ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence             112223445889999999999999999     666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=4.1e-33  Score=309.34  Aligned_cols=249  Identities=24%  Similarity=0.415  Sum_probs=204.9

Q ss_pred             CCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeec
Q 001566          775 GNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFL  853 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  853 (1052)
                      .+|++.+.||.|+||.||+|.. .+++.||+|.+........+.+.+|+..++.++|||++++++++......++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            4689999999999999999954 568999999997665555678889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccc
Q 001566          854 SGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA  933 (1052)
Q Consensus       854 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  933 (1052)
                      ++++|.+++...   .+++.++..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||++........ .
T Consensus        99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~  171 (296)
T cd06655          99 AGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-K  171 (296)
T ss_pred             CCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc-c
Confidence            999999998754   489999999999999999999999   999999999999999999999999999886543322 2


Q ss_pred             ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhc
Q 001566          934 TTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWE 1013 (1052)
Q Consensus       934 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1013 (1052)
                      .....++..|+|||.+.+..++.++|||||||++|+|++|+.||......        .......... ....       
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~--------~~~~~~~~~~-~~~~-------  235 (296)
T cd06655         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--------RALYLIATNG-TPEL-------  235 (296)
T ss_pred             CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhcC-Cccc-------
Confidence            22345788999999999988999999999999999999999999743221        1111111111 1100       


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1014 AGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1014 ~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ..+...+..+.+++.+||..||++||++.++++
T Consensus       236 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            112233456889999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.3e-33  Score=311.55  Aligned_cols=250  Identities=24%  Similarity=0.393  Sum_probs=205.1

Q ss_pred             hCCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      ..+|++.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+|++++++++..+...++||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            35799999999999999999965 56899999999776655567788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      +++++|.+++...   .+++.++..++.|++.|+.|||+.   +|+||||||+||+++.++.++|+|||++........ 
T Consensus        98 ~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-  170 (297)
T cd06656          98 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  170 (297)
T ss_pred             cCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-
Confidence            9999999998653   478899999999999999999999   999999999999999999999999999876543221 


Q ss_pred             cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhh
Q 001566          933 ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012 (1052)
Q Consensus       933 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1012 (1052)
                      ......+++.|+|||.+.+..++.++||||+|+++|++++|+.||....+...        .......+...        
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~--------~~~~~~~~~~~--------  234 (297)
T cd06656         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--------LYLIATNGTPE--------  234 (297)
T ss_pred             CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh--------eeeeccCCCCC--------
Confidence            22234678899999999998899999999999999999999999974322110        00000011000        


Q ss_pred             cCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1013 EAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1013 ~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ...+...+..+.+++.+||..+|++||+++++++
T Consensus       235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         235 LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0112233455889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.8e-33  Score=320.89  Aligned_cols=258  Identities=25%  Similarity=0.323  Sum_probs=196.8

Q ss_pred             hhCCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCc--cccHHHHHHHHHHhhccCCCceeeEEEEEecC------
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGR--FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGE------  843 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  843 (1052)
                      ..++|++.+.||+|+||.||+|.. ..++.||+|++....  ......+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            456899999999999999999954 458899999986542  22345678899999999999999999988643      


Q ss_pred             CeeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccc
Q 001566          844 AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLA  923 (1052)
Q Consensus       844 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla  923 (1052)
                      ...++||||++ +++.+++..    .+++..+..++.|+++|++|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        95 ~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~  166 (355)
T cd07874          95 QDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_pred             ceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCccc
Confidence            35799999995 577777753    378899999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCc
Q 001566          924 RLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRS 1003 (1052)
Q Consensus       924 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1052)
                      +.....  .......+++.|+|||++.+..++.++||||+||++|||++|+.||......       ..+.......+..
T Consensus       167 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~~~~~~~~~  237 (355)
T cd07874         167 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-------DQWNKVIEQLGTP  237 (355)
T ss_pred             ccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHHHhCCC
Confidence            865422  2223456899999999999999999999999999999999999999743211       1111111000000


Q ss_pred             ----------------------cccccchh-----h---cCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001566         1004 ----------------------SELFLPEL-----W---EAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus      1004 ----------------------~~~~~~~l-----~---~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                                            .....+..     .   ...+......+.+++.+|++.||++|||+.|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             CHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                                  00000000     0   00111223568899999999999999999999873

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.1e-33  Score=315.46  Aligned_cols=241  Identities=23%  Similarity=0.324  Sum_probs=194.1

Q ss_pred             CCccceeeeccCceEEEEEEec-CCcEEEEEEeccCc---cccHHHHHHHHHHhhccC-CCceeeEEEEEecCCeeEEEE
Q 001566          776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRIR-HKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      +|+..+.||+|+||+||+|... +|+.||+|++....   ....+.+..|..+++.+. |++|+++++++.+.+..|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3778899999999999999654 68899999986532   223456778888888885 577888999999999999999


Q ss_pred             eecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccC
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~  930 (1052)
                      ||+++|+|.+++...  ..+++.++..++.|++.|++|||++   +|+||||||+||++++++.+||+|||+++......
T Consensus        81 Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~  155 (323)
T cd05615          81 EYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG  155 (323)
T ss_pred             cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence            999999999998765  4689999999999999999999999   99999999999999999999999999987543221


Q ss_pred             cccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccch
Q 001566          931 THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010 (1052)
Q Consensus       931 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1052)
                       .......|++.|+|||++.+..++.++||||+||++|||++|+.||.....        ....+..... ..       
T Consensus       156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~~~i~~~-~~-------  218 (323)
T cd05615         156 -VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--------DELFQSIMEH-NV-------  218 (323)
T ss_pred             -ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhC-CC-------
Confidence             222345689999999999998999999999999999999999999974321        1222222221 11       


Q ss_pred             hhcCCChHHHHHHHHHHHHccccCCCCCCCH
Q 001566         1011 LWEAGPQENLLGMMRLASTCTVETLSTRPSV 1041 (1052)
Q Consensus      1011 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~ 1041 (1052)
                         ..+......+.+++.+|++.+|++|++.
T Consensus       219 ---~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         219 ---SYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             ---CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence               1122334458899999999999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=6e-33  Score=301.62  Aligned_cols=250  Identities=23%  Similarity=0.382  Sum_probs=206.6

Q ss_pred             CCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCc--cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          776 NFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGR--FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      +|+..+.||+|+||.||.++. .+++.+++|++....  .....++.+|++++++++|+||+++++++.+....+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            488899999999999999954 458899999886543  33456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      +++++|.+++.......+++.++..++.|++.|++|||+.   +++||||+|+||++++++.+||+|||.+........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            9999999999876556789999999999999999999998   999999999999999999999999999986643332 


Q ss_pred             cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhh
Q 001566          933 ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012 (1052)
Q Consensus       933 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1012 (1052)
                      ......+++.|+|||...+..++.++||||+|+++|||++|..||....        ..+....... +....       
T Consensus       157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~--------~~~~~~~~~~-~~~~~-------  220 (256)
T cd08221         157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN--------PLNLVVKIVQ-GNYTP-------  220 (256)
T ss_pred             cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHc-CCCCC-------
Confidence            2334568899999999998888999999999999999999999986422        1222222222 11111       


Q ss_pred             cCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001566         1013 EAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus      1013 ~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                        .+...+..+.+++.+||+.+|++||++.|+++.
T Consensus       221 --~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         221 --VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             --CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence              112334568899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.3e-33  Score=315.73  Aligned_cols=243  Identities=22%  Similarity=0.315  Sum_probs=193.1

Q ss_pred             eeeeccCceEEEEEEec-CCcEEEEEEeccCcc---ccHHHHHHHHHHhhcc-CCCceeeEEEEEecCCeeEEEEeecCC
Q 001566          781 NLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF---QGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEAEMFLVYNFLSG  855 (1052)
Q Consensus       781 ~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  855 (1052)
                      +.||+|+||+||+|... +++.||+|+++....   ...+.+..|+.++.++ +||+|+++++++.+....|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999654 578999999975422   3345678899999888 699999999999999999999999999


Q ss_pred             CCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccccc
Q 001566          856 GNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT  935 (1052)
Q Consensus       856 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  935 (1052)
                      |+|.+++...  ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+++..... .....
T Consensus        81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~  154 (327)
T cd05617          81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTTS  154 (327)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCcee
Confidence            9999988764  4699999999999999999999999   9999999999999999999999999998743211 12223


Q ss_pred             ccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCC
Q 001566          936 DVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAG 1015 (1052)
Q Consensus       936 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 1015 (1052)
                      ...|++.|+|||++.+..++.++||||+||++|||++|+.||.......  .....++..........          ..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~----------~~  222 (327)
T cd05617         155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNP--DMNTEDYLFQVILEKPI----------RI  222 (327)
T ss_pred             cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCc--ccccHHHHHHHHHhCCC----------CC
Confidence            4568999999999999999999999999999999999999996432211  11122222222222111          11


Q ss_pred             ChHHHHHHHHHHHHccccCCCCCCCH
Q 001566         1016 PQENLLGMMRLASTCTVETLSTRPSV 1041 (1052)
Q Consensus      1016 ~~~~~~~l~~Li~~cl~~dP~~RPt~ 1041 (1052)
                      |......+.+++.+|++.||++|+++
T Consensus       223 p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         223 PRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            22234458899999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=6.6e-34  Score=320.18  Aligned_cols=240  Identities=27%  Similarity=0.354  Sum_probs=190.1

Q ss_pred             eeeeccCceEEEEEEe-cCCcEEEEEEeccCc---cccHHHHHHHHH-HhhccCCCceeeEEEEEecCCeeEEEEeecCC
Q 001566          781 NLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGR---FQGIQQFDAEIG-TLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSG  855 (1052)
Q Consensus       781 ~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  855 (1052)
                      +.||+|+||+||+|.. .+|+.||+|++....   ......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4689999999999965 468999999986432   122344555554 56778999999999999999999999999999


Q ss_pred             CCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccccc
Q 001566          856 GNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT  935 (1052)
Q Consensus       856 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  935 (1052)
                      |+|..++...  ..+++..+..++.||+.|++|||++   ||+||||||+||++++++.+||+|||++..... ......
T Consensus        81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~-~~~~~~  154 (325)
T cd05604          81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA-QSDTTT  154 (325)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCC-CCCCcc
Confidence            9999988764  4689999999999999999999999   999999999999999999999999999874321 112233


Q ss_pred             ccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCC
Q 001566          936 DVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAG 1015 (1052)
Q Consensus       936 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 1015 (1052)
                      ...|++.|+|||++.+..++.++||||+||++|||++|+.||....        ..+..+......   ..        .
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~--------~~~~~~~~~~~~---~~--------~  215 (325)
T cd05604         155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD--------VAEMYDNILHKP---LV--------L  215 (325)
T ss_pred             cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC--------HHHHHHHHHcCC---cc--------C
Confidence            4568999999999999999999999999999999999999997421        122222222111   00        1


Q ss_pred             ChHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 001566         1016 PQENLLGMMRLASTCTVETLSTRPSVKQVL 1045 (1052)
Q Consensus      1016 ~~~~~~~l~~Li~~cl~~dP~~RPt~~eil 1045 (1052)
                      ++.....+.+++.+|++.+|.+||++++.+
T Consensus       216 ~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         216 RPGASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             CCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence            112344588999999999999999876433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.3e-33  Score=304.86  Aligned_cols=250  Identities=28%  Similarity=0.427  Sum_probs=205.1

Q ss_pred             hCCCccceeeeccCceEEEEEEecC-CcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      .++|++.+.||+|+||.||+|.... ++.+|+|.+.....  .+++.+|++++++++|||++++++++.++...|+++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            3579999999999999999997764 78999999865533  57899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      +++++|.+++.... ..+++..+..++.|+++|+.|||+.   +|+||||+|+||++++++.++|+|||++........ 
T Consensus        80 ~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (256)
T cd06612          80 CGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-  154 (256)
T ss_pred             CCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence            99999999997643 5789999999999999999999999   999999999999999999999999999986643221 


Q ss_pred             cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhh
Q 001566          933 ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012 (1052)
Q Consensus       933 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1012 (1052)
                      ......++..|+|||.+.+..++.++||||||+++|||++|+.||....+.        .... ..... ...    .  
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~--------~~~~-~~~~~-~~~----~--  218 (256)
T cd06612         155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM--------RAIF-MIPNK-PPP----T--  218 (256)
T ss_pred             ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh--------hhhh-hhccC-CCC----C--
Confidence            223345788999999999989999999999999999999999998743221        0000 00000 000    0  


Q ss_pred             cCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1013 EAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1013 ~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ...+......+.+++.+|++.+|++||++.|+++
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         219 LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            0112233456899999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=5.4e-33  Score=308.21  Aligned_cols=252  Identities=25%  Similarity=0.391  Sum_probs=202.7

Q ss_pred             hCCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      .+.|++.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+++++.++|||++++++++..+...++||||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            357999999999999999999765 4889999999876666677889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      +++++|..++.... ..+++..+..++.|++.|++|||+.   +|+||||+|+||+++.++.++|+|||.+...... ..
T Consensus        91 ~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~  165 (292)
T cd06644          91 CPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQ  165 (292)
T ss_pred             CCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc-cc
Confidence            99999998886543 4689999999999999999999998   9999999999999999999999999998754322 12


Q ss_pred             cccccccccccccccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccc
Q 001566          933 ATTDVAGTFGYVAPEYAT-----TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELF 1007 (1052)
Q Consensus       933 ~~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1052)
                      ......+++.|+|||.+.     ...++.++|||||||++|||++|+.||.....        .+...... ......  
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--------~~~~~~~~-~~~~~~--  234 (292)
T cd06644         166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLLKIA-KSEPPT--  234 (292)
T ss_pred             ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH--------HHHHHHHh-cCCCcc--
Confidence            223345788999999985     34467789999999999999999999863211        11111111 111110  


Q ss_pred             cchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1008 LPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1008 ~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                         .  ..+......+.+++.+||+.+|++||++.|+++
T Consensus       235 ---~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         235 ---L--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             ---C--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence               0  112233456889999999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-33  Score=301.77  Aligned_cols=254  Identities=25%  Similarity=0.396  Sum_probs=206.4

Q ss_pred             hCCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      .++|++.+.||+|+||.||+|... +++.+|+|.+........+.+.+|++++++++|||++++++++.+....+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            357999999999999999999664 5788999999876666677899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      +++++|.+++.... ..+++.++..++.|++.|++|||+.   +|+||||+|+||++++++.++|+|||.+....... .
T Consensus        82 ~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~  156 (262)
T cd06613          82 CGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-A  156 (262)
T ss_pred             CCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh-h
Confidence            99999999987653 4689999999999999999999998   99999999999999999999999999998654321 1


Q ss_pred             cccccccccccccccccCCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccc
Q 001566          933 ATTDVAGTFGYVAPEYATTC---RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009 (1052)
Q Consensus       933 ~~~~~~g~~~y~aPE~~~~~---~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                      ......++..|+|||.+.+.   .++.++||||+|+++|||++|+.||......        ..............    
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~--------~~~~~~~~~~~~~~----  224 (262)
T cd06613         157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM--------RALFLISKSNFPPP----  224 (262)
T ss_pred             ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhccCCCc----
Confidence            22334678899999999876   7889999999999999999999999743211        11111111100000    


Q ss_pred             hhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1010 ELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1010 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      .  ...+...+..+.+++.+||+.+|.+||++.+++.
T Consensus       225 ~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         225 K--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             c--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0  0112334567899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=7.5e-33  Score=301.01  Aligned_cols=249  Identities=26%  Similarity=0.417  Sum_probs=202.6

Q ss_pred             CCccceeeeccCceEEEEEEec-CCcEEEEEEeccCcc--ccHHHHHHHHHHhhccCCCceeeEEEEEec-CCeeEEEEe
Q 001566          776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKNLVTLIGYYVG-EAEMFLVYN  851 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e  851 (1052)
                      +|++.+.||+|++|.||+|... +++.||+|++.....  ...+.+.+|++++++++|+|++++++.+.. +...++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4889999999999999999654 578899999865432  334568889999999999999999998764 446799999


Q ss_pred             ecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCc
Q 001566          852 FLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET  931 (1052)
Q Consensus       852 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~  931 (1052)
                      |+++++|.+++.......+++.++..++.+++.|+++||+.   +|+||||+|+||+++.++.++|+|||++....... 
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-  156 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-  156 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence            99999999999876556789999999999999999999999   99999999999999999999999999998664322 


Q ss_pred             ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchh
Q 001566          932 HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPEL 1011 (1052)
Q Consensus       932 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1011 (1052)
                      .......+++.|+|||.+.+..++.++||||+|+++|||++|+.||....        ...+..... .+...       
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~--------~~~~~~~~~-~~~~~-------  220 (257)
T cd08223         157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD--------MNSLVYRII-EGKLP-------  220 (257)
T ss_pred             CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHH-hcCCC-------
Confidence            22334467889999999999999999999999999999999999986321        122222222 22111       


Q ss_pred             hcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1012 WEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1012 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                        ..+......+.+++.+|++.+|++||++.++++
T Consensus       221 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         221 --PMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             --CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence              112234456899999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.1e-33  Score=318.54  Aligned_cols=241  Identities=25%  Similarity=0.320  Sum_probs=189.8

Q ss_pred             eeeeccCceEEEEEEec-CCcEEEEEEeccCcc---ccHHHHHHHH-HHhhccCCCceeeEEEEEecCCeeEEEEeecCC
Q 001566          781 NLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF---QGIQQFDAEI-GTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSG  855 (1052)
Q Consensus       781 ~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  855 (1052)
                      +.||+|+||+||+|... +++.||+|++.....   .....+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999665 578899999864321   2223344444 456788999999999999999999999999999


Q ss_pred             CCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccccc
Q 001566          856 GNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT  935 (1052)
Q Consensus       856 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  935 (1052)
                      |+|.+++...  ..+.+..+..++.|+++|++|||+.   ||+||||||+||+++.++.+||+|||+++..... .....
T Consensus        81 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~~~  154 (325)
T cd05602          81 GELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGTTS  154 (325)
T ss_pred             CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCCcc
Confidence            9999999764  4578888999999999999999999   9999999999999999999999999998753221 12233


Q ss_pred             ccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCC
Q 001566          936 DVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAG 1015 (1052)
Q Consensus       936 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 1015 (1052)
                      ...|++.|+|||++.+..++.++||||+||++|||++|+.||.....        .+..+...... .          ..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~~~-~----------~~  215 (325)
T cd05602         155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--------AEMYDNILNKP-L----------QL  215 (325)
T ss_pred             cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH--------HHHHHHHHhCC-c----------CC
Confidence            45689999999999999999999999999999999999999973221        12222222111 0          11


Q ss_pred             ChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1016 PQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1016 ~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ++.....+.+++.+|++.||.+||++.+.+.
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         216 KPNITNSARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             CCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence            1233455889999999999999998875443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=4.8e-33  Score=303.52  Aligned_cols=250  Identities=26%  Similarity=0.432  Sum_probs=193.7

Q ss_pred             eeeeccCceEEEEEEec----CCcEEEEEEeccC-ccccHHHHHHHHHHhhccCCCceeeEEEEEe-cCCeeEEEEeecC
Q 001566          781 NLIGTGGFGSTYKAELV----PGYLVAVKKLSIG-RFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV-GEAEMFLVYNFLS  854 (1052)
Q Consensus       781 ~~Lg~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~  854 (1052)
                      +.||+|+||.||+|...    .+..||+|++... .....+.+.+|+.+++.++|||++++++++. .++..++|+||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999653    2457999987543 2334567889999999999999999999876 4556899999999


Q ss_pred             CCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCc---
Q 001566          855 GGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET---  931 (1052)
Q Consensus       855 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~---  931 (1052)
                      +|+|.+++.... ...++..+..++.|+++|++|||+.   +|+||||||+||++++++.+||+|||+++.......   
T Consensus        81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~  156 (262)
T cd05058          81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV  156 (262)
T ss_pred             CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence            999999997653 3467788899999999999999999   999999999999999999999999999975532211   


Q ss_pred             ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchh
Q 001566          932 HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPEL 1011 (1052)
Q Consensus       932 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1011 (1052)
                      .......++..|+|||.+.+..++.++||||||+++|||++|+.|+....       +..+..+.........       
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-------~~~~~~~~~~~~~~~~-------  222 (262)
T cd05058         157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-------DSFDITVYLLQGRRLL-------  222 (262)
T ss_pred             cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC-------CHHHHHHHHhcCCCCC-------
Confidence            11123345678999999998889999999999999999999655433211       1222222222211110       


Q ss_pred             hcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1012 WEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1012 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                         .+...+..+.+++.+||+.+|++||++.|+++.|+++
T Consensus       223 ---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         223 ---QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             ---CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence               1122344688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.3e-33  Score=305.56  Aligned_cols=252  Identities=32%  Similarity=0.505  Sum_probs=201.0

Q ss_pred             CccceeeeccCceEEEEEEec-CCcEEEEEEeccCccccHH--HHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeec
Q 001566          777 FSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGIQ--QFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFL  853 (1052)
Q Consensus       777 ~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~--~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  853 (1052)
                      |++.+.||+|+||+||+|... +++.||+|++.........  ....|+.++++++||||+++++++.+....++|||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            678899999999999999765 4678999999876544322  3356999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccc
Q 001566          854 SGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA  933 (1052)
Q Consensus       854 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  933 (1052)
                      ++++|.+++...  ..+++..+..++.|+++|+++||+.   +|+|+||||+||++++++.++|+|||.+.... .....
T Consensus        81 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~  154 (260)
T PF00069_consen   81 PGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNEN  154 (260)
T ss_dssp             TTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSE
T ss_pred             cccccccccccc--ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccccc
Confidence            999999999843  4689999999999999999999999   99999999999999999999999999997541 22233


Q ss_pred             ccccccccccccccccC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhh
Q 001566          934 TTDVAGTFGYVAPEYAT-TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012 (1052)
Q Consensus       934 ~~~~~g~~~y~aPE~~~-~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1012 (1052)
                      .....++..|+|||++. +..++.++||||+|+++|+|++|..||....     ..+............     ..... 
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~-----~~~~~~~~~~~~~~~-----~~~~~-  223 (260)
T PF00069_consen  155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN-----SDDQLEIIEKILKRP-----LPSSS-  223 (260)
T ss_dssp             BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS-----HHHHHHHHHHHHHTH-----HHHHT-
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccc-----chhhhhhhhhccccc-----ccccc-
Confidence            44556889999999998 8889999999999999999999999998431     011111111111100     00000 


Q ss_pred             cCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1013 EAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1013 ~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                       .........+.+++.+|++.||++||++.++++
T Consensus       224 -~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  224 -QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             -TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             -cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             001111367999999999999999999999975

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=4.6e-33  Score=306.01  Aligned_cols=256  Identities=22%  Similarity=0.338  Sum_probs=205.6

Q ss_pred             CCCccceeeeccCceEEEEEEec------CCcEEEEEEeccCccc-cHHHHHHHHHHhhccCCCceeeEEEEEecCCeeE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSIGRFQ-GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMF  847 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  847 (1052)
                      ++|++.+.||+|+||+||+|...      +...|++|.+...... ..+.+.+|++++++++|+|++++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            56889999999999999999754      2467999988654433 3567899999999999999999999999989999


Q ss_pred             EEEeecCCCCHHHHHhhccC-------CcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeee
Q 001566          848 LVYNFLSGGNLETFIHKKSG-------KKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDF  920 (1052)
Q Consensus       848 lv~e~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Df  920 (1052)
                      +||||+++|+|.++++....       ..+++..+..++.|++.|++|||+.   +|+||||||+||++++++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence            99999999999999986542       2589999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHH
Q 001566          921 GLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIK  999 (1052)
Q Consensus       921 gla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  999 (1052)
                      |++...............++..|+|||.+.+..++.++||||+|+++|||++ |..||.....        ...... ..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--------~~~~~~-~~  232 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--------EEVLNR-LQ  232 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--------HHHHHH-HH
Confidence            9987554333333344456788999999988888999999999999999999 7778753211        111111 11


Q ss_pred             hCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 001566         1000 EGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQ 1050 (1052)
Q Consensus      1000 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~ 1050 (1052)
                      .+....        ..+...+..+.+++.+|++.+|++||++.|+++.|.+
T Consensus       233 ~~~~~~--------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         233 AGKLEL--------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             cCCcCC--------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence            111110        1122334569999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=6.6e-33  Score=303.60  Aligned_cols=252  Identities=23%  Similarity=0.321  Sum_probs=191.6

Q ss_pred             eeeeccCceEEEEEEecC---CcEEEEEEeccCcc-ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecCCC
Q 001566          781 NLIGTGGFGSTYKAELVP---GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGG  856 (1052)
Q Consensus       781 ~~Lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  856 (1052)
                      +.||+|+||.||+|.+.+   +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            358999999999997643   45799998865443 23457888999999999999999999999999999999999999


Q ss_pred             CHHHHHhhcc---CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc-
Q 001566          857 NLETFIHKKS---GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH-  932 (1052)
Q Consensus       857 sL~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~-  932 (1052)
                      +|.++++...   ....++..+..++.|++.|++|||+.   +++||||||+||+++.++.++++|||.+......... 
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999997643   22456778889999999999999999   9999999999999999999999999999754322221 


Q ss_pred             cccccccccccccccccCCC-------CCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCcc
Q 001566          933 ATTDVAGTFGYVAPEYATTC-------RVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSS 1004 (1052)
Q Consensus       933 ~~~~~~g~~~y~aPE~~~~~-------~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1052)
                      ......++..|+|||++.+.       .++.++||||||+++|||++ |+.||......        +.......... .
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~-~  228 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE--------QVLTYTVREQQ-L  228 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH--------HHHHHHhhccc-C
Confidence            12234567889999998642       35789999999999999996 99998632211        11111111111 1


Q ss_pred             ccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 001566         1005 ELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLK 1049 (1052)
Q Consensus      1005 ~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~ 1049 (1052)
                      ....+.+.    ......+.+++..|| .+|++|||++|+.+.|+
T Consensus       229 ~~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         229 KLPKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            11112211    122345788999998 58999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3.8e-33  Score=313.34  Aligned_cols=196  Identities=23%  Similarity=0.414  Sum_probs=161.7

Q ss_pred             ceeeeccCceEEEEEEec---CCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEec--CCeeEEEEeecC
Q 001566          780 RNLIGTGGFGSTYKAELV---PGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG--EAEMFLVYNFLS  854 (1052)
Q Consensus       780 ~~~Lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  854 (1052)
                      .++||+|+||+||+|...   +++.||+|.+.....  ...+.+|++++++++||||+++++++..  +...++||||+ 
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~-   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA-   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc-
Confidence            367999999999999754   467899998864432  2457889999999999999999999864  45689999999 


Q ss_pred             CCCHHHHHhhcc-------CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE----CCCCcEEEeeeccc
Q 001566          855 GGNLETFIHKKS-------GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILL----DEELNAYLSDFGLA  923 (1052)
Q Consensus       855 ~gsL~~~l~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill----~~~~~~kl~Dfgla  923 (1052)
                      +++|.+++....       ...+++..+..++.|++.|++|||++   +|+||||||+||++    +.++.+||+|||++
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            568988876432       23588999999999999999999999   99999999999999    45678999999999


Q ss_pred             ccccccCc--ccccccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 001566          924 RLLEVSET--HATTDVAGTFGYVAPEYATTC-RVSDKADVYSFGVVLLELISGKRSLDPSF  981 (1052)
Q Consensus       924 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~  981 (1052)
                      +.......  .......+|+.|+|||++.+. .++.++||||+||++|||++|++||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            87643221  122345789999999998774 57889999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-33  Score=308.21  Aligned_cols=253  Identities=25%  Similarity=0.417  Sum_probs=204.4

Q ss_pred             hCCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      .++|++.+.||.|+||.||+|... ++..||+|.+........+.+..|++++++++|||++++++++..+...++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            356999999999999999999764 5889999999776666667889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      +++++|.+++.... ..+++..+..++.|++.|+.|||++   +|+||||+|+||+++.++.++|+|||.+....... .
T Consensus        84 ~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~  158 (280)
T cd06611          84 CDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-Q  158 (280)
T ss_pred             cCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccc-c
Confidence            99999999987653 4689999999999999999999999   99999999999999999999999999987543221 1


Q ss_pred             cccccccccccccccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccc
Q 001566          933 ATTDVAGTFGYVAPEYAT-----TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELF 1007 (1052)
Q Consensus       933 ~~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1052)
                      ......+++.|+|||.+.     +..++.++||||+|+++|||++|+.||.....        ....... ..+..... 
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~--------~~~~~~~-~~~~~~~~-  228 (280)
T cd06611         159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP--------MRVLLKI-LKSEPPTL-  228 (280)
T ss_pred             ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH--------HHHHHHH-hcCCCCCc-
Confidence            223345788999999875     34467799999999999999999999874311        1111111 11111100 


Q ss_pred             cchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001566         1008 LPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus      1008 ~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                            ..+...+..+.+++.+||+.+|++||++.++++.
T Consensus       229 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         229 ------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             ------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence                  1122334568899999999999999999999763

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=7.3e-33  Score=309.31  Aligned_cols=257  Identities=23%  Similarity=0.374  Sum_probs=200.6

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCcc-ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      ++|++.+.||+|+||.||+|... ++..+|+|.+..... ....++.+|++++++++||||+++++++.+++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36899999999999999999654 578899998865432 2345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      +++++|.++++..  ..+++..+..++.|+++|++|||+.+  +++||||||+||+++.++.++|+|||++......   
T Consensus        81 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---  153 (308)
T cd06615          81 MDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  153 (308)
T ss_pred             cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence            9999999999765  46889999999999999999999742  8999999999999999999999999998754322   


Q ss_pred             cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCC-------------------------
Q 001566          933 ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNG-------------------------  987 (1052)
Q Consensus       933 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~-------------------------  987 (1052)
                      ......++..|+|||.+.+..++.++||||||+++|||++|+.||..........                         
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (308)
T cd06615         154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS  233 (308)
T ss_pred             ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence            1233467889999999988889999999999999999999999986432110000                         


Q ss_pred             ---ccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001566          988 ---FNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus       988 ---~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                         ....+..+......      .+.+.   .......+.+++.+|++.+|++||++.|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~------~~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         234 PRPMAIFELLDYIVNEP------PPKLP---SGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             cchhhHHHHHHHHhcCC------CccCc---CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               00000000000000      00000   01134468999999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=6.1e-33  Score=302.44  Aligned_cols=248  Identities=28%  Similarity=0.437  Sum_probs=203.9

Q ss_pred             eeeeccCceEEEEEEecC----CcEEEEEEeccCcccc-HHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecCC
Q 001566          781 NLIGTGGFGSTYKAELVP----GYLVAVKKLSIGRFQG-IQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSG  855 (1052)
Q Consensus       781 ~~Lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  855 (1052)
                      +.||+|+||.||+|....    +..||+|.+....... .+++.+|++.++.++|+|++++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            468999999999997653    7889999987654433 67889999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhcc-------CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccc
Q 001566          856 GNLETFIHKKS-------GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV  928 (1052)
Q Consensus       856 gsL~~~l~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~  928 (1052)
                      ++|.+++....       ...+++.++..++.|++.|++|||++   +|+||||+|+||++++++.++|+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence            99999998752       35789999999999999999999999   999999999999999999999999999987654


Q ss_pred             cCc-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCcccc
Q 001566          929 SET-HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSEL 1006 (1052)
Q Consensus       929 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      ... .......++..|+|||.+.+..++.++||||+|+++|||++ |..||...        ...+..+.... +...  
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--------~~~~~~~~~~~-~~~~--  226 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL--------SNEEVLEYLRK-GYRL--  226 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC--------CHHHHHHHHHc-CCCC--
Confidence            321 22334457889999999998889999999999999999999 58888643        11222222221 1111  


Q ss_pred             ccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 001566         1007 FLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLK 1049 (1052)
Q Consensus      1007 ~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~ 1049 (1052)
                             ..+...+..+.+++.+|++.+|++||++.|+++.|+
T Consensus       227 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         227 -------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             -------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                   122333556999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=5.6e-33  Score=304.33  Aligned_cols=248  Identities=27%  Similarity=0.420  Sum_probs=194.8

Q ss_pred             eeeeccCceEEEEEEecC-Cc--EEEEEEeccCc-cccHHHHHHHHHHhhcc-CCCceeeEEEEEecCCeeEEEEeecCC
Q 001566          781 NLIGTGGFGSTYKAELVP-GY--LVAVKKLSIGR-FQGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEAEMFLVYNFLSG  855 (1052)
Q Consensus       781 ~~Lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  855 (1052)
                      +.||+|+||.||+|.... +.  .+|+|.++... ....+.+..|++++.++ +||||+++++++......++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999997653 33  46888876432 33456788999999999 799999999999999999999999999


Q ss_pred             CCHHHHHhhcc--------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeec
Q 001566          856 GNLETFIHKKS--------------GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFG  921 (1052)
Q Consensus       856 gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfg  921 (1052)
                      |+|.+++....              ...++++++..++.|++.|++|||+.   +++||||||+||++++++.+|++|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence            99999997542              13478999999999999999999998   99999999999999999999999999


Q ss_pred             ccccccccCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHh
Q 001566          922 LARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKE 1000 (1052)
Q Consensus       922 la~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1052)
                      ++......  ........+..|+|||++.+..++.++||||||+++|||++ |..||....        ..+..+.. ..
T Consensus       158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~--------~~~~~~~~-~~  226 (270)
T cd05047         158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CAELYEKL-PQ  226 (270)
T ss_pred             Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC--------HHHHHHHH-hC
Confidence            98632211  11111233567999999988889999999999999999997 999986321        11212211 11


Q ss_pred             CCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1001 GRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1001 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                      +...         ..+......+.+++.+||+.+|.+||++.|+++.|+++
T Consensus       227 ~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         227 GYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             CCCC---------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence            1111         11122344688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.4e-33  Score=308.78  Aligned_cols=259  Identities=25%  Similarity=0.370  Sum_probs=197.7

Q ss_pred             CCccceeeeccCceEEEEEEec-CCcEEEEEEeccCcc--ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      +|++.+.||+|++|.||+|... ++..||+|++.....  .....+.+|+.++++++|||++++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4788899999999999999764 689999999865432  2346788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcc-CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCc
Q 001566          853 LSGGNLETFIHKKS-GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET  931 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~  931 (1052)
                      ++ ++|.+++.... +..+++..+..++.|+++||+|||+.   +|+||||+|+||++++++.++|+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            96 68999987643 35689999999999999999999999   99999999999999999999999999997654221 


Q ss_pred             ccccccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccc-----
Q 001566          932 HATTDVAGTFGYVAPEYATTC-RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE----- 1005 (1052)
Q Consensus       932 ~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 1005 (1052)
                      .......+++.|+|||.+.+. .++.++||||+|+++|||+||+.||.......       .........+....     
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~  228 (285)
T cd07861         156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID-------QLFRIFRILGTPTEDVWPG  228 (285)
T ss_pred             ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHHHhCCCChhhhhc
Confidence            222233568899999988754 46889999999999999999999997432210       00000000000000     


Q ss_pred             ------------cccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1006 ------------LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1006 ------------~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                                  ................++.+++.+|++.||++|||+.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         229 VTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             chhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence                        00000000001123455789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.6e-33  Score=307.51  Aligned_cols=264  Identities=25%  Similarity=0.401  Sum_probs=208.2

Q ss_pred             CCCccceeeeccCceEEEEEEec-----CCcEEEEEEeccCccc-cHHHHHHHHHHhhccCCCceeeEEEEEec--CCee
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-----PGYLVAVKKLSIGRFQ-GIQQFDAEIGTLGRIRHKNLVTLIGYYVG--EAEM  846 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~  846 (1052)
                      +.|++.+.||+|+||.||+|.+.     ++..||||++...... ..+++.+|++++++++|||++++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45788899999999999999753     3688999998765443 45789999999999999999999999887  5578


Q ss_pred             EEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccc
Q 001566          847 FLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL  926 (1052)
Q Consensus       847 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~  926 (1052)
                      ++||||+++++|.+++.... ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||.+...
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVL  159 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence            99999999999999998754 3589999999999999999999999   9999999999999999999999999999876


Q ss_pred             cccCcc--cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCC-------CccHHHHHHHH
Q 001566          927 EVSETH--ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGN-------GFNIVSWAKLL  997 (1052)
Q Consensus       927 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~-------~~~~~~~~~~~  997 (1052)
                      ......  ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.........       ......+.. .
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~  238 (284)
T cd05038         160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE-L  238 (284)
T ss_pred             ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH-H
Confidence            532211  111233456799999999888999999999999999999999998643322100       001111111 1


Q ss_pred             HHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccC
Q 001566          998 IKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQLK 1052 (1052)
Q Consensus       998 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~lk 1052 (1052)
                      .......         ..+..++..+.+++.+|++.+|++||++.|++++|++++
T Consensus       239 ~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~  284 (284)
T cd05038         239 LKEGERL---------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR  284 (284)
T ss_pred             HHcCCcC---------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence            1111110         112233456999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=4.1e-33  Score=304.92  Aligned_cols=252  Identities=23%  Similarity=0.371  Sum_probs=201.6

Q ss_pred             CCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeec
Q 001566          775 GNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFL  853 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  853 (1052)
                      ++|++.+.||+|+||.||+|.. .+++.||+|.++.........+.+|+.+++.++|||++++++++.+++..++|+||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            4688889999999999999965 468899999987665555567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccc
Q 001566          854 SGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA  933 (1052)
Q Consensus       854 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  933 (1052)
                      ++++|.+++...  ..+++.++..++.|++.|+.|||+.   +|+|+||||+||+++.++.++|+|||++...... ...
T Consensus        89 ~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~~~  162 (267)
T cd06645          89 GGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT-IAK  162 (267)
T ss_pred             CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCc-ccc
Confidence            999999998765  4689999999999999999999999   9999999999999999999999999998765422 222


Q ss_pred             ccccccccccccccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccch
Q 001566          934 TTDVAGTFGYVAPEYAT---TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010 (1052)
Q Consensus       934 ~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1052)
                      .....|+..|+|||.+.   ...++.++||||+||++|||++|+.||....+.        ....... .....    +.
T Consensus       163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~--------~~~~~~~-~~~~~----~~  229 (267)
T cd06645         163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM--------RALFLMT-KSNFQ----PP  229 (267)
T ss_pred             cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch--------hhHHhhh-ccCCC----CC
Confidence            23456889999999874   455788999999999999999999998643211        0011111 11111    10


Q ss_pred             hhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1011 LWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1011 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ... .....+..+.+++.+|++.+|++||+++++++
T Consensus       230 ~~~-~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         230 KLK-DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             ccc-ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            000 01122345889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=4.1e-33  Score=315.15  Aligned_cols=257  Identities=26%  Similarity=0.432  Sum_probs=204.1

Q ss_pred             hCCCccceeeeccCceEEEEEEec--------CCcEEEEEEeccCc-cccHHHHHHHHHHhhcc-CCCceeeEEEEEecC
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELV--------PGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGE  843 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  843 (1052)
                      ..+|++.+.||+|+||.||+|...        .+..||+|.+.... ....+++.+|+++++++ +||||+++++++..+
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            346899999999999999999642        12368999886543 23356789999999999 799999999999999


Q ss_pred             CeeEEEEeecCCCCHHHHHhhcc--------------CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE
Q 001566          844 AEMFLVYNFLSGGNLETFIHKKS--------------GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILL  909 (1052)
Q Consensus       844 ~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill  909 (1052)
                      ...++++||+++|+|.+++....              ...+++.++.+++.|++.|++|||++   +|+||||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill  167 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLV  167 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEE
Confidence            99999999999999999997642              23578899999999999999999999   99999999999999


Q ss_pred             CCCCcEEEeeecccccccccCcc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCC
Q 001566          910 DEELNAYLSDFGLARLLEVSETH-ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNG  987 (1052)
Q Consensus       910 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~  987 (1052)
                      ++++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||...       
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-------  240 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-------  240 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC-------
Confidence            99999999999999865432211 1122234568999999999999999999999999999998 77877532       


Q ss_pred             ccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566          988 FNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus       988 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                       ...++.+.. ..+...         ..+......+.+++.+||+.+|++||++.|+++.|+++
T Consensus       241 -~~~~~~~~~-~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~  293 (334)
T cd05100         241 -PVEELFKLL-KEGHRM---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV  293 (334)
T ss_pred             -CHHHHHHHH-HcCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence             122222222 111111         11223345688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=1.7e-36  Score=329.09  Aligned_cols=367  Identities=26%  Similarity=0.330  Sum_probs=247.2

Q ss_pred             CCCCCeeEecCCCcee-cCCCCccCCCCccEEEccCccccccCCccccCCCCCCeEecccccccccCCccccCCCCCcEE
Q 001566          122 LTELRTLSVPHNSFSG-EIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVI  200 (1052)
Q Consensus       122 l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  200 (1052)
                      |+..+-.|+++|.|+| ..|.....+++++-|.|...++. .+|..++.+.+|++|.+++|++. .+-..+..++.|+.+
T Consensus         6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv   83 (1255)
T KOG0444|consen    6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSV   83 (1255)
T ss_pred             cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHH
Confidence            4445566666666663 56666666666666666666666 66666666666677777666665 555566666666666


Q ss_pred             EccCCcccCccccCCCcccCCCCEEEccCCcCCCCCCcccCCCCCCCEEEcCCCccccccchhhcCCCCCCEEEccCCCC
Q 001566          201 DMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSL  280 (1052)
Q Consensus       201 ~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l  280 (1052)
                      ++..|++..+-.+..+..+..|+.||||+|+++ ..|..+...+++-.|+|++|+|..+....|-+++.|-.||||+|++
T Consensus        84 ~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrL  162 (1255)
T KOG0444|consen   84 IVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRL  162 (1255)
T ss_pred             hhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchh
Confidence            676666653222233445677777777777777 4677777777888888888888743334456777788888888888


Q ss_pred             CCCCCcccccCCCCCceecccccccccCCCCCCccccccCCCchhhhcccCCcEEecCCCCCC-ccCCccccCCCCccEE
Q 001566          281 TDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLG-GRLPDNWSESCSLKVL  359 (1052)
Q Consensus       281 ~~~~p~~l~~l~~L~~L~L~~n~~~~~l~~~~~~~~~~~~~~p~~~~~~~~L~~L~l~~n~l~-~~~p~~~~~~~~L~~L  359 (1052)
                      . .+|+.+..+..|+.|.|++|++..        |      -...+..+++|+.|++++.+-+ ..+|..+..+.+|..+
T Consensus       163 e-~LPPQ~RRL~~LqtL~Ls~NPL~h--------f------QLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dv  227 (1255)
T KOG0444|consen  163 E-MLPPQIRRLSMLQTLKLSNNPLNH--------F------QLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDV  227 (1255)
T ss_pred             h-hcCHHHHHHhhhhhhhcCCChhhH--------H------HHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhc
Confidence            6 567777788888888888776541        0      0011223344555555544322 3455555555566666


Q ss_pred             eCCCCcccccCCccccccCCCCEEeCCCCcCcCCCCCCCCCCCcceEecccCcccccCCCCCccccCcccCccccccccc
Q 001566          360 NLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANV  439 (1052)
Q Consensus       360 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~l~~~~~  439 (1052)
                      |||.|.+. .+|+.+-++++|+.|+||+|+|+..--                                            
T Consensus       228 DlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~--------------------------------------------  262 (1255)
T KOG0444|consen  228 DLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNM--------------------------------------------  262 (1255)
T ss_pred             cccccCCC-cchHHHhhhhhhheeccCcCceeeeec--------------------------------------------
Confidence            66666665 556655556666666666555542100                                            


Q ss_pred             cccccccccceeEEeeccCCccccccCcccccccccccccchhHHhhccCCcccCCCCCccccccCCCcceEEecCcccc
Q 001566          440 PVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLL  519 (1052)
Q Consensus       440 ~~~~~~~~~~~l~~ldls~n~~~g~~p~~~~~~~~~~~~~~~~~~l~l~~n~~~~~~p~~~~~~~~~l~~~~l~l~~n~l  519 (1052)
                                                                                                      
T Consensus       263 --------------------------------------------------------------------------------  262 (1255)
T KOG0444|consen  263 --------------------------------------------------------------------------------  262 (1255)
T ss_pred             --------------------------------------------------------------------------------
Confidence                                                                                            


Q ss_pred             cCcchHHHHhcCcCccEEEccCcccccccccccCCCCCCCEEEccCCcCCC-CCcccccCCccCcEEEcCCCccCCcCch
Q 001566          520 SGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSG-SLPDELGKLKFLKWILLGGNNLTGEIPS  598 (1052)
Q Consensus       520 ~~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  598 (1052)
                         ..    ....+|++|+|+.|+++ ..|+++.++++|+.|++.+|+++- -+|..+++|.+|+.+..++|.+. ..|+
T Consensus       263 ---~~----~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPE  333 (1255)
T KOG0444|consen  263 ---TE----GEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPE  333 (1255)
T ss_pred             ---cH----HHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCch
Confidence               00    12346788888888888 788888888888888888888762 37888888888888888888887 7888


Q ss_pred             hhcCCCCCcEEEcCCCCCCCCCchhhhcccccceeeccCccCC
Q 001566          599 QFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLS  641 (1052)
Q Consensus       599 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  641 (1052)
                      .++.+.+|+.|.|++|++. .+|+.+.-|+.|+.|||.+|.--
T Consensus       334 glcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnL  375 (1255)
T KOG0444|consen  334 GLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNL  375 (1255)
T ss_pred             hhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCc
Confidence            8888888888888888877 68888888888888888888654

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-33  Score=302.42  Aligned_cols=248  Identities=28%  Similarity=0.397  Sum_probs=200.1

Q ss_pred             eeeeccCceEEEEEEecCCcEEEEEEeccCccc-cHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecCCCCHH
Q 001566          781 NLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQ-GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLE  859 (1052)
Q Consensus       781 ~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  859 (1052)
                      ++||+|+||.||+|...+++.||+|++...... ....+.+|+++++++.|+||+++++++.+....++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            468999999999998766999999988765443 4567899999999999999999999999999999999999999999


Q ss_pred             HHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcccc-cccc
Q 001566          860 TFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT-TDVA  938 (1052)
Q Consensus       860 ~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~-~~~~  938 (1052)
                      +++.... ..+++..+..++.+++.|++|||++   +++||||+|+||+++.++.++|+|||++........... ....
T Consensus        81 ~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (251)
T cd05041          81 TFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ  156 (251)
T ss_pred             HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence            9997653 4688999999999999999999999   999999999999999999999999999986542211111 1223


Q ss_pred             cccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCCCh
Q 001566          939 GTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQ 1017 (1052)
Q Consensus       939 g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 1017 (1052)
                      .+..|+|||.+.+..++.++|+||+|+++|||+| |..||......        .... ........         ..+.
T Consensus       157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--------~~~~-~~~~~~~~---------~~~~  218 (251)
T cd05041         157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--------QTRE-RIESGYRM---------PAPQ  218 (251)
T ss_pred             ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--------HHHH-HHhcCCCC---------CCCc
Confidence            4567999999998889999999999999999999 77777533211        1111 11111100         1122


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 001566         1018 ENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQ 1050 (1052)
Q Consensus      1018 ~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~ 1050 (1052)
                      ..+..+.+++.+|++.+|++||++.|+++.|+.
T Consensus       219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             cCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            334569999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.9e-33  Score=315.81  Aligned_cols=255  Identities=23%  Similarity=0.319  Sum_probs=198.6

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCc---cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      ++|++.++||+|+||+||++... +++.||+|++....   ......+.+|+.++..++|++|+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46899999999999999999765 47889999985422   222345788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccC
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~  930 (1052)
                      ||+++|+|.+++.... ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++.......
T Consensus        81 ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  156 (332)
T ss_pred             eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence            9999999999997643 4689999999999999999999999   99999999999999999999999999997654333


Q ss_pred             cccccccccccccccccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccc
Q 001566          931 THATTDVAGTFGYVAPEYAT-----TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005 (1052)
Q Consensus       931 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1052)
                      ........|++.|+|||++.     ...++.++|||||||++|||++|+.||...        +..+....+..... ..
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~--------~~~~~~~~i~~~~~-~~  227 (332)
T cd05623         157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE--------SLVETYGKIMNHKE-RF  227 (332)
T ss_pred             cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC--------CHHHHHHHHhCCCc-cc
Confidence            33333457899999999986     345788999999999999999999999732        12222222222111 00


Q ss_pred             cccchhhcCCChHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 001566         1006 LFLPELWEAGPQENLLGMMRLASTCTVETLST--RPSVKQVLIK 1047 (1052)
Q Consensus      1006 ~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~--RPt~~eil~~ 1047 (1052)
                      .+ +    .........+.+++.+|++.++++  |++++|+++.
T Consensus       228 ~~-p----~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         228 QF-P----AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             cC-C----CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            00 1    111223455888999988665544  6889988753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=7.3e-33  Score=301.23  Aligned_cols=251  Identities=28%  Similarity=0.460  Sum_probs=203.9

Q ss_pred             CccceeeeccCceEEEEEEecC-----CcEEEEEEeccCccc-cHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEE
Q 001566          777 FSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQ-GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       777 ~~~~~~Lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      +++.+.||+|+||.||+|....     +..||+|++...... ..+.+..|+++++.++|+|++++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            4567899999999999997653     388999998765443 4678899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccC
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~  930 (1052)
                      ||+++++|.+++.......+++.++..++.|++.|++|||+.   +++||||+|+||++++++.++|+|||++.......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            999999999999876533389999999999999999999999   99999999999999999999999999998765443


Q ss_pred             cccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccc
Q 001566          931 THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009 (1052)
Q Consensus       931 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                      ........+++.|+|||.+.+..++.++||||+|+++|||++ |..||...        ......+.... +...     
T Consensus       158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~--------~~~~~~~~~~~-~~~~-----  223 (258)
T smart00219      158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM--------SNEEVLEYLKK-GYRL-----  223 (258)
T ss_pred             ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHhc-CCCC-----
Confidence            332222346789999999988889999999999999999999 77777531        11222222221 1111     


Q ss_pred             hhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 001566         1010 ELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKL 1048 (1052)
Q Consensus      1010 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L 1048 (1052)
                          ..+...+..+.+++.+|+..+|++|||+.|+++.|
T Consensus       224 ----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      224 ----PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ----CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                11122455689999999999999999999998864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=6.5e-33  Score=301.33  Aligned_cols=249  Identities=24%  Similarity=0.391  Sum_probs=204.9

Q ss_pred             CCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCc--cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          776 NFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGR--FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      +|++.+.||+|+||.||++.. .+|+.||+|++....  .....++.+|+.++++++|||++++++++.+.+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            488899999999999999954 468899999986532  23346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      +++++|.+++.......+++.++..++.|++.|++|||++   +++|+||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-  156 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-  156 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence            9999999999876555688999999999999999999999   999999999999999999999999999986543221 


Q ss_pred             cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhh
Q 001566          933 ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012 (1052)
Q Consensus       933 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1012 (1052)
                      ......+++.|+|||...+..++.++||||||+++|||++|+.||....        ..+.......... .        
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~--------~~~~~~~~~~~~~-~--------  219 (256)
T cd08218         157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN--------MKNLVLKIIRGSY-P--------  219 (256)
T ss_pred             hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC--------HHHHHHHHhcCCC-C--------
Confidence            1223457889999999999889999999999999999999999986321        1222222222111 1        


Q ss_pred             cCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1013 EAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1013 ~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                       ..+......+.+++.+|++.+|++||++.|+++
T Consensus       220 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         220 -PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             -CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence             112334456899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=4.2e-33  Score=318.92  Aligned_cols=257  Identities=24%  Similarity=0.320  Sum_probs=196.0

Q ss_pred             hhCCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCc--cccHHHHHHHHHHhhccCCCceeeEEEEEecC------
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGR--FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGE------  843 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  843 (1052)
                      ..++|++.+.||+|+||.||+|.. ..++.||||++....  ......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            346899999999999999999964 458899999986532  23345678899999999999999999987643      


Q ss_pred             CeeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccc
Q 001566          844 AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLA  923 (1052)
Q Consensus       844 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla  923 (1052)
                      ...|+||||++ +++.+++..    .+++..+..++.|+++|++|||++   +|+||||||+||+++.++.+||+|||++
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875         102 QDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             CeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence            35799999995 578887753    378899999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCc
Q 001566          924 RLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRS 1003 (1052)
Q Consensus       924 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1052)
                      +.....  .......+++.|+|||++.+..++.++||||+||++|||++|+.||......       ..+.+.....+..
T Consensus       174 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-------~~~~~~~~~~~~~  244 (364)
T cd07875         174 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-------DQWNKVIEQLGTP  244 (364)
T ss_pred             cccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHHhcCCC
Confidence            865422  2223456889999999999999999999999999999999999999643211       1111111100000


Q ss_pred             ccc--------------------------ccchhh----cCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1004 SEL--------------------------FLPELW----EAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1004 ~~~--------------------------~~~~l~----~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ...                          ..+...    ..........+.+++.+|++.||++|||+.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         245 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             CHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            000                          000000    0001112346889999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=7.7e-33  Score=302.39  Aligned_cols=250  Identities=25%  Similarity=0.437  Sum_probs=201.4

Q ss_pred             CCccceeeeccCceEEEEEEecCCcEEEEEEeccCcc------ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEE
Q 001566          776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRF------QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLV  849 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  849 (1052)
                      +|++.+.||+|+||+||+|...+++.+|+|.+.....      .....+.+|++++++++|+|++++++++.+....++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            4788899999999999999887899999998864422      2235688899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccccccc
Q 001566          850 YNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS  929 (1052)
Q Consensus       850 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~  929 (1052)
                      +||+++++|.+++.+.  ..+++..+..++.|++.|++|||+.   +|+|+||+|+||++++++.++|+|||.+......
T Consensus        81 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          81 MEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV  155 (265)
T ss_pred             EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence            9999999999999765  3578999999999999999999999   9999999999999999999999999998765321


Q ss_pred             C-----cccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCcc
Q 001566          930 E-----THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSS 1004 (1052)
Q Consensus       930 ~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1052)
                      .     ........++..|+|||.+.+..++.++||||+|+++|||++|+.||.....        ............  
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~~~~--  225 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR--------LAAMFYIGAHRG--  225 (265)
T ss_pred             cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh--------HHHHHHhhhccC--
Confidence            1     1122234678899999999998899999999999999999999999963211        111111111100  


Q ss_pred             ccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1005 ELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1005 ~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                        ..+.+    +......+.+++.+|++.+|++||++.|+++
T Consensus       226 --~~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         226 --LMPRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             --CCCCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence              11111    2233455899999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=5.1e-33  Score=301.75  Aligned_cols=247  Identities=28%  Similarity=0.489  Sum_probs=200.5

Q ss_pred             CCCccceeeeccCceEEEEEEecCCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecC
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLS  854 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  854 (1052)
                      ++|++.+.||+|+||.||+|.. .++.||+|++....  ..+.+.+|+.++++++|||++++++++..+ ..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4588999999999999999975 57889999986543  236788999999999999999999998754 4799999999


Q ss_pred             CCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcccc
Q 001566          855 GGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT  934 (1052)
Q Consensus       855 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  934 (1052)
                      +++|.+++.......+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||.+......    .
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----~  154 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----V  154 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc----C
Confidence            99999999876555689999999999999999999998   9999999999999999999999999998754321    1


Q ss_pred             cccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhc
Q 001566          935 TDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWE 1013 (1052)
Q Consensus       935 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1013 (1052)
                      .....+..|+|||.+.+..++.++||||+|+++|||++ |+.||....        ..+.... ...+...         
T Consensus       155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--------~~~~~~~-~~~~~~~---------  216 (254)
T cd05083         155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS--------LKEVKEC-VEKGYRM---------  216 (254)
T ss_pred             CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC--------HHHHHHH-HhCCCCC---------
Confidence            12234568999999998899999999999999999998 888886321        1122222 2222111         


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 001566         1014 AGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQ 1050 (1052)
Q Consensus      1014 ~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~ 1050 (1052)
                      ..+...+..+.+++.+||+.+|++||+++++++.|++
T Consensus       217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            1122334568899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.6e-33  Score=315.94  Aligned_cols=254  Identities=22%  Similarity=0.306  Sum_probs=198.4

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCc---cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++....   ......+.+|..+++.++|++|+++++++.+.+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46899999999999999999764 57889999986422   223455788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccC
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~  930 (1052)
                      ||+++|+|.+++.... ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||++.......
T Consensus        81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence            9999999999998643 4688999999999999999999999   99999999999999999999999999998665433


Q ss_pred             cccccccccccccccccccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccc
Q 001566          931 THATTDVAGTFGYVAPEYATT-----CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005 (1052)
Q Consensus       931 ~~~~~~~~g~~~y~aPE~~~~-----~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1052)
                      ........|++.|+|||++.+     ..++.++||||+||++|||++|+.||....        ..+.......... ..
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~--------~~~~~~~i~~~~~-~~  227 (331)
T cd05624         157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETYGKIMNHEE-RF  227 (331)
T ss_pred             ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC--------HHHHHHHHHcCCC-cc
Confidence            333334568999999999876     457889999999999999999999997422        1222222221111 00


Q ss_pred             cccchhhcCCChHHHHHHHHHHHHccccCCCC--CCCHHHHHH
Q 001566         1006 LFLPELWEAGPQENLLGMMRLASTCTVETLST--RPSVKQVLI 1046 (1052)
Q Consensus      1006 ~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~--RPt~~eil~ 1046 (1052)
                      .+ +...    ......+.+++.+|++.++++  |++++++++
T Consensus       228 ~~-p~~~----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         228 QF-PSHI----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             cC-CCcc----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            01 1111    123456888999999876554  467887764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=296.12  Aligned_cols=249  Identities=25%  Similarity=0.417  Sum_probs=208.4

Q ss_pred             CCccceeeeccCceEEEEEEec-CCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecC
Q 001566          776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLS  854 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  854 (1052)
                      -|.++++||+|.||.||+|.++ .|+.+|+|++...  .+.+++..|+.+|++...|+||++||.|.....+++|||||.
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            3778899999999999999654 6999999988643  456888999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcccc
Q 001566          855 GGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT  934 (1052)
Q Consensus       855 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  934 (1052)
                      .|+..+.++.++ ++++++++..+....++||+|||..   .-||||||+.||++..+|.+|++|||.|..+... -...
T Consensus       112 AGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-MAKR  186 (502)
T KOG0574|consen  112 AGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-MAKR  186 (502)
T ss_pred             CCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh-HHhh
Confidence            999999998765 8899999999999999999999999   8899999999999999999999999999866422 2234


Q ss_pred             cccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcC
Q 001566          935 TDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEA 1014 (1052)
Q Consensus       935 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 1014 (1052)
                      ..+.|||.|||||++..-.|..++||||+|+...||..|++||..--+-.         +-..+........       .
T Consensus       187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR---------AIFMIPT~PPPTF-------~  250 (502)
T KOG0574|consen  187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR---------AIFMIPTKPPPTF-------K  250 (502)
T ss_pred             CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc---------eeEeccCCCCCCC-------C
Confidence            55789999999999999999999999999999999999999987322210         0111111111111       1


Q ss_pred             CChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001566         1015 GPQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus      1015 ~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                      .|+....++.++++.|+-..|++|-|+.++++.
T Consensus       251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            244455679999999999999999999988763

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=6.3e-33  Score=312.67  Aligned_cols=198  Identities=21%  Similarity=0.337  Sum_probs=166.0

Q ss_pred             cceeeecc--CceEEEEEEe-cCCcEEEEEEeccCcc--ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeec
Q 001566          779 IRNLIGTG--GFGSTYKAEL-VPGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFL  853 (1052)
Q Consensus       779 ~~~~Lg~G--~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  853 (1052)
                      +.++||+|  +|++||++.. .+|+.||+|++.....  ...+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            56789999  6889999955 4689999999865432  23456778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCc--
Q 001566          854 SGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET--  931 (1052)
Q Consensus       854 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~--  931 (1052)
                      ++|+|.+++..+....+++..+.+++.|++.|++|||++   +|+||||||+||+++.++.++++||+.+........  
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            999999999776555689999999999999999999999   999999999999999999999999986543321110  


Q ss_pred             ----ccccccccccccccccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 001566          932 ----HATTDVAGTFGYVAPEYATT--CRVSDKADVYSFGVVLLELISGKRSLDP  979 (1052)
Q Consensus       932 ----~~~~~~~g~~~y~aPE~~~~--~~~~~~sDvwslG~il~elltg~~p~~~  979 (1052)
                          .......++..|+|||++.+  ..++.++||||+||++|||++|+.||..
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  212 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD  212 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence                01112346678999999976  4588999999999999999999999963

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=6.6e-33  Score=303.46  Aligned_cols=253  Identities=23%  Similarity=0.333  Sum_probs=199.7

Q ss_pred             hhCCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEe
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYN  851 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  851 (1052)
                      +.+.+.....||+|+||.||+|... ++..||+|.+........+.+.+|++++++++|+||+++++++..++..++|+|
T Consensus         6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   85 (268)
T cd06624           6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME   85 (268)
T ss_pred             ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence            4445555678999999999999654 578899999877666666789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhccCCcc--cHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-CCcEEEeeecccccccc
Q 001566          852 FLSGGNLETFIHKKSGKKI--QWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDE-ELNAYLSDFGLARLLEV  928 (1052)
Q Consensus       852 ~~~~gsL~~~l~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~-~~~~kl~Dfgla~~~~~  928 (1052)
                      |+++++|.+++.... ..+  ++..+..++.|++.|++|||++   +|+||||||+||+++. ++.++|+|||.+.....
T Consensus        86 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  161 (268)
T cd06624          86 QVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG  161 (268)
T ss_pred             cCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence            999999999998653 234  7888899999999999999999   9999999999999976 67899999999876532


Q ss_pred             cCcccccccccccccccccccCCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCcccc
Q 001566          929 SETHATTDVAGTFGYVAPEYATTCR--VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSEL 1006 (1052)
Q Consensus       929 ~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      .. .......+++.|+|||.+.+..  ++.++||||+|+++|||++|+.||......     ....+.....   ..   
T Consensus       162 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~-----~~~~~~~~~~---~~---  229 (268)
T cd06624         162 IN-PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP-----QAAMFKVGMF---KI---  229 (268)
T ss_pred             CC-CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh-----hhhHhhhhhh---cc---
Confidence            22 1222345788999999986643  788999999999999999999998632211     0011110000   00   


Q ss_pred             ccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1007 FLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1007 ~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                       .    ...+......+.+++.+||+.+|++||++.|+++
T Consensus       230 -~----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         230 -H----PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             -C----CCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence             0    1122334456889999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.9e-33  Score=320.79  Aligned_cols=259  Identities=24%  Similarity=0.289  Sum_probs=198.5

Q ss_pred             hCCCccceeeeccCceEEEEEEec---CCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEE
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELV---PGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      ..+|++.+.||+|+||.||+|...   .+..||+|.+...     ....+|++++++++||||+++++++......++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            457999999999999999999543   3578999987543     23467999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccC
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~  930 (1052)
                      |++ .++|.+++...  ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.++|+|||+++......
T Consensus       166 e~~-~~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        166 PKY-KCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP  239 (392)
T ss_pred             hhc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence            999 57899998543  5789999999999999999999999   99999999999999999999999999998664332


Q ss_pred             c-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHh---------
Q 001566          931 T-HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE--------- 1000 (1052)
Q Consensus       931 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 1000 (1052)
                      . .......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ....+....+.....         
T Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~l~~i~~~~~~~~~~~~~~~~  318 (392)
T PHA03207        240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS-SSSQLRSIIRCMQVHPLEFPQNGS  318 (392)
T ss_pred             ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC-cHHHHHHHHHHhccCccccCCccc
Confidence            2 22234578999999999999999999999999999999999999997543321 111111111110000         


Q ss_pred             ------------CCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1001 ------------GRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1001 ------------~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                                  ........+....  .......+.+++++|+..||++||++.|++.
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~  374 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIR--KYGMHMDVEYLIAKMLTFDQEFRPSAQDILS  374 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhh--ccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence                        0000000000000  0112345788999999999999999999985

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.3e-33  Score=315.31  Aligned_cols=237  Identities=25%  Similarity=0.346  Sum_probs=188.5

Q ss_pred             eeeeccCceEEEEEEec-CCcEEEEEEeccCcc---ccHHHHHHHH-HHhhccCCCceeeEEEEEecCCeeEEEEeecCC
Q 001566          781 NLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF---QGIQQFDAEI-GTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSG  855 (1052)
Q Consensus       781 ~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  855 (1052)
                      ++||+|+||.||+|+.. +++.||+|++.....   .....+..|. .+++.++||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999764 588999999864321   2233444554 467889999999999999999999999999999


Q ss_pred             CCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccccc
Q 001566          856 GNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT  935 (1052)
Q Consensus       856 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  935 (1052)
                      ++|.+++...  ..+++..+..++.||++|++|||+.   +|+||||||+||+++.++.+||+|||++...... .....
T Consensus        81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~  154 (321)
T cd05603          81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EETTS  154 (321)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCccc
Confidence            9999988764  4688899999999999999999999   9999999999999999999999999998753211 12233


Q ss_pred             ccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCC
Q 001566          936 DVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAG 1015 (1052)
Q Consensus       936 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 1015 (1052)
                      ...|++.|+|||.+.+..++.++||||+||++|||++|+.||....        ..+....... ...          ..
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~-~~~----------~~  215 (321)
T cd05603         155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--------VSQMYDNILH-KPL----------QL  215 (321)
T ss_pred             cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC--------HHHHHHHHhc-CCC----------CC
Confidence            4568999999999999899999999999999999999999997431        1222222211 110          11


Q ss_pred             ChHHHHHHHHHHHHccccCCCCCCCHH
Q 001566         1016 PQENLLGMMRLASTCTVETLSTRPSVK 1042 (1052)
Q Consensus      1016 ~~~~~~~l~~Li~~cl~~dP~~RPt~~ 1042 (1052)
                      +......+.+++.+|++.||++||++.
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         216 PGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            223345688999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4.6e-33  Score=310.16  Aligned_cols=261  Identities=21%  Similarity=0.322  Sum_probs=198.5

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCcc-ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      ++|++.+.||+|+||.||+|... +++.||+|.+..... .....+.+|++++++++||||+++++++..+...++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            46899999999999999999654 578999999865432 2345677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      ++ ++|.+++.... ..+++..+..++.|+++|++|||+.   +|+||||||+||++++++.++|+|||++....... .
T Consensus        86 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~  159 (301)
T cd07873          86 LD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-K  159 (301)
T ss_pred             cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-C
Confidence            96 69999987653 4688999999999999999999999   99999999999999999999999999997543221 1


Q ss_pred             cccccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHH------------H
Q 001566          933 ATTDVAGTFGYVAPEYATTC-RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLI------------K  999 (1052)
Q Consensus       933 ~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------~  999 (1052)
                      ......+++.|+|||.+.+. .++.++||||+|+++|||++|+.||......     ..........            .
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~  234 (301)
T cd07873         160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE-----EQLHFIFRILGTPTEETWPGILS  234 (301)
T ss_pred             cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHcCCCChhhchhhhc
Confidence            22234568899999988754 4788999999999999999999999743221     0111000000            0


Q ss_pred             hCCccccccchhh----cCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1000 EGRSSELFLPELW----EAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1000 ~~~~~~~~~~~l~----~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      .......-.+...    ..........+.+++.+|++.||.+|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0000000000000    0011223446889999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-33  Score=290.55  Aligned_cols=263  Identities=24%  Similarity=0.342  Sum_probs=215.1

Q ss_pred             hhHHHhhCCCccceeeeccCceEEEEEEecC------CcEEEEEEeccCccc-cHHHHHHHHHHhhccCCCceeeEEEEE
Q 001566          768 DNVVRATGNFSIRNLIGTGGFGSTYKAELVP------GYLVAVKKLSIGRFQ-GIQQFDAEIGTLGRIRHKNLVTLIGYY  840 (1052)
Q Consensus       768 ~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~  840 (1052)
                      .++.....+++....+-+|.||.||.|.|++      .+.|.+|.++....+ +...+..|...+....|||+..+.+++
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            3455556678888899999999999996653      345677766543332 345678899999999999999999998


Q ss_pred             ecC-CeeEEEEeecCCCCHHHHHhhc------cCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC
Q 001566          841 VGE-AEMFLVYNFLSGGNLETFIHKK------SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEEL  913 (1052)
Q Consensus       841 ~~~-~~~~lv~e~~~~gsL~~~l~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~  913 (1052)
                      .++ ...++++.++.-|+|..|+...      ..+.++..+...++.|++.|++|||+.   +|||.||.++|+++++..
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~L  433 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQL  433 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhhe
Confidence            754 5678889999999999999832      245678889999999999999999999   999999999999999999


Q ss_pred             cEEEeeecccccccccCcccccc-cccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHH
Q 001566          914 NAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIV  991 (1052)
Q Consensus       914 ~~kl~Dfgla~~~~~~~~~~~~~-~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~  991 (1052)
                      .+||+|=.+++...+.+++.-++ ...+.+||+||.+....|+.++|||||||++|||+| |+.|+..-        +-.
T Consensus       434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeI--------DPf  505 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI--------DPF  505 (563)
T ss_pred             eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc--------CHH
Confidence            99999999999998888876554 345679999999999999999999999999999999 88887632        222


Q ss_pred             HHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566          992 SWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus       992 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                      | +.....+|...         ..|.+++.++..++.-||+.+|++||+++|++.-|.++
T Consensus       506 E-m~~ylkdGyRl---------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  506 E-MEHYLKDGYRL---------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             H-HHHHHhcccee---------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence            3 33334444322         34667888899999999999999999999999887653

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.8e-33  Score=303.99  Aligned_cols=255  Identities=24%  Similarity=0.435  Sum_probs=204.3

Q ss_pred             hCCCccceeeeccCceEEEEEEecC-C----cEEEEEEeccCcc-ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeE
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELVP-G----YLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMF  847 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~~-~----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  847 (1052)
                      .++|++.+.||+|+||.||+|.... |    ..||+|....... ....++.+|++.+++++|||++++++++.. ...+
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            3578899999999999999997542 3    3689998765543 234678899999999999999999999987 7889


Q ss_pred             EEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccccc
Q 001566          848 LVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE  927 (1052)
Q Consensus       848 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~  927 (1052)
                      +|+||+++|+|.+++.... ..+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+||+|||.++...
T Consensus        85 ~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          85 LITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccccc
Confidence            9999999999999998754 4589999999999999999999998   99999999999999999999999999998765


Q ss_pred             ccCcc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCccc
Q 001566          928 VSETH-ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005 (1052)
Q Consensus       928 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1052)
                      ..... ......++..|+|||.+....++.++|+||||+++||+++ |+.||....        ..++..... .+... 
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--------~~~~~~~~~-~~~~~-  230 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP--------AVEIPDLLE-KGERL-  230 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC--------HHHHHHHHh-CCCCC-
Confidence            33221 1122234568999999988889999999999999999999 999987432        122222222 21111 


Q ss_pred             cccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1006 ~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                              ..+..+...+.+++.+||..+|++||++.++++.|+++
T Consensus       231 --------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~  268 (279)
T cd05057         231 --------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM  268 (279)
T ss_pred             --------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                    11222334588999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-33  Score=305.51  Aligned_cols=255  Identities=25%  Similarity=0.401  Sum_probs=201.3

Q ss_pred             HHhhCCCccceeeeccCceEEEEEEecCCcEEEEEEecc--CccccHHHHHHHHHHhhcc-CCCceeeEEEEEecCCeeE
Q 001566          771 VRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSI--GRFQGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEAEMF  847 (1052)
Q Consensus       771 ~~~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  847 (1052)
                      .+....|++.++||+||.++||++...+.+.||+|++..  .+.+...-|..|+..|.++ .|.+||.+++|-..++..|
T Consensus       357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY  436 (677)
T KOG0596|consen  357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY  436 (677)
T ss_pred             EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence            344567999999999999999999888888899987753  3445567899999999999 5999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccccc
Q 001566          848 LVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE  927 (1052)
Q Consensus       848 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~  927 (1052)
                      +|||+= ..+|..+|+.......+| .+..+..|++.|+.+.|..   ||||.|+||.|+++-.. .+||+|||.|..+.
T Consensus       437 mvmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVkG-~LKLIDFGIA~aI~  510 (677)
T KOG0596|consen  437 MVMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVKG-RLKLIDFGIANAIQ  510 (677)
T ss_pred             EEeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEee-eEEeeeechhcccC
Confidence            999976 679999999876544445 7788999999999999999   99999999999999875 99999999999886


Q ss_pred             ccCcc-cccccccccccccccccCCCC-----------CCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHH
Q 001566          928 VSETH-ATTDVAGTFGYVAPEYATTCR-----------VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAK  995 (1052)
Q Consensus       928 ~~~~~-~~~~~~g~~~y~aPE~~~~~~-----------~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  995 (1052)
                      ...+. .....+||+.||+||++....           .++++||||+|||+|+|+.|++||....         -.|.+
T Consensus       511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~---------n~~aK  581 (677)
T KOG0596|consen  511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII---------NQIAK  581 (677)
T ss_pred             ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH---------HHHHH
Confidence            54433 334568999999999986432           4578999999999999999999997211         12223


Q ss_pred             HHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566          996 LLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus       996 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ...-....++.--    ...+..  .+++++++.|++.||++||++.|+++
T Consensus       582 l~aI~~P~~~Ief----p~~~~~--~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  582 LHAITDPNHEIEF----PDIPEN--DELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             HHhhcCCCccccc----cCCCCc--hHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            2222111111111    111221  22899999999999999999999986

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=8.6e-33  Score=303.18  Aligned_cols=239  Identities=24%  Similarity=0.317  Sum_probs=187.3

Q ss_pred             eeeccCceEEEEEEecC-------------------------CcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeE
Q 001566          782 LIGTGGFGSTYKAELVP-------------------------GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTL  836 (1052)
Q Consensus       782 ~Lg~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l  836 (1052)
                      .||+|+||.||+|.+..                         ...||+|++..........+.+|+++++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            58999999999996421                         13588998865544445678889999999999999999


Q ss_pred             EEEEecCCeeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC---
Q 001566          837 IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEEL---  913 (1052)
Q Consensus       837 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~---  913 (1052)
                      ++++.+....++||||+++|+|..++.... ..+++..+..++.|+++|++|||++   +|+||||||+||+++..+   
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCccc
Confidence            999999999999999999999999987643 4688999999999999999999999   999999999999997643   


Q ss_pred             ----cEEEeeecccccccccCcccccccccccccccccccCC-CCCCcchhHHHHHHHHHHHH-hCCCCCCCCcccCCCC
Q 001566          914 ----NAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT-CRVSDKADVYSFGVVLLELI-SGKRSLDPSFSEYGNG  987 (1052)
Q Consensus       914 ----~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~ell-tg~~p~~~~~~~~~~~  987 (1052)
                          .++++|||.+......     ....++..|+|||.+.+ ..++.++||||||+++||++ +|+.||......    
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~----  228 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS----  228 (274)
T ss_pred             CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH----
Confidence                3899999988643211     22346788999998875 56789999999999999995 688888633211    


Q ss_pred             ccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 001566          988 FNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLK 1049 (1052)
Q Consensus       988 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~ 1049 (1052)
                       ...    ........           .+......+.+++.+||+.+|++||++.++++.|+
T Consensus       229 -~~~----~~~~~~~~-----------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         229 -EKE----RFYEKKHR-----------LPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             -HHH----HHHHhccC-----------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence             011    11111110           01111235889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=6.6e-33  Score=327.25  Aligned_cols=262  Identities=22%  Similarity=0.249  Sum_probs=192.1

Q ss_pred             HHHhhCCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCccccHHHHHHHHHHhhccCC------CceeeEEEEEec
Q 001566          770 VVRATGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRH------KNLVTLIGYYVG  842 (1052)
Q Consensus       770 ~~~~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~l~~~~~~  842 (1052)
                      +....++|++.++||+|+||+||+|.. ..++.||||+++... ....++..|++++++++|      .+++++++++..
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            334567899999999999999999965 457889999986432 223445667777777654      458899998875


Q ss_pred             C-CeeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC--------
Q 001566          843 E-AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEEL--------  913 (1052)
Q Consensus       843 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~--------  913 (1052)
                      . ...|+|||++ +++|.+++...  ..+++..+..++.||+.||+|||+++  +||||||||+|||++.++        
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~~~~  277 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPVTN  277 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCcccccccc
Confidence            4 5789999988 88999998765  46899999999999999999999732  899999999999998765        


Q ss_pred             --------cEEEeeecccccccccCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCC
Q 001566          914 --------NAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYG  985 (1052)
Q Consensus       914 --------~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~  985 (1052)
                              .+||+|||.+....    .......||+.|+|||++.+..++.++|||||||++|||++|+.||+.....  
T Consensus       278 ~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~--  351 (467)
T PTZ00284        278 RALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL--  351 (467)
T ss_pred             cccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--
Confidence                    49999999886432    2233457899999999999999999999999999999999999999743211  


Q ss_pred             CCccHHHHHHHH--------------------HHh-CCccccccchhh----cCC---ChHHHHHHHHHHHHccccCCCC
Q 001566          986 NGFNIVSWAKLL--------------------IKE-GRSSELFLPELW----EAG---PQENLLGMMRLASTCTVETLST 1037 (1052)
Q Consensus       986 ~~~~~~~~~~~~--------------------~~~-~~~~~~~~~~l~----~~~---~~~~~~~l~~Li~~cl~~dP~~ 1037 (1052)
                         .....+...                    +.. +......++...    ...   .......+.+|+.+|++.||++
T Consensus       352 ---~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~  428 (467)
T PTZ00284        352 ---EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK  428 (467)
T ss_pred             ---HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence               111100000                    000 000000011000    000   0011345789999999999999


Q ss_pred             CCCHHHHHH
Q 001566         1038 RPSVKQVLI 1046 (1052)
Q Consensus      1038 RPt~~eil~ 1046 (1052)
                      |||++|+++
T Consensus       429 R~ta~e~L~  437 (467)
T PTZ00284        429 RLNARQMTT  437 (467)
T ss_pred             CCCHHHHhc
Confidence            999999986

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.9e-33  Score=319.61  Aligned_cols=251  Identities=24%  Similarity=0.342  Sum_probs=196.7

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCc---cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      ++|++.+.||+|+||.||+|... +++.||+|++....   ......+.+|+.++..++||+++++++.+.+.+..|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36889999999999999999664 58999999986432   233466788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccC
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~  930 (1052)
                      ||+++|+|.+++...  ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.++|+|||++.......
T Consensus        81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          81 EFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             eCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence            999999999999765  4689999999999999999999999   99999999999999999999999999987542110


Q ss_pred             c----------------------------------ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 001566          931 T----------------------------------HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRS  976 (1052)
Q Consensus       931 ~----------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p  976 (1052)
                      .                                  ......+||+.|+|||++.+..++.++||||+||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence            0                                  001134689999999999999999999999999999999999999


Q ss_pred             CCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 001566          977 LDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS---VKQVLI 1046 (1052)
Q Consensus       977 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt---~~eil~ 1046 (1052)
                      |....+        .+..+.+... .....+.+.      ......+.+++.+++ .||++|++   +.|+++
T Consensus       236 f~~~~~--------~~~~~~i~~~-~~~~~~p~~------~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         236 FCSETP--------QETYRKVMNW-KETLVFPPE------VPISEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCCCCH--------HHHHHHHHcC-CCceecCCC------CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            974322        1222222211 111111110      112345778888876 49999985   566553

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.6e-32  Score=300.37  Aligned_cols=248  Identities=25%  Similarity=0.441  Sum_probs=200.2

Q ss_pred             CCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCccc---------cHHHHHHHHHHhhccCCCceeeEEEEEecCCe
Q 001566          776 NFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQ---------GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAE  845 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  845 (1052)
                      +|.+.+.||+|+||.||+|.. .+++.||+|.+......         ..+.+.+|++++++++||||+++++++.+...
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            477889999999999999965 45789999988654322         12567889999999999999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccc
Q 001566          846 MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARL  925 (1052)
Q Consensus       846 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~  925 (1052)
                      .++|+||+++++|.+++...  ..+++..+..++.|++.|++|||+.   +++||||+|+||++++++.++|+|||.++.
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~  155 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKK  155 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence            99999999999999999765  4688999999999999999999999   999999999999999999999999999986


Q ss_pred             ccccCc-----ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHh
Q 001566          926 LEVSET-----HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE 1000 (1052)
Q Consensus       926 ~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1052)
                      ......     .......++..|+|||.+.+..++.++||||+|+++|||++|+.||.....       . ........ 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~-~~~~~~~~-  226 (267)
T cd06628         156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ-------L-QAIFKIGE-  226 (267)
T ss_pred             cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH-------H-HHHHHHhc-
Confidence            642111     111223578899999999998899999999999999999999999974211       1 11111111 


Q ss_pred             CCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1001 GRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1001 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      .     ..+.    .+...+..+.+++.+||+.||++||++.|+++
T Consensus       227 ~-----~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         227 N-----ASPE----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             c-----CCCc----CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            1     1111    12234456889999999999999999999976

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.6e-33  Score=334.85  Aligned_cols=256  Identities=26%  Similarity=0.376  Sum_probs=198.6

Q ss_pred             HHhhCCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCc--cccHHHHHHHHHHhhccCCCceeeEEEEEec--CCe
Q 001566          771 VRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR--FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG--EAE  845 (1052)
Q Consensus       771 ~~~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~  845 (1052)
                      ....++|++.+.||+|+||+||+|... ++..||+|++....  ......+..|+.++++++||||++++++|.+  ...
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            345568999999999999999999654 57789999886542  2335678899999999999999999998854  356


Q ss_pred             eEEEEeecCCCCHHHHHhhcc--CCcccHHHHHHHHHHHHHHHHHHHhcCC----CCeeeCCCCCCCEEECCC-------
Q 001566          846 MFLVYNFLSGGNLETFIHKKS--GKKIQWSVIHKIAIDIAQALAYLHYSCV----PRIVHRDIKPSNILLDEE-------  912 (1052)
Q Consensus       846 ~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~----~~iiHrDik~~Nill~~~-------  912 (1052)
                      +|+||||+++|+|.+++....  ...+++..++.|+.||+.||+|||+...    .+||||||||+|||++.+       
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            899999999999999997632  2468999999999999999999998521    259999999999999642       


Q ss_pred             ----------CcEEEeeecccccccccCcccccccccccccccccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 001566          913 ----------LNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT--CRVSDKADVYSFGVVLLELISGKRSLDPS  980 (1052)
Q Consensus       913 ----------~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~sDvwslG~il~elltg~~p~~~~  980 (1052)
                                +.+||+|||++......  .......|++.|+|||++.+  ..++.++|||||||++|||+||+.||...
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~--s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIE--SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             cccccccCCCCceEEccCCcccccccc--ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                      34899999999865422  22234568999999999864  45788999999999999999999999632


Q ss_pred             cccCCCCccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566          981 FSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus       981 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      .       ........+ .....       +.   ....+..+.++|..||+.+|++||++.|+++
T Consensus       247 ~-------~~~qli~~l-k~~p~-------lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        247 N-------NFSQLISEL-KRGPD-------LP---IKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             C-------cHHHHHHHH-hcCCC-------CC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            1       112222221 11110       00   0122345889999999999999999999984

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.1e-32  Score=303.33  Aligned_cols=248  Identities=25%  Similarity=0.378  Sum_probs=203.5

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCc-cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      +.|+..+.||.|+||.||+|... ++..||+|.+.... ......+.+|+++++++.|||++++++++.++...++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            45778899999999999999764 58899999887543 23456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      +++++|.+++...   .+++.++..++.|++.|++|+|+.   +++|+||+|+||+++.++.++++|||++....... .
T Consensus        84 ~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~  156 (277)
T cd06640          84 LGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-I  156 (277)
T ss_pred             CCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc-c
Confidence            9999999998653   588999999999999999999999   99999999999999999999999999997654322 1


Q ss_pred             cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhh
Q 001566          933 ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012 (1052)
Q Consensus       933 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1012 (1052)
                      ......++..|+|||.+.+..++.++|+||||+++|||++|..||....+.        ...... ..+.         .
T Consensus       157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--------~~~~~~-~~~~---------~  218 (277)
T cd06640         157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM--------RVLFLI-PKNN---------P  218 (277)
T ss_pred             ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH--------hHhhhh-hcCC---------C
Confidence            223345788899999999888999999999999999999999998743221        111111 1111         1


Q ss_pred             cCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001566         1013 EAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus      1013 ~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                      ...+...+..+.+++.+||+.+|++||++.++++.
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            12234456679999999999999999999999754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.5e-32  Score=298.44  Aligned_cols=248  Identities=23%  Similarity=0.384  Sum_probs=202.4

Q ss_pred             CCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCc--cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          776 NFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGR--FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      +|++.+.||+|+||.||+|.. .+++.+|+|.+....  ......+..|++++++++|||++++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            488899999999999999955 468899999986543  23356788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC-CcEEEeeecccccccccCc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEE-LNAYLSDFGLARLLEVSET  931 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~-~~~kl~Dfgla~~~~~~~~  931 (1052)
                      +++++|.+++.......+++..+.+++.++++|++|||++   +|+||||+|+||+++++ +.++++|||.+......  
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~--  155 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK--  155 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC--
Confidence            9999999999876656789999999999999999999999   99999999999999865 45799999999866432  


Q ss_pred             ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchh
Q 001566          932 HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPEL 1011 (1052)
Q Consensus       932 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1011 (1052)
                      .......++..|+|||.+.+..++.++||||+|+++|+|++|+.||.....        ............ .       
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~--------~~~~~~~~~~~~-~-------  219 (256)
T cd08220         156 SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL--------PALVLKIMSGTF-A-------  219 (256)
T ss_pred             ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch--------HHHHHHHHhcCC-C-------
Confidence            122234678899999999988889999999999999999999999864321        112222211111 1       


Q ss_pred             hcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1012 WEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1012 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                        ..+...+..+.+++.+||+.+|++|||+.|+++
T Consensus       220 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         220 --PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             --CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence              112223456889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.3e-32  Score=309.08  Aligned_cols=194  Identities=24%  Similarity=0.428  Sum_probs=160.2

Q ss_pred             eeeeccCceEEEEEEec---CCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEec--CCeeEEEEeecCC
Q 001566          781 NLIGTGGFGSTYKAELV---PGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG--EAEMFLVYNFLSG  855 (1052)
Q Consensus       781 ~~Lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~  855 (1052)
                      .+||+|+||+||+|...   ++..||+|.+.....  ...+.+|++++++++||||+++++++..  +...++|+||+. 
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-   83 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-   83 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence            57999999999999764   357899998865432  3467889999999999999999999853  567899999985 


Q ss_pred             CCHHHHHhhcc-------CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE----CCCCcEEEeeecccc
Q 001566          856 GNLETFIHKKS-------GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILL----DEELNAYLSDFGLAR  924 (1052)
Q Consensus       856 gsL~~~l~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill----~~~~~~kl~Dfgla~  924 (1052)
                      ++|.+++....       ...+++..+..++.|++.|++|||+.   +|+||||||+||++    ++++.+||+|||+++
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence            58888875321       23578899999999999999999999   99999999999999    566789999999998


Q ss_pred             cccccCc--ccccccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 001566          925 LLEVSET--HATTDVAGTFGYVAPEYATTC-RVSDKADVYSFGVVLLELISGKRSLDPS  980 (1052)
Q Consensus       925 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~  980 (1052)
                      .......  .......+++.|+|||.+.+. .++.++||||+||++|||+||++||...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            7653322  122345688999999998764 5788999999999999999999999744

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-33  Score=304.86  Aligned_cols=248  Identities=27%  Similarity=0.419  Sum_probs=203.2

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCc-cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      ++|++.+.||.|+||.||+|... +++.||+|.+.... ......+.+|++++++++|+|++++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36888999999999999999654 68899999987553 33456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      +++++|.+++...   .+++..+..++.|++.|+.|||++   +++||||+|+||++++++.++|+|||++....... .
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~  153 (274)
T cd06609          81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-S  153 (274)
T ss_pred             eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc-c
Confidence            9999999999764   689999999999999999999999   99999999999999999999999999998765332 2


Q ss_pred             cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhh
Q 001566          933 ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012 (1052)
Q Consensus       933 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1012 (1052)
                      ......+++.|+|||.+.+..++.++||||||+++|||+||+.||....+        ...... .......     .+.
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~--------~~~~~~-~~~~~~~-----~~~  219 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP--------MRVLFL-IPKNNPP-----SLE  219 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch--------HHHHHH-hhhcCCC-----CCc
Confidence            22334678899999999998899999999999999999999999964321        111111 1111111     111


Q ss_pred             cCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1013 EAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1013 ~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ..   ..+..+.+++.+|++.+|++||+++++++
T Consensus       220 ~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         220 GN---KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             cc---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            11   13445889999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.2e-33  Score=314.54  Aligned_cols=193  Identities=26%  Similarity=0.359  Sum_probs=165.6

Q ss_pred             hhCCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEe
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYN  851 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  851 (1052)
                      ...+|++.+.||+|+||.||+|... +++.||+|+....      ....|+.++++++||||+++++++.+....++|+|
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            3457999999999999999999665 4678999974322      23568999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCc
Q 001566          852 FLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET  931 (1052)
Q Consensus       852 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~  931 (1052)
                      ++ .++|.+++.... ..+++..+..++.||+.|++|||++   +|+||||||+||+++.++.+||+|||.++.....  
T Consensus       138 ~~-~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--  210 (357)
T PHA03209        138 HY-SSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--  210 (357)
T ss_pred             cc-CCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence            99 579999987643 5789999999999999999999999   9999999999999999999999999999743221  


Q ss_pred             ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 001566          932 HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLD  978 (1052)
Q Consensus       932 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~  978 (1052)
                      .......|++.|+|||++.+..++.++|||||||++|||+++..|+.
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f  257 (357)
T PHA03209        211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF  257 (357)
T ss_pred             cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence            12233568999999999999999999999999999999999665553

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=5.8e-33  Score=306.40  Aligned_cols=260  Identities=24%  Similarity=0.449  Sum_probs=204.4

Q ss_pred             cchhhHHHhhCCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCccccHHHHHHHHHHhhcc-CCCceeeEEEEEec
Q 001566          765 LTYDNVVRATGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRI-RHKNLVTLIGYYVG  842 (1052)
Q Consensus       765 ~~~~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  842 (1052)
                      .++.+...+.+.|++.+.||+|+||.||+|.. .+++.||+|++.... ....++..|+.+++++ +|+|++++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            34555556778999999999999999999966 458899999886543 2345678899999998 69999999999853


Q ss_pred             ------CCeeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEE
Q 001566          843 ------EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY  916 (1052)
Q Consensus       843 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~k  916 (1052)
                            ....+++|||+++|+|.+++.......+++..+..++.|+++|++|||+.   +|+||||+|+||++++++.++
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence                  45789999999999999999876666788999999999999999999999   999999999999999999999


Q ss_pred             EeeecccccccccCcccccccccccccccccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHH
Q 001566          917 LSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT-----TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIV  991 (1052)
Q Consensus       917 l~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~  991 (1052)
                      |+|||++....... .......+++.|+|||.+.     +..++.++||||+||++|||++|+.||....+.       .
T Consensus       162 l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~-------~  233 (282)
T cd06636         162 LVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM-------R  233 (282)
T ss_pred             EeeCcchhhhhccc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH-------h
Confidence            99999987553221 1223356888999999876     345778999999999999999999999643211       0


Q ss_pred             HHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566          992 SWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus       992 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      . .... ......     .   ......+..+.+++.+||+.||.+||++.|+++
T Consensus       234 ~-~~~~-~~~~~~-----~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         234 A-LFLI-PRNPPP-----K---LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             h-hhhH-hhCCCC-----C---CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            0 0001 111000     0   011223456999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.9e-32  Score=300.04  Aligned_cols=251  Identities=23%  Similarity=0.335  Sum_probs=189.2

Q ss_pred             eeeccCceEEEEEEecC---CcEEEEEEeccCcc-ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecCCCC
Q 001566          782 LIGTGGFGSTYKAELVP---GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGN  857 (1052)
Q Consensus       782 ~Lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  857 (1052)
                      .||+|+||+||+|....   ...+|+|.+..... .....+.+|++.++.++||||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999996543   35688887754332 234567899999999999999999999999999999999999999


Q ss_pred             HHHHHhhccC---CcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc-c
Q 001566          858 LETFIHKKSG---KKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH-A  933 (1052)
Q Consensus       858 L~~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~-~  933 (1052)
                      |.+++.....   ...++..+..++.|++.|++|||++   +|+||||||+||++++++.+||+|||++......... .
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            9999977542   2346788899999999999999999   9999999999999999999999999998754322211 1


Q ss_pred             ccccccccccccccccCC-------CCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCccc
Q 001566          934 TTDVAGTFGYVAPEYATT-------CRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005 (1052)
Q Consensus       934 ~~~~~g~~~y~aPE~~~~-------~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1052)
                      .....++..|+|||+...       ..++.++||||+||++|||++ |..||.....        .+.......... ..
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------~~~~~~~~~~~~-~~  229 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD--------EQVLKQVVREQD-IK  229 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH--------HHHHHHHhhccC-cc
Confidence            223345678999998743       356789999999999999999 6677753211        111222222221 11


Q ss_pred             cccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 001566         1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLK 1049 (1052)
Q Consensus      1006 ~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~ 1049 (1052)
                      ...+..    +......+.+++..|| .||++||+++|+++.+.
T Consensus       230 ~~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         230 LPKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            111211    2233445777888898 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=9.9e-33  Score=305.23  Aligned_cols=262  Identities=25%  Similarity=0.390  Sum_probs=203.3

Q ss_pred             cchhhHHHhhCCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCccccHHHHHHHHHHhhcc-CCCceeeEEEEEe-
Q 001566          765 LTYDNVVRATGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRI-RHKNLVTLIGYYV-  841 (1052)
Q Consensus       765 ~~~~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~-  841 (1052)
                      +.++.+..+.++|++.+.||+|+||.||+|.. .+++.+|+|++..... ...++.+|+.+++++ +|||++++++++. 
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            34556667888999999999999999999965 4578999998764322 235678899999999 6999999999874 


Q ss_pred             ----cCCeeEEEEeecCCCCHHHHHhhc--cCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcE
Q 001566          842 ----GEAEMFLVYNFLSGGNLETFIHKK--SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNA  915 (1052)
Q Consensus       842 ----~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~  915 (1052)
                          .+...++||||+++++|.+++...  ....+++..+..++.|+++|+.|||+.   +|+||||||+||++++++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCE
Confidence                345689999999999999988642  235688999999999999999999999   99999999999999999999


Q ss_pred             EEeeecccccccccCcccccccccccccccccccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccH
Q 001566          916 YLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT-----CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI  990 (1052)
Q Consensus       916 kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~  990 (1052)
                      +|+|||++....... .......|++.|+|||++..     ..++.++||||+||++|||++|+.||......       
T Consensus       164 kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~-------  235 (286)
T cd06638         164 KLVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM-------  235 (286)
T ss_pred             EEccCCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh-------
Confidence            999999998654322 22233468899999998853     44788999999999999999999998743211       


Q ss_pred             HHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001566          991 VSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                      ....+  ..........+       +......+.+++.+||+.||++||++.|+++.
T Consensus       236 ~~~~~--~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         236 RALFK--IPRNPPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             HHHhh--ccccCCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            11110  01111111111       11223458899999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.2e-32  Score=299.58  Aligned_cols=253  Identities=25%  Similarity=0.441  Sum_probs=202.1

Q ss_pred             CCccceeeeccCceEEEEEEecC--CcEEEEEEeccCc----------cccHHHHHHHHHHhhc-cCCCceeeEEEEEec
Q 001566          776 NFSIRNLIGTGGFGSTYKAELVP--GYLVAVKKLSIGR----------FQGIQQFDAEIGTLGR-IRHKNLVTLIGYYVG  842 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~  842 (1052)
                      .|++.+.||+|+||.||+|....  ++.+|+|.+....          .....++..|+.++.+ ++|||++++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999997654  6889999875322          1223456778888865 699999999999999


Q ss_pred             CCeeEEEEeecCCCCHHHHHhhc--cCCcccHHHHHHHHHHHHHHHHHHHh-cCCCCeeeCCCCCCCEEECCCCcEEEee
Q 001566          843 EAEMFLVYNFLSGGNLETFIHKK--SGKKIQWSVIHKIAIDIAQALAYLHY-SCVPRIVHRDIKPSNILLDEELNAYLSD  919 (1052)
Q Consensus       843 ~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDik~~Nill~~~~~~kl~D  919 (1052)
                      ++..++||||+++++|.+++...  ....+++..++.++.|++.|+.|||+ .   +++||||+|+||++++++.++|+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence            99999999999999999988542  23568999999999999999999996 5   899999999999999999999999


Q ss_pred             ecccccccccCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHH
Q 001566          920 FGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIK  999 (1052)
Q Consensus       920 fgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  999 (1052)
                      ||.+.......  ......++..|+|||.+.+..++.++||||||+++|||++|+.||....        ..........
T Consensus       158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~--------~~~~~~~~~~  227 (269)
T cd08528         158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN--------MLSLATKIVE  227 (269)
T ss_pred             ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC--------HHHHHHHHhh
Confidence            99998654332  3344568889999999999889999999999999999999999986321        1222222221


Q ss_pred             hCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 001566         1000 EGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQ 1050 (1052)
Q Consensus      1000 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~ 1050 (1052)
                      .. ...    .    .....+..+.+++.+||+.||++||++.|+.+++++
T Consensus       228 ~~-~~~----~----~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         228 AV-YEP----L----PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             cc-CCc----C----CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence            11 110    0    011234568999999999999999999999998863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.1e-32  Score=302.01  Aligned_cols=249  Identities=24%  Similarity=0.426  Sum_probs=197.7

Q ss_pred             eeeeccCceEEEEEEecC-------CcEEEEEEeccCcc-ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          781 NLIGTGGFGSTYKAELVP-------GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       781 ~~Lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      +.||+|+||.||+|+..+       +..+|+|.+..... ....++.+|+++++.++||||+++++++......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999996542       25789998765432 3456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcc-----CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC-----cEEEeeecc
Q 001566          853 LSGGNLETFIHKKS-----GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEEL-----NAYLSDFGL  922 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~-----~~kl~Dfgl  922 (1052)
                      +++++|.+++....     ...+++.++..++.|++.|++|||+.   +++|+||+|+||+++.++     .++++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999997642     23478899999999999999999998   999999999999999887     899999999


Q ss_pred             cccccccCc-ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHh
Q 001566          923 ARLLEVSET-HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKE 1000 (1052)
Q Consensus       923 a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1052)
                      +........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.....        .+....... 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--------~~~~~~~~~-  228 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--------QEVLQHVTA-  228 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--------HHHHHHHhc-
Confidence            976543222 11222345678999999999999999999999999999998 9988863211        111222111 


Q ss_pred             CCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 001566         1001 GRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQ 1050 (1052)
Q Consensus      1001 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~ 1050 (1052)
                      +...         ..+...+..+.+++.+||+.+|++||+++++++.|++
T Consensus       229 ~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         229 GGRL---------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             CCcc---------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            1100         1123345668999999999999999999999999864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.9e-32  Score=297.92  Aligned_cols=247  Identities=27%  Similarity=0.405  Sum_probs=201.3

Q ss_pred             CCccceeeeccCceEEEEEEec-CCcEEEEEEeccCcc-----ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEE
Q 001566          776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF-----QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLV  849 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  849 (1052)
                      +|+..+.||+|+||.||+|... +++.|++|.+.....     +..+.+.+|++++++++|+|++++++++.++...++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4778899999999999999765 789999998865432     2346788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccccccc
Q 001566          850 YNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS  929 (1052)
Q Consensus       850 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~  929 (1052)
                      +||+++++|.+++...  ..+++..+..++.|+++|++|||+.   +|+|+||+|+||+++.++.+||+|||.+......
T Consensus        81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~  155 (258)
T cd06632          81 LELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF  155 (258)
T ss_pred             EEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence            9999999999999765  3588999999999999999999999   9999999999999999999999999998765432


Q ss_pred             CcccccccccccccccccccCCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCcccccc
Q 001566          930 ETHATTDVAGTFGYVAPEYATTCR-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFL 1008 (1052)
Q Consensus       930 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                      .  ......++..|+|||.+.... ++.++|+||+|+++|+|++|+.||.....        ............ ..   
T Consensus       156 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~--------~~~~~~~~~~~~-~~---  221 (258)
T cd06632         156 S--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG--------VAAVFKIGRSKE-LP---  221 (258)
T ss_pred             c--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH--------HHHHHHHHhccc-CC---
Confidence            2  223456788999999988766 88999999999999999999999874321        111111111111 11   


Q ss_pred             chhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1009 PELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1009 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                           ..+......+.+++.+||+.+|++||++.++++
T Consensus       222 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         222 -----PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             -----CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence                 112233456889999999999999999999975

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.1e-32  Score=302.63  Aligned_cols=259  Identities=25%  Similarity=0.341  Sum_probs=202.1

Q ss_pred             CCccceeeeccCceEEEEEEec-CCcEEEEEEeccCcc--ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      +|++.+.||+|+||.||+|... +|+.||+|++.....  .....+.+|+.++++++|||++++++++..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4888999999999999999764 689999999876542  2346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      + +++|.+++.... ..+++.++..++.|+++|++|||+.   +|+|+||+|+||+++.++.++|+|||.+.........
T Consensus        81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~  155 (286)
T cd07832          81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR  155 (286)
T ss_pred             c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence            9 999999987654 5689999999999999999999999   9999999999999999999999999999876543322


Q ss_pred             cccccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccch-
Q 001566          933 ATTDVAGTFGYVAPEYATTC-RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE- 1010 (1052)
Q Consensus       933 ~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 1010 (1052)
                      ......++..|+|||.+.+. .++.++||||+|+++|||++|.+||.....       ...+.+.....+.......+. 
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND-------IEQLAIVFRTLGTPNEETWPGL  228 (286)
T ss_pred             ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH-------HHHHHHHHHHcCCCChHHHhhc
Confidence            23345688899999998754 458899999999999999999877753221       111111111111000000000 


Q ss_pred             -----------------hhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1011 -----------------LWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1011 -----------------l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                                       .+....++....+.+++.+|++.+|++||+++++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         229 TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             cCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                             000011233467899999999999999999999986

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=6e-33  Score=306.65  Aligned_cols=258  Identities=22%  Similarity=0.300  Sum_probs=197.6

Q ss_pred             CCccceeeeccCceEEEEEEec-CCcEEEEEEeccCccc--cHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQ--GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      +|++.+.||+|+||.||+|... +|+.||+|++......  ....+.+|++++++++|||++++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4788899999999999999664 6889999998654322  235677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      ++ ++|.+++.... ..+++..+..++.||++|+.|||++   +|+||||||+||+++.++.++|+|||++....... .
T Consensus        81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~  154 (284)
T cd07839          81 CD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-R  154 (284)
T ss_pred             CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC-C
Confidence            95 68888887643 4689999999999999999999999   99999999999999999999999999998654322 1


Q ss_pred             cccccccccccccccccCCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCC---------
Q 001566          933 ATTDVAGTFGYVAPEYATTCR-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGR--------- 1002 (1052)
Q Consensus       933 ~~~~~~g~~~y~aPE~~~~~~-~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 1002 (1052)
                      ......++..|+|||.+.+.. ++.++||||+||++|||+||+.|+.+....       .+..+.......         
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~  227 (284)
T cd07839         155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-------DDQLKRIFRLLGTPTEESWPG  227 (284)
T ss_pred             CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH-------HHHHHHHHHHhCCCChHHhHH
Confidence            223345788999999987644 688999999999999999999987543221       111111111000         


Q ss_pred             ----ccccccch-----hhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1003 ----SSELFLPE-----LWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1003 ----~~~~~~~~-----l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                          ......+.     .+....+.....+.+++.+|++.||++|||++|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         228 VSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             hhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence                00000000     001111233456889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.5e-33  Score=313.92  Aligned_cols=256  Identities=25%  Similarity=0.349  Sum_probs=194.8

Q ss_pred             HhhCCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCcc--ccHHHHHHHHHHhhccCCCceeeEEEEEecC-----
Q 001566          772 RATGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGE-----  843 (1052)
Q Consensus       772 ~~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----  843 (1052)
                      ...++|++.+.||+|+||.||+|.. .+++.||||++.....  .....+.+|++++++++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            3457899999999999999999964 4688999999865322  2345677899999999999999999987543     


Q ss_pred             -CeeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecc
Q 001566          844 -AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGL  922 (1052)
Q Consensus       844 -~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgl  922 (1052)
                       ...|+++|++ +++|.++++.   ..+++..+..++.|++.|++|||++   +|+||||||+||++++++.+||+|||+
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~  164 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGL  164 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCcc
Confidence             3578999988 8899988864   3589999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCcccccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHH-Hh
Q 001566          923 ARLLEVSETHATTDVAGTFGYVAPEYATT-CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLI-KE 1000 (1052)
Q Consensus       923 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~ 1000 (1052)
                      ++.....    .....+++.|+|||++.+ ..++.++||||+||++|||++|+.||......        +...... ..
T Consensus       165 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~~~~~~  232 (343)
T cd07878         165 ARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI--------DQLKRIMEVV  232 (343)
T ss_pred             ceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHHHh
Confidence            9865421    233468899999999877 56888999999999999999999999642211        1111110 00


Q ss_pred             CCccccccchhh-----------cCCC--------hHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1001 GRSSELFLPELW-----------EAGP--------QENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1001 ~~~~~~~~~~l~-----------~~~~--------~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      +.....+...+.           ...+        ......+.+++.+|++.||++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         233 GTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             CCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            000000000000           0000        011234789999999999999999999985

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.3e-32  Score=306.51  Aligned_cols=255  Identities=25%  Similarity=0.424  Sum_probs=200.7

Q ss_pred             hCCCccceeeeccCceEEEEEEec-CCc----EEEEEEeccCcc-ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeE
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELV-PGY----LVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMF  847 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  847 (1052)
                      .++|+..+.||+|+||.||+|.+. ++.    .||+|.+..... ....++.+|+.++++++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            356888899999999999999653 343    578888765432 2234688999999999999999999998754 567


Q ss_pred             EEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccccc
Q 001566          848 LVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE  927 (1052)
Q Consensus       848 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~  927 (1052)
                      +++||+++|+|.+++.... ..++++.+..++.|++.|++|||++   +|+||||||+||++++++.+||+|||+++...
T Consensus        85 ~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             eeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccccc
Confidence            9999999999999997653 4688999999999999999999999   99999999999999999999999999998664


Q ss_pred             ccCcc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHHHhCCccc
Q 001566          928 VSETH-ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005 (1052)
Q Consensus       928 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1052)
                      ..... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||....        ..+.. .....+....
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~--------~~~~~-~~~~~~~~~~  231 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP--------TREIP-DLLEKGERLP  231 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC--------HHHHH-HHHHCCCCCC
Confidence            32221 1222345678999999999899999999999999999998 888886321        11111 2222221110


Q ss_pred             cccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566         1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1006 ~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                               .+..++..+.+++.+||..+|++||+++++++.++++
T Consensus       232 ---------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~  268 (303)
T cd05110         232 ---------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM  268 (303)
T ss_pred             ---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                     1122345688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.3e-32  Score=302.34  Aligned_cols=261  Identities=25%  Similarity=0.350  Sum_probs=199.1

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCcc--ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEe
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYN  851 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  851 (1052)
                      ++|++.+.||+|+||.||+|... +++.||+|++.....  ...+.+.+|++++++++|||++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46889999999999999999765 589999998864432  223567899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCc
Q 001566          852 FLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET  931 (1052)
Q Consensus       852 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~  931 (1052)
                      |++++.+..+....  ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||++........
T Consensus        81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          81 YCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD  155 (286)
T ss_pred             ccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence            99998888876543  3689999999999999999999998   999999999999999999999999999987643221


Q ss_pred             ccccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHH-----------
Q 001566          932 HATTDVAGTFGYVAPEYATT-CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIK-----------  999 (1052)
Q Consensus       932 ~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----------  999 (1052)
                       ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||......     ...........           
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07847         156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV-----DQLYLIRKTLGDLIPRHQQIFS  229 (286)
T ss_pred             -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhCCCChHHhhhcc
Confidence             2223457789999999876 45788999999999999999999999743221     00110000000           


Q ss_pred             hCC-ccccccchhhcCCC-----hHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1000 EGR-SSELFLPELWEAGP-----QENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1000 ~~~-~~~~~~~~l~~~~~-----~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ... ......+......+     ......+.+++.+||+.+|++||++.|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            000 00000000000000     122456889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.2e-33  Score=302.32  Aligned_cols=240  Identities=25%  Similarity=0.321  Sum_probs=189.7

Q ss_pred             eeeeccCceEEEEEEecC--------CcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          781 NLIGTGGFGSTYKAELVP--------GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       781 ~~Lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      +.||+|+||.||+|....        ...||+|.+........+.+.+|+.+++.++|||++++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            368999999999996532        234888887655545557788999999999999999999999998999999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc--------EEEeeecccc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELN--------AYLSDFGLAR  924 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~--------~kl~Dfgla~  924 (1052)
                      +++|+|.++++... ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.        ++++|||.+.
T Consensus        81 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          81 VKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             CCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            99999999998654 4689999999999999999999999   9999999999999987765        6999999886


Q ss_pred             cccccCcccccccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCC-CCCCCCcccCCCCccHHHHHHHHHHhCC
Q 001566          925 LLEVSETHATTDVAGTFGYVAPEYATTC-RVSDKADVYSFGVVLLELISGK-RSLDPSFSEYGNGFNIVSWAKLLIKEGR 1002 (1052)
Q Consensus       925 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1052)
                      ....     .....++..|+|||.+.+. .++.++||||||+++|||++|. .|+.....        ..... .... .
T Consensus       157 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~--------~~~~~-~~~~-~  221 (258)
T cd05078         157 TVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS--------QKKLQ-FYED-R  221 (258)
T ss_pred             ccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH--------HHHHH-HHHc-c
Confidence            5432     2224577889999999874 5788999999999999999996 44432111        11111 1111 0


Q ss_pred             ccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 001566         1003 SSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLK 1049 (1052)
Q Consensus      1003 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~ 1049 (1052)
                       .         ..+......+.+++.+||+.||++|||++++++.|+
T Consensus       222 -~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         222 -H---------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             -c---------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence             0         112223356899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.6e-32  Score=303.56  Aligned_cols=252  Identities=23%  Similarity=0.409  Sum_probs=200.2

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccC-ccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIG-RFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      ++|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|++++++++|+|++++++++...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            36889999999999999999765 6899999988654 223356788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcc-CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCc
Q 001566          853 LSGGNLETFIHKKS-GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET  931 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~  931 (1052)
                      +++++|.++++... ...+++..+..++.|+++|+.|||+.+  +|+||||||+||+++.++.++|+|||.+......  
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  156 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--  156 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence            99999999987642 236899999999999999999999743  8999999999999999999999999998755322  


Q ss_pred             ccccccccccccccccccCCCC------CCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccc
Q 001566          932 HATTDVAGTFGYVAPEYATTCR------VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005 (1052)
Q Consensus       932 ~~~~~~~g~~~y~aPE~~~~~~------~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1052)
                       ......+++.|+|||.+.+..      ++.++||||+||++|||++|+.||......     ........ ...+... 
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~~~~-~~~~~~~-  228 (286)
T cd06622         157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA-----NIFAQLSA-IVDGDPP-  228 (286)
T ss_pred             -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-----hHHHHHHH-HhhcCCC-
Confidence             122345778999999986543      478999999999999999999999642111     11111111 1111111 


Q ss_pred             cccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1006 ~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                              ..+......+.+++.+|++.+|++||++.++++
T Consensus       229 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         229 --------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             --------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence                    122334556889999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.3e-32  Score=300.16  Aligned_cols=255  Identities=25%  Similarity=0.401  Sum_probs=199.5

Q ss_pred             CccceeeeccCceEEEEEEec----CCcEEEEEEeccCc--cccHHHHHHHHHHhhccCCCceeeEEEEEecCC------
Q 001566          777 FSIRNLIGTGGFGSTYKAELV----PGYLVAVKKLSIGR--FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEA------  844 (1052)
Q Consensus       777 ~~~~~~Lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  844 (1052)
                      |++.++||+|+||.||+|...    ++..||+|++....  ....+++.+|++++++++|||++++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567889999999999999653    36889999886542  234567889999999999999999999886432      


Q ss_pred             eeEEEEeecCCCCHHHHHhhcc----CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeee
Q 001566          845 EMFLVYNFLSGGNLETFIHKKS----GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDF  920 (1052)
Q Consensus       845 ~~~lv~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Df  920 (1052)
                      ..++++||+++|+|.+++....    ...+++..+.+++.|++.|++|||+.   +|+||||||+||++++++.+|++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence            2478899999999999875432    12578899999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCcc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHHHHHHH
Q 001566          921 GLARLLEVSETH-ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLI  998 (1052)
Q Consensus       921 gla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  998 (1052)
                      |.++........ ......+++.|++||.+....++.++||||||+++|||++ |++||.....        .+......
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--------~~~~~~~~  229 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--------SEIYNYLI  229 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--------HHHHHHHH
Confidence            999866432211 1222345678999999998889999999999999999999 7888763211        12222222


Q ss_pred             HhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccC
Q 001566          999 KEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQLK 1052 (1052)
Q Consensus       999 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~lk 1052 (1052)
                      ......          .+......+.+++.+|++.+|++||++.|+++.|+++.
T Consensus       230 ~~~~~~----------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~~  273 (273)
T cd05074         230 KGNRLK----------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW  273 (273)
T ss_pred             cCCcCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence            111111          11233456999999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=5.2e-33  Score=305.82  Aligned_cols=246  Identities=26%  Similarity=0.403  Sum_probs=200.1

Q ss_pred             CCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCc-cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeec
Q 001566          776 NFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFL  853 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  853 (1052)
                      .|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++..+...++|+||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            467778899999999999965 457899999886443 233567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccc
Q 001566          854 SGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA  933 (1052)
Q Consensus       854 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  933 (1052)
                      ++++|.+++..   ..+++..+..++.|+++|+.|||++   +++|+||+|+||++++++.++++|||++....... ..
T Consensus        85 ~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~  157 (277)
T cd06642          85 GGGSALDLLKP---GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IK  157 (277)
T ss_pred             CCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc-hh
Confidence            99999999864   3588999999999999999999998   99999999999999999999999999997654322 12


Q ss_pred             ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhc
Q 001566          934 TTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWE 1013 (1052)
Q Consensus       934 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1013 (1052)
                      .....++..|+|||.+.+..++.++||||||+++|||++|+.||....+.        .... ....+.     .+    
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--------~~~~-~~~~~~-----~~----  219 (277)
T cd06642         158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM--------RVLF-LIPKNS-----PP----  219 (277)
T ss_pred             hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh--------hHHh-hhhcCC-----CC----
Confidence            22345788999999999988999999999999999999999998633211        1111 111111     11    


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1014 AGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1014 ~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ..+...+..+.+++.+|++.+|++||++.++++
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            112234456899999999999999999999987

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=3e-32  Score=298.09  Aligned_cols=256  Identities=24%  Similarity=0.409  Sum_probs=204.8

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCcc-ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      ++|++.+.||.|+||+||+|... ++..+|+|++..... .....+.+|++.++.++|+|++++++.+..+...++|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            36899999999999999999754 578999999865432 3457789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhccC-CcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCc
Q 001566          853 LSGGNLETFIHKKSG-KKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET  931 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~  931 (1052)
                      +++++|.++++.... ..+++..+..++.|++.|++|||+.   +|+||||+|+||++++++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999987543 5689999999999999999999999   999999999999999999999999999986653322


Q ss_pred             c---cccccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccc
Q 001566          932 H---ATTDVAGTFGYVAPEYATTC-RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELF 1007 (1052)
Q Consensus       932 ~---~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1052)
                      .   ......++..|+|||.+... .++.++|+||||+++|||++|+.||......        ............  .+
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~--~~  227 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--------KVLMLTLQNDPP--SL  227 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--------hhHHHHhcCCCC--Cc
Confidence            2   22334678899999998876 7889999999999999999999999743221        111111111110  00


Q ss_pred             cchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1008 LPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1008 ~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ...   ......+..+.+++.+|++.||++||++.|+++
T Consensus       228 ~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         228 ETG---ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CCc---cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            000   001234456899999999999999999999985

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.5e-32  Score=303.36  Aligned_cols=257  Identities=26%  Similarity=0.405  Sum_probs=205.1

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCcc-ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      ++|++.+.||+|+||+||+|... +++.||+|++..... ....++.+|+++++.++||||+++++++......++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            46888999999999999999654 588999998765432 3356788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      +++++|.+++...  ..+++..+..++.+++.|+.|||+.+  +|+||||+|+||++++++.++|+|||++......   
T Consensus        85 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~---  157 (284)
T cd06620          85 MDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---  157 (284)
T ss_pred             CCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh---
Confidence            9999999998764  46899999999999999999999742  8999999999999999999999999998654321   


Q ss_pred             cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCC---CCccHHHHHHHHHHhCCccccccc
Q 001566          933 ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYG---NGFNIVSWAKLLIKEGRSSELFLP 1009 (1052)
Q Consensus       933 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                      ......++..|+|||++.+..++.++|||||||++||+++|+.||........   ......++.+........      
T Consensus       158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------  231 (284)
T cd06620         158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP------  231 (284)
T ss_pred             ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCC------
Confidence            12234688999999999888899999999999999999999999985433211   111122222222221110      


Q ss_pred             hhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001566         1010 ELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus      1010 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                      .+.   ....+..+.+++.+|++.||++||++.|+++.
T Consensus       232 ~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         232 RLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             CCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            110   11234568999999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.1e-32  Score=297.91  Aligned_cols=238  Identities=25%  Similarity=0.368  Sum_probs=189.4

Q ss_pred             eeeeccCceEEEEEEecCC-----------cEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEE
Q 001566          781 NLIGTGGFGSTYKAELVPG-----------YLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLV  849 (1052)
Q Consensus       781 ~~Lg~G~~g~V~~~~~~~~-----------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  849 (1052)
                      +.||+|+||.||+|.....           ..|++|.+...... ...+.+|+.++++++|||++++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            4689999999999976543           25788877654433 5788999999999999999999999988 778999


Q ss_pred             EeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC-------cEEEeeecc
Q 001566          850 YNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEEL-------NAYLSDFGL  922 (1052)
Q Consensus       850 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~-------~~kl~Dfgl  922 (1052)
                      |||+++|+|.+++.... ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++       .+||+|||+
T Consensus        79 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          79 EEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             EEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            99999999999998754 3688999999999999999999999   999999999999999887       799999999


Q ss_pred             cccccccCcccccccccccccccccccCCC--CCCcchhHHHHHHHHHHHHhC-CCCCCCCcccCCCCccHHHHHHHHHH
Q 001566          923 ARLLEVSETHATTDVAGTFGYVAPEYATTC--RVSDKADVYSFGVVLLELISG-KRSLDPSFSEYGNGFNIVSWAKLLIK  999 (1052)
Q Consensus       923 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~sDvwslG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~  999 (1052)
                      +.....     .....++..|+|||++.+.  .++.++||||||+++|||++| ..||.....        .++.... .
T Consensus       155 a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~--------~~~~~~~-~  220 (259)
T cd05037         155 PITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS--------SEKERFY-Q  220 (259)
T ss_pred             cccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc--------hhHHHHH-h
Confidence            986542     2223466789999999876  788999999999999999994 666653211        1111111 1


Q ss_pred             hCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 001566         1000 EGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLK 1049 (1052)
Q Consensus      1000 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~ 1049 (1052)
                      .....           +......+.+++.+||..+|++||++.|+++.|+
T Consensus       221 ~~~~~-----------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 DQHRL-----------PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             cCCCC-----------CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            11100           1111156889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.3e-32  Score=297.49  Aligned_cols=248  Identities=25%  Similarity=0.382  Sum_probs=195.3

Q ss_pred             CCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCcc-----ccHHHHHHHHHHhhccCCCceeeEEEEEec--CCeeE
Q 001566          776 NFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRF-----QGIQQFDAEIGTLGRIRHKNLVTLIGYYVG--EAEMF  847 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~  847 (1052)
                      +|+..+.||+|+||.||+|.. .++..||+|++.....     +....+.+|++++++++||||+++++++.+  ....+
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            688899999999999999965 4588999998864321     234568889999999999999999999875  35678


Q ss_pred             EEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccccc
Q 001566          848 LVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE  927 (1052)
Q Consensus       848 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~  927 (1052)
                      +++||+++++|.+++...  ..+++.....++.|++.|++|||+.   +|+||||+|+||+++.++.++|+|||++....
T Consensus        83 l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          83 IFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             EEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence            999999999999999765  3588999999999999999999998   99999999999999999999999999987653


Q ss_pred             ccC--cccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccc
Q 001566          928 VSE--THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005 (1052)
Q Consensus       928 ~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1052)
                      ...  ........++..|+|||.+.+..++.++||||+||++|||++|+.||.....        ............   
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~--------~~~~~~~~~~~~---  226 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA--------MAAIFKIATQPT---  226 (266)
T ss_pred             cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch--------HHHHHHHhcCCC---
Confidence            211  1111234578899999999998899999999999999999999999973211        111111111111   


Q ss_pred             cccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1006 ~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                        .+.    .+......+.+++ +||..+|++||+++|+++
T Consensus       227 --~~~----~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         227 --NPQ----LPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             --CCC----CchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence              111    1223344567777 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-32  Score=305.62  Aligned_cols=252  Identities=26%  Similarity=0.381  Sum_probs=203.1

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCccc---cHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQ---GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      ++|++.+.||+|+||.||+|... +++.||+|.+......   ..+.+..|+++++.++|+||+++++++.+....++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888999999999999999665 4899999998765432   3456889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccC
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~  930 (1052)
                      ||+.+++|.+++.......+++..+..++.|+++|++|||+.   +++||||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            999999999999876666799999999999999999999999   99999999999999999999999999987653221


Q ss_pred             cc----------------------------cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcc
Q 001566          931 TH----------------------------ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFS  982 (1052)
Q Consensus       931 ~~----------------------------~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~  982 (1052)
                      ..                            ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence            10                            11123578899999999998899999999999999999999999974321


Q ss_pred             cCCCCccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 001566          983 EYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS----VKQVLI 1046 (1052)
Q Consensus       983 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt----~~eil~ 1046 (1052)
                      .        +...... .....      .  ......+..+.+++.+|++.||++||+    ++|+++
T Consensus       238 ~--------~~~~~~~-~~~~~------~--~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         238 D--------ETFSNIL-KKEVT------F--PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             H--------HHHHHHh-cCCcc------C--CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            1        1111111 11110      0  001114566999999999999999999    666654

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=3.6e-32  Score=297.51  Aligned_cols=251  Identities=20%  Similarity=0.329  Sum_probs=189.4

Q ss_pred             eeeccCceEEEEEEecCC---cEEEEEEeccCc-cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecCCCC
Q 001566          782 LIGTGGFGSTYKAELVPG---YLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGN  857 (1052)
Q Consensus       782 ~Lg~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  857 (1052)
                      .||+|+||+||+|+..++   ..+++|.+.... ....+.+.+|+..++.++||||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            589999999999965433   346677665433 2345678999999999999999999999999999999999999999


Q ss_pred             HHHHHhhcc--CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccC-cccc
Q 001566          858 LETFIHKKS--GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE-THAT  934 (1052)
Q Consensus       858 L~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~-~~~~  934 (1052)
                      |.++++...  ....++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||++....... ....
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            999997643  23466777889999999999999999   99999999999999999999999999986432111 1122


Q ss_pred             cccccccccccccccCC-------CCCCcchhHHHHHHHHHHHHhC-CCCCCCCcccCCCCccHHHHHHHHHHhCCcccc
Q 001566          935 TDVAGTFGYVAPEYATT-------CRVSDKADVYSFGVVLLELISG-KRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSEL 1006 (1052)
Q Consensus       935 ~~~~g~~~y~aPE~~~~-------~~~~~~sDvwslG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      ....++..|+|||++..       ..++.++||||||+++|||+++ ..||....        ..+......... ....
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~--------~~~~~~~~~~~~-~~~~  229 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS--------DREVLNHVIKDQ-QVKL  229 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHhhc-cccc
Confidence            34567889999998753       2456789999999999999975 55664221        122233333222 2222


Q ss_pred             ccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 001566         1007 FLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLK 1049 (1052)
Q Consensus      1007 ~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~ 1049 (1052)
                      .++.+...    ....+.+++..|| .+|++||+++++++.|.
T Consensus       230 ~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         230 FKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            33333222    3345788999999 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.7e-32  Score=299.78  Aligned_cols=253  Identities=26%  Similarity=0.418  Sum_probs=204.8

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCcc-ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      ++|++.+.||+|+||.||+|... +++.||+|++..... ....++.+|++++++++||||+++++++..+...++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            35788899999999999999765 588999998876532 3456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHh-cCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY-SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET  931 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~  931 (1052)
                      +++++|.+++.... ..+++..+..++.|+++|++|||+ .   +++||||+|+||++++++.++|+|||.+........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          81 MDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             cCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence            99999999998764 578899999999999999999999 7   999999999999999999999999999876532221


Q ss_pred             ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchh
Q 001566          932 HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPEL 1011 (1052)
Q Consensus       932 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1011 (1052)
                      .   ...++..|+|||.+.+..++.++||||+|+++|+|++|+.||......   .....+..+..... ...     .+
T Consensus       157 ~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~-~~~-----~~  224 (265)
T cd06605         157 K---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP---PDGIFELLQYIVNE-PPP-----RL  224 (265)
T ss_pred             h---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc---cccHHHHHHHHhcC-CCC-----CC
Confidence            1   156788999999999999999999999999999999999999754321   11222222222221 111     11


Q ss_pred             hcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1012 WEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1012 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ..   ......+.++|.+||..+|++||++.++++
T Consensus       225 ~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         225 PS---GKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             Ch---hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            00   113455899999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-35  Score=338.28  Aligned_cols=466  Identities=26%  Similarity=0.297  Sum_probs=347.8

Q ss_pred             hcCCCCCCeeEecCCCceecCCCCccCCCCccEEEccCccccccCCccccCCCCCCeEecccccccccCCccccCCCCCc
Q 001566          119 IAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELS  198 (1052)
Q Consensus       119 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  198 (1052)
                      +.+--+|+.||+++|++. ..|..+..+.+|+.|+++.|.|. ..|.+.+++.+|++|.|..|.+. ..|.++..+.+|+
T Consensus        41 ~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~  117 (1081)
T KOG0618|consen   41 VEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQ  117 (1081)
T ss_pred             hhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhccc
Confidence            333444888888888887 78888888888888888888888 77888888888888888888887 7888888888888


Q ss_pred             EEEccCCcccCccccCCCcccCCCCEEEccCCcCCCCCCcccCCCCCCCEEEcCCCccccccchhhcCCCCCCEEEccCC
Q 001566          199 VIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRN  278 (1052)
Q Consensus       199 ~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  278 (1052)
                      .|+++.|++.. +| ..+..++.++.+..++|.....    ++... ++.+++..|.+.+.++..+..++.  .|||.+|
T Consensus       118 ~LdlS~N~f~~-~P-l~i~~lt~~~~~~~s~N~~~~~----lg~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N  188 (1081)
T KOG0618|consen  118 YLDLSFNHFGP-IP-LVIEVLTAEEELAASNNEKIQR----LGQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYN  188 (1081)
T ss_pred             ccccchhccCC-Cc-hhHHhhhHHHHHhhhcchhhhh----hcccc-chhhhhhhhhcccchhcchhhhhe--eeecccc
Confidence            88888888864 33 4455677778888888832222    22222 888888888888888888888777  7999999


Q ss_pred             CCCCCCCcccccCCCCCceecccccccccCCCCCCccccccCCCchhhhcccCCcEEecCCCCCCccCCccccCCCCccE
Q 001566          279 SLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKV  358 (1052)
Q Consensus       279 ~l~~~~p~~l~~l~~L~~L~L~~n~~~~~l~~~~~~~~~~~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~  358 (1052)
                      .+.   -..+.++.+|+.|....|.+...-                  ....+|+.|+.+.|.+....+.  .-..+|++
T Consensus       189 ~~~---~~dls~~~~l~~l~c~rn~ls~l~------------------~~g~~l~~L~a~~n~l~~~~~~--p~p~nl~~  245 (1081)
T KOG0618|consen  189 EME---VLDLSNLANLEVLHCERNQLSELE------------------ISGPSLTALYADHNPLTTLDVH--PVPLNLQY  245 (1081)
T ss_pred             hhh---hhhhhhccchhhhhhhhcccceEE------------------ecCcchheeeeccCcceeeccc--ccccccee
Confidence            886   346777888888888776655211                  1235889999999999844432  23357999


Q ss_pred             EeCCCCcccccCCccccccCCCCEEeCCCCcCcCCCCCCCCCCCcceEecccCcccccCCCCCccccCcccCcccccccc
Q 001566          359 LNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYAN  438 (1052)
Q Consensus       359 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~l~~~~  438 (1052)
                      +++++|+++ .+|++++.+.+|+.++..+|+|+..+-..+...+|+.|.+.+|.+.-++|..+..               
T Consensus       246 ~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~~lp~ri~~~~~L~~l~~~~nel~yip~~le~~---------------  309 (1081)
T KOG0618|consen  246 LDISHNNLS-NLPEWIGACANLEALNANHNRLVALPLRISRITSLVSLSAAYNELEYIPPFLEGL---------------  309 (1081)
T ss_pred             eecchhhhh-cchHHHHhcccceEecccchhHHhhHHHHhhhhhHHHHHhhhhhhhhCCCccccc---------------
Confidence            999999999 5779999999999999999999765555667888999999999998877765433               


Q ss_pred             ccccccccccceeEEeeccCCccccccCcccccccccccccchhHHhhccCCcccCCCCCccccccCCCcceEEecCccc
Q 001566          439 VPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANL  518 (1052)
Q Consensus       439 ~~~~~~~~~~~~l~~ldls~n~~~g~~p~~~~~~~~~~~~~~~~~~l~l~~n~~~~~~p~~~~~~~~~l~~~~l~l~~n~  518 (1052)
                                +.++.||+..|++. .+|                               +..+..... .+-.++-+.|.
T Consensus       310 ----------~sL~tLdL~~N~L~-~lp-------------------------------~~~l~v~~~-~l~~ln~s~n~  346 (1081)
T KOG0618|consen  310 ----------KSLRTLDLQSNNLP-SLP-------------------------------DNFLAVLNA-SLNTLNVSSNK  346 (1081)
T ss_pred             ----------ceeeeeeehhcccc-ccc-------------------------------hHHHhhhhH-HHHHHhhhhcc
Confidence                      33556666666653 222                               111111110 00123445555


Q ss_pred             ccCcchHHHHhcCcCccEEEccCcccccccccccCCCCCCCEEEccCCcCCCCCcccccCCccCcEEEcCCCccCCcCch
Q 001566          519 LSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPS  598 (1052)
Q Consensus       519 l~~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  598 (1052)
                      +...+... ......|+.|++.+|.++...-..+.++.+|+.|+|++|+|.......+.++..|++|+||+|+++ .+|.
T Consensus       347 l~~lp~~~-e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~  424 (1081)
T KOG0618|consen  347 LSTLPSYE-ENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPD  424 (1081)
T ss_pred             cccccccc-chhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhH
Confidence            55554211 124567999999999999988889999999999999999999666678889999999999999999 8899


Q ss_pred             hhcCCCCCcEEEcCCCCCCCCCchhhhcccccceeeccCccCCCCCCcccccccccCceeccccccc----CCCCCcccc
Q 001566          599 QFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLS----GHIPHLQHL  674 (1052)
Q Consensus       599 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~----~~~p~~~~l  674 (1052)
                      .+..++.|++|...+|+|. ..| .+..++.|+.+|+|.|+|+-..-..-..-++|++|||+||.-.    ..+|.+.++
T Consensus       425 tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~d~~~l~~l~~l  502 (1081)
T KOG0618|consen  425 TVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLVFDHKTLKVLKSL  502 (1081)
T ss_pred             HHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcccccchhhhHHhhhh
Confidence            9999999999999999998 788 7999999999999999998443222222389999999999842    344444455


Q ss_pred             ccccccCC
Q 001566          675 DCIAFKGN  682 (1052)
Q Consensus       675 ~~~~~~~n  682 (1052)
                      ....+.-|
T Consensus       503 ~~~~i~~~  510 (1081)
T KOG0618|consen  503 SQMDITLN  510 (1081)
T ss_pred             hheecccC
Confidence            44444433

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=4.2e-32  Score=300.98  Aligned_cols=260  Identities=27%  Similarity=0.399  Sum_probs=202.5

Q ss_pred             chhhHHHhhCCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCccccHHHHHHHHHHhhcc-CCCceeeEEEEEecC
Q 001566          766 TYDNVVRATGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGE  843 (1052)
Q Consensus       766 ~~~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  843 (1052)
                      ..+.+..+.++|++.+.||+|+||.||+|.. .+++.+|+|++..... ...++.+|+.+++++ +|||++++++++...
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            3445556778999999999999999999965 4688999998864432 245678899999999 899999999998753


Q ss_pred             -----CeeEEEEeecCCCCHHHHHhhc--cCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEE
Q 001566          844 -----AEMFLVYNFLSGGNLETFIHKK--SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY  916 (1052)
Q Consensus       844 -----~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~k  916 (1052)
                           ...++|+||+++++|.++++..  ....+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+|
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~k  168 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVK  168 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEE
Confidence                 3589999999999999998642  235689999999999999999999999   999999999999999999999


Q ss_pred             EeeecccccccccCcccccccccccccccccccCCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHH
Q 001566          917 LSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC-----RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIV  991 (1052)
Q Consensus       917 l~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~  991 (1052)
                      |+|||.+........ ......++..|+|||.+...     .++.++||||+||++|||++|+.||....+.        
T Consensus       169 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~--------  239 (291)
T cd06639         169 LVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--------  239 (291)
T ss_pred             Eeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--------
Confidence            999999886543221 12234578899999987643     3678999999999999999999998743211        


Q ss_pred             HHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566          992 SWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus       992 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      +..... ........       ..+......+.+++.+||+.+|++||++.|+++
T Consensus       240 ~~~~~~-~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         240 KTLFKI-PRNPPPTL-------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             HHHHHH-hcCCCCCC-------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            111111 11111111       012223446899999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=7e-32  Score=294.84  Aligned_cols=249  Identities=24%  Similarity=0.348  Sum_probs=197.0

Q ss_pred             CCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCc-----cccHHHHHHHHHHhhccCCCceeeEEEEEecC--Cee
Q 001566          775 GNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGR-----FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGE--AEM  846 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  846 (1052)
                      .+|++.+.||+|+||.||+|.. .+++.||+|.+....     ....+.+.+|++++++++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            4688999999999999999965 458999999875432     12245778899999999999999999998764  467


Q ss_pred             EEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccc
Q 001566          847 FLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL  926 (1052)
Q Consensus       847 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~  926 (1052)
                      ++||||+++++|.+++...  ..+++..+.+++.|++.|++|||++   +|+|+||+|+||+++.++.++|+|||++...
T Consensus        82 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~  156 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRL  156 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence            8999999999999999765  3578889999999999999999999   9999999999999999999999999999865


Q ss_pred             cccCc--ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCcc
Q 001566          927 EVSET--HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSS 1004 (1052)
Q Consensus       927 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1052)
                      .....  .......++..|+|||.+.+..++.++||||||+++|||++|+.||.....       ... ........  .
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-------~~~-~~~~~~~~--~  226 (265)
T cd06652         157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA-------MAA-IFKIATQP--T  226 (265)
T ss_pred             ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch-------HHH-HHHHhcCC--C
Confidence            32111  112234578899999999988899999999999999999999999863211       111 11111111  0


Q ss_pred             ccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1005 ELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1005 ~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                         .    ...+......+.+++.+|+. +|++||+++|+++
T Consensus       227 ---~----~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         227 ---N----PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             ---C----CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence               0    11234445568889999985 9999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-32  Score=329.72  Aligned_cols=262  Identities=25%  Similarity=0.384  Sum_probs=212.9

Q ss_pred             hHHHhhCCCccceeeeccCceEEEEEEec--------CCcEEEEEEeccCcc-ccHHHHHHHHHHhhcc-CCCceeeEEE
Q 001566          769 NVVRATGNFSIRNLIGTGGFGSTYKAELV--------PGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRI-RHKNLVTLIG  838 (1052)
Q Consensus       769 ~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~  838 (1052)
                      .++...++.++.+.+|+|+||.||+|...        ....||||..+.... .+.+.+..|+++|+.+ +|+|++.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            34455556677789999999999999533        146799999875433 4567899999999999 5999999999


Q ss_pred             EEecCCeeEEEEeecCCCCHHHHHhhcc------------C--CcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCC
Q 001566          839 YYVGEAEMFLVYNFLSGGNLETFIHKKS------------G--KKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKP  904 (1052)
Q Consensus       839 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~  904 (1052)
                      +|...+..++|.||+..|+|.+|++..+            .  ..++..+...++.|||.|++||+++   +++|||+.+
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence            9999999999999999999999998765            1  2388999999999999999999999   999999999


Q ss_pred             CCEEECCCCcEEEeeecccccccccCcccccccc--cccccccccccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCc
Q 001566          905 SNILLDEELNAYLSDFGLARLLEVSETHATTDVA--GTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSF  981 (1052)
Q Consensus       905 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~--g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt-g~~p~~~~~  981 (1052)
                      +||+++++..+||+|||+|+.....+.+....-.  -+.+|||||.+....|+.++||||||+++||++| |..||.. .
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~-~  525 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG-I  525 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC-C
Confidence            9999999999999999999976655544422222  4568999999999999999999999999999999 5566542 1


Q ss_pred             ccCCCCccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 001566          982 SEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQ 1050 (1052)
Q Consensus       982 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~ 1050 (1052)
                      .      ...+..+ ..+.|...+         .|..+..++.++|+.||+.+|++||++.|+++.++.
T Consensus       526 ~------~~~~l~~-~l~~G~r~~---------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~  578 (609)
T KOG0200|consen  526 P------PTEELLE-FLKEGNRME---------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK  578 (609)
T ss_pred             C------cHHHHHH-HHhcCCCCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence            1      0122222 444544432         355566779999999999999999999999999875

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.1e-32  Score=298.89  Aligned_cols=259  Identities=25%  Similarity=0.340  Sum_probs=202.0

Q ss_pred             CCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCcc-ccHHHHHHHHHHhhccCCCceeeEEEEEecC--CeeEEEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGE--AEMFLVY  850 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  850 (1052)
                      ++|+..+.||.|++|.||+|.. .+++.+|+|.+..... ....++.+|++++++++||||+++++++.+.  ...++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            3688889999999999999976 4588999998875433 3456789999999999999999999998653  4689999


Q ss_pred             eecCCCCHHHHHhhc--cCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccc
Q 001566          851 NFLSGGNLETFIHKK--SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV  928 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~  928 (1052)
                      ||+++++|.+++...  ....+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            999999999987642  235688999999999999999999999   999999999999999999999999999875432


Q ss_pred             cCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCcccccc
Q 001566          929 SETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFL 1008 (1052)
Q Consensus       929 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                      ..   .....++..|+|||.+.+..++.++||||+|+++|||++|+.||.....+....   .+........ ... .+.
T Consensus       158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~-~~~-~~~  229 (287)
T cd06621         158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGP---IELLSYIVNM-PNP-ELK  229 (287)
T ss_pred             cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCCh---HHHHHHHhcC-Cch-hhc
Confidence            21   123356788999999999899999999999999999999999998553321122   2222222111 111 111


Q ss_pred             chhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1009 PELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1009 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ...  ......+..+.+++.+||+.+|++|||+.|+++
T Consensus       230 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         230 DEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             cCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            010  001123456899999999999999999999986

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=6.5e-32  Score=294.91  Aligned_cols=251  Identities=31%  Similarity=0.477  Sum_probs=202.3

Q ss_pred             CCccceeeeccCceEEEEEEec-CCcEEEEEEeccCccc--cHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQ--GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      +|++.+.||+|+||.||+|... +++.||+|.+......  ..+.+..|++++++++|+||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            5888999999999999999654 6889999998766543  567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      +++++|.+++...  ..+++..+..++.|+++|++|||+.   +|+|+||+|+||++++++.+||+|||.+.........
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          81 CSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             CCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence            9999999999764  3578999999999999999999999   9999999999999999999999999999876533222


Q ss_pred             cc---cccccccccccccccCCCC---CCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCcccc
Q 001566          933 AT---TDVAGTFGYVAPEYATTCR---VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSEL 1006 (1052)
Q Consensus       933 ~~---~~~~g~~~y~aPE~~~~~~---~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      ..   ....++..|+|||++.+..   ++.++||||||+++||+++|+.||......       ...... ...+ ..  
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-------~~~~~~-~~~~-~~--  224 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-------FQIMFH-VGAG-HK--  224 (264)
T ss_pred             ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-------HHHHHH-HhcC-CC--
Confidence            21   1345788999999998766   788999999999999999999999743211       111111 1111 11  


Q ss_pred             ccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1007 FLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1007 ~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                        +.+..  .......+.+++.+|++.+|++||++.|++.
T Consensus       225 --~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         225 --PPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             --CCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence              11110  1122455789999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.4e-32  Score=296.97  Aligned_cols=253  Identities=24%  Similarity=0.426  Sum_probs=198.7

Q ss_pred             CCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCccc----------cHHHHHHHHHHhhccCCCceeeEEEEEecCC
Q 001566          776 NFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQ----------GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEA  844 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~----------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  844 (1052)
                      +|.+.+.||+|+||.||+|.. .+++.||+|.+......          ..+.+..|+.++++++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            477889999999999999954 46889999988542111          1245788999999999999999999999999


Q ss_pred             eeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccc
Q 001566          845 EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR  924 (1052)
Q Consensus       845 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~  924 (1052)
                      ..++|+||+++++|.++++..  ..+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++++|||++.
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~  156 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISK  156 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccc
Confidence            999999999999999999775  4689999999999999999999999   99999999999999999999999999997


Q ss_pred             cccccCc-ccccccccccccccccccCCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhC
Q 001566          925 LLEVSET-HATTDVAGTFGYVAPEYATTCR--VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEG 1001 (1052)
Q Consensus       925 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~--~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1052)
                      ....... .......++..|+|||.+....  ++.++||||+|+++||+++|..||.....        .+....... .
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~-~  227 (272)
T cd06629         157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA--------IAAMFKLGN-K  227 (272)
T ss_pred             cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch--------HHHHHHhhc-c
Confidence            5532211 1122345788999999987654  78899999999999999999999863211        111111111 1


Q ss_pred             CccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1002 RSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1002 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      .....+.+..    ....+..+.+++.+|++.+|++||+++++++
T Consensus       228 ~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         228 RSAPPIPPDV----SMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             ccCCcCCccc----cccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            1111111111    1233456899999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2e-32  Score=302.86  Aligned_cols=259  Identities=27%  Similarity=0.389  Sum_probs=199.3

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCccc--cHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEe
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQ--GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYN  851 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  851 (1052)
                      ++|++.+.||+|+||.||+|... +++.||+|++......  ..+.+.+|+++++.++||||+++++++.++...++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            36889999999999999999775 5899999987643322  24568889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCc
Q 001566          852 FLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET  931 (1052)
Q Consensus       852 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~  931 (1052)
                      |++++++.++....  ..+++.++..++.|+++|++|||+.   +|+||||+|+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-  154 (286)
T cd07846          81 FVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-  154 (286)
T ss_pred             cCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence            99999998876543  3589999999999999999999999   99999999999999999999999999988654332 


Q ss_pred             ccccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccc-----
Q 001566          932 HATTDVAGTFGYVAPEYATT-CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE----- 1005 (1052)
Q Consensus       932 ~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 1005 (1052)
                      .......++..|+|||++.+ ..++.++||||||+++|||++|++||.....       ...+.+.....+....     
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~  227 (286)
T cd07846         155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD-------IDQLYHIIKCLGNLIPRHQEI  227 (286)
T ss_pred             cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch-------HHHHHHHHHHhCCCchhhHHH
Confidence            22233457889999999875 4467899999999999999999988863321       1111111100000000     


Q ss_pred             ---------cccchhh-----cCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1006 ---------LFLPELW-----EAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1006 ---------~~~~~l~-----~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                               ...+...     ....+..+..+.+++.+||+.+|++||++.++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         228 FQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence                     0000000     0011233566999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.9e-32  Score=302.12  Aligned_cols=250  Identities=24%  Similarity=0.394  Sum_probs=203.9

Q ss_pred             CCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeec
Q 001566          775 GNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFL  853 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  853 (1052)
                      ++|++.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.++++++|||++++++++......++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            5789999999999999999954 467899999987655555677899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccc
Q 001566          854 SGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA  933 (1052)
Q Consensus       854 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  933 (1052)
                      ++++|.+++...   .+++.++..++.|++.|++|||++   +++||||+|+||+++.++.++|+|||++........ .
T Consensus        99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~  171 (293)
T cd06647          99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K  171 (293)
T ss_pred             CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-c
Confidence            999999999764   478999999999999999999999   999999999999999999999999999876543322 2


Q ss_pred             ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhc
Q 001566          934 TTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWE 1013 (1052)
Q Consensus       934 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1013 (1052)
                      .....+++.|+|||.+.+..++.++||||||+++||+++|+.||.......        ........+...        .
T Consensus       172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~--------~~~~~~~~~~~~--------~  235 (293)
T cd06647         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--------ALYLIATNGTPE--------L  235 (293)
T ss_pred             cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh--------heeehhcCCCCC--------C
Confidence            233467889999999988889999999999999999999999997432210        000011111100        0


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001566         1014 AGPQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus      1014 ~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                      ..+......+.+++.+||..+|++||++.++++.
T Consensus       236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1122334568899999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-33  Score=312.77  Aligned_cols=240  Identities=24%  Similarity=0.300  Sum_probs=186.3

Q ss_pred             eeccCceEEEEEEec-CCcEEEEEEeccCcc---ccHHHHHHHHHHhhcc---CCCceeeEEEEEecCCeeEEEEeecCC
Q 001566          783 IGTGGFGSTYKAELV-PGYLVAVKKLSIGRF---QGIQQFDAEIGTLGRI---RHKNLVTLIGYYVGEAEMFLVYNFLSG  855 (1052)
Q Consensus       783 Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  855 (1052)
                      ||+|+||+||+|+.. +++.||+|++.....   .....+..|..++.+.   +||+|+++++++.+....|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999654 589999999864322   2233445566666655   699999999999999999999999999


Q ss_pred             CCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccccc
Q 001566          856 GNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT  935 (1052)
Q Consensus       856 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  935 (1052)
                      |+|.+++...  ..+++..+..++.||++|++|||++   +|+||||||+||+++.++.++|+|||++....... ....
T Consensus        81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~  154 (330)
T cd05586          81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTN  154 (330)
T ss_pred             ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCcc
Confidence            9999998764  4689999999999999999999999   99999999999999999999999999987543221 2233


Q ss_pred             ccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcC
Q 001566          936 DVAGTFGYVAPEYATTC-RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEA 1014 (1052)
Q Consensus       936 ~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 1014 (1052)
                      ...|++.|+|||++.+. .++.++||||+||++|||++|+.||....        ..+..+... .+...  +    .  
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~--------~~~~~~~i~-~~~~~--~----~--  217 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED--------TQQMYRNIA-FGKVR--F----P--  217 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC--------HHHHHHHHH-cCCCC--C----C--
Confidence            45689999999998764 47899999999999999999999997422        122222221 11111  0    0  


Q ss_pred             CChHHHHHHHHHHHHccccCCCCCC----CHHHHHH
Q 001566         1015 GPQENLLGMMRLASTCTVETLSTRP----SVKQVLI 1046 (1052)
Q Consensus      1015 ~~~~~~~~l~~Li~~cl~~dP~~RP----t~~eil~ 1046 (1052)
                       .......+.+++.+|++.||++||    ++.++++
T Consensus       218 -~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         218 -KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             -CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence             011234578999999999999999    4555544

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.8e-32  Score=303.58  Aligned_cols=248  Identities=24%  Similarity=0.377  Sum_probs=199.3

Q ss_pred             CccceeeeccCceEEEEEEe-cCCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecCC
Q 001566          777 FSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSG  855 (1052)
Q Consensus       777 ~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  855 (1052)
                      |.....||+|+||.||+|.. .++..||||++........+.+.+|+.+++.++|+|++++++.+...+..++||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            44446799999999999965 45889999998766555567788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccccc
Q 001566          856 GNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT  935 (1052)
Q Consensus       856 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  935 (1052)
                      ++|.+++...   .++++++..++.|++.|++|||++   +|+||||||+||++++++.++|+|||++....... ....
T Consensus       104 ~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~  176 (292)
T cd06658         104 GALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKRK  176 (292)
T ss_pred             CcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-ccCc
Confidence            9999988543   588999999999999999999999   99999999999999999999999999987553221 2223


Q ss_pred             ccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCC
Q 001566          936 DVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAG 1015 (1052)
Q Consensus       936 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 1015 (1052)
                      ...++..|+|||.+.+..++.++||||+|+++|||++|+.||.....        .+..... ....     .+.+.  .
T Consensus       177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--------~~~~~~~-~~~~-----~~~~~--~  240 (292)
T cd06658         177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP--------LQAMRRI-RDNL-----PPRVK--D  240 (292)
T ss_pred             eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHH-HhcC-----CCccc--c
Confidence            34678899999999988899999999999999999999999874221        1111111 1110     11111  1


Q ss_pred             ChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001566         1016 PQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus      1016 ~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                      .......+.+++.+|+..||++|||++|+++.
T Consensus       241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            11233458899999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-32  Score=298.44  Aligned_cols=254  Identities=28%  Similarity=0.461  Sum_probs=201.7

Q ss_pred             HhhCCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCccccHHHHHHHHHHhhcc-CCCceeeEEEEEecCC-----
Q 001566          772 RATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEA-----  844 (1052)
Q Consensus       772 ~~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-----  844 (1052)
                      .+.++|++.+.||+|++|.||+|... +++.+++|++..... ..+++.+|+++++++ .|+|++++++++.+..     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            35678999999999999999999764 578999998875543 346789999999999 6999999999997644     


Q ss_pred             -eeEEEEeecCCCCHHHHHhhcc--CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeec
Q 001566          845 -EMFLVYNFLSGGNLETFIHKKS--GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFG  921 (1052)
Q Consensus       845 -~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfg  921 (1052)
                       ..++||||+++++|.+++....  ...+++..+..++.|+++|++|||+.   +++||||+|+||++++++.++|+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence             4899999999999999987643  46789999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCcccccccccccccccccccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHH
Q 001566          922 LARLLEVSETHATTDVAGTFGYVAPEYATT-----CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKL  996 (1052)
Q Consensus       922 la~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  996 (1052)
                      .+....... .......++..|+|||.+..     ..++.++||||+|+++|||++|+.||......       .. ...
T Consensus       159 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~-~~~  229 (275)
T cd06608         159 VSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-------RA-LFK  229 (275)
T ss_pred             cceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-------HH-HHH
Confidence            987654222 22234568889999998754     34677899999999999999999999632111       11 111


Q ss_pred             HHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566          997 LIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus       997 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      . ..+....     +  ..+......+.+++.+|+..||++|||+.|+++
T Consensus       230 ~-~~~~~~~-----~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         230 I-PRNPPPT-----L--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             h-hccCCCC-----C--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            1 1111111     1  112234556899999999999999999999976

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-33  Score=307.07  Aligned_cols=251  Identities=25%  Similarity=0.406  Sum_probs=207.5

Q ss_pred             CCCccceeeeccCceEEEEEEecC-CcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeec
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFL  853 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  853 (1052)
                      +.|+|..-||.|+||.||+|..++ +-..|.|++........++|.-|++++....||+||++++.|+.++.+++..|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            457788889999999999996553 4556778888777788899999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccc
Q 001566          854 SGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA  933 (1052)
Q Consensus       854 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  933 (1052)
                      .||-.+..+-.- +..+++.++..+++|++.||.|||++   .|||||+|+.|||++-+|.++++|||.+.... .....
T Consensus       112 ~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~-~t~qk  186 (1187)
T KOG0579|consen  112 GGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNK-STRQK  186 (1187)
T ss_pred             CCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccch-hHHhh
Confidence            999998877654 37899999999999999999999999   99999999999999999999999999886432 23344


Q ss_pred             ccccccccccccccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCcccccc
Q 001566          934 TTDVAGTFGYVAPEYAT-----TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFL 1008 (1052)
Q Consensus       934 ~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                      ...+.|||.|||||+..     ..+|..++||||||+.+.||..+.+|.+.-.        ... +-..+........+-
T Consensus       187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln--------pMR-VllKiaKSePPTLlq  257 (1187)
T KOG0579|consen  187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN--------PMR-VLLKIAKSEPPTLLQ  257 (1187)
T ss_pred             hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc--------hHH-HHHHHhhcCCCcccC
Confidence            56688999999999864     5778999999999999999999998876321        111 122223333333433


Q ss_pred             chhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1009 PELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1009 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      |.       .....+.+++++|+..+|..||+++++++
T Consensus       258 PS-------~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  258 PS-------HWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             cc-------hhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            33       34556999999999999999999999876

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=3.7e-32  Score=295.51  Aligned_cols=249  Identities=26%  Similarity=0.392  Sum_probs=203.1

Q ss_pred             CCccceeeeccCceEEEEEEec-CCcEEEEEEeccCc--cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR--FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      +|++.+.||+|+||.||+|... +|..||+|.+....  ....+.+.+|++++++++|+|++++++.+.+....++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4788999999999999999664 57889999986542  23346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc-EEEeeecccccccccCc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELN-AYLSDFGLARLLEVSET  931 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~-~kl~Dfgla~~~~~~~~  931 (1052)
                      +++++|.+++.......+++..+..++.|+++|++|||+.   +++|+||+|+||++++++. ++++|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            9999999999876555689999999999999999999999   9999999999999998854 69999999986643221


Q ss_pred             ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchh
Q 001566          932 HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPEL 1011 (1052)
Q Consensus       932 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1011 (1052)
                       ......|++.|+|||...+..++.++||||||+++|||++|+.||...        ...++........ ..       
T Consensus       158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~--------~~~~~~~~~~~~~-~~-------  220 (257)
T cd08225         158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN--------NLHQLVLKICQGY-FA-------  220 (257)
T ss_pred             -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc--------cHHHHHHHHhccc-CC-------
Confidence             222345788999999999888999999999999999999999998632        1222333222211 11       


Q ss_pred             hcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1012 WEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1012 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                        ..+...+..+.+++.+|+..+|++||++.|+++
T Consensus       221 --~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         221 --PISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             --CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence              112233456899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=3.2e-32  Score=302.37  Aligned_cols=247  Identities=23%  Similarity=0.368  Sum_probs=199.3

Q ss_pred             CccceeeeccCceEEEEEEec-CCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecCC
Q 001566          777 FSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSG  855 (1052)
Q Consensus       777 ~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  855 (1052)
                      |+....||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|||++++++++..++..++|+||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            334457999999999999654 6899999998765555567788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccccc
Q 001566          856 GNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT  935 (1052)
Q Consensus       856 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  935 (1052)
                      ++|.+++...   .+++..+..++.|++.|++|||+.   +|+||||+|+||+++.++.++|+|||++....... ....
T Consensus       103 ~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~  175 (297)
T cd06659         103 GALTDIVSQT---RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRK  175 (297)
T ss_pred             CCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc-cccc
Confidence            9999988653   589999999999999999999999   99999999999999999999999999987554322 2223


Q ss_pred             ccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCC
Q 001566          936 DVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAG 1015 (1052)
Q Consensus       936 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 1015 (1052)
                      ...++..|+|||.+.+..++.++||||+|+++|||++|+.||.....        .+..+.. .......  .     ..
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--------~~~~~~~-~~~~~~~--~-----~~  239 (297)
T cd06659         176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP--------VQAMKRL-RDSPPPK--L-----KN  239 (297)
T ss_pred             ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHH-hccCCCC--c-----cc
Confidence            35688999999999988899999999999999999999999873211        1111111 1111000  0     01


Q ss_pred             ChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1016 PQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1016 ~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      .......+.+++.+|++.+|++||++.++++
T Consensus       240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         240 AHKISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             cCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            1223345889999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-32  Score=299.83  Aligned_cols=262  Identities=25%  Similarity=0.360  Sum_probs=201.9

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCc--cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEe
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR--FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYN  851 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  851 (1052)
                      ++|++.+.||+|+||.||+|... +++.||+|+++...  ....+.+.+|++++++++|+||+++++++.+++..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36899999999999999999765 57899999886532  2334678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCc
Q 001566          852 FLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET  931 (1052)
Q Consensus       852 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~  931 (1052)
                      |++++.+..+....  ..+++.++..++.|++.|++|||+.   +++|||++|+||++++++.+||+|||++........
T Consensus        81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~  155 (288)
T cd07833          81 YVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA  155 (288)
T ss_pred             cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence            99887776655443  4589999999999999999999999   999999999999999999999999999987654433


Q ss_pred             ccccccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHH-----------
Q 001566          932 HATTDVAGTFGYVAPEYATTC-RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIK-----------  999 (1052)
Q Consensus       932 ~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----------  999 (1052)
                      .......++..|+|||++.+. .++.++||||+|+++|||++|+.||......     +..........           
T Consensus       156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T cd07833         156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI-----DQLYLIQKCLGPLPPSHQELFS  230 (288)
T ss_pred             ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhCCCCHHHhhhcc
Confidence            233445678899999999888 7889999999999999999999998643211     00000000000           


Q ss_pred             -hCCc-----cccccch-hhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1000 -EGRS-----SELFLPE-LWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1000 -~~~~-----~~~~~~~-l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                       ....     ....++. .....+...+..+.+++.+||..+|++||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence             0000     0000000 001122233567999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=6.4e-32  Score=299.22  Aligned_cols=243  Identities=27%  Similarity=0.417  Sum_probs=200.3

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCc---cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      ++|++.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|++++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            36889999999999999999664 58999999986432   223466888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccC
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~  930 (1052)
                      ||+++++|.+++...  ..+++..+..++.|+++|++|||+.   +|+||||+|+||++++++.+||+|||++...... 
T Consensus        81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-  154 (290)
T cd05580          81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-  154 (290)
T ss_pred             ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence            999999999999775  4689999999999999999999998   9999999999999999999999999999866433 


Q ss_pred             cccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccch
Q 001566          931 THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010 (1052)
Q Consensus       931 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1052)
                         .....+++.|+|||.+.+...+.++||||+|+++|+|++|+.||.....        .+..+... .+..       
T Consensus       155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~-~~~~-------  215 (290)
T cd05580         155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--------IQIYEKIL-EGKV-------  215 (290)
T ss_pred             ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHh-cCCc-------
Confidence               2334678899999999888889999999999999999999999874321        11111111 1111       


Q ss_pred             hhcCCChHHHHHHHHHHHHccccCCCCCC-----CHHHHH
Q 001566         1011 LWEAGPQENLLGMMRLASTCTVETLSTRP-----SVKQVL 1045 (1052)
Q Consensus      1011 l~~~~~~~~~~~l~~Li~~cl~~dP~~RP-----t~~eil 1045 (1052)
                         ..+......+.+++.+||..+|++||     +++|++
T Consensus       216 ---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         216 ---RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             ---cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence               11222345688999999999999999     677765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=6.8e-32  Score=295.49  Aligned_cols=252  Identities=24%  Similarity=0.423  Sum_probs=201.4

Q ss_pred             CCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCcc------ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEE
Q 001566          776 NFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRF------QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFL  848 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  848 (1052)
                      +|+..+.||+|+||.||+|.. .+++.||+|++.....      ...+.+..|++++++++|+|++++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            478889999999999999964 5689999999864331      124678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC-cEEEeeeccccccc
Q 001566          849 VYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEEL-NAYLSDFGLARLLE  927 (1052)
Q Consensus       849 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~-~~kl~Dfgla~~~~  927 (1052)
                      |+||+++++|.+++...  ..+++..+..++.|++.|++|||++   +++||||+|+||+++.++ .++|+|||.+....
T Consensus        81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          81 FVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             EEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            99999999999999765  4688999999999999999999999   999999999999998775 59999999998665


Q ss_pred             ccCc---ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCcc
Q 001566          928 VSET---HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSS 1004 (1052)
Q Consensus       928 ~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1052)
                      ....   .......++..|+|||.+.+..++.++||||+|+++|+|++|..||......     ............ ...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~-~~~  229 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS-----NHLALIFKIASA-TTA  229 (268)
T ss_pred             cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc-----chHHHHHHHhcc-CCC
Confidence            3321   1122346788999999998888999999999999999999999998632211     111111111111 111


Q ss_pred             ccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1005 ELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1005 ~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                              ...+......+.+++.+|+..+|++||++.|+++
T Consensus       230 --------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         230 --------PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             --------CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                    1223344566899999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.7e-32  Score=299.46  Aligned_cols=259  Identities=28%  Similarity=0.391  Sum_probs=198.8

Q ss_pred             CCccceeeeccCceEEEEEEec-CCcEEEEEEeccCcc--ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      +|++.+.||+|++|.||+|... +++.||||++.....  .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788999999999999999654 688999998865432  2235788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      +. ++|.+++.......+++..+..++.|+++|++|||+.   +++||||+|+||++++++.+||+|||++........ 
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-  155 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-  155 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence            95 6899999876666789999999999999999999999   999999999999999999999999999876543221 


Q ss_pred             cccccccccccccccccCCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccch-
Q 001566          933 ATTDVAGTFGYVAPEYATTCR-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE- 1010 (1052)
Q Consensus       933 ~~~~~~g~~~y~aPE~~~~~~-~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 1010 (1052)
                      ......+++.|+|||.+.+.. ++.++||||||+++|||+||+.||......       ....+.....+.......+. 
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~  228 (284)
T cd07860         156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-------DQLFRIFRTLGTPDEVVWPGV  228 (284)
T ss_pred             ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHHHhCCCChhhhhhh
Confidence            122234678899999887644 578899999999999999999999643211       11111111111111000000 


Q ss_pred             ----------------hhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1011 ----------------LWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1011 ----------------l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                                      ......+.....+.+++.+|++.||++||+++|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         229 TSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             hHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                            000001122345789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-33  Score=296.58  Aligned_cols=248  Identities=26%  Similarity=0.347  Sum_probs=203.0

Q ss_pred             hhCCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCcc---ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEE
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF---QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFL  848 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  848 (1052)
                      ..+.|+.-++||+|+||+||-++.+ +|+.+|.|++.+.+.   +...-...|-+++.+++.++||.+--+|+..+.+|+
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl  262 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL  262 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence            3456888899999999999999654 699999998854432   233456789999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccc
Q 001566          849 VYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV  928 (1052)
Q Consensus       849 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~  928 (1052)
                      |+..|.||+|.-++.......++++.+.-+|.+|+.||++||..   +||.||+||+|||+|+.|+++|+|.|+|..+..
T Consensus       263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            99999999999999888778899999999999999999999999   999999999999999999999999999998764


Q ss_pred             cCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCcccccc
Q 001566          929 SETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFL 1008 (1052)
Q Consensus       929 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                      ...  ....+||.+|||||++.+..|+...|.||+||++|||+.|+.||....+.    ....+ +......       +
T Consensus       340 g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK----vk~eE-vdrr~~~-------~  405 (591)
T KOG0986|consen  340 GKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK----VKREE-VDRRTLE-------D  405 (591)
T ss_pred             CCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh----hhHHH-HHHHHhc-------c
Confidence            433  34458999999999999999999999999999999999999999732211    00101 1111111       1


Q ss_pred             chhhcCCChHHHHHHHHHHHHccccCCCCCCC
Q 001566         1009 PELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040 (1052)
Q Consensus      1009 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt 1040 (1052)
                      +   ..++....++..++.+..++.||++|.-
T Consensus       406 ~---~ey~~kFS~eakslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  406 P---EEYSDKFSEEAKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             h---hhcccccCHHHHHHHHHHHccCHHHhcc
Confidence            1   1233444556788888999999999973

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.1e-31  Score=293.03  Aligned_cols=251  Identities=29%  Similarity=0.437  Sum_probs=206.8

Q ss_pred             CCccceeeeccCceEEEEEEec-CCcEEEEEEeccCcc-ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeec
Q 001566          776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFL  853 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  853 (1052)
                      +|++.+.||+|++|.||+|... +++.||+|++..... ....++.+|++.+.+++|+|++++++++......++|+||+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM   81 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence            6888999999999999999765 489999999876544 34578899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHh-cCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc
Q 001566          854 SGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY-SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       854 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      ++++|.+++...  ..+++..+..++.|+++|++|||+ .   +++||||+|+||+++.++.++|+|||.+.........
T Consensus        82 ~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~  156 (264)
T cd06623          82 DGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ  156 (264)
T ss_pred             CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence            999999999865  468999999999999999999999 8   9999999999999999999999999999866432222


Q ss_pred             cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhh
Q 001566          933 ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012 (1052)
Q Consensus       933 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1012 (1052)
                       .....++..|+|||.+.+..++.++|+||||+++|||++|+.||.....     ....+..+.......      +   
T Consensus       157 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-----~~~~~~~~~~~~~~~------~---  221 (264)
T cd06623         157 -CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-----PSFFELMQAICDGPP------P---  221 (264)
T ss_pred             -ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-----cCHHHHHHHHhcCCC------C---
Confidence             2234578899999999998899999999999999999999999975432     111222222221111      0   


Q ss_pred             cCCChH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001566         1013 EAGPQE-NLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus      1013 ~~~~~~-~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                       ..+.. .+..+.+++.+|++.+|++||++.|+++.
T Consensus       222 -~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         222 -SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             -CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence             11122 44569999999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=8.5e-32  Score=300.47  Aligned_cols=253  Identities=23%  Similarity=0.316  Sum_probs=199.4

Q ss_pred             CCccceeeeccCceEEEEEEec-CCcEEEEEEeccCcc---ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEe
Q 001566          776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF---QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYN  851 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  851 (1052)
                      +|++.+.||+|+||.||+|... +++.||+|.+.....   .....+.+|+++++.++||||+++++.+..++..++|||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME   81 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence            6888999999999999999665 478999998865432   234567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccC-
Q 001566          852 FLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE-  930 (1052)
Q Consensus       852 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~-  930 (1052)
                      |+++++|.+++...  ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++++|||+++...... 
T Consensus        82 ~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          82 YVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence            99999999999765  4689999999999999999999999   99999999999999999999999999986421110 


Q ss_pred             -------------cccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHH
Q 001566          931 -------------THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLL  997 (1052)
Q Consensus       931 -------------~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  997 (1052)
                                   ........++..|+|||.+.+..++.++|+||||+++|||++|+.||....        ..++....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~--------~~~~~~~~  228 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT--------PEELFGQV  228 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHH
Confidence                         001112356788999999998889999999999999999999999986321        11222222


Q ss_pred             HHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 001566          998 IKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLK 1049 (1052)
Q Consensus       998 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~ 1049 (1052)
                      ..... .   .+.    .+...+..+.+++.+||+.+|++||++.++.+.++
T Consensus       229 ~~~~~-~---~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         229 ISDDI-E---WPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             Hhccc-C---CCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence            22111 1   000    11123445899999999999999999655555443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=4.3e-32  Score=300.86  Aligned_cols=261  Identities=21%  Similarity=0.327  Sum_probs=197.2

Q ss_pred             hhCCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCcccc-HHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEE
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQG-IQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      +.++|++.+.||+|+||.||+|.. .+++.||+|++....... ...+.+|+++++.++|+||+++++++.++...++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            356899999999999999999965 468899999986543322 346788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccC
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~  930 (1052)
                      ||+. +++.+++.... ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||+++......
T Consensus        83 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  157 (291)
T cd07870          83 EYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPS  157 (291)
T ss_pred             eccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence            9995 78888776543 4578888999999999999999999   99999999999999999999999999987543221


Q ss_pred             cccccccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHH-hCCcc----
Q 001566          931 THATTDVAGTFGYVAPEYATTC-RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIK-EGRSS---- 1004 (1052)
Q Consensus       931 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~---- 1004 (1052)
                       .......+++.|+|||.+.+. .++.++||||+|+++|||++|+.||+.....       .+.....+. .+...    
T Consensus       158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~-------~~~~~~~~~~~~~~~~~~~  229 (291)
T cd07870         158 -QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV-------FEQLEKIWTVLGVPTEDTW  229 (291)
T ss_pred             -CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH-------HHHHHHHHHHcCCCChhhh
Confidence             112334568899999998764 4788999999999999999999999743221       111111100 00000    


Q ss_pred             ------ccccchhhcCC----------ChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1005 ------ELFLPELWEAG----------PQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1005 ------~~~~~~l~~~~----------~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                            ....+......          .......+.+++.+|+..||++|||+.|++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         230 PGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence                  00000000000          0112456889999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1e-31  Score=296.60  Aligned_cols=247  Identities=23%  Similarity=0.358  Sum_probs=201.1

Q ss_pred             CccceeeeccCceEEEEEEe-cCCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecCC
Q 001566          777 FSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSG  855 (1052)
Q Consensus       777 ~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  855 (1052)
                      |...+.||+|++|.||+|.. .+++.+++|++........+.+.+|+.+++.++|||++++++++...+..++|+||+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~  100 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG  100 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence            45557999999999999965 46889999998765555556788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccccc
Q 001566          856 GNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT  935 (1052)
Q Consensus       856 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  935 (1052)
                      ++|.+++..   ..++++.+..++.|++.|++|||+.   +|+||||+|+||+++.++.++|+|||.+....... ....
T Consensus       101 ~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-~~~~  173 (285)
T cd06648         101 GALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-PRRK  173 (285)
T ss_pred             CCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC-cccc
Confidence            999999876   3589999999999999999999999   99999999999999999999999999887553221 2223


Q ss_pred             ccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCC
Q 001566          936 DVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAG 1015 (1052)
Q Consensus       936 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 1015 (1052)
                      ...|++.|+|||.+.+..++.++||||+|+++|||++|+.||....        ..+..+..... ....     .  ..
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~--------~~~~~~~~~~~-~~~~-----~--~~  237 (285)
T cd06648         174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP--------PLQAMKRIRDN-LPPK-----L--KN  237 (285)
T ss_pred             cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC--------HHHHHHHHHhc-CCCC-----C--cc
Confidence            3468889999999998889999999999999999999999986422        12222222211 1110     0  01


Q ss_pred             ChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1016 PQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1016 ~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      +...+..+.+++.+||+.+|++||++.++++
T Consensus       238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            1123456999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4.2e-32  Score=296.44  Aligned_cols=249  Identities=27%  Similarity=0.431  Sum_probs=201.5

Q ss_pred             CCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCc--cccHHHHHHHHHHhhccCCCceeeEEEEEec--CCeeEEEE
Q 001566          776 NFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGR--FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG--EAEMFLVY  850 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~  850 (1052)
                      +|++.+.||.|+||.||+|.. .+++.||+|.+....  ....+++..|++++++++|||++++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            478889999999999999954 467899999886433  2334678889999999999999999998764  45679999


Q ss_pred             eecCCCCHHHHHhhcc--CCcccHHHHHHHHHHHHHHHHHHH-----hcCCCCeeeCCCCCCCEEECCCCcEEEeeeccc
Q 001566          851 NFLSGGNLETFIHKKS--GKKIQWSVIHKIAIDIAQALAYLH-----YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLA  923 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH-----~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla  923 (1052)
                      ||+++++|.+++....  ...+++..+..++.|+++|++|||     +.   +|+|+||+|+||++++++.+||+|||++
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence            9999999999997642  356899999999999999999999     66   9999999999999999999999999999


Q ss_pred             ccccccCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCc
Q 001566          924 RLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRS 1003 (1052)
Q Consensus       924 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1052)
                      ........ ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||....        ..+..+.. ..+..
T Consensus       158 ~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~-~~~~~  227 (265)
T cd08217         158 KILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--------QLQLASKI-KEGKF  227 (265)
T ss_pred             ccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--------HHHHHHHH-hcCCC
Confidence            87653322 1233468899999999999889999999999999999999999997432        11222221 11111


Q ss_pred             cccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1004 SELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1004 ~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                               ...+...+..+.+++.+|++.+|++||++.++++
T Consensus       228 ---------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         228 ---------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             ---------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                     1123344566899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-32  Score=299.30  Aligned_cols=259  Identities=22%  Similarity=0.334  Sum_probs=196.5

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCccc-cHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQ-GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      ++|++.+.||+|++|.||+|... +++.||+|.+...... ....+.+|++++++++|+||+++++++.++...++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57899999999999999999665 6899999998654322 234567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      ++ ++|.+++.... ..+++..+..++.|+++|+.|||+.   +|+||||||+||++++++.+||+|||+++...... .
T Consensus        85 ~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~  158 (291)
T cd07844          85 LD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-K  158 (291)
T ss_pred             CC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC-c
Confidence            96 59999987654 4689999999999999999999999   99999999999999999999999999987543211 1


Q ss_pred             cccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHh-CCccccc---
Q 001566          933 ATTDVAGTFGYVAPEYATT-CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE-GRSSELF--- 1007 (1052)
Q Consensus       933 ~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~--- 1007 (1052)
                      ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||......       .+..+..... +......   
T Consensus       159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~  231 (291)
T cd07844         159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV-------EDQLHKIFRVLGTPTEETWPG  231 (291)
T ss_pred             cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH-------HHHHHHHHHhcCCCChhhhhh
Confidence            1122346788999999876 45788999999999999999999999643211       0111111100 0000000   


Q ss_pred             ----------------cchhhcCC-ChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1008 ----------------LPELWEAG-PQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1008 ----------------~~~l~~~~-~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                                      ...+.... .......+.+++.+|++.+|++||++.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         232 VSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             hhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence                            00000000 0111256789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-32  Score=304.88  Aligned_cols=245  Identities=25%  Similarity=0.426  Sum_probs=196.1

Q ss_pred             ccceeeeccCceEEEEE-EecCCcEEEEEEec---c-CccccHHHHHHHHHHhhccCCCceeeEEEEEecCCe--eEEEE
Q 001566          778 SIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLS---I-GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAE--MFLVY  850 (1052)
Q Consensus       778 ~~~~~Lg~G~~g~V~~~-~~~~~~~vavK~~~---~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~lv~  850 (1052)
                      +...+||+|+|-+||+| +-.+|..||=-.++   . ......++|..|+.+|+.++||||++++.++.+...  .-+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            44578999999999999 43456666632221   1 123345789999999999999999999999987654  78899


Q ss_pred             eecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-CCcEEEeeeccccccccc
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDE-ELNAYLSDFGLARLLEVS  929 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~-~~~~kl~Dfgla~~~~~~  929 (1052)
                      |.+..|+|..|.++++  ..+...+.+|+.||++||.|||++ .|+|||||||.+||+|+. .|.|||+|+|+|.....+
T Consensus       123 EL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             ecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            9999999999999884  688899999999999999999998 678999999999999975 589999999999977532


Q ss_pred             CcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccc
Q 001566          930 ETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009 (1052)
Q Consensus       930 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                        +. ..++|||.|||||... ..|...+||||||+.+.||+|+..||....       ...+..+.+....+. ..+.+
T Consensus       200 --~a-ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~-------n~AQIYKKV~SGiKP-~sl~k  267 (632)
T KOG0584|consen  200 --HA-KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT-------NPAQIYKKVTSGIKP-AALSK  267 (632)
T ss_pred             --cc-ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC-------CHHHHHHHHHcCCCH-HHhhc
Confidence              22 2378999999999988 589999999999999999999999987543       344555555443322 22211


Q ss_pred             hhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1010 ELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1010 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                          -..+    ++.++|.+|+.. .++|||+.|+++
T Consensus       268 ----V~dP----evr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  268 ----VKDP----EVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             ----cCCH----HHHHHHHHHhcC-chhccCHHHHhh
Confidence                1122    388999999999 999999999985

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-32  Score=296.93  Aligned_cols=247  Identities=26%  Similarity=0.431  Sum_probs=198.9

Q ss_pred             CCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCc-cccHHHHHHHHHHhhccC---CCceeeEEEEEecCCeeEEEE
Q 001566          776 NFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIR---HKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      .|++.+.||+|+||.||+|.. .+++.||+|.+.... ....+++.+|+.++++++   |||++++++++.+....++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            477889999999999999975 568999999886542 334567888999999996   999999999999999999999


Q ss_pred             eecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccC
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~  930 (1052)
                      ||+++++|.++++..   .+++..+..++.|+++|+.|||+.   +|+||||+|+||++++++.++|+|||.+.......
T Consensus        82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06917          82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS  155 (277)
T ss_pred             ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence            999999999998653   589999999999999999999999   99999999999999999999999999998765333


Q ss_pred             cccccccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccc
Q 001566          931 THATTDVAGTFGYVAPEYATTC-RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009 (1052)
Q Consensus       931 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                       .......|+..|+|||.+.++ .++.++||||||+++|+|++|+.||......        ...... ...     ..+
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--------~~~~~~-~~~-----~~~  220 (277)
T cd06917         156 -SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF--------RAMMLI-PKS-----KPP  220 (277)
T ss_pred             -cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh--------hhhhcc-ccC-----CCC
Confidence             222334688899999988754 4688999999999999999999999743211        111110 011     011


Q ss_pred             hhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1010 ELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1010 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      .+...   ..+..+.+++.+||+.||++||++.|+++
T Consensus       221 ~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         221 RLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             CCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            11111   13456899999999999999999999975

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1e-31  Score=298.14  Aligned_cols=258  Identities=24%  Similarity=0.301  Sum_probs=198.5

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCccc--cHHHHHHHHHHhhccCCCceeeEEEEEecC--CeeEEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQ--GIQQFDAEIGTLGRIRHKNLVTLIGYYVGE--AEMFLV  849 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv  849 (1052)
                      ++|++.+.||+|+||.||+|... +++.+|+|.++.....  ....+.+|++++++++||||+++++++...  ...|+|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46889999999999999999765 5889999998754332  234567899999999999999999998877  889999


Q ss_pred             EeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccccccc
Q 001566          850 YNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS  929 (1052)
Q Consensus       850 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~  929 (1052)
                      +||++ ++|.+++.... ..+++..+..++.|++.|++|||++   +|+||||+|+||+++.++.++|+|||++......
T Consensus        85 ~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  159 (293)
T cd07843          85 MEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSP  159 (293)
T ss_pred             ehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence            99996 59999987654 4689999999999999999999999   9999999999999999999999999999866533


Q ss_pred             CcccccccccccccccccccCCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHh--------
Q 001566          930 ETHATTDVAGTFGYVAPEYATTCR-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE-------- 1000 (1052)
Q Consensus       930 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 1000 (1052)
                      . .......+++.|+|||.+.+.. ++.++|+||+|+++|||++|+.||......        +........        
T Consensus       160 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~--------~~~~~~~~~~~~~~~~~  230 (293)
T cd07843         160 L-KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI--------DQLNKIFKLLGTPTEKI  230 (293)
T ss_pred             c-cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHHHHhCCCchHH
Confidence            2 1222345678999999987644 688999999999999999999999743211        111111100        


Q ss_pred             ------------CCccccccchhhcCCChH-HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1001 ------------GRSSELFLPELWEAGPQE-NLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1001 ------------~~~~~~~~~~l~~~~~~~-~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                                  ..........+....+.. ....+.+++.+|++.+|++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         231 WPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             HHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                        000000000111111111 3556889999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1e-31  Score=298.95  Aligned_cols=258  Identities=24%  Similarity=0.309  Sum_probs=198.4

Q ss_pred             CCccceeeeccCceEEEEEEec-CCcEEEEEEeccCccc-----cHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEE
Q 001566          776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQ-----GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLV  849 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  849 (1052)
                      +|++.+.||+|+||.||+|... +++.||+|++......     ....+..|++++++++|+||+++++++.+....++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4788899999999999999654 6899999998755432     234567899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccccccc
Q 001566          850 YNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS  929 (1052)
Q Consensus       850 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~  929 (1052)
                      |||+ +++|.+++.... ..+++..+..++.|+++|++|||++   +|+||||+|+||+++.++.++|+|||++......
T Consensus        81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence            9999 999999997653 4689999999999999999999999   9999999999999999999999999999876533


Q ss_pred             CcccccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHh-CCccc--
Q 001566          930 ETHATTDVAGTFGYVAPEYATT-CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE-GRSSE-- 1005 (1052)
Q Consensus       930 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-- 1005 (1052)
                      .. ......+++.|+|||.+.+ ..++.++|||||||++|||++|.+||......       .. ....... +....  
T Consensus       156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-------~~-~~~~~~~~~~~~~~~  226 (298)
T cd07841         156 NR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-------DQ-LGKIFEALGTPTEEN  226 (298)
T ss_pred             Cc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-------HH-HHHHHHHcCCCchhh
Confidence            22 1222346788999998865 45788999999999999999997777532211       11 1111110 00000  


Q ss_pred             ---------cccchhhcC-----CChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001566         1006 ---------LFLPELWEA-----GPQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus      1006 ---------~~~~~l~~~-----~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                               .........     ........+.+++.+||+.+|++||++.|+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         227 WPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             hhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence                     000000000     012234568899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.7e-31  Score=293.80  Aligned_cols=246  Identities=25%  Similarity=0.419  Sum_probs=200.3

Q ss_pred             CCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCcc-ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeec
Q 001566          776 NFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFL  853 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  853 (1052)
                      -|++.+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+.++++++|||++++++++.++...++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            477889999999999999965 4688999998864432 33467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccc
Q 001566          854 SGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA  933 (1052)
Q Consensus       854 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  933 (1052)
                      ++++|.+++...   .+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        85 ~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~  157 (277)
T cd06641          85 GGGSALDLLEPG---PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IK  157 (277)
T ss_pred             CCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch-hh
Confidence            999999998753   588999999999999999999999   99999999999999999999999999987654322 12


Q ss_pred             ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhc
Q 001566          934 TTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWE 1013 (1052)
Q Consensus       934 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1013 (1052)
                      .....++..|+|||.+.+..++.++|+||+||++|||++|..||.....        ..+.... ..+..     +    
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~-~~~~~-----~----  219 (277)
T cd06641         158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP--------MKVLFLI-PKNNP-----P----  219 (277)
T ss_pred             hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch--------HHHHHHH-hcCCC-----C----
Confidence            2234578899999999988889999999999999999999999863211        1111111 11111     1    


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1014 AGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1014 ~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ..+...+..+.+++.+|++.+|++||++.++++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  252 (277)
T cd06641         220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK  252 (277)
T ss_pred             CCCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            112233456889999999999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.5e-31  Score=295.61  Aligned_cols=252  Identities=26%  Similarity=0.400  Sum_probs=205.3

Q ss_pred             hhCCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEe
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYN  851 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  851 (1052)
                      ..+.|+..+.||+|+||.||+|... ++..||+|++..... ..+.+.+|++.+++++|+|++++++++......++|+|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            4456888899999999999999766 688999999876544 45678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCc
Q 001566          852 FLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET  931 (1052)
Q Consensus       852 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~  931 (1052)
                      |+++++|.+++.... ..+++..+..++.|++.|++|||+.   ||+|+||+|+||+++.++.++|+|||.+....... 
T Consensus        96 ~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-  170 (286)
T cd06614          96 YMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK-  170 (286)
T ss_pred             ccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccch-
Confidence            999999999998764 4799999999999999999999998   99999999999999999999999999987554221 


Q ss_pred             ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchh
Q 001566          932 HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPEL 1011 (1052)
Q Consensus       932 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1011 (1052)
                      .......++..|+|||.+.+..++.++||||||+++|||++|+.||......        ........ ......     
T Consensus       171 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~--------~~~~~~~~-~~~~~~-----  236 (286)
T cd06614         171 SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL--------RALFLITT-KGIPPL-----  236 (286)
T ss_pred             hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHh-cCCCCC-----
Confidence            1222335778999999999888999999999999999999999998632111        11111111 111110     


Q ss_pred             hcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1012 WEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1012 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                        ..+...+..+.+++.+|++.+|.+||++.++++
T Consensus       237 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         237 --KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             --cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence              011223456899999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.8e-31  Score=298.17  Aligned_cols=247  Identities=30%  Similarity=0.384  Sum_probs=197.5

Q ss_pred             hCCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCcc---ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEE
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF---QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLV  849 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  849 (1052)
                      ...|++.+.||+|+||.||+|... +++.||+|++.....   ....++.+|+++++.++|||++++++++.++...++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            356889999999999999999664 689999998864332   2335688999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccccccc
Q 001566          850 YNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS  929 (1052)
Q Consensus       850 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~  929 (1052)
                      +||++ |++.+++.... ..+++..+..++.|++.|+.|||+.   +|+||||+|+||++++++.++|+|||++......
T Consensus        94 ~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          94 MEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             HHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            99995 68888776543 4689999999999999999999999   9999999999999999999999999998754322


Q ss_pred             CcccccccccccccccccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCcccc
Q 001566          930 ETHATTDVAGTFGYVAPEYAT---TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSEL 1006 (1052)
Q Consensus       930 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                           ....+++.|+|||.+.   ...++.++||||||+++|||+||+.||.....        ........ .....  
T Consensus       169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~--------~~~~~~~~-~~~~~--  232 (307)
T cd06607         169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIA-QNDSP--  232 (307)
T ss_pred             -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH--------HHHHHHHh-cCCCC--
Confidence                 2345778999999874   45678899999999999999999999863211        11111111 11111  


Q ss_pred             ccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001566         1007 FLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus      1007 ~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                            ...+...+..+.+++.+||+.+|++||++.++++.
T Consensus       233 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         233 ------TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             ------CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                  01122345568999999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=5.8e-35  Score=317.15  Aligned_cols=372  Identities=28%  Similarity=0.362  Sum_probs=292.9

Q ss_pred             cCCCCccEEEccCcccc-ccCCccccCCCCCCeEecccccccccCCccccCCCCCcEEEccCCcccCccccCCCcccCCC
Q 001566          144 GELRLLEVLELQGNNFS-GKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFL  222 (1052)
Q Consensus       144 ~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L  222 (1052)
                      +-|+-.+-.|+++|.++ +..|.....+++++.|.|...++. .+|+.++.+.+|++|.+++|++..  ....++.++.|
T Consensus         4 gVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~--vhGELs~Lp~L   80 (1255)
T KOG0444|consen    4 GVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLIS--VHGELSDLPRL   80 (1255)
T ss_pred             cccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHh--hhhhhccchhh
Confidence            34566778899999999 578999999999999999999998 899999999999999999999975  23456778899


Q ss_pred             CEEEccCCcCC-CCCCcccCCCCCCCEEEcCCCccccccchhhcCCCCCCEEEccCCCCCCCCCcccccCCCCCceeccc
Q 001566          223 TYLKLSDNFLT-ESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTN  301 (1052)
Q Consensus       223 ~~L~Ls~N~l~-~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~  301 (1052)
                      +.+++.+|++. .-+|..+..+..|..|+|++|+++ ..|..+..-+++-+|+||+|+|..++..-|.+++.|-.|+||+
T Consensus        81 Rsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~  159 (1255)
T KOG0444|consen   81 RSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSN  159 (1255)
T ss_pred             HHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhcccc
Confidence            99999999986 337888889999999999999998 8899999999999999999999864445567888888888888


Q ss_pred             ccccccCCCCCCccccccCCCchhhhcccCCcEEecCCCCCCccCCccccCCCCccEEeCCCCccc-ccCCccccccCCC
Q 001566          302 IDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLK-GAVPKSLGMCRNL  380 (1052)
Q Consensus       302 n~~~~~l~~~~~~~~~~~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~Ls~N~l~-~~~p~~~~~l~~L  380 (1052)
                      |++.               .+|+.+-.+..|+.|.|++|.+..---..+-.|++|++|.+++.+=+ ..+|.++..|.+|
T Consensus       160 NrLe---------------~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL  224 (1255)
T KOG0444|consen  160 NRLE---------------MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNL  224 (1255)
T ss_pred             chhh---------------hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhh
Confidence            7654               34555555555555555555544332222333445555555554332 2345555555555


Q ss_pred             CEEeCCCCcCcCCCCCCCCCCCcceEecccCcccccCCCCCccccCcccCccccccccccccccccccceeEEeeccCCc
Q 001566          381 TYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNK  460 (1052)
Q Consensus       381 ~~L~Ls~N~l~~~~p~~~~~~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~l~~ldls~n~  460 (1052)
                      ..+|||.|.+.-                       ++.                                          
T Consensus       225 ~dvDlS~N~Lp~-----------------------vPe------------------------------------------  239 (1255)
T KOG0444|consen  225 RDVDLSENNLPI-----------------------VPE------------------------------------------  239 (1255)
T ss_pred             hhccccccCCCc-----------------------chH------------------------------------------
Confidence            555555554431                       100                                          


Q ss_pred             cccccCcccccccccccccchhHHhhccCCcccCCCCCccccccCCCcceEEecCcccccCcchHHHHhcCcCccEEEcc
Q 001566          461 FLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAA  540 (1052)
Q Consensus       461 ~~g~~p~~~~~~~~~~~~~~~~~~l~l~~n~~~~~~p~~~~~~~~~l~~~~l~l~~n~l~~~~~~~~~~~~~~L~~L~l~  540 (1052)
                                                                                      -  ...+.+|+.|+|+
T Consensus       240 ----------------------------------------------------------------c--ly~l~~LrrLNLS  253 (1255)
T KOG0444|consen  240 ----------------------------------------------------------------C--LYKLRNLRRLNLS  253 (1255)
T ss_pred             ----------------------------------------------------------------H--HhhhhhhheeccC
Confidence                                                                            0  1245677888888


Q ss_pred             CcccccccccccCCCCCCCEEEccCCcCCCCCcccccCCccCcEEEcCCCccC-CcCchhhcCCCCCcEEEcCCCCCCCC
Q 001566          541 NNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLT-GEIPSQFGHLISLVVLDLSHNALTGS  619 (1052)
Q Consensus       541 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~  619 (1052)
                      +|+|+ ......+...+|++|+||.|+++ .+|+.+.+|++|+.|++.+|+++ .-+|..++.+.+|+.+..++|.+. .
T Consensus       254 ~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-l  330 (1255)
T KOG0444|consen  254 GNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-L  330 (1255)
T ss_pred             cCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-c
Confidence            88888 55556667789999999999999 99999999999999999999987 247999999999999999999999 8


Q ss_pred             CchhhhcccccceeeccCccCCCCCCcccccccccCceecccccccCCCC
Q 001566          620 IPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIP  669 (1052)
Q Consensus       620 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  669 (1052)
                      +|+.++.+.+|+.|.|++|++- .+|..+.-|+.|+.|||..|+=--.+|
T Consensus       331 VPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPP  379 (1255)
T KOG0444|consen  331 VPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPP  379 (1255)
T ss_pred             CchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCC
Confidence            9999999999999999999998 789999999999999999997655555

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.98  E-value=8e-32  Score=297.47  Aligned_cols=258  Identities=26%  Similarity=0.350  Sum_probs=198.2

Q ss_pred             CccceeeeccCceEEEEEEec-CCcEEEEEEeccCcc--ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeec
Q 001566          777 FSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFL  853 (1052)
Q Consensus       777 ~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  853 (1052)
                      |++.+.||.|++|.||+|... +|..||+|++.....  .....+.+|++++++++|||++++++++.+....+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            677899999999999999654 689999999865432  22356788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccc
Q 001566          854 SGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA  933 (1052)
Q Consensus       854 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  933 (1052)
                       +++|.+++.......+++..+.+++.|+++|++|||+.   +++||||+|+||+++.++.++|+|||.+........ .
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~  155 (283)
T cd07835          81 -DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-T  155 (283)
T ss_pred             -CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-c
Confidence             57999999876545789999999999999999999998   999999999999999999999999999976542211 1


Q ss_pred             ccccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccc-----
Q 001566          934 TTDVAGTFGYVAPEYATTC-RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELF----- 1007 (1052)
Q Consensus       934 ~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 1007 (1052)
                      .....++..|+|||++.+. .++.++||||+|+++|||++|+.||......       .+..+.....+......     
T Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd07835         156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI-------DQLFRIFRTLGTPDEDVWPGVT  228 (283)
T ss_pred             cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHHHhCCCChHHhhhhh
Confidence            1223567899999988664 4688999999999999999999998643211       11111110000000000     


Q ss_pred             ------------cchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1008 ------------LPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1008 ------------~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                                  ...............+.+++.+|++.||++||+++|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         229 SLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                        000000111223456889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.98  E-value=2.6e-31  Score=287.81  Aligned_cols=249  Identities=29%  Similarity=0.460  Sum_probs=205.4

Q ss_pred             CCccceeeeccCceEEEEEEec-CCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecC
Q 001566          776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLS  854 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  854 (1052)
                      +|++.+.||+|++|.||+|... +++.+++|++..........+.+|++.+++++|++++++++++..+...++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4778899999999999999765 688999999977665566789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcccc
Q 001566          855 GGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT  934 (1052)
Q Consensus       855 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  934 (1052)
                      +++|.+++.... ..+++..+..++.|+++|+++||+.   +++||||+|+||++++++.++|+|||.+........  .
T Consensus        81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~  154 (253)
T cd05122          81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R  154 (253)
T ss_pred             CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence            999999997753 4689999999999999999999998   999999999999999999999999999987654332  3


Q ss_pred             cccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcC
Q 001566          935 TDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEA 1014 (1052)
Q Consensus       935 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 1014 (1052)
                      ....++..|+|||.+.+..++.++||||+|+++|+|++|+.||.....        .+....... ......     .  
T Consensus       155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~-~~~~~~-----~--  218 (253)
T cd05122         155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP--------MKALFKIAT-NGPPGL-----R--  218 (253)
T ss_pred             cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch--------HHHHHHHHh-cCCCCc-----C--
Confidence            345678899999999988889999999999999999999999873211        111111111 111111     0  


Q ss_pred             CChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1015 GPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1015 ~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      .+...+..+.+++.+|++.||++|||+.|+++
T Consensus       219 ~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         219 NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             cccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11112456899999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=1.9e-32  Score=276.72  Aligned_cols=264  Identities=26%  Similarity=0.373  Sum_probs=206.9

Q ss_pred             hhhHHHhhCCCccceeeeccCceEEEEE-EecCCcEEEEEEeccCccccHHHHHHHHHHhhcc-CCCceeeEEEEEecCC
Q 001566          767 YDNVVRATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEA  844 (1052)
Q Consensus       767 ~~~~~~~~~~~~~~~~Lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  844 (1052)
                      +.++.+.++     +.||+|+|+.|-.+ ...+|..||||++.+.......++.+|++++... .|+||+.++++|++++
T Consensus        75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~  149 (463)
T KOG0607|consen   75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT  149 (463)
T ss_pred             HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence            445544443     67999999999988 5678999999999888777788899999999998 5999999999999999


Q ss_pred             eeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC---cEEEeeec
Q 001566          845 EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEEL---NAYLSDFG  921 (1052)
Q Consensus       845 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~---~~kl~Dfg  921 (1052)
                      .+|+|||.|.||+|..+++++  ..+++.++.++.++|+.||.+||.+   ||.|||+||+|||..+..   .+|||||.
T Consensus       150 ~FYLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfD  224 (463)
T KOG0607|consen  150 RFYLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFD  224 (463)
T ss_pred             eEEEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccc
Confidence            999999999999999999887  4699999999999999999999999   999999999999997654   37999999


Q ss_pred             ccccccccC------cccccccccccccccccccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCcc------cC
Q 001566          922 LARLLEVSE------THATTDVAGTFGYVAPEYAT-----TCRVSDKADVYSFGVVLLELISGKRSLDPSFS------EY  984 (1052)
Q Consensus       922 la~~~~~~~------~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslG~il~elltg~~p~~~~~~------~~  984 (1052)
                      ++.-+....      +......+|+..|||||+..     .-.|+.+.|.||+|||+|-|+.|.+||.+.-.      ..
T Consensus       225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrG  304 (463)
T KOG0607|consen  225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRG  304 (463)
T ss_pred             cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCC
Confidence            886543211      11223457888999999864     23477899999999999999999999965432      22


Q ss_pred             CCCccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566          985 GNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus       985 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      +....-.+..-..+.+|+..  |-..=|.    ....+..++++..+..|+.+|.++.+++.
T Consensus       305 e~Cr~CQ~~LFesIQEGkYe--FPdkdWa----hIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  305 EVCRVCQNKLFESIQEGKYE--FPDKDWA----HISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             CccHHHHHHHHHHHhccCCc--CChhhhH----HhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            22333333333445555443  1112222    23344678888999999999999988765

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.98  E-value=5.8e-32  Score=299.41  Aligned_cols=253  Identities=27%  Similarity=0.387  Sum_probs=195.1

Q ss_pred             CCccceeeeccCceEEEEEEec-CCcEEEEEEeccCcc-ccHHHHHHHHHHhhccC-CCceeeEEEEEecCCeeEEEEee
Q 001566          776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR-HKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      +|+..+.||+|+||.||++... +++.||+|++..... .....+.+|+..+.++. |+||+++++++..+...+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4666788999999999999654 589999999865432 34567889999999996 99999999999998999999999


Q ss_pred             cCCCCHHHHH---hhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccccccc
Q 001566          853 LSGGNLETFI---HKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS  929 (1052)
Q Consensus       853 ~~~gsL~~~l---~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~  929 (1052)
                      +. +++.++.   .......+++..+.+++.|+++|++|||+..  +|+||||||+||+++.++.++|+|||++......
T Consensus        85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            84 5665543   2233356899999999999999999999743  8999999999999999999999999999765422


Q ss_pred             CcccccccccccccccccccCCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCcccc
Q 001566          930 ETHATTDVAGTFGYVAPEYATTC---RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSEL 1006 (1052)
Q Consensus       930 ~~~~~~~~~g~~~y~aPE~~~~~---~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      .  ......++..|+|||.+.+.   .++.++||||+|+++|||++|+.||....       ...+.........     
T Consensus       162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~~~-----  227 (288)
T cd06616         162 I--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-------SVFDQLTQVVKGD-----  227 (288)
T ss_pred             C--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-------hHHHHHhhhcCCC-----
Confidence            2  11223578899999999876   68889999999999999999999987421       1111111111111     


Q ss_pred             ccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1007 FLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1007 ~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                       .+.+....+...+..+.+++.+||+.+|++||++.++++
T Consensus       228 -~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         228 -PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             -CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             111222222334556999999999999999999999886

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.98  E-value=2e-31  Score=294.39  Aligned_cols=251  Identities=26%  Similarity=0.425  Sum_probs=193.4

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCcc-ccHHHHHHHHHH-hhccCCCceeeEEEEEecCCeeEEEEe
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF-QGIQQFDAEIGT-LGRIRHKNLVTLIGYYVGEAEMFLVYN  851 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e  851 (1052)
                      ++|++.+.||+|+||.||+|... +|+.||+|++..... +...++..|+.. ++..+|||++++++++..+...++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            36889999999999999999664 689999999875432 223455556654 666789999999999999999999999


Q ss_pred             ecCCCCHHHHHhhc--cCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccccccc
Q 001566          852 FLSGGNLETFIHKK--SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS  929 (1052)
Q Consensus       852 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~  929 (1052)
                      |++ |+|.+++...  ....+++..+..++.|++.|++|||+++  +++||||||+||+++.++.+||+|||++......
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            995 7898888653  2346899999999999999999999853  8999999999999999999999999999865322


Q ss_pred             CcccccccccccccccccccCC----CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccc
Q 001566          930 ETHATTDVAGTFGYVAPEYATT----CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005 (1052)
Q Consensus       930 ~~~~~~~~~g~~~y~aPE~~~~----~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1052)
                        .......++..|+|||.+.+    ..++.++|+||+|+++|||++|+.||......       .+.......... . 
T Consensus       158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~-~-  226 (283)
T cd06617         158 --VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-------FQQLKQVVEEPS-P-  226 (283)
T ss_pred             --cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-------HHHHHHHHhcCC-C-
Confidence              11222457889999998865    44678999999999999999999998632211       111111111111 1 


Q ss_pred             cccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1006 ~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                          .+.   ....+..+.+++.+||..+|++||++.++++
T Consensus       227 ----~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         227 ----QLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             ----CCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                110   1123456899999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.98  E-value=6.8e-32  Score=293.67  Aligned_cols=247  Identities=28%  Similarity=0.361  Sum_probs=202.9

Q ss_pred             CCccceeeeccCceEEEEEEec-CCcEEEEEEeccCcc---ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEe
Q 001566          776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF---QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYN  851 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  851 (1052)
                      +|++.+.||.|+||.||+|... +++.||+|.+.....   ...+.+.+|++++++++|||++++++++.+....++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4888999999999999999765 589999999865432   345778999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCc
Q 001566          852 FLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET  931 (1052)
Q Consensus       852 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~  931 (1052)
                      |+++++|.+++...  ..+++..+..++.|+++|+.|||+.   +++|+||+|+||++++++.++|+|||.+....... 
T Consensus        81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-  154 (258)
T cd05578          81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-  154 (258)
T ss_pred             CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence            99999999999775  4689999999999999999999999   99999999999999999999999999998664332 


Q ss_pred             ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchh
Q 001566          932 HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPEL 1011 (1052)
Q Consensus       932 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1011 (1052)
                       ......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||......      ...+.......  ..       
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~--~~-------  218 (258)
T cd05578         155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT------IRDQIRAKQET--AD-------  218 (258)
T ss_pred             -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc------HHHHHHHHhcc--cc-------
Confidence             223345788999999999888999999999999999999999999754321      11111111111  11       


Q ss_pred             hcCCChHHHHHHHHHHHHccccCCCCCCCH--HHHH
Q 001566         1012 WEAGPQENLLGMMRLASTCTVETLSTRPSV--KQVL 1045 (1052)
Q Consensus      1012 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~--~eil 1045 (1052)
                       ...+...+..+.+++.+||+.||.+||++  +|++
T Consensus       219 -~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         219 -VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             -ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence             11223344678999999999999999999  6654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.98  E-value=2.8e-31  Score=294.88  Aligned_cols=260  Identities=25%  Similarity=0.310  Sum_probs=197.0

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCcc--ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEe
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYN  851 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  851 (1052)
                      ++|++.+.||+|++|.||+|... +++.||+|++.....  ...+.+.+|++++++++|||++++++++.+....++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46899999999999999999765 688999998865432  224568889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-CCcEEEeeecccccccccC
Q 001566          852 FLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDE-ELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       852 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~-~~~~kl~Dfgla~~~~~~~  930 (1052)
                      |++ +++.+++........++..+..++.||+.|++|||++   +|+||||+|+||+++. ++.+||+|||++...... 
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~-  156 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-  156 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCC-
Confidence            995 6888888765545568888999999999999999999   9999999999999985 557999999999765432 


Q ss_pred             cccccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccc--
Q 001566          931 THATTDVAGTFGYVAPEYATT-CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELF-- 1007 (1052)
Q Consensus       931 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 1007 (1052)
                      ........+++.|+|||.+.+ ..++.++||||+|+++|+|+||+.||......       .+..+.....+......  
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~  229 (294)
T PLN00009        157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI-------DELFKIFRILGTPNEETWP  229 (294)
T ss_pred             ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHHHhCCCChhhcc
Confidence            112223456889999998876 45788999999999999999999999643211       11111111000000000  


Q ss_pred             ---------------cchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1008 ---------------LPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1008 ---------------~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                                     .+.......+.....+.+++.+|++.+|++||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        230 GVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             ccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence                           000000011223455889999999999999999999875

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.98  E-value=2e-31  Score=294.85  Aligned_cols=257  Identities=27%  Similarity=0.325  Sum_probs=198.8

Q ss_pred             CccceeeeccCceEEEEEEec-CCcEEEEEEeccCc--cccHHHHHHHHHHhhccCCCceeeEEEEEecC--CeeEEEEe
Q 001566          777 FSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR--FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGE--AEMFLVYN  851 (1052)
Q Consensus       777 ~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  851 (1052)
                      |++.+.||+|+||.||+|... +++.+|+|++....  ......+.+|++++++++|+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            677899999999999999765 48899999997653  33346788999999999999999999999987  88999999


Q ss_pred             ecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCc
Q 001566          852 FLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET  931 (1052)
Q Consensus       852 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~  931 (1052)
                      |++ ++|.+++.... ..+++..+..++.|+++|++|||+.   +++|+||+|+||++++++.++|+|||.+........
T Consensus        81 ~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~  155 (287)
T cd07840          81 YMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS  155 (287)
T ss_pred             ccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence            996 58998887653 4689999999999999999999999   999999999999999999999999999987654432


Q ss_pred             ccccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCC--------
Q 001566          932 HATTDVAGTFGYVAPEYATT-CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGR-------- 1002 (1052)
Q Consensus       932 ~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 1002 (1052)
                      .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......        ...........        
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~--------~~~~~~~~~~~~~~~~~~~  227 (287)
T cd07840         156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL--------EQLEKIFELCGSPTDENWP  227 (287)
T ss_pred             ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHHHHhCCCchhhcc
Confidence            22333456788999998765 45788999999999999999999998743321        11111111000        


Q ss_pred             ------------ccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1003 ------------SSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1003 ------------~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                                  ........+.......+...+.+++.+|++.+|++||++.++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             ccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                        00000000000011112556899999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.98  E-value=2.2e-32  Score=275.50  Aligned_cols=268  Identities=22%  Similarity=0.310  Sum_probs=204.9

Q ss_pred             CCCccceeeeccCceEEEEEEec---C--CcEEEEEEeccCcccc--HHHHHHHHHHhhccCCCceeeEEEEEec-CCee
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV---P--GYLVAVKKLSIGRFQG--IQQFDAEIGTLGRIRHKNLVTLIGYYVG-EAEM  846 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~---~--~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~  846 (1052)
                      ..|+..+.||+|.||.||+|...   +  ...+|+|+++......  ....-+|+..++.++|||++.+..++.. +..+
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            46889999999999999999332   2  2378999997653321  3456789999999999999999999887 7899


Q ss_pred             EEEEeecCCCCHHHHHhhcc---CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC----CcEEEee
Q 001566          847 FLVYNFLSGGNLETFIHKKS---GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEE----LNAYLSD  919 (1052)
Q Consensus       847 ~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~----~~~kl~D  919 (1052)
                      ++++||.+. +|.+.++-++   .+.++...+.+|..||+.|+.|||+.   =|+|||+||.||||..+    |.|||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence            999999965 8888886543   45688899999999999999999999   79999999999999887    8999999


Q ss_pred             ecccccccccCc--ccccccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCC--CccHHHHH
Q 001566          920 FGLARLLEVSET--HATTDVAGTFGYVAPEYATTC-RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGN--GFNIVSWA  994 (1052)
Q Consensus       920 fgla~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~--~~~~~~~~  994 (1052)
                      +|+++.+...-.  .....++.|..|.|||.+.|. .|+.+.|||+.|||+.||+|-.+-|.........  .....+..
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            999998864322  234557789999999999875 5788999999999999999999888654433222  23333333


Q ss_pred             HHHHHhCCccccccchhhcC--C-------------C----------hHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566          995 KLLIKEGRSSELFLPELWEA--G-------------P----------QENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus       995 ~~~~~~~~~~~~~~~~l~~~--~-------------~----------~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      +...--|...+...|.+..-  +             +          ........+|+.+++.+||.+|.|+.+.++
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle  336 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE  336 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence            44444444444333332210  0             0          001112678999999999999999999875

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.98  E-value=3.3e-31  Score=288.08  Aligned_cols=249  Identities=27%  Similarity=0.447  Sum_probs=206.1

Q ss_pred             CCccceeeeccCceEEEEEEec-CCcEEEEEEeccCcc--ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      +|++.+.||+|+||.||+|... ++..||+|++.....  ....++.+|++++++++|||++++++.+......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4788899999999999999664 588999999876543  4456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcc--CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccC
Q 001566          853 LSGGNLETFIHKKS--GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~  930 (1052)
                      +++++|.+++....  +..+++.++..++.+++.|++|||+.   +++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999998753  46799999999999999999999999   99999999999999999999999999998664332


Q ss_pred             cccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccch
Q 001566          931 THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010 (1052)
Q Consensus       931 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1052)
                       .......+++.|+|||...+..++.++||||+|+++|+|++|+.||....        ..+......... .       
T Consensus       158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--------~~~~~~~~~~~~-~-------  220 (258)
T cd08215         158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN--------LLELALKILKGQ-Y-------  220 (258)
T ss_pred             -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc--------HHHHHHHHhcCC-C-------
Confidence             22233467889999999998889999999999999999999999986332        112222222111 1       


Q ss_pred             hhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1011 LWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1011 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                        ...+......+.+++.+|+..+|++||++.|+++
T Consensus       221 --~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         221 --PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             --CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence              1112233456899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.98  E-value=2.3e-31  Score=294.97  Aligned_cols=260  Identities=20%  Similarity=0.245  Sum_probs=185.9

Q ss_pred             hhCCCccceeeeccCceEEEEEEecCC----cEEEEEEeccCccccH-----------HHHHHHHHHhhccCCCceeeEE
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAELVPG----YLVAVKKLSIGRFQGI-----------QQFDAEIGTLGRIRHKNLVTLI  837 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~~~~~----~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~l~  837 (1052)
                      ..++|++.++||+|+||.||+|...++    ..+|+|+.........           .....+...+..+.|+++++++
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~   89 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY   89 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence            346899999999999999999976543    4566665432221110           1122334456667899999999


Q ss_pred             EEEecCC----eeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC
Q 001566          838 GYYVGEA----EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEEL  913 (1052)
Q Consensus       838 ~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~  913 (1052)
                      +++....    ..++++|++ ..++.+.+...  ...++..+..++.|++.|++|||++   +|+||||||+||+++.++
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         90 GCGSFKRCRMYYRFILLEKL-VENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNN  163 (294)
T ss_pred             EeeeEecCCceEEEEEEehh-ccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence            9866443    346778877 45777776553  2357888899999999999999999   999999999999999999


Q ss_pred             cEEEeeecccccccccCcc------cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCC
Q 001566          914 NAYLSDFGLARLLEVSETH------ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNG  987 (1052)
Q Consensus       914 ~~kl~Dfgla~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~  987 (1052)
                      .++|+|||+|+.+......      ......||+.|+|||++.+..++.++||||+||++|||++|+.||......    
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~----  239 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN----  239 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc----
Confidence            9999999999866422211      112246899999999999999999999999999999999999999744221    


Q ss_pred             ccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 001566          988 FNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLK 1049 (1052)
Q Consensus       988 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~ 1049 (1052)
                      .......+.-....-...    ..   .....+..+.+++..|+..+|++||+++++++.++
T Consensus       240 ~~~~~~~~~~~~~~~~~~----~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        240 GNLIHAAKCDFIKRLHEG----KI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             hHHHHHhHHHHHHHhhhh----hh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            111111110000000000    00   01123456889999999999999999999998763

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.98  E-value=2.2e-31  Score=294.15  Aligned_cols=258  Identities=21%  Similarity=0.343  Sum_probs=198.5

Q ss_pred             CCccceeeeccCceEEEEEEec-CCcEEEEEEeccCccc-cHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeec
Q 001566          776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQ-GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFL  853 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  853 (1052)
                      +|++.+.||+|++|.||+|... +|+.||+|++...... ..+.+.+|++++++++|+|++++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4888999999999999999765 5889999998765432 3466778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhcc-CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc
Q 001566          854 SGGNLETFIHKKS-GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       854 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      + ++|.+++.... ...++++.+..++.|+++|++|||+.   +|+||||+|+||++++++.++++|||++....... .
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-~  155 (284)
T cd07836          81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-N  155 (284)
T ss_pred             C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-c
Confidence            7 58999887643 24589999999999999999999999   99999999999999999999999999997553221 1


Q ss_pred             cccccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCC-c-------
Q 001566          933 ATTDVAGTFGYVAPEYATTC-RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGR-S------- 1003 (1052)
Q Consensus       933 ~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~------- 1003 (1052)
                      ......++..|++||.+.+. .++.++||||+|+++|||++|+.||......        +.......... .       
T Consensus       156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~  227 (284)
T cd07836         156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE--------DQLLKIFRIMGTPTESTWPG  227 (284)
T ss_pred             ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH--------HHHHHHHHHhCCCChhhHHH
Confidence            22234567899999988664 5688999999999999999999998743221        11111111000 0       


Q ss_pred             ---cccccchh-------hcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1004 ---SELFLPEL-------WEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1004 ---~~~~~~~l-------~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                         ...+....       .....+.....+.+++.+|++.||++||++.|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         228 ISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             HhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence               00000000       00111223456889999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.98  E-value=2.9e-31  Score=302.43  Aligned_cols=257  Identities=27%  Similarity=0.355  Sum_probs=197.2

Q ss_pred             hhCCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccC--ccccHHHHHHHHHHhhccCCCceeeEEEEEecC------
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIG--RFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGE------  843 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  843 (1052)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|++...  ......++.+|+.++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            456899999999999999999965 46899999988643  223345677899999999999999999998643      


Q ss_pred             CeeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccc
Q 001566          844 AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLA  923 (1052)
Q Consensus       844 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla  923 (1052)
                      ...|+||||+. ++|.+++...    +++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||++
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccc
Confidence            35799999994 6888887643    88999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCc
Q 001566          924 RLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRS 1003 (1052)
Q Consensus       924 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1052)
                      ......  .......++..|+|||.+.+..++.++||||+||++|+|++|+.||......       ..+.+.....+..
T Consensus       166 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~  236 (353)
T cd07850         166 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-------DQWNKIIEQLGTP  236 (353)
T ss_pred             eeCCCC--CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHHhcCCC
Confidence            865432  2223345788999999999999999999999999999999999999643211       1111111000000


Q ss_pred             c---------------------------ccccchhh----cCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1004 S---------------------------ELFLPELW----EAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1004 ~---------------------------~~~~~~l~----~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      .                           ..+....+    ...+......+.+++.+|++.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         237 SDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             CHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            0                           00000000    0001234556889999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.98  E-value=3.3e-31  Score=294.47  Aligned_cols=260  Identities=23%  Similarity=0.314  Sum_probs=194.9

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCccc--cHHHHHHHHHHhhccC-CCceeeEEEEEecCCe-----
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQ--GIQQFDAEIGTLGRIR-HKNLVTLIGYYVGEAE-----  845 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~-----  845 (1052)
                      ++|++.+.||+|+||.||+|... +++.||+|++......  ....+.+|+.++++++ |||++++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            36889999999999999999764 6899999987654322  2356788999999995 6999999999886655     


Q ss_pred             eEEEEeecCCCCHHHHHhhcc---CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-CCcEEEeeec
Q 001566          846 MFLVYNFLSGGNLETFIHKKS---GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDE-ELNAYLSDFG  921 (1052)
Q Consensus       846 ~~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~-~~~~kl~Dfg  921 (1052)
                      .|+||||+++ ++.+++....   ...+++..+..++.||++|++|||++   +|+||||+|+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999975 8999886543   24589999999999999999999999   9999999999999998 8899999999


Q ss_pred             ccccccccCcccccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHh
Q 001566          922 LARLLEVSETHATTDVAGTFGYVAPEYATT-CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE 1000 (1052)
Q Consensus       922 la~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1052)
                      ++..+.... .......+++.|+|||.+.+ ..++.++||||||+++|||++|..||.....       ..+..+.....
T Consensus       157 ~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~-------~~~~~~~~~~~  228 (295)
T cd07837         157 LGRAFSIPV-KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE-------LQQLLHIFKLL  228 (295)
T ss_pred             cceecCCCc-cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHHHHh
Confidence            988653221 11122346788999998865 4578899999999999999999999864221       11111111111


Q ss_pred             CCccccccc----------------hhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1001 GRSSELFLP----------------ELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1001 ~~~~~~~~~----------------~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      +.......+                .......+.....+.+++.+|++++|++||++.|++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             CCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            111100000                0000001224456889999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.98  E-value=2.6e-31  Score=298.48  Aligned_cols=267  Identities=22%  Similarity=0.309  Sum_probs=197.3

Q ss_pred             CCccceeeeccCceEEEEEEec---CCcEEEEEEeccCc---cccHHHHHHHHHHhhccCCCceeeEEEEEecC--CeeE
Q 001566          776 NFSIRNLIGTGGFGSTYKAELV---PGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGE--AEMF  847 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~  847 (1052)
                      +|++.+.||+|+||.||+|...   +++.||+|.+....   ....+.+.+|+.++++++|||++++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4788899999999999999664   47899999987633   33346678899999999999999999999988  7899


Q ss_pred             EEEeecCCCCHHHHHhhcc---CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC----CCcEEEeee
Q 001566          848 LVYNFLSGGNLETFIHKKS---GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDE----ELNAYLSDF  920 (1052)
Q Consensus       848 lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~----~~~~kl~Df  920 (1052)
                      +||||++ +++.+++....   ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            9999996 57777775432   23688999999999999999999999   9999999999999999    899999999


Q ss_pred             cccccccccCc--ccccccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCc--cHHHHHH
Q 001566          921 GLARLLEVSET--HATTDVAGTFGYVAPEYATTC-RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGF--NIVSWAK  995 (1052)
Q Consensus       921 gla~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~--~~~~~~~  995 (1052)
                      |++........  .......+++.|+|||.+.+. .++.++||||||+++|||++|++||...........  ......+
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99986643222  122334678899999988764 578899999999999999999999975443321000  0000000


Q ss_pred             HHHHhCC----------------------cccccc-chhhcCCCh--HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566          996 LLIKEGR----------------------SSELFL-PELWEAGPQ--ENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus       996 ~~~~~~~----------------------~~~~~~-~~l~~~~~~--~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ....-+.                      ....+. ..+....+.  .....+.+++.+|++.||++|||+.|+++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0000000                      000000 000000000  23346889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.98  E-value=7.6e-32  Score=318.97  Aligned_cols=263  Identities=21%  Similarity=0.254  Sum_probs=188.7

Q ss_pred             hCCCccceeeeccCceEEEEEEecC--CcEEEEEEe--------------c---cCccccHHHHHHHHHHhhccCCCcee
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELVP--GYLVAVKKL--------------S---IGRFQGIQQFDAEIGTLGRIRHKNLV  834 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~~--~~~vavK~~--------------~---~~~~~~~~~~~~e~~~l~~l~h~niv  834 (1052)
                      .++|++.+.||+|+||+||+|..+.  +..+++|.+              .   ........++.+|++++++++||||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            4689999999999999999986532  222222211              0   01112245678999999999999999


Q ss_pred             eEEEEEecCCeeEEEEeecCCCCHHHHHhhcc---CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC
Q 001566          835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKS---GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDE  911 (1052)
Q Consensus       835 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~  911 (1052)
                      ++++++.+.+..|+|+|++ .+++.+++....   .......++..++.|++.||+|||++   +|+||||||+||+++.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~  302 (501)
T PHA03210        227 KIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNC  302 (501)
T ss_pred             cEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC
Confidence            9999999999999999998 568888875432   12234566778999999999999999   9999999999999999


Q ss_pred             CCcEEEeeecccccccccCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHH
Q 001566          912 ELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIV  991 (1052)
Q Consensus       912 ~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~  991 (1052)
                      ++.+||+|||+++.+............|++.|+|||++.+..++.++|||||||++|||++|+.++......    ....
T Consensus       303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~----~~~~  378 (501)
T PHA03210        303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGG----KPGK  378 (501)
T ss_pred             CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCC----CHHH
Confidence            999999999999877544333344567999999999999999999999999999999999988554322111    0011


Q ss_pred             HHHHHHHHhCCcccccc----------------------chhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566          992 SWAKLLIKEGRSSELFL----------------------PELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus       992 ~~~~~~~~~~~~~~~~~----------------------~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      +..+.....+.....+.                      +.+...  ......+.+++.+|++.||++|||+.|+++
T Consensus       379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRN--LGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHh--cCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            11111110000000000                      000000  012235778899999999999999999986

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.98  E-value=5.8e-31  Score=286.27  Aligned_cols=250  Identities=31%  Similarity=0.429  Sum_probs=206.1

Q ss_pred             CCccceeeeccCceEEEEEEec-CCcEEEEEEeccCcc--ccHHHHHHHHHHhhccCCCceeeEEEEEecC--CeeEEEE
Q 001566          776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGE--AEMFLVY  850 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  850 (1052)
                      +|++.+.||+|++|.||+|... +++.|++|++.....  ...+.+.+|++.+++++|+|++++++++.+.  ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4778899999999999999765 689999999876543  3467889999999999999999999999988  8899999


Q ss_pred             eecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccC
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~  930 (1052)
                      ||+++++|.+++....  .+++.++..++.|+++|++|||+.   +++|+|++|+||+++.++.++|+|||.+.......
T Consensus        81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  155 (260)
T cd06606          81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE  155 (260)
T ss_pred             EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence            9999999999998764  789999999999999999999998   99999999999999999999999999998765433


Q ss_pred             cc-cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccc
Q 001566          931 TH-ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009 (1052)
Q Consensus       931 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                      .. ......++..|+|||.+.+...+.++||||+|+++|+|++|+.||....       .........   ...      
T Consensus       156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~---~~~------  219 (260)
T cd06606         156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-------NPMAALYKI---GSS------  219 (260)
T ss_pred             ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------chHHHHHhc---ccc------
Confidence            21 1233567889999999998889999999999999999999999997433       111111111   110      


Q ss_pred             hhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1010 ELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1010 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ......+...+..+.+++.+|++.+|++||++.|+++
T Consensus       220 ~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         220 GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            0111223344567999999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.97  E-value=9.3e-35  Score=331.57  Aligned_cols=455  Identities=25%  Similarity=0.320  Sum_probs=364.6

Q ss_pred             ccccccchhhcCCCCCCeeEecCCCceecCCCCccCCCCccEEEccCccccccCCccccCCCCCCeEecccccccccCCc
Q 001566          110 VISGTLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPR  189 (1052)
Q Consensus       110 ~l~g~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  189 (1052)
                      ...+..|..+..+.+|+.|+++.|-|. .+|.+.+++.+|++|+|.+|.+. ..|..+..+++|++||+|+|++. .+|.
T Consensus        55 n~~~~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl  131 (1081)
T KOG0618|consen   55 NQISSFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPL  131 (1081)
T ss_pred             cccccCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCch
Confidence            356777888999999999999999999 88999999999999999999999 89999999999999999999997 8999


Q ss_pred             cccCCCCCcEEEccCCcccCccccCCCcccCCCCEEEccCCcCCCCCCcccCCCCCCCEEEcCCCccccccchhhcCCCC
Q 001566          190 GLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISE  269 (1052)
Q Consensus       190 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  269 (1052)
                      -+..++.++.+.+++|....     .++.. .++.++|..|.+.+.++..+..+..  .|+|.+|.+.   -..+.++.+
T Consensus       132 ~i~~lt~~~~~~~s~N~~~~-----~lg~~-~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~  200 (1081)
T KOG0618|consen  132 VIEVLTAEEELAASNNEKIQ-----RLGQT-SIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLAN  200 (1081)
T ss_pred             hHHhhhHHHHHhhhcchhhh-----hhccc-cchhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccc
Confidence            99999999999999993221     12222 2889999999999999888887777  7999999987   345678899


Q ss_pred             CCEEEccCCCCCCCCCcccccCCCCCceecccccccccCCCCCCccccccCCCchhhhcccCCcEEecCCCCCCccCCcc
Q 001566          270 LKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDN  349 (1052)
Q Consensus       270 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~~~~~l~~~~~~~~~~~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~  349 (1052)
                      |+.|....|++....    -...+|+.|+.++|+++...          .-..      ..+|++++++.|++++.. ++
T Consensus       201 l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~~~----------~~p~------p~nl~~~dis~n~l~~lp-~w  259 (1081)
T KOG0618|consen  201 LEVLHCERNQLSELE----ISGPSLTALYADHNPLTTLD----------VHPV------PLNLQYLDISHNNLSNLP-EW  259 (1081)
T ss_pred             hhhhhhhhcccceEE----ecCcchheeeeccCcceeec----------cccc------cccceeeecchhhhhcch-HH
Confidence            999999999998522    34567899999888876221          1122      358999999999998754 99


Q ss_pred             ccCCCCccEEeCCCCcccccCCccccccCCCCEEeCCCCcCcCCCCCCCCCCCcceEecccCcccccCCCCCccccCccc
Q 001566          350 WSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNITGVLPRFENVSCDNHF  429 (1052)
Q Consensus       350 ~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~l~~N~l~~~~p~~~~~~~~~~~  429 (1052)
                      ++.+.+|+.++..+|+|+ .+|..+..+.+|+.|+..+|.+.-.+|..-++.+|++|+|..|+|...++.+...      
T Consensus       260 i~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v------  332 (1081)
T KOG0618|consen  260 IGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAV------  332 (1081)
T ss_pred             HHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeehhccccccchHHHhh------
Confidence            999999999999999997 8999999999999999999999976666666999999999999997554422100      


Q ss_pred             CccccccccccccccccccceeEEeeccCCccccccCcccccccccccccchhHHhhccCCcccCCCCCccccccCCCcc
Q 001566          430 GFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQS  509 (1052)
Q Consensus       430 ~~~~l~~~~~~~~~~~~~~~~l~~ldls~n~~~g~~p~~~~~~~~~~~~~~~~~~l~l~~n~~~~~~p~~~~~~~~~l~~  509 (1052)
                        .               ...+..+..|-|++. ..|.+                               .-.....|+ 
T Consensus       333 --~---------------~~~l~~ln~s~n~l~-~lp~~-------------------------------~e~~~~~Lq-  362 (1081)
T KOG0618|consen  333 --L---------------NASLNTLNVSSNKLS-TLPSY-------------------------------EENNHAALQ-  362 (1081)
T ss_pred             --h---------------hHHHHHHhhhhcccc-ccccc-------------------------------cchhhHHHH-
Confidence              0               000122223333322 11100                               000111222 


Q ss_pred             eEEecCcccccCcchHHHHhcCcCccEEEccCcccccccccccCCCCCCCEEEccCCcCCCCCcccccCCccCcEEEcCC
Q 001566          510 FSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGG  589 (1052)
Q Consensus       510 ~~l~l~~n~l~~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~  589 (1052)
                       .|.+.+|.+++--.+.+ .+...|+.|+|++|+|...+...+.++..|++|+||+|+++ .+|+.+.+++.|+.|...+
T Consensus       363 -~LylanN~Ltd~c~p~l-~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahs  439 (1081)
T KOG0618|consen  363 -ELYLANNHLTDSCFPVL-VNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHS  439 (1081)
T ss_pred             -HHHHhcCcccccchhhh-ccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcC
Confidence             36789999988777666 57899999999999999888889999999999999999999 8899999999999999999


Q ss_pred             CccCCcCchhhcCCCCCcEEEcCCCCCCCC-CchhhhcccccceeeccCccCCCCCCcccccccccCceecccc
Q 001566          590 NNLTGEIPSQFGHLISLVVLDLSHNALTGS-IPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFN  662 (1052)
Q Consensus       590 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N  662 (1052)
                      |++. ..| ++..+++|+.+|+|.|+|+.. +|..... ++|++|||++|.-.-..-..|..+.++..+++.-|
T Consensus       440 N~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~-p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~  510 (1081)
T KOG0618|consen  440 NQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPS-PNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN  510 (1081)
T ss_pred             Ccee-ech-hhhhcCcceEEecccchhhhhhhhhhCCC-cccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence            9998 788 899999999999999999843 3433332 79999999999844355667777888888888777

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.97  E-value=3.4e-31  Score=291.34  Aligned_cols=244  Identities=27%  Similarity=0.325  Sum_probs=193.9

Q ss_pred             eeccCceEEEEEEec-CCcEEEEEEeccCc---cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecCCCCH
Q 001566          783 IGTGGFGSTYKAELV-PGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL  858 (1052)
Q Consensus       783 Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  858 (1052)
                      ||+|+||+||+|... +|+.||+|.+....   ......+..|++++++++|||++++++++...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999654 68899999886432   22234567899999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcccccccc
Q 001566          859 ETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVA  938 (1052)
Q Consensus       859 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  938 (1052)
                      .+++.......+++.++..++.|++.|+.|||+.   +++||||+|+||++++++.++|+|||.+.....  ........
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~~  155 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG--GKKIKGRA  155 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc--CCcccccc
Confidence            9999876555789999999999999999999999   999999999999999999999999999876542  22223345


Q ss_pred             cccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCCChH
Q 001566          939 GTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQE 1018 (1052)
Q Consensus       939 g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 1018 (1052)
                      ++..|+|||.+.+..++.++||||+|+++|+|++|+.||.......    ......+     .....  .    ...+..
T Consensus       156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~-----~~~~~--~----~~~~~~  220 (277)
T cd05577         156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV----EKEELKR-----RTLEM--A----VEYPDK  220 (277)
T ss_pred             CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc----cHHHHHh-----ccccc--c----ccCCcc
Confidence            7789999999988889999999999999999999999997433210    1111111     10000  0    111223


Q ss_pred             HHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 001566         1019 NLLGMMRLASTCTVETLSTRP-----SVKQVLI 1046 (1052)
Q Consensus      1019 ~~~~l~~Li~~cl~~dP~~RP-----t~~eil~ 1046 (1052)
                      ....+.+++.+||+.+|++||     ++.++++
T Consensus       221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            345689999999999999999     6666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.97  E-value=8.2e-31  Score=294.06  Aligned_cols=246  Identities=29%  Similarity=0.389  Sum_probs=196.5

Q ss_pred             CCccceeeeccCceEEEEEEec-CCcEEEEEEeccCcc---ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEe
Q 001566          776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF---QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYN  851 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  851 (1052)
                      .|+..+.||+|+||.||+|... ++..||+|++.....   +...++..|++++++++|||++++++++.++...++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3777889999999999999654 688999999864422   224568889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCc
Q 001566          852 FLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET  931 (1052)
Q Consensus       852 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~  931 (1052)
                      |++ |++.+++.... ..+++.++..++.|++.|+.|||+.   +|+||||+|+||+++.++.++|+|||++.....   
T Consensus       106 ~~~-g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---  177 (317)
T cd06635         106 YCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP---  177 (317)
T ss_pred             CCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC---
Confidence            996 58888776543 5689999999999999999999999   999999999999999999999999999875432   


Q ss_pred             ccccccccccccccccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCcccccc
Q 001566          932 HATTDVAGTFGYVAPEYAT---TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFL 1008 (1052)
Q Consensus       932 ~~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                        .....+++.|+|||.+.   +..++.++|||||||++|||++|+.||....        ...............    
T Consensus       178 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--------~~~~~~~~~~~~~~~----  243 (317)
T cd06635         178 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNESPT----  243 (317)
T ss_pred             --cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHHhccCCC----
Confidence              22345788999999974   4567889999999999999999999986421        111112222211111    


Q ss_pred             chhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 001566         1009 PELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKL 1048 (1052)
Q Consensus      1009 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L 1048 (1052)
                           ..+......+.+++.+|++.+|.+||++.++++..
T Consensus       244 -----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         244 -----LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             -----CCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence                 11123345689999999999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.97  E-value=4.5e-31  Score=295.34  Aligned_cols=259  Identities=27%  Similarity=0.364  Sum_probs=196.0

Q ss_pred             hCCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCcccc--HHHHHHHHHHhhccCCCceeeEEEEEecC--CeeEE
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQG--IQQFDAEIGTLGRIRHKNLVTLIGYYVGE--AEMFL  848 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  848 (1052)
                      .++|++.+.||+|+||.||+|... +|+.||+|+++......  ...+.+|+.++++++|+|++++++++.+.  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            457999999999999999999664 58999999986543221  23466899999999999999999998754  56899


Q ss_pred             EEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccc
Q 001566          849 VYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV  928 (1052)
Q Consensus       849 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~  928 (1052)
                      ||||+. ++|.+++.... ..+++.++..++.|+++|++|||+.   +++||||+|+||++++++.+||+|||.+.....
T Consensus        86 v~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          86 VMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             EEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            999995 58999887653 5689999999999999999999999   999999999999999999999999999987653


Q ss_pred             cCcccccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHh-CCcccc
Q 001566          929 SETHATTDVAGTFGYVAPEYATT-CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE-GRSSEL 1006 (1052)
Q Consensus       929 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 1006 (1052)
                      .. .......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||.....        .+........ +.....
T Consensus       161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~--------~~~~~~~~~~~~~~~~~  231 (309)
T cd07845         161 PA-KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE--------IEQLDLIIQLLGTPNES  231 (309)
T ss_pred             cc-CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHHhcCCCChh
Confidence            32 12222345778999999876 4578899999999999999999999963321        1111111110 000000


Q ss_pred             ccch-----------hh-------cCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1007 FLPE-----------LW-------EAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1007 ~~~~-----------l~-------~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ..+.           +.       ..........+.+++.+|++.||++|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         232 IWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             hchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0000           00       0000112455789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.97  E-value=5e-31  Score=295.81  Aligned_cols=261  Identities=20%  Similarity=0.266  Sum_probs=193.9

Q ss_pred             ccceeeeccCceEEEEEEecCCcEEEEEEeccC--ccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecCC
Q 001566          778 SIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIG--RFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSG  855 (1052)
Q Consensus       778 ~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  855 (1052)
                      .+.+.+|.|+++.||++.. +++.||+|++...  .....+.+..|++++++++|+||+++++++.++...+++|||+++
T Consensus         5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY   83 (314)
T ss_pred             hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence            4445556666666666644 5899999998754  334457889999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCc----
Q 001566          856 GNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET----  931 (1052)
Q Consensus       856 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~----  931 (1052)
                      |+|.+++.......+++..+..++.|+++|++|||++   +|+||||||+||+++.++.+||+|||.+........    
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            9999999876556789999999999999999999999   999999999999999999999999998875532211    


Q ss_pred             --ccccccccccccccccccCCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHH----HhCC-
Q 001566          932 --HATTDVAGTFGYVAPEYATTC--RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLI----KEGR- 1002 (1052)
Q Consensus       932 --~~~~~~~g~~~y~aPE~~~~~--~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~- 1002 (1052)
                        .......++..|+|||++.+.  .++.++||||+||++|||++|+.||......    ....+......    .... 
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~  236 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT----QMLLEKVRGTVPCLLDKSTY  236 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhccCccccccCch
Confidence              111223467789999998763  5788999999999999999999999742211    00000000000    0000 


Q ss_pred             ------ccc----cccch----hhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1003 ------SSE----LFLPE----LWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1003 ------~~~----~~~~~----l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                            ...    ..++.    ............+.+++.+||+.||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence                  000    00000    001112333456889999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.97  E-value=4.9e-31  Score=287.64  Aligned_cols=242  Identities=23%  Similarity=0.303  Sum_probs=196.8

Q ss_pred             eeccCceEEEEEEec-CCcEEEEEEeccCcc---ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecCCCCH
Q 001566          783 IGTGGFGSTYKAELV-PGYLVAVKKLSIGRF---QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL  858 (1052)
Q Consensus       783 Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  858 (1052)
                      ||+|+||.||+|... +++.||+|++.....   ...+.+.+|++++++++||||+++++++.++...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999665 488999999865432   2346788999999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcccccccc
Q 001566          859 ETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVA  938 (1052)
Q Consensus       859 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  938 (1052)
                      .+++...  ..+++..+..++.|+++|++|||++   +++|+||+|+||+++.++.++|+|||.+.......  ......
T Consensus        81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~  153 (262)
T cd05572          81 WTILRDR--GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFC  153 (262)
T ss_pred             HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccccc
Confidence            9999765  3589999999999999999999998   99999999999999999999999999998664322  223346


Q ss_pred             cccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCCChH
Q 001566          939 GTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQE 1018 (1052)
Q Consensus       939 g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 1018 (1052)
                      ++..|++||.+.+..++.++|+||+|+++|||++|..||.....      +..+..+....... .        ...+..
T Consensus       154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~-~--------~~~~~~  218 (262)
T cd05572         154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE------DPMEIYNDILKGNG-K--------LEFPNY  218 (262)
T ss_pred             CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC------CHHHHHHHHhccCC-C--------CCCCcc
Confidence            78899999999888899999999999999999999999975432      11222222221111 1        112222


Q ss_pred             HHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 001566         1019 NLLGMMRLASTCTVETLSTRPS-----VKQVLI 1046 (1052)
Q Consensus      1019 ~~~~l~~Li~~cl~~dP~~RPt-----~~eil~ 1046 (1052)
                      ....+.+++.+||+.+|++||+     ++|+++
T Consensus       219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            3556999999999999999999     777765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.97  E-value=1.7e-31  Score=301.23  Aligned_cols=255  Identities=20%  Similarity=0.292  Sum_probs=192.5

Q ss_pred             eeeecc--CceEEEEEEe-cCCcEEEEEEeccCcc--ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecCC
Q 001566          781 NLIGTG--GFGSTYKAEL-VPGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSG  855 (1052)
Q Consensus       781 ~~Lg~G--~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  855 (1052)
                      ..||+|  +||+||+|.. .+|+.||+|++.....  ...+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            346666  9999999966 4689999999865432  2346788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc---
Q 001566          856 GNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH---  932 (1052)
Q Consensus       856 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~---  932 (1052)
                      +++.+++.......+++..+..++.|++.||+|||++   +|+||||||+||+++.++.++++||+.+.........   
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            9999999876555689999999999999999999999   9999999999999999999999999865433211100   


Q ss_pred             ---cccccccccccccccccCCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHh-------
Q 001566          933 ---ATTDVAGTFGYVAPEYATTC--RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE------- 1000 (1052)
Q Consensus       933 ---~~~~~~g~~~y~aPE~~~~~--~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------- 1000 (1052)
                         ......++..|+|||++.+.  .++.++||||+||++|||++|+.||......        +........       
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~  232 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT--------QMLLQKLKGPPYSPLD  232 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH--------HHHHHHhcCCCCCCcc
Confidence               00112345679999999763  4688999999999999999999999743211        000000000       


Q ss_pred             -----------------------------CCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1001 -----------------------------GRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1001 -----------------------------~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                                                   +......+..+....+......+.+++.+||+.||++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         233 ITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             ccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                                         0000000111111123345667999999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.97  E-value=2.7e-31  Score=300.61  Aligned_cols=262  Identities=23%  Similarity=0.346  Sum_probs=194.7

Q ss_pred             hCCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCc-cccHHHHHHHHHHhhccCCCceeeEEEEEecC-----Cee
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGE-----AEM  846 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~  846 (1052)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+.++++++|||++++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            46899999999999999999964 468999999986432 22345678899999999999999999987644     357


Q ss_pred             EEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccc
Q 001566          847 FLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL  926 (1052)
Q Consensus       847 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~  926 (1052)
                      ++|+||++ +++.+++..   ..+++..+..++.|+++|++|||+.   +|+||||||+||+++.++.+||+|||++...
T Consensus        84 ~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  156 (336)
T cd07849          84 YIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIA  156 (336)
T ss_pred             EEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeec
Confidence            99999995 588888754   3589999999999999999999999   9999999999999999999999999999865


Q ss_pred             cccCcc--cccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCc
Q 001566          927 EVSETH--ATTDVAGTFGYVAPEYATT-CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRS 1003 (1052)
Q Consensus       927 ~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1052)
                      ......  ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||......     ...............
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~-----~~~~~~~~~~~~~~~  231 (336)
T cd07849         157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL-----HQLNLILGVLGTPSQ  231 (336)
T ss_pred             cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHcCCCCH
Confidence            432211  1223467889999998754 56788999999999999999999999642110     000000000000000


Q ss_pred             -----------c---c--cccchh-hcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001566         1004 -----------S---E--LFLPEL-WEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus      1004 -----------~---~--~~~~~l-~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                                 .   .  ...+.. +....+.....+.+++.+||+.+|++||++.|+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                       0   0  000000 000001224558899999999999999999999864

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.97  E-value=5.8e-31  Score=293.59  Aligned_cols=263  Identities=26%  Similarity=0.334  Sum_probs=198.6

Q ss_pred             HhhCCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCcc--ccHHHHHHHHHHhhccCCCceeeEEEEEecCC----
Q 001566          772 RATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEA----  844 (1052)
Q Consensus       772 ~~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----  844 (1052)
                      ...++|++.+.||+|+||.||+|... +++.||+|+++....  .....+.+|++++++++|||++++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45578999999999999999999765 588999999865432  23356778999999999999999999987654    


Q ss_pred             ------eeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEe
Q 001566          845 ------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLS  918 (1052)
Q Consensus       845 ------~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~  918 (1052)
                            ..++|+||+++ ++.+++... ...++++.+..++.|++.|++|||+.   +|+||||+|+||++++++.+||+
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~  158 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLA  158 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeC
Confidence                  78999999965 787877654 24689999999999999999999999   99999999999999999999999


Q ss_pred             eecccccccccCcccccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHH
Q 001566          919 DFGLARLLEVSETHATTDVAGTFGYVAPEYATT-CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLL  997 (1052)
Q Consensus       919 Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  997 (1052)
                      |||.+...............++..|+|||.+.+ ..++.++||||+||++|||++|++||.....     ....+.....
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-----~~~~~~~~~~  233 (302)
T cd07864         159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-----LAQLELISRL  233 (302)
T ss_pred             cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHH
Confidence            999998665333222233356778999998865 4568899999999999999999999873211     1111111111


Q ss_pred             HHhCCccccccchh------------------hcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566          998 IKEGRSSELFLPEL------------------WEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus       998 ~~~~~~~~~~~~~l------------------~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ..  .......+.+                  ........+..+.+++.+||+.+|++||++.++++
T Consensus       234 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         234 CG--SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             hC--CCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            10  0000000000                  00001123456899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.97  E-value=5.3e-31  Score=286.23  Aligned_cols=247  Identities=23%  Similarity=0.379  Sum_probs=203.1

Q ss_pred             CCccceeeeccCceEEEEEEec-CCcEEEEEEeccCc--cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR--FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      +|++.+.||+|+||.||+|... +++.+|+|.+....  .....++.+|++++++++|+||+++++++.+....++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4788899999999999999554 67899999987543  23345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhcc--CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccC
Q 001566          853 LSGGNLETFIHKKS--GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~  930 (1052)
                      +++++|.+++....  ...++++.+..++.|+++|++|||+.   +++||||+|.||++++++.+|++|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            99999999987632  35689999999999999999999999   9999999999999999999999999999876533 


Q ss_pred             cccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccch
Q 001566          931 THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010 (1052)
Q Consensus       931 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1052)
                        ......+++.|++||.+.+..++.++|+||+|+++|||++|+.||.....        .+.... ...+...      
T Consensus       157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~-~~~~~~~------  219 (256)
T cd08530         157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM--------QDLRYK-VQRGKYP------  219 (256)
T ss_pred             --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHH-HhcCCCC------
Confidence              22234578899999999998899999999999999999999999964321        111111 1111111      


Q ss_pred             hhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1011 LWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1011 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                         ..+.....++.+++.+|++.+|++||++.|+++
T Consensus       220 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         220 ---PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             ---CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence               122344566999999999999999999999975

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.97  E-value=5.1e-31  Score=291.78  Aligned_cols=244  Identities=24%  Similarity=0.388  Sum_probs=197.1

Q ss_pred             ceeeeccCceEEEEEEe-cCCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecCCCCH
Q 001566          780 RNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL  858 (1052)
Q Consensus       780 ~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  858 (1052)
                      ..+||+|+||.||+|.. .+++.||+|++..........+.+|+.+++.++|+|++++++++...+..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            36799999999999966 46899999998665555567788999999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcccccccc
Q 001566          859 ETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVA  938 (1052)
Q Consensus       859 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  938 (1052)
                      .+++...   .+++..+..++.|++.|++|||+.   +++||||+|+||++++++.++|+|||++....... .......
T Consensus       105 ~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~  177 (292)
T cd06657         105 TDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLV  177 (292)
T ss_pred             HHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccccc
Confidence            9988543   478999999999999999999999   99999999999999999999999999987553221 2223346


Q ss_pred             cccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCCChH
Q 001566          939 GTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQE 1018 (1052)
Q Consensus       939 g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 1018 (1052)
                      +++.|+|||.+.+..++.++|+||+|+++|||++|..||.....        .+..... ......     .+.  ....
T Consensus       178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--------~~~~~~~-~~~~~~-----~~~--~~~~  241 (292)
T cd06657         178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--------LKAMKMI-RDNLPP-----KLK--NLHK  241 (292)
T ss_pred             cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHH-HhhCCc-----ccC--Cccc
Confidence            78899999999888889999999999999999999999863211        1111111 111110     000  0112


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1019 NLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1019 ~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      .+..+.+++.+|++.+|.+||++.++++
T Consensus       242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         242 VSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             CCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            3445889999999999999999999886

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.97  E-value=7e-32  Score=316.47  Aligned_cols=252  Identities=28%  Similarity=0.399  Sum_probs=192.1

Q ss_pred             hCCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCc-cccHHHHHHHHHHhhccCCCceeeEEEEEec---------
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG---------  842 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~---------  842 (1052)
                      ..+|+..++||+||||.||+++.+ +|+.||||++.... .+....+.+|+..+.+++|||||+++..+.+         
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            356888899999999999999765 79999999997653 3335678899999999999999998852210         


Q ss_pred             --------------------------------------------------------------------------------
Q 001566          843 --------------------------------------------------------------------------------  842 (1052)
Q Consensus       843 --------------------------------------------------------------------------------  842 (1052)
                                                                                                      
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                                                            


Q ss_pred             ----------------------C--------CeeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhc
Q 001566          843 ----------------------E--------AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS  892 (1052)
Q Consensus       843 ----------------------~--------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~  892 (1052)
                                            +        ...|+=||||+...++++++..... -.....++++.+|++|++|+|++
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGLaYIH~~  716 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGLAYIHDQ  716 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHHHHHHhC
Confidence                                  0        0147789999988888888765411 14678899999999999999999


Q ss_pred             CCCCeeeCCCCCCCEEECCCCcEEEeeeccccccc----c-------------cCcccccccccccccccccccCCCC--
Q 001566          893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE----V-------------SETHATTDVAGTFGYVAPEYATTCR--  953 (1052)
Q Consensus       893 ~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~----~-------------~~~~~~~~~~g~~~y~aPE~~~~~~--  953 (1052)
                         |||||||||.||+++++..|||+|||+|....    .             ......+..+||.-|+|||++.+..  
T Consensus       717 ---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~  793 (1351)
T KOG1035|consen  717 ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN  793 (1351)
T ss_pred             ---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence               99999999999999999999999999998721    0             0111334568999999999997654  


Q ss_pred             -CCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccc
Q 001566          954 -VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTV 1032 (1052)
Q Consensus       954 -~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~ 1032 (1052)
                       |+.|+||||+|++++||+   .||..       .+........+. .+.....  +.+    .......-.++|.+|++
T Consensus       794 ~Yn~KiDmYSLGIVlFEM~---yPF~T-------sMERa~iL~~LR-~g~iP~~--~~f----~~~~~~~e~slI~~Ll~  856 (1351)
T KOG1035|consen  794 KYNSKIDMYSLGIVLFEML---YPFGT-------SMERASILTNLR-KGSIPEP--ADF----FDPEHPEEASLIRWLLS  856 (1351)
T ss_pred             cccchhhhHHHHHHHHHHh---ccCCc-------hHHHHHHHHhcc-cCCCCCC--ccc----ccccchHHHHHHHHHhc
Confidence             899999999999999998   34653       333344333333 2222221  222    22233345789999999


Q ss_pred             cCCCCCCCHHHHHH
Q 001566         1033 ETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1033 ~dP~~RPt~~eil~ 1046 (1052)
                      .||.+||||.|++.
T Consensus       857 hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  857 HDPSKRPTATELLN  870 (1351)
T ss_pred             CCCccCCCHHHHhh
Confidence            99999999999985

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.97  E-value=5.6e-31  Score=290.75  Aligned_cols=257  Identities=26%  Similarity=0.341  Sum_probs=199.8

Q ss_pred             CccceeeeccCceEEEEEEec-CCcEEEEEEeccCccc--cHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeec
Q 001566          777 FSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQ--GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFL  853 (1052)
Q Consensus       777 ~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  853 (1052)
                      |++.+.||+|++|.||+|... +++.+++|++......  ....+..|++++++++|+|++++++++.++...++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            567789999999999999664 6889999998655433  3467888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccc
Q 001566          854 SGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA  933 (1052)
Q Consensus       854 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  933 (1052)
                      + +++.+++.... ..+++..+..++.|+++|++|||+.   +|+|+||+|+||+++.++.++|+|||.+....... ..
T Consensus        81 ~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~  154 (283)
T cd05118          81 D-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP  154 (283)
T ss_pred             C-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence            6 58988887754 5789999999999999999999999   99999999999999999999999999998665432 12


Q ss_pred             ccccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhh
Q 001566          934 TTDVAGTFGYVAPEYATTC-RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012 (1052)
Q Consensus       934 ~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1012 (1052)
                      .....++..|+|||.+.+. .++.++||||+|+++|+|+||+.||......       .+..+.....+.......+...
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~  227 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI-------DQLFKIFRTLGTPDPEVWPKFT  227 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHHHcCCCchHhcccch
Confidence            2334577889999998876 7889999999999999999999998632211       1111111110110000000000


Q ss_pred             ------------------cCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1013 ------------------EAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1013 ------------------~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                                        ..........+.+++.+||+.||.+||++.+++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         228 SLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                              0111234567899999999999999999999975

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.97  E-value=4.4e-31  Score=292.34  Aligned_cols=254  Identities=24%  Similarity=0.329  Sum_probs=201.0

Q ss_pred             CCccceeeeccCceEEEEEEe----cCCcEEEEEEeccCc----cccHHHHHHHHHHhhcc-CCCceeeEEEEEecCCee
Q 001566          776 NFSIRNLIGTGGFGSTYKAEL----VPGYLVAVKKLSIGR----FQGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEAEM  846 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  846 (1052)
                      +|++.+.||+|+||.||+|..    .+++.||||.++...    ......+..|+++++++ +||+++++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            378889999999999999964    246889999886432    22345678899999999 599999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccc
Q 001566          847 FLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL  926 (1052)
Q Consensus       847 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~  926 (1052)
                      ++||||+++++|.+++...  ..+++..+..++.|+++|++|||+.   +++||||+|+||+++.++.++|+|||++...
T Consensus        81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~  155 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence            9999999999999998764  4688999999999999999999998   9999999999999999999999999998866


Q ss_pred             cccCcccccccccccccccccccCCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCcc
Q 001566          927 EVSETHATTDVAGTFGYVAPEYATTCR--VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSS 1004 (1052)
Q Consensus       927 ~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1052)
                      ............++..|+|||.+.+..  .+.++||||+|+++|||++|..||......    ....+..+.......  
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----~~~~~~~~~~~~~~~--  229 (288)
T cd05583         156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ----NSQSEISRRILKSKP--  229 (288)
T ss_pred             ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc----chHHHHHHHHHccCC--
Confidence            443333333446788999999987765  678999999999999999999998632111    111222222221110  


Q ss_pred             ccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 001566         1005 ELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLK 1049 (1052)
Q Consensus      1005 ~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~ 1049 (1052)
                               ..+......+.+++.+||+.+|++|||+.++.+.++
T Consensus       230 ---------~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~  265 (288)
T cd05583         230 ---------PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN  265 (288)
T ss_pred             ---------CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence                     112223445889999999999999999888877664

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.97  E-value=1.2e-30  Score=288.80  Aligned_cols=256  Identities=25%  Similarity=0.338  Sum_probs=195.7

Q ss_pred             CccceeeeccCceEEEEEEec-CCcEEEEEEeccCcccc--HHHHHHHHHHhhcc---CCCceeeEEEEEecCCe-----
Q 001566          777 FSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQG--IQQFDAEIGTLGRI---RHKNLVTLIGYYVGEAE-----  845 (1052)
Q Consensus       777 ~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~-----  845 (1052)
                      |++.+.||+|+||.||+|+.. +++.||+|++.......  ...+.+|+.+++++   .|||++++++++.+...     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            677899999999999999876 48999999997543322  34556777777666   59999999999987766     


Q ss_pred             eEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccc
Q 001566          846 MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARL  925 (1052)
Q Consensus       846 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~  925 (1052)
                      .+++|||+. ++|.+++.......+++..+..++.|+++|++|||+.   +++|+||+|+||++++++.++|+|||.+..
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence            899999996 5899998876545689999999999999999999999   999999999999999999999999999986


Q ss_pred             ccccCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCcc-
Q 001566          926 LEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSS- 1004 (1052)
Q Consensus       926 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 1004 (1052)
                      ......  .....++..|+|||.+.+..++.++||||||+++|||++|++||......        +............ 
T Consensus       157 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~--------~~~~~~~~~~~~~~  226 (287)
T cd07838         157 YSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA--------DQLDKIFDVIGLPS  226 (287)
T ss_pred             ccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH--------HHHHHHHHHcCCCC
Confidence            643221  12234678999999999988999999999999999999999888743211        1111111110000 


Q ss_pred             ------c------cccc---hhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1005 ------E------LFLP---ELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1005 ------~------~~~~---~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                            .      .+..   .......+.....+.+++.+||+.||++||++.|+++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             hHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                  0      0000   0001111233466789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.97  E-value=9.3e-31  Score=288.83  Aligned_cols=257  Identities=23%  Similarity=0.271  Sum_probs=192.9

Q ss_pred             CccceeeeccCceEEEEEEe-cCCcEEEEEEeccCcc-ccHHHHHHHHHHhhccC-CCceeeEEEEEecC--CeeEEEEe
Q 001566          777 FSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR-HKNLVTLIGYYVGE--AEMFLVYN  851 (1052)
Q Consensus       777 ~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e  851 (1052)
                      |++.+.||+|+||.||+|.. .+++.||+|+++.... ........|+.+++++. |+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            67789999999999999965 4688999998865422 22234457888898885 99999999999987  88999999


Q ss_pred             ecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCc
Q 001566          852 FLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET  931 (1052)
Q Consensus       852 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~  931 (1052)
                      |++ +++.+++.... ..+++.++..++.|++.|++|||+.   +|+||||+|+||+++. +.+||+|||++........
T Consensus        81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~  154 (282)
T cd07831          81 LMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP  154 (282)
T ss_pred             cCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence            996 68888887643 4689999999999999999999999   9999999999999999 9999999999986643222


Q ss_pred             ccccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHH-----------HH
Q 001566          932 HATTDVAGTFGYVAPEYATT-CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLL-----------IK  999 (1052)
Q Consensus       932 ~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----------~~  999 (1052)
                        .....++..|+|||.+.. ..++.++||||+||++|||++|+.||......     +...+....           ..
T Consensus       155 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~  227 (282)
T cd07831         155 --YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL-----DQIAKIHDVLGTPDAEVLKKFR  227 (282)
T ss_pred             --cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH-----HHHHHHHHHcCCCCHHHHHhhc
Confidence              123457889999997654 55788999999999999999999999643221     111111110           00


Q ss_pred             hCCccccccchhh----cCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1000 EGRSSELFLPELW----EAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1000 ~~~~~~~~~~~l~----~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      .........+...    .......+..+.+++.+|++++|++||++.++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            0000000000000    0001234567999999999999999999999975

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=5e-33  Score=327.36  Aligned_cols=250  Identities=30%  Similarity=0.436  Sum_probs=204.9

Q ss_pred             CCCccceeeeccCceEEEEE-EecCCcEEEEEEeccCc--cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEe
Q 001566          775 GNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGR--FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYN  851 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~-~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  851 (1052)
                      -+|+....||.|.||.||.| ...+|+-.|+|.+....  .+....+.+|..++..++|||+|+++|+-.+.+..++.||
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence            36778889999999999999 45679999999876543  3345667899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccC-
Q 001566          852 FLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE-  930 (1052)
Q Consensus       852 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~-  930 (1052)
                      ||++|+|.+.++..  ...++.....+..|++.|++|||+.   |||||||||.||+++.+|.+|.+|||.|..+.... 
T Consensus      1315 yC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred             HhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence            99999999999765  3466777778899999999999999   99999999999999999999999999999886442 


Q ss_pred             --cccccccccccccccccccCCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHH-HHHhCCcc
Q 001566          931 --THATTDVAGTFGYVAPEYATTC---RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKL-LIKEGRSS 1004 (1052)
Q Consensus       931 --~~~~~~~~g~~~y~aPE~~~~~---~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 1004 (1052)
                        ........||+.|||||++.+.   ....++||||+||++.||+||++||.....+         |+-. ....|.. 
T Consensus      1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne---------~aIMy~V~~gh~- 1459 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE---------WAIMYHVAAGHK- 1459 (1509)
T ss_pred             cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch---------hHHHhHHhccCC-
Confidence              1233456899999999999763   3556899999999999999999999854333         3222 2222221 


Q ss_pred             ccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001566         1005 ELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus      1005 ~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                              ++.|.....+-.+++.+|+..||++|.++.|+++.
T Consensus      1460 --------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1460 --------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             --------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                    23455566678899999999999999999888753

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1e-30  Score=283.59  Aligned_cols=247  Identities=27%  Similarity=0.471  Sum_probs=203.3

Q ss_pred             CCccceeeeccCceEEEEEEec-CCcEEEEEEeccCcc--ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      +|++.+.||+|++|.||+|... +++.||+|.+.....  ...+.+.+|++++++++|+|++++++++.++...++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4788899999999999999654 578999999976654  3457789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      +++++|.+++...  ..+++..+..++.|++.|+.|||+.   +|+||||+|+||+++.++.++|+|||.+.........
T Consensus        81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (254)
T cd06627          81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD  155 (254)
T ss_pred             CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence            9999999999765  4689999999999999999999999   9999999999999999999999999999876543321


Q ss_pred             cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhh
Q 001566          933 ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012 (1052)
Q Consensus       933 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1012 (1052)
                       .....++..|+|||...+..++.++|||++|+++|+|++|+.||....       ......+ ... . ...       
T Consensus       156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~-------~~~~~~~-~~~-~-~~~-------  217 (254)
T cd06627         156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN-------PMAALFR-IVQ-D-DHP-------  217 (254)
T ss_pred             -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHH-Hhc-c-CCC-------
Confidence             233457889999999988888899999999999999999999986321       1111111 111 1 111       


Q ss_pred             cCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1013 EAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1013 ~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                       ..+...+..+.+++.+|+..+|++||++.|++.
T Consensus       218 -~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         218 -PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             -CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence             112233456889999999999999999999875

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.97  E-value=1.2e-30  Score=285.00  Aligned_cols=245  Identities=21%  Similarity=0.296  Sum_probs=190.1

Q ss_pred             HhhCCCccceee--eccCceEEEEEEe-cCCcEEEEEEeccCccccHHHHHHHHHHhhcc-CCCceeeEEEEEecCCeeE
Q 001566          772 RATGNFSIRNLI--GTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEAEMF  847 (1052)
Q Consensus       772 ~~~~~~~~~~~L--g~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  847 (1052)
                      ...++|++.+.+  |+|+||.||++.. .++..+|+|.+........     |+.....+ +|||++++++++...+..+
T Consensus        11 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~   85 (267)
T PHA03390         11 QFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHV   85 (267)
T ss_pred             HHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence            334567777766  9999999999965 4678899998865432211     22222222 6999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC-cEEEeeecccccc
Q 001566          848 LVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEEL-NAYLSDFGLARLL  926 (1052)
Q Consensus       848 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~-~~kl~Dfgla~~~  926 (1052)
                      +||||+++++|.+++....  .++++++..++.|+++|++|||+.   +++||||+|+||+++.++ .++|+|||.+...
T Consensus        86 iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~  160 (267)
T PHA03390         86 LIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKII  160 (267)
T ss_pred             EEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence            9999999999999997753  789999999999999999999999   999999999999999998 9999999998755


Q ss_pred             cccCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCcccc
Q 001566          927 EVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSEL 1006 (1052)
Q Consensus       927 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      ...     ....++..|+|||++.+..++.++||||+|+++|||++|+.||......   ......+....   ....  
T Consensus       161 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~---~~~~--  227 (267)
T PHA03390        161 GTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE---ELDLESLLKRQ---QKKL--  227 (267)
T ss_pred             CCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc---hhhHHHHHHhh---cccC--
Confidence            422     2235788999999999989999999999999999999999999743222   11122222111   1000  


Q ss_pred             ccchhhcCCChHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 001566         1007 FLPELWEAGPQENLLGMMRLASTCTVETLSTRPS-VKQVLI 1046 (1052)
Q Consensus      1007 ~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt-~~eil~ 1046 (1052)
                         .    .+......+.+++.+|++.+|.+||+ ++|+++
T Consensus       228 ---~----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        228 ---P----FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             ---C----cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence               1    11234456899999999999999996 588874

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.97  E-value=6.2e-31  Score=289.26  Aligned_cols=242  Identities=24%  Similarity=0.323  Sum_probs=186.8

Q ss_pred             eeeccCceEEEEEEe-cCCcEEEEEEeccCccc---cHHHHHHHHHHhhc---cCCCceeeEEEEEecCCeeEEEEeecC
Q 001566          782 LIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQ---GIQQFDAEIGTLGR---IRHKNLVTLIGYYVGEAEMFLVYNFLS  854 (1052)
Q Consensus       782 ~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~---l~h~niv~l~~~~~~~~~~~lv~e~~~  854 (1052)
                      +||+|+||.||+|.. .+++.||+|.+......   ....+.+|..+++.   .+||+++.+++++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999965 45889999988653221   12234445444333   479999999999999999999999999


Q ss_pred             CCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcccc
Q 001566          855 GGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT  934 (1052)
Q Consensus       855 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  934 (1052)
                      +++|.+++...  ..+++..+..++.|++.|++|||+.   +|+||||||+||++++++.++++|||++.......   .
T Consensus        81 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~  152 (279)
T cd05633          81 GGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P  152 (279)
T ss_pred             CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---c
Confidence            99999998765  4689999999999999999999999   99999999999999999999999999987553221   2


Q ss_pred             cccccccccccccccC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhc
Q 001566          935 TDVAGTFGYVAPEYAT-TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWE 1013 (1052)
Q Consensus       935 ~~~~g~~~y~aPE~~~-~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1013 (1052)
                      ....|+..|+|||.+. +..++.++||||+||++|||++|..||......     .. .........      ....   
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~-~~~~~~~~~------~~~~---  217 (279)
T cd05633         153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DK-HEIDRMTLT------VNVE---  217 (279)
T ss_pred             cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc-----CH-HHHHHHhhc------CCcC---
Confidence            2346889999999986 456789999999999999999999999743221     11 111111100      0111   


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 001566         1014 AGPQENLLGMMRLASTCTVETLSTRP-----SVKQVLIK 1047 (1052)
Q Consensus      1014 ~~~~~~~~~l~~Li~~cl~~dP~~RP-----t~~eil~~ 1047 (1052)
                       .+...+..+.+++.+|++.||++||     +++|+++.
T Consensus       218 -~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         218 -LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             -CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence             1233445689999999999999999     59988763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.97  E-value=7.3e-32  Score=301.61  Aligned_cols=266  Identities=26%  Similarity=0.352  Sum_probs=202.9

Q ss_pred             CCCccceeeeccCceEEEEEE-ecCCcEEEEEEeccC-ccccHHHHHHHHHHhhccCCCceeeEEEEEecC------Cee
Q 001566          775 GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGE------AEM  846 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~  846 (1052)
                      .-|...+.||+|+||.||+|+ ..+|+.||||.+... .....++..+|++++++++|+|||+++++=++.      ...
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            346677899999999999997 457999999998653 334567788999999999999999999986543      356


Q ss_pred             EEEEeecCCCCHHHHHhhcc-CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC--CCCc--EEEeeec
Q 001566          847 FLVYNFLSGGNLETFIHKKS-GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLD--EELN--AYLSDFG  921 (1052)
Q Consensus       847 ~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~--~~~~--~kl~Dfg  921 (1052)
                      .+|||||.+|||+..++... ...+++.++..+..+++.||.|||++   ||+||||||.||++-  ++|.  .||+|||
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccc
Confidence            89999999999999998654 46799999999999999999999999   999999999999983  3343  6999999


Q ss_pred             ccccccccCcccccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHh
Q 001566          922 LARLLEVSETHATTDVAGTFGYVAPEYATT-CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE 1000 (1052)
Q Consensus       922 la~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1000 (1052)
                      .|+.+..+  ......+||..|.+||.... +.|+..+|.|||||++||++||..||.+...+...    .+.+......
T Consensus       170 ~Arel~d~--s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~----~~~~~~~~tk  243 (732)
T KOG4250|consen  170 AARELDDN--SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNN----KEIMWHIITK  243 (732)
T ss_pred             ccccCCCC--CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcccc----chhhhhhhcc
Confidence            99977533  35667899999999999995 78888999999999999999999999876555322    2222222222


Q ss_pred             CCcc--ccccch-----hhcC---C----ChHHHHHHHHHHHHccccCCCCCC--CHHHHHHHHh
Q 001566         1001 GRSS--ELFLPE-----LWEA---G----PQENLLGMMRLASTCTVETLSTRP--SVKQVLIKLK 1049 (1052)
Q Consensus      1001 ~~~~--~~~~~~-----l~~~---~----~~~~~~~l~~Li~~cl~~dP~~RP--t~~eil~~L~ 1049 (1052)
                      ....  ....++     -|+.   .    .......+.+.+..++..+|++|-  .+.+....+.
T Consensus       244 kp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~  308 (732)
T KOG4250|consen  244 KPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVD  308 (732)
T ss_pred             CCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHH
Confidence            2111  111111     1111   1    133445567788888899999998  5555444443

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.97  E-value=9.6e-31  Score=289.89  Aligned_cols=251  Identities=24%  Similarity=0.365  Sum_probs=198.3

Q ss_pred             CCccceeeeccCceEEEEEEe----cCCcEEEEEEeccCcc----ccHHHHHHHHHHhhcc-CCCceeeEEEEEecCCee
Q 001566          776 NFSIRNLIGTGGFGSTYKAEL----VPGYLVAVKKLSIGRF----QGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEAEM  846 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  846 (1052)
                      +|++.+.||+|+||.||+|..    .+|+.||+|++.....    ...+.+.+|+++++++ +|++|+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            478889999999999999965    3688999999865322    2245678899999999 599999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccc
Q 001566          847 FLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL  926 (1052)
Q Consensus       847 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~  926 (1052)
                      ++|+||+++++|.+++...  ..+++..+..++.|+++|++|||+.   +++||||+|+||++++++.+||+|||++...
T Consensus        81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  155 (290)
T cd05613          81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF  155 (290)
T ss_pred             EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence            9999999999999999765  4688999999999999999999999   9999999999999999999999999999866


Q ss_pred             cccCcccccccccccccccccccCCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCcc
Q 001566          927 EVSETHATTDVAGTFGYVAPEYATTC--RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSS 1004 (1052)
Q Consensus       927 ~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1052)
                      ............++..|+|||.+.+.  .++.++||||+|+++|+|++|+.||.....    .....++.+.......  
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~----~~~~~~~~~~~~~~~~--  229 (290)
T cd05613         156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE----KNSQAEISRRILKSEP--  229 (290)
T ss_pred             ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc----cccHHHHHHHhhccCC--
Confidence            43332333345678899999998753  467889999999999999999999863211    1122222222222111  


Q ss_pred             ccccchhhcCCChHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 001566         1005 ELFLPELWEAGPQENLLGMMRLASTCTVETLSTRP-----SVKQVLI 1046 (1052)
Q Consensus      1005 ~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RP-----t~~eil~ 1046 (1052)
                               ..+......+.+++.+|++.||++||     ++.++..
T Consensus       230 ---------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         230 ---------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             ---------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                     11223345688999999999999997     6666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.97  E-value=7e-31  Score=294.13  Aligned_cols=262  Identities=24%  Similarity=0.325  Sum_probs=194.5

Q ss_pred             hhCCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCccc--cHHHHHHHHHHhhccCCCceeeEEEEEecCC-----
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQ--GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEA-----  844 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  844 (1052)
                      ..++|++.+.||+|+||.||+|... +++.||+|++......  ....+.+|++++++++|||++++++++....     
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            3457999999999999999999664 6899999988654322  2345678999999999999999999987543     


Q ss_pred             ---eeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeec
Q 001566          845 ---EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFG  921 (1052)
Q Consensus       845 ---~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfg  921 (1052)
                         ..++||||+. +++.+++.... ..+++.++..++.|+++|++|||++   +++|+||+|+||+++.++.+||+|||
T Consensus        90 ~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          90 YKGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             CCceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCC
Confidence               4599999995 58888886643 4689999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccccCcc---cccccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHH
Q 001566          922 LARLLEVSETH---ATTDVAGTFGYVAPEYATTC-RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLL  997 (1052)
Q Consensus       922 la~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  997 (1052)
                      ++.........   ......++..|+|||.+.+. .++.++||||+|+++|||++|+.||......     .........
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~-----~~~~~~~~~  239 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ-----HQLTLISQL  239 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHH
Confidence            99866432211   12234567889999988664 3688999999999999999999998643221     111111111


Q ss_pred             HHhCCccccccch-------------------hhcC-CChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566          998 IKEGRSSELFLPE-------------------LWEA-GPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus       998 ~~~~~~~~~~~~~-------------------l~~~-~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ..  .....+.+.                   .... .+......+.+++.+|++.||++|||++|+++
T Consensus       240 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         240 CG--SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hC--CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            10  000000000                   0000 00011235678999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.7e-30  Score=283.72  Aligned_cols=249  Identities=24%  Similarity=0.347  Sum_probs=197.1

Q ss_pred             CCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCc-----cccHHHHHHHHHHhhccCCCceeeEEEEEecC--Cee
Q 001566          775 GNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGR-----FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGE--AEM  846 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  846 (1052)
                      .+|++.+.||+|+||.||+|.. .++..||+|.+....     .+....+.+|++++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4689999999999999999965 458999999875321     22345788999999999999999999998764  468


Q ss_pred             EEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccc
Q 001566          847 FLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL  926 (1052)
Q Consensus       847 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~  926 (1052)
                      ++|+||+++++|.+++...  ..+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||+++..
T Consensus        82 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  156 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRI  156 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence            8999999999999999764  3578999999999999999999999   9999999999999999999999999999865


Q ss_pred             cccC--cccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCcc
Q 001566          927 EVSE--THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSS 1004 (1052)
Q Consensus       927 ~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1052)
                      ....  ........++..|+|||.+.+..++.++|+|||||++||+++|+.||.....        ............ .
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~-~  227 (264)
T cd06653         157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA--------MAAIFKIATQPT-K  227 (264)
T ss_pred             ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH--------HHHHHHHHcCCC-C
Confidence            3211  1112234578899999999988899999999999999999999999863211        111111111110 1


Q ss_pred             ccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1005 ELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1005 ~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                              ...+......+.+++.+|+. +|.+||++.+++.
T Consensus       228 --------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         228 --------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             --------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence                    11233445569999999999 5799999998865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.97  E-value=4.4e-31  Score=288.35  Aligned_cols=244  Identities=26%  Similarity=0.396  Sum_probs=195.5

Q ss_pred             eeccCceEEEEEEec-CCcEEEEEEeccCcc---ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecCCCCH
Q 001566          783 IGTGGFGSTYKAELV-PGYLVAVKKLSIGRF---QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL  858 (1052)
Q Consensus       783 Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  858 (1052)
                      ||+|+||.||+|... +|+.+|+|.+.....   ...+.+.+|++++++++|||++++++++......|+++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999776 489999999865433   3456788899999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCc-------
Q 001566          859 ETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET-------  931 (1052)
Q Consensus       859 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~-------  931 (1052)
                      .+++....  .+++..+..++.|+++|++|||+.   +++||||+|+||++++++.++|+|||++........       
T Consensus        81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence            99998753  689999999999999999999999   999999999999999999999999999875533211       


Q ss_pred             ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchh
Q 001566          932 HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPEL 1011 (1052)
Q Consensus       932 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1011 (1052)
                      .......++..|+|||...+...+.++||||||+++||+++|+.||.....        .+....... +....   +  
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~-~~~~~---~--  221 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP--------EEIFQNILN-GKIEW---P--  221 (265)
T ss_pred             ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhc-CCcCC---C--
Confidence            122334577899999999988889999999999999999999999974321        122222211 11110   0  


Q ss_pred             hcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 001566         1012 WEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKL 1048 (1052)
Q Consensus      1012 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L 1048 (1052)
                         .....+..+.+++.+|++.+|++|||+.++.+.+
T Consensus       222 ---~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         222 ---EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             ---ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence               0011245688999999999999999995554444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.6e-32  Score=273.51  Aligned_cols=242  Identities=24%  Similarity=0.326  Sum_probs=199.7

Q ss_pred             hhCCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCcc---ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEE
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRF---QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFL  848 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  848 (1052)
                      ..++|+..++||+|.||.|..++- .+++.+|+|++++...   .+.+.-..|-++++..+||.+..+--.|+..+..|+
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            446789999999999999999954 4689999999876533   334555779999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccc
Q 001566          849 VYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV  928 (1052)
Q Consensus       849 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~  928 (1052)
                      ||||..||.|.-++.+.  ..++++...-+-..|+.||.|||++   +||.||+|.+|.|+|.+|.+||+|||+++.- -
T Consensus       246 VMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~-I  319 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEE-I  319 (516)
T ss_pred             EEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhc-c
Confidence            99999999999888775  5789999999999999999999999   9999999999999999999999999999742 2


Q ss_pred             cCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCcccccc
Q 001566          929 SETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFL 1008 (1052)
Q Consensus       929 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                      .........+|||.|+|||++....|..+.|.|.+||++|||++|+.||+.-..+     .+.+    ++..+..     
T Consensus       320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~-----kLFe----LIl~ed~-----  385 (516)
T KOG0690|consen  320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE-----KLFE----LILMEDL-----  385 (516)
T ss_pred             cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh-----HHHH----HHHhhhc-----
Confidence            2334556789999999999999999999999999999999999999999843222     1111    1111110     


Q ss_pred             chhhcCCChHHHHHHHHHHHHccccCCCCCC
Q 001566         1009 PELWEAGPQENLLGMMRLASTCTVETLSTRP 1039 (1052)
Q Consensus      1009 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RP 1039 (1052)
                           ..|.....+...|+...+..||.+|.
T Consensus       386 -----kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  386 -----KFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             -----cCCccCCHHHHHHHHHHhhcChHhhc
Confidence                 12333344577899999999999997

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=6.1e-31  Score=297.72  Aligned_cols=261  Identities=21%  Similarity=0.275  Sum_probs=196.6

Q ss_pred             hCCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccC--ccccHHHHHHHHHHhhccCCCceeeEEEEEecC-----Ce
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIG--RFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGE-----AE  845 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~  845 (1052)
                      ..+|++.+.||+|+||.||+|.. .+++.||||++...  ......++.+|+.+++.++|+|++++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            35799999999999999999965 46899999988643  223345677899999999999999999987644     34


Q ss_pred             eEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccc
Q 001566          846 MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARL  925 (1052)
Q Consensus       846 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~  925 (1052)
                      .++|+||+ +++|.+++...  ..+++..+..++.|++.|+.|||++   +++||||||+||+++.++.+||+|||++..
T Consensus        84 ~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  157 (337)
T cd07858          84 VYIVYELM-DTDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLART  157 (337)
T ss_pred             EEEEEeCC-CCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence            79999999 47899988754  4689999999999999999999999   999999999999999999999999999986


Q ss_pred             ccccCcccccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHh----
Q 001566          926 LEVSETHATTDVAGTFGYVAPEYATT-CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE---- 1000 (1052)
Q Consensus       926 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 1000 (1052)
                      ..... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......     ............    
T Consensus       158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~  231 (337)
T cd07858         158 TSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV-----HQLKLITELLGSPSEE  231 (337)
T ss_pred             cCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH-----HHHHHHHHHhCCCChH
Confidence            64322 22233457889999998865 46889999999999999999999999643110     000000000000    


Q ss_pred             -------CC-------ccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001566         1001 -------GR-------SSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus      1001 -------~~-------~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                             ..       ......+... ...+.....+.+++.+|++.+|++||+++|+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         232 DLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             HhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence                   00       0000000000 0112344568999999999999999999999864

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.97  E-value=1.2e-30  Score=289.81  Aligned_cols=253  Identities=25%  Similarity=0.414  Sum_probs=195.4

Q ss_pred             hCCCccceeeeccCceEEEEEEecC-CcEEEEEEeccCcc-ccHHHHHHHHHHhhccC-CCceeeEEEEEecCCeeEEEE
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR-HKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      .++|++.+.||+|+||.||+|.... ++.||||++..... .....+..|+..+.+.. ||||+++++++.++...++||
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            3568899999999999999997764 89999999875432 23345666777676664 999999999999999999999


Q ss_pred             eecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccC
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~  930 (1052)
                      ||+ .+++.++..... ..+++..+..++.|++.|++|||+..  +|+||||+|+||++++++.+||+|||++..+....
T Consensus        94 e~~-~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          94 ELM-STCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             ecc-CcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence            998 457888776643 47899999999999999999999732  89999999999999999999999999987654222


Q ss_pred             cccccccccccccccccccCCCC----CCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCcccc
Q 001566          931 THATTDVAGTFGYVAPEYATTCR----VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSEL 1006 (1052)
Q Consensus       931 ~~~~~~~~g~~~y~aPE~~~~~~----~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      .  .....++..|+|||.+.+..    ++.++||||||+++|||++|+.||......       .+............  
T Consensus       170 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~--  238 (296)
T cd06618         170 A--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-------FEVLTKILQEEPPS--  238 (296)
T ss_pred             c--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-------HHHHHHHhcCCCCC--
Confidence            1  12235778999999987654    788999999999999999999998632111       12222222221110  


Q ss_pred             ccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001566         1007 FLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus      1007 ~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                          ..  .....+.++.+++.+||+.||++||++.++++.
T Consensus       239 ----~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         239 ----LP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             ----CC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                00  011234568999999999999999999999764

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-31  Score=264.74  Aligned_cols=250  Identities=24%  Similarity=0.429  Sum_probs=197.5

Q ss_pred             CCccceeeeccCceEEEEEEec-CCcEEEEEEeccC-ccccHHHHHHHHHHhhccC-CCceeeEEEEEecCCeeEEEEee
Q 001566          776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIG-RFQGIQQFDAEIGTLGRIR-HKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      +.+...-||.|.-|.||+++++ +|..+|||.+... ..++.+++...+.++.+-+ +|.||+.+|+|..+..+++.||.
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel  172 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL  172 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence            3455677999999999999776 4899999998654 4445667777787776664 89999999999999999999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      | ....+.++++.. +++++..+-++...+++||.||.+++  +|+|||+||+|||+|+.|.+|+||||.+..+-  +..
T Consensus       173 M-s~C~ekLlkrik-~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlv--dSk  246 (391)
T KOG0983|consen  173 M-STCAEKLLKRIK-GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLV--DSK  246 (391)
T ss_pred             H-HHHHHHHHHHhc-CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceee--ccc
Confidence            8 456666666554 67899899999999999999999996  99999999999999999999999999998664  334


Q ss_pred             cccccccccccccccccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccc
Q 001566          933 ATTDVAGTFGYVAPEYATT---CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009 (1052)
Q Consensus       933 ~~~~~~g~~~y~aPE~~~~---~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                      ......|-+.|||||.+.-   ..|..++||||||+.++|+.||..||.....++       +....+..+ .. ..+..
T Consensus       247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF-------e~ltkvln~-eP-P~L~~  317 (391)
T KOG0983|consen  247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF-------EVLTKVLNE-EP-PLLPG  317 (391)
T ss_pred             ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH-------HHHHHHHhc-CC-CCCCc
Confidence            4444578899999999864   457889999999999999999999998644332       222222221 11 11111


Q ss_pred             hhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1010 ELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1010 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      .      ......+++++..|+..|+.+||...++++
T Consensus       318 ~------~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  318 H------MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             c------cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            1      113455999999999999999999998875

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.1e-30  Score=284.46  Aligned_cols=242  Identities=22%  Similarity=0.292  Sum_probs=187.6

Q ss_pred             eeeeccCceEEEEEEe-cCCcEEEEEEeccCccc---cHHHHHHHHHHh-hccCCCceeeEEEEEecCCeeEEEEeecCC
Q 001566          781 NLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQ---GIQQFDAEIGTL-GRIRHKNLVTLIGYYVGEAEMFLVYNFLSG  855 (1052)
Q Consensus       781 ~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  855 (1052)
                      +.||+|+||.||+|.. .+++.||+|.+......   ....+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5689999999999965 45889999998654321   123344454444 445899999999999999999999999999


Q ss_pred             CCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccccc
Q 001566          856 GNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT  935 (1052)
Q Consensus       856 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  935 (1052)
                      ++|.+++...  ..+++..+..++.|++.|+.|||+.   +++||||+|+||++++++.++|+|||++.....     ..
T Consensus        82 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~  151 (260)
T cd05611          82 GDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NK  151 (260)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----cc
Confidence            9999999765  4688999999999999999999999   999999999999999999999999999875432     22


Q ss_pred             ccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCC
Q 001566          936 DVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAG 1015 (1052)
Q Consensus       936 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 1015 (1052)
                      ...++..|+|||.+.+..++.++||||+|+++|||++|..||.....        .+...... .+...  ..+.    .
T Consensus       152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~-~~~~~--~~~~----~  216 (260)
T cd05611         152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP--------DAVFDNIL-SRRIN--WPEE----V  216 (260)
T ss_pred             cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHH-hcccC--CCCc----c
Confidence            34578899999999988889999999999999999999999964321        11112111 11111  0111    1


Q ss_pred             ChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001566         1016 PQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus      1016 ~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                      ....+..+.+++.+||+.+|++||++.++.+.
T Consensus       217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~  248 (260)
T cd05611         217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEI  248 (260)
T ss_pred             cccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence            12334568999999999999999977544443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.97  E-value=1.2e-30  Score=295.43  Aligned_cols=260  Identities=27%  Similarity=0.352  Sum_probs=196.4

Q ss_pred             hhCCCccceeeeccCceEEEEEEec-CCcEEEEEEeccC--ccccHHHHHHHHHHhhcc-CCCceeeEEEEEecC--Cee
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIG--RFQGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGE--AEM  846 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~~  846 (1052)
                      ..++|++.+.||+|+||.||+|... +++.+|+|++...  .......+.+|+.+++++ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            3467999999999999999999654 5889999988542  223345677899999999 999999999998653  368


Q ss_pred             EEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccc
Q 001566          847 FLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL  926 (1052)
Q Consensus       847 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~  926 (1052)
                      ++||||++ ++|.+++...   .+++..+..++.|++.|++|||+.   +|+||||+|+||+++.++.+||+|||++...
T Consensus        85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSL  157 (337)
T ss_pred             EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence            99999996 6999988754   578899999999999999999999   9999999999999999999999999999866


Q ss_pred             cccCc----ccccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhC
Q 001566          927 EVSET----HATTDVAGTFGYVAPEYATT-CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEG 1001 (1052)
Q Consensus       927 ~~~~~----~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1052)
                      .....    .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......       ...+.....+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~-------~~~~~~~~~~  230 (337)
T cd07852         158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN-------QLEKIIEVIG  230 (337)
T ss_pred             ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH-------HHHHHHHHhC
Confidence            43221    12233467889999998765 457889999999999999999999986432110       0000000000


Q ss_pred             Cccc-------------ccc-------chhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001566         1002 RSSE-------------LFL-------PELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus      1002 ~~~~-------------~~~-------~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                      ....             .+.       .... ......+..+.+++.+||+.||++|||+.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         231 PPSAEDIESIKSPFAATMLDSLPSRPRKPLD-ELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             CCCHHHHHHHHhhhHHHhhhhcccccccchh-hhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            0000             000       0000 0011235568999999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.97  E-value=8.1e-31  Score=296.42  Aligned_cols=264  Identities=22%  Similarity=0.315  Sum_probs=196.7

Q ss_pred             hCCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCcc--ccHHHHHHHHHHhhccCCCceeeEEEEEec----CCee
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKNLVTLIGYYVG----EAEM  846 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~  846 (1052)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++.....  .....+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            36799999999999999999965 4689999999865422  334667889999999999999999998763    3468


Q ss_pred             EEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccc
Q 001566          847 FLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL  926 (1052)
Q Consensus       847 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~  926 (1052)
                      ++|+||+. ++|.+++...  ..+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+||+|||++...
T Consensus        84 ~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGL  157 (334)
T ss_pred             EEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceee
Confidence            99999994 6999998654  4589999999999999999999999   9999999999999999999999999999765


Q ss_pred             cccCc---ccccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCC----------CCccHH-
Q 001566          927 EVSET---HATTDVAGTFGYVAPEYATT-CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYG----------NGFNIV-  991 (1052)
Q Consensus       927 ~~~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~----------~~~~~~-  991 (1052)
                      .....   .......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||........          ...... 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~  237 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN  237 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence            43221   11223467889999999865 4578899999999999999999999964321100          000000 


Q ss_pred             ----HHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566          992 ----SWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus       992 ----~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                          ..............   +..+....+..+..+.+++.+|++.+|++||++.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         238 RIGSDRVRKYIQNLPRKQ---PVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hhchhhHHHHHhhcccCC---CCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                00000000000000   00000011223566999999999999999999999876

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.97  E-value=4.1e-30  Score=287.71  Aligned_cols=243  Identities=30%  Similarity=0.383  Sum_probs=193.3

Q ss_pred             CccceeeeccCceEEEEEEe-cCCcEEEEEEeccCcc---ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          777 FSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRF---QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       777 ~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      |...+.||+|+||.||+|.. .+++.||+|++.....   .....+.+|+++++.++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            66667899999999999965 4688999999865432   2335678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      +. |++.+++.... ..+++.++..++.|++.|++|||++   +|+||||+|+||++++++.++|+|||++....     
T Consensus       103 ~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~-----  172 (313)
T cd06633         103 CL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSS-----  172 (313)
T ss_pred             CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccC-----
Confidence            95 68888886643 5689999999999999999999999   99999999999999999999999999986432     


Q ss_pred             cccccccccccccccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccc
Q 001566          933 ATTDVAGTFGYVAPEYAT---TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009 (1052)
Q Consensus       933 ~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                      ......++..|+|||.+.   +..++.++||||||+++|||++|..||.....        ........... ....   
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~--------~~~~~~~~~~~-~~~~---  240 (313)
T cd06633         173 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQND-SPTL---  240 (313)
T ss_pred             CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHhcC-CCCC---
Confidence            122346788999999984   45678899999999999999999999864321        11122221111 1110   


Q ss_pred             hhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1010 ELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1010 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                           ........+.+++.+|++.+|++||++.++++
T Consensus       241 -----~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         241 -----QSNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             -----CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 01122345889999999999999999999885

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.97  E-value=7.6e-31  Score=289.14  Aligned_cols=248  Identities=24%  Similarity=0.385  Sum_probs=202.4

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCc---cccHHHHHHHHHHhhccC-CCceeeEEEEEecCCeeEEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRIR-HKNLVTLIGYYVGEAEMFLV  849 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv  849 (1052)
                      ++|++.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|++++++++ ||||+++++++.+++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            36889999999999999999664 68999999886532   233466788999999998 99999999999999999999


Q ss_pred             EeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccccccc
Q 001566          850 YNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS  929 (1052)
Q Consensus       850 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~  929 (1052)
                      |||+++++|.+++...  ..+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||++......
T Consensus        81 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~  155 (280)
T cd05581          81 LEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN  155 (280)
T ss_pred             EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence            9999999999999875  3699999999999999999999999   9999999999999999999999999999866432


Q ss_pred             Cc-------------------ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccH
Q 001566          930 ET-------------------HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI  990 (1052)
Q Consensus       930 ~~-------------------~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~  990 (1052)
                      ..                   .......++..|+|||...+..++.++||||+|+++|++++|+.||....        .
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~  227 (280)
T cd05581         156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN--------E  227 (280)
T ss_pred             cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc--------H
Confidence            21                   12223457789999999998889999999999999999999999997432        1


Q ss_pred             HHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCH----HHHHH
Q 001566          991 VSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSV----KQVLI 1046 (1052)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~----~eil~ 1046 (1052)
                      ....+......           ...+...+..+.+++.+|++.+|++||++    .|+++
T Consensus       228 ~~~~~~~~~~~-----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         228 YLTFQKILKLE-----------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HHHHHHHHhcC-----------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            11112221111           01222334568999999999999999999    77764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.97  E-value=9.8e-32  Score=269.80  Aligned_cols=252  Identities=23%  Similarity=0.306  Sum_probs=198.5

Q ss_pred             hCCCccc-eeeeccCceEEEEEEe-cCCcEEEEEEeccCccccHHHHHHHHHHhhcc-CCCceeeEEEEEec----CCee
Q 001566          774 TGNFSIR-NLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRI-RHKNLVTLIGYYVG----EAEM  846 (1052)
Q Consensus       774 ~~~~~~~-~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~~  846 (1052)
                      +++|++. ++||-|-.|.|..+.. .+++++|+|++...     ....+|++..-.. .|||||.++++|+.    ...+
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL  134 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL  134 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence            3455554 5799999999999954 57899999987532     3446777765544 69999999999864    3567


Q ss_pred             EEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---CCcEEEeeeccc
Q 001566          847 FLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDE---ELNAYLSDFGLA  923 (1052)
Q Consensus       847 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~---~~~~kl~Dfgla  923 (1052)
                      .+|||.|+||.|.+.++.+..+.+++.++..|++||+.|+.|||+.   +|.|||+||+|+|.+.   +..+|++|||+|
T Consensus       135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFA  211 (400)
T KOG0604|consen  135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFA  211 (400)
T ss_pred             EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccc
Confidence            8999999999999999999888999999999999999999999999   9999999999999964   456899999999


Q ss_pred             ccccccCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCc
Q 001566          924 RLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRS 1003 (1052)
Q Consensus       924 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1052)
                      +....  ........-||.|.|||++...+|+...|+||+||++|-|++|.+||+..-..     .+.--++..++.+..
T Consensus       212 K~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~-----aispgMk~rI~~gqy  284 (400)
T KOG0604|consen  212 KETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-----AISPGMKRRIRTGQY  284 (400)
T ss_pred             cccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc-----cCChhHHhHhhccCc
Confidence            96542  33344556799999999999999999999999999999999999999843221     111123334444332


Q ss_pred             cccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1004 SELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1004 ~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      .  |-..-|    ....+...++|+.++..+|++|.|+.|++.
T Consensus       285 ~--FP~pEW----s~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  285 E--FPEPEW----SCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             c--CCChhH----hHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            2  111112    234556889999999999999999999864

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.97  E-value=2.2e-30  Score=289.29  Aligned_cols=245  Identities=29%  Similarity=0.379  Sum_probs=194.6

Q ss_pred             CCccceeeeccCceEEEEEEec-CCcEEEEEEeccCc---cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEe
Q 001566          776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYN  851 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  851 (1052)
                      .|+..+.||+|+||.||+|... ++..+|+|.+....   .....++.+|+++++.++|+|++++++++.+....++|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            4777788999999999999754 57889999886432   2234567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCc
Q 001566          852 FLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET  931 (1052)
Q Consensus       852 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~  931 (1052)
                      |+. |++.+++.... ..+++.++..++.|++.|+.|||+.   +++||||+|+||+++.++.++|+|||++......  
T Consensus        96 ~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--  168 (308)
T cd06634          96 YCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (308)
T ss_pred             ccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence            995 68888776543 4689999999999999999999999   9999999999999999999999999998755422  


Q ss_pred             ccccccccccccccccccC---CCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCcccccc
Q 001566          932 HATTDVAGTFGYVAPEYAT---TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFL 1008 (1052)
Q Consensus       932 ~~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                         ....+++.|+|||.+.   ...++.++|||||||++|||++|+.||.....        .+....... +...    
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------~~~~~~~~~-~~~~----  232 (308)
T cd06634         169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQ-NESP----  232 (308)
T ss_pred             ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH--------HHHHHHHhh-cCCC----
Confidence               2345788999999974   35578899999999999999999999863211        111111111 1111    


Q ss_pred             chhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001566         1009 PELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus      1009 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                       .   ..+......+.+++.+||+.+|++||++.++++.
T Consensus       233 -~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         233 -A---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             -C---cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence             0   0112344568899999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.1e-30  Score=295.09  Aligned_cols=258  Identities=24%  Similarity=0.325  Sum_probs=200.9

Q ss_pred             CCccceeeeccCceEEEEEEec-CCcEEEEEEeccCc--cccHHHHHHHHHHhhccCCCceeeEEEEEecCC-----eeE
Q 001566          776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR--FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEA-----EMF  847 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~  847 (1052)
                      +|++.+.||+|+||.||+|... +++.||+|++....  ....+.+.+|+.+++.++|+||+++++++....     ..|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5888999999999999999765 48999999987543  334567889999999999999999999988765     789


Q ss_pred             EEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccccc
Q 001566          848 LVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE  927 (1052)
Q Consensus       848 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~  927 (1052)
                      +||||++ ++|.+++...  ..+++..+..++.|++.|++|||+.   ||+||||||.||+++.++.++|+|||.+....
T Consensus        81 lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~  154 (330)
T cd07834          81 IVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVD  154 (330)
T ss_pred             EEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence            9999996 5899988764  3789999999999999999999999   99999999999999999999999999998765


Q ss_pred             ccCc--ccccccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCC-c
Q 001566          928 VSET--HATTDVAGTFGYVAPEYATTC-RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGR-S 1003 (1052)
Q Consensus       928 ~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 1003 (1052)
                      ....  .......++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||......        +..+....... .
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~--------~~~~~i~~~~~~~  226 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI--------DQLNLIVEVLGTP  226 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH--------HHHHHHHHhcCCC
Confidence            4321  123344678899999999887 7889999999999999999999999643211        11111111000 0


Q ss_pred             ccc-------------------ccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001566         1004 SEL-------------------FLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus      1004 ~~~-------------------~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                      ...                   ..+.-+.......+..+.+++.+||+.+|++||++.++++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         227 SEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             ChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            000                   00000001112235568999999999999999999999873

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.97  E-value=1e-30  Score=296.42  Aligned_cols=258  Identities=18%  Similarity=0.282  Sum_probs=194.0

Q ss_pred             hCCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecC---------
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGE---------  843 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---------  843 (1052)
                      ..+|++.+.||+|+||.||+|.. .+++.||+|++........+.+.+|++++++++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            36899999999999999999965 46889999998776666667889999999999999999999876543         


Q ss_pred             -----CeeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC-CCCcEEE
Q 001566          844 -----AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLD-EELNAYL  917 (1052)
Q Consensus       844 -----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~-~~~~~kl  917 (1052)
                           ...++|+||++ ++|.+++...   .+++..+..++.|+++|++|||+.   +|+||||||+||+++ +++.+++
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl  156 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKI  156 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEE
Confidence                 35789999996 6998888643   588999999999999999999999   999999999999997 4567899


Q ss_pred             eeecccccccccCcc--cccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHH
Q 001566          918 SDFGLARLLEVSETH--ATTDVAGTFGYVAPEYATT-CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWA  994 (1052)
Q Consensus       918 ~Dfgla~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  994 (1052)
                      +|||.+.........  ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||....+.        +..
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~--------~~~  228 (342)
T cd07854         157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL--------EQM  228 (342)
T ss_pred             CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHH
Confidence            999999865432211  1122357888999998654 55788999999999999999999999743221        001


Q ss_pred             HHHHHhCCcc-------------cccc------chhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566          995 KLLIKEGRSS-------------ELFL------PELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus       995 ~~~~~~~~~~-------------~~~~------~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ..........             ....      ........+....++.+++.+|++.||++||++.|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         229 QLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             HHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            1000000000             0000      00000001123356889999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=1.4e-30  Score=287.59  Aligned_cols=263  Identities=26%  Similarity=0.351  Sum_probs=197.0

Q ss_pred             CccceeeeccCceEEEEEEec-CCcEEEEEEeccCcc-ccHHHHHHHHHHhhccC-CCceeeEEEEEecCCeeEEEEeec
Q 001566          777 FSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR-HKNLVTLIGYYVGEAEMFLVYNFL  853 (1052)
Q Consensus       777 ~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  853 (1052)
                      |++.+.||+|++|+||+|... +++.||+|++..... .......+|+..+++++ |+|++++++++.+++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            677899999999999999765 478899998865432 22234567899999998 999999999999999999999999


Q ss_pred             CCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccc
Q 001566          854 SGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA  933 (1052)
Q Consensus       854 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  933 (1052)
                       +|+|.+++.......+++.++..++.|+++|+.|||++   +++|+||+|+||++++++.++|+|||.+........  
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--  154 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--  154 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence             88999999876555789999999999999999999999   999999999999999999999999999986543221  


Q ss_pred             ccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCC--------CccHHHHHHHHHHhCCcc
Q 001566          934 TTDVAGTFGYVAPEYATT-CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGN--------GFNIVSWAKLLIKEGRSS 1004 (1052)
Q Consensus       934 ~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~ 1004 (1052)
                      .....++..|+|||.+.+ ..++.++|+||||+++|||++|+.||.........        ......|...........
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07830         155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG  234 (283)
T ss_pred             cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence            223457889999998754 45788999999999999999999998643211000        000001111111110000


Q ss_pred             cccc----chhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1005 ELFL----PELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1005 ~~~~----~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ..+.    ..+ ....+.....+.+++.+||+.+|++||++.|++.
T Consensus       235 ~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         235 FRFPQFAPTSL-HQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             ccccccccccH-HHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            0000    000 0001112456899999999999999999999975

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.97  E-value=1.6e-30  Score=291.38  Aligned_cols=259  Identities=25%  Similarity=0.332  Sum_probs=193.3

Q ss_pred             hCCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCccc--cHHHHHHHHHHhhccCCCceeeEEEEEecC-------
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQ--GIQQFDAEIGTLGRIRHKNLVTLIGYYVGE-------  843 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------  843 (1052)
                      .++|++.+.||+|+||.||+|... +++.||+|++......  ....+.+|++++++++||||+++++++.+.       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468999999999999999999754 5889999988654322  234567899999999999999999987543       


Q ss_pred             -CeeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecc
Q 001566          844 -AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGL  922 (1052)
Q Consensus       844 -~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgl  922 (1052)
                       ...++|+||+. +++..++.... ..+++.++..++.|+++|++|||++   +|+||||||+||++++++.++|+|||+
T Consensus        87 ~~~~~lv~~~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~  161 (311)
T cd07866          87 RGSVYMVTPYMD-HDLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGL  161 (311)
T ss_pred             CceEEEEEecCC-cCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCcc
Confidence             34699999995 57877776542 5699999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCcc----------cccccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHH
Q 001566          923 ARLLEVSETH----------ATTDVAGTFGYVAPEYATTC-RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIV  991 (1052)
Q Consensus       923 a~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~  991 (1052)
                      +.........          ......+++.|+|||.+.+. .++.++||||+|+++|||++|++||......        
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~--------  233 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI--------  233 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH--------
Confidence            9865432211          11223567889999987654 5788999999999999999999998643221        


Q ss_pred             HHHHHHHHhCCc------------cc--------cccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566          992 SWAKLLIKEGRS------------SE--------LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus       992 ~~~~~~~~~~~~------------~~--------~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ...+........            ..        ...+.+.. ........+.+++.+|++.||++|||+.|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         234 DQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE-RFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHH-HcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            111111110000            00        00000000 00112246889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.97  E-value=3e-30  Score=292.79  Aligned_cols=261  Identities=24%  Similarity=0.348  Sum_probs=196.3

Q ss_pred             hhHHHhhCCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCc--cccHHHHHHHHHHhhccCCCceeeEEEEEecC-
Q 001566          768 DNVVRATGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGR--FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGE-  843 (1052)
Q Consensus       768 ~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-  843 (1052)
                      ..+....++|++.+.||+|+||.||+|.. .+++.||+|++....  ....+.+.+|+.++++++||||+++++++... 
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            34556778999999999999999999954 568999999986532  22345678899999999999999999988643 


Q ss_pred             -----CeeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEe
Q 001566          844 -----AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLS  918 (1052)
Q Consensus       844 -----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~  918 (1052)
                           ...+++++++ +++|.+++...   .+++..+..++.|+++|++|||+.   +|+||||||+||++++++.+||+
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~  162 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL  162 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEe
Confidence                 3468888887 88999888653   589999999999999999999999   99999999999999999999999


Q ss_pred             eecccccccccCcccccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHH
Q 001566          919 DFGLARLLEVSETHATTDVAGTFGYVAPEYATT-CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLL  997 (1052)
Q Consensus       919 Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  997 (1052)
                      |||++.....    ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||......       ....+..
T Consensus       163 dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-------~~~~~~~  231 (345)
T cd07877         163 DFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-------DQLKLIL  231 (345)
T ss_pred             cccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHH
Confidence            9999875432    2233467889999998876 46788999999999999999999998532211       0000000


Q ss_pred             HHhCCccccccchh-------------------hcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566          998 IKEGRSSELFLPEL-------------------WEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus       998 ~~~~~~~~~~~~~l-------------------~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ...+.....+.+.+                   ...........+.+++.+|++.||++||++.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         232 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             HHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence            00010000000000                   00000012345889999999999999999999875

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=9.9e-32  Score=312.54  Aligned_cols=256  Identities=23%  Similarity=0.306  Sum_probs=209.6

Q ss_pred             hHHHhhCCCccceeeeccCceEEEEEEec-CCcEEEEEEeccC---ccccHHHHHHHHHHhhccCCCceeeEEEEEecCC
Q 001566          769 NVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIG---RFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEA  844 (1052)
Q Consensus       769 ~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  844 (1052)
                      ++....++|++.++||+|+||+|..++++ +++.||+|++.+.   .......|.+|-.+|.--..+=|+.++-+|.+..
T Consensus        69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~  148 (1317)
T KOG0612|consen   69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER  148 (1317)
T ss_pred             HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence            44445678999999999999999999765 5888999998652   2344578999999999989999999999999999


Q ss_pred             eeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccc
Q 001566          845 EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR  924 (1052)
Q Consensus       845 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~  924 (1052)
                      .+|+|||||+||+|-..+.+..  .+++.-+..++..|+-||..+|+.   |+|||||||+|||+|..|.+|++|||.+.
T Consensus       149 ~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsCl  223 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCL  223 (1317)
T ss_pred             ceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHH
Confidence            9999999999999999998874  799999999999999999999999   99999999999999999999999999998


Q ss_pred             cccccCcccccccccccccccccccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHH
Q 001566          925 LLEVSETHATTDVAGTFGYVAPEYATT-----CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIK  999 (1052)
Q Consensus       925 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  999 (1052)
                      .+.....-.....+|||.|.+||+++.     +.|++.+|.||+||++|||+.|..||+.        .++++-...+..
T Consensus       224 km~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa--------dslveTY~KIm~  295 (1317)
T KOG0612|consen  224 KMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA--------DSLVETYGKIMN  295 (1317)
T ss_pred             hcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH--------HHHHHHHHHHhc
Confidence            887666666667899999999999853     5688999999999999999999999983        234443333332


Q ss_pred             hCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCC---HHHHH
Q 001566         1000 EGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS---VKQVL 1045 (1052)
Q Consensus      1000 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt---~~eil 1045 (1052)
                      .......       +.....+....+||.+.++ +|+.|..   +.|+.
T Consensus       296 hk~~l~F-------P~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik  336 (1317)
T KOG0612|consen  296 HKESLSF-------PDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK  336 (1317)
T ss_pred             hhhhcCC-------CcccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence            2111110       1112345567888888776 7777776   77664

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.97  E-value=3.8e-30  Score=282.98  Aligned_cols=241  Identities=24%  Similarity=0.321  Sum_probs=186.4

Q ss_pred             eeeccCceEEEEEEe-cCCcEEEEEEeccCccc---cHHHHHHHHH---HhhccCCCceeeEEEEEecCCeeEEEEeecC
Q 001566          782 LIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQ---GIQQFDAEIG---TLGRIRHKNLVTLIGYYVGEAEMFLVYNFLS  854 (1052)
Q Consensus       782 ~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  854 (1052)
                      +||+|+||.||+|.. .+++.||+|.+......   ....+..|..   .++...||+++++++++.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999965 45889999988654322   1122334433   3444579999999999999999999999999


Q ss_pred             CCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcccc
Q 001566          855 GGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT  934 (1052)
Q Consensus       855 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  934 (1052)
                      +++|.+++...  ..+++..+..++.|++.|++|||+.   +|+||||||+||++++++.++|+|||++.......   .
T Consensus        81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~  152 (278)
T cd05606          81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P  152 (278)
T ss_pred             CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---C
Confidence            99999998754  4689999999999999999999999   99999999999999999999999999987553221   2


Q ss_pred             cccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhc
Q 001566          935 TDVAGTFGYVAPEYATTC-RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWE 1013 (1052)
Q Consensus       935 ~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1013 (1052)
                      ....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||.......     ... ........      ...+  
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~-----~~~-~~~~~~~~------~~~~--  218 (278)
T cd05606         153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHE-IDRMTLTM------AVEL--  218 (278)
T ss_pred             cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccc-----hHH-HHHHhhcc------CCCC--
Confidence            234688999999998754 58899999999999999999999997532211     011 11111110      1111  


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 001566         1014 AGPQENLLGMMRLASTCTVETLSTRP-----SVKQVLI 1046 (1052)
Q Consensus      1014 ~~~~~~~~~l~~Li~~cl~~dP~~RP-----t~~eil~ 1046 (1052)
                        +......+.+++.+|+..+|++||     ++.++++
T Consensus       219 --~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         219 --PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             --CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence              222345689999999999999999     9999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.97  E-value=4.7e-30  Score=288.83  Aligned_cols=264  Identities=25%  Similarity=0.362  Sum_probs=196.4

Q ss_pred             HHhhCCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCc--cccHHHHHHHHHHhhccCCCceeeEEEEEec-CCee
Q 001566          771 VRATGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGR--FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG-EAEM  846 (1052)
Q Consensus       771 ~~~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~  846 (1052)
                      ....++|++.+.||+|+||.||+|.. .+++.||+|++....  ....+.+..|++++++++|||++++++++.. ....
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            34667899999999999999999954 478999999875432  2234677889999999999999999999875 5578


Q ss_pred             EEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccc
Q 001566          847 FLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL  926 (1052)
Q Consensus       847 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~  926 (1052)
                      ++|+||+ +++|.+++...   .+++..+..++.|+++|++|||+.   +|+||||+|+||++++++.++|+|||.+...
T Consensus        86 ~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~  158 (328)
T cd07856          86 YFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQ  158 (328)
T ss_pred             EEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence            9999998 67999888643   478888999999999999999999   9999999999999999999999999998754


Q ss_pred             cccCcccccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCC-------CccHHHHHHHHH
Q 001566          927 EVSETHATTDVAGTFGYVAPEYATT-CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGN-------GFNIVSWAKLLI  998 (1052)
Q Consensus       927 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~-------~~~~~~~~~~~~  998 (1052)
                      ..    ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||.........       .....++.+...
T Consensus       159 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (328)
T cd07856         159 DP----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC  234 (328)
T ss_pred             CC----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            32    1223456788999998766 56889999999999999999999998643211000       000000000000


Q ss_pred             HhCCccccccchhh--cCCC-----hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001566          999 KEGRSSELFLPELW--EAGP-----QENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus       999 ~~~~~~~~~~~~l~--~~~~-----~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                      ... ..+ +...+.  ...+     +.....+.+++.+|++.+|++||++.+++..
T Consensus       235 ~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         235 SEN-TLR-FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             chh-hHH-HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000 000 000000  0001     1234568999999999999999999998753

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=2.5e-30  Score=281.72  Aligned_cols=248  Identities=23%  Similarity=0.360  Sum_probs=194.8

Q ss_pred             CCccceeeeccCceEEEEEEecC-CcEEEEEEeccC-----ccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEE
Q 001566          776 NFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIG-----RFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLV  849 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv  849 (1052)
                      +|.+.+.||+|+||.||+|.... +..+++|..+..     ......++..|+.++++++|||++++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            58889999999999999996543 444555555432     122334567899999999999999999999998999999


Q ss_pred             EeecCCCCHHHHHhhc--cCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccccc
Q 001566          850 YNFLSGGNLETFIHKK--SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE  927 (1052)
Q Consensus       850 ~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~  927 (1052)
                      +||+++++|.+++...  ....+++..+..++.|+++|+.|||+.   +++|+||+|+||++++ +.++|+|||.+....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999998752  245789999999999999999999999   9999999999999986 469999999987654


Q ss_pred             ccCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccc
Q 001566          928 VSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELF 1007 (1052)
Q Consensus       928 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1052)
                      ... .......+++.|+|||...+..++.++|+||+|+++|+|++|..||...        ........... +...   
T Consensus       157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~--------~~~~~~~~~~~-~~~~---  223 (260)
T cd08222         157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ--------NFLSVVLRIVE-GPTP---  223 (260)
T ss_pred             CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc--------cHHHHHHHHHc-CCCC---
Confidence            322 2223345788999999998888899999999999999999999998632        11222222211 1111   


Q ss_pred             cchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1008 LPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1008 ~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                            ..+...+..+.+++.+|++.+|++||++.|+++
T Consensus       224 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         224 ------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             ------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence                  112344556899999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.97  E-value=4.2e-30  Score=291.35  Aligned_cols=256  Identities=23%  Similarity=0.362  Sum_probs=195.0

Q ss_pred             HhhCCCccceeeeccCceEEEEEE-ecCCcEEEEEEeccCcc--ccHHHHHHHHHHhhccCCCceeeEEEEEecCC----
Q 001566          772 RATGNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEA----  844 (1052)
Q Consensus       772 ~~~~~~~~~~~Lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----  844 (1052)
                      ...++|++.+.||+|+||.||+|. ..+++.||||++.....  .....+.+|++++++++||||+++++++..+.    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            345689999999999999999995 44689999998854322  22356788999999999999999999987543    


Q ss_pred             --eeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecc
Q 001566          845 --EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGL  922 (1052)
Q Consensus       845 --~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgl  922 (1052)
                        ..++||||+ +++|.+++..   ..+++..+..++.|+++|++|||+.   +|+||||||+||+++.++.++++|||+
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~  164 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL  164 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccc
Confidence              458999999 7899988864   3589999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCcccccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHh-
Q 001566          923 ARLLEVSETHATTDVAGTFGYVAPEYATT-CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE- 1000 (1052)
Q Consensus       923 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 1000 (1052)
                      +......    .....+++.|+|||.+.+ ..++.++|+||+|+++|++++|+.||......        ......... 
T Consensus       165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~--------~~~~~~~~~~  232 (343)
T cd07880         165 ARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL--------DQLMEIMKVT  232 (343)
T ss_pred             ccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHHhc
Confidence            9865422    223456889999999876 45788999999999999999999999743211        111111110 


Q ss_pred             CCccccccch------------h-------hcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1001 GRSSELFLPE------------L-------WEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1001 ~~~~~~~~~~------------l-------~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ......+.+.            +       ...........+.+++.+|++.||++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         233 GTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             CCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0000000000            0       00001123345889999999999999999999883

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=3.3e-30  Score=292.15  Aligned_cols=254  Identities=22%  Similarity=0.344  Sum_probs=191.5

Q ss_pred             hCCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCcc--ccHHHHHHHHHHhhccCCCceeeEEEEEecC------C
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGE------A  844 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~  844 (1052)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++.....  .....+.+|++++++++||||+++++++...      .
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            46899999999999999999975 4689999999865322  2235678899999999999999999998754      3


Q ss_pred             eeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccc
Q 001566          845 EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR  924 (1052)
Q Consensus       845 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~  924 (1052)
                      ..++|+||+. .++.++..    ..++++.+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||+++
T Consensus        94 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~  165 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLAR  165 (342)
T ss_pred             eEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence            4699999995 47776652    3588999999999999999999999   99999999999999999999999999987


Q ss_pred             cccccCcccccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCc
Q 001566          925 LLEVSETHATTDVAGTFGYVAPEYATT-CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRS 1003 (1052)
Q Consensus       925 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1052)
                      ....    ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.....       ...+.......+..
T Consensus       166 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~-------~~~~~~~~~~~~~~  234 (342)
T cd07879         166 HADA----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-------LDQLTQILKVTGVP  234 (342)
T ss_pred             CCCC----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHHhcCCC
Confidence            5432    1223457889999999876 4578899999999999999999999974321       11111111100000


Q ss_pred             ccccc---------------chhh----cCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1004 SELFL---------------PELW----EAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1004 ~~~~~---------------~~l~----~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ...+.               +...    ....+.....+.+++.+|++.||++||+++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~  296 (342)
T cd07879         235 GPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE  296 (342)
T ss_pred             CHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            00000               0000    0000123345889999999999999999999984

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=3.2e-30  Score=284.51  Aligned_cols=256  Identities=27%  Similarity=0.361  Sum_probs=197.9

Q ss_pred             CccceeeeccCceEEEEEEec-CCcEEEEEEeccCc--cccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeec
Q 001566          777 FSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR--FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFL  853 (1052)
Q Consensus       777 ~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  853 (1052)
                      |++.+.||+|+||.||+|... +++.||+|++....  ....+.+..|++++++++|+|++++++++.+....++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            566788999999999999765 48999999987653  233467788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccc
Q 001566          854 SGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA  933 (1052)
Q Consensus       854 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  933 (1052)
                      + ++|.+++.... ..+++..+..++.|++.|++|||+.   +|+||||+|+||++++++.++|+|||.+........ .
T Consensus        81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~  154 (282)
T cd07829          81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-T  154 (282)
T ss_pred             C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-c
Confidence            6 69999998763 4689999999999999999999999   999999999999999999999999999986543221 2


Q ss_pred             ccccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCC----------
Q 001566          934 TTDVAGTFGYVAPEYATTC-RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGR---------- 1002 (1052)
Q Consensus       934 ~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---------- 1002 (1052)
                      .....++..|+|||.+.+. .++.++||||+|+++||+++|+.||......        +..........          
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~  226 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI--------DQLFKIFQILGTPTEESWPGV  226 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH--------HHHHHHHHHhCCCcHHHHHhh
Confidence            2223456789999998776 7889999999999999999999988643211        11111100000          


Q ss_pred             -----cccc---ccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1003 -----SSEL---FLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1003 -----~~~~---~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                           ....   ..........+.....+.+++.+|+..+|++||++.+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence                 0000   0000000001122456999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.97  E-value=4.5e-30  Score=290.64  Aligned_cols=260  Identities=24%  Similarity=0.325  Sum_probs=194.6

Q ss_pred             hCCCc-cceeeeccCceEEEEEEe-cCCcEEEEEEeccCcccc--------------HHHHHHHHHHhhccCCCceeeEE
Q 001566          774 TGNFS-IRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQG--------------IQQFDAEIGTLGRIRHKNLVTLI  837 (1052)
Q Consensus       774 ~~~~~-~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~l~  837 (1052)
                      .++|. +.+.||+|+||+||+|.. .+++.||+|+++......              ...+.+|++++++++|+|+++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            34565 457799999999999964 468999999886543221              12467899999999999999999


Q ss_pred             EEEecCCeeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEE
Q 001566          838 GYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYL  917 (1052)
Q Consensus       838 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl  917 (1052)
                      +++......++||||+. |+|.+++...  ..++++....++.|++.|++|||+.   +|+||||+|+||+++.++.++|
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEE
Confidence            99999999999999995 6999998764  4689999999999999999999999   9999999999999999999999


Q ss_pred             eeecccccccccC-------------cccccccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCccc
Q 001566          918 SDFGLARLLEVSE-------------THATTDVAGTFGYVAPEYATTC-RVSDKADVYSFGVVLLELISGKRSLDPSFSE  983 (1052)
Q Consensus       918 ~Dfgla~~~~~~~-------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~  983 (1052)
                      +|||.+.......             ........++..|+|||.+.+. .++.++||||+|+++|||++|+.||......
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~  240 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI  240 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            9999997654111             1111223467789999998764 4688999999999999999999999743221


Q ss_pred             CCCCccHHHHHHHHHHhCCcccc-------------cc---chhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566          984 YGNGFNIVSWAKLLIKEGRSSEL-------------FL---PELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus       984 ~~~~~~~~~~~~~~~~~~~~~~~-------------~~---~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                           ..........  +.....             +.   +.............+.+++.+|++.+|++||+++|++.
T Consensus       241 -----~~~~~i~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        241 -----DQLGRIFELL--GTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             -----HHHHHHHHHh--CCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence                 1111110000  000000             00   00000011123456889999999999999999999985

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-30  Score=241.73  Aligned_cols=258  Identities=22%  Similarity=0.351  Sum_probs=200.2

Q ss_pred             CCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCcccc--HHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          776 NFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQG--IQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      .|...++||+|.||+||+|+. .+++.||+|+++..+..+  .....+|+-+++.++|.|||+++++...+....+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            466678899999999999954 468899999987654432  45678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      | ..+|..|...-. ..++.+.+.+++.|+++|+.++|++   ++.|||+||+|.++..+|++|++|||+++.++.. ..
T Consensus        83 c-dqdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgip-vr  156 (292)
T KOG0662|consen   83 C-DQDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIP-VR  156 (292)
T ss_pred             h-hHHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCc-eE
Confidence            9 668999987764 5789999999999999999999999   9999999999999999999999999999987643 33


Q ss_pred             cccccccccccccccccCCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHH-HHHHHhCCccccccch
Q 001566          933 ATTDVAGTFGYVAPEYATTCR-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWA-KLLIKEGRSSELFLPE 1010 (1052)
Q Consensus       933 ~~~~~~g~~~y~aPE~~~~~~-~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 1010 (1052)
                      +....+.|..|.+|+++.+.+ |+...|+||-|||+.|+...+.|..+..       ++.... +....-|...+.-.|.
T Consensus       157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~-------dvddqlkrif~~lg~p~ed~wps  229 (292)
T KOG0662|consen  157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-------DVDDQLKRIFRLLGTPTEDQWPS  229 (292)
T ss_pred             eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC-------cHHHHHHHHHHHhCCCccccCCc
Confidence            445556789999999998865 7788899999999999999666655321       122222 2222223322222222


Q ss_pred             h--------hcCCC---------hHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1011 L--------WEAGP---------QENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1011 l--------~~~~~---------~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      +        ++-++         +.....-.+++.+.+.-+|.+|.++++.++
T Consensus       230 ~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  230 MTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             cccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            1        11111         222223467788888889999999998875

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=9.8e-31  Score=289.09  Aligned_cols=248  Identities=27%  Similarity=0.400  Sum_probs=205.0

Q ss_pred             hCCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCcccc--HHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEE
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQG--IQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      .+.|.+.+.||+|.|++|..|.+ .++..||+|.+.......  .+.+.+|+++|+.+.|||||+++.+.+.+..+|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            45799999999999999999965 468999999987654332  345788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccC
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~  930 (1052)
                      ||+.+|.+.+|+.++.  ...+..+..++.|+++|++|+|++   .|+|||||++|++++.+.++||+|||++..+.  .
T Consensus       135 eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--~  207 (596)
T KOG0586|consen  135 EYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD--Y  207 (596)
T ss_pred             EeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec--c
Confidence            9999999999998874  566688889999999999999999   99999999999999999999999999998776  3


Q ss_pred             cccccccccccccccccccCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccc
Q 001566          931 THATTDVAGTFGYVAPEYATTCRV-SDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009 (1052)
Q Consensus       931 ~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                      .......+|++.|.|||++.+..| .+++|+||+|+++|-|+.|..||++..-.        +-...+....        
T Consensus       208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk--------~Lr~rvl~gk--------  271 (596)
T KOG0586|consen  208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK--------ELRPRVLRGK--------  271 (596)
T ss_pred             cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc--------cccchheeee--------
Confidence            344566789999999999999876 58999999999999999999999843211        1111111111        


Q ss_pred             hhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001566         1010 ELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus      1010 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                       +  ..+.-...+..+++++++-.+|.+|++.+++.+.
T Consensus       272 -~--rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  272 -Y--RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             -e--cccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence             0  1122223447789999999999999999998753

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=4e-31  Score=282.51  Aligned_cols=243  Identities=28%  Similarity=0.447  Sum_probs=197.7

Q ss_pred             ceeeeccCceEEEEEEe-cCCcEEEEEEeccCcc--ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecCCC
Q 001566          780 RNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGG  856 (1052)
Q Consensus       780 ~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  856 (1052)
                      .++||.|.||+||-|.+ ++|+.||||++.+-+.  +...+.++|+.+++.++||.||.+...|+..+.+++|||.+ +|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence            57899999999999965 4799999999966543  33478899999999999999999999999999999999999 55


Q ss_pred             CHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC---CcEEEeeecccccccccCccc
Q 001566          857 NLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEE---LNAYLSDFGLARLLEVSETHA  933 (1052)
Q Consensus       857 sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~---~~~kl~Dfgla~~~~~~~~~~  933 (1052)
                      +..+.+-.....++++....-++.||+.||.|||.+   +|+|+|+||+|||+.+.   ..+||||||+|++++  +...
T Consensus       648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg--EksF  722 (888)
T KOG4236|consen  648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG--EKSF  722 (888)
T ss_pred             hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecc--hhhh
Confidence            666665554457899888888999999999999999   99999999999999754   469999999999886  3344


Q ss_pred             ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhc
Q 001566          934 TTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWE 1013 (1052)
Q Consensus       934 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1013 (1052)
                      ...++|||.|+|||+++.+.|...-||||.|||+|.-++|..||..+.    +       +...+.  ...-.+-+.-|+
T Consensus       723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE----d-------IndQIQ--NAaFMyPp~PW~  789 (888)
T KOG4236|consen  723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE----D-------INDQIQ--NAAFMYPPNPWS  789 (888)
T ss_pred             hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc----c-------hhHHhh--ccccccCCCchh
Confidence            566899999999999999999999999999999999999999997321    1       111221  222233344455


Q ss_pred             CCChHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 001566         1014 AGPQENLLGMMRLASTCTVETLSTRPSVKQVL 1045 (1052)
Q Consensus      1014 ~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil 1045 (1052)
                      ..+.+    ..++|...++..=.+|-++++.+
T Consensus       790 eis~~----AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  790 EISPE----AIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             hcCHH----HHHHHHHHHHHHHHHhcchHhhc
Confidence            44444    77888888998888999887654

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.97  E-value=3.8e-30  Score=291.81  Aligned_cols=255  Identities=25%  Similarity=0.366  Sum_probs=195.5

Q ss_pred             hhCCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCc--cccHHHHHHHHHHhhccCCCceeeEEEEEecCCe----
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGR--FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAE----  845 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----  845 (1052)
                      ..++|++.+.||+|++|.||+|... +++.||+|++....  ......+.+|+.++++++|||++++++++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            3567999999999999999999765 57899999886532  2234567789999999999999999998776554    


Q ss_pred             --eEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccc
Q 001566          846 --MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLA  923 (1052)
Q Consensus       846 --~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla  923 (1052)
                        .++|+||+ +++|.+++..   ..+++..+..++.|+++|++|||+.   +|+||||+|+||++++++.++|+|||++
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~  165 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLA  165 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccc
Confidence              89999999 7799999875   3589999999999999999999999   9999999999999999999999999999


Q ss_pred             ccccccCcccccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHh-C
Q 001566          924 RLLEVSETHATTDVAGTFGYVAPEYATT-CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE-G 1001 (1052)
Q Consensus       924 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~ 1001 (1052)
                      ......    .....++..|+|||.+.+ ..++.++||||+|+++||+++|+.||......        +........ +
T Consensus       166 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~--------~~~~~i~~~~~  233 (343)
T cd07851         166 RHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI--------DQLKRIMNLVG  233 (343)
T ss_pred             cccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHHHhcC
Confidence            865422    233457888999998865 46788999999999999999999999633211        111111110 0


Q ss_pred             Cccccccchh-------------------hcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1002 RSSELFLPEL-------------------WEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1002 ~~~~~~~~~l-------------------~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ...+.+....                   ...........+.+++.+|++.+|++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         234 TPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             CCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            0000000000                   00000112456899999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.97  E-value=1.5e-29  Score=285.83  Aligned_cols=265  Identities=21%  Similarity=0.222  Sum_probs=191.0

Q ss_pred             CCccceeeeccCceEEEEEEec-C--CcEEEEEEeccCcc--ccHHHHHHHHHHhhcc-CCCceeeEEEEEecC----Ce
Q 001566          776 NFSIRNLIGTGGFGSTYKAELV-P--GYLVAVKKLSIGRF--QGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGE----AE  845 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~-~--~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~~  845 (1052)
                      +|++.+.||+|+||.||+|... .  +..||+|++.....  ...+.+.+|+++++++ +||||+++++++...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4788899999999999999664 3  67899998864322  2245678899999999 599999999975432    45


Q ss_pred             eEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccc
Q 001566          846 MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARL  925 (1052)
Q Consensus       846 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~  925 (1052)
                      .++++||+ +++|.+++...  ..+++..+..++.|++.|++|||++   +|+||||||+||++++++.++|+|||++..
T Consensus        81 ~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~  154 (332)
T cd07857          81 LYLYEELM-EADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARG  154 (332)
T ss_pred             EEEEEecc-cCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence            78888988 47999998654  4689999999999999999999999   999999999999999999999999999986


Q ss_pred             ccccCc---ccccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCC-------ccHHHHH
Q 001566          926 LEVSET---HATTDVAGTFGYVAPEYATT-CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNG-------FNIVSWA  994 (1052)
Q Consensus       926 ~~~~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~-------~~~~~~~  994 (1052)
                      ......   .......|+..|+|||.+.+ ..++.++||||+|+++|+|++|+.||..........       ....++.
T Consensus       155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (332)
T cd07857         155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL  234 (332)
T ss_pred             cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            643221   11233468899999998766 467899999999999999999999987432110000       0000000


Q ss_pred             HHHHHhCC-----ccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566          995 KLLIKEGR-----SSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus       995 ~~~~~~~~-----~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ........     ..............+.....+.+++.+|++.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00000000     00000000000001122456889999999999999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=9.9e-32  Score=265.44  Aligned_cols=253  Identities=26%  Similarity=0.390  Sum_probs=195.9

Q ss_pred             CccceeeeccCceEEEEEEec-CCcEEEEEEeccCcc-ccHHHHHHHHHHhhcc-CCCceeeEEEEEecCCeeEEEEeec
Q 001566          777 FSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEAEMFLVYNFL  853 (1052)
Q Consensus       777 ~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  853 (1052)
                      .+-...||.|+||+|++-.++ .|+.+|||+++.... .+..++..|.+...+- +.||||+++|++..++..++.||.|
T Consensus        66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM  145 (361)
T KOG1006|consen   66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM  145 (361)
T ss_pred             HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence            334467999999999999665 589999999987654 5567788888765554 7999999999999999999999999


Q ss_pred             CCCCHHHHHhh---ccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccC
Q 001566          854 SGGNLETFIHK---KSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       854 ~~gsL~~~l~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~  930 (1052)
                       ..|++.+-+.   .....+++..+-+|+...+.||.||-+..  .|||||+||+|||++..|.+|+||||.+..+..  
T Consensus       146 -d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~--  220 (361)
T KOG1006|consen  146 -DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD--  220 (361)
T ss_pred             -hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH--
Confidence             6687765432   23457899999999999999999999886  899999999999999999999999999986642  


Q ss_pred             cccccccccccccccccccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCcccccc
Q 001566          931 THATTDVAGTFGYVAPEYATT--CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFL 1008 (1052)
Q Consensus       931 ~~~~~~~~g~~~y~aPE~~~~--~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                      ....+.-.|-..|||||.+..  ..|..+|||||+|+++||+.||+.|+....       ++.+....+. .++......
T Consensus       221 SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-------svfeql~~Vv-~gdpp~l~~  292 (361)
T KOG1006|consen  221 SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-------SVFEQLCQVV-IGDPPILLF  292 (361)
T ss_pred             HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-------HHHHHHHHHH-cCCCCeecC
Confidence            223333457788999999964  348889999999999999999999987432       2222222222 333332211


Q ss_pred             chhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1009 PELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1009 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                          +....+....+.++|..|+..|-.+||...++.+
T Consensus       293 ----~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  293 ----DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             ----cccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence                1112334556899999999999999999998765

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=5e-30  Score=292.09  Aligned_cols=261  Identities=26%  Similarity=0.455  Sum_probs=213.5

Q ss_pred             cchhhHHHhhCCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCccccHHHHHHHHHHhhcc-CCCceeeEEEEEec
Q 001566          765 LTYDNVVRATGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRI-RHKNLVTLIGYYVG  842 (1052)
Q Consensus       765 ~~~~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  842 (1052)
                      ..++.....++-|++.++||+|.+|.||+++. ++|+.+|+|+....... .++++.|+.+++.. .|||++.++|+|..
T Consensus         9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k   87 (953)
T KOG0587|consen    9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIK   87 (953)
T ss_pred             cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence            44555666778899999999999999999954 56889999988665544 37788999999998 69999999999863


Q ss_pred             -----CCeeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEE
Q 001566          843 -----EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYL  917 (1052)
Q Consensus       843 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl  917 (1052)
                           ++.+++|||||.+||..|+++...+..+.|+.+..|++.++.|+.+||..   .++|||||-.||+++.++.||+
T Consensus        88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKL  164 (953)
T KOG0587|consen   88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKL  164 (953)
T ss_pred             ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEE
Confidence                 57899999999999999999988888999999999999999999999999   9999999999999999999999


Q ss_pred             eeecccccccccCcccccccccccccccccccCC-----CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHH
Q 001566          918 SDFGLARLLEVSETHATTDVAGTFGYVAPEYATT-----CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVS  992 (1052)
Q Consensus       918 ~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~  992 (1052)
                      +|||.+...... .......+|||.|||||++.-     ..|+.++|+||+|++..||.-|.+|+-..-+-         
T Consensus       165 vDFGvSaQldsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm---------  234 (953)
T KOG0587|consen  165 VDFGVSAQLDST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM---------  234 (953)
T ss_pred             eeeeeeeeeecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh---------
Confidence            999999877643 344556789999999999853     34677899999999999999999998632211         


Q ss_pred             HHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566          993 WAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus       993 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      -+...+..+......       .+....+++.++|..|+..|-++||++.++++
T Consensus       235 raLF~IpRNPPPkLk-------rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  235 RALFLIPRNPPPKLK-------RPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             hhhccCCCCCCcccc-------chhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            111112222222222       23455667999999999999999999998875

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=2.5e-29  Score=306.69  Aligned_cols=145  Identities=30%  Similarity=0.472  Sum_probs=131.0

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCcc---ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF---QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      ++|++.+.||+|+||.||+|... +++.||+|++.....   .....+.+|+.+++.++||||+++++++......|+||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57999999999999999999665 689999999865432   22467888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccc
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR  924 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~  924 (1052)
                      ||+++++|.+++...  ..+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999765  3588999999999999999999998   99999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.8e-29  Score=273.12  Aligned_cols=236  Identities=28%  Similarity=0.364  Sum_probs=193.0

Q ss_pred             eeccCceEEEEEEec-CCcEEEEEEeccCccc---cHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecCCCCH
Q 001566          783 IGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQ---GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL  858 (1052)
Q Consensus       783 Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  858 (1052)
                      ||+|+||.||+|... +++.+|+|.+......   ..+.+..|++++++++|||++++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999765 5889999998654332   356788999999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcccccccc
Q 001566          859 ETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVA  938 (1052)
Q Consensus       859 ~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  938 (1052)
                      .+++...  ..+++..+..++.|+++|+.|+|+.   +++|+||+|+||+++.++.++|+|||.+....... .......
T Consensus        81 ~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~  154 (250)
T cd05123          81 FSHLSKE--GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC  154 (250)
T ss_pred             HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCc
Confidence            9999765  3589999999999999999999998   99999999999999999999999999998654321 1233446


Q ss_pred             cccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCCChH
Q 001566          939 GTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQE 1018 (1052)
Q Consensus       939 g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 1018 (1052)
                      ++..|+|||...+...+.++|+||||+++||+++|..||.....        .+..+.... ...          ..+..
T Consensus       155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~-~~~----------~~~~~  215 (250)
T cd05123         155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--------KEIYEKILK-DPL----------RFPEF  215 (250)
T ss_pred             CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHhc-CCC----------CCCCC
Confidence            78899999999988889999999999999999999999963211        122222221 110          11222


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHH
Q 001566         1019 NLLGMMRLASTCTVETLSTRPSVKQ 1043 (1052)
Q Consensus      1019 ~~~~l~~Li~~cl~~dP~~RPt~~e 1043 (1052)
                      .+..+.+++.+||..||++||++.+
T Consensus       216 ~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         216 LSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCHHHHHHHHHHhcCCHhhCCCccc
Confidence            2456889999999999999999943

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2e-30  Score=269.78  Aligned_cols=240  Identities=24%  Similarity=0.353  Sum_probs=196.4

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCcc---ccHHHHHHHHHHhhcc-CCCceeeEEEEEecCCeeEEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF---QGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEAEMFLV  849 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv  849 (1052)
                      .+|....+||+|+||.|.+|+.+ +.+.+|||+++....   .+.+--+.|-+++..- +-|.++.++.+|+.-+.+|+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            46899999999999999999655 467899999876532   2233345577777666 578999999999999999999


Q ss_pred             EeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccccccc
Q 001566          850 YNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS  929 (1052)
Q Consensus       850 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~  929 (1052)
                      |||+.||+|--.++..  ..+.++.+.-+|..||-||-+||++   |||.||+|.+|||++.+|.+||+|||+++.- .-
T Consensus       429 MEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn-i~  502 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN-IF  502 (683)
T ss_pred             EEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccc-cc
Confidence            9999999999888876  4688899999999999999999999   9999999999999999999999999999732 22


Q ss_pred             CcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccc
Q 001566          930 ETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009 (1052)
Q Consensus       930 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                      +...+....|||.|+|||++...+|+..+|.||+||++|||+.|++||+++.++        +..+.+....-       
T Consensus       503 ~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~--------elF~aI~ehnv-------  567 (683)
T KOG0696|consen  503 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--------ELFQAIMEHNV-------  567 (683)
T ss_pred             CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHHHccC-------
Confidence            334455678999999999999999999999999999999999999999965443        22333222211       


Q ss_pred             hhhcCCChHHHHHHHHHHHHccccCCCCCC
Q 001566         1010 ELWEAGPQENLLGMMRLASTCTVETLSTRP 1039 (1052)
Q Consensus      1010 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RP 1039 (1052)
                          .+|.....+...+.+..+...|.+|.
T Consensus       568 ----syPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  568 ----SYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             ----cCcccccHHHHHHHHHHhhcCCcccc
Confidence                23445556678888899999999986

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-30  Score=271.26  Aligned_cols=260  Identities=20%  Similarity=0.276  Sum_probs=200.4

Q ss_pred             hhCCCccceeeeccCceEEEEE-EecCCcEEEEEEeccCccccHHHHHHHHHHhhccC-CC-----ceeeEEEEEecCCe
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIR-HK-----NLVTLIGYYVGEAE  845 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~~~~  845 (1052)
                      ..++|++.+.+|+|.||.|.++ +...+..||||+++..... .+..+-|++++.++. +.     -++.+.++|.-.++
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh  165 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH  165 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence            3678999999999999999999 4445899999998754433 355678999999993 22     36777788888999


Q ss_pred             eEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC--------------
Q 001566          846 MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDE--------------  911 (1052)
Q Consensus       846 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~--------------  911 (1052)
                      .|+|+|.+ |.|+.+++......+++...+..|+.|+++++++||+.   +++|.|+||+||++.+              
T Consensus       166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccc
Confidence            99999999 77999999998888899999999999999999999999   9999999999999832              


Q ss_pred             ------CCcEEEeeecccccccccCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCC
Q 001566          912 ------ELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYG  985 (1052)
Q Consensus       912 ------~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~  985 (1052)
                            +..++|+|||.|..-.    ......+.|..|.|||++.+-.++.++||||+|||+.|++||...|+....   
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~----e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen---  314 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDH----EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN---  314 (415)
T ss_pred             eeccCCCcceEEEecCCcceec----cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc---
Confidence                  2348999999998543    223556789999999999999999999999999999999999998874331   


Q ss_pred             CCccHHHHHHHHHHhCCc-------------ccccc-c---------h---------hhcCCChHHHHHHHHHHHHcccc
Q 001566          986 NGFNIVSWAKLLIKEGRS-------------SELFL-P---------E---------LWEAGPQENLLGMMRLASTCTVE 1033 (1052)
Q Consensus       986 ~~~~~~~~~~~~~~~~~~-------------~~~~~-~---------~---------l~~~~~~~~~~~l~~Li~~cl~~ 1033 (1052)
                       ...+ .+++.+...-..             ...+| +         .         ........+...+.+|+++|+..
T Consensus       315 -~EHL-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f  392 (415)
T KOG0671|consen  315 -LEHL-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF  392 (415)
T ss_pred             -HHHH-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence             1111 122111110000             00000 0         0         00111234456799999999999


Q ss_pred             CCCCCCCHHHHHH
Q 001566         1034 TLSTRPSVKQVLI 1046 (1052)
Q Consensus      1034 dP~~RPt~~eil~ 1046 (1052)
                      ||.+|+|++|+++
T Consensus       393 DP~~RiTl~EAL~  405 (415)
T KOG0671|consen  393 DPARRITLREALS  405 (415)
T ss_pred             CccccccHHHHhc
Confidence            9999999999975

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.3e-31  Score=262.10  Aligned_cols=261  Identities=24%  Similarity=0.358  Sum_probs=196.5

Q ss_pred             hCCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCcccc--HHHHHHHHHHhhccCCCceeeEEEEEec--------
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQG--IQQFDAEIGTLGRIRHKNLVTLIGYYVG--------  842 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~--------  842 (1052)
                      .+.|+...+||+|.||+||+|+.+ +|+.||+|++-....+.  .....+|++++..++|+|++.+++.|..        
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~   95 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD   95 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence            345777789999999999999665 57889998775533322  3456889999999999999999988763        


Q ss_pred             CCeeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecc
Q 001566          843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGL  922 (1052)
Q Consensus       843 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgl  922 (1052)
                      ...+|+||++|+. +|.-.+.... .+++..++.+++.++..|+.|+|..   .|+|||+||.|++++.++.+||+|||+
T Consensus        96 r~t~ylVf~~ceh-DLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   96 RATFYLVFDFCEH-DLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             cceeeeeHHHhhh-hHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccc
Confidence            2458999999954 8888887653 6789999999999999999999999   999999999999999999999999999


Q ss_pred             cccccccCc---ccccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHH
Q 001566          923 ARLLEVSET---HATTDVAGTFGYVAPEYATT-CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLI  998 (1052)
Q Consensus       923 a~~~~~~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  998 (1052)
                      ++.+...+.   ......+.|..|.+||.+.| +.|+++.|||+-||++.||+||.+-+.+..+.     .....+..+.
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteq-----qql~~Is~Lc  245 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQ-----QQLHLISQLC  245 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHH-----HHHHHHHHHh
Confidence            987753322   22345677999999998876 56899999999999999999999888754322     1111222221


Q ss_pred             HhCCccccccch-----hhcCC-----C-------hHHH------HHHHHHHHHccccCCCCCCCHHHHHH
Q 001566          999 KEGRSSELFLPE-----LWEAG-----P-------QENL------LGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus       999 ~~~~~~~~~~~~-----l~~~~-----~-------~~~~------~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      .  .....+.|.     ++...     +       ++..      ....+|+..++..||.+|+++++++.
T Consensus       246 G--s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  246 G--SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             c--cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence            1  111111111     11110     0       1111      24678999999999999999999875

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.2e-30  Score=270.26  Aligned_cols=257  Identities=25%  Similarity=0.400  Sum_probs=197.7

Q ss_pred             hhCCCccceeeeccCceEEEEE-EecCCcEEEEEEeccCcccc-------HHHHHHHHHHhhccCCCceeeEEEEEe-cC
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQG-------IQQFDAEIGTLGRIRHKNLVTLIGYYV-GE  843 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~h~niv~l~~~~~-~~  843 (1052)
                      ..++|-+...||+|+|++||+| +....+.||||+-.......       .+...+|..+.+.+.||.||++|+++. +.
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt  540 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT  540 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence            3457888999999999999999 66678899999764432211       234578999999999999999999986 55


Q ss_pred             CeeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC---CCCcEEEeee
Q 001566          844 AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDF  920 (1052)
Q Consensus       844 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~---~~~~~kl~Df  920 (1052)
                      +.+|-|+|||+|.+|+-|++.+  +.+++.++..|+.||+.||.||.+. .++|||-|+||.|||+.   ..|.+||+||
T Consensus       541 dsFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF  617 (775)
T KOG1151|consen  541 DSFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF  617 (775)
T ss_pred             ccceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence            7889999999999999999887  4689999999999999999999987 56899999999999995   4578999999


Q ss_pred             cccccccccCcc------cccccccccccccccccCC----CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccH
Q 001566          921 GLARLLEVSETH------ATTDVAGTFGYVAPEYATT----CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI  990 (1052)
Q Consensus       921 gla~~~~~~~~~------~~~~~~g~~~y~aPE~~~~----~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~  990 (1052)
                      |+++++....+.      .+....||..|++||.+.-    ...+.|+||||+|||+|+++.|+.||......       
T Consensus       618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ-------  690 (775)
T KOG1151|consen  618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ-------  690 (775)
T ss_pred             chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH-------
Confidence            999988643322      2345679999999998753    34577999999999999999999999743222       


Q ss_pred             HHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 001566          991 VSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVL 1045 (1052)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil 1045 (1052)
                          +.+..++.....-  ++.-..-+....+...+|++|+++--++|..+.++.
T Consensus       691 ----QdILqeNTIlkAt--EVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  691 ----QDILQENTILKAT--EVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             ----HHHHhhhchhcce--eccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence                1122222111110  000011122334577899999999999998877764

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.96  E-value=3.3e-29  Score=268.54  Aligned_cols=219  Identities=26%  Similarity=0.252  Sum_probs=175.1

Q ss_pred             cCceEEEEEEe-cCCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecCCCCHHHHHhh
Q 001566          786 GGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHK  864 (1052)
Q Consensus       786 G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~  864 (1052)
                      |.+|.||+|.. .+++.||+|++....     .+..|...+....|||++++++++.+....++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            89999999955 468999999986543     223445555556799999999999999999999999999999999976


Q ss_pred             ccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcccccccccccccc
Q 001566          865 KSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYV  944 (1052)
Q Consensus       865 ~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~  944 (1052)
                      .  ..+++..+..++.|+++|++|||++   +|+||||||+||++++++.++++|||.+......    .....++..|+
T Consensus        79 ~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~  149 (237)
T cd05576          79 F--LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYC  149 (237)
T ss_pred             h--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcccc
Confidence            5  3589999999999999999999999   9999999999999999999999999987655322    12234567799


Q ss_pred             cccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHH
Q 001566          945 APEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMM 1024 (1052)
Q Consensus       945 aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 1024 (1052)
                      |||.+.+..++.++||||+|+++|||++|+.|+.......              ..  ...   .    ..+......+.
T Consensus       150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~--------------~~--~~~---~----~~~~~~~~~~~  206 (237)
T cd05576         150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI--------------NT--HTT---L----NIPEWVSEEAR  206 (237)
T ss_pred             CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc--------------cc--ccc---c----CCcccCCHHHH
Confidence            9999988888999999999999999999998875321110              00  000   0    11222344588


Q ss_pred             HHHHHccccCCCCCCCH
Q 001566         1025 RLASTCTVETLSTRPSV 1041 (1052)
Q Consensus      1025 ~Li~~cl~~dP~~RPt~ 1041 (1052)
                      +++.+|++.||++||++
T Consensus       207 ~li~~~l~~dp~~R~~~  223 (237)
T cd05576         207 SLLQQLLQFNPTERLGA  223 (237)
T ss_pred             HHHHHHccCCHHHhcCC
Confidence            99999999999999986

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.1e-29  Score=280.20  Aligned_cols=239  Identities=27%  Similarity=0.308  Sum_probs=190.8

Q ss_pred             hCCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCccccHHHHHHHHHHhhcc-CCCceeeEEEEEecCCeeEEEEe
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEAEMFLVYN  851 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  851 (1052)
                      .++|++...+|.|+|+.|-.+.. .+++..+||++....    .+-.+|+.++... +|||++++.+++.+..+.|+|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            45688888899999999999854 467889999997652    2234566555555 79999999999999999999999


Q ss_pred             ecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEE-CCCCcEEEeeecccccccccC
Q 001566          852 FLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILL-DEELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       852 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill-~~~~~~kl~Dfgla~~~~~~~  930 (1052)
                      .+.++-+.+.+...+   ....++..|+.+|+.|+.|||++   ||||||+||.|||+ ++.++++|+|||.++..+.. 
T Consensus       397 ~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-  469 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-  469 (612)
T ss_pred             hccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence            999998887776553   33377788999999999999999   99999999999999 58899999999999976644 


Q ss_pred             cccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccch
Q 001566          931 THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010 (1052)
Q Consensus       931 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1052)
                         ....+-|..|.|||+.....|++++|+||+|+++|+|++|+.||......        ......+..+..       
T Consensus       470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--------~ei~~~i~~~~~-------  531 (612)
T KOG0603|consen  470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--------IEIHTRIQMPKF-------  531 (612)
T ss_pred             ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--------HHHHHhhcCCcc-------
Confidence               12234577899999999999999999999999999999999999743221        112222222211       


Q ss_pred             hhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1011 LWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1011 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                           .........+|+.+|++.||.+||++.++..
T Consensus       532 -----s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  532 -----SECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             -----ccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence                 1334556889999999999999999999864

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.96  E-value=7.8e-29  Score=294.30  Aligned_cols=261  Identities=25%  Similarity=0.310  Sum_probs=170.2

Q ss_pred             hhCCCccceeeeccCceEEEEEEec-C----CcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEE------Ee
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAELV-P----GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGY------YV  841 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------~~  841 (1052)
                      ..++|++.+.||+|+||.||+|... +    +..||+|++......  +....|  .++...+.++..++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            4568999999999999999999764 4    689999987543221  111111  1111122222222211      24


Q ss_pred             cCCeeEEEEeecCCCCHHHHHhhccC------------------CcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCC
Q 001566          842 GEAEMFLVYNFLSGGNLETFIHKKSG------------------KKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIK  903 (1052)
Q Consensus       842 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik  903 (1052)
                      .....++|+||+.+++|.+++.....                  .......+..++.|++.||+|||++   +|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence            56689999999999999999875421                  0112344667999999999999999   99999999


Q ss_pred             CCCEEECC-CCcEEEeeecccccccccCcccccccccccccccccccCCC----------------------CCCcchhH
Q 001566          904 PSNILLDE-ELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC----------------------RVSDKADV  960 (1052)
Q Consensus       904 ~~Nill~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----------------------~~~~~sDv  960 (1052)
                      |+|||+++ ++.+||+|||+|+.+............+++.|+|||.+...                      .+..++||
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV  362 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI  362 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence            99999986 57899999999987654444444556789999999965422                      23345699


Q ss_pred             HHHHHHHHHHHhCCCCCCCCcccC-----CCCccHHHHHHHHHHhCCccccccchhhcCC--ChHHHHHHHHHHHHcccc
Q 001566          961 YSFGVVLLELISGKRSLDPSFSEY-----GNGFNIVSWAKLLIKEGRSSELFLPELWEAG--PQENLLGMMRLASTCTVE 1033 (1052)
Q Consensus       961 wslG~il~elltg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--~~~~~~~l~~Li~~cl~~ 1033 (1052)
                      ||+||++|||+++..|++......     ....+...|.......      ..+++....  .........+|+.+|++.
T Consensus       363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~  436 (566)
T PLN03225        363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMRF  436 (566)
T ss_pred             HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHccC
Confidence            999999999998766543211000     0011111221111100      000000000  001122356899999999


Q ss_pred             CCCCCCCHHHHHH
Q 001566         1034 TLSTRPSVKQVLI 1046 (1052)
Q Consensus      1034 dP~~RPt~~eil~ 1046 (1052)
                      ||++|||++|+++
T Consensus       437 dP~kR~ta~e~L~  449 (566)
T PLN03225        437 KGRQRISAKAALA  449 (566)
T ss_pred             CcccCCCHHHHhC
Confidence            9999999999986

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=3.3e-28  Score=280.85  Aligned_cols=261  Identities=24%  Similarity=0.298  Sum_probs=181.0

Q ss_pred             hhCCCccceeeeccCceEEEEEEe-----------------cCCcEEEEEEeccCccccHHH--------------HHHH
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAEL-----------------VPGYLVAVKKLSIGRFQGIQQ--------------FDAE  821 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~e  821 (1052)
                      ..++|++.++||+|+||.||+|..                 ..++.||||++........++              ...|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            456899999999999999999953                 235679999986543222222              3346


Q ss_pred             HHHhhccCCCce-----eeEEEEEec--------CCeeEEEEeecCCCCHHHHHhhcc----------------------
Q 001566          822 IGTLGRIRHKNL-----VTLIGYYVG--------EAEMFLVYNFLSGGNLETFIHKKS----------------------  866 (1052)
Q Consensus       822 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~----------------------  866 (1052)
                      +.++.+++|.++     ++++++|..        .+..++||||+++++|.++++...                      
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777766554     667777653        356899999999999999987532                      


Q ss_pred             CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcccccccccccccccc
Q 001566          867 GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAP  946 (1052)
Q Consensus       867 ~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aP  946 (1052)
                      ...+++..+..++.|+++|+.|+|+.   +|+||||||+||+++.++.+||+|||++...............+++.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence            12346778889999999999999999   999999999999999999999999999976543322222223457899999


Q ss_pred             cccCCCCC----------------------CcchhHHHHHHHHHHHHhCCC-CCCCCcc---cC-CCCccHHHHHHHHHH
Q 001566          947 EYATTCRV----------------------SDKADVYSFGVVLLELISGKR-SLDPSFS---EY-GNGFNIVSWAKLLIK  999 (1052)
Q Consensus       947 E~~~~~~~----------------------~~~sDvwslG~il~elltg~~-p~~~~~~---~~-~~~~~~~~~~~~~~~  999 (1052)
                      |.+.....                      ..+.||||+||++|||++|.. ||.....   +. ....+...|...  .
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~--~  457 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY--K  457 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh--c
Confidence            98754321                      124699999999999999875 5542110   00 001111222211  1


Q ss_pred             hCCccccccchhhcCCChHHHHHHHHHHHHccccCC---CCCCCHHHHHH
Q 001566         1000 EGRSSELFLPELWEAGPQENLLGMMRLASTCTVETL---STRPSVKQVLI 1046 (1052)
Q Consensus      1000 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP---~~RPt~~eil~ 1046 (1052)
                      ...    ++-..+.    .......+++.+++..+|   .+|+|++|+++
T Consensus       458 ~~~----~~~~~~d----~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        458 GQK----YDFSLLD----RNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             ccC----CCccccc----ccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            111    1111122    223457889999999766   68999999975

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=2.3e-29  Score=239.87  Aligned_cols=209  Identities=26%  Similarity=0.397  Sum_probs=171.3

Q ss_pred             HHHhhCCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCc-cccHHHHHHHHHHhhc-cCCCceeeEEEEEecCCee
Q 001566          770 VVRATGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGR-IRHKNLVTLIGYYVGEAEM  846 (1052)
Q Consensus       770 ~~~~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~  846 (1052)
                      .++..+...-...||+|+||.|-+-++ .+|+..|+|.+...- .+..++...|+.+..+ ..+|.+|.++|...+...+
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            344445556667899999999988865 469999999997653 3445667778876555 4799999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhhc--cCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccc
Q 001566          847 FLVYNFLSGGNLETFIHKK--SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR  924 (1052)
Q Consensus       847 ~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~  924 (1052)
                      ++.||.| ..||+.|-+..  .+..+++..+-+||..+++|+.|||++.  .+||||+||.|||++.+|+|||||||.+.
T Consensus       121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence            9999999 67888876542  3678999999999999999999999997  89999999999999999999999999998


Q ss_pred             cccccCcccccccccccccccccccCC----CCCCcchhHHHHHHHHHHHHhCCCCCCCCccc
Q 001566          925 LLEVSETHATTDVAGTFGYVAPEYATT----CRVSDKADVYSFGVVLLELISGKRSLDPSFSE  983 (1052)
Q Consensus       925 ~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~sDvwslG~il~elltg~~p~~~~~~~  983 (1052)
                      .+..+-  ..+.-.|-..|||||.+..    ..|+-++||||+|+.+.||.+++.||+....+
T Consensus       198 ~L~dSi--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp  258 (282)
T KOG0984|consen  198 YLVDSI--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP  258 (282)
T ss_pred             eehhhh--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence            764322  2222346678999998864    46888999999999999999999999866555

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4.6e-28  Score=258.83  Aligned_cols=264  Identities=24%  Similarity=0.351  Sum_probs=200.5

Q ss_pred             CCCccceeeeccCceEEEEE-EecCCcEEEEEEeccCccccHHHHHHHHHHhhccC-----C---CceeeEEEEEec---
Q 001566          775 GNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIR-----H---KNLVTLIGYYVG---  842 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~~---  842 (1052)
                      ++|.+.++||-|.|++||+| +.+..+.||+|+.+..+.. .+....|++++++++     |   .+||++++.|..   
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhY-tEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHY-TEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHH-HHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            68999999999999999999 6667899999998766544 366788999999983     2   479999999975   


Q ss_pred             -CCeeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC---------
Q 001566          843 -EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEE---------  912 (1052)
Q Consensus       843 -~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~---------  912 (1052)
                       +.++|+|+|++ |.+|..++.....+.++...+.+|+.||+.||.|||++|  ||||.||||+|||+..+         
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~~~  233 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKDAR  233 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhhhh
Confidence             45899999999 889999999888888999999999999999999999998  99999999999998211         


Q ss_pred             --C-----------------------------------------------------------------------------
Q 001566          913 --L-----------------------------------------------------------------------------  913 (1052)
Q Consensus       913 --~-----------------------------------------------------------------------------  913 (1052)
                        +                                                                             
T Consensus       234 ~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~  313 (590)
T KOG1290|consen  234 EAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNE  313 (590)
T ss_pred             hhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccc
Confidence              0                                                                             


Q ss_pred             ------------------------------------------------------------------------------cE
Q 001566          914 ------------------------------------------------------------------------------NA  915 (1052)
Q Consensus       914 ------------------------------------------------------------------------------~~  915 (1052)
                                                                                                    .|
T Consensus       314 ~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~v  393 (590)
T KOG1290|consen  314 STVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRV  393 (590)
T ss_pred             cchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeE
Confidence                                                                                          02


Q ss_pred             EEeeecccccccccCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcc-cCCCCccHH-HH
Q 001566          916 YLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFS-EYGNGFNIV-SW  993 (1052)
Q Consensus       916 kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~-~~~~~~~~~-~~  993 (1052)
                      ||+|||-|+.+...    .+.-..|..|.|||++.+..|+..+||||++|++||++||...|+|... .|..+.+.. .+
T Consensus       394 KIaDlGNACW~~kh----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i  469 (590)
T KOG1290|consen  394 KIADLGNACWVHKH----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALI  469 (590)
T ss_pred             EEeeccchhhhhhh----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHH
Confidence            34444444332211    1112356789999999999999999999999999999999999986532 233222222 11


Q ss_pred             H-------HHHHHhCCccc-cccch-----------------hh--cCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566          994 A-------KLLIKEGRSSE-LFLPE-----------------LW--EAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus       994 ~-------~~~~~~~~~~~-~~~~~-----------------l~--~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      +       +.+...|+..+ .|...                 +.  -..+.+....+.+++.-|++.+|++||||.+.++
T Consensus       470 ~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~  549 (590)
T KOG1290|consen  470 MELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK  549 (590)
T ss_pred             HHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc
Confidence            1       23333333332 22211                 11  1235778889999999999999999999999875

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6.6e-30  Score=272.84  Aligned_cols=242  Identities=22%  Similarity=0.280  Sum_probs=199.4

Q ss_pred             CCCccceeeeccCceEEEEEEecCCc-EEEEEEecc---CccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEE
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELVPGY-LVAVKKLSI---GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~~~~-~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      .++++...||.|+||.|=.+...... .+|+|.+++   .+.+..+.+..|-.+|...+.|.||++|..|.++..+|+.|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            34666778999999999999766433 377776654   34555677888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccC
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~  930 (1052)
                      |-|-||.++..++.+  ..++.....-++..+++|++|||++   +||.||+||+|.+++.+|.+||.|||+|+.+..+ 
T Consensus       500 EaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g-  573 (732)
T KOG0614|consen  500 EACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG-  573 (732)
T ss_pred             HhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC-
Confidence            999999999999876  4789999999999999999999999   9999999999999999999999999999988643 


Q ss_pred             cccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccch
Q 001566          931 THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010 (1052)
Q Consensus       931 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1052)
                       ..+-..+|||.|.|||++..+.+..++|.||+|+++||+++|.+||....+-       ..  ...+-.|-..-     
T Consensus       574 -~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm-------kt--Yn~ILkGid~i-----  638 (732)
T KOG0614|consen  574 -RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM-------KT--YNLILKGIDKI-----  638 (732)
T ss_pred             -CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH-------HH--HHHHHhhhhhh-----
Confidence             3455678999999999999999999999999999999999999999853321       11  11222221111     


Q ss_pred             hhcCCChHHHHHHHHHHHHccccCCCCCCC
Q 001566         1011 LWEAGPQENLLGMMRLASTCTVETLSTRPS 1040 (1052)
Q Consensus      1011 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt 1040 (1052)
                         ..|........++|++.+..+|.+|.-
T Consensus       639 ---~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  639 ---EFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             ---hcccccchhHHHHHHHHHhcCcHhhhc
Confidence               124445556788999999999999984

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=7.8e-28  Score=258.69  Aligned_cols=238  Identities=30%  Similarity=0.437  Sum_probs=194.2

Q ss_pred             CceEEEEEEecC-CcEEEEEEeccCcccc-HHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecCCCCHHHHHhh
Q 001566          787 GFGSTYKAELVP-GYLVAVKKLSIGRFQG-IQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHK  864 (1052)
Q Consensus       787 ~~g~V~~~~~~~-~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~  864 (1052)
                      +||.||+|.... ++.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            589999997764 8999999997665544 67899999999999999999999999999999999999999999999976


Q ss_pred             ccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcccccccccccccc
Q 001566          865 KSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYV  944 (1052)
Q Consensus       865 ~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~  944 (1052)
                      ..  .+++..+..++.+++.++.|||+.   +|+|+||+|+||++++++.++++|||.+.......  ......++..|+
T Consensus        81 ~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~  153 (244)
T smart00220       81 RG--RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYM  153 (244)
T ss_pred             cc--CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCC
Confidence            53  388999999999999999999999   99999999999999999999999999998765332  233456788999


Q ss_pred             cccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHH
Q 001566          945 APEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMM 1024 (1052)
Q Consensus       945 aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 1024 (1052)
                      +||...+..++.++|||++|+++|++++|..||....       ......+... .......       ......+..+.
T Consensus       154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~-------~~~~~~~~~~-~~~~~~~-------~~~~~~~~~~~  218 (244)
T smart00220      154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD-------QLLELFKKIG-KPKPPFP-------PPEWKISPEAK  218 (244)
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------cHHHHHHHHh-ccCCCCc-------cccccCCHHHH
Confidence            9999998888999999999999999999999986421       1112222221 1111100       00000345689


Q ss_pred             HHHHHccccCCCCCCCHHHHHH
Q 001566         1025 RLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1025 ~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      +++.+|+..+|++||++.++++
T Consensus       219 ~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      219 DLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHccCCchhccCHHHHhh
Confidence            9999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.3e-28  Score=247.99  Aligned_cols=247  Identities=22%  Similarity=0.329  Sum_probs=197.7

Q ss_pred             hCCCccceeeeccCceEEEEEEec-CCcEEEEEEeccC---ccccHHHHHHHHHHhhcc-CCCceeeEEEEEecCCeeEE
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIG---RFQGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEAEMFL  848 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  848 (1052)
                      -.+|.+.++||+|+|++|..+++. +.+.+|+|++++.   +.++.+....|-.+..+- +||.+|.++.+|..+..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            457999999999999999999765 5788999998764   334455667787777776 79999999999999999999


Q ss_pred             EEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccc
Q 001566          849 VYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV  928 (1052)
Q Consensus       849 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~  928 (1052)
                      |.||++||+|--++++.  ..++++.+.-+...|.-|+.|||++   |||.||+|..||++|..|.+|++|+|+++.- -
T Consensus       329 vieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~-l  402 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG-L  402 (593)
T ss_pred             EEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcC-C
Confidence            99999999998888766  4799999999999999999999999   9999999999999999999999999999742 2


Q ss_pred             cCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCc--ccCCCCccHHHHHHHHHHhCCcccc
Q 001566          929 SETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSF--SEYGNGFNIVSWAKLLIKEGRSSEL 1006 (1052)
Q Consensus       929 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      .....+....|||.|.|||++++..|....|.|++||+++||+.|+.||+--.  .+..+   -..+.-.++-+....  
T Consensus       403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~n---tedylfqvilekqir--  477 (593)
T KOG0695|consen  403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMN---TEDYLFQVILEKQIR--  477 (593)
T ss_pred             CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccc---hhHHHHHHHhhhccc--
Confidence            23345567899999999999999999999999999999999999999997321  22111   112222222221111  


Q ss_pred             ccchhhcCCChHHHHHHHHHHHHccccCCCCCC
Q 001566         1007 FLPELWEAGPQENLLGMMRLASTCTVETLSTRP 1039 (1052)
Q Consensus      1007 ~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RP 1039 (1052)
                              .|.....+...+++.-++.||++|.
T Consensus       478 --------iprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  478 --------IPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             --------ccceeehhhHHHHHHhhcCCcHHhc
Confidence                    1222233466788889999999986

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.95  E-value=8.6e-29  Score=280.75  Aligned_cols=244  Identities=25%  Similarity=0.337  Sum_probs=188.0

Q ss_pred             CccceeeeccCce-EEEEEEecCCcEEEEEEeccCccccHHHHHHHHHHhhcc-CCCceeeEEEEEecCCeeEEEEeecC
Q 001566          777 FSIRNLIGTGGFG-STYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEAEMFLVYNFLS  854 (1052)
Q Consensus       777 ~~~~~~Lg~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  854 (1052)
                      |.-.+++|.|+.| .||+|... |+.||||++-...   .....+|++.++.- .|||||++++.-.++...|++.|.| 
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence            4445678999988 57899775 8899999885332   34567899999988 6999999999999999999999999 


Q ss_pred             CCCHHHHHhhc--cCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC---C--CcEEEeeeccccccc
Q 001566          855 GGNLETFIHKK--SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDE---E--LNAYLSDFGLARLLE  927 (1052)
Q Consensus       855 ~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~---~--~~~kl~Dfgla~~~~  927 (1052)
                      ..+|.++++..  ............+..|+++|+++||+.   +|||||+||+||||+.   +  .+++|+|||+++...
T Consensus       586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            67999999874  211112144567889999999999998   9999999999999975   3  468999999999886


Q ss_pred             ccCc--ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCcccCCCCccHHHHHHHHHHhCCcc
Q 001566          928 VSET--HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG-KRSLDPSFSEYGNGFNIVSWAKLLIKEGRSS 1004 (1052)
Q Consensus       928 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1052)
                      ....  .......||.+|+|||.+....-+.++||||+||++|+.++| ..||.......          ..+.......
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~----------~NIl~~~~~L  732 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ----------ANILTGNYTL  732 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh----------hhhhcCccce
Confidence            4432  334567899999999999998888899999999999999996 89997433221          1111111111


Q ss_pred             ccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1005 ELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1005 ~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ..+.     . ..++  ...+||.+|+++||..||++.+|+.
T Consensus       733 ~~L~-----~-~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  733 VHLE-----P-LPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             eeec-----c-CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            1111     1 1111  6889999999999999999999874

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=7.4e-28  Score=262.87  Aligned_cols=214  Identities=23%  Similarity=0.418  Sum_probs=178.9

Q ss_pred             CCccceeeeccCceEEEEEE-ecCCcEEEEEEeccCcc---ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEe
Q 001566          776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRF---QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYN  851 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  851 (1052)
                      -|...+.||-|+||+|.+++ ..+...||.|.+.+.+.   ......++|.++|..-..+=||+++-.|.+++.+|+|||
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            37778899999999999994 45567799998876543   334567899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccccc---c
Q 001566          852 FLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE---V  928 (1052)
Q Consensus       852 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~---~  928 (1052)
                      |++||++-.+|-+.  ..+.++.+..++..+.+|+++.|..   |+|||||||+|||||.+|.+||+|||++.-+.   .
T Consensus       710 YIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd  784 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  784 (1034)
T ss_pred             ccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceeccc
Confidence            99999999998776  4688888888999999999999999   99999999999999999999999999986441   1


Q ss_pred             cCccc--------------------------------------ccccccccccccccccCCCCCCcchhHHHHHHHHHHH
Q 001566          929 SETHA--------------------------------------TTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLEL  970 (1052)
Q Consensus       929 ~~~~~--------------------------------------~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~el  970 (1052)
                      +.++.                                      ....+||+.|+|||++....++..+|.||.|||+|||
T Consensus       785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em  864 (1034)
T KOG0608|consen  785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM  864 (1034)
T ss_pred             cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence            11000                                      1124699999999999999999999999999999999


Q ss_pred             HhCCCCCCCCcccCCCCccHHHHHH
Q 001566          971 ISGKRSLDPSFSEYGNGFNIVSWAK  995 (1052)
Q Consensus       971 ltg~~p~~~~~~~~~~~~~~~~~~~  995 (1052)
                      +.|++||....+. +.+..+..|..
T Consensus       865 ~~g~~pf~~~tp~-~tq~kv~nw~~  888 (1034)
T KOG0608|consen  865 LVGQPPFLADTPG-ETQYKVINWRN  888 (1034)
T ss_pred             hhCCCCccCCCCC-cceeeeeehhh
Confidence            9999999866554 33444555543

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.95  E-value=2.9e-28  Score=235.55  Aligned_cols=269  Identities=19%  Similarity=0.264  Sum_probs=200.8

Q ss_pred             CCccchhhHHHhh---CCCccceeeeccCceEEEEEE-ecCCcEEEEEEeccCccccHHHHHHHHHHhhccC-CCceeeE
Q 001566          762 PAELTYDNVVRAT---GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIR-HKNLVTL  836 (1052)
Q Consensus       762 ~~~~~~~~~~~~~---~~~~~~~~Lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l  836 (1052)
                      ....+|+.....+   ++|++.+++|+|.|++||.|. ..+.++++||+++...   .+.+.+|+.+++.+. ||||+++
T Consensus        22 ~eYWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L   98 (338)
T KOG0668|consen   22 REYWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKL   98 (338)
T ss_pred             hhhcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeeh
Confidence            3344555544433   479999999999999999994 4567899999987544   356789999999996 9999999


Q ss_pred             EEEEecC--CeeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC-C
Q 001566          837 IGYYVGE--AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEE-L  913 (1052)
Q Consensus       837 ~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~-~  913 (1052)
                      +++..+.  ....+|+||+.+.+....-.     .++..++..+..+++.|+.|+|++   ||+|||+||.|+|++.. .
T Consensus        99 ~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~r  170 (338)
T KOG0668|consen   99 LDIVKDPESKTPSLIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELR  170 (338)
T ss_pred             hhhhcCccccCchhHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhc
Confidence            9998764  46789999999988776653     477788899999999999999999   99999999999999865 5


Q ss_pred             cEEEeeecccccccccCcccccccccccccccccccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHH
Q 001566          914 NAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT-CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVS  992 (1052)
Q Consensus       914 ~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~  992 (1052)
                      .++++|+|+|..+.+...+.  -.+.+..|.-||.+-. ..|...-|+|||||++..|+..+.||.....   +..+++.
T Consensus       171 kLrlIDWGLAEFYHp~~eYn--VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d---N~DQLVk  245 (338)
T KOG0668|consen  171 KLRLIDWGLAEFYHPGKEYN--VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD---NYDQLVK  245 (338)
T ss_pred             eeeeeecchHhhcCCCceee--eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC---CHHHHHH
Confidence            69999999999887654433  2355677899998876 4467788999999999999999999863322   2333443


Q ss_pred             HHHHHHHh------CCccccccchhhc---CC------------C-hHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566          993 WAKLLIKE------GRSSELFLPELWE---AG------------P-QENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus       993 ~~~~~~~~------~~~~~~~~~~l~~---~~------------~-~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      .++.+-.+      ++....++|.+..   ..            . .-...+..+++.+.+..|-.+|||++|..+
T Consensus       246 IakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  246 IAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            33221110      1111223333211   11            0 111246889999999999999999999864

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=4.1e-29  Score=246.99  Aligned_cols=260  Identities=23%  Similarity=0.346  Sum_probs=193.3

Q ss_pred             CccceeeeccCceEEEEE-EecCCcEEEEEEeccC--ccccHHHHHHHHHHhhccCCCceeeEEEEEecC-----CeeEE
Q 001566          777 FSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIG--RFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGE-----AEMFL  848 (1052)
Q Consensus       777 ~~~~~~Lg~G~~g~V~~~-~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~l  848 (1052)
                      .+-.+.||.|+||.||.+ +-++|+.||.|++...  .....+.+.+|+.++..++|+|++..+++..-.     .+.|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            455688999999999998 4467999999988543  223457788999999999999999988876532     35688


Q ss_pred             EEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccc
Q 001566          849 VYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV  928 (1052)
Q Consensus       849 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~  928 (1052)
                      ++|.| ..+|...+-.  .+.++.+.+.-+.+||++|+.|||+.   +|.||||||.|.++.++-.+||||||+|+....
T Consensus       135 ~TELm-QSDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  135 LTELM-QSDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHH-Hhhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccch
Confidence            88888 5577766643  36788889999999999999999999   999999999999999999999999999998776


Q ss_pred             cCcccccccccccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHH------------HH
Q 001566          929 SETHATTDVAGTFGYVAPEYATTC-RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSW------------AK  995 (1052)
Q Consensus       929 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~------------~~  995 (1052)
                      .+.......+.|-.|.|||.+.|. .|+.+.||||.|||+.|++.++..|....     .....+.            ++
T Consensus       209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~-----PiqQL~lItdLLGTPs~EaMr  283 (449)
T KOG0664|consen  209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAG-----PIEQLQMIIDLLGTPSQEAMK  283 (449)
T ss_pred             hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccC-----hHHHHHHHHHHhCCCcHHHHH
Confidence            666666666788899999999885 58899999999999999998887775321     1111111            11


Q ss_pred             HHHHhCCc-------cccccchhhcCC-ChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001566          996 LLIKEGRS-------SELFLPELWEAG-PQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus       996 ~~~~~~~~-------~~~~~~~l~~~~-~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                      ......+.       ...-.+.++.-. +.....+...+...++..||++|.+..+.++.
T Consensus       284 ~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~  343 (449)
T KOG0664|consen  284 YACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH  343 (449)
T ss_pred             HHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence            11111111       111111222111 12223345677888999999999998887653

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.94  E-value=1.5e-27  Score=243.02  Aligned_cols=254  Identities=27%  Similarity=0.362  Sum_probs=199.6

Q ss_pred             CCCccceeeeccCceEEEEE-EecCCcEEEEEEeccC--ccccHHHHHHHHHHhhccCCCceeeEEEEEecC------Ce
Q 001566          775 GNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIG--RFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGE------AE  845 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~-~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~  845 (1052)
                      .+|.-.+.+|.|+- .|..| +.-.+++||+|+....  .....++..+|..++..+.|+|+++++.+|.-.      ..
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            35667788899988 55555 4446899999987543  233456778999999999999999999998743      35


Q ss_pred             eEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccc
Q 001566          846 MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARL  925 (1052)
Q Consensus       846 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~  925 (1052)
                      +|+|||+| ..+|...+..    .++-+.+.++..|+++|+.|||+.   ||+|||+||+||++..+..+||.|||+|+.
T Consensus        96 ~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~  167 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLART  167 (369)
T ss_pred             HHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcc
Confidence            79999999 6799999874    378889999999999999999999   999999999999999999999999999985


Q ss_pred             ccccCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccc
Q 001566          926 LEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005 (1052)
Q Consensus       926 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1052)
                      .+..  ...+.++.+..|.|||++.+..+.+.+||||.||++.||++|+.-|.+       ...+.+|.+....-|...+
T Consensus       168 e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g-------~d~idQ~~ki~~~lgtpd~  238 (369)
T KOG0665|consen  168 EDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG-------KDHIDQWNKIIEQLGTPDP  238 (369)
T ss_pred             cCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC-------chHHHHHHHHHHHhcCCCH
Confidence            4432  456677889999999999998899999999999999999999988863       2334455544444443333


Q ss_pred             cccchhhc---------------------------C---CChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1006 LFLPELWE---------------------------A---GPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1006 ~~~~~l~~---------------------------~---~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      .+...+.+                           .   .+.-......+++.+|+-.+|++|.+++++++
T Consensus       239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence            22222111                           0   01122334789999999999999999999875

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=5.4e-27  Score=254.70  Aligned_cols=197  Identities=23%  Similarity=0.373  Sum_probs=170.2

Q ss_pred             hCCCccceeeeccCceEEEEEEecC-CcEEEEEEeccCcc--------ccHHHHHHHHHHhhccC---CCceeeEEEEEe
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRF--------QGIQQFDAEIGTLGRIR---HKNLVTLIGYYV  841 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~---h~niv~l~~~~~  841 (1052)
                      ..+|...+.+|+|+||.|+.|.++. ...|+||.+.+.+.        .....+-.|+++|..++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            3468999999999999999997654 57788998865432        11233556999999997   999999999999


Q ss_pred             cCCeeEEEEeec-CCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeee
Q 001566          842 GEAEMFLVYNFL-SGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDF  920 (1052)
Q Consensus       842 ~~~~~~lv~e~~-~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Df  920 (1052)
                      +++.+|++||.. ++.+|.+|++.+  ..+++.++..|++||+.|+++||++   ||||||||-+||.++.+|-+||+||
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidf  714 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDF  714 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeec
Confidence            999999999975 566999999887  4799999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccccCcccccccccccccccccccCCCCCC-cchhHHHHHHHHHHHHhCCCCCC
Q 001566          921 GLARLLEVSETHATTDVAGTFGYVAPEYATTCRVS-DKADVYSFGVVLLELISGKRSLD  978 (1052)
Q Consensus       921 gla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~sDvwslG~il~elltg~~p~~  978 (1052)
                      |.|.....   ......+||..|.|||++.|..|- ..-|||++|+++|.++....||+
T Consensus       715 gsaa~~ks---gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  715 GSAAYTKS---GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             cchhhhcC---CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99986643   344557899999999999998874 56799999999999999888886

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.93  E-value=3.2e-25  Score=232.56  Aligned_cols=210  Identities=34%  Similarity=0.573  Sum_probs=183.7

Q ss_pred             eeccCceEEEEEEecC-CcEEEEEEeccCccc-cHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecCCCCHHH
Q 001566          783 IGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQ-GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLET  860 (1052)
Q Consensus       783 Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~  860 (1052)
                      ||+|.+|.||++.... ++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++|++++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999997754 899999998765443 34678999999999999999999999999899999999999999999


Q ss_pred             HHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-CCcEEEeeecccccccccCccccccccc
Q 001566          861 FIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDE-ELNAYLSDFGLARLLEVSETHATTDVAG  939 (1052)
Q Consensus       861 ~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~g  939 (1052)
                      ++.... ..+++..+..++.++++++++||+.   +++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus        81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~  155 (215)
T cd00180          81 LLKENE-GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG  155 (215)
T ss_pred             HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence            998753 4589999999999999999999999   9999999999999999 89999999999986643321 2233457


Q ss_pred             ccccccccccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCCChH
Q 001566          940 TFGYVAPEYATTC-RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQE 1018 (1052)
Q Consensus       940 ~~~y~aPE~~~~~-~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 1018 (1052)
                      ...|++||..... .++.++|+|++|++++++                                                
T Consensus       156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------  187 (215)
T cd00180         156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------  187 (215)
T ss_pred             CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence            7899999999887 788899999999999999                                                


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001566         1019 NLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus      1019 ~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                        ..+.+++.+|++.+|++||+++++++.
T Consensus       188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 --PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             --HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence              347889999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=3.1e-27  Score=260.90  Aligned_cols=252  Identities=25%  Similarity=0.392  Sum_probs=204.5

Q ss_pred             hhCCCccceeeeccCceEEEEEE-ecCCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEe
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYN  851 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  851 (1052)
                      ..++|+...++|.|.||.||+|+ ...++..|+|+++.....+..-...|+-+++..+||||+.++|.+...+..+++||
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            34579999999999999999994 45789999999988877777888899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCc
Q 001566          852 FLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET  931 (1052)
Q Consensus       852 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~  931 (1052)
                      |+.+|+|.+.-+-.  ..+++.++..+.+..++|++|||++   |-+|||||-.||++++.|.+|++|||.+..+.. ..
T Consensus        93 ycgggslQdiy~~T--gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita-ti  166 (829)
T KOG0576|consen   93 YCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA-TI  166 (829)
T ss_pred             ecCCCcccceeeec--ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh-hh
Confidence            99999999977654  5799999999999999999999999   899999999999999999999999999987753 23


Q ss_pred             cccccccccccccccccc---CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHH-hC-Ccccc
Q 001566          932 HATTDVAGTFGYVAPEYA---TTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIK-EG-RSSEL 1006 (1052)
Q Consensus       932 ~~~~~~~g~~~y~aPE~~---~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~ 1006 (1052)
                      .+.....||+.|||||+.   +.+.|...+|||+.|+...|+---++|...-- +        ..+..+.. .+ .....
T Consensus       167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh-p--------mr~l~LmTkS~~qpp~l  237 (829)
T KOG0576|consen  167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH-P--------MRALFLMTKSGFQPPTL  237 (829)
T ss_pred             hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc-h--------HHHHHHhhccCCCCCcc
Confidence            445667899999999976   34668889999999999999987776643110 0        11111111 11 11112


Q ss_pred             ccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1007 FLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1007 ~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      -|+       ......+-++++.|+..+|++||++..+++
T Consensus       238 kDk-------~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  238 KDK-------TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             cCC-------ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            222       233445889999999999999999987764

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=4.4e-26  Score=226.12  Aligned_cols=253  Identities=20%  Similarity=0.304  Sum_probs=190.6

Q ss_pred             hCCCccceeeeccCceEEEEEEecC-CcEEEEEEeccCccccHHHHHHHHHHhhcc-CCCceeeEEEE-EecCCeeEEEE
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFDAEIGTLGRI-RHKNLVTLIGY-YVGEAEMFLVY  850 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~-~~~~~~~~lv~  850 (1052)
                      .+.|.+.+.+|+|.||.+-+++++. .+.+++|.+..... ..++|.+|..---.+ .|.||+.-+++ |+..+.+++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            3568999999999999999998764 67889998865543 357888888765566 59999988775 66777888999


Q ss_pred             eecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC--CCCcEEEeeecccccccc
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLD--EELNAYLSDFGLARLLEV  928 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~--~~~~~kl~Dfgla~~~~~  928 (1052)
                      ||++.|+|.+-+...   .+.+....+++.|+++|+.|+|++   .+||||||.+||||-  +..++|+||||..+..+.
T Consensus       102 E~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~  175 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT  175 (378)
T ss_pred             ccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCc
Confidence            999999999988764   588899999999999999999999   999999999999993  335799999999986543


Q ss_pred             cCcccccccccccccccccccCCC-----CCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCc
Q 001566          929 SETHATTDVAGTFGYVAPEYATTC-----RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRS 1003 (1052)
Q Consensus       929 ~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1052)
                      .-.+    ..-+..|.+||.....     ...+.+|||.||++++.++||+.||......   +..+.+|.+  +..+..
T Consensus       176 tV~~----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~---d~~Y~~~~~--w~~rk~  246 (378)
T KOG1345|consen  176 TVKY----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM---DKPYWEWEQ--WLKRKN  246 (378)
T ss_pred             eehh----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc---CchHHHHHH--HhcccC
Confidence            2211    1234568999976542     2356789999999999999999999854333   334444433  333332


Q ss_pred             cccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 001566         1004 SELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKL 1048 (1052)
Q Consensus      1004 ~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L 1048 (1052)
                      ..  .|+......+    .++++.++-+.++|++|-...++.++.
T Consensus       247 ~~--~P~~F~~fs~----~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  247 PA--LPKKFNPFSE----KALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             cc--CchhhcccCH----HHHHHHHHhcCCcccccchhHHHHHHH
Confidence            21  2333333333    377888899999999997666655543

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.93  E-value=3.4e-26  Score=245.22  Aligned_cols=212  Identities=23%  Similarity=0.263  Sum_probs=176.4

Q ss_pred             CCccchhhHHHhhCCCccceeeeccCceEEEEEEe-cCCcEEEEEEeccCccccHHHHHHHHHHhhccC------CCcee
Q 001566          762 PAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIR------HKNLV  834 (1052)
Q Consensus       762 ~~~~~~~~~~~~~~~~~~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv  834 (1052)
                      ..+|.+.-.+....+|.+....|+|-|++|.+|.. ..|..||||++.....-. ..=..|+++|+++.      --|.+
T Consensus       419 EGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~-KtGl~EleiLkKL~~AD~Edk~Hcl  497 (752)
T KOG0670|consen  419 EGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH-KTGLKELEILKKLNDADPEDKFHCL  497 (752)
T ss_pred             cceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh-hhhhHHHHHHHHhhccCchhhhHHH
Confidence            44555666666778999999999999999999944 458899999997554332 33467999999994      34889


Q ss_pred             eEEEEEecCCeeEEEEeecCCCCHHHHHhhcc-CCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC
Q 001566          835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKS-GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEEL  913 (1052)
Q Consensus       835 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~  913 (1052)
                      +++..|....++|+|||.+ .-+|.+.++... ...+....+..++.|+.-||..|-..   +|+|.||||.||||.+..
T Consensus       498 rl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k  573 (752)
T KOG0670|consen  498 RLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESK  573 (752)
T ss_pred             HHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCc
Confidence            9999999999999999988 679999998764 45688889999999999999999988   999999999999998764


Q ss_pred             -cEEEeeecccccccccCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCc
Q 001566          914 -NAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSF  981 (1052)
Q Consensus       914 -~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~  981 (1052)
                       .+||||||.|......+   ...+..+..|.|||++.|..|....|+||+||.+||+.||+..|.+..
T Consensus       574 ~iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T  639 (752)
T KOG0670|consen  574 NILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT  639 (752)
T ss_pred             ceeeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence             57999999998665332   223345668999999999999999999999999999999999886543

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.93  E-value=1.2e-24  Score=231.18  Aligned_cols=198  Identities=35%  Similarity=0.548  Sum_probs=173.4

Q ss_pred             CccceeeeccCceEEEEEEecC-CcEEEEEEeccCccc-cHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecC
Q 001566          777 FSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQ-GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLS  854 (1052)
Q Consensus       777 ~~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  854 (1052)
                      |++.+.||.|++|.||+|.... ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++|+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            5677899999999999997764 889999999766554 56788999999999999999999999999899999999999


Q ss_pred             CCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcccc
Q 001566          855 GGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT  934 (1052)
Q Consensus       855 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  934 (1052)
                      +++|.+++..... .+++..+..++.+++.++.+||+.   +++|+|++|.||+++.++.++|+|||.+...........
T Consensus        81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~  156 (225)
T smart00221       81 GGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL  156 (225)
T ss_pred             CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence            9999999987542 278999999999999999999999   999999999999999999999999999987654321122


Q ss_pred             ccccccccccccccc-CCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 001566          935 TDVAGTFGYVAPEYA-TTCRVSDKADVYSFGVVLLELISGKRSLD  978 (1052)
Q Consensus       935 ~~~~g~~~y~aPE~~-~~~~~~~~sDvwslG~il~elltg~~p~~  978 (1052)
                      ....++..|++||.. ....++.++|||+||++++||++|+.||+
T Consensus       157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~  201 (225)
T smart00221      157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS  201 (225)
T ss_pred             cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence            334577889999998 66777889999999999999999999996

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.92  E-value=7e-26  Score=224.15  Aligned_cols=250  Identities=21%  Similarity=0.330  Sum_probs=197.1

Q ss_pred             CCccceeeeccCceEEEEEEecCCcEEEEEEeccCcc--ccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeec
Q 001566          776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFL  853 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  853 (1052)
                      +..+..+|.+...|+.|+|+|+ |..+++|++...+.  ....+|.+|.-.++.+.||||.+++|.|.......++..||
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m  269 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM  269 (448)
T ss_pred             hhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence            3455667899999999999998 66677787765432  23468999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEe--eecccccccccCc
Q 001566          854 SGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLS--DFGLARLLEVSET  931 (1052)
Q Consensus       854 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~--Dfgla~~~~~~~~  931 (1052)
                      +.|+|+..++...+-..+..++.+++.++|+|++|||+.- |-|----+.++.|++|++.+++|.  |--++..    + 
T Consensus       270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfq----e-  343 (448)
T KOG0195|consen  270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ----E-  343 (448)
T ss_pred             cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeee----c-
Confidence            9999999999988778899999999999999999999873 334445689999999999888764  3222221    1 


Q ss_pred             ccccccccccccccccccCCCCCC---cchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCcccccc
Q 001566          932 HATTDVAGTFGYVAPEYATTCRVS---DKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFL 1008 (1052)
Q Consensus       932 ~~~~~~~g~~~y~aPE~~~~~~~~---~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                         ....-.|.||+||.++.++..   .++|+|||++++||+-|...||... ++.+-++       .+.         .
T Consensus       344 ---~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadl-spmecgm-------kia---------l  403 (448)
T KOG0195|consen  344 ---VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADL-SPMECGM-------KIA---------L  403 (448)
T ss_pred             ---cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccC-Cchhhhh-------hhh---------h
Confidence               112235789999999876543   5789999999999999999999743 2222111       111         1


Q ss_pred             chhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhccC
Q 001566         1009 PELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQLK 1052 (1052)
Q Consensus      1009 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~lk 1052 (1052)
                      +.+.-..|+.....+.+++.-|+.+||.+||.++.++-.||+++
T Consensus       404 eglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  404 EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            22333456777778999999999999999999999999999874

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.91  E-value=7.8e-27  Score=243.30  Aligned_cols=294  Identities=17%  Similarity=0.110  Sum_probs=191.6

Q ss_pred             ceEeecCCCceEEEEEccCCCCCCCCCcccccccchhhcCCCCCCeeEecCCCceecCCCCccCCCCccEEEccCccccc
Q 001566           82 GVTCDHFTGRVTALRITGKATPWPSKSSVISGTLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSG  161 (1052)
Q Consensus        82 gV~C~~~~~~v~~l~l~~~~~~~~~~~~~l~g~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  161 (1052)
                      -|+|+..+..-++-++|..+                        +.+.|..|+|+...|.+|+.+++|+.||||+|+|+.
T Consensus        50 ~VdCr~~GL~eVP~~LP~~t------------------------veirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~  105 (498)
T KOG4237|consen   50 IVDCRGKGLTEVPANLPPET------------------------VEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISF  105 (498)
T ss_pred             eEEccCCCcccCcccCCCcc------------------------eEEEeccCCcccCChhhccchhhhceecccccchhh
Confidence            38888776666666666655                        456666666665445566666666666666666666


Q ss_pred             cCCccccCCCCCCeEeccc-ccccccCCccccCCCCCcEEEccCCcccCccccCCCcccCCCCEEEccCCcCCCCCCccc
Q 001566          162 KIPYQMSNLERLRVLNLSF-NSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEI  240 (1052)
Q Consensus       162 ~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l  240 (1052)
                      +-|++|.++.+|.+|-+.+ |+|+..-.+.|.++..|+.|.+.-|++.- +..+.+..+++|..|.+.+|.+...--..|
T Consensus       106 I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~C-ir~~al~dL~~l~lLslyDn~~q~i~~~tf  184 (498)
T KOG4237|consen  106 IAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINC-IRQDALRDLPSLSLLSLYDNKIQSICKGTF  184 (498)
T ss_pred             cChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcc-hhHHHHHHhhhcchhcccchhhhhhccccc
Confidence            6666666666666655555 66664444566666666666666666653 445566666666666666666663222366


Q ss_pred             CCCCCCCEEEcCCCc------------cccccchhhcCCCCCCEEEccCCCCCCCCCcccccC-CCCCceeccccccccc
Q 001566          241 GKCRNLKNLLLDGNI------------LEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADC-SKLSVLVLTNIDASLD  307 (1052)
Q Consensus       241 ~~l~~L~~L~L~~N~------------l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l-~~L~~L~L~~n~~~~~  307 (1052)
                      ..+.+++.+.+..|.            .....|.+++...-..-..+.++++...-+..|... ..+..-..+.+     
T Consensus       185 ~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d-----  259 (498)
T KOG4237|consen  185 QGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSED-----  259 (498)
T ss_pred             cchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhcccc-----
Confidence            666667777766666            222345556666666666666666665444444322 11111011110     


Q ss_pred             CCCCCCccccccCCCch-hhhcccCCcEEecCCCCCCccCCccccCCCCccEEeCCCCcccccCCccccccCCCCEEeCC
Q 001566          308 LDNSRGEFSAFDGGVPY-ELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLS  386 (1052)
Q Consensus       308 l~~~~~~~~~~~~~~p~-~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  386 (1052)
                               ...+..|. .+..+++|+.|+|++|.++++-+.+|.+...+++|.|..|+|...-...|.++..|+.|+|.
T Consensus       260 ---------~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~  330 (498)
T KOG4237|consen  260 ---------FPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLY  330 (498)
T ss_pred             ---------CcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeec
Confidence                     11222333 24667788888888888888888888888888889999998887777788888888889999


Q ss_pred             CCcCcCCCCCCCC-CCCcceEecccCccc
Q 001566          387 LNNLEGYLPMQLP-VPCMVYFNVSQNNIT  414 (1052)
Q Consensus       387 ~N~l~~~~p~~~~-~~~L~~l~l~~N~l~  414 (1052)
                      +|+|+...|..|. +.+|..|+|-.|.+.
T Consensus       331 ~N~it~~~~~aF~~~~~l~~l~l~~Np~~  359 (498)
T KOG4237|consen  331 DNQITTVAPGAFQTLFSLSTLNLLSNPFN  359 (498)
T ss_pred             CCeeEEEecccccccceeeeeehccCccc
Confidence            9998888887774 677888888888763

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.90  E-value=3.1e-24  Score=227.59  Aligned_cols=267  Identities=25%  Similarity=0.358  Sum_probs=198.2

Q ss_pred             HHHhhCCCccceeeeccCceEEEEEEec----CCcEEEEEEeccCccccHHHHHHHHHHhhcc-CCCceeeEEEEEecCC
Q 001566          770 VVRATGNFSIRNLIGTGGFGSTYKAELV----PGYLVAVKKLSIGRFQGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEA  844 (1052)
Q Consensus       770 ~~~~~~~~~~~~~Lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  844 (1052)
                      +....+.|...++||+|.|++||+|...    ..+.||+|.+.....  ..++.+|++++..+ .+.||+++.+++...+
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            3345567899999999999999999433    468899998865543  36789999999999 5999999999999999


Q ss_pred             eeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC-CCCcEEEeeeccc
Q 001566          845 EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLD-EELNAYLSDFGLA  923 (1052)
Q Consensus       845 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~-~~~~~kl~Dfgla  923 (1052)
                      .+.+|+||++.....++...     ++..++..+...+..||+++|..   |||||||||.|++.+ ..+.-.|+|||+|
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA  180 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLA  180 (418)
T ss_pred             eeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhH
Confidence            99999999999999988854     66888999999999999999999   999999999999997 4567899999999


Q ss_pred             cccccc------Cc-------------------------------------ccccccccccccccccccCCCC-CCcchh
Q 001566          924 RLLEVS------ET-------------------------------------HATTDVAGTFGYVAPEYATTCR-VSDKAD  959 (1052)
Q Consensus       924 ~~~~~~------~~-------------------------------------~~~~~~~g~~~y~aPE~~~~~~-~~~~sD  959 (1052)
                      ......      ..                                     .......||++|.|||++.... -++++|
T Consensus       181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD  260 (418)
T KOG1167|consen  181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID  260 (418)
T ss_pred             HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence            832100      00                                     0011346999999999987644 578999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHH------HHHHHHhCC--ccc---------------ccc-chhhc--
Q 001566          960 VYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSW------AKLLIKEGR--SSE---------------LFL-PELWE-- 1013 (1052)
Q Consensus       960 vwslG~il~elltg~~p~~~~~~~~~~~~~~~~~------~~~~~~~~~--~~~---------------~~~-~~l~~-- 1013 (1052)
                      |||.|||+.-+++++.||.....+..........      .+.....|.  ...               .++ +.+.+  
T Consensus       261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~  340 (418)
T KOG1167|consen  261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR  340 (418)
T ss_pred             eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence            9999999999999999997554442222221111      111111111  000               000 00000  


Q ss_pred             ------C-CChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1014 ------A-GPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1014 ------~-~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                            . .....+..+.+++++|+..+|.+|.|++|.++
T Consensus       341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence                  0 01122336789999999999999999999875

>PLN03210 Resistant to P

Probab=99.90  E-value=1.7e-22  Score=260.72  Aligned_cols=268  Identities=20%  Similarity=0.159  Sum_probs=149.2

Q ss_pred             hhhcCCCCCCeeEecCCC------ceecCCCCccCCC-CccEEEccCccccccCCccccCCCCCCeEecccccccccCCc
Q 001566          117 ASIAKLTELRTLSVPHNS------FSGEIPAGVGELR-LLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPR  189 (1052)
Q Consensus       117 ~~l~~l~~L~~L~L~~n~------l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  189 (1052)
                      .+|..+++|+.|.+..+.      +...+|+.|..++ +|+.|++.+|.+. .+|..| ...+|+.|+|++|++. .+|.
T Consensus       552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~  628 (1153)
T PLN03210        552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWD  628 (1153)
T ss_pred             HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccc
Confidence            456677777777775543      3335666666654 4777777777766 566665 4567777777777766 5666


Q ss_pred             cccCCCCCcEEEccCCcccCccccCCCcccCCCCEEEccCCcCCCCCCcccCCCCCCCEEEcCCCccccccchhhcCCCC
Q 001566          190 GLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISE  269 (1052)
Q Consensus       190 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  269 (1052)
                      .+..+++|+.|+|++|...+.+|  .++.+++|++|+|++|.....+|..++++++|+.|++++|..-+.+|..+ ++++
T Consensus       629 ~~~~l~~Lk~L~Ls~~~~l~~ip--~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~s  705 (1153)
T PLN03210        629 GVHSLTGLRNIDLRGSKNLKEIP--DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKS  705 (1153)
T ss_pred             ccccCCCCCEEECCCCCCcCcCC--ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCC
Confidence            66677777777777665433343  25556677777777765555666667777777777777654444556554 5667


Q ss_pred             CCEEEccCCCCCCCCCcccccCCCCCceecccccccccCCCCCCccccccCCCchhhhcccCCcEEecCCCCC-------
Q 001566          270 LKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANL-------  342 (1052)
Q Consensus       270 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~~~~~l~~~~~~~~~~~~~~p~~~~~~~~L~~L~l~~n~l-------  342 (1052)
                      |+.|++++|.....+|..   ..+|+.|++++|.+.               .+|..+ .+++|..|.+.++..       
T Consensus       706 L~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~---------------~lP~~~-~l~~L~~L~l~~~~~~~l~~~~  766 (1153)
T PLN03210        706 LYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE---------------EFPSNL-RLENLDELILCEMKSEKLWERV  766 (1153)
T ss_pred             CCEEeCCCCCCccccccc---cCCcCeeecCCCccc---------------cccccc-cccccccccccccchhhccccc
Confidence            777777766554444432   345566666654432               122111 234455554444221       


Q ss_pred             CccCCccccCCCCccEEeCCCCcccccCCccccccCCCCEEeCCCCcCcCCCCCCCCCCCcceEecc
Q 001566          343 GGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVS  409 (1052)
Q Consensus       343 ~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~l~  409 (1052)
                      ....+..+...++|+.|+|++|...+.+|.+++++++|+.|+|++|...+.+|....+++|+.|+++
T Consensus       767 ~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~~L~sL~~L~Ls  833 (1153)
T PLN03210        767 QPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGINLESLESLDLS  833 (1153)
T ss_pred             cccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCCCccccCEEECC
Confidence            1111111222345566666665555555666666666666666555433333333333333333333

syringae 6; Provisional

>PLN03210 Resistant to P

Probab=99.90  E-value=2.9e-22  Score=258.56  Aligned_cols=127  Identities=20%  Similarity=0.256  Sum_probs=104.2

Q ss_pred             CcCccEEEccCcccccccccccCCCCCCCEEEccCCcCCCCCcccccCCccCcEEEcCCCccCCcCchhhcCCCCCcEEE
Q 001566          531 CVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLD  610 (1052)
Q Consensus       531 ~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  610 (1052)
                      .++|+.|++++|...+.+|..++++++|+.|+|++|..-+.+|..+ ++++|+.|+|++|..-..+|..   ..+|++|+
T Consensus       777 ~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~  852 (1153)
T PLN03210        777 SPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLN  852 (1153)
T ss_pred             cccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeE
Confidence            4578889999988777889899999999999999876444777666 7899999999998655456653   36789999


Q ss_pred             cCCCCCCCCCchhhhcccccceeeccCc-cCCCCCCcccccccccCceeccccc
Q 001566          611 LSHNALTGSIPASLTKATKLESLFLAHN-RLSGEIPVSFSTLVNLSALDLSFNN  663 (1052)
Q Consensus       611 l~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~l~~N~  663 (1052)
                      |++|.|+ .+|.++..+++|+.|+|++| ++. .+|..+..+++|+.+++++|.
T Consensus       853 Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        853 LSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             CCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence            9999998 68989999999999999984 566 577788889999999998874

syringae 6; Provisional

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.89  E-value=1.6e-25  Score=233.50  Aligned_cols=266  Identities=21%  Similarity=0.203  Sum_probs=198.9

Q ss_pred             cCCCCccCCCCccEEEccCccccccCCccccCCCCCCeEecccccccccCCccccCCCCCcEEEccC-CcccCccccCCC
Q 001566          138 EIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSS-NRLSGGLAIDSS  216 (1052)
Q Consensus       138 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~  216 (1052)
                      ++|..+-  ..-..++|..|+|+.+.|.+|+.+++|+.||||+|+|+.+-|++|.++.+|..|-+.+ |+|+. ++.+.|
T Consensus        60 eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~-l~k~~F  136 (498)
T KOG4237|consen   60 EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITD-LPKGAF  136 (498)
T ss_pred             cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhh-hhhhHh
Confidence            4554432  3457899999999988889999999999999999999999999999999988877766 88886 888999


Q ss_pred             cccCCCCEEEccCCcCCCCCCcccCCCCCCCEEEcCCCccccccchhhcCCCCCCEEEccCCCCCC------------CC
Q 001566          217 SECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTD------------RI  284 (1052)
Q Consensus       217 ~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~------------~~  284 (1052)
                      .++..|+.|.+.-|++.-.....|..+++|..|.+.+|.+...--..|..+..++.+.+..|.+..            ..
T Consensus       137 ~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~  216 (498)
T KOG4237|consen  137 GGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMN  216 (498)
T ss_pred             hhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhc
Confidence            999999999999999998778889999999999999999984444489999999999999988432            11


Q ss_pred             CcccccCCCCCceecccccccccCCCCCCccccccCCCchhhhcccCCcEEecCCCCCCccCCc-cccCCCCccEEeCCC
Q 001566          285 PVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPD-NWSESCSLKVLNLGQ  363 (1052)
Q Consensus       285 p~~l~~l~~L~~L~L~~n~~~~~l~~~~~~~~~~~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~-~~~~~~~L~~L~Ls~  363 (1052)
                      |.+++...-..-..+.+.++.-.   ....|.          ..+.++..-..+.....+..|. .|..+++|+.|+|++
T Consensus       217 ~ietsgarc~~p~rl~~~Ri~q~---~a~kf~----------c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsn  283 (498)
T KOG4237|consen  217 PIETSGARCVSPYRLYYKRINQE---DARKFL----------CSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSN  283 (498)
T ss_pred             hhhcccceecchHHHHHHHhccc---chhhhh----------hhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCC
Confidence            22222222222222221111100   000000          1111222222334445555554 499999999999999


Q ss_pred             CcccccCCccccccCCCCEEeCCCCcCcCCCCCCC-CCCCcceEecccCcccccCCC
Q 001566          364 NSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQL-PVPCMVYFNVSQNNITGVLPR  419 (1052)
Q Consensus       364 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~~~L~~l~l~~N~l~~~~p~  419 (1052)
                      |+|+++-+.+|..+..+++|.|..|+|...-...+ ++..|+.|+|.+|+|+.+-|.
T Consensus       284 N~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~  340 (498)
T KOG4237|consen  284 NKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPG  340 (498)
T ss_pred             CccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecc
Confidence            99999999999999999999999999986555445 478899999999999987665

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.89  E-value=1.3e-23  Score=263.36  Aligned_cols=195  Identities=17%  Similarity=0.202  Sum_probs=138.5

Q ss_pred             ccCC-CceeeEEEEE-------ecCCeeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 001566          827 RIRH-KNLVTLIGYY-------VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV  898 (1052)
Q Consensus       827 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ii  898 (1052)
                      .++| +||+++++++       .+...++.++|++ +++|.++++.. ...+++.++..++.||++||+|||++   ||+
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---gIv  102 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQ---GIV  102 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence            3445 5777778776       2334678888988 67999999754 35699999999999999999999999   999


Q ss_pred             eCCCCCCCEEECCC-------------------CcEEEeeecccccccccCc---------------ccccccccccccc
Q 001566          899 HRDIKPSNILLDEE-------------------LNAYLSDFGLARLLEVSET---------------HATTDVAGTFGYV  944 (1052)
Q Consensus       899 HrDik~~Nill~~~-------------------~~~kl~Dfgla~~~~~~~~---------------~~~~~~~g~~~y~  944 (1052)
                      ||||||+|||++..                   +.+|++|||+++.......               .......||+.||
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            99999999999654                   4456666666653211000               0011135788899


Q ss_pred             cccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHH
Q 001566          945 APEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMM 1024 (1052)
Q Consensus       945 aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 1024 (1052)
                      |||++.+..++.++|||||||++|||++|.+|+....          ......... .    +.+..     ........
T Consensus       183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----------~~~~~~~~~-~----~~~~~-----~~~~~~~~  242 (793)
T PLN00181        183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----------RTMSSLRHR-V----LPPQI-----LLNWPKEA  242 (793)
T ss_pred             ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----------HHHHHHHHh-h----cChhh-----hhcCHHHH
Confidence            9999999999999999999999999999887764211          111111110 0    01111     11122356


Q ss_pred             HHHHHccccCCCCCCCHHHHHH
Q 001566         1025 RLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1025 ~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      .++.+||+++|.+||++.|+++
T Consensus       243 ~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        243 SFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHHhCCCChhhCcChHHHhh
Confidence            7888999999999999999975

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.88  E-value=2e-22  Score=205.24  Aligned_cols=166  Identities=17%  Similarity=0.203  Sum_probs=126.4

Q ss_pred             CCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCccccc
Q 001566          856 GNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT  935 (1052)
Q Consensus       856 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  935 (1052)
                      |+|.++++.+. ..++++++..++.|++.|++|||++   +      ||+||+++.++.+++  ||.+.......     
T Consensus         1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-----   63 (176)
T smart00750        1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ-----   63 (176)
T ss_pred             CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc-----
Confidence            78999998653 5699999999999999999999998   5      999999999999999  99988654321     


Q ss_pred             ccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCC
Q 001566          936 DVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAG 1015 (1052)
Q Consensus       936 ~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 1015 (1052)
                       ..|++.|||||++.+..++.++|||||||++|||+||+.||.....       .....+............+    ...
T Consensus        64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~----~~~  131 (176)
T smart00750       64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE-------LSAILEILLNGMPADDPRD----RSN  131 (176)
T ss_pred             -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch-------hcHHHHHHHHHhccCCccc----ccc
Confidence             2578999999999999999999999999999999999999864321       1112222221111110000    011


Q ss_pred             ChHHHH--HHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 001566         1016 PQENLL--GMMRLASTCTVETLSTRPSVKQVLIKLKQ 1050 (1052)
Q Consensus      1016 ~~~~~~--~l~~Li~~cl~~dP~~RPt~~eil~~L~~ 1050 (1052)
                      +.....  .+.+++.+||+.+|++||++.|+++.+..
T Consensus       132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~  168 (176)
T smart00750      132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA  168 (176)
T ss_pred             HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence            122222  58999999999999999999999988754

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.88  E-value=3.5e-22  Score=238.28  Aligned_cols=82  Identities=27%  Similarity=0.325  Sum_probs=39.7

Q ss_pred             ccEEEccCcccccccccccCCCCCCCEEEccCCcCCCCCcccccCCccCcEEEcCCCccCCcCchhhcCCCCCcEEEcCC
Q 001566          534 LVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSH  613 (1052)
Q Consensus       534 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~  613 (1052)
                      |+.|++++|+|++ +|..   .++|+.|++++|+|++ +|..+   .+|+.|+|++|+|+ .+|..++++++|+.|+|++
T Consensus       384 L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~  454 (788)
T PRK15387        384 LKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEG  454 (788)
T ss_pred             cceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCC
Confidence            4444555555542 2221   1345555555555552 34322   23445555555555 4555555555555555555


Q ss_pred             CCCCCCCchhh
Q 001566          614 NALTGSIPASL  624 (1052)
Q Consensus       614 N~l~~~~p~~~  624 (1052)
                      |+|++..|..+
T Consensus       455 N~Ls~~~~~~L  465 (788)
T PRK15387        455 NPLSERTLQAL  465 (788)
T ss_pred             CCCCchHHHHH
Confidence            55555444443

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.88  E-value=2.9e-22  Score=238.99  Aligned_cols=121  Identities=31%  Similarity=0.355  Sum_probs=66.6

Q ss_pred             CccEEEccCcccccccccccCCCCCCCEEEccCCcCCCCCcccccCCccCcEEEcCCCccCCcCchhhcCCCCCcEEEcC
Q 001566          533 QLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLS  612 (1052)
Q Consensus       533 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  612 (1052)
                      +|++|++++|+|++ +|..   ..+|+.|++++|+|+ .+|..   ..+|+.|+|++|+|+ .+|..   .++|+.|+++
T Consensus       343 ~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~-~LP~l---~~~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS  410 (788)
T PRK15387        343 GLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLT-SLPVL---PSELKELMVS  410 (788)
T ss_pred             ccceEecCCCccCC-CCCC---Ccccceehhhccccc-cCccc---ccccceEEecCCccc-CCCCc---ccCCCEEEcc
Confidence            34555555555553 2221   234555566666665 24432   234566666666666 34432   2456666666


Q ss_pred             CCCCCCCCchhhhcccccceeeccCccCCCCCCcccccccccCceecccccccCCCCC
Q 001566          613 HNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPH  670 (1052)
Q Consensus       613 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~  670 (1052)
                      +|+|+ .+|..+   .+|+.|++++|+|+ .+|..+..+++|+.|+|++|+|+|.+|.
T Consensus       411 ~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~  463 (788)
T PRK15387        411 GNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ  463 (788)
T ss_pred             CCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence            66666 355432   34566666666666 5566666666666666666666665543

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=5.3e-21  Score=213.71  Aligned_cols=257  Identities=22%  Similarity=0.254  Sum_probs=193.1

Q ss_pred             CCccceeeeccCceEEEEEEecCC--cEEEEEEeccCccccHHHHHHHHHHhhccCC----CceeeEEEEE-ecCCeeEE
Q 001566          776 NFSIRNLIGTGGFGSTYKAELVPG--YLVAVKKLSIGRFQGIQQFDAEIGTLGRIRH----KNLVTLIGYY-VGEAEMFL  848 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~l~~~~-~~~~~~~l  848 (1052)
                      +|.+.+.||+|+||.||.|.....  ..+|+|............+..|..++..+..    +++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999965543  5788887765433333377889999988863    6889999998 47778899


Q ss_pred             EEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC-----CcEEEeeeccc
Q 001566          849 VYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEE-----LNAYLSDFGLA  923 (1052)
Q Consensus       849 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~-----~~~kl~Dfgla  923 (1052)
                      ||+.+ |.+|.++........++..+...++.|++.+|+++|+.   |++||||||.|+++...     ..+.+.|||++
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99988 99999988777667899999999999999999999999   99999999999999865     35899999999


Q ss_pred             cccc--ccCc-----c-c-ccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHH
Q 001566          924 RLLE--VSET-----H-A-TTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWA  994 (1052)
Q Consensus       924 ~~~~--~~~~-----~-~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  994 (1052)
                      +.+.  ....     . . .....||.+|+++++..+...+++.|+||+++++.|+..|..||.......    ......
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~----~~~~~~  250 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTD----LKSKFE  250 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccc----hHHHHH
Confidence            8332  1111     1 1 223569999999999999999999999999999999999999985322111    111111


Q ss_pred             HHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 001566          995 KLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQ 1050 (1052)
Q Consensus       995 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~ 1050 (1052)
                      +..... ...    .     .....+..+.++...+-..+..++|....+...+++
T Consensus       251 ~~~~~~-~~~----~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~  296 (322)
T KOG1164|consen  251 KDPRKL-LTD----R-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKD  296 (322)
T ss_pred             HHhhhh-ccc----c-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHH
Confidence            111111 000    0     111122345556556666889999999988887654

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.86  E-value=3.4e-21  Score=231.80  Aligned_cols=207  Identities=18%  Similarity=0.235  Sum_probs=107.3

Q ss_pred             CCChhhHHHHHHHHHhccCCCCCcccC----CCCCCCCCCCCc----------------eEeecCCCceEEEEEccCCCC
Q 001566           44 SVPTTDSASLLSFKASISRDPSNLLAT----WNSSTDHCTWHG----------------VTCDHFTGRVTALRITGKATP  103 (1052)
Q Consensus        44 ~~~~~d~~all~~k~~~~~~p~~~l~~----W~~~~~~C~w~g----------------V~C~~~~~~v~~l~l~~~~~~  103 (1052)
                      ...++|...+++..+.+...+  .+.+    |..++|+|-=..                |.|.  .+.|+.+.+.|....
T Consensus        59 ~~~~~~~~~~~~~~~~l~~p~--~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~--~~~vt~l~~~g~~~~  134 (754)
T PRK15370         59 TASPEEIKSKFECLRMLAFPA--YADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGG--GKSVTYTRVTESEQA  134 (754)
T ss_pred             CCCHHHHHHHHHHHHHhcCCc--hhhccccccCCCCcccccCCcchhhheeeecCCceEEecC--CCccccccccccccc
Confidence            456889999999999996433  4445    999999995332                6775  456777766663211


Q ss_pred             CCCCCccccc-ccchhhcCCCCCCeeEecCCCcee----------cCCCCccCCCCccEEEccCccccccCCccccCCCC
Q 001566          104 WPSKSSVISG-TLSASIAKLTELRTLSVPHNSFSG----------EIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLER  172 (1052)
Q Consensus       104 ~~~~~~~l~g-~l~~~l~~l~~L~~L~L~~n~l~~----------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  172 (1052)
                      -.. +..-.. .-......-.        .+.-.+          .+.+++  ..+...|+++++.++ .+|..+.  ++
T Consensus       135 ~~~-~~~~~~~~~~~~w~~w~--------~~~~~~~~~~r~~a~~r~~~Cl--~~~~~~L~L~~~~Lt-sLP~~Ip--~~  200 (754)
T PRK15370        135 SSA-SGSKDAVNYELIWSEWV--------KEAPAKEAANREEAVQRMRDCL--KNNKTELRLKILGLT-TIPACIP--EQ  200 (754)
T ss_pred             ccC-CCCCChhhHHHHHHHHH--------hcCCCCccccHHHHHHHHHhhc--ccCceEEEeCCCCcC-cCCcccc--cC
Confidence            000 000000 0000000000        000000          011111  134566777777777 4565443  46


Q ss_pred             CCeEecccccccccCCccccCCCCCcEEEccCCcccCccccCCCcccCCCCEEEccCCcCCCCCCcccCCCCCCCEEEcC
Q 001566          173 LRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLD  252 (1052)
Q Consensus       173 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~  252 (1052)
                      |+.|+|++|+|+ .+|..+.  ++|+.|++++|+++. +|...   ..+|+.|+|++|.++ .+|..+.  ++|+.|+++
T Consensus       201 L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lts-LP~~l---~~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls  270 (754)
T PRK15370        201 ITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTS-IPATL---PDTIQEMELSINRIT-ELPERLP--SALQSLDLF  270 (754)
T ss_pred             CcEEEecCCCCC-cCChhhc--cCCCEEECCCCcccc-CChhh---hccccEEECcCCccC-cCChhHh--CCCCEEECc
Confidence            777777777777 4555443  356666666666553 33211   134566666666665 3454443  356666666


Q ss_pred             CCccccccchhhcCCCCCCEEEccCCCCC
Q 001566          253 GNILEGSIPKEIGTISELKVLDVSRNSLT  281 (1052)
Q Consensus       253 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  281 (1052)
                      +|+|+ .+|..+.  ++|+.|+|++|+|+
T Consensus       271 ~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt  296 (754)
T PRK15370        271 HNKIS-CLPENLP--EELRYLSVYDNSIR  296 (754)
T ss_pred             CCccC-ccccccC--CCCcEEECCCCccc
Confidence            66665 3454432  35666666666555

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=2.9e-21  Score=188.96  Aligned_cols=259  Identities=22%  Similarity=0.289  Sum_probs=198.8

Q ss_pred             hhCCCccceeeeccCceEEEEEE-ecCCcEEEEEEeccCccccHHHHHHHHHHhhccCC-CceeeEEEEEecCCeeEEEE
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRH-KNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~  850 (1052)
                      ..++|.+.++||.|+||.+|.|. ..+|+.||+|.-+.....  .+...|..+.+.+++ ..|..+..+..+...-.+||
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            34689999999999999999994 567999999987654433  567789999999964 56777777888888889999


Q ss_pred             eecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC---CcEEEeeeccccccc
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEE---LNAYLSDFGLARLLE  927 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~---~~~kl~Dfgla~~~~  927 (1052)
                      |.. |.+|.+.+.-.. ..++..+++-.|-|++.-++|+|.+   ++|||||||+|+++.-+   ..+.++|||+|+.+.
T Consensus        91 dLL-GPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             ecc-CccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            999 899999876543 6799999999999999999999999   99999999999999643   468999999999875


Q ss_pred             ccC------cccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhC
Q 001566          928 VSE------THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEG 1001 (1052)
Q Consensus       928 ~~~------~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1052)
                      ...      +.......||.+|.+-.+..+..-+.+.|+-|+|+++.++-.|..||.+-.....     .+ ....+.+.
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk-----~Q-KyEkI~Ek  239 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK-----KQ-KYEKISEK  239 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH-----HH-HHHHHHHh
Confidence            332      2234456799999999999888889999999999999999999999986433310     01 11122222


Q ss_pred             CccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 001566         1002 RSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLK 1049 (1052)
Q Consensus      1002 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~ 1049 (1052)
                      +... ....+....|.+    +.-.+..|-...-++-|+..-+.+.++
T Consensus       240 K~s~-~ie~LC~G~P~E----F~myl~Y~R~L~F~E~Pdy~ylrqlFr  282 (341)
T KOG1163|consen  240 KMST-PIEVLCKGFPAE----FAMYLNYCRGLGFEEKPDYMYLRQLFR  282 (341)
T ss_pred             hcCC-CHHHHhCCCcHH----HHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence            2221 122334444443    777788888888888888776666554

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=2.9e-21  Score=214.01  Aligned_cols=167  Identities=21%  Similarity=0.212  Sum_probs=130.1

Q ss_pred             hHHHhhCCCccceeeeccCceEEEEEEec--CCcEEEEEEeccC-----ccccHHHHHHHHHHhhccCCCceee-EEEEE
Q 001566          769 NVVRATGNFSIRNLIGTGGFGSTYKAELV--PGYLVAVKKLSIG-----RFQGIQQFDAEIGTLGRIRHKNLVT-LIGYY  840 (1052)
Q Consensus       769 ~~~~~~~~~~~~~~Lg~G~~g~V~~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~  840 (1052)
                      ......++|++.+.||+|+||+||+|.+.  +++.||||+....     .....+.+.+|++++++++|+|+++ +++  
T Consensus        12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~--   89 (365)
T PRK09188         12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA--   89 (365)
T ss_pred             ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE--
Confidence            34456678999999999999999999764  5778899987532     1122456899999999999999985 443  


Q ss_pred             ecCCeeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCC-CCCCEEECCCCcEEEee
Q 001566          841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI-KPSNILLDEELNAYLSD  919 (1052)
Q Consensus       841 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDi-k~~Nill~~~~~~kl~D  919 (1052)
                        .+..|+||||++|++|... ..     ..   ...++.++++|++|||++   ||+|||| ||+||+++.++.+||+|
T Consensus        90 --~~~~~LVmE~~~G~~L~~~-~~-----~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiD  155 (365)
T PRK09188         90 --TGKDGLVRGWTEGVPLHLA-RP-----HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVID  155 (365)
T ss_pred             --cCCcEEEEEccCCCCHHHh-Cc-----cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEE
Confidence              2457999999999999632 11     11   146788999999999999   9999999 99999999999999999


Q ss_pred             ecccccccccCcc-------cccccccccccccccccCC
Q 001566          920 FGLARLLEVSETH-------ATTDVAGTFGYVAPEYATT  951 (1052)
Q Consensus       920 fgla~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~  951 (1052)
                      ||+|+.+......       ......+++.|+|||.+..
T Consensus       156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             CccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            9999977532211       1134567888999998864

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=3.5e-20  Score=189.71  Aligned_cols=259  Identities=19%  Similarity=0.230  Sum_probs=198.0

Q ss_pred             hhCCCccceeeeccCceEEEEE-EecCCcEEEEEEeccCccccHHHHHHHHHHhhcc-CCCceeeEEEEEecCCeeEEEE
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      ..-.|++.++||+|.||+++.| ..-++++||||.-....  ...++..|....+.+ ..++|..++-+..++..-.+|+
T Consensus        26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi  103 (449)
T KOG1165|consen   26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI  103 (449)
T ss_pred             ecccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence            3447999999999999999999 45579999999654332  336788899999988 5789999998888888889999


Q ss_pred             eecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC-----CcEEEeeeccccc
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEE-----LNAYLSDFGLARL  925 (1052)
Q Consensus       851 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~-----~~~kl~Dfgla~~  925 (1052)
                      |.+ |.||.|+.+-. +..++..++..+|.|++.-++|+|++   ..|.|||||+|+||...     ..+.|+|||+|+.
T Consensus       104 dLL-GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  104 DLL-GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             hhh-CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            999 89999988765 47899999999999999999999999   99999999999999643     3489999999998


Q ss_pred             ccccCc------ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHH
Q 001566          926 LEVSET------HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIK  999 (1052)
Q Consensus       926 ~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  999 (1052)
                      +...++      .......||.+||+=....|++-+.+.|+-|+|-++.+.+.|..||.+-..+.     ..+ ....+.
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t-----nK~-kYeKIG  252 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT-----NKE-KYEKIG  252 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc-----hHH-HHHHhc
Confidence            864432      23345579999999999999999999999999999999999999998643331     111 111222


Q ss_pred             hCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 001566         1000 EGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLK 1049 (1052)
Q Consensus      1000 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~ 1049 (1052)
                      +.+.... ...+....    +.++..-+.-.-..+-.+-|+.+-+...+.
T Consensus       253 e~Kr~T~-i~~Lc~g~----P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~  297 (449)
T KOG1165|consen  253 ETKRSTP-IEVLCEGF----PEEFATYLRYVRRLDFFETPDYDYLRKLFD  297 (449)
T ss_pred             cccccCC-HHHHHhcC----HHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence            2222211 12233333    334666666666677778888766655543

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.82  E-value=4.3e-20  Score=222.28  Aligned_cols=54  Identities=37%  Similarity=0.473  Sum_probs=28.9

Q ss_pred             CCEEEccCCcCCCCCCcccCCCCCCCEEEcCCCccccccchhhcCCCCCCEEEccCCCCC
Q 001566          222 LTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLT  281 (1052)
Q Consensus       222 L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  281 (1052)
                      ...|+++++.++. +|..+.  ++|+.|+|++|+|+ .+|..+.  ++|+.|++++|+++
T Consensus       180 ~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt  233 (754)
T PRK15370        180 KTELRLKILGLTT-IPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT  233 (754)
T ss_pred             ceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc
Confidence            4455555555553 444332  35666666666665 3444432  35666666666665

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.82  E-value=1.6e-18  Score=196.06  Aligned_cols=259  Identities=30%  Similarity=0.431  Sum_probs=198.1

Q ss_pred             CccceeeeccCceEEEEEEecCCcEEEEEEeccCccc---cHHHHHHHHHHhhccCCC-ceeeEEEEEecCCeeEEEEee
Q 001566          777 FSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQ---GIQQFDAEIGTLGRIRHK-NLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       777 ~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      |.+.+.||.|+||.||++...  ..+++|.+......   ....+.+|+..++.+.|+ +++++.+++......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            677889999999999999776  78899988665443   367789999999999988 799999999877778999999


Q ss_pred             cCCCCHHHHHhhccC-CcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC-cEEEeeecccccccccC
Q 001566          853 LSGGNLETFIHKKSG-KKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEEL-NAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~-~~kl~Dfgla~~~~~~~  930 (1052)
                      +.++++.+++..... ..+.......+..|++.++.|+|+.   +++|||+||+||+++..+ .++++|||.+.......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999977765432 2688999999999999999999999   999999999999999988 69999999998654333


Q ss_pred             cc-----cccccccccccccccccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCC
Q 001566          931 TH-----ATTDVAGTFGYVAPEYATT---CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGR 1002 (1052)
Q Consensus       931 ~~-----~~~~~~g~~~y~aPE~~~~---~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1052)
                      ..     ......++..|+|||.+.+   ..+....|+|++|++++++++|..||......    ...............
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~----~~~~~~~~~~~~~~~  232 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS----SATSQTLKIILELPT  232 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc----ccHHHHHHHHHhcCC
Confidence            21     3456689999999999988   57888999999999999999999996643221    011122222222221


Q ss_pred             ccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1003 SSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1003 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      .  .................+.+++..|+..+|..|.++.+...
T Consensus       233 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~  274 (384)
T COG0515         233 P--SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS  274 (384)
T ss_pred             c--ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence            1  00001111111222346889999999999999999887654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.82  E-value=8.9e-21  Score=224.24  Aligned_cols=252  Identities=17%  Similarity=0.177  Sum_probs=186.7

Q ss_pred             cceeeeccCceEEEEEEe-cCCcEEEEEEecc----Ccc-cc-HHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEe
Q 001566          779 IRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSI----GRF-QG-IQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYN  851 (1052)
Q Consensus       779 ~~~~Lg~G~~g~V~~~~~-~~~~~vavK~~~~----~~~-~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  851 (1052)
                      ..+++|.|++|.|+.+.. ......+.|.+..    ... .. ...+..|+-+-..++|+|++..+..+.+.....-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            457899999998887743 3334444444331    111 11 1125668888888999999888877776666666699


Q ss_pred             ecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCc
Q 001566          852 FLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET  931 (1052)
Q Consensus       852 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~  931 (1052)
                      |+++ +|..++...  ..++..++..+++|+..|++|+|+.   ||.|||+|++|++++.++.+||+|||.+..+.....
T Consensus       402 ~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             cccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence            9998 999998765  3588899999999999999999999   999999999999999999999999999987754332


Q ss_pred             ---ccccccccccccccccccCCCCCCc-chhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccc
Q 001566          932 ---HATTDVAGTFGYVAPEYATTCRVSD-KADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELF 1007 (1052)
Q Consensus       932 ---~~~~~~~g~~~y~aPE~~~~~~~~~-~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1052)
                         ....+.+|+..|+|||++.+..|.+ ..||||.|+++..|.+|+.||..........          .........-
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~----------~~~~~~~~~~  545 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF----------KTNNYSDQRN  545 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch----------hhhccccccc
Confidence               4566788999999999999999986 4699999999999999999997543332110          0000000000


Q ss_pred             cchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566         1008 LPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1008 ~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ...-........+...+.++.+|+++||.+|.|+.+|++
T Consensus       546 ~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  546 IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            000001112344556889999999999999999999986

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.80  E-value=2.3e-20  Score=217.56  Aligned_cols=249  Identities=22%  Similarity=0.252  Sum_probs=183.6

Q ss_pred             CCccceeeeccCceEEEEEEecCCcEEEEEEeccCc-cccHHHHHH---HHHHhhccCCCceeeEEEEEecCCeeEEEEe
Q 001566          776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGR-FQGIQQFDA---EIGTLGRIRHKNLVTLIGYYVGEAEMFLVYN  851 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~---e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  851 (1052)
                      ++...+.||.+.|=+|.+|+++.|. |+||++.... .-..+.|++   |++ ...++|||++++.-+-..+...|+|-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            5777899999999999999998887 9999986654 233344443   444 455689999999888777788899999


Q ss_pred             ecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccC-
Q 001566          852 FLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE-  930 (1052)
Q Consensus       852 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~-  930 (1052)
                      |+ .-+|+|.+..++  .+..-+.+.|+.|++.|+..+|+.   ||+|||||.+|||+++-..+.|+||..-+...-.+ 
T Consensus       102 yv-khnLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  102 YV-KHNLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             HH-hhhhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence            99 459999998774  577888889999999999999999   99999999999999999999999998766442111 


Q ss_pred             -ccc----ccccccccccccccccCCC----------C-CCcchhHHHHHHHHHHHHh-CCCCCCCCcccCCCCccHHHH
Q 001566          931 -THA----TTDVAGTFGYVAPEYATTC----------R-VSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSW  993 (1052)
Q Consensus       931 -~~~----~~~~~g~~~y~aPE~~~~~----------~-~~~~sDvwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  993 (1052)
                       +..    ......-..|.|||.+...          . .+++.||||+||++.|+++ |++||.-              
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L--------------  241 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL--------------  241 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH--------------
Confidence             111    1111223479999987541          1 4678899999999999999 5777751              


Q ss_pred             HHHHHHhCCccccccchh-hcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566          994 AKLLIKEGRSSELFLPEL-WEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus       994 ~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                       .++....... ..+++. ....+.   ..+++++..|++.||++|.+++++++.-+.+
T Consensus       242 -SQL~aYr~~~-~~~~e~~Le~Ied---~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~  295 (1431)
T KOG1240|consen  242 -SQLLAYRSGN-ADDPEQLLEKIED---VSLRNLILSMIQRDPSKRLSAEDYLQKYRGL  295 (1431)
T ss_pred             -HHHHhHhccC-ccCHHHHHHhCcC---ccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence             1112111111 112211 111111   1488999999999999999999999876543

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.79  E-value=2.9e-19  Score=183.51  Aligned_cols=171  Identities=13%  Similarity=0.132  Sum_probs=133.1

Q ss_pred             hhCCCccceeeeccCceEEEEEEecCCcEEEEEEeccCccccHHH---------HHHHHHHhhccCCCceeeEEEEEecC
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQ---------FDAEIGTLGRIRHKNLVTLIGYYVGE  843 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~h~niv~l~~~~~~~  843 (1052)
                      ..++|+..+++|.|+||.||.++. ++..+|+|.+..........         +.+|++.+.++.|+++..+.+++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            467899999999999999999866 47789999997544332222         68899999999999999998886532


Q ss_pred             --------CeeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcE
Q 001566          844 --------AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNA  915 (1052)
Q Consensus       844 --------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~  915 (1052)
                              +..++||||++|.+|.++..      +++    ....+++.++..+|+.   |++|||++|.||+++.++ +
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i  173 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-L  173 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-E
Confidence                    35799999999999988732      222    2456999999999999   999999999999999988 9


Q ss_pred             EEeeecccccccccCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHH
Q 001566          916 YLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELI  971 (1052)
Q Consensus       916 kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ell  971 (1052)
                      +++|||...........             ........+..++|+|++|+.+....
T Consensus       174 ~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        174 RIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence            99999988754211110             01333444567899999999877664

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.78  E-value=7.4e-19  Score=197.56  Aligned_cols=215  Identities=30%  Similarity=0.433  Sum_probs=167.7

Q ss_pred             hhccCCCceeeEEEEEecCCeeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCe-eeCCCC
Q 001566          825 LGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI-VHRDIK  903 (1052)
Q Consensus       825 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i-iHrDik  903 (1052)
                      |+.+.|.|+.+++|.+.++...+.|.+|+..|+|.|.+.... ..+++.....+.++|+.|++|+|..   .| .|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeec
Confidence            467899999999999999999999999999999999998753 7789999999999999999999988   55 899999


Q ss_pred             CCCEEECCCCcEEEeeecccccccc-cCcccccccccccccccccccCCCC-------CCcchhHHHHHHHHHHHHhCCC
Q 001566          904 PSNILLDEELNAYLSDFGLARLLEV-SETHATTDVAGTFGYVAPEYATTCR-------VSDKADVYSFGVVLLELISGKR  975 (1052)
Q Consensus       904 ~~Nill~~~~~~kl~Dfgla~~~~~-~~~~~~~~~~g~~~y~aPE~~~~~~-------~~~~sDvwslG~il~elltg~~  975 (1052)
                      +.|++++....+|++|||+...... ..........-..-|.|||.+.+..       .+.+.||||||++++|+++.+.
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            9999999999999999999886642 1111222223445799999988742       3567899999999999999999


Q ss_pred             CCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcc
Q 001566          976 SLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus       976 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~l 1051 (1052)
                      ||+........    .+.+..+..  .....+.|.++...  +....+..++.+||.++|++||+++++...++.+
T Consensus       157 ~~~~~~~~~~~----~eii~~~~~--~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~  224 (484)
T KOG1023|consen  157 PFDLRNLVEDP----DEIILRVKK--GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI  224 (484)
T ss_pred             ccccccccCCh----HHHHHHHHh--cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence            99854433222    233333222  23334455555332  3344689999999999999999999998877653

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.77  E-value=1.2e-18  Score=177.75  Aligned_cols=140  Identities=19%  Similarity=0.215  Sum_probs=108.7

Q ss_pred             ceeeeccCceEEEEEEecCCcEEEEEEeccCccc--c-------H-----------------HHHHHHHHHhhccCCCce
Q 001566          780 RNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQ--G-------I-----------------QQFDAEIGTLGRIRHKNL  833 (1052)
Q Consensus       780 ~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~e~~~l~~l~h~ni  833 (1052)
                      ...||+|+||.||+|...+|+.||||+++.....  .       .                 .....|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999998778999999998654221  0       0                 122349999999988776


Q ss_pred             eeEEEEEecCCeeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHH-HhcCCCCeeeCCCCCCCEEECCC
Q 001566          834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL-HYSCVPRIVHRDIKPSNILLDEE  912 (1052)
Q Consensus       834 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~iiHrDik~~Nill~~~  912 (1052)
                      .....+..  ...++||||++++++.......  ..++..++..++.|++.++.|+ |+.   ||+||||||+||++++ 
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~~-  153 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYHD-  153 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEEC-
Confidence            43332222  2348999999887776543222  4688999999999999999999 688   9999999999999984 


Q ss_pred             CcEEEeeeccccccc
Q 001566          913 LNAYLSDFGLARLLE  927 (1052)
Q Consensus       913 ~~~kl~Dfgla~~~~  927 (1052)
                      +.++|+|||+|....
T Consensus       154 ~~v~LiDFG~a~~~~  168 (190)
T cd05147         154 GKLYIIDVSQSVEHD  168 (190)
T ss_pred             CcEEEEEccccccCC
Confidence            689999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.77  E-value=4.4e-18  Score=180.12  Aligned_cols=231  Identities=19%  Similarity=0.289  Sum_probs=151.6

Q ss_pred             CccceeeeccCceEEEEEEec-CCcEEEEEEeccCcc---ccHHHHHHHHHHhhccC----------CCceeeEEEEEe-
Q 001566          777 FSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF---QGIQQFDAEIGTLGRIR----------HKNLVTLIGYYV-  841 (1052)
Q Consensus       777 ~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~----------h~niv~l~~~~~-  841 (1052)
                      +...+.||.|+++.||.++.. +++++|+|++.....   ...+++++|.-....+.          |-.++--++... 
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            456789999999999999665 589999998865442   23566777776665532          212222222111 


Q ss_pred             -----------cCC-----eeEEEEeecCCCCHHHHHhh---ccC--CcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeC
Q 001566          842 -----------GEA-----EMFLVYNFLSGGNLETFIHK---KSG--KKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR  900 (1052)
Q Consensus       842 -----------~~~-----~~~lv~e~~~~gsL~~~l~~---~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHr  900 (1052)
                                 +..     ..+++|+-+ .++|.+++..   ...  ..+....+..+..|+++.+++||..   |++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence                       111     236677777 6788888643   221  1244455667779999999999999   99999


Q ss_pred             CCCCCCEEECCCCcEEEeeecccccccccCcccccccccccccccccccCC--------CCCCcchhHHHHHHHHHHHHh
Q 001566          901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT--------CRVSDKADVYSFGVVLLELIS  972 (1052)
Q Consensus       901 Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~sDvwslG~il~ellt  972 (1052)
                      ||+|+|++++.+|.++|+||+.....+.....    ...+..|.+||....        -.++.+.|.|++|+++|.|++
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC  245 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC  245 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence            99999999999999999999988755432111    234577999997643        246788999999999999999


Q ss_pred             CCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCC
Q 001566          973 GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTR 1038 (1052)
Q Consensus       973 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~R 1038 (1052)
                      |..||+...+......                      -+..+. +.++.+..||..+++++|++|
T Consensus       246 ~~lPf~~~~~~~~~~~----------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  246 GRLPFGLSSPEADPEW----------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             SS-STCCCGGGSTSGG----------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             ccCCCCCCCccccccc----------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9999986544322111                      234555 677889999999999999988

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.76  E-value=1.1e-17  Score=167.73  Aligned_cols=188  Identities=15%  Similarity=0.089  Sum_probs=140.6

Q ss_pred             ccceeeeccCceEEEEEEecCCcEEEEEEeccCcccc----HHHHHHHHHHhhccC-CCceeeEEEEEecCCeeEEEEee
Q 001566          778 SIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQG----IQQFDAEIGTLGRIR-HKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       778 ~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      .+...|++|+||+||.+.. ++.+++.+.+.......    ...+.+|++++++++ |+++.+++++    ...+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3567899999999998866 57888888776543311    225789999999995 5789888886    346999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCC-CCCCEEECCCCcEEEeeecccccccccCc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI-KPSNILLDEELNAYLSDFGLARLLEVSET  931 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDi-k~~Nill~~~~~~kl~Dfgla~~~~~~~~  931 (1052)
                      +.|.+|.+....        . ...++.|++++++++|++   ||+|||| ||.||+++.++.++|+|||+|........
T Consensus        80 I~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~  147 (218)
T PRK12274         80 LAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR  147 (218)
T ss_pred             ecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence            999998754321        1 134778999999999999   9999999 79999999999999999999986543221


Q ss_pred             c----c--------ccccccccccccccccCCC-CCC-cchhHHHHHHHHHHHHhCCCCCCCCcc
Q 001566          932 H----A--------TTDVAGTFGYVAPEYATTC-RVS-DKADVYSFGVVLLELISGKRSLDPSFS  982 (1052)
Q Consensus       932 ~----~--------~~~~~g~~~y~aPE~~~~~-~~~-~~sDvwslG~il~elltg~~p~~~~~~  982 (1052)
                      .    .        ......++.|++|+...-- ..+ .+.+.++-|+.+|.++|++.+...+.+
T Consensus       148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence            0    1        0112246677777754332 223 567999999999999999988765433

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.75  E-value=2.2e-20  Score=173.32  Aligned_cols=168  Identities=34%  Similarity=0.541  Sum_probs=154.9

Q ss_pred             hcCCCCCCeeEecCCCceecCCCCccCCCCccEEEccCccccccCCccccCCCCCCeEecccccccccCCccccCCCCCc
Q 001566          119 IAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELS  198 (1052)
Q Consensus       119 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  198 (1052)
                      +..+.+.+.|.||+|.++ .+|+.+..|.+|+.|++++|++. .+|.+++.+++|+.|+++-|++. ..|.+|+.++.|+
T Consensus        29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le  105 (264)
T KOG0617|consen   29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE  105 (264)
T ss_pred             ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence            556778899999999999 88999999999999999999999 89999999999999999999998 8999999999999


Q ss_pred             EEEccCCcccCccccCCCcccCCCCEEEccCCcCCCCCCcccCCCCCCCEEEcCCCccccccchhhcCCCCCCEEEccCC
Q 001566          199 VIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRN  278 (1052)
Q Consensus       199 ~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  278 (1052)
                      .|||++|++....-+..|..++.|..|+|++|.+. .+|..++++++|+.|.+..|.+- .+|.+++.+++|+.|.+.+|
T Consensus       106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn  183 (264)
T KOG0617|consen  106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN  183 (264)
T ss_pred             hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence            99999999987555667778899999999999998 78999999999999999999998 79999999999999999999


Q ss_pred             CCCCCCCcccccCC
Q 001566          279 SLTDRIPVELADCS  292 (1052)
Q Consensus       279 ~l~~~~p~~l~~l~  292 (1052)
                      +++ .+|.+++++.
T Consensus       184 rl~-vlppel~~l~  196 (264)
T KOG0617|consen  184 RLT-VLPPELANLD  196 (264)
T ss_pred             eee-ecChhhhhhh
Confidence            999 6787777654

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.75  E-value=1.2e-17  Score=171.57  Aligned_cols=140  Identities=19%  Similarity=0.234  Sum_probs=111.1

Q ss_pred             cceeeeccCceEEEEEEecCCcEEEEEEeccCccc---------------------c-----HHHHHHHHHHhhccCCCc
Q 001566          779 IRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQ---------------------G-----IQQFDAEIGTLGRIRHKN  832 (1052)
Q Consensus       779 ~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~e~~~l~~l~h~n  832 (1052)
                      +.+.||+|++|.||+|...+|+.||||++......                     .     ...+..|.+.+.++.|++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            35789999999999998778999999998754211                     0     122357899999999998


Q ss_pred             eeeEEEEEecCCeeEEEEeecCCCCHHHH-HhhccCCcccHHHHHHHHHHHHHHHHHHHh-cCCCCeeeCCCCCCCEEEC
Q 001566          833 LVTLIGYYVGEAEMFLVYNFLSGGNLETF-IHKKSGKKIQWSVIHKIAIDIAQALAYLHY-SCVPRIVHRDIKPSNILLD  910 (1052)
Q Consensus       833 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDik~~Nill~  910 (1052)
                      +.....+...  ..++||||++++++... +..   ..++..+...++.|++.++.++|+ .   ||+||||||+||+++
T Consensus        81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~  152 (190)
T cd05145          81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH  152 (190)
T ss_pred             CCCceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence            7544443332  24899999988755433 332   357788999999999999999999 8   999999999999999


Q ss_pred             CCCcEEEeeeccccccc
Q 001566          911 EELNAYLSDFGLARLLE  927 (1052)
Q Consensus       911 ~~~~~kl~Dfgla~~~~  927 (1052)
                       ++.++|+|||++....
T Consensus       153 -~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 -DGKPYIIDVSQAVELD  168 (190)
T ss_pred             -CCCEEEEEcccceecC
Confidence             7899999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.74  E-value=5e-18  Score=177.66  Aligned_cols=193  Identities=22%  Similarity=0.295  Sum_probs=136.9

Q ss_pred             CCCceeeEEEEEec---------------------------CCeeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHH
Q 001566          829 RHKNLVTLIGYYVG---------------------------EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAID  881 (1052)
Q Consensus       829 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~  881 (1052)
                      +|||||++.++|.+                           ....|+||..+ ..+|.+|+..+.   .+.....-+..|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~---~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH---RSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC---CchHHHHHHHHH
Confidence            59999999987753                           23579999988 469999998764   566667778999


Q ss_pred             HHHHHHHHHhcCCCCeeeCCCCCCCEEEC--CC--CcEEEeeecccccccccC---cc--cccccccccccccccccCCC
Q 001566          882 IAQALAYLHYSCVPRIVHRDIKPSNILLD--EE--LNAYLSDFGLARLLEVSE---TH--ATTDVAGTFGYVAPEYATTC  952 (1052)
Q Consensus       882 i~~~l~~LH~~~~~~iiHrDik~~Nill~--~~--~~~kl~Dfgla~~~~~~~---~~--~~~~~~g~~~y~aPE~~~~~  952 (1052)
                      +++|+.|||.+   ||.|||+|++||++.  +|  ..+.|+|||.+---....   .+  ..-..-|...-||||+....
T Consensus       350 lLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~  426 (598)
T KOG4158|consen  350 LLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV  426 (598)
T ss_pred             HHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence            99999999999   999999999999993  33  347899999765322110   11  11123466788999998653


Q ss_pred             C------CCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHHHH
Q 001566          953 R------VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRL 1026 (1052)
Q Consensus       953 ~------~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~L 1026 (1052)
                      +      ...|+|.|+.|.+.||+++...||+...+-   ..+...          +.+.-.|.+    |..++..++++
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem---~L~~r~----------Yqe~qLPal----p~~vpp~~rql  489 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM---LLDTRT----------YQESQLPAL----PSRVPPVARQL  489 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHhccCCcccccchh---eechhh----------hhhhhCCCC----cccCChHHHHH
Confidence            3      135899999999999999999999852111   001111          111112333    34445558899


Q ss_pred             HHHccccCCCCCCCHHHHH
Q 001566         1027 ASTCTVETLSTRPSVKQVL 1045 (1052)
Q Consensus      1027 i~~cl~~dP~~RPt~~eil 1045 (1052)
                      +...++.||.+|++..=..
T Consensus       490 V~~lL~r~pskRvsp~iAA  508 (598)
T KOG4158|consen  490 VFDLLKRDPSKRVSPNIAA  508 (598)
T ss_pred             HHHHhcCCccccCCccHHH
Confidence            9999999999999865433

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.74  E-value=5.8e-20  Score=170.52  Aligned_cols=166  Identities=28%  Similarity=0.393  Sum_probs=141.6

Q ss_pred             cCcccccCcchHHHHhcCcCccEEEccCcccccccccccCCCCCCCEEEccCCcCCCCCcccccCCccCcEEEcCCCccC
Q 001566          514 LSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLT  593 (1052)
Q Consensus       514 l~~n~l~~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  593 (1052)
                      ||+|.++.+++..  +.+.+|+.|++++|+|+ ..|..++.+++|+.|+++-|++. ..|..|+.++.|+.|||.+|++.
T Consensus        40 LSHNKl~~vppni--a~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~  115 (264)
T KOG0617|consen   40 LSHNKLTVVPPNI--AELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLN  115 (264)
T ss_pred             cccCceeecCCcH--HHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccc
Confidence            3444444444332  35678888889999988 78888999999999999999998 89999999999999999999986


Q ss_pred             C-cCchhhcCCCCCcEEEcCCCCCCCCCchhhhcccccceeeccCccCCCCCCcccccccccCceecccccccCCCCCcc
Q 001566          594 G-EIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPHLQ  672 (1052)
Q Consensus       594 ~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~  672 (1052)
                      . .+|+.|..|..|+.|+|+.|.+. .+|..++++++|+.|.+.+|.+- ..|.+++.++.|+.|.+.+|+++-.+|.+.
T Consensus       116 e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~vlppel~  193 (264)
T KOG0617|consen  116 ENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLTVLPPELA  193 (264)
T ss_pred             cccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceeeecChhhh
Confidence            3 57999999999999999999998 88999999999999999999998 789999999999999999999999999877


Q ss_pred             cc------ccccccCCccc
Q 001566          673 HL------DCIAFKGNKYL  685 (1052)
Q Consensus       673 ~l------~~~~~~~n~~~  685 (1052)
                      .+      +...++.|||.
T Consensus       194 ~l~l~~~k~v~r~E~NPwv  212 (264)
T KOG0617|consen  194 NLDLVGNKQVMRMEENPWV  212 (264)
T ss_pred             hhhhhhhHHHHhhhhCCCC
Confidence            55      34567889985

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.72  E-value=1.7e-18  Score=193.65  Aligned_cols=225  Identities=27%  Similarity=0.322  Sum_probs=179.9

Q ss_pred             eeeccCceEEEEEE----ecCCcEEEEEEeccCcccc--HHHHHHHHHHhhccC-CCceeeEEEEEecCCeeEEEEeecC
Q 001566          782 LIGTGGFGSTYKAE----LVPGYLVAVKKLSIGRFQG--IQQFDAEIGTLGRIR-HKNLVTLIGYYVGEAEMFLVYNFLS  854 (1052)
Q Consensus       782 ~Lg~G~~g~V~~~~----~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  854 (1052)
                      ++|+|.||.|+.++    ...|.-+|.|+.+......  ......|..++...+ ||.+++++-+++.+...+++.+|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999999873    3346778888776543221  124566888888886 9999999999999999999999999


Q ss_pred             CCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcccc
Q 001566          855 GGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT  934 (1052)
Q Consensus       855 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  934 (1052)
                      +|.+...+...  ..+++.....+...++-+++++|+.   +|+|||+|++||+++.+|.+++.|||+++..-..+..  
T Consensus        81 gg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--  153 (612)
T KOG0603|consen   81 GGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--  153 (612)
T ss_pred             cchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence            99998877665  4577777888888999999999999   9999999999999999999999999999865322211  


Q ss_pred             cccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcC
Q 001566          935 TDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEA 1014 (1052)
Q Consensus       935 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 1014 (1052)
                         +|+..|||||++.  .+..++|.||||++++||+||..||.+            +..+.+.+..           -.
T Consensus       154 ---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------------~~~~~Il~~~-----------~~  205 (612)
T KOG0603|consen  154 ---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------------DTMKRILKAE-----------LE  205 (612)
T ss_pred             ---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------------HHHHHHhhhc-----------cC
Confidence               7899999999999  567789999999999999999999984            2233332221           12


Q ss_pred             CChHHHHHHHHHHHHccccCCCCCCCH
Q 001566         1015 GPQENLLGMMRLASTCTVETLSTRPSV 1041 (1052)
Q Consensus      1015 ~~~~~~~~l~~Li~~cl~~dP~~RPt~ 1041 (1052)
                      .|.+......+++..+...+|..|.-.
T Consensus       206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  206 MPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             CchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            355566668888889999999988743

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.72  E-value=2.4e-17  Score=197.79  Aligned_cols=197  Identities=23%  Similarity=0.282  Sum_probs=160.4

Q ss_pred             HHHhhCCCccceeeeccCceEEEEEEecCCcEEEEEEeccCccccHHHHHHHHHHhhccC---CCceeeEEEEEecCCee
Q 001566          770 VVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIR---HKNLVTLIGYYVGEAEM  846 (1052)
Q Consensus       770 ~~~~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~  846 (1052)
                      .....+.|.|.+.||+|+||+||+|...+|+.||+|+-+.....   +|.-=.+++.+++   -+.|+.+..+..-.+.-
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S  769 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNAS  769 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence            34456679999999999999999998888999999987765543   2222334444444   23455555555567778


Q ss_pred             EEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEEC-------CCCcEEEee
Q 001566          847 FLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLD-------EELNAYLSD  919 (1052)
Q Consensus       847 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~-------~~~~~kl~D  919 (1052)
                      ++|+||.+.|+|.+++...  +..++..++.++.|++..+++||..   +|||+||||+|+++.       ....++|+|
T Consensus       770 ~lv~ey~~~Gtlld~~N~~--~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lID  844 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLINTN--KVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLID  844 (974)
T ss_pred             eeeeeccccccHHHhhccC--CCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEe
Confidence            9999999999999999843  6799999999999999999999999   999999999999994       234689999


Q ss_pred             eccccccccc-CcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCC
Q 001566          920 FGLARLLEVS-ETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGK  974 (1052)
Q Consensus       920 fgla~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~  974 (1052)
                      ||.+..+..- +.......++|-.+-.+|...|+.++.++|-|.++.+++-|+.|+
T Consensus       845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence            9999866422 223455677889999999999999999999999999999999987

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.71  E-value=1.1e-18  Score=196.21  Aligned_cols=132  Identities=31%  Similarity=0.380  Sum_probs=63.8

Q ss_pred             cCccEEEccCcccccc----cccccCCCCCCCEEEccCCcCCCC----CcccccCCccCcEEEcCCCccCCcCchhhcC-
Q 001566          532 VQLVEFEAANNQISGS----IAAGVGKLMKLQRLDLRGNRVSGS----LPDELGKLKFLKWILLGGNNLTGEIPSQFGH-  602 (1052)
Q Consensus       532 ~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-  602 (1052)
                      .+|++|++++|.+++.    ++..+..+++|+.|+|++|.+++.    ++..+..+++|++|++++|.+++.....+.. 
T Consensus       165 ~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~  244 (319)
T cd00116         165 RDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASA  244 (319)
T ss_pred             CCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHH
Confidence            3445555555554421    122333445566666666655432    2233445555666666666665422222211 


Q ss_pred             ----CCCCcEEEcCCCCCCC----CCchhhhcccccceeeccCccCCCC----CCcccccc-cccCceeccccc
Q 001566          603 ----LISLVVLDLSHNALTG----SIPASLTKATKLESLFLAHNRLSGE----IPVSFSTL-VNLSALDLSFNN  663 (1052)
Q Consensus       603 ----l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l-~~L~~L~l~~N~  663 (1052)
                          .++|+.|++++|.++.    .+...+..+++|+++++++|+++..    ....+... +.|+.+++.+|+
T Consensus       245 ~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (319)
T cd00116         245 LLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDS  318 (319)
T ss_pred             HhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCC
Confidence                2566666666666651    1223344445566666666666533    22222223 455566665554

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.70  E-value=6.6e-19  Score=197.99  Aligned_cols=264  Identities=22%  Similarity=0.188  Sum_probs=141.0

Q ss_pred             cchhhcCCCCCCeeEecCCCcee----cCCCCccCCCCccEEEccCccccc------cCCccccCCCCCCeEeccccccc
Q 001566          115 LSASIAKLTELRTLSVPHNSFSG----EIPAGVGELRLLEVLELQGNNFSG------KIPYQMSNLERLRVLNLSFNSFS  184 (1052)
Q Consensus       115 l~~~l~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~------~~p~~~~~l~~L~~L~Ls~N~l~  184 (1052)
                      ....+..+++|+.|+++++.+++    .+++.+...++|++|+++++.+.+      .++..+..+++|+.|+|++|.+.
T Consensus        15 ~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~   94 (319)
T cd00116          15 ATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALG   94 (319)
T ss_pred             hHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCC
Confidence            34455566667777777777643    245555666667777777776652      23344556667777777777666


Q ss_pred             ccCCccccCCCC---CcEEEccCCcccCccc---cCCCccc-CCCCEEEccCCcCCCC----CCcccCCCCCCCEEEcCC
Q 001566          185 GEVPRGLIGNGE---LSVIDMSSNRLSGGLA---IDSSSEC-EFLTYLKLSDNFLTES----IPKEIGKCRNLKNLLLDG  253 (1052)
Q Consensus       185 ~~~p~~~~~l~~---L~~L~L~~N~l~~~~~---~~~~~~l-~~L~~L~Ls~N~l~~~----~~~~l~~l~~L~~L~L~~  253 (1052)
                      +..+..+..+.+   |++|++++|++++...   ...+..+ ++|+.|++++|.+++.    ++..+..+++|++|++++
T Consensus        95 ~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~  174 (319)
T cd00116          95 PDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLAN  174 (319)
T ss_pred             hhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcC
Confidence            545554444443   6666666666542100   0112233 4555556665555522    222334445555555555


Q ss_pred             Cccccc----cchhhcCCCCCCEEEccCCCCCCCCCcccccCCCCCceecccccccccCCCCCCccccccCCCchhhhcc
Q 001566          254 NILEGS----IPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLS  329 (1052)
Q Consensus       254 N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~~~~~l~~~~~~~~~~~~~~p~~~~~~  329 (1052)
                      |.+++.    ++..+..+++|+.|+|++|.+++.....                                  ++..+...
T Consensus       175 n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~----------------------------------l~~~~~~~  220 (319)
T cd00116         175 NGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASA----------------------------------LAETLASL  220 (319)
T ss_pred             CCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHH----------------------------------HHHHhccc
Confidence            555521    2233334445555555555554322111                                  11122233


Q ss_pred             cCCcEEecCCCCCCccCCcccc-----CCCCccEEeCCCCccc----ccCCccccccCCCCEEeCCCCcCcCCCCC----
Q 001566          330 RSLEVLWAPRANLGGRLPDNWS-----ESCSLKVLNLGQNSLK----GAVPKSLGMCRNLTYLDLSLNNLEGYLPM----  396 (1052)
Q Consensus       330 ~~L~~L~l~~n~l~~~~p~~~~-----~~~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~----  396 (1052)
                      ++|+.|++++|.+++.....+.     ..+.|+.|++++|.++    ..+...+..+++|+++++++|.++.....    
T Consensus       221 ~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~  300 (319)
T cd00116         221 KSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAE  300 (319)
T ss_pred             CCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHH
Confidence            4555555555555542222221     2367888888888876    22344556667888888888888754222    


Q ss_pred             CCC-C-CCcceEecccCc
Q 001566          397 QLP-V-PCMVYFNVSQNN  412 (1052)
Q Consensus       397 ~~~-~-~~L~~l~l~~N~  412 (1052)
                      .+. . +.++.+++.+|.
T Consensus       301 ~~~~~~~~~~~~~~~~~~  318 (319)
T cd00116         301 SLLEPGNELESLWVKDDS  318 (319)
T ss_pred             HHhhcCCchhhcccCCCC
Confidence            121 2 467777777664

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>PRK10345 hypothetical protein; Provisional

Probab=99.70  E-value=1.7e-16  Score=163.24  Aligned_cols=136  Identities=18%  Similarity=0.213  Sum_probs=106.6

Q ss_pred             cceeeeccCceEEEEEEecCCcEEEEEEeccCccccHHHHHHHHHHhhcc-----CCCceeeEEEEEecCC---e-eEEE
Q 001566          779 IRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRI-----RHKNLVTLIGYYVGEA---E-MFLV  849 (1052)
Q Consensus       779 ~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~-~~lv  849 (1052)
                      -.+.||+|+||.||.  +......+||++........+++.+|+.+++.+     .||||++++|+++++.   . +.+|
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I   83 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI   83 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence            357899999999996  433333479988765555567899999999999     5799999999998763   3 3378


Q ss_pred             Eee--cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHH-HHHHhcCCCCeeeCCCCCCCEEECC----CCcEEEeee-c
Q 001566          850 YNF--LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQAL-AYLHYSCVPRIVHRDIKPSNILLDE----ELNAYLSDF-G  921 (1052)
Q Consensus       850 ~e~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~iiHrDik~~Nill~~----~~~~kl~Df-g  921 (1052)
                      +||  +++++|.+++...   .++++  ..++.+++.++ +|||+.   +|+||||||+||+++.    ++.++|+|| |
T Consensus        84 ~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         84 ADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             ecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            999  5579999999653   35555  35677888777 999999   9999999999999974    347999994 5


Q ss_pred             ccc
Q 001566          922 LAR  924 (1052)
Q Consensus       922 la~  924 (1052)
                      ...
T Consensus       156 ~~~  158 (210)
T PRK10345        156 EST  158 (210)
T ss_pred             Ccc
Confidence            443

>smart00090 RIO RIO-like kinase

Probab=99.64  E-value=7.2e-16  Score=162.95  Aligned_cols=142  Identities=23%  Similarity=0.210  Sum_probs=111.7

Q ss_pred             CCccceeeeccCceEEEEEE--ecCCcEEEEEEeccCccc------------------------cHHHHHHHHHHhhccC
Q 001566          776 NFSIRNLIGTGGFGSTYKAE--LVPGYLVAVKKLSIGRFQ------------------------GIQQFDAEIGTLGRIR  829 (1052)
Q Consensus       776 ~~~~~~~Lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~  829 (1052)
                      -|++.+.||+|+||.||+|.  ..+|+.||+|++......                        ....+..|++.++++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48889999999999999997  567999999998754311                        0123568999999997


Q ss_pred             CCc--eeeEEEEEecCCeeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCC-eeeCCCCCCC
Q 001566          830 HKN--LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPR-IVHRDIKPSN  906 (1052)
Q Consensus       830 h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-iiHrDik~~N  906 (1052)
                      +..  +.++++.    ...++||||++++++..+....  ......+...++.|++.++++||+.   + |+||||||+|
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~N  179 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYN  179 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhh
Confidence            533  3344442    2358999999998887664322  3456667789999999999999999   8 9999999999


Q ss_pred             EEECCCCcEEEeeeccccccc
Q 001566          907 ILLDEELNAYLSDFGLARLLE  927 (1052)
Q Consensus       907 ill~~~~~~kl~Dfgla~~~~  927 (1052)
                      |+++ ++.++++|||.+....
T Consensus       180 Ili~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      180 ILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EEEE-CCCEEEEEChhhhccC
Confidence            9999 7899999999987543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.62  E-value=3.1e-15  Score=157.06  Aligned_cols=134  Identities=24%  Similarity=0.411  Sum_probs=113.5

Q ss_pred             eeeeccCceEEEEEEecCCcEEEEEEeccCccc--------cHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          781 NLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQ--------GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       781 ~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      +.||+|++|.||+|.. .|..|++|+.......        ....+.+|+.++..+.|+++.....++.+....++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5789999999999987 5778999986543221        124577899999999999988777777777888999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARL  925 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~  925 (1052)
                      ++|++|.+++....     . .+..++.+++.++.++|+.   +++|||++|.||+++ ++.++++|||.+..
T Consensus        81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999986542     2 7888999999999999999   999999999999999 78999999999874

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.61  E-value=4.8e-15  Score=153.59  Aligned_cols=141  Identities=21%  Similarity=0.206  Sum_probs=110.6

Q ss_pred             HhhCCCccceeeeccCceEEEEEEecCCcEEEEEEeccCccc----------------------cHHHHHHHHHHhhccC
Q 001566          772 RATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQ----------------------GIQQFDAEIGTLGRIR  829 (1052)
Q Consensus       772 ~~~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~~l~  829 (1052)
                      .....|.+.+.||+|+||.||+|...+|+.||||++......                      ....+..|...+.++.
T Consensus        12 ~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~   91 (198)
T cd05144          12 KRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY   91 (198)
T ss_pred             HcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence            333448888999999999999998888999999987543210                      0123567888899888


Q ss_pred             CCc--eeeEEEEEecCCeeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCE
Q 001566          830 HKN--LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNI  907 (1052)
Q Consensus       830 h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Ni  907 (1052)
                      |++  +...++    ....++||||+++++|.+....        .....++.+++.++.++|+.   +|+||||+|.||
T Consensus        92 ~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Ni  156 (198)
T cd05144          92 EEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNI  156 (198)
T ss_pred             HcCCCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccE
Confidence            774  444443    2456899999999998765431        33567889999999999998   999999999999


Q ss_pred             EECCCCcEEEeeeccccccc
Q 001566          908 LLDEELNAYLSDFGLARLLE  927 (1052)
Q Consensus       908 ll~~~~~~kl~Dfgla~~~~  927 (1052)
                      ++++++.++|+|||++....
T Consensus       157 ll~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         157 LVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             EEcCCCcEEEEECCccccCC
Confidence            99999999999999996543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.60  E-value=3.3e-16  Score=172.16  Aligned_cols=174  Identities=28%  Similarity=0.506  Sum_probs=132.7

Q ss_pred             eeEEEEeecCCCCHHHHHhhc-cCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccc
Q 001566          845 EMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLA  923 (1052)
Q Consensus       845 ~~~lv~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla  923 (1052)
                      ..|+.|+++.-.+|.+|+..+ .....++.....++.|++.|++|   +   +.+|||+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence            468999999999999999743 35677888999999999999999   6   8999999999999999999999999998


Q ss_pred             ccccccC-----cccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHH
Q 001566          924 RLLEVSE-----THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLI  998 (1052)
Q Consensus       924 ~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  998 (1052)
                      .......     .......+||..||+||.+.+..|+.++||||+|++++|++.   +|...+..        .-...-+
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~~er--------~~t~~d~  472 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQFER--------IATLTDI  472 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccHHHH--------HHhhhhh
Confidence            8665433     223455689999999999999999999999999999999986   22211110        0011111


Q ss_pred             HhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHH
Q 001566          999 KEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQV 1044 (1052)
Q Consensus       999 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~ei 1044 (1052)
                      +.+    .+.|..+..+|.+     ..++.++++..|.+||++.+.
T Consensus       473 r~g----~ip~~~~~d~p~e-----~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  473 RDG----IIPPEFLQDYPEE-----YTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             hcC----CCChHHhhcCcHH-----HHHHHHhcCCCcccCchHHHH
Confidence            222    2333444455543     458889999999999965544

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.60  E-value=6.8e-15  Score=175.92  Aligned_cols=137  Identities=24%  Similarity=0.327  Sum_probs=111.6

Q ss_pred             hCCCccceeeeccCceEEEEEEecCCcEEEEEEeccCc--c------ccHHHHHHHHHHhhccCCCceeeEEEEEecCCe
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGR--F------QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAE  845 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  845 (1052)
                      ...|...+.||+|+||+||+|.+... .+++|+.....  .      ...+++.+|++++++++|++++....++.+...
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            34456788999999999999977644 44554432211  1      113567899999999999999888877777778


Q ss_pred             eEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccc
Q 001566          846 MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARL  925 (1052)
Q Consensus       846 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~  925 (1052)
                      .++||||+++++|.+++.          ....++.++++++.|||+.   +|+|||+||+||++ +++.++|+|||+++.
T Consensus       411 ~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             CEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            899999999999999885          3457899999999999999   99999999999999 577999999999974

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.60  E-value=5.9e-15  Score=153.35  Aligned_cols=130  Identities=25%  Similarity=0.403  Sum_probs=106.4

Q ss_pred             eeeccCceEEEEEEecCCcEEEEEEeccCccc--------cHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeec
Q 001566          782 LIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQ--------GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFL  853 (1052)
Q Consensus       782 ~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  853 (1052)
                      .||+|+||.||+|.+ ++..|++|+.......        ...++.+|+++++.++|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            379999999999985 4788999986543211        1355778999999999887655555555666789999999


Q ss_pred             CCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccc
Q 001566          854 SGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARL  925 (1052)
Q Consensus       854 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~  925 (1052)
                      +|++|.+++....   .      .++.+++.++.++|+.   +++|||++|.||+++ ++.++++|||.+..
T Consensus        80 ~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN---D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH---H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999999875532   1      7899999999999999   999999999999999 78999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.58  E-value=1.9e-15  Score=177.35  Aligned_cols=208  Identities=23%  Similarity=0.309  Sum_probs=145.1

Q ss_pred             CCCccceeeeccCceEEEEEEec-CCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeec
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFL  853 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  853 (1052)
                      .+|+..+.|..|+||.||.++++ +.+++|+|+ ....     -+.+-  ++.....|.+|                   
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~-----lilRn--ilt~a~npfvv-------------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN-----LILRN--ILTFAGNPFVV-------------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhcc-cccc-----hhhhc--cccccCCccee-------------------
Confidence            46888999999999999999776 367788843 2111     11110  23333344443                   


Q ss_pred             CCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCc--
Q 001566          854 SGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET--  931 (1052)
Q Consensus       854 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~--  931 (1052)
                        |+-...++...  .++.+        .+.+++|+|+.   ||+|||+||+|.+|+.-|.+|++|||+++.......  
T Consensus       136 --gDc~tllk~~g--~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn  200 (1205)
T KOG0606|consen  136 --GDCATLLKNIG--PLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN  200 (1205)
T ss_pred             --chhhhhcccCC--CCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence              33334443322  23322        27889999999   999999999999999999999999999986632211  


Q ss_pred             ------------ccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHH
Q 001566          932 ------------HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIK  999 (1052)
Q Consensus       932 ------------~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  999 (1052)
                                  .....++||+.|.|||++....|...+|.|++|+|+||.+-|+.||.++.++        +....++.
T Consensus       201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe--------elfg~vis  272 (1205)
T KOG0606|consen  201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE--------ELFGQVIS  272 (1205)
T ss_pred             hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH--------HHHhhhhh
Confidence                        0123468999999999999999999999999999999999999999977555        12222222


Q ss_pred             hCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCC
Q 001566         1000 EGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040 (1052)
Q Consensus      1000 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt 1040 (1052)
                      +.        ..|.+.....+.+.++++.+.++.+|..|--
T Consensus       273 d~--------i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  273 DD--------IEWPEEDEALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             hh--------ccccccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence            11        1122223333455889999999999999873

>PLN03150 hypothetical protein; Provisional

Probab=99.58  E-value=6.7e-15  Score=177.49  Aligned_cols=136  Identities=33%  Similarity=0.586  Sum_probs=90.2

Q ss_pred             CChhhHHHHHHHHHhccCCCCCcccCCCCCCCCC----CCCceEeecCC----CceEEEEEccCCCCCCCCCcccccccc
Q 001566           45 VPTTDSASLLSFKASISRDPSNLLATWNSSTDHC----TWHGVTCDHFT----GRVTALRITGKATPWPSKSSVISGTLS  116 (1052)
Q Consensus        45 ~~~~d~~all~~k~~~~~~p~~~l~~W~~~~~~C----~w~gV~C~~~~----~~v~~l~l~~~~~~~~~~~~~l~g~l~  116 (1052)
                      ..++|..||+++|+++. +|..  .+|+. .+||    .|.||.|+...    .+|..+++.+.         .+.|.+|
T Consensus       369 t~~~~~~aL~~~k~~~~-~~~~--~~W~g-~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n---------~L~g~ip  435 (623)
T PLN03150        369 TLLEEVSALQTLKSSLG-LPLR--FGWNG-DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQ---------GLRGFIP  435 (623)
T ss_pred             cCchHHHHHHHHHHhcC-Cccc--CCCCC-CCCCCcccccccceeeccCCCCceEEEEEECCCC---------CccccCC
Confidence            45679999999999995 4432  48963 3342    79999996321    13555555432         3566666


Q ss_pred             hhhcCCCCCCeeEecCCCceecCCCCccCCCCccEEEccCccccccCCccccCCCCCCeEecccccccccCCccccC
Q 001566          117 ASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIG  193 (1052)
Q Consensus       117 ~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  193 (1052)
                      ++++.+++|+.|+|++|+++|.+|+.++.+++|+.|||++|+++|.+|..++++++|++|+|++|.++|.+|..+..
T Consensus       436 ~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~  512 (623)
T PLN03150        436 NDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGG  512 (623)
T ss_pred             HHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhh
Confidence            66666666666666666666666666666666666666666666666666666666666666666666666666543

>PLN03150 hypothetical protein; Provisional

Probab=99.52  E-value=4.8e-14  Score=170.16  Aligned_cols=113  Identities=39%  Similarity=0.622  Sum_probs=60.8

Q ss_pred             CCEEEccCCcCCCCCcccccCCccCcEEEcCCCccCCcCchhhcCCCCCcEEEcCCCCCCCCCchhhhcccccceeeccC
Q 001566          558 LQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAH  637 (1052)
Q Consensus       558 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L~~  637 (1052)
                      ++.|+|++|.++|.+|..+.++++|+.|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|..++++++|+.|+|++
T Consensus       420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~  499 (623)
T PLN03150        420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG  499 (623)
T ss_pred             EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence            44555555555555555555555555555555555555555555555555555555555555555555555555555555


Q ss_pred             ccCCCCCCcccccccccCceecccccccCCCCCccccccccccCCccccCCC
Q 001566          638 NRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPHLQHLDCIAFKGNKYLASCP  689 (1052)
Q Consensus       638 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~~~~~~n~~~~~~~  689 (1052)
                      |+++|.+|..+..+                   ..++..+.+.+|+..|.++
T Consensus       500 N~l~g~iP~~l~~~-------------------~~~~~~l~~~~N~~lc~~p  532 (623)
T PLN03150        500 NSLSGRVPAALGGR-------------------LLHRASFNFTDNAGLCGIP  532 (623)
T ss_pred             CcccccCChHHhhc-------------------cccCceEEecCCccccCCC
Confidence            55555555444321                   1123445677788886654

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.50  E-value=9.2e-14  Score=137.40  Aligned_cols=135  Identities=19%  Similarity=0.173  Sum_probs=114.2

Q ss_pred             cceeeeccCceEEEEEEecCCcEEEEEEeccCccccHHHHHHHHHHhhccCC--CceeeEEEEEecCCeeEEEEeecCCC
Q 001566          779 IRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRH--KNLVTLIGYYVGEAEMFLVYNFLSGG  856 (1052)
Q Consensus       779 ~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g  856 (1052)
                      +.+.||+|.++.||++...+ ..+++|.......  ...+.+|+..++.++|  ..+.++++++..++..++++||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            45789999999999998764 7899998865443  4678899999999976  58999999888888899999999887


Q ss_pred             CHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccc
Q 001566          857 NLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARL  925 (1052)
Q Consensus       857 sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~  925 (1052)
                      .+..+         +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.+..
T Consensus        79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77544         4456677899999999999986445799999999999999989999999999874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.48  E-value=1.9e-13  Score=140.57  Aligned_cols=136  Identities=24%  Similarity=0.289  Sum_probs=97.9

Q ss_pred             ceeeeccCceEEEEEEecCCcEEEEEEeccCccc--cHHH----------------------HHHHHHHhhccCCCc--e
Q 001566          780 RNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQ--GIQQ----------------------FDAEIGTLGRIRHKN--L  833 (1052)
Q Consensus       780 ~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~h~n--i  833 (1052)
                      .+.||+|+||.||+|...+++.||||++......  ....                      ...|.+.+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4679999999999998778999999988653221  1111                      134566666664432  3


Q ss_pred             eeEEEEEecCCeeEEEEeecCCCCHHH-HHhhccCCcccHHHHHHHHHHHHHHHHHHHh-cCCCCeeeCCCCCCCEEECC
Q 001566          834 VTLIGYYVGEAEMFLVYNFLSGGNLET-FIHKKSGKKIQWSVIHKIAIDIAQALAYLHY-SCVPRIVHRDIKPSNILLDE  911 (1052)
Q Consensus       834 v~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiHrDik~~Nill~~  911 (1052)
                      .+.+++    ...++||||++++.+.. .+....   .. .++..++.+++.++.++|. .   +|+||||+|+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-
Confidence            444443    24589999999854321 111111   11 5678899999999999999 7   999999999999999 


Q ss_pred             CCcEEEeeeccccccc
Q 001566          912 ELNAYLSDFGLARLLE  927 (1052)
Q Consensus       912 ~~~~kl~Dfgla~~~~  927 (1052)
                      ++.++++|||.+....
T Consensus       150 ~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CCcEEEEECccccccc
Confidence            8899999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.46  E-value=5.8e-13  Score=141.20  Aligned_cols=134  Identities=22%  Similarity=0.267  Sum_probs=104.8

Q ss_pred             eeee-ccCceEEEEEEecCCcEEEEEEeccCc-------------cccHHHHHHHHHHhhccCCCce--eeEEEEEecC-
Q 001566          781 NLIG-TGGFGSTYKAELVPGYLVAVKKLSIGR-------------FQGIQQFDAEIGTLGRIRHKNL--VTLIGYYVGE-  843 (1052)
Q Consensus       781 ~~Lg-~G~~g~V~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~-  843 (1052)
                      ..|| .|+.|+||.++.. +..++||.+....             ......+.+|++++.+++|+++  ++.+++.... 
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            5687 8999999999775 7789999885321             1123567889999999998875  6677664432 


Q ss_pred             C---eeEEEEeecCC-CCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEee
Q 001566          844 A---EMFLVYNFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSD  919 (1052)
Q Consensus       844 ~---~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~D  919 (1052)
                      .   ..++|+|++++ .+|.+++...   .++..    .+.+++.++.+||+.   ||+||||||.|||++.++.++|+|
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LID  185 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLID  185 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEE
Confidence            2   23599999997 6999988653   34443    356899999999999   999999999999999988999999


Q ss_pred             eccccc
Q 001566          920 FGLARL  925 (1052)
Q Consensus       920 fgla~~  925 (1052)
                      ||.+..
T Consensus       186 fg~~~~  191 (239)
T PRK01723        186 FDRGEL  191 (239)
T ss_pred             CCCccc
Confidence            999874

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.43  E-value=1.7e-14  Score=171.10  Aligned_cols=255  Identities=26%  Similarity=0.342  Sum_probs=190.3

Q ss_pred             hCCCccceeeeccCceEEEEEEecC--CcEEEEEEeccCc--cccHHHHHHHHHHhhccC-CCceeeEEEEEecCCeeEE
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELVP--GYLVAVKKLSIGR--FQGIQQFDAEIGTLGRIR-HKNLVTLIGYYVGEAEMFL  848 (1052)
Q Consensus       774 ~~~~~~~~~Lg~G~~g~V~~~~~~~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l  848 (1052)
                      ...|.+.+.||+|+|+.|-.+....  ...+|+|.+....  .........|..+-+... |+|++.+++...+....++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            3467888889999999998885532  4456667665443  222344455777777776 9999999999999999999


Q ss_pred             EEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHH-hcCCCCeeeCCCCCCCEEECCCC-cEEEeeecccccc
Q 001566          849 VYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH-YSCVPRIVHRDIKPSNILLDEEL-NAYLSDFGLARLL  926 (1052)
Q Consensus       849 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~iiHrDik~~Nill~~~~-~~kl~Dfgla~~~  926 (1052)
                      +.||..++++.+-+........+......+..|+..++.|+| ..   ++.||||||+|.+++..+ ..+++|||+|..+
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccc
Confidence            999999999988883222225667778889999999999999 77   999999999999999999 9999999999987


Q ss_pred             cc--cCccccccccc-ccccccccccCCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCC
Q 001566          927 EV--SETHATTDVAG-TFGYVAPEYATTCR-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGR 1002 (1052)
Q Consensus       927 ~~--~~~~~~~~~~g-~~~y~aPE~~~~~~-~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1052)
                      ..  +.........| ++.|+|||...+.. ..+..|+||.|+++.-+++|..|++.......   ....|....     
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~---~~~~~~~~~-----  247 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG---RYSSWKSNK-----  247 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc---cceeecccc-----
Confidence            65  33344445667 99999999998854 45678999999999999999999975544321   112221111     


Q ss_pred             ccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 001566         1003 SSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVL 1045 (1052)
Q Consensus      1003 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil 1045 (1052)
                        ..+....|....    ....++..+++..+|..|.+.+++.
T Consensus       248 --~~~~~~~~~~~~----~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  248 --GRFTQLPWNSIS----DQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             --cccccCccccCC----hhhhhcccccccCCchhcccccccc
Confidence              111112222222    2366788889989999999988764

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.34  E-value=4.5e-14  Score=155.03  Aligned_cols=175  Identities=33%  Similarity=0.474  Sum_probs=107.0

Q ss_pred             CCCccEEEccCccccccCCccccCCCCCCeEecccccccccCCccccCCCCCcEEEccCCcccCccccCCCcccCCCCEE
Q 001566          146 LRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYL  225 (1052)
Q Consensus       146 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L  225 (1052)
                      +.--...||+.|++. ++|..+..+..|..|.|+.|.+. .+|..+.++..|++|||+.|+++. +| ..+..+ -|+.|
T Consensus        74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS~-lp-~~lC~l-pLkvl  148 (722)
T KOG0532|consen   74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLSH-LP-DGLCDL-PLKVL  148 (722)
T ss_pred             ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhhc-CC-hhhhcC-cceeE
Confidence            333445566666665 55666555556666666666665 555555555555555555555542 11 111112 26666


Q ss_pred             EccCCcCCCCCCcccCCCCCCCEEEcCCCccccccchhhcCCCCCCEEEccCCCCCCCCCcccccCCCCCceeccccccc
Q 001566          226 KLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDAS  305 (1052)
Q Consensus       226 ~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~~~  305 (1052)
                      -+++|+++ .+|..++.+..|..|+.+.|.+. .+|..++++.+|+.|.+..|++.. +|.++..|              
T Consensus       149 i~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~-lp~El~~L--------------  211 (722)
T KOG0532|consen  149 IVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLED-LPEELCSL--------------  211 (722)
T ss_pred             EEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhh-CCHHHhCC--------------
Confidence            67777766 46666666677777777777776 666677777777777777777663 44443322              


Q ss_pred             ccCCCCCCccccccCCCchhhhcccCCcEEecCCCCCCccCCccccCCCCccEEeCCCCcccccCCccccccCCCCEEeC
Q 001566          306 LDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDL  385 (1052)
Q Consensus       306 ~~l~~~~~~~~~~~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  385 (1052)
                                                                       .|..||+|.|+++ .+|..|.+|+.|++|-|
T Consensus       212 -------------------------------------------------pLi~lDfScNkis-~iPv~fr~m~~Lq~l~L  241 (722)
T KOG0532|consen  212 -------------------------------------------------PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQL  241 (722)
T ss_pred             -------------------------------------------------ceeeeecccCcee-ecchhhhhhhhheeeee
Confidence                                                             3667777777777 67777777777777777


Q ss_pred             CCCcCcC
Q 001566          386 SLNNLEG  392 (1052)
Q Consensus       386 s~N~l~~  392 (1052)
                      .+|.|+.
T Consensus       242 enNPLqS  248 (722)
T KOG0532|consen  242 ENNPLQS  248 (722)
T ss_pred             ccCCCCC
Confidence            7777764

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.30  E-value=8.9e-12  Score=143.75  Aligned_cols=141  Identities=21%  Similarity=0.245  Sum_probs=102.2

Q ss_pred             ceeeeccCceEEEEEEecCCcEEEEEEeccCcccc----------------------------------------HHHHH
Q 001566          780 RNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQG----------------------------------------IQQFD  819 (1052)
Q Consensus       780 ~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~  819 (1052)
                      .+.||.|++|.||+|+..+|+.||||+.+....+.                                        .-+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            36799999999999999999999999986542111                                        01245


Q ss_pred             HHHHHhhccC----CCceeeEEEEEe-cCCeeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHH-HHHHHHhcC
Q 001566          820 AEIGTLGRIR----HKNLVTLIGYYV-GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQ-ALAYLHYSC  893 (1052)
Q Consensus       820 ~e~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~-~l~~LH~~~  893 (1052)
                      .|++.+.+++    |.+-+.+-.++. ..+..++||||++|++|.++..... ...   ...+++..++. .+..+|.. 
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-~~~---~~~~ia~~~~~~~l~ql~~~-  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-AGL---DRKALAENLARSFLNQVLRD-  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh-cCC---CHHHHHHHHHHHHHHHHHhC-
Confidence            5666666652    333333333332 2456799999999999998875432 112   23456666666 46788888 


Q ss_pred             CCCeeeCCCCCCCEEECCCCcEEEeeeccccccc
Q 001566          894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE  927 (1052)
Q Consensus       894 ~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~  927 (1052)
                        |++|+|++|.||+++.++.++++|||++..+.
T Consensus       277 --g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 --GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             --CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence              99999999999999999999999999998765

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.29  E-value=7.4e-11  Score=134.03  Aligned_cols=167  Identities=18%  Similarity=0.226  Sum_probs=132.0

Q ss_pred             EecCCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEeecCCCCHHHHHhhccCCcccHHH
Q 001566          795 ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSV  874 (1052)
Q Consensus       795 ~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~  874 (1052)
                      +..++.+|.|...+.......+...+-++.++.++||+|+++++.++.++..|+|+|-+  ..|..++++.     +...
T Consensus        33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l-----~~~~  105 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKEL-----GKEE  105 (690)
T ss_pred             eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHh-----HHHH
Confidence            34468889999887666544566788899999999999999999999999999999988  4788888764     4677


Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcccccccccccccccccccCCCCC
Q 001566          875 IHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV  954 (1052)
Q Consensus       875 ~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~  954 (1052)
                      ...-+.||+.||.+||..+  +++|+++....|+|++.|..||++|.++........ .....+.--.|..|+.+.... 
T Consensus       106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~-  181 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE-  181 (690)
T ss_pred             HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc-
Confidence            7788999999999999776  899999999999999999999999998865432111 111122223466777555432 


Q ss_pred             CcchhHHHHHHHHHHHHhC
Q 001566          955 SDKADVYSFGVVLLELISG  973 (1052)
Q Consensus       955 ~~~sDvwslG~il~elltg  973 (1052)
                       -..|.|.||+++||++.|
T Consensus       182 -~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 -WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             -cchhhhhHHHHHHHHhCc
Confidence             346999999999999998

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.27  E-value=6.7e-12  Score=129.40  Aligned_cols=200  Identities=22%  Similarity=0.343  Sum_probs=139.2

Q ss_pred             HhhccCCCceeeEEEEEecC-----CeeEEEEeecCCCCHHHHHhhcc--CCcccHHHHHHHHHHHHHHHHHHHhcCCCC
Q 001566          824 TLGRIRHKNLVTLIGYYVGE-----AEMFLVYNFLSGGNLETFIHKKS--GKKIQWSVIHKIAIDIAQALAYLHYSCVPR  896 (1052)
Q Consensus       824 ~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~  896 (1052)
                      -+-.+-|.|+++++.++.+.     .+..++.|||..|++..+|++..  ...+......+|+.||..||.|||+. .|.
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp  198 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence            34445699999999998653     45789999999999999998754  45677888899999999999999975 678


Q ss_pred             eeeCCCCCCCEEECCCCcEEEeeecccccccc----cCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHh
Q 001566          897 IVHRDIKPSNILLDEELNAYLSDFGLARLLEV----SETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS  972 (1052)
Q Consensus       897 iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~----~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~ellt  972 (1052)
                      |+|+++..+-|++..++-+|+.--.-.. +..    ..........+-++|.+||.=.....+-++|||+||+...||..
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             cccCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            9999999999999999888874211111 110    11111222345679999998777777789999999999999998


Q ss_pred             CCCCCCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566          973 GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus       973 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      +..--...............   ..+.       ....+           =+.++..|++..|..||+|++++.
T Consensus       278 lEiq~tnseS~~~~ee~ia~---~i~~-------len~l-----------qr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  278 LEIQSTNSESKVEVEENIAN---VIIG-------LENGL-----------QRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             heeccCCCcceeehhhhhhh---heee-------ccCcc-----------ccCcCcccccCCCCCCcchhhhhc
Confidence            87543322222111111110   0000       00000           124777899999999999998764

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.26  E-value=2.1e-13  Score=149.89  Aligned_cols=109  Identities=30%  Similarity=0.509  Sum_probs=67.5

Q ss_pred             ccEEEccCcccccccccccCCCCCCCEEEccCCcCCCCCcccccCCccCcEEEcCCCccCCcCchhhcCCCCCcEEEcCC
Q 001566          534 LVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSH  613 (1052)
Q Consensus       534 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~  613 (1052)
                      |+.|-+++|+++ .+|..++.+..|..||.+.|.|. .+|..++++.+|+.|.+..|++. .+|.+++. -.|..||+|.
T Consensus       145 Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~-LpLi~lDfSc  220 (722)
T KOG0532|consen  145 LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCS-LPLIRLDFSC  220 (722)
T ss_pred             ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhC-Cceeeeeccc
Confidence            455555666665 55556666666666666666666 55666666666666666666666 45555553 3566666666


Q ss_pred             CCCCCCCchhhhcccccceeeccCccCCCCCCccc
Q 001566          614 NALTGSIPASLTKATKLESLFLAHNRLSGEIPVSF  648 (1052)
Q Consensus       614 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~  648 (1052)
                      |+++ .+|-.|.+|+.|++|-|.+|.|+ ..|..+
T Consensus       221 Nkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqI  253 (722)
T KOG0532|consen  221 NKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQI  253 (722)
T ss_pred             Ccee-ecchhhhhhhhheeeeeccCCCC-CChHHH
Confidence            6666 56666666666666666666666 344433

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.25  E-value=6.7e-12  Score=141.60  Aligned_cols=247  Identities=24%  Similarity=0.319  Sum_probs=183.3

Q ss_pred             CCccceeeec--cCceEEEEEEe---cCCcEEEEEEeccCcc--ccHHHHHHHHHHhhcc-CCCceeeEEEEEecCCeeE
Q 001566          776 NFSIRNLIGT--GGFGSTYKAEL---VPGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEAEMF  847 (1052)
Q Consensus       776 ~~~~~~~Lg~--G~~g~V~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  847 (1052)
                      .+.+.+.+|.  |.+|.||.+..   .++..+|+|+-+....  .....-.+|+...+++ .|++.++.+..+.+.+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4666788999  99999999965   4578899998544332  2233445677777777 4999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHH----HHHHHHhcCCCCeeeCCCCCCCEEECCC-CcEEEeeecc
Q 001566          848 LVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQ----ALAYLHYSCVPRIVHRDIKPSNILLDEE-LNAYLSDFGL  922 (1052)
Q Consensus       848 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~iiHrDik~~Nill~~~-~~~kl~Dfgl  922 (1052)
                      +-+|.+ +.++..+.+... ..++...++.+..+..+    |+.++|+.   .|+|-|+||.||....+ ..++++|||+
T Consensus       195 iqtE~~-~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  195 IQTELC-GESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             eeeccc-cchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcce
Confidence            999998 689999987754 45777788888888888    99999999   99999999999999999 8899999999


Q ss_pred             cccccccCcc----cccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHH
Q 001566          923 ARLLEVSETH----ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLI  998 (1052)
Q Consensus       923 a~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  998 (1052)
                      ...+......    ......+...|++||...+ .++.++|+|++|.++.+..++-.++......        .|.+  .
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~--------~W~~--~  338 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNS--------SWSQ--L  338 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCC--------Cccc--c
Confidence            9988654321    1222356778999998887 5788999999999999999988776533111        1111  1


Q ss_pred             HhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001566          999 KEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus       999 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      +.+....    ++...    -..++...+..|+.++|..|++.+.+..
T Consensus       339 r~~~ip~----e~~~~----~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  339 RQGYIPL----EFCEG----GSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             ccccCch----hhhcC----cchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            1111110    11111    1223445888899999999999887654

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.24  E-value=1.1e-11  Score=143.42  Aligned_cols=200  Identities=32%  Similarity=0.435  Sum_probs=119.1

Q ss_pred             EEEccCccccccCCccccCCCCCCeEecccccccccCCccccCCC-CCcEEEccCCcccCccccCCCcccCCCCEEEccC
Q 001566          151 VLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNG-ELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSD  229 (1052)
Q Consensus       151 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~  229 (1052)
                      .++++.|.+.. .+..+..++.++.|++.+|.++ .+|.....+. +|+.|++++|++.. ++ .....+++|+.|++++
T Consensus        97 ~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~~-l~-~~~~~l~~L~~L~l~~  172 (394)
T COG4886          97 SLDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIES-LP-SPLRNLPNLKNLDLSF  172 (394)
T ss_pred             eeecccccccc-CchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchhh-hh-hhhhccccccccccCC
Confidence            46666666542 2333444466666666666666 5555555453 56666666666553 11 2344556666666666


Q ss_pred             CcCCCCCCcccCCCCCCCEEEcCCCccccccchhhcCCCCCCEEEccCCCCCCCCCcccccCCCCCceecccccccccCC
Q 001566          230 NFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLD  309 (1052)
Q Consensus       230 N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~n~~~~~l~  309 (1052)
                      |+++. +|...+.+++|+.|++++|+++ .+|...+....|++|++++|++. ..+..+.++.++..+.+.+|+      
T Consensus       173 N~l~~-l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~------  243 (394)
T COG4886         173 NDLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNK------  243 (394)
T ss_pred             chhhh-hhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCce------
Confidence            66663 4444445666666666666666 55655555555666666666433 244455555555555444332      


Q ss_pred             CCCCccccccCCCchhhhcccCCcEEecCCCCCCccCCccccCCCCccEEeCCCCcccccCCccccccCCCCEEeCCCCc
Q 001566          310 NSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNN  389 (1052)
Q Consensus       310 ~~~~~~~~~~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  389 (1052)
                                                      +.. ++..++.+++++.|++++|+++. ++. ++.+.+|+.|++++|.
T Consensus       244 --------------------------------~~~-~~~~~~~l~~l~~L~~s~n~i~~-i~~-~~~~~~l~~L~~s~n~  288 (394)
T COG4886         244 --------------------------------LED-LPESIGNLSNLETLDLSNNQISS-ISS-LGSLTNLRELDLSGNS  288 (394)
T ss_pred             --------------------------------eee-ccchhccccccceeccccccccc-ccc-ccccCccCEEeccCcc
Confidence                                            221 25556677778888888888873 443 7788888888888888


Q ss_pred             CcCCCCCCC
Q 001566          390 LEGYLPMQL  398 (1052)
Q Consensus       390 l~~~~p~~~  398 (1052)
                      ++..+|...
T Consensus       289 ~~~~~~~~~  297 (394)
T COG4886         289 LSNALPLIA  297 (394)
T ss_pred             ccccchhhh
Confidence            877666544

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.22  E-value=9.3e-12  Score=144.08  Aligned_cols=179  Identities=32%  Similarity=0.512  Sum_probs=107.9

Q ss_pred             hhcCCCCCCeeEecCCCceecCCCCccCCC-CccEEEccCccccccCCccccCCCCCCeEecccccccccCCccccCCCC
Q 001566          118 SIAKLTELRTLSVPHNSFSGEIPAGVGELR-LLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGE  196 (1052)
Q Consensus       118 ~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  196 (1052)
                      .+..++.++.|++.+|+++ .+|...+.+. +|+.|++++|++. .+|..++.+++|+.|++++|+++ .+|...+.+++
T Consensus       111 ~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~  187 (394)
T COG4886         111 ELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSN  187 (394)
T ss_pred             hhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhh
Confidence            3445566667777777766 5666566663 6777777777766 55566666677777777777766 55555556666


Q ss_pred             CcEEEccCCcccCccccCCCcccCCCCEEEccCCcCCCCCCcccCCCCCCCEEEcCCCccccccchhhcCCCCCCEEEcc
Q 001566          197 LSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVS  276 (1052)
Q Consensus       197 L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  276 (1052)
                      |+.|++++|+++. ++. ....+..|++|.+++|.+. ..+..+.++.++..+.+.+|++. .++..++.+++++.|+++
T Consensus       188 L~~L~ls~N~i~~-l~~-~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s  263 (394)
T COG4886         188 LNNLDLSGNKISD-LPP-EIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLS  263 (394)
T ss_pred             hhheeccCCcccc-Cch-hhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccceeccc
Confidence            6666666666654 221 1123344666666666433 24455666666666666666665 335666666666666666


Q ss_pred             CCCCCCCCCcccccCCCCCceeccccccc
Q 001566          277 RNSLTDRIPVELADCSKLSVLVLTNIDAS  305 (1052)
Q Consensus       277 ~N~l~~~~p~~l~~l~~L~~L~L~~n~~~  305 (1052)
                      +|+++. ++. ++.+.+|+.|++++|.++
T Consensus       264 ~n~i~~-i~~-~~~~~~l~~L~~s~n~~~  290 (394)
T COG4886         264 NNQISS-ISS-LGSLTNLRELDLSGNSLS  290 (394)
T ss_pred             cccccc-ccc-ccccCccCEEeccCcccc
Confidence            666664 333 556666666666554433

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.19  E-value=7.3e-10  Score=129.05  Aligned_cols=142  Identities=18%  Similarity=0.226  Sum_probs=96.5

Q ss_pred             CCCccceeeeccCceEEEEEEecC-CcEEEEEEeccCcccc----------------------------------H----
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQG----------------------------------I----  815 (1052)
Q Consensus       775 ~~~~~~~~Lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~----------------------------------~----  815 (1052)
                      ..|+. +.||.|++|.||+|+.++ |+.||||+.+....+.                                  .    
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45776 789999999999999887 9999999986542110                                  0    


Q ss_pred             --HHHHHHHHHhhccC----CCceeeEEEEEec-CCeeEEEEeecCCCCHHHHH--hhccC--CcccHHHHHHHHHHHHH
Q 001566          816 --QQFDAEIGTLGRIR----HKNLVTLIGYYVG-EAEMFLVYNFLSGGNLETFI--HKKSG--KKIQWSVIHKIAIDIAQ  884 (1052)
Q Consensus       816 --~~~~~e~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~~--~~l~~~~~~~i~~~i~~  884 (1052)
                        -++.+|+..+.+++    +...+.+-.++.+ .+..++||||++|+++.++-  .....  ..+....+..++.|+  
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--  276 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--  276 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence              12444555555552    4444444444433 46678999999999998753  22110  013333333344444  


Q ss_pred             HHHHHHhcCCCCeeeCCCCCCCEEECCCC----cEEEeeeccccccc
Q 001566          885 ALAYLHYSCVPRIVHRDIKPSNILLDEEL----NAYLSDFGLARLLE  927 (1052)
Q Consensus       885 ~l~~LH~~~~~~iiHrDik~~Nill~~~~----~~kl~Dfgla~~~~  927 (1052)
                           ...   |++|+|++|.||+++.++    .++++|||++..+.
T Consensus       277 -----f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        277 -----FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             -----HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence                 345   999999999999999888    99999999997654

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.12  E-value=4.1e-11  Score=118.38  Aligned_cols=84  Identities=31%  Similarity=0.412  Sum_probs=21.9

Q ss_pred             CccCcEEEcCCCccCCcCchhhcCCCCCcEEEcCCCCCCCCCchhh-hcccccceeeccCccCCCCCC-cccccccccCc
Q 001566          579 LKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASL-TKATKLESLFLAHNRLSGEIP-VSFSTLVNLSA  656 (1052)
Q Consensus       579 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~  656 (1052)
                      +.+|+.|+|++|+|+ .++ .+..++.|++|++++|+|+ .+++.+ ..+++|++|+|++|+|...-. ..+..+++|+.
T Consensus        41 l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~  117 (175)
T PF14580_consen   41 LDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRV  117 (175)
T ss_dssp             -TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--E
T ss_pred             hcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcce
Confidence            444444444444444 222 2444444444444444444 222222 234445555555554442111 23344555555


Q ss_pred             eeccccccc
Q 001566          657 LDLSFNNLS  665 (1052)
Q Consensus       657 L~l~~N~l~  665 (1052)
                      |+|.+|+++
T Consensus       118 L~L~~NPv~  126 (175)
T PF14580_consen  118 LSLEGNPVC  126 (175)
T ss_dssp             EE-TT-GGG
T ss_pred             eeccCCccc
Confidence            555555554

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.12  E-value=2e-10  Score=115.88  Aligned_cols=129  Identities=22%  Similarity=0.171  Sum_probs=96.2

Q ss_pred             eeeeccCceEEEEEEecCCcEEEEEEeccCccccHHHHHHHHHHhhccCCCcee-eEEEEEecCCeeEEEEeecCCCCHH
Q 001566          781 NLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV-TLIGYYVGEAEMFLVYNFLSGGNLE  859 (1052)
Q Consensus       781 ~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~gsL~  859 (1052)
                      +.++.|.++.||+++.. +..|++|....... ....+..|+.+++.+.+.+++ +++.+.  ....++||||+++.++.
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~   79 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL   79 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence            56889999999999876 77899998754432 224567899999998665554 444443  23458999999998875


Q ss_pred             HHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcC--CCCeeeCCCCCCCEEECCCCcEEEeeecccc
Q 001566          860 TFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC--VPRIVHRDIKPSNILLDEELNAYLSDFGLAR  924 (1052)
Q Consensus       860 ~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~iiHrDik~~Nill~~~~~~kl~Dfgla~  924 (1052)
                      +..          .....++.+++++++.||...  ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus        80 ~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          80 TED----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ccc----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            430          111245678999999999882  12359999999999999 5689999999986

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.11  E-value=2.5e-11  Score=123.27  Aligned_cols=133  Identities=29%  Similarity=0.319  Sum_probs=111.1

Q ss_pred             CcCccEEEccCcccccccccccCCCCCCCEEEccCCcCCCCCcccccCCccCcEEEcCCCccCCcCchhhcCCCCCcEEE
Q 001566          531 CVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLD  610 (1052)
Q Consensus       531 ~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  610 (1052)
                      +..|+++||++|.|+ .+.++..-.+.++.|+++.|.|..+  +.+..+++|+.||||+|.++ .+.++-..+.+.+.|.
T Consensus       283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~  358 (490)
T KOG1259|consen  283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLK  358 (490)
T ss_pred             Hhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeee
Confidence            357899999999998 6777778889999999999999833  34888999999999999998 6778888889999999


Q ss_pred             cCCCCCCCCCchhhhcccccceeeccCccCCCCC-CcccccccccCceecccccccCCCC
Q 001566          611 LSHNALTGSIPASLTKATKLESLFLAHNRLSGEI-PVSFSTLVNLSALDLSFNNLSGHIP  669 (1052)
Q Consensus       611 l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~p  669 (1052)
                      |++|.|.. + ..++.|-+|..||+++|+|.... -..++++|-|+.+.|.+|++++.+.
T Consensus       359 La~N~iE~-L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd  416 (490)
T KOG1259|consen  359 LAQNKIET-L-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD  416 (490)
T ss_pred             hhhhhHhh-h-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence            99999873 2 45778889999999999998432 2568899999999999999987655

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.06  E-value=1.6e-09  Score=109.36  Aligned_cols=137  Identities=15%  Similarity=0.153  Sum_probs=98.3

Q ss_pred             ceeeeccCceEEEEEEecC-------CcEEEEEEeccCcc---------------------cc-HHH----HHHHHHHhh
Q 001566          780 RNLIGTGGFGSTYKAELVP-------GYLVAVKKLSIGRF---------------------QG-IQQ----FDAEIGTLG  826 (1052)
Q Consensus       780 ~~~Lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~---------------------~~-~~~----~~~e~~~l~  826 (1052)
                      ...||.|.-+.||.|.-.+       +..+|||+++....                     .. ...    .++|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3578999999999995442       47899998743210                     00 112    237999999


Q ss_pred             ccCC--CceeeEEEEEecCCeeEEEEeecCCCCHHH-HHhhccCCcccHHHHHHHHHHHHHHHHHH-HhcCCCCeeeCCC
Q 001566          827 RIRH--KNLVTLIGYYVGEAEMFLVYNFLSGGNLET-FIHKKSGKKIQWSVIHKIAIDIAQALAYL-HYSCVPRIVHRDI  902 (1052)
Q Consensus       827 ~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~iiHrDi  902 (1052)
                      ++..  -++...+++    ...++||||+.+..+.. .++.   ..++.++...+..+++.++..+ |..   +|+|||+
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL  151 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL  151 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence            9853  345556654    56789999996643321 2222   2345566778889999999999 788   9999999


Q ss_pred             CCCCEEECCCCcEEEeeeccccccc
Q 001566          903 KPSNILLDEELNAYLSDFGLARLLE  927 (1052)
Q Consensus       903 k~~Nill~~~~~~kl~Dfgla~~~~  927 (1052)
                      ++.||++++ +.++++|||.+....
T Consensus       152 s~~NIL~~~-~~v~iIDF~qav~~~  175 (197)
T cd05146         152 SEYNMLWHD-GKVWFIDVSQSVEPT  175 (197)
T ss_pred             CHHHEEEEC-CcEEEEECCCceeCC
Confidence            999999974 589999999987554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.06  E-value=3.1e-09  Score=101.89  Aligned_cols=144  Identities=21%  Similarity=0.287  Sum_probs=109.4

Q ss_pred             cceeeeccCceEEEEEEecCCcEEEEEEeccCccc--------cHHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEE
Q 001566          779 IRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQ--------GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       779 ~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      ....+.+|+-+.|+++.+. |+...||.-......        ...+.++|++.+.+.+--.|.--.-++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            5678899999999999886 777777744322221        1345678999999886555544444555667778999


Q ss_pred             eecCC-CCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCC---cEEEeeecccccc
Q 001566          851 NFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEEL---NAYLSDFGLARLL  926 (1052)
Q Consensus       851 e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~---~~kl~Dfgla~~~  926 (1052)
                      ||++| .++.+|+...-......+....++..|-+.+.-||..   +|+|+|+..+||++..++   .+.++|||++..-
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            99965 4889998877655555555578999999999999999   999999999999996554   4689999998754

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.06  E-value=1.1e-10  Score=115.24  Aligned_cols=125  Identities=30%  Similarity=0.317  Sum_probs=52.1

Q ss_pred             hcCcCccEEEccCcccccccccccC-CCCCCCEEEccCCcCCCCCcccccCCccCcEEEcCCCccCCcCchhh-cCCCCC
Q 001566          529 LDCVQLVEFEAANNQISGSIAAGVG-KLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQF-GHLISL  606 (1052)
Q Consensus       529 ~~~~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L  606 (1052)
                      .+...+++|+|.+|+|+.+  +.++ .+.+|+.|+|++|+|+.. + .+..+++|+.|++++|+|+. +.+.+ ..+++|
T Consensus        16 ~n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l-~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L   90 (175)
T PF14580_consen   16 NNPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL-E-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNL   90 (175)
T ss_dssp             ----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT-
T ss_pred             ccccccccccccccccccc--cchhhhhcCCCEEECCCCCCccc-c-CccChhhhhhcccCCCCCCc-cccchHHhCCcC
Confidence            3556789999999999953  3455 588999999999999954 3 58899999999999999994 54444 469999


Q ss_pred             cEEEcCCCCCCCCC-chhhhcccccceeeccCccCCCCCC----cccccccccCceec
Q 001566          607 VVLDLSHNALTGSI-PASLTKATKLESLFLAHNRLSGEIP----VSFSTLVNLSALDL  659 (1052)
Q Consensus       607 ~~L~l~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~l  659 (1052)
                      ++|+|++|+|...- -..+..+++|+.|+|.+|+++.. +    ..+..+|+|+.||-
T Consensus        91 ~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD~  147 (175)
T PF14580_consen   91 QELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLDG  147 (175)
T ss_dssp             -EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEETT
T ss_pred             CEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeCC
Confidence            99999999997432 24577899999999999999843 3    23566788887773

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.03  E-value=2.7e-11  Score=123.05  Aligned_cols=142  Identities=24%  Similarity=0.308  Sum_probs=78.9

Q ss_pred             ccccccchhhcCCCCCCeeEecCCCceecCCCCccCCCCccEEEccCccccccCCccccCCCCCCeEecccccccccCCc
Q 001566          110 VISGTLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPR  189 (1052)
Q Consensus       110 ~l~g~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  189 (1052)
                      ..+|..-.++..-+.|++||||+|.|+ ++.++..-++.++.|++|+|.+. .+- .+..|++|+.||||+|.++ .+..
T Consensus       271 t~~G~~~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~G  346 (490)
T KOG1259|consen  271 TSNGSALVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVG  346 (490)
T ss_pred             ccCCceEEecchHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhh
Confidence            345555555555666677777777776 66666666666777777777666 222 2666666666666666666 3444


Q ss_pred             cccCCCCCcEEEccCCcccCccccCCCcccCCCCEEEccCCcCCCCCCcccCCCCCCCEEEcCCCccccc-cchhhcCCC
Q 001566          190 GLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGS-IPKEIGTIS  268 (1052)
Q Consensus       190 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~-~p~~~~~l~  268 (1052)
                      +-..+.+.+.|.|++|.+..                           -+.++.+-+|..|++++|+|... --..+++++
T Consensus       347 wh~KLGNIKtL~La~N~iE~---------------------------LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LP  399 (490)
T KOG1259|consen  347 WHLKLGNIKTLKLAQNKIET---------------------------LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLP  399 (490)
T ss_pred             hHhhhcCEeeeehhhhhHhh---------------------------hhhhHhhhhheeccccccchhhHHHhccccccc
Confidence            44445555555555555432                           12234444455555555555421 122355555


Q ss_pred             CCCEEEccCCCCCC
Q 001566          269 ELKVLDVSRNSLTD  282 (1052)
Q Consensus       269 ~L~~L~L~~N~l~~  282 (1052)
                      -|+.+.|.+|.+.+
T Consensus       400 CLE~l~L~~NPl~~  413 (490)
T KOG1259|consen  400 CLETLRLTGNPLAG  413 (490)
T ss_pred             HHHHHhhcCCCccc
Confidence            55555555555553

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.03  E-value=2.7e-09  Score=103.14  Aligned_cols=131  Identities=24%  Similarity=0.398  Sum_probs=100.9

Q ss_pred             eeeeccCceEEEEEEecCCcEEEEEEeccCccc--c------HHHHHHHHHHhhccCCCceeeEEEEEecCCeeEEEEee
Q 001566          781 NLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQ--G------IQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       781 ~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  852 (1052)
                      ..+++|+-+.+|.+.+. |.++++|.-..+...  .      ..+-.+|+.++.+++--.|..-+-+..+.....++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35789999999999886 555666643322211  1      23456799999998765655545555667778999999


Q ss_pred             cCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccc
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARL  925 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~  925 (1052)
                      ++|..|.+++...         ...++..+-.-+.-||..   ||+|+|+.++||.+..+. +.++|||++..
T Consensus        81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999998765         245677788888999999   999999999999999874 99999999974

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.02  E-value=4.1e-11  Score=128.44  Aligned_cols=217  Identities=22%  Similarity=0.184  Sum_probs=148.7

Q ss_pred             ccCCCCccEEEccCccccccCC--ccccCCCCCCeEecccccccc--cCCccccCCCCCcEEEccCCcccCccccCCCcc
Q 001566          143 VGELRLLEVLELQGNNFSGKIP--YQMSNLERLRVLNLSFNSFSG--EVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSE  218 (1052)
Q Consensus       143 ~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~  218 (1052)
                      =.++.+|+...|.+.... ..+  .....+++++.||||+|-+..  .+-.-...+++|+.|+|+.|++.-......-..
T Consensus       117 Qsn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~  195 (505)
T KOG3207|consen  117 QSNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLL  195 (505)
T ss_pred             hhhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhh
Confidence            367788888888888877 333  356788899999999998873  233455578899999999998875444444446


Q ss_pred             cCCCCEEEccCCcCCCC-CCcccCCCCCCCEEEcCCCccccccchhhcCCCCCCEEEccCCCCCCCCC--cccccCCCCC
Q 001566          219 CEFLTYLKLSDNFLTES-IPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIP--VELADCSKLS  295 (1052)
Q Consensus       219 l~~L~~L~Ls~N~l~~~-~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p--~~l~~l~~L~  295 (1052)
                      +++|+.|.|+.|.|+.. +...+..+|+|+.|+|..|...+.......-++.|+.|||++|++-. .+  ...+.++.|+
T Consensus       196 l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~-~~~~~~~~~l~~L~  274 (505)
T KOG3207|consen  196 LSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLID-FDQGYKVGTLPGLN  274 (505)
T ss_pred             hhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccc-cccccccccccchh
Confidence            77899999999998832 23345678899999999996443444455567889999999998874 33  3466777777


Q ss_pred             ceecccccccccCCCCCCccccccCCCchhhhcccCCcEEecCCCCCCccCCccccCCCCccEEeCCCCcccc-cCCccc
Q 001566          296 VLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKG-AVPKSL  374 (1052)
Q Consensus       296 ~L~L~~n~~~~~l~~~~~~~~~~~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~Ls~N~l~~-~~p~~~  374 (1052)
                      .|.++.+.+..                         +...+       ...-+.-..+++|++|+++.|+|.. ..-..+
T Consensus       275 ~Lnls~tgi~s-------------------------i~~~d-------~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l  322 (505)
T KOG3207|consen  275 QLNLSSTGIAS-------------------------IAEPD-------VESLDKTHTFPKLEYLNISENNIRDWRSLNHL  322 (505)
T ss_pred             hhhccccCcch-------------------------hcCCC-------ccchhhhcccccceeeecccCccccccccchh
Confidence            77777655431                         00000       0000113455689999999999852 122355


Q ss_pred             cccCCCCEEeCCCCcCcCC
Q 001566          375 GMCRNLTYLDLSLNNLEGY  393 (1052)
Q Consensus       375 ~~l~~L~~L~Ls~N~l~~~  393 (1052)
                      ..+++|+.|....|.|+..
T Consensus       323 ~~l~nlk~l~~~~n~ln~e  341 (505)
T KOG3207|consen  323 RTLENLKHLRITLNYLNKE  341 (505)
T ss_pred             hccchhhhhhccccccccc
Confidence            6677888888888988754

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.02  E-value=1.8e-11  Score=127.95  Aligned_cols=174  Identities=22%  Similarity=0.268  Sum_probs=84.9

Q ss_pred             hhhcCCCCCCeeEecCCCcee----cCCCCccCCCCccEEEccCcc---ccccCCcc-------ccCCCCCCeEeccccc
Q 001566          117 ASIAKLTELRTLSVPHNSFSG----EIPAGVGELRLLEVLELQGNN---FSGKIPYQ-------MSNLERLRVLNLSFNS  182 (1052)
Q Consensus       117 ~~l~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~Ls~N~---l~~~~p~~-------~~~l~~L~~L~Ls~N~  182 (1052)
                      +.+.....++.++|++|.|..    .+.+.+.+.++|+..++|+=-   +...+|..       +-..++|++||||.|.
T Consensus        24 ~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA  103 (382)
T KOG1909|consen   24 EELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNA  103 (382)
T ss_pred             HHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccc
Confidence            345556667777777777654    244455666677777766532   22234433       3445677777777777


Q ss_pred             ccccCCcccc----CCCCCcEEEccCCcccCccccCCCcccCCCCEEEccCCcCCCCCCcccCCCCCCCEEEcCCCcccc
Q 001566          183 FSGEVPRGLI----GNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEG  258 (1052)
Q Consensus       183 l~~~~p~~~~----~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~  258 (1052)
                      |....+..|.    .+..|++|+|.+|.+.- .....++  .-|.+|.  .|       ...+.-+.|+++..++|++..
T Consensus       104 ~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~-~ag~~l~--~al~~l~--~~-------kk~~~~~~Lrv~i~~rNrlen  171 (382)
T KOG1909|consen  104 FGPKGIRGLEELLSSCTDLEELYLNNCGLGP-EAGGRLG--RALFELA--VN-------KKAASKPKLRVFICGRNRLEN  171 (382)
T ss_pred             cCccchHHHHHHHHhccCHHHHhhhcCCCCh-hHHHHHH--HHHHHHH--HH-------hccCCCcceEEEEeecccccc
Confidence            7644444333    34555555555555431 0000000  0011111  11       112233456666666666642


Q ss_pred             c----cchhhcCCCCCCEEEccCCCCCCCC----CcccccCCCCCceecccc
Q 001566          259 S----IPKEIGTISELKVLDVSRNSLTDRI----PVELADCSKLSVLVLTNI  302 (1052)
Q Consensus       259 ~----~p~~~~~l~~L~~L~L~~N~l~~~~----p~~l~~l~~L~~L~L~~n  302 (1052)
                      .    +...|...+.|+.+.+++|.+....    -..|..++.|++|+|.+|
T Consensus       172 ~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DN  223 (382)
T KOG1909|consen  172 GGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDN  223 (382)
T ss_pred             ccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccc
Confidence            2    2233445566666666666654221    123444555555555443

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=98.98  E-value=4.7e-11  Score=124.82  Aligned_cols=112  Identities=30%  Similarity=0.342  Sum_probs=71.1

Q ss_pred             hcCcCccEEEccCcccccc----cccccCCCCCCCEEEccCCcCCCC----CcccccCCccCcEEEcCCCccCCcCchhh
Q 001566          529 LDCVQLVEFEAANNQISGS----IAAGVGKLMKLQRLDLRGNRVSGS----LPDELGKLKFLKWILLGGNNLTGEIPSQF  600 (1052)
Q Consensus       529 ~~~~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  600 (1052)
                      ..++.|+++.+..|.|...    ....|..+++|+.|||++|.++..    +.+.+..+++|++|++++|.+...-...|
T Consensus       182 ~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~  261 (382)
T KOG1909|consen  182 QSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAF  261 (382)
T ss_pred             HhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHH
Confidence            4457888888888887522    234567788888888888888742    34566777788888888888764433332


Q ss_pred             -----cCCCCCcEEEcCCCCCCCC----CchhhhcccccceeeccCccC
Q 001566          601 -----GHLISLVVLDLSHNALTGS----IPASLTKATKLESLFLAHNRL  640 (1052)
Q Consensus       601 -----~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l  640 (1052)
                           ...++|+.|.+.+|.|+..    +-..+...+.|..|+|++|++
T Consensus       262 ~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l  310 (382)
T KOG1909|consen  262 VDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL  310 (382)
T ss_pred             HHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence                 2356777777777777621    122233445555555555555

>PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=98.97  E-value=4.9e-10  Score=83.14  Aligned_cols=40  Identities=53%  Similarity=1.130  Sum_probs=31.7

Q ss_pred             hhhHHHHHHHHHhccCCCCCcccCCCCC--CCCCCCCceEee
Q 001566           47 TTDSASLLSFKASISRDPSNLLATWNSS--TDHCTWHGVTCD   86 (1052)
Q Consensus        47 ~~d~~all~~k~~~~~~p~~~l~~W~~~--~~~C~w~gV~C~   86 (1052)
                      .+|++||++||+++..+|.+.+.+|+.+  ++||+|.||+|+
T Consensus         2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd   43 (43)
T PF08263_consen    2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD   43 (43)
T ss_dssp             HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred             cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence            5799999999999987888899999977  799999999996

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A.

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=98.94  E-value=1.6e-10  Score=123.94  Aligned_cols=62  Identities=21%  Similarity=0.336  Sum_probs=33.2

Q ss_pred             CCCCccEEeCCCCcccccCC--ccccccCCCCEEeCCCCcCcCCCCCC---CCCCCcceEecccCccc
Q 001566          352 ESCSLKVLNLGQNSLKGAVP--KSLGMCRNLTYLDLSLNNLEGYLPMQ---LPVPCMVYFNVSQNNIT  414 (1052)
Q Consensus       352 ~~~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p~~---~~~~~L~~l~l~~N~l~  414 (1052)
                      ++.+|+...|.+.... ..+  .....|++++.||||+|-|....|..   -++|+|+.|+|+.|++.
T Consensus       119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~  185 (505)
T KOG3207|consen  119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLS  185 (505)
T ss_pred             hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhccccccccc
Confidence            3445666666666655 222  24455666666666666665432210   13566666666666553

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.90  E-value=8.4e-09  Score=109.17  Aligned_cols=142  Identities=19%  Similarity=0.231  Sum_probs=108.7

Q ss_pred             eeeeccCceEEEEEEecCCcEEEEEEeccCcc-ccHHHHHHHHHHhhccCCC--ceeeEEEEEecC---CeeEEEEeecC
Q 001566          781 NLIGTGGFGSTYKAELVPGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHK--NLVTLIGYYVGE---AEMFLVYNFLS  854 (1052)
Q Consensus       781 ~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~---~~~~lv~e~~~  854 (1052)
                      +.|+.|.++.||+++..+|+.+++|....... ....++..|+++++.+++.  .+.+++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            56899999999999887668899998765432 1346788999999999753  456677776653   25689999999


Q ss_pred             CCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 001566          855 GGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC-----------------------------------------  893 (1052)
Q Consensus       855 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----------------------------------------  893 (1052)
                      |.++.+.+..   ..++.++...++.++++++.+||+..                                         
T Consensus        84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (223)
T cd05154          84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL  160 (223)
T ss_pred             CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence            9888765431   23667777778888888888887421                                         


Q ss_pred             ------------CCCeeeCCCCCCCEEECC--CCcEEEeeeccccc
Q 001566          894 ------------VPRIVHRDIKPSNILLDE--ELNAYLSDFGLARL  925 (1052)
Q Consensus       894 ------------~~~iiHrDik~~Nill~~--~~~~kl~Dfgla~~  925 (1052)
                                  ...++|+|+.+.||+++.  ++.+.|+||+.+..
T Consensus       161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                        246799999999999998  66789999998863

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=98.90  E-value=2e-10  Score=133.12  Aligned_cols=244  Identities=26%  Similarity=0.295  Sum_probs=115.7

Q ss_pred             CCCCCCeeEecCCCceecCCCCccCCCCccEEEccCccccccCCccccCCCCCCeEecccccccccCCccccCCCCCcEE
Q 001566          121 KLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVI  200 (1052)
Q Consensus       121 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  200 (1052)
                      .+..++.+++..|.+. .+-..+..+++|+.|++.+|+|. .+...+..+++|++|+|++|.|+...  .+..++.|+.|
T Consensus        70 ~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L  145 (414)
T KOG0531|consen   70 SLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKEL  145 (414)
T ss_pred             HhHhHHhhccchhhhh-hhhcccccccceeeeeccccchh-hcccchhhhhcchheecccccccccc--chhhccchhhh
Confidence            3445555556666555 22333555566666666666665 23333555566666666666655322  22333334444


Q ss_pred             EccCCcccCccccCCCcccCCCCEEEccCCcCCCCCCcccCCCCCCCEEEcCCCccccccchh-hcCCCCCCEEEccCCC
Q 001566          201 DMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKE-IGTISELKVLDVSRNS  279 (1052)
Q Consensus       201 ~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~  279 (1052)
                      ++++|.++.   .                        ..+..+.+|+.+++++|++...-+ . ...+.+++.+++..|.
T Consensus       146 ~l~~N~i~~---~------------------------~~~~~l~~L~~l~l~~n~i~~ie~-~~~~~~~~l~~l~l~~n~  197 (414)
T KOG0531|consen  146 NLSGNLISD---I------------------------SGLESLKSLKLLDLSYNRIVDIEN-DELSELISLEELDLGGNS  197 (414)
T ss_pred             eeccCcchh---c------------------------cCCccchhhhcccCCcchhhhhhh-hhhhhccchHHHhccCCc
Confidence            555554442   1                        223334455555555555542222 1 3444555555555555


Q ss_pred             CCCCCCcccccCCCCCceecccccccccCCCCCCccccccCCCchhhhccc--CCcEEecCCCCCCccCCccccCCCCcc
Q 001566          280 LTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSR--SLEVLWAPRANLGGRLPDNWSESCSLK  357 (1052)
Q Consensus       280 l~~~~p~~l~~l~~L~~L~L~~n~~~~~l~~~~~~~~~~~~~~p~~~~~~~--~L~~L~l~~n~l~~~~p~~~~~~~~L~  357 (1052)
                      +..  ...+..+..+..+++.+|.++..           .| ++    ...  .|+.+++++|.+.... ..+..+..+.
T Consensus       198 i~~--i~~~~~~~~l~~~~l~~n~i~~~-----------~~-l~----~~~~~~L~~l~l~~n~i~~~~-~~~~~~~~l~  258 (414)
T KOG0531|consen  198 IRE--IEGLDLLKKLVLLSLLDNKISKL-----------EG-LN----ELVMLHLRELYLSGNRISRSP-EGLENLKNLP  258 (414)
T ss_pred             hhc--ccchHHHHHHHHhhcccccceec-----------cC-cc----cchhHHHHHHhcccCcccccc-cccccccccc
Confidence            542  12223333333333333333210           00 00    001  2455555555554321 3455566777


Q ss_pred             EEeCCCCcccccCCccccccCCCCEEeCCCCcCcCCC---CC--CCCCCCcceEecccCcccccC
Q 001566          358 VLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYL---PM--QLPVPCMVYFNVSQNNITGVL  417 (1052)
Q Consensus       358 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~---p~--~~~~~~L~~l~l~~N~l~~~~  417 (1052)
                      .|++.+|++...  ..+...+.+..+.+..|++....   ..  ....+.+..+.+..|.+....
T Consensus       259 ~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
T KOG0531|consen  259 VLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKIS  321 (414)
T ss_pred             ccchhhcccccc--ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCcccccc
Confidence            777777777632  22344456666677777765321   11  223456666666666665443

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.88  E-value=1.5e-09  Score=122.80  Aligned_cols=245  Identities=21%  Similarity=0.205  Sum_probs=174.8

Q ss_pred             hhCCCccceeeeccCceEEEEEEec--CCcEEEEEEeccCccccHHH--HHHHHHHhhcc-CCCceeeEEEEEecCCeeE
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAELV--PGYLVAVKKLSIGRFQGIQQ--FDAEIGTLGRI-RHKNLVTLIGYYVGEAEMF  847 (1052)
Q Consensus       773 ~~~~~~~~~~Lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  847 (1052)
                      ...+|..+..||.|.|+.|+....+  ++..|++|...........+  -..|+.+...+ .|.++++.+..+......|
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            4457888999999999999998543  57788999775543332222  24566666666 5889998888888778888


Q ss_pred             EEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC-CcEEEeeecccccc
Q 001566          848 LVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEE-LNAYLSDFGLARLL  926 (1052)
Q Consensus       848 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~-~~~kl~Dfgla~~~  926 (1052)
                      +=-||+++++........  ..+++..++++..|++.++.++|+.   .++|+|++|.||++..+ +..++.|||.+..+
T Consensus       343 ip~e~~~~~s~~l~~~~~--~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~  417 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSVTS--QMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRL  417 (524)
T ss_pred             CchhhhcCcchhhhhHHH--HhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccccc
Confidence            889999999887766332  4678888999999999999999999   99999999999999986 78899999988632


Q ss_pred             cccCcccccccccccccc--cccccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCcccCCCCccHHHHHHHHHHhCCcc
Q 001566          927 EVSETHATTDVAGTFGYV--APEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSS 1004 (1052)
Q Consensus       927 ~~~~~~~~~~~~g~~~y~--aPE~~~~~~~~~~sDvwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1052)
                      .....    ......+++  +|+......+..+.|+||||.-+.|.+++..--. ...         +|..  ++.+...
T Consensus       418 ~~~~~----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~-~~~---------~~~~--i~~~~~p  481 (524)
T KOG0601|consen  418 AFSSG----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE-SGV---------QSLT--IRSGDTP  481 (524)
T ss_pred             ceecc----cccccccccccchhhccccccccccccccccccccccccCcccCc-ccc---------ccee--eeccccc
Confidence            21111    111223444  5555666778889999999999999998874322 111         1111  1111111


Q ss_pred             ccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 001566         1005 ELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKL 1048 (1052)
Q Consensus      1005 ~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L 1048 (1052)
                           .    . ......++.+.+.+..+++..||.+.+.....
T Consensus       482 -----~----~-~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~  515 (524)
T KOG0601|consen  482 -----N----L-PGLKLQLQVLLKVMINPDRKRRPSAVELSLHS  515 (524)
T ss_pred             -----C----C-CchHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence                 1    1 11225577888889999999999988876543

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=98.83  E-value=3.9e-10  Score=130.63  Aligned_cols=217  Identities=25%  Similarity=0.235  Sum_probs=140.4

Q ss_pred             CCCCeEecccccccccCCccccCCCCCcEEEccCCcccCccccCC-CcccCCCCEEEccCCcCCCCCCcccCCCCCCCEE
Q 001566          171 ERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDS-SSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNL  249 (1052)
Q Consensus       171 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L  249 (1052)
                      ..++.+++..|.+. .+-..+..+.+|..|++..|++..   ... +..+++|++|++++|.|+...  .+..++.|+.|
T Consensus        72 ~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~~---i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L  145 (414)
T KOG0531|consen   72 TSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIEK---IENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKEL  145 (414)
T ss_pred             HhHHhhccchhhhh-hhhcccccccceeeeeccccchhh---cccchhhhhcchheecccccccccc--chhhccchhhh
Confidence            33444444444444 222334445555555555555543   112 456788888888888888643  46677889999


Q ss_pred             EcCCCccccccchhhcCCCCCCEEEccCCCCCCCCC-cccccCCCCCceecccccccccCCCCCCccccccCCCchhhhc
Q 001566          250 LLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIP-VELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLL  328 (1052)
Q Consensus       250 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~n~~~~~l~~~~~~~~~~~~~~p~~~~~  328 (1052)
                      ++++|.|+.  ...+..+++|+.+++++|++...-+ . ...+.+++.+++.+|.+...                ..+..
T Consensus       146 ~l~~N~i~~--~~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i----------------~~~~~  206 (414)
T KOG0531|consen  146 NLSGNLISD--ISGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI----------------EGLDL  206 (414)
T ss_pred             eeccCcchh--ccCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc----------------cchHH
Confidence            999999983  3455668999999999999996544 2 68889999999998876521                11222


Q ss_pred             ccCCcEEecCCCCCCccCCccccCCCCccEEeCCCCcccccCCccccccCCCCEEeCCCCcCcCCCCCCCCCCCcceEec
Q 001566          329 SRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNV  408 (1052)
Q Consensus       329 ~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~L~~l~l  408 (1052)
                      ...+..+++..|.+...-+-....+.+|+.+++++|++. .++..+..+..+..|++.+|++...-. .-..+.+..+..
T Consensus       207 ~~~l~~~~l~~n~i~~~~~l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~~~-~~~~~~~~~~~~  284 (414)
T KOG0531|consen  207 LKKLVLLSLLDNKISKLEGLNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNLEG-LERLPKLSELWL  284 (414)
T ss_pred             HHHHHHhhcccccceeccCcccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccccc-ccccchHHHhcc
Confidence            334444567777776554322222224888899999988 454677788888888998888875422 112345566666


Q ss_pred             ccCccc
Q 001566          409 SQNNIT  414 (1052)
Q Consensus       409 ~~N~l~  414 (1052)
                      ..|.+.
T Consensus       285 ~~~~~~  290 (414)
T KOG0531|consen  285 NDNKLA  290 (414)
T ss_pred             Ccchhc
Confidence            666654

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.80  E-value=1.2e-07  Score=104.82  Aligned_cols=168  Identities=22%  Similarity=0.329  Sum_probs=129.4

Q ss_pred             CceEEEEEE-ecCCcEEEEEEeccCccccHHHHHHHHHHhhccCCCceeeEEEEEe----cCCeeEEEEeecCC-CCHHH
Q 001566          787 GFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV----GEAEMFLVYNFLSG-GNLET  860 (1052)
Q Consensus       787 ~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~-gsL~~  860 (1052)
                      -..+.|++. ..+|..|++|++...+......-..-++.++++.|+|+|++.+++.    .+...++||+|.++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            345788984 4579999999996555544434456788999999999999999987    34578999999876 47777


Q ss_pred             HHhhc-------------cCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccccccc
Q 001566          861 FIHKK-------------SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE  927 (1052)
Q Consensus       861 ~l~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~  927 (1052)
                      +-...             .+...++..++.++.|+..||.++|+.   |...+-+.+++|+++.+.+++|...|..-.+.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence            54322             134577899999999999999999999   99999999999999999999998888765543


Q ss_pred             ccCcccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCC
Q 001566          928 VSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKR  975 (1052)
Q Consensus       928 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~  975 (1052)
                      ....               |-+.+   ..+-|.=.+|.++..+.||..
T Consensus       445 ~d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  445 EDPT---------------EPLES---QQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             CCCC---------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence            2220               11111   236799999999999999964

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.78  E-value=3.3e-09  Score=86.20  Aligned_cols=59  Identities=39%  Similarity=0.531  Sum_probs=29.1

Q ss_pred             CCCEEEccCCcCCCCCcccccCCccCcEEEcCCCccCCcCchhhcCCCCCcEEEcCCCC
Q 001566          557 KLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNA  615 (1052)
Q Consensus       557 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~  615 (1052)
                      +|++|++++|+|+...++.|.++++|++|++++|+++...|+.|.++++|++|++++|+
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            34455555555554444445555555555555555544444445555555555555544

...

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.78  E-value=2.6e-09  Score=126.66  Aligned_cols=251  Identities=23%  Similarity=0.312  Sum_probs=175.8

Q ss_pred             HHhhCCCccceeeeccCceEEEEEEec-CCcEEEEEEeccC---ccccHHHHHHHHHHhhccCCCceeeEEEEEecCCee
Q 001566          771 VRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIG---RFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEM  846 (1052)
Q Consensus       771 ~~~~~~~~~~~~Lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  846 (1052)
                      ....+.+.+.+.+-+|.++.++-+.-. .|...+.|.....   .....+....+-.+.-..++|.+++....+.-....
T Consensus       800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~  879 (1205)
T KOG0606|consen  800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL  879 (1205)
T ss_pred             cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence            345567888889999999999988432 2433344433221   111122233333344344567777666555556778


Q ss_pred             EEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccc
Q 001566          847 FLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL  926 (1052)
Q Consensus       847 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~  926 (1052)
                      +++++|..+++|..-++...  ..+.+........+..+.+|||..   .+.|||++|.|.+...++..+++|||.....
T Consensus       880 ~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v  954 (1205)
T KOG0606|consen  880 PLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV  954 (1205)
T ss_pred             chhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccc
Confidence            99999999999999988753  455556666777888999999998   7999999999999999999999999844333


Q ss_pred             ccc---C---------------------------cccccccccccccccccccCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 001566          927 EVS---E---------------------------THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRS  976 (1052)
Q Consensus       927 ~~~---~---------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG~il~elltg~~p  976 (1052)
                      ...   .                           ........+|+.|.+||...+......+|.|+.|++++|.++|.+|
T Consensus       955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen  955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred             ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence            100   0                           0112345689999999999999999999999999999999999999


Q ss_pred             CCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHccccCCCCCCCHH
Q 001566          977 LDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVK 1042 (1052)
Q Consensus       977 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~ 1042 (1052)
                      |....++..        .+.+..    ..    .-|...+.......++++...+..+|.+|-.+.
T Consensus      1035 ~na~tpq~~--------f~ni~~----~~----~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQI--------FENILN----RD----IPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCcchhhh--------hhcccc----CC----CCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            986555411        111110    00    113344555566688899999999999998765

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.76  E-value=1.6e-07  Score=100.62  Aligned_cols=140  Identities=17%  Similarity=0.134  Sum_probs=100.4

Q ss_pred             eeeeccCceEEEEEEecCCcEEEEEEeccCccc-----------cHHHHHHHHHHhhccCCCc--eeeEEEEEec-----
Q 001566          781 NLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQ-----------GIQQFDAEIGTLGRIRHKN--LVTLIGYYVG-----  842 (1052)
Q Consensus       781 ~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~-----  842 (1052)
                      +.+-+.....|+++++. |+.|.||+.......           ....+.+|...+.++...+  +.+.+++...     
T Consensus        28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            34444444456777664 788999977433311           1124778988888884333  2344445432     


Q ss_pred             CCeeEEEEeecCCC-CHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECC-------CCc
Q 001566          843 EAEMFLVYNFLSGG-NLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDE-------ELN  914 (1052)
Q Consensus       843 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~-------~~~  914 (1052)
                      ....++|+|++++. +|.+++........+......++.+++..+..||..   ||+|+|++++||+++.       +..
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCce
Confidence            23578999999876 899998643223456677788999999999999999   9999999999999975       467


Q ss_pred             EEEeeecccc
Q 001566          915 AYLSDFGLAR  924 (1052)
Q Consensus       915 ~kl~Dfgla~  924 (1052)
                      +.++||+.+.
T Consensus       184 ~~LIDl~r~~  193 (268)
T PRK15123        184 LSVIDLHRAQ  193 (268)
T ss_pred             EEEEECCccc
Confidence            9999999885

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.72  E-value=7.1e-09  Score=84.24  Aligned_cols=61  Identities=28%  Similarity=0.449  Sum_probs=57.5

Q ss_pred             cCccEEEccCcccccccccccCCCCCCCEEEccCCcCCCCCcccccCCccCcEEEcCCCcc
Q 001566          532 VQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNL  592 (1052)
Q Consensus       532 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  592 (1052)
                      ++|++|++++|+|+.+.+..|.++++|++|++++|.|+.+.|+.|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            4789999999999988889999999999999999999988889999999999999999986

...

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.70  E-value=7.9e-08  Score=96.90  Aligned_cols=125  Identities=26%  Similarity=0.308  Sum_probs=83.4

Q ss_pred             EEEEEEecCCcEEEEEEeccCcc-------------c-------------cHHHHHHHHHHhhccCCC--ceeeEEEEEe
Q 001566          790 STYKAELVPGYLVAVKKLSIGRF-------------Q-------------GIQQFDAEIGTLGRIRHK--NLVTLIGYYV  841 (1052)
Q Consensus       790 ~V~~~~~~~~~~vavK~~~~~~~-------------~-------------~~~~~~~e~~~l~~l~h~--niv~l~~~~~  841 (1052)
                      .||.|...+|..+|+|+.+....             .             ......+|++.|.++..-  ++.+.+++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            48999888899999998743210             0             023457799999999765  345555442 


Q ss_pred             cCCeeEEEEeecC--CCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHH-HHhcCCCCeeeCCCCCCCEEECCCCcEEEe
Q 001566          842 GEAEMFLVYNFLS--GGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY-LHYSCVPRIVHRDIKPSNILLDEELNAYLS  918 (1052)
Q Consensus       842 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~~~~iiHrDik~~Nill~~~~~~kl~  918 (1052)
                         ..++||||++  |..+..+....    ++.+....++.+++..+.. +|..   ||+|+|+.+.||+++++ .+.|+
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iI  148 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYII  148 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE-
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEE
Confidence               4589999997  55554433222    2244566778888886666 4677   99999999999999988 99999


Q ss_pred             eecccccc
Q 001566          919 DFGLARLL  926 (1052)
Q Consensus       919 Dfgla~~~  926 (1052)
                      |||.+...
T Consensus       149 Df~qav~~  156 (188)
T PF01163_consen  149 DFGQAVDS  156 (188)
T ss_dssp             -GTTEEET
T ss_pred             ecCcceec
Confidence            99998754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.69  E-value=7.1e-09  Score=127.89  Aligned_cols=105  Identities=30%  Similarity=0.338  Sum_probs=52.6

Q ss_pred             CCCeeEecCCC--ceecCCCCccCCCCccEEEccCccccccCCccccCCCCCCeEecccccccccCCccccCCCCCcEEE
Q 001566          124 ELRTLSVPHNS--FSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVID  201 (1052)
Q Consensus       124 ~L~~L~L~~n~--l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  201 (1052)
                      .|++|-+..|.  +....++.|..++.|++||||+|.=-+.+|..+++|-+|++|+|++..++ .+|..+.++.+|.+|+
T Consensus       546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln  624 (889)
T KOG4658|consen  546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN  624 (889)
T ss_pred             ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheec
Confidence            45555555554  33222223455555555555555444455555555555555555555555 5555555555555555


Q ss_pred             ccCCcccCccccCCCcccCCCCEEEccCC
Q 001566          202 MSSNRLSGGLAIDSSSECEFLTYLKLSDN  230 (1052)
Q Consensus       202 L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N  230 (1052)
                      +..+.-...+ ......+++|++|.+..-
T Consensus       625 l~~~~~l~~~-~~i~~~L~~Lr~L~l~~s  652 (889)
T KOG4658|consen  625 LEVTGRLESI-PGILLELQSLRVLRLPRS  652 (889)
T ss_pred             cccccccccc-cchhhhcccccEEEeecc
Confidence            5555433322 233333555555555443

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.66  E-value=8.2e-07  Score=95.58  Aligned_cols=261  Identities=17%  Similarity=0.163  Sum_probs=158.7

Q ss_pred             CccceeeeccCceEEEEEEecCCcEEEEEEeccCccccHHHHHHHHHHhhcc-CCCceeeEEEEE------e-cCCeeEE
Q 001566          777 FSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRI-RHKNLVTLIGYY------V-GEAEMFL  848 (1052)
Q Consensus       777 ~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~------~-~~~~~~l  848 (1052)
                      ....+.||+|+.+.+|-..--  ...+.|++.........+   .+.+|... .||-+-.-+.+=      - .+....+
T Consensus        13 i~~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf   87 (637)
T COG4248          13 IPPGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF   87 (637)
T ss_pred             cCCCccccCCccceeeecchh--hchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence            345678999999999976221  123567665544332222   23334443 465443312110      1 1223567


Q ss_pred             EEeecCCC-CHHHHHh----hccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeeccc
Q 001566          849 VYNFLSGG-NLETFIH----KKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLA  923 (1052)
Q Consensus       849 v~e~~~~g-sL~~~l~----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla  923 (1052)
                      .|..+++- ...++..    +.......|+...+++..++.+.+.||+.   |.+-+|+.++|+||.+++.|.+.|-+.-
T Consensus        88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccce
Confidence            77776553 3333332    12234578999999999999999999999   9999999999999999999999987654


Q ss_pred             ccccccCcccccccccccccccccccC-----CCCCCcchhHHHHHHHHHHHHhC-CCCCCCCcccCCCCccHHHHHHHH
Q 001566          924 RLLEVSETHATTDVAGTFGYVAPEYAT-----TCRVSDKADVYSFGVVLLELISG-KRSLDPSFSEYGNGFNIVSWAKLL  997 (1052)
Q Consensus       924 ~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~  997 (1052)
                      ..-.  ........+|...|++||.-.     +..-+...|-|.+|+++++++.| +.||.+-....... .-.|   .-
T Consensus       165 qi~~--ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap-~p~E---~~  238 (637)
T COG4248         165 QINA--NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAP-NPLE---TD  238 (637)
T ss_pred             eecc--CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCC-Ccch---hh
Confidence            3321  223334467889999999765     33445678999999999999987 88886433211111 0011   01


Q ss_pred             HHhCCccccccchh-----hcCCC-hHHHHHHHHHHHHccccC--CCCCCCHHHHHHHHhcc
Q 001566          998 IKEGRSSELFLPEL-----WEAGP-QENLLGMMRLASTCTVET--LSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus       998 ~~~~~~~~~~~~~l-----~~~~~-~~~~~~l~~Li~~cl~~d--P~~RPt~~eil~~L~~l 1051 (1052)
                      +..+.....-+...     ....| .-.+..+..+..+|+...  +.-||+++.++..|..+
T Consensus       239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al  300 (637)
T COG4248         239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL  300 (637)
T ss_pred             hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence            11111111111000     00111 122345778888888764  45799999998887654

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.64  E-value=1.7e-07  Score=96.36  Aligned_cols=136  Identities=24%  Similarity=0.221  Sum_probs=101.6

Q ss_pred             CccceeeeccCceEEEEEEecCCcEEEEEEeccCccc----------------------cHHHHHHHHHHhhccCCC--c
Q 001566          777 FSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQ----------------------GIQQFDAEIGTLGRIRHK--N  832 (1052)
Q Consensus       777 ~~~~~~Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~--n  832 (1052)
                      ..+...||.|.-+.||.|....|.++|||.-+....+                      .....++|.+.|.++.-.  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            4567899999999999999989999999954322110                      123457799999998644  5


Q ss_pred             eeeEEEEEecCCeeEEEEeecCCCCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCC
Q 001566          833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEE  912 (1052)
Q Consensus       833 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~  912 (1052)
                      |.+.++    .+...+|||+++|-.|...-       ++.+....++..|++-+...-..   ||||+|+++-||+++++
T Consensus       173 VP~P~~----~nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~d  238 (304)
T COG0478         173 VPKPIA----WNRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTED  238 (304)
T ss_pred             CCCccc----cccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecC
Confidence            555554    35678999999886664321       23444556666777777766667   99999999999999999


Q ss_pred             CcEEEeeecccccc
Q 001566          913 LNAYLSDFGLARLL  926 (1052)
Q Consensus       913 ~~~kl~Dfgla~~~  926 (1052)
                      |.+.++||-.+...
T Consensus       239 g~~~vIDwPQ~v~~  252 (304)
T COG0478         239 GDIVVIDWPQAVPI  252 (304)
T ss_pred             CCEEEEeCcccccC
Confidence            99999999887643

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.59  E-value=2.8e-08  Score=122.78  Aligned_cols=163  Identities=23%  Similarity=0.363  Sum_probs=95.2

Q ss_pred             chhhcCCCCCCeeEecCCCceecCCCCccCCCCccEEEccCccccccCCccccCCCCCCeEecccccccccCCccccCCC
Q 001566          116 SASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNG  195 (1052)
Q Consensus       116 ~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  195 (1052)
                      ++.|..++.|++|||++|.=-+.+|..+++|-+|++|+|++..++ .+|..+++|..|.+||+..+.-...+|.....++
T Consensus       564 ~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~  642 (889)
T KOG4658|consen  564 GEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQ  642 (889)
T ss_pred             HHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcc
Confidence            344677888888888877666678888888888888888888887 7788888888888888887776556666666688


Q ss_pred             CCcEEEccCCcccC-ccccCCCcccCCCCEEEccCCcCCCCCCcccCCCCCCC----EEEcCCCccccccchhhcCCCCC
Q 001566          196 ELSVIDMSSNRLSG-GLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLK----NLLLDGNILEGSIPKEIGTISEL  270 (1052)
Q Consensus       196 ~L~~L~L~~N~l~~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~----~L~L~~N~l~~~~p~~~~~l~~L  270 (1052)
                      +|++|.+..-.... ......+..+.+|+.+.......  .+-..+..++.|.    .+.+.++... ..+..+..+.+|
T Consensus       643 ~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L  719 (889)
T KOG4658|consen  643 SLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNL  719 (889)
T ss_pred             cccEEEeeccccccchhhHHhhhcccchhhheeecchh--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCc
Confidence            88888776654221 11111122333333333322211  0111122222222    2222232322 345556666666


Q ss_pred             CEEEccCCCCCC
Q 001566          271 KVLDVSRNSLTD  282 (1052)
Q Consensus       271 ~~L~L~~N~l~~  282 (1052)
                      +.|.+.++.+..
T Consensus       720 ~~L~i~~~~~~e  731 (889)
T KOG4658|consen  720 EELSILDCGISE  731 (889)
T ss_pred             ceEEEEcCCCch
Confidence            666666666654

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.51  E-value=2.3e-08  Score=90.78  Aligned_cols=131  Identities=21%  Similarity=0.278  Sum_probs=86.1

Q ss_pred             ccEEEccCcccccccccc---cCCCCCCCEEEccCCcCCCCCcccc-cCCccCcEEEcCCCccCCcCchhhcCCCCCcEE
Q 001566          534 LVEFEAANNQISGSIAAG---VGKLMKLQRLDLRGNRVSGSLPDEL-GKLKFLKWILLGGNNLTGEIPSQFGHLISLVVL  609 (1052)
Q Consensus       534 L~~L~l~~N~l~~~~~~~---~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  609 (1052)
                      +-.++|++++|. .+++.   +.....|+..+|++|.+.. .|..| .+.+.++.|+|++|+|+ .+|.++..++.|+.|
T Consensus        29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~-fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l  105 (177)
T KOG4579|consen   29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKK-FPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL  105 (177)
T ss_pred             hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhh-CCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence            344555555544 22322   3334456666788887773 44444 34457788888888887 677778888888888


Q ss_pred             EcCCCCCCCCCchhhhcccccceeeccCccCCCCCCcccccccccCceecccccccCCCC
Q 001566          610 DLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIP  669 (1052)
Q Consensus       610 ~l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  669 (1052)
                      +++.|.+. ..|..+..|.+|-.|+..+|.+. .+|..+---+++-..++.++++.+..+
T Consensus       106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~  163 (177)
T KOG4579|consen  106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETK  163 (177)
T ss_pred             ccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCc
Confidence            88888887 67777777888888888888777 555543333444555667777776555

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.50  E-value=1e-08  Score=92.93  Aligned_cols=104  Identities=28%  Similarity=0.383  Sum_probs=67.1

Q ss_pred             CCEEEccCCcCCCCCcccc---cCCccCcEEEcCCCccCCcCchhhcC-CCCCcEEEcCCCCCCCCCchhhhccccccee
Q 001566          558 LQRLDLRGNRVSGSLPDEL---GKLKFLKWILLGGNNLTGEIPSQFGH-LISLVVLDLSHNALTGSIPASLTKATKLESL  633 (1052)
Q Consensus       558 L~~L~L~~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L  633 (1052)
                      +..++|+++++. .+++..   .+...|+..+|++|.+. .+|..|.. .+.+++|+|++|+|+ .+|..+..++.|+.|
T Consensus        29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l  105 (177)
T KOG4579|consen   29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL  105 (177)
T ss_pred             hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence            455667777665 344433   34455666677777776 45555544 346777777777777 567667777777777


Q ss_pred             eccCccCCCCCCcccccccccCceeccccccc
Q 001566          634 FLAHNRLSGEIPVSFSTLVNLSALDLSFNNLS  665 (1052)
Q Consensus       634 ~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  665 (1052)
                      +++.|++. ..|..+..|.+|-.|+..+|.+.
T Consensus       106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~  136 (177)
T KOG4579|consen  106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARA  136 (177)
T ss_pred             ccccCccc-cchHHHHHHHhHHHhcCCCCccc
Confidence            77777776 56666666777777777766554

>PRK09902 hypothetical protein; Provisional

Probab=98.44  E-value=2.4e-06  Score=86.46  Aligned_cols=137  Identities=15%  Similarity=0.125  Sum_probs=103.7

Q ss_pred             eccCceEEEEEEecCCcEEEEEEeccCc------cccHHHHHHHHHHhhccCCCc--eeeEEEEEe-c----CCeeEEEE
Q 001566          784 GTGGFGSTYKAELVPGYLVAVKKLSIGR------FQGIQQFDAEIGTLGRIRHKN--LVTLIGYYV-G----EAEMFLVY  850 (1052)
Q Consensus       784 g~G~~g~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~-~----~~~~~lv~  850 (1052)
                      |+||-+-|+..+.. |..+-+|+-...-      .-....|.+|...+.++..-+  +.+.+ ++. .    ....++|+
T Consensus        27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence            67888999998776 4478888764211      224578999999999985322  44444 322 1    23468999


Q ss_pred             eecCC-CCHHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCc--EEEeeeccccc
Q 001566          851 NFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELN--AYLSDFGLARL  925 (1052)
Q Consensus       851 e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~--~kl~Dfgla~~  925 (1052)
                      |-+++ .+|.+++....-.+.+......+..+++..++-||..   |+.|+|+.++||+++.++.  ++++||.-++.
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            98743 5999998765444567888889999999999999999   9999999999999986666  99999987763

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.41  E-value=1.2e-08  Score=115.61  Aligned_cols=129  Identities=27%  Similarity=0.261  Sum_probs=85.6

Q ss_pred             cCccEEEccCcccccccccccCCCCCCCEEEccCCcCCCCCcccccCCccCcEEEcCCCccCCcCchh-hcCCCCCcEEE
Q 001566          532 VQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQ-FGHLISLVVLD  610 (1052)
Q Consensus       532 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~  610 (1052)
                      ..|...+.+.|.+. ....++.-++.|+.|+|+.|+++..  +.+..+++|++|||++|.++ .+|.. ..++. |+.|+
T Consensus       164 n~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~  238 (1096)
T KOG1859|consen  164 NKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLN  238 (1096)
T ss_pred             hhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhh-heeee
Confidence            35667777777777 5666677777778888888877744  26777777888888888777 45432 22333 77777


Q ss_pred             cCCCCCCCCCchhhhcccccceeeccCccCCCCCC-cccccccccCceecccccccCC
Q 001566          611 LSHNALTGSIPASLTKATKLESLFLAHNRLSGEIP-VSFSTLVNLSALDLSFNNLSGH  667 (1052)
Q Consensus       611 l~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~  667 (1052)
                      |++|.++. + ..+.+|.+|..||++.|-|++.-. .-++.|..|+.|+|.||++-+.
T Consensus       239 lrnN~l~t-L-~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~  294 (1096)
T KOG1859|consen  239 LRNNALTT-L-RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA  294 (1096)
T ss_pred             ecccHHHh-h-hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence            77777763 2 236677777777777777765322 2244566677777777777543

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.38  E-value=9.8e-08  Score=109.57  Aligned_cols=150  Identities=19%  Similarity=0.268  Sum_probs=103.4

Q ss_pred             HHHHHHHHHHHhcCCCCeeeCCCCCCCEEECCCCcEEEeeecccccccccCcccccc--------cccccccccccccCC
Q 001566          880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD--------VAGTFGYVAPEYATT  951 (1052)
Q Consensus       880 ~~i~~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~--------~~g~~~y~aPE~~~~  951 (1052)
                      .+++.|+.|+|...  ++||++|.|++|.+++.+.+||+.|+.+........+....        ..-...|.|||++.+
T Consensus       106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            45569999999874  89999999999999999999999999987665422111111        123457999999999


Q ss_pred             CCCCcchhHHHHHHHHHHHHhCCCC-CCCCcccCCCCccHHHHHHHHHHhCCccccccchhhcCCChHHHHHHHHHHHHc
Q 001566          952 CRVSDKADVYSFGVVLLELISGKRS-LDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTC 1030 (1052)
Q Consensus       952 ~~~~~~sDvwslG~il~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~c 1030 (1052)
                      ...+.++|+||+|+++|.+..|+.+ +......     ...+...   .....       -...++.+.+.++.+=+.++
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~-----~~~~~~~---~~~~~-------~~~~~s~~~p~el~~~l~k~  248 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL-----LSYSFSR---NLLNA-------GAFGYSNNLPSELRESLKKL  248 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCc-----chhhhhh---ccccc-------ccccccccCcHHHHHHHHHH
Confidence            8889999999999999999955444 3321111     0011000   00000       01123345566688888899


Q ss_pred             cccCCCCCCCHHHHHH
Q 001566         1031 TVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1031 l~~dP~~RPt~~eil~ 1046 (1052)
                      +..++..||++.++..
T Consensus       249 l~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  249 LNGDSAVRPTLDLLLS  264 (700)
T ss_pred             hcCCcccCcchhhhhc
Confidence            9999999998776653

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.34  E-value=4.4e-06  Score=86.73  Aligned_cols=107  Identities=25%  Similarity=0.360  Sum_probs=83.9

Q ss_pred             HHHHHHHHHHhhccCCCc--eeeEEEEEecC----CeeEEEEeecCCC-CHHHHHhhccCCcccHHHHHHHHHHHHHHHH
Q 001566          815 IQQFDAEIGTLGRIRHKN--LVTLIGYYVGE----AEMFLVYNFLSGG-NLETFIHKKSGKKIQWSVIHKIAIDIAQALA  887 (1052)
Q Consensus       815 ~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~  887 (1052)
                      .....+|...+.++....  +.+.+++.+..    ...++|+|++++. +|.+++....  ..+......++.+++..++
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIA  132 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHH
Confidence            346778888887774332  44555555542    2458999999874 8999997643  2666778889999999999


Q ss_pred             HHHhcCCCCeeeCCCCCCCEEECCCC---cEEEeeecccccc
Q 001566          888 YLHYSCVPRIVHRDIKPSNILLDEEL---NAYLSDFGLARLL  926 (1052)
Q Consensus       888 ~LH~~~~~~iiHrDik~~Nill~~~~---~~kl~Dfgla~~~  926 (1052)
                      -||+.   ||+|+|+++.|||++.+.   .+.++||+-++..
T Consensus       133 ~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  133 KLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99999   999999999999999887   7999999987643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.32  E-value=4e-06  Score=85.70  Aligned_cols=153  Identities=22%  Similarity=0.233  Sum_probs=101.6

Q ss_pred             cchhhHHHhhCCCcccee---eeccCceEEEEEEecCCcEEEEEEeccCcccc------------------------HHH
Q 001566          765 LTYDNVVRATGNFSIRNL---IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQG------------------------IQQ  817 (1052)
Q Consensus       765 ~~~~~~~~~~~~~~~~~~---Lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~------------------------~~~  817 (1052)
                      .+.+.+.....+..+...   |..|.-+.||+|...++..+|||+++.....-                        ...
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W  114 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW  114 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence            344555555555555554   55777889999988889999999985432110                        112


Q ss_pred             HHHHHHHhhccC--CCceeeEEEEEecCCeeEEEEeecCCCC-HHHHHhhccCCcccHHHHHHHHHHHHHHHHHHHhcCC
Q 001566          818 FDAEIGTLGRIR--HKNLVTLIGYYVGEAEMFLVYNFLSGGN-LETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV  894 (1052)
Q Consensus       818 ~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~  894 (1052)
                      ..+|+..|+++.  +-.+.+-+++.    ...+||||+.... -.-.|.   ..++..++...+..++++.+.-|-..+ 
T Consensus       115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk---Dv~~e~~e~~~~~~~~v~~~~~l~~~a-  186 (268)
T COG1718         115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK---DVPLELEEAEGLYEDVVEYMRRLYKEA-  186 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc---cCCcCchhHHHHHHHHHHHHHHHHHhc-
Confidence            345777777763  33333444433    3479999984431 000111   122333467778889999999888733 


Q ss_pred             CCeeeCCCCCCCEEECCCCcEEEeeeccccccc
Q 001566          895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLE  927 (1052)
Q Consensus       895 ~~iiHrDik~~Nill~~~~~~kl~Dfgla~~~~  927 (1052)
                       ++||+|++.-|||+. ++.+.|+|+|.|....
T Consensus       187 -~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         187 -GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             -CcccccchhhheEEE-CCeEEEEECccccccC
Confidence             999999999999999 7799999999997554

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	1052
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		7e-51
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-49
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		3e-36
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		6e-35
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		4e-36
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		7e-35
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-34
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-34
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		9e-30
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-29
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		7e-29
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-27
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		9e-26
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-25
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		6e-24
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		9e-22
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		9e-22
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		9e-22
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-21
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-21
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-21
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-21
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-21
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-21
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-21
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-21
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-21
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-21
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-21
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		5e-21
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-21
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		6e-21
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-21
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		8e-21
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-20
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-20
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-20
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-20
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-20
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-20
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-20
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-20
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-20
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-20
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-20
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-20
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-20
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		7e-20
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		8e-20
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		8e-20
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		9e-20
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		9e-20
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		9e-20
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		9e-20
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		9e-20
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		9e-20
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-19
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-19
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-19
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-19
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-19
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-19
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-19
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-19
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-19
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-19
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		4e-19
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-19
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-19
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-19
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-19
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-19
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-19
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-19
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-19
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-19
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-19
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-19
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-19
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-19
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-19
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		5e-19
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-18
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-18
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-18
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-18
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-18
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-18
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-18
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-18
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-18
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-18
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-18
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-18
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-18
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-18
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-18
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-18
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-18
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-18
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-18
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-18
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-18
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-18
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-18
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-18
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-18
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		5e-18
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		5e-18
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-18
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		6e-18
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		7e-18
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		7e-18
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		7e-18
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		7e-18
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		7e-18
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		8e-18
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		8e-18
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		8e-18
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		9e-18
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-17
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-17
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-17
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-17
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-17
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-17
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-17
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-17
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-17
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-17
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-17
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-17
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-17
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-17
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-17
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-17
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-17
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-17
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-17
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-17
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-17
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-17
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-17
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-17
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-17
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-17
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-17
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-17
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-17
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-17
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-17
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-17
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-17
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-17
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-17
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-17
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-17
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-17
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-17
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-17
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-17
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-17
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-17
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-17
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		5e-17
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		5e-17
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		5e-17
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		6e-17
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		6e-17
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		6e-17
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		6e-17
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		7e-17
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		7e-17
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		7e-17
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-17
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-17
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		8e-17
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		8e-17
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		9e-17
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		9e-17
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		9e-17
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		9e-17
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-16
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-16
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-16
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-16
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-16
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-16
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-16
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-16
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-16
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-16
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-16
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-16
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-16
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-16
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-16
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-16
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-16
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-16
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-16
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-16
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-16
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-16
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-16
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-16
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-16
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-16
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-16
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		5e-16
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-16
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-16
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-16
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-16
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-16
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		6e-16
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		6e-16
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		6e-16
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		6e-16
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		6e-16
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		7e-16
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		7e-16
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		7e-16
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		8e-16
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		8e-16
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		8e-16
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		9e-16
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		9e-16
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-15
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-15
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-15
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-15
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-15
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-15
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-15
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-15
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-15
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-15
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-15
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-15
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-15
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-15
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-15
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-15
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-15
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-15
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-15
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-15
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-15
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-15
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-15
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		3e-15
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-15
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-15
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		4e-15
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-15
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-15
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		6e-15
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-15
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		6e-15
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		7e-15
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		7e-15
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-14
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-14
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-14
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-14
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-14
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-14
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-14
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-14
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-14
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-14
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-14
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-14
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-14
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-14
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-14
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-14
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-14
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-14
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-14
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-14
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-14
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-14
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-14
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-14
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-14
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-14
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-14
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-14
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-14
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		5e-14
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		5e-14
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		5e-14
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-14
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-14
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-14
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-14
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		5e-14
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		5e-14
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-14
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		5e-14
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-14
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		6e-14
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		6e-14
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		6e-14
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		6e-14
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		6e-14
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		6e-14
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		7e-14
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-14
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		7e-14
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		7e-14
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		7e-14
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-14
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		7e-14
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-14
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		7e-14
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		7e-14
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		7e-14
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		7e-14
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		7e-14
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		7e-14
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		7e-14
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		7e-14
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		8e-14
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		8e-14
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		8e-14
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		8e-14
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		8e-14
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		8e-14
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		9e-14
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-13
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-13
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-13
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-13
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-13
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-13
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-13
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-13
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-13
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-13
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-13
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-13
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-13
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-13
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-13
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-13
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-13
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-13
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-13
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-13
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-13
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-13
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-13
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-13
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-13
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-13
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-13
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-13
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-13
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-13
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-13
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-13
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-13
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-13
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-13
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-13
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-13
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-13
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-13
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-13
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-13
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-13
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-13
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-13
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-13
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-13
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-13
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		6e-13
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-13
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		6e-13
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-13
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		7e-13
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		8e-13
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-13
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		8e-13
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-13
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-12
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-12
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-12
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-12
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-12
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-12
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-12
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-12
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-12
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-12
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-12
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-12
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-12
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-12
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-12
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-12
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-12
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-12
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-12
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-12
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-12
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-12
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-12
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-12
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-12
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-12
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-12
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-12
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-12
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-12
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-12
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-12
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-12
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-12
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-12
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-12
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-12
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-12
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		5e-12
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-12
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-12
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		5e-12
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		5e-12
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-12
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		5e-12
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		7e-12
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		7e-12
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		7e-12
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		8e-12
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		8e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-12
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-12
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		9e-12
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		9e-12
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-12
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		9e-12
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		9e-12
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		9e-12
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		9e-12
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		9e-12
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		9e-12
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		9e-12
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		9e-12
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-12
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		9e-12
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-11
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-11
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-11
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-11
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-11
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-11
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-11
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-11
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-11
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-11
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-11
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-11
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-11
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-11
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-11
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-11
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-11
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-11
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-11
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-11
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-11
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-11
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-11
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-11
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-11
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-11
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-11
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-11
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-11
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-11
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-11
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-11
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-11
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-11
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-11
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-11
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-11
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-11
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-11
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-11
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-11
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-11
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-11
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-11
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-11
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-11
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-11
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-11
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-11
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-11
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-11
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-11
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-11
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-11
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-11
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-11
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-11
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-11
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-11
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-11
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-11
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-11
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-11
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-11
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-11
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-11
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-11
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-11
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-11
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-11
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-11
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-11
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-11
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-11
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-11
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-11
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-11
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-11
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-11
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-11
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-11
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-11
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-11
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		4e-11
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-11
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-11
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-11
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-11
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-11
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		4e-11
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		4e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		4e-11
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-11
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-11
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-11
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-11
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-11
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-11
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		4e-11
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-11
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-11
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		5e-11
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		5e-11
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		5e-11
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		6e-11
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		6e-11
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		6e-11
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		6e-11
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-11
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		6e-11
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		6e-11
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		6e-11
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-11
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		6e-11
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		7e-11
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		7e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		7e-11
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		7e-11
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		8e-11
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		8e-11
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		8e-11
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-11
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		8e-11
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		8e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		9e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		9e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-11
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		9e-11
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		9e-11
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		9e-11
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-10
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-10
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-10
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-10
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-10
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-10
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-10
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-10
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-10
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-10
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-10
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-10
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-10
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-10
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-10
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-10
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-10
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-10
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-10
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-10
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-10
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-10
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-10
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-10
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-10
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-10
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-10
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-10
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-10
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-10
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-10
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-10
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-10
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-10
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-10
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-10
3soa_A	444	Full-Length Human Camkii Length = 444		4e-10
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-10
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-10
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		4e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-10
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-10
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-10
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-10
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-10
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		5e-10
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		6e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		6e-10
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		6e-10
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-10
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		6e-10
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-10
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		7e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		7e-10
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-10
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		8e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		8e-10
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		8e-10
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		8e-10
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		8e-10
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		9e-10
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		9e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		9e-10
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-10
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-09
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-09
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-09
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-09
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-09
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-09
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-09
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-09
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-09
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-09
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-09
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-09
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-09
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-09
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-09
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-09
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-09
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-09
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-09
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-09
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-09
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-09
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-09
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-09
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-09
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		4e-09
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-09
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		4e-09
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-09
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-09
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-09
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-09
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-09
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-09
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-09
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		5e-09
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		5e-09
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		5e-09
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		5e-09
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		5e-09
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		5e-09
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		5e-09
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		5e-09
2oza_A	356	Structure Of P38alpha Complex Length = 356		6e-09
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		6e-09
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		6e-09
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		7e-09
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		8e-09
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		9e-09
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		9e-09
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		9e-09
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-08
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-08
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-08
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-08
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-08
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-08
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-08
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-08
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-08
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-08
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-08
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-08
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-08
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-08
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-08
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		3e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		4e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-08
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-08
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		4e-08
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		5e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		5e-08
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-08
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		5e-08
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		5e-08
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		5e-08
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		6e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		6e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		6e-08
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		7e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		7e-08
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		7e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		8e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		9e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		9e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		9e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-07
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-07
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-07
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-07
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-07
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-07
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-07
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-07
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-07
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-07
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-07
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-07
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-07
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-07
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-07
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-07
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-07
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-07
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		3e-07
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-07
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-07
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-07
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		4e-07
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-07
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-07
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		4e-07
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		5e-07
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-07
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		5e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-07
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		5e-07
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		5e-07
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		5e-07
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-07
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		6e-07
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		6e-07
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-07
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		6e-07
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		6e-07
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		6e-07
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		7e-07
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		7e-07
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		7e-07
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		7e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		7e-07
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		7e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		7e-07
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		7e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		7e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		7e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		7e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		7e-07
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		7e-07
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		7e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		8e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		8e-07
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		8e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		8e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		8e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		8e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		9e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		9e-07
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		1e-06
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-06
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-06
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-06
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-06
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-06
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-06
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-06
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-06
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-06
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-06
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-06
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-06
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-06
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-06
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-06
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-06
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-06
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-06
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-06
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-06
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-06
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-06
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-06
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-06
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-06
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-06
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-06
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		4e-06
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-06
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-06
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-06
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-06
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		4e-06
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		4e-06
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		5e-06
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		5e-06
3rfs_A	272	Design Of A Binding Scaffold Based On Variable Lymp		5e-06
2z7x_B	520	Crystal Structure Of The Tlr1-Tlr2 Heterodimer Indu		6e-06
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		7e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		7e-06
4b8c_D	727	Nuclease Module Of The Yeast Ccr4-Not Complex Lengt		7e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		7e-06
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		9e-06
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-06
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		9e-06
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		9e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		9e-06
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		9e-06
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		9e-06
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		9e-06
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		9e-06
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-06
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-06
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-05
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-05
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-05
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-05
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-05
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-05
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-05
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-05
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-05
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-05
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-05
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-05
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-05
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-05
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-05
3e6j_A	229	Crystal Structure Of Variable Lymphocyte Receptor (		1e-05
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-05
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-05
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-05
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-05
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-05
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-05
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-05
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		2e-05

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  199 bits (506), Expect = 7e-51,   Method: Composition-based stats.
 Identities = 104/270 (38%), Positives = 162/270 (60%), Gaps = 3/270 (1%)
Query: 773  ATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQ-QFDAEIGTLGRIRHK 831
            A+ NFS +N++G GGFG  YK  L  G LVAVK+L   R QG + QF  E+  +    H+
Sbjct: 36   ASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHR 95
Query: 832  NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKK--SGKKIQWSVIHKIAIDIAQALAYL 889
            NL+ L G+ +   E  LVY +++ G++ + + ++  S   + W    +IA+  A+ LAYL
Sbjct: 96   NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYL 155
Query: 890  HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
            H  C P+I+HRD+K +NILLDEE  A + DFGLA+L++  + H    V GT G++APEY 
Sbjct: 156  HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYL 215
Query: 950  TTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009
            +T + S+K DV+ +GV+LLELI+G+R+ D +     +   ++ W K L+KE +   L   
Sbjct: 216  STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDV 275
Query: 1010 ELWEAGPQENLLGMMRLASTCTVETLSTRP 1039
            +L      E +  ++++A  CT  +   RP
Sbjct: 276  DLQGNYKDEEVEQLIQVALLCTQSSPMERP 305

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  195 bits (495), Expect = 1e-49,   Method: Composition-based stats.
 Identities = 102/270 (37%), Positives = 160/270 (59%), Gaps = 3/270 (1%)
Query: 773  ATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQ-QFDAEIGTLGRIRHK 831
            A+ NF  +N++G GGFG  YK  L  G LVAVK+L   R QG + QF  E+  +    H+
Sbjct: 28   ASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 87
Query: 832  NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKK--SGKKIQWSVIHKIAIDIAQALAYL 889
            NL+ L G+ +   E  LVY +++ G++ + + ++  S   + W    +IA+  A+ LAYL
Sbjct: 88   NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYL 147
Query: 890  HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
            H  C P+I+HRD+K +NILLDEE  A + DFGLA+L++  + H    V G  G++APEY 
Sbjct: 148  HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPEYL 207
Query: 950  TTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009
            +T + S+K DV+ +GV+LLELI+G+R+ D +     +   ++ W K L+KE +   L   
Sbjct: 208  STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDV 267
Query: 1010 ELWEAGPQENLLGMMRLASTCTVETLSTRP 1039
            +L      E +  ++++A  CT  +   RP
Sbjct: 268  DLQGNYKDEEVEQLIQVALLCTQSSPMERP 297

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  150 bits (379), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 181/645 (28%), Positives = 265/645 (41%), Gaps = 134/645 (20%)
Query: 53  LLSFKASISRDPSNLLATWNSSTDHCTWHGVTCDHFTGRVTALRITGKATPWPSKS---- 108
           L+SFK  +     NLL  W+S+ + CT+ GVTC     +VT++ ++ K       +    
Sbjct: 17  LISFKDVLPD--KNLLPDWSSNKNPCTFDGVTCRD--DKVTSIDLSSKPLNVGFSAVSSS 72
Query: 109 --------------SVISGTLSASIAKLTELRTLSVPHNSFSGEIPAXXXXXXXXXXXXX 154
                         S I+G++S        L +L +  NS SG +               
Sbjct: 73  LLSLTGLESLFLSNSHINGSVSGFKCS-ASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFL 131
Query: 155 QGNNFSGKIPYQMS---NLERLRVLNLSFNSFSGEVPRGLI---GNGELSVIDMSSNRLS 208
             ++ +   P ++S    L  L VL+LS NS SG    G +   G GEL  + +S N++S
Sbjct: 132 NVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKIS 191
Query: 209 GGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTIS 268
           G + +   S C  L +L +S N  +  IP  +G C  L++L + GN L G   + I T +
Sbjct: 192 GDVDV---SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCT 247
Query: 269 ELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLL 328
           ELK+L++S N     IP                                     P  L  
Sbjct: 248 ELKLLNISSNQFVGPIP-------------------------------------PLPL-- 268
Query: 329 SRSLEVLWAPRANLGGRLPDNWSESC-SLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSL 387
            +SL+ L        G +PD  S +C +L  L+L  N   GAVP   G C  L  L LS 
Sbjct: 269 -KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSS 327
Query: 388 NNLEGYLPMQ--LPVPCMVYFNVSQNNITGVLPR-FENVSCDNHFGFQDLQYANVPVMGS 444
           NN  G LPM   L +  +   ++S N  +G LP    N+S                    
Sbjct: 328 NNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSAS------------------ 369
Query: 445 ISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKC 504
                 ++  D S N F G      I              L L NN F G +P       
Sbjct: 370 ------LLTLDLSSNNFSG-----PILPNLCQNPKNTLQELYLQNNGFTGKIP------- 411
Query: 505 NDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLR 564
                                  L +C +LV    + N +SG+I + +G L KL+ L L 
Sbjct: 412 ---------------------PTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLW 450
Query: 565 GNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASL 624
            N + G +P EL  +K L+ ++L  N+LTGEIPS   +  +L  + LS+N LTG IP  +
Sbjct: 451 LNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWI 510
Query: 625 TKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIP 669
            +   L  L L++N  SG IP       +L  LDL+ N  +G IP
Sbjct: 511 GRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIP 555

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  146 bits (368), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 177/603 (29%), Positives = 269/603 (44%), Gaps = 87/603 (14%)
Query: 124 ELRTLSVPHNSFSGEIPAXXXXXXXXXXXXXQGNNFSGKIPYQMSNLERLRVLNLSFNSF 183
           EL+ L++  N  SG++                 NNFS  IP+ + +   L+ L++S N  
Sbjct: 179 ELKHLAISGNKISGDVDVSRCVNLEFLDV--SSNNFSTGIPF-LGDCSALQHLDISGNKL 235
Query: 184 SGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEI-GK 242
           SG+  R +    EL ++++SSN+  G +        + L YL L++N  T  IP  + G 
Sbjct: 236 SGDFSRAISTCTELKLLNISSNQFVGPIP---PLPLKSLQYLSLAENKFTGEIPDFLSGA 292
Query: 243 CRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVE-LADCSKLSVL---- 297
           C  L  L L GN   G++P   G+ S L+ L +S N+ +  +P++ L     L VL    
Sbjct: 293 CDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSF 352
Query: 298 ---------VLTNIDASL-DLDNSRGEFSAFDGGVPYELLLS--RSLEVLWAPRANLGGR 345
                     LTN+ ASL  LD S   FS   G +   L  +   +L+ L+       G+
Sbjct: 353 NEFSGELPESLTNLSASLLTLDLSSNNFS---GPILPNLCQNPKNTLQELYLQNNGFTGK 409
Query: 346 LPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLP-VPCMV 404
           +P   S    L  L+L  N L G +P SLG    L  L L LN LEG +P +L  V  + 
Sbjct: 410 IPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLE 469
Query: 405 YFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISD-----ENFVIIHDFSGN 459
              +  N++TG +P        N      +  +N  + G I       EN  I+   S N
Sbjct: 470 TLILDFNDLTGEIPS----GLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILK-LSNN 524
Query: 460 KFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLL 519
            F G++P   +GD       +    L LN N+FNG++P     +       S  ++AN +
Sbjct: 525 SFSGNIPA-ELGD------CRSLIWLDLNTNLFNGTIPAAMFKQ-------SGKIAANFI 570
Query: 520 SGMSYEAFLLDCVQ--------LVEFEAANNQISGSIAAGVGKLMKLQRLDLRG-----N 566
           +G  Y     D ++        L+EF+   ++             +L RL  R      +
Sbjct: 571 AGKRYVYIKNDGMKKECHGAGNLLEFQGIRSE-------------QLNRLSTRNPCNITS 617
Query: 567 RVSGSLP----DELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPA 622
           RV G       D  G + FL    +  N L+G IP + G +  L +L+L HN ++GSIP 
Sbjct: 618 RVYGGHTSPTFDNNGSMMFLD---MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPD 674
Query: 623 SLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPHLQHLDCIAFKGN 682
            +     L  L L+ N+L G IP + S L  L+ +DLS NNLSG IP +   +   F   
Sbjct: 675 EVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFE--TFPPA 732
Query: 683 KYL 685
           K+L
Sbjct: 733 KFL 735

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  150 bits (379), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 181/645 (28%), Positives = 265/645 (41%), Gaps = 134/645 (20%)
Query: 53  LLSFKASISRDPSNLLATWNSSTDHCTWHGVTCDHFTGRVTALRITGKATPWPSKS---- 108
           L+SFK  +     NLL  W+S+ + CT+ GVTC     +VT++ ++ K       +    
Sbjct: 14  LISFKDVLPD--KNLLPDWSSNKNPCTFDGVTCRD--DKVTSIDLSSKPLNVGFSAVSSS 69
Query: 109 --------------SVISGTLSASIAKLTELRTLSVPHNSFSGEIPAXXXXXXXXXXXXX 154
                         S I+G++S        L +L +  NS SG +               
Sbjct: 70  LLSLTGLESLFLSNSHINGSVSGFKCS-ASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFL 128
Query: 155 QGNNFSGKIPYQMS---NLERLRVLNLSFNSFSGEVPRGLI---GNGELSVIDMSSNRLS 208
             ++ +   P ++S    L  L VL+LS NS SG    G +   G GEL  + +S N++S
Sbjct: 129 NVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKIS 188
Query: 209 GGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTIS 268
           G + +   S C  L +L +S N  +  IP  +G C  L++L + GN L G   + I T +
Sbjct: 189 GDVDV---SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCT 244
Query: 269 ELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLL 328
           ELK+L++S N     IP                                     P  L  
Sbjct: 245 ELKLLNISSNQFVGPIP-------------------------------------PLPL-- 265
Query: 329 SRSLEVLWAPRANLGGRLPDNWSESC-SLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSL 387
            +SL+ L        G +PD  S +C +L  L+L  N   GAVP   G C  L  L LS 
Sbjct: 266 -KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSS 324
Query: 388 NNLEGYLPMQ--LPVPCMVYFNVSQNNITGVLPR-FENVSCDNHFGFQDLQYANVPVMGS 444
           NN  G LPM   L +  +   ++S N  +G LP    N+S                    
Sbjct: 325 NNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSAS------------------ 366
Query: 445 ISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKC 504
                 ++  D S N F G      I              L L NN F G +P       
Sbjct: 367 ------LLTLDLSSNNFSG-----PILPNLCQNPKNTLQELYLQNNGFTGKIP------- 408
Query: 505 NDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLR 564
                                  L +C +LV    + N +SG+I + +G L KL+ L L 
Sbjct: 409 ---------------------PTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLW 447
Query: 565 GNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASL 624
            N + G +P EL  +K L+ ++L  N+LTGEIPS   +  +L  + LS+N LTG IP  +
Sbjct: 448 LNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWI 507
Query: 625 TKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIP 669
            +   L  L L++N  SG IP       +L  LDL+ N  +G IP
Sbjct: 508 GRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIP 552

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  146 bits (368), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 177/603 (29%), Positives = 269/603 (44%), Gaps = 87/603 (14%)
Query: 124 ELRTLSVPHNSFSGEIPAXXXXXXXXXXXXXQGNNFSGKIPYQMSNLERLRVLNLSFNSF 183
           EL+ L++  N  SG++                 NNFS  IP+ + +   L+ L++S N  
Sbjct: 176 ELKHLAISGNKISGDVDVSRCVNLEFLDV--SSNNFSTGIPF-LGDCSALQHLDISGNKL 232
Query: 184 SGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEI-GK 242
           SG+  R +    EL ++++SSN+  G +        + L YL L++N  T  IP  + G 
Sbjct: 233 SGDFSRAISTCTELKLLNISSNQFVGPIP---PLPLKSLQYLSLAENKFTGEIPDFLSGA 289
Query: 243 CRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVE-LADCSKLSVL---- 297
           C  L  L L GN   G++P   G+ S L+ L +S N+ +  +P++ L     L VL    
Sbjct: 290 CDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSF 349
Query: 298 ---------VLTNIDASL-DLDNSRGEFSAFDGGVPYELLLS--RSLEVLWAPRANLGGR 345
                     LTN+ ASL  LD S   FS   G +   L  +   +L+ L+       G+
Sbjct: 350 NEFSGELPESLTNLSASLLTLDLSSNNFS---GPILPNLCQNPKNTLQELYLQNNGFTGK 406
Query: 346 LPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLP-VPCMV 404
           +P   S    L  L+L  N L G +P SLG    L  L L LN LEG +P +L  V  + 
Sbjct: 407 IPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLE 466
Query: 405 YFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISD-----ENFVIIHDFSGN 459
              +  N++TG +P        N      +  +N  + G I       EN  I+   S N
Sbjct: 467 TLILDFNDLTGEIPS----GLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILK-LSNN 521
Query: 460 KFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLL 519
            F G++P   +GD       +    L LN N+FNG++P     +       S  ++AN +
Sbjct: 522 SFSGNIPA-ELGD------CRSLIWLDLNTNLFNGTIPAAMFKQ-------SGKIAANFI 567
Query: 520 SGMSYEAFLLDCVQ--------LVEFEAANNQISGSIAAGVGKLMKLQRLDLRG-----N 566
           +G  Y     D ++        L+EF+   ++             +L RL  R      +
Sbjct: 568 AGKRYVYIKNDGMKKECHGAGNLLEFQGIRSE-------------QLNRLSTRNPCNITS 614
Query: 567 RVSGSLP----DELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPA 622
           RV G       D  G + FL    +  N L+G IP + G +  L +L+L HN ++GSIP 
Sbjct: 615 RVYGGHTSPTFDNNGSMMFLD---MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPD 671
Query: 623 SLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPHLQHLDCIAFKGN 682
            +     L  L L+ N+L G IP + S L  L+ +DLS NNLSG IP +   +   F   
Sbjct: 672 EVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFE--TFPPA 729
Query: 683 KYL 685
           K+L
Sbjct: 730 KFL 732

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  144 bits (364), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 98/271 (36%), Positives = 143/271 (52%), Gaps = 8/271 (2%)
Query: 773  ATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKN 832
            AT NF  + LIG G FG  YK  L  G  VA+K+ +    QGI++F+ EI TL   RH +
Sbjct: 37   ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPH 96
Query: 833  LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKS--GKKIQWSVIHKIAIDIAQALAYLH 890
            LV+LIG+     EM L+Y ++  GNL+  ++        + W    +I I  A+ L YLH
Sbjct: 97   LVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH 156
Query: 891  YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARL-LEVSETHATTDVAGTFGYVAPEYA 949
                  I+HRD+K  NILLDE     ++DFG+++   E+ +TH    V GT GY+ PEY 
Sbjct: 157  TRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYF 213
Query: 950  TTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009
               R+++K+DVYSFGVVL E++  + ++  S        N+  WA      G+  ++  P
Sbjct: 214  IKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR--EMVNLAEWAVESHNNGQLEQIVDP 271
Query: 1010 ELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
             L +    E+L      A  C   +   RPS
Sbjct: 272  NLADKIRPESLRKFGDTAVKCLALSSEDRPS 302

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  144 bits (364), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 98/271 (36%), Positives = 143/271 (52%), Gaps = 8/271 (2%)
Query: 773  ATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKN 832
            AT NF  + LIG G FG  YK  L  G  VA+K+ +    QGI++F+ EI TL   RH +
Sbjct: 37   ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPH 96
Query: 833  LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKS--GKKIQWSVIHKIAIDIAQALAYLH 890
            LV+LIG+     EM L+Y ++  GNL+  ++        + W    +I I  A+ L YLH
Sbjct: 97   LVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH 156
Query: 891  YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARL-LEVSETHATTDVAGTFGYVAPEYA 949
                  I+HRD+K  NILLDE     ++DFG+++   E+ +TH    V GT GY+ PEY 
Sbjct: 157  TRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYF 213
Query: 950  TTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009
               R+++K+DVYSFGVVL E++  + ++  S        N+  WA      G+  ++  P
Sbjct: 214  IKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR--EMVNLAEWAVESHNNGQLEQIVDP 271
Query: 1010 ELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
             L +    E+L      A  C   +   RPS
Sbjct: 272  NLADKIRPESLRKFGDTAVKCLALSSEDRPS 302

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  129 bits (324), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 87/217 (40%), Positives = 123/217 (56%), Gaps = 17/217 (7%)
Query: 774 TGNFSIR------NLIGTGGFGSTYKAELVPGYLVAVKKLS----IGRFQGIQQFDAEIG 823
           T NF  R      N +G GGFG  YK   V    VAVKKL+    I   +  QQFD EI 
Sbjct: 24  TNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEELKQQFDQEIK 82
Query: 824 TLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK-IQWSVIHKIAIDI 882
            + + +H+NLV L+G+     ++ LVY ++  G+L   +    G   + W +  KIA   
Sbjct: 83  VMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGA 142
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE-VSETHATTDVAGTF 941
           A  + +LH +     +HRDIK +NILLDE   A +SDFGLAR  E  ++T   + + GT 
Sbjct: 143 ANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTT 199
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLD 978
            Y+APE A    ++ K+D+YSFGVVLLE+I+G  ++D
Sbjct: 200 AYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVD 235

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  128 bits (322), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 87/217 (40%), Positives = 122/217 (56%), Gaps = 17/217 (7%)
Query: 774 TGNFSIR------NLIGTGGFGSTYKAELVPGYLVAVKKLS----IGRFQGIQQFDAEIG 823
           T NF  R      N +G GGFG  YK   V    VAVKKL+    I   +  QQFD EI 
Sbjct: 24  TNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEELKQQFDQEIK 82
Query: 824 TLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK-IQWSVIHKIAIDI 882
            + + +H+NLV L+G+     ++ LVY ++  G+L   +    G   + W +  KIA   
Sbjct: 83  VMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGA 142
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE-VSETHATTDVAGTF 941
           A  + +LH +     +HRDIK +NILLDE   A +SDFGLAR  E  ++T     + GT 
Sbjct: 143 ANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTT 199
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLD 978
            Y+APE A    ++ K+D+YSFGVVLLE+I+G  ++D
Sbjct: 200 AYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVD 235

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  126 bits (316), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 86/217 (39%), Positives = 121/217 (55%), Gaps = 17/217 (7%)
Query: 774 TGNFSIR------NLIGTGGFGSTYKAELVPGYLVAVKKLS----IGRFQGIQQFDAEIG 823
           T NF  R      N +G GGFG  YK   V    VAVKKL+    I   +  QQFD EI 
Sbjct: 18  TNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEELKQQFDQEIK 76
Query: 824 TLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK-IQWSVIHKIAIDI 882
            + + +H+NLV L+G+     ++ LVY ++  G+L   +    G   + W +  KIA   
Sbjct: 77  VMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGA 136
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE-VSETHATTDVAGTF 941
           A  + +LH +     +HRDIK +NILLDE   A +SDFGLAR  E  ++      + GT 
Sbjct: 137 ANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTT 193
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLD 978
            Y+APE A    ++ K+D+YSFGVVLLE+I+G  ++D
Sbjct: 194 AYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVD 229

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  121 bits (303), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 86/217 (39%), Positives = 117/217 (53%), Gaps = 17/217 (7%)
Query: 774 TGNFSIR------NLIGTGGFGSTYKAELVPGYLVAVKKLS----IGRFQGIQQFDAEIG 823
           T NF  R      N  G GGFG  YK   V    VAVKKL+    I   +  QQFD EI 
Sbjct: 15  TNNFDERPISVGGNKXGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEELKQQFDQEIK 73
Query: 824 TLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK-IQWSVIHKIAIDI 882
              + +H+NLV L+G+     ++ LVY +   G+L   +    G   + W    KIA   
Sbjct: 74  VXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGA 133
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE-VSETHATTDVAGTF 941
           A  + +LH +     +HRDIK +NILLDE   A +SDFGLAR  E  ++    + + GT 
Sbjct: 134 ANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTT 190
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLD 978
            Y APE A    ++ K+D+YSFGVVLLE+I+G  ++D
Sbjct: 191 AYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVD 226

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  115 bits (289), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 73/201 (36%), Positives = 113/201 (56%), Gaps = 8/201 (3%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQG--IQQFDAEIGTLGRIRHKNL 833
           + +I+  IG G FG+ ++AE   G  VAVK L    F    + +F  E+  + R+RH N+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKI--AIDIAQALAYLHY 891
           V  +G       + +V  +LS G+L   +HK SG + Q     ++  A D+A+ + YLH 
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT 951
              P IVHRD+K  N+L+D++    + DFGL+R L+ S    +   AGT  ++APE    
Sbjct: 156 RNPP-IVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKASXFLXSKXAAGTPEWMAPEVLRD 213
Query: 952 CRVSDKADVYSFGVVLLELIS 972
              ++K+DVYSFGV+L EL +
Sbjct: 214 EPSNEKSDVYSFGVILWELAT 234

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  115 bits (287), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 72/201 (35%), Positives = 114/201 (56%), Gaps = 8/201 (3%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQG--IQQFDAEIGTLGRIRHKNL 833
           + +I+  IG G FG+ ++AE   G  VAVK L    F    + +F  E+  + R+RH N+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKI--AIDIAQALAYLHY 891
           V  +G       + +V  +LS G+L   +H KSG + Q     ++  A D+A+ + YLH 
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-KSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT 951
              P IVHR++K  N+L+D++    + DFGL+R L+ S   ++   AGT  ++APE    
Sbjct: 156 RNPP-IVHRNLKSPNLLVDKKYTVKVCDFGLSR-LKASTFLSSKSAAGTPEWMAPEVLRD 213
Query: 952 CRVSDKADVYSFGVVLLELIS 972
              ++K+DVYSFGV+L EL +
Sbjct: 214 EPSNEKSDVYSFGVILWELAT 234

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  109 bits (273), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 76/232 (32%), Positives = 116/232 (50%), Gaps = 26/232 (11%)
Query: 775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQ----FDAEIGTLGRIRH 830
              ++  +IG GGFG  Y+A  + G  VAVK       + I Q       E      ++H
Sbjct: 7   AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            N++ L G  + E  + LV  F  GG L   +   SGK+I   ++   A+ IA+ + YLH
Sbjct: 66  PNIIALRGVCLKEPNLCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQIARGMNYLH 122
Query: 891 YSCVPRIVHRDIKPSNILLDEELN--------AYLSDFGLARLLEVSETHATTDV--AGT 940
              +  I+HRD+K SNIL+ +++           ++DFGLAR     E H TT +  AG 
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTTKMSAAGA 177
Query: 941 FGYVAPEYATTCRVSDKADVYSFGVVLLELISGK---RSLDPSFSEYGNGFN 989
           + ++APE       S  +DV+S+GV+L EL++G+   R +D     YG   N
Sbjct: 178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN 229

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  102 bits (255), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 109/207 (52%), Gaps = 15/207 (7%)
Query: 775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
           G  ++   IG+G FG+ YK +      V +  ++    Q +Q F  E+G L + RH N++
Sbjct: 35  GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 94
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
             +GY   + ++ +V  +  G +L   +H    K     +I  IA   AQ + YLH    
Sbjct: 95  LFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLHAKS- 151
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLL-EVSETHATTDVAGTFGYVAPEYATTCR 953
             I+HRD+K +NI L E+L   + DFGLA +    S +H    ++G+  ++APE     R
Sbjct: 152 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIR 206
Query: 954 VSDK------ADVYSFGVVLLELISGK 974
           + DK      +DVY+FG+VL EL++G+
Sbjct: 207 MQDKNPYSFQSDVYAFGIVLYELMTGQ 233

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  102 bits (255), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 109/207 (52%), Gaps = 15/207 (7%)
Query: 775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
           G  ++   IG+G FG+ YK +      V +  ++    Q +Q F  E+G L + RH N++
Sbjct: 13  GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 72
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
             +GY   + ++ +V  +  G +L   +H    K     +I  IA   AQ + YLH    
Sbjct: 73  LFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLHAKS- 129
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLL-EVSETHATTDVAGTFGYVAPEYATTCR 953
             I+HRD+K +NI L E+L   + DFGLA +    S +H    ++G+  ++APE     R
Sbjct: 130 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIR 184
Query: 954 VSDK------ADVYSFGVVLLELISGK 974
           + DK      +DVY+FG+VL EL++G+
Sbjct: 185 MQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  102 bits (255), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 109/207 (52%), Gaps = 15/207 (7%)
Query: 775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
           G  ++   IG+G FG+ YK +      V +  ++    Q +Q F  E+G L + RH N++
Sbjct: 36  GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 95
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
             +GY   + ++ +V  +  G +L   +H    K     +I  IA   AQ + YLH    
Sbjct: 96  LFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLHAKS- 152
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLL-EVSETHATTDVAGTFGYVAPEYATTCR 953
             I+HRD+K +NI L E+L   + DFGLA +    S +H    ++G+  ++APE     R
Sbjct: 153 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIR 207
Query: 954 VSDK------ADVYSFGVVLLELISGK 974
           + DK      +DVY+FG+VL EL++G+
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  102 bits (254), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 109/207 (52%), Gaps = 15/207 (7%)
Query: 775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
           G  ++   IG+G FG+ YK +      V +  ++    Q +Q F  E+G L + RH N++
Sbjct: 10  GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 69
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
             +GY   + ++ +V  +  G +L   +H    K     +I  IA   AQ + YLH    
Sbjct: 70  LFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLHAKS- 126
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLL-EVSETHATTDVAGTFGYVAPEYATTCR 953
             I+HRD+K +NI L E+L   + DFGLA +    S +H    ++G+  ++APE     R
Sbjct: 127 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIR 181
Query: 954 VSDK------ADVYSFGVVLLELISGK 974
           + DK      +DVY+FG+VL EL++G+
Sbjct: 182 MQDKNPYSFQSDVYAFGIVLYELMTGQ 208

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  102 bits (254), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 109/207 (52%), Gaps = 15/207 (7%)
Query: 775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
           G  ++   IG+G FG+ YK +      V +  ++    Q +Q F  E+G L + RH N++
Sbjct: 13  GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 72
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
             +GY   + ++ +V  +  G +L   +H    K     +I  IA   AQ + YLH    
Sbjct: 73  LFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLHAKS- 129
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLL-EVSETHATTDVAGTFGYVAPEYATTCR 953
             I+HRD+K +NI L E+L   + DFGLA +    S +H    ++G+  ++APE     R
Sbjct: 130 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIR 184
Query: 954 VSDK------ADVYSFGVVLLELISGK 974
           + DK      +DVY+FG+VL EL++G+
Sbjct: 185 MQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  102 bits (254), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 109/207 (52%), Gaps = 15/207 (7%)
Query: 775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
           G  ++   IG+G FG+ YK +      V +  ++    Q +Q F  E+G L + RH N++
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
             +GY   + ++ +V  +  G +L   +H    K     +I  IA   AQ + YLH    
Sbjct: 68  LFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLHAKS- 124
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLL-EVSETHATTDVAGTFGYVAPEYATTCR 953
             I+HRD+K +NI L E+L   + DFGLA +    S +H    ++G+  ++APE     R
Sbjct: 125 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIR 179
Query: 954 VSDK------ADVYSFGVVLLELISGK 974
           + DK      +DVY+FG+VL EL++G+
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 108/207 (52%), Gaps = 15/207 (7%)
Query: 775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
           G  ++   IG+G FG+ YK +      V +  ++    Q +Q F  E+G L + RH N++
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
             +GY     ++ +V  +  G +L   +H    K     +I  IA   AQ + YLH    
Sbjct: 68  LFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLHAKS- 124
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLL-EVSETHATTDVAGTFGYVAPEYATTCR 953
             I+HRD+K +NI L E+L   + DFGLA +    S +H    ++G+  ++APE     R
Sbjct: 125 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIR 179
Query: 954 VSDK------ADVYSFGVVLLELISGK 974
           + DK      +DVY+FG+VL EL++G+
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  101 bits (252), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 108/207 (52%), Gaps = 15/207 (7%)
Query: 775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
           G  ++   IG+G FG+ YK +      V +  ++    Q +Q F  E+G L + RH N++
Sbjct: 28  GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 87
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
             +GY   + ++ +V  +  G +L   +H    K     +I  IA   AQ + YLH    
Sbjct: 88  LFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLHAKS- 144
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLA-RLLEVSETHATTDVAGTFGYVAPEYATTCR 953
             I+HRD+K +NI L E+L   + DFGLA      S +H    ++G+  ++APE     R
Sbjct: 145 --IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE---VIR 199
Query: 954 VSDK------ADVYSFGVVLLELISGK 974
           + DK      +DVY+FG+VL EL++G+
Sbjct: 200 MQDKNPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  101 bits (252), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 108/207 (52%), Gaps = 15/207 (7%)
Query: 775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
           G  ++   IG+G FG+ YK +      V +  ++    Q +Q F  E+G L + RH N++
Sbjct: 36  GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 95
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
             +GY   + ++ +V  +  G +L   +H    K     +I  IA   AQ + YLH    
Sbjct: 96  LFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLHAKS- 152
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLA-RLLEVSETHATTDVAGTFGYVAPEYATTCR 953
             I+HRD+K +NI L E+L   + DFGLA      S +H    ++G+  ++APE     R
Sbjct: 153 --IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE---VIR 207
Query: 954 VSDK------ADVYSFGVVLLELISGK 974
           + DK      +DVY+FG+VL EL++G+
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 108/207 (52%), Gaps = 15/207 (7%)
Query: 775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
           G  ++   IG+G FG+ YK +      V +  ++    Q +Q F  E+G L + RH N++
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
             +GY   + ++ +V  +  G +L   +H    K     +I  IA   AQ + YLH    
Sbjct: 68  LFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLI-DIARQTAQGMDYLHAKS- 124
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLA-RLLEVSETHATTDVAGTFGYVAPEYATTCR 953
             I+HRD+K +NI L E+L   + DFGLA      S +H    ++G+  ++APE     R
Sbjct: 125 --IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE---VIR 179
Query: 954 VSDK------ADVYSFGVVLLELISGK 974
           + DK      +DVY+FG+VL EL++G+
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/193 (33%), Positives = 102/193 (52%), Gaps = 5/193 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  +         VA+K L  G     + F  E   + ++RH+ LV L    V 
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAV-VS 332
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           E  +++V  ++S G+L  F+  ++GK ++   +  +A  IA  +AY+        VHRD+
Sbjct: 333 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 389
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
           + +NIL+ E L   ++DFGLARL+E +E  A         + APE A   R + K+DV+S
Sbjct: 390 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 449
Query: 963 FGVVLLELISGKR 975
           FG++L EL +  R
Sbjct: 450 FGILLTELTTKGR 462

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 5/197 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  +         VA+K L  G     + F  E   + ++RH+ LV L    V 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAV-VS 249
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           E  +++V  ++S G+L  F+  ++GK ++   +  +A  IA  +AY+        VHRD+
Sbjct: 250 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 306
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
           + +NIL+ E L   ++DFGLARL+E +E  A         + APE A   R + K+DV+S
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 366
Query: 963 FGVVLLELISGKRSLDP 979
           FG++L EL +  R   P
Sbjct: 367 FGILLTELTTKGRVPYP 383

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  100 bits (249), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 5/197 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  +         VA+K L  G     + F  E   + ++RH+ LV L    V 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAV-VS 249
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           E  +++V  ++S G+L  F+  ++GK ++   +  +A  IA  +AY+        VHRD+
Sbjct: 250 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 306
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
           + +NIL+ E L   ++DFGLARL+E +E  A         + APE A   R + K+DV+S
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 366
Query: 963 FGVVLLELISGKRSLDP 979
           FG++L EL +  R   P
Sbjct: 367 FGILLTELTTKGRVPYP 383

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  100 bits (249), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 109/207 (52%), Gaps = 15/207 (7%)
Query: 775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
           G  ++   IG+G FG+ YK +      V +  ++    Q +Q F  E+G L + RH N++
Sbjct: 12  GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 71
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
             +GY   + ++ +V  +  G +L   +H  S  K +   +  IA   A+ + YLH    
Sbjct: 72  LFMGYST-KPQLAIVTQWCEGSSLYHHLH-ASETKFEMKKLIDIARQTARGMDYLHAKS- 128
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLL-EVSETHATTDVAGTFGYVAPEYATTCR 953
             I+HRD+K +NI L E+    + DFGLA +    S +H    ++G+  ++APE     R
Sbjct: 129 --IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIR 183
Query: 954 VSD------KADVYSFGVVLLELISGK 974
           + D      ++DVY+FG+VL EL++G+
Sbjct: 184 MQDSNPYSFQSDVYAFGIVLYELMTGQ 210

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  100 bits (248), Expect = 5e-21,   Method: Composition-based stats.
 Identities = 64/193 (33%), Positives = 102/193 (52%), Gaps = 5/193 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  +         VA+K L  G     + F  E   + ++RH+ LV L    V 
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV-VS 76
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           E  +++V  ++S G+L  F+  ++GK ++   +  +A  IA  +AY+        VHRD+
Sbjct: 77  EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 133
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
           + +NIL+ E L   ++DFGLARL+E +E  A         + APE A   R + K+DV+S
Sbjct: 134 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 193
Query: 963 FGVVLLELISGKR 975
           FG++L EL +  R
Sbjct: 194 FGILLTELTTKGR 206

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  100 bits (248), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 5/197 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  +         VA+K L  G     + F  E   + ++RH+ LV L    V 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAV-VS 249
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           E  +++V  ++S G+L  F+  ++GK ++   +  +A  IA  +AY+        VHRD+
Sbjct: 250 EEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 306
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
           + +NIL+ E L   ++DFGLARL+E +E  A         + APE A   R + K+DV+S
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 366
Query: 963 FGVVLLELISGKRSLDP 979
           FG++L EL +  R   P
Sbjct: 367 FGILLTELTTKGRVPYP 383

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  100 bits (248), Expect = 6e-21,   Method: Composition-based stats.
 Identities = 65/193 (33%), Positives = 101/193 (52%), Gaps = 5/193 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  +         VA+K L  G     + F  E   + +IRH+ LV L    V 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKIRHEKLVQLYAV-VS 83
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           E  +++V  ++S G+L  F+  + GK ++   +  +A  IA  +AY+        VHRD+
Sbjct: 84  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 140
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
           + +NIL+ E L   ++DFGLARL+E +E  A         + APE A   R + K+DV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 963 FGVVLLELISGKR 975
           FG++L EL +  R
Sbjct: 201 FGILLTELTTKGR 213

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 99.8 bits (247), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 108/207 (52%), Gaps = 15/207 (7%)
Query: 775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
           G  ++   IG+G FG+ YK +      V +  ++    Q +Q F  E+G L + RH N++
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
             +GY   + ++ +V  +  G +L   +H  S  K +   +  IA   A+ + YLH    
Sbjct: 84  LFMGYST-KPQLAIVTQWCEGSSLYHHLH-ASETKFEMKKLIDIARQTARGMDYLHAKS- 140
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLA-RLLEVSETHATTDVAGTFGYVAPEYATTCR 953
             I+HRD+K +NI L E+    + DFGLA      S +H    ++G+  ++APE     R
Sbjct: 141 --IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE---VIR 195
Query: 954 VSD------KADVYSFGVVLLELISGK 974
           + D      ++DVY+FG+VL EL++G+
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 99.4 bits (246), Expect = 8e-21,   Method: Composition-based stats.
 Identities = 64/193 (33%), Positives = 101/193 (52%), Gaps = 5/193 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  +         VA+K L  G     + F  E   + ++RH+ LV L    V 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV-VS 83
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           E  +++V  ++S G+L  F+  + GK ++   +  +A  IA  +AY+        VHRD+
Sbjct: 84  EEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 140
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
           + +NIL+ E L   ++DFGLARL+E +E  A         + APE A   R + K+DV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 963 FGVVLLELISGKR 975
           FG++L EL +  R
Sbjct: 201 FGILLTELTTKGR 213

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 99.4 bits (246), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 107/207 (51%), Gaps = 15/207 (7%)
Query: 775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
           G  ++   IG+G FG+ YK +      V +  ++    Q +Q F  E+G L + RH N++
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
             +GY     ++ +V  +  G +L   +H  S  K +   +  IA   A+ + YLH    
Sbjct: 84  LFMGYSTA-PQLAIVTQWCEGSSLYHHLH-ASETKFEMKKLIDIARQTARGMDYLHAKS- 140
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLA-RLLEVSETHATTDVAGTFGYVAPEYATTCR 953
             I+HRD+K +NI L E+    + DFGLA      S +H    ++G+  ++APE     R
Sbjct: 141 --IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE---VIR 195
Query: 954 VSD------KADVYSFGVVLLELISGK 974
           + D      ++DVY+FG+VL EL++G+
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Composition-based stats.
 Identities = 64/193 (33%), Positives = 101/193 (52%), Gaps = 5/193 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  +         VA+K L  G     + F  E   + ++RH+ LV L    V 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV-VS 83
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           E  +++V  ++S G+L  F+  + GK ++   +  +A  IA  +AY+        VHRD+
Sbjct: 84  EEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 140
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
           + +NIL+ E L   ++DFGLARL+E +E  A         + APE A   R + K+DV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 963 FGVVLLELISGKR 975
           FG++L EL +  R
Sbjct: 201 FGILLTELTTKGR 213

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Composition-based stats.
 Identities = 64/193 (33%), Positives = 101/193 (52%), Gaps = 5/193 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  +         VA+K L  G     + F  E   + ++RH+ LV L    V 
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV-VS 72
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           E  +++V  ++S G+L  F+  + GK ++   +  +A  IA  +AY+        VHRD+
Sbjct: 73  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 129
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
           + +NIL+ E L   ++DFGLARL+E +E  A         + APE A   R + K+DV+S
Sbjct: 130 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 189
Query: 963 FGVVLLELISGKR 975
           FG++L EL +  R
Sbjct: 190 FGILLTELTTKGR 202

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Composition-based stats.
 Identities = 64/193 (33%), Positives = 101/193 (52%), Gaps = 5/193 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  +         VA+K L  G     + F  E   + ++RH+ LV L    V 
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV-VS 74
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           E  +++V  ++S G+L  F+  + GK ++   +  +A  IA  +AY+        VHRD+
Sbjct: 75  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 131
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
           + +NIL+ E L   ++DFGLARL+E +E  A         + APE A   R + K+DV+S
Sbjct: 132 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 191
Query: 963 FGVVLLELISGKR 975
           FG++L EL +  R
Sbjct: 192 FGILLTELTTKGR 204

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Composition-based stats.
 Identities = 64/193 (33%), Positives = 101/193 (52%), Gaps = 5/193 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  +         VA+K L  G     + F  E   + ++RH+ LV L    V 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV-VS 83
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           E  +++V  ++S G+L  F+  + GK ++   +  +A  IA  +AY+        VHRD+
Sbjct: 84  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 140
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
           + +NIL+ E L   ++DFGLARL+E +E  A         + APE A   R + K+DV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 963 FGVVLLELISGKR 975
           FG++L EL +  R
Sbjct: 201 FGILLTELTTKGR 213

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Composition-based stats.
 Identities = 64/193 (33%), Positives = 101/193 (52%), Gaps = 5/193 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  +         VA+K L  G     + F  E   + ++RH+ LV L    V 
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV-VS 73
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           E  + +V  ++S G+L  F+  ++GK ++   +  +A  IA  +AY+        VHRD+
Sbjct: 74  EEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 130
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
           + +NIL+ E L   ++DFGLARL+E +E  A         + APE A   R + K+DV+S
Sbjct: 131 RAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 190
Query: 963 FGVVLLELISGKR 975
           FG++L EL +  R
Sbjct: 191 FGILLTELTTKGR 203

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 98.6 bits (244), Expect = 2e-20,   Method: Composition-based stats.
 Identities = 64/193 (33%), Positives = 101/193 (52%), Gaps = 5/193 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  +         VA+K L  G     + F  E   + ++RH+ LV L    V 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV-VS 83
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           E  +++V  ++S G+L  F+  + GK ++   +  +A  IA  +AY+        VHRD+
Sbjct: 84  EEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 140
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
           + +NIL+ E L   ++DFGLARL+E +E  A         + APE A   R + K+DV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 963 FGVVLLELISGKR 975
           FG++L EL +  R
Sbjct: 201 FGILLTELTTKGR 213

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 101/197 (51%), Gaps = 5/197 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  +         VA+K L  G     + F  E   + ++RH+ LV L    V 
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNM-SPEAFLQEAQVMKKLRHEKLVQLYAV-VS 250
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           E  +++V  ++S G+L  F+  + GK ++   +  +A  IA  +AY+        VHRD+
Sbjct: 251 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 307
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
           + +NIL+ E L   ++DFGL RL+E +E  A         + APE A   R + K+DV+S
Sbjct: 308 RAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 367
Query: 963 FGVVLLELISGKRSLDP 979
           FG++L EL +  R   P
Sbjct: 368 FGILLTELTTKGRVPYP 384

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-20,   Method: Composition-based stats.
 Identities = 64/193 (33%), Positives = 100/193 (51%), Gaps = 5/193 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  +         VA+K L  G     + F  E   + ++RH+ LV L    V 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV-VS 83
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           E  +++V  ++S G L  F+  + GK ++   +  +A  IA  +AY+        VHRD+
Sbjct: 84  EEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 140
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
           + +NIL+ E L   ++DFGLARL+E +E  A         + APE A   R + K+DV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 963 FGVVLLELISGKR 975
           FG++L EL +  R
Sbjct: 201 FGILLTELTTKGR 213

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-20,   Method: Composition-based stats.
 Identities = 64/193 (33%), Positives = 100/193 (51%), Gaps = 5/193 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  +         VA+K L  G     + F  E   + ++RH+ LV L    V 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV-VS 83
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           E  +++V  ++S G+L  F+  + GK ++   +  +A  IA  +AY+        VHRD+
Sbjct: 84  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 140
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
             +NIL+ E L   ++DFGLARL+E +E  A         + APE A   R + K+DV+S
Sbjct: 141 AAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 963 FGVVLLELISGKR 975
           FG++L EL +  R
Sbjct: 201 FGILLTELTTKGR 213

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Composition-based stats.
 Identities = 62/193 (32%), Positives = 102/193 (52%), Gaps = 5/193 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  +         VA+K L  G     + F  E   + ++RH+ LV L    V 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV-VS 80
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           E  +++V  +++ G+L  F+  ++GK ++   +  ++  IA  +AY+        VHRD+
Sbjct: 81  EEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERM---NYVHRDL 137
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
           + +NIL+ E L   ++DFGLARL+E +E  A         + APE A   R + K+DV+S
Sbjct: 138 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 197
Query: 963 FGVVLLELISGKR 975
           FG++L EL +  R
Sbjct: 198 FGILLTELTTKGR 210

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Composition-based stats.
 Identities = 64/193 (33%), Positives = 100/193 (51%), Gaps = 5/193 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  +         VA+K L  G     + F  E   + ++RH+ LV L    V 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV-VS 83
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           E  +++V  ++S G L  F+  + GK ++   +  +A  IA  +AY+        VHRD+
Sbjct: 84  EEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 140
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
           + +NIL+ E L   ++DFGLARL+E +E  A         + APE A   R + K+DV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 963 FGVVLLELISGKR 975
           FG++L EL +  R
Sbjct: 201 FGILLTELTTKGR 213

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 97.4 bits (241), Expect = 4e-20,   Method: Composition-based stats.
 Identities = 62/193 (32%), Positives = 102/193 (52%), Gaps = 5/193 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  +         VA+K L  G     + F  E   + ++RH+ LV L    V 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV-VS 80
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           E  +++V  +++ G+L  F+  ++GK ++   +  ++  IA  +AY+        VHRD+
Sbjct: 81  EEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERM---NYVHRDL 137
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
           + +NIL+ E L   ++DFGLARL+E +E  A         + APE A   R + K+DV+S
Sbjct: 138 RAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 197
Query: 963 FGVVLLELISGKR 975
           FG++L EL +  R
Sbjct: 198 FGILLTELTTKGR 210

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 96.7 bits (239), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 126/264 (47%), Gaps = 28/264 (10%)
Query: 783  IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
            IG+G FG+ YK +      V + K+     +  Q F  E+  L + RH N++  +GY   
Sbjct: 44   IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK 103
Query: 843  EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
            +  + +V  +  G +L   +H +  K   + +I  IA   AQ + YLH      I+HRD+
Sbjct: 104  D-NLAIVTQWCEGSSLYKHLHVQETKFQMFQLI-DIARQTAQGMDYLH---AKNIIHRDM 158
Query: 903  KPSNILLDEELNAYLSDFGLARLL-EVSETHATTDVAGTFGYVAPEYATTCRVSD----- 956
            K +NI L E L   + DFGLA +    S +       G+  ++APE     R+ D     
Sbjct: 159  KSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPE---VIRMQDNNPFS 215
Query: 957  -KADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAG 1015
             ++DVYS+G+VL EL++G    +  +S   N   I+     ++  G +S   L +L++  
Sbjct: 216  FQSDVYSYGIVLYELMTG----ELPYSHINNRDQII----FMVGRGYASP-DLSKLYKNC 266
Query: 1016 PQENLLGMMRLASTCTVETLSTRP 1039
            P+     M RL + C  +    RP
Sbjct: 267  PK----AMKRLVADCVKKVKEERP 286

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 96.3 bits (238), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 111/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
           NF     IG G +G  YKA   + G +VA+KK+ +    +G+      EI  L  + H N
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 67
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V L+     E +++LV+ FL   +L+ F+   +   I   +I      + Q LA+ H  
Sbjct: 68  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 126
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
              R++HRD+KP N+L++ E    L+DFGLAR   V     T +V  T  Y APE    C
Sbjct: 127 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGC 182
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
           +  S   D++S G +  E+++ +R+L P  SE    F I
Sbjct: 183 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 220

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 96.3 bits (238), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 111/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
           NF     IG G +G  YKA   + G +VA+KK+ +    +G+      EI  L  + H N
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 70
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V L+     E +++LV+ FL   +L+ F+   +   I   +I      + Q LA+ H  
Sbjct: 71  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 129
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
              R++HRD+KP N+L++ E    L+DFGLAR   V     T +V  T  Y APE    C
Sbjct: 130 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGC 185
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
           +  S   D++S G +  E+++ +R+L P  SE    F I
Sbjct: 186 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 223

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 96.3 bits (238), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 111/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
           NF     IG G +G  YKA   + G +VA+KK+ +    +G+      EI  L  + H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V L+     E +++LV+ FL   +L+ F+   +   I   +I      + Q LA+ H  
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
              R++HRD+KP N+L++ E    L+DFGLAR   V     T +V  T  Y APE    C
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGC 178
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
           +  S   D++S G +  E+++ +R+L P  SE    F I
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 216

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 96.3 bits (238), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 111/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
           NF     IG G +G  YKA   + G +VA+KK+ +    +G+      EI  L  + H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V L+     E +++LV+ FL   +L+ F+   +   I   +I      + Q LA+ H  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
              R++HRD+KP N+L++ E    L+DFGLAR   V     T +V  T  Y APE    C
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGC 177
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
           +  S   D++S G +  E+++ +R+L P  SE    F I
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 215

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 96.3 bits (238), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 111/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
           NF     IG G +G  YKA   + G +VA+KK+ +    +G+      EI  L  + H N
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V L+     E +++LV+ FL   +L+TF+   +   I   +I      + Q LA+ H  
Sbjct: 67  IVKLLDVIHTENKLYLVFEFLHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
              R++HRD+KP N+L++ E    L+DFGLAR   V       +V  T  Y APE    C
Sbjct: 126 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 181
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
           +  S   D++S G +  E+++ +R+L P  SE    F I
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 219

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 96.3 bits (238), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 111/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
           NF     IG G +G  YKA   + G +VA+KK+ +    +G+      EI  L  + H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V L+     E +++LV+ FL   +L+ F+   +   I   +I      + Q LA+ H  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
              R++HRD+KP N+L++ E    L+DFGLAR   V     T +V  T  Y APE    C
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGC 177
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
           +  S   D++S G +  E+++ +R+L P  SE    F I
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 215

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 95.9 bits (237), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 111/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
           NF     IG G +G  YKA   + G +VA+KK+ +    +G+      EI  L  + H N
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V L+     E +++LV+ FL   +L+ F+   +   I   +I      + Q LA+ H  
Sbjct: 65  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
              R++HRD+KP N+L++ E    L+DFGLAR   V     T +V  T  Y APE    C
Sbjct: 124 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGC 179
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
           +  S   D++S G +  E+++ +R+L P  SE    F I
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 217

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 95.9 bits (237), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 111/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
           NF     IG G +G  YKA   + G +VA+KK+ +    +G+      EI  L  + H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V L+     E +++LV+ FL   +L+ F+   +   I   +I      + Q LA+ H  
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
              R++HRD+KP N+L++ E    L+DFGLAR   V     T +V  T  Y APE    C
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGC 178
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
           +  S   D++S G +  E+++ +R+L P  SE    F I
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 216

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 95.9 bits (237), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 111/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
           NF     IG G +G  YKA   + G +VA+KK+ +    +G+      EI  L  + H N
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V L+     E +++LV+ FLS  +L+ F+   +   I   +I      + Q LA+ H  
Sbjct: 67  IVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
              R++HRD+KP N+L++ E    L+DFGLAR   V       +V  T  Y APE    C
Sbjct: 126 ---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 181
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
           +  S   D++S G +  E+++ +R+L P  SE    F I
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 219

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 111/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
           NF     IG G +G  YKA   + G +VA+KK+ +    +G+      EI  L  + H N
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V L+     E +++LV+ FLS  +L+ F+   +   I   +I      + Q LA+ H  
Sbjct: 65  IVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
              R++HRD+KP N+L++ E    L+DFGLAR   V       +V  T  Y APE    C
Sbjct: 124 ---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 179
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
           +  S   D++S G +  E+++ +R+L P  SE    F I
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 217

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 111/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
           NF     IG G +G  YKA   + G +VA+KK+ +    +G+      EI  L  + H N
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V L+     E +++LV+ FLS  +L+ F+   +   I   +I      + Q LA+ H  
Sbjct: 67  IVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
              R++HRD+KP N+L++ E    L+DFGLAR   V       +V  T  Y APE    C
Sbjct: 126 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 181
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
           +  S   D++S G +  E+++ +R+L P  SE    F I
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 219

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 111/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
           NF     IG G +G  YKA   + G +VA+KK+ +    +G+      EI  L  + H N
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 65
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V L+     E +++LV+ FLS  +L+ F+   +   I   +I      + Q LA+ H  
Sbjct: 66  IVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
              R++HRD+KP N+L++ E    L+DFGLAR   V       +V  T  Y APE    C
Sbjct: 125 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 180
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
           +  S   D++S G +  E+++ +R+L P  SE    F I
Sbjct: 181 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 218

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 111/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
           NF     IG G +G  YKA   + G +VA+KK+ +    +G+      EI  L  + H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V L+     E +++LV+ FL   +L+ F+   +   I   +I      + Q L++ H  
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSH 122
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
              R++HRD+KP N+L++ E    L+DFGLAR   V     T +V  T  Y APE    C
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGC 178
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
           +  S   D++S G +  E+++ +R+L P  SE    F I
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 216

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/230 (31%), Positives = 113/230 (49%), Gaps = 27/230 (11%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKAELVPGY-LVAVKKLSIGRFQG-------IQQFDAEIGT 824
           A         IG GGFG  +K  LV    +VA+K L +G  +G        Q+F  E+  
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 825 LGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQ 884
           +  + H N+V L G       M  V  F+  G+L   +  K+   I+WSV  ++ +DIA 
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIAL 133
Query: 885 ALAYLHYSCVPRIVHRDIKPSNILL---DEE--LNAYLSDFGLARLLEVSETHATTDVAG 939
            + Y+     P IVHRD++  NI L   DE   + A ++DFGL++       H+ + + G
Sbjct: 134 GIEYMQNQNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLG 188
Query: 940 TFGYVAPEY--ATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNG 987
            F ++APE   A     ++KAD YSF ++L  +++G+   D    EY  G
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD----EYSYG 234

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
           NF     IG G +G  YKA   + G +VA+KK+ +    +G+      EI  L  + H N
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 67
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V L+     E +++LV+ FL   +L+ F+   +   I   +I      + Q LA+ H  
Sbjct: 68  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 126
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
              R++HRD+KP N+L++ E    L+DFGLAR   V       +V  T  Y APE    C
Sbjct: 127 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 182
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
           +  S   D++S G +  E+++ +R+L P  SE    F I
Sbjct: 183 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 220

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
           NF     IG G +G  YKA   + G +VA+KK+ +    +G+      EI  L  + H N
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V L+     E +++LV+ FL   +L+ F+   +   I   +I      + Q LA+ H  
Sbjct: 67  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
              R++HRD+KP N+L++ E    L+DFGLAR   V       +V  T  Y APE    C
Sbjct: 126 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 181
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
           +  S   D++S G +  E+++ +R+L P  SE    F I
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 219

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
           NF     IG G +G  YKA   + G +VA+KK+ +    +G+      EI  L  + H N
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 65
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V L+     E +++LV+ FL   +L+ F+   +   I   +I      + Q LA+ H  
Sbjct: 66  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
              R++HRD+KP N+L++ E    L+DFGLAR   V       +V  T  Y APE    C
Sbjct: 125 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 180
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
           +  S   D++S G +  E+++ +R+L P  SE    F I
Sbjct: 181 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 218

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
           NF     IG G +G  YKA   + G +VA+KK+ +    +G+      EI  L  + H N
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 65
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V L+     E +++LV+ FL   +L+ F+   +   I   +I      + Q LA+ H  
Sbjct: 66  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
              R++HRD+KP N+L++ E    L+DFGLAR   V       +V  T  Y APE    C
Sbjct: 125 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 180
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
           +  S   D++S G +  E+++ +R+L P  SE    F I
Sbjct: 181 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 218

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 94.0 bits (232), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 111/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
           NF     IG G +G  YKA   + G +VA+KK+ +    +G+      EI  L  + H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V L+     E +++LV+  +   +L+TF+   +   I   +I      + Q LA+ H  
Sbjct: 63  IVKLLDVIHTENKLYLVFEHVHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
              R++HRD+KP N+L++ E    L+DFGLAR   V     T +V  T  Y APE    C
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGC 177
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
           +  S   D++S G +  E+++ +R+L P  SE    F I
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 215

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 94.0 bits (232), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
           NF     IG G +G  YKA   + G +VA+KK+ +    +G+      EI  L  + H N
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V L+     E +++LV+ FL   +L+ F+   +   I   +I      + Q LA+ H  
Sbjct: 65  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
              R++HRD+KP N+L++ E    L+DFGLAR   V       +V  T  Y APE    C
Sbjct: 124 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 179
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
           +  S   D++S G +  E+++ +R+L P  SE    F I
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 217

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 94.0 bits (232), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
           NF     IG G +G  YKA   + G +VA+KK+ +    +G+      EI  L  + H N
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V L+     E +++LV+ FL   +L+ F+   +   I   +I      + Q LA+ H  
Sbjct: 67  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
              R++HRD+KP N+L++ E    L+DFGLAR   V       +V  T  Y APE    C
Sbjct: 126 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 181
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
           +  S   D++S G +  E+++ +R+L P  SE    F I
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 219

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 94.0 bits (232), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
           NF     IG G +G  YKA   + G +VA+KK+ +    +G+      EI  L  + H N
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 65
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V L+     E +++LV+ FL   +L+ F+   +   I   +I      + Q LA+ H  
Sbjct: 66  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
              R++HRD+KP N+L++ E    L+DFGLAR   V       +V  T  Y APE    C
Sbjct: 125 ---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 180
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
           +  S   D++S G +  E+++ +R+L P  SE    F I
Sbjct: 181 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 218

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 94.0 bits (232), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
           NF     IG G +G  YKA   + G +VA+KK+ +    +G+      EI  L  + H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V L+     E +++LV+ FL   +L+ F+   +   I   +I      + Q LA+ H  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
              R++HRD+KP N+L++ E    L+DFGLAR   V       +V  T  Y APE    C
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 177
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
           +  S   D++S G +  E+++ +R+L P  SE    F I
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 215

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 94.0 bits (232), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
           NF     IG G +G  YKA   + G +VA+KK+ +    +G+      EI  L  + H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V L+     E +++LV+ FL   +L+ F+   +   I   +I      + Q LA+ H  
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
              R++HRD+KP N+L++ E    L+DFGLAR   V       +V  T  Y APE    C
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 178
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
           +  S   D++S G +  E+++ +R+L P  SE    F I
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 216

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 94.0 bits (232), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
           NF     IG G +G  YKA   + G +VA+KK+ +    +G+      EI  L  + H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V L+     E +++LV+ FL   +L+ F+   +   I   +I      + Q LA+ H  
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
              R++HRD+KP N+L++ E    L+DFGLAR   V       +V  T  Y APE    C
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 178
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
           +  S   D++S G +  E+++ +R+L P  SE    F I
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 216

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 94.0 bits (232), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
           NF     IG G +G  YKA   + G +VA+KK+ +    +G+      EI  L  + H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V L+     E +++LV+ FL   +L+ F+   +   I   +I      + Q LA+ H  
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
              R++HRD+KP N+L++ E    L+DFGLAR   V       +V  T  Y APE    C
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 178
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
           +  S   D++S G +  E+++ +R+L P  SE    F I
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 216

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 94.0 bits (232), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
           NF     IG G +G  YKA   + G +VA+KK+ +    +G+      EI  L  + H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V L+     E +++LV+ FL   +L+ F+   +   I   +I      + Q LA+ H  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
              R++HRD+KP N+L++ E    L+DFGLAR   V       +V  T  Y APE    C
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 177
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
           +  S   D++S G +  E+++ +R+L P  SE    F I
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 215

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 94.0 bits (232), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
           NF     IG G +G  YKA   + G +VA+KK+ +    +G+      EI  L  + H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V L+     E +++LV+ FL   +L+ F+   +   I   +I      + Q LA+ H  
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
              R++HRD+KP N+L++ E    L+DFGLAR   V       +V  T  Y APE    C
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 178
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
           +  S   D++S G +  E+++ +R+L P  SE    F I
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 216

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 94.0 bits (232), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
           NF     IG G +G  YKA   + G +VA+KK+ +    +G+      EI  L  + H N
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V L+     E +++LV+ FL   +L+ F+   +   I   +I      + Q LA+ H  
Sbjct: 65  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
              R++HRD+KP N+L++ E    L+DFGLAR   V       +V  T  Y APE    C
Sbjct: 124 ---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 179
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
           +  S   D++S G +  E+++ +R+L P  SE    F I
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 217

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 94.0 bits (232), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
           NF     IG G +G  YKA   + G +VA+ K+ +    +G+      EI  L  + H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V L+     E +++LV+ FL   +L+ F+   +   I   +I      + Q LA+ H  
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
              R++HRD+KP N+L++ E    L+DFGLAR   V     T +V  T  Y APE    C
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGC 178
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
           +  S   D++S G +  E+++ +R+L P  SE    F I
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 216

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 94.0 bits (232), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
           NF     IG G +G  YKA   + G +VA+ K+ +    +G+      EI  L  + H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V L+     E +++LV+ FL   +L+ F+   +   I   +I      + Q LA+ H  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
              R++HRD+KP N+L++ E    L+DFGLAR   V     T +V  T  Y APE    C
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGC 177
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
           +  S   D++S G +  E+++ +R+L P  SE    F I
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 215

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 94.0 bits (232), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 101/200 (50%), Gaps = 5/200 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  +         VA+K L  G     + F  E   + +++H  LV L    V 
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSP-ESFLEEAQIMKKLKHDKLVQLYAV-VS 74
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           E  +++V  +++ G+L  F+    G+ ++   +  +A  +A  +AY+        +HRD+
Sbjct: 75  EEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDL 131
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
           + +NIL+   L   ++DFGLARL+E +E  A         + APE A   R + K+DV+S
Sbjct: 132 RSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 191
Query: 963 FGVVLLELISGKRSLDPSFS 982
           FG++L EL++  R   P  +
Sbjct: 192 FGILLTELVTKGRVPYPGMN 211

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 94.0 bits (232), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
           NF     IG G +G  YKA   + G +VA+KK+ +    +G+      EI  L  + H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V L+     E +++LV+ FL   +L+ F+   +   I   +I      + Q LA+ H  
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQ-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
              R++HRD+KP N+L++ E    L+DFGLAR   V       +V  T  Y APE    C
Sbjct: 123 ---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 178
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
           +  S   D++S G +  E+++ +R+L P  SE    F I
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 216

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 93.6 bits (231), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
           NF     IG G +G  YKA   + G +VA+KK+ +    +G+      EI  L  + H N
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V L+     E +++LV+ FL   +L+ F+   +   I   +I      + Q LA+ H  
Sbjct: 65  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
              R++HRD+KP N+L++ E    L+DFGLAR   V       +V  T  Y APE    C
Sbjct: 124 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 179
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
           +  S   D++S G +  E+++ +R+L P  SE    F I
Sbjct: 180 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 217

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/230 (31%), Positives = 112/230 (48%), Gaps = 27/230 (11%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKAELVPGY-LVAVKKLSIGRFQG-------IQQFDAEIGT 824
           A         IG GGFG  +K  LV    +VA+K L +G  +G        Q+F  E+  
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 825 LGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQ 884
           +  + H N+V L G       M  V  F+  G+L   +  K+   I+WSV  ++ +DIA 
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIAL 133
Query: 885 ALAYLHYSCVPRIVHRDIKPSNILL---DEE--LNAYLSDFGLARLLEVSETHATTDVAG 939
            + Y+     P IVHRD++  NI L   DE   + A ++DFG ++       H+ + + G
Sbjct: 134 GIEYMQNQNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ----QSVHSVSGLLG 188
Query: 940 TFGYVAPEY--ATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNG 987
            F ++APE   A     ++KAD YSF ++L  +++G+   D    EY  G
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD----EYSYG 234

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/230 (31%), Positives = 112/230 (48%), Gaps = 27/230 (11%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKAELVPGY-LVAVKKLSIGRFQG-------IQQFDAEIGT 824
           A         IG GGFG  +K  LV    +VA+K L +G  +G        Q+F  E+  
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 825 LGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQ 884
           +  + H N+V L G       M  V  F+  G+L   +  K+   I+WSV  ++ +DIA 
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIAL 133
Query: 885 ALAYLHYSCVPRIVHRDIKPSNILL---DEE--LNAYLSDFGLARLLEVSETHATTDVAG 939
            + Y+     P IVHRD++  NI L   DE   + A ++DF L++       H+ + + G
Sbjct: 134 GIEYMQNQNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ----QSVHSVSGLLG 188
Query: 940 TFGYVAPEY--ATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNG 987
            F ++APE   A     ++KAD YSF ++L  +++G+   D    EY  G
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD----EYSYG 234

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 58/200 (29%), Positives = 103/200 (51%), Gaps = 5/200 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  +         VAVK L  G       F AE   + +++H+ LV L    V 
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV-VT 86
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           +  ++++  ++  G+L  F+   SG K+  + +  +A  IA+ +A++        +HRD+
Sbjct: 87  QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 143
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
           + +NIL+ + L+  ++DFGLARL+E +E  A         + APE       + K+DV+S
Sbjct: 144 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 203
Query: 963 FGVVLLELISGKRSLDPSFS 982
           FG++L E+++  R   P  +
Sbjct: 204 FGILLTEIVTHGRIPYPGMT 223

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 58/200 (29%), Positives = 103/200 (51%), Gaps = 5/200 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  +         VAVK L  G       F AE   + +++H+ LV L    V 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV-VT 84
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           +  ++++  ++  G+L  F+   SG K+  + +  +A  IA+ +A++        +HRD+
Sbjct: 85  QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 141
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
           + +NIL+ + L+  ++DFGLARL+E +E  A         + APE       + K+DV+S
Sbjct: 142 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 201
Query: 963 FGVVLLELISGKRSLDPSFS 982
           FG++L E+++  R   P  +
Sbjct: 202 FGILLTEIVTHGRIPYPGMT 221

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 58/200 (29%), Positives = 103/200 (51%), Gaps = 5/200 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  +         VAVK L  G       F AE   + +++H+ LV L    V 
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV-VT 80
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           +  ++++  ++  G+L  F+   SG K+  + +  +A  IA+ +A++        +HRD+
Sbjct: 81  QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 137
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
           + +NIL+ + L+  ++DFGLARL+E +E  A         + APE       + K+DV+S
Sbjct: 138 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 197
Query: 963 FGVVLLELISGKRSLDPSFS 982
           FG++L E+++  R   P  +
Sbjct: 198 FGILLTEIVTHGRIPYPGMT 217

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 58/200 (29%), Positives = 103/200 (51%), Gaps = 5/200 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  +         VAVK L  G       F AE   + +++H+ LV L    V 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV-VT 78
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           +  ++++  ++  G+L  F+   SG K+  + +  +A  IA+ +A++        +HRD+
Sbjct: 79  QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 135
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
           + +NIL+ + L+  ++DFGLARL+E +E  A         + APE       + K+DV+S
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 963 FGVVLLELISGKRSLDPSFS 982
           FG++L E+++  R   P  +
Sbjct: 196 FGILLTEIVTHGRIPYPGMT 215

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 58/200 (29%), Positives = 103/200 (51%), Gaps = 5/200 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  +         VAVK L  G       F AE   + +++H+ LV L    V 
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV-VT 87
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           +  ++++  ++  G+L  F+   SG K+  + +  +A  IA+ +A++        +HRD+
Sbjct: 88  QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 144
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
           + +NIL+ + L+  ++DFGLARL+E +E  A         + APE       + K+DV+S
Sbjct: 145 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 204
Query: 963 FGVVLLELISGKRSLDPSFS 982
           FG++L E+++  R   P  +
Sbjct: 205 FGILLTEIVTHGRIPYPGMT 224

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 92.0 bits (227), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 103/200 (51%), Gaps = 5/200 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  +         VAVK L  G       F AE   + +++H+ LV L    V 
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV-VT 79
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           +  ++++  ++  G+L  F+   SG K+  + +  +A  IA+ +A++        +HRD+
Sbjct: 80  QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 136
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
           + +NIL+ + L+  ++DFGLARL+E +E  A         + APE       + K+DV+S
Sbjct: 137 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 196
Query: 963 FGVVLLELISGKRSLDPSFS 982
           FG++L E+++  R   P  +
Sbjct: 197 FGILLTEIVTHGRIPYPGMT 216

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
           NF     IG G +G  YKA   + G +VA+KK+ +    +G+      EI  L  + H N
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 70
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V L+     E +++LV+ FL   +L+ F+   +   I   +I      + Q LA+ H  
Sbjct: 71  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 129
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
              R++HRD+KP N+L++ E    L+DFGLAR   V     T +V  T  Y APE     
Sbjct: 130 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGX 185
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
           +  S   D++S G +  E+++ +R+L P  SE    F I
Sbjct: 186 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 223

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 58/200 (29%), Positives = 103/200 (51%), Gaps = 5/200 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  +         VAVK L  G       F AE   + +++H+ LV L    V 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV-VT 84
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           +  ++++  ++  G+L  F+   SG K+  + +  +A  IA+ +A++        +HRD+
Sbjct: 85  QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 141
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
           + +NIL+ + L+  ++DFGLARL+E +E  A         + APE       + K+DV+S
Sbjct: 142 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 201
Query: 963 FGVVLLELISGKRSLDPSFS 982
           FG++L E+++  R   P  +
Sbjct: 202 FGILLTEIVTHGRIPYPGMT 221

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 58/200 (29%), Positives = 103/200 (51%), Gaps = 5/200 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  +         VAVK L  G       F AE   + +++H+ LV L    V 
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV-VT 88
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           +  ++++  ++  G+L  F+   SG K+  + +  +A  IA+ +A++        +HRD+
Sbjct: 89  QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 145
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
           + +NIL+ + L+  ++DFGLARL+E +E  A         + APE       + K+DV+S
Sbjct: 146 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 205
Query: 963 FGVVLLELISGKRSLDPSFS 982
           FG++L E+++  R   P  +
Sbjct: 206 FGILLTEIVTHGRIPYPGMT 225

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 58/200 (29%), Positives = 103/200 (51%), Gaps = 5/200 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  +         VAVK L  G       F AE   + +++H+ LV L    V 
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV-VT 83
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           +  ++++  ++  G+L  F+   SG K+  + +  +A  IA+ +A++        +HRD+
Sbjct: 84  QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 140
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
           + +NIL+ + L+  ++DFGLARL+E +E  A         + APE       + K+DV+S
Sbjct: 141 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 200
Query: 963 FGVVLLELISGKRSLDPSFS 982
           FG++L E+++  R   P  +
Sbjct: 201 FGILLTEIVTHGRIPYPGMT 220

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 54/190 (28%), Positives = 95/190 (50%), Gaps = 4/190 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  +         VAVK L  G    +Q F  E   +  ++H  LV L      
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           E  ++++  +++ G+L  F+    G K+    +   +  IA+ +AY+        +HRD+
Sbjct: 80  EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDL 136
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
           + +N+L+ E L   ++DFGLAR++E +E  A         + APE       + K+DV+S
Sbjct: 137 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDVWS 196
Query: 963 FGVVLLELIS 972
           FG++L E+++
Sbjct: 197 FGILLYEIVT 206

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 103/200 (51%), Gaps = 5/200 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  +         VAVK L  G       F AE   + +++H+ LV L    V 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV-VT 78
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           +  ++++  ++  G+L  F+   SG K+  + +  +A  IA+ +A++        +HRD+
Sbjct: 79  QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 135
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
           + +NIL+ + L+  ++DFGLARL+E +E  A         + APE       + K+DV+S
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 963 FGVVLLELISGKRSLDPSFS 982
           FG++L E+++  R   P  +
Sbjct: 196 FGILLTEIVTHGRIPYPGMT 215

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
           NF     IG G +G  YKA   + G +VA+KK+ +    +G+      EI  L  + H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V L+     E +++LV+ FL   +L+ F+   +   I   +I      + Q LA+ H  
Sbjct: 64  IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
              R++HRD+KP N+L++ E    L+DFGLAR   V     T +V  T  Y APE     
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGX 178
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
           +  S   D++S G +  E+++ +R+L P  SE    F I
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 216

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 54/190 (28%), Positives = 95/190 (50%), Gaps = 4/190 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  +         VAVK L  G    +Q F  E   +  ++H  LV L      
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           E  ++++  F++ G+L  F+    G K+    +   +  IA+ +AY+        +HRD+
Sbjct: 79  EEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDL 135
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
           + +N+L+ E L   ++DFGLAR++E +E  A         + APE       + K++V+S
Sbjct: 136 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNVWS 195
Query: 963 FGVVLLELIS 972
           FG++L E+++
Sbjct: 196 FGILLYEIVT 205

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 76/280 (27%), Positives = 129/280 (46%), Gaps = 22/280 (7%)
Query: 762  PAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDA 820
            P+   YD       + ++++ +G G +G  Y+       L VAVK L     + +++F  
Sbjct: 5    PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLK 63
Query: 821  EIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI 880
            E   +  I+H NLV L+G    E   +++  F++ GNL  ++ + + +++   V+  +A 
Sbjct: 64   EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 123
Query: 881  DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT 940
             I+ A+ YL        +HRD+   N L+ E     ++DFGL+RL+      A       
Sbjct: 124  QISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFP 180
Query: 941  FGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE 1000
              + APE     + S K+DV++FGV+L E+ +   S  P       G ++    +LL K+
Sbjct: 181  IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKD 233
Query: 1001 GRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
             R      PE    G  E +  +MR    C     S RPS
Sbjct: 234  YRMER---PE----GCPEKVYELMR---ACWQWNPSDRPS 263

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 91.3 bits (225), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 103/200 (51%), Gaps = 5/200 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  +         VAVK L  G       F AE   + +++H+ LV L    V 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV-VT 78
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           +  ++++  ++  G+L  F+   SG K+  + +  +A  IA+ +A++        +HRD+
Sbjct: 79  QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 135
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
           + +NIL+ + L+  ++DFGLARL+E +E  A         + APE       + K+DV+S
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 963 FGVVLLELISGKRSLDPSFS 982
           FG++L E+++  R   P  +
Sbjct: 196 FGILLTEIVTHGRIPYPGMT 215

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 91.3 bits (225), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 103/200 (51%), Gaps = 5/200 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  +         VAVK L  G       F AE   + +++H+ LV L    V 
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV-VT 73
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           +  ++++  ++  G+L  F+   SG K+  + +  +A  IA+ +A++        +HRD+
Sbjct: 74  QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 130
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
           + +NIL+ + L+  ++DFGLARL+E +E  A         + APE       + K+DV+S
Sbjct: 131 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 190
Query: 963 FGVVLLELISGKRSLDPSFS 982
           FG++L E+++  R   P  +
Sbjct: 191 FGILLTEIVTHGRIPYPGMT 210

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 91.3 bits (225), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 100/223 (44%), Gaps = 34/223 (15%)
Query: 772 RATGNFSIRNL-----IGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDAE 821
           R    F  R+L     +G G FGS       P     G +VAVKKL     + ++ F+ E
Sbjct: 5   RDPTQFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 64
Query: 822 IGTLGRIRHKNLVTLIG--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
           I  L  ++H N+V   G  Y  G   + L+  FL  G+L  ++ K           HK  
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQK-----------HKER 113
Query: 880 IDIAQALAY-------LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH 932
           ID  + L Y       + Y    R +HRD+   NIL++ E    + DFGL ++L   +  
Sbjct: 114 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 173
Query: 933 ATTDVAGT---FGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
                 G    F Y APE  T  + S  +DV+SFGVVL EL +
Sbjct: 174 XKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 76/280 (27%), Positives = 129/280 (46%), Gaps = 22/280 (7%)
Query: 762  PAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDA 820
            P+   YD       + ++++ +G G +G  Y+       L VAVK L     + +++F  
Sbjct: 5    PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLK 63
Query: 821  EIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI 880
            E   +  I+H NLV L+G    E   +++  F++ GNL  ++ + + +++   V+  +A 
Sbjct: 64   EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 123
Query: 881  DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT 940
             I+ A+ YL        +HRD+   N L+ E     ++DFGL+RL+      A       
Sbjct: 124  QISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 180
Query: 941  FGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE 1000
              + APE     + S K+DV++FGV+L E+ +   S  P       G ++    +LL K+
Sbjct: 181  IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKD 233
Query: 1001 GRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
             R      PE    G  E +  +MR    C     S RPS
Sbjct: 234  YRMER---PE----GCPEKVYELMR---ACWQWNPSDRPS 263

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 76/280 (27%), Positives = 129/280 (46%), Gaps = 22/280 (7%)
Query: 762  PAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDA 820
            P+   YD       + ++++ +G G +G  Y+       L VAVK L     + +++F  
Sbjct: 5    PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLK 63
Query: 821  EIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI 880
            E   +  I+H NLV L+G    E   +++  F++ GNL  ++ + + +++   V+  +A 
Sbjct: 64   EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 123
Query: 881  DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT 940
             I+ A+ YL        +HRD+   N L+ E     ++DFGL+RL+      A       
Sbjct: 124  QISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 180
Query: 941  FGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE 1000
              + APE     + S K+DV++FGV+L E+ +   S  P       G ++    +LL K+
Sbjct: 181  IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKD 233
Query: 1001 GRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
             R      PE    G  E +  +MR    C     S RPS
Sbjct: 234  YRMER---PE----GCPEKVYELMR---ACWQWNPSDRPS 263

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 76/280 (27%), Positives = 129/280 (46%), Gaps = 22/280 (7%)
Query: 762  PAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDA 820
            P+   YD       + ++++ +G G +G  Y+       L VAVK L     + +++F  
Sbjct: 5    PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLK 63
Query: 821  EIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI 880
            E   +  I+H NLV L+G    E   +++  F++ GNL  ++ + + +++   V+  +A 
Sbjct: 64   EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 123
Query: 881  DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT 940
             I+ A+ YL        +HRD+   N L+ E     ++DFGL+RL+      A       
Sbjct: 124  QISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 180
Query: 941  FGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE 1000
              + APE     + S K+DV++FGV+L E+ +   S  P       G ++    +LL K+
Sbjct: 181  IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKD 233
Query: 1001 GRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
             R      PE    G  E +  +MR    C     S RPS
Sbjct: 234  YRMER---PE----GCPEKVYELMR---ACWQWNPSDRPS 263

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 76/280 (27%), Positives = 129/280 (46%), Gaps = 22/280 (7%)
Query: 762  PAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDA 820
            P+   YD       + ++++ +G G +G  Y+       L VAVK L     + +++F  
Sbjct: 5    PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLK 63
Query: 821  EIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI 880
            E   +  I+H NLV L+G    E   +++  F++ GNL  ++ + + +++   V+  +A 
Sbjct: 64   EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 123
Query: 881  DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT 940
             I+ A+ YL        +HRD+   N L+ E     ++DFGL+RL+      A       
Sbjct: 124  QISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 180
Query: 941  FGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE 1000
              + APE     + S K+DV++FGV+L E+ +   S  P       G ++    +LL K+
Sbjct: 181  IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKD 233
Query: 1001 GRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
             R      PE    G  E +  +MR    C     S RPS
Sbjct: 234  YRMER---PE----GCPEKVYELMR---ACWQWNPSDRPS 263

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 90.9 bits (224), Expect = 4e-18,   Method: Composition-based stats.
 Identities = 67/227 (29%), Positives = 110/227 (48%), Gaps = 27/227 (11%)
Query: 777 FSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSI---GRFQGIQQFDAEIGTLGRIRHKN 832
           + I + +G GG  + Y AE  +    VA+K + I    + + +++F+ E+    ++ H+N
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIA-----QALA 887
           +V++I     +   +LV  ++ G  L  +I               +++D A     Q L 
Sbjct: 73  IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG----------PLSVDTAINFTNQILD 122
Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE 947
            + ++   RIVHRDIKP NIL+D      + DFG+A+ L  +    T  V GT  Y +PE
Sbjct: 123 GIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE 182
Query: 948 YATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWA 994
            A      +  D+YS G+VL E++ G    +P F    NG   VS A
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVG----EPPF----NGETAVSIA 221

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 90.5 bits (223), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 108/231 (46%), Gaps = 24/231 (10%)
Query: 775 GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSI-------GRFQGIQQFDAEIGTLG 826
            NF I   IG G F   Y+A  L+ G  VA+KK+ I        R   I+    EI  L 
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIK----EIDLLK 87
Query: 827 RIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIH--KKSGKKIQWSVIHKIAIDIAQ 884
           ++ H N++     ++ + E+ +V      G+L   I   KK  + I    + K  + +  
Sbjct: 88  QLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS 147
Query: 885 ALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYV 944
           AL ++H     R++HRDIKP+N+ +       L D GL R    S+T A   + GT  Y+
Sbjct: 148 ALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYM 203
Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAK 995
           +PE       + K+D++S G +L E+     +L   F  YG+  N+ S  K
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMA----ALQSPF--YGDKMNLYSLCK 248

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 90.5 bits (223), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 109/219 (49%), Gaps = 10/219 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-RFQGIQQFD-AEIGTLGRIRHKN 832
           NF     IG G +G  YKA   + G +VA+KK+ +    +G+      EI  L  + H N
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V L+     E +++LV+  +   +L+ F+   +   I   +I      + Q LA+ H  
Sbjct: 67  IVKLLDVIHTENKLYLVFEHVDQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
              R++HRD+KP N+L++ E    L+DFGLAR   V       +V  T  Y APE    C
Sbjct: 126 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 181
Query: 953 R-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
           +  S   D++S G +  E+++ +R+L P  SE    F I
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 219

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 70/224 (31%), Positives = 101/224 (45%), Gaps = 34/224 (15%)
Query: 771 VRATGNFSIRNL-----IGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDA 820
           +R    F  R+L     +G G FGS       P     G +VAVKKL     + ++ F+ 
Sbjct: 1   MRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 60
Query: 821 EIGTLGRIRHKNLVTLIG--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKI 878
           EI  L  ++H N+V   G  Y  G   + L+  +L  G+L  ++ K           HK 
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-----------HKE 109
Query: 879 AIDIAQALAY-------LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET 931
            ID  + L Y       + Y    R +HRD+   NIL++ E    + DFGL ++L   + 
Sbjct: 110 RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 169
Query: 932 HATTDVAGT---FGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
                  G    F Y APE  T  + S  +DV+SFGVVL EL +
Sbjct: 170 XXKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 90.1 bits (222), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 70/223 (31%), Positives = 100/223 (44%), Gaps = 34/223 (15%)
Query: 772 RATGNFSIRNL-----IGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDAE 821
           R    F  R+L     +G G FGS       P     G +VAVKKL     + ++ F+ E
Sbjct: 6   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 65
Query: 822 IGTLGRIRHKNLVTLIG--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
           I  L  ++H N+V   G  Y  G   + L+  +L  G+L  ++ K           HK  
Sbjct: 66  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-----------HKER 114
Query: 880 IDIAQALAY-------LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH 932
           ID  + L Y       + Y    R +HRD+   NIL++ E    + DFGL ++L   +  
Sbjct: 115 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 174
Query: 933 ATTDVAGT---FGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
                 G    F Y APE  T  + S  +DV+SFGVVL EL +
Sbjct: 175 XKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 90.1 bits (222), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 70/223 (31%), Positives = 100/223 (44%), Gaps = 34/223 (15%)
Query: 772 RATGNFSIRNL-----IGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDAE 821
           R    F  R+L     +G G FGS       P     G +VAVKKL     + ++ F+ E
Sbjct: 5   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 64
Query: 822 IGTLGRIRHKNLVTLIG--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
           I  L  ++H N+V   G  Y  G   + L+  +L  G+L  ++ K           HK  
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-----------HKER 113
Query: 880 IDIAQALAY-------LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH 932
           ID  + L Y       + Y    R +HRD+   NIL++ E    + DFGL ++L   +  
Sbjct: 114 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 173
Query: 933 ATTDVAGT---FGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
                 G    F Y APE  T  + S  +DV+SFGVVL EL +
Sbjct: 174 XKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 70/223 (31%), Positives = 100/223 (44%), Gaps = 34/223 (15%)
Query: 772 RATGNFSIRNL-----IGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDAE 821
           R    F  R+L     +G G FGS       P     G +VAVKKL     + ++ F+ E
Sbjct: 1   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 60
Query: 822 IGTLGRIRHKNLVTLIG--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
           I  L  ++H N+V   G  Y  G   + L+  +L  G+L  ++ K           HK  
Sbjct: 61  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-----------HKER 109
Query: 880 IDIAQALAY-------LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH 932
           ID  + L Y       + Y    R +HRD+   NIL++ E    + DFGL ++L   +  
Sbjct: 110 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 169
Query: 933 ATTDVAGT---FGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
                 G    F Y APE  T  + S  +DV+SFGVVL EL +
Sbjct: 170 XKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 70/223 (31%), Positives = 100/223 (44%), Gaps = 34/223 (15%)
Query: 772 RATGNFSIRNL-----IGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDAE 821
           R    F  R+L     +G G FGS       P     G +VAVKKL     + ++ F+ E
Sbjct: 9   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 68
Query: 822 IGTLGRIRHKNLVTLIG--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
           I  L  ++H N+V   G  Y  G   + L+  +L  G+L  ++ K           HK  
Sbjct: 69  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-----------HKER 117
Query: 880 IDIAQALAY-------LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH 932
           ID  + L Y       + Y    R +HRD+   NIL++ E    + DFGL ++L   +  
Sbjct: 118 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 177
Query: 933 ATTDVAGT---FGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
                 G    F Y APE  T  + S  +DV+SFGVVL EL +
Sbjct: 178 XKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 70/223 (31%), Positives = 100/223 (44%), Gaps = 34/223 (15%)
Query: 772 RATGNFSIRNL-----IGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDAE 821
           R    F  R+L     +G G FGS       P     G +VAVKKL     + ++ F+ E
Sbjct: 8   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 67
Query: 822 IGTLGRIRHKNLVTLIG--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
           I  L  ++H N+V   G  Y  G   + L+  +L  G+L  ++ K           HK  
Sbjct: 68  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-----------HKER 116
Query: 880 IDIAQALAY-------LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH 932
           ID  + L Y       + Y    R +HRD+   NIL++ E    + DFGL ++L   +  
Sbjct: 117 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 176
Query: 933 ATTDVAGT---FGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
                 G    F Y APE  T  + S  +DV+SFGVVL EL +
Sbjct: 177 XKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 114/229 (49%), Gaps = 25/229 (10%)
Query: 766 TYDNVVRATGNF---------SIRNLIGTGGFGSTYKAEL-VPGYL---VAVKKLSIGRF 812
           TY++  +A   F         +I  +IG G FG      L +PG     VA+K L +G  
Sbjct: 4   TYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYT 63
Query: 813 QGIQQ-FDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQ 871
           +  ++ F  E   +G+  H N++ L G       + +V  ++  G+L+TF+ K  G   Q
Sbjct: 64  EKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDG---Q 120
Query: 872 WSVIHKIAI--DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS 929
           ++VI  + +   I+  + YL        VHRD+   NIL++  L   +SDFGL+R+LE  
Sbjct: 121 FTVIQLVGMLRGISAGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDD 177
Query: 930 ETHATTDVAGTFG--YVAPEYATTCRVSDKADVYSFGVVLLELIS-GKR 975
              A T   G     + APE     + +  +DV+S+G+V+ E++S G+R
Sbjct: 178 PEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGER 226

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 89.7 bits (221), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 70/223 (31%), Positives = 100/223 (44%), Gaps = 34/223 (15%)
Query: 772 RATGNFSIRNL-----IGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDAE 821
           R    F  R+L     +G G FGS       P     G +VAVKKL     + ++ F+ E
Sbjct: 33  RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 92
Query: 822 IGTLGRIRHKNLVTLIG--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
           I  L  ++H N+V   G  Y  G   + L+  +L  G+L  ++ K           HK  
Sbjct: 93  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-----------HKER 141
Query: 880 IDIAQALAY-------LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH 932
           ID  + L Y       + Y    R +HRD+   NIL++ E    + DFGL ++L   +  
Sbjct: 142 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 201
Query: 933 ATTDVAGT---FGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
                 G    F Y APE  T  + S  +DV+SFGVVL EL +
Sbjct: 202 XKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 89.7 bits (221), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 70/223 (31%), Positives = 100/223 (44%), Gaps = 34/223 (15%)
Query: 772 RATGNFSIRNL-----IGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDAE 821
           R    F  R+L     +G G FGS       P     G +VAVKKL     + ++ F+ E
Sbjct: 7   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 66
Query: 822 IGTLGRIRHKNLVTLIG--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
           I  L  ++H N+V   G  Y  G   + L+  +L  G+L  ++ K           HK  
Sbjct: 67  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-----------HKER 115
Query: 880 IDIAQALAY-------LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH 932
           ID  + L Y       + Y    R +HRD+   NIL++ E    + DFGL ++L   +  
Sbjct: 116 IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEX 175
Query: 933 ATTDVAGT---FGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
                 G    F Y APE  T  + S  +DV+SFGVVL EL +
Sbjct: 176 XKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 89.7 bits (221), Expect = 8e-18,   Method: Composition-based stats.
 Identities = 57/200 (28%), Positives = 99/200 (49%), Gaps = 5/200 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  + A       VAVK +  G    ++ F AE   +  ++H  LV L      
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVTK 81
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           E  ++++  F++ G+L  F+    G K     +   +  IA+ +A++        +HRD+
Sbjct: 82  EP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDL 137
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
           + +NIL+   L   ++DFGLAR++E +E  A         + APE       + K+DV+S
Sbjct: 138 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 197
Query: 963 FGVVLLELISGKRSLDPSFS 982
           FG++L+E+++  R   P  S
Sbjct: 198 FGILLMEIVTYGRIPYPGMS 217

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 89.4 bits (220), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 103/200 (51%), Gaps = 5/200 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G FG  +         VAVK L  G       F AE   + +++H+ LV L    V 
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV-VT 74
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           +  ++++  ++  G+L  F+   SG K+  + +  +A  IA+ +A++        +HR++
Sbjct: 75  QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRNL 131
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
           + +NIL+ + L+  ++DFGLARL+E +E  A         + APE       + K+DV+S
Sbjct: 132 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 191
Query: 963 FGVVLLELISGKRSLDPSFS 982
           FG++L E+++  R   P  +
Sbjct: 192 FGILLTEIVTHGRIPYPGMT 211

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 89.4 bits (220), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 109/212 (51%), Gaps = 27/212 (12%)
Query: 780 RNLIGTGGFGSTYKAEL--------VPGYLVAVKKLSIGRFQGIQQFD--AEIGTLGRIR 829
           + +IG G FG  YK  L        VP   VA+K L  G +   Q+ D   E G +G+  
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVP---VAIKTLKAG-YTEKQRVDFLGEAGIMGQFS 104
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALA 887
           H N++ L G       M ++  ++  G L+ F+ +K G   ++SV+  + +   IA  + 
Sbjct: 105 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMK 161
Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYV 944
           YL        VHRD+   NIL++  L   +SDFGL+R+LE  +  AT   +G      + 
Sbjct: 162 YLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE-DDPEATYTTSGGKIPIRWT 217
Query: 945 APEYATTCRVSDKADVYSFGVVLLELIS-GKR 975
           APE  +  + +  +DV+SFG+V+ E+++ G+R
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVMTYGER 249

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 89.4 bits (220), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 128/275 (46%), Gaps = 22/275 (8%)
Query: 767  YDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDAEIGTL 825
            YD       + ++++ +G G +G  Y+       L VAVK L     + +++F  E   +
Sbjct: 251  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 309
Query: 826  GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
              I+H NLV L+G    E   +++  F++ GNL  ++ + + +++   V+  +A  I+ A
Sbjct: 310  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 369
Query: 886  LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
            + YL        +HR++   N L+ E     ++DFGL+RL+      A         + A
Sbjct: 370  MEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 426
Query: 946  PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005
            PE     + S K+DV++FGV+L E+ +   S  P       G ++    +LL K+ R   
Sbjct: 427  PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKDYR--- 476
Query: 1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
            +  PE    G  E +  +MR    C     S RPS
Sbjct: 477  MERPE----GCPEKVYELMR---ACWQWNPSDRPS 504

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 89.4 bits (220), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 60/210 (28%), Positives = 106/210 (50%), Gaps = 9/210 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
           + ++++ +G G FG  Y+       L VAVK L     + +++F  E   +  I+H NLV
Sbjct: 12  DITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 70
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
            L+G    E   +++  F++ GNL  ++ + + +++   V+  +A  I+ A+ YL     
Sbjct: 71  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK-- 128
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV 954
              +HRD+   N L+ E     ++DFGL+RL+      A         + APE     + 
Sbjct: 129 -NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKF 187
Query: 955 SDKADVYSFGVVLLEL----ISGKRSLDPS 980
           S K+DV++FGV+L E+    +S    +DPS
Sbjct: 188 SIKSDVWAFGVLLWEIATYGMSPYPGIDPS 217

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 89.4 bits (220), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 95/207 (45%), Gaps = 29/207 (14%)
Query: 783 IGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLI 837
           +G G FGS       P     G +VAVKKL     + ++ F+ EI  L  ++H N+V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 838 G--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY------- 888
           G  Y  G   + L+  +L  G+L  ++ K           HK  ID  + L Y       
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQK-----------HKERIDHIKLLQYTSQICKG 126
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT---FGYVA 945
           + Y    R +HRD+   NIL++ E    + DFGL ++L   +        G    F Y A
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-A 185
Query: 946 PEYATTCRVSDKADVYSFGVVLLELIS 972
           PE  T  + S  +DV+SFGVVL EL +
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 89.4 bits (220), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 95/207 (45%), Gaps = 29/207 (14%)
Query: 783 IGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLI 837
           +G G FGS       P     G +VAVKKL     + ++ F+ EI  L  ++H N+V   
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 838 G--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY------- 888
           G  Y  G   + L+  +L  G+L  ++ K           HK  ID  + L Y       
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQK-----------HKERIDHIKLLQYTSQICKG 144
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT---FGYVA 945
           + Y    R +HRD+   NIL++ E    + DFGL ++L   +        G    F Y A
Sbjct: 145 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-A 203
Query: 946 PEYATTCRVSDKADVYSFGVVLLELIS 972
           PE  T  + S  +DV+SFGVVL EL +
Sbjct: 204 PESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 75/275 (27%), Positives = 127/275 (46%), Gaps = 22/275 (8%)
Query: 767  YDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDAEIGTL 825
            YD       + ++++ +G G +G  Y+       L VAVK L     + +++F  E   +
Sbjct: 6    YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 64
Query: 826  GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
              I+H NLV L+G    E   +++  F++ GNL  ++ + + +++   V+  +A  I+ A
Sbjct: 65   KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 124
Query: 886  LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
            + YL        +HRD+   N L+ E     ++DFGL+RL+      A         + A
Sbjct: 125  MEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTA 181
Query: 946  PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005
            PE     + S K+DV++FGV+L E+ +   S  P       G ++    +LL K+ R   
Sbjct: 182  PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKDYRMER 234
Query: 1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
               PE    G  E +  +MR    C     S RPS
Sbjct: 235  ---PE----GCPEKVYELMR---ACWQWNPSDRPS 259

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 95/207 (45%), Gaps = 29/207 (14%)
Query: 783 IGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLI 837
           +G G FGS       P     G +VAVKKL     + ++ F+ EI  L  ++H N+V   
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 838 G--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY------- 888
           G  Y  G   + L+  +L  G+L  ++ K           HK  ID  + L Y       
Sbjct: 76  GVCYSAGRRNLKLIMEYLPYGSLRDYLQK-----------HKERIDHIKLLQYTSQICKG 124
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT---FGYVA 945
           + Y    R +HRD+   NIL++ E    + DFGL ++L   +        G    F Y A
Sbjct: 125 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-A 183
Query: 946 PEYATTCRVSDKADVYSFGVVLLELIS 972
           PE  T  + S  +DV+SFGVVL EL +
Sbjct: 184 PESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 95/207 (45%), Gaps = 29/207 (14%)
Query: 783 IGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLI 837
           +G G FGS       P     G +VAVKKL     + ++ F+ EI  L  ++H N+V   
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 838 G--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY------- 888
           G  Y  G   + L+  +L  G+L  ++ K           HK  ID  + L Y       
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQK-----------HKERIDHIKLLQYTSQICKG 144
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT---FGYVA 945
           + Y    R +HRD+   NIL++ E    + DFGL ++L   +        G    F Y A
Sbjct: 145 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-A 203
Query: 946 PEYATTCRVSDKADVYSFGVVLLELIS 972
           PE  T  + S  +DV+SFGVVL EL +
Sbjct: 204 PESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 128/275 (46%), Gaps = 22/275 (8%)
Query: 767  YDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDAEIGTL 825
            YD       + ++++ +G G +G  Y+       L VAVK L     + +++F  E   +
Sbjct: 212  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 270
Query: 826  GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
              I+H NLV L+G    E   +++  F++ GNL  ++ + + +++   V+  +A  I+ A
Sbjct: 271  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 330
Query: 886  LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
            + YL        +HR++   N L+ E     ++DFGL+RL+      A         + A
Sbjct: 331  MEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 387
Query: 946  PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005
            PE     + S K+DV++FGV+L E+ +   S  P       G ++    +LL K+ R   
Sbjct: 388  PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKDYR--- 437
Query: 1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
            +  PE    G  E +  +MR    C     S RPS
Sbjct: 438  MERPE----GCPEKVYELMR---ACWQWNPSDRPS 465

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 5/207 (2%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
           +  +   +G G FG  + A       VAVK +  G    ++ F AE   +  ++H  LV 
Sbjct: 189 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVK 247
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
           L      E  ++++  F++ G+L  F+    G K     +   +  IA+ +A++      
Sbjct: 248 LHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR--- 303
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVS 955
             +HRD++ +NIL+   L   ++DFGLAR++E +E  A         + APE       +
Sbjct: 304 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 363
Query: 956 DKADVYSFGVVLLELISGKRSLDPSFS 982
            K+DV+SFG++L+E+++  R   P  S
Sbjct: 364 IKSDVWSFGILLMEIVTYGRIPYPGMS 390

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 57/200 (28%), Positives = 102/200 (51%), Gaps = 5/200 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +G G  G  +         VAVK L  G       F AE   + +++H+ LV L    V 
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV-VT 78
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           +  ++++  ++  G+L  F+   SG K+  + +  +A  IA+ +A++        +HRD+
Sbjct: 79  QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 135
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
           + +NIL+ + L+  ++DFGLARL+E +E  A         + APE       + K+DV+S
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 963 FGVVLLELISGKRSLDPSFS 982
           FG++L E+++  R   P  +
Sbjct: 196 FGILLTEIVTHGRIPYPGMT 215

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 75/275 (27%), Positives = 127/275 (46%), Gaps = 22/275 (8%)
Query: 767  YDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDAEIGTL 825
            YD       + ++++ +G G +G  Y+       L VAVK L     + +++F  E   +
Sbjct: 6    YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 64
Query: 826  GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
              I+H NLV L+G    E   +++  F++ GNL  ++ + + +++   V+  +A  I+ A
Sbjct: 65   KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 124
Query: 886  LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
            + YL        +HRD+   N L+ E     ++DFGL+RL+      A         + A
Sbjct: 125  MEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTA 181
Query: 946  PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005
            PE     + S K+DV++FGV+L E+ +   S  P       G ++    +LL K+ R   
Sbjct: 182  PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKDYRMER 234
Query: 1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
               PE    G  E +  +MR    C     S RPS
Sbjct: 235  ---PE----GCPEKVYELMR---ACWQWNPSDRPS 259

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 75/275 (27%), Positives = 127/275 (46%), Gaps = 22/275 (8%)
Query: 767  YDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDAEIGTL 825
            YD       + ++++ +G G +G  Y+       L VAVK L     + +++F  E   +
Sbjct: 7    YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 65
Query: 826  GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
              I+H NLV L+G    E   +++  F++ GNL  ++ + + +++   V+  +A  I+ A
Sbjct: 66   KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 125
Query: 886  LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
            + YL        +HRD+   N L+ E     ++DFGL+RL+      A         + A
Sbjct: 126  MEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTA 182
Query: 946  PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005
            PE     + S K+DV++FGV+L E+ +   S  P       G ++    +LL K+ R   
Sbjct: 183  PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKDYRMER 235
Query: 1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
               PE    G  E +  +MR    C     S RPS
Sbjct: 236  ---PE----GCPEKVYELMR---ACWQWNPSDRPS 260

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 19/215 (8%)
Query: 781 NLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGY 839
            ++G G FG   K      G ++ +K+L     +  + F  E+  +  + H N++  IG 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 840 YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
              +  +  +  ++ GG L   I K    +  WS     A DIA  +AYLH      I+H
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGII-KSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIH 131
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT-------------TDVAGTFGYVAP 946
           RD+   N L+ E  N  ++DFGLARL+   +T                  V G   ++AP
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 947 EYATTCRVSDKADVYSFGVVLLELISGKRSLDPSF 981
           E        +K DV+SFG+VL E+I G+ + DP +
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEII-GRVNADPDY 225

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 75/275 (27%), Positives = 127/275 (46%), Gaps = 22/275 (8%)
Query: 767  YDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDAEIGTL 825
            YD       + ++++ +G G +G  Y+       L VAVK L     + +++F  E   +
Sbjct: 5    YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 63
Query: 826  GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
              I+H NLV L+G    E   +++  F++ GNL  ++ + + +++   V+  +A  I+ A
Sbjct: 64   KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 886  LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
            + YL        +HRD+   N L+ E     ++DFGL+RL+      A         + A
Sbjct: 124  MEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 180
Query: 946  PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005
            PE     + S K+DV++FGV+L E+ +   S  P       G ++    +LL K+ R   
Sbjct: 181  PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKDYRMER 233
Query: 1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
               PE    G  E +  +MR    C     S RPS
Sbjct: 234  ---PE----GCPEKVYELMR---ACWQWNPSDRPS 258

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 75/275 (27%), Positives = 127/275 (46%), Gaps = 22/275 (8%)
Query: 767  YDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDAEIGTL 825
            YD       + ++++ +G G +G  Y+       L VAVK L     + +++F  E   +
Sbjct: 5    YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 63
Query: 826  GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
              I+H NLV L+G    E   +++  F++ GNL  ++ + + +++   V+  +A  I+ A
Sbjct: 64   KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 886  LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
            + YL        +HRD+   N L+ E     ++DFGL+RL+      A         + A
Sbjct: 124  MEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 180
Query: 946  PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005
            PE     + S K+DV++FGV+L E+ +   S  P       G ++    +LL K+ R   
Sbjct: 181  PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKDYRMER 233
Query: 1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
               PE    G  E +  +MR    C     S RPS
Sbjct: 234  ---PE----GCPEKVYELMR---ACWQWNPSDRPS 258

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 75/275 (27%), Positives = 127/275 (46%), Gaps = 22/275 (8%)
Query: 767  YDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDAEIGTL 825
            YD       + ++++ +G G +G  Y+       L VAVK L     + +++F  E   +
Sbjct: 18   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 76
Query: 826  GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
              I+H NLV L+G    E   +++  F++ GNL  ++ + + +++   V+  +A  I+ A
Sbjct: 77   KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 136
Query: 886  LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
            + YL        +HRD+   N L+ E     ++DFGL+RL+      A         + A
Sbjct: 137  MEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 193
Query: 946  PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005
            PE     + S K+DV++FGV+L E+ +   S  P       G ++    +LL K+ R   
Sbjct: 194  PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKDYRMER 246
Query: 1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
               PE    G  E +  +MR    C     S RPS
Sbjct: 247  ---PE----GCPEKVYELMR---ACWQWNPSDRPS 271

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 75/275 (27%), Positives = 127/275 (46%), Gaps = 22/275 (8%)
Query: 767  YDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDAEIGTL 825
            YD       + ++++ +G G +G  Y+       L VAVK L     + +++F  E   +
Sbjct: 5    YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 63
Query: 826  GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
              I+H NLV L+G    E   +++  F++ GNL  ++ + + +++   V+  +A  I+ A
Sbjct: 64   KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 123
Query: 886  LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
            + YL        +HRD+   N L+ E     ++DFGL+RL+      A         + A
Sbjct: 124  MEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 180
Query: 946  PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005
            PE     + S K+DV++FGV+L E+ +   S  P       G ++    +LL K+ R   
Sbjct: 181  PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKDYRMER 233
Query: 1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
               PE    G  E +  +MR    C     S RPS
Sbjct: 234  ---PE----GCPEKVYELMR---ACWQWNPSDRPS 258

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 75/275 (27%), Positives = 127/275 (46%), Gaps = 22/275 (8%)
Query: 767  YDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDAEIGTL 825
            YD       + ++++ +G G +G  Y+       L VAVK L     + +++F  E   +
Sbjct: 9    YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 67
Query: 826  GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
              I+H NLV L+G    E   +++  F++ GNL  ++ + + +++   V+  +A  I+ A
Sbjct: 68   KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 127
Query: 886  LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
            + YL        +HRD+   N L+ E     ++DFGL+RL+      A         + A
Sbjct: 128  MEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 184
Query: 946  PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005
            PE     + S K+DV++FGV+L E+ +   S  P       G ++    +LL K+ R   
Sbjct: 185  PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKDYRMER 237
Query: 1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
               PE    G  E +  +MR    C     S RPS
Sbjct: 238  ---PE----GCPEKVYELMR---ACWQWNPSDRPS 262

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 75/275 (27%), Positives = 127/275 (46%), Gaps = 22/275 (8%)
Query: 767  YDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDAEIGTL 825
            YD       + ++++ +G G +G  Y+       L VAVK L     + +++F  E   +
Sbjct: 5    YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 63
Query: 826  GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
              I+H NLV L+G    E   +++  F++ GNL  ++ + + +++   V+  +A  I+ A
Sbjct: 64   KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 123
Query: 886  LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
            + YL        +HRD+   N L+ E     ++DFGL+RL+      A         + A
Sbjct: 124  MEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 180
Query: 946  PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005
            PE     + S K+DV++FGV+L E+ +   S  P       G ++    +LL K+ R   
Sbjct: 181  PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKDYRMER 233
Query: 1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
               PE    G  E +  +MR    C     S RPS
Sbjct: 234  ---PE----GCPEKVYELMR---ACWQWNPSDRPS 258

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 75/275 (27%), Positives = 127/275 (46%), Gaps = 22/275 (8%)
Query: 767  YDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDAEIGTL 825
            YD       + ++++ +G G +G  Y+       L VAVK L     + +++F  E   +
Sbjct: 7    YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 65
Query: 826  GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
              I+H NLV L+G    E   +++  F++ GNL  ++ + + +++   V+  +A  I+ A
Sbjct: 66   KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 125
Query: 886  LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
            + YL        +HRD+   N L+ E     ++DFGL+RL+      A         + A
Sbjct: 126  MEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 182
Query: 946  PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005
            PE     + S K+DV++FGV+L E+ +   S  P       G ++    +LL K+ R   
Sbjct: 183  PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKDYRMER 235
Query: 1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
               PE    G  E +  +MR    C     S RPS
Sbjct: 236  ---PE----GCPEKVYELMR---ACWQWNPSDRPS 260

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 75/275 (27%), Positives = 127/275 (46%), Gaps = 22/275 (8%)
Query: 767  YDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDAEIGTL 825
            YD       + ++++ +G G +G  Y+       L VAVK L     + +++F  E   +
Sbjct: 7    YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 65
Query: 826  GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
              I+H NLV L+G    E   +++  F++ GNL  ++ + + +++   V+  +A  I+ A
Sbjct: 66   KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 125
Query: 886  LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
            + YL        +HRD+   N L+ E     ++DFGL+RL+      A         + A
Sbjct: 126  MEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 182
Query: 946  PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005
            PE     + S K+DV++FGV+L E+ +   S  P       G ++    +LL K+ R   
Sbjct: 183  PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKDYRMER 235
Query: 1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
               PE    G  E +  +MR    C     S RPS
Sbjct: 236  ---PE----GCPEKVYELMR---ACWQWNPSDRPS 260

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 75/275 (27%), Positives = 127/275 (46%), Gaps = 22/275 (8%)
Query: 767  YDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDAEIGTL 825
            YD       + ++++ +G G +G  Y+       L VAVK L     + +++F  E   +
Sbjct: 5    YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 63
Query: 826  GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
              I+H NLV L+G    E   +++  F++ GNL  ++ + + +++   V+  +A  I+ A
Sbjct: 64   KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 886  LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
            + YL        +HRD+   N L+ E     ++DFGL+RL+      A         + A
Sbjct: 124  MEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 180
Query: 946  PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005
            PE     + S K+DV++FGV+L E+ +   S  P       G ++    +LL K+ R   
Sbjct: 181  PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKDYRMER 233
Query: 1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
               PE    G  E +  +MR    C     S RPS
Sbjct: 234  ---PE----GCPEKVYELMR---ACWQWNPSDRPS 258

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 75/275 (27%), Positives = 127/275 (46%), Gaps = 22/275 (8%)
Query: 767  YDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDAEIGTL 825
            YD       + ++++ +G G +G  Y+       L VAVK L     + +++F  E   +
Sbjct: 5    YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 63
Query: 826  GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
              I+H NLV L+G    E   +++  F++ GNL  ++ + + +++   V+  +A  I+ A
Sbjct: 64   KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 886  LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
            + YL        +HRD+   N L+ E     ++DFGL+RL+      A         + A
Sbjct: 124  MEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 180
Query: 946  PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005
            PE     + S K+DV++FGV+L E+ +   S  P       G ++    +LL K+ R   
Sbjct: 181  PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKDYRMER 233
Query: 1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
               PE    G  E +  +MR    C     S RPS
Sbjct: 234  ---PE----GCPEKVYELMR---ACWQWNPSDRPS 258

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 88.6 bits (218), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 106/210 (50%), Gaps = 9/210 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
           + ++++ +G G +G  Y+       L VAVK L     + +++F  E   +  I+H NLV
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 70
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
            L+G    E   +++  F++ GNL  ++ + + +++   V+  +A  I+ A+ YL     
Sbjct: 71  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK-- 128
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV 954
              +HRD+   N L+ E     ++DFGL+RL+      A         + APE     + 
Sbjct: 129 -NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKF 187
Query: 955 SDKADVYSFGVVLLEL----ISGKRSLDPS 980
           S K+DV++FGV+L E+    +S    +DPS
Sbjct: 188 SIKSDVWAFGVLLWEIATYGMSPYPGIDPS 217

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 95/207 (45%), Gaps = 29/207 (14%)
Query: 783 IGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLI 837
           +G G FGS       P     G +VAVKKL     + ++ F+ EI  L  ++H N+V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 838 G--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY------- 888
           G  Y  G   + L+  +L  G+L  ++ K           HK  ID  + L Y       
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQK-----------HKERIDHIKLLQYTSQICKG 126
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT---FGYVA 945
           + Y    R +HRD+   NIL++ E    + DFGL ++L   +        G    F Y A
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY-A 185
Query: 946 PEYATTCRVSDKADVYSFGVVLLELIS 972
           PE  T  + S  +DV+SFGVVL EL +
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 106/210 (50%), Gaps = 16/210 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAEL-VPGYL---VAVKKLSIGRFQGIQQ-FDAEIGTLGRIRH 830
           N SI  ++G G FG      L +P      VA+K L +G  +  ++ F  E   +G+  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALAY 888
            N++ L G       + +V  ++  G+L++F+ K      Q++VI  + +   IA  + Y
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKY 162
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAP 946
           L        VHRD+   NIL++  L   +SDFGLAR+LE     A T   G     + +P
Sbjct: 163 LSDMGY---VHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 947 EYATTCRVSDKADVYSFGVVLLELIS-GKR 975
           E     + +  +DV+S+G+VL E++S G+R
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 101/223 (45%), Gaps = 34/223 (15%)
Query: 772 RATGNFSIRNL-----IGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDAE 821
           R    F  R+L     +G G FGS       P     G +VAVKKL     + ++ F+ E
Sbjct: 3   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 62
Query: 822 IGTLGRIRHKNLVTLIG--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
           I  L  ++H N+V   G  Y  G   + L+  +L  G+L  ++ K           HK  
Sbjct: 63  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-----------HKER 111
Query: 880 IDIAQALAY-------LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH 932
           ID  + L Y       + Y    R +HR++   NIL++ E    + DFGL ++L   + +
Sbjct: 112 IDHIKLLQYTSQICKGMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEY 171
Query: 933 ATTDVAGT---FGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
                 G    F Y APE  T  + S  +DV+SFGVVL EL +
Sbjct: 172 YKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 108/228 (47%), Gaps = 23/228 (10%)
Query: 775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
           G+  +  +   G FG  +KA+L+  + VAVK   +   Q  Q  + EI +   ++H+NL+
Sbjct: 15  GSLQLLEIKARGRFGCVWKAQLMNDF-VAVKIFPLQDKQSWQS-EREIFSTPGMKHENLL 72
Query: 835 TLIGYYVG----EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
             I         E E++L+  F   G+L  ++    G  I W+ +  +A  +++ L+YLH
Sbjct: 73  QFIAAEKRGSNLEVELWLITAFHDKGSLTDYL---KGNIITWNELCHVAETMSRGLSYLH 129
Query: 891 YSC--------VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTF 941
                       P I HRD K  N+LL  +L A L+DFGLA   E  +    T    GT 
Sbjct: 130 EDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTR 189
Query: 942 GYVAPEYATTC-----RVSDKADVYSFGVVLLELISGKRSLDPSFSEY 984
            Y+APE              + D+Y+ G+VL EL+S  ++ D    EY
Sbjct: 190 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEY 237

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 99/203 (48%), Gaps = 14/203 (6%)
Query: 777 FSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQ-FDAEIGTLGRIRHKNLV 834
           F  +  +GTG F     AE    G L AVK +     +G +   + EI  L +I+H+N+V
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
            L   Y     ++LV   +SGG L +  + K    +   S + +  +D   A+ YLH   
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLD---AVYYLHRMG 140
Query: 894 VPRIVHRDIKPSNILL---DEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
              IVHRD+KP N+L    DEE    +SDFGL+++    +  +T    GT GYVAPE   
Sbjct: 141 ---IVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTA--CGTPGYVAPEVLA 195
Query: 951 TCRVSDKADVYSFGVVLLELISG 973
               S   D +S GV+   L+ G
Sbjct: 196 QKPYSKAVDCWSIGVIAYILLCG 218

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 118/257 (45%), Gaps = 24/257 (9%)
Query: 775  GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQ---QFDAEIGTLGRIRH 830
            G++ + + +G G FG     E  + G+ VAVK L+  + + +    +   EI  L   RH
Sbjct: 11   GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH 70
Query: 831  KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
             +++ L        + F+V  ++SGG L  +I K    +++     ++   I  A+ Y H
Sbjct: 71   PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCH 128
Query: 891  YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
               V   VHRD+KP N+LLD  +NA ++DFGL+ ++  S+     D  G+  Y APE  +
Sbjct: 129  RHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRDSCGSPNYAAPEVIS 183
Query: 951  -TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009
                   + D++S GV+L  L+ G    D                  L K+ R    ++P
Sbjct: 184  GRLYAGPEVDIWSCGVILYALLCGTLPFDDEH------------VPTLFKKIRGGVFYIP 231
Query: 1010 ELWEAGPQENLLGMMRL 1026
            E         L+ M+++
Sbjct: 232  EYLNRSVATLLMHMLQV 248

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 24/208 (11%)
Query: 777 FSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQ-QFDAEIGTLGRIRHKNLV 834
           +  R+++GTG F     AE      LVA+K ++    +G +   + EI  L +I+H N+V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNL------ETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
            L   Y     ++L+   +SGG L      + F  ++   ++ + V+         A+ Y
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVL--------DAVKY 131
Query: 889 LHYSCVPRIVHRDIKPSNIL---LDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
           LH      IVHRD+KP N+L   LDE+    +SDFGL+++ +     +T    GT GYVA
Sbjct: 132 LHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA--CGTPGYVA 186
Query: 946 PEYATTCRVSDKADVYSFGVVLLELISG 973
           PE       S   D +S GV+   L+ G
Sbjct: 187 PEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 106/210 (50%), Gaps = 16/210 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAEL-VPGYL---VAVKKLSIGRFQGIQQ-FDAEIGTLGRIRH 830
           N SI  ++G G FG      L +P      VA+K L +G  +  ++ F  E   +G+  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALAY 888
            N++ L G       + +V  ++  G+L++F+ K      Q++VI  + +   IA  + Y
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKY 162
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAP 946
           L        VHRD+   NIL++  L   +SDFGL+R+LE     A T   G     + +P
Sbjct: 163 LSDMG---FVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 947 EYATTCRVSDKADVYSFGVVLLELIS-GKR 975
           E     + +  +DV+S+G+VL E++S G+R
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 109/212 (51%), Gaps = 18/212 (8%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGY-LVAVKKLSIGRFQ-GIQQFDAEIGTLGRIRHKNL 833
           ++ ++ +IG+G       A   P    VA+K++++ + Q  + +   EI  + +  H N+
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFI-------HKKSGKKIQWSVIHKIAIDIAQAL 886
           V+    +V + E++LV   LSGG++   I         KSG  +  S I  I  ++ + L
Sbjct: 76  VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV-LDESTIATILREVLEGL 134
Query: 887 AYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL----EVSETHATTDVAGTFG 942
            YLH +     +HRD+K  NILL E+ +  ++DFG++  L    +++         GT  
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 943 YVAPEYATTCRVSD-KADVYSFGVVLLELISG 973
           ++APE     R  D KAD++SFG+  +EL +G
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATG 223

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-17,   Method: Composition-based stats.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 24/208 (11%)
Query: 777 FSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQ-QFDAEIGTLGRIRHKNLV 834
           +  R+++GTG F     AE      LVA+K ++    +G +   + EI  L +I+H N+V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNL------ETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
            L   Y     ++L+   +SGG L      + F  ++   ++ + V+         A+ Y
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVL--------DAVKY 131
Query: 889 LHYSCVPRIVHRDIKPSNIL---LDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
           LH      IVHRD+KP N+L   LDE+    +SDFGL+++ +     +T    GT GYVA
Sbjct: 132 LHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA--CGTPGYVA 186
Query: 946 PEYATTCRVSDKADVYSFGVVLLELISG 973
           PE       S   D +S GV+   L+ G
Sbjct: 187 PEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-17,   Method: Composition-based stats.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 24/208 (11%)
Query: 777 FSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQ-QFDAEIGTLGRIRHKNLV 834
           +  R+++GTG F     AE      LVA+K ++    +G +   + EI  L +I+H N+V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNL------ETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
            L   Y     ++L+   +SGG L      + F  ++   ++ + V+         A+ Y
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVL--------DAVKY 131
Query: 889 LHYSCVPRIVHRDIKPSNIL---LDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
           LH      IVHRD+KP N+L   LDE+    +SDFGL+++ +     +T    GT GYVA
Sbjct: 132 LHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA--CGTPGYVA 186
Query: 946 PEYATTCRVSDKADVYSFGVVLLELISG 973
           PE       S   D +S GV+   L+ G
Sbjct: 187 PEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-17,   Method: Composition-based stats.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 24/208 (11%)
Query: 777 FSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQ-QFDAEIGTLGRIRHKNLV 834
           +  R+++GTG F     AE      LVA+K ++    +G +   + EI  L +I+H N+V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNL------ETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
            L   Y     ++L+   +SGG L      + F  ++   ++ + V+         A+ Y
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVL--------DAVKY 131
Query: 889 LHYSCVPRIVHRDIKPSNIL---LDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
           LH      IVHRD+KP N+L   LDE+    +SDFGL+++ +     +T    GT GYVA
Sbjct: 132 LHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA--CGTPGYVA 186
Query: 946 PEYATTCRVSDKADVYSFGVVLLELISG 973
           PE       S   D +S GV+   L+ G
Sbjct: 187 PEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 16/208 (7%)
Query: 776 NFSIRNLIGTGGFGST---YKAELVPGYLVAV--KKLSIGRFQGIQQFDAEIGTLGRIRH 830
           +F I   IG G FG      K +    Y +    K+  + R   ++    E+  +  + H
Sbjct: 16  HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVER-NEVRNVFKELQIMQGLEH 74
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
             LV L   +  E +MF+V + L GG+L    H +     +   +     ++  AL YL 
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLR--YHLQQNVHFKEETVKLFICELVMALDYLQ 132
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
                RI+HRD+KP NILLDE  + +++DF +A +L   ET  TT +AGT  Y+APE  +
Sbjct: 133 NQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP-RETQITT-MAGTKPYMAPEMFS 187
Query: 951 TCR---VSDKADVYSFGVVLLELISGKR 975
           + +    S   D +S GV   EL+ G+R
Sbjct: 188 SRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-17,   Method: Composition-based stats.
 Identities = 59/210 (28%), Positives = 106/210 (50%), Gaps = 9/210 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
           + ++++ +G G +G  Y+       L VAVK L     + +++F  E   +  I+H NLV
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 70
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
            L+G    E   +++  F++ GNL  ++ + + +++   V+  +A  I+ A+ YL     
Sbjct: 71  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK-- 128
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV 954
              +HRD+   N L+ E     ++DFGL+RL+      A         + APE     + 
Sbjct: 129 -NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKF 187
Query: 955 SDKADVYSFGVVLLEL----ISGKRSLDPS 980
           S K+DV++FGV+L E+    +S    +DPS
Sbjct: 188 SIKSDVWAFGVLLWEIATYGMSPYPGIDPS 217

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 106/210 (50%), Gaps = 16/210 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAEL-VPGYL---VAVKKLSIGRFQGIQQ-FDAEIGTLGRIRH 830
           N SI  ++G G FG      L +P      VA+K L +G  +  ++ F  E   +G+  H
Sbjct: 34  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 93
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALAY 888
            N++ L G       + +V  ++  G+L++F+ K      Q++VI  + +   IA  + Y
Sbjct: 94  PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKY 150
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAP 946
           L        VHRD+   NIL++  L   +SDFGL+R+LE     A T   G     + +P
Sbjct: 151 LSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 207
Query: 947 EYATTCRVSDKADVYSFGVVLLELIS-GKR 975
           E     + +  +DV+S+G+VL E++S G+R
Sbjct: 208 EAIAYRKFTSASDVWSYGIVLWEVMSYGER 237

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 106/210 (50%), Gaps = 16/210 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAEL-VPGYL---VAVKKLSIGRFQGIQQ-FDAEIGTLGRIRH 830
           N SI  ++G G FG      L +P      VA+K L +G  +  ++ F  E   +G+  H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALAY 888
            N++ L G       + +V  ++  G+L++F+ K      Q++VI  + +   IA  + Y
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKY 133
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAP 946
           L        VHRD+   NIL++  L   +SDFGL+R+LE     A T   G     + +P
Sbjct: 134 LSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 190
Query: 947 EYATTCRVSDKADVYSFGVVLLELIS-GKR 975
           E     + +  +DV+S+G+VL E++S G+R
Sbjct: 191 EAIAYRKFTSASDVWSYGIVLWEVMSYGER 220

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 109/212 (51%), Gaps = 18/212 (8%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGY-LVAVKKLSIGRFQ-GIQQFDAEIGTLGRIRHKNL 833
           ++ ++ +IG+G       A   P    VA+K++++ + Q  + +   EI  + +  H N+
Sbjct: 11  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 70
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFI-------HKKSGKKIQWSVIHKIAIDIAQAL 886
           V+    +V + E++LV   LSGG++   I         KSG  +  S I  I  ++ + L
Sbjct: 71  VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV-LDESTIATILREVLEGL 129
Query: 887 AYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL----EVSETHATTDVAGTFG 942
            YLH +     +HRD+K  NILL E+ +  ++DFG++  L    +++         GT  
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 186
Query: 943 YVAPEYATTCRVSD-KADVYSFGVVLLELISG 973
           ++APE     R  D KAD++SFG+  +EL +G
Sbjct: 187 WMAPEVMEQVRGYDFKADIWSFGITAIELATG 218

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Composition-based stats.
 Identities = 70/229 (30%), Positives = 111/229 (48%), Gaps = 25/229 (10%)
Query: 766 TYDNVVRATGNFS---------IRNLIGTGGFGSTYKAEL-VPG---YLVAVKKLSIGRF 812
           TY++  RA   F+         I  +IG G FG      L +PG     VA+K L +G  
Sbjct: 25  TYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYT 84
Query: 813 QGIQQ-FDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQ 871
           +  ++ F  E   +G+  H N+V L G       + +V  F+  G L+ F+ K  G   Q
Sbjct: 85  EKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDG---Q 141
Query: 872 WSVIHKIAI--DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS 929
           ++VI  + +   IA  + YL        VHRD+   NIL++  L   +SDFGL+R++E  
Sbjct: 142 FTVIQLVGMLRGIAAGMRYL---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDD 198
Query: 930 ETHATTDVAGTFG--YVAPEYATTCRVSDKADVYSFGVVLLELIS-GKR 975
                T   G     + APE     + +  +DV+S+G+V+ E++S G+R
Sbjct: 199 PEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER 247

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 106/210 (50%), Gaps = 16/210 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAEL-VPGYL---VAVKKLSIGRFQGIQQ-FDAEIGTLGRIRH 830
           N SI  ++G G FG      L +P      VA+K L +G  +  ++ F  E   +G+  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALAY 888
            N++ L G       + +V  ++  G+L++F+ K      Q++VI  + +   IA  + Y
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKY 162
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAP 946
           L        VHRD+   NIL++  L   +SDFGL+R+LE     A T   G     + +P
Sbjct: 163 LSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 947 EYATTCRVSDKADVYSFGVVLLELIS-GKR 975
           E     + +  +DV+S+G+VL E++S G+R
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 118/236 (50%), Gaps = 20/236 (8%)
Query: 776  NFSIRNLIGTGGFGSTY--KAELVPGY--LVAVKKLSIGRFQGIQQFDAEIGTLGRIRHK 831
            +F I   +GTG FG  +  ++     Y  +  +KK  + R + ++  + E   L  + H 
Sbjct: 7    DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 66
Query: 832  NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
             ++ + G +    ++F++ +++ GG L + + K   ++    V    A ++  AL YLH 
Sbjct: 67   FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHS 124
Query: 892  SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT 951
                 I++RD+KP NILLD+  +  ++DFG A+ +       T  + GT  Y+APE  +T
Sbjct: 125  K---DIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYXLCGTPDYIAPEVVST 177
Query: 952  CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELF 1007
               +   D +SFG+++ E+++G       ++ + +   + ++ K+L  E R    F
Sbjct: 178  KPYNKSIDWWSFGILIYEMLAG-------YTPFYDSNTMKTYEKILNAELRFPPFF 226

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 106/210 (50%), Gaps = 16/210 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAEL-VPGYL---VAVKKLSIGRFQGIQQ-FDAEIGTLGRIRH 830
           N SI  ++G G FG      L +P      VA+K L +G  +  ++ F  E   +G+  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALAY 888
            N++ L G       + +V  ++  G+L++F+ K      Q++VI  + +   IA  + Y
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKY 162
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAP 946
           L        VHRD+   NIL++  L   +SDFGL+R+LE     A T   G     + +P
Sbjct: 163 LSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 947 EYATTCRVSDKADVYSFGVVLLELIS-GKR 975
           E     + +  +DV+S+G+VL E++S G+R
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 106/210 (50%), Gaps = 16/210 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAEL-VPGYL---VAVKKLSIGRFQGIQQ-FDAEIGTLGRIRH 830
           N SI  ++G G FG      L +P      VA+K L +G  +  ++ F  E   +G+  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALAY 888
            N++ L G       + +V  ++  G+L++F+ K      Q++VI  + +   IA  + Y
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKY 162
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAP 946
           L        VHRD+   NIL++  L   +SDFGL+R+LE     A T   G     + +P
Sbjct: 163 LSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 947 EYATTCRVSDKADVYSFGVVLLELIS-GKR 975
           E     + +  +DV+S+G+VL E++S G+R
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 106/210 (50%), Gaps = 16/210 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAEL-VPGYL---VAVKKLSIGRFQGIQQ-FDAEIGTLGRIRH 830
           N SI  ++G G FG      L +P      VA+K L +G  +  ++ F  E   +G+  H
Sbjct: 44  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 103
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALAY 888
            N++ L G       + +V  ++  G+L++F+ K      Q++VI  + +   IA  + Y
Sbjct: 104 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKY 160
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAP 946
           L        VHRD+   NIL++  L   +SDFGL+R+LE     A T   G     + +P
Sbjct: 161 LSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 217
Query: 947 EYATTCRVSDKADVYSFGVVLLELIS-GKR 975
           E     + +  +DV+S+G+VL E++S G+R
Sbjct: 218 EAIAYRKFTSASDVWSYGIVLWEVMSYGER 247

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 106/210 (50%), Gaps = 16/210 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAEL-VPGYL---VAVKKLSIGRFQGIQQ-FDAEIGTLGRIRH 830
           N SI  ++G G FG      L +P      VA+K L +G  +  ++ F  E   +G+  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALAY 888
            N++ L G       + +V  ++  G+L++F+ K      Q++VI  + +   IA  + Y
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKY 162
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAP 946
           L        VHRD+   NIL++  L   +SDFGL+R+LE     A T   G     + +P
Sbjct: 163 LSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 947 EYATTCRVSDKADVYSFGVVLLELIS-GKR 975
           E     + +  +DV+S+G+VL E++S G+R
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 105/210 (50%), Gaps = 16/210 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAEL-VPGYL---VAVKKLSIGRFQGIQQ-FDAEIGTLGRIRH 830
           N SI  ++G G FG      L +P      VA+K L +G  +  ++ F  E   +G+  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALAY 888
            N++ L G       + +V  ++  G+L++F+ K      Q++VI  + +   IA  + Y
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKY 162
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAP 946
           L        VHRD+   NIL++  L   +SDFGL R+LE     A T   G     + +P
Sbjct: 163 LSDMGY---VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 947 EYATTCRVSDKADVYSFGVVLLELIS-GKR 975
           E     + +  +DV+S+G+VL E++S G+R
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 104/216 (48%), Gaps = 22/216 (10%)
Query: 786 GGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG--- 842
           G FG  +KA+L+  Y VAVK   I   Q  Q  + E+ +L  ++H+N++  IG       
Sbjct: 35  GRFGCVWKAQLLNEY-VAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQFIGAEKRGTS 92
Query: 843 -EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC-------V 894
            + +++L+  F   G+L  F+       + W+ +  IA  +A+ LAYLH           
Sbjct: 93  VDVDLWLITAFHEKGSLSDFL---KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHK 149
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYATTC- 952
           P I HRDIK  N+LL   L A ++DFGLA   E  ++   T    GT  Y+APE      
Sbjct: 150 PAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAI 209
Query: 953 ----RVSDKADVYSFGVVLLELISGKRSLDPSFSEY 984
                   + D+Y+ G+VL EL S   + D    EY
Sbjct: 210 NFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 86.7 bits (213), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 118/257 (45%), Gaps = 24/257 (9%)
Query: 775  GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQ---QFDAEIGTLGRIRH 830
            G++ + + +G G FG     E  + G+ VAVK L+  + + +    +   EI  L   RH
Sbjct: 11   GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH 70
Query: 831  KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
             +++ L        + F+V  ++SGG L  +I K    +++     ++   I  A+ Y H
Sbjct: 71   PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCH 128
Query: 891  YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
               V   VHRD+KP N+LLD  +NA ++DFGL+ ++   E   T+   G+  Y APE  +
Sbjct: 129  RHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVIS 183
Query: 951  -TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009
                   + D++S GV+L  L+ G    D                  L K+ R    ++P
Sbjct: 184  GRLYAGPEVDIWSCGVILYALLCGTLPFDDEH------------VPTLFKKIRGGVFYIP 231
Query: 1010 ELWEAGPQENLLGMMRL 1026
            E         L+ M+++
Sbjct: 232  EYLNRSVATLLMHMLQV 248

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 86.7 bits (213), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 108/209 (51%), Gaps = 18/209 (8%)
Query: 779 IRNLIGTGGFGSTYKAEL-VPG---YLVAVKKLSIGRFQGIQQ-FDAEIGTLGRIRHKNL 833
           I  +IG G FG      L +PG     VA+K L  G  +  ++ F +E   +G+  H N+
Sbjct: 37  IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNV 96
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALAYLHY 891
           + L G       + ++  F+  G+L++F+ +  G   Q++VI  + +   IA  + YL  
Sbjct: 97  IHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYL-- 151
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE--VSETHATTDVAGTFG--YVAPE 947
                 VHRD+   NIL++  L   +SDFGL+R LE   S+   T+ + G     + APE
Sbjct: 152 -ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 210
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKR 975
                + +  +DV+S+G+V+ E++S G+R
Sbjct: 211 AIQYRKFTSASDVWSYGIVMWEVMSYGER 239

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
           A  +F I   +G G FG+ Y A E    +++A+K L   + +  G++ Q   E+     +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
           RH N++ L GY+     ++L+  +   G +   + K S    Q +  +    ++A AL+Y
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 123
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA----TTDVAGTFGYV 944
            H     R++HRDIKP N+LL       ++DFG +        HA     TD+ GT  Y+
Sbjct: 124 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDYL 173
Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGK 974
            PE        +K D++S GV+  E + GK
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
           A  +F I   +G G FG+ Y A E    +++A+K L   + +  G++ Q   E+     +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
           RH N++ L GY+     ++L+  +   G +   + K S    Q +  +    ++A AL+Y
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 128
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA----TTDVAGTFGYV 944
            H     R++HRDIKP N+LL       ++DFG +        HA     TD+ GT  Y+
Sbjct: 129 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDYL 178
Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGK 974
            PE        +K D++S GV+  E + GK
Sbjct: 179 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
           A  +F I   +G G FG+ Y A E    +++A+K L   + +  G++ Q   E+     +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
           RH N++ L GY+     ++L+  +   G +   + K S    Q +  +    ++A AL+Y
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 123
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA----TTDVAGTFGYV 944
            H     R++HRDIKP N+LL       ++DFG +        HA     TD+ GT  Y+
Sbjct: 124 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDYL 173
Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGK 974
            PE        +K D++S GV+  E + GK
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 97/190 (51%), Gaps = 5/190 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           IG+G FG  +    +    VA+K +  G     + F  E   + ++ H  LV L G  + 
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           +A + LV+ F+  G L  ++  + G     +++  + +D+ + +AYL  +CV   +HRD+
Sbjct: 77  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLL-GMCLDVCEGMAYLEEACV---IHRDL 132
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
              N L+ E     +SDFG+ R +   +  ++T       + +PE  +  R S K+DV+S
Sbjct: 133 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 192
Query: 963 FGVVLLELIS 972
           FGV++ E+ S
Sbjct: 193 FGVLMWEVFS 202

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 97/190 (51%), Gaps = 5/190 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           IG+G FG  +    +    VA+K +  G     + F  E   + ++ H  LV L G  + 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           +A + LV+ F+  G L  ++  + G     +++  + +D+ + +AYL  +CV   +HRD+
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLL-GMCLDVCEGMAYLEEACV---IHRDL 129
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
              N L+ E     +SDFG+ R +   +  ++T       + +PE  +  R S K+DV+S
Sbjct: 130 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 963 FGVVLLELIS 972
           FGV++ E+ S
Sbjct: 190 FGVLMWEVFS 199

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 86.3 bits (212), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 100/194 (51%), Gaps = 11/194 (5%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           IG G FG     +   G  VAVK   I      Q F AE   + ++RH NLV L+G  V 
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 843 E-AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
           E   +++V  +++ G+L  ++  +    +    + K ++D+ +A+ YL  +     VHRD
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRD 127
Query: 902 IKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVY 961
           +   N+L+ E+  A +SDFGL +  E S T  T  +     + APE     + S K+DV+
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTKSDVW 183
Query: 962 SFGVVLLELISGKR 975
           SFG++L E+ S  R
Sbjct: 184 SFGILLWEIYSFGR 197

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 86.3 bits (212), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
           A  +F I   +G G FG+ Y A E    +++A+K L   + +  G++ Q   E+     +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
           RH N++ L GY+     ++L+  +   G +   + K S    Q +  +    ++A AL+Y
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 124
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA----TTDVAGTFGYV 944
            H     R++HRDIKP N+LL       ++DFG +        HA     TD+ GT  Y+
Sbjct: 125 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDYL 174
Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGK 974
            PE        +K D++S GV+  E + GK
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 97/190 (51%), Gaps = 5/190 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           IG+G FG  +    +    VA+K +  G     + F  E   + ++ H  LV L G  + 
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           +A + LV+ F+  G L  ++  + G     +++  + +D+ + +AYL  +CV   +HRD+
Sbjct: 72  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLL-GMCLDVCEGMAYLEEACV---IHRDL 127
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
              N L+ E     +SDFG+ R +   +  ++T       + +PE  +  R S K+DV+S
Sbjct: 128 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 187
Query: 963 FGVVLLELIS 972
           FGV++ E+ S
Sbjct: 188 FGVLMWEVFS 197

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 101/216 (46%), Gaps = 20/216 (9%)
Query: 772 RATGNFSIRNL-----IGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDAE 821
           R    F  R+L     +G G FGS       P     G +VAVKKL     + ++ F+ E
Sbjct: 5   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 64
Query: 822 IGTLGRIRHKNLVTLIG--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
           I  L  ++H N+V   G  Y  G   + L+  +L  G+L  ++ +   ++I    + +  
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QAHAERIDHIKLLQYT 123
Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG 939
             I + + YL      R +HRD+   NIL++ E    + DFGL ++L   +        G
Sbjct: 124 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 180
Query: 940 T---FGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
               F Y APE  T  + S  +DV+SFGVVL EL +
Sbjct: 181 ESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 100/194 (51%), Gaps = 11/194 (5%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           IG G FG     +   G  VAVK   I      Q F AE   + ++RH NLV L+G  V 
Sbjct: 29  IGKGEFGDVMLGDY-RGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 843 E-AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
           E   +++V  +++ G+L  ++  +    +    + K ++D+ +A+ YL  +     VHRD
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRD 142
Query: 902 IKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVY 961
           +   N+L+ E+  A +SDFGL +  E S T  T  +     + APE     + S K+DV+
Sbjct: 143 LAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTKSDVW 198
Query: 962 SFGVVLLELISGKR 975
           SFG++L E+ S  R
Sbjct: 199 SFGILLWEIYSFGR 212

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
           A  +F I   +G G FG+ Y A E    +++A+K L   + +  G++ Q   E+     +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
           RH N++ L GY+     ++L+  +   G +   + K S    Q +  +    ++A AL+Y
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 149
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT----DVAGTFGYV 944
            H     R++HRDIKP N+LL       ++DFG +        HA +    D+ GT  Y+
Sbjct: 150 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDDLCGTLDYL 199
Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGK 974
            PE        +K D++S GV+  E + GK
Sbjct: 200 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 105/210 (50%), Gaps = 16/210 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAEL-VPGYL---VAVKKLSIGRFQGIQQ-FDAEIGTLGRIRH 830
           N SI  ++G G FG      L +P      VA+K L +G  +  ++ F  E   +G+  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALAY 888
            N++ L G       + +V   +  G+L++F+ K      Q++VI  + +   IA  + Y
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKY 162
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAP 946
           L        VHRD+   NIL++  L   +SDFGL+R+LE     A T   G     + +P
Sbjct: 163 LSDMGA---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 947 EYATTCRVSDKADVYSFGVVLLELIS-GKR 975
           E     + +  +DV+S+G+VL E++S G+R
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 99/194 (51%), Gaps = 11/194 (5%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           IG G FG     +   G  VAVK   I      Q F AE   + ++RH NLV L+G  V 
Sbjct: 20  IGKGEFGDVMLGDY-RGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 843 E-AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
           E   +++V  +++ G+L  ++  +    +    + K ++D+ +A+ YL  +     VHRD
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRD 133
Query: 902 IKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVY 961
           +   N+L+ E+  A +SDFGL +  E S T  T  +     + APE       S K+DV+
Sbjct: 134 LAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREAAFSTKSDVW 189
Query: 962 SFGVVLLELISGKR 975
           SFG++L E+ S  R
Sbjct: 190 SFGILLWEIYSFGR 203

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 96/190 (50%), Gaps = 5/190 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           IG+G FG  +    +    VA+K +  G       F  E   + ++ H  LV L G  + 
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSE-DDFIEEAEVMMKLSHPKLVQLYGVCLE 93
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           +A + LV+ F+  G L  ++  + G     +++  + +D+ + +AYL  +CV   +HRD+
Sbjct: 94  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLL-GMCLDVCEGMAYLEEACV---IHRDL 149
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
              N L+ E     +SDFG+ R +   +  ++T       + +PE  +  R S K+DV+S
Sbjct: 150 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 209
Query: 963 FGVVLLELIS 972
           FGV++ E+ S
Sbjct: 210 FGVLMWEVFS 219

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 105/210 (50%), Gaps = 16/210 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAEL-VPGYL---VAVKKLSIGRFQGIQQ-FDAEIGTLGRIRH 830
           N SI  ++G G FG      L +P      VA+K L +G  +  ++ F  E   +G+  H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALAY 888
            N++ L G       + +V   +  G+L++F+ K      Q++VI  + +   IA  + Y
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKY 133
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAP 946
           L        VHRD+   NIL++  L   +SDFGL+R+LE     A T   G     + +P
Sbjct: 134 LSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 190
Query: 947 EYATTCRVSDKADVYSFGVVLLELIS-GKR 975
           E     + +  +DV+S+G+VL E++S G+R
Sbjct: 191 EAIAYRKFTSASDVWSYGIVLWEVMSYGER 220

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 117/243 (48%), Gaps = 30/243 (12%)
Query: 753 QVMVTFADTPAELTYDNVVRATGNFS---------IRNLIGTGGFGSTYKAEL-VPG--- 799
           Q + TF D     T+++  +A   F+         I  +IG G FG      L VPG   
Sbjct: 1   QGVRTFVDP---FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKRE 57
Query: 800 YLVAVKKLSIGRFQGIQQFD--AEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGN 857
             VA+K L  G +   Q+ D  +E   +G+  H N++ L G       + ++  ++  G+
Sbjct: 58  ICVAIKTLKAG-YTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGS 116
Query: 858 LETFIHKKSGKKIQWSVIHKIAI--DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNA 915
           L+ F+ K  G+   ++VI  + +   I   + YL        VHRD+   NIL++  L  
Sbjct: 117 LDAFLRKNDGR---FTVIQLVGMLRGIGSGMKYLSDMSA---VHRDLAARNILVNSNLVC 170
Query: 916 YLSDFGLARLLEVSETHATTDVAGT--FGYVAPEYATTCRVSDKADVYSFGVVLLELIS- 972
            +SDFG++R+LE     A T   G     + APE     + +  +DV+S+G+V+ E++S 
Sbjct: 171 KVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSY 230
Query: 973 GKR 975
           G+R
Sbjct: 231 GER 233

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
           +F + NL+G G F   Y+AE +  G  VA+K   K ++ +   +Q+   E+    +++H 
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
           +++ L  Y+     ++LV      G +  ++ K   K    +        I   + YLH 
Sbjct: 72  SILELYNYFEDSNYVYLVLEMCHNGEMNRYL-KNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV-SETHATTDVAGTFGYVAPEYAT 950
                I+HRD+  SN+LL   +N  ++DFGLA  L++  E H T  + GT  Y++PE AT
Sbjct: 131 HG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIAT 185
Query: 951 TCRVSDKADVYSFGVVLLELISGKRSLD 978
                 ++DV+S G +   L+ G+   D
Sbjct: 186 RSAHGLESDVWSLGCMFYTLLIGRPPFD 213

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 100/195 (51%), Gaps = 9/195 (4%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSI-GRFQGIQQFD-AEIGTLGRIRHKNLVTLIGYY 840
           +G G +G  YKA+   G +VA+K++ +    +GI      EI  L  + H N+V+LI   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
             E  + LV+ F+     +     K+G  +Q S I      + + +A+ H     RI+HR
Sbjct: 89  HSERCLTLVFEFMEKDLKKVLDENKTG--LQDSQIKIYLYQLLRGVAHCHQH---RILHR 143
Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT-TCRVSDKAD 959
           D+KP N+L++ +    L+DFGLAR   +     T +V  T  Y AP+    + + S   D
Sbjct: 144 DLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYSTSVD 202
Query: 960 VYSFGVVLLELISGK 974
           ++S G +  E+I+GK
Sbjct: 203 IWSIGCIFAEMITGK 217

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/195 (31%), Positives = 100/195 (51%), Gaps = 9/195 (4%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSI-GRFQGIQQFD-AEIGTLGRIRHKNLVTLIGYY 840
           +G G +G  YKA+   G +VA+K++ +    +GI      EI  L  + H N+V+LI   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
             E  + LV+ F+     +     K+G  +Q S I      + + +A+ H     RI+HR
Sbjct: 89  HSERCLTLVFEFMEKDLKKVLDENKTG--LQDSQIKIYLYQLLRGVAHCHQH---RILHR 143
Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT-TCRVSDKAD 959
           D+KP N+L++ +    L+DFGLAR   +     T +V  T  Y AP+    + + S   D
Sbjct: 144 DLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYSTSVD 202
Query: 960 VYSFGVVLLELISGK 974
           ++S G +  E+I+GK
Sbjct: 203 IWSIGCIFAEMITGK 217

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 105/210 (50%), Gaps = 16/210 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAEL-VPGYL---VAVKKLSIGRFQGIQQ-FDAEIGTLGRIRH 830
           N SI  ++G G FG      L +P      VA+K L +G  +  ++ F  E   +G+  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALAY 888
            N++ L G       + +V   +  G+L++F+ K      Q++VI  + +   IA  + Y
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKY 162
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAP 946
           L        VHRD+   NIL++  L   +SDFGL+R+LE     A T   G     + +P
Sbjct: 163 LSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 947 EYATTCRVSDKADVYSFGVVLLELIS-GKR 975
           E     + +  +DV+S+G+VL E++S G+R
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 103/193 (53%), Gaps = 8/193 (4%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV 841
           IG G  G+ Y A ++  G  VA++++++ +    +    EI  +   ++ N+V  +  Y+
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 842 GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
              E+++V  +L+GG+L   + +    + Q   I  +  +  QAL +LH +   +++HRD
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCMDEGQ---IAAVCRECLQALEFLHSN---QVIHRD 141
Query: 902 IKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVY 961
           IK  NILL  + +  L+DFG    +   E    +++ GT  ++APE  T      K D++
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRSEMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 962 SFGVVLLELISGK 974
           S G++ +E+I G+
Sbjct: 201 SLGIMAIEMIEGE 213

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 13/202 (6%)
Query: 783 IGTGGFGSTYKAELVP----GYLVAVKKLSIGRFQGIQQFDA--EIGTLGRIRHKNLVTL 836
           IG G FG   KA LV     G    +K+++I R    ++ ++  E+  L  ++H N+V  
Sbjct: 32  IGEGSFG---KAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQY 88
Query: 837 IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPR 896
              +     +++V ++  GG+L   I+ + G   Q   I    + I  AL ++H     +
Sbjct: 89  RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---K 145
Query: 897 IVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD 956
           I+HRDIK  NI L ++    L DFG+AR+L  S         GT  Y++PE       ++
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLN-STVELARACIGTPYYLSPEICENKPYNN 204
Query: 957 KADVYSFGVVLLELISGKRSLD 978
           K+D+++ G VL EL + K + +
Sbjct: 205 KSDIWALGCVLYELCTLKHAFE 226

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 12/206 (5%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
           A  +F I   +G G FG+ Y A E    +++A+K L   + +  G++ Q   E+     +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
           RH N++ L GY+     ++L+  +   G +   + K S    Q +  +    ++A AL+Y
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATY--ITELANALSY 128
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
            H     R++HRDIKP N+LL       ++DFG +  +    +  TT + GT  Y+ PE 
Sbjct: 129 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYLPPEM 182
Query: 949 ATTCRVSDKADVYSFGVVLLELISGK 974
                  +K D++S GV+  E + GK
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 101/198 (51%), Gaps = 11/198 (5%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           IG G FG     +   G  VAVK   I      Q F AE   + ++RH NLV L+G  V 
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 843 E-AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
           E   +++V  +++ G+L  ++  +    +    + K ++D+ +A+ YL  +     VHRD
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRD 314
Query: 902 IKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVY 961
           +   N+L+ E+  A +SDFGL +  E S T  T  +     + APE     + S K+DV+
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTKSDVW 370
Query: 962 SFGVVLLELISGKRSLDP 979
           SFG++L E+ S  R   P
Sbjct: 371 SFGILLWEIYSFGRVPYP 388

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 104/193 (53%), Gaps = 8/193 (4%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV 841
           IG G  G+ Y A ++  G  VA++++++ +    +    EI  +   ++ N+V  +  Y+
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 842 GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
              E+++V  +L+GG+L   + +    + Q   I  +  +  QAL +LH +   +++HRD
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCMDEGQ---IAAVCRECLQALEFLHSN---QVIHRD 141
Query: 902 IKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVY 961
           IK  NILL  + +  L+DFG    +   ++  +T + GT  ++APE  T      K D++
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 962 SFGVVLLELISGK 974
           S G++ +E+I G+
Sbjct: 201 SLGIMAIEMIEGE 213

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 12/206 (5%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
           A  +F I   +G G FG+ Y A E    +++A+K L   + +  G++ Q   E+     +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
           RH N++ L GY+     ++L+  +   G +   + K S    Q +  +    ++A AL+Y
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 149
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
            H     R++HRDIKP N+LL       ++DFG +  +    +  TT + GT  Y+ PE 
Sbjct: 150 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYLPPEM 203
Query: 949 ATTCRVSDKADVYSFGVVLLELISGK 974
                  +K D++S GV+  E + GK
Sbjct: 204 IEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
           A  +F I   +G G FG+ Y A E    +++A+K L   + +  G++ Q   E+     +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
           RH N++ L GY+     ++L+  +   G +   + K S    Q +  +    ++A AL+Y
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 123
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA----TTDVAGTFGYV 944
            H     R++HRDIKP N+LL       ++DFG +        HA     T++ GT  Y+
Sbjct: 124 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTELCGTLDYL 173
Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGK 974
            PE        +K D++S GV+  E + GK
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 104/210 (49%), Gaps = 18/210 (8%)
Query: 777 FSIRNLIGTGGFGSTYKAEL-VPG---YLVAVKKLSIGRFQGIQQFD--AEIGTLGRIRH 830
             I  +IG G FG      L VPG     VA+K L  G +   Q+ D  +E   +G+  H
Sbjct: 10  IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAG-YTDKQRRDFLSEASIMGQFDH 68
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALAY 888
            N++ L G       + ++  ++  G+L+ F+ K  G+   ++VI  + +   I   + Y
Sbjct: 69  PNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGR---FTVIQLVGMLRGIGSGMKY 125
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAP 946
           L        VHRD+   NIL++  L   +SDFG++R+LE     A T   G     + AP
Sbjct: 126 LSDMSY---VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAP 182
Query: 947 EYATTCRVSDKADVYSFGVVLLELIS-GKR 975
           E     + +  +DV+S+G+V+ E++S G+R
Sbjct: 183 EAIAYRKFTSASDVWSYGIVMWEVMSYGER 212

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 104/210 (49%), Gaps = 18/210 (8%)
Query: 777 FSIRNLIGTGGFGSTYKAEL-VPG---YLVAVKKLSIGRFQGIQQFD--AEIGTLGRIRH 830
             I  +IG G FG      L VPG     VA+K L  G +   Q+ D  +E   +G+  H
Sbjct: 16  IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAG-YTDKQRRDFLSEASIMGQFDH 74
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALAY 888
            N++ L G       + ++  ++  G+L+ F+ K  G+   ++VI  + +   I   + Y
Sbjct: 75  PNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGR---FTVIQLVGMLRGIGSGMKY 131
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAP 946
           L        VHRD+   NIL++  L   +SDFG++R+LE     A T   G     + AP
Sbjct: 132 LSDMSY---VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAP 188
Query: 947 EYATTCRVSDKADVYSFGVVLLELIS-GKR 975
           E     + +  +DV+S+G+V+ E++S G+R
Sbjct: 189 EAIAYRKFTSASDVWSYGIVMWEVMSYGER 218

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
           A  +F I   +G G FG+ Y A E    +++A+K L   + +  G++ Q   E+     +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
           RH N++ L GY+     ++L+  +   G +   + K S    Q +  +    ++A AL+Y
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 126
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT----DVAGTFGYV 944
            H     R++HRDIKP N+LL       ++DFG +        HA +    D+ GT  Y+
Sbjct: 127 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDDLCGTLDYL 176
Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGK 974
            PE        +K D++S GV+  E + GK
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 96/190 (50%), Gaps = 5/190 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           IG+G FG  +    +    VA+K +  G     + F  E   + ++ H  LV L G  + 
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           +A + LV  F+  G L  ++  + G     +++  + +D+ + +AYL  +CV   +HRD+
Sbjct: 75  QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLL-GMCLDVCEGMAYLEEACV---IHRDL 130
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
              N L+ E     +SDFG+ R +   +  ++T       + +PE  +  R S K+DV+S
Sbjct: 131 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 190
Query: 963 FGVVLLELIS 972
           FGV++ E+ S
Sbjct: 191 FGVLMWEVFS 200

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 95/185 (51%), Gaps = 10/185 (5%)
Query: 799 GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL 858
           G LVAVKK+ + + Q  +    E+  +   +H+N+V +   Y+   E+++V  FL GG L
Sbjct: 176 GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 235
Query: 859 ETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLS 918
              +   +  ++    I  + + + QAL+ LH   V   +HRDIK  +ILL  +    LS
Sbjct: 236 TDIV---THTRMNEEQIAAVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDGRVKLS 289
Query: 919 DFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLD 978
           DFG    +   E      + GT  ++APE  +      + D++S G++++E++ G+    
Sbjct: 290 DFGFCAQVS-KEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE---P 345
Query: 979 PSFSE 983
           P F+E
Sbjct: 346 PYFNE 350

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 12/206 (5%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
           A  +F I   +G G FG+ Y A E    +++A+K L   + +  G++ Q   E+     +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
           RH N++ L GY+     ++L+  +   G +   + K S    Q +  +    ++A AL+Y
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 140
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
            H     R++HRDIKP N+LL       ++DFG +  +    +  TT + GT  Y+ PE 
Sbjct: 141 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYLPPEM 194
Query: 949 ATTCRVSDKADVYSFGVVLLELISGK 974
                  +K D++S GV+  E + GK
Sbjct: 195 IEGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 14/210 (6%)
Query: 775 GNFSIRNLIGTGGFGSTY--KAELVPGYLVAVKKLSIGRFQGIQ---QFDAEIGTLGRIR 829
           G++ + + +G G FG     K EL  G+ VAVK L+  + + +    +   EI  L   R
Sbjct: 16  GHYILGDTLGVGTFGKVKVGKHELT-GHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR 74
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           H +++ L       +++F+V  ++SGG L  +I K    ++      ++   I   + Y 
Sbjct: 75  HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYC 132
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
           H   V   VHRD+KP N+LLD  +NA ++DFGL+ ++  S+        G+  Y APE  
Sbjct: 133 HRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRXSCGSPNYAAPEVI 187
Query: 950 T-TCRVSDKADVYSFGVVLLELISGKRSLD 978
           +       + D++S GV+L  L+ G    D
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCGTLPFD 217

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 8/199 (4%)
Query: 777 FSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
           F +   +G G +GS YKA     G +VA+K++ +     +Q+   EI  + +    ++V 
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVK 88
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
             G Y    ++++V  +   G++   I  ++ K +    I  I     + L YLH+    
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFM--- 144
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVS 955
           R +HRDIK  NILL+ E +A L+DFG+A  L          V GT  ++APE       +
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQL-TDXMAKRNXVIGTPFWMAPEVIQEIGYN 203
Query: 956 DKADVYSFGVVLLELISGK 974
             AD++S G+  +E+  GK
Sbjct: 204 CVADIWSLGITAIEMAEGK 222

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 12/206 (5%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
           A  +F I   +G G FG+ Y A E    +++A+K L   + +  G++ Q   E+     +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
           RH N++ L GY+     ++L+  +   G +   + K S    Q +  +    ++A AL+Y
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 126
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
            H     R++HRDIKP N+LL       ++DFG +  +    +  TT + GT  Y+ PE 
Sbjct: 127 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYLPPEM 180
Query: 949 ATTCRVSDKADVYSFGVVLLELISGK 974
                  +K D++S GV+  E + GK
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 779 IRNLIGTGGFGSTYKAEL-VPGY---LVAVKKLSIGRFQ-GIQQFDAEIGTLGRIRHKNL 833
           I  +IG G FG   +  L  PG     VA+K L  G  +   ++F +E   +G+  H N+
Sbjct: 20  IEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNI 79
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALAYLHY 891
           + L G       + ++  F+  G L++F+    G   Q++VI  + +   IA  + YL  
Sbjct: 80  IRLEGVVTNSMPVMILTEFMENGALDSFLRLNDG---QFTVIQLVGMLRGIASGMRYLAE 136
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE--VSETHATTDVAGTFG--YVAPE 947
                 VHRD+   NIL++  L   +SDFGL+R LE   S+   T+ + G     + APE
Sbjct: 137 MSY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPE 193
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKR 975
                + +  +D +S+G+V+ E++S G+R
Sbjct: 194 AIAFRKFTSASDAWSYGIVMWEVMSFGER 222

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 12/206 (5%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
           A  +F I   +G G FG+ Y A E    +++A+K L   + +  G++ Q   E+     +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
           RH N++ L GY+     ++L+  +   G +   + K S    Q +  +    ++A AL+Y
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 123
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
            H     R++HRDIKP N+LL       ++DFG +  +    +  TT + GT  Y+ PE 
Sbjct: 124 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYLPPEM 177
Query: 949 ATTCRVSDKADVYSFGVVLLELISGK 974
                  +K D++S GV+  E + GK
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 84.0 bits (206), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 12/206 (5%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
           A  +F I   +G G FG+ Y A E    +++A+K L   + +  G++ Q   E+     +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
           RH N++ L GY+     ++L+  +   G +   + K S    Q +  +    ++A AL+Y
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 128
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
            H     R++HRDIKP N+LL       ++DFG +  +    +  TT + GT  Y+ PE 
Sbjct: 129 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYLPPEM 182
Query: 949 ATTCRVSDKADVYSFGVVLLELISGK 974
                  +K D++S GV+  E + GK
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Composition-based stats.
 Identities = 59/206 (28%), Positives = 106/206 (51%), Gaps = 18/206 (8%)
Query: 777 FSIRNLIGTGGFGSTYKAELVPG------YLVAVKKLSIGRFQGIQQFDAEIGTLGRIRH 830
           F +  ++G G FG  +  + + G      Y + V K +  + +   +   E   L  + H
Sbjct: 27  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 86
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKK---SGKKIQWSVIHKIAIDIAQALA 887
             +V L   +  E +++L+ +FL GG+L T + K+   + + +++ +      ++A AL 
Sbjct: 87  PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-----ELALALD 141
Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE 947
           +LH      I++RD+KP NILLDEE +  L+DFGL++   +          GT  Y+APE
Sbjct: 142 HLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPE 197
Query: 948 YATTCRVSDKADVYSFGVVLLELISG 973
                  +  AD +SFGV++ E+++G
Sbjct: 198 VVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Composition-based stats.
 Identities = 59/206 (28%), Positives = 106/206 (51%), Gaps = 18/206 (8%)
Query: 777 FSIRNLIGTGGFGSTYKAELVPG------YLVAVKKLSIGRFQGIQQFDAEIGTLGRIRH 830
           F +  ++G G FG  +  + + G      Y + V K +  + +   +   E   L  + H
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 85
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKK---SGKKIQWSVIHKIAIDIAQALA 887
             +V L   +  E +++L+ +FL GG+L T + K+   + + +++ +      ++A AL 
Sbjct: 86  PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-----ELALALD 140
Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE 947
           +LH      I++RD+KP NILLDEE +  L+DFGL++   +          GT  Y+APE
Sbjct: 141 HLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPE 196
Query: 948 YATTCRVSDKADVYSFGVVLLELISG 973
                  +  AD +SFGV++ E+++G
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Composition-based stats.
 Identities = 59/206 (28%), Positives = 106/206 (51%), Gaps = 18/206 (8%)
Query: 777 FSIRNLIGTGGFGSTYKAELVPG------YLVAVKKLSIGRFQGIQQFDAEIGTLGRIRH 830
           F +  ++G G FG  +  + + G      Y + V K +  + +   +   E   L  + H
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 85
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKK---SGKKIQWSVIHKIAIDIAQALA 887
             +V L   +  E +++L+ +FL GG+L T + K+   + + +++ +      ++A AL 
Sbjct: 86  PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-----ELALALD 140
Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE 947
           +LH      I++RD+KP NILLDEE +  L+DFGL++   +          GT  Y+APE
Sbjct: 141 HLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPE 196
Query: 948 YATTCRVSDKADVYSFGVVLLELISG 973
                  +  AD +SFGV++ E+++G
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 102/193 (52%), Gaps = 8/193 (4%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV 841
           IG G  G+ Y A ++  G  VA++++++ +    +    EI  +   ++ N+V  +  Y+
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 842 GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
              E+++V  +L+GG+L   + +    + Q   I  +  +  QAL +LH +   +++HRD
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCMDEGQ---IAAVCRECLQALEFLHSN---QVIHRD 141
Query: 902 IKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVY 961
           IK  NILL  + +  L+DFG    +   E    + + GT  ++APE  T      K D++
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 962 SFGVVLLELISGK 974
           S G++ +E+I G+
Sbjct: 201 SLGIMAIEMIEGE 213

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 95/185 (51%), Gaps = 10/185 (5%)
Query: 799 GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL 858
           G LVAVKK+ + + Q  +    E+  +   +H+N+V +   Y+   E+++V  FL GG L
Sbjct: 56  GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 115
Query: 859 ETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLS 918
              +   +  ++    I  + + + QAL+ LH   V   +HRDIK  +ILL  +    LS
Sbjct: 116 TDIV---THTRMNEEQIAAVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDGRVKLS 169
Query: 919 DFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLD 978
           DFG    +   E      + GT  ++APE  +      + D++S G++++E++ G+    
Sbjct: 170 DFGFCAQVS-KEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE---P 225
Query: 979 PSFSE 983
           P F+E
Sbjct: 226 PYFNE 230

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 83.6 bits (205), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 107/209 (51%), Gaps = 18/209 (8%)
Query: 779 IRNLIGTGGFGSTYKAEL-VPG---YLVAVKKLSIGRFQGIQQ-FDAEIGTLGRIRHKNL 833
           I  +IG G FG      L +PG     VA+K L  G  +  ++ F +E   +G+  H N+
Sbjct: 11  IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNV 70
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALAYLHY 891
           + L G       + ++  F+  G+L++F+ +  G   Q++VI  + +   IA  + YL  
Sbjct: 71  IHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYL-- 125
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE--VSETHATTDVAGT--FGYVAPE 947
                 VHR +   NIL++  L   +SDFGL+R LE   S+   T+ + G     + APE
Sbjct: 126 -ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 184
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKR 975
                + +  +DV+S+G+V+ E++S G+R
Sbjct: 185 AIQYRKFTSASDVWSYGIVMWEVMSYGER 213

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 102/193 (52%), Gaps = 8/193 (4%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV 841
           IG G  G+ Y A ++  G  VA++++++ +    +    EI  +   ++ N+V  +  Y+
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 842 GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
              E+++V  +L+GG+L   + +    + Q   I  +  +  QAL +LH +   +++HRD
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTETCMDEGQ---IAAVCRECLQALEFLHSN---QVIHRD 142
Query: 902 IKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVY 961
           IK  NILL  + +  L+DFG    +   E    + + GT  ++APE  T      K D++
Sbjct: 143 IKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIW 201
Query: 962 SFGVVLLELISGK 974
           S G++ +E+I G+
Sbjct: 202 SLGIMAIEMIEGE 214

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 83.6 bits (205), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 779 IRNLIGTGGFGSTYKAEL-VPGY---LVAVKKLSIGRFQ-GIQQFDAEIGTLGRIRHKNL 833
           I  +IG G FG   +  L  PG     VA+K L  G  +   ++F +E   +G+  H N+
Sbjct: 18  IEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNI 77
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI--DIAQALAYLHY 891
           + L G       + ++  F+  G L++F+    G   Q++VI  + +   IA  + YL  
Sbjct: 78  IRLEGVVTNSMPVMILTEFMENGALDSFLRLNDG---QFTVIQLVGMLRGIASGMRYLAE 134
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE--VSETHATTDVAGTFG--YVAPE 947
                 VHRD+   NIL++  L   +SDFGL+R LE   S+   T+ + G     + APE
Sbjct: 135 MSY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPE 191
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKR 975
                + +  +D +S+G+V+ E++S G+R
Sbjct: 192 AIAFRKFTSASDAWSYGIVMWEVMSFGER 220

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 83.6 bits (205), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 12/206 (5%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
           A  +F I   +G G FG+ Y A E    +++A+K L   + +  G++ Q   E+     +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
           RH N++ L GY+     ++L+  +   G +   + K S    Q +  +    ++A AL+Y
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 128
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
            H     R++HRDIKP N+LL       ++DFG +  +    +  TT + GT  Y+ PE 
Sbjct: 129 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYLPPEX 182
Query: 949 ATTCRVSDKADVYSFGVVLLELISGK 974
                  +K D++S GV+  E + GK
Sbjct: 183 IEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 83.6 bits (205), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 95/185 (51%), Gaps = 10/185 (5%)
Query: 799 GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL 858
           G LVAVKK+ + + Q  +    E+  +   +H+N+V +   Y+   E+++V  FL GG L
Sbjct: 54  GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 113
Query: 859 ETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLS 918
              +   +  ++    I  + + + QAL+ LH   V   +HRDIK  +ILL  +    LS
Sbjct: 114 TDIV---THTRMNEEQIAAVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDGRVKLS 167
Query: 919 DFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLD 978
           DFG    +   E      + GT  ++APE  +      + D++S G++++E++ G+    
Sbjct: 168 DFGFCAQVS-KEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE---P 223
Query: 979 PSFSE 983
           P F+E
Sbjct: 224 PYFNE 228

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 95/185 (51%), Gaps = 10/185 (5%)
Query: 799 GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL 858
           G LVAVKK+ + + Q  +    E+  +   +H+N+V +   Y+   E+++V  FL GG L
Sbjct: 45  GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104
Query: 859 ETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLS 918
              +   +  ++    I  + + + QAL+ LH   V   +HRDIK  +ILL  +    LS
Sbjct: 105 TDIV---THTRMNEEQIAAVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDGRVKLS 158
Query: 919 DFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLD 978
           DFG    +   E      + GT  ++APE  +      + D++S G++++E++ G+    
Sbjct: 159 DFGFCAQVS-KEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE---P 214
Query: 979 PSFSE 983
           P F+E
Sbjct: 215 PYFNE 219

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
           A  +F I   +G G FG+ Y A E    +++A+K L   + +  G++ Q   E+     +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
           RH N++ L GY+     ++L+  +   G +   + K S    Q +  +    ++A AL+Y
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 124
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA----TTDVAGTFGYV 944
            H     R++HRDIKP N+LL       ++DFG +        HA     T ++GT  Y+
Sbjct: 125 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------CHAPSSRRTTLSGTLDYL 174
Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGK 974
            PE        +K D++S GV+  E + GK
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 110/232 (47%), Gaps = 22/232 (9%)
Query: 759 ADTPA----ELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQ 813
           +D+PA    E+    +    G F +  L+G G +G  YK   V  G L A+K + +   +
Sbjct: 4   SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE 63
Query: 814 GIQQFDAEIGTLGRI-RHKNLVTLIGYYVG------EAEMFLVYNFLSGGNLETFIHKKS 866
             ++   EI  L +   H+N+ T  G ++       + +++LV  F   G++   I    
Sbjct: 64  E-EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK 122
Query: 867 GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL 926
           G  ++   I  I  +I + L++LH     +++HRDIK  N+LL E     L DFG++  L
Sbjct: 123 GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179
Query: 927 EVSETHATTDVAGTFGYVAPEYATTCRVSD-----KADVYSFGVVLLELISG 973
           + +     T + GT  ++APE        D     K+D++S G+  +E+  G
Sbjct: 180 DRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 83.2 bits (204), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 12/206 (5%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
           A  +F I   +G G FG+ Y A E    +++A+K L   + +  G++ Q   E+     +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
           RH N++ L GY+     ++L+  +   G +   + K S    Q +  +    ++A AL+Y
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 122
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
            H     R++HRDIKP N+LL       ++DFG +  +    +  TT + GT  Y+ PE 
Sbjct: 123 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYLPPEM 176
Query: 949 ATTCRVSDKADVYSFGVVLLELISGK 974
                  +K D++S GV+  E + GK
Sbjct: 177 IEGRMHDEKVDLWSLGVLCYEFLVGK 202

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 83.2 bits (204), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 95/185 (51%), Gaps = 10/185 (5%)
Query: 799 GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL 858
           G LVAVKK+ + + Q  +    E+  +   +H+N+V +   Y+   E+++V  FL GG L
Sbjct: 49  GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 108
Query: 859 ETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLS 918
              +   +  ++    I  + + + QAL+ LH   V   +HRDIK  +ILL  +    LS
Sbjct: 109 TDIV---THTRMNEEQIAAVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDGRVKLS 162
Query: 919 DFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLD 978
           DFG    +   E      + GT  ++APE  +      + D++S G++++E++ G+    
Sbjct: 163 DFGFCAQVS-KEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE---P 218
Query: 979 PSFSE 983
           P F+E
Sbjct: 219 PYFNE 223

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 12/206 (5%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
           A  +F I   +G G FG+ Y A E    +++A+K L   + +  G++ Q   E+     +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
           RH N++ L GY+     ++L+  +   G +   + K S    Q +  +    ++A AL+Y
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 127
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
            H     R++HRDIKP N+LL       ++DFG +  +    +  TT + GT  Y+ PE 
Sbjct: 128 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYLPPEM 181
Query: 949 ATTCRVSDKADVYSFGVVLLELISGK 974
                  +K D++S GV+  E + GK
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGK 207

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 82.8 bits (203), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 12/206 (5%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
           A  +F I   +G G FG+ Y A E    +++A+K L   + +  G++ Q   E+     +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
           RH N++ L GY+     ++L+  +   G +   + K S    Q +  +    ++A AL+Y
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 126
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
            H     R++HRDIKP N+LL       ++DFG +  +    +  TT + GT  Y+ PE 
Sbjct: 127 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYLPPEM 180
Query: 949 ATTCRVSDKADVYSFGVVLLELISGK 974
                  +K D++S GV+  E + GK
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 82.8 bits (203), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
           A  +F I   +G G FG+ Y A E    +++A+K L   + +  G++ Q   E+     +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
           RH N++ L GY+     ++L+  +   G +   + K S    Q +  +    ++A AL+Y
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATY--ITELANALSY 128
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD----VAGTFGYV 944
            H     R++HRDIKP N+LL       ++DFG +        HA +     + GT  Y+
Sbjct: 129 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLXGTLDYL 178
Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGK 974
            PE        +K D++S GV+  E + GK
Sbjct: 179 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 12/206 (5%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
           A  +F I   +G G FG+ Y A E    +++A+K L   + +  G++ Q   E+     +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
           RH N++ L GY+     ++L+  +   G +   + K S    Q +  +    ++A AL+Y
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 120
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
            H     R++HRDIKP N+LL       ++DFG +  +    +  TT + GT  Y+ PE 
Sbjct: 121 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTT-LCGTLDYLPPEM 174
Query: 949 ATTCRVSDKADVYSFGVVLLELISGK 974
                  +K D++S GV+  E + GK
Sbjct: 175 IEGRMHDEKVDLWSLGVLCYEFLVGK 200

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
           A  +F I   +G G FG+ Y A E    +++A+K L   + +  G++ Q   E+     +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
           RH N++ L GY+     ++L+  +   G +   + K S    Q +  +    ++A AL+Y
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 123
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA----TTDVAGTFGYV 944
            H     R++HRDIKP N+LL       ++DFG +        HA     T + GT  Y+
Sbjct: 124 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTXLCGTLDYL 173
Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGK 974
            PE        +K D++S GV+  E + GK
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 108/207 (52%), Gaps = 18/207 (8%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP----GYLVAVKKLSIG--RFQGIQQFDAEIGTLGRIR 829
           +F +  ++G G FG  +    V     G+L A+K L     + +   +   E   L  + 
Sbjct: 29  HFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVN 88
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKK---SGKKIQWSVIHKIAIDIAQAL 886
           H  +V L   +  E +++L+ +FL GG+L T + K+   + + +++ +      ++A  L
Sbjct: 89  HPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-----ELALGL 143
Query: 887 AYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAP 946
            +LH      I++RD+KP NILLDEE +  L+DFGL++     E  A +   GT  Y+AP
Sbjct: 144 DHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS-FCGTVEYMAP 199
Query: 947 EYATTCRVSDKADVYSFGVVLLELISG 973
           E       S  AD +S+GV++ E+++G
Sbjct: 200 EVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 104/193 (53%), Gaps = 8/193 (4%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV 841
           IG G  G+ Y A ++  G  VA++++++ +    +    EI  +   ++ N+V  +  Y+
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 842 GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
              E+++V  +L+GG+L   + +    + Q   I  +  +  QAL +LH +   +++HR+
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTETCMDEGQ---IAAVCRECLQALEFLHSN---QVIHRN 142
Query: 902 IKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVY 961
           IK  NILL  + +  L+DFG    +   ++  +T V GT  ++APE  T      K D++
Sbjct: 143 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 201
Query: 962 SFGVVLLELISGK 974
           S G++ +E+I G+
Sbjct: 202 SLGIMAIEMIEGE 214

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 104/222 (46%), Gaps = 18/222 (8%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGI--QQFDAEIGTLGRIRHKN 832
           ++ +   IGTG +G   K      G ++  K+L  G       Q   +E+  L  ++H N
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 833 LVTLIGYYVGEAE--MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
           +V      +      +++V  +  GG+L + I K  G K +  +  +  + +   L    
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK--GTKERQYLDEEFVLRVMTQLTLAL 124
Query: 891 YSCVPR------IVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYV 944
             C  R      ++HRD+KP+N+ LD + N  L DFGLAR+L   E  A  +  GT  Y+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFA-KEFVGTPYYM 183
Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGN 986
           +PE       ++K+D++S G +L EL     +L P F+ +  
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELC----ALMPPFTAFSQ 221

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 12/206 (5%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
           A  +F I   +G G FG+ Y A E    +++A+K L   + +  G++ Q   E+     +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
           RH N++ L GY+     ++L+  +   G +   + K S    Q +  +    ++A AL+Y
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 126
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
            H     R++HRDIKP N+LL       ++DFG +     S   A   + GT  Y+ PE 
Sbjct: 127 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA---LCGTLDYLPPEM 180
Query: 949 ATTCRVSDKADVYSFGVVLLELISGK 974
                  +K D++S GV+  E + GK
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 18/222 (8%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGI--QQFDAEIGTLGRIRHKN 832
           ++ +   IGTG +G   K      G ++  K+L  G       Q   +E+  L  ++H N
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 833 LVTLIGYYVGEAE--MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
           +V      +      +++V  +  GG+L + I K  G K +  +  +  + +   L    
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK--GTKERQYLDEEFVLRVMTQLTLAL 124
Query: 891 YSCVPR------IVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYV 944
             C  R      ++HRD+KP+N+ LD + N  L DFGLAR+L    + A T V GT  Y+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYM 183
Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGN 986
           +PE       ++K+D++S G +L EL     +L P F+ +  
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELC----ALMPPFTAFSQ 221

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
           A  +F I   +G G FG+ Y A E    +++A+K L   + +  G++ Q   E+     +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
           RH N++ L GY+     ++L+  +   G +   + K S    Q +  +    ++A AL+Y
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 125
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD----VAGTFGYV 944
            H     R++HRDIKP N+LL       ++DFG +        HA +     + GT  Y+
Sbjct: 126 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLCGTLDYL 175
Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGK 974
            PE        +K D++S GV+  E + GK
Sbjct: 176 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 110/227 (48%), Gaps = 21/227 (9%)
Query: 766 TYDNVVRATGNFS---------IRNLIGTGGFGSTYKAEL-VPGYL---VAVKKLSIGRF 812
           TY+   RA  +F+         I  +IG+G  G      L VPG     VA+K L  G  
Sbjct: 31  TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT 90
Query: 813 QGIQQ-FDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQ 871
           +  ++ F +E   +G+  H N++ L G         +V  ++  G+L+TF+    G   Q
Sbjct: 91  ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG---Q 147
Query: 872 WSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET 931
           ++++  + + +    A + Y      VHRD+   N+L+D  L   +SDFGL+R+LE    
Sbjct: 148 FTIMQLVGM-LRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD 206
Query: 932 HATTDVAGT--FGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKR 975
            A T   G     + APE       S  +DV+SFGVV+ E+++ G+R
Sbjct: 207 AAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGER 253

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
           A  +F I   +G G FG+ Y A E    +++A+K L   + +  G++ Q   E+     +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
           RH N++ L GY+     ++L+  +   G +   + K S    Q +  +    ++A AL+Y
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 124
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD----VAGTFGYV 944
            H     R++HRDIKP N+LL       ++DFG +        HA +     + GT  Y+
Sbjct: 125 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDTLCGTLDYL 174
Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGK 974
            PE        +K D++S GV+  E + GK
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 96/190 (50%), Gaps = 5/190 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           IG+G FG  +    +    VA+K +  G     + F  E   + ++ H  LV L G  + 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           +A + LV+ F+  G L  ++  + G     +++  + +D+ + +AYL  + V   +HRD+
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLL-GMCLDVCEGMAYLEEASV---IHRDL 129
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
              N L+ E     +SDFG+ R +   +  ++T       + +PE  +  R S K+DV+S
Sbjct: 130 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 963 FGVVLLELIS 972
           FGV++ E+ S
Sbjct: 190 FGVLMWEVFS 199

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 12/206 (5%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
           A  +F I   +G G FG+ Y A E    +++A+K L   + +  G++ Q   E+     +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
           RH N++ L GY+     ++L+  +   G +   + K S    Q +  +    ++A AL+Y
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 123
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
            H     R++HRDIKP N+LL       ++DFG +     S   A   + GT  Y+ PE 
Sbjct: 124 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA---LCGTLDYLPPEM 177
Query: 949 ATTCRVSDKADVYSFGVVLLELISGK 974
                  +K D++S GV+  E + GK
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 102/206 (49%), Gaps = 12/206 (5%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
           A  +F I   +G G FG+ Y A E    +++A+K L   + +  G++ Q   E+     +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
           RH N++ L GY+     ++L+  +   G +   + K S    Q +  +    ++A AL+Y
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 125
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
            H     R++HRDIKP N+LL       +++FG +  +    +  TT + GT  Y+ PE 
Sbjct: 126 CHSK---RVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTT-LCGTLDYLPPEM 179
Query: 949 ATTCRVSDKADVYSFGVVLLELISGK 974
                  +K D++S GV+  E + GK
Sbjct: 180 IEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 109/224 (48%), Gaps = 17/224 (7%)
Query: 771 VRATGNFSIRNLIGTGGFGSTYK-AELVPGYLVAVKKLSIG-RFQGIQQFDAEIGTLGRI 828
            +  G + ++  +GTGGFG   +      G  VA+K+       +  +++  EI  + ++
Sbjct: 10  TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69
Query: 829 RHKNLVTLIGYYVGEAEM------FLVYNFLSGGNLETFIHK-KSGKKIQWSVIHKIAID 881
            H N+V+      G  ++       L   +  GG+L  ++++ ++   ++   I  +  D
Sbjct: 70  NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129
Query: 882 IAQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSETHATTDVA 938
           I+ AL YLH +   RI+HRD+KP NI+L    + L   + D G A+  E+ +    T+  
Sbjct: 130 ISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGELCTEFV 184
Query: 939 GTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFS 982
           GT  Y+APE     + +   D +SFG +  E I+G R   P++ 
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 13/204 (6%)
Query: 777 FSIRNLIGTGGFGSTY-KAELVPGYLVAVKKLSIGRFQ-GIQQFDAEIGTLGRIRHKNLV 834
           F  +  +G+G FG  +   E   G    +K ++  R Q  ++Q +AEI  L  + H N++
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 835 TLIGYYVGEAEMFLVYNFLSGGN-LETFIHKKS-GKKIQWSVIHKIAIDIAQALAYLHYS 892
            +   +     M++V     GG  LE  +  ++ GK +    + ++   +  ALAY H  
Sbjct: 84  KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 893 CVPRIVHRDIKPSNILLDE---ELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
               +VH+D+KP NIL  +        + DFGLA L +  E   +T+ AGT  Y+APE  
Sbjct: 144 ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE--HSTNAAGTALYMAPEVF 198
Query: 950 TTCRVSDKADVYSFGVVLLELISG 973
               V+ K D++S GVV+  L++G
Sbjct: 199 KR-DVTFKCDIWSAGVVMYFLLTG 221

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 109/224 (48%), Gaps = 17/224 (7%)
Query: 771 VRATGNFSIRNLIGTGGFGSTYK-AELVPGYLVAVKKLSIG-RFQGIQQFDAEIGTLGRI 828
            +  G + ++  +GTGGFG   +      G  VA+K+       +  +++  EI  + ++
Sbjct: 11  TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 70
Query: 829 RHKNLVTLIGYYVGEAEM------FLVYNFLSGGNLETFIHK-KSGKKIQWSVIHKIAID 881
            H N+V+      G  ++       L   +  GG+L  ++++ ++   ++   I  +  D
Sbjct: 71  NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 130
Query: 882 IAQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSETHATTDVA 938
           I+ AL YLH +   RI+HRD+KP NI+L    + L   + D G A+  E+ +    T+  
Sbjct: 131 ISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK--ELDQGELCTEFV 185
Query: 939 GTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFS 982
           GT  Y+APE     + +   D +SFG +  E I+G R   P++ 
Sbjct: 186 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 229

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 110/227 (48%), Gaps = 21/227 (9%)
Query: 766 TYDNVVRATGNFS---------IRNLIGTGGFGSTYKAEL-VPGYL---VAVKKLSIGRF 812
           TY+   RA  +F+         I  +IG+G  G      L VPG     VA+K L  G  
Sbjct: 31  TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT 90
Query: 813 QGIQQ-FDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQ 871
           +  ++ F +E   +G+  H N++ L G         +V  ++  G+L+TF+    G   Q
Sbjct: 91  ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG---Q 147
Query: 872 WSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET 931
           ++++  + + +    A + Y      VHRD+   N+L+D  L   +SDFGL+R+LE    
Sbjct: 148 FTIMQLVGM-LRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD 206
Query: 932 HATTDVAGT--FGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKR 975
            A T   G     + APE       S  +DV+SFGVV+ E+++ G+R
Sbjct: 207 AAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGER 253

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 102/206 (49%), Gaps = 12/206 (5%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
           A  +F I   +G G FG+ Y A E    +++A+K L   + +  G++ Q   E+     +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
           RH N++ L GY+     ++L+  +   G +   + K S    Q +  +    ++A AL+Y
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 126
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
            H     R++HRDIKP N+LL       +++FG +  +    +  TT + GT  Y+ PE 
Sbjct: 127 CHSK---RVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTT-LCGTLDYLPPEM 180
Query: 949 ATTCRVSDKADVYSFGVVLLELISGK 974
                  +K D++S GV+  E + GK
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
           A  +F I   +G G FG+ Y A E    +++A+K L   + +  G++ Q   E+     +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
           RH N++ L GY+     ++L+  +   G +   + K S    Q +  +    ++A AL+Y
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 126
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD----VAGTFGYV 944
            H     R++HRDIKP N+LL       ++DFG +        HA +     + GT  Y+
Sbjct: 127 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLCGTLDYL 176
Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGK 974
            PE        +K D++S GV+  E + GK
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
           A  +F I   +G G FG+ Y A E    +++A+K L   + +  G++ Q   E+     +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
           RH N++ L GY+     ++L+  +   G +   + K S    Q +  +    ++A AL+Y
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 123
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD----VAGTFGYV 944
            H     R++HRDIKP N+LL       ++DFG +        HA +     + GT  Y+
Sbjct: 124 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLCGTLDYL 173
Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGK 974
            PE        +K D++S GV+  E + GK
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV 841
           IG G  G    A E   G  VAVKK+ + + Q  +    E+  +    H N+V +   Y+
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 842 GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
              E+++V  FL GG L   +   +  ++    I  + + + +AL+YLH   V   +HRD
Sbjct: 113 VGDELWVVMEFLEGGALTDIV---THTRMNEEQIATVCLSVLRALSYLHNQGV---IHRD 166
Query: 902 IKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVY 961
           IK  +ILL  +    LSDFG    +   E      + GT  ++APE  +      + D++
Sbjct: 167 IKSDSILLTSDGRIKLSDFGFCAQVS-KEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIW 225
Query: 962 SFGVVLLELISGKRSLDPSFSE 983
           S G++++E+I G+    P F+E
Sbjct: 226 SLGIMVIEMIDGE---PPYFNE 244

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 16/209 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGY----LVAVKKLS----IGRFQGIQQFDAEIGTLGR 827
           NF +  ++GTG +G  +    + G+    L A+K L     + + +  +    E   L  
Sbjct: 55  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 114
Query: 828 IRHKN-LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQAL 886
           IR    LVTL   +  E ++ L+ ++++GG L  F H    ++     +     +I  AL
Sbjct: 115 IRQSPFLVTLHYAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHEVQIYVGEIVLAL 172
Query: 887 AYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAP 946
            +LH      I++RDIK  NILLD   +  L+DFGL++     ET    D  GT  Y+AP
Sbjct: 173 EHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 229
Query: 947 EYATTCRV-SDKA-DVYSFGVVLLELISG 973
           +         DKA D +S GV++ EL++G
Sbjct: 230 DIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 55/198 (27%), Positives = 98/198 (49%), Gaps = 5/198 (2%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
           + ++++ +G G +G  Y        L VAVK L     + +++F  E   +  I+H NLV
Sbjct: 33  DITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 91
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
            L+G    E   ++V  ++  GNL  ++ + + +++   V+  +A  I+ A+ YL     
Sbjct: 92  QLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKK-- 149
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV 954
              +HRD+   N L+ E     ++DFGL+RL+      A         + APE       
Sbjct: 150 -NFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTF 208
Query: 955 SDKADVYSFGVVLLELIS 972
           S K+DV++FGV+L E+ +
Sbjct: 209 SIKSDVWAFGVLLWEIAT 226

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/190 (32%), Positives = 88/190 (46%), Gaps = 28/190 (14%)
Query: 527 FLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKL-KFLKWI 585
           FL     LV  + + N +SG++   +  L  L  +   GNR+SG++PD  G   K    +
Sbjct: 120 FLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSM 179
Query: 586 LLGGNNLTGEIPSQFGHLISLVVLDLSHNALTG--------------------SIPASLT 625
            +  N LTG+IP  F +L +L  +DLS N L G                    S+   L 
Sbjct: 180 TISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238
Query: 626 K---ATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPH---LQHLDCIAF 679
           K   +  L  L L +NR+ G +P   + L  L +L++SFNNL G IP    LQ  D  A+
Sbjct: 239 KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAY 298
Query: 680 KGNKYLASCP 689
             NK L   P
Sbjct: 299 ANNKCLCGSP 308

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 126/270 (46%), Gaps = 33/270 (12%)
Query: 776  NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
               +  ++G G FG   KA+      VA+K++     +  + F  E+  L R+ H N+V 
Sbjct: 10   EIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVK 66
Query: 836  LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA--IDIAQALAYLHYSC 893
            L G  +    + LV  +  GG+L   +H        ++  H ++  +  +Q +AYLH   
Sbjct: 67   LYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGVAYLHSMQ 123
Query: 894  VPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
               ++HRD+KP N+LL        + DFG A  ++   TH T +  G+  ++APE     
Sbjct: 124  PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THMTNN-KGSAAWMAPEVFEGS 179
Query: 953  RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELF--LPE 1010
              S+K DV+S+G++L E+I+ ++  D    E G     + WA   +  G    L   LP+
Sbjct: 180  NYSEKCDVFSWGIILWEVITRRKPFD----EIGGPAFRIMWA---VHNGTRPPLIKNLPK 232
Query: 1011 LWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
                 P E+L+      + C  +  S RPS
Sbjct: 233  -----PIESLM------TRCWSKDPSQRPS 251

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 75/270 (27%), Positives = 126/270 (46%), Gaps = 33/270 (12%)
Query: 776  NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
               +  ++G G FG   KA+      VA+K++     +  + F  E+  L R+ H N+V 
Sbjct: 9    EIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVK 65
Query: 836  LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA--IDIAQALAYLHYSC 893
            L G  +    + LV  +  GG+L   +H        ++  H ++  +  +Q +AYLH   
Sbjct: 66   LYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 894  VPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
               ++HRD+KP N+LL        + DFG A  ++   TH T +  G+  ++APE     
Sbjct: 123  PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THMTNN-KGSAAWMAPEVFEGS 178
Query: 953  RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELF--LPE 1010
              S+K DV+S+G++L E+I+ ++  D    E G     + WA   +  G    L   LP+
Sbjct: 179  NYSEKCDVFSWGIILWEVITRRKPFD----EIGGPAFRIMWA---VHNGTRPPLIKNLPK 231
Query: 1011 LWEAGPQENLLGMMRLASTCTVETLSTRPS 1040
                 P E+L+      + C  +  S RPS
Sbjct: 232  -----PIESLM------TRCWSKDPSQRPS 250

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 58/230 (25%), Positives = 112/230 (48%), Gaps = 17/230 (7%)
Query: 783  IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
            +G+G FG     +    Y VAVK +  G      +F  E  T+ ++ H  LV   G    
Sbjct: 16   LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 843  EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
            E  +++V  ++S G L  ++ +  GK ++ S + ++  D+ + +A+L      + +HRD+
Sbjct: 75   EYPIYIVTEYISNGCLLNYL-RSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDL 130
Query: 903  KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
               N L+D +L   +SDFG+ R +   +  ++        + APE     + S K+DV++
Sbjct: 131  AARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWA 190
Query: 963  FGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPEL 1011
            FG+++ E+ S GK   D           + + +++++K  +   L+ P L
Sbjct: 191  FGILMWEVFSLGKMPYD-----------LYTNSEVVLKVSQGHRLYRPHL 229

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 104/222 (46%), Gaps = 18/222 (8%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGI--QQFDAEIGTLGRIRHKN 832
           ++ +   IGTG +G   K      G ++  K+L  G       Q   +E+  L  ++H N
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 833 LVTLIGYYVGEAE--MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
           +V      +      +++V  +  GG+L + I K  G K +  +  +  + +   L    
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK--GTKERQYLDEEFVLRVMTQLTLAL 124
Query: 891 YSCVPR------IVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYV 944
             C  R      ++HRD+KP+N+ LD + N  L DFGLAR+L    + A   V GT  Y+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV-GTPYYM 183
Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGN 986
           +PE       ++K+D++S G +L EL     +L P F+ +  
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELC----ALMPPFTAFSQ 221

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 9/206 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGI--QQFDAEIGTLGRIRHKNL 833
           +F   + +G G  G   K +  P  L+  +KL     +     Q   E+  L       +
Sbjct: 17  DFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 76
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
           V   G +  + E+ +    + GG+L+  +  K  K+I   ++ K++I + + LAYL    
Sbjct: 77  VGFYGAFYSDGEISICMEHMDGGSLDQVL--KEAKRIPEEILGKVSIAVLRGLAYLREKH 134
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCR 953
             +I+HRD+KPSNIL++      L DFG++  L  S  ++     GT  Y+APE      
Sbjct: 135 --QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMAPERLQGTH 189
Query: 954 VSDKADVYSFGVVLLELISGKRSLDP 979
            S ++D++S G+ L+EL  G+  + P
Sbjct: 190 YSVQSDIWSMGLSLVELAVGRYPIPP 215

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 73/243 (30%), Positives = 110/243 (45%), Gaps = 32/243 (13%)
Query: 745 GRIASLRGQVMVT--FADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVP-GYL 801
           GR  SL+   +    F D P +L           FS    IG G FG+ Y A  V    +
Sbjct: 33  GRAGSLKDPDVAELFFKDDPEKL-----------FSDLREIGHGSFGAVYFARDVRNSEV 81
Query: 802 VAVKKLSIGRFQGIQQFD---AEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL 858
           VA+KK+S    Q  +++     E+  L ++RH N +   G Y+ E   +LV  +  G   
Sbjct: 82  VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSAS 141
Query: 859 ETF-IHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYL 917
           +   +HKK  ++++ + +   A+   Q LAYLH      ++HRD+K  NILL E     L
Sbjct: 142 DLLEVHKKPLQEVEIAAVTHGAL---QGLAYLHSH---NMIHRDVKAGNILLSEPGLVKL 195
Query: 918 SDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC---RVSDKADVYSFGVVLLELISGK 974
            DFG A ++            GT  ++APE        +   K DV+S G+  +EL   K
Sbjct: 196 GDFGSASIMA-----PANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
Query: 975 RSL 977
             L
Sbjct: 251 PPL 253

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-15,   Method: Composition-based stats.
 Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 783 IGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV 841
           IG G  G    A +   G LVAVKK+ + + Q  +    E+  +   +H+N+V +   Y+
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 842 GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
              E+++V  FL GG L   +   +  ++    I  + + + QAL+ LH   V   +HRD
Sbjct: 142 VGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLQALSVLHAQGV---IHRD 195
Query: 902 IKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVY 961
           IK  +ILL  +    LSDFG    +   E      + GT  ++APE  +      + D++
Sbjct: 196 IKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLVGTPYWMAPELISRLPYGPEVDIW 254
Query: 962 SFGVVLLELISGKRSLDPSFSE 983
           S G++++E++ G+    P F+E
Sbjct: 255 SLGIMVIEMVDGE---PPYFNE 273

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 12/206 (5%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRI 828
           A  +F I   +G G FG+ Y A E    +++A+K L   + +  G++ Q   E+     +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
           RH N++ L GY+     ++L+  +   G +   + K S    Q +  +    ++A AL+Y
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 123
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
            H     +++HRDIKP N+LL       ++DFG +     S   A   + GT  Y+ PE 
Sbjct: 124 CHSK---KVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA---LCGTLDYLPPEM 177
Query: 949 ATTCRVSDKADVYSFGVVLLELISGK 974
                  +K D++S GV+  E + GK
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 80.1 bits (196), Expect = 7e-15,   Method: Composition-based stats.
 Identities = 56/213 (26%), Positives = 104/213 (48%), Gaps = 26/213 (12%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
           +F    LIG+GGFG  +KA+  + G    +K++        ++ + E+  L ++ H N+V
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIV 67
Query: 835 TLIGYYVG---EAE-------------MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKI 878
              G + G   + E             +F+   F   G LE +I K+ G+K+   +  ++
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVA 938
              I + + Y+H     ++++RD+KPSNI L +     + DFGL   L+       +   
Sbjct: 128 FEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSK-- 182
Query: 939 GTFGYVAPEYATTCRVSDKADVYSFGVVLLELI 971
           GT  Y++PE  ++     + D+Y+ G++L EL+
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 12/202 (5%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRIRHK 831
           +F I   +G G FG+ Y A E    +++A+K L   + +  G++ Q   E+     +RH 
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
           N++ L GY+     ++L+  +   G +   + K S    Q +  +    ++A AL+Y H 
Sbjct: 73  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATY--ITELANALSYCHS 130
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT 951
               R++HRDIKP N+LL       ++DFG +  +    +  TT + GT  Y+ PE    
Sbjct: 131 K---RVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRTT-LCGTLDYLPPEMIEG 184
Query: 952 CRVSDKADVYSFGVVLLELISG 973
               +K D++S GV+  E + G
Sbjct: 185 RMHDEKVDLWSLGVLCYEFLVG 206

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 83/151 (54%), Gaps = 15/151 (9%)
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           H +++TLI  Y   + MFLV++ +  G L  ++ +K    +       I   + +A+++L
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA--LSEKETRSIMRSLLEAVSFL 216
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
           H +    IVHRD+KP NILLD+ +   LSDFG +  LE  E     ++ GT GY+APE  
Sbjct: 217 HAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK--LRELCGTPGYLAPE-I 270
Query: 950 TTCRVSD-------KADVYSFGVVLLELISG 973
             C + +       + D+++ GV+L  L++G
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 106/225 (47%), Gaps = 18/225 (8%)
Query: 755 MVTFADTPAELTYD-NVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQ 813
           M TF     E  Y+      +G F+I       G G  Y A+ +    ++  +  + R  
Sbjct: 2   MSTFRQEDVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSR-- 59
Query: 814 GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS 873
             ++ + E+  L  IRH N++TL   +  + ++ L+   +SGG L  F+ +K       S
Sbjct: 60  --EEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE------S 111
Query: 874 VIHKIAID-IAQALAYLHYSCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLARLLEV 928
           +    A   + Q L  +HY    RI H D+KP NI LLD+ +      L DFG+A  +E 
Sbjct: 112 LTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 171
Query: 929 SETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
              +   ++ GT  +VAPE      +  +AD++S GV+   L+SG
Sbjct: 172 G--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 106/209 (50%), Gaps = 12/209 (5%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFD-AEIGTLGRIRH 830
           ++  F     +G G + + YK      G  VA+K++ +   +G       EI  +  ++H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKS----GKKIQWSVIHKIAIDIAQAL 886
           +N+V L      E ++ LV+ F+   +L+ ++  ++     + ++ +++      + Q L
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 887 AYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAP 946
           A+ H +   +I+HRD+KP N+L+++     L DFGLAR   +     +++V  T  Y AP
Sbjct: 122 AFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAP 177
Query: 947 EYATTCRV-SDKADVYSFGVVLLELISGK 974
           +     R  S   D++S G +L E+I+GK
Sbjct: 178 DVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 14/212 (6%)
Query: 776 NFSIRNLIGTGGFG----STYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGR-IRH 830
           +F    +IG G FG    + +KAE V   +  ++K +I + +  +   +E   L + ++H
Sbjct: 39  DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH 98
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
             LV L   +    +++ V ++++GG  E F H +  +          A +IA AL YLH
Sbjct: 99  PFLVGLHFSFQTADKLYFVLDYINGG--ELFYHLQRERCFLEPRARFYAAEIASALGYLH 156
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
                 IV+RD+KP NILLD + +  L+DFGL +   +     T+   GT  Y+APE   
Sbjct: 157 SL---NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTPEYLAPEVLH 212
Query: 951 TCRVSDKADVYSFGVVLLELISGKRSLDPSFS 982
                   D +  G VL E++ G   L P +S
Sbjct: 213 KQPYDRTVDWWCLGAVLYEMLYG---LPPFYS 241

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 69/216 (31%), Positives = 98/216 (45%), Gaps = 30/216 (13%)
Query: 783 IGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLI 837
           +G G FGS       P     G LVAVK+L        + F  EI  L  +    +V   
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 838 G--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY------- 888
           G  Y  G  E+ LV  +L  G L  F+ +           H+  +D ++ L Y       
Sbjct: 75  GVSYGPGRPELRLVMEYLPSGCLRDFLQR-----------HRARLDASRLLLYSSQICKG 123
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT---FGYVA 945
           + Y    R VHRD+   NIL++ E +  ++DFGLA+LL + +        G    F Y A
Sbjct: 124 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWY-A 182
Query: 946 PEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPS 980
           PE  +    S ++DV+SFGVVL EL +   +S  PS
Sbjct: 183 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS 218

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 12/223 (5%)
Query: 754 VMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYK-AELVPGYLVAVKKLSIGRF 812
           +   +   P E+ +D+V+    ++ I   +GTG FG  ++  E   G   A K +     
Sbjct: 33  IWKQYYPQPVEIKHDHVL---DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE 89
Query: 813 QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQW 872
              +    EI T+  +RH  LV L   +  + EM ++Y F+SGG L   +  +  K  + 
Sbjct: 90  SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED 149
Query: 873 SVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLS--DFGLARLLEVSE 930
             +  +   + + L ++H +     VH D+KP NI+   + +  L   DFGL   L+  +
Sbjct: 150 EAVEYMR-QVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 205
Query: 931 THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
           +   T   GT  + APE A    V    D++S GV+   L+SG
Sbjct: 206 SVKVT--TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 246

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 104/228 (45%), Gaps = 30/228 (13%)
Query: 758 FADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQ 816
           F D P +L           FS    IG G FG+ Y A  V    +VA+KK+S    Q  +
Sbjct: 9   FKDDPEKL-----------FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE 57
Query: 817 QFD---AEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETF-IHKKSGKKIQW 872
           ++     E+  L ++RH N +   G Y+ E   +LV  +  G   +   +HKK  ++++ 
Sbjct: 58  KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEI 117
Query: 873 SVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH 932
           + +   A+   Q LAYLH      ++HRD+K  NILL E     L DFG A ++      
Sbjct: 118 AAVTHGAL---QGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA----- 166
Query: 933 ATTDVAGTFGYVAPEYATTC---RVSDKADVYSFGVVLLELISGKRSL 977
                 GT  ++APE        +   K DV+S G+  +EL   K  L
Sbjct: 167 PANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 110/240 (45%), Gaps = 17/240 (7%)
Query: 776  NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
            +F    ++G G F +T  A EL      A+K   K  I +   +     E   + R+ H 
Sbjct: 31   DFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 832  NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
              V L   +  + +++   ++   G L  +I K        +       +I  AL YLH 
Sbjct: 91   FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 148
Query: 892  SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYAT 950
                 I+HRD+KP NILL+E+++  ++DFG A++L      A  +   GT  YV+PE  T
Sbjct: 149  KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 951  TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
                   +D+++ G ++ +L++G     P F   GN + I  + K++  E    E F P+
Sbjct: 206  EKSACKSSDLWALGCIIYQLVAGL----PPFRA-GNEYLI--FQKIIKLEYDFPEKFFPK 258

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKN 832
            +G F+I       G G  Y A+ +    ++  +  + R    ++ + E+  L  IRH N
Sbjct: 14  GSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSR----EEIEREVNILREIRHPN 69
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAID-IAQALAYLHY 891
           ++TL   +  + ++ L+   +SGG L  F+ +K       S+    A   + Q L  +HY
Sbjct: 70  IITLHDIFENKTDVVLILELVSGGELFDFLAEKE------SLTEDEATQFLKQILDGVHY 123
Query: 892 SCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE 947
               RI H D+KP NI LLD+ +      L DFG+A  +E    +   ++ GT  +VAPE
Sbjct: 124 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG--NEFKNIFGTPEFVAPE 181
Query: 948 YATTCRVSDKADVYSFGVVLLELISG 973
                 +  +AD++S GV+   L+SG
Sbjct: 182 IVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 19/209 (9%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
           +  +   +G G FG  + A       VAVK +  G    ++ F AE   +  ++H  LV 
Sbjct: 183 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVK 241
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
           L      E  ++++  F++ G+L  F+    G K     +   +  IA+ +A++      
Sbjct: 242 LHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR--- 297
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF--GYVAPEYATTCR 953
             +HRD++ +NIL+   L   ++DFGLAR            V   F   + APE      
Sbjct: 298 NYIHRDLRAANILVSASLVCKIADFGLAR------------VGAKFPIKWTAPEAINFGS 345
Query: 954 VSDKADVYSFGVVLLELISGKRSLDPSFS 982
            + K+DV+SFG++L+E+++  R   P  S
Sbjct: 346 FTIKSDVWSFGILLMEIVTYGRIPYPGMS 374

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 12/223 (5%)
Query: 754 VMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYK-AELVPGYLVAVKKLSIGRF 812
           +   +   P E+ +D+V+    ++ I   +GTG FG  ++  E   G   A K +     
Sbjct: 139 IWKQYYPQPVEIKHDHVL---DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE 195
Query: 813 QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQW 872
              +    EI T+  +RH  LV L   +  + EM ++Y F+SGG L   +  +  K  + 
Sbjct: 196 SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED 255
Query: 873 SVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLS--DFGLARLLEVSE 930
             +  +   + + L ++H +     VH D+KP NI+   + +  L   DFGL   L+  +
Sbjct: 256 EAVEYMR-QVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311
Query: 931 THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
           +   T   GT  + APE A    V    D++S GV+   L+SG
Sbjct: 312 SVKVT--TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 96/207 (46%), Gaps = 15/207 (7%)
Query: 783 IGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQ-QFDAEIGTLGRIRHKNLVTLIGYY 840
           IG G FG  +   L     LVAVK         ++ +F  E   L +  H N+V LIG  
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
             +  +++V   + GG+  TF+ +  G +++   + ++  D A  + YL   C    +HR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLESKCC---IHR 237
Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF-----GYVAPEYATTCRVS 955
           D+   N L+ E+    +SDFG++R     E       +G        + APE     R S
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSR----EEADGVXAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 956 DKADVYSFGVVLLELISGKRSLDPSFS 982
            ++DV+SFG++L E  S   S  P+ S
Sbjct: 294 SESDVWSFGILLWETFSLGASPYPNLS 320

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 9/206 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGI--QQFDAEIGTLGRIRHKNL 833
           +F   + +G G  G  +K    P  LV  +KL     +     Q   E+  L       +
Sbjct: 69  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 128
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
           V   G +  + E+ +    + GG+L+  + KK+G+ I   ++ K++I + + L YL    
Sbjct: 129 VGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGR-IPEQILGKVSIAVIKGLTYLREKH 186
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCR 953
             +I+HRD+KPSNIL++      L DFG++  L  S  ++     GT  Y++PE      
Sbjct: 187 --KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTH 241
Query: 954 VSDKADVYSFGVVLLELISGKRSLDP 979
            S ++D++S G+ L+E+  G+  + P
Sbjct: 242 YSVQSDIWSMGLSLVEMAVGRYPIPP 267

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 57/226 (25%), Positives = 104/226 (46%), Gaps = 39/226 (17%)
Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
           +F    LIG+GGFG  +KA+  + G    ++++        ++ + E+  L ++ H N+V
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNN----EKAEREVKALAKLDHVNIV 68
Query: 835 TLIGYYVG------------EAE-----------------MFLVYNFLSGGNLETFIHKK 865
              G + G            E+                  +F+   F   G LE +I K+
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 866 SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARL 925
            G+K+   +  ++   I + + Y+H     +++HRD+KPSNI L +     + DFGL   
Sbjct: 129 RGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLVTS 185
Query: 926 LEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELI 971
           L+       T   GT  Y++PE  ++     + D+Y+ G++L EL+
Sbjct: 186 LK--NDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 105/218 (48%), Gaps = 19/218 (8%)
Query: 772 RATGNFSIRNLIGTGGFGSTYKAELVPGYL----VAVKKLS---IGRFQGIQQFDAEIGT 824
           R  G + IR  +G G FG   K +L   Y     VA+K +S   + +     + + EI  
Sbjct: 6   RHIGPYIIRETLGEGSFG---KVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISY 62
Query: 825 LGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQ 884
           L  +RH +++ L        ++ +V  + +GG L  +I +K  K++      +    I  
Sbjct: 63  LKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEK--KRMTEDEGRRFFQQIIC 119
Query: 885 ALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYV 944
           A+ Y H     +IVHRD+KP N+LLD+ LN  ++DFGL+ ++       T+   G+  Y 
Sbjct: 120 AIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYA 174
Query: 945 APEYAT-TCRVSDKADVYSFGVVLLELISGKRSLDPSF 981
           APE          + DV+S G+VL  ++ G+   D  F
Sbjct: 175 APEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF 212

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRIRHK 831
           +F I   +G G FG+ Y A E    +++A+K L   + +  G++ Q   E+     +RH 
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
           N++ L GY+     ++L+  +   G +   + K S    Q +  +    ++A AL+Y H 
Sbjct: 73  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATY--ITELANALSYCHS 130
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD----VAGTFGYVAPE 947
               R++HRDIKP N+LL       ++DFG +        HA +     + GT  Y+ PE
Sbjct: 131 K---RVIHRDIKPENLLLGSNGELKIADFGWS-------VHAPSSRRDTLCGTLDYLPPE 180
Query: 948 YATTCRVSDKADVYSFGVVLLELISG 973
                   +K D++S GV+  E + G
Sbjct: 181 MIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 17/206 (8%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKN 832
            +G F+I       G G  Y A+ +    +   +  + R    ++ + E+  L  IRH N
Sbjct: 35  GSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSR----EEIEREVNILREIRHPN 90
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAID-IAQALAYLHY 891
           ++TL   +  + ++ L+   +SGG L  F+ +K       S+    A   + Q L  +HY
Sbjct: 91  IITLHDIFENKTDVVLILELVSGGELFDFLAEKE------SLTEDEATQFLKQILDGVHY 144
Query: 892 SCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE 947
               RI H D+KP NI LLD+ +      L DFG+A  +E    +   ++ GT  +VAPE
Sbjct: 145 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG--NEFKNIFGTPEFVAPE 202
Query: 948 YATTCRVSDKADVYSFGVVLLELISG 973
                 +  +AD++S GV+   L+SG
Sbjct: 203 IVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 777 FSIRNLIGTGGFGSTYKAELVPGY------LVAVKKLSIGRF----QGIQQFDAEI---- 822
           F +R L G+G +G     +   G+      ++   +   GR+    + I++F  EI    
Sbjct: 39  FKVRKL-GSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97
Query: 823 GTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKIAID 881
             L  + H N++ L   +  +   +LV  F  GG L E  I++    +   + I K    
Sbjct: 98  SLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMK---Q 154
Query: 882 IAQALAYLHYSCVPRIVHRDIKPSNILLDEE---LNAYLSDFGLARLLEVSETHATTDVA 938
           I   + YLH      IVHRDIKP NILL+ +   LN  + DFGL+     S+ +   D  
Sbjct: 155 ILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF--SKDYKLRDRL 209
Query: 939 GTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
           GT  Y+APE     + ++K DV+S GV++  L+ G
Sbjct: 210 GTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCG 243

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 96/207 (46%), Gaps = 15/207 (7%)
Query: 783 IGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQ-QFDAEIGTLGRIRHKNLVTLIGYY 840
           IG G FG  +   L     LVAVK         ++ +F  E   L +  H N+V LIG  
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
             +  +++V   + GG+  TF+ +  G +++   + ++  D A  + YL   C    +HR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLESKCC---IHR 237
Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF-----GYVAPEYATTCRVS 955
           D+   N L+ E+    +SDFG++R     E       +G        + APE     R S
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSR----EEADGVYAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 956 DKADVYSFGVVLLELISGKRSLDPSFS 982
            ++DV+SFG++L E  S   S  P+ S
Sbjct: 294 SESDVWSFGILLWETFSLGASPYPNLS 320

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 781 NLIGTGGFGSTYKAELVPG----YLVAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
            +IG G FG  Y   L+         AVK L+ I     + QF  E   +    H N+++
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 836 LIGYYV-GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
           L+G  +  E    +V  ++  G+L  FI  ++       +I    + +A+ + YL     
Sbjct: 95  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYL---AS 150
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLL---EVSETHATTDVAGTFGYVAPEYATT 951
            + VHRD+   N +LDE+    ++DFGLAR +   E    H  T       ++A E   T
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQT 210
Query: 952 CRVSDKADVYSFGVVLLELIS 972
            + + K+DV+SFGV+L EL++
Sbjct: 211 QKFTTKSDVWSFGVLLWELMT 231

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 110/240 (45%), Gaps = 17/240 (7%)
Query: 776  NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
            +F    ++G G F +   A EL      A+K   K  I +   +     E   + R+ H 
Sbjct: 33   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 832  NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
              V L   +  + +++   ++   G L  +I K        +       +I  AL YLH 
Sbjct: 93   FFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 150
Query: 892  SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYAT 950
                 I+HRD+KP NILL+E+++  ++DFG A++L      A  +   GT  YV+PE  T
Sbjct: 151  KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 207
Query: 951  TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
                S  +D+++ G ++ +L++G     P F   GN + I  + K++  E    E F P+
Sbjct: 208  EKSASKSSDLWALGCIIYQLVAGL----PPFRA-GNEYLI--FQKIIKLEYDFPEKFFPK 260

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 68/216 (31%), Positives = 98/216 (45%), Gaps = 30/216 (13%)
Query: 783 IGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLI 837
           +G G FGS       P     G LVAVK+L        + F  EI  L  +    +V   
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 838 G--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY------- 888
           G  Y  G   + LV  +L  G L  F+ +           H+  +D ++ L Y       
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFLQR-----------HRARLDASRLLLYSSQICKG 126
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT---FGYVA 945
           + Y    R VHRD+   NIL++ E +  ++DFGLA+LL + + +      G    F Y A
Sbjct: 127 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY-A 185
Query: 946 PEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPS 980
           PE  +    S ++DV+SFGVVL EL +   +S  PS
Sbjct: 186 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS 221

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 68/216 (31%), Positives = 98/216 (45%), Gaps = 30/216 (13%)
Query: 783 IGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLI 837
           +G G FGS       P     G LVAVK+L        + F  EI  L  +    +V   
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 838 G--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY------- 888
           G  Y  G   + LV  +L  G L  F+ +           H+  +D ++ L Y       
Sbjct: 79  GVSYGPGRQSLRLVMEYLPSGCLRDFLQR-----------HRARLDASRLLLYSSQICKG 127
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT---FGYVA 945
           + Y    R VHRD+   NIL++ E +  ++DFGLA+LL + + +      G    F Y A
Sbjct: 128 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY-A 186
Query: 946 PEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPS 980
           PE  +    S ++DV+SFGVVL EL +   +S  PS
Sbjct: 187 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS 222

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 68/216 (31%), Positives = 98/216 (45%), Gaps = 30/216 (13%)
Query: 783 IGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLI 837
           +G G FGS       P     G LVAVK+L        + F  EI  L  +    +V   
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 838 G--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY------- 888
           G  Y  G   + LV  +L  G L  F+ +           H+  +D ++ L Y       
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQR-----------HRARLDASRLLLYSSQICKG 139
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT---FGYVA 945
           + Y    R VHRD+   NIL++ E +  ++DFGLA+LL + + +      G    F Y A
Sbjct: 140 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY-A 198
Query: 946 PEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPS 980
           PE  +    S ++DV+SFGVVL EL +   +S  PS
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS 234

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 9/206 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGI--QQFDAEIGTLGRIRHKNL 833
           +F   + +G G  G  +K    P  LV  +KL     +     Q   E+  L       +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
           V   G +  + E+ +    + GG+L+  + KK+G+ I   ++ K++I + + L YL    
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGR-IPEQILGKVSIAVIKGLTYLREKH 124
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCR 953
             +I+HRD+KPSNIL++      L DFG++  L  S  ++     GT  Y++PE      
Sbjct: 125 --KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTH 179
Query: 954 VSDKADVYSFGVVLLELISGKRSLDP 979
            S ++D++S G+ L+E+  G+  + P
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 9/206 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGI--QQFDAEIGTLGRIRHKNL 833
           +F   + +G G  G  +K    P  LV  +KL     +     Q   E+  L       +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
           V   G +  + E+ +    + GG+L+  + KK+G+ I   ++ K++I + + L YL    
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGR-IPEQILGKVSIAVIKGLTYLREKH 124
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCR 953
             +I+HRD+KPSNIL++      L DFG++  L  S  ++     GT  Y++PE      
Sbjct: 125 --KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTH 179
Query: 954 VSDKADVYSFGVVLLELISGKRSLDP 979
            S ++D++S G+ L+E+  G+  + P
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 9/206 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGI--QQFDAEIGTLGRIRHKNL 833
           +F   + +G G  G  +K    P  LV  +KL     +     Q   E+  L       +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
           V   G +  + E+ +    + GG+L+  + KK+G+ I   ++ K++I + + L YL    
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGR-IPEQILGKVSIAVIKGLTYLREKH 124
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCR 953
             +I+HRD+KPSNIL++      L DFG++  L  S  ++     GT  Y++PE      
Sbjct: 125 --KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTH 179
Query: 954 VSDKADVYSFGVVLLELISGKRSLDP 979
            S ++D++S G+ L+E+  G+  + P
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 15/210 (7%)
Query: 775 GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQ--GIQQFDAEIGTLGRIRHK 831
           GN+ +   IG G F     A  ++ G  VA+K +   +     +Q+   E+  +  + H 
Sbjct: 12  GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHP 71
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYL 889
           N+V L      E  ++L+  + SGG +  ++  H +  +K   S   +I      A+ Y 
Sbjct: 72  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV----SAVQYC 127
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
           H     RIVHRD+K  N+LLD ++N  ++DFG +    V     T    G+  Y APE  
Sbjct: 128 HQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT--FCGSPPYAAPELF 182
Query: 950 TTCRVSD-KADVYSFGVVLLELISGKRSLD 978
              +    + DV+S GV+L  L+SG    D
Sbjct: 183 QGKKYDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 17/240 (7%)
Query: 776  NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
            +F    ++G G F +   A EL      A+K   K  I +   +     E   + R+ H 
Sbjct: 11   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 70
Query: 832  NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
              V L   +  + +++   ++   G L  +I K        +       +I  AL YLH 
Sbjct: 71   FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 128
Query: 892  SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYAT 950
                 I+HRD+KP NILL+E+++  ++DFG A++L      A  +   GT  YV+PE  T
Sbjct: 129  KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 185
Query: 951  TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
                   +D+++ G ++ +L++G     P F   GN + I  + K++  E    E F P+
Sbjct: 186  EKSACKSSDLWALGCIIYQLVAGL----PPFRA-GNEYLI--FQKIIKLEYDFPEKFFPK 238

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 9/206 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGI--QQFDAEIGTLGRIRHKNL 833
           +F   + +G G  G  +K    P  LV  +KL     +     Q   E+  L       +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
           V   G +  + E+ +    + GG+L+  + KK+G+ I   ++ K++I + + L YL    
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGR-IPEQILGKVSIAVIKGLTYLREKH 124
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCR 953
             +I+HRD+KPSNIL++      L DFG++  L  S  ++     GT  Y++PE      
Sbjct: 125 --KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTH 179
Query: 954 VSDKADVYSFGVVLLELISGKRSLDP 979
            S ++D++S G+ L+E+  G+  + P
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 9/206 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGI--QQFDAEIGTLGRIRHKNL 833
           +F   + +G G  G  +K    P  LV  +KL     +     Q   E+  L       +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
           V   G +  + E+ +    + GG+L+  + KK+G+ I   ++ K++I + + L YL    
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGR-IPEQILGKVSIAVIKGLTYLREKH 124
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCR 953
             +I+HRD+KPSNIL++      L DFG++  L  S  ++     GT  Y++PE      
Sbjct: 125 --KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTH 179
Query: 954 VSDKADVYSFGVVLLELISGKRSLDP 979
            S ++D++S G+ L+E+  G+  + P
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 9/206 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGI--QQFDAEIGTLGRIRHKNL 833
           +F   + +G G  G  +K    P  LV  +KL     +     Q   E+  L       +
Sbjct: 34  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 93
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
           V   G +  + E+ +    + GG+L+  + KK+G+ I   ++ K++I + + L YL    
Sbjct: 94  VGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGR-IPEQILGKVSIAVIKGLTYLREKH 151
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCR 953
             +I+HRD+KPSNIL++      L DFG++  L  S  ++     GT  Y++PE      
Sbjct: 152 --KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTH 206
Query: 954 VSDKADVYSFGVVLLELISGKRSLDP 979
            S ++D++S G+ L+E+  G+  + P
Sbjct: 207 YSVQSDIWSMGLSLVEMAVGRYPIPP 232

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 108/240 (45%), Gaps = 17/240 (7%)
Query: 776  NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
            +F    ++G G F +   A EL      A+K   K  I +   +     E   + R+ H 
Sbjct: 33   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 832  NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
              V L   +  + +++   ++   G L  +I K        +       +I  AL YLH 
Sbjct: 93   FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 150
Query: 892  SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYAT 950
                 I+HRD+KP NILL+E+++  ++DFG A++L      A  +   GT  YV+PE  T
Sbjct: 151  KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 951  TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
                   +D+++ G ++ +L++G     P F     G   + +AK++  E    E F P+
Sbjct: 208  EKSAXKSSDLWALGCIIYQLVAGL----PPFRAGNEG---LIFAKIIKLEYDFPEKFFPK 260

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 104/206 (50%), Gaps = 16/206 (7%)
Query: 777 FSIRNLIGTGGFGSTYKAELVPGY-------LVAVKKLSIGR-FQGIQQFDAEIGTLGRI 828
           F +  ++G GG+G  ++   V G        +  +KK  I R  +      AE   L  +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIH-KKSGKKIQWSVIHKIAIDIAQALA 887
           +H  +V LI  +    +++L+  +LSGG L  F+  ++ G  ++ +    +A +I+ AL 
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLA-EISMALG 135
Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE 947
           +LH      I++RD+KP NI+L+ + +  L+DFGL +   + +   T    GT  Y+APE
Sbjct: 136 HLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHXFCGTIEYMAPE 191
Query: 948 YATTCRVSDKADVYSFGVVLLELISG 973
                  +   D +S G ++ ++++G
Sbjct: 192 ILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 108/240 (45%), Gaps = 17/240 (7%)
Query: 776  NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
            +F    ++G G F +   A EL      A+K   K  I +   +     E   + R+ H 
Sbjct: 33   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 832  NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
              V L   +  + +++   ++   G L  +I K        +       +I  AL YLH 
Sbjct: 93   FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 150
Query: 892  SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYAT 950
                 I+HRD+KP NILL+E+++  ++DFG A++L      A  +   GT  YV+PE  T
Sbjct: 151  KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 951  TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
                   +D+++ G ++ +L++G     P F     G   + +AK++  E    E F P+
Sbjct: 208  EKSACKSSDLWALGCIIYQLVAGL----PPFRAGNEG---LIFAKIIKLEYDFPEKFFPK 260

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 781 NLIGTGGFGSTYKAELVPG----YLVAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
            +IG G FG  Y   L+         AVK L+ I     + QF  E   +    H N+++
Sbjct: 54  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 113
Query: 836 LIGYYV-GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
           L+G  +  E    +V  ++  G+L  FI  ++       +I    + +A+ + YL     
Sbjct: 114 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYL---AS 169
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLL---EVSETHATTDVAGTFGYVAPEYATT 951
            + VHRD+   N +LDE+    ++DFGLAR +   E    H  T       ++A E   T
Sbjct: 170 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 229
Query: 952 CRVSDKADVYSFGVVLLELIS 972
            + + K+DV+SFGV+L EL++
Sbjct: 230 QKFTTKSDVWSFGVLLWELMT 250

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 104/206 (50%), Gaps = 16/206 (7%)
Query: 777 FSIRNLIGTGGFGSTYKAELVPGY-------LVAVKKLSIGR-FQGIQQFDAEIGTLGRI 828
           F +  ++G GG+G  ++   V G        +  +KK  I R  +      AE   L  +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIH-KKSGKKIQWSVIHKIAIDIAQALA 887
           +H  +V LI  +    +++L+  +LSGG L  F+  ++ G  ++ +    +A +I+ AL 
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLA-EISMALG 135
Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE 947
           +LH      I++RD+KP NI+L+ + +  L+DFGL +   + +   T    GT  Y+APE
Sbjct: 136 HLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFCGTIEYMAPE 191
Query: 948 YATTCRVSDKADVYSFGVVLLELISG 973
                  +   D +S G ++ ++++G
Sbjct: 192 ILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 17/240 (7%)
Query: 776  NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
            +F    ++G G F +   A EL      A+K   K  I +   +     E   + R+ H 
Sbjct: 8    DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 67
Query: 832  NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
              V L   +  + +++   ++   G L  +I K        +       +I  AL YLH 
Sbjct: 68   FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 125
Query: 892  SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYAT 950
                 I+HRD+KP NILL+E+++  ++DFG A++L      A  +   GT  YV+PE  T
Sbjct: 126  KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 182
Query: 951  TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
                   +D+++ G ++ +L++G     P F   GN + I  + K++  E    E F P+
Sbjct: 183  EKSACKSSDLWALGCIIYQLVAGL----PPFRA-GNEYLI--FQKIIKLEYDFPEKFFPK 235

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 781 NLIGTGGFGSTYKAELVPG----YLVAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
            +IG G FG  Y   L+         AVK L+ I     + QF  E   +    H N+++
Sbjct: 55  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 114
Query: 836 LIGYYV-GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
           L+G  +  E    +V  ++  G+L  FI  ++       +I    + +A+ + YL     
Sbjct: 115 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYL---AS 170
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLL---EVSETHATTDVAGTFGYVAPEYATT 951
            + VHRD+   N +LDE+    ++DFGLAR +   E    H  T       ++A E   T
Sbjct: 171 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 230
Query: 952 CRVSDKADVYSFGVVLLELIS 972
            + + K+DV+SFGV+L EL++
Sbjct: 231 QKFTTKSDVWSFGVLLWELMT 251

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 17/240 (7%)
Query: 776  NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
            +F    ++G G F +   A EL      A+K   K  I +   +     E   + R+ H 
Sbjct: 10   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 69
Query: 832  NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
              V L   +  + +++   ++   G L  +I K        +       +I  AL YLH 
Sbjct: 70   FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 127
Query: 892  SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYAT 950
                 I+HRD+KP NILL+E+++  ++DFG A++L      A  +   GT  YV+PE  T
Sbjct: 128  KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 184
Query: 951  TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
                   +D+++ G ++ +L++G     P F   GN + I  + K++  E    E F P+
Sbjct: 185  EKSACKSSDLWALGCIIYQLVAGL----PPFRA-GNEYLI--FQKIIKLEYDFPEKFFPK 237

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 17/240 (7%)
Query: 776  NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
            +F    ++G G F +   A EL      A+K   K  I +   +     E   + R+ H 
Sbjct: 31   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 832  NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
              V L   +  + +++   ++   G L  +I K        +       +I  AL YLH 
Sbjct: 91   FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 148
Query: 892  SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDV-AGTFGYVAPEYAT 950
                 I+HRD+KP NILL+E+++  ++DFG A++L      A  +   GT  YV+PE  T
Sbjct: 149  KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLT 205
Query: 951  TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
                   +D+++ G ++ +L++G     P F   GN + I  + K++  E    E F P+
Sbjct: 206  EKSACKSSDLWALGCIIYQLVAGL----PPFRA-GNEYLI--FQKIIKLEYDFPEKFFPK 258

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 775 GNFSIRNLIGTGGFGS------TYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRI 828
           GN+ I   +G G FG       T   + V   ++  K L+    QG  + + EI  L  +
Sbjct: 14  GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLL 71
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
           RH +++ L      + E+ +V  + +G  L  +I ++   K+      +    I  A+ Y
Sbjct: 72  RHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRD--KMSEQEARRFFQQIISAVEY 128
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
            H     +IVHRD+KP N+LLDE LN  ++DFGL+ ++       T+   G+  Y APE 
Sbjct: 129 CHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEV 183
Query: 949 AT-TCRVSDKADVYSFGVVLLELISGKRSLD 978
            +       + DV+S GV+L  ++  +   D
Sbjct: 184 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 781 NLIGTGGFGSTYKAELVPG----YLVAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
            +IG G FG  Y   L+         AVK L+ I     + QF  E   +    H N+++
Sbjct: 28  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 87
Query: 836 LIGYYV-GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
           L+G  +  E    +V  ++  G+L  FI  ++       +I    + +A+ + YL     
Sbjct: 88  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYL---AS 143
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLL---EVSETHATTDVAGTFGYVAPEYATT 951
            + VHRD+   N +LDE+    ++DFGLAR +   E    H  T       ++A E   T
Sbjct: 144 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 203
Query: 952 CRVSDKADVYSFGVVLLELIS 972
            + + K+DV+SFGV+L EL++
Sbjct: 204 QKFTTKSDVWSFGVLLWELMT 224

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 105/220 (47%), Gaps = 24/220 (10%)
Query: 777 FSIRNLIGTGGFGSTYKAE---LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNL 833
           F + + +G G     Y+ +       Y + V K ++ +    +    EIG L R+ H N+
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK----KIVRTEIGVLLRLSHPNI 110
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
           + L   +    E+ LV   ++GG L   I +K G   +      +   I +A+AYLH + 
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGELFDRIVEK-GYYSERDAADAVK-QILEAVAYLHENG 168
Query: 894 VPRIVHRDIKPSNILL-----DEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
              IVHRD+KP N+L      D  L   ++DFGL++++E      T  V GT GY APE 
Sbjct: 169 ---IVHRDLKPENLLYATPAPDAPLK--IADFGLSKIVEHQVLMKT--VCGTPGYCAPEI 221
Query: 949 ATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGF 988
              C    + D++S G++   L+ G    +P + E G+ F
Sbjct: 222 LRGCAYGPEVDMWSVGIITYILLCG---FEPFYDERGDQF 258

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 17/240 (7%)
Query: 776  NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
            +F    ++G G F +   A EL      A+K   K  I +   +     E   + R+ H 
Sbjct: 9    DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 832  NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
              V L   +  + +++   ++   G L  +I K        +       +I  AL YLH 
Sbjct: 69   FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 126
Query: 892  SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYAT 950
                 I+HRD+KP NILL+E+++  ++DFG A++L      A  +   GT  YV+PE  T
Sbjct: 127  KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 183
Query: 951  TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
                   +D+++ G ++ +L++G     P F   GN + I  + K++  E    E F P+
Sbjct: 184  EKSACKSSDLWALGCIIYQLVAGL----PPFRA-GNEYLI--FQKIIKLEYDFPEKFFPK 236

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 781 NLIGTGGFGSTYKAELVPG----YLVAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
            +IG G FG  Y   L+         AVK L+ I     + QF  E   +    H N+++
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 836 LIGYYV-GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
           L+G  +  E    +V  ++  G+L  FI  ++       +I    + +A+ + YL     
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYL---AS 151
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLL---EVSETHATTDVAGTFGYVAPEYATT 951
            + VHRD+   N +LDE+    ++DFGLAR +   E    H  T       ++A E   T
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 952 CRVSDKADVYSFGVVLLELIS 972
            + + K+DV+SFGV+L EL++
Sbjct: 212 QKFTTKSDVWSFGVLLWELMT 232

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 17/240 (7%)
Query: 776  NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
            +F    ++G G F +   A EL      A+K   K  I +   +     E   + R+ H 
Sbjct: 34   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 832  NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
              V L   +  + +++   ++   G L  +I K        +       +I  AL YLH 
Sbjct: 94   FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 151
Query: 892  SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYAT 950
                 I+HRD+KP NILL+E+++  ++DFG A++L      A  +   GT  YV+PE  T
Sbjct: 152  KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 208
Query: 951  TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
                   +D+++ G ++ +L++G     P F   GN + I  + K++  E    E F P+
Sbjct: 209  EKSACKSSDLWALGCIIYQLVAGL----PPFRA-GNEYLI--FQKIIKLEYDFPEKFFPK 261

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 110/232 (47%), Gaps = 21/232 (9%)
Query: 752 GQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYK-AELVPGYLVAVKKLSIG 810
           G +M     TP      +    +  +  + ++G G FG      + + G   AVK +S  
Sbjct: 3   GSMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS-- 60
Query: 811 RFQGIQQFDAE-----IGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHK 864
           + Q  Q+ D E     +  L ++ H N++ L  ++  +   +LV    +GG L +  I +
Sbjct: 61  KRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR 120
Query: 865 KSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFG 921
           K   ++  + I      I Q L+ + Y    +IVHRD+KP N+LL+   ++ N  + DFG
Sbjct: 121 KRFSEVDAARI------IRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFG 174
Query: 922 LARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
           L+   E S+     D  GT  Y+APE        +K DV+S GV+L  L+SG
Sbjct: 175 LSTHFEASK--KMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 17/240 (7%)
Query: 776  NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
            +F    ++G G F +   A EL      A+K   K  I +   +     E   + R+ H 
Sbjct: 34   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 832  NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
              V L   +  + +++   ++   G L  +I K        +       +I  AL YLH 
Sbjct: 94   FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 151
Query: 892  SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYAT 950
                 I+HRD+KP NILL+E+++  ++DFG A++L      A  +   GT  YV+PE  T
Sbjct: 152  KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 208
Query: 951  TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
                   +D+++ G ++ +L++G     P F   GN + I  + K++  E    E F P+
Sbjct: 209  EKSACKSSDLWALGCIIYQLVAGL----PPFRA-GNEYLI--FQKIIKLEYDFPEKFFPK 261

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 17/240 (7%)
Query: 776  NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
            +F    ++G G F +   A EL      A+K   K  I +   +     E   + R+ H 
Sbjct: 33   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 832  NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
              V L   +  + +++   ++   G L  +I K        +       +I  AL YLH 
Sbjct: 93   FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 150
Query: 892  SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYAT 950
                 I+HRD+KP NILL+E+++  ++DFG A++L      A  +   GT  YV+PE  T
Sbjct: 151  KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 951  TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
                   +D+++ G ++ +L++G     P F   GN + I  + K++  E    E F P+
Sbjct: 208  EKSACKSSDLWALGCIIYQLVAGL----PPFRA-GNEYLI--FQKIIKLEYDFPEKFFPK 260

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 775 GNFSIRNLIGTGGFGS------TYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRI 828
           GN+ I   +G G FG       T   + V   ++  K L+    QG  + + EI  L  +
Sbjct: 13  GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLL 70
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
           RH +++ L      + E+ +V  + +G  L  +I ++   K+      +    I  A+ Y
Sbjct: 71  RHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRD--KMSEQEARRFFQQIISAVEY 127
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
            H     +IVHRD+KP N+LLDE LN  ++DFGL+ ++       T+   G+  Y APE 
Sbjct: 128 CHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEV 182
Query: 949 AT-TCRVSDKADVYSFGVVLLELISGKRSLD 978
            +       + DV+S GV+L  ++  +   D
Sbjct: 183 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 17/240 (7%)
Query: 776  NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
            +F    ++G G F +   A EL      A+K   K  I +   +     E   + R+ H 
Sbjct: 31   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 832  NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
              V L   +  + +++   ++   G L  +I K        +       +I  AL YLH 
Sbjct: 91   FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 148
Query: 892  SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYAT 950
                 I+HRD+KP NILL+E+++  ++DFG A++L      A  +   GT  YV+PE  T
Sbjct: 149  KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 951  TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
                   +D+++ G ++ +L++G     P F   GN + I  + K++  E    E F P+
Sbjct: 206  EKSACKSSDLWALGCIIYQLVAGL----PPFRA-GNEYLI--FQKIIKLEYDFPEKFFPK 258

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 17/240 (7%)
Query: 776  NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
            +F    ++G G F +   A EL      A+K   K  I +   +     E   + R+ H 
Sbjct: 33   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 832  NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
              V L   +  + +++   ++   G L  +I K        +       +I  AL YLH 
Sbjct: 93   FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 150
Query: 892  SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYAT 950
                 I+HRD+KP NILL+E+++  ++DFG A++L      A  +   GT  YV+PE  T
Sbjct: 151  KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 951  TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
                   +D+++ G ++ +L++G     P F   GN + I  + K++  E    E F P+
Sbjct: 208  EKSACKSSDLWALGCIIYQLVAGL----PPFRA-GNEYLI--FQKIIKLEYDFPEKFFPK 260

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 17/240 (7%)
Query: 776  NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
            +F    ++G G F +   A EL      A+K   K  I +   +     E   + R+ H 
Sbjct: 31   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 832  NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
              V L   +  + +++   ++   G L  +I K        +       +I  AL YLH 
Sbjct: 91   FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 148
Query: 892  SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYAT 950
                 I+HRD+KP NILL+E+++  ++DFG A++L      A  +   GT  YV+PE  T
Sbjct: 149  KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 205
Query: 951  TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
                   +D+++ G ++ +L++G     P F   GN + I  + K++  E    E F P+
Sbjct: 206  EKSACKSSDLWALGCIIYQLVAGL----PPFRA-GNEYLI--FQKIIKLEYDFPEKFFPK 258

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 775 GNFSIRNLIGTGGFGS------TYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRI 828
           GN+ I   +G G FG       T   + V   ++  K L+    QG  + + EI  L  +
Sbjct: 8   GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLL 65
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
           RH +++ L      + E+ +V  + +G  L  +I ++   K+      +    I  A+ Y
Sbjct: 66  RHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRD--KMSEQEARRFFQQIISAVEY 122
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
            H     +IVHRD+KP N+LLDE LN  ++DFGL+ ++       T+   G+  Y APE 
Sbjct: 123 CHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEV 177
Query: 949 AT-TCRVSDKADVYSFGVVLLELISGKRSLD 978
            +       + DV+S GV+L  ++  +   D
Sbjct: 178 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 17/240 (7%)
Query: 776  NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
            +F    ++G G F +   A EL      A+K   K  I +   +     E   + R+ H 
Sbjct: 38   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 97
Query: 832  NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
              V L   +  + +++   ++   G L  +I K        +       +I  AL YLH 
Sbjct: 98   FFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 155
Query: 892  SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYAT 950
                 I+HRD+KP NILL+E+++  ++DFG A++L      A  +   GT  YV+PE  T
Sbjct: 156  KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 212
Query: 951  TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
                   +D+++ G ++ +L++G     P F   GN + I  + K++  E    E F P+
Sbjct: 213  EKSACKSSDLWALGCIIYQLVAGL----PPFRA-GNEYLI--FQKIIKLEYDFPEKFFPK 265

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Composition-based stats.
 Identities = 56/195 (28%), Positives = 99/195 (50%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV 841
           +G G FG  YKA+    G L A K +     + ++ +  EI  L    H  +V L+G Y 
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 842 GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
            + +++++  F  GG ++  I  +  + +    I  +   + +AL +LH     RI+HRD
Sbjct: 79  HDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRD 134
Query: 902 IKPSNILLDEELNAYLSDFGL-ARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD---- 956
           +K  N+L+  E +  L+DFG+ A+ L+  +   +    GT  ++APE      + D    
Sbjct: 135 LKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCETMKDTPYD 192
Query: 957 -KADVYSFGVVLLEL 970
            KAD++S G+ L+E+
Sbjct: 193 YKADIWSLGITLIEM 207

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 775 GNFSIRNLIGTGGFGS------TYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRI 828
           GN+ I   +G G FG       T   + V   ++  K L+    QG  + + EI  L  +
Sbjct: 4   GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLL 61
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
           RH +++ L      + E+ +V  + +G  L  +I ++   K+      +    I  A+ Y
Sbjct: 62  RHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRD--KMSEQEARRFFQQIISAVEY 118
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
            H     +IVHRD+KP N+LLDE LN  ++DFGL+ ++       T+   G+  Y APE 
Sbjct: 119 CHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEV 173
Query: 949 AT-TCRVSDKADVYSFGVVLLELISGKRSLD 978
            +       + DV+S GV+L  ++  +   D
Sbjct: 174 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Composition-based stats.
 Identities = 56/195 (28%), Positives = 99/195 (50%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV 841
           +G G FG  YKA+    G L A K +     + ++ +  EI  L    H  +V L+G Y 
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 842 GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
            + +++++  F  GG ++  I  +  + +    I  +   + +AL +LH     RI+HRD
Sbjct: 87  HDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRD 142
Query: 902 IKPSNILLDEELNAYLSDFGL-ARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD---- 956
           +K  N+L+  E +  L+DFG+ A+ L+  +   +    GT  ++APE      + D    
Sbjct: 143 LKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCETMKDTPYD 200
Query: 957 -KADVYSFGVVLLEL 970
            KAD++S G+ L+E+
Sbjct: 201 YKADIWSLGITLIEM 215

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 781 NLIGTGGFGSTYKAELVPG----YLVAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
            +IG G FG  Y   L+         AVK L+ I     + QF  E   +    H N+++
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 836 LIGYYV-GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
           L+G  +  E    +V  ++  G+L  FI  ++       +I    + +A+ + YL     
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYL---AS 149
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLL---EVSETHATTDVAGTFGYVAPEYATT 951
            + VHRD+   N +LDE+    ++DFGLAR +   E    H  T       ++A E   T
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 209
Query: 952 CRVSDKADVYSFGVVLLELIS 972
            + + K+DV+SFGV+L EL++
Sbjct: 210 QKFTTKSDVWSFGVLLWELMT 230

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 781 NLIGTGGFGSTYKAELVPG----YLVAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
            +IG G FG  Y   L+         AVK L+ I     + QF  E   +    H N+++
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 836 LIGYYV-GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
           L+G  +  E    +V  ++  G+L  FI  ++       +I    + +A+ + YL     
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYL---AS 148
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLL---EVSETHATTDVAGTFGYVAPEYATT 951
            + VHRD+   N +LDE+    ++DFGLAR +   E    H  T       ++A E   T
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 208
Query: 952 CRVSDKADVYSFGVVLLELIS 972
            + + K+DV+SFGV+L EL++
Sbjct: 209 QKFTTKSDVWSFGVLLWELMT 229

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 111/222 (50%), Gaps = 23/222 (10%)
Query: 763 AELTYDNVVRATGNFSIRNLIGTGGFG-------STYKAELVPGYLVAVKKLSIGRFQGI 815
           +E   +   + + N+ ++  +G G F         T   E     ++  KKLS   FQ +
Sbjct: 17  SEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFA-AKIINTKKLSARDFQKL 75
Query: 816 QQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSV 874
           ++   E     +++H N+V L      E+  +LV++ ++GG L E  + ++   +   S 
Sbjct: 76  ER---EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS- 131
Query: 875 IHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSET 931
            H I   I +++AY H +    IVHR++KP N+LL  +       L+DFGLA  +EV+++
Sbjct: 132 -HCIQ-QILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDS 184
Query: 932 HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
            A    AGT GY++PE       S   D+++ GV+L  L+ G
Sbjct: 185 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 17/240 (7%)
Query: 776  NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
            +F    ++G G F +   A EL      A+K   K  I +   +     E   + R+ H 
Sbjct: 33   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 832  NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
              V L   +  + +++   ++   G L  +I K        +       +I  AL YLH 
Sbjct: 93   FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 150
Query: 892  SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYAT 950
                 I+HRD+KP NILL+E+++  ++DFG A++L      A  +   GT  YV+PE  T
Sbjct: 151  KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 207
Query: 951  TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
                   +D+++ G ++ +L++G     P F   GN + I  + K++  E    E F P+
Sbjct: 208  EKSACKSSDLWALGCIIYQLVAGL----PPFRA-GNEYLI--FQKIIKLEYDFPEKFFPK 260

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 781 NLIGTGGFGSTYKAELVPG----YLVAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
            +IG G FG  Y   L+         AVK L+ I     + QF  E   +    H N+++
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 836 LIGYYV-GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
           L+G  +  E    +V  ++  G+L  FI  ++       +I    + +A+ + YL     
Sbjct: 95  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYL---AS 150
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLL---EVSETHATTDVAGTFGYVAPEYATT 951
            + VHRD+   N +LDE+    ++DFGLAR +   E    H  T       ++A E   T
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 210
Query: 952 CRVSDKADVYSFGVVLLELIS 972
            + + K+DV+SFGV+L EL++
Sbjct: 211 QKFTTKSDVWSFGVLLWELMT 231

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 781 NLIGTGGFGSTYKAELVPG----YLVAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
            +IG G FG  Y   L+         AVK L+ I     + QF  E   +    H N+++
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 836 LIGYYV-GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
           L+G  +  E    +V  ++  G+L  FI  ++       +I    + +A+ + YL     
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYL---AS 151
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLL---EVSETHATTDVAGTFGYVAPEYATT 951
            + VHRD+   N +LDE+    ++DFGLAR +   E    H  T       ++A E   T
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 952 CRVSDKADVYSFGVVLLELIS 972
            + + K+DV+SFGV+L EL++
Sbjct: 212 QKFTTKSDVWSFGVLLWELMT 232

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 9/206 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGI--QQFDAEIGTLGRIRHKNL 833
           +F   + +G G  G  +K    P  LV  +KL     +     Q   E+  L       +
Sbjct: 10  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 69
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
           V   G +  + E+ +    + GG+L+  + KK+G+ I   ++ K++I + + L YL    
Sbjct: 70  VGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGR-IPEQILGKVSIAVIKGLTYLREKH 127
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCR 953
             +I+HRD+KPSNIL++      L DFG++  L + E     +  GT  Y++PE      
Sbjct: 128 --KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDEM--ANEFVGTRSYMSPERLQGTH 182
Query: 954 VSDKADVYSFGVVLLELISGKRSLDP 979
            S ++D++S G+ L+E+  G+    P
Sbjct: 183 YSVQSDIWSMGLSLVEMAVGRYPRPP 208

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 11/208 (5%)
Query: 775 GNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQ--GIQQFDAEIGTLGRIRHK 831
           GN+ ++  IG G F     A  V  G  VAVK +   +     +Q+   E+  +  + H 
Sbjct: 15  GNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHP 74
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
           N+V L      E  ++LV  + SGG  E F +  +  +++          I  A+ Y H 
Sbjct: 75  NIVKLFEVIETEKTLYLVMEYASGG--EVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 132
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT 951
                IVHRD+K  N+LLD ++N  ++DFG +    V     T    G+  Y APE    
Sbjct: 133 KY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT--FCGSPPYAAPELFQG 187
Query: 952 CRVS-DKADVYSFGVVLLELISGKRSLD 978
            +    + DV+S GV+L  L+SG    D
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 781 NLIGTGGFGSTYKAELVPG----YLVAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
            +IG G FG  Y   L+         AVK L+ I     + QF  E   +    H N+++
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 836 LIGYYV-GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
           L+G  +  E    +V  ++  G+L  FI  ++       +I    + +A+ + YL     
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYL---AS 146
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLL---EVSETHATTDVAGTFGYVAPEYATT 951
            + VHRD+   N +LDE+    ++DFGLAR +   E    H  T       ++A E   T
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206
Query: 952 CRVSDKADVYSFGVVLLELIS 972
            + + K+DV+SFGV+L EL++
Sbjct: 207 QKFTTKSDVWSFGVLLWELMT 227

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 17/240 (7%)
Query: 776  NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
            +F    ++G G F +   A EL      A+K   K  I +   +     E   + R+ H 
Sbjct: 15   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 74
Query: 832  NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
              V L   +  + +++   ++   G L  +I K        +       +I  AL YLH 
Sbjct: 75   FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 132
Query: 892  SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYAT 950
                 I+HRD+KP NILL+E+++  ++DFG A++L      A  +   GT  YV+PE  T
Sbjct: 133  KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 189
Query: 951  TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
                   +D+++ G ++ +L++G     P F   GN + I  + K++  E    E F P+
Sbjct: 190  EKSACKSSDLWALGCIIYQLVAGL----PPFRA-GNEYLI--FQKIIKLEYDFPEKFFPK 242

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 13/200 (6%)
Query: 782 LIGTGGFGSTYKAELVPG----YLVAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVTL 836
           +IG G FG  Y   L+         AVK L+ I     + QF  E   +    H N+++L
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 837 IGYYV-GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
           +G  +  E    +V  ++  G+L  FI  ++       +I    + +A+ + +L      
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKFL---ASK 153
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLL---EVSETHATTDVAGTFGYVAPEYATTC 952
           + VHRD+   N +LDE+    ++DFGLAR +   E    H  T       ++A E   T 
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQ 213
Query: 953 RVSDKADVYSFGVVLLELIS 972
           + + K+DV+SFGV+L EL++
Sbjct: 214 KFTTKSDVWSFGVLLWELMT 233

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 10/203 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
           +F    ++G G F +   A EL      A+K   K  I +   +     E   + R+ H 
Sbjct: 36  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 95
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
             V L   +  + +++   ++   G L  +I K        +       +I  AL YLH 
Sbjct: 96  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 153
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYAT 950
                I+HRD+KP NILL+E+++  ++DFG A++L      A  +   GT  YV+PE  T
Sbjct: 154 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 210
Query: 951 TCRVSDKADVYSFGVVLLELISG 973
                  +D+++ G ++ +L++G
Sbjct: 211 EKSACKSSDLWALGCIIYQLVAG 233

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 13/200 (6%)
Query: 782 LIGTGGFGSTYKAELVPG----YLVAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVTL 836
           +IG G FG  Y   L+         AVK L+ I     + QF  E   +    H N+++L
Sbjct: 42  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 101
Query: 837 IGYYV-GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
           +G  +  E    +V  ++  G+L  FI  ++       +I    + +A+ + +L      
Sbjct: 102 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKFL---ASK 157
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLL---EVSETHATTDVAGTFGYVAPEYATTC 952
           + VHRD+   N +LDE+    ++DFGLAR +   E    H  T       ++A E   T 
Sbjct: 158 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 217
Query: 953 RVSDKADVYSFGVVLLELIS 972
           + + K+DV+SFGV+L EL++
Sbjct: 218 KFTTKSDVWSFGVLLWELMT 237

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 775 GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQ--GIQQFDAEIGTLGRIRHK 831
           GN+ +   IG G F     A  ++ G  VA+K +   +     +Q+   E+  +  + H 
Sbjct: 15  GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHP 74
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYL 889
           N+V L      E  ++L+  + SGG +  ++  H +  +K   S   +I      A+ Y 
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV----SAVQYC 130
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
           H     RIVHRD+K  N+LLD ++N  ++DFG +   E +         G   Y APE  
Sbjct: 131 HQK---RIVHRDLKAENLLLDADMNIKIADFGFSN--EFTVGGKLDAFCGAPPYAAPELF 185
Query: 950 TTCRVS-DKADVYSFGVVLLELISGKRSLD 978
              +    + DV+S GV+L  L+SG    D
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 102/219 (46%), Gaps = 22/219 (10%)
Query: 771 VRATGNFSIRNLIGTGGFGSTY-KAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIR 829
           +R T  F    ++G+G F   +   + + G L A+K +           + EI  L +I+
Sbjct: 7   IRKT--FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIK 64
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKS--GKKIQWSVIHKIAIDIAQALA 887
           H+N+VTL   Y      +LV   +SGG L   I ++    +K    VI +    +  A+ 
Sbjct: 65  HENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ----VLSAVK 120
Query: 888 YLHYSCVPRIVHRDIKPSNILL---DEELNAYLSDFGLARLLEVSETHATTDVAGTFGYV 944
           YLH +    IVHRD+KP N+L    +E     ++DFGL+++    +    +   GT GYV
Sbjct: 121 YLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIMSTACGTPGYV 174
Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSE 983
           APE       S   D +S GV+   L+ G     P F E
Sbjct: 175 APEVLAQKPYSKAVDCWSIGVITYILLCGY----PPFYE 209

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 17/240 (7%)
Query: 776  NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
            +F    ++G G F +   A EL      A+K   K  I +   +     E   + R+ H 
Sbjct: 30   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 832  NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
              V L   +  + +++   ++   G L  +I K        +       +I  AL YLH 
Sbjct: 90   FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 147
Query: 892  SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYAT 950
                 I+HRD+KP NILL+E+++  ++DFG A++L      A  +   GT  YV+PE  T
Sbjct: 148  KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 204
Query: 951  TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
                   +D+++ G ++ +L++G     P F   GN + I  + K++  E    E F P+
Sbjct: 205  EKSACKSSDLWALGCIIYQLVAGL----PPFRA-GNEYLI--FQKIIKLEYDFPEKFFPK 257

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 13/200 (6%)
Query: 782 LIGTGGFGSTYKAELVPG----YLVAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVTL 836
           +IG G FG  Y   L+         AVK L+ I     + QF  E   +    H N+++L
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 837 IGYYV-GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
           +G  +  E    +V  ++  G+L  FI  ++       +I    + +A+ + +L      
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKFL---ASK 153
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLL---EVSETHATTDVAGTFGYVAPEYATTC 952
           + VHRD+   N +LDE+    ++DFGLAR +   E    H  T       ++A E   T 
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 213
Query: 953 RVSDKADVYSFGVVLLELIS 972
           + + K+DV+SFGV+L EL++
Sbjct: 214 KFTTKSDVWSFGVLLWELMT 233

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 781 NLIGTGGFGSTYKAELVPG----YLVAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
            +IG G FG  Y   L+         AVK L+ I     + QF  E   +    H N+++
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 836 LIGYYV-GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
           L+G  +  E    +V  ++  G+L  FI  ++       +I    + +A+ + +L     
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKFL---AS 210
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLL---EVSETHATTDVAGTFGYVAPEYATT 951
            + VHRD+   N +LDE+    ++DFGLAR +   E    H  T       ++A E   T
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270
Query: 952 CRVSDKADVYSFGVVLLELIS 972
            + + K+DV+SFGV+L EL++
Sbjct: 271 QKFTTKSDVWSFGVLLWELMT 291

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 109/240 (45%), Gaps = 17/240 (7%)
Query: 776  NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
            +F    ++G G F +   A EL      A+K   K  I +   +     E   + R+ H 
Sbjct: 30   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 832  NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
              V L   +  + +++   ++   G L  +I K        +       +I  AL YLH 
Sbjct: 90   FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHG 147
Query: 892  SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYAT 950
                 I+HRD+KP NILL+E+++  ++DFG A++L      A  +   GT  YV+PE  T
Sbjct: 148  KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 204
Query: 951  TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
                   +D+++ G ++ +L++G     P F   GN + I  + K++  E    E F P+
Sbjct: 205  EKSACKSSDLWALGCIIYQLVAGL----PPFRA-GNEYLI--FQKIIKLEYDFPEKFFPK 257

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 13/200 (6%)
Query: 782 LIGTGGFGSTYKAELVPG----YLVAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVTL 836
           +IG G FG  Y   L+         AVK L+ I     + QF  E   +    H N+++L
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 837 IGYYV-GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
           +G  +  E    +V  ++  G+L  FI  ++       +I    + +A+ + +L      
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKFL---ASK 150
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLL---EVSETHATTDVAGTFGYVAPEYATTC 952
           + VHRD+   N +LDE+    ++DFGLAR +   E    H  T       ++A E   T 
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 210
Query: 953 RVSDKADVYSFGVVLLELIS 972
           + + K+DV+SFGV+L EL++
Sbjct: 211 KFTTKSDVWSFGVLLWELMT 230

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 13/200 (6%)
Query: 782 LIGTGGFGSTYKAELVPG----YLVAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVTL 836
           +IG G FG  Y   L+         AVK L+ I     + QF  E   +    H N+++L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 837 IGYYV-GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
           +G  +  E    +V  ++  G+L  FI  ++       +I    + +A+ + +L      
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKFL---ASK 152
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLL---EVSETHATTDVAGTFGYVAPEYATTC 952
           + VHRD+   N +LDE+    ++DFGLAR +   E    H  T       ++A E   T 
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 212
Query: 953 RVSDKADVYSFGVVLLELIS 972
           + + K+DV+SFGV+L EL++
Sbjct: 213 KFTTKSDVWSFGVLLWELMT 232

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 13/200 (6%)
Query: 782 LIGTGGFGSTYKAELVPG----YLVAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVTL 836
           +IG G FG  Y   L+         AVK L+ I     + QF  E   +    H N+++L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 837 IGYYV-GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
           +G  +  E    +V  ++  G+L  FI  ++       +I    + +A+ + +L      
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKFL---ASK 152
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLL---EVSETHATTDVAGTFGYVAPEYATTC 952
           + VHRD+   N +LDE+    ++DFGLAR +   E    H  T       ++A E   T 
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 212
Query: 953 RVSDKADVYSFGVVLLELIS 972
           + + K+DV+SFGV+L EL++
Sbjct: 213 KFTTKSDVWSFGVLLWELMT 232

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 11/208 (5%)
Query: 775 GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQG--IQQFDAEIGTLGRIRHK 831
           GN+ +   IG G F     A  ++ G  VAV+ +   +     +Q+   E+  +  + H 
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
           N+V L      E  ++LV  + SGG  E F +  +  +++          I  A+ Y H 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGG--EVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT 951
                IVHRD+K  N+LLD ++N  ++DFG +   E +  +   +  G+  Y APE    
Sbjct: 132 KF---IVHRDLKAENLLLDADMNIKIADFGFSN--EFTFGNKLDEFCGSPPYAAPELFQG 186
Query: 952 CRVS-DKADVYSFGVVLLELISGKRSLD 978
            +    + DV+S GV+L  L+SG    D
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 96/192 (50%), Gaps = 9/192 (4%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +GTG FG     +    Y VA+K +  G      +F  E   +  + H+ LV L G    
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           +  +F++  +++ G L  ++ ++   + Q   + ++  D+ +A+ YL      + +HRD+
Sbjct: 91  QRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 146
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF--GYVAPEYATTCRVSDKADV 960
              N L++++    +SDFGL+R   V +   T+ V   F   +  PE     + S K+D+
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRY--VLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDI 204
Query: 961 YSFGVVLLELIS 972
           ++FGV++ E+ S
Sbjct: 205 WAFGVLMWEIYS 216

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 106/229 (46%), Gaps = 23/229 (10%)
Query: 753 QVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGR 811
           +VM   + TP  LT    +    +F I   +G G FG+ Y A E    ++VA+K L   +
Sbjct: 4   KVMENSSGTPDILTRHFTI---DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQ 60
Query: 812 FQ--GIQ-QFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGK 868
            +  G++ Q   EI     + H N++ L  Y+     ++L+  +   G L   + K    
Sbjct: 61  IEKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTF 120
Query: 869 KIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV 928
             Q +    I  ++A AL Y H     +++HRDIKP N+LL  +    ++DFG +     
Sbjct: 121 DEQRTAT--IMEELADALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFGWS----- 170
Query: 929 SETHATT----DVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
              HA +     + GT  Y+ PE       ++K D++  GV+  EL+ G
Sbjct: 171 --VHAPSLRRKTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 107/218 (49%), Gaps = 25/218 (11%)
Query: 770 VVRATGNFSIR----NLIGTGGFGSTYK-AELVPGYLVAVKKLSIGRFQGIQQFDAE--- 821
           V  +T  FS R     ++G G FG      + + G   AVK +S  + Q  Q+ D E   
Sbjct: 40  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS--KRQVKQKTDKESLL 97
Query: 822 --IGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKI 878
             +  L ++ H N++ L  ++  +   +LV    +GG L +  I +K   ++  + I   
Sbjct: 98  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI--- 154
Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSETHATT 935
              I Q L+ + Y    +IVHRD+KP N+LL+   ++ N  + DFGL+   E S+     
Sbjct: 155 ---IRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KMK 209
Query: 936 DVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
           D  GT  Y+APE        +K DV+S GV+L  L+SG
Sbjct: 210 DKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSG 246

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 107/220 (48%), Gaps = 28/220 (12%)
Query: 767 YDNVVR---ATGNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEI 822
           Y++V R       + I   +G G FG  YKA+      L A K +     + ++ +  EI
Sbjct: 26  YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 85
Query: 823 GTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHK--KSGKKIQWSVIHKIAI 880
             L    H N+V L+  +  E  ++++  F +GG ++  + +  +   + Q  V+ K  +
Sbjct: 86  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 145
Query: 881 DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLA----RLLEVSETHATTD 936
           D   AL YLH +   +I+HRD+K  NIL   + +  L+DFG++    R ++  ++     
Sbjct: 146 D---ALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDS----- 194
Query: 937 VAGTFGYVAPEYATTCRVSD------KADVYSFGVVLLEL 970
             GT  ++APE    C  S       KADV+S G+ L+E+
Sbjct: 195 FIGTPYWMAPE-VVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 110/229 (48%), Gaps = 46/229 (20%)
Query: 770 VVRATGNFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFDA-------- 820
           V   + +F +++L+G G +G    A   P G +VA+KK        I+ FD         
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK--------IEPFDKPLFALRTL 57
Query: 821 -EIGTLGRIRHKNLVTLIGYYVGEAEMFLVYN--FLSGGNLETFIHKK------SGKKIQ 871
            EI  L   +H+N++T+  + +   + F  +N  ++    ++T +H+       S   IQ
Sbjct: 58  REIKILKHFKHENIITI--FNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQ 115
Query: 872 WSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS-- 929
           + +   +     +A+  LH S V   +HRD+KPSN+L++   +  + DFGLAR+++ S  
Sbjct: 116 YFIYQTL-----RAVKVLHGSNV---IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167
Query: 930 -------ETHATTDVAGTFGYVAPEYA-TTCRVSDKADVYSFGVVLLEL 970
                  +    T+   T  Y APE   T+ + S   DV+S G +L EL
Sbjct: 168 DNSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 109/229 (47%), Gaps = 46/229 (20%)
Query: 770 VVRATGNFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFDA-------- 820
           V   + +F +++L+G G +G    A   P G +VA+KK        I+ FD         
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK--------IEPFDKPLFALRTL 57
Query: 821 -EIGTLGRIRHKNLVTLIGYYVGEAEMFLVYN--FLSGGNLETFIHKK------SGKKIQ 871
            EI  L   +H+N++T+    +   + F  +N  ++    ++T +H+       S   IQ
Sbjct: 58  REIKILKHFKHENIITIFN--IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQ 115
Query: 872 WSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS-- 929
           + +   +     +A+  LH S V   +HRD+KPSN+L++   +  + DFGLAR+++ S  
Sbjct: 116 YFIYQTL-----RAVKVLHGSNV---IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167
Query: 930 -------ETHATTDVAGTFGYVAPEYA-TTCRVSDKADVYSFGVVLLEL 970
                  +    T+   T  Y APE   T+ + S   DV+S G +L EL
Sbjct: 168 DNSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 107/218 (49%), Gaps = 25/218 (11%)
Query: 770 VVRATGNFSIR----NLIGTGGFGSTYK-AELVPGYLVAVKKLSIGRFQGIQQFDAE--- 821
           V  +T  FS R     ++G G FG      + + G   AVK +S  + Q  Q+ D E   
Sbjct: 41  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS--KRQVKQKTDKESLL 98
Query: 822 --IGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKI 878
             +  L ++ H N++ L  ++  +   +LV    +GG L +  I +K   ++  + I   
Sbjct: 99  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI--- 155
Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSETHATT 935
              I Q L+ + Y    +IVHRD+KP N+LL+   ++ N  + DFGL+   E S+     
Sbjct: 156 ---IRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KMK 210
Query: 936 DVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
           D  GT  Y+APE        +K DV+S GV+L  L+SG
Sbjct: 211 DKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSG 247

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 107/220 (48%), Gaps = 28/220 (12%)
Query: 767 YDNVVR---ATGNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEI 822
           Y++V R       + I   +G G FG  YKA+      L A K +     + ++ +  EI
Sbjct: 26  YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 85
Query: 823 GTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHK--KSGKKIQWSVIHKIAI 880
             L    H N+V L+  +  E  ++++  F +GG ++  + +  +   + Q  V+ K  +
Sbjct: 86  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 145
Query: 881 DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLA----RLLEVSETHATTD 936
           D   AL YLH +   +I+HRD+K  NIL   + +  L+DFG++    R ++  ++     
Sbjct: 146 D---ALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS----- 194
Query: 937 VAGTFGYVAPEYATTCRVSD------KADVYSFGVVLLEL 970
             GT  ++APE    C  S       KADV+S G+ L+E+
Sbjct: 195 FIGTPYWMAPE-VVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 106/223 (47%), Gaps = 21/223 (9%)
Query: 761 TPAELTYDNVVRATGNFSIRNLIGTGGFGSTYK-AELVPGYLVAVKKLSIGRFQGIQQFD 819
           TP      +    +  +  + ++G G FG      + + G   AVK +S  + Q  Q+ D
Sbjct: 12  TPGXFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS--KRQVKQKTD 69
Query: 820 AE-----IGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWS 873
            E     +  L ++ H N+  L  ++  +   +LV    +GG L +  I +K   ++  +
Sbjct: 70  KESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA 129
Query: 874 VIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSE 930
            I      I Q L+ + Y    +IVHRD+KP N+LL+   ++ N  + DFGL+   E S+
Sbjct: 130 RI------IRQVLSGITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183
Query: 931 THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
                D  GT  Y+APE        +K DV+S GV+L  L+SG
Sbjct: 184 --KXKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 11/208 (5%)
Query: 775 GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQG--IQQFDAEIGTLGRIRHK 831
           GN+ +   IG G F     A  ++ G  VAVK +   +     +Q+   E+  +  + H 
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
           N+V L      E  ++LV  + SGG  E F +  +  +++          I  A+ Y H 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGG--EVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT 951
                IVHRD+K  N+LLD ++N  ++DFG +   E +  +      G+  Y APE    
Sbjct: 132 KF---IVHRDLKAENLLLDADMNIKIADFGFSN--EFTFGNKLDTFCGSPPYAAPELFQG 186
Query: 952 CRVS-DKADVYSFGVVLLELISGKRSLD 978
            +    + DV+S GV+L  L+SG    D
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 11/208 (5%)
Query: 775 GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQG--IQQFDAEIGTLGRIRHK 831
           GN+ +   IG G F     A  ++ G  VAVK +   +     +Q+   E+  +  + H 
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
           N+V L      E  ++LV  + SGG  E F +  +  +++          I  A+ Y H 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGG--EVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT 951
                IVHRD+K  N+LLD ++N  ++DFG +   E +  +      G+  Y APE    
Sbjct: 132 KF---IVHRDLKAENLLLDADMNIKIADFGFSN--EFTFGNKLDTFCGSPPYAAPELFQG 186
Query: 952 CRVS-DKADVYSFGVVLLELISGKRSLD 978
            +    + DV+S GV+L  L+SG    D
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 96/192 (50%), Gaps = 9/192 (4%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +GTG FG     +    Y VA+K +  G      +F  E   +  + H+ LV L G    
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           +  +F++  +++ G L  ++ ++   + Q   + ++  D+ +A+ YL      + +HRD+
Sbjct: 91  QRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 146
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF--GYVAPEYATTCRVSDKADV 960
              N L++++    +SDFGL+R   V +   T+ V   F   +  PE     + S K+D+
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 204
Query: 961 YSFGVVLLELIS 972
           ++FGV++ E+ S
Sbjct: 205 WAFGVLMWEIYS 216

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 20/216 (9%)
Query: 767 YDNVVR---ATGNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEI 822
           Y++V R       + I   +G G FG  YKA+      L A K +     + ++ +  EI
Sbjct: 26  YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 85
Query: 823 GTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHK--KSGKKIQWSVIHKIAI 880
             L    H N+V L+  +  E  ++++  F +GG ++  + +  +   + Q  V+ K  +
Sbjct: 86  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 145
Query: 881 DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT 940
           D   AL YLH +   +I+HRD+K  NIL   + +  L+DFG++               GT
Sbjct: 146 D---ALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS-AKNTRXIQRRDXFIGT 198
Query: 941 FGYVAPEYATTCRVSD------KADVYSFGVVLLEL 970
             ++APE    C  S       KADV+S G+ L+E+
Sbjct: 199 PYWMAPE-VVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 107/211 (50%), Gaps = 23/211 (10%)
Query: 774 TGNFSIRNLIGTGGFGSTYKA-------ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLG 826
           + N+ ++  +G G F    +        E     ++  KKLS   FQ +++   E     
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFA-AKIINTKKLSARDFQKLER---EARICR 60
Query: 827 RIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKIAIDIAQA 885
           +++H N+V L      E+  +LV++ ++GG L E  + ++   +   S  H I   I ++
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS--HCIQ-QILES 117
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELN---AYLSDFGLARLLEVSETHATTDVAGTFG 942
           +AY H +    IVHR++KP N+LL  +       L+DFGLA  +EV+++ A    AGT G
Sbjct: 118 IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPG 172
Query: 943 YVAPEYATTCRVSDKADVYSFGVVLLELISG 973
           Y++PE       S   D+++ GV+L  L+ G
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 107/211 (50%), Gaps = 23/211 (10%)
Query: 774 TGNFSIRNLIGTGGFGSTYKA-------ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLG 826
           + N+ ++  +G G F    +        E     ++  KKLS   FQ +++   E     
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFA-AKIINTKKLSARDFQKLER---EARICR 60
Query: 827 RIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKIAIDIAQA 885
           +++H N+V L      E+  +LV++ ++GG L E  + ++   +   S  H I   I ++
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS--HCIQ-QILES 117
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTFG 942
           +AY H +    IVHR++KP N+LL  +       L+DFGLA  +EV+++ A    AGT G
Sbjct: 118 IAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPG 172
Query: 943 YVAPEYATTCRVSDKADVYSFGVVLLELISG 973
           Y++PE       S   D+++ GV+L  L+ G
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 96/192 (50%), Gaps = 9/192 (4%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +GTG FG     +    Y VA+K +  G      +F  E   +  + H+ LV L G    
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           +  +F++  +++ G L  ++ ++   + Q   + ++  D+ +A+ YL      + +HRD+
Sbjct: 75  QRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 130
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF--GYVAPEYATTCRVSDKADV 960
              N L++++    +SDFGL+R   V +   T+ V   F   +  PE     + S K+D+
Sbjct: 131 AARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 188
Query: 961 YSFGVVLLELIS 972
           ++FGV++ E+ S
Sbjct: 189 WAFGVLMWEIYS 200

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 57/174 (32%), Positives = 85/174 (48%), Gaps = 19/174 (10%)
Query: 817 QFDAEIGTLGRIRHKNLVTLIGYYVGEAEM------FLVYNFLSGGNLETFIHKKSGKKI 870
           +F  E      + H  +V +  Y  GEAE       ++V  ++ G  L   +H + G   
Sbjct: 58  RFRREAQNAAALNHPAIVAV--YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMT 114
Query: 871 QWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS- 929
               I  IA D  QAL + H +    I+HRD+KP+NIL+       + DFG+AR +  S 
Sbjct: 115 PKRAIEVIA-DACQALNFSHQN---GIIHRDVKPANILISATNAVKVVDFGIARAIADSG 170
Query: 930 -ETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFS 982
                T  V GT  Y++PE A    V  ++DVYS G VL E+++G    +P F+
Sbjct: 171 NSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG----EPPFT 220

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 56/174 (32%), Positives = 85/174 (48%), Gaps = 19/174 (10%)
Query: 817 QFDAEIGTLGRIRHKNLVTLIGYYVGEAEM------FLVYNFLSGGNLETFIHKKSGKKI 870
           +F  E      + H  +V +  Y  GEAE       ++V  ++ G  L   +H + G   
Sbjct: 75  RFRREAQNAAALNHPAIVAV--YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMT 131
Query: 871 QWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE 930
               I  IA D  QAL + H +    I+HRD+KP+NI++       + DFG+AR +  S 
Sbjct: 132 PKRAIEVIA-DACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 187
Query: 931 THATTDVA--GTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFS 982
              T   A  GT  Y++PE A    V  ++DVYS G VL E+++G    +P F+
Sbjct: 188 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG----EPPFT 237

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV 841
           IG G  G    A E   G  VAVK + + + Q  +    E+  +   +H N+V +   Y+
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 842 GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
              E++++  FL GG L   +   S  ++    I  +   + QALAYLH   V   +HRD
Sbjct: 113 VGEELWVLMEFLQGGALTDIV---SQVRLNEEQIATVCEAVLQALAYLHAQGV---IHRD 166
Query: 902 IKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVY 961
           IK  +ILL  +    LSDFG    +   +      + GT  ++APE  +    + + D++
Sbjct: 167 IKSDSILLTLDGRVKLSDFGFCAQIS-KDVPKRKXLVGTPYWMAPEVISRSLYATEVDIW 225
Query: 962 SFGVVLLELISGKRSLDPSFSE 983
           S G++++E++ G+    P FS+
Sbjct: 226 SLGIMVIEMVDGE---PPYFSD 244

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 107/211 (50%), Gaps = 23/211 (10%)
Query: 774 TGNFSIRNLIGTGGFGSTYKA-------ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLG 826
           + N+ ++  +G G F    +        E     ++  KKLS   FQ +++   E     
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFA-AKIINTKKLSARDFQKLER---EARICR 59
Query: 827 RIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKIAIDIAQA 885
           +++H N+V L      E+  +LV++ ++GG L E  + ++   +   S  H I   I ++
Sbjct: 60  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS--HCIQ-QILES 116
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELN---AYLSDFGLARLLEVSETHATTDVAGTFG 942
           +AY H +    IVHR++KP N+LL  +       L+DFGLA  +EV+++ A    AGT G
Sbjct: 117 IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPG 171
Query: 943 YVAPEYATTCRVSDKADVYSFGVVLLELISG 973
           Y++PE       S   D+++ GV+L  L+ G
Sbjct: 172 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 56/174 (32%), Positives = 85/174 (48%), Gaps = 19/174 (10%)
Query: 817 QFDAEIGTLGRIRHKNLVTLIGYYVGEAEM------FLVYNFLSGGNLETFIHKKSGKKI 870
           +F  E      + H  +V +  Y  GEAE       ++V  ++ G  L   +H + G   
Sbjct: 58  RFRREAQNAAALNHPAIVAV--YATGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMT 114
Query: 871 QWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE 930
               I  IA D  QAL + H +    I+HRD+KP+NI++       + DFG+AR +  S 
Sbjct: 115 PKRAIEVIA-DACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170
Query: 931 THATTDVA--GTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFS 982
              T   A  GT  Y++PE A    V  ++DVYS G VL E+++G    +P F+
Sbjct: 171 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG----EPPFT 220

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 96/192 (50%), Gaps = 9/192 (4%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +GTG FG     +    Y VA+K +  G      +F  E   +  + H+ LV L G    
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           +  +F++  +++ G L  ++ ++   + Q   + ++  D+ +A+ YL      + +HRD+
Sbjct: 71  QRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 126
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF--GYVAPEYATTCRVSDKADV 960
              N L++++    +SDFGL+R   V +   T+ V   F   +  PE     + S K+D+
Sbjct: 127 AARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 184
Query: 961 YSFGVVLLELIS 972
           ++FGV++ E+ S
Sbjct: 185 WAFGVLMWEIYS 196

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 96/192 (50%), Gaps = 9/192 (4%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +GTG FG     +    Y VA+K +  G      +F  E   +  + H+ LV L G    
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           +  +F++  +++ G L  ++ ++   + Q   + ++  D+ +A+ YL      + +HRD+
Sbjct: 76  QRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 131
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF--GYVAPEYATTCRVSDKADV 960
              N L++++    +SDFGL+R   V +   T+ V   F   +  PE     + S K+D+
Sbjct: 132 AARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 189
Query: 961 YSFGVVLLELIS 972
           ++FGV++ E+ S
Sbjct: 190 WAFGVLMWEIYS 201

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 11/208 (5%)
Query: 775 GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQG--IQQFDAEIGTLGRIRHK 831
           GN+ +   IG G F     A  ++ G  VAVK +   +     +Q+   E+  +  + H 
Sbjct: 7   GNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 66
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
           N+V L      E  ++LV  + SGG +  ++         W    +      Q ++ + Y
Sbjct: 67  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG-----WMKEKEARAKFRQIVSAVQY 121
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT 951
                IVHRD+K  N+LLD ++N  ++DFG +   E +  +      G+  Y APE    
Sbjct: 122 CHQKFIVHRDLKAENLLLDADMNIKIADFGFSN--EFTFGNKLDTFCGSPPYAAPELFQG 179
Query: 952 CRVS-DKADVYSFGVVLLELISGKRSLD 978
            +    + DV+S GV+L  L+SG    D
Sbjct: 180 KKYDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 96/216 (44%), Gaps = 20/216 (9%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDA-----EIGTLG 826
           AT  +     IG G +G+ YKA +   G+ VA+K + +    G           E+  L 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 827 RIR---HKNLVTLIGYYVG-----EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKI 878
           R+    H N+V L+          E ++ LV+  +   +L T++ K     +    I  +
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDL 125
Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVA 938
                + L +LH +C   IVHRD+KP NIL+       L+DFGLAR+   S   A T V 
Sbjct: 126 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALTPVV 180
Query: 939 GTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
            T  Y APE       +   D++S G +  E+   K
Sbjct: 181 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 96/192 (50%), Gaps = 9/192 (4%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +GTG FG     +    Y VA+K +  G      +F  E   +  + H+ LV L G    
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           +  +F++  +++ G L  ++ ++   + Q   + ++  D+ +A+ YL      + +HRD+
Sbjct: 82  QRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 137
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF--GYVAPEYATTCRVSDKADV 960
              N L++++    +SDFGL+R   V +   T+ V   F   +  PE     + S K+D+
Sbjct: 138 AARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 195
Query: 961 YSFGVVLLELIS 972
           ++FGV++ E+ S
Sbjct: 196 WAFGVLMWEIYS 207

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 77/154 (50%), Gaps = 5/154 (3%)
Query: 821 EIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI 880
           E   L ++  + +V+L   Y  +  + LV   ++GG+L+  I+         +     A 
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 881 DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT 940
           +I   L  LH     RIV+RD+KP NILLD+  +  +SD GLA  + V E        GT
Sbjct: 294 EICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGT 348
Query: 941 FGYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
            GY+APE     R +   D ++ G +L E+I+G+
Sbjct: 349 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 77/154 (50%), Gaps = 5/154 (3%)
Query: 821 EIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI 880
           E   L ++  + +V+L   Y  +  + LV   ++GG+L+  I+         +     A 
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 881 DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT 940
           +I   L  LH     RIV+RD+KP NILLD+  +  +SD GLA  + V E        GT
Sbjct: 294 EICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGT 348
Query: 941 FGYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
            GY+APE     R +   D ++ G +L E+I+G+
Sbjct: 349 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 19/208 (9%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFDAEIG-TLGRIR---- 829
           +F +  ++G G FG  + AE        A+K L     + +   D ++  T+   R    
Sbjct: 19  DFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALK----KDVVLMDDDVECTMVEKRVLSL 74
Query: 830 ---HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQAL 886
              H  L  +   +  +  +F V  +L+GG+L    H +S  K   S     A +I   L
Sbjct: 75  AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAAEIILGL 132
Query: 887 AYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAP 946
            +LH      IV+RD+K  NILLD++ +  ++DFG+ +   + +   T +  GT  Y+AP
Sbjct: 133 QFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-KTNEFCGTPDYIAP 188
Query: 947 EYATTCRVSDKADVYSFGVVLLELISGK 974
           E     + +   D +SFGV+L E++ G+
Sbjct: 189 EILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 11/208 (5%)
Query: 775 GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQG--IQQFDAEIGTLGRIRHK 831
           GN+ +   IG G F     A  ++ G  VAVK +   +     +Q+   E+  +  + H 
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
           N+V L      E  ++LV  + SGG  E F +  +  +++          I  A+ Y H 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGG--EVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT 951
                IVHRD+K  N+LLD ++N  ++DFG +   E +  +      G   Y APE    
Sbjct: 132 KF---IVHRDLKAENLLLDADMNIKIADFGFSN--EFTFGNKLDAFCGAPPYAAPELFQG 186
Query: 952 CRVS-DKADVYSFGVVLLELISGKRSLD 978
            +    + DV+S GV+L  L+SG    D
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 56/174 (32%), Positives = 85/174 (48%), Gaps = 19/174 (10%)
Query: 817 QFDAEIGTLGRIRHKNLVTLIGYYVGEAEM------FLVYNFLSGGNLETFIHKKSGKKI 870
           +F  E      + H  +V +  Y  GEAE       ++V  ++ G  L   +H + G   
Sbjct: 58  RFRREAQNAAALNHPAIVAV--YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMT 114
Query: 871 QWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE 930
               I  IA D  QAL + H +    I+HRD+KP+NI++       + DFG+AR +  S 
Sbjct: 115 PKRAIEVIA-DACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170
Query: 931 THATTDVA--GTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFS 982
              T   A  GT  Y++PE A    V  ++DVYS G VL E+++G    +P F+
Sbjct: 171 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG----EPPFT 220

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 56/174 (32%), Positives = 85/174 (48%), Gaps = 19/174 (10%)
Query: 817 QFDAEIGTLGRIRHKNLVTLIGYYVGEAEM------FLVYNFLSGGNLETFIHKKSGKKI 870
           +F  E      + H  +V +  Y  GEAE       ++V  ++ G  L   +H + G   
Sbjct: 58  RFRREAQNAAALNHPAIVAV--YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMT 114
Query: 871 QWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE 930
               I  IA D  QAL + H +    I+HRD+KP+NI++       + DFG+AR +  S 
Sbjct: 115 PKRAIEVIA-DACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170
Query: 931 THATTDVA--GTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFS 982
              T   A  GT  Y++PE A    V  ++DVYS G VL E+++G    +P F+
Sbjct: 171 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG----EPPFT 220

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 11/208 (5%)
Query: 775 GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQG--IQQFDAEIGTLGRIRHK 831
           GN+ +   IG G F     A  ++ G  VAV+ +   +     +Q+   E+  +  + H 
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
           N+V L      E  ++LV  + SGG  E F +  +  +++          I  A+ Y H 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGG--EVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT 951
                IVHRD+K  N+LLD ++N  ++DFG +   E +  +      G+  Y APE    
Sbjct: 132 KF---IVHRDLKAENLLLDADMNIKIADFGFSN--EFTFGNKLDTFCGSPPYAAPELFQG 186
Query: 952 CRVS-DKADVYSFGVVLLELISGKRSLD 978
            +    + DV+S GV+L  L+SG    D
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 56/174 (32%), Positives = 85/174 (48%), Gaps = 19/174 (10%)
Query: 817 QFDAEIGTLGRIRHKNLVTLIGYYVGEAEM------FLVYNFLSGGNLETFIHKKSGKKI 870
           +F  E      + H  +V +  Y  GEAE       ++V  ++ G  L   +H + G   
Sbjct: 58  RFRREAQNAAALNHPAIVAV--YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMT 114
Query: 871 QWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE 930
               I  IA D  QAL + H +    I+HRD+KP+NI++       + DFG+AR +  S 
Sbjct: 115 PKRAIEVIA-DACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170
Query: 931 THATTDVA--GTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFS 982
              T   A  GT  Y++PE A    V  ++DVYS G VL E+++G    +P F+
Sbjct: 171 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG----EPPFT 220

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 9/201 (4%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGI--QQFDAEIGTLGRIRHKNL 833
           +F   + +G G  G  +K    P  LV  +KL     +     Q   E+  L       +
Sbjct: 26  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 85
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
           V   G +  + E+ +    + GG+L+  + KK+G+ I   ++ K++I + + L YL    
Sbjct: 86  VGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGR-IPEQILGKVSIAVIKGLTYLREK- 142
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCR 953
             +I+HRD+KPSNIL++      L DFG++  L  S  ++     GT  Y++PE      
Sbjct: 143 -HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTH 198
Query: 954 VSDKADVYSFGVVLLELISGK 974
            S ++D++S G+ L+E+  G+
Sbjct: 199 YSVQSDIWSMGLSLVEMAVGR 219

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 47/190 (24%), Positives = 94/190 (49%), Gaps = 5/190 (2%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           +GTG FG     +    Y VA+K +  G      +F  E   +  + H+ LV L G    
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDI 902
           +  +F++  +++ G L  ++ ++   + Q   + ++  D+ +A+ YL      + +HRD+
Sbjct: 76  QRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 131
Query: 903 KPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYS 962
              N L++++    +SDFGL+R +   E  ++        +  PE     + S K+D+++
Sbjct: 132 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDIWA 191
Query: 963 FGVVLLELIS 972
           FGV++ E+ S
Sbjct: 192 FGVLMWEIYS 201

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 20/220 (9%)
Query: 768 DNVVRATGNFSIRNLIGTGGFGSTYKAELVP--GYLVAVKKLSIGR------FQGIQQFD 819
           D + RA   +     IG G +G  +KA  +   G  VA+K++ +           I++  
Sbjct: 4   DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV- 62
Query: 820 AEIGTLGRIRHKNLVTL-----IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSV 874
           A +  L    H N+V L     +     E ++ LV+  +   +L T++ K     +    
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTET 121
Query: 875 IHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT 934
           I  +   + + L +LH     R+VHRD+KP NIL+       L+DFGLAR+   S   A 
Sbjct: 122 IKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMAL 176
Query: 935 TDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
           T V  T  Y APE       +   D++S G +  E+   K
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Composition-based stats.
 Identities = 66/218 (30%), Positives = 108/218 (49%), Gaps = 25/218 (11%)
Query: 770 VVRATGNFSIR----NLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAE--- 821
           V  +T  FS R     ++G G FG      + + G   AVK +S  + Q  Q+ D E   
Sbjct: 23  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS--KRQVKQKTDKESLL 80
Query: 822 --IGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKI 878
             +  L ++ H N++ L  ++  +   +LV    +GG L +  I +K   ++  +   +I
Sbjct: 81  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA---RI 137
Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSETHATT 935
              +   + Y+H +   +IVHRD+KP N+LL+   ++ N  + DFGL+   E S+     
Sbjct: 138 IRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--MK 192
Query: 936 DVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
           D  GT  Y+APE        +K DV+S GV+L  L+SG
Sbjct: 193 DKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 9/209 (4%)
Query: 768 DNVVRATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQF-DAEIGTL 825
           +N+      F+    IG G FG  +K  +     +VA+K + +   +   +    EI  L
Sbjct: 16  NNIADPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVL 75
Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
            +     +    G Y+  ++++++  +L GG+    +      + Q + + K   +I + 
Sbjct: 76  SQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKG 132
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
           L YLH     + +HRDIK +N+LL E+ +  L+DFG+A  L  ++    T V   F ++A
Sbjct: 133 LDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMA 188
Query: 946 PEYATTCRVSDKADVYSFGVVLLELISGK 974
           PE         KAD++S G+  +EL  G+
Sbjct: 189 PEVIQQSAYDSKADIWSLGITAIELAKGE 217

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 95/213 (44%), Gaps = 17/213 (7%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDA--EIGTLGRIR 829
           AT  +     IG G +G+ YKA +   G+ VA+K + +   +         E+  L R+ 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 830 ---HKNLVTLIGYYVG-----EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAID 881
              H N+V L+          E ++ LV+  +   +L T++ K     +    I  +   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 882 IAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF 941
             + L +LH +C   IVHRD+KP NIL+       L+DFGLAR+   S   A   V  T 
Sbjct: 121 FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALAPVVVTL 175
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
            Y APE       +   D++S G +  E+   K
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 108/229 (47%), Gaps = 46/229 (20%)
Query: 770 VVRATGNFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFDA-------- 820
           V   + +F +++L+G G +G    A   P G +VA+KK        I+ FD         
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK--------IEPFDKPLFALRTL 57
Query: 821 -EIGTLGRIRHKNLVTLIGYYVGEAEMFLVYN--FLSGGNLETFIHKK------SGKKIQ 871
            EI  L   +H+N++T+    +   + F  +N  ++    ++T +H+       S   IQ
Sbjct: 58  REIKILKHFKHENIITIFN--IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQ 115
Query: 872 WSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS-- 929
           + +   +     +A+  LH S V   +HRD+KPSN+L++   +  + DFGLAR+++ S  
Sbjct: 116 YFIYQTL-----RAVKVLHGSNV---IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167
Query: 930 -------ETHATTDVAGTFGYVAPEYA-TTCRVSDKADVYSFGVVLLEL 970
                  +     +   T  Y APE   T+ + S   DV+S G +L EL
Sbjct: 168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 95/213 (44%), Gaps = 17/213 (7%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDA--EIGTLGRIR 829
           AT  +     IG G +G+ YKA +   G+ VA+K + +   +         E+  L R+ 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 830 ---HKNLVTLIGYYVG-----EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAID 881
              H N+V L+          E ++ LV+  +   +L T++ K     +    I  +   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 882 IAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF 941
             + L +LH +C   IVHRD+KP NIL+       L+DFGLAR+   S   A   V  T 
Sbjct: 121 FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALDPVVVTL 175
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
            Y APE       +   D++S G +  E+   K
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 10/200 (5%)
Query: 781 NLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQ---GIQQFDAEIGTLGRIRHKNLVTL 836
            ++G GGFG  +  ++   G L A KKL+  R +   G Q    E   L ++  + +V+L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 837 IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKI--AIDIAQALAYLHYSCV 894
              +  + ++ LV   ++GG++   I+        +     I     I   L +LH    
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR-- 308
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV 954
             I++RD+KP N+LLD++ N  +SD GLA  L+  +T  T   AGT G++APE       
Sbjct: 309 -NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGEEY 366
Query: 955 SDKADVYSFGVVLLELISGK 974
               D ++ GV L E+I+ +
Sbjct: 367 DFSVDYFALGVTLYEMIAAR 386

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 777 FSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQF-DAEIGTLGRIRHKNLV 834
           F+  + IG G FG  YK  +     +VA+K + +   +   +    EI  L +     + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
              G Y+   +++++  +L GG+    +  K G  ++ + I  I  +I + L YLH    
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLL--KPGP-LEETYIATILREILKGLDYLHSE-- 135
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV 954
            R +HRDIK +N+LL E+ +  L+DFG+A  L  ++      V   F ++APE       
Sbjct: 136 -RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPF-WMAPEVIKQSAY 193
Query: 955 SDKADVYSFGVVLLELISGK 974
             KAD++S G+  +EL  G+
Sbjct: 194 DFKADIWSLGITAIELAKGE 213

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 10/200 (5%)
Query: 781 NLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQ---GIQQFDAEIGTLGRIRHKNLVTL 836
            ++G GGFG  +  ++   G L A KKL+  R +   G Q    E   L ++  + +V+L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 837 IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKI--AIDIAQALAYLHYSCV 894
              +  + ++ LV   ++GG++   I+        +     I     I   L +LH    
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR-- 308
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV 954
             I++RD+KP N+LLD++ N  +SD GLA  L+  +T  T   AGT G++APE       
Sbjct: 309 -NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGEEY 366
Query: 955 SDKADVYSFGVVLLELISGK 974
               D ++ GV L E+I+ +
Sbjct: 367 DFSVDYFALGVTLYEMIAAR 386

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 10/200 (5%)
Query: 781 NLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQ---GIQQFDAEIGTLGRIRHKNLVTL 836
            ++G GGFG  +  ++   G L A KKL+  R +   G Q    E   L ++  + +V+L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 837 IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKI--AIDIAQALAYLHYSCV 894
              +  + ++ LV   ++GG++   I+        +     I     I   L +LH    
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR-- 308
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV 954
             I++RD+KP N+LLD++ N  +SD GLA  L+  +T  T   AGT G++APE       
Sbjct: 309 -NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGEEY 366
Query: 955 SDKADVYSFGVVLLELISGK 974
               D ++ GV L E+I+ +
Sbjct: 367 DFSVDYFALGVTLYEMIAAR 386

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 10/200 (5%)
Query: 781 NLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQ---GIQQFDAEIGTLGRIRHKNLVTL 836
            ++G GGFG  +  ++   G L A KKL+  R +   G Q    E   L ++  + +V+L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 837 IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKI--AIDIAQALAYLHYSCV 894
              +  + ++ LV   ++GG++   I+        +     I     I   L +LH    
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR-- 308
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV 954
             I++RD+KP N+LLD++ N  +SD GLA  L+  +T  T   AGT G++APE       
Sbjct: 309 -NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGEEY 366
Query: 955 SDKADVYSFGVVLLELISGK 974
               D ++ GV L E+I+ +
Sbjct: 367 DFSVDYFALGVTLYEMIAAR 386

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 99/198 (50%), Gaps = 13/198 (6%)
Query: 781 NLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRF----QGIQQFD-AEIGTLGRIRHKNLV 834
           + +G G F + YKA +     +VA+KK+ +G       GI +    EI  L  + H N++
Sbjct: 16  DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
            L+  +  ++ + LV++F+   +LE  I K +   +  S I    +   Q L YLH    
Sbjct: 76  GLLDAFGHKSNISLVFDFMET-DLEVII-KDNSLVLTPSHIKAYMLMTLQGLEYLHQHW- 132
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV 954
             I+HRD+KP+N+LLDE     L+DFGLA+    S   A      T  Y APE     R+
Sbjct: 133 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYXHQVVTRWYRAPELLFGARM 189
Query: 955 SD-KADVYSFGVVLLELI 971
                D+++ G +L EL+
Sbjct: 190 YGVGVDMWAVGCILAELL 207

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 73/251 (29%), Positives = 112/251 (44%), Gaps = 23/251 (9%)
Query: 782  LIGTGGFGSTYKAE-LVPGYLVAVKK-LSIGRFQGIQQFDA-EIGTLGRIRHKNLVTLIG 838
            L+G G +G   K      G +VA+KK L     + +++    EI  L ++RH+NLV L+ 
Sbjct: 32   LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 839  YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
                +   +LV+ F+    L+      +G  + + V+ K    I   + + H      I+
Sbjct: 92   VCKKKKRWYLVFEFVDHTILDDLELFPNG--LDYQVVQKYLFQIINGIGFCHSH---NII 146
Query: 899  HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT-TCRVSDK 957
            HRDIKP NIL+ +     L DFG AR L  +      D   T  Y APE      +    
Sbjct: 147  HRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVATRWYRAPELLVGDVKYGKA 205
Query: 958  ADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELF---------- 1007
             DV++ G ++ E+  G+  L P  S+    ++I+     LI   R  ELF          
Sbjct: 206  VDVWAIGCLVTEMFMGE-PLFPGDSDIDQLYHIMMCLGNLIP--RHQELFNKNPVFAGVR 262
Query: 1008 LPELWEAGPQE 1018
            LPE+ E  P E
Sbjct: 263  LPEIKEREPLE 273

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 20/220 (9%)
Query: 768 DNVVRATGNFSIRNLIGTGGFGSTYKAELVP--GYLVAVKKLSIGR------FQGIQQFD 819
           D + RA   +     IG G +G  +KA  +   G  VA+K++ +           I++  
Sbjct: 4   DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV- 62
Query: 820 AEIGTLGRIRHKNLVTL-----IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSV 874
           A +  L    H N+V L     +     E ++ LV+  +   +L T++ K     +    
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTET 121
Query: 875 IHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT 934
           I  +   + + L +LH     R+VHRD+KP NIL+       L+DFGLAR+   S   A 
Sbjct: 122 IKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMAL 176
Query: 935 TDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
           T V  T  Y APE       +   D++S G +  E+   K
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 108/213 (50%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G+ VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +          +++LV   L G +L   +   K +   +Q+ +       I + L Y+H
Sbjct: 89  VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 142
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
            +    I+HRD+KPSN+ ++E+    + DFGLAR       H   ++AG   T  Y APE
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVATRWYRAPE 192
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                   +   D++S G ++ EL++G R+L P
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 224

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 108/213 (50%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G+ VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +          +++LV   L G +L   +   K +   +Q+ +       I + L Y+H
Sbjct: 89  VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 142
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
            +    I+HRD+KPSN+ ++E+    + DFGLAR       H   ++AG   T  Y APE
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVATRWYRAPE 192
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                   +   D++S G ++ EL++G R+L P
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 224

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 20/220 (9%)
Query: 768 DNVVRATGNFSIRNLIGTGGFGSTYKAELVP--GYLVAVKKLSIGR------FQGIQQFD 819
           D + RA   +     IG G +G  +KA  +   G  VA+K++ +           I++  
Sbjct: 4   DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV- 62
Query: 820 AEIGTLGRIRHKNLVTL-----IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSV 874
           A +  L    H N+V L     +     E ++ LV+  +   +L T++ K     +    
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTET 121
Query: 875 IHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT 934
           I  +   + + L +LH     R+VHRD+KP NIL+       L+DFGLAR+   S   A 
Sbjct: 122 IKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMAL 176
Query: 935 TDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
           T V  T  Y APE       +   D++S G +  E+   K
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 95/213 (44%), Gaps = 17/213 (7%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDA--EIGTLGRIR 829
           AT  +     IG G +G+ YKA +   G+ VA+K + +   +         E+  L R+ 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 830 ---HKNLVTLIGYYVG-----EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAID 881
              H N+V L+          E ++ LV+  +   +L T++ K     +    I  +   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 882 IAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF 941
             + L +LH +C   IVHRD+KP NIL+       L+DFGLAR+   S   A   V  T 
Sbjct: 121 FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALFPVVVTL 175
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
            Y APE       +   D++S G +  E+   K
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 102/201 (50%), Gaps = 20/201 (9%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VA+KKLS   FQ     ++   E+  L  ++H+N++ L+ 
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLS-RPFQSEIFAKRAYRELLLLKHMQHENVIGLLD 90
Query: 839 YYVGEAEMFLVYNF-LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
            +   + +   Y+F L    ++T + K  G K     I  +   + + L Y+H + V   
Sbjct: 91  VFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGV--- 147
Query: 898 VHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYATT-CR 953
           VHRD+KP N+ ++E+    + DFGLAR       HA  ++ G   T  Y APE   +   
Sbjct: 148 VHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVTRWYRAPEVILSWMH 200
Query: 954 VSDKADVYSFGVVLLELISGK 974
            +   D++S G ++ E+++GK
Sbjct: 201 YNQTVDIWSVGCIMAEMLTGK 221

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 10/194 (5%)
Query: 783 IGTGGFGSTYKAELV----PGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLI 837
           IG G FG  ++   +    P   VA+K         + ++F  E  T+ +  H ++V LI
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 838 GYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
           G  + E  ++++    + G L +F+  +       S+I   A  ++ ALAYL      R 
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLI-LYAYQLSTALAYLESK---RF 132
Query: 898 VHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDK 957
           VHRDI   N+L+       L DFGL+R +E S  +  +       ++APE     R +  
Sbjct: 133 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 192
Query: 958 ADVYSFGVVLLELI 971
           +DV+ FGV + E++
Sbjct: 193 SDVWMFGVCMWEIL 206

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 104/225 (46%), Gaps = 18/225 (8%)
Query: 755 MVTFADTPAELTYD-NVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQ 813
           M TF     E  YD      +G F+I         G  Y A+ +        +  + R  
Sbjct: 2   METFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCR-- 59
Query: 814 GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS 873
             ++ + E+  L ++ H N++TL   Y    ++ L+   +SGG L  F+ +K       S
Sbjct: 60  --EEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE------S 111
Query: 874 VIHKIAID-IAQALAYLHYSCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLARLLEV 928
           +  + A   I Q L  ++Y    +I H D+KP NI LLD+ +   +  L DFGLA   E+
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EI 169
Query: 929 SETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
            +     ++ GT  +VAPE      +  +AD++S GV+   L+SG
Sbjct: 170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 10/194 (5%)
Query: 783 IGTGGFGSTYKAELV----PGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLI 837
           IG G FG  ++   +    P   VA+K         + ++F  E  T+ +  H ++V LI
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 838 GYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
           G  + E  ++++    + G L +F+  +       S+I   A  ++ ALAYL      R 
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLIL-YAYQLSTALAYLESK---RF 132
Query: 898 VHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDK 957
           VHRDI   N+L+       L DFGL+R +E S  +  +       ++APE     R +  
Sbjct: 133 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 192
Query: 958 ADVYSFGVVLLELI 971
           +DV+ FGV + E++
Sbjct: 193 SDVWMFGVCMWEIL 206

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 13/209 (6%)
Query: 777 FSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQF-DAEIGTLGRIRHKNLV 834
           F+    IG G FG  +K  +     +VA+K + +   +   +    EI  L +     + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
              G Y+ + +++++  +L GG+    +      + Q + I +   +I + L YLH    
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR---EILKGLDYLHSE-- 143
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV 954
            + +HRDIK +N+LL E     L+DFG+A  L  ++    T V   F ++APE       
Sbjct: 144 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVIKQSAY 201
Query: 955 SDKADVYSFGVVLLELISGKRSLDPSFSE 983
             KAD++S G+  +EL  G    +P  SE
Sbjct: 202 DSKADIWSLGITAIELARG----EPPHSE 226

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 107/211 (50%), Gaps = 30/211 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G+ VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
            +          +++LV   L G +L   +     +K+    +  +   I + L Y+H +
Sbjct: 85  VFTPARSLEEFNDVYLV-THLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKYIHSA 140
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
               I+HRD+KPSN+ ++E+    + DFGLAR       H   ++AG   T  Y APE  
Sbjct: 141 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVATRWYRAPEIM 190
Query: 950 TT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                 +   D++S G ++ EL++G R+L P
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 220

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 10/194 (5%)
Query: 783 IGTGGFGSTYKAELV----PGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLI 837
           IG G FG  ++   +    P   VA+K         + ++F  E  T+ +  H ++V LI
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 838 GYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
           G  + E  ++++    + G L +F+  +       S+I   A  ++ ALAYL      R 
Sbjct: 106 GV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLI-LYAYQLSTALAYLESK---RF 160
Query: 898 VHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDK 957
           VHRDI   N+L+       L DFGL+R +E S  +  +       ++APE     R +  
Sbjct: 161 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 220
Query: 958 ADVYSFGVVLLELI 971
           +DV+ FGV + E++
Sbjct: 221 SDVWMFGVCMWEIL 234

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 10/194 (5%)
Query: 783 IGTGGFGSTYKAELV----PGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLI 837
           IG G FG  ++   +    P   VA+K         + ++F  E  T+ +  H ++V LI
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 838 GYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
           G  + E  ++++    + G L +F+  +       S+I   A  ++ ALAYL      R 
Sbjct: 83  GV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLIL-YAYQLSTALAYLESK---RF 137
Query: 898 VHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDK 957
           VHRDI   N+L+       L DFGL+R +E S  +  +       ++APE     R +  
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 197
Query: 958 ADVYSFGVVLLELI 971
           +DV+ FGV + E++
Sbjct: 198 SDVWMFGVCMWEIL 211

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 10/194 (5%)
Query: 783 IGTGGFGSTYKAELV----PGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLI 837
           IG G FG  ++   +    P   VA+K         + ++F  E  T+ +  H ++V LI
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 838 GYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
           G  + E  ++++    + G L +F+  +       S+I   A  ++ ALAYL      R 
Sbjct: 75  GV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLI-LYAYQLSTALAYLESK---RF 129
Query: 898 VHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDK 957
           VHRDI   N+L+       L DFGL+R +E S  +  +       ++APE     R +  
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 189
Query: 958 ADVYSFGVVLLELI 971
           +DV+ FGV + E++
Sbjct: 190 SDVWMFGVCMWEIL 203

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 98/218 (44%), Gaps = 12/218 (5%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNL 833
           ++ +   +G G +G    A   V    VAVK + + R     +    EI     + H+N+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
           V   G+       +L   + SGG L   I    G  +      +    +   + YLH   
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYATTC 952
              I HRDIKP N+LLDE  N  +SDFGLA +   +      + + GT  YVAPE     
Sbjct: 126 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 953 RV-SDKADVYSFGVVLLELISGKRSLD-PSFS--EYGN 986
              ++  DV+S G+VL  +++G+   D PS S  EY +
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 220

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 98/218 (44%), Gaps = 12/218 (5%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNL 833
           ++ +   +G G +G    A   V    VAVK + + R     +    EI     + H+N+
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
           V   G+       +L   + SGG L   I    G  +      +    +   + YLH   
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYATTC 952
              I HRDIKP N+LLDE  N  +SDFGLA +   +      + + GT  YVAPE     
Sbjct: 125 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 953 RV-SDKADVYSFGVVLLELISGKRSLD-PSFS--EYGN 986
              ++  DV+S G+VL  +++G+   D PS S  EY +
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 219

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 10/194 (5%)
Query: 783 IGTGGFGSTYKAELV----PGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLI 837
           IG G FG  ++   +    P   VA+K         + ++F  E  T+ +  H ++V LI
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 838 GYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
           G  + E  ++++    + G L +F+  +       S+I   A  ++ ALAYL      R 
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLIL-YAYQLSTALAYLESK---RF 132
Query: 898 VHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDK 957
           VHRDI   N+L+       L DFGL+R +E S  +  +       ++APE     R +  
Sbjct: 133 VHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 192
Query: 958 ADVYSFGVVLLELI 971
           +DV+ FGV + E++
Sbjct: 193 SDVWMFGVCMWEIL 206

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 91/194 (46%), Gaps = 10/194 (5%)
Query: 783 IGTGGFGSTYKAELV----PGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLI 837
           IG G FG  ++   +    P   VA+K         + ++F  E  T+ +  H ++V LI
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 838 GYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
           G  + E  ++++    + G L +F+  +       S+I   A  ++ ALAYL      R 
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLIL-YAYQLSTALAYLESK---RF 132
Query: 898 VHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDK 957
           VHRDI   N+L+       L DFGL+R +E S     +       ++APE     R +  
Sbjct: 133 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRRFTSA 192
Query: 958 ADVYSFGVVLLELI 971
           +DV+ FGV + E++
Sbjct: 193 SDVWMFGVCMWEIL 206

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 10/194 (5%)
Query: 783 IGTGGFGSTYKAELV----PGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLI 837
           IG G FG  ++   +    P   VA+K         + ++F  E  T+ +  H ++V LI
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 838 GYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
           G  + E  ++++    + G L +F+  +       S+I   A  ++ ALAYL      R 
Sbjct: 81  GV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLIL-YAYQLSTALAYLESK---RF 135
Query: 898 VHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDK 957
           VHRDI   N+L+       L DFGL+R +E S  +  +       ++APE     R +  
Sbjct: 136 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 195
Query: 958 ADVYSFGVVLLELI 971
           +DV+ FGV + E++
Sbjct: 196 SDVWMFGVCMWEIL 209

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 10/194 (5%)
Query: 783 IGTGGFGSTYKAELV----PGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLI 837
           IG G FG  ++   +    P   VA+K         + ++F  E  T+ +  H ++V LI
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 838 GYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
           G  + E  ++++    + G L +F+  +       S+I   A  ++ ALAYL      R 
Sbjct: 80  GV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLIL-YAYQLSTALAYLESK---RF 134
Query: 898 VHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDK 957
           VHRDI   N+L+       L DFGL+R +E S  +  +       ++APE     R +  
Sbjct: 135 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 194
Query: 958 ADVYSFGVVLLELI 971
           +DV+ FGV + E++
Sbjct: 195 SDVWMFGVCMWEIL 208

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 13/209 (6%)
Query: 777 FSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQF-DAEIGTLGRIRHKNLV 834
           F+    IG G FG  +K  +     +VA+K + +   +   +    EI  L +     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
              G Y+ + +++++  +L GG+    +      + Q   I  I  +I + L YLH    
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ---IATILREILKGLDYLHSE-- 123
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV 954
            + +HRDIK +N+LL E     L+DFG+A  L  ++    T V GT  ++APE       
Sbjct: 124 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAY 181
Query: 955 SDKADVYSFGVVLLELISGKRSLDPSFSE 983
             KAD++S G+  +EL  G    +P  SE
Sbjct: 182 DSKADIWSLGITAIELARG----EPPHSE 206

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 10/204 (4%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRF-QGIQQFD-AEIGTLGRIRHKNLVTLIGYY 840
           IG G +G  YKA+   G   A+KK+ + +  +GI      EI  L  ++H N+V L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
             +  + LV+  L   +L+  +    G  ++        + +   +AY H     R++HR
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHDR---RVLHR 124
Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT-TCRVSDKAD 959
           D+KP N+L++ E    ++DFGLAR   +     T +V  T  Y AP+    + + S   D
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMGSKKYSTTID 183
Query: 960 VYSFGVVLLELISGKRSLDPSFSE 983
           ++S G +  E+++G   L P  SE
Sbjct: 184 IWSVGCIFAEMVNGT-PLFPGVSE 206

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 10/204 (4%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRF-QGIQQFD-AEIGTLGRIRHKNLVTLIGYY 840
           IG G +G  YKA+   G   A+KK+ + +  +GI      EI  L  ++H N+V L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
             +  + LV+  L   +L+  +    G  ++        + +   +AY H     R++HR
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHDR---RVLHR 124
Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT-TCRVSDKAD 959
           D+KP N+L++ E    ++DFGLAR   +     T +V  T  Y AP+    + + S   D
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMGSKKYSTTID 183
Query: 960 VYSFGVVLLELISGKRSLDPSFSE 983
           ++S G +  E+++G   L P  SE
Sbjct: 184 IWSVGCIFAEMVNGA-PLFPGVSE 206

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 98/218 (44%), Gaps = 12/218 (5%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNL 833
           ++ +   +G G +G    A   V    VAVK + + R     +    EI     + H+N+
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
           V   G+       +L   + SGG L   I    G  +      +    +   + YLH   
Sbjct: 66  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYATTC 952
              I HRDIKP N+LLDE  N  +SDFGLA +   +      + + GT  YVAPE     
Sbjct: 124 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 953 RV-SDKADVYSFGVVLLELISGKRSLD-PSFS--EYGN 986
              ++  DV+S G+VL  +++G+   D PS S  EY +
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 218

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 98/218 (44%), Gaps = 12/218 (5%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNL 833
           ++ +   +G G +G    A   V    VAVK + + R     +    EI     + H+N+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
           V   G+       +L   + SGG L   I    G  +      +    +   + YLH   
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYATTC 952
              I HRDIKP N+LLDE  N  +SDFGLA +   +      + + GT  YVAPE     
Sbjct: 126 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 953 RV-SDKADVYSFGVVLLELISGKRSLD-PSFS--EYGN 986
              ++  DV+S G+VL  +++G+   D PS S  EY +
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 220

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 98/218 (44%), Gaps = 12/218 (5%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNL 833
           ++ +   +G G +G    A   V    VAVK + + R     +    EI     + H+N+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
           V   G+       +L   + SGG L   I    G  +      +    +   + YLH   
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYATTC 952
              I HRDIKP N+LLDE  N  +SDFGLA +   +      + + GT  YVAPE     
Sbjct: 126 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 953 RV-SDKADVYSFGVVLLELISGKRSLD-PSFS--EYGN 986
              ++  DV+S G+VL  +++G+   D PS S  EY +
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 220

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 98/218 (44%), Gaps = 12/218 (5%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNL 833
           ++ +   +G G +G    A   V    VAVK + + R     +    EI     + H+N+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
           V   G+       +L   + SGG L   I    G  +      +    +   + YLH   
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYATTC 952
              I HRDIKP N+LLDE  N  +SDFGLA +   +      + + GT  YVAPE     
Sbjct: 126 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182
Query: 953 RV-SDKADVYSFGVVLLELISGKRSLD-PSFS--EYGN 986
              ++  DV+S G+VL  +++G+   D PS S  EY +
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 220

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 97/218 (44%), Gaps = 12/218 (5%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNL 833
           ++ +   +G G +G    A   V    VAVK + + R     +    EI     + H+N+
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 66
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
           V   G+       +L   + SGG L   I    G  +      +    +   + YLH   
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV-SETHATTDVAGTFGYVAPEYATTC 952
              I HRDIKP N+LLDE  N  +SDFGLA +    +       + GT  YVAPE     
Sbjct: 125 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 953 RV-SDKADVYSFGVVLLELISGKRSLD-PSFS--EYGN 986
              ++  DV+S G+VL  +++G+   D PS S  EY +
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 219

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 97/218 (44%), Gaps = 12/218 (5%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNL 833
           ++ +   +G G +G    A   V    VAVK + + R     +    EI     + H+N+
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
           V   G+       +L   + SGG L   I    G  +      +    +   + YLH   
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV-SETHATTDVAGTFGYVAPEYATTC 952
              I HRDIKP N+LLDE  N  +SDFGLA +    +       + GT  YVAPE     
Sbjct: 125 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 181
Query: 953 RV-SDKADVYSFGVVLLELISGKRSLD-PSFS--EYGN 986
              ++  DV+S G+VL  +++G+   D PS S  EY +
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 219

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRIRHK 831
           +F I   +G G FG+ Y A E    +++A+K L   + +  G++ Q   EI     +RH 
Sbjct: 16  DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 75
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
           N++ +  Y+     ++L+  F   G L   + K      Q S       ++A AL Y H 
Sbjct: 76  NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA--TFMEELADALHYCHE 133
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT----DVAGTFGYVAPE 947
               +++HRDIKP N+L+  +    ++DFG +        HA +     + GT  Y+ PE
Sbjct: 134 R---KVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRRRXMCGTLDYLPPE 183
Query: 948 YATTCRVSDKADVYSFGVVLLELISGKRSLD-PSFSE 983
                   +K D++  GV+  E + G    D PS +E
Sbjct: 184 MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE 220

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 102/201 (50%), Gaps = 20/201 (9%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VA+KKLS   FQ     ++   E+  L  ++H+N++ L+ 
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLS-RPFQSEIFAKRAYRELLLLKHMQHENVIGLLD 108
Query: 839 YYVGEAEMFLVYNF-LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
            +   + +   Y+F L    ++T + K  G +     I  +   + + L Y+H + V   
Sbjct: 109 VFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGV--- 165
Query: 898 VHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYATT-CR 953
           VHRD+KP N+ ++E+    + DFGLAR       HA  ++ G   T  Y APE   +   
Sbjct: 166 VHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVTRWYRAPEVILSWMH 218
Query: 954 VSDKADVYSFGVVLLELISGK 974
            +   D++S G ++ E+++GK
Sbjct: 219 YNQTVDIWSVGCIMAEMLTGK 239

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Composition-based stats.
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ--GIQ-QFDAEIGTLGRIRHK 831
           +F I   +G G FG+ Y A E    +++A+K L   + +  G++ Q   EI     +RH 
Sbjct: 15  DFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 74
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
           N++ +  Y+     ++L+  F   G L   + K      Q S       ++A AL Y H 
Sbjct: 75  NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA--TFMEELADALHYCHE 132
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT----DVAGTFGYVAPE 947
               +++HRDIKP N+L+  +    ++DFG +        HA +     + GT  Y+ PE
Sbjct: 133 R---KVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRRRXMCGTLDYLPPE 182
Query: 948 YATTCRVSDKADVYSFGVVLLELISGKRSLD-PSFSE 983
                   +K D++  GV+  E + G    D PS +E
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE 219

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 79/316 (25%), Positives = 129/316 (40%), Gaps = 47/316 (14%)
Query: 750  LRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSI 809
             + Q +  F D   EL        +G F+I         G  Y A+ +        +  +
Sbjct: 5    FKQQKVEDFYDIGEEL-------GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGV 57
Query: 810  GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK 869
             R    ++ + E+  L ++ H N++TL   Y    ++ L+   +SGG L  F+ +K    
Sbjct: 58   SR----EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE--- 110
Query: 870  IQWSVIHKIAID-IAQALAYLHYSCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLAR 924
               S+  + A   I Q L  ++Y    +I H D+KP NI LLD+ +   +  L DFGLA 
Sbjct: 111  ---SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
Query: 925  LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG----------- 973
              E+ +     ++ GT  +VAPE      +  +AD++S GV+   L+SG           
Sbjct: 168  --EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 225
Query: 974  --------KRSLDPSFSEYGNGFNIVSWAKLLIKEGRSS---ELFLPELWEAGPQENLLG 1022
                        D  F  + +        KLL+KE R     +  L   W   P +N   
Sbjct: 226  TLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPW-ITPVDNQQA 284
Query: 1023 MMRLASTCTVETLSTR 1038
            M+R  S   +E    +
Sbjct: 285  MVRRESVVNLENFRKQ 300

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 10/204 (4%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRF-QGIQQFD-AEIGTLGRIRHKNLVTLIGYY 840
           IG G +G  YKA+   G   A+KK+ + +  +GI      EI  L  ++H N+V L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
             +  + LV+  L   +L+  +    G  ++        + +   +AY H     R++HR
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHDR---RVLHR 124
Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT-TCRVSDKAD 959
           D+KP N+L++ E    ++DFGLAR   +     T ++  T  Y AP+    + + S   D
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGSKKYSTTID 183
Query: 960 VYSFGVVLLELISGKRSLDPSFSE 983
           ++S G +  E+++G   L P  SE
Sbjct: 184 IWSVGCIFAEMVNGT-PLFPGVSE 206

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 77/315 (24%), Positives = 127/315 (40%), Gaps = 45/315 (14%)
Query: 750  LRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSI 809
             + Q +  F D   EL        +G F+I         G  Y A+ +        +  +
Sbjct: 5    FKQQKVEDFYDIGEEL-------GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGV 57
Query: 810  GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK 869
             R    ++ + E+  L ++ H N++TL   Y    ++ L+   +SGG L  F+ +K    
Sbjct: 58   SR----EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLS 113
Query: 870  IQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLARL 925
             + +        I Q L  ++Y    +I H D+KP NI LLD+ +   +  L DFGLA  
Sbjct: 114  EEEATSF-----IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH- 167
Query: 926  LEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKR---------- 975
             E+ +     ++ GT  +VAPE      +  +AD++S GV+   L+SG            
Sbjct: 168  -EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET 226
Query: 976  ---------SLDPSFSEYGNGFNIVSWAKLLIKEGRSS---ELFLPELWEAGPQENLLGM 1023
                       D  F  + +        KLL+KE R     +  L   W   P +N   M
Sbjct: 227  LANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPW-ITPVDNQQAM 285
Query: 1024 MRLASTCTVETLSTR 1038
            +R  S   +E    +
Sbjct: 286  VRRESVVNLENFRKQ 300

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 92/206 (44%), Gaps = 17/206 (8%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFDAE-------IGTLGR 827
           NF    ++G G FG    A +   G L AVK L       +Q  D E       I +L R
Sbjct: 24  NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVI--LQDDDVECTMTEKRILSLAR 81
Query: 828 IRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALA 887
             H  L  L   +     +F V  F++GG+L    H +  ++   +     A +I  AL 
Sbjct: 82  -NHPFLTQLFCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEIISALM 138
Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE 947
           +LH      I++RD+K  N+LLD E +  L+DFG+ +   +     T    GT  Y+APE
Sbjct: 139 FLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATFCGTPDYIAPE 194
Query: 948 YATTCRVSDKADVYSFGVVLLELISG 973
                      D ++ GV+L E++ G
Sbjct: 195 ILQEMLYGPAVDWWAMGVLLYEMLCG 220

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 97/218 (44%), Gaps = 12/218 (5%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNL 833
           ++ +   +G G +G    A   V    VAVK + + R     +    EI     + H+N+
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
           V   G+       +L   + SGG L   I    G  +      +    +   + YLH   
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV-SETHATTDVAGTFGYVAPEYATTC 952
              I HRDIKP N+LLDE  N  +SDFGLA +    +       + GT  YVAPE     
Sbjct: 125 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 953 RV-SDKADVYSFGVVLLELISGKRSLD-PSFS--EYGN 986
              ++  DV+S G+VL  +++G+   D PS S  EY +
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 219

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 97/218 (44%), Gaps = 12/218 (5%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNL 833
           ++ +   +G G +G    A   V    VAVK + + R     +    EI     + H+N+
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 66
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
           V   G+       +L   + SGG L   I    G  +      +    +   + YLH   
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV-SETHATTDVAGTFGYVAPEYATTC 952
              I HRDIKP N+LLDE  N  +SDFGLA +    +       + GT  YVAPE     
Sbjct: 125 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 953 RV-SDKADVYSFGVVLLELISGKRSLD-PSFS--EYGN 986
              ++  DV+S G+VL  +++G+   D PS S  EY +
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 219

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 15/210 (7%)
Query: 775 GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQG--IQQFDAEIGTLGRIRHK 831
           GN+ +   IG G F     A  ++ G  VAVK +   +     +Q+   E+     + H 
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHP 73
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYL 889
           N+V L      E  ++LV  + SGG +  ++  H +  +K   +   +I      A+ Y 
Sbjct: 74  NIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIV----SAVQYC 129
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
           H      IVHRD+K  N+LLD + N  ++DFG +   E +  +      G   Y APE  
Sbjct: 130 HQKF---IVHRDLKAENLLLDADXNIKIADFGFSN--EFTFGNKLDAFCGAPPYAAPELF 184
Query: 950 TTCRVS-DKADVYSFGVVLLELISGKRSLD 978
              +    + DV+S GV+L  L+SG    D
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 105/229 (45%), Gaps = 24/229 (10%)
Query: 750 LRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSI 809
            + Q +  F D   EL        +G F+I         G  Y A+ +        +  +
Sbjct: 5   FKQQKVEDFYDIGEEL-------GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGV 57
Query: 810 GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK 869
            R    ++ + E+  L ++ H N++TL   Y    ++ L+   +SGG L  F+ +K    
Sbjct: 58  SR----EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE--- 110
Query: 870 IQWSVIHKIAID-IAQALAYLHYSCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLAR 924
              S+  + A   I Q L  ++Y    +I H D+KP NI LLD+ +   +  L DFGLA 
Sbjct: 111 ---SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
Query: 925 LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
             E+ +     ++ GT  +VAPE      +  +AD++S GV+   L+SG
Sbjct: 168 --EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 22/204 (10%)
Query: 783 IGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKN-----LVTL 836
           +G+G  G  +K      G+++AVK++   R  G ++ +  I     +  K+     +V  
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQM---RRSGNKEENKRILMDLDVVLKSHDCPYIVQC 89
Query: 837 IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPR 896
            G ++   ++F+    +  G     + K+    I   ++ K+ + I +AL YL       
Sbjct: 90  FGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HG 145
Query: 897 IVHRDIKPSNILLDEELNAYLSDFGLA-RLLEVSETHATTDVAGTFGYVAPEY-----AT 950
           ++HRD+KPSNILLDE     L DFG++ RL+   +  A    AG   Y+APE       T
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRLV---DDKAKDRSAGCAAYMAPERIDPPDPT 202
Query: 951 TCRVSDKADVYSFGVVLLELISGK 974
                 +ADV+S G+ L+EL +G+
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQ 226

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 83/161 (51%), Gaps = 16/161 (9%)
Query: 821 EIGTLGRIR-HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
           E+  L ++  H N++ L   Y      FLV++ +  G L  ++ +K    +      KI 
Sbjct: 60  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIM 117
Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG 939
             + + +  LH      IVHRD+KP NILLD+++N  L+DFG +  L+  E     +V G
Sbjct: 118 RALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCG 172
Query: 940 TFGYVAPEYATTCRVSD-------KADVYSFGVVLLELISG 973
           T  Y+APE    C ++D       + D++S GV++  L++G
Sbjct: 173 TPSYLAPE-IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 101/231 (43%), Gaps = 24/231 (10%)
Query: 765 LTYDNVVRATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIG 823
           L YD      G+   R ++G G +G  Y   +L     +A+K++     +  Q    EI 
Sbjct: 15  LEYDYEYDENGD---RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIA 71
Query: 824 TLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGK-KIQWSVIHKIAIDI 882
               ++HKN+V  +G +     + +    + GG+L   +  K G  K     I      I
Sbjct: 72  LHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI 131
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-----LSDFGLARLLEVSETHATTDV 937
            + L YLH +   +IVHRDIK  N+L    +N Y     +SDFG ++ L       T   
Sbjct: 132 LEGLKYLHDN---QIVHRDIKGDNVL----INTYSGVLKISDFGTSKRL-AGINPCTETF 183
Query: 938 AGTFGYVAPEYATTCR--VSDKADVYSFGVVLLELISGKRSLDPSFSEYGN 986
            GT  Y+APE            AD++S G  ++E+ +GK    P F E G 
Sbjct: 184 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK----PPFYELGE 230

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 10/194 (5%)
Query: 783 IGTGGFGSTYKAELV----PGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLI 837
           IG G FG  ++   +    P   VA+K         + ++F  E  T+ +  H ++V LI
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 838 GYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
           G  + E  ++++    + G L +F+  +       S+I   A  ++ ALAYL      R 
Sbjct: 458 GV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLI-LYAYQLSTALAYLESK---RF 512
Query: 898 VHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDK 957
           VHRDI   N+L+       L DFGL+R +E S  +  +       ++APE     R +  
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 572
Query: 958 ADVYSFGVVLLELI 971
           +DV+ FGV + E++
Sbjct: 573 SDVWMFGVCMWEIL 586

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 18/199 (9%)
Query: 783 IGTGGFGSTY----KAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +G       K   V   +  ++K S+      +  + E+  L  + H N++ L  
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE-EVAVLKLLDHPNIMKLYD 103
Query: 839 YYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
           ++  +   +LV     GG L +  IH+    ++  +VI      I Q L+ + Y     I
Sbjct: 104 FFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVI------IKQVLSGVTYLHKHNI 157
Query: 898 VHRDIKPSNILLD-EELNAYLS--DFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV 954
           VHRD+KP N+LL+ +E +A +   DFGL+ + E        +  GT  Y+APE     + 
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVFE--NQKKMKERLGTAYYIAPEVLRK-KY 214
Query: 955 SDKADVYSFGVVLLELISG 973
            +K DV+S GV+L  L++G
Sbjct: 215 DEKCDVWSIGVILFILLAG 233

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 12/218 (5%)
Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNL 833
           ++ +   +G G +G    A   V    VAVK + + R     +    EI     + H+N+
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
           V   G+       +L   + SGG L   I    G  +      +    +   + YLH   
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV-SETHATTDVAGTFGYVAPEYATTC 952
              I HRDIKP N+LLDE  N  +SDFGLA +    +       + GT  YVAPE     
Sbjct: 125 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRR 181
Query: 953 RV-SDKADVYSFGVVLLELISGKRSLDP---SFSEYGN 986
              ++  DV+S G+VL  +++G+   D    S  EY +
Sbjct: 182 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSD 219

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 107/213 (50%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G+ VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +          +++LV   L G +L   +   K +   +Q+ +       I + L Y+H
Sbjct: 89  VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 142
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
            +    I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 192
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                   +   D++S G ++ EL++G R+L P
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 224

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 67/216 (31%), Positives = 100/216 (46%), Gaps = 27/216 (12%)
Query: 782 LIGTGGFGSTYKAELVPG----YLVAVKKLS-IGRFQGIQQFDAEIGTLGR-IRHKNLVT 835
           +IG G FG  Y  E +         A+K LS I   Q ++ F  E G L R + H N++ 
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLRE-GLLMRGLNHPNVLA 86
Query: 836 LIGYYVG-EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
           LIG  +  E    ++  ++  G+L  FI           +I    + +A+ + YL     
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLI-SFGLQVARGMEYLAEQ-- 143
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE-------THATTDVAGTFGYVAPE 947
            + VHRD+   N +LDE     ++DFGLAR +   E        HA   V     + A E
Sbjct: 144 -KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVK----WTALE 198
Query: 948 YATTCRVSDKADVYSFGVVLLELISGK----RSLDP 979
              T R + K+DV+SFGV+L EL++      R +DP
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP 234

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 107/213 (50%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G+ VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 98
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +          +++LV   L G +L   +   K +   +Q+ +       I + L Y+H
Sbjct: 99  VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 152
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
            +    I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE
Sbjct: 153 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 202
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                   +   D++S G ++ EL++G R+L P
Sbjct: 203 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 234

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 103/228 (45%), Gaps = 22/228 (9%)
Query: 750 LRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSI 809
            + Q +  F D   EL        +G F+I         G  Y A+ +        +  +
Sbjct: 5   FKQQKVEDFYDIGEEL-------GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGV 57
Query: 810 GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK 869
            R    ++ + E+  L ++ H N++TL   Y    ++ L+   +SGG L  F+ +K    
Sbjct: 58  SR----EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLS 113
Query: 870 IQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLARL 925
            + +        I Q L  ++Y    +I H D+KP NI LLD+ +   +  L DFGLA  
Sbjct: 114 EEEATSF-----IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH- 167
Query: 926 LEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
            E+ +     ++ GT  +VAPE      +  +AD++S GV+   L+SG
Sbjct: 168 -EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 30/211 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G+ VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 107
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
            +          +++LV   L G +L   +     +K+    +  +   I + L Y+H +
Sbjct: 108 VFTPARSLEEFNDVYLV-THLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKYIHSA 163
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
               I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE  
Sbjct: 164 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIM 213
Query: 950 TT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                 +   D++S G ++ EL++G R+L P
Sbjct: 214 LNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 243

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 30/211 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G+ VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 108
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
            +          +++LV   L G +L   +     +K+    +  +   I + L Y+H +
Sbjct: 109 VFTPARSLEEFNDVYLV-THLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKYIHSA 164
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
               I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE  
Sbjct: 165 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIM 214
Query: 950 TT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                 +   D++S G ++ EL++G R+L P
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 244

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 30/211 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G+ VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 108
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
            +          +++LV   L G +L   +     +K+    +  +   I + L Y+H +
Sbjct: 109 VFTPARSLEEFNDVYLV-THLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKYIHSA 164
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
               I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE  
Sbjct: 165 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMXGXVATRWYRAPEIM 214
Query: 950 TT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                 +   D++S G ++ EL++G R+L P
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 244

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 30/211 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G+ VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 94
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
            +          +++LV   L G +L   +     +K+    +  +   I + L Y+H +
Sbjct: 95  VFTPARSLEEFNDVYLV-THLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKYIHSA 150
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
               I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE  
Sbjct: 151 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIM 200
Query: 950 TT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                 +   D++S G ++ EL++G R+L P
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 230

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 10/194 (5%)
Query: 783 IGTGGFGSTYKAELV----PGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLI 837
           IG G FG  ++   +    P   VA+K         + ++F  E  T+ +  H ++V LI
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 838 GYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
           G  + E  ++++    + G L +F+  +       S+I   A  ++ ALAYL      R 
Sbjct: 458 GV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLI-LYAYQLSTALAYLESK---RF 512
Query: 898 VHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDK 957
           VHRDI   N+L+       L DFGL+R +E S  +  +       ++APE     R +  
Sbjct: 513 VHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 572
Query: 958 ADVYSFGVVLLELI 971
           +DV+ FGV + E++
Sbjct: 573 SDVWMFGVCMWEIL 586

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 98/216 (45%), Gaps = 15/216 (6%)
Query: 781 NLIGTGGFGSTYKAEL----VPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNLVT 835
           +L+ T G G+  + +L    V    VAVK + + R     +    EI     + H+N+V 
Sbjct: 9   DLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK 68
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
             G+       +L   + SGG L   I    G  +      +    +   + YLH     
Sbjct: 69  FYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIG-- 124
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEV-SETHATTDVAGTFGYVAPEYATTCRV 954
            I HRDIKP N+LLDE  N  +SDFGLA +    +       + GT  YVAPE       
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 955 -SDKADVYSFGVVLLELISGKRSLD-PSFS--EYGN 986
            ++  DV+S G+VL  +++G+   D PS S  EY +
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 219

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 83/161 (51%), Gaps = 16/161 (9%)
Query: 821 EIGTLGRIR-HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
           E+  L ++  H N++ L   Y      FLV++ +  G L  ++ +K    +      KI 
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIM 130
Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG 939
             + + +  LH      IVHRD+KP NILLD+++N  L+DFG +  L+  E     +V G
Sbjct: 131 RALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCG 185
Query: 940 TFGYVAPEYATTCRVSD-------KADVYSFGVVLLELISG 973
           T  Y+APE    C ++D       + D++S GV++  L++G
Sbjct: 186 TPSYLAPE-IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 30/211 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G+ VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
            +          +++LV   L G +L   +     +K+    +  +   I + L Y+H +
Sbjct: 85  VFTPARSLEEFNDVYLV-THLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKYIHSA 140
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
               I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE  
Sbjct: 141 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIM 190
Query: 950 TT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                 +   D++S G ++ EL++G R+L P
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 220

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 13/209 (6%)
Query: 777 FSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQF-DAEIGTLGRIRHKNLV 834
           F+    IG G FG  +K  +     +VA+K + +   +   +    EI  L +     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
              G Y+ + +++++  +L GG+    +      + Q + I +   +I + L YLH    
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR---EILKGLDYLHSE-- 138
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV 954
            + +HRDIK +N+LL E     L+DFG+A  L  ++      V GT  ++APE       
Sbjct: 139 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEVIKQSAY 196
Query: 955 SDKADVYSFGVVLLELISGKRSLDPSFSE 983
             KAD++S G+  +EL  G    +P  SE
Sbjct: 197 DSKADIWSLGITAIELARG----EPPHSE 221

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 105/229 (45%), Gaps = 24/229 (10%)
Query: 750 LRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSI 809
            + Q +  F D   EL        +G F+I         G  Y A+ +        +  +
Sbjct: 5   FKQQKVEDFYDIGEEL-------GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGV 57
Query: 810 GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK 869
            R    ++ + E+  L ++ H N++TL   Y    ++ L+   +SGG L  F+ +K    
Sbjct: 58  SR----EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE--- 110
Query: 870 IQWSVIHKIAID-IAQALAYLHYSCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLAR 924
              S+  + A   I Q L  ++Y    +I H D+KP NI LLD+ +   +  L DFGLA 
Sbjct: 111 ---SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
Query: 925 LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
             E+ +     ++ GT  +VAPE      +  +AD++S GV+   L+SG
Sbjct: 168 --EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +          +++LV   L G +L   +   K +   +Q+ +       I + L Y+H
Sbjct: 89  VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 142
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
            +    I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 192
Query: 948 YA-TTCRVSDKADVYSFGVVLLELISGKRSLDP 979
                   +   D++S G ++ EL++G R+L P
Sbjct: 193 IMLNAMHYNQTVDIWSVGCIMAELLTG-RTLFP 224

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           IG+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 93
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +          +++LV   L G +L   +   K +   +Q+ +       I + L Y+H
Sbjct: 94  VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 147
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
            +    I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE
Sbjct: 148 SA---DIIHRDLKPSNLAVNEDXELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 197
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                   +   D++S G ++ EL++G R+L P
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 229

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 95
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +          +++LV   L G +L   +   K +   +Q+ +       I + L Y+H
Sbjct: 96  VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 149
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
            +    I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE
Sbjct: 150 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTADEMTGYVATRWYRAPE 199
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                   +   D++S G ++ EL++G R+L P
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 231

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 101/231 (43%), Gaps = 24/231 (10%)
Query: 765 LTYDNVVRATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIG 823
           L YD      G+   R ++G G +G  Y   +L     +A+K++     +  Q    EI 
Sbjct: 1   LEYDYEYDENGD---RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIA 57
Query: 824 TLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGK-KIQWSVIHKIAIDI 882
               ++HKN+V  +G +     + +    + GG+L   +  K G  K     I      I
Sbjct: 58  LHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI 117
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-----LSDFGLARLLEVSETHATTDV 937
            + L YLH +   +IVHRDIK  N+L    +N Y     +SDFG ++ L       T   
Sbjct: 118 LEGLKYLHDN---QIVHRDIKGDNVL----INTYSGVLKISDFGTSKRL-AGINPCTETF 169
Query: 938 AGTFGYVAPEYATTCR--VSDKADVYSFGVVLLELISGKRSLDPSFSEYGN 986
            GT  Y+APE            AD++S G  ++E+ +GK    P F E G 
Sbjct: 170 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK----PPFYELGE 216

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 95
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +          +++LV   L G +L   +   K +   +Q+ +       I + L Y+H
Sbjct: 96  VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 149
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
            +    I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE
Sbjct: 150 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTADEMTGYVATRWYRAPE 199
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                   +   D++S G ++ EL++G R+L P
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 231

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 13/209 (6%)
Query: 777 FSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQF-DAEIGTLGRIRHKNLV 834
           F+    IG G FG  +K  +     +VA+K + +   +   +    EI  L +     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
              G Y+ + +++++  +L GG+    +      + Q   I  I  +I + L YLH    
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ---IATILREILKGLDYLHSE-- 123
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV 954
            + +HRDIK +N+LL E     L+DFG+A  L  ++      V GT  ++APE       
Sbjct: 124 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEVIKQSAY 181
Query: 955 SDKADVYSFGVVLLELISGKRSLDPSFSE 983
             KAD++S G+  +EL  G    +P  SE
Sbjct: 182 DSKADIWSLGITAIELARG----EPPHSE 206

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 30/211 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
            +          +++LV   L G +L   +     +K+    +  +   I + L Y+H +
Sbjct: 89  VFTPARSLEEFNDVYLV-THLMGADLNNIV---KXQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
               I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE  
Sbjct: 145 ---DIIHRDLKPSNLAVNEDXELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIM 194
Query: 950 TT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                 +   D++S G ++ EL++G R+L P
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 224

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +          +++LV   L G +L   +   K +   +Q+ +       I + L Y+H
Sbjct: 89  VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 142
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
            +    I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 192
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                   +   D++S G ++ EL++G R+L P
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 224

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +          +++LV   L G +L   +   K +   +Q+ +       I + L Y+H
Sbjct: 89  VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 142
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
            +    I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGXVATRWYRAPE 192
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                   +   D++S G ++ EL++G R+L P
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 224

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 783 IGTGGFGSTYKAELV------PGYL--VAVKKL-SIGRFQGIQQFDAEIGTLGRI-RHKN 832
           +G G FG    AE +      P  +  VAVK L S    + +    +E+  +  I +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSV--------------IHKI 878
           ++ L+G    +  ++++  + S GNL  ++  +    +++S               +   
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDV 937
           A  +A+ + YL      + +HRD+   N+L+ E+    ++DFGLAR +  +     TT+ 
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 938 AGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
                ++APE       + ++DV+SFGV+L E+ +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 95
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +          +++LV   L G +L   +   K +   +Q+ +       I + L Y+H
Sbjct: 96  VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 149
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
            +    I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE
Sbjct: 150 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTADEMTGYVATRWYRAPE 199
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                   +   D++S G ++ EL++G R+L P
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 231

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 30/211 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLS-KPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 100
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
            +          +++LV   L G +L   +     +K+    +  +   I + L Y+H +
Sbjct: 101 VFTPARSLEEFNDVYLV-THLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKYIHSA 156
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
               I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE  
Sbjct: 157 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIM 206
Query: 950 TT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                 +   D++S G ++ EL++G R+L P
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 236

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 107/213 (50%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G+ VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIH--KKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +          +++LV   L G +L   +   K +   +Q+ +       I + L Y+H
Sbjct: 85  VFTPARSLEEFNDVYLV-THLMGADLNNIVKCAKLTDDHVQFLIYQ-----ILRGLKYIH 138
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
            +    I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE
Sbjct: 139 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 188
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                   +   D++S G ++ EL++G R+L P
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +          +++LV   L G +L   +   K +   +Q+ +       I + L Y+H
Sbjct: 89  VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 142
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
            +    I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 192
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                   +   D++S G ++ EL++G R+L P
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 224

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 102/221 (46%), Gaps = 32/221 (14%)
Query: 769 NVVRATGNFSIRNLIGTGGFGSTY---KAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTL 825
           N+     +FS+  +IG GGFG  Y   KA+   G + A+K L   R +  Q      G  
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADT--GKMYAMKCLDKKRIKMKQ------GET 234
Query: 826 GRIRHKNLVTLIG-----YYVGEAEMF-------LVYNFLSGGNLETFIHKKSGKKIQWS 873
             +  + +++L+      + V  +  F        + + ++GG+L    H         +
Sbjct: 235 LALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH--YHLSQHGVFSEA 292
Query: 874 VIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA 933
            +   A +I   L ++H   V   V+RD+KP+NILLDE  +  +SD GLA      + HA
Sbjct: 293 DMRFYAAEIILGLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 349
Query: 934 TTDVAGTFGYVAPEYATTCRVSD-KADVYSFGVVLLELISG 973
           +    GT GY+APE        D  AD +S G +L +L+ G
Sbjct: 350 SV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 102/221 (46%), Gaps = 32/221 (14%)
Query: 769 NVVRATGNFSIRNLIGTGGFGSTY---KAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTL 825
           N+     +FS+  +IG GGFG  Y   KA+   G + A+K L   R +  Q      G  
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADT--GKMYAMKCLDKKRIKMKQ------GET 234
Query: 826 GRIRHKNLVTLIG-----YYVGEAEMF-------LVYNFLSGGNLETFIHKKSGKKIQWS 873
             +  + +++L+      + V  +  F        + + ++GG+L    H         +
Sbjct: 235 LALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH--YHLSQHGVFSEA 292
Query: 874 VIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA 933
            +   A +I   L ++H   V   V+RD+KP+NILLDE  +  +SD GLA      + HA
Sbjct: 293 DMRFYAAEIILGLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 349
Query: 934 TTDVAGTFGYVAPEYATTCRVSD-KADVYSFGVVLLELISG 973
           +    GT GY+APE        D  AD +S G +L +L+ G
Sbjct: 350 SV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +          +++LV   L G +L   +   K +   +Q+ +       I + L Y+H
Sbjct: 89  VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 142
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
            +    I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 192
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                   +   D++S G ++ EL++G R+L P
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 224

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 102/211 (48%), Gaps = 23/211 (10%)
Query: 783 IGTGGFGSTYKAEL---VPG---YLVAVKKLSIGRFQGI--QQFDAEIGTLGRIRHKNLV 834
           +G   FG  YK  L    PG     VA+K L   + +G   ++F  E     R++H N+V
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-DKAEGPLREEFRHEAMLRARLQHPNVV 92
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFI-----HKKSGKKIQWSVIHKIAID-------I 882
            L+G    +  + +++++ S G+L  F+     H   G       + K A++       +
Sbjct: 93  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV-KSALEPPDFVHLV 151
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT-DVAGTF 941
           AQ  A + Y     +VH+D+   N+L+ ++LN  +SD GL R +  ++ +    +     
Sbjct: 152 AQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPI 211
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
            ++APE     + S  +D++S+GVVL E+ S
Sbjct: 212 RWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 107/226 (47%), Gaps = 31/226 (13%)
Query: 760 DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGIQQF 818
           D P E++Y +            +IG G FG  Y+A+L   G LVA+KK+     QG    
Sbjct: 15  DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFK 60
Query: 819 DAEIGTLGRIRHKNLVTLIGYYVGEAE------MFLVYNFLSGGNLETFIHKKSGKKIQW 872
           + E+  + ++ H N+V L  ++    E      + LV +++         H    K+   
Sbjct: 61  NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLP 120
Query: 873 SVIHKIAI-DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVSE 930
            +  K+ +  + ++LAY+H      I HRDIKP N+LLD +     L DFG A+ L   E
Sbjct: 121 VIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177
Query: 931 THATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
            + +  +   + Y APE  +  T   S   DV+S G VL EL+ G+
Sbjct: 178 PNVSX-ICSRY-YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 220

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 82/161 (50%), Gaps = 16/161 (9%)
Query: 821 EIGTLGRIR-HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
           E+  L ++  H N++ L   Y      FLV++ +  G L  ++ +K    +      KI 
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIM 130
Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG 939
             + + +  LH      IVHRD+KP NILLD+++N  L+DFG +  L+  E      V G
Sbjct: 131 RALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLRSVCG 185
Query: 940 TFGYVAPEYATTCRVSD-------KADVYSFGVVLLELISG 973
           T  Y+APE    C ++D       + D++S GV++  L++G
Sbjct: 186 TPSYLAPE-IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 30/211 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 111
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
            +          +++LV   L G +L   +     +K+    +  +   I + L Y+H +
Sbjct: 112 VFTPARSLEEFNDVYLV-THLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKYIHSA 167
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
               I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE  
Sbjct: 168 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIM 217
Query: 950 TT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                 +   D++S G ++ EL++G R+L P
Sbjct: 218 LNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 247

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 30/211 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 94
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
            +          +++LV   L G +L   +     +K+    +  +   I + L Y+H +
Sbjct: 95  VFTPARSLEEFNDVYLV-THLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKYIHSA 150
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
               I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE  
Sbjct: 151 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIM 200
Query: 950 TT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                 +   D++S G ++ EL++G R+L P
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 230

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +          +++LV   L G +L   +   K +   +Q+ +       I + L Y+H
Sbjct: 89  VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 142
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
            +    I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 192
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                   +   D++S G ++ EL++G R+L P
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 224

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +          +++LV   L G +L   +   K +   +Q+ +       I + L Y+H
Sbjct: 89  VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 142
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
            +    I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 192
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                   +   D++S G ++ EL++G R+L P
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 224

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 30/211 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
            +          +++LV   L G +L   +     +K+    +  +   I + L Y+H +
Sbjct: 89  VFTPARSLEEFNDVYLV-THLMGADLNNIV---KXQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
               I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE  
Sbjct: 145 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIM 194
Query: 950 TT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                 +   D++S G ++ EL++G R+L P
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 224

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 30/211 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 108
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
            +          +++LV   L G +L   +     +K+    +  +   I + L Y+H +
Sbjct: 109 VFTPARSLEEFNDVYLV-THLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKYIHSA 164
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
               I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE  
Sbjct: 165 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIM 214
Query: 950 TT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                 +   D++S G ++ EL++G R+L P
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 244

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 95
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +          +++LV   L G +L   +   K +   +Q+ +       I + L Y+H
Sbjct: 96  VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 149
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
            +    I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE
Sbjct: 150 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 199
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                   +   D++S G ++ EL++G R+L P
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 231

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 93
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +          +++LV   L G +L   +   K +   +Q+ +       I + L Y+H
Sbjct: 94  VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 147
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
            +    I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE
Sbjct: 148 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 197
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                   +   D++S G ++ EL++G R+L P
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 229

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 102/221 (46%), Gaps = 32/221 (14%)
Query: 769 NVVRATGNFSIRNLIGTGGFGSTY---KAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTL 825
           N+     +FS+  +IG GGFG  Y   KA+   G + A+K L   R +  Q      G  
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADT--GKMYAMKCLDKKRIKMKQ------GET 234
Query: 826 GRIRHKNLVTLIG-----YYVGEAEMF-------LVYNFLSGGNLETFIHKKSGKKIQWS 873
             +  + +++L+      + V  +  F        + + ++GG+L    H         +
Sbjct: 235 LALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH--YHLSQHGVFSEA 292
Query: 874 VIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA 933
            +   A +I   L ++H   V   V+RD+KP+NILLDE  +  +SD GLA      + HA
Sbjct: 293 DMRFYAAEIILGLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 349
Query: 934 TTDVAGTFGYVAPEYATTCRVSD-KADVYSFGVVLLELISG 973
           +    GT GY+APE        D  AD +S G +L +L+ G
Sbjct: 350 SV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 93
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +          +++LV   L G +L   +   K +   +Q+ +       I + L Y+H
Sbjct: 94  VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 147
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
            +    I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE
Sbjct: 148 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 197
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                   +   D++S G ++ EL++G R+L P
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 229

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 87
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +          +++LV   L G +L   +   K +   +Q+ +       I + L Y+H
Sbjct: 88  VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 141
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
            +    I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE
Sbjct: 142 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 191
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                   +   D++S G ++ EL++G R+L P
Sbjct: 192 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 223

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +          +++LV   L G +L   +   K +   +Q+ +       I + L Y+H
Sbjct: 89  VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 142
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
            +    I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 192
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                   +   D++S G ++ EL++G R+L P
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 224

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 93
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +          +++LV   L G +L   +   K +   +Q+ +       I + L Y+H
Sbjct: 94  VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 147
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
            +    I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE
Sbjct: 148 SA---DIIHRDLKPSNLAVNEDXELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 197
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                   +   D++S G ++ EL++G R+L P
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 229

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 90
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +          +++LV   L G +L   +   K +   +Q+ +       I + L Y+H
Sbjct: 91  VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 144
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
            +    I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE
Sbjct: 145 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 194
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                   +   D++S G ++ EL++G R+L P
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 226

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 102/221 (46%), Gaps = 32/221 (14%)
Query: 769 NVVRATGNFSIRNLIGTGGFGSTY---KAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTL 825
           N+     +FS+  +IG GGFG  Y   KA+   G + A+K L   R +  Q      G  
Sbjct: 182 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADT--GKMYAMKCLDKKRIKMKQ------GET 233
Query: 826 GRIRHKNLVTLIG-----YYVGEAEMF-------LVYNFLSGGNLETFIHKKSGKKIQWS 873
             +  + +++L+      + V  +  F        + + ++GG+L    H         +
Sbjct: 234 LALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH--YHLSQHGVFSEA 291
Query: 874 VIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA 933
            +   A +I   L ++H   V   V+RD+KP+NILLDE  +  +SD GLA      + HA
Sbjct: 292 DMRFYAAEIILGLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 348
Query: 934 TTDVAGTFGYVAPEYATTCRVSD-KADVYSFGVVLLELISG 973
           +    GT GY+APE        D  AD +S G +L +L+ G
Sbjct: 349 SV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 386

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 85
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +          +++LV   L G +L   +   K +   +Q+ +       I + L Y+H
Sbjct: 86  VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 139
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
            +    I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE
Sbjct: 140 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 189
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                   +   D++S G ++ EL++G R+L P
Sbjct: 190 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 221

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 30/211 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 100
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
            +          +++LV   L G +L   +     +K+    +  +   I + L Y+H +
Sbjct: 101 VFTPARSLEEFNDVYLV-THLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKYIHSA 156
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
               I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE  
Sbjct: 157 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIM 206
Query: 950 TT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                 +   D++S G ++ EL++G R+L P
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 236

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 30/211 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 100
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
            +          +++LV   L G +L   +     +K+    +  +   I + L Y+H +
Sbjct: 101 VFTPARSLEEFNDVYLV-THLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKYIHSA 156
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
               I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE  
Sbjct: 157 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIM 206
Query: 950 TT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                 +   D++S G ++ EL++G R+L P
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 236

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 782 LIGTGGFGSTYKAELVP-----GYLVAVKKL--SIGRFQGIQQFDAEIGTLGRIRHKNLV 834
           ++G+G FG+ YK   VP        VA+K L  + G    ++  D E   +  + H +LV
Sbjct: 45  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMD-EALIMASMDHPHLV 103
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
            L+G  +    + LV   +  G L  ++H+     I   ++    + IA+ + YL     
Sbjct: 104 RLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEER-- 159
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT-FGYVAPEYATTCR 953
            R+VHRD+   N+L+    +  ++DFGLARLLE  E     D       ++A E     +
Sbjct: 160 -RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK 218
Query: 954 VSDKADVYSFGVVLLELIS 972
            + ++DV+S+GV + EL++
Sbjct: 219 FTHQSDVWSYGVTIWELMT 237

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 782 LIGTGGFGSTYKAELVP-----GYLVAVKKL--SIGRFQGIQQFDAEIGTLGRIRHKNLV 834
           ++G+G FG+ YK   VP        VA+K L  + G    ++  D E   +  + H +LV
Sbjct: 22  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMD-EALIMASMDHPHLV 80
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
            L+G  +    + LV   +  G L  ++H+     I   ++    + IA+ + YL     
Sbjct: 81  RLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEER-- 136
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT-FGYVAPEYATTCR 953
            R+VHRD+   N+L+    +  ++DFGLARLLE  E     D       ++A E     +
Sbjct: 137 -RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK 195
Query: 954 VSDKADVYSFGVVLLELIS 972
            + ++DV+S+GV + EL++
Sbjct: 196 FTHQSDVWSYGVTIWELMT 214

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 30/211 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 94
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
            +          +++LV   L G +L   +     +K+    +  +   I + L Y+H +
Sbjct: 95  VFTPARSLEEFNDVYLV-THLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKYIHSA 150
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
               I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE  
Sbjct: 151 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIM 200
Query: 950 TT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                 +   D++S G ++ EL++G R+L P
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 230

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 99
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +          +++LV   L G +L   +   K +   +Q+ +       I + L Y+H
Sbjct: 100 VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 153
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
            +    I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE
Sbjct: 154 SA---DIIHRDLKPSNLAVNEDXELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 203
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                   +   D++S G ++ EL++G R+L P
Sbjct: 204 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 235

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 30/211 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 99
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
            +          +++LV   L G +L   +     +K+    +  +   I + L Y+H +
Sbjct: 100 VFTPARSLEEFNDVYLV-THLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKYIHSA 155
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
               I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE  
Sbjct: 156 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIM 205
Query: 950 TT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                 +   D++S G ++ EL++G R+L P
Sbjct: 206 LNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 235

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 90
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +          +++LV   L G +L   +   K +   +Q+ +       I + L Y+H
Sbjct: 91  VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 144
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
            +    I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE
Sbjct: 145 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 194
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                   +   D++S G ++ EL++G R+L P
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 226

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 30/211 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 90
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
            +          +++LV   L G +L   +     +K+    +  +   I + L Y+H +
Sbjct: 91  VFTPARSLEEFNDVYLV-THLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKYIHSA 146
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
               I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE  
Sbjct: 147 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIM 196
Query: 950 TT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                 +   D++S G ++ EL++G R+L P
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 226

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +          +++LV   L G +L   +   K +   +Q+ +       I + L Y+H
Sbjct: 89  VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 142
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
            +    I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 192
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                   +   D++S G ++ EL++G R+L P
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 224

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 111
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +          +++LV   L G +L   +   K +   +Q+ +       I + L Y+H
Sbjct: 112 VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 165
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
            +    I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE
Sbjct: 166 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMXGYVATRWYRAPE 215
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                   +   D++S G ++ EL++G R+L P
Sbjct: 216 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 247

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 93/206 (45%), Gaps = 19/206 (9%)
Query: 779 IRNLIGTGGFGSTYKAELVP-----GYLVAVKKL---SIGRFQGIQQFDAEIGTLGRIRH 830
           IR+L G G FG        P     G  VAVK L   S G    I     EI  L  + H
Sbjct: 14  IRDL-GEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH--IADLKKEIEILRNLYH 70
Query: 831 KNLVTLIGYYV--GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
           +N+V   G     G   + L+  FL  G+L+ ++  K+  KI      K A+ I + + Y
Sbjct: 71  ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDY 129
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT--DVAGTFGYVAP 946
           L      + VHRD+   N+L++ E    + DFGL + +E  +   T   D      + AP
Sbjct: 130 LGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAP 186
Query: 947 EYATTCRVSDKADVYSFGVVLLELIS 972
           E     +    +DV+SFGV L EL++
Sbjct: 187 ECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 30/211 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 107
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
            +          +++LV   L G +L   +     +K+    +  +   I + L Y+H +
Sbjct: 108 VFTPARSLEEFNDVYLV-THLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKYIHSA 163
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
               I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE  
Sbjct: 164 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIM 213
Query: 950 TT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                 +   D++S G ++ EL++G R+L P
Sbjct: 214 LNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 243

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 15/217 (6%)
Query: 768 DNVVRATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQG-----IQQFDAE 821
           D+ V     + +  +IG G F    +      G   AVK + + +F        +    E
Sbjct: 17  DDDVLFEDVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKRE 76
Query: 822 IGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS--VIHKIA 879
                 ++H ++V L+  Y  +  +++V+ F+ G +L   I K++     +S  V     
Sbjct: 77  ASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYM 136
Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTD 936
             I +AL Y H +    I+HRD+KP N+LL  + N+    L DFG+A  L  S   A   
Sbjct: 137 RQILEALRYCHDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGR 193
Query: 937 VAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
           V GT  ++APE           DV+  GV+L  L+SG
Sbjct: 194 V-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +          +++LV   L G +L   +   K +   +Q+ +       I + L Y+H
Sbjct: 85  VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 138
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
            +    I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE
Sbjct: 139 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 188
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                   +   D++S G ++ EL++G R+L P
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 220

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 30/211 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 86
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
            +          +++LV   L G +L   +     +K+    +  +   I + L Y+H +
Sbjct: 87  VFTPARSLEEFNDVYLV-THLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKYIHSA 142
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
               I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE  
Sbjct: 143 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIM 192
Query: 950 TT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                 +   D++S G ++ EL++G R+L P
Sbjct: 193 LNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 222

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 102/211 (48%), Gaps = 23/211 (10%)
Query: 783 IGTGGFGSTYKAEL---VPG---YLVAVKKLSIGRFQGI--QQFDAEIGTLGRIRHKNLV 834
           +G   FG  YK  L    PG     VA+K L   + +G   ++F  E     R++H N+V
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-DKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFI-----HKKSGKKIQWSVIHKIAID-------I 882
            L+G    +  + +++++ S G+L  F+     H   G       + K A++       +
Sbjct: 76  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV-KSALEPPDFVHLV 134
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT-DVAGTF 941
           AQ  A + Y     +VH+D+   N+L+ ++LN  +SD GL R +  ++ +    +     
Sbjct: 135 AQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPI 194
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
            ++APE     + S  +D++S+GVVL E+ S
Sbjct: 195 RWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 98/198 (49%), Gaps = 16/198 (8%)
Query: 783 IGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQ---FDAEIGTLGRIRHKNLVTLIG 838
           +G G +G   K   VP G ++AVK++        Q+    D +I ++  +     VT  G
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDI-SMRTVDCPFTVTFYG 117
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHK--KSGKKIQWSVIHKIAIDIAQALAYLHYSCVPR 896
               E ++++    +   +L+ F  +    G+ I   ++ KIA+ I +AL +LH      
Sbjct: 118 ALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--S 174
Query: 897 IVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA----TTC 952
           ++HRD+KPSN+L++      + DFG++  L V     T D AG   Y+APE         
Sbjct: 175 VIHRDVKPSNVLINALGQVKMCDFGISGYL-VDSVAKTID-AGCKPYMAPERINPELNQK 232
Query: 953 RVSDKADVYSFGVVLLEL 970
             S K+D++S G+ ++EL
Sbjct: 233 GYSVKSDIWSLGITMIEL 250

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 85
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +          +++LV   L G +L   +   K +   +Q+ +       I + L Y+H
Sbjct: 86  VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 139
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
            +    I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE
Sbjct: 140 SA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 189
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                   +   D++S G ++ EL++G R+L P
Sbjct: 190 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 221

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 93/206 (45%), Gaps = 19/206 (9%)
Query: 779 IRNLIGTGGFGSTYKAELVP-----GYLVAVKKL---SIGRFQGIQQFDAEIGTLGRIRH 830
           IR+L G G FG        P     G  VAVK L   S G    I     EI  L  + H
Sbjct: 26  IRDL-GEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH--IADLKKEIEILRNLYH 82
Query: 831 KNLVTLIGYYV--GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
           +N+V   G     G   + L+  FL  G+L+ ++  K+  KI      K A+ I + + Y
Sbjct: 83  ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDY 141
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT--DVAGTFGYVAP 946
           L      + VHRD+   N+L++ E    + DFGL + +E  +   T   D      + AP
Sbjct: 142 LGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAP 198
Query: 947 EYATTCRVSDKADVYSFGVVLLELIS 972
           E     +    +DV+SFGV L EL++
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 107/221 (48%), Gaps = 27/221 (12%)
Query: 801  LVAVKKLSIGRFQGIQ---QFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGN 857
            +++ +K +IG  +        + EI  L ++ H  ++ +  ++  E + ++V   + GG 
Sbjct: 42   IISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGE 100
Query: 858  LETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILL---DEELN 914
            L  F      K+++ +        +  A+ YLH +    I+HRD+KP N+LL   +E+  
Sbjct: 101  L--FDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCL 155
Query: 915  AYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT---TCRVSDKADVYSFGVVLLELI 971
              ++DFG +++L   ET     + GT  Y+APE      T   +   D +S GV+L   +
Sbjct: 156  IKITDFGHSKIL--GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 213
Query: 972  SGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012
            SG     P FSE+    ++    K  I  G+ +  F+PE+W
Sbjct: 214  SGY----PPFSEHRTQVSL----KDQITSGKYN--FIPEVW 244

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 33/227 (14%)
Query: 760 DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKK-LSIGRFQGIQQ 817
           D P E++Y +            +IG G FG  Y+A+L   G LVA+KK L   RF+    
Sbjct: 49  DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---- 94
Query: 818 FDAEIGTLGRIRHKNLVTLIGYYVGEAE------MFLVYNFLSGGNLETFIHKKSGKKIQ 871
            + E+  + ++ H N+V L  ++    E      + LV +++         H    K+  
Sbjct: 95  -NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 153
Query: 872 WSVIHKIAI-DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVS 929
             +  K+ +  + ++LAY+H      I HRDIKP N+LLD +     L DFG A+ L   
Sbjct: 154 PVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 210
Query: 930 ETHATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
           E + +  +   + Y APE  +  T   S   DV+S G VL EL+ G+
Sbjct: 211 EPNVSX-ICSRY-YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 254

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 107/221 (48%), Gaps = 27/221 (12%)
Query: 801  LVAVKKLSIGRFQGIQ---QFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGN 857
            +++ +K +IG  +        + EI  L ++ H  ++ +  ++  E + ++V   + GG 
Sbjct: 42   IISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGE 100
Query: 858  LETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILL---DEELN 914
            L  F      K+++ +        +  A+ YLH +    I+HRD+KP N+LL   +E+  
Sbjct: 101  L--FDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCL 155
Query: 915  AYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT---TCRVSDKADVYSFGVVLLELI 971
              ++DFG +++L   ET     + GT  Y+APE      T   +   D +S GV+L   +
Sbjct: 156  IKITDFGHSKIL--GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 213
Query: 972  SGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012
            SG     P FSE+    ++    K  I  G+ +  F+PE+W
Sbjct: 214  SGY----PPFSEHRTQVSL----KDQITSGKYN--FIPEVW 244

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 107/221 (48%), Gaps = 27/221 (12%)
Query: 801  LVAVKKLSIGRFQGIQ---QFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGN 857
            +++ +K +IG  +        + EI  L ++ H  ++ +  ++  E + ++V   + GG 
Sbjct: 48   IISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGE 106
Query: 858  LETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILL---DEELN 914
            L  F      K+++ +        +  A+ YLH +    I+HRD+KP N+LL   +E+  
Sbjct: 107  L--FDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCL 161
Query: 915  AYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT---TCRVSDKADVYSFGVVLLELI 971
              ++DFG +++L   ET     + GT  Y+APE      T   +   D +S GV+L   +
Sbjct: 162  IKITDFGHSKIL--GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 219
Query: 972  SGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012
            SG     P FSE+    ++    K  I  G+ +  F+PE+W
Sbjct: 220  SGY----PPFSEHRTQVSL----KDQITSGKYN--FIPEVW 250

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 99/219 (45%), Gaps = 34/219 (15%)
Query: 777 FSIRNLIGTGGFGSTYKAELVPGYLV--AVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
           +++ N IG G +G   K  +  G  +  A KK+     + + +F  EI  +  + H N++
Sbjct: 11  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
            L   +    +++LV    +GG L E  +HK+  ++   S   +I  D+  A+AY H   
Sbjct: 70  RLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRE---SDAARIMKDVLSAVAYCHKLN 126
Query: 894 VPRIVHRDIKPSNILL-----DEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE- 947
           V    HRD+KP N L      D  L   L DFGLA   +  +   T    GT  YV+P+ 
Sbjct: 127 V---AHRDLKPENFLFLTDSPDSPLK--LIDFGLAARFKPGKMMRTK--VGTPYYVSPQV 179
Query: 948 ----YATTCRVSDKADVYSFGVVLLELISGKRSLDPSFS 982
               Y   C      D +S GV++  L+ G     P FS
Sbjct: 180 LEGLYGPEC------DEWSAGVMMYVLLCGY----PPFS 208

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 94
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +          +++LV   L G +L   +   K +   +Q+ +       I + L Y+H
Sbjct: 95  VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 148
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
            +    I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE
Sbjct: 149 SA---DIIHRDLKPSNLAVNEDSELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 198
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                   +   D++S G ++ EL++G R+L P
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 230

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 99/219 (45%), Gaps = 34/219 (15%)
Query: 777 FSIRNLIGTGGFGSTYKAELVPGYLV--AVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
           +++ N IG G +G   K  +  G  +  A KK+     + + +F  EI  +  + H N++
Sbjct: 28  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 86
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
            L   +    +++LV    +GG L E  +HK+  ++   S   +I  D+  A+AY H   
Sbjct: 87  RLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRE---SDAARIMKDVLSAVAYCHKLN 143
Query: 894 VPRIVHRDIKPSNILL-----DEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE- 947
           V    HRD+KP N L      D  L   L DFGLA   +  +   T    GT  YV+P+ 
Sbjct: 144 V---AHRDLKPENFLFLTDSPDSPLK--LIDFGLAARFKPGKMMRTK--VGTPYYVSPQV 196
Query: 948 ----YATTCRVSDKADVYSFGVVLLELISGKRSLDPSFS 982
               Y   C      D +S GV++  L+ G     P FS
Sbjct: 197 LEGLYGPEC------DEWSAGVMMYVLLCGY----PPFS 225

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFDAEIG-TLGRIR---- 829
           +F +  ++G G FG  + AE        A+K L     + +   D ++  T+   R    
Sbjct: 18  DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALK----KDVVLMDDDVECTMVEKRVLSL 73
Query: 830 ---HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQAL 886
              H  L  +   +  +  +F V  +L+GG+L    H +S  K   S     A +I   L
Sbjct: 74  AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAAEIILGL 131
Query: 887 AYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAP 946
            +LH      IV+RD+K  NILLD++ +  ++DFG+ +   + +   T    GT  Y+AP
Sbjct: 132 QFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNXFCGTPDYIAP 187
Query: 947 EYATTCRVSDKADVYSFGVVLLELISGK 974
           E     + +   D +SFGV+L E++ G+
Sbjct: 188 EILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 107/221 (48%), Gaps = 27/221 (12%)
Query: 801  LVAVKKLSIGRFQGIQ---QFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGN 857
            +++ +K +IG  +        + EI  L ++ H  ++ +  ++  E + ++V   + GG 
Sbjct: 42   IISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGE 100
Query: 858  LETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILL---DEELN 914
            L  F      K+++ +        +  A+ YLH +    I+HRD+KP N+LL   +E+  
Sbjct: 101  L--FDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCL 155
Query: 915  AYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT---TCRVSDKADVYSFGVVLLELI 971
              ++DFG +++L   ET     + GT  Y+APE      T   +   D +S GV+L   +
Sbjct: 156  IKITDFGHSKIL--GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 213
Query: 972  SGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012
            SG     P FSE+    ++    K  I  G+ +  F+PE+W
Sbjct: 214  SGY----PPFSEHRTQVSL----KDQITSGKYN--FIPEVW 244

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 107/221 (48%), Gaps = 27/221 (12%)
Query: 801  LVAVKKLSIGRFQGIQ---QFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGN 857
            +++ +K +IG  +        + EI  L ++ H  ++ +  ++  E + ++V   + GG 
Sbjct: 41   IISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGE 99
Query: 858  LETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILL---DEELN 914
            L  F      K+++ +        +  A+ YLH +    I+HRD+KP N+LL   +E+  
Sbjct: 100  L--FDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCL 154
Query: 915  AYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT---TCRVSDKADVYSFGVVLLELI 971
              ++DFG +++L   ET     + GT  Y+APE      T   +   D +S GV+L   +
Sbjct: 155  IKITDFGHSKIL--GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 212
Query: 972  SGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012
            SG     P FSE+    ++    K  I  G+ +  F+PE+W
Sbjct: 213  SGY----PPFSEHRTQVSL----KDQITSGKYN--FIPEVW 243

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 783 IGTGGFGSTYKAELV------PGYL--VAVKKL-SIGRFQGIQQFDAEIGTLGRI-RHKN 832
           +G G FG    AE +      P  +  VAVK L S    + +    +E+  +  I +HKN
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSV--------------IHKI 878
           ++ L+G    +  ++++  + S GNL  ++  +    +++S               +   
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDV 937
           A  +A+ + YL      + +HRD+   N+L+ E+    ++DFGLAR +  +     TT+ 
Sbjct: 145 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 938 AGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
                ++APE       + ++DV+SFGV+L E+ +
Sbjct: 202 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 783 IGTGGFGSTYKAELV------PGYL--VAVKKL-SIGRFQGIQQFDAEIGTLGRI-RHKN 832
           +G G FG    AE +      P  +  VAVK L S    + +    +E+  +  I +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSV--------------IHKI 878
           ++ L+G    +  ++++  + S GNL  ++  +    +++S               +   
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDV 937
           A  +A+ + YL      + +HRD+   N+L+ E+    ++DFGLAR +  +     TT+ 
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 938 AGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
                ++APE       + ++DV+SFGV+L E+ +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 13/201 (6%)
Query: 783 IGTGGFGSTYKAELVP-GYLVAVKKL-SIGRFQGIQQFDAEIGTLGRIRH-KNLVTLIGY 839
           IG G +GS  K    P G ++AVK++ S    +  +Q   ++  + R      +V   G 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 840 YVGEAEMFLVYNFLSGG--NLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
              E + ++    +S        +++      I   ++ KI +   +AL +L  +   +I
Sbjct: 90  LFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KI 147
Query: 898 VHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY----ATTCR 953
           +HRDIKPSNILLD   N  L DFG++   ++ ++ A T  AG   Y+APE     A+   
Sbjct: 148 IHRDIKPSNILLDRSGNIKLCDFGISG--QLVDSIAKTRDAGCRPYMAPERIDPSASRQG 205
Query: 954 VSDKADVYSFGVVLLELISGK 974
              ++DV+S G+ L EL +G+
Sbjct: 206 YDVRSDVWSLGITLYELATGR 226

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 134/291 (46%), Gaps = 37/291 (12%)
Query: 751  RGQVMVTFADTPAELT-YDNVVRATGNFSIRNLIGTGGFGSTYKA------ELVPGYLVA 803
            R +V V F  T  + + Y   +R    + +   +G+G  G    A      + V   +++
Sbjct: 112  RNKVFVFFDLTVDDQSVYPKALR--DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIIS 169
Query: 804  VKKLSIGRFQGIQ---QFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLET 860
             +K +IG  +        + EI  L ++ H  ++ +  ++  E + ++V   + GG L  
Sbjct: 170  KRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGEL-- 226
Query: 861  FIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILL---DEELNAYL 917
            F      K+++ +        +  A+ YLH +    I+HRD+KP N+LL   +E+    +
Sbjct: 227  FDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI 283
Query: 918  SDFGLARLLEVSETHATTDVAGTFGYVAPEYAT---TCRVSDKADVYSFGVVLLELISGK 974
            +DFG +++L   ET     + GT  Y+APE      T   +   D +S GV+L   +SG 
Sbjct: 284  TDFGHSKIL--GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 341
Query: 975  RSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMR 1025
                P FSE+    ++    K  I  G+ +  F+PE+W A   E  L +++
Sbjct: 342  ----PPFSEHRTQVSL----KDQITSGKYN--FIPEVW-AEVSEKALDLVK 381

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 100/229 (43%), Gaps = 33/229 (14%)
Query: 771 VRATGNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIR 829
           +R   +F    ++G G FG   KA   +     A+KK+     + +    +E+  L  + 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLN 60
Query: 830 HKNLVTLIGYYV-------------GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH 876
           H+ +V     ++              ++ +F+   +   G L   IH ++  + Q     
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQ-QRDEYW 119
Query: 877 KIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS------- 929
           ++   I +AL+Y+H      I+HRD+KP NI +DE  N  + DFGLA+ +  S       
Sbjct: 120 RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 930 ------ETHATTDVAGTFGYVAPEYAT-TCRVSDKADVYSFGVVLLELI 971
                  +   T   GT  YVA E    T   ++K D+YS G++  E+I
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 58/198 (29%), Positives = 95/198 (47%), Gaps = 16/198 (8%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDA--EIGTLGRIRHKNLVTLIGY 839
           IG G +G  +K      G +VA+KK        + +  A  EI  L +++H NLV L+  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 840 YVGEAEMFLVYNFLSGGNLETFIHK--KSGKKIQWSVIHKIAIDIAQALAYLH-YSCVPR 896
           +  +  + LV+ +       T +H+  +  + +   ++  I     QA+ + H ++C+  
Sbjct: 71  FRRKRRLHLVFEYCD----HTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCI-- 124
Query: 897 IVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT-TCRVS 955
             HRD+KP NIL+ +     L DFG ARLL     +   +VA T  Y +PE      +  
Sbjct: 125 --HRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPELLVGDTQYG 181
Query: 956 DKADVYSFGVVLLELISG 973
              DV++ G V  EL+SG
Sbjct: 182 PPVDVWAIGCVFAELLSG 199

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 783 IGTGGFGSTYKAELV------PGYL--VAVKKL-SIGRFQGIQQFDAEIGTLGRI-RHKN 832
           +G G FG    AE +      P  +  VAVK L S    + +    +E+  +  I +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSV--------------IHKI 878
           ++ L+G    +  ++++  + S GNL  ++  +    +++S               +   
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDV 937
           A  +A+ + YL      + +HRD+   N+L+ E+    ++DFGLAR +  +     TT+ 
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 938 AGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
                ++APE       + ++DV+SFGV+L E+ +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 29/206 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +G+   A +   G  VA+KKL    FQ     ++   E+  L  +RH+N++ L+ 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKL-YRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 91
Query: 839 YYVGE------AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
            +  +       + +LV  F+     +   H+K G+        +I   + Q L  L Y 
Sbjct: 92  VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGED-------RIQFLVYQMLKGLRYI 144
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
               I+HRD+KP N+ ++E+    + DFGLAR        A +++ G   T  Y APE  
Sbjct: 145 HAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------QADSEMXGXVVTRWYRAPEVI 197
Query: 950 TT-CRVSDKADVYSFGVVLLELISGK 974
               R +   D++S G ++ E+I+GK
Sbjct: 198 LNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 783 IGTGGFGSTYKAELV------PGYL--VAVKKL-SIGRFQGIQQFDAEIGTLGRI-RHKN 832
           +G G FG    AE +      P  +  VAVK L S    + +    +E+  +  I +HKN
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSV--------------IHKI 878
           ++ L+G    +  ++++  + S GNL  ++  +    +++S               +   
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDV 937
           A  +A+ + YL      + +HRD+   N+L+ E+    ++DFGLAR +  +     TT+ 
Sbjct: 149 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 938 AGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
                ++APE       + ++DV+SFGV+L E+ +
Sbjct: 206 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 90
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +          +++LV   L G +L   +   K +   +Q+ +       I + L Y+H
Sbjct: 91  VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 144
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
            +    I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE
Sbjct: 145 SA---DIIHRDLKPSNLAVNEDSELKILDFGLAR-------HTDDEMTGYVATRWYRAPE 194
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                   +   D++S G ++ EL++G R+L P
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 226

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
           IG G +G    A + V    VA+KK+S    Q   Q+   EI  L R RH+N++ +    
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDIL 110
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
                  +   ++    +ET ++K    +++    I      I + L Y+H + V   +H
Sbjct: 111 RASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSANV---LH 167
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
           RD+KPSN+L++   +  + DFGLAR+ +    H    T+   T  Y APE     +   K
Sbjct: 168 RDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTK 227
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
           + D++S G +L E++S      GK  LD
Sbjct: 228 SIDIWSVGCILAEMLSNRPIFPGKHYLD 255

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 134/291 (46%), Gaps = 37/291 (12%)
Query: 751  RGQVMVTFADTPAELT-YDNVVRATGNFSIRNLIGTGGFGSTYKA------ELVPGYLVA 803
            R +V V F  T  + + Y   +R    + +   +G+G  G    A      + V   +++
Sbjct: 126  RNKVFVFFDLTVDDQSVYPKALR--DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIIS 183
Query: 804  VKKLSIGRFQGIQ---QFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLET 860
             +K +IG  +        + EI  L ++ H  ++ +  ++  E + ++V   + GG L  
Sbjct: 184  KRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGEL-- 240
Query: 861  FIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILL---DEELNAYL 917
            F      K+++ +        +  A+ YLH +    I+HRD+KP N+LL   +E+    +
Sbjct: 241  FDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI 297
Query: 918  SDFGLARLLEVSETHATTDVAGTFGYVAPEYAT---TCRVSDKADVYSFGVVLLELISGK 974
            +DFG +++L   ET     + GT  Y+APE      T   +   D +S GV+L   +SG 
Sbjct: 298  TDFGHSKIL--GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 355
Query: 975  RSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMR 1025
                P FSE+    ++    K  I  G+ +  F+PE+W A   E  L +++
Sbjct: 356  ----PPFSEHRTQVSL----KDQITSGKYN--FIPEVW-AEVSEKALDLVK 395

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 783 IGTGGFGSTYKAELV------PGYL--VAVKKL-SIGRFQGIQQFDAEIGTLGRI-RHKN 832
           +G G FG    AE +      P  +  VAVK L S    + +    +E+  +  I +HKN
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSV--------------IHKI 878
           ++ L+G    +  ++++  + S GNL  ++  +    +++S               +   
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDV 937
           A  +A+ + YL      + +HRD+   N+L+ E+    ++DFGLAR +  +     TT+ 
Sbjct: 148 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 938 AGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
                ++APE       + ++DV+SFGV+L E+ +
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 783 IGTGGFGSTYKAELV------PGYL--VAVKKL-SIGRFQGIQQFDAEIGTLGRI-RHKN 832
           +G G FG    AE +      P  +  VAVK L S    + +    +E+  +  I +HKN
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSV--------------IHKI 878
           ++ L+G    +  ++++  + S GNL  ++  +    +++S               +   
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDV 937
           A  +A+ + YL      + +HRD+   N+L+ E+    ++DFGLAR +  +     TT+ 
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 938 AGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
                ++APE       + ++DV+SFGV+L E+ +
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 33/227 (14%)
Query: 760 DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKK-LSIGRFQGIQQ 817
           D P E++Y +            +IG G FG  Y+A+L   G LVA+KK L   RF+    
Sbjct: 27  DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---- 72
Query: 818 FDAEIGTLGRIRHKNLVTLIGYYVGEAE------MFLVYNFLSGGNLETFIHKKSGKKIQ 871
            + E+  + ++ H N+V L  ++    E      + LV +++         H    K+  
Sbjct: 73  -NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 131
Query: 872 WSVIHKIAI-DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVS 929
             +  K+ +  + ++LAY+H      I HRDIKP N+LLD +     L DFG A+ L   
Sbjct: 132 PVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 188
Query: 930 ETHATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
           E + +  +   + Y APE  +  T   S   DV+S G VL EL+ G+
Sbjct: 189 EPNVSX-ICSRY-YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 232

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 33/227 (14%)
Query: 760 DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKK-LSIGRFQGIQQ 817
           D P E++Y +            +IG G FG  Y+A+L   G LVA+KK L   RF+    
Sbjct: 16  DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---- 61
Query: 818 FDAEIGTLGRIRHKNLVTLIGYYVGEAE------MFLVYNFLSGGNLETFIHKKSGKKIQ 871
            + E+  + ++ H N+V L  ++    E      + LV +++         H    K+  
Sbjct: 62  -NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 120
Query: 872 WSVIHKIAI-DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVS 929
             +  K+ +  + ++LAY+H      I HRDIKP N+LLD +     L DFG A+ L   
Sbjct: 121 PVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 177
Query: 930 ETHATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
           E + +  +   + Y APE  +  T   S   DV+S G VL EL+ G+
Sbjct: 178 EPNVSX-ICSRY-YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 221

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 33/227 (14%)
Query: 760 DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKK-LSIGRFQGIQQ 817
           D P E++Y +            +IG G FG  Y+A+L   G LVA+KK L   RF+    
Sbjct: 51  DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---- 96
Query: 818 FDAEIGTLGRIRHKNLVTLIGYYVGEAE------MFLVYNFLSGGNLETFIHKKSGKKIQ 871
            + E+  + ++ H N+V L  ++    E      + LV +++         H    K+  
Sbjct: 97  -NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 155
Query: 872 WSVIHKIAI-DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVS 929
             +  K+ +  + ++LAY+H      I HRDIKP N+LLD +     L DFG A+ L   
Sbjct: 156 PVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 212
Query: 930 ETHATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
           E + +  +   + Y APE  +  T   S   DV+S G VL EL+ G+
Sbjct: 213 EPNVSY-ICSRY-YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 256

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 33/227 (14%)
Query: 760 DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKK-LSIGRFQGIQQ 817
           D P E++Y +            +IG G FG  Y+A+L   G LVA+KK L   RF+    
Sbjct: 27  DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---- 72
Query: 818 FDAEIGTLGRIRHKNLVTLIGYYVGEAE------MFLVYNFLSGGNLETFIHKKSGKKIQ 871
            + E+  + ++ H N+V L  ++    E      + LV +++         H    K+  
Sbjct: 73  -NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 131
Query: 872 WSVIHKIAI-DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVS 929
             +  K+ +  + ++LAY+H      I HRDIKP N+LLD +     L DFG A+ L   
Sbjct: 132 PVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 188
Query: 930 ETHATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
           E + +  +   + Y APE  +  T   S   DV+S G VL EL+ G+
Sbjct: 189 EPNVSX-ICSRY-YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 232

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 33/227 (14%)
Query: 760 DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKK-LSIGRFQGIQQ 817
           D P E++Y +            +IG G FG  Y+A+L   G LVA+KK L   RF+    
Sbjct: 34  DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---- 79
Query: 818 FDAEIGTLGRIRHKNLVTLIGYYVGEAE------MFLVYNFLSGGNLETFIHKKSGKKIQ 871
            + E+  + ++ H N+V L  ++    E      + LV +++         H    K+  
Sbjct: 80  -NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 138
Query: 872 WSVIHKIAI-DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVS 929
             +  K+ +  + ++LAY+H      I HRDIKP N+LLD +     L DFG A+ L   
Sbjct: 139 PVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 195
Query: 930 ETHATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
           E + +  +   + Y APE  +  T   S   DV+S G VL EL+ G+
Sbjct: 196 EPNVSX-ICSRY-YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 239

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 33/227 (14%)
Query: 760 DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKK-LSIGRFQGIQQ 817
           D P E++Y +            +IG G FG  Y+A+L   G LVA+KK L   RF+    
Sbjct: 53  DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---- 98
Query: 818 FDAEIGTLGRIRHKNLVTLIGYYVGEAE------MFLVYNFLSGGNLETFIHKKSGKKIQ 871
            + E+  + ++ H N+V L  ++    E      + LV +++         H    K+  
Sbjct: 99  -NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 157
Query: 872 WSVIHKIAI-DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVS 929
             +  K+ +  + ++LAY+H      I HRDIKP N+LLD +     L DFG A+ L   
Sbjct: 158 PVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 214
Query: 930 ETHATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
           E + +  +   + Y APE  +  T   S   DV+S G VL EL+ G+
Sbjct: 215 EPNVSY-ICSRY-YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 258

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 33/227 (14%)
Query: 760 DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKK-LSIGRFQGIQQ 817
           D P E++Y +            +IG G FG  Y+A+L   G LVA+KK L   RF+    
Sbjct: 94  DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---- 139
Query: 818 FDAEIGTLGRIRHKNLVTLIGYYVGEAE------MFLVYNFLSGGNLETFIHKKSGKKIQ 871
            + E+  + ++ H N+V L  ++    E      + LV +++         H    K+  
Sbjct: 140 -NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 198
Query: 872 WSVIHKIAI-DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVS 929
             +  K+ +  + ++LAY+H      I HRDIKP N+LLD +     L DFG A+ L   
Sbjct: 199 PVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 255
Query: 930 ETHATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
           E + +  +   + Y APE  +  T   S   DV+S G VL EL+ G+
Sbjct: 256 EPNVSY-ICSRY-YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 299

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 33/227 (14%)
Query: 760 DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKK-LSIGRFQGIQQ 817
           D P E++Y +            +IG G FG  Y+A+L   G LVA+KK L   RF+    
Sbjct: 15  DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---- 60
Query: 818 FDAEIGTLGRIRHKNLVTLIGYYVGEAE------MFLVYNFLSGGNLETFIHKKSGKKIQ 871
            + E+  + ++ H N+V L  ++    E      + LV +++         H    K+  
Sbjct: 61  -NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 119
Query: 872 WSVIHKIAI-DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVS 929
             +  K+ +  + ++LAY+H      I HRDIKP N+LLD +     L DFG A+ L   
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 930 ETHATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
           E + +  +   + Y APE  +  T   S   DV+S G VL EL+ G+
Sbjct: 177 EPNVSX-ICSRY-YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 220

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 33/227 (14%)
Query: 760 DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKK-LSIGRFQGIQQ 817
           D P E++Y +            +IG G FG  Y+A+L   G LVA+KK L   RF+    
Sbjct: 23  DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---- 68
Query: 818 FDAEIGTLGRIRHKNLVTLIGYYVGEAE------MFLVYNFLSGGNLETFIHKKSGKKIQ 871
            + E+  + ++ H N+V L  ++    E      + LV +++         H    K+  
Sbjct: 69  -NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 127
Query: 872 WSVIHKIAI-DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVS 929
             +  K+ +  + ++LAY+H      I HRDIKP N+LLD +     L DFG A+ L   
Sbjct: 128 PVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 184
Query: 930 ETHATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
           E + +  +   + Y APE  +  T   S   DV+S G VL EL+ G+
Sbjct: 185 EPNVSX-ICSRY-YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 228

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +          +++LV   L G +L   +   K +   +Q+ +       I + L Y+H
Sbjct: 89  VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 142
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
            +    I+HRD+KPSN+ ++E+    + D+GLAR       H   ++ G   T  Y APE
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDYGLAR-------HTDDEMTGYVATRWYRAPE 192
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                   +   D++S G ++ EL++G R+L P
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 224

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 33/227 (14%)
Query: 760 DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKK-LSIGRFQGIQQ 817
           D P E++Y +            +IG G FG  Y+A+L   G LVA+KK L   RF+    
Sbjct: 49  DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---- 94
Query: 818 FDAEIGTLGRIRHKNLVTLIGYYVGEAE------MFLVYNFLSGGNLETFIHKKSGKKIQ 871
            + E+  + ++ H N+V L  ++    E      + LV +++         H    K+  
Sbjct: 95  -NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 153
Query: 872 WSVIHKIAI-DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVS 929
             +  K+ +  + ++LAY+H      I HRDIKP N+LLD +     L DFG A+ L   
Sbjct: 154 PVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 210
Query: 930 ETHATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
           E + +  +   + Y APE  +  T   S   DV+S G VL EL+ G+
Sbjct: 211 EPNVSY-ICSRY-YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 254

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 31/207 (14%)
Query: 783 IGTGGFGST---YKAELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTL 836
           +G+G +GS    Y A L     VAVKKLS   FQ +   ++   E+  L  ++H+N++ L
Sbjct: 36  VGSGAYGSVCSAYDARLRQK--VAVKKLS-RPFQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 837 IGYYVGE------AEMFLVYNFLSGGNLETFIHKK--SGKKIQWSVIHKIAIDIAQALAY 888
           +  +         +E++LV   + G +L   +  +  S + +Q+ V       + + L Y
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLM-GADLNNIVKSQALSDEHVQFLVYQ-----LLRGLKY 146
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
           +H +    I+HRD+KPSN+ ++E+    + DFGLAR          T    T  Y APE 
Sbjct: 147 IHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR----QADEEMTGYVATRWYRAPEI 199
Query: 949 ATT-CRVSDKADVYSFGVVLLELISGK 974
                  +   D++S G ++ EL+ GK
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 33/227 (14%)
Query: 760 DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKK-LSIGRFQGIQQ 817
           D P E++Y +            +IG G FG  Y+A+L   G LVA+KK L   RF+    
Sbjct: 15  DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---- 60
Query: 818 FDAEIGTLGRIRHKNLVTLIGYYVGEAE------MFLVYNFLSGGNLETFIHKKSGKKIQ 871
            + E+  + ++ H N+V L  ++    E      + LV +++         H    K+  
Sbjct: 61  -NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 119
Query: 872 WSVIHKIAI-DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVS 929
             +  K+ +  + ++LAY+H      I HRDIKP N+LLD +     L DFG A+ L   
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 930 ETHATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
           E + +  +   + Y APE  +  T   S   DV+S G VL EL+ G+
Sbjct: 177 EPNVSX-ICSRY-YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 220

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 33/227 (14%)
Query: 760 DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKK-LSIGRFQGIQQ 817
           D P E++Y +            +IG G FG  Y+A+L   G LVA+KK L   RF+    
Sbjct: 15  DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---- 60
Query: 818 FDAEIGTLGRIRHKNLVTLIGYYVGEAE------MFLVYNFLSGGNLETFIHKKSGKKIQ 871
            + E+  + ++ H N+V L  ++    E      + LV +++         H    K+  
Sbjct: 61  -NRELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTL 119
Query: 872 WSVIHKIAI-DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVS 929
             +  K+ +  + ++LAY+H      I HRDIKP N+LLD +     L DFG A+ L   
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 930 ETHATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
           E + +  +   + Y APE  +  T   S   DV+S G VL EL+ G+
Sbjct: 177 EPNVSX-ICSRY-YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 220

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 12/211 (5%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNLVTLIGYY 840
           +G G +G    A   V    VAVK + + R     +    EI     + H+N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
                 +L   + SGG L   I    G  +      +    +   + YLH      I HR
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGI---GITHR 129
Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYATTCRV-SDKA 958
           DIKP N+LLDE  N  +SDFGLA +   +      + + GT  YVAPE        ++  
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 189
Query: 959 DVYSFGVVLLELISGKRSLD-PSFS--EYGN 986
           DV+S G+VL  +++G+   D PS S  EY +
Sbjct: 190 DVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 220

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 33/227 (14%)
Query: 760 DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKK-LSIGRFQGIQQ 817
           D P E++Y +            +IG G FG  Y+A+L   G LVA+KK L   RF+    
Sbjct: 43  DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---- 88
Query: 818 FDAEIGTLGRIRHKNLVTLIGYYVGEAE------MFLVYNFLSGGNLETFIHKKSGKKIQ 871
            + E+  + ++ H N+V L  ++    E      + LV +++         H    K+  
Sbjct: 89  -NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 147
Query: 872 WSVIHKIAI-DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVS 929
             +  K+ +  + ++LAY+H      I HRDIKP N+LLD +     L DFG A+ L   
Sbjct: 148 PVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 204
Query: 930 ETHATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
           E + +  +   + Y APE  +  T   S   DV+S G VL EL+ G+
Sbjct: 205 EPNVSY-ICSRY-YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 248

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 776 NFSIRNLIGTGGFGSTYKAE---LVP---GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIR 829
           N  ++  +G G FG  + AE   L P     LVAVK L        + F  E   L  ++
Sbjct: 14  NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 73
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKI------------QWSVIHK 877
           H+++V   G  V    + +V+ ++  G+L  F+       +            Q  ++H 
Sbjct: 74  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLH- 132
Query: 878 IAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDV 937
           IA  IA  + YL        VHRD+   N L+ E L   + DFG++R +  ++ +    V
Sbjct: 133 IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYR---V 186
Query: 938 AG----TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKR 975
            G       ++ PE     + + ++DV+S GVVL E+ + GK+
Sbjct: 187 GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 229

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 33/227 (14%)
Query: 760 DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKK-LSIGRFQGIQQ 817
           D P E++Y +            +IG G FG  Y+A+L   G LVA+KK L   RF+    
Sbjct: 19  DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---- 64
Query: 818 FDAEIGTLGRIRHKNLVTLIGYYVGEAE------MFLVYNFLSGGNLETFIHKKSGKKIQ 871
            + E+  + ++ H N+V L  ++    E      + LV +++         H    K+  
Sbjct: 65  -NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 123
Query: 872 WSVIHKIAI-DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVS 929
             +  K+ +  + ++LAY+H      I HRDIKP N+LLD +     L DFG A+ L   
Sbjct: 124 PVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 180
Query: 930 ETHATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
           E + +  +   + Y APE  +  T   S   DV+S G VL EL+ G+
Sbjct: 181 EPNVSX-ICSRY-YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 224

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 107/226 (47%), Gaps = 31/226 (13%)
Query: 760 DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGIQQF 818
           D P E++Y +            +IG G FG  Y+A+L   G LVA+KK+     QG    
Sbjct: 15  DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFK 60
Query: 819 DAEIGTLGRIRHKNLVTLIGYYVGEAE------MFLVYNFLSGGNLETFIHKKSGKKIQW 872
           + E+  + ++ H N+V L  ++    E      + LV +++         H    K+   
Sbjct: 61  NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP 120
Query: 873 SVIHKIAI-DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVSE 930
            +  K+ +  + ++LAY+H      I HRDIKP N+LLD +     L DFG A+ L   E
Sbjct: 121 VIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177
Query: 931 THATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
            + +  +   + Y APE  +  T   S   DV+S G VL EL+ G+
Sbjct: 178 PNVSY-ICSRY-YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 220

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 107/226 (47%), Gaps = 31/226 (13%)
Query: 760 DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGIQQF 818
           D P E++Y +            +IG G FG  Y+A+L   G LVA+KK+     QG    
Sbjct: 15  DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFK 60
Query: 819 DAEIGTLGRIRHKNLVTLIGYYVGEAE------MFLVYNFLSGGNLETFIHKKSGKKIQW 872
           + E+  + ++ H N+V L  ++    E      + LV +++         H    K+   
Sbjct: 61  NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP 120
Query: 873 SVIHKIAI-DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVSE 930
            +  K+ +  + ++LAY+H      I HRDIKP N+LLD +     L DFG A+ L   E
Sbjct: 121 VIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177
Query: 931 THATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
            + +  +   + Y APE  +  T   S   DV+S G VL EL+ G+
Sbjct: 178 PNVSY-ICSRY-YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 220

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 96/211 (45%), Gaps = 21/211 (9%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLV----TL 836
           IG G +G    A + V    VA+KK+S    Q   Q+   EI  L R RH+N++     +
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 837 IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPR 896
               + + +   +   L G +L   +      K Q      I   + Q L  L Y     
Sbjct: 111 RAPTIEQMKDVYLVTHLMGADLYKLL------KTQHLSNDHICYFLYQILRGLKYIHSAN 164
Query: 897 IVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRV 954
           ++HRD+KPSN+LL+   +  + DFGLAR+ +    H    T+   T  Y APE     + 
Sbjct: 165 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 224
Query: 955 SDKA-DVYSFGVVLLELIS------GKRSLD 978
             K+ D++S G +L E++S      GK  LD
Sbjct: 225 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 255

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 78/150 (52%), Gaps = 8/150 (5%)
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           H  LV L   +  E+ +F V  +++GG+L    H +  +K+        + +I+ AL YL
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYL 169
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARL-LEVSETHATTDVAGTFGYVAPEY 948
           H      I++RD+K  N+LLD E +  L+D+G+ +  L   +T  T+   GT  Y+APE 
Sbjct: 170 HERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEI 224
Query: 949 ATTCRVSDKADVYSFGVVLLELISGKRSLD 978
                     D ++ GV++ E+++G+   D
Sbjct: 225 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 33/227 (14%)
Query: 760 DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKK-LSIGRFQGIQQ 817
           D P E++Y +            +IG G FG  Y+A+L   G LVA+KK L   RF+    
Sbjct: 20  DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---- 65
Query: 818 FDAEIGTLGRIRHKNLVTLIGYYVGEAE------MFLVYNFLSGGNLETFIHKKSGKKIQ 871
            + E+  + ++ H N+V L  ++    E      + LV +++         H    K+  
Sbjct: 66  -NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 124
Query: 872 WSVIHKIAI-DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVS 929
             +  K+ +  + ++LAY+H      I HRDIKP N+LLD +     L DFG A+ L   
Sbjct: 125 PVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 181
Query: 930 ETHATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
           E + +  +   + Y APE  +  T   S   DV+S G VL EL+ G+
Sbjct: 182 EPNVSY-ICSRY-YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 225

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 102/223 (45%), Gaps = 23/223 (10%)
Query: 777 FSIRNLIGTGGFGSTYKAE---LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNL 833
           ++I  ++G G FG   K +       Y V V   +  + +       E+  L ++ H N+
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           + L       +  ++V    +GG L +  I +K   +      H  A  I Q  + + Y 
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE------HDAARIIKQVFSGITYM 137
Query: 893 CVPRIVHRDIKPSNILL---DEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
               IVHRD+KP NILL   +++ +  + DFGL+   +  +     D  GT  Y+APE  
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRIGTAYYIAPEVL 195
Query: 950 TTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYG-NGFNIV 991
                 +K DV+S GV+L  L+SG     P F  YG N ++I+
Sbjct: 196 RGT-YDEKCDVWSAGVILYILLSGT----PPF--YGKNEYDIL 231

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 31/207 (14%)
Query: 783 IGTGGFGST---YKAELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTL 836
           +G+G +GS    Y A L     VAVKKLS   FQ +   ++   E+  L  ++H+N++ L
Sbjct: 28  VGSGAYGSVCSAYDARLRQK--VAVKKLS-RPFQSLIHARRTYRELRLLKHLKHENVIGL 84
Query: 837 IGYYVGE------AEMFLVYNFLSGGNLETFIHKK--SGKKIQWSVIHKIAIDIAQALAY 888
           +  +         +E++LV   + G +L   +  +  S + +Q+ V       + + L Y
Sbjct: 85  LDVFTPATSIEDFSEVYLVTTLM-GADLNNIVKCQALSDEHVQFLVYQ-----LLRGLKY 138
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
           +H +    I+HRD+KPSN+ ++E+    + DFGLAR          T    T  Y APE 
Sbjct: 139 IHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR----QADEEMTGYVATRWYRAPEI 191
Query: 949 ATT-CRVSDKADVYSFGVVLLELISGK 974
                  +   D++S G ++ EL+ GK
Sbjct: 192 MLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 84/192 (43%), Gaps = 13/192 (6%)
Query: 830  HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
            H N+V L   +  +   FLV   L+GG L   I KK  K    +    I   +  A++++
Sbjct: 65   HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHM 122
Query: 890  HYSCVPRIVHRDIKPSNILLDEE---LNAYLSDFGLARLLEVSETHATTDVAGTFGYVAP 946
            H   V   VHRD+KP N+L  +E   L   + DFG ARL +  +         T  Y AP
Sbjct: 123  HDVGV---VHRDLKPENLLFTDENDNLEIKIIDFGFARL-KPPDNQPLKTPCFTLHYAAP 178
Query: 947  EYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSEL 1006
            E        +  D++S GV+L  ++SG+      F  +       S  +++ K  +    
Sbjct: 179  ELLNQNGYDESCDLWSLGVILYTMLSGQ----VPFQSHDRSLTCTSAVEIMKKIKKGDFS 234
Query: 1007 FLPELWEAGPQE 1018
            F  E W+   QE
Sbjct: 235  FEGEAWKNVSQE 246

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 33/227 (14%)
Query: 760 DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKK-LSIGRFQGIQQ 817
           D P E++Y +            +IG G FG  Y+A+L   G LVA+KK L   RF+    
Sbjct: 28  DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---- 73
Query: 818 FDAEIGTLGRIRHKNLVTLIGYYVGEAE------MFLVYNFLSGGNLETFIHKKSGKKIQ 871
            + E+  + ++ H N+V L  ++    E      + LV +++         H    K+  
Sbjct: 74  -NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 132
Query: 872 WSVIHKIAI-DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVS 929
             +  K+ +  + ++LAY+H      I HRDIKP N+LLD +     L DFG A+ L   
Sbjct: 133 PVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 189
Query: 930 ETHATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
           E + +  +   + Y APE  +  T   S   DV+S G VL EL+ G+
Sbjct: 190 EPNVSY-ICSRY-YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 233

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 78/150 (52%), Gaps = 8/150 (5%)
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           H  LV L   +  E+ +F V  +++GG+L    H +  +K+        + +I+ AL YL
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYL 137
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARL-LEVSETHATTDVAGTFGYVAPEY 948
           H      I++RD+K  N+LLD E +  L+D+G+ +  L   +T  T+   GT  Y+APE 
Sbjct: 138 HERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIAPEI 192
Query: 949 ATTCRVSDKADVYSFGVVLLELISGKRSLD 978
                     D ++ GV++ E+++G+   D
Sbjct: 193 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 78/150 (52%), Gaps = 8/150 (5%)
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           H  LV L   +  E+ +F V  +++GG+L    H +  +K+        + +I+ AL YL
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYL 126
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARL-LEVSETHATTDVAGTFGYVAPEY 948
           H      I++RD+K  N+LLD E +  L+D+G+ +  L   +T  T+   GT  Y+APE 
Sbjct: 127 HERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIAPEI 181
Query: 949 ATTCRVSDKADVYSFGVVLLELISGKRSLD 978
                     D ++ GV++ E+++G+   D
Sbjct: 182 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 87/165 (52%), Gaps = 12/165 (7%)
Query: 815 IQQFDAEIGTLGRIRHKNLVTLIGYY--VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQW 872
           I+Q   EI  L ++ H N+V L+       E  +++V+  ++ G +      K   + Q 
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQA 139
Query: 873 SVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH 932
               +   D+ + + YLHY    +I+HRDIKPSN+L+ E+ +  ++DFG++   + S+  
Sbjct: 140 RFYFQ---DLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA- 192
Query: 933 ATTDVAGTFGYVAPEYATTCR--VSDKA-DVYSFGVVLLELISGK 974
             ++  GT  ++APE  +  R   S KA DV++ GV L   + G+
Sbjct: 193 LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 24/229 (10%)
Query: 750 LRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSI 809
            R + +  + DT  EL        +G F++         G  Y A+ +        +  +
Sbjct: 4   FRQENVDDYYDTGEEL-------GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV 56
Query: 810 GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK 869
            R    +  + E+  L  I+H N++TL   Y  + ++ L+   ++GG L  F+ +K    
Sbjct: 57  SR----EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--- 109
Query: 870 IQWSVIHKIAID-IAQALAYLHYSCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLAR 924
              S+  + A + + Q L  ++Y    +I H D+KP NI LLD  +      + DFGLA 
Sbjct: 110 ---SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 925 LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
            ++    +   ++ GT  +VAPE      +  +AD++S GV+   L+SG
Sbjct: 167 KIDFG--NEFKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 33/227 (14%)
Query: 760 DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKK-LSIGRFQGIQQ 817
           D P E++Y +            +IG G FG  Y+A+L   G LVA+KK L   RF+    
Sbjct: 15  DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---- 60
Query: 818 FDAEIGTLGRIRHKNLVTLIGYYVGEAE------MFLVYNFLSGGNLETFIHKKSGKKIQ 871
            + E+  + ++ H N+V L  ++    E      + LV +++         H    K+  
Sbjct: 61  -NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 119
Query: 872 WSVIHKIAI-DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVS 929
             +  K+ +  + ++LAY+H      I HRDIKP N+LLD +     L DFG A+ L   
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 930 ETHATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
           E + +  +   + Y APE  +  T   S   DV+S G VL EL+ G+
Sbjct: 177 EPNVSY-ICSRY-YRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQ 220

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 78/150 (52%), Gaps = 8/150 (5%)
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           H  LV L   +  E+ +F V  +++GG+L    H +  +K+        + +I+ AL YL
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYL 122
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARL-LEVSETHATTDVAGTFGYVAPEY 948
           H      I++RD+K  N+LLD E +  L+D+G+ +  L   +T  T+   GT  Y+APE 
Sbjct: 123 HERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIAPEI 177
Query: 949 ATTCRVSDKADVYSFGVVLLELISGKRSLD 978
                     D ++ GV++ E+++G+   D
Sbjct: 178 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 104/211 (49%), Gaps = 30/211 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
            +          +++LV   L G +L   +     +K+    +  +   I + L Y+H +
Sbjct: 89  VFTPARSLEEFNDVYLV-THLMGADLNNIV---KSQKLTDDHVQFLIYQILRGLKYIHSA 144
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
               I+HRD+KPSN+ ++E+    + DFGL R       H   ++ G   T  Y APE  
Sbjct: 145 ---DIIHRDLKPSNLAVNEDSELKILDFGLCR-------HTDDEMTGYVATRWYRAPEIM 194
Query: 950 TT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                 +   D++S G ++ EL++G R+L P
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 224

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
           IG G +G    A + V    VA+KK+S    Q   Q+   EI  L R RH+N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
                  +   ++    +ET ++K    + +    I      I + L Y+H +    ++H
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 149
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
           RD+KPSN+LL+   +  + DFGLAR+ +    H    T+   T  Y APE     +   K
Sbjct: 150 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 209
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
           + D++S G +L E++S      GK  LD
Sbjct: 210 SIDIWSVGCILAEMLSNRPIFPGKHYLD 237

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 12/211 (5%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNLVTLIGYY 840
           +G G +G    A   V    VAVK + + R     +    EI     + H+N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
                 +L   + SGG L   I    G  +      +    +   + YLH      I HR
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGI---GITHR 129
Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYATTCRV-SDKA 958
           DIKP N+LLDE  N  +SDFGLA +   +      + + GT  YVAPE        ++  
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPV 189
Query: 959 DVYSFGVVLLELISGKRSLD-PSFS--EYGN 986
           DV+S G+VL  +++G+   D PS S  EY +
Sbjct: 190 DVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 220

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 106/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G+ VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +          +++LV   L G +L   +   K +   +Q+ +       I + L Y+H
Sbjct: 89  VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 142
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
            +    I+HRD+KPSN+ ++E+    + DF LAR       H   ++ G   T  Y APE
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDFYLAR-------HTDDEMTGYVATRWYRAPE 192
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                   +   D++S G ++ EL++G R+L P
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 224

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 106/211 (50%), Gaps = 30/211 (14%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   + ++  G  +AVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 117
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
            +          +++LV   L G +L   +     +K+    +  +   I + L Y+H +
Sbjct: 118 VFTPATSLEEFNDVYLV-THLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLKYIHSA 173
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPEYA 949
               I+HRD+KPSN+ ++E+    + DFGLAR       H   ++ G   T  Y APE  
Sbjct: 174 ---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIM 223
Query: 950 TT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                 +   D++S G ++ EL++G R+L P
Sbjct: 224 LNWMHYNMTVDIWSVGCIMAELLTG-RTLFP 253

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
           IG G +G    A + V    VA+KK+S    Q   Q+   EI  L R RH+N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
                  +   ++    +ET ++K    + +    I      I + L Y+H +    ++H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 147
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
           RD+KPSN+LL+   +  + DFGLAR+ +    H    T+   T  Y APE     +   K
Sbjct: 148 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
           + D++S G +L E++S      GK  LD
Sbjct: 208 SIDIWSVGCILAEMLSNRPIFPGKHYLD 235

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
           IG G +G    A + V    VA+KK+S    Q   Q+   EI  L R RH+N++ +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
                  +   ++    +ET ++K    + +    I      I + L Y+H +    ++H
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 155
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
           RD+KPSN+LL+   +  + DFGLAR+ +    H    T+   T  Y APE     +   K
Sbjct: 156 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 215
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
           + D++S G +L E++S      GK  LD
Sbjct: 216 SIDIWSVGCILAEMLSNRPIFPGKHYLD 243

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
           IG G +G    A + V    VA+KK+S    Q   Q+   EI  L R RH+N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
                  +   ++    +ET ++K    + +    I      I + L Y+H +    ++H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 147
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
           RD+KPSN+LL+   +  + DFGLAR+ +    H    T+   T  Y APE     +   K
Sbjct: 148 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
           + D++S G +L E++S      GK  LD
Sbjct: 208 SIDIWSVGCILAEMLSNRPIFPGKHYLD 235

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 104/234 (44%), Gaps = 22/234 (9%)
Query: 757 TFADTPAELTYDNVVR-ATGNFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQG 814
           TF D P +L Y+        N      +G G FG   +A     G   AV K+++   + 
Sbjct: 20  TFID-PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKS 78
Query: 815 IQQFDAEIGTLGRIR-------HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKS- 866
               D +   +  ++       H+N+V L+G       + ++  +   G+L  F+ +K+ 
Sbjct: 79  TAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAE 138
Query: 867 -------GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSD 919
                  G+ ++   +   +  +AQ +A+L        +HRD+   N+LL     A + D
Sbjct: 139 ADLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGD 195
Query: 920 FGLAR-LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
           FGLAR ++  S      +      ++APE    C  + ++DV+S+G++L E+ S
Sbjct: 196 FGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 12/211 (5%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNLVTLIGYY 840
           +G G +G    A   V    VAVK + + R     +    EI     + H+N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
                 +L   + SGG L   I    G  +      +    +   + YLH      I HR
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGI---GITHR 128
Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYATTCRV-SDKA 958
           DIKP N+LLDE  N  +SDFGLA +   +      + + GT  YVAPE        ++  
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 188
Query: 959 DVYSFGVVLLELISGKRSLD-PSFS--EYGN 986
           DV+S G+VL  +++G+   D PS S  EY +
Sbjct: 189 DVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 219

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 12/211 (5%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNLVTLIGYY 840
           +G G +G    A   V    VAVK + + R     +    EI     + H+N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
                 +L   + SGG L   I    G  +      +    +   + YLH      I HR
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGI---GITHR 129
Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYATTCRV-SDKA 958
           DIKP N+LLDE  N  +SDFGLA +   +      + + GT  YVAPE        ++  
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 189
Query: 959 DVYSFGVVLLELISGKRSLD-PSFS--EYGN 986
           DV+S G+VL  +++G+   D PS S  EY +
Sbjct: 190 DVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 220

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 12/211 (5%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNLVTLIGYY 840
           +G G +G    A   V    VAVK + + R     +    EI     + H+N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
                 +L   + SGG L   I    G  +      +    +   + YLH      I HR
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGI---GITHR 128
Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYATTCRV-SDKA 958
           DIKP N+LLDE  N  +SDFGLA +   +      + + GT  YVAPE        ++  
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 188
Query: 959 DVYSFGVVLLELISGKRSLD-PSFS--EYGN 986
           DV+S G+VL  +++G+   D PS S  EY +
Sbjct: 189 DVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 219

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 12/211 (5%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNLVTLIGYY 840
           +G G +G    A   V    VAVK + + R     +    EI     + H+N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
                 +L   + SGG L   I    G  +      +    +   + YLH      I HR
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGI---GITHR 128
Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYATTCRV-SDKA 958
           DIKP N+LLDE  N  +SDFGLA +   +      + + GT  YVAPE        ++  
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 188
Query: 959 DVYSFGVVLLELISGKRSLD-PSFS--EYGN 986
           DV+S G+VL  +++G+   D PS S  EY +
Sbjct: 189 DVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 219

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 12/211 (5%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNLVTLIGYY 840
           +G G +G    A   V    VAVK + + R     +    EI     + H+N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
                 +L   + SGG L   I    G  +      +    +   + YLH      I HR
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGI---GITHR 128
Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYATTCRV-SDKA 958
           DIKP N+LLDE  N  +SDFGLA +   +      + + GT  YVAPE        ++  
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 188
Query: 959 DVYSFGVVLLELISGKRSLD-PSFS--EYGN 986
           DV+S G+VL  +++G+   D PS S  EY +
Sbjct: 189 DVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 219

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 12/211 (5%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNLVTLIGYY 840
           +G G +G    A   V    VAVK + + R     +    EI     + H+N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
                 +L   + SGG L   I    G  +      +    +   + YLH      I HR
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGI---GITHR 129
Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYATTCRV-SDKA 958
           DIKP N+LLDE  N  +SDFGLA +   +      + + GT  YVAPE        ++  
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 189
Query: 959 DVYSFGVVLLELISGKRSLD-PSFS--EYGN 986
           DV+S G+VL  +++G+   D PS S  EY +
Sbjct: 190 DVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 220

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 108/226 (47%), Gaps = 21/226 (9%)
Query: 758 FADTPAELTYDNVVRATGNFSIRNL-IGTGGFGSTYKAELVPGYLVAVKKLSIG---RFQ 813
           F+D P EL    +     N  I ++ +G G FGS  +      Y +  K++ +      Q
Sbjct: 319 FSD-PEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGV----YRMRKKQIDVAIKVLKQ 373
Query: 814 GIQQFDAE-IGTLGRIRHK----NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGK 868
           G ++ D E +    +I H+     +V LIG    EA + LV     GG L  F+  K  +
Sbjct: 374 GTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKR-E 431
Query: 869 KIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV 928
           +I  S + ++   ++  + YL        VHR++   N+LL     A +SDFGL++ L  
Sbjct: 432 EIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488
Query: 929 SETHATTDVAGTF--GYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
            +++ T   AG +   + APE     + S ++DV+S+GV + E +S
Sbjct: 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
           IG G +G    A + V    VA+KK+S    Q   Q+   EI  L R RH+N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
                  +   ++    +ET ++K    + +    I      I + L Y+H +    ++H
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 167
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
           RD+KPSN+LL+   +  + DFGLAR+ +    H    T+   T  Y APE     +   K
Sbjct: 168 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 227
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
           + D++S G +L E++S      GK  LD
Sbjct: 228 SIDIWSVGCILAEMLSNRPIFPGKHYLD 255

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
           IG G +G    A + V    VA+KK+S    Q   Q+   EI  L R RH+N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
                  +   ++    +ET ++K    + +    I      I + L Y+H +    ++H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 147
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
           RD+KPSN+LL+   +  + DFGLAR+ +    H    T+   T  Y APE     +   K
Sbjct: 148 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
           + D++S G +L E++S      GK  LD
Sbjct: 208 SIDIWSVGCILAEMLSNRPIFPGKHYLD 235

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 12/211 (5%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNLVTLIGYY 840
           +G G +G    A   V    VAVK + + R     +    EI     + H+N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
                 +L   + SGG L   I    G  +      +    +   + YLH      I HR
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGI---GITHR 128
Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPEYATTCRV-SDKA 958
           DIKP N+LLDE  N  +SDFGLA +   +      + + GT  YVAPE        ++  
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPV 188
Query: 959 DVYSFGVVLLELISGKRSLD-PSFS--EYGN 986
           DV+S G+VL  +++G+   D PS S  EY +
Sbjct: 189 DVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 219

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
           IG G +G    A + V    VA+KK+S    Q   Q+   EI  L R RH+N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
                  +   ++    +ET ++K    + +    I      I + L Y+H + V   +H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV---LH 147
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
           RD+KPSN+LL+   +  + DFGLAR+ +    H    T+   T  Y APE     +   K
Sbjct: 148 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
           + D++S G +L E++S      GK  LD
Sbjct: 208 SIDIWSVGCILAEMLSNRPIFPGKHYLD 235

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
           IG G +G    A + V    VA+KK+S    Q   Q+   EI  L R RH+N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
                  +   ++    +ET ++K    + +    I      I + L Y+H + V   +H
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV---LH 147
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
           RD+KPSN+LL+   +  + DFGLAR+ +    H    T+   T  Y APE     +   K
Sbjct: 148 RDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
           + D++S G +L E++S      GK  LD
Sbjct: 208 SIDIWSVGCILAEMLSNRPIFPGKHYLD 235

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 101/215 (46%), Gaps = 28/215 (13%)
Query: 783 IGTGGFGSTYKAELV------PGYL--VAVKKL-SIGRFQGIQQFDAEIGTLGRI-RHKN 832
           +G G FG    AE +      P  +  VAVK L S    + +    +E+  +  I +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSV--------------IHKI 878
           ++ L+G    +  ++++  + S GNL  ++  +    +++                +   
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDV 937
           A  +A+ + YL      + +HRD+   N+L+ E+    ++DFGLAR +  +     TT+ 
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 938 AGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
                ++APE       + ++DV+SFGV+L E+ +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 101/215 (46%), Gaps = 28/215 (13%)
Query: 783 IGTGGFGSTYKAELV------PGYL--VAVKKL-SIGRFQGIQQFDAEIGTLGRI-RHKN 832
           +G G FG    AE +      P  +  VAVK L S    + +    +E+  +  I +HKN
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSV--------------IHKI 878
           ++ L+G    +  ++++  + S GNL  ++  +    +++                +   
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDV 937
           A  +A+ + YL      + +HRD+   N+L+ E+    ++DFGLAR +  +     TT+ 
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 938 AGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
                ++APE       + ++DV+SFGV+L E+ +
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 21/214 (9%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-----PGYL-VAVKKL-SIGRFQGIQQFDAEIGTLGRI 828
           N ++   +G G FG  Y+ ++      P  L VAVK L  +   Q    F  E   + ++
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKL 91
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS------VIHKIAIDI 882
            H+N+V  IG  +     F++   ++GG+L++F+ +   +  Q S      ++H +A DI
Sbjct: 92  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDI 150
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSETHATTDVAG 939
           A    YL  +     +HRDI   N LL        A + DFG+AR +  +  +     A 
Sbjct: 151 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 207
Query: 940 -TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
               ++ PE       + K D +SFGV+L E+ S
Sbjct: 208 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 67.0 bits (162), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 782 LIGTGGFGSTYK------AELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
            +G GGF   ++       E+  G +V  K L +   Q  ++   EI     + H+++V 
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVP-KSLLLKPHQR-EKMSMEISIHRSLAHQHVVG 85
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
             G++     +F+V       +L   +HK+     +    + +   I     YLH +   
Sbjct: 86  FHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR-QIVLGCQYLHRN--- 140
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVS 955
           R++HRD+K  N+ L+E+L   + DFGLA  +E       T + GT  Y+APE  +    S
Sbjct: 141 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHS 199
Query: 956 DKADVYSFGVVLLELISGKRSLDPS 980
            + DV+S G ++  L+ GK   + S
Sbjct: 200 FEVDVWSIGCIMYTLLVGKPPFETS 224

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 67.0 bits (162), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 24/229 (10%)
Query: 750 LRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSI 809
            R + +  + DT  EL        +G F++         G  Y A+ +        +  +
Sbjct: 4   FRQENVDDYYDTGEEL-------GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV 56
Query: 810 GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK 869
            R    +  + E+  L  I+H N++TL   Y  + ++ L+   ++GG L  F+ +K    
Sbjct: 57  SR----EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--- 109
Query: 870 IQWSVIHKIAID-IAQALAYLHYSCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLAR 924
              S+  + A + + Q L  ++Y    +I H D+KP NI LLD  +      + DFGLA 
Sbjct: 110 ---SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 925 LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
            ++    +   ++ GT  +VAPE      +  +AD++S GV+   L+SG
Sbjct: 167 KIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 782 LIGTGGFGSTYK------AELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
            +G GGF   ++       E+  G +V  K L +   Q  ++   EI     + H+++V 
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVP-KSLLLKPHQR-EKMSMEISIHRSLAHQHVVG 81
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
             G++     +F+V       +L   +HK+     +    + +   I     YLH +   
Sbjct: 82  FHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR-QIVLGCQYLHRN--- 136
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVS 955
           R++HRD+K  N+ L+E+L   + DFGLA  +E       T + GT  Y+APE  +    S
Sbjct: 137 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHS 195
Query: 956 DKADVYSFGVVLLELISGKRSLDPS 980
            + DV+S G ++  L+ GK   + S
Sbjct: 196 FEVDVWSIGCIMYTLLVGKPPFETS 220

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 67.0 bits (162), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 87/199 (43%), Gaps = 14/199 (7%)
Query: 783 IGTGGFGSTYKAEL-VPG---YLVAVKKLS---IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
           +G G FG   + E   P      VAVK L    + + + +  F  E+  +  + H+NL+ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
           L G  V    M +V      G+L   + K  G  +    + + A+ +A+ + YL      
Sbjct: 86  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLL-GTLSRYAVQVAEGMGYLESK--- 140
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAPEYATTCR 953
           R +HRD+   N+LL       + DFGL R L  ++ H          F + APE   T  
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRT 200
Query: 954 VSDKADVYSFGVVLLELIS 972
            S  +D + FGV L E+ +
Sbjct: 201 FSHASDTWMFGVTLWEMFT 219

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 67.0 bits (162), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 21/214 (9%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-----PGYL-VAVKKL-SIGRFQGIQQFDAEIGTLGRI 828
           N ++   +G G FG  Y+ ++      P  L VAVK L  +   Q    F  E   + ++
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKL 105
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS------VIHKIAIDI 882
            H+N+V  IG  +     F++   ++GG+L++F+ +   +  Q S      ++H +A DI
Sbjct: 106 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDI 164
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSETHATTDVAG 939
           A    YL  +     +HRDI   N LL        A + DFG+AR +  +  +     A 
Sbjct: 165 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 221
Query: 940 -TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
               ++ PE       + K D +SFGV+L E+ S
Sbjct: 222 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 782 LIGTGGFGSTYK------AELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
            +G GGF   ++       E+  G +V  K L +   Q  ++   EI     + H+++V 
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVP-KSLLLKPHQR-EKMSMEISIHRSLAHQHVVG 81
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
             G++     +F+V       +L   +HK+     +    + +   I     YLH +   
Sbjct: 82  FHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR-QIVLGCQYLHRN--- 136
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVS 955
           R++HRD+K  N+ L+E+L   + DFGLA  +E       T + GT  Y+APE  +    S
Sbjct: 137 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHS 195
Query: 956 DKADVYSFGVVLLELISGKRSLDPS 980
            + DV+S G ++  L+ GK   + S
Sbjct: 196 FEVDVWSIGCIMYTLLVGKPPFETS 220

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 31/207 (14%)
Query: 783 IGTGGFGST---YKAELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTL 836
           +G+G +GS    Y A L     VAVKKLS   FQ +   ++   E+  L  ++H+N++ L
Sbjct: 36  VGSGAYGSVCSAYDARLRQK--VAVKKLS-RPFQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 837 IGYYVGE------AEMFLVYNFLSGGNLETFIHKK--SGKKIQWSVIHKIAIDIAQALAY 888
           +  +         +E++LV   + G +L   +  +  S + +Q+ V       + + L Y
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLM-GADLNNIVKCQALSDEHVQFLVYQ-----LLRGLKY 146
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
           +H +    I+HRD+KPSN+ ++E+    + DFGLAR          T    T  Y APE 
Sbjct: 147 IHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR----QADEEMTGYVATRWYRAPEI 199
Query: 949 ATT-CRVSDKADVYSFGVVLLELISGK 974
                  +   D++S G ++ EL+ GK
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 102/225 (45%), Gaps = 23/225 (10%)
Query: 776 NFSIRNLIGTGGFGSTYKAE---LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKN 832
            ++I  ++G G FG   K +       Y V V   +  + +       E+  L ++ H N
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN 82
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
           ++ L       +  ++V    +GG L +  I +K   +      H  A  I Q  + + Y
Sbjct: 83  IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE------HDAARIIKQVFSGITY 136
Query: 892 SCVPRIVHRDIKPSNILL---DEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
                IVHRD+KP NILL   +++ +  + DFGL+   +  +     D  GT  Y+APE 
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRIGTAYYIAPE- 193
Query: 949 ATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYG-NGFNIVS 992
                  +K DV+S GV+L  L+SG     P F  YG N ++I+ 
Sbjct: 194 VLRGTYDEKCDVWSAGVILYILLSGT----PPF--YGKNEYDILK 232

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-----PGYL-VAVKKL-SIGRFQGIQQFDAEIGTLGRI 828
           N ++   +G G FG  Y+ ++      P  L VAVK L  +   Q    F  E   + + 
Sbjct: 31  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 90
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS------VIHKIAIDI 882
            H+N+V  IG  +     F++   ++GG+L++F+ +   +  Q S      ++H +A DI
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDI 149
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSETHATTDVAG 939
           A    YL  +     +HRDI   N LL        A + DFG+AR +  +  +     A 
Sbjct: 150 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206
Query: 940 -TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
               ++ PE       + K D +SFGV+L E+ S
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 102/225 (45%), Gaps = 23/225 (10%)
Query: 776 NFSIRNLIGTGGFGSTYKAE---LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKN 832
            ++I  ++G G FG   K +       Y V V   +  + +       E+  L ++ H N
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN 82
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
           ++ L       +  ++V    +GG L +  I +K   +      H  A  I Q  + + Y
Sbjct: 83  IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE------HDAARIIKQVFSGITY 136
Query: 892 SCVPRIVHRDIKPSNILL---DEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
                IVHRD+KP NILL   +++ +  + DFGL+   +  +     D  GT  Y+APE 
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRIGTAYYIAPE- 193
Query: 949 ATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYG-NGFNIVS 992
                  +K DV+S GV+L  L+SG     P F  YG N ++I+ 
Sbjct: 194 VLRGTYDEKCDVWSAGVILYILLSGT----PPF--YGKNEYDILK 232

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 104/214 (48%), Gaps = 24/214 (11%)
Query: 772 RATGNFSIRNLIGTGGFGSTYKA------ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTL 825
           R T ++ +   +G G F    +       +     ++  KKLS    Q +++ +A I  L
Sbjct: 28  RFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLER-EARICRL 86
Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWS-VIHKIAIDIA 883
             ++H N+V L      E   +LV++ ++GG L E  + ++   +   S  IH+I     
Sbjct: 87  --LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQIL---- 140
Query: 884 QALAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVS-ETHATTDVAG 939
           +++ ++H      IVHRD+KP N+LL  +       L+DFGLA  +EV  E  A    AG
Sbjct: 141 ESVNHIHQH---DIVHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGEQQAWFGFAG 195
Query: 940 TFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
           T GY++PE           D+++ GV+L  L+ G
Sbjct: 196 TPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-----PGYL-VAVKKL-SIGRFQGIQQFDAEIGTLGRI 828
           N ++   +G G FG  Y+ ++      P  L VAVK L  +   Q    F  E   + + 
Sbjct: 23  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 82
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS------VIHKIAIDI 882
            H+N+V  IG  +     F++   ++GG+L++F+ +   +  Q S      ++H +A DI
Sbjct: 83  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDI 141
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSETHATTDVAG 939
           A    YL  +     +HRDI   N LL        A + DFG+AR +  +  +     A 
Sbjct: 142 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 198
Query: 940 -TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
               ++ PE       + K D +SFGV+L E+ S
Sbjct: 199 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 98/198 (49%), Gaps = 16/198 (8%)
Query: 783 IGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQ---FDAEIGTLGRIRHKNLVTLIG 838
           +G G +G   K   VP G ++AVK++        Q+    D +I ++  +     VT  G
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDI-SMRTVDCPFTVTFYG 73
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHK--KSGKKIQWSVIHKIAIDIAQALAYLHYSCVPR 896
               E ++++    +   +L+ F  +    G+ I   ++ KIA+ I +AL +LH      
Sbjct: 74  ALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--S 130
Query: 897 IVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA----TTC 952
           ++HRD+KPSN+L++      + DFG++  L V +     D AG   Y+APE         
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDID-AGCKPYMAPERINPELNQK 188
Query: 953 RVSDKADVYSFGVVLLEL 970
             S K+D++S G+ ++EL
Sbjct: 189 GYSVKSDIWSLGITMIEL 206

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 104/234 (44%), Gaps = 22/234 (9%)
Query: 757 TFADTPAELTYDNVVR-ATGNFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQG 814
           TF D P +L Y+        N      +G G FG   +A     G   AV K+++   + 
Sbjct: 28  TFID-PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKS 86
Query: 815 IQQFDAEIGTLGRIR-------HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKS- 866
               D +   +  ++       H+N+V L+G       + ++  +   G+L  F+ +K+ 
Sbjct: 87  TAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAE 146
Query: 867 -------GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSD 919
                  G+ ++   +   +  +AQ +A+L        +HRD+   N+LL     A + D
Sbjct: 147 ADLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGD 203
Query: 920 FGLAR-LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
           FGLAR ++  S      +      ++APE    C  + ++DV+S+G++L E+ S
Sbjct: 204 FGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 24/229 (10%)
Query: 750 LRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSI 809
            R + +  + DT  EL        +G F++         G  Y A+ +        +  +
Sbjct: 4   FRQENVDDYYDTGEEL-------GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV 56
Query: 810 GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK 869
            R    +  + E+  L  I+H N++TL   Y  + ++ L+   ++GG L  F+ +K    
Sbjct: 57  SR----EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--- 109
Query: 870 IQWSVIHKIAID-IAQALAYLHYSCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLAR 924
              S+  + A + + Q L  ++Y    +I H D+KP NI LLD  +      + DFGLA 
Sbjct: 110 ---SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 925 LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
            ++    +   ++ GT  +VAPE      +  +AD++S GV+   L+SG
Sbjct: 167 KIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 66.6 bits (161), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 87/199 (43%), Gaps = 14/199 (7%)
Query: 783 IGTGGFGSTYKAEL-VPG---YLVAVKKLS---IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
           +G G FG   + E   P      VAVK L    + + + +  F  E+  +  + H+NL+ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
           L G  V    M +V      G+L   + K  G  +    + + A+ +A+ + YL      
Sbjct: 80  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLL-GTLSRYAVQVAEGMGYLESK--- 134
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAPEYATTCR 953
           R +HRD+   N+LL       + DFGL R L  ++ H          F + APE   T  
Sbjct: 135 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 194
Query: 954 VSDKADVYSFGVVLLELIS 972
            S  +D + FGV L E+ +
Sbjct: 195 FSHASDTWMFGVTLWEMFT 213

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-----PGYL-VAVKKL-SIGRFQGIQQFDAEIGTLGRI 828
           N ++   +G G FG  Y+ ++      P  L VAVK L  +   Q    F  E   + + 
Sbjct: 31  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 90
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS------VIHKIAIDI 882
            H+N+V  IG  +     F++   ++GG+L++F+ +   +  Q S      ++H +A DI
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDI 149
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSETHATTDVAG 939
           A    YL  +     +HRDI   N LL        A + DFG+AR +  +  +     A 
Sbjct: 150 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206
Query: 940 -TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
               ++ PE       + K D +SFGV+L E+ S
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 24/229 (10%)
Query: 750 LRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSI 809
            R + +  + DT  EL        +G F++         G  Y A+ +        +  +
Sbjct: 4   FRQENVDDYYDTGEEL-------GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV 56
Query: 810 GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK 869
            R    +  + E+  L  I+H N++TL   Y  + ++ L+   ++GG L  F+ +K    
Sbjct: 57  SR----EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--- 109
Query: 870 IQWSVIHKIAID-IAQALAYLHYSCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLAR 924
              S+  + A + + Q L  ++Y    +I H D+KP NI LLD  +      + DFGLA 
Sbjct: 110 ---SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 925 LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
            ++    +   ++ GT  +VAPE      +  +AD++S GV+   L+SG
Sbjct: 167 KIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-----PGYL-VAVKKL-SIGRFQGIQQFDAEIGTLGRI 828
           N ++   +G G FG  Y+ ++      P  L VAVK L  +   Q    F  E   + + 
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 91
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS------VIHKIAIDI 882
            H+N+V  IG  +     F++   ++GG+L++F+ +   +  Q S      ++H +A DI
Sbjct: 92  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDI 150
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSETHATTDVAG 939
           A    YL  +     +HRDI   N LL        A + DFG+AR +  +  +     A 
Sbjct: 151 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 207
Query: 940 -TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
               ++ PE       + K D +SFGV+L E+ S
Sbjct: 208 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-----PGYL-VAVKKL-SIGRFQGIQQFDAEIGTLGRI 828
           N ++   +G G FG  Y+ ++      P  L VAVK L  +   Q    F  E   + + 
Sbjct: 48  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 107
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS------VIHKIAIDI 882
            H+N+V  IG  +     F++   ++GG+L++F+ +   +  Q S      ++H +A DI
Sbjct: 108 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDI 166
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSETHATTDVAG 939
           A    YL  +     +HRDI   N LL        A + DFG+AR +  +  +     A 
Sbjct: 167 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 223
Query: 940 -TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
               ++ PE       + K D +SFGV+L E+ S
Sbjct: 224 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 24/229 (10%)
Query: 750 LRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSI 809
            R + +  + DT  EL        +G F++         G  Y A+ +        +  +
Sbjct: 4   FRQENVDDYYDTGEEL-------GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV 56
Query: 810 GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK 869
            R    +  + E+  L  I+H N++TL   Y  + ++ L+   ++GG L  F+ +K    
Sbjct: 57  SR----EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--- 109
Query: 870 IQWSVIHKIAID-IAQALAYLHYSCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLAR 924
              S+  + A + + Q L  ++Y    +I H D+KP NI LLD  +      + DFGLA 
Sbjct: 110 ---SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 925 LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
            ++    +   ++ GT  +VAPE      +  +AD++S GV+   L+SG
Sbjct: 167 KIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 87/199 (43%), Gaps = 14/199 (7%)
Query: 783 IGTGGFGSTYKAEL-VPG---YLVAVKKLS---IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
           +G G FG   + E   P      VAVK L    + + + +  F  E+  +  + H+NL+ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
           L G  V    M +V      G+L   + K  G  +    + + A+ +A+ + YL      
Sbjct: 80  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLL-GTLSRYAVQVAEGMGYLESK--- 134
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAPEYATTCR 953
           R +HRD+   N+LL       + DFGL R L  ++ H          F + APE   T  
Sbjct: 135 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 194
Query: 954 VSDKADVYSFGVVLLELIS 972
            S  +D + FGV L E+ +
Sbjct: 195 FSHASDTWMFGVTLWEMFT 213

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 120/284 (42%), Gaps = 38/284 (13%)
Query: 772  RATGNFSIRNLIGTGGFGSTYK------AELVPGYLVAVKKLSIGRFQGIQQFDAEIGTL 825
            R    +     +G GGF   Y+       E+  G +V  K + +   Q  ++   EI   
Sbjct: 39   RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVP-KSMLLKPHQK-EKMSTEIAIH 96
Query: 826  GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
              + + ++V   G++  +  +++V       +L   +HK+  K +             Q 
Sbjct: 97   KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRR-KAVTEPEARYFMRQTIQG 154
Query: 886  LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
            + YLH +   R++HRD+K  N+ L+++++  + DFGLA  +E  +     D+ GT  Y+A
Sbjct: 155  VQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEF-DGERKKDLCGTPNYIA 210
Query: 946  PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSF----------SEYGNGFNIVSWAK 995
            PE       S + D++S G +L  L+ GK   + S           +EY    +I   A 
Sbjct: 211  PEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVAS 270
Query: 996  LLIK---------EGRSSELFLPELWEAGPQENLLGMMRLASTC 1030
             LI+             +EL   E + +G        MRL ++C
Sbjct: 271  ALIRRMLHADPTLRPSVAELLTDEFFTSG-----YAPMRLPTSC 309

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 87/199 (43%), Gaps = 14/199 (7%)
Query: 783 IGTGGFGSTYKAEL-VPG---YLVAVKKLS---IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
           +G G FG   + E   P      VAVK L    + + + +  F  E+  +  + H+NL+ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
           L G  V    M +V      G+L   + K  G  +    + + A+ +A+ + YL      
Sbjct: 86  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLL-GTLSRYAVQVAEGMGYLESK--- 140
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAPEYATTCR 953
           R +HRD+   N+LL       + DFGL R L  ++ H          F + APE   T  
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 200
Query: 954 VSDKADVYSFGVVLLELIS 972
            S  +D + FGV L E+ +
Sbjct: 201 FSHASDTWMFGVTLWEMFT 219

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 14/215 (6%)
Query: 772 RATGNFSIRNLIGTGGFGSTYK------AELVPGYLVAVKKLSIGRFQGIQQFDAEIGTL 825
           R    +     +G GGF   Y+       E+  G +V  K + +   Q  ++   EI   
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVP-KSMLLKPHQK-EKMSTEIAIH 80
Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
             + + ++V   G++  +  +++V       +L   +HK+  K +             Q 
Sbjct: 81  KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRR-KAVTEPEARYFMRQTIQG 138
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
           + YLH +   R++HRD+K  N+ L+++++  + DFGLA  +E  +     D+ GT  Y+A
Sbjct: 139 VQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEF-DGERKKDLCGTPNYIA 194
Query: 946 PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPS 980
           PE       S + D++S G +L  L+ GK   + S
Sbjct: 195 PEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 229

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-----PGYL-VAVKKL-SIGRFQGIQQFDAEIGTLGRI 828
           N ++   +G G FG  Y+ ++      P  L VAVK L  +   Q    F  E   + + 
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 105
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS------VIHKIAIDI 882
            H+N+V  IG  +     F++   ++GG+L++F+ +   +  Q S      ++H +A DI
Sbjct: 106 NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDI 164
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSETHATTDVAG 939
           A    YL  +     +HRDI   N LL        A + DFG+AR +  +  +     A 
Sbjct: 165 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 221
Query: 940 -TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
               ++ PE       + K D +SFGV+L E+ S
Sbjct: 222 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 24/229 (10%)
Query: 750 LRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSI 809
            R + +  + DT  EL        +G F++         G  Y A+ +        +  +
Sbjct: 4   FRQENVDDYYDTGEEL-------GSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV 56
Query: 810 GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK 869
            R    +  + E+  L  I+H N++TL   Y  + ++ L+   ++GG L  F+ +K    
Sbjct: 57  SR----EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--- 109
Query: 870 IQWSVIHKIAID-IAQALAYLHYSCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLAR 924
              S+  + A + + Q L  ++Y    +I H D+KP NI LLD  +      + DFGLA 
Sbjct: 110 ---SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 925 LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
            ++    +   ++ GT  +VAPE      +  +AD++S GV+   L+SG
Sbjct: 167 KIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 24/229 (10%)
Query: 750 LRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSI 809
            R + +  + DT  EL        +G F++         G  Y A+ +        +  +
Sbjct: 3   FRQENVDDYYDTGEEL-------GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV 55
Query: 810 GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK 869
            R    +  + E+  L  I+H N++TL   Y  + ++ L+   ++GG L  F+ +K    
Sbjct: 56  SR----EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--- 108
Query: 870 IQWSVIHKIAID-IAQALAYLHYSCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLAR 924
              S+  + A + + Q L  ++Y    +I H D+KP NI LLD  +      + DFGLA 
Sbjct: 109 ---SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165
Query: 925 LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
            ++    +   ++ GT  +VAPE      +  +AD++S GV+   L+SG
Sbjct: 166 KIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 24/229 (10%)
Query: 750 LRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSI 809
            R + +  + DT  EL        +G F++         G  Y A+ +        +  +
Sbjct: 3   FRQENVDDYYDTGEEL-------GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV 55
Query: 810 GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK 869
            R    +  + E+  L  I+H N++TL   Y  + ++ L+   ++GG L  F+ +K    
Sbjct: 56  SR----EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--- 108
Query: 870 IQWSVIHKIAID-IAQALAYLHYSCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLAR 924
              S+  + A + + Q L  ++Y    +I H D+KP NI LLD  +      + DFGLA 
Sbjct: 109 ---SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165
Query: 925 LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
            ++    +   ++ GT  +VAPE      +  +AD++S GV+   L+SG
Sbjct: 166 KIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-----PGYL-VAVKKL-SIGRFQGIQQFDAEIGTLGRI 828
           N ++   +G G FG  Y+ ++      P  L VAVK L  +   Q    F  E   + + 
Sbjct: 38  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 97
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS------VIHKIAIDI 882
            H+N+V  IG  +     F++   ++GG+L++F+ +   +  Q S      ++H +A DI
Sbjct: 98  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDI 156
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSETHATTDVAG 939
           A    YL  +     +HRDI   N LL        A + DFG+AR +  +  +     A 
Sbjct: 157 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 213
Query: 940 -TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
               ++ PE       + K D +SFGV+L E+ S
Sbjct: 214 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 87/199 (43%), Gaps = 14/199 (7%)
Query: 783 IGTGGFGSTYKAEL-VPG---YLVAVKKLS---IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
           +G G FG   + E   P      VAVK L    + + + +  F  E+  +  + H+NL+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
           L G  V    M +V      G+L   + K  G  +    + + A+ +A+ + YL      
Sbjct: 76  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLL-GTLSRYAVQVAEGMGYLESK--- 130
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAPEYATTCR 953
           R +HRD+   N+LL       + DFGL R L  ++ H          F + APE   T  
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190
Query: 954 VSDKADVYSFGVVLLELIS 972
            S  +D + FGV L E+ +
Sbjct: 191 FSHASDTWMFGVTLWEMFT 209

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
           IG G +G    A + +    VA+KK+S    Q   Q+   EI  L R RH+N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
                  +   ++    +ET ++K    + +    I      I + L Y+H +    ++H
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 152
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
           RD+KPSN+LL+   +  + DFGLAR+ +    H    T+   T  Y APE     +   K
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 212
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
           + D++S G +L E++S      GK  LD
Sbjct: 213 SIDIWSVGCILAEMLSNRPIFPGKHYLD 240

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
           IG G +G    A + +    VA+KK+S    Q   Q+   EI  L R RH+N++ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
                  +   ++    +ET ++K    + +    I      I + L Y+H +    ++H
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 153
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
           RD+KPSN+LL+   +  + DFGLAR+ +    H    T+   T  Y APE     +   K
Sbjct: 154 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 213
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
           + D++S G +L E++S      GK  LD
Sbjct: 214 SIDIWSVGCILAEMLSNRPIFPGKHYLD 241

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
           IG G +G    A + +    VA+KK+S    Q   Q+   EI  L R RH+N++ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
                  +   ++    +ET ++K    + +    I      I + L Y+H +    ++H
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 144
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
           RD+KPSN+LL+   +  + DFGLAR+ +    H    T+   T  Y APE     +   K
Sbjct: 145 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 204
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
           + D++S G +L E++S      GK  LD
Sbjct: 205 SIDIWSVGCILAEMLSNRPIFPGKHYLD 232

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
           IG G +G    A + +    VA+KK+S    Q   Q+   EI  L R RH+N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
                  +   ++    +ET ++K    + +    I      I + L Y+H +    ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 151
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
           RD+KPSN+LL+   +  + DFGLAR+ +    H    T+   T  Y APE     +   K
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
           + D++S G +L E++S      GK  LD
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGKHYLD 239

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
           IG G +G    A + +    VA+KK+S    Q   Q+   EI  L R RH+N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
                  +   ++    +ET ++K    + +    I      I + L Y+H +    ++H
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 145
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
           RD+KPSN+LL+   +  + DFGLAR+ +    H    T+   T  Y APE     +   K
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 205
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
           + D++S G +L E++S      GK  LD
Sbjct: 206 SIDIWSVGCILAEMLSNRPIFPGKHYLD 233

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 22/205 (10%)
Query: 781 NLIGTGGFGSTYKAELVPGYLVAVKK-LSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGY 839
            +IG G FG  ++A+LV    VA+KK L   RF+     + E+  +  ++H N+V L  +
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFK-----NRELQIMRIVKHPNVVDLKAF 100
Query: 840 YVG----EAEMFL--VYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI-DIAQALAYLHYS 892
           +      + E+FL  V  ++         H    K+    ++ K+ +  + ++LAY+H  
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI 160
Query: 893 CVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVSETHATTDVAGTFGYVAPE--YA 949
               I HRDIKP N+LLD       L DFG A++L   E + +  +   + Y APE  + 
Sbjct: 161 G---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSX-ICSRY-YRAPELIFG 215
Query: 950 TTCRVSDKADVYSFGVVLLELISGK 974
            T   ++  D++S G V+ EL+ G+
Sbjct: 216 ATNYTTN-IDIWSTGCVMAELMQGQ 239

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
           IG G +G    A + +    VA+KK+S    Q   Q+   EI  L R RH+N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
                  +   ++    +ET ++K    + +    I      I + L Y+H +    ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSA---NVLH 151
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
           RD+KPSN+LL+   +  + DFGLAR+ +    H    T+   T  Y APE     +   K
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
           + D++S G +L E++S      GK  LD
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGKHYLD 239

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 105/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +          +++LV   L G +L   +   K +   +Q+ +       I + L Y+H
Sbjct: 89  VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 142
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
            +    I+HRD+KPSN+ ++E+    + D GLAR       H   ++ G   T  Y APE
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDAGLAR-------HTDDEMTGYVATRWYRAPE 192
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                   +   D++S G ++ EL++G R+L P
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 224

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 24/229 (10%)
Query: 750 LRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSI 809
            R + +  + DT  EL        +G F++         G  Y A+ +        +  +
Sbjct: 4   FRQENVDDYYDTGEEL-------GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV 56
Query: 810 GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK 869
            R    +  + E+  L  I+H N++TL   Y  + ++ L+   ++GG L  F+ +K    
Sbjct: 57  SR----EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--- 109
Query: 870 IQWSVIHKIAID-IAQALAYLHYSCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLAR 924
              S+  + A + + Q L  ++Y    +I H D+KP NI LLD  +      + DFGLA 
Sbjct: 110 ---SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 925 LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
            ++    +   ++ GT  +VAPE      +  +AD++S GV+   L+SG
Sbjct: 167 KIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 105/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +          +++LV   L G +L   +   K +   +Q+ +       I + L Y+H
Sbjct: 89  VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 142
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
            +    I+HRD+KPSN+ ++E+    +  FGLAR       H   ++ G   T  Y APE
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILGFGLAR-------HTDDEMTGYVATRWYRAPE 192
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                   +   D++S G ++ EL++G R+L P
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 224

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
           IG G +G    A + +    VA+KK+S    Q   Q+   EI  L R RH+N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
                  +   ++    +ET ++K    + +    I      I + L Y+H +    ++H
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 145
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
           RD+KPSN+LL+   +  + DFGLAR+ +    H    T+   T  Y APE     +   K
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 205
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
           + D++S G +L E++S      GK  LD
Sbjct: 206 SIDIWSVGCILAEMLSNRPIFPGKHYLD 233

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 24/229 (10%)
Query: 750 LRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSI 809
            R + +  + DT  EL        +G F++         G  Y A+ +        +  +
Sbjct: 4   FRQENVDDYYDTGEEL-------GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV 56
Query: 810 GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK 869
            R    +  + E+  L  I+H N++TL   Y  + ++ L+   ++GG L  F+ +K    
Sbjct: 57  SR----EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--- 109
Query: 870 IQWSVIHKIAID-IAQALAYLHYSCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLAR 924
              S+  + A + + Q L  ++Y    +I H D+KP NI LLD  +      + DFGLA 
Sbjct: 110 ---SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 925 LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
            ++    +   ++ GT  +VAPE      +  +AD++S GV+   L+SG
Sbjct: 167 KIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-----PGYL-VAVKKL-SIGRFQGIQQFDAEIGTLGRI 828
           N ++   +G G FG  Y+ ++      P  L VAVK L  +   Q    F  E   + + 
Sbjct: 58  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 117
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS------VIHKIAIDI 882
            H+N+V  IG  +     F++   ++GG+L++F+ +   +  Q S      ++H +A DI
Sbjct: 118 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDI 176
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSETHATTDVAG 939
           A    YL  +     +HRDI   N LL        A + DFG+AR +  +  +     A 
Sbjct: 177 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 233
Query: 940 -TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
               ++ PE       + K D +SFGV+L E+ S
Sbjct: 234 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 116/290 (40%), Gaps = 48/290 (16%)
Query: 776  NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQF--DAEIGTLGRIRHKNL 833
            N  +  LIG G +G+ YK  L     VAVK  S   F   Q F  +  I  +  + H N+
Sbjct: 14   NLKLLELIGRGRYGAVYKGSL-DERPVAVKVFS---FANRQNFINEKNIYRVPLMEHDNI 69
Query: 834  VTLIG-----YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
               I         G  E  LV  +   G+L  ++   +     W    ++A  + + LAY
Sbjct: 70   ARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS---DWVSSCRLAHSVTRGLAY 126
Query: 889  LHYSC------VPRIVHRDIKPSNILLDEELNAYLSDFGLA------RLLEV-SETHATT 935
            LH          P I HRD+   N+L+  +    +SDFGL+      RL+    E +A  
Sbjct: 127  LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186
Query: 936  DVAGTFGYVAPEY---ATTCRVSDKA----DVYSFGVVLLELISGKRSLDP--SFSEYGN 986
               GT  Y+APE    A   R  + A    D+Y+ G++  E+      L P  S  EY  
Sbjct: 187  SEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM 246
Query: 987  GFN-------IVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLAST 1029
             F             ++L+   +    F PE W    +EN L +  L  T
Sbjct: 247  AFQTEVGNHPTFEDMQVLVSREKQRPKF-PEAW----KENSLAVRSLKET 291

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 105/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +          +++LV   L G +L   +   K +   +Q+ +       I + L Y+H
Sbjct: 89  VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 142
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
            +    I+HRD+KPSN+ ++E+    + D GLAR       H   ++ G   T  Y APE
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDRGLAR-------HTDDEMTGYVATRWYRAPE 192
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                   +   D++S G ++ EL++G R+L P
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 224

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 37/222 (16%)
Query: 783 IGTGGFGSTYKAELVPGYL-------VAVKKLSIGRFQGIQ-QFDAEIGTLGRIRHKNLV 834
           IG G FG  ++A   PG L       VAVK L       +Q  F  E   +    + N+V
Sbjct: 55  IGEGAFGRVFQAR-APGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHK----------------- 877
            L+G       M L++ +++ G+L  F+   S   +  S+ H                  
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTV-CSLSHSDLSTRARVSSPGPPPLS 172
Query: 878 ------IAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET 931
                 IA  +A  +AYL      + VHRD+   N L+ E +   ++DFGL+R +  ++ 
Sbjct: 173 CAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 932 H-ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
           + A  + A    ++ PE     R + ++DV+++GVVL E+ S
Sbjct: 230 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 24/229 (10%)
Query: 750 LRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSI 809
            R + +  + DT  EL        +G F++         G  Y A+ +        +  +
Sbjct: 4   FRQENVDDYYDTGEEL-------GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV 56
Query: 810 GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK 869
            R    +  + E+  L  I+H N++TL   Y  + ++ L+   ++GG L  F+ +K    
Sbjct: 57  SR----EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--- 109
Query: 870 IQWSVIHKIAID-IAQALAYLHYSCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLAR 924
              S+  + A + + Q L  ++Y    +I H D+KP NI LLD  +      + DFGLA 
Sbjct: 110 ---SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 925 LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
            ++    +   ++ GT  +VAPE      +  +AD++S GV+   L+SG
Sbjct: 167 KIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFD-AEIGTLGRIRHKNLVTLIGYY 840
           IG G +G    A + +    VA+KK+S    Q   Q    EI  L R RH+N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
                  +   ++    +ET ++K    + +    I      I + L Y+H + V   +H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV---LH 151
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
           RD+KPSN+LL+   +  + DFGLAR+ +    H    T+   T  Y APE     +   K
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
           + D++S G +L E++S      GK  LD
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGKHYLD 239

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 24/229 (10%)
Query: 750 LRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSI 809
            R + +  + DT  EL        +G F++         G  Y A+ +        +  +
Sbjct: 4   FRQENVDDYYDTGEEL-------GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV 56
Query: 810 GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK 869
            R    +  + E+  L  I+H N++TL   Y  + ++ L+   ++GG L  F+ +K    
Sbjct: 57  SR----EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--- 109
Query: 870 IQWSVIHKIAID-IAQALAYLHYSCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLAR 924
              S+  + A + + Q L  ++Y    +I H D+KP NI LLD  +      + DFGLA 
Sbjct: 110 ---SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 925 LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
            ++    +   ++ GT  +VAPE      +  +AD++S GV+   L+SG
Sbjct: 167 KIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
           IG G +G    A + +    VA+KK+S    Q   Q+   EI  L R RH+N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
                  +   ++    +ET ++K    + +    I      I + L Y+H +    ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 151
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
           RD+KPSN+LL+   +  + DFGLAR+ +    H    T+   T  Y APE     +   K
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
           + D++S G +L E++S      GK  LD
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGKHYLD 239

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-----PGYL-VAVKKL-SIGRFQGIQQFDAEIGTLGRI 828
           N ++   +G G FG  Y+ ++      P  L VAVK L  +   Q    F  E   + + 
Sbjct: 49  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 108
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS------VIHKIAIDI 882
            H+N+V  IG  +     F++   ++GG+L++F+ +   +  Q S      ++H +A DI
Sbjct: 109 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDI 167
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSETHATTDVAG 939
           A    YL  +     +HRDI   N LL        A + DFG+AR +  +  +     A 
Sbjct: 168 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 224
Query: 940 -TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
               ++ PE       + K D +SFGV+L E+ S
Sbjct: 225 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 99/229 (43%), Gaps = 33/229 (14%)
Query: 771 VRATGNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIR 829
           +R   +F    ++G G FG   KA   +     A+KK+     + +    +E+  L  + 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLN 60
Query: 830 HKNLVTLIGYYV-------------GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH 876
           H+ +V     ++              ++ +F+   +     L   IH ++  + Q     
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQ-QRDEYW 119
Query: 877 KIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS------- 929
           ++   I +AL+Y+H      I+HRD+KP NI +DE  N  + DFGLA+ +  S       
Sbjct: 120 RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 930 ------ETHATTDVAGTFGYVAPEYAT-TCRVSDKADVYSFGVVLLELI 971
                  +   T   GT  YVA E    T   ++K D+YS G++  E+I
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 96/195 (49%), Gaps = 9/195 (4%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQ-QFDAEIGTLGRIRHKNLVTLIGYY 840
           +G G + + YK +  +   LVA+K++ +   +G       E+  L  ++H N+VTL    
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
             E  + LV+ +L   +L+ ++    G  I    +H + + + Q L  L Y    +++HR
Sbjct: 70  HTEKSLTLVFEYLDK-DLKQYL-DDCGNIIN---MHNVKLFLFQLLRGLAYCHRQKVLHR 124
Query: 901 DIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT-TCRVSDKAD 959
           D+KP N+L++E     L+DFGLAR   +       +V  T  Y  P+    +   S + D
Sbjct: 125 DLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLGSTDYSTQID 183
Query: 960 VYSFGVVLLELISGK 974
           ++  G +  E+ +G+
Sbjct: 184 MWGVGCIFYEMATGR 198

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-----PGYL-VAVKKL-SIGRFQGIQQFDAEIGTLGRI 828
           N ++   +G G FG  Y+ ++      P  L VAVK L  +   Q    F  E   + + 
Sbjct: 72  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 131
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS------VIHKIAIDI 882
            H+N+V  IG  +     F++   ++GG+L++F+ +   +  Q S      ++H +A DI
Sbjct: 132 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDI 190
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSETHATTDVAG 939
           A    YL  +     +HRDI   N LL        A + DFG+AR +  +  +     A 
Sbjct: 191 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247
Query: 940 -TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
               ++ PE       + K D +SFGV+L E+ S
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-----PGYL-VAVKKL-SIGRFQGIQQFDAEIGTLGRI 828
           N ++   +G G FG  Y+ ++      P  L VAVK L  +   Q    F  E   + + 
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKF 105
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS------VIHKIAIDI 882
            H+N+V  IG  +     F++   ++GG+L++F+ +   +  Q S      ++H +A DI
Sbjct: 106 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDI 164
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSETHATTDVAG 939
           A    YL  +     +HRDI   N LL        A + DFG+AR +  +  +     A 
Sbjct: 165 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 221
Query: 940 -TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
               ++ PE       + K D +SFGV+L E+ S
Sbjct: 222 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 24/229 (10%)
Query: 750 LRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSI 809
            R + +  + DT  EL        +G F++         G  Y A+ +        +  +
Sbjct: 4   FRQENVDDYYDTGEEL-------GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV 56
Query: 810 GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK 869
            R    +  + E+  L  I+H N++TL   Y  + ++ L+   ++GG L  F+ +K    
Sbjct: 57  SR----EDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKE--- 109
Query: 870 IQWSVIHKIAID-IAQALAYLHYSCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLAR 924
              S+  + A + + Q L  ++Y    +I H D+KP NI LLD  +      + DFGLA 
Sbjct: 110 ---SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 925 LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
            ++    +   ++ GT  +VAPE      +  +AD++S GV+   L+SG
Sbjct: 167 KIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 105/213 (49%), Gaps = 34/213 (15%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKNLVTLIG 838
           +G+G +GS   A +   G  VAVKKLS   FQ I   ++   E+  L  ++H+N++ L+ 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 839 YYVGEA------EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +          +++LV   L G +L   +   K +   +Q+ +       I + L Y+H
Sbjct: 89  VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 142
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---TFGYVAPE 947
            +    I+HRD+KPSN+ ++E+    + D GLAR       H   ++ G   T  Y APE
Sbjct: 143 SA---DIIHRDLKPSNLAVNEDCELKILDGGLAR-------HTDDEMTGYVATRWYRAPE 192
Query: 948 YATT-CRVSDKADVYSFGVVLLELISGKRSLDP 979
                   +   D++S G ++ EL++G R+L P
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFP 224

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 59/200 (29%), Positives = 97/200 (48%), Gaps = 19/200 (9%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIG---RFQGIQQFDAE-IGTLGRIRHK----NLV 834
           +G G FGS  +      Y +  K++ +      QG ++ D E +    +I H+     +V
Sbjct: 18  LGCGNFGSVRQGV----YRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
            LIG    EA M LV     GG L  F+  K  ++I  S + ++   ++  + YL     
Sbjct: 74  RLIGVCQAEALM-LVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK-- 129
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF--GYVAPEYATTC 952
              VHRD+   N+LL     A +SDFGL++ L   +++ T   AG +   + APE     
Sbjct: 130 -NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 188
Query: 953 RVSDKADVYSFGVVLLELIS 972
           + S ++DV+S+GV + E +S
Sbjct: 189 KFSSRSDVWSYGVTMWEALS 208

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
           IG G +G    A + +    VA++K+S    Q   Q+   EI  L R RH+N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
                  +   ++    +ET ++K    + +    I      I + L Y+H +    ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 151
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
           RD+KPSN+LL+   +  + DFGLAR+ +    H    T+   T  Y APE     +   K
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
           + D++S G +L E++S      GK  LD
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGKHYLD 239

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 67/268 (25%), Positives = 119/268 (44%), Gaps = 40/268 (14%)
Query: 783  IGTGGFGSTYKAELV--------PGYLVAVKKLSI-GRFQGIQQFDAEIGTLGRI-RHKN 832
            +G G FG    AE V            VAVK L      + +    +E+  +  I +HKN
Sbjct: 43   LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 833  LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS----------VIHKIAIDI 882
            ++TL+G    +  ++++  + S GNL  ++  +    +++S          +  K  +  
Sbjct: 103  IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 883  AQALAY-LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGT 940
               LA  + Y    + +HRD+   N+L+ E     ++DFGLAR +  +     TT+    
Sbjct: 163  TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 941  FGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE 1000
              ++APE       + ++DV+SFGV++ E+ +   S  P       G  +    KLL KE
Sbjct: 223  VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP-------GIPVEELFKLL-KE 274
Query: 1001 GR--------SSELF--LPELWEAGPQE 1018
            G         ++EL+  + + W A P +
Sbjct: 275  GHRMDKPANCTNELYMMMRDCWHAVPSQ 302

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 90/195 (46%), Gaps = 9/195 (4%)
Query: 782 LIGTGGFGSTYK-AELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYY 840
           ++G G FG  +K  E   G  +A K +     +  ++   EI  + ++ H NL+ L   +
Sbjct: 96  ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF 155
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHR 900
             + ++ LV  ++ GG L   I  +S    +   I  +   I + + ++H      I+H 
Sbjct: 156 ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMK-QICEGIRHMHQMY---ILHL 211
Query: 901 DIKPSNILL--DEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           D+KP NIL    +     + DFGLAR  +  E        GT  ++APE      VS   
Sbjct: 212 DLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN--FGTPEFLAPEVVNYDFVSFPT 269
Query: 959 DVYSFGVVLLELISG 973
           D++S GV+   L+SG
Sbjct: 270 DMWSVGVIAYMLLSG 284

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 14/205 (6%)
Query: 782 LIGTGGFGSTYK------AELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
            +G GGF   ++       E+  G +V  K L +   Q  ++   EI     + H+++V 
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVP-KSLLLKPHQR-EKMSMEISIHRSLAHQHVVG 103
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
             G++     +F+V       +L   +HK+     +    + +   I     YLH +   
Sbjct: 104 FHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR-QIVLGCQYLHRN--- 158
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVS 955
           R++HRD+K  N+ L+E+L   + DFGLA  +E         + GT  Y+APE  +    S
Sbjct: 159 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHS 217
Query: 956 DKADVYSFGVVLLELISGKRSLDPS 980
            + DV+S G ++  L+ GK   + S
Sbjct: 218 FEVDVWSIGCIMYTLLVGKPPFETS 242

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 14/205 (6%)
Query: 782 LIGTGGFGSTYK------AELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
            +G GGF   ++       E+  G +V  K L +   Q  ++   EI     + H+++V 
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVP-KSLLLKPHQR-EKMSMEISIHRSLAHQHVVG 105
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
             G++     +F+V       +L   +HK+     +    + +   I     YLH +   
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR-QIVLGCQYLHRN--- 160
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVS 955
           R++HRD+K  N+ L+E+L   + DFGLA  +E         + GT  Y+APE  +    S
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHS 219
Query: 956 DKADVYSFGVVLLELISGKRSLDPS 980
            + DV+S G ++  L+ GK   + S
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPPFETS 244

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 774 TGNFSIRNLIGTGGFGSTYKAELVP------GYLVAVKKLSIGRFQGIQQFDAEIGTLGR 827
           T  + +   +G G F    +   +P        ++  KKLS    Q +++ +A I  L  
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLER-EARICRL-- 59
Query: 828 IRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKIAIDIAQAL 886
           ++H N+V L      E   +LV++ ++GG L E  + ++   +   S        I Q L
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHC------IQQIL 113
Query: 887 AYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVS-ETHATTDVAGTFG 942
             +++  +  IVHRD+KP N+LL  +       L+DFGLA  +EV  +  A    AGT G
Sbjct: 114 ESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPG 171
Query: 943 YVAPEYATTCRVSDKADVYSFGVVLLELISG 973
           Y++PE           D+++ GV+L  L+ G
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 24/229 (10%)
Query: 750 LRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSI 809
            R + +  + DT  EL        +G F++         G  Y A+ +        +  +
Sbjct: 4   FRQENVDDYYDTGEEL-------GSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGV 56
Query: 810 GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK 869
            R    +  + E+  L  I+H N++TL   Y  + ++ L+   ++GG L  F+ +K    
Sbjct: 57  SR----EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--- 109
Query: 870 IQWSVIHKIAID-IAQALAYLHYSCVPRIVHRDIKPSNI-LLDEEL---NAYLSDFGLAR 924
              S+  + A + + Q L  ++Y    +I H D+KP NI LLD  +      + DFGLA 
Sbjct: 110 ---SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 925 LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
            ++    +   ++ GT  +VAPE      +  +AD++S GV+   L+SG
Sbjct: 167 KIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 119/284 (41%), Gaps = 38/284 (13%)
Query: 772  RATGNFSIRNLIGTGGFGSTYK------AELVPGYLVAVKKLSIGRFQGIQQFDAEIGTL 825
            R    +     +G GGF   Y+       E+  G +V  K + +   Q  ++   EI   
Sbjct: 39   RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVP-KSMLLKPHQK-EKMSTEIAIH 96
Query: 826  GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
              + + ++V   G++  +  +++V       +L   +HK+  K +             Q 
Sbjct: 97   KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRR-KAVTEPEARYFMRQTIQG 154
Query: 886  LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
            + YLH +   R++HRD+K  N+ L+++++  + DFGLA  +E       T + GT  Y+A
Sbjct: 155  VQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT-LCGTPNYIA 210
Query: 946  PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSF----------SEYGNGFNIVSWAK 995
            PE       S + D++S G +L  L+ GK   + S           +EY    +I   A 
Sbjct: 211  PEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVAS 270
Query: 996  LLIK---------EGRSSELFLPELWEAGPQENLLGMMRLASTC 1030
             LI+             +EL   E + +G        MRL ++C
Sbjct: 271  ALIRRMLHADPTLRPSVAELLTDEFFTSG-----YAPMRLPTSC 309

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 774 TGNFSIRNLIGTGGFGSTYKAELVP------GYLVAVKKLSIGRFQGIQQFDAEIGTLGR 827
           T  + +   +G G F    +   +P        ++  KKLS    Q +++ +A I  L  
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLER-EARICRL-- 59
Query: 828 IRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKIAIDIAQAL 886
           ++H N+V L      E   +LV++ ++GG L E  + ++   +   S        I Q L
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHC------IQQIL 113
Query: 887 AYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVS-ETHATTDVAGTFG 942
             +++  +  IVHRD+KP N+LL  +       L+DFGLA  +EV  +  A    AGT G
Sbjct: 114 ESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPG 171
Query: 943 YVAPEYATTCRVSDKADVYSFGVVLLELISG 973
           Y++PE           D+++ GV+L  L+ G
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 107/222 (48%), Gaps = 40/222 (18%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIR-HKNLVTLI 837
           +G G +G  +K+ +   G +VAVKK+    FQ     Q+   EI  L  +  H+N+V L+
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKI-FDAFQNSTDAQRTFREIMILTELSGHENIVNLL 75
Query: 838 GYYVGE--AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHK--IAIDIAQALAYLHYSC 893
                +   +++LV++++     ET +H      I    +HK  +   + + + YLH   
Sbjct: 76  NVLRADNDRDVYLVFDYM-----ETDLHAVIRANI-LEPVHKQYVVYQLIKVIKYLHSGG 129
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARL------------LEVSETHAT------- 934
              ++HRD+KPSNILL+ E +  ++DFGL+R             L ++E           
Sbjct: 130 ---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 935 -TDVAGTFGYVAPEYAT-TCRVSDKADVYSFGVVLLELISGK 974
            TD   T  Y APE    + + +   D++S G +L E++ GK
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
           IG G +G    A + V    VA+KK+S    Q   Q+   EI  L   RH+N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
                  +   ++    +ET ++K    + +    I      I + L Y+H +    ++H
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 149
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
           RD+KPSN+LL+   +  + DFGLAR+ +    H    T+   T  Y APE     +   K
Sbjct: 150 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 209
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
           + D++S G +L E++S      GK  LD
Sbjct: 210 SIDIWSVGCILAEMLSNRPIFPGKHYLD 237

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 97/212 (45%), Gaps = 22/212 (10%)
Query: 783 IGTGGFGSTYKAELV--------PGYLVAVKKLSI-GRFQGIQQFDAEIGTLGRI-RHKN 832
           +G G FG    AE V            VAVK L      + +    +E+  +  I +HKN
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS----------VIHKIAIDI 882
           ++ L+G    +  ++++  + S GNL  ++  +    +++S          +  K  +  
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 883 AQALAY-LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL-EVSETHATTDVAGT 940
              LA  + Y    + +HRD+   N+L+ E     ++DFGLAR +  +     TT+    
Sbjct: 209 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 268
Query: 941 FGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
             ++APE       + ++DV+SFGV++ E+ +
Sbjct: 269 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-----PGYL-VAVKKL-SIGRFQGIQQFDAEIGTLGRI 828
           N ++   +G G FG  Y+ ++      P  L VAVK L  +   Q    F  E   + + 
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 91
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS------VIHKIAIDI 882
            H+N+V  IG  +     F++   ++GG+L++F+ +   +  Q S      ++H +A DI
Sbjct: 92  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDI 150
Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSETHATTDVAG 939
           A    YL  +     +HRDI   N LL        A + DFG+A+ +  +  +     A 
Sbjct: 151 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAM 207
Query: 940 -TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
               ++ PE       + K D +SFGV+L E+ S
Sbjct: 208 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 82/282 (29%), Positives = 121/282 (42%), Gaps = 40/282 (14%)
Query: 779  IRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQ---FDAEIGTLGRIRH 830
            IR+L G G FG        P     G +VAVK L      G Q    +  EI  L  + H
Sbjct: 36   IRDL-GEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTLYH 92
Query: 831  KNLVTLIGYY--VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
            ++++   G     G A + LV  ++  G+L  ++ + S   I  + +   A  I + +AY
Sbjct: 93   EHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAY 149
Query: 889  LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDV-----AGTFGY 943
            LH       +HRD+   N+LLD +    + DFGLA+   V E H    V     +  F Y
Sbjct: 150  LH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAK--AVPEGHEXYRVREDGDSPVFWY 204
Query: 944  VAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRS 1003
             APE     +    +DV+SFGV L EL++     D S S       ++      I +G+ 
Sbjct: 205  -APECLKEYKFYYASDVWSFGVTLYELLT---HCDSSQSPPTKFLELIG-----IAQGQM 255
Query: 1004 SELFLPELWEAG-----PQENLLGMMRLASTCTVETLSTRPS 1040
            + L L EL E G     P +    +  L   C     S RP+
Sbjct: 256  TVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPT 297

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 98/201 (48%), Gaps = 10/201 (4%)
Query: 783 IGTGGFGSTYKAELVPGY-LVAVKKLSIGRF-QGIQQFD-AEIGTLGRIRHKNLVTLIGY 839
           IG G +G+ +KA+    + +VA+K++ +    +G+      EI  L  ++HKN+V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 840 YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
              + ++ LV+ F    +L+ +    +G  +   ++      + + L + H      ++H
Sbjct: 70  LHSDKKLTLVFEF-CDQDLKKYFDSCNGD-LDPEIVKSFLFQLLKGLGFCHSR---NVLH 124
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV-SDKA 958
           RD+KP N+L++      L+DFGLAR   +     + +V  T  Y  P+     ++ S   
Sbjct: 125 RDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTSI 183
Query: 959 DVYSFGVVLLELISGKRSLDP 979
           D++S G +  EL +  R L P
Sbjct: 184 DMWSAGCIFAELANAARPLFP 204

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 14/205 (6%)
Query: 782 LIGTGGFGSTYK------AELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
            +G GGF   ++       E+  G +V  K L +   Q  ++   EI     + H+++V 
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVP-KSLLLKPHQR-EKMSMEISIHRSLAHQHVVG 79
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
             G++     +F+V       +L   +HK+     +    + +   I     YLH +   
Sbjct: 80  FHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLR-QIVLGCQYLHRN--- 134
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVS 955
           R++HRD+K  N+ L+E+L   + DFGLA  +E         + GT  Y+APE  +    S
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHS 193
Query: 956 DKADVYSFGVVLLELISGKRSLDPS 980
            + DV+S G ++  L+ GK   + S
Sbjct: 194 FEVDVWSIGCIMYTLLVGKPPFETS 218

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 99/203 (48%), Gaps = 19/203 (9%)
Query: 775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
           G FS+         G  Y A+++       KKLS    Q +++ +A I  L  ++H N+V
Sbjct: 33  GAFSVVRRCVKVLAGQEYAAKII-----NTKKLSARDHQKLER-EARICRL--LKHPNIV 84
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
            L      E   +L+++ ++GG L E  + ++   +   S  H I   I +A+ + H   
Sbjct: 85  RLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS--HCIQ-QILEAVLHCHQMG 141
Query: 894 VPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
           V   VHRD+KP N+LL  +L      L+DFGLA  +E  E  A    AGT GY++PE   
Sbjct: 142 V---VHRDLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWFGFAGTPGYLSPEVLR 197
Query: 951 TCRVSDKADVYSFGVVLLELISG 973
                   D+++ GV+L  L+ G
Sbjct: 198 KDPYGKPVDLWACGVILYILLVG 220

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 20/212 (9%)
Query: 772 RATGNFSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSIGRFQGIQQFDAEIGTL 825
           R T  + +   +G G F    +   V         ++  KKLS    Q +++ +A I  L
Sbjct: 8   RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLER-EARICRL 66
Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKIAIDIAQ 884
             ++H N+V L      E   +L+++ ++GG L E  + ++   +   S  H I   I +
Sbjct: 67  --LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS--HCIQ-QILE 121
Query: 885 ALAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTF 941
           A+ + H   V   VHR++KP N+LL  +L      L+DFGLA  +E  E  A    AGT 
Sbjct: 122 AVLHCHQMGV---VHRNLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWFGFAGTP 177
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
           GY++PE           D+++ GV+L  L+ G
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 66/268 (24%), Positives = 118/268 (44%), Gaps = 40/268 (14%)
Query: 783  IGTGGFGSTYKAELV--------PGYLVAVKKLSI-GRFQGIQQFDAEIGTLGRI-RHKN 832
            +G G FG    AE V            VAVK L      + +    +E+  +  I +HKN
Sbjct: 43   LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 833  LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS----------VIHKIAIDI 882
            ++ L+G    +  ++++  + S GNL  ++  +    +++S          +  K  +  
Sbjct: 103  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 883  AQALAY-LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGT 940
               LA  + Y    + +HRD+   N+L+ E     ++DFGLAR +  +     TT+    
Sbjct: 163  TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLP 222
Query: 941  FGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE 1000
              ++APE       + ++DV+SFGV++ E+ +   S  P       G  +    KLL KE
Sbjct: 223  VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP-------GIPVEELFKLL-KE 274
Query: 1001 GR--------SSELF--LPELWEAGPQE 1018
            G         ++EL+  + + W A P +
Sbjct: 275  GHRMDKPANCTNELYMMMRDCWHAVPSQ 302

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/241 (23%), Positives = 105/241 (43%), Gaps = 30/241 (12%)
Query: 757 TFADTPAELTYDNVVR-ATGNFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQG 814
           TF D P +L Y+        N      +G G FG   +A     G   AV K+++   + 
Sbjct: 28  TFID-PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKS 86
Query: 815 IQQFDAEIGTLGRIR-------HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSG 867
               D +   +  ++       H+N+V L+G       + ++  +   G+L  F+ +K  
Sbjct: 87  TAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRP 146
Query: 868 KKIQWS---------------VIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEE 912
             +++S               ++H  +  +AQ +A+L        +HRD+   N+LL   
Sbjct: 147 PGLEYSYNPSHNPEEQLSSRDLLH-FSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNG 202
Query: 913 LNAYLSDFGLAR-LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELI 971
             A + DFGLAR ++  S      +      ++APE    C  + ++DV+S+G++L E+ 
Sbjct: 203 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 262
Query: 972 S 972
           S
Sbjct: 263 S 263

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 25/214 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQ-----FDAEIGTLGRIRH 830
           +F I  +IG G FG     +L     V   K+ + +++ +++     F  E   L     
Sbjct: 75  DFEILKVIGRGAFGEVAVVKLKNADKVFAMKI-LNKWEMLKRAETACFREERDVLVNGDS 133
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQ-----WSVIHKIAIDIAQA 885
           K + TL   +  +  ++LV ++  GG+L T + K   +  +     +     IAID    
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ 193
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
           L Y         VHRDIKP NIL+D   +  L+DFG    L    T  ++   GT  Y++
Sbjct: 194 LHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 244
Query: 946 PEYATTC-----RVSDKADVYSFGVVLLELISGK 974
           PE          R   + D +S GV + E++ G+
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 101/226 (44%), Gaps = 29/226 (12%)
Query: 772 RATGNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSI-GRFQGIQQFDAEIGTLGRIR 829
           R   +F     +G GGFG  ++A+  V     A+K++ +  R    ++   E+  L ++ 
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 830 HKNLVTLIGYYVGE------------AEMFLVYNFLSGGNLETFIHKKSG-KKIQWSVIH 876
           H  +V     ++ +              +++        NL+ +++ +   ++ + SV  
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 877 KIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT-- 934
            I + IA+A+ +LH      ++HRD+KPSNI    +    + DFGL   ++  E   T  
Sbjct: 122 HIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 935 ---------TDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELI 971
                    T   GT  Y++PE       S K D++S G++L EL+
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
           IG G +G    A + +    VA+KK+S    Q   Q+   EI  L R RH+N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
                  +   ++    +ET ++K    + +    I      I + L Y+H +    ++H
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 151
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
           RD+KPSN+LL+   +  + DFGLAR+ +    H     +   T  Y APE     +   K
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTK 211
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
           + D++S G +L E++S      GK  LD
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGKHYLD 239

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
           IG G +G    A + +    VA+KK+S    Q   Q+   EI  L R RH+N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
                  +   ++    +ET ++K    + +    I      I + L Y+H +    ++H
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 152
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
           RD+KPSN+LL+   +  + DFGLAR+ +    H     +   T  Y APE     +   K
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTK 212
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
           + D++S G +L E++S      GK  LD
Sbjct: 213 SIDIWSVGCILAEMLSNRPIFPGKHYLD 240

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 77/157 (49%), Gaps = 13/157 (8%)
Query: 821 EIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKIA 879
           E+  L ++ H N++ L  ++  +   +LV     GG L +  I ++   ++  +VI K  
Sbjct: 71  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMK-- 128
Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYL---SDFGLARLLEVSETHATTD 936
             +     YLH      IVHRD+KP N+LL+ +    L    DFGL+   EV       +
Sbjct: 129 -QVLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG--GKMKE 182
Query: 937 VAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
             GT  Y+APE     +  +K DV+S GV+L  L+ G
Sbjct: 183 RLGTAYYIAPEVLRK-KYDEKCDVWSCGVILYILLCG 218

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 77/157 (49%), Gaps = 13/157 (8%)
Query: 821 EIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKIA 879
           E+  L ++ H N++ L  ++  +   +LV     GG L +  I ++   ++  +VI K  
Sbjct: 54  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMK-- 111
Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYL---SDFGLARLLEVSETHATTD 936
             +     YLH      IVHRD+KP N+LL+ +    L    DFGL+   EV       +
Sbjct: 112 -QVLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG--GKMKE 165
Query: 937 VAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
             GT  Y+APE     +  +K DV+S GV+L  L+ G
Sbjct: 166 RLGTAYYIAPEVLRK-KYDEKCDVWSCGVILYILLCG 201

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 55/199 (27%), Positives = 87/199 (43%), Gaps = 14/199 (7%)
Query: 783 IGTGGFGSTYKAEL-VPG---YLVAVKKLS---IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
           +G G FG   + E   P      VAVK L    + + + +  F  E+  +  + H+NL+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
           L G  V    M +V      G+L   + K  G  +    + + A+ +A+ + YL      
Sbjct: 76  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLESK--- 130
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAPEYATTCR 953
           R +HRD+   N+LL       + DFGL R L  ++ H          F + APE   T  
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRT 190
Query: 954 VSDKADVYSFGVVLLELIS 972
            S  +D + FGV L E+ +
Sbjct: 191 FSHASDTWMFGVTLWEMFT 209

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNLVTLIGYY 840
           IG G +G    A + V    VA+KK+S    Q   Q+   EI  L   RH+N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 841 VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
                  +   ++    +ET ++K    + +    I      I + L Y+H +    ++H
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVLH 149
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHA--TTDVAGTFGYVAPEYATTCRVSDK 957
           RD+KPSN+LL+   +  + DFGLAR+ +    H    T+   T  Y APE     +   K
Sbjct: 150 RDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 209
Query: 958 A-DVYSFGVVLLELIS------GKRSLD 978
           + D++S G +L E++S      GK  LD
Sbjct: 210 SIDIWSVGCILAEMLSNRPIFPGKHYLD 237

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 97/221 (43%), Gaps = 34/221 (15%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL---VAVKKL-SIGRFQGIQQFDAEIGTLGRI-RH 830
           +   +++IG G FG   KA +    L    A+K++         + F  E+  L ++  H
Sbjct: 16  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 75
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKK--------------SGKKIQWSVIH 876
            N++ L+G       ++L   +   GNL  F+ K               +   +    + 
Sbjct: 76  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 135
Query: 877 KIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD 936
             A D+A+ + YL      + +HRD+   NIL+ E   A ++DFGL+R  EV        
Sbjct: 136 HFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVY------- 185
Query: 937 VAGTFG-----YVAPEYATTCRVSDKADVYSFGVVLLELIS 972
           V  T G     ++A E       +  +DV+S+GV+L E++S
Sbjct: 186 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 97/221 (43%), Gaps = 34/221 (15%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL---VAVKKL-SIGRFQGIQQFDAEIGTLGRI-RH 830
           +   +++IG G FG   KA +    L    A+K++         + F  E+  L ++  H
Sbjct: 26  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 85
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKK--------------SGKKIQWSVIH 876
            N++ L+G       ++L   +   GNL  F+ K               +   +    + 
Sbjct: 86  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145
Query: 877 KIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD 936
             A D+A+ + YL      + +HRD+   NIL+ E   A ++DFGL+R  EV        
Sbjct: 146 HFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVY------- 195
Query: 937 VAGTFG-----YVAPEYATTCRVSDKADVYSFGVVLLELIS 972
           V  T G     ++A E       +  +DV+S+GV+L E++S
Sbjct: 196 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 21/209 (10%)
Query: 781 NLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIR-HKNLVTLIG 838
            L+G G +     A  L  G   AVK +         +   E+ TL + + +KN++ LI 
Sbjct: 19  ELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIE 78
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
           ++  +   +LV+  L GG++   I K+  K        ++  D+A AL +LH      I 
Sbjct: 79  FFEDDTRFYLVFEKLQGGSILAHIQKQ--KHFNEREASRVVRDVAAALDFLH---TKGIA 133
Query: 899 HRDIKPSNILLD--EELN-AYLSDFGLARLLEVSE------THATTDVAGTFGYVAPE-- 947
           HRD+KP NIL +  E+++   + DF L   ++++       T   T   G+  Y+APE  
Sbjct: 134 HRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVV 193
Query: 948 --YATTCRVSDK-ADVYSFGVVLLELISG 973
             +       DK  D++S GVVL  ++SG
Sbjct: 194 EVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 66/268 (24%), Positives = 118/268 (44%), Gaps = 40/268 (14%)
Query: 783  IGTGGFGSTYKAELV--------PGYLVAVKKLSI-GRFQGIQQFDAEIGTLGRI-RHKN 832
            +G G FG    AE V            VAVK L      + +    +E+  +  I +HKN
Sbjct: 43   LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 833  LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS----------VIHKIAIDI 882
            ++ L+G    +  ++++  + S GNL  ++  +    +++S          +  K  +  
Sbjct: 103  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 883  AQALAY-LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGT 940
               LA  + Y    + +HRD+   N+L+ E     ++DFGLAR +  +     TT+    
Sbjct: 163  TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 941  FGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE 1000
              ++APE       + ++DV+SFGV++ E+ +   S  P       G  +    KLL KE
Sbjct: 223  VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP-------GIPVEELFKLL-KE 274
Query: 1001 GR--------SSELF--LPELWEAGPQE 1018
            G         ++EL+  + + W A P +
Sbjct: 275  GHRMDKPANCTNELYMMMRDCWHAVPSQ 302

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 55/199 (27%), Positives = 87/199 (43%), Gaps = 14/199 (7%)
Query: 783 IGTGGFGSTYKAEL-VPG---YLVAVKKLS---IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
           +G G FG   + E   P      VAVK L    + + + +  F  E+  +  + H+NL+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
           L G  V    M +V      G+L   + K  G  +    + + A+ +A+ + YL      
Sbjct: 76  LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFL-LGTLSRYAVQVAEGMGYLESK--- 130
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT--FGYVAPEYATTCR 953
           R +HRD+   N+LL       + DFGL R L  ++ H          F + APE   T  
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190
Query: 954 VSDKADVYSFGVVLLELIS 972
            S  +D + FGV L E+ +
Sbjct: 191 FSHASDTWMFGVTLWEMFT 209

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 66/268 (24%), Positives = 118/268 (44%), Gaps = 40/268 (14%)
Query: 783  IGTGGFGSTYKAELV--------PGYLVAVKKLSI-GRFQGIQQFDAEIGTLGRI-RHKN 832
            +G G FG    AE V            VAVK L      + +    +E+  +  I +HKN
Sbjct: 43   LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 833  LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS----------VIHKIAIDI 882
            ++ L+G    +  ++++  + S GNL  ++  +    +++S          +  K  +  
Sbjct: 103  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 883  AQALAY-LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGT 940
               LA  + Y    + +HRD+   N+L+ E     ++DFGLAR +  +     TT+    
Sbjct: 163  TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLP 222
Query: 941  FGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE 1000
              ++APE       + ++DV+SFGV++ E+ +   S  P       G  +    KLL KE
Sbjct: 223  VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP-------GIPVEELFKLL-KE 274
Query: 1001 GR--------SSELF--LPELWEAGPQE 1018
            G         ++EL+  + + W A P +
Sbjct: 275  GHRMDKPANCTNELYMMMRDCWHAVPSQ 302

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/284 (23%), Positives = 119/284 (41%), Gaps = 38/284 (13%)
Query: 772  RATGNFSIRNLIGTGGFGSTYK------AELVPGYLVAVKKLSIGRFQGIQQFDAEIGTL 825
            R    +     +G GGF   Y+       E+  G +V  K + +   Q  ++   EI   
Sbjct: 39   RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVP-KSMLLKPHQK-EKMSTEIAIH 96
Query: 826  GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
              + + ++V   G++  +  +++V       +L   +HK+  K +             Q 
Sbjct: 97   KSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRR-KAVTEPEARYFMRQTIQG 154
Query: 886  LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
            + YLH +   R++HRD+K  N+ L+++++  + DFGLA  +E  +      + GT  Y+A
Sbjct: 155  VQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEF-DGERKKXLCGTPNYIA 210
Query: 946  PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSF----------SEYGNGFNIVSWAK 995
            PE       S + D++S G +L  L+ GK   + S           +EY    +I   A 
Sbjct: 211  PEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVAS 270
Query: 996  LLIK---------EGRSSELFLPELWEAGPQENLLGMMRLASTC 1030
             LI+             +EL   E + +G        MRL ++C
Sbjct: 271  ALIRRMLHADPTLRPSVAELLTDEFFTSG-----YAPMRLPTSC 309

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 27/208 (12%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           IG G FG  ++ +   G  VAVK  S  R +     +AEI     +RH+N++  I     
Sbjct: 50  IGKGRFGEVWRGKW-RGEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAADNK 107
Query: 843 E----AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV---- 894
           +     +++LV ++   G+L  ++++ +   +    + K+A+  A  LA+LH   V    
Sbjct: 108 DNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQG 164
Query: 895 -PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVA-----GTFGYVAPEY 948
            P I HRD+K  NIL+ +     ++D GLA  +       T D+A     GT  Y+APE 
Sbjct: 165 KPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAPEV 222
Query: 949 ATTC------RVSDKADVYSFGVVLLEL 970
                         +AD+Y+ G+V  E+
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Composition-based stats.
 Identities = 66/268 (24%), Positives = 118/268 (44%), Gaps = 40/268 (14%)
Query: 783  IGTGGFGSTYKAELV--------PGYLVAVKKLSI-GRFQGIQQFDAEIGTLGRI-RHKN 832
            +G G FG    AE V            VAVK L      + +    +E+  +  I +HKN
Sbjct: 43   LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 833  LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS----------VIHKIAIDI 882
            ++ L+G    +  ++++  + S GNL  ++  +    +++S          +  K  +  
Sbjct: 103  IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 883  AQALAY-LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGT 940
               LA  + Y    + +HRD+   N+L+ E     ++DFGLAR +  +     TT+    
Sbjct: 163  TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 941  FGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE 1000
              ++APE       + ++DV+SFGV++ E+ +   S  P       G  +    KLL KE
Sbjct: 223  VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP-------GIPVEELFKLL-KE 274
Query: 1001 GR--------SSELF--LPELWEAGPQE 1018
            G         ++EL+  + + W A P +
Sbjct: 275  GHRMDKPANCTNELYMMMRDCWHAVPSQ 302

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 103/228 (45%), Gaps = 22/228 (9%)
Query: 766 TYDNVVRATGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKL--SIGRFQGIQQFDAEI 822
           ++D        + I   IG G +G    A   + G  VA+KK+  +       ++   E+
Sbjct: 46  SFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLREL 105
Query: 823 GTLGRIRHKNLVTL-------IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVI 875
             L   +H N++ +       + Y  GE +   V   L   +L   IH  S + +    +
Sbjct: 106 KILKHFKHDNIIAIKDILRPTVPY--GEFKSVYVVLDLMESDLHQIIH--SSQPLTLEHV 161
Query: 876 HKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS---ETH 932
                 + + L Y+H +   +++HRD+KPSN+L++E     + DFG+AR L  S     +
Sbjct: 162 RYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQY 218
Query: 933 ATTDVAGTFGYVAPEYATTCRVSDKA-DVYSFGVVLLELISGKRSLDP 979
             T+   T  Y APE   +     +A D++S G +  E+++ +R L P
Sbjct: 219 FMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA-RRQLFP 265

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 23/206 (11%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV- 841
           +G G +G  ++  L  G  VAVK  S  R +     + EI     +RH N++  I   + 
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFS-SRDEQSWFRETEIYNTVLLRHDNILGFIASDMT 73
Query: 842 ---GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV---- 894
                 +++L+ ++   G+L  F+ +++   ++  +  ++A+  A  LA+LH        
Sbjct: 74  SRNSSTQLWLITHYHEHGSLYDFLQRQT---LEPHLALRLAVSAACGLAHLHVEIFGTQG 130
Query: 895 -PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH---ATTDVAGTFGYVAPEY-- 948
            P I HRD K  N+L+   L   ++D GLA +      +         GT  Y+APE   
Sbjct: 131 KPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVLD 190
Query: 949 ---ATTCRVSDK-ADVYSFGVVLLEL 970
               T C  S K  D+++FG+VL E+
Sbjct: 191 EQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Composition-based stats.
 Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 22/211 (10%)
Query: 774 TGNFSIRNLIGTGGFGSTYK-AELVPGY-----LVAVKKLSIGRFQGIQQFDAEIGTLGR 827
           T  + +   IG G F    +  +L  G+     ++  KKLS    Q +++ +A I  L  
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLER-EARICRL-- 59
Query: 828 IRHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKIAIDIAQAL 886
           ++H N+V L      E   +LV++ ++GG L E  + ++   +   S  H I   I +A+
Sbjct: 60  LKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS--HCIQ-QILEAV 116
Query: 887 AYLHYSCVPRIVHRDIKPSNILLDEELNAY---LSDFGLARLLEVS-ETHATTDVAGTFG 942
            + H   V   VHRD+KP N+LL  +       L+DFGLA  +EV  +  A    AGT G
Sbjct: 117 LHCHQMGV---VHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPG 171
Query: 943 YVAPEYATTCRVSDKADVYSFGVVLLELISG 973
           Y++PE           D+++ GV+L  L+ G
Sbjct: 172 YLSPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 102/215 (47%), Gaps = 21/215 (9%)
Query: 781 NLIGTGGFGSTY----KAELVPGYLVAVK--KLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
            ++G G FGS      K E      VAVK  KL     + I++F +E   +    H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 835 TLIGYYV-----GEAEMFLVYNFLSGGNLETFI---HKKSG-KKIQWSVIHKIAIDIAQA 885
            L+G  +     G  +  ++  F+  G+L T++     ++G K I    + K  +DIA  
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT-FGYV 944
           + YL        +HRD+   N +L +++   ++DFGL++ +   + +    +A     ++
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGKRSLDP 979
           A E       + K+DV++FGV + E+ +  R + P
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIAT--RGMTP 249

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 101/236 (42%), Gaps = 22/236 (9%)
Query: 757 TFADTPAELTYDNVVR-ATGNFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQG 814
           TF D P +L Y+        N      +G G FG   +A     G   AV K+++   + 
Sbjct: 28  TFID-PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKS 86
Query: 815 IQQFDAEIGTLGRIR-------HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSG 867
               D +   +  ++       H+N+V L+G       + ++  +   G+L  F+ +KS 
Sbjct: 87  TAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKS- 145
Query: 868 KKIQWSVIHKIAIDIAQALAYLHYS----------CVPRIVHRDIKPSNILLDEELNAYL 917
           + ++      IA   A     LH+S               +HRD+   N+LL     A +
Sbjct: 146 RVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKI 205
Query: 918 SDFGLAR-LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
            DFGLAR ++  S      +      ++APE    C  + ++DV+S+G++L E+ S
Sbjct: 206 GDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 88/200 (44%), Gaps = 9/200 (4%)
Query: 777 FSIRNLIGTGGFGSTYK-AELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
           + I   +G+G FG  ++  E   G +   K ++            EI  + ++ H  L+ 
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
           L   +  + EM L+  FLSGG L   I  +  K  +  VI+ +     + L ++H     
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR-QACEGLKHMHEHS-- 169
Query: 896 RIVHRDIKPSNILLDEELNAYLS--DFGLARLLEVSETHATTDVAGTFGYVAPEYATTCR 953
            IVH DIKP NI+ + +  + +   DFGLA  L   E    T     F   APE      
Sbjct: 170 -IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFA--APEIVDREP 226
Query: 954 VSDKADVYSFGVVLLELISG 973
           V    D+++ GV+   L+SG
Sbjct: 227 VGFYTDMWAIGVLGYVLLSG 246

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/247 (22%), Positives = 104/247 (42%), Gaps = 35/247 (14%)
Query: 757 TFADTPAELTYDNVVR-ATGNFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQG 814
           TF D P +L Y+        N      +G G FG   +A     G   AV K+++   + 
Sbjct: 13  TFID-PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKS 71
Query: 815 IQQFDAEIGTLGRIR-------HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKS- 866
               D +   +  ++       H+N+V L+G       + ++  +   G+L  F+ +K+ 
Sbjct: 72  TAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAE 131
Query: 867 --------------------GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSN 906
                               G+ ++   +   +  +AQ +A+L        +HRD+   N
Sbjct: 132 AMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARN 188
Query: 907 ILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGV 965
           +LL     A + DFGLAR ++  S      +      ++APE    C  + ++DV+S+G+
Sbjct: 189 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 248
Query: 966 VLLELIS 972
           +L E+ S
Sbjct: 249 LLWEIFS 255

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 27/208 (12%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           IG G FG  ++ +   G  VAVK  S  R +     +AEI     +RH+N++  I     
Sbjct: 37  IGKGRFGEVWRGKW-RGEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAADNK 94
Query: 843 E----AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV---- 894
           +     +++LV ++   G+L  ++++ +   +    + K+A+  A  LA+LH   V    
Sbjct: 95  DNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQG 151
Query: 895 -PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVA-----GTFGYVAPEY 948
            P I HRD+K  NIL+ +     ++D GLA  +       T D+A     GT  Y+APE 
Sbjct: 152 KPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAPEV 209
Query: 949 ATTC------RVSDKADVYSFGVVLLEL 970
                         +AD+Y+ G+V  E+
Sbjct: 210 LDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 66/268 (24%), Positives = 118/268 (44%), Gaps = 40/268 (14%)
Query: 783  IGTGGFGSTYKAELV--------PGYLVAVKKLSI-GRFQGIQQFDAEIGTLGRI-RHKN 832
            +G G FG    AE V            VAVK L      + +    +E+  +  I +HKN
Sbjct: 43   LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 833  LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS----------VIHKIAIDI 882
            ++ L+G    +  ++++  + S GNL  ++  +    +++S          +  K  +  
Sbjct: 103  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 883  AQALAY-LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGT 940
               LA  + Y    + +HRD+   N+L+ E     ++DFGLAR +  +     TT+    
Sbjct: 163  TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLP 222
Query: 941  FGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE 1000
              ++APE       + ++DV+SFGV++ E+ +   S  P       G  +    KLL KE
Sbjct: 223  VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP-------GIPVEELFKLL-KE 274
Query: 1001 GR--------SSELF--LPELWEAGPQE 1018
            G         ++EL+  + + W A P +
Sbjct: 275  GHRMDKPANCTNELYMMMRDCWHAVPSQ 302

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 36/220 (16%)
Query: 783 IGTGGFGSTYKAE---LVP---GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTL 836
           +G G FG  + AE   L+P     LVAVK L        Q F  E   L  ++H+++V  
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 837 IGYYVGEAEMFLVYNFLSGGNLETFI--HKKSGK-----------KIQWSVIHKIAIDIA 883
            G       + +V+ ++  G+L  F+  H    K            +    +  +A  +A
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 884 QALAY---LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG- 939
             + Y   LH+      VHRD+   N L+ + L   + DFG++R +  ++ +    V G 
Sbjct: 146 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR---VGGR 196
Query: 940 ---TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKR 975
                 ++ PE     + + ++DV+SFGVVL E+ + GK+
Sbjct: 197 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ 236

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 36/220 (16%)
Query: 783 IGTGGFGSTYKAE---LVP---GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTL 836
           +G G FG  + AE   L+P     LVAVK L        Q F  E   L  ++H+++V  
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 837 IGYYVGEAEMFLVYNFLSGGNLETFI--HKKSGK-----------KIQWSVIHKIAIDIA 883
            G       + +V+ ++  G+L  F+  H    K            +    +  +A  +A
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 884 QALAY---LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG- 939
             + Y   LH+      VHRD+   N L+ + L   + DFG++R +  ++ +    V G 
Sbjct: 140 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR---VGGR 190
Query: 940 ---TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKR 975
                 ++ PE     + + ++DV+SFGVVL E+ + GK+
Sbjct: 191 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ 230

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 36/220 (16%)
Query: 783 IGTGGFGSTYKAE---LVP---GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTL 836
           +G G FG  + AE   L+P     LVAVK L        Q F  E   L  ++H+++V  
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 837 IGYYVGEAEMFLVYNFLSGGNLETFI--HKKSGK-----------KIQWSVIHKIAIDIA 883
            G       + +V+ ++  G+L  F+  H    K            +    +  +A  +A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 884 QALAY---LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG- 939
             + Y   LH+      VHRD+   N L+ + L   + DFG++R +  ++ +    V G 
Sbjct: 169 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR---VGGR 219
Query: 940 ---TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKR 975
                 ++ PE     + + ++DV+SFGVVL E+ + GK+
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQ 259

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 66/268 (24%), Positives = 118/268 (44%), Gaps = 40/268 (14%)
Query: 783  IGTGGFGSTYKAELV--------PGYLVAVKKLSI-GRFQGIQQFDAEIGTLGRI-RHKN 832
            +G G FG    AE V            VAVK L      + +    +E+  +  I +HKN
Sbjct: 43   LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 833  LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS----------VIHKIAIDI 882
            ++ L+G    +  ++++  + S GNL  ++  +    +++S          +  K  +  
Sbjct: 103  IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 883  AQALAY-LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGT 940
               LA  + Y    + +HRD+   N+L+ E     ++DFGLAR +  +     TT+    
Sbjct: 163  TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 941  FGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE 1000
              ++APE       + ++DV+SFGV++ E+ +   S  P       G  +    KLL KE
Sbjct: 223  VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP-------GIPVEELFKLL-KE 274
Query: 1001 GR--------SSELF--LPELWEAGPQE 1018
            G         ++EL+  + + W A P +
Sbjct: 275  GHRMDKPANCTNELYMMMRDCWHAVPSQ 302

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 27/208 (12%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           IG G FG  ++ +   G  VAVK  S  R +     +AEI     +RH+N++  I     
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 843 E----AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV---- 894
           +     +++LV ++   G+L  ++++ +   +    + K+A+  A  LA+LH   V    
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQG 125
Query: 895 -PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVA-----GTFGYVAPEY 948
            P I HRD+K  NIL+ +     ++D GLA  +       T D+A     GT  Y+APE 
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 949 ATTC------RVSDKADVYSFGVVLLEL 970
                         +AD+Y+ G+V  E+
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 27/208 (12%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           IG G FG  ++ +   G  VAVK  S  R +     +AEI     +RH+N++  I     
Sbjct: 17  IGKGRFGEVWRGKW-RGEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAADNK 74
Query: 843 E----AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV---- 894
           +     +++LV ++   G+L  ++++ +   +    + K+A+  A  LA+LH   V    
Sbjct: 75  DNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQG 131
Query: 895 -PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVA-----GTFGYVAPEY 948
            P I HRD+K  NIL+ +     ++D GLA  +       T D+A     GT  Y+APE 
Sbjct: 132 KPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAPEV 189
Query: 949 ATTC------RVSDKADVYSFGVVLLEL 970
                         +AD+Y+ G+V  E+
Sbjct: 190 LDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 27/208 (12%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           IG G FG  ++ +   G  VAVK  S  R +     +AEI     +RH+N++  I     
Sbjct: 12  IGKGRFGEVWRGKW-RGEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAADNK 69
Query: 843 E----AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV---- 894
           +     +++LV ++   G+L  ++++ +   +    + K+A+  A  LA+LH   V    
Sbjct: 70  DNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQG 126
Query: 895 -PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVA-----GTFGYVAPEY 948
            P I HRD+K  NIL+ +     ++D GLA  +       T D+A     GT  Y+APE 
Sbjct: 127 KPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAPEV 184
Query: 949 ATTC------RVSDKADVYSFGVVLLEL 970
                         +AD+Y+ G+V  E+
Sbjct: 185 LDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 66/268 (24%), Positives = 118/268 (44%), Gaps = 40/268 (14%)
Query: 783  IGTGGFGSTYKAELV--------PGYLVAVKKLSI-GRFQGIQQFDAEIGTLGRI-RHKN 832
            +G G FG    AE V            VAVK L      + +    +E+  +  I +HKN
Sbjct: 43   LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 833  LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS----------VIHKIAIDI 882
            ++ L+G    +  ++++  + S GNL  ++  +    +++S          +  K  +  
Sbjct: 103  IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 883  AQALAY-LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGT 940
               LA  + Y    + +HRD+   N+L+ E     ++DFGLAR +  +     TT+    
Sbjct: 163  TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 222
Query: 941  FGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE 1000
              ++APE       + ++DV+SFGV++ E+ +   S  P       G  +    KLL KE
Sbjct: 223  VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP-------GIPVEELFKLL-KE 274
Query: 1001 GR--------SSELF--LPELWEAGPQE 1018
            G         ++EL+  + + W A P +
Sbjct: 275  GHRMDKPANCTNELYMMMRDCWHAVPSQ 302

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 100/213 (46%), Gaps = 19/213 (8%)
Query: 773 ATGNFSIRNLIGTGGFGSTY-------KAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTL 825
           A  +  +  ++G G FG  Y       K E +   +   KK         ++F +E   +
Sbjct: 22  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT--LDNKEKFMSEAVIM 79
Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHK-KSGKKIQWSVIHKIAIDIAQ 884
             + H ++V LIG  + E   +++      G L  ++ + K+  K+   V++  ++ I +
Sbjct: 80  KNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY--SLQICK 136
Query: 885 ALAYLH-YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGY 943
           A+AYL   +CV    HRDI   NIL+       L DFGL+R +E  + +  +       +
Sbjct: 137 AMAYLESINCV----HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKW 192
Query: 944 VAPEYATTCRVSDKADVYSFGVVLLELIS-GKR 975
           ++PE     R +  +DV+ F V + E++S GK+
Sbjct: 193 MSPESINFRRFTTASDVWMFAVCMWEILSFGKQ 225

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 27/208 (12%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG 842
           IG G FG  ++ +   G  VAVK  S  R +     +AEI     +RH+N++  I     
Sbjct: 14  IGKGRFGEVWRGKW-RGEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAADNK 71
Query: 843 E----AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV---- 894
           +     +++LV ++   G+L  ++++ +   +    + K+A+  A  LA+LH   V    
Sbjct: 72  DNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQG 128
Query: 895 -PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVA-----GTFGYVAPEY 948
            P I HRD+K  NIL+ +     ++D GLA  +       T D+A     GT  Y+APE 
Sbjct: 129 KPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAPEV 186
Query: 949 ATTC------RVSDKADVYSFGVVLLEL 970
                         +AD+Y+ G+V  E+
Sbjct: 187 LDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 66/268 (24%), Positives = 117/268 (43%), Gaps = 40/268 (14%)
Query: 783  IGTGGFGSTYKAELV--------PGYLVAVKKLSI-GRFQGIQQFDAEIGTLGRI-RHKN 832
            +G G FG    AE V            VAVK L      + +    +E+  +  I +HKN
Sbjct: 43   LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 833  LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS----------VIHKIAIDI 882
            ++ L+G    +  ++++  + S GNL  ++  +    ++ S          +  K  +  
Sbjct: 103  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 883  AQALAY-LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGT 940
               LA  + Y    + +HRD+   N+L+ E     ++DFGLAR +  +     TT+    
Sbjct: 163  TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLP 222
Query: 941  FGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE 1000
              ++APE       + ++DV+SFGV++ E+ +   S  P       G  +    KLL KE
Sbjct: 223  VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP-------GIPVEELFKLL-KE 274
Query: 1001 GR--------SSELF--LPELWEAGPQE 1018
            G         ++EL+  + + W A P +
Sbjct: 275  GHRMDKPANCTNELYMMMRDCWHAVPSQ 302

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 78/156 (50%), Gaps = 10/156 (6%)
Query: 820 AEIGTLGRIRHKNLVTLIGYYVGEAEMF-LVYNFLSGGNLETFIHKKSGKKIQWSVIHKI 878
           AE   + ++ +  +V +IG  + EAE + LV      G L  ++ +   + ++   I ++
Sbjct: 420 AEANVMQQLDNPYIVRMIG--ICEAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIEL 475
Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVA 938
              ++  + YL  S     VHRD+   N+LL  +  A +SDFGL++ L   E +      
Sbjct: 476 VHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 532
Query: 939 GTF--GYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
           G +   + APE     + S K+DV+SFGV++ E  S
Sbjct: 533 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 78/156 (50%), Gaps = 10/156 (6%)
Query: 820 AEIGTLGRIRHKNLVTLIGYYVGEAEMF-LVYNFLSGGNLETFIHKKSGKKIQWSVIHKI 878
           AE   + ++ +  +V +IG  + EAE + LV      G L  ++ +   + ++   I ++
Sbjct: 419 AEANVMQQLDNPYIVRMIG--ICEAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIEL 474
Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVA 938
              ++  + YL  S     VHRD+   N+LL  +  A +SDFGL++ L   E +      
Sbjct: 475 VHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 531
Query: 939 GTF--GYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
           G +   + APE     + S K+DV+SFGV++ E  S
Sbjct: 532 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 97/229 (42%), Gaps = 33/229 (14%)
Query: 771 VRATGNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIR 829
           +R   +F    ++G G FG   KA   +     A+KK+     + +    +E+  L  + 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVXLLASLN 60
Query: 830 HKNLVTLIGYYV-------------GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH 876
           H+ +V     ++              ++ +F+   +     L   IH ++  + Q     
Sbjct: 61  HQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQ-QRDEYW 119
Query: 877 KIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS------- 929
           ++   I +AL+Y+H      I+HR++KP NI +DE  N  + DFGLA+ +  S       
Sbjct: 120 RLFRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 930 ------ETHATTDVAGTFGYVAPEYAT-TCRVSDKADVYSFGVVLLELI 971
                  +   T   GT  YVA E    T   ++K D YS G++  E I
Sbjct: 177 SQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 15/217 (6%)
Query: 768 DNVVRATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQG-----IQQFDAE 821
           D+ V     + +  +IG G F    +      G   AVK + + +F        +    E
Sbjct: 19  DDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKRE 78
Query: 822 IGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS--VIHKIA 879
                 ++H ++V L+  Y  +  +++V+ F+ G +L   I K++     +S  V     
Sbjct: 79  ASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYM 138
Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTD 936
             I +AL Y H +    I+HRD+KP  +LL  + N+    L  FG+A  L  S   A   
Sbjct: 139 RQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR 195
Query: 937 VAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
           V GT  ++APE           DV+  GV+L  L+SG
Sbjct: 196 V-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 103/228 (45%), Gaps = 22/228 (9%)
Query: 766 TYDNVVRATGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKL--SIGRFQGIQQFDAEI 822
           ++D        + I   IG G +G    A   + G  VA+KK+  +       ++   E+
Sbjct: 45  SFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLREL 104
Query: 823 GTLGRIRHKNLVTL-------IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVI 875
             L   +H N++ +       + Y  GE +   V   L   +L   IH  S + +    +
Sbjct: 105 KILKHFKHDNIIAIKDILRPTVPY--GEFKSVYVVLDLMESDLHQIIH--SSQPLTLEHV 160
Query: 876 HKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS---ETH 932
                 + + L Y+H +   +++HRD+KPSN+L++E     + DFG+AR L  S     +
Sbjct: 161 RYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQY 217
Query: 933 ATTDVAGTFGYVAPEYATTCRVSDKA-DVYSFGVVLLELISGKRSLDP 979
             T+   T  Y APE   +     +A D++S G +  E+++ +R L P
Sbjct: 218 FMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLA-RRQLFP 264

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 98/221 (44%), Gaps = 30/221 (13%)
Query: 776 NFSIRNLIGTGGFGSTYKAE---LVP---GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIR 829
           +  ++  +G G FG  + AE   L P     LVAVK L        + F  E   L  ++
Sbjct: 16  DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQ 75
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIH--------------KKSGKKIQWSVI 875
           H+++V   G       + +V+ ++  G+L  F+               +++  ++  S +
Sbjct: 76  HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135
Query: 876 HKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT 935
             IA  IA  + YL        VHRD+   N L+   L   + DFG++R +  ++ +   
Sbjct: 136 LHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR-- 190
Query: 936 DVAG----TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
            V G       ++ PE     + + ++DV+SFGV+L E+ +
Sbjct: 191 -VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 98/201 (48%), Gaps = 10/201 (4%)
Query: 783 IGTGGFGSTYKAELVPGY-LVAVKKLSIGRF-QGIQQFD-AEIGTLGRIRHKNLVTLIGY 839
           IG G +G+ +KA+    + +VA+K++ +    +G+      EI  L  ++HKN+V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 840 YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
              + ++ LV+ F    +L+ +    +G  +   ++      + + L + H      ++H
Sbjct: 70  LHSDKKLTLVFEFCDQ-DLKKYFDSCNGD-LDPEIVKSFLFQLLKGLGFCHSR---NVLH 124
Query: 900 RDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV-SDKA 958
           RD+KP N+L++      L++FGLAR   +     + +V  T  Y  P+     ++ S   
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTSI 183
Query: 959 DVYSFGVVLLELISGKRSLDP 979
           D++S G +  EL +  R L P
Sbjct: 184 DMWSAGCIFAELANAGRPLFP 204

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 21/216 (9%)
Query: 773 ATGNFSIRNLIGTGGFGSTY-------KAELVPGYLVAVKKLSIG-RFQGIQQFDAEIGT 824
           A  +  +  ++G G FG  Y       K E +    VAVK           ++F +E   
Sbjct: 6   AREDVVLNRILGEGFFGEVYEGVYTNHKGEKIN---VAVKTCKKDCTLDNKEKFMSEAVI 62
Query: 825 LGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHK-KSGKKIQWSVIHKIAIDIA 883
           +  + H ++V LIG  + E   +++      G L  ++ + K+  K+   V++  ++ I 
Sbjct: 63  MKNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY--SLQIC 119
Query: 884 QALAYLH-YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFG 942
           +A+AYL   +CV    HRDI   NIL+       L DFGL+R +E  + +  +       
Sbjct: 120 KAMAYLESINCV----HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK 175
Query: 943 YVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSL 977
           +++PE     R +  +DV+ F V + E++S GK+  
Sbjct: 176 WMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 211

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 21/214 (9%)
Query: 773 ATGNFSIRNLIGTGGFGSTY-------KAELVPGYLVAVKKLSIG-RFQGIQQFDAEIGT 824
           A  +  +  ++G G FG  Y       K E +    VAVK           ++F +E   
Sbjct: 10  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKIN---VAVKTCKKDCTLDNKEKFMSEAVI 66
Query: 825 LGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHK-KSGKKIQWSVIHKIAIDIA 883
           +  + H ++V LIG  + E   +++      G L  ++ + K+  K+   V++  ++ I 
Sbjct: 67  MKNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY--SLQIC 123
Query: 884 QALAYLH-YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFG 942
           +A+AYL   +CV    HRDI   NIL+       L DFGL+R +E  + +  +       
Sbjct: 124 KAMAYLESINCV----HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK 179
Query: 943 YVAPEYATTCRVSDKADVYSFGVVLLELIS-GKR 975
           +++PE     R +  +DV+ F V + E++S GK+
Sbjct: 180 WMSPESINFRRFTTASDVWMFAVCMWEILSFGKQ 213

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 66/268 (24%), Positives = 118/268 (44%), Gaps = 40/268 (14%)
Query: 783  IGTGGFGSTYKAELV--------PGYLVAVKKLSI-GRFQGIQQFDAEIGTLGRI-RHKN 832
            +G G FG    AE V            VAVK L      + +    +E+  +  I +HKN
Sbjct: 30   LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 833  LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS----------VIHKIAIDI 882
            ++ L+G    +  ++++  + S GNL  ++  +    +++S          +  K  +  
Sbjct: 90   IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 883  AQALAY-LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGT 940
               LA  + Y    + +HRD+   N+L+ E     ++DFGLAR +  +     TT+    
Sbjct: 150  TYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 209
Query: 941  FGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE 1000
              ++APE       + ++DV+SFGV++ E+ +   S  P       G  +    KLL KE
Sbjct: 210  VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP-------GIPVEELFKLL-KE 261
Query: 1001 GR--------SSELF--LPELWEAGPQE 1018
            G         ++EL+  + + W A P +
Sbjct: 262  GHRMDKPANCTNELYMMMRDCWHAVPSQ 289

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 66/268 (24%), Positives = 118/268 (44%), Gaps = 40/268 (14%)
Query: 783  IGTGGFGSTYKAELV--------PGYLVAVKKLSI-GRFQGIQQFDAEIGTLGRI-RHKN 832
            +G G FG    AE V            VAVK L      + +    +E+  +  I +HKN
Sbjct: 35   LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 833  LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS----------VIHKIAIDI 882
            ++ L+G    +  ++++  + S GNL  ++  +    +++S          +  K  +  
Sbjct: 95   IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 883  AQALAY-LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGT 940
               LA  + Y    + +HRD+   N+L+ E     ++DFGLAR +  +     TT+    
Sbjct: 155  TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 214
Query: 941  FGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE 1000
              ++APE       + ++DV+SFGV++ E+ +   S  P       G  +    KLL KE
Sbjct: 215  VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP-------GIPVEELFKLL-KE 266
Query: 1001 GR--------SSELF--LPELWEAGPQE 1018
            G         ++EL+  + + W A P +
Sbjct: 267  GHRMDKPANCTNELYMMMRDCWHAVPSQ 294

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 66/268 (24%), Positives = 118/268 (44%), Gaps = 40/268 (14%)
Query: 783  IGTGGFGSTYKAELV--------PGYLVAVKKLSI-GRFQGIQQFDAEIGTLGRI-RHKN 832
            +G G FG    AE V            VAVK L      + +    +E+  +  I +HKN
Sbjct: 32   LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 833  LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS----------VIHKIAIDI 882
            ++ L+G    +  ++++  + S GNL  ++  +    +++S          +  K  +  
Sbjct: 92   IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 883  AQALAY-LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGT 940
               LA  + Y    + +HRD+   N+L+ E     ++DFGLAR +  +     TT+    
Sbjct: 152  TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP 211
Query: 941  FGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE 1000
              ++APE       + ++DV+SFGV++ E+ +   S  P       G  +    KLL KE
Sbjct: 212  VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP-------GIPVEELFKLL-KE 263
Query: 1001 GR--------SSELF--LPELWEAGPQE 1018
            G         ++EL+  + + W A P +
Sbjct: 264  GHRMDKPANCTNELYMMMRDCWHAVPSQ 291

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 15/217 (6%)
Query: 768 DNVVRATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQG-----IQQFDAE 821
           D+ V     + +  +IG G F    +      G   AVK + + +F        +    E
Sbjct: 17  DDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKRE 76
Query: 822 IGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS--VIHKIA 879
                 ++H ++V L+  Y  +  +++V+ F+ G +L   I K++     +S  V     
Sbjct: 77  ASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYM 136
Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTD 936
             I +AL Y H +    I+HRD+KP  +LL  + N+    L  FG+A  L  S   A   
Sbjct: 137 RQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR 193
Query: 937 VAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
           V GT  ++APE           DV+  GV+L  L+SG
Sbjct: 194 V-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 108/251 (43%), Gaps = 27/251 (10%)
Query: 783  IGTGGFGSTYKAE------LVPGYLVAVKKLSIGRFQGIQQ-FDAEIGTLGRI-RHKNLV 834
            +G G FG   +A+            VAVK L  G      +   +E+  L  I  H N+V
Sbjct: 35   LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 835  TLIGYYVGEA-EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY----- 888
             L+G        + ++  F   GNL T++  K  + + +  ++K  + +   + Y     
Sbjct: 95   NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 889  --LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT-DVAGTFGYVA 945
              + +    + +HRD+   NILL E+    + DFGLAR +     +    D      ++A
Sbjct: 155  KGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMA 214
Query: 946  PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEG---R 1002
            PE       + ++DV+SFGV+L E+ S   S  P       G  I       +KEG   R
Sbjct: 215  PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP-------GVKIDEEFXRRLKEGTRMR 267
Query: 1003 SSELFLPELWE 1013
            + +   PE+++
Sbjct: 268  APDYTTPEMYQ 278

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 17/207 (8%)
Query: 783 IGTGGFGSTYKAE------LVPGYLVAVKKLSIGRFQGIQQ-FDAEIGTLGRI-RHKNLV 834
           +G G FG   +A+            VAVK L  G      +   +E+  L  I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 835 TLIGYYVGEA-EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY----- 888
            L+G        + ++  F   GNL T++  K  + + +  ++K  + +   + Y     
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 889 --LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT-DVAGTFGYVA 945
             + +    + +HRD+   NILL E+    + DFGLAR +     +    D      ++A
Sbjct: 155 KGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 214
Query: 946 PEYATTCRVSDKADVYSFGVVLLELIS 972
           PE       + ++DV+SFGV+L E+ S
Sbjct: 215 PETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 71/149 (47%), Gaps = 11/149 (7%)
Query: 840 YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
           Y G   + +V   L GG L + I  +  +        +I   I +A+ YLH      I H
Sbjct: 82  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAH 138
Query: 900 RDIKPSNILL-DEELNAYL--SDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD 956
           RD+KP N+L   +  NA L  +DFG A+  E +  ++ T+   T  YVAPE     +   
Sbjct: 139 RDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTEPCYTPYYVAPEVLGPEKYDK 196
Query: 957 KADVYSFGVVLLELISGKRSLDPSFSEYG 985
             D++S GV++  L+ G     P +S +G
Sbjct: 197 SCDMWSLGVIMYILLCG---YPPFYSNHG 222

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 71/133 (53%), Gaps = 6/133 (4%)
Query: 846 MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPS 905
           ++ V  +++GG+L   I +    K   +V +  A +I+  L +LH      I++RD+K  
Sbjct: 95  LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY--AAEISIGLFFLHKRG---IIYRDLKLD 149
Query: 906 NILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGV 965
           N++LD E +  ++DFG+ +   + +   T +  GT  Y+APE           D +++GV
Sbjct: 150 NVMLDSEGHIKIADFGMCK-EHMMDGVTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGV 208
Query: 966 VLLELISGKRSLD 978
           +L E+++G+   D
Sbjct: 209 LLYEMLAGQPPFD 221

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 97/221 (43%), Gaps = 34/221 (15%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL---VAVKKL-SIGRFQGIQQFDAEIGTLGRI-RH 830
           +   +++IG G FG   KA +    L    A+K++         + F  E+  L ++  H
Sbjct: 23  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 82
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKK--------------SGKKIQWSVIH 876
            N++ L+G       ++L   +   GNL  F+ K               +   +    + 
Sbjct: 83  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 142
Query: 877 KIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD 936
             A D+A+ + YL      + +HR++   NIL+ E   A ++DFGL+R  EV        
Sbjct: 143 HFAADVARGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLSRGQEVY------- 192
Query: 937 VAGTFG-----YVAPEYATTCRVSDKADVYSFGVVLLELIS 972
           V  T G     ++A E       +  +DV+S+GV+L E++S
Sbjct: 193 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 80/280 (28%), Positives = 120/280 (42%), Gaps = 36/280 (12%)
Query: 779  IRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIG-RFQGIQQFDAEIGTLGRIRHKN 832
            IR+L G G FG        P     G +VAVK L      Q    +  EI  L  + H++
Sbjct: 19   IRDL-GEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEH 77
Query: 833  LVTLIGYY--VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            ++   G     GE  + LV  ++  G+L  ++ + S   I  + +   A  I + +AYLH
Sbjct: 78   IIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLH 134
Query: 891  YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDV-----AGTFGYVA 945
                   +HR++   N+LLD +    + DFGLA+   V E H    V     +  F Y A
Sbjct: 135  ---AQHYIHRNLAARNVLLDNDRLVKIGDFGLAK--AVPEGHEYYRVREDGDSPVFWY-A 188
Query: 946  PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005
            PE     +    +DV+SFGV L EL++     D S S       ++      I +G+ + 
Sbjct: 189  PECLKEYKFYYASDVWSFGVTLYELLT---HCDSSQSPPTKFLELIG-----IAQGQMTV 240
Query: 1006 LFLPELWEAG-----PQENLLGMMRLASTCTVETLSTRPS 1040
            L L EL E G     P +    +  L   C     S RP+
Sbjct: 241  LRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPT 280

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 87/213 (40%), Gaps = 30/213 (14%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEI------------- 822
           +F    L+G G FG           ++ V++ + GR+  ++    E+             
Sbjct: 6   DFDYLKLLGKGTFGK----------VILVREKATGRYYAMKILRKEVIIAKDEVAHTVTE 55
Query: 823 -GTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAID 881
              L   RH  L  L   +     +  V  + +GG L  F H    +            +
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAE 113
Query: 882 IAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF 941
           I  AL YLH   V   V+RDIK  N++LD++ +  ++DFGL +   +S+        GT 
Sbjct: 114 IVSALEYLHSRDV---VYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTP 169
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
            Y+APE           D +  GVV+ E++ G+
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 87/213 (40%), Gaps = 30/213 (14%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEI------------- 822
           +F    L+G G FG           ++ V++ + GR+  ++    E+             
Sbjct: 9   DFDYLKLLGKGTFGK----------VILVREKATGRYYAMKILRKEVIIAKDEVAHTVTE 58
Query: 823 -GTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAID 881
              L   RH  L  L   +     +  V  + +GG L  F H    +            +
Sbjct: 59  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAE 116
Query: 882 IAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF 941
           I  AL YLH   V   V+RDIK  N++LD++ +  ++DFGL +   +S+        GT 
Sbjct: 117 IVSALEYLHSRDV---VYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTP 172
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
            Y+APE           D +  GVV+ E++ G+
Sbjct: 173 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 101/238 (42%), Gaps = 26/238 (10%)
Query: 757 TFADTPAELTYDNVVR-ATGNFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQG 814
           TF D P +L Y+        N      +G G FG   +A     G   AV K+++   + 
Sbjct: 28  TFID-PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKS 86
Query: 815 IQQFDAEIGTLGRIR-------HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKS- 866
               D +   +  ++       H+N+V L+G       + ++  +   G+L  F+ +KS 
Sbjct: 87  TAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSR 146
Query: 867 -----------GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNA 915
                         +    +   +  +AQ +A+L        +HRD+   N+LL     A
Sbjct: 147 VLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVA 203
Query: 916 YLSDFGLAR-LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
            + DFGLAR ++  S      +      ++APE    C  + ++DV+S+G++L E+ S
Sbjct: 204 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 80/280 (28%), Positives = 120/280 (42%), Gaps = 36/280 (12%)
Query: 779  IRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIG-RFQGIQQFDAEIGTLGRIRHKN 832
            IR+L G G FG        P     G +VAVK L      Q    +  EI  L  + H++
Sbjct: 19   IRDL-GEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEH 77
Query: 833  LVTLIGYY--VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            ++   G     GE  + LV  ++  G+L  ++ + S   I  + +   A  I + +AYLH
Sbjct: 78   IIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLH 134
Query: 891  YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDV-----AGTFGYVA 945
                   +HR++   N+LLD +    + DFGLA+   V E H    V     +  F Y A
Sbjct: 135  SQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAK--AVPEGHEYYRVREDGDSPVFWY-A 188
Query: 946  PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005
            PE     +    +DV+SFGV L EL++     D S S       ++      I +G+ + 
Sbjct: 189  PECLKEYKFYYASDVWSFGVTLYELLT---HCDSSQSPPTKFLELIG-----IAQGQMTV 240
Query: 1006 LFLPELWEAG-----PQENLLGMMRLASTCTVETLSTRPS 1040
            L L EL E G     P +    +  L   C     S RP+
Sbjct: 241  LRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPT 280

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 109/239 (45%), Gaps = 28/239 (11%)
Query: 783  IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTLIG 838
            IG+G  G    A + V G  VAVKKLS   FQ     ++   E+  L  + HKN+++L+ 
Sbjct: 30   IGSGAQGIVCAAFDTVLGINVAVKKLS-RPFQNQTHAKRAYRELVLLKCVNHKNIISLLN 88
Query: 839  YYVGE------AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
             +  +       +++LV   +   NL   IH +   +    +++++   I     +LH +
Sbjct: 89   VFTPQKTLEEFQDVYLVMELMDA-NLCQVIHMELDHERMSYLLYQMLCGIK----HLHSA 143
Query: 893  CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
                I+HRD+KPSNI++  +    + DFGLAR    S     T    T  Y APE     
Sbjct: 144  G---IIHRDLKPSNIVVKSDCTLKILDFGLART--ASTNFMMTPYVVTRYYRAPEVILGM 198
Query: 953  RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPEL 1011
               +  D++S G ++ EL+ G          +    +I  W K++ + G  S  F+  L
Sbjct: 199  GYKENVDIWSVGCIMGELVKGSVI-------FQGTDHIDQWNKVIEQLGTPSAEFMAAL 250

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 81/285 (28%), Positives = 121/285 (42%), Gaps = 46/285 (16%)
Query: 779  IRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQ-FDAEIGTLGRIRHKN 832
            IR+L G G FG        P     G +VAVK L  G    ++  +  EI  L  + H++
Sbjct: 13   IRDL-GEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEH 71
Query: 833  LVTLIGYY--VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +V   G     GE  + LV  ++  G+L  ++ +     +  + +   A  I + +AYLH
Sbjct: 72   IVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC---VGLAQLLLFAQQICEGMAYLH 128
Query: 891  YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDV-----AGTFGYVA 945
                   +HR +   N+LLD +    + DFGLA+   V E H    V     +  F Y A
Sbjct: 129  ---AQHYIHRALAARNVLLDNDRLVKIGDFGLAK--AVPEGHEYYRVREDGDSPVFWY-A 182
Query: 946  PEYATTCRVSDKADVYSFGVVLLELIS---GKRSLDPSFSEYGNGFNIVSWAKLLI--KE 1000
            PE    C+    +DV+SFGV L EL++     +S    F+E             LI   +
Sbjct: 183  PECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTE-------------LIGHTQ 229
Query: 1001 GRSSELFLPELWEAG-----PQENLLGMMRLASTCTVETLSTRPS 1040
            G+ + L L EL E G     P      +  L   C     S RP+
Sbjct: 230  GQMTVLRLTELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPT 274

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 81/285 (28%), Positives = 121/285 (42%), Gaps = 46/285 (16%)
Query: 779  IRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQ-FDAEIGTLGRIRHKN 832
            IR+L G G FG        P     G +VAVK L  G    ++  +  EI  L  + H++
Sbjct: 14   IRDL-GEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEH 72
Query: 833  LVTLIGYY--VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +V   G     GE  + LV  ++  G+L  ++ +     +  + +   A  I + +AYLH
Sbjct: 73   IVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC---VGLAQLLLFAQQICEGMAYLH 129
Query: 891  YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDV-----AGTFGYVA 945
                   +HR +   N+LLD +    + DFGLA+   V E H    V     +  F Y A
Sbjct: 130  ---AQHYIHRALAARNVLLDNDRLVKIGDFGLAK--AVPEGHEYYRVREDGDSPVFWY-A 183
Query: 946  PEYATTCRVSDKADVYSFGVVLLELIS---GKRSLDPSFSEYGNGFNIVSWAKLLI--KE 1000
            PE    C+    +DV+SFGV L EL++     +S    F+E             LI   +
Sbjct: 184  PECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTE-------------LIGHTQ 230
Query: 1001 GRSSELFLPELWEAG-----PQENLLGMMRLASTCTVETLSTRPS 1040
            G+ + L L EL E G     P      +  L   C     S RP+
Sbjct: 231  GQMTVLRLTELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPT 275

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 11/149 (7%)
Query: 840 YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
           Y G   + +V   L GG L + I  +  +        +I   I +A+ YLH      I H
Sbjct: 98  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAH 154
Query: 900 RDIKPSNILL-DEELNAYL--SDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD 956
           RD+KP N+L   +  NA L  +DFG A+  E +  ++ T    T  YVAPE     +   
Sbjct: 155 RDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDK 212
Query: 957 KADVYSFGVVLLELISGKRSLDPSFSEYG 985
             D++S GV++  L+ G     P +S +G
Sbjct: 213 SCDMWSLGVIMYILLCG---YPPFYSNHG 238

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 81/165 (49%), Gaps = 21/165 (12%)
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWS-VIHKIAIDIAQAL 886
           +H N++TL   Y     ++LV   + GG L +  + +K   + + S V+H I     + +
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIG----KTV 134
Query: 887 AYLHYSCVPRIVHRDIKPSNIL-LDEELNA---YLSDFGLARLLEVSETHATTDVAGTFG 942
            YLH   V   VHRD+KPSNIL +DE  N     + DFG A+ L  +E         T  
Sbjct: 135 EYLHSQGV---VHRDLKPSNILYVDESGNPECLRICDFGFAKQLR-AENGLLMTPCYTAN 190
Query: 943 YVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNG 987
           +VAPE        +  D++S G++L  +++G       ++ + NG
Sbjct: 191 FVAPEVLKRQGYDEGCDIWSLGILLYTMLAG-------YTPFANG 228

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 11/149 (7%)
Query: 840 YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
           Y G   + +V   L GG L + I  +  +        +I   I +A+ YLH      I H
Sbjct: 90  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAH 146
Query: 900 RDIKPSNILL-DEELNAYL--SDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD 956
           RD+KP N+L   +  NA L  +DFG A+  E +  ++ T    T  YVAPE     +   
Sbjct: 147 RDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDK 204
Query: 957 KADVYSFGVVLLELISGKRSLDPSFSEYG 985
             D++S GV++  L+ G     P +S +G
Sbjct: 205 SCDMWSLGVIMYILLCG---YPPFYSNHG 230

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 44/155 (28%), Positives = 76/155 (49%), Gaps = 8/155 (5%)
Query: 820 AEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
           AE   + ++ +  +V +IG    E+ M LV      G L  ++ +   + ++   I ++ 
Sbjct: 55  AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQN--RHVKDKNIIELV 111
Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG 939
             ++  + YL  S     VHRD+   N+LL  +  A +SDFGL++ L   E +      G
Sbjct: 112 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 168
Query: 940 TF--GYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
            +   + APE     + S K+DV+SFGV++ E  S
Sbjct: 169 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 44/155 (28%), Positives = 76/155 (49%), Gaps = 8/155 (5%)
Query: 820 AEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
           AE   + ++ +  +V +IG    E+ M LV      G L  ++ +   + ++   I ++ 
Sbjct: 67  AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQN--RHVKDKNIIELV 123
Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG 939
             ++  + YL  S     VHRD+   N+LL  +  A +SDFGL++ L   E +      G
Sbjct: 124 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 180
Query: 940 TF--GYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
            +   + APE     + S K+DV+SFGV++ E  S
Sbjct: 181 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 44/155 (28%), Positives = 76/155 (49%), Gaps = 8/155 (5%)
Query: 820 AEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
           AE   + ++ +  +V +IG    E+ M LV      G L  ++ +   + ++   I ++ 
Sbjct: 77  AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQN--RHVKDKNIIELV 133
Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG 939
             ++  + YL  S     VHRD+   N+LL  +  A +SDFGL++ L   E +      G
Sbjct: 134 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 190
Query: 940 TF--GYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
            +   + APE     + S K+DV+SFGV++ E  S
Sbjct: 191 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 44/155 (28%), Positives = 76/155 (49%), Gaps = 8/155 (5%)
Query: 820 AEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
           AE   + ++ +  +V +IG    E+ M LV      G L  ++ +   + ++   I ++ 
Sbjct: 77  AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQN--RHVKDKNIIELV 133
Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG 939
             ++  + YL  S     VHRD+   N+LL  +  A +SDFGL++ L   E +      G
Sbjct: 134 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 190
Query: 940 TF--GYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
            +   + APE     + S K+DV+SFGV++ E  S
Sbjct: 191 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 44/155 (28%), Positives = 76/155 (49%), Gaps = 8/155 (5%)
Query: 820 AEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
           AE   + ++ +  +V +IG    E+ M LV      G L  ++ +   + ++   I ++ 
Sbjct: 57  AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQN--RHVKDKNIIELV 113
Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG 939
             ++  + YL  S     VHRD+   N+LL  +  A +SDFGL++ L   E +      G
Sbjct: 114 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170
Query: 940 TF--GYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
            +   + APE     + S K+DV+SFGV++ E  S
Sbjct: 171 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 44/155 (28%), Positives = 76/155 (49%), Gaps = 8/155 (5%)
Query: 820 AEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
           AE   + ++ +  +V +IG    E+ M LV      G L  ++ +   + ++   I ++ 
Sbjct: 61  AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQN--RHVKDKNIIELV 117
Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG 939
             ++  + YL  S     VHRD+   N+LL  +  A +SDFGL++ L   E +      G
Sbjct: 118 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 174
Query: 940 TF--GYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
            +   + APE     + S K+DV+SFGV++ E  S
Sbjct: 175 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 44/155 (28%), Positives = 76/155 (49%), Gaps = 8/155 (5%)
Query: 820 AEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
           AE   + ++ +  +V +IG    E+ M LV      G L  ++ +   + ++   I ++ 
Sbjct: 75  AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQN--RHVKDKNIIELV 131
Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG 939
             ++  + YL  S     VHRD+   N+LL  +  A +SDFGL++ L   E +      G
Sbjct: 132 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 188
Query: 940 TF--GYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
            +   + APE     + S K+DV+SFGV++ E  S
Sbjct: 189 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 11/149 (7%)
Query: 840 YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
           Y G   + +V   L GG L + I  +  +        +I   I +A+ YLH      I H
Sbjct: 128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAH 184
Query: 900 RDIKPSNILL-DEELNAYL--SDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD 956
           RD+KP N+L   +  NA L  +DFG A+  E +  ++ T    T  YVAPE     +   
Sbjct: 185 RDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDK 242
Query: 957 KADVYSFGVVLLELISGKRSLDPSFSEYG 985
             D++S GV++  L+ G     P +S +G
Sbjct: 243 SCDMWSLGVIMYILLCG---YPPFYSNHG 268

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 11/149 (7%)
Query: 840 YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
           Y G   + +V   L GG L + I  +  +        +I   I +A+ YLH      I H
Sbjct: 89  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAH 145
Query: 900 RDIKPSNILL-DEELNAYL--SDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD 956
           RD+KP N+L   +  NA L  +DFG A+  E +  ++ T    T  YVAPE     +   
Sbjct: 146 RDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDK 203
Query: 957 KADVYSFGVVLLELISGKRSLDPSFSEYG 985
             D++S GV++  L+ G     P +S +G
Sbjct: 204 SCDMWSLGVIMYILLCG---YPPFYSNHG 229

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 11/149 (7%)
Query: 840 YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
           Y G   + +V   L GG L + I  +  +        +I   I +A+ YLH      I H
Sbjct: 134 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAH 190
Query: 900 RDIKPSNILL-DEELNAYL--SDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD 956
           RD+KP N+L   +  NA L  +DFG A+  E +  ++ T    T  YVAPE     +   
Sbjct: 191 RDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDK 248
Query: 957 KADVYSFGVVLLELISGKRSLDPSFSEYG 985
             D++S GV++  L+ G     P +S +G
Sbjct: 249 SCDMWSLGVIMYILLCG---YPPFYSNHG 274

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 11/149 (7%)
Query: 840 YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
           Y G   + +V   L GG L + I  +  +        +I   I +A+ YLH      I H
Sbjct: 88  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAH 144
Query: 900 RDIKPSNILL-DEELNAYL--SDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD 956
           RD+KP N+L   +  NA L  +DFG A+  E +  ++ T    T  YVAPE     +   
Sbjct: 145 RDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDK 202
Query: 957 KADVYSFGVVLLELISGKRSLDPSFSEYG 985
             D++S GV++  L+ G     P +S +G
Sbjct: 203 SCDMWSLGVIMYILLCG---YPPFYSNHG 228

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 97/199 (48%), Gaps = 12/199 (6%)
Query: 781 NLIGTGGFGSTYKAELVPG-----YLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLV 834
            ++G+G FG+ YK   +P        VA+K L      +  ++   E   +  +    + 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
            L+G  +  + + LV   +  G L   + +  G+     +++   + IA+ ++YL     
Sbjct: 83  RLLGICL-TSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLN-WCMQIAKGMSYLEDV-- 138
Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT-FGYVAPEYATTCR 953
            R+VHRD+   N+L+    +  ++DFGLARLL++ ET    D       ++A E     R
Sbjct: 139 -RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRR 197
Query: 954 VSDKADVYSFGVVLLELIS 972
            + ++DV+S+GV + EL++
Sbjct: 198 FTHQSDVWSYGVTVWELMT 216

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 11/149 (7%)
Query: 840 YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
           Y G   + +V   L GG L + I  +  +        +I   I +A+ YLH      I H
Sbjct: 82  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAH 138
Query: 900 RDIKPSNILL-DEELNAYL--SDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD 956
           RD+KP N+L   +  NA L  +DFG A+  E +  ++ T    T  YVAPE     +   
Sbjct: 139 RDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDK 196
Query: 957 KADVYSFGVVLLELISGKRSLDPSFSEYG 985
             D++S GV++  L+ G     P +S +G
Sbjct: 197 SCDMWSLGVIMYILLCG---YPPFYSNHG 222

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 93/198 (46%), Gaps = 16/198 (8%)
Query: 783 IGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQ---FDAEIGTLGRIRHKNLVTLIG 838
           +G G +G   K   VP G + AVK++        Q+    D +I +   +     VT  G
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDI-SXRTVDCPFTVTFYG 100
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHK--KSGKKIQWSVIHKIAIDIAQALAYLHYSCVPR 896
               E ++++    L   +L+ F  +    G+ I   ++ KIA+ I +AL +LH      
Sbjct: 101 ALFREGDVWICXE-LXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--S 157
Query: 897 IVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA----TTC 952
           ++HRD+KPSN+L++        DFG++  L V +     D AG   Y APE         
Sbjct: 158 VIHRDVKPSNVLINALGQVKXCDFGISGYL-VDDVAKDID-AGCKPYXAPERINPELNQK 215
Query: 953 RVSDKADVYSFGVVLLEL 970
             S K+D++S G+  +EL
Sbjct: 216 GYSVKSDIWSLGITXIEL 233

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 11/149 (7%)
Query: 840 YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
           Y G   + +V   L GG L + I  +  +        +I   I +A+ YLH      I H
Sbjct: 83  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAH 139
Query: 900 RDIKPSNILL-DEELNAYL--SDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD 956
           RD+KP N+L   +  NA L  +DFG A+  E +  ++ T    T  YVAPE     +   
Sbjct: 140 RDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDK 197
Query: 957 KADVYSFGVVLLELISGKRSLDPSFSEYG 985
             D++S GV++  L+ G     P +S +G
Sbjct: 198 SCDMWSLGVIMYILLCG---YPPFYSNHG 223

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 11/149 (7%)
Query: 840 YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
           Y G   + +V   L GG L + I  +  +        +I   I +A+ YLH      I H
Sbjct: 84  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAH 140
Query: 900 RDIKPSNILL-DEELNAYL--SDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD 956
           RD+KP N+L   +  NA L  +DFG A+  E +  ++ T    T  YVAPE     +   
Sbjct: 141 RDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDK 198
Query: 957 KADVYSFGVVLLELISGKRSLDPSFSEYG 985
             D++S GV++  L+ G     P +S +G
Sbjct: 199 SCDMWSLGVIMYILLCG---YPPFYSNHG 224

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 30/214 (14%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDA-----EIGTLGRIRH 830
           ++ +  +IG G FG            V   KL + +F+ I++ D+     E   +     
Sbjct: 76  DYDVVKVIGRGAFGEVQLVRHKASQKVYAMKL-LSKFEMIKRSDSAFFWEERDIMAFANS 134
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
             +V L   +  +  +++V  ++ GG+L   +      + +W+  +    ++  AL  +H
Sbjct: 135 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE-KWAKFY--TAEVVLALDAIH 191
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLA-RLLEVSETHATTDVAGTFGYVAPE-- 947
                 ++HRD+KP N+LLD+  +  L+DFG   ++ E    H  T V GT  Y++PE  
Sbjct: 192 SMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV-GTPDYISPEVL 247
Query: 948 --------YATTCRVSDKADVYSFGVVLLELISG 973
                   Y   C      D +S GV L E++ G
Sbjct: 248 KSQGGDGYYGREC------DWWSVGVFLFEMLVG 275

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/174 (31%), Positives = 85/174 (48%), Gaps = 22/174 (12%)
Query: 821 EIGTLGRI-RHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWS-VIHK 877
           EI  L R  +H N++TL   Y     ++LV   + GG L +  + +K   + + S V+H 
Sbjct: 70  EIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHT 129
Query: 878 IAIDIAQALAYLHYSCVPRIVHRDIKPSNIL-LDEELNA---YLSDFGLARLLEVSETHA 933
           I     + + YLH   V   VHRD+KPSNIL +DE  N     + DFG A+ L  +E   
Sbjct: 130 IG----KTVEYLHSQGV---VHRDLKPSNILYVDESGNPECLRICDFGFAKQLR-AENGL 181
Query: 934 TTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNG 987
                 T  +VAPE        +  D++S G++L  +++G       ++ + NG
Sbjct: 182 LMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG-------YTPFANG 228

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 11/149 (7%)
Query: 840 YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
           Y G   + +V   L GG L + I  +  +        +I   I +A+ YLH      I H
Sbjct: 84  YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAH 140
Query: 900 RDIKPSNILL-DEELNAYL--SDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD 956
           RD+KP N+L   +  NA L  +DFG A+  E +  ++ T    T  YVAPE     +   
Sbjct: 141 RDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDK 198
Query: 957 KADVYSFGVVLLELISGKRSLDPSFSEYG 985
             D++S GV++  L+ G     P +S +G
Sbjct: 199 SCDMWSLGVIMYILLCG---YPPFYSNHG 224

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 102/221 (46%), Gaps = 16/221 (7%)
Query: 762 PAELTYDNVVRATGNFSIRNL--IGTGGFGSTYKAELVP-------GYLVAVKKLSIGRF 812
           P+E     + R      +R L  +G+G FG+ +K   +P          + V +   GR 
Sbjct: 16  PSEKANKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR- 74
Query: 813 QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQW 872
           Q  Q     +  +G + H ++V L+G   G + + LV  +L  G+L   + +  G  +  
Sbjct: 75  QSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGA-LGP 132
Query: 873 SVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH 932
            ++    + IA+ + YL       +VHR++   N+LL       ++DFG+A LL   +  
Sbjct: 133 QLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 189
Query: 933 ATTDVAGT-FGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
                A T   ++A E     + + ++DV+S+GV + EL++
Sbjct: 190 LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 52/213 (24%), Positives = 87/213 (40%), Gaps = 30/213 (14%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEI------------- 822
           +F    L+G G FG           ++ V++ + GR+  ++    E+             
Sbjct: 6   DFDYLKLLGKGTFGK----------VILVREKATGRYYAMKILRKEVIIAKDEVAHTVTE 55
Query: 823 -GTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAID 881
              L   RH  L  L   +     +  V  + +GG  E F H    +            +
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG--ELFFHLSRERVFTEERARFYGAE 113
Query: 882 IAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF 941
           I  AL YLH      +V+RDIK  N++LD++ +  ++DFGL +   +S+        GT 
Sbjct: 114 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTP 169
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
            Y+APE           D +  GVV+ E++ G+
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 52/213 (24%), Positives = 87/213 (40%), Gaps = 30/213 (14%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEI------------- 822
           +F    L+G G FG           ++ V++ + GR+  ++    E+             
Sbjct: 11  DFDYLKLLGKGTFGK----------VILVREKATGRYYAMKILRKEVIIAKDEVAHTVTE 60
Query: 823 -GTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAID 881
              L   RH  L  L   +     +  V  + +GG  E F H    +            +
Sbjct: 61  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG--ELFFHLSRERVFTEERARFYGAE 118
Query: 882 IAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF 941
           I  AL YLH      +V+RDIK  N++LD++ +  ++DFGL +   +S+        GT 
Sbjct: 119 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTP 174
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
            Y+APE           D +  GVV+ E++ G+
Sbjct: 175 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 52/213 (24%), Positives = 87/213 (40%), Gaps = 30/213 (14%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEI------------- 822
           +F    L+G G FG           ++ V++ + GR+  ++    E+             
Sbjct: 6   DFDYLKLLGKGTFGK----------VILVREKATGRYYAMKILRKEVIIAKDEVAHTVTE 55
Query: 823 -GTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAID 881
              L   RH  L  L   +     +  V  + +GG  E F H    +            +
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG--ELFFHLSRERVFTEERARFYGAE 113
Query: 882 IAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF 941
           I  AL YLH      +V+RDIK  N++LD++ +  ++DFGL +   +S+        GT 
Sbjct: 114 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTP 169
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
            Y+APE           D +  GVV+ E++ G+
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 52/213 (24%), Positives = 87/213 (40%), Gaps = 30/213 (14%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEI------------- 822
           +F    L+G G FG           ++ V++ + GR+  ++    E+             
Sbjct: 6   DFDYLKLLGKGTFGK----------VILVREKATGRYYAMKILRKEVIIAKDEVAHTVTE 55
Query: 823 -GTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAID 881
              L   RH  L  L   +     +  V  + +GG  E F H    +            +
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG--ELFFHLSRERVFTEERARFYGAE 113
Query: 882 IAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF 941
           I  AL YLH      +V+RDIK  N++LD++ +  ++DFGL +   +S+        GT 
Sbjct: 114 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTP 169
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
            Y+APE           D +  GVV+ E++ G+
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 52/213 (24%), Positives = 87/213 (40%), Gaps = 30/213 (14%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEI------------- 822
           +F    L+G G FG           ++ V++ + GR+  ++    E+             
Sbjct: 6   DFDYLKLLGKGTFGK----------VILVREKATGRYYAMKILRKEVIIAKDEVAHTVTE 55
Query: 823 -GTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAID 881
              L   RH  L  L   +     +  V  + +GG  E F H    +            +
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG--ELFFHLSRERVFTEERARFYGAE 113
Query: 882 IAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF 941
           I  AL YLH      +V+RDIK  N++LD++ +  ++DFGL +   +S+        GT 
Sbjct: 114 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTP 169
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
            Y+APE           D +  GVV+ E++ G+
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 8/155 (5%)
Query: 820 AEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
           AE   + ++ +  +V +IG    E+ M LV      G L  ++ +   + ++   I ++ 
Sbjct: 61  AEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQN--RHVKDKNIIELV 117
Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG 939
             ++  + YL  S     VHRD+   N+LL  +  A +SDFGL++ L   E        G
Sbjct: 118 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHG 174
Query: 940 TF--GYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
            +   + APE     + S K+DV+SFGV++ E  S
Sbjct: 175 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 88/218 (40%), Gaps = 30/218 (13%)
Query: 772 RATGN-FSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEI-------- 822
           R T N F    L+G G FG           ++ VK+ + GR+  ++    E+        
Sbjct: 4   RVTMNEFEYLKLLGKGTFGK----------VILVKEKATGRYYAMKILKKEVIVAKDEVA 53
Query: 823 ------GTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH 876
                   L   RH  L  L   +     +  V  + +GG L  F H    +        
Sbjct: 54  HTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRAR 111
Query: 877 KIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD 936
               +I  AL YLH      +V+RD+K  N++LD++ +  ++DFGL +   + +      
Sbjct: 112 FYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKX 168
Query: 937 VAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
             GT  Y+APE           D +  GVV+ E++ G+
Sbjct: 169 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 88/218 (40%), Gaps = 30/218 (13%)
Query: 772 RATGN-FSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEI-------- 822
           R T N F    L+G G FG           ++ VK+ + GR+  ++    E+        
Sbjct: 144 RVTMNEFEYLKLLGKGTFGK----------VILVKEKATGRYYAMKILKKEVIVAKDEVA 193
Query: 823 ------GTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH 876
                   L   RH  L  L   +     +  V  + +GG L  F H    +        
Sbjct: 194 HTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRAR 251
Query: 877 KIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD 936
               +I  AL YLH      +V+RD+K  N++LD++ +  ++DFGL +   + +      
Sbjct: 252 FYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKT 308
Query: 937 VAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
             GT  Y+APE           D +  GVV+ E++ G+
Sbjct: 309 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 88/218 (40%), Gaps = 30/218 (13%)
Query: 772 RATGN-FSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEI-------- 822
           R T N F    L+G G FG           ++ VK+ + GR+  ++    E+        
Sbjct: 147 RVTMNEFEYLKLLGKGTFGK----------VILVKEKATGRYYAMKILKKEVIVAKDEVA 196
Query: 823 ------GTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH 876
                   L   RH  L  L   +     +  V  + +GG L  F H    +        
Sbjct: 197 HTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRAR 254
Query: 877 KIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD 936
               +I  AL YLH      +V+RD+K  N++LD++ +  ++DFGL +   + +      
Sbjct: 255 FYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKT 311
Query: 937 VAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
             GT  Y+APE           D +  GVV+ E++ G+
Sbjct: 312 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 56/203 (27%), Positives = 90/203 (44%), Gaps = 16/203 (7%)
Query: 816  QQFDAEIGTLGRIRHKNLVTLIGYY----VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQ 871
            Q+F  E   L  ++H N+V     +     G+  + LV    + G L+T++ +    KI+
Sbjct: 70   QRFKEEAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIK 129
Query: 872  WSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVSE 930
              V+      I + L +LH +  P I+HRD+K  NI +     +  + D GLA L   S 
Sbjct: 130  --VLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF 186
Query: 931  THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
              A   V GT  + APE     +  +  DVY+FG   LE  + +      +SE  N   I
Sbjct: 187  AKA---VIGTPEFXAPEXYEE-KYDESVDVYAFGXCXLEXATSEY----PYSECQNAAQI 238
Query: 991  VSWAKLLIKEGRSSELFLPELWE 1013
                   +K     ++ +PE+ E
Sbjct: 239  YRRVTSGVKPASFDKVAIPEVKE 261

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 96/250 (38%), Gaps = 58/250 (23%)
Query: 777 FSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFD--------AEIGTLGRI 828
           + ++  IG G +G    A  +     A++ + I     I+Q +         E+  + ++
Sbjct: 28  YHLKGAIGQGSYGVVRVA--IENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNL----ETFIHKKSGK------KIQW------ 872
            H N+  L   Y  E  + LV     GG+L      FI   +GK      K Q       
Sbjct: 86  HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145
Query: 873 ----------------------SVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILL- 909
                                  +I  I   I  AL YLH      I HRDIKP N L  
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFS 202
Query: 910 -DEELNAYLSDFGLAR---LLEVSETHATTDVAGTFGYVAPEYATTCRVS--DKADVYSF 963
            ++     L DFGL++    L   E +  T  AGT  +VAPE   T   S   K D +S 
Sbjct: 203 TNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262
Query: 964 GVVLLELISG 973
           GV+L  L+ G
Sbjct: 263 GVLLHLLLMG 272

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 110/255 (43%), Gaps = 31/255 (12%)
Query: 783  IGTGGFGSTYKAE------LVPGYLVAVKKLSIGRFQGIQQ-FDAEIGTLGRI-RHKNLV 834
            +G G FG   +A+            VAVK L  G      +   +E+  L  I  H N+V
Sbjct: 35   LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 835  TLIGYYVGEA-EMFLVYNFLSGGNLETFIHKKSGKKIQWSV----IHKIAIDIAQALAY- 888
             L+G        + ++  F   GNL T++  K  + + + V    ++K  + +   + Y 
Sbjct: 95   NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 889  ------LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGTF 941
                  + +    + +HRD+   NILL E+    + DFGLAR + +  +     D     
Sbjct: 155  FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 214
Query: 942  GYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEG 1001
             ++APE       + ++DV+SFGV+L E+ S   S  P       G  I       +KEG
Sbjct: 215  KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP-------GVKIDEEFCRRLKEG 267
Query: 1002 ---RSSELFLPELWE 1013
               R+ +   PE+++
Sbjct: 268  TRMRAPDYTTPEMYQ 282

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 109/255 (42%), Gaps = 31/255 (12%)
Query: 783  IGTGGFGSTYKAE------LVPGYLVAVKKLSIGRFQGIQQ-FDAEIGTLGRI-RHKNLV 834
            +G G FG   +A+            VAVK L  G      +   +E+  L  I  H N+V
Sbjct: 35   LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 835  TLIGYYVGEA-EMFLVYNFLSGGNLETFIHKKSGKKIQWSV----IHKIAIDIAQALAY- 888
             L+G        + ++  F   GNL T++  K  + + + V    ++K  + +   + Y 
Sbjct: 95   NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 889  ------LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT-DVAGTF 941
                  + +    + +HRD+   NILL E+    + DFGLAR +     +    D     
Sbjct: 155  FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 214
Query: 942  GYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEG 1001
             ++APE       + ++DV+SFGV+L E+ S   S  P       G  I       +KEG
Sbjct: 215  KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP-------GVKIDEEFCRRLKEG 267
Query: 1002 ---RSSELFLPELWE 1013
               R+ +   PE+++
Sbjct: 268  TRMRAPDYTTPEMYQ 282

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV- 841
           +G G +G  ++     G  VAVK  S  R +     + E+     +RH+N++  I   + 
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVKIFS-SRDEKSWFRETELYNTVMLRHENILGFIASDMT 102
Query: 842 ---GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV---- 894
                 +++L+ ++   G+L  ++   +   +      +I + IA  LA+LH        
Sbjct: 103 SRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVS---CLRIVLSIASGLAHLHIEIFGTQG 159
Query: 895 -PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDV-----AGTFGYVAPEY 948
            P I HRD+K  NIL+ +     ++D GLA +   S++    DV      GT  Y+APE 
Sbjct: 160 KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH--SQSTNQLDVGNNPRVGTKRYMAPEV 217
Query: 949 -ATTCRVS-----DKADVYSFGVVLLEL 970
              T +V       + D+++FG+VL E+
Sbjct: 218 LDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 100/215 (46%), Gaps = 27/215 (12%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
           + ++   +G G +G  ++     G  VAVK  S  R +     + E+     +RH+N++ 
Sbjct: 9   DITLLECVGKGRYGEVWRGSW-QGENVAVKIFS-SRDEKSWFRETELYNTVMLRHENILG 66
Query: 836 LIGYYV----GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
            I   +       +++L+ ++   G+L  ++   +   +      +I + IA  LA+LH 
Sbjct: 67  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVS---CLRIVLSIASGLAHLHI 123
Query: 892 SCV-----PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDV-----AGTF 941
                   P I HRD+K  NIL+ +     ++D GLA +   S++    DV      GT 
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH--SQSTNQLDVGNNPRVGTK 181
Query: 942 GYVAPEY-ATTCRVS-----DKADVYSFGVVLLEL 970
            Y+APE    T +V       + D+++FG+VL E+
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 114/281 (40%), Gaps = 29/281 (10%)
Query: 764  ELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIG 823
            ++ +D+V      + +  +IG G FG   KA     +     K+     +  +Q   EI 
Sbjct: 89   QVPHDHVAY---RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR 145
Query: 824  TLGRIRHK------NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHK 877
             L  +R +      N++ ++  +     + + +  LS  NL   I K   +     ++ K
Sbjct: 146  ILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRK 204
Query: 878  IAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLS--DFGLARLLEVSETHATT 935
             A  I Q L  LH +   RI+H D+KP NILL ++  + +   DFG +           T
Sbjct: 205  FAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYT 258
Query: 936  DVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAK 995
             +   F Y APE     R     D++S G +L EL++G     P       G  +    +
Sbjct: 259  XIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELLTGY----PLLPGEDEGDQLACMIE 313
Query: 996  LLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLS 1036
            LL   G  S+  L     A   +N +        CTV TLS
Sbjct: 314  LL---GMPSQKLLDASKRA---KNFVSXKGYPRYCTVTTLS 348

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 25/214 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHK---- 831
           +F I  +IG G FG     ++     +   K+ + +++ +++  AE       R      
Sbjct: 75  DFEIIKVIGRGAFGEVAVVKMKNTERIYAMKI-LNKWEMLKR--AETACFREERDVLVNG 131
Query: 832 --NLVTLIGY-YVGEAEMFLVYNFLSGGNLETFIHKKSGK---KIQWSVIHKIAIDIAQA 885
               +T + Y +  E  ++LV ++  GG+L T + K   K    +    I ++ + I  +
Sbjct: 132 DCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAI-DS 190
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
           +  LHY      VHRDIKP N+LLD   +  L+DFG    +    T  ++   GT  Y++
Sbjct: 191 IHQLHY------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYIS 244
Query: 946 PEYATTC-----RVSDKADVYSFGVVLLELISGK 974
           PE          +   + D +S GV + E++ G+
Sbjct: 245 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 278

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 54/220 (24%), Positives = 89/220 (40%), Gaps = 30/220 (13%)
Query: 770 VVRATGN-FSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEI------ 822
           + R T N F    L+G G FG           ++ VK+ + GR+  ++    E+      
Sbjct: 3   MARVTMNEFEYLKLLGKGTFGK----------VILVKEKATGRYYAMKILKKEVIVAKDE 52
Query: 823 --------GTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSV 874
                     L   RH  L  L   +     +  V  + +GG  E F H    +      
Sbjct: 53  VAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG--ELFFHLSRERVFSEDR 110
Query: 875 IHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT 934
                 +I  AL YLH      +V+RD+K  N++LD++ +  ++DFGL +   + +    
Sbjct: 111 ARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATM 167
Query: 935 TDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
               GT  Y+APE           D +  GVV+ E++ G+
Sbjct: 168 KXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 110/255 (43%), Gaps = 31/255 (12%)
Query: 783  IGTGGFGSTYKAE------LVPGYLVAVKKLSIGRFQGIQQ-FDAEIGTLGRI-RHKNLV 834
            +G G FG   +A+            VAVK L  G      +   +E+  L  I  H N+V
Sbjct: 35   LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 835  TLIGYYVGEA-EMFLVYNFLSGGNLETFIHKKSGKKIQWSV----IHKIAIDIAQALAY- 888
             L+G        + ++  F   GNL T++  K  + + + V    ++K  + +   + Y 
Sbjct: 95   NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 889  ------LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGTF 941
                  + +    + +HRD+   NILL E+    + DFGLAR + +  +     D     
Sbjct: 155  FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPL 214
Query: 942  GYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEG 1001
             ++APE       + ++DV+SFGV+L E+ S   S  P       G  I       +KEG
Sbjct: 215  KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP-------GVKIDEEFCRRLKEG 267
Query: 1002 ---RSSELFLPELWE 1013
               R+ +   PE+++
Sbjct: 268  TRMRAPDYTTPEMYQ 282

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 109/255 (42%), Gaps = 31/255 (12%)
Query: 783  IGTGGFGSTYKAE------LVPGYLVAVKKLSIGRFQGIQQ-FDAEIGTLGRI-RHKNLV 834
            +G G FG   +A+            VAVK L  G      +   +E+  L  I  H N+V
Sbjct: 72   LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 835  TLIGYYVGEA-EMFLVYNFLSGGNLETFIHKKSGKKIQWSV----IHKIAIDIAQALAY- 888
             L+G        + ++  F   GNL T++  K  + + + V    ++K  + +   + Y 
Sbjct: 132  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 889  ------LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT-DVAGTF 941
                  + +    + +HRD+   NILL E+    + DFGLAR +     +    D     
Sbjct: 192  FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 251
Query: 942  GYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEG 1001
             ++APE       + ++DV+SFGV+L E+ S   S  P       G  I       +KEG
Sbjct: 252  KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP-------GVKIDEEFCRRLKEG 304
Query: 1002 ---RSSELFLPELWE 1013
               R+ +   PE+++
Sbjct: 305  TRMRAPDYTTPEMYQ 319

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 21/201 (10%)
Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTLIG 838
           IG+G  G    A + V G  VAVKKLS   FQ     ++   E+  L  + HKN+++L+ 
Sbjct: 32  IGSGAQGIVCAAFDTVLGINVAVKKLS-RPFQNQTHAKRAYRELVLLKCVNHKNIISLLN 90
Query: 839 YYVGE------AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
            +  +       +++LV   +   NL   IH +   +    +++++   I     +LH +
Sbjct: 91  VFTPQKTLEEFQDVYLVMELMDA-NLCQVIHMELDHERMSYLLYQMLCGIK----HLHSA 145
Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
               I+HRD+KPSNI++  +    + DFGLAR          T    T  Y APE     
Sbjct: 146 ---GIIHRDLKPSNIVVKSDCTLKILDFGLART--ACTNFMMTPYVVTRYYRAPEVILGM 200
Query: 953 RVSDKADVYSFGVVLLELISG 973
             +   D++S G ++ EL+ G
Sbjct: 201 GYAANVDIWSVGCIMGELVKG 221

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 68/149 (45%), Gaps = 11/149 (7%)
Query: 840 YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVH 899
           Y G   + +V   L GG L + I  +  +        +I   I +A+ YLH      I H
Sbjct: 128 YAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSI---NIAH 184
Query: 900 RDIKPSNILL-DEELNAY--LSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD 956
           RD+KP N+L   +  NA   L+DFG A+  E +  ++ T    T  YVAPE     +   
Sbjct: 185 RDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDK 242
Query: 957 KADVYSFGVVLLELISGKRSLDPSFSEYG 985
             D +S GV+   L+ G     P +S +G
Sbjct: 243 SCDXWSLGVIXYILLCG---YPPFYSNHG 268

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 54/218 (24%), Positives = 88/218 (40%), Gaps = 30/218 (13%)
Query: 772 RATGN-FSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEI-------- 822
           R T N F    L+G G FG           ++ VK+ + GR+  ++    E+        
Sbjct: 6   RVTMNEFEYLKLLGKGTFGK----------VILVKEKATGRYYAMKILKKEVIVAKDEVA 55
Query: 823 ------GTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH 876
                   L   RH  L  L   +     +  V  + +GG  E F H    +        
Sbjct: 56  HTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG--ELFFHLSRERVFSEDRAR 113
Query: 877 KIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD 936
               +I  AL YLH      +V+RD+K  N++LD++ +  ++DFGL +   + +      
Sbjct: 114 FYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKX 170
Query: 937 VAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
             GT  Y+APE           D +  GVV+ E++ G+
Sbjct: 171 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 25/214 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHK---- 831
           +F I  +IG G FG     ++     +   K+ + +++ +++  AE       R      
Sbjct: 91  DFEIIKVIGRGAFGEVAVVKMKNTERIYAMKI-LNKWEMLKR--AETACFREERDVLVNG 147
Query: 832 --NLVTLIGY-YVGEAEMFLVYNFLSGGNLETFIHKKSGK---KIQWSVIHKIAIDIAQA 885
               +T + Y +  E  ++LV ++  GG+L T + K   K    +    I ++ + I  +
Sbjct: 148 DCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAI-DS 206
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
           +  LHY      VHRDIKP N+LLD   +  L+DFG    +    T  ++   GT  Y++
Sbjct: 207 IHQLHY------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYIS 260
Query: 946 PEYATTC-----RVSDKADVYSFGVVLLELISGK 974
           PE          +   + D +S GV + E++ G+
Sbjct: 261 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 294

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 19/219 (8%)
Query: 763 AELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEI 822
            ++ +D+V      + +  +IG G FG   KA     +     K+     +  +Q   EI
Sbjct: 88  VQVPHDHVAY---RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEI 144
Query: 823 GTLGRIRHK------NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH 876
             L  +R +      N++ ++  +     + + +  LS  NL   I K   +     ++ 
Sbjct: 145 RILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVR 203
Query: 877 KIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLS--DFGLARLLEVSETHAT 934
           K A  I Q L  LH +   RI+H D+KP NILL ++  + +   DFG +           
Sbjct: 204 KFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVY 257
Query: 935 TDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
           T +   F Y APE     R     D++S G +L EL++G
Sbjct: 258 TXIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 27/208 (12%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV- 841
           +G G +G  ++     G  VAVK  S  R +     + E+     +RH+N++  I   + 
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFS-SRDEKSWFRETELYNTVMLRHENILGFIASDMT 73
Query: 842 ---GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV---- 894
                 +++L+ ++   G+L  ++   +   +      +I + IA  LA+LH        
Sbjct: 74  SRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVS---CLRIVLSIASGLAHLHIEIFGTQG 130
Query: 895 -PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDV-----AGTFGYVAPEY 948
            P I HRD+K  NIL+ +     ++D GLA +   S++    DV      GT  Y+APE 
Sbjct: 131 KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH--SQSTNQLDVGNNPRVGTKRYMAPEV 188
Query: 949 -ATTCRVS-----DKADVYSFGVVLLEL 970
              T +V       + D+++FG+VL E+
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 69/133 (51%), Gaps = 6/133 (4%)
Query: 846 MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPS 905
           ++ V  +++GG+L   I +    K   +V +  A +IA  L +L       I++RD+K  
Sbjct: 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY--AAEIAIGLFFLQSKG---IIYRDLKLD 471
Query: 906 NILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGV 965
           N++LD E +  ++DFG+ +   + +   T    GT  Y+APE           D ++FGV
Sbjct: 472 NVMLDSEGHIKIADFGMCK-ENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGV 530
Query: 966 VLLELISGKRSLD 978
           +L E+++G+   +
Sbjct: 531 LLYEMLAGQAPFE 543

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 21/211 (9%)
Query: 783 IGTGGFGSTYKAE------LVPGYLVAVKKLSIGRFQGIQQ-FDAEIGTLGRI-RHKNLV 834
           +G G FG   +A+            VAVK L  G      +   +E+  L  I  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 835 TLIGYYVGEA-EMFLVYNFLSGGNLETFIHKKSGKKIQWSV----IHKIAIDIAQALAY- 888
            L+G        + ++  F   GNL T++  K  + + + V    ++K  + +   + Y 
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 889 ------LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGTF 941
                 + +    + +HRD+   NILL E+    + DFGLAR + +  +     D     
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 205
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
            ++APE       + ++DV+SFGV+L E+ S
Sbjct: 206 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 101/228 (44%), Gaps = 25/228 (10%)
Query: 767 YDNVVRATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTL 825
           + N ++ T  + ++  IG G +    +          AVK +   +    +    EI  L
Sbjct: 14  HRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEIL 69
Query: 826 GRI-RHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKIAIDIA 883
            R  +H N++TL   Y     +++V   + GG L +  + +K   + + S +      I 
Sbjct: 70  LRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV---LFTIT 126
Query: 884 QALAYLHYSCVPRIVHRDIKPSNIL-LDEELNA---YLSDFGLARLLEVSETHATTDVAG 939
           + + YLH   V   VHRD+KPSNIL +DE  N     + DFG A+ L  +E         
Sbjct: 127 KTVEYLHAQGV---VHRDLKPSNILYVDESGNPESIRICDFGFAKQLR-AENGLLMTPCY 182
Query: 940 TFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNG 987
           T  +VAPE           D++S GV+L  +++G       ++ + NG
Sbjct: 183 TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG-------YTPFANG 223

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 69/133 (51%), Gaps = 6/133 (4%)
Query: 846 MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPS 905
           ++ V  +++GG+L   I +    K   +V +  A +IA  L +L       I++RD+K  
Sbjct: 96  LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY--AAEIAIGLFFLQSKG---IIYRDLKLD 150
Query: 906 NILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGV 965
           N++LD E +  ++DFG+ +   + +   T    GT  Y+APE           D ++FGV
Sbjct: 151 NVMLDSEGHIKIADFGMCK-ENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGV 209
Query: 966 VLLELISGKRSLD 978
           +L E+++G+   +
Sbjct: 210 LLYEMLAGQAPFE 222

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 781 NLIGTGGFGSTYKAELVP-------GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNL 833
            ++G+G FG+ +K   +P          + V +   GR Q  Q     +  +G + H ++
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR-QSFQAVTDHMLAIGSLDHAHI 77
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
           V L+G   G + + LV  +L  G+L   + +  G  +   ++    + IA+ + YL    
Sbjct: 78  VRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGA-LGPQLLLNWGVQIAKGMYYLEEHG 135
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT-FGYVAPEYATTC 952
              +VHR++   N+LL       ++DFG+A LL   +       A T   ++A E     
Sbjct: 136 ---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 192
Query: 953 RVSDKADVYSFGVVLLELIS 972
           + + ++DV+S+GV + EL++
Sbjct: 193 KYTHQSDVWSYGVTVWELMT 212

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 110/245 (44%), Gaps = 44/245 (17%)
Query: 764 ELTYDNVVRATGNFSIRNLIGTGGFGSTYKA----ELVPGYLVAVKKLSIGRFQGIQQFD 819
           E  Y+ V + +  F I + IG G F S Y A    ++ P   +A+K L I     I+   
Sbjct: 10  EKLYEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHL-IPTSHPIR-IA 67
Query: 820 AEIGTLGRIRHKNLVTLIGY-YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKI 878
           AE+  L     ++ V  + Y +     + +   +L     E+F+   +   + +  + + 
Sbjct: 68  AELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEH---ESFLDILNS--LSFQEVREY 122
Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLAR--------LLEVS 929
            +++ +AL  +H      IVHRD+KPSN L +  L  Y L DFGLA+        LL+  
Sbjct: 123 MLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFV 179
Query: 930 ETHATTD-------------------VAGTFGYVAPEYATTCRVSDKA-DVYSFGVVLLE 969
           ++ A  +                    AGT G+ APE  T C     A D++S GV+ L 
Sbjct: 180 QSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLS 239
Query: 970 LISGK 974
           L+SG+
Sbjct: 240 LLSGR 244

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 109/255 (42%), Gaps = 31/255 (12%)
Query: 783  IGTGGFGSTYKAE------LVPGYLVAVKKLSIGRFQGIQQ-FDAEIGTLGRI-RHKNLV 834
            +G G FG   +A+            VAVK L  G      +   +E+  L  I  H N+V
Sbjct: 26   LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 835  TLIGYYVGEA-EMFLVYNFLSGGNLETFIHKKSGKKIQWSV----IHKIAIDIAQALAY- 888
             L+G        + ++  F   GNL T++  K  + + + V    ++K  + +   + Y 
Sbjct: 86   NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 889  ------LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT-DVAGTF 941
                  + +    + +HRD+   NILL E+    + DFGLAR +     +    D     
Sbjct: 146  FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 205
Query: 942  GYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEG 1001
             ++APE       + ++DV+SFGV+L E+ S   S  P       G  I       +KEG
Sbjct: 206  KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP-------GVKIDEEFCRRLKEG 258
Query: 1002 ---RSSELFLPELWE 1013
               R+ +   PE+++
Sbjct: 259  TRMRAPDYTTPEMYQ 273

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 21/211 (9%)
Query: 783 IGTGGFGSTYKAE------LVPGYLVAVKKLSIGRFQGIQQ-FDAEIGTLGRI-RHKNLV 834
           +G G FG   +A+            VAVK L  G      +   +E+  L  I  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 835 TLIGYYVGEA-EMFLVYNFLSGGNLETFIHKKSGKKIQWSV----IHKIAIDIAQALAY- 888
            L+G        + ++  F   GNL T++  K  + + + V    ++K  + +   + Y 
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 889 ------LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGTF 941
                 + +    + +HRD+   NILL E+    + DFGLAR + +  +     D     
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 205
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
            ++APE       + ++DV+SFGV+L E+ S
Sbjct: 206 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 21/211 (9%)
Query: 783 IGTGGFGSTYKAE------LVPGYLVAVKKLSIGRFQGIQQ-FDAEIGTLGRI-RHKNLV 834
           +G G FG   +A+            VAVK L  G      +   +E+  L  I  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 835 TLIGYYVGEA-EMFLVYNFLSGGNLETFIHKKSGKKIQWSV----IHKIAIDIAQALAY- 888
            L+G        + ++  F   GNL T++  K  + + + V    ++K  + +   + Y 
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 889 ------LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT-DVAGTF 941
                 + +    + +HRD+   NILL E+    + DFGLAR +     +    D     
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 205
Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
            ++APE       + ++DV+SFGV+L E+ S
Sbjct: 206 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 28/75 (37%), Positives = 41/75 (54%)
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           HRD+KP NIL+  +  AYL DFG+A      +     +  GT  Y APE  +    + +A
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRA 216
Query: 959 DVYSFGVVLLELISG 973
           D+Y+   VL E ++G
Sbjct: 217 DIYALTCVLYECLTG 231

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 109/254 (42%), Gaps = 30/254 (11%)
Query: 783  IGTGGFGSTYKAE------LVPGYLVAVKKLSIGRFQGIQQ-FDAEIGTLGRI-RHKNLV 834
            +G G FG   +A+            VAVK L  G      +   +E+  L  I  H N+V
Sbjct: 36   LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 835  TLIGYYVGEA-EMFLVYNFLSGGNLETFIHKKSGKKIQWSV---IHKIAIDIAQALAY-- 888
             L+G        + ++  F   GNL T++  K  + + +     ++K  + +   + Y  
Sbjct: 96   NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 889  -----LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGTFG 942
                 + +    + +HRD+   NILL E+    + DFGLAR + +  +     D      
Sbjct: 156  QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLK 215
Query: 943  YVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEG- 1001
            ++APE       + ++DV+SFGV+L E+ S   S  P       G  I       +KEG 
Sbjct: 216  WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP-------GVKIDEEFCRRLKEGT 268
Query: 1002 --RSSELFLPELWE 1013
              R+ +   PE+++
Sbjct: 269  RMRAPDYTTPEMYQ 282

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 49/195 (25%), Positives = 91/195 (46%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           IGTG FG     + +  G   A+K   K  + + + I+    E   L  +    LV L  
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  ++ GG++  F H +   +         A  I     YLH      ++
Sbjct: 109 SFKDNSNLYMVMEYMPGGDM--FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+L+D++    ++DFG A+ ++      T  + GT  Y+APE   +   +   
Sbjct: 164 YRDLKPENLLIDQQGYIKVADFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 111/284 (39%), Gaps = 32/284 (11%)
Query: 762  PAELTYDNVVRATGN-FSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSI-GRFQ 813
            P +L YD+      N  S    +G G FG   +A             VAVK L       
Sbjct: 9    PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT 68
Query: 814  GIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKI-- 870
              +   +E+  L  +  H N+V L+G         ++  +   G+L  F+ +K    I  
Sbjct: 69   EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 128
Query: 871  --------------QWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY 916
                              +   +  +A+ +A+L        +HRD+   NILL       
Sbjct: 129  KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITK 185
Query: 917  LSDFGLARLLEVSETHATTDVAG-TFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKR 975
            + DFGLAR ++    +     A     ++APE    C  + ++DV+S+G+ L EL S   
Sbjct: 186  ICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 245
Query: 976  SLDPSFSEYGNGFNIVSWA-KLLIKEGRSSELF--LPELWEAGP 1016
            S  P        + ++    ++L  E   +E++  +   W+A P
Sbjct: 246  SPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADP 289

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 111/284 (39%), Gaps = 32/284 (11%)
Query: 762  PAELTYDNVVRATGN-FSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSI-GRFQ 813
            P +L YD+      N  S    +G G FG   +A             VAVK L       
Sbjct: 25   PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT 84
Query: 814  GIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKI-- 870
              +   +E+  L  +  H N+V L+G         ++  +   G+L  F+ +K    I  
Sbjct: 85   EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 144
Query: 871  --------------QWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY 916
                              +   +  +A+ +A+L        +HRD+   NILL       
Sbjct: 145  KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITK 201
Query: 917  LSDFGLARLLEVSETHATTDVAG-TFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKR 975
            + DFGLAR ++    +     A     ++APE    C  + ++DV+S+G+ L EL S   
Sbjct: 202  ICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 261
Query: 976  SLDPSFSEYGNGFNIVSWA-KLLIKEGRSSELF--LPELWEAGP 1016
            S  P        + ++    ++L  E   +E++  +   W+A P
Sbjct: 262  SPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADP 305

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 90/195 (46%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGST----YKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +GTG FG      +K       +  + K  + + + I+    E   L  +    LV L  
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  +++GG  E F H +   +         A  I     YLH      ++
Sbjct: 130 SFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 184
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+L+D++    ++DFG A+ ++     AT  + GT  Y+APE   +   +   
Sbjct: 185 YRDLKPENLLIDQQGYIQVTDFGFAKRVK----GATWTLCGTPEYLAPEIILSKGYNKAV 240
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 241 DWWALGVLIYEMAAG 255

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 106/252 (42%), Gaps = 24/252 (9%)
Query: 748 ASLRGQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKK 806
           A  +G   ++ +  P+  + D   R T        +G G +G  YKA + V    VA+K+
Sbjct: 14  AQTQGPGSMSVSAAPSATSIDRYRRITK-------LGEGTYGEVYKAIDTVTNETVAIKR 66
Query: 807 LSIGRFQGIQQFDA--EIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHK 864
           + +   +      A  E+  L  ++H+N++ L         + L++ + +  +L+ ++ K
Sbjct: 67  IRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY-AENDLKKYMDK 125
Query: 865 KSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILL-----DEELNAYLSD 919
                +   VI      +   + + H     R +HRD+KP N+LL      E     + D
Sbjct: 126 NPD--VSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGD 180
Query: 920 FGLARLLEVSETHATTDVAGTFGYVAPEYATTCR-VSDKADVYSFGVVLLELISGKRSLD 978
           FGLAR   +     T ++  T  Y  PE     R  S   D++S   +  E++  K  L 
Sbjct: 181 FGLARAFGIPIRQFTHEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLM-KTPLF 238
Query: 979 PSFSEYGNGFNI 990
           P  SE    F I
Sbjct: 239 PGDSEIDQLFKI 250

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 91/195 (46%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           IGTG FG     + +  G   A+K   K  + + + I+    E   L  +    LV L  
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  ++ GG++  F H +   +         A  I     YLH      ++
Sbjct: 109 SFKDNSNLYMVMEYMPGGDM--FSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+L+D++    ++DFG A+ ++      T  + GT  Y+APE   +   +   
Sbjct: 164 YRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 84/159 (52%), Gaps = 21/159 (13%)
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSG-KKIQWSVIHKIAIDIAQALAY 888
           H+N++ LI ++  E   +LV+  + GG++ + IHK+    +++ SV+ +   D+A AL +
Sbjct: 70  HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ---DVASALDF 126
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELN---AYLSDFGLARLLEVS------ETHATTDVAG 939
           LH      I HRD+KP NIL +         + DFGL   ++++       T       G
Sbjct: 127 LHNK---GIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCG 183
Query: 940 TFGYVAPE----YATTCRVSDK-ADVYSFGVVLLELISG 973
           +  Y+APE    ++    + DK  D++S GV+L  L+SG
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 19/218 (8%)
Query: 764 ELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIG 823
           ++ +D+V      + +  +IG G FG   KA     +     K+     +  +Q   EI 
Sbjct: 89  QVPHDHVAY---RYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR 145
Query: 824 TLGRIRHK------NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHK 877
            L  +R +      N++ ++  +     + + +  LS  NL   I K   +     ++ K
Sbjct: 146 ILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRK 204
Query: 878 IAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLS--DFGLARLLEVSETHATT 935
            A  I Q L  LH +   RI+H D+KP NILL ++  + +   DFG +      E     
Sbjct: 205 FAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVY 257
Query: 936 DVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
               +  Y APE     R     D++S G +L EL++G
Sbjct: 258 XXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 111/284 (39%), Gaps = 32/284 (11%)
Query: 762  PAELTYDNVVRATGN-FSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSI-GRFQ 813
            P +L YD+      N  S    +G G FG   +A             VAVK L       
Sbjct: 32   PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT 91
Query: 814  GIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKI-- 870
              +   +E+  L  +  H N+V L+G         ++  +   G+L  F+ +K    I  
Sbjct: 92   EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 151
Query: 871  --------------QWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY 916
                              +   +  +A+ +A+L        +HRD+   NILL       
Sbjct: 152  KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITK 208
Query: 917  LSDFGLARLLEVSETHATTDVAG-TFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKR 975
            + DFGLAR ++    +     A     ++APE    C  + ++DV+S+G+ L EL S   
Sbjct: 209  ICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 268
Query: 976  SLDPSFSEYGNGFNIVSWA-KLLIKEGRSSELF--LPELWEAGP 1016
            S  P        + ++    ++L  E   +E++  +   W+A P
Sbjct: 269  SPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADP 312

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 111/284 (39%), Gaps = 32/284 (11%)
Query: 762  PAELTYDNVVRATGN-FSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSI-GRFQ 813
            P +L YD+      N  S    +G G FG   +A             VAVK L       
Sbjct: 27   PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT 86
Query: 814  GIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKI-- 870
              +   +E+  L  +  H N+V L+G         ++  +   G+L  F+ +K    I  
Sbjct: 87   EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 146
Query: 871  --------------QWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY 916
                              +   +  +A+ +A+L        +HRD+   NILL       
Sbjct: 147  KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITK 203
Query: 917  LSDFGLARLLEVSETHATTDVAG-TFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKR 975
            + DFGLAR ++    +     A     ++APE    C  + ++DV+S+G+ L EL S   
Sbjct: 204  ICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 263
Query: 976  SLDPSFSEYGNGFNIVSWA-KLLIKEGRSSELF--LPELWEAGP 1016
            S  P        + ++    ++L  E   +E++  +   W+A P
Sbjct: 264  SPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADP 307

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Composition-based stats.
 Identities = 60/226 (26%), Positives = 90/226 (39%), Gaps = 35/226 (15%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV 841
           +G GGF      E L  G+  A+K++     Q  ++   E        H N++ L+ Y +
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 842 GEA----EMFLVYNFLSGGNLETFIH--KKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
            E     E +L+  F   G L   I   K  G  +    I  + + I + L  +H     
Sbjct: 97  RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AK 153
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG---------------T 940
              HRD+KP+NILL +E    L D G       S   A   V G               T
Sbjct: 154 GYAHRDLKPTNILLGDEGQPVLMDLG-------SMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 941 FGYVAPEYATT---CRVSDKADVYSFGVVLLELISGKRSLDPSFSE 983
             Y APE  +    C + ++ DV+S G VL  ++ G+   D  F +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK 252

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 90/195 (46%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGST----YKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +GTG FG      +K       +  + K  + + + I+    E   L  +    LV L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  +++GG  E F H +   +         A  I     YLH      ++
Sbjct: 109 SFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+L+D++    ++DFG A+ ++      T  +AGT  Y+APE   +   +   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLAGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 40/158 (25%), Positives = 75/158 (47%), Gaps = 13/158 (8%)
Query: 818 FDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETF------IHKKSGKKIQ 871
           F  E+  +  I+++  +T  G      E++++Y ++   ++  F      + K     I 
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 872 WSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET 931
             VI  I   +  + +Y+H      I HRD+KPSNIL+D+     LSDFG +  +   + 
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207
Query: 932 HATTDVAGTFGYVAPEYAT--TCRVSDKADVYSFGVVL 967
             +    GT+ ++ PE+ +  +     K D++S G+ L
Sbjct: 208 KGSR---GTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 90/195 (46%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           IGTG FG     + +  G   A+K   K  + + + I+    E   L  +    LV L  
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  ++ GG  E F H +   +         A  I     YLH      ++
Sbjct: 109 SFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+L+D++    ++DFG A+ ++      T  + GT  Y+APE   +   +   
Sbjct: 164 YRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 65/284 (22%), Positives = 111/284 (39%), Gaps = 32/284 (11%)
Query: 762  PAELTYDNVVRATGN-FSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSI-GRFQ 813
            P +L YD+      N  S    +G G FG   +A             VAVK L       
Sbjct: 32   PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT 91
Query: 814  GIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKI-- 870
              +   +E+  L  +  H N+V L+G         ++  +   G+L  F+ +K    I  
Sbjct: 92   EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 151
Query: 871  --------------QWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY 916
                              +   +  +A+ +A+L        +HRD+   NILL       
Sbjct: 152  KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITK 208
Query: 917  LSDFGLARLLEVSETHATTDVAG-TFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKR 975
            + DFGLAR ++    +     A     ++APE    C  + ++DV+S+G+ L EL S   
Sbjct: 209  ICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 268
Query: 976  SLDPSFSEYGNGFNIVSWA-KLLIKEGRSSELF--LPELWEAGP 1016
            S  P        + ++    ++L  E   +E++  +   W+A P
Sbjct: 269  SPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADP 312

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 19/209 (9%)
Query: 783 IGTGGFGSTYKAE------LVPGYLVAVKKLSIGRFQGIQQ-FDAEIGTLGRI-RHKNLV 834
           +G G FG   +A+            VAVK L  G      +   +E+  L  I  H N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 835 TLIGYYVGEA-EMFLVYNFLSGGNLETFIHKKSGKKIQWSV--IHKIAIDIAQALAY--- 888
            L+G        + ++  F   GNL T++  K  + + +    ++K  + +   + Y   
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 889 ----LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGTFGY 943
               + +    + +HRD+   NILL E+    + DFGLAR + +  +     D      +
Sbjct: 157 VAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKW 216
Query: 944 VAPEYATTCRVSDKADVYSFGVVLLELIS 972
           +APE       + ++DV+SFGV+L E+ S
Sbjct: 217 MAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 111/241 (46%), Gaps = 32/241 (13%)
Query: 783  IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
            IG+G  G   + Y A L     VA+KKLS   FQ     ++   E+  +  + HKN++ L
Sbjct: 32   IGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYRELVLMKVVNHKNIIGL 88
Query: 837  IGYYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +  +  +       ++++V   +   NL   I  +   +    +++++ + I     +LH
Sbjct: 89   LNVFTPQKSLEEFQDVYIVMELMDA-NLSQVIQMELDHERMSYLLYQMLVGIK----HLH 143
Query: 891  YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
             +    I+HRD+KPSNI++  +    + DFGLAR    S     T    T  Y APE   
Sbjct: 144  SAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVIL 198
Query: 951  TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
                 +  D++S GV++ E+I G   L P         +I  W K++ + G  S  F+ +
Sbjct: 199  GMGYKENVDIWSVGVIMGEMIKGG-VLFPGTD------HIDQWNKVIEQLGTPSPEFMKK 251
Query: 1011 L 1011
            L
Sbjct: 252  L 252

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 91/195 (46%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +GTG FG     + +  G   A+K   K  + + + I+    E   L  +    LV L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  +++GG  E F H +   +         A  I     YLH      ++
Sbjct: 109 SFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+L+D++    ++DFG A+ ++      T  + GT  Y+APE   +   +   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 89/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGST----YKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +GTG FG      +K       +  + K  + + + I+    E   L  +    LV L  
Sbjct: 36  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 95
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  +++GG  E F H +   +         A  I     YLH      ++
Sbjct: 96  SFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 150
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+L+DE+    ++DFG A+ ++      T  + GT  Y+APE   +   +   
Sbjct: 151 YRDLKPENLLIDEQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAV 206
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 207 DWWALGVLIYEMAAG 221

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 111/241 (46%), Gaps = 32/241 (13%)
Query: 783  IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
            IG+G  G   + Y A L     VA+KKLS   FQ     ++   E+  +  + HKN++ L
Sbjct: 32   IGSGAQGIVVAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYRELVLMKVVNHKNIIGL 88
Query: 837  IGYYVGE------AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +  +  +       ++++V   +   NL   I  +   +    +++++ + I     +LH
Sbjct: 89   LNVFTPQKSLEEFQDVYIVMELMDA-NLSQVIQMELDHERMSYLLYQMLVGIK----HLH 143
Query: 891  YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
             +    I+HRD+KPSNI++  +    + DFGLAR    S     T    T  Y APE   
Sbjct: 144  SAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVIL 198
Query: 951  TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
                 +  D++S GV++ E+I G   L P         +I  W K++ + G  S  F+ +
Sbjct: 199  GMGYKENVDIWSVGVIMGEMIKGG-VLFPGTD------HIDQWNKVIEQLGTPSPEFMKK 251
Query: 1011 L 1011
            L
Sbjct: 252  L 252

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 108/255 (42%), Gaps = 31/255 (12%)
Query: 783  IGTGGFGSTYKAE------LVPGYLVAVKKLSIGRFQGIQQ-FDAEIGTLGRI-RHKNLV 834
            +G G FG   +A+            VAVK L  G      +   +E+  L  I  H N+V
Sbjct: 37   LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 835  TLIGYYVGEA-EMFLVYNFLSGGNLETFIHKKSGKKIQWSV----IHKIAIDIAQALAY- 888
             L+G        + ++  F   GNL T++  K  + + +      ++K  + +   + Y 
Sbjct: 97   NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 889  ------LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATT-DVAGTF 941
                  + +    + +HRD+   NILL E+    + DFGLAR +     +    D     
Sbjct: 157  FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 216
Query: 942  GYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEG 1001
             ++APE       + ++DV+SFGV+L E+ S   S  P       G  I       +KEG
Sbjct: 217  KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP-------GVKIDEEFCRRLKEG 269
Query: 1002 ---RSSELFLPELWE 1013
               R+ +   PE+++
Sbjct: 270  TRMRAPDYTTPEMYQ 284

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +GTG FG     + +  G   A+K   K  + + + I+    E   L  +    LV L  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  ++ GG  E F H +   +         A  I     YLH      ++
Sbjct: 110 SFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 164
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+L+D++    ++DFG A+ ++      T  + GT  Y+APE   +   +   
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 220
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 221 DWWALGVLIYEMAAG 235

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +GTG FG     + +  G   A+K   K  + + + I+    E   L  +    LV L  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  ++ GG  E F H +   +         A  I     YLH      ++
Sbjct: 110 SFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH---SLDLI 164
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+L+D++    ++DFG A+ ++      T  + GT  Y+APE   +   +   
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 220
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 221 DWWALGVLIYEMAAG 235

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +GTG FG     + +  G   A+K   K  + + + I+    E   L  +    LV L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  ++ GG  E F H +   +         A  I     YLH      ++
Sbjct: 109 SFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+L+D++    ++DFG A+ ++      T  + GT  Y+APE   +   +   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +GTG FG     + +  G   A+K   K  + + + I+    E   L  +    LV L  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  ++ GG  E F H +   +         A  I     YLH      ++
Sbjct: 110 SFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 164
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+L+D++    ++DFG A+ ++      T  + GT  Y+APE   +   +   
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEYLAPEIILSKGYNKAV 220
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 221 DWWALGVLIYEMAAG 235

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +GTG FG     + +  G   A+K   K  + + + I+    E   L  +    LV L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  ++ GG  E F H +   +         A  I     YLH      ++
Sbjct: 109 SFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+L+D++    ++DFG A+ ++      T  + GT  Y+APE   +   +   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +GTG FG     + +  G   A+K   K  + + + I+    E   L  +    LV L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  ++ GG  E F H +   +         A  I     YLH      ++
Sbjct: 109 SFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+L+D++    ++DFG A+ ++      T  + GT  Y+APE   +   +   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +GTG FG     + +  G   A+K   K  + + + I+    E   L  +    LV L  
Sbjct: 35  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 94
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  ++ GG  E F H +   +         A  I     YLH      ++
Sbjct: 95  SFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 149
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+L+D++    ++DFG A+ ++      T  + GT  Y+APE   +   +   
Sbjct: 150 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEYLAPEIILSKGYNKAV 205
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 206 DWWALGVLIYEMAAG 220

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +GTG FG     + +  G   A+K   K  + + + I+    E   L  +    LV L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  ++ GG  E F H +   +         A  I     YLH      ++
Sbjct: 109 SFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+L+D++    ++DFG A+ ++      T  + GT  Y+APE   +   +   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 88/206 (42%), Gaps = 16/206 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKA-------ELVPGYLVAVKKLSIGRFQG--IQQFDAEIGTLG 826
            +S  + +G+G FG  + A       E+V  ++   K L     +   + +   EI  L 
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 827 RIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQAL 886
           R+ H N++ ++  +  +    LV     G  L+ F       ++   +   I   +  A+
Sbjct: 85  RVEHANIIKVLDIFENQGFFQLVME-KHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143
Query: 887 AYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAP 946
            YL    +  I+HRDIK  NI++ E+    L DFG A  LE  +   T    GT  Y AP
Sbjct: 144 GYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT--FCGTIEYCAP 198
Query: 947 EYAT-TCRVSDKADVYSFGVVLLELI 971
           E          + +++S GV L  L+
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 51/198 (25%), Positives = 92/198 (46%), Gaps = 19/198 (9%)
Query: 783 IGTGGFGSTYKAELV----PGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
           +GTG FG   +  LV     G   A+K   K  + + + I+    E   L  +    LV 
Sbjct: 44  LGTGSFG---RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 100
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
           L   +   + +++V  +++GG  E F H +   +         A  I     YLH     
Sbjct: 101 LEFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL--- 155
Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVS 955
            +++RD+KP N+L+D++    ++DFG A+ ++      T  + GT  Y+APE   +   +
Sbjct: 156 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYN 211
Query: 956 DKADVYSFGVVLLELISG 973
              D ++ GV++ E+ +G
Sbjct: 212 KAVDWWALGVLIYEMAAG 229

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +GTG FG     + +  G   A+K   K  + + + I+    E   L  +    LV L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  ++ GG  E F H +   +         A  I     YLH      ++
Sbjct: 109 SFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+L+D++    ++DFG A+ ++      T  + GT  Y+APE   +   +   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 70/158 (44%), Gaps = 9/158 (5%)
Query: 821 EIGTLGRIRHKNLVTLIG--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKI 878
           EI  L R+RHKN++ L+   Y   + +M++V  +   G ++  +     K+      H  
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGY 114
Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVA 938
              +   L YLH      IVH+DIKP N+LL       +S  G+A  L       T   +
Sbjct: 115 FCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS 171
Query: 939 -GTFGYVAPEYATTCRVSD--KADVYSFGVVLLELISG 973
            G+  +  PE A         K D++S GV L  + +G
Sbjct: 172 QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +GTG FG     + +  G   A+K   K  + + + I+    E   L  +    LV L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  +  GG  E F H +   +         A  I     YLH      ++
Sbjct: 109 SFKDNSNLYMVMEYAPGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+++D++    ++DFGLA+ ++      T  + GT  Y+APE   +   +   
Sbjct: 164 YRDLKPENLMIDQQGYIQVTDFGLAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 99/228 (43%), Gaps = 25/228 (10%)
Query: 767 YDNVVRATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTL 825
           + N ++ T  + ++  IG G +    +          AVK +   +    +    EI  L
Sbjct: 14  HRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTE----EIEIL 69
Query: 826 GRI-RHKNLVTLIGYYVGEAEMFLVYNFLSGGNL-ETFIHKKSGKKIQWSVIHKIAIDIA 883
            R  +H N++TL   Y     +++V     GG L +  + +K   + + S +      I 
Sbjct: 70  LRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAV---LFTIT 126
Query: 884 QALAYLHYSCVPRIVHRDIKPSNIL-LDEELNA---YLSDFGLARLLEVSETHATTDVAG 939
           + + YLH   V   VHRD+KPSNIL +DE  N     + DFG A+ L  +E         
Sbjct: 127 KTVEYLHAQGV---VHRDLKPSNILYVDESGNPESIRICDFGFAKQLR-AENGLLXTPCY 182
Query: 940 TFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNG 987
           T  +VAPE           D++S GV+L   ++G       ++ + NG
Sbjct: 183 TANFVAPEVLERQGYDAACDIWSLGVLLYTXLTG-------YTPFANG 223

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 71/151 (47%), Gaps = 12/151 (7%)
Query: 842 GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
           G+  + ++   + GG L + I ++  +        +I  DI  A+ +LH      I HRD
Sbjct: 97  GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRD 153
Query: 902 IKPSNILL-DEELNAYL--SDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +KP N+L   +E +A L  +DFG A+  E ++    T     + YVAPE     +     
Sbjct: 154 VKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPY-YVAPEVLGPEKYDKSC 210
Query: 959 DVYSFGVVLLELISGKRSLDPSFSEYGNGFN 989
           D++S GV++  L+ G     P +S  G   +
Sbjct: 211 DMWSLGVIMYILLCG---FPPFYSNTGQAIS 238

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 67/259 (25%), Positives = 108/259 (41%), Gaps = 59/259 (22%)
Query: 783  IGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDA--EIGTLGRIRHKNLVTLIG- 838
            IG G FG  +KA     G  VA+KK+ +   +      A  EI  L  ++H+N+V LI  
Sbjct: 26   IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 839  -------YYVGEAEMFLVYNFLS---GGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
                   Y   +A ++LV++F      G L   +      K   S I ++   +   L Y
Sbjct: 86   CRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYY 140
Query: 889  LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR---LLEVSETHATTDVAGTFGYVA 945
            +H +   +I+HRD+K +N+L+  +    L+DFGLAR   L + S+ +   +   T  Y  
Sbjct: 141  IHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 946  PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVS-WAKLLIKEGRSS 1004
            P                      EL+ G+R   P    +G G  +   W +  I +G + 
Sbjct: 198  P----------------------ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 235
Query: 1005 ELFL-----------PELW 1012
            +  L           PE+W
Sbjct: 236  QHQLALISQLCGSITPEVW 254

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 89/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGST----YKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +GTG FG      +K       +  + K  + + + I+    E   L  +    LV L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  +++GG  E F H +   +         A  I     YLH      ++
Sbjct: 109 SFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+L+D++    ++DFG A+ ++      T  + GT  Y+APE   +   +   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +GTG FG     + +  G   A+K   K  + + + I+    E   L  +    LV L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  +  GG  E F H +   +         A  I     YLH      ++
Sbjct: 109 SFKDNSNLYMVMEYAPGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+++D++    ++DFGLA+ ++      T  + GT  Y+APE   +   +   
Sbjct: 164 YRDLKPENLMIDQQGYIKVTDFGLAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 88/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTY---KAELVPGYLVAV-KKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +GTG FG        E    Y + +  K  + + + I+    E   L  +    LV L  
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 101
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  ++ GG  E F H +   +         A  I     YLH      ++
Sbjct: 102 SFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 156
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+L+D++    ++DFG A+ ++      T  + GT  Y+APE   +   +   
Sbjct: 157 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 212
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 213 DWWALGVLIYEMAAG 227

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 88/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTY---KAELVPGYLVAV-KKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +GTG FG        E    Y + +  K  + + + I+    E   L  +    LV L  
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 101
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  ++ GG  E F H +   +         A  I     YLH      ++
Sbjct: 102 SFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH---SLDLI 156
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+L+D++    ++DFG A+ ++      T  + GT  Y+APE   +   +   
Sbjct: 157 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 212
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 213 DWWALGVLIYEMAAG 227

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 89/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGST----YKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +GTG FG      +K       +  + K  + + + I+    E   L  +    LV L  
Sbjct: 50  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  +++GG  E F H +   +         A  I     YLH      ++
Sbjct: 110 SFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 164
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+L+D++    ++DFG A+ ++      T  + GT  Y+APE   +   +   
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAV 220
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 221 DWWALGVLIYEMAAG 235

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 89/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGST----YKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +GTG FG      +K       +  + K  + + + I+    E   L  +    LV L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  +++GG  E F H +   +         A  I     YLH      ++
Sbjct: 109 SFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+L+D++    ++DFG A+ ++      T  + GT  Y+APE   +   +   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 89/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGST----YKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +GTG FG      +K       +  + K  + + + I+    E   L  +    LV L  
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  +++GG  E F H +   +         A  I     YLH      ++
Sbjct: 130 SFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH---SLDLI 184
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+L+D++    ++DFG A+ ++      T  + GT  Y+APE   +   +   
Sbjct: 185 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 240
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 241 DWWALGVLIYEMAAG 255

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/222 (22%), Positives = 100/222 (45%), Gaps = 20/222 (9%)
Query: 768 DNVVRATGNFSIRNLIGTGGFGSTYKAELVPG----YLVAVK--KLSIGRFQGIQQFDAE 821
           ++V+     F++  ++G G FGS  +A+L         VAVK  K  I     I++F  E
Sbjct: 16  EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75
Query: 822 IGTLGRIRHKNLVTLIGYYVGEAEM------FLVYNFLSGGNLETFI-HKKSGKK---IQ 871
              +    H ++  L+G  +            ++  F+  G+L  F+   + G+    + 
Sbjct: 76  AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP 135
Query: 872 WSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET 931
              + +  +DIA  + YL        +HRD+   N +L E++   ++DFGL+R +   + 
Sbjct: 136 LQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY 192
Query: 932 HATTDVAG-TFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
           +     +     ++A E       +  +DV++FGV + E+++
Sbjct: 193 YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 88/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTY---KAELVPGYLVAV-KKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +GTG FG        E    Y + +  K  + + + I+    E   L  +    LV L  
Sbjct: 70  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  ++ GG  E F H +   +         A  I     YLH      ++
Sbjct: 130 SFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 184
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+L+D++    ++DFG A+ ++      T  + GT  Y+APE   +   +   
Sbjct: 185 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 240
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 241 DWWALGVLIYEMAAG 255

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 89/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGST----YKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +GTG FG      +K       +  + K  + + + I+    E   L  +    LV L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  +++GG  E F H +   +         A  I     YLH      ++
Sbjct: 109 SFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+L+D++    ++DFG A+ ++      T  + GT  Y+APE   +   +   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 89/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGST----YKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +GTG FG      +K       +  + K  + + + I+    E   L  +    LV L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  +++GG  E F H +   +         A  I     YLH      ++
Sbjct: 109 SFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+L+D++    ++DFG A+ ++      T  + GT  Y+APE   +   +   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 86/163 (52%), Gaps = 16/163 (9%)
Query: 777 FSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLGRIRHKN 832
           + IR+LIGTG +G   +A + +   +VA+KK+ +  F+ +   ++   EI  L R+ H +
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI-LRVFEDLIDCKRILREIAILNRLNHDH 113
Query: 833 LVTLIGYYVGEA-----EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALA 887
           +V ++   + +      E+++V         + F   ++   +    I  +  ++   + 
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLF---RTPVYLTELHIKTLLYNLLVGVK 170
Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE 930
           Y+H +    I+HRD+KP+N L++++ +  + DFGLAR ++  E
Sbjct: 171 YVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 89/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGST----YKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +GTG FG      +K       +  + K  + + + I+    E   L  +    LV L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  +++GG  E F H +   +         A  I     YLH      ++
Sbjct: 109 SFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+L+D++    ++DFG A+ ++      T  + GT  Y+APE   +   +   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLXGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 89/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGST----YKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +GTG FG      +K       +  + K  + + + I+    E   L  +    LV L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  +++GG  E F H +   +         A  I     YLH      ++
Sbjct: 109 SFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+L+D++    ++DFG A+ ++      T  + GT  Y+APE   +   +   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 89/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGST----YKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +GTG FG      +K       +  + K  + + + I+    E   L  +    LV L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  +++GG  E F H +   +         A  I     YLH      ++
Sbjct: 109 SFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+L+D++    ++DFG A+ ++      T  + GT  Y+APE   +   +   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 96/214 (44%), Gaps = 16/214 (7%)
Query: 767 YDNVVRATGNFSIRNLIGTGGFGSTYKAELVP----GYLVAVK---KLSIGRFQGIQQFD 819
           ++N  + T +      I T G GS  +  LV     G   A+K   K  + + + I+   
Sbjct: 30  WENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTL 89
Query: 820 AEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
            E   L  +    LV L   +   + +++V  ++ GG  E F H +   +         A
Sbjct: 90  NEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEPHARFYA 147
Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG 939
             I     YLH      +++RD+KP N+L+D++    ++DFG A+ ++      T  + G
Sbjct: 148 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCG 200
Query: 940 TFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
           T  Y+APE   +   +   D ++ GV++ E+ +G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 88/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTY---KAELVPGYLVAV-KKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +GTG FG        E    Y + +  K  + + + I+    E   L  +    LV L  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  ++ GG  E F H +   +         A  I     YLH      ++
Sbjct: 110 SFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 164
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+L+D++    ++DFG A+ ++      T  + GT  Y+APE   +   +   
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 220
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 221 DWWALGVLIYEMAAG 235

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 89/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGST----YKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +GTG FG      +K       +  + K  + + + I+    E   L  +    LV L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  +++GG  E F H +   +         A  I     YLH      ++
Sbjct: 109 SFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+L+D++    ++DFG A+ ++      T  + GT  Y+APE   +   +   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 42/151 (27%), Positives = 71/151 (47%), Gaps = 12/151 (7%)
Query: 842 GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
           G+  + ++   + GG L + I ++  +        +I  DI  A+ +LH      I HRD
Sbjct: 78  GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRD 134
Query: 902 IKPSNILL-DEELNAYL--SDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +KP N+L   +E +A L  +DFG A+  E ++    T     + YVAPE     +     
Sbjct: 135 VKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPY-YVAPEVLGPEKYDKSC 191
Query: 959 DVYSFGVVLLELISGKRSLDPSFSEYGNGFN 989
           D++S GV++  L+ G     P +S  G   +
Sbjct: 192 DMWSLGVIMYILLCG---FPPFYSNTGQAIS 219

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 89/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGST----YKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +GTG FG      +K       +  + K  + + + I+    E   L  +    LV L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  +++GG  E F H +   +         A  I     YLH      ++
Sbjct: 109 SFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+L+D++    ++DFG A+ ++      T  + GT  Y+APE   +   +   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 52/214 (24%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 777 FSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFD-----AEIGTLGRIRHK 831
           + I   +G G FG  ++         + KK  + +F  ++  D      EI  L   RH+
Sbjct: 7   YMIAEDLGRGEFGIVHRC-----VETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHR 61
Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
           N++ L   +    E+ +++ F+SG ++   I+  + +  +  ++  +   + +AL +LH 
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH-QVCEALQFLHS 120
Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLS--DFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
                I H DI+P NI+     ++ +   +FG AR L+  +       A    Y APE  
Sbjct: 121 H---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPE--YYAPEVH 175
Query: 950 TTCRVSDKADVYSFGVVLLELISGKRSLDPSFSE 983
               VS   D++S G ++  L+SG   ++P  +E
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSG---INPFLAE 206

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 96/214 (44%), Gaps = 16/214 (7%)
Query: 767 YDNVVRATGNFSIRNLIGTGGFGSTYKAELVP----GYLVAVK---KLSIGRFQGIQQFD 819
           ++N  + T +      I T G GS  +  LV     G   A+K   K  + + + I+   
Sbjct: 30  WENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTL 89
Query: 820 AEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
            E   L  +    LV L   +   + +++V  ++ GG  E F H +   +         A
Sbjct: 90  NEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEPHARFYA 147
Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG 939
             I     YLH      +++RD+KP N+L+D++    ++DFG A+ ++      T  + G
Sbjct: 148 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCG 200
Query: 940 TFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
           T  Y+APE   +   +   D ++ GV++ E+ +G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 88/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTY---KAELVPGYLVAV-KKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +GTG FG        E    Y + +  K  + + + I+    E   L  +    LV L  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  ++ GG  E F H +   +         A  I     YLH      ++
Sbjct: 110 SFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 164
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+L+D++    ++DFG A+ ++      T  + GT  Y+APE   +   +   
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 220
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 221 DWWALGVLIYEMAAG 235

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 112/274 (40%), Gaps = 35/274 (12%)
Query: 776  NFSIRNLIGTGGFGSTYKAELVP-GYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
            +F I  +IG G F      ++   G + A+K   K  + +   +  F  E   L     +
Sbjct: 62   DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRR 121
Query: 832  NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
             +  L   +  E  ++LV  +  GG+L T +  K G++I   +      +I  A+  +H 
Sbjct: 122  WITQLHFAFQDENYLYLVMEYYVGGDLLTLL-SKFGERIPAEMARFYLAEIVMAIDSVH- 179
Query: 892  SCVPRI--VHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
                R+  VHRDIKP NILLD   +  L+DFG    L    T  +    GT  Y++PE  
Sbjct: 180  ----RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEIL 235
Query: 950  TTCRVSD-------KADVYSFGVVLLELISGKRSL--DPSFSEYGNGFNIVSWAKLLIKE 1000
                          + D ++ GV   E+  G+     D +   YG    IV + +     
Sbjct: 236  QAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG---KIVHYKE----- 287
Query: 1001 GRSSELFLPELWEAGPQENLLGMMRLASTCTVET 1034
                 L LP + E  P+E    + RL   C  ET
Sbjct: 288  ----HLSLPLVDEGVPEEARDFIQRL--LCPPET 315

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/138 (27%), Positives = 66/138 (47%), Gaps = 15/138 (10%)
Query: 846 MFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKP 904
           +++        NL+ +++++ S +  +  V   I I IA+A+ +LH      ++HRD+KP
Sbjct: 136 LYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKP 192
Query: 905 SNILLDEELNAYLSDFGLARLLEVSETHATT-----------DVAGTFGYVAPEYATTCR 953
           SNI    +    + DFGL   ++  E   T               GT  Y++PE      
Sbjct: 193 SNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGNN 252
Query: 954 VSDKADVYSFGVVLLELI 971
            S K D++S G++L EL+
Sbjct: 253 YSHKVDIFSLGLILFELL 270

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 88/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTY---KAELVPGYLVAV-KKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +GTG FG        E    Y + +  K  + + + I+    E   L  +    LV L  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  ++ GG  E F H +   +         A  I     YLH      ++
Sbjct: 110 SFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 164
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+L+D++    ++DFG A+ ++      T  + GT  Y+APE   +   +   
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 220
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 221 DWWALGVLIYEMAAG 235

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 102/227 (44%), Gaps = 21/227 (9%)
Query: 754 VMVTFADTPAELTYDNVVRATGNFSIRNL-IGTGGFGSTYKAE-LVPGYLVAVKKLSIGR 811
           V++T    P +  Y   V    +++   L +G G FG  ++ E    G+  AVKK+ +  
Sbjct: 75  VLLTEKLKPVDYEYREEV----HWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEV 130
Query: 812 FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQ 871
           F+       E+     +    +V L G       + +    L GG+L   + ++      
Sbjct: 131 FRA-----EELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPED 185
Query: 872 WSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEE-LNAYLSDFGLARLLE--- 927
            ++ +     + QAL  L Y    RI+H D+K  N+LL  +  +A L DFG A  L+   
Sbjct: 186 RALYY-----LGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDG 240
Query: 928 VSETHATTD-VAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
           + ++  T D + GT  ++APE         K DV+S   ++L +++G
Sbjct: 241 LGKSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 89/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGST----YKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +GTG FG      +K       +  + K  + + + I+    E   L  +    LV L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  +++GG  E F H +   +         A  I     YLH      ++
Sbjct: 109 SFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFAEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+L+D++    ++DFG A+ ++      T  + GT  Y+APE   +   +   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 96/214 (44%), Gaps = 16/214 (7%)
Query: 767 YDNVVRATGNFSIRNLIGTGGFGSTYKAELVP----GYLVAVK---KLSIGRFQGIQQFD 819
           ++N  + T +      I T G GS  +  LV     G   A+K   K  + + + I+   
Sbjct: 30  WENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTL 89
Query: 820 AEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
            E   L  +    LV L   +   + +++V  ++ GG  E F H +   +         A
Sbjct: 90  NEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGG--EMFSHLRRIGRFSEPHARFYA 147
Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG 939
             I     YLH      +++RD+KP N+L+D++    ++DFG A+ ++      T  + G
Sbjct: 148 AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCG 200
Query: 940 TFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
           T  Y+APE   +   +   D ++ GV++ E+ +G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 110/241 (45%), Gaps = 32/241 (13%)
Query: 783  IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
            IG+G  G   + Y A L     VA+KKLS   FQ     ++   E+  +  + HKN++ L
Sbjct: 32   IGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYRELVLMKVVNHKNIIGL 88
Query: 837  IGYYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +  +  +       ++++V   +   NL   I  +   +    +++++ + I     +LH
Sbjct: 89   LNVFTPQKSLEEFQDVYIVMELMDA-NLSQVIQMELDHERMSYLLYQMLVGIK----HLH 143
Query: 891  YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
             +    I+HRD+KPSNI++  +    + DFGLAR    S     T    T  Y APE   
Sbjct: 144  SAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVIL 198
Query: 951  TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
                 +  D++S G ++ E+I G   L P         +I  W K++ + G  S  F+ +
Sbjct: 199  GMGYKENVDIWSVGCIMGEMIKGG-VLFPGTD------HIDQWNKVIEQLGTPSPEFMKK 251
Query: 1011 L 1011
            L
Sbjct: 252  L 252

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 89/213 (41%), Gaps = 28/213 (13%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDA-----EIGTLGRIRH 830
           ++ +  +IG G FG            V   KL + +F+ I++ D+     E   +     
Sbjct: 70  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL-LSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
             +V L   +  +  +++V  ++ GG+L   +      + +W+  +    ++  AL  +H
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWARFY--TAEVVLALDAIH 185
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE--- 947
                  +HRD+KP N+LLD+  +  L+DFG    +            GT  Y++PE   
Sbjct: 186 SMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 242
Query: 948 -------YATTCRVSDKADVYSFGVVLLELISG 973
                  Y   C      D +S GV L E++ G
Sbjct: 243 SQGGDGYYGREC------DWWSVGVFLYEMLVG 269

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 107/254 (42%), Gaps = 52/254 (20%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIR-HKNL 833
              +R ++  GGF   Y+A+ V  G   A+K+L     +  +    E+  + ++  H N+
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 834 VTL-----IGYY---VGEAEMFLVYNFLSGGNLETFIHK-KSGKKIQWSVIHKIAIDIAQ 884
           V       IG      G+AE FL+   L  G L  F+ K +S   +    + KI     +
Sbjct: 89  VQFCSAASIGKEESDTGQAE-FLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCR 147
Query: 885 ALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR----------------LLEV 928
           A+ ++H    P I+HRD+K  N+LL  +    L DFG A                 L+E 
Sbjct: 148 AVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 929 SETHATTDVAGTFGYVAPEYA---TTCRVSDKADVYSFGVVL---------------LEL 970
             T  TT +     Y  PE     +   + +K D+++ G +L               L +
Sbjct: 207 EITRNTTPM-----YRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI 261
Query: 971 ISGKRSLDPSFSEY 984
           ++GK S+ P  ++Y
Sbjct: 262 VNGKYSIPPHDTQY 275

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 89/213 (41%), Gaps = 28/213 (13%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDA-----EIGTLGRIRH 830
           ++ +  +IG G FG            V   KL + +F+ I++ D+     E   +     
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL-LSKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
             +V L   +  +  +++V  ++ GG+L   +      + +W+  +    ++  AL  +H
Sbjct: 134 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWARFY--TAEVVLALDAIH 190
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE--- 947
                  +HRD+KP N+LLD+  +  L+DFG    +            GT  Y++PE   
Sbjct: 191 SMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 247
Query: 948 -------YATTCRVSDKADVYSFGVVLLELISG 973
                  Y   C      D +S GV L E++ G
Sbjct: 248 SQGGDGYYGREC------DWWSVGVFLYEMLVG 274

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/195 (23%), Positives = 89/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGST----YKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +GTG FG      +K       +  + K  + + + I+    E   L  +    LV L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  +++GG  E F H +   +         A  I     YLH      ++
Sbjct: 109 SFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+++D++    ++DFG A+ ++      T  + GT  Y+APE   +   +   
Sbjct: 164 YRDLKPENLIIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEYLAPEIIISKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 83/159 (52%), Gaps = 21/159 (13%)
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSG-KKIQWSVIHKIAIDIAQALAY 888
           H+N++ LI ++  E   +LV+  + GG++ + IHK+    +++ SV+ +   D+A AL +
Sbjct: 70  HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ---DVASALDF 126
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELN---AYLSDFGLARLLEVS------ETHATTDVAG 939
           LH      I HRD+KP NIL +         + DF L   ++++       T       G
Sbjct: 127 LHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCG 183
Query: 940 TFGYVAPE----YATTCRVSDK-ADVYSFGVVLLELISG 973
           +  Y+APE    ++    + DK  D++S GV+L  L+SG
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 89/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +GTG FG     + +  G   A+K   K  + + + I+    E   L  +    LV L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  +  GG  E F H +   +         A  I     YLH      ++
Sbjct: 109 SFKDNSNLYMVMEYAPGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+++D++    ++DFG A+ ++      T  + GT  Y+APE   +   +   
Sbjct: 164 YRDLKPENLMIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
            F    ++G+G FG+ YK   +P        VA+K+L      +  ++   E   +  + 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           + ++  L+G  +  + + L+   +  G L  ++ ++    I    +    + IA+ + YL
Sbjct: 80  NPHVCRLLGICLT-STVQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 137
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
                 R+VHRD+   N+L+    +  ++DFGLA+LL  E  E HA         ++A E
Sbjct: 138 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 193
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
                  + ++DV+S+GV + EL++ G +  D
Sbjct: 194 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
            F    ++G+G FG+ YK   +P        VA+K+L      +  ++   E   +  + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           + ++  L+G  +  + + L+   +  G L  ++ ++    I    +    + IA+ + YL
Sbjct: 79  NPHVCRLLGICLT-STVQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 136
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
                 R+VHRD+   N+L+    +  ++DFGLA+LL  E  E HA         ++A E
Sbjct: 137 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 192
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
                  + ++DV+S+GV + EL++ G +  D
Sbjct: 193 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
            F    ++G+G FG+ YK   +P        VA+K+L      +  ++   E   +  + 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           + ++  L+G  +  + + L+   +  G L  ++ ++    I    +    + IA+ + YL
Sbjct: 77  NPHVCRLLGICLT-STVQLIMQLMPFGXLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 134
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
                 R+VHRD+   N+L+    +  ++DFGLA+LL  E  E HA         ++A E
Sbjct: 135 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 190
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
                  + ++DV+S+GV + EL++ G +  D
Sbjct: 191 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 89/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +GTG FG     + +  G   A+K   K  + + + I+    E   L  +    LV L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  +  GG  E F H +   +         A  I     YLH      ++
Sbjct: 109 SFKDNSNLYMVMEYAPGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+++D++    ++DFG A+ ++      T  + GT  Y+APE   +   +   
Sbjct: 164 YRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 89/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTYKAE-LVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +GTG FG     + +  G   A+K   K  + + + I+    E   L  +    LV L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  +  GG  E F H +   +         A  I     YLH      ++
Sbjct: 109 SFKDNSNLYMVMEYAPGG--EMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+++D++    ++DFG A+ ++      T  + GT  Y+APE   +   +   
Sbjct: 164 YRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
            F    ++G+G FG+ YK   +P        VA+K+L      +  ++   E   +  + 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           + ++  L+G  +  + + L+   +  G L  ++ ++    I    +    + IA+ + YL
Sbjct: 77  NPHVCRLLGICLT-STVQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 134
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
                 R+VHRD+   N+L+    +  ++DFGLA+LL  E  E HA         ++A E
Sbjct: 135 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 190
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
                  + ++DV+S+GV + EL++ G +  D
Sbjct: 191 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 89/213 (41%), Gaps = 28/213 (13%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDA-----EIGTLGRIRH 830
           ++ +  +IG G FG            V   KL + +F+ I++ D+     E   +     
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL-LSKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
             +V L   +  +  +++V  ++ GG+L   +      + +W+  +    ++  AL  +H
Sbjct: 134 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWARFY--TAEVVLALDAIH 190
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE--- 947
                  +HRD+KP N+LLD+  +  L+DFG    +            GT  Y++PE   
Sbjct: 191 SMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 247
Query: 948 -------YATTCRVSDKADVYSFGVVLLELISG 973
                  Y   C      D +S GV L E++ G
Sbjct: 248 SQGGDGYYGREC------DWWSVGVFLYEMLVG 274

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
            F    ++G+G FG+ YK   +P        VA+K+L      +  ++   E   +  + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           + ++  L+G  +  + + L+   +  G L  ++ ++    I    +    + IA+ + YL
Sbjct: 78  NPHVCRLLGICLT-STVQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
                 R+VHRD+   N+L+    +  ++DFGLA+LL  E  E HA         ++A E
Sbjct: 136 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 191
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
                  + ++DV+S+GV + EL++ G +  D
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 107/259 (41%), Gaps = 59/259 (22%)
Query: 783  IGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDA--EIGTLGRIRHKNLVTLIG- 838
            IG G FG  +KA     G  VA+KK+ +   +      A  EI  L  ++H+N+V LI  
Sbjct: 26   IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 839  -------YYVGEAEMFLVYNFLS---GGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
                   Y   +  ++LV++F      G L   +      K   S I ++   +   L Y
Sbjct: 86   CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYY 140
Query: 889  LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR---LLEVSETHATTDVAGTFGYVA 945
            +H +   +I+HRD+K +N+L+  +    L+DFGLAR   L + S+ +   +   T  Y  
Sbjct: 141  IHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 946  PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVS-WAKLLIKEGRSS 1004
            P                      EL+ G+R   P    +G G  +   W +  I +G + 
Sbjct: 198  P----------------------ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 235
Query: 1005 ELFL-----------PELW 1012
            +  L           PE+W
Sbjct: 236  QHQLALISQLCGSITPEVW 254

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 27/205 (13%)
Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
           IG+G  G   + Y A L     VA+KKLS   FQ     ++   E+  +  + HKN+++L
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYRELVLMKXVNHKNIISL 88
Query: 837 IGYYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAIDIAQALAYL 889
           +  +  +       +++LV   +     +          IQ  + H +++  + Q L  +
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDANLCQV---------IQMELDHERMSYLLYQMLCGI 139
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
            +     I+HRD+KPSNI++  +    + DFGLAR      +   T    T  Y APE  
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVI 197
Query: 950 TTCRVSDKADVYSFGVVLLELISGK 974
                 +  D++S G ++ E++  K
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 27/205 (13%)
Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
           IG+G  G   + Y A L     VA+KKLS   FQ     ++   E+  +  + HKN+++L
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYRELVLMKXVNHKNIISL 88
Query: 837 IGYYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAIDIAQALAYL 889
           +  +  +       +++LV   +     +          IQ  + H +++  + Q L  +
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDANLXQV---------IQMELDHERMSYLLYQMLCGI 139
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
            +     I+HRD+KPSNI++  +    + DFGLAR    S     T    T  Y APE  
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVI 197
Query: 950 TTCRVSDKADVYSFGVVLLELISGK 974
                 +  D++S G ++ E++  K
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 25/204 (12%)
Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
           IG+G  G   + Y A L     VA+KKLS   FQ     ++   E+  +  + HKN+++L
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYRELVLMKXVNHKNIISL 88
Query: 837 IGYYVGE------AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
           +  +  +       +++LV   +   NL   I  +   +    +++++   I     +LH
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDA-NLXQVIQMELDHERMSYLLYQMLXGIK----HLH 143
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
            +    I+HRD+KPSNI++  +    + DFGLAR    S     T    T  Y APE   
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVIL 198
Query: 951 TCRVSDKADVYSFGVVLLELISGK 974
                +  D++S G ++ E++  K
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
            F    ++G+G FG+ YK   +P        VA+K+L      +  ++   E   +  + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           + ++  L+G  +  + + L+   +  G L  ++ ++    I    +    + IA+ + YL
Sbjct: 76  NPHVCRLLGICLT-STVQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
                 R+VHRD+   N+L+    +  ++DFGLA+LL  E  E HA         ++A E
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 189
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
                  + ++DV+S+GV + EL++ G +  D
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/195 (23%), Positives = 89/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGST----YKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +GTG FG      +K       +  + K  + + + I+    E   L  +    LV L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  +++GG  E F H +   +         A  I     YLH      ++
Sbjct: 109 SFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+L+D++    ++DFG A+ ++      T  + GT  Y+APE   +   +   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ ++ +G
Sbjct: 220 DWWALGVLIYQMAAG 234

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
            F    ++G+G FG+ YK   +P        VA+K+L      +  ++   E   +  + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           + ++  L+G  +  + + L+   +  G L  ++ ++    I    +    + IA+ + YL
Sbjct: 76  NPHVCRLLGICLT-STVQLITQLMPFGXLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
                 R+VHRD+   N+L+    +  ++DFGLA+LL  E  E HA         ++A E
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 189
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
                  + ++DV+S+GV + EL++ G +  D
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
            F    ++G+G FG+ YK   +P        VA+K+L      +  ++   E   +  + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           + ++  L+G  +  + + L+   +  G L  ++ ++    I    +    + IA+ + YL
Sbjct: 79  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 136
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
                 R+VHRD+   N+L+    +  ++DFGLA+LL  E  E HA         ++A E
Sbjct: 137 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 192
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
                  + ++DV+S+GV + EL++ G +  D
Sbjct: 193 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
            F    ++G+G FG+ YK   +P        VA+K+L      +  ++   E   +  + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           + ++  L+G  +  + + L+   +  G L  ++ ++    I    +    + IA+ + YL
Sbjct: 79  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 136
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
                 R+VHRD+   N+L+    +  ++DFGLA+LL  E  E HA         ++A E
Sbjct: 137 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 192
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
                  + ++DV+S+GV + EL++ G +  D
Sbjct: 193 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
            F    ++G+G FG+ YK   +P        VA+K+L      +  ++   E   +  + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           + ++  L+G  +  + + L+   +  G L  ++ ++    I    +    + IA+ + YL
Sbjct: 76  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
                 R+VHRD+   N+L+    +  ++DFGLA+LL  E  E HA         ++A E
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 189
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
                  + ++DV+S+GV + EL++ G +  D
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
            F    ++G+G FG+ YK   +P        VA+K+L      +  ++   E   +  + 
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           + ++  L+G  +  + + L+   +  G L  ++ ++    I    +    + IA+ + YL
Sbjct: 73  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAEGMNYL 130
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
                 R+VHRD+   N+L+    +  ++DFGLA+LL  E  E HA         ++A E
Sbjct: 131 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 186
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
                  + ++DV+S+GV + EL++ G +  D
Sbjct: 187 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 218

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
            F    ++G+G FG+ YK   +P        VA+K+L      +  ++   E   +  + 
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 81
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           + ++  L+G  +  + + L+   +  G L  ++ ++    I    +    + IA+ + YL
Sbjct: 82  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 139
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
                 R+VHRD+   N+L+    +  ++DFGLA+LL  E  E HA         ++A E
Sbjct: 140 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 195
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
                  + ++DV+S+GV + EL++ G +  D
Sbjct: 196 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 227

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 107/259 (41%), Gaps = 59/259 (22%)
Query: 783  IGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDA--EIGTLGRIRHKNLVTLIG- 838
            IG G FG  +KA     G  VA+KK+ +   +      A  EI  L  ++H+N+V LI  
Sbjct: 25   IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 839  -------YYVGEAEMFLVYNFLS---GGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
                   Y   +  ++LV++F      G L   +      K   S I ++   +   L Y
Sbjct: 85   CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYY 139
Query: 889  LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR---LLEVSETHATTDVAGTFGYVA 945
            +H +   +I+HRD+K +N+L+  +    L+DFGLAR   L + S+ +   +   T  Y  
Sbjct: 140  IHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 196
Query: 946  PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVS-WAKLLIKEGRSS 1004
            P                      EL+ G+R   P    +G G  +   W +  I +G + 
Sbjct: 197  P----------------------ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 234
Query: 1005 ELFL-----------PELW 1012
            +  L           PE+W
Sbjct: 235  QHQLALISQLCGSITPEVW 253

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
            F    ++G+G FG+ YK   +P        VA+K+L      +  ++   E   +  + 
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 85
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           + ++  L+G  +  + + L+   +  G L  ++ ++    I    +    + IA+ + YL
Sbjct: 86  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 143
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
                 R+VHRD+   N+L+    +  ++DFGLA+LL  E  E HA         ++A E
Sbjct: 144 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 199
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
                  + ++DV+S+GV + EL++ G +  D
Sbjct: 200 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 231

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
            F    ++G+G FG+ YK   +P        VA+K+L      +  ++   E   +  + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           + ++  L+G  +  + + L+   +  G L  ++ ++    I    +    + IA+ + YL
Sbjct: 78  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
                 R+VHRD+   N+L+    +  ++DFGLA+LL  E  E HA         ++A E
Sbjct: 136 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 191
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
                  + ++DV+S+GV + EL++ G +  D
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
            F    ++G+G FG+ YK   +P        VA+K+L      +  ++   E   +  + 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           + ++  L+G  +  + + L+   +  G L  ++ ++    I    +    + IA+ + YL
Sbjct: 83  NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 140
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
                 R+VHRD+   N+L+    +  ++DFGLA+LL  E  E HA         ++A E
Sbjct: 141 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 196
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
                  + ++DV+S+GV + EL++ G +  D
Sbjct: 197 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
            F    ++G+G FG+ YK   +P        VA+K+L      +  ++   E   +  + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           + ++  L+G  +  + + L+   +  G L  ++ ++    I    +    + IA+ + YL
Sbjct: 79  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 136
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
                 R+VHRD+   N+L+    +  ++DFGLA+LL  E  E HA         ++A E
Sbjct: 137 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 192
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
                  + ++DV+S+GV + EL++ G +  D
Sbjct: 193 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 108/242 (44%), Gaps = 34/242 (14%)
Query: 783  IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
            IG+G  G   + Y A L     VA+KKLS   FQ     ++   E+  +  + HKN+++L
Sbjct: 70   IGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISL 126
Query: 837  IGYYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAIDIAQALAYL 889
            +  +  +       +++LV   +     +          IQ  + H +++  + Q L  +
Sbjct: 127  LNVFTPQKTLEEFQDVYLVMELMDANLCQV---------IQMELDHERMSYLLYQMLCGI 177
Query: 890  HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
             +     I+HRD+KPSNI++  +    + DFGLAR    S     T    T  Y APE  
Sbjct: 178  KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVI 235
Query: 950  TTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009
                  +  D++S G ++ E++  K  L P     G  + I  W K++ + G     F+ 
Sbjct: 236  LGMGYKENVDIWSVGCIMGEMVRHK-ILFP-----GRDY-IDQWNKVIEQLGTPCPEFMK 288
Query: 1010 EL 1011
            +L
Sbjct: 289  KL 290

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 107/259 (41%), Gaps = 59/259 (22%)
Query: 783  IGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDA--EIGTLGRIRHKNLVTLIG- 838
            IG G FG  +KA     G  VA+KK+ +   +      A  EI  L  ++H+N+V LI  
Sbjct: 26   IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 839  -------YYVGEAEMFLVYNFLS---GGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
                   Y   +  ++LV++F      G L   +      K   S I ++   +   L Y
Sbjct: 86   CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYY 140
Query: 889  LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR---LLEVSETHATTDVAGTFGYVA 945
            +H +   +I+HRD+K +N+L+  +    L+DFGLAR   L + S+ +   +   T  Y  
Sbjct: 141  IHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 946  PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVS-WAKLLIKEGRSS 1004
            P                      EL+ G+R   P    +G G  +   W +  I +G + 
Sbjct: 198  P----------------------ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 235
Query: 1005 ELFL-----------PELW 1012
            +  L           PE+W
Sbjct: 236  QHQLALISQLCGSITPEVW 254

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/205 (22%), Positives = 91/205 (44%), Gaps = 33/205 (16%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAE-IGTLGRIRH----KNLVTLI 837
           +GTG FG           ++ VK +  G    ++  D + +  L +I H    K ++  +
Sbjct: 50  LGTGSFGR----------VMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 838 GY---------YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
            +         +   + +++V  +  GG  E F H +   +         A  I     Y
Sbjct: 100 NFPFLTKLEFSFKDNSNLYMVMEYAPGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
           LH      +++RD+KP N+++D++    ++DFG A+ ++      T  + GT  Y+APE 
Sbjct: 158 LH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLAPEI 210
Query: 949 ATTCRVSDKADVYSFGVVLLELISG 973
             +   +   D ++ GV++ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
            F    ++G+G FG+ YK   +P        VA+K+L      +  ++   E   +  + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           + ++  L+G  +  + + L+   +  G L  ++ ++    I    +    + IA+ + YL
Sbjct: 76  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
                 R+VHRD+   N+L+    +  ++DFGLA+LL  E  E HA         ++A E
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 189
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
                  + ++DV+S+GV + EL++ G +  D
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/205 (22%), Positives = 91/205 (44%), Gaps = 33/205 (16%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAE-IGTLGRIRH----KNLVTLI 837
           +GTG FG           ++ VK +  G    ++  D + +  L +I H    K ++  +
Sbjct: 50  LGTGSFGR----------VMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 838 GY---------YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
            +         +   + +++V  +  GG  E F H +   +         A  I     Y
Sbjct: 100 NFPFLTKLEFSFKDNSNLYMVMEYAPGG--EMFSHLRRIGRFXEPHARFYAAQIVLTFEY 157
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
           LH      +++RD+KP N+++D++    ++DFG A+ ++      T  + GT  Y+APE 
Sbjct: 158 LH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLAPEI 210
Query: 949 ATTCRVSDKADVYSFGVVLLELISG 973
             +   +   D ++ GV++ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/205 (22%), Positives = 91/205 (44%), Gaps = 33/205 (16%)
Query: 783 IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAE-IGTLGRIRH----KNLVTLI 837
           +GTG FG           ++ VK +  G    ++  D + +  L +I H    K ++  +
Sbjct: 50  LGTGSFGR----------VMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 838 GY---------YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
            +         +   + +++V  +  GG  E F H +   +         A  I     Y
Sbjct: 100 NFPFLTKLEFSFKDNSNLYMVMEYAPGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
           LH      +++RD+KP N+++D++    ++DFG A+ ++      T  + GT  Y+APE 
Sbjct: 158 LH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLAPEI 210
Query: 949 ATTCRVSDKADVYSFGVVLLELISG 973
             +   +   D ++ GV++ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 19/226 (8%)
Query: 754 VMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYK-AELVPGYLVAVKKLSIGRF 812
           V++T    P +  Y   V      + +  +G G FG  ++  +   G+  AVKK+ +  F
Sbjct: 56  VLLTEKLKPVDYEYREEVHW---MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF 112
Query: 813 QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQW 872
           + +++  A  G    +    +V L G       + +    L GG+L   I     K++  
Sbjct: 113 R-VEELVACAG----LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI-----KQMGC 162
Query: 873 SVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEE-LNAYLSDFGLARLLE---V 928
               +    + QAL  L Y    RI+H D+K  N+LL  +   A L DFG A  L+   +
Sbjct: 163 LPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 222
Query: 929 SETHATTD-VAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
            ++  T D + GT  ++APE         K D++S   ++L +++G
Sbjct: 223 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 101/227 (44%), Gaps = 21/227 (9%)
Query: 754 VMVTFADTPAELTYDNVVRATGNFSIRNL-IGTGGFGSTYKAE-LVPGYLVAVKKLSIGR 811
           V++T    P +  Y   V    +++   L +G G FG  ++ E    G+  AVKK+ +  
Sbjct: 56  VLLTEKLKPVDYEYREEV----HWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEV 111
Query: 812 FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQ 871
           F+       E+     +    +V L G       + +    L GG+L   + ++      
Sbjct: 112 FRA-----EELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPED 166
Query: 872 WSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEE-LNAYLSDFGLARLLE--- 927
            ++ +     + QAL  L Y    RI+H D+K  N+LL  +  +A L DFG A  L+   
Sbjct: 167 RALYY-----LGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDG 221
Query: 928 VSETHATTD-VAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
           + +   T D + GT  ++APE         K DV+S   ++L +++G
Sbjct: 222 LGKDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 105/237 (44%), Gaps = 41/237 (17%)
Query: 782 LIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV 841
           ++G G  G+        G  VAVK++ I  F  I   + ++ T     H N+   I YY 
Sbjct: 22  ILGYGSSGTVVFQGSFQGRPVAVKRMLID-FCDIALMEIKLLTESD-DHPNV---IRYYC 76
Query: 842 GEAEMFLVYNFLS--GGNLETFIHKKS----GKKIQWSVIHKIAI--DIAQALAYLHYSC 893
            E     +Y  L     NL+  +  K+      K+Q    + I++   IA  +A+LH   
Sbjct: 77  SETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEY-NPISLLRQIASGVAHLH--- 132
Query: 894 VPRIVHRDIKPSNILLD-------------EELNAYLSDFGLARLLEVSETHATTDV--- 937
             +I+HRD+KP NIL+              E L   +SDFGL + L+  ++   T++   
Sbjct: 133 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192
Query: 938 AGTFGYVAPE-------YATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGN 986
           +GT G+ APE         T  R++   D++S G V   ++S GK      +S   N
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 249

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
            F    ++G+G FG+ YK   +P        VA+K+L      +  ++   E   +  + 
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 100
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           + ++  L+G  +  + + L+   +  G L  ++ ++    I    +    + IA+ + YL
Sbjct: 101 NPHVCRLLGICLT-STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 158
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
                 R+VHRD+   N+L+    +  ++DFGLA+LL  E  E HA         ++A E
Sbjct: 159 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 214
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
                  + ++DV+S+GV + EL++ G +  D
Sbjct: 215 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 246

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 108/242 (44%), Gaps = 34/242 (14%)
Query: 783  IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
            IG+G  G   + Y A L     VA+KKLS   FQ     ++   E+  +  + HKN+++L
Sbjct: 31   IGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISL 87
Query: 837  IGYYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAIDIAQALAYL 889
            +  +  +       +++LV   +     +          IQ  + H +++  + Q L  +
Sbjct: 88   LNVFTPQKTLEEFQDVYLVMELMDANLCQV---------IQMELDHERMSYLLYQMLCGI 138
Query: 890  HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
             +     I+HRD+KPSNI++  +    + DFGLAR    S     T    T  Y APE  
Sbjct: 139  KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVI 196
Query: 950  TTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009
                  +  D++S G ++ E++  K  L P     G  + I  W K++ + G     F+ 
Sbjct: 197  LGMGYKENVDIWSVGCIMGEMVRHK-ILFP-----GRDY-IDQWNKVIEQLGTPCPEFMK 249
Query: 1010 EL 1011
            +L
Sbjct: 250  KL 251

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 87/195 (44%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGSTY---KAELVPGYLVAV-KKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +GTG FG        E    Y + +  K  + + + I+    E   L  +    LV L  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  +  GG  E F H +   +         A  I     YLH      ++
Sbjct: 110 SFKDNSNLYMVMEYAPGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 164
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+++D++    ++DFG A+ ++      T  + GT  Y+APE   +   +   
Sbjct: 165 YRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGYNKAV 220
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 221 DWWALGVLIYEMAAG 235

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
            F    ++G+G FG+ YK   +P        VA+K+L      +  ++   E   +  + 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           + ++  L+G  +  + + L+   +  G L  ++ ++    I    +    + IA+ + YL
Sbjct: 70  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
                 R+VHRD+   N+L+    +  ++DFGLA+LL  E  E HA         ++A E
Sbjct: 128 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 183
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
                  + ++DV+S+GV + EL++ G +  D
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 215

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 27/205 (13%)
Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
           IG+G  G   + Y A L     VA+KKLS   FQ     ++   E+  +  + HKN+++L
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISL 88
Query: 837 IGYYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAIDIAQALAYL 889
           +  +  +       +++LV   +     +          IQ  + H +++  + Q L  +
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDANLCQV---------IQMELDHERMSYLLYQMLCGI 139
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
            +     I+HRD+KPSNI++  +    + DFGLAR    S     T    T  Y APE  
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVI 197
Query: 950 TTCRVSDKADVYSFGVVLLELISGK 974
                 +  D++S G ++ E++  K
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 109/241 (45%), Gaps = 32/241 (13%)
Query: 783  IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
            IG+G  G   + Y A L     VA+KKLS   FQ     ++   E+  +  + HKN++ L
Sbjct: 32   IGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 837  IGYYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +  +  +       ++++V   +   NL   I  +   +    +++++   I     +LH
Sbjct: 89   LNVFTPQKSLEEFQDVYIVMELMDA-NLSQVIQMELDHERMSYLLYQMLCGIK----HLH 143
Query: 891  YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
             +    I+HRD+KPSNI++  +    + DFGLAR    S     T    T  Y APE   
Sbjct: 144  SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVIL 198
Query: 951  TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
                 +  D++S G ++ E+I G   L P         +I  W K++ + G  S  F+ +
Sbjct: 199  GMGYKENVDIWSVGCIMGEMIKGG-VLFPGTD------HIDQWNKVIEQLGTPSPEFMKK 251
Query: 1011 L 1011
            L
Sbjct: 252  L 252

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 109/241 (45%), Gaps = 32/241 (13%)
Query: 783  IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
            IG+G  G   + Y A L     VA+KKLS   FQ     ++   E+  +  + HKN++ L
Sbjct: 32   IGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYRELVLMKVVNHKNIIGL 88
Query: 837  IGYYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +  +  +       ++++V   +   NL   I  +   +    +++++   I     +LH
Sbjct: 89   LNVFTPQKSLEEFQDVYIVMELMDA-NLSQVIQMELDHERMSYLLYQMLCGIK----HLH 143
Query: 891  YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
             +    I+HRD+KPSNI++  +    + DFGLAR    S     T    T  Y APE   
Sbjct: 144  SAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVIL 198
Query: 951  TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
                 +  D++S G ++ E+I G   L P         +I  W K++ + G  S  F+ +
Sbjct: 199  GMGYKENVDIWSVGCIMGEMIKGG-VLFPGTD------HIDQWNKVIEQLGTPSPEFMKK 251
Query: 1011 L 1011
            L
Sbjct: 252  L 252

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 107/242 (44%), Gaps = 34/242 (14%)
Query: 783  IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
            IG+G  G   + Y A L     VA+KKLS   FQ     ++   E+  +  + HKN++ L
Sbjct: 32   IGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 837  IGYYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAIDIAQALAYL 889
            +  +  +       ++++V   +     +          IQ  + H +++  + Q L  +
Sbjct: 89   LNVFTPQKSLEEFQDVYIVMELMDANLCQV---------IQMELDHERMSYLLYQMLCGI 139
Query: 890  HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
             +     I+HRD+KPSNI++  +    + DFGLAR    S     T    T  Y APE  
Sbjct: 140  KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVI 197
Query: 950  TTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009
                  +  D++S G ++ E+I G   L P         +I  W K++ + G  S  F+ 
Sbjct: 198  LGMGYKENVDIWSVGCIMGEMIKGG-VLFPGTD------HIDQWNKVIEQLGTPSPEFMK 250
Query: 1010 EL 1011
            +L
Sbjct: 251  KL 252

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 27/205 (13%)
Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
           IG+G  G   + Y A L     VA+KKLS   FQ     ++   E+  +  + HKN+++L
Sbjct: 33  IGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISL 89
Query: 837 IGYYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAIDIAQALAYL 889
           +  +  +       +++LV   +     +          IQ  + H +++  + Q L  +
Sbjct: 90  LNVFTPQKTLEEFQDVYLVMELMDANLCQV---------IQMELDHERMSYLLYQMLCGI 140
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
            +     I+HRD+KPSNI++  +    + DFGLAR    S     T    T  Y APE  
Sbjct: 141 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVI 198
Query: 950 TTCRVSDKADVYSFGVVLLELISGK 974
                 +  D++S G ++ E++  K
Sbjct: 199 LGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 108/242 (44%), Gaps = 34/242 (14%)
Query: 783  IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
            IG+G  G   + Y A L     VA+KKLS   FQ     ++   E+  +  + HKN+++L
Sbjct: 32   IGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISL 88
Query: 837  IGYYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAIDIAQALAYL 889
            +  +  +       +++LV   +     +          IQ  + H +++  + Q L  +
Sbjct: 89   LNVFTPQKTLEEFQDVYLVMELMDANLCQV---------IQMELDHERMSYLLYQMLCGI 139
Query: 890  HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
             +     I+HRD+KPSNI++  +    + DFGLAR    S     T    T  Y APE  
Sbjct: 140  KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVI 197
Query: 950  TTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009
                  +  D++S G ++ E++  K  L P     G  + I  W K++ + G     F+ 
Sbjct: 198  LGMGYKENVDIWSVGCIMGEMVRHK-ILFP-----GRDY-IDQWNKVIEQLGTPCPEFMK 250
Query: 1010 EL 1011
            +L
Sbjct: 251  KL 252

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 108/242 (44%), Gaps = 34/242 (14%)
Query: 783  IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
            IG+G  G   + Y A L     VA+KKLS   FQ     ++   E+  +  + HKN+++L
Sbjct: 33   IGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISL 89
Query: 837  IGYYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAIDIAQALAYL 889
            +  +  +       +++LV   +     +          IQ  + H +++  + Q L  +
Sbjct: 90   LNVFTPQKTLEEFQDVYLVMELMDANLCQV---------IQMELDHERMSYLLYQMLCGI 140
Query: 890  HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
             +     I+HRD+KPSNI++  +    + DFGLAR    S     T    T  Y APE  
Sbjct: 141  KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVI 198
Query: 950  TTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009
                  +  D++S G ++ E++  K  L P     G  + I  W K++ + G     F+ 
Sbjct: 199  LGMGYKENVDIWSVGCIMGEMVRHK-ILFP-----GRDY-IDQWNKVIEQLGTPCPEFMK 251
Query: 1010 EL 1011
            +L
Sbjct: 252  KL 253

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 36/221 (16%)
Query: 777 FSIRNLIGTGGFGSTYKAELVPGYLVAVKKL----SIGRFQGI-------QQFDAEIGTL 825
           ++++  I +G +G+        G  VA+K++    S GR   I       ++   EI  L
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 826 GRIRHKNLVTLIGYYVGEAE-----MFLVYNFLSGGNLETFIHKK----SGKKIQWSVIH 876
               H N++ L   +V   E     ++LV   +   +L   IH +    S + IQ+ + H
Sbjct: 84  NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYH 142
Query: 877 KIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR--LLEVSETHAT 934
                I   L  LH + V   VHRD+ P NILL +  +  + DF LAR    + ++TH  
Sbjct: 143 -----ILLGLHVLHEAGV---VHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYV 194
Query: 935 TDVAGTFGYVAPEYATTCRVSDK-ADVYSFGVVLLELISGK 974
           T       Y APE     +   K  D++S G V+ E+ + K
Sbjct: 195 THR----WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 80/170 (47%), Gaps = 20/170 (11%)
Query: 821 EIGTLGRIRHKNLVTLIGYYVGEAE--MFLVYNFLSGGNLETFIHKKSGK------KIQW 872
           EI  L  ++H N+++L   ++  A+  ++L++++            ++ K      ++  
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 127
Query: 873 SVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILL----DEELNAYLSDFGLARLLEV 928
            ++  +   I   + YLH + V   +HRD+KP+NIL+     E     ++D G ARL   
Sbjct: 128 GMVKSLLYQILDGIHYLHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFN- 183
Query: 929 SETHATTD---VAGTFGYVAPEYATTCRVSDKA-DVYSFGVVLLELISGK 974
           S      D   V  TF Y APE     R   KA D+++ G +  EL++ +
Sbjct: 184 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 108/242 (44%), Gaps = 34/242 (14%)
Query: 783  IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
            IG+G  G   + Y A L     VA+KKLS   FQ     ++   E+  +  + HKN+++L
Sbjct: 26   IGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISL 82
Query: 837  IGYYVGE------AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAIDIAQALAYL 889
            +  +  +       +++LV   +     +          IQ  + H +++  + Q L  +
Sbjct: 83   LNVFTPQKTLEEFQDVYLVMELMDANLCQV---------IQMELDHERMSYLLYQMLCGI 133
Query: 890  HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
             +     I+HRD+KPSNI++  +    + DFGLAR    S     T    T  Y APE  
Sbjct: 134  KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVI 191
Query: 950  TTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009
                  +  D++S G ++ E++  K  L P     G  + I  W K++ + G     F+ 
Sbjct: 192  LGMGYKENVDIWSVGCIMGEMVRHK-ILFP-----GRDY-IDQWNKVIEQLGTPCPEFMK 244
Query: 1010 EL 1011
            +L
Sbjct: 245  KL 246

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 25/204 (12%)
Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
           IG+G  G   + Y A L     VA+KKLS   FQ     ++   E+  +  + HKN+++L
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISL 88
Query: 837 IGYYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
           +  +  +       +++LV   +   NL   I  +   +    +++++   I     +LH
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDA-NLXQVIQMELDHERMSYLLYQMLXGIK----HLH 143
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
            +    I+HRD+KPSNI++  +    + DFGLAR    S     T    T  Y APE   
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVIL 198
Query: 951 TCRVSDKADVYSFGVVLLELISGK 974
                +  D++S G ++ E++  K
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 109/241 (45%), Gaps = 32/241 (13%)
Query: 783  IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
            IG+G  G   + Y A L     VA+KKLS   FQ     ++   E+  +  + HKN++ L
Sbjct: 32   IGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 837  IGYYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +  +  +       ++++V   +   NL   I  +   +    +++++   I     +LH
Sbjct: 89   LNVFTPQKSLEEFQDVYIVMELMDA-NLSQVIQMELDHERMSYLLYQMLCGIK----HLH 143
Query: 891  YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
             +    I+HRD+KPSNI++  +    + DFGLAR    S     T    T  Y APE   
Sbjct: 144  SAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVIL 198
Query: 951  TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
                 +  D++S G ++ E+I G   L P         +I  W K++ + G  S  F+ +
Sbjct: 199  GMGYKENVDIWSVGCIMGEMIKGG-VLFPGTD------HIDQWNKVIEQLGTPSPEFMKK 251
Query: 1011 L 1011
            L
Sbjct: 252  L 252

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 108/242 (44%), Gaps = 34/242 (14%)
Query: 783  IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
            IG+G  G   + Y A L     VA+KKLS   FQ     ++   E+  +  + HKN+++L
Sbjct: 70   IGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISL 126
Query: 837  IGYYVGE------AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAIDIAQALAYL 889
            +  +  +       +++LV   +     +          IQ  + H +++  + Q L  +
Sbjct: 127  LNVFTPQKTLEEFQDVYLVMELMDANLCQV---------IQMELDHERMSYLLYQMLCGI 177
Query: 890  HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
             +     I+HRD+KPSNI++  +    + DFGLAR    S     T    T  Y APE  
Sbjct: 178  KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVI 235
Query: 950  TTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009
                  +  D++S G ++ E++  K  L P     G  + I  W K++ + G     F+ 
Sbjct: 236  LGMGYKENVDIWSVGCIMGEMVRHK-ILFP-----GRDY-IDQWNKVIEQLGTPCPEFMK 288
Query: 1010 EL 1011
            +L
Sbjct: 289  KL 290

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 108/242 (44%), Gaps = 34/242 (14%)
Query: 783  IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
            IG+G  G   + Y A L     VA+KKLS   FQ     ++   E+  +  + HKN+++L
Sbjct: 25   IGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 837  IGYYVGE------AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAIDIAQALAYL 889
            +  +  +       +++LV   +     +          IQ  + H +++  + Q L  +
Sbjct: 82   LNVFTPQKTLEEFQDVYLVMELMDANLCQV---------IQMELDHERMSYLLYQMLCGI 132
Query: 890  HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
             +     I+HRD+KPSNI++  +    + DFGLAR      +   T    T  Y APE  
Sbjct: 133  KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVI 190
Query: 950  TTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009
                  +  D++S G ++ E++  K  L P     G  + I  W K++ + G     F+ 
Sbjct: 191  LGMGYKENVDIWSVGCIMGEMVRHK-ILFP-----GRDY-IDQWNKVIEQLGTPCPEFMK 243
Query: 1010 EL 1011
            +L
Sbjct: 244  KL 245

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 25/204 (12%)
Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
           IG+G  G   + Y A L     VA+KKLS   FQ     ++   E+  +  + HKN+++L
Sbjct: 25  IGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 837 IGYYVGE------AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
           +  +  +       +++LV   +   NL   I  +   +    +++++   I     +LH
Sbjct: 82  LNVFTPQKTLEEFQDVYLVMELMDA-NLXQVIQMELDHERMSYLLYQMLXGIK----HLH 136
Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
            +    I+HRD+KPSNI++  +    + DFGLAR    S     T    T  Y APE   
Sbjct: 137 SAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVIL 191
Query: 951 TCRVSDKADVYSFGVVLLELISGK 974
                +  D++S G ++ E++  K
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 108/242 (44%), Gaps = 34/242 (14%)
Query: 783  IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
            IG+G  G   + Y A L     VA+KKLS   FQ     ++   E+  +  + HKN+++L
Sbjct: 26   IGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISL 82
Query: 837  IGYYVGE------AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAIDIAQALAYL 889
            +  +  +       +++LV   +     +          IQ  + H +++  + Q L  +
Sbjct: 83   LNVFTPQKTLEEFQDVYLVMELMDANLCQV---------IQMELDHERMSYLLYQMLCGI 133
Query: 890  HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
             +     I+HRD+KPSNI++  +    + DFGLAR    S     T    T  Y APE  
Sbjct: 134  KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVI 191
Query: 950  TTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009
                  +  D++S G ++ E++  K  L P     G  + I  W K++ + G     F+ 
Sbjct: 192  LGMGYKENVDIWSVGCIMGEMVRHK-ILFP-----GRDY-IDQWNKVIEQLGTPCPEFMK 244
Query: 1010 EL 1011
            +L
Sbjct: 245  KL 246

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 36/221 (16%)
Query: 777 FSIRNLIGTGGFGSTYKAELVPGYLVAVKKL----SIGRFQGI-------QQFDAEIGTL 825
           ++++  I +G +G+        G  VA+K++    S GR   I       ++   EI  L
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 826 GRIRHKNLVTLIGYYVGEAE-----MFLVYNFLSGGNLETFIHKK----SGKKIQWSVIH 876
               H N++ L   +V   E     ++LV   +   +L   IH +    S + IQ+ + H
Sbjct: 84  NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYH 142
Query: 877 KIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR--LLEVSETHAT 934
                I   L  LH + V   VHRD+ P NILL +  +  + DF LAR    + ++TH  
Sbjct: 143 -----ILLGLHVLHEAGV---VHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYV 194
Query: 935 TDVAGTFGYVAPEYATTCRVSDK-ADVYSFGVVLLELISGK 974
           T       Y APE     +   K  D++S G V+ E+ + K
Sbjct: 195 THR----WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 92/204 (45%), Gaps = 27/204 (13%)
Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
           IG+G  G   + Y A L     VA+KKLS   FQ     ++   E+  +  + HKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 837 IGYYVGE------AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAIDIAQALAYL 889
           +  +  +       ++++V   +     +          IQ  + H +++  + Q L  +
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQV---------IQMELDHERMSYLLYQMLCGI 139
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
            +     I+HRD+KPSNI++  +    + DFGLAR    S     T    T  Y APE  
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVI 197
Query: 950 TTCRVSDKADVYSFGVVLLELISG 973
                 +  D++S G ++ E+I G
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 27/204 (13%)
Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
           IG+G  G   + Y A L     VA+KKLS   FQ     ++   E+  +  + HKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 837 IGYYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAIDIAQALAYL 889
           +  +  +       ++++V   +     +          IQ  + H +++  + Q L  +
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDANLCQV---------IQMELDHERMSYLLYQMLCGI 139
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
            +     I+HRD+KPSNI++  +    + DFGLAR    S    T +V   + Y APE  
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPEVVTRY-YRAPEVI 197
Query: 950 TTCRVSDKADVYSFGVVLLELISG 973
                 +  D++S G ++ E+I G
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/195 (23%), Positives = 88/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGST----YKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +GTG FG      +K       +  + K  + + + I+    E   L  +    LV L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  +++GG  E F H +   +         A  I     YLH      ++
Sbjct: 109 SFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+L+D++    ++DFG A+ ++      T  + GT  Y+AP    +   +   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPAIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 88/210 (41%), Gaps = 22/210 (10%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGR--FQGIQQFDAEIGTLGRIRHKNL 833
              I  LIG G FG  Y         VA++ + I R     ++ F  E+    + RH+N+
Sbjct: 34  QLEIGELIGKGRFGQVYHGRWHGE--VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENV 91
Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
           V  +G  +    + ++ +   G  L + + + +   +  +   +IA +I + + YLH   
Sbjct: 92  VLFMGACMSPPHLAIITSLCKGRTLYSVV-RDAKIVLDVNKTRQIAQEIVKGMGYLHAKG 150
Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVA----GTFGYVAPEYA 949
              I+H+D+K  N+  D      ++DFGL  +  V +     D      G   ++APE  
Sbjct: 151 ---ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206
Query: 950 TTCR---------VSDKADVYSFGVVLLEL 970
                         S  +DV++ G +  EL
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 92/204 (45%), Gaps = 27/204 (13%)
Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
           IG+G  G   + Y A L     VA+KKLS   FQ     ++   E+  +  + HKN++ L
Sbjct: 33  IGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGL 89
Query: 837 IGYYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAIDIAQALAYL 889
           +  +  +       ++++V   +     +          IQ  + H +++  + Q L  +
Sbjct: 90  LNVFTPQKSLEEFQDVYIVMELMDANLCQV---------IQMELDHERMSYLLYQMLCGI 140
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
            +     I+HRD+KPSNI++  +    + DFGLAR    S     T    T  Y APE  
Sbjct: 141 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVI 198
Query: 950 TTCRVSDKADVYSFGVVLLELISG 973
                 +  D++S G ++ E+I G
Sbjct: 199 LGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 104/234 (44%), Gaps = 37/234 (15%)
Query: 781 NLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYY 840
            ++G G  G+        G  VAVK++ I  F  I   + ++ T     H N+   I YY
Sbjct: 39  KILGYGSSGTVVFQGSFQGRPVAVKRMLID-FCDIALMEIKLLTESD-DHPNV---IRYY 93
Query: 841 VGEAEMFLVYNFLS--GGNLETFIHKKS----GKKIQWSVIHKIAI--DIAQALAYLHYS 892
             E     +Y  L     NL+  +  K+      K+Q    + I++   IA  +A+LH  
Sbjct: 94  CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEY-NPISLLRQIASGVAHLHSL 152
Query: 893 CVPRIVHRDIKPSNILLD-------------EELNAYLSDFGLARLLEVSETHATTDV-- 937
              +I+HRD+KP NIL+              E L   +SDFGL + L+  +     ++  
Sbjct: 153 ---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNN 209
Query: 938 -AGTFGYVAPEY---ATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGN 986
            +GT G+ APE    +T  R++   D++S G V   ++S GK      +S   N
Sbjct: 210 PSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 263

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/240 (23%), Positives = 104/240 (43%), Gaps = 41/240 (17%)
Query: 771 VRATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLG 826
           V+   N+ I++LIG G +G  Y A +      VA+KK++   F+ +   ++   EI  L 
Sbjct: 24  VKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVN-RMFEDLIDCKRILREITILN 82
Query: 827 RIRHKNLVTLIGYYVGEA-----EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAID 881
           R++   ++ L    + E      E+++V         + F   K+   +    +  I  +
Sbjct: 83  RLKSDYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLF---KTPIFLTEQHVKTILYN 139
Query: 882 IAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV-SETHATTDVAG- 939
           +     ++H S    I+HRD+KP+N LL+++ +  + DFGLAR +    + H   D+   
Sbjct: 140 LLLGEKFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEK 196
Query: 940 ----------------------TFGYVAPEYATTCR-VSDKADVYSFGVVLLELISGKRS 976
                                 T  Y APE        ++  D++S G +  EL++  +S
Sbjct: 197 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKS 256

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 104/234 (44%), Gaps = 37/234 (15%)
Query: 781 NLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYY 840
            ++G G  G+        G  VAVK++ I  F  I   + ++ T     H N+   I YY
Sbjct: 39  KILGYGSSGTVVFQGSFQGRPVAVKRMLID-FCDIALMEIKLLTESD-DHPNV---IRYY 93
Query: 841 VGEAEMFLVYNFLS--GGNLETFIHKKS----GKKIQWSVIHKIAI--DIAQALAYLHYS 892
             E     +Y  L     NL+  +  K+      K+Q    + I++   IA  +A+LH  
Sbjct: 94  CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEY-NPISLLRQIASGVAHLHSL 152
Query: 893 CVPRIVHRDIKPSNILLD-------------EELNAYLSDFGLARLLEVSETHATTDV-- 937
              +I+HRD+KP NIL+              E L   +SDFGL + L+  +     ++  
Sbjct: 153 ---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNN 209
Query: 938 -AGTFGYVAPEY---ATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGN 986
            +GT G+ APE    +T  R++   D++S G V   ++S GK      +S   N
Sbjct: 210 PSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 263

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 90/209 (43%), Gaps = 34/209 (16%)
Query: 779 IRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAE-IGTLGRIRHK------ 831
           IR L GTG FG           ++ VK    G    ++  D + +  L +I H       
Sbjct: 47  IRTL-GTGSFGR----------VMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 832 -------NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQ 884
                   LV L   +   + +++V  +  GG  E F H +   +         A  I  
Sbjct: 96  QQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGG--EMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 885 ALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYV 944
              YLH      +++RD+KP N+L+D++    ++DFG A+ ++      T  + GT  Y+
Sbjct: 154 TFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYL 206
Query: 945 APEYATTCRVSDKADVYSFGVVLLELISG 973
           APE   +   +   D ++ GV++ E+ +G
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 96/227 (42%), Gaps = 33/227 (14%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-----PGYL-VAVKKLSI-GRFQGIQQFDAEIGTLGRI 828
           N  +   +G G FG   KA         GY  VAVK L        ++   +E   L ++
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV 83
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIH--KKSG------------------- 867
            H +++ L G    +  + L+  +   G+L  F+   +K G                   
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 868 -KKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL 926
            + +    +   A  I+Q + YL      ++VHRD+   NIL+ E     +SDFGL+R +
Sbjct: 144 ERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 927 EVSETHATTDVAGT-FGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
              +++           ++A E       + ++DV+SFGV+L E+++
Sbjct: 201 YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 23/216 (10%)
Query: 770 VVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRI- 828
           V+    +F  ++++G G  G+     +     VAVK++    F      D E+  L    
Sbjct: 19  VIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFA---DREVQLLRESD 75
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNF--LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQAL 886
            H N+   I Y+  E +    Y    L    L+ ++ +K    +    I  +       L
Sbjct: 76  EHPNV---IRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPI-TLLQQTTSGL 131
Query: 887 AYLHYSCVPRIVHRDIKPSNILLDE-----ELNAYLSDFGLARLLEVSETHAT--TDVAG 939
           A+LH      IVHRD+KP NIL+       ++ A +SDFGL + L V     +  + V G
Sbjct: 132 AHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPG 188
Query: 940 TFGYVAPEY-ATTCRVSD--KADVYSFGVVLLELIS 972
           T G++APE  +  C+ +     D++S G V   +IS
Sbjct: 189 TEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 99/212 (46%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
            F    ++G+G FG+ YK   +P        VA+K+L      +  ++   E   +  + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           + ++  L+G  +  + + L+   +  G L  ++ ++    I    +    + IA+ + YL
Sbjct: 78  NPHVCRLLGICLT-STVQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
                 R+VHRD+   N+L+    +  ++DFG A+LL  E  E HA         ++A E
Sbjct: 136 EDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV-PIKWMALE 191
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
                  + ++DV+S+GV + EL++ G +  D
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 99/212 (46%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
            F    ++G+G FG+ YK   +P        VA+K+L      +  ++   E   +  + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           + ++  L+G  +  + + L+   +  G L  ++ ++    I    +    + IA+ + YL
Sbjct: 78  NPHVCRLLGICLT-STVQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
                 R+VHRD+   N+L+    +  ++DFG A+LL  E  E HA         ++A E
Sbjct: 136 EDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV-PIKWMALE 191
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
                  + ++DV+S+GV + EL++ G +  D
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/220 (22%), Positives = 97/220 (44%), Gaps = 27/220 (12%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA------ELVPGYLVAVKKLS-IGRFQGIQQFDAEIGTL 825
           A    ++   +G G FG  Y+       +  P   VA+K ++     +   +F  E   +
Sbjct: 8   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 67
Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH--------K 877
                 ++V L+G         ++   ++ G+L++++     +     V+         +
Sbjct: 68  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 127
Query: 878 IAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDV 937
           +A +IA  +AYL+ +   + VHRD+   N ++ E+    + DFG+ R  ++ ET      
Sbjct: 128 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIXETDXXR-- 180
Query: 938 AGTFG-----YVAPEYATTCRVSDKADVYSFGVVLLELIS 972
            G  G     +++PE       +  +DV+SFGVVL E+ +
Sbjct: 181 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 99/231 (42%), Gaps = 41/231 (17%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-----PGYL-VAVKKLSI-GRFQGIQQFDAEIGTLGRI 828
           N  +   +G G FG   KA         GY  VAVK L        ++   +E   L ++
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV 83
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIH--KKSG------------------- 867
            H +++ L G    +  + L+  +   G+L  F+   +K G                   
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 868 -KKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL 926
            + +    +   A  I+Q + YL      ++VHRD+   NIL+ E     +SDFGL+R  
Sbjct: 144 ERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR-- 198
Query: 927 EVSETHATTDVAGTFGYVAPEYATTCRVSD-----KADVYSFGVVLLELIS 972
           +V E  +   V  + G +  ++     + D     ++DV+SFGV+L E+++
Sbjct: 199 DVYEEDSX--VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 99/212 (46%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
            F    ++G+G FG+ YK   +P        VA+K+L      +  ++   E   +  + 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           + ++  L+G  +  + + L+   +  G L  ++ ++    I    +    + IA+ + YL
Sbjct: 80  NPHVCRLLGICLT-STVQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 137
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
                 R+VHRD+   N+L+    +  ++DFG A+LL  E  E HA         ++A E
Sbjct: 138 EDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV-PIKWMALE 193
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
                  + ++DV+S+GV + EL++ G +  D
Sbjct: 194 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/195 (23%), Positives = 88/195 (45%), Gaps = 13/195 (6%)
Query: 783 IGTGGFGST----YKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +GTG FG      +K       +  + K  + + + I+    E   L  +    LV L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
            +   + +++V  +++GG  E F H +   +         A  I     YLH      ++
Sbjct: 109 SFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH---SLDLI 163
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA 958
           +RD+KP N+L+D++    ++DFG A+ ++      T  + GT   +APE   +   +   
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWXLCGTPEALAPEIILSKGYNKAV 219
Query: 959 DVYSFGVVLLELISG 973
           D ++ GV++ E+ +G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 99/212 (46%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
            F    ++ +G FG+ YK   +P        VA+K+L      +  ++   E   +  + 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           + ++  L+G  +  + + L+   +  G L  ++ ++    I    +    + IA+ + YL
Sbjct: 83  NPHVCRLLGICLT-STVQLIMQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 140
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
                 R+VHRD+   N+L+    +  ++DFGLA+LL  E  E HA         ++A E
Sbjct: 141 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 196
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
                  + ++DV+S+GV + EL++ G +  D
Sbjct: 197 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 99/212 (46%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
            F    ++G+G FG+ YK   +P        VA+K+L      +  ++   E   +  + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           + ++  L+G  +  + + L+   +  G L  ++ ++    I    +    + IA+ + YL
Sbjct: 78  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
                 R+VHRD+   N+L+    +  ++DFG A+LL  E  E HA         ++A E
Sbjct: 136 EDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV-PIKWMALE 191
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
                  + ++DV+S+GV + EL++ G +  D
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 99/212 (46%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
            F    ++G+G FG+ YK   +P        VA+K+L      +  ++   E   +  + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           + ++  L+G  +  + + L+   +  G L  ++ ++    I    +    + IA+ + YL
Sbjct: 76  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
                 R+VHRD+   N+L+    +  ++DFG A+LL  E  E HA         ++A E
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV-PIKWMALE 189
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
                  + ++DV+S+GV + EL++ G +  D
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 99/212 (46%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
            F    ++G+G FG+ YK   +P        VA+ +L      +  ++   E   +  + 
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVD 109
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           + ++  L+G  +  + + L+   +  G L  ++ ++    I    +    + IA+ + YL
Sbjct: 110 NPHVCRLLGICLT-STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 167
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
                 R+VHRD+   N+L+    +  ++DFGLA+LL  E  E HA         ++A E
Sbjct: 168 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 223
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
                  + ++DV+S+GV + EL++ G +  D
Sbjct: 224 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 255

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 99/212 (46%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
            F    ++G+G FG+ YK   +P        VA+K+L      +  ++   E   +  + 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           + ++  L+G  +  + + L+   +  G L  ++ ++    I    +    + IA+ + YL
Sbjct: 83  NPHVCRLLGICL-TSTVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 140
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
                 R+VHRD+   N+L+    +  ++DFG A+LL  E  E HA         ++A E
Sbjct: 141 EDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV-PIKWMALE 196
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
                  + ++DV+S+GV + EL++ G +  D
Sbjct: 197 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/220 (22%), Positives = 97/220 (44%), Gaps = 27/220 (12%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA------ELVPGYLVAVKKLS-IGRFQGIQQFDAEIGTL 825
           A    ++   +G G FG  Y+       +  P   VA+K ++     +   +F  E   +
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH--------K 877
                 ++V L+G         ++   ++ G+L++++     +     V+         +
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 136
Query: 878 IAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDV 937
           +A +IA  +AYL+ +   + VHRD+   N ++ E+    + DFG+ R  ++ ET      
Sbjct: 137 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIXETDXXR-- 189
Query: 938 AGTFG-----YVAPEYATTCRVSDKADVYSFGVVLLELIS 972
            G  G     +++PE       +  +DV+SFGVVL E+ +
Sbjct: 190 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 99/212 (46%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
            F    ++ +G FG+ YK   +P        VA+K+L      +  ++   E   +  + 
Sbjct: 16  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           + ++  L+G  +  + + L+   +  G L  ++ ++    I    +    + IA+ + YL
Sbjct: 76  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
                 R+VHRD+   N+L+    +  ++DFGLA+LL  E  E HA         ++A E
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 189
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
                  + ++DV+S+GV + EL++ G +  D
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 99/212 (46%), Gaps = 15/212 (7%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIR 829
            F    ++ +G FG+ YK   +P        VA+K+L      +  ++   E   +  + 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           + ++  L+G  +  + + L+   +  G L  ++ ++    I    +    + IA+ + YL
Sbjct: 83  NPHVCRLLGICLT-STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 140
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL--EVSETHATTDVAGTFGYVAPE 947
                 R+VHRD+   N+L+    +  ++DFGLA+LL  E  E HA         ++A E
Sbjct: 141 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-PIKWMALE 196
Query: 948 YATTCRVSDKADVYSFGVVLLELIS-GKRSLD 978
                  + ++DV+S+GV + EL++ G +  D
Sbjct: 197 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 95/212 (44%), Gaps = 31/212 (14%)
Query: 783 IGTGGFGSTYKA---ELVPGYL---VAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
           +G G FG  Y+    +++ G     VAVK ++     +   +F  E   +      ++V 
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHK----------KSGKKIQWSVIHKIAIDIAQA 885
           L+G         +V   ++ G+L++++            +    +Q  +  ++A +IA  
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI--QMAAEIADG 139
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFG--- 942
           +AYL+     + VHRD+   N ++  +    + DFG+ R  ++ ET       G  G   
Sbjct: 140 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIXETDXXR--KGGKGLLP 192
Query: 943 --YVAPEYATTCRVSDKADVYSFGVVLLELIS 972
             ++APE       +  +D++SFGVVL E+ S
Sbjct: 193 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 27/204 (13%)
Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
           IG+G  G   + Y A L     VA+KKLS   FQ     ++   E+  +  + HKN++ L
Sbjct: 34  IGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGL 90
Query: 837 IGYYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAIDIAQALAYL 889
           +  +  +       ++++V   +     +          IQ  + H +++  + Q L  +
Sbjct: 91  LNVFTPQKSLEEFQDVYIVMELMDANLCQV---------IQMELDHERMSYLLYQMLCGI 141
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
            +     I+HRD+KPSNI++  +    + DFGLAR    S          T  Y APE  
Sbjct: 142 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMVPFVVTRYYRAPEVI 199
Query: 950 TTCRVSDKADVYSFGVVLLELISG 973
                 +  D++S G ++ E+I G
Sbjct: 200 LGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 95/212 (44%), Gaps = 31/212 (14%)
Query: 783 IGTGGFGSTYKA---ELVPGYL---VAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
           +G G FG  Y+    +++ G     VAVK ++     +   +F  E   +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHK----------KSGKKIQWSVIHKIAIDIAQA 885
           L+G         +V   ++ G+L++++            +    +Q  +  ++A +IA  
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI--QMAAEIADG 142
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFG--- 942
           +AYL+     + VHRD+   N ++  +    + DFG+ R  ++ ET       G  G   
Sbjct: 143 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIXETDXXR--KGGKGLLP 195
Query: 943 --YVAPEYATTCRVSDKADVYSFGVVLLELIS 972
             ++APE       +  +D++SFGVVL E+ S
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 105/246 (42%), Gaps = 55/246 (22%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHK 831
           ++  +S+   +GTG FG   +  ++  G   A+KK+     Q  +  + E+  +  + H 
Sbjct: 5   SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV----LQDPRYKNRELDIMKVLDHV 60
Query: 832 NLVTLIGYY--VGEAEMFLV-----YNFLSGGN--------------------------- 857
           N++ L+ Y+   G+ E         +N L G N                           
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 858 -------LETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLD 910
                  L++FI  +SG+ I  ++I      + +A+ ++H      I HRDIKP N+L++
Sbjct: 121 PDTLHKVLKSFI--RSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVN 175
Query: 911 EELNAY-LSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT-TCRVSDKADVYSFGVVLL 968
            + N   L DFG A+ L  SE  +   +   F Y APE        +   D++S G V  
Sbjct: 176 SKDNTLKLCDFGSAKKLIPSEP-SVAXICSRF-YRAPELMLGATEYTPSIDLWSIGCVFG 233
Query: 969 ELISGK 974
           ELI GK
Sbjct: 234 ELILGK 239

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 95/212 (44%), Gaps = 31/212 (14%)
Query: 783 IGTGGFGSTYKA---ELVPGYL---VAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
           +G G FG  Y+    +++ G     VAVK ++     +   +F  E   +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHK----------KSGKKIQWSVIHKIAIDIAQA 885
           L+G         +V   ++ G+L++++            +    +Q  +  ++A +IA  
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI--QMAAEIADG 142
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFG--- 942
           +AYL+     + VHRD+   N ++  +    + DFG+ R  ++ ET       G  G   
Sbjct: 143 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIXETDXXR--KGGKGLLP 195
Query: 943 --YVAPEYATTCRVSDKADVYSFGVVLLELIS 972
             ++APE       +  +D++SFGVVL E+ S
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 103/237 (43%), Gaps = 41/237 (17%)
Query: 782 LIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV 841
           ++G G  G+        G  VAVK++ I  F  I   + ++ T     H N+   I YY 
Sbjct: 22  ILGYGSSGTVVFQGSFQGRPVAVKRMLID-FCDIALMEIKLLTESD-DHPNV---IRYYC 76
Query: 842 GEAEMFLVYNFLS--GGNLETFIHKKS----GKKIQWSVIHKIAI--DIAQALAYLHYSC 893
            E     +Y  L     NL+  +  K+      K+Q    + I++   IA  +A+LH   
Sbjct: 77  SETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEY-NPISLLRQIASGVAHLHSL- 134
Query: 894 VPRIVHRDIKPSNILLD-------------EELNAYLSDFGLARLLEVSETHATTDV--- 937
             +I+HRD+KP NIL+              E L   +SDFGL + L+  +     ++   
Sbjct: 135 --KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNP 192
Query: 938 AGTFGYVAPE-------YATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGN 986
           +GT G+ APE         T  R++   D++S G V   ++S GK      +S   N
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 249

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 95/216 (43%), Gaps = 19/216 (8%)
Query: 772 RATGNFSIRNLIGTGGFGSTY-KAELVPGYLVAVKK-LSIGRFQGIQ-QFDAEIGTLGRI 828
           +    F +  + G G FG+     E   G  VA+KK +   RF+  + Q   ++  L   
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL--- 76
Query: 829 RHKNLVTLIGYY--VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSV------IHKIAI 880
            H N+V L  Y+  +GE +   +Y  +    +   +H+      +  V      I     
Sbjct: 77  HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLF 136
Query: 881 DIAQALAYLHYSCVPRIVHRDIKPSNILLDE-ELNAYLSDFGLARLLEVSETHATTDVAG 939
            + +++  LH   V  + HRDIKP N+L++E +    L DFG A+ L  SE +    +  
Sbjct: 137 QLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY-ICS 194
Query: 940 TFGYVAPEYA-TTCRVSDKADVYSFGVVLLELISGK 974
            + Y APE        +   D++S G +  E++ G+
Sbjct: 195 RY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 80/186 (43%), Gaps = 8/186 (4%)
Query: 509 SFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRV 568
           +F+  + ANL      +A   + +  ++   ANN    S+  G+  L  ++ L L GN++
Sbjct: 17  AFAETIKANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQ-GIQYLPNVRYLALGGNKL 75
Query: 569 SGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKAT 628
                  L +L  L +++L GN L       F  L +L  L L  N L         K T
Sbjct: 76  HDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLT 133
Query: 629 KLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLS----GHIPHLQHLDCIAFKGNKY 684
            L  L LAHN+L       F  L NL+ LDLS+N L     G    L  L  +    N+ 
Sbjct: 134 NLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQ- 192
Query: 685 LASCPD 690
           L S PD
Sbjct: 193 LKSVPD 198

>pdb|2Z7X|B Chain B, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By Binding Of A Tri-Acylated Lipopeptide Length = 520

Iteration: 1
 Score = 50.4 bits (119), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 129/537 (24%), Positives = 212/537 (39%), Gaps = 86/537 (16%)
Query: 163 IPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFL 222
           +P  +S  ++  +LN+S N  S      ++   +L ++ +S NR+   L I      + L
Sbjct: 15  VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY-LDISVFKFNQEL 71
Query: 223 TYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEG-SIPKEIGTISELKVLDVSRNSL- 280
            YL LS N L   +        NLK+L L  N  +   I KE G +S+LK L +S   L 
Sbjct: 72  EYLDLSHNKL---VKISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLE 128
Query: 281 -TDRIPVELADCSKLSVLVLTNIDASLDLD-----NSRGEFSAFDGGVPYELLLSRSLE- 333
            +  +P+   + SK+ +++        D +     N+      F     +  +L  S++ 
Sbjct: 129 KSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKT 188
Query: 334 VLWAPRANLGGRLPDNWSESCS--LKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLE 391
           V     +N+   L DN    CS  L +L   Q + K +              +L+LNN+E
Sbjct: 189 VANLELSNIKCVLEDN---KCSYFLSILAKLQTNPKLS--------------NLTLNNIE 231
Query: 392 GYLPMQLPVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFV 451
                 + +  +V+                      H        +NV + G +   +F 
Sbjct: 232 TTWNSFIRILQLVW----------------------HTTVWYFSISNVKLQGQLDFRDF- 268
Query: 452 IIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERI------SKCN 505
              D+SG   L +L +  +            Y +  N N+ N +V G R+      SK +
Sbjct: 269 ---DYSGTS-LKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKIS 324
Query: 506 DLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEA---ANNQIS--GSIAAGVGKLMKLQR 560
                 ++ S NLL+   +E    +C  L E E      NQ+     IA    ++  LQ+
Sbjct: 325 PF--LHLDFSNNLLTDTVFE----NCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQ 378
Query: 561 LDLRGNRVSGSLPDELGKLKFLKWIL---LGGNNLTGEIPSQFGHLISLVVLDLSHNALT 617
           LD+  N VS    ++ G   + K +L   +  N LT  I       I   VLDL  N + 
Sbjct: 379 LDISQNSVSYD--EKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIK--VLDLHSNKI- 433
Query: 618 GSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPHLQHL 674
            SIP  + K   L+ L +A N+L       F  L +L  + L  N      P + +L
Sbjct: 434 KSIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYL 490

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 50.4 bits (119), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 98/231 (42%), Gaps = 41/231 (17%)
Query: 776 NFSIRNLIGTGGFGSTYKAELV-----PGYL-VAVKKLSI-GRFQGIQQFDAEIGTLGRI 828
           N  +   +G G FG   KA         GY  VAVK L        ++   +E   L ++
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV 83
Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIH--KKSG------------------- 867
            H +++ L G    +  + L+  +   G+L  F+   +K G                   
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 868 -KKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL 926
            + +    +   A  I+Q + YL       +VHRD+   NIL+ E     +SDFGL+R  
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAEGRKMKISDFGLSR-- 198
Query: 927 EVSETHATTDVAGTFGYVAPEYATTCRVSD-----KADVYSFGVVLLELIS 972
           +V E  +   V  + G +  ++     + D     ++DV+SFGV+L E+++
Sbjct: 199 DVYEEDSX--VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 33/143 (23%), Positives = 71/143 (49%), Gaps = 8/143 (5%)
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           ++ L   Y   +E+ L+  + +GG + +    +  + +  + + ++   I + + YLH +
Sbjct: 91  VINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN 150
Query: 893 CVPRIVHRDIKPSNILLDEEL---NAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
               IVH D+KP NILL       +  + DFG++R  ++       ++ GT  Y+APE  
Sbjct: 151 ---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR--KIGHACELREIMGTPEYLAPEIL 205
Query: 950 TTCRVSDKADVYSFGVVLLELIS 972
               ++   D+++ G++   L++
Sbjct: 206 NYDPITTATDMWNIGIIAYMLLT 228

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Composition-based stats.
 Identities = 54/197 (27%), Positives = 93/197 (47%), Gaps = 16/197 (8%)
Query: 783 IGTGGFGSTYK-AELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV 841
           +G G FG  ++  +   G+  AVKK+ +  F+ +++  A  G    +    +V L G   
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-VEELVACAG----LSSPRIVPLYGAVR 120
Query: 842 GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
               + +    L GG+L   I K+ G   +   ++ +     QAL  L Y    RI+H D
Sbjct: 121 EGPWVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLG----QALEGLEYLHTRRILHGD 175
Query: 902 IKPSNILLDEE-LNAYLSDFGLARLLE---VSETHATTD-VAGTFGYVAPEYATTCRVSD 956
           +K  N+LL  +   A L DFG A  L+   + ++  T D + GT  ++APE         
Sbjct: 176 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDA 235
Query: 957 KADVYSFGVVLLELISG 973
           K D++S   ++L +++G
Sbjct: 236 KVDIWSSCCMMLHMLNG 252

>pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 35/87 (40%), Positives = 50/87 (57%), Gaps = 3/87 (3%)
Query: 578 KLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAH 637
           K  FL  + L GN+LT E+P++  +L +L VLDLSHN LT S+PA L    +L+  +   
Sbjct: 245 KYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFD 302
Query: 638 NRLSGEIPVSFSTLVNLSALDLSFNNL 664
           N ++  +P  F  L NL  L +  N L
Sbjct: 303 NMVTT-LPWEFGNLCNLQFLGVEGNPL 328

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 27/205 (13%)
Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
           IG+G  G   + Y A L     VA+KKLS   FQ     ++   E+  +  + HKN++ L
Sbjct: 37  IGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGL 93
Query: 837 IGYYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAIDIAQALAYL 889
           +  +  +       ++++V   +     +          IQ  + H +++  + Q L  +
Sbjct: 94  LNVFTPQKSLEEFQDVYIVMELMDANLCQV---------IQMELDHERMSYLLYQMLCGI 144
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
            +     I+HRD+KPSNI++  +    + DFGLAR    S     T    T  Y APE  
Sbjct: 145 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVI 202
Query: 950 TTCRVSDKADVYSFGVVLLELISGK 974
                 +  D++S G ++ E++  K
Sbjct: 203 LGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFD------AEIGTLGRI 828
            + +  L+G+GGFGS Y    V   L VA+K +   R     +         E+  L ++
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 829 R--HKNLVTLIGYYVGEAEMFLVYNFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
                 ++ L+ ++       L+        +L  FI ++    +Q  +       + +A
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 154
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTFG 942
           + + H +C   ++HRDIK  NIL+D  LN     L DFG   LL+ +     TD  GT  
Sbjct: 155 VRHCH-NC--GVLHRDIKDENILID--LNRGELKLIDFGSGALLKDT---VYTDFDGTRV 206
Query: 943 YVAPEYATTCRVSDK-ADVYSFGVVLLELISG 973
           Y  PE+    R   + A V+S G++L +++ G
Sbjct: 207 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFD------AEIGTLGRI 828
            + +  L+G+GGFGS Y    V   L VA+K +   R     +         E+  L ++
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 829 R--HKNLVTLIGYYVGEAEMFLVYNFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
                 ++ L+ ++       L+        +L  FI ++    +Q  +       + +A
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 155
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTFG 942
           + + H +C   ++HRDIK  NIL+D  LN     L DFG   LL+ +     TD  GT  
Sbjct: 156 VRHCH-NC--GVLHRDIKDENILID--LNRGELKLIDFGSGALLKDT---VYTDFDGTRV 207
Query: 943 YVAPEYATTCRVSDK-ADVYSFGVVLLELISG 973
           Y  PE+    R   + A V+S G++L +++ G
Sbjct: 208 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFD------AEIGTLGRI 828
            + +  L+G+GGFGS Y    V   L VA+K +   R     +         E+  L ++
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 829 R--HKNLVTLIGYYVGEAEMFLVYNFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
                 ++ L+ ++       L+        +L  FI ++    +Q  +       + +A
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 154
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTFG 942
           + + H +C   ++HRDIK  NIL+D  LN     L DFG   LL+ +     TD  GT  
Sbjct: 155 VRHCH-NC--GVLHRDIKDENILID--LNRGELKLIDFGSGALLKDT---VYTDFDGTRV 206
Query: 943 YVAPEYATTCRVSDK-ADVYSFGVVLLELISG 973
           Y  PE+    R   + A V+S G++L +++ G
Sbjct: 207 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFD------AEIGTLGRI 828
            + +  L+G+GGFGS Y    V   L VA+K +   R     +         E+  L ++
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 829 R--HKNLVTLIGYYVGEAEMFLVYNFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
                 ++ L+ ++       L+        +L  FI ++    +Q  +       + +A
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 154
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTFG 942
           + + H +C   ++HRDIK  NIL+D  LN     L DFG   LL+ +     TD  GT  
Sbjct: 155 VRHCH-NC--GVLHRDIKDENILID--LNRGELKLIDFGSGALLKDT---VYTDFDGTRV 206
Query: 943 YVAPEYATTCRVSDK-ADVYSFGVVLLELISG 973
           Y  PE+    R   + A V+S G++L +++ G
Sbjct: 207 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 27/205 (13%)
Query: 783 IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
           IG+G  G   + Y A L     VA+KKLS   FQ     ++   E+  +  + HKN++ L
Sbjct: 26  IGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGL 82
Query: 837 IGYYVGE------AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAIDIAQALAYL 889
           +  +  +       ++++V   +     +          IQ  + H +++  + Q L  +
Sbjct: 83  LNVFTPQKSLEEFQDVYIVMELMDANLCQV---------IQMELDHERMSYLLYQMLCGI 133
Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
            +     I+HRD+KPSNI++  +    + DFGLAR    S     T    T  Y APE  
Sbjct: 134 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVI 191
Query: 950 TTCRVSDKADVYSFGVVLLELISGK 974
                 +  D++S G ++ E++  K
Sbjct: 192 LGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFD------AEIGTLGRI 828
            + +  L+G+GGFGS Y    V   L VA+K +   R     +         E+  L ++
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 829 R--HKNLVTLIGYYVGEAEMFLVYNFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
                 ++ L+ ++       L+        +L  FI ++    +Q  +       + +A
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 155
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTFG 942
           + + H +C   ++HRDIK  NIL+D  LN     L DFG   LL+ +     TD  GT  
Sbjct: 156 VRHCH-NC--GVLHRDIKDENILID--LNRGELKLIDFGSGALLKDT---VYTDFDGTRV 207
Query: 943 YVAPEYATTCRVSDK-ADVYSFGVVLLELISG 973
           Y  PE+    R   + A V+S G++L +++ G
Sbjct: 208 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Composition-based stats.
 Identities = 54/197 (27%), Positives = 93/197 (47%), Gaps = 16/197 (8%)
Query: 783 IGTGGFGSTYK-AELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV 841
           +G G FG  ++  +   G+  AVKK+ +  F+ +++  A  G    +    +V L G   
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-VEELVACAG----LSSPRIVPLYGAVR 134
Query: 842 GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRD 901
               + +    L GG+L   I K+ G   +   ++ +     QAL  L Y    RI+H D
Sbjct: 135 EGPWVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLG----QALEGLEYLHTRRILHGD 189
Query: 902 IKPSNILLDEE-LNAYLSDFGLARLLE---VSETHATTD-VAGTFGYVAPEYATTCRVSD 956
           +K  N+LL  +   A L DFG A  L+   + ++  T D + GT  ++APE         
Sbjct: 190 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDA 249
Query: 957 KADVYSFGVVLLELISG 973
           K D++S   ++L +++G
Sbjct: 250 KVDIWSSCCMMLHMLNG 266

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFD------AEIGTLGRI 828
            + +  L+G+GGFGS Y    V   L VA+K +   R     +         E+  L ++
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 829 R--HKNLVTLIGYYVGEAEMFLVYNFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
                 ++ L+ ++       L+        +L  FI ++    +Q  +       + +A
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 154
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTFG 942
           + + H +C   ++HRDIK  NIL+D  LN     L DFG   LL+ +     TD  GT  
Sbjct: 155 VRHCH-NC--GVLHRDIKDENILID--LNRGELKLIDFGSGALLKDT---VYTDFDGTRV 206
Query: 943 YVAPEYATTCRVSDK-ADVYSFGVVLLELISG 973
           Y  PE+    R   + A V+S G++L +++ G
Sbjct: 207 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFD------AEIGTLGRI 828
            + +  L+G+GGFGS Y    V   L VA+K +   R     +         E+  L ++
Sbjct: 24  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 829 R--HKNLVTLIGYYVGEAEMFLVYNFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
                 ++ L+ ++       L+        +L  FI ++    +Q  +       + +A
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 141
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTFG 942
           + + H +C   ++HRDIK  NIL+D  LN     L DFG   LL+ +     TD  GT  
Sbjct: 142 VRHCH-NC--GVLHRDIKDENILID--LNRGELKLIDFGSGALLKDT---VYTDFDGTRV 193
Query: 943 YVAPEYATTCRVSDK-ADVYSFGVVLLELISG 973
           Y  PE+    R   + A V+S G++L +++ G
Sbjct: 194 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFD------AEIGTLGRI 828
            + +  L+G+GGFGS Y    V   L VA+K +   R     +         E+  L ++
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 829 R--HKNLVTLIGYYVGEAEMFLVYNFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
                 ++ L+ ++       L+        +L  FI ++    +Q  +       + +A
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 161
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTFG 942
           + + H +C   ++HRDIK  NIL+D  LN     L DFG   LL+ +     TD  GT  
Sbjct: 162 VRHCH-NC--GVLHRDIKDENILID--LNRGELKLIDFGSGALLKDT---VYTDFDGTRV 213
Query: 943 YVAPEYATTCRVSDK-ADVYSFGVVLLELISG 973
           Y  PE+    R   + A V+S G++L +++ G
Sbjct: 214 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFD------AEIGTLGRI 828
            + +  L+G+GGFGS Y    V   L VA+K +   R     +         E+  L ++
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 829 R--HKNLVTLIGYYVGEAEMFLVYNFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
                 ++ L+ ++       L+        +L  FI ++    +Q  +       + +A
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 155
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTFG 942
           + + H +C   ++HRDIK  NIL+D  LN     L DFG   LL+ +     TD  GT  
Sbjct: 156 VRHCH-NC--GVLHRDIKDENILID--LNRGELKLIDFGSGALLKDT---VYTDFDGTRV 207
Query: 943 YVAPEYATTCRVSDK-ADVYSFGVVLLELISG 973
           Y  PE+    R   + A V+S G++L +++ G
Sbjct: 208 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFD------AEIGTLGRI 828
            + +  L+G+GGFGS Y    V   L VA+K +   R     +         E+  L ++
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 829 R--HKNLVTLIGYYVGEAEMFLVYNFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
                 ++ L+ ++       L+        +L  FI ++    +Q  +       + +A
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 155
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTFG 942
           + + H +C   ++HRDIK  NIL+D  LN     L DFG   LL+ +     TD  GT  
Sbjct: 156 VRHCH-NC--GVLHRDIKDENILID--LNRGELKLIDFGSGALLKDT---VYTDFDGTRV 207
Query: 943 YVAPEYATTCRVSDK-ADVYSFGVVLLELISG 973
           Y  PE+    R   + A V+S G++L +++ G
Sbjct: 208 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFD------AEIGTLGRI 828
            + +  L+G+GGFGS Y    V   L VA+K +   R     +         E+  L ++
Sbjct: 52  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 829 R--HKNLVTLIGYYVGEAEMFLVYNFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
                 ++ L+ ++       L+        +L  FI ++    +Q  +       + +A
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 169
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTFG 942
           + + H +C   ++HRDIK  NIL+D  LN     L DFG   LL+ +     TD  GT  
Sbjct: 170 VRHCH-NC--GVLHRDIKDENILID--LNRGELKLIDFGSGALLKDT---VYTDFDGTRV 221
Query: 943 YVAPEYATTCRVSDK-ADVYSFGVVLLELISG 973
           Y  PE+    R   + A V+S G++L +++ G
Sbjct: 222 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFD------AEIGTLGRI 828
            + +  L+G+GGFGS Y    V   L VA+K +   R     +         E+  L ++
Sbjct: 24  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 829 R--HKNLVTLIGYYVGEAEMFLVYNFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
                 ++ L+ ++       L+        +L  FI ++    +Q  +       + +A
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 141
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTFG 942
           + + H +C   ++HRDIK  NIL+D  LN     L DFG   LL+ +     TD  GT  
Sbjct: 142 VRHCH-NC--GVLHRDIKDENILID--LNRGELKLIDFGSGALLKDT---VYTDFDGTRV 193
Query: 943 YVAPEYATTCRVSDK-ADVYSFGVVLLELISG 973
           Y  PE+    R   + A V+S G++L +++ G
Sbjct: 194 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFD------AEIGTLGRI 828
            + +  L+G+GGFGS Y    V   L VA+K +   R     +         E+  L ++
Sbjct: 52  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 829 R--HKNLVTLIGYYVGEAEMFLVYNFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
                 ++ L+ ++       L+        +L  FI ++    +Q  +       + +A
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 169
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTFG 942
           + + H +C   ++HRDIK  NIL+D  LN     L DFG   LL+ +     TD  GT  
Sbjct: 170 VRHCH-NC--GVLHRDIKDENILID--LNRGELKLIDFGSGALLKDT---VYTDFDGTRV 221
Query: 943 YVAPEYATTCRVSDK-ADVYSFGVVLLELISG 973
           Y  PE+    R   + A V+S G++L +++ G
Sbjct: 222 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFD------AEIGTLGRI 828
            + +  L+G+GGFGS Y    V   L VA+K +   R     +         E+  L ++
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 829 R--HKNLVTLIGYYVGEAEMFLVYNFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
                 ++ L+ ++       L+        +L  FI ++    +Q  +       + +A
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 142
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTFG 942
           + + H +C   ++HRDIK  NIL+D  LN     L DFG   LL+ +     TD  GT  
Sbjct: 143 VRHCH-NC--GVLHRDIKDENILID--LNRGELKLIDFGSGALLKDT---VYTDFDGTRV 194
Query: 943 YVAPEYATTCRVSDK-ADVYSFGVVLLELISG 973
           Y  PE+    R   + A V+S G++L +++ G
Sbjct: 195 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 107/242 (44%), Gaps = 34/242 (14%)
Query: 783  IGTGGFG---STYKAELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTL 836
            IG+G  G   + Y A L     VA+KKLS   FQ     ++   E+  +  + HKN++ L
Sbjct: 32   IGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 837  IGYYVGE------AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAIDIAQALAYL 889
            +  +  +       ++++V   +     +          IQ  + H +++  + Q L  +
Sbjct: 89   LNVFTPQKSLEEFQDVYIVMELMDANLCQV---------IQMELDHERMSYLLYQMLCGI 139
Query: 890  HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
             +     I+HRD+KPSNI++  +    + DFGLAR    S       V  T  Y APE  
Sbjct: 140  KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVV--TRYYRAPEVI 197
Query: 950  TTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009
                  +  D++S G ++ E++  K  L P     G  + I  W K++ + G     F+ 
Sbjct: 198  LGMGYKENVDIWSVGCIMGEMVCHK-ILFP-----GRDY-IDQWNKVIEQLGTPCPAFMK 250
Query: 1010 EL 1011
            +L
Sbjct: 251  KL 252

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/220 (22%), Positives = 97/220 (44%), Gaps = 27/220 (12%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA------ELVPGYLVAVKKLS-IGRFQGIQQFDAEIGTL 825
           A    ++   +G G FG  Y+       +  P   VA+K ++     +   +F  E   +
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH--------K 877
                 ++V L+G         ++   ++ G+L++++     +     V+         +
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 129
Query: 878 IAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDV 937
           +A +IA  +AYL+ +   + VHRD+   N ++ E+    + DFG+ R  ++ ET      
Sbjct: 130 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR-- 182
Query: 938 AGTFG-----YVAPEYATTCRVSDKADVYSFGVVLLELIS 972
            G  G     +++PE       +  +DV+SFGVVL E+ +
Sbjct: 183 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 119/289 (41%), Gaps = 50/289 (17%)
Query: 783  IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYV- 841
            IG G +G  +  +   G  VAVK       +     + EI     +RH+N++  I   + 
Sbjct: 45   IGKGRYGEVWMGKW-RGEKVAVKVFFTTE-EASWFRETEIYQTVLMRHENILGFIAADIK 102
Query: 842  ---GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV---- 894
                  +++L+ ++   G+L  ++   +   +    + K+A      L +LH        
Sbjct: 103  GTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGLCHLHTEIFSTQG 159
Query: 895  -PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDV-----AGTFGYVAPEY 948
             P I HRD+K  NIL+ +     ++D GLA    +S+T+   D+      GT  Y+ PE 
Sbjct: 160  KPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF-ISDTNE-VDIPPNTRVGTKRYMPPEV 217
Query: 949  ATTCRVSDK------ADVYSFGVVLLEL----ISG---------KRSLDPSFSEYGNGFN 989
                   +       AD+YSFG++L E+    +SG            L PS   Y +   
Sbjct: 218  LDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMRE 277
Query: 990  IVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTR 1038
            IV      IK+ R S    P  W +   E L  M +L + C     ++R
Sbjct: 278  IVC-----IKKLRPS---FPNRWSS--DECLRQMGKLMTECWAHNPASR 316

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFD------AEIGTLGRI 828
            + +  L+G+GGFGS Y    V   L VA+K +   R     +         E+  L ++
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 829 R--HKNLVTLIGYYVGEAEMFLVYNFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
                 ++ L+ ++       L+        +L  FI ++    +Q  +       + +A
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 127
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTFG 942
           + + H +C   ++HRDIK  NIL+D  LN     L DFG   LL+ +     TD  GT  
Sbjct: 128 VRHCH-NC--GVLHRDIKDENILID--LNRGELKLIDFGSGALLKDT---VYTDFDGTRV 179
Query: 943 YVAPEYATTCRVSDK-ADVYSFGVVLLELISG 973
           Y  PE+    R   + A V+S G++L +++ G
Sbjct: 180 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFD------AEIGTLGRI 828
            + +  L+G+GGFGS Y    V   L VA+K +   R     +         E+  L ++
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 829 R--HKNLVTLIGYYVGEAEMFLVYNFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
                 ++ L+ ++       L+        +L  FI ++    +Q  +       + +A
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 142
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTFG 942
           + + H +C   ++HRDIK  NIL+D  LN     L DFG   LL+ +     TD  GT  
Sbjct: 143 VRHCH-NC--GVLHRDIKDENILID--LNRGELKLIDFGSGALLKDT---VYTDFDGTRV 194
Query: 943 YVAPEYATTCRVSDK-ADVYSFGVVLLELISG 973
           Y  PE+    R   + A V+S G++L +++ G
Sbjct: 195 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFD------AEIGTLGRI 828
            + +  L+G+GGFGS Y    V   L VA+K +   R     +         E+  L ++
Sbjct: 57  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 116
Query: 829 R--HKNLVTLIGYYVGEAEMFLVYNFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
                 ++ L+ ++       L+        +L  FI ++    +Q  +       + +A
Sbjct: 117 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 174
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTFG 942
           + + H +C   ++HRDIK  NIL+D  LN     L DFG   LL+ +     TD  GT  
Sbjct: 175 VRHCH-NC--GVLHRDIKDENILID--LNRGELKLIDFGSGALLKDT---VYTDFDGTRV 226
Query: 943 YVAPEYATTCRVSDK-ADVYSFGVVLLELISG 973
           Y  PE+    R   + A V+S G++L +++ G
Sbjct: 227 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 258

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFD------AEIGTLGRI 828
            + +  L+G+GGFGS Y    V   L VA+K +   R     +         E+  L ++
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 829 R--HKNLVTLIGYYVGEAEMFLVYNFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
                 ++ L+ ++       L+        +L  FI ++    +Q  +       + +A
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 142
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTFG 942
           + + H +C   ++HRDIK  NIL+D  LN     L DFG   LL+ +     TD  GT  
Sbjct: 143 VRHCH-NC--GVLHRDIKDENILID--LNRGELKLIDFGSGALLKDT---VYTDFDGTRV 194
Query: 943 YVAPEYATTCRVSDK-ADVYSFGVVLLELISG 973
           Y  PE+    R   + A V+S G++L +++ G
Sbjct: 195 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/178 (23%), Positives = 85/178 (47%), Gaps = 14/178 (7%)
Query: 801 LVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMF--LVYNFLSGGNL 858
           +V V K+     +  + F+ E   L    H N++ ++G           L+ +++  G+L
Sbjct: 37  VVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSL 96
Query: 859 ETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLS 918
              +H+ +   +  S   K A+D+A+ +A+LH +  P I    +   ++++DE++ A +S
Sbjct: 97  YNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARIS 155
Query: 919 DFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD----KADVYSFGVVLLELIS 972
                 + +V  +  +        +VAPE A   +  D     AD++SF V+L EL++
Sbjct: 156 ------MADVKFSFQSPGRMYAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVT 206

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 92/208 (44%), Gaps = 23/208 (11%)
Query: 783 IGTGGFGSTYKA---ELVPGYL---VAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
           +G G FG  Y+    +++ G     VAVK ++     +   +F  E   +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHK----------KSGKKIQWSVIHKIAIDIAQA 885
           L+G         +V   ++ G+L++++            +    +Q  +  ++A +IA  
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI--QMAAEIADG 142
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGTFGYV 944
           +AYL+     + VHRD+   N ++  +    + DFG+ R + E +             ++
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWM 199
Query: 945 APEYATTCRVSDKADVYSFGVVLLELIS 972
           APE       +  +D++SFGVVL E+ S
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGRFQGIQQFD------AEIGTLGRI 828
            + +  L+G+GGFGS Y    V   L VA+K +   R     +         E+  L ++
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 829 R--HKNLVTLIGYYVGEAEMFLVYNFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
                 ++ L+ ++       L+        +L  FI ++    +Q  +       + +A
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEA 127
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETHATTDVAGTFG 942
           + + H +C   ++HRDIK  NIL+D  LN     L DFG   LL+ +     TD  GT  
Sbjct: 128 VRHCH-NC--GVLHRDIKDENILID--LNRGELKLIDFGSGALLKDT---VYTDFDGTRV 179
Query: 943 YVAPEYATTCRVSDK-ADVYSFGVVLLELISG 973
           Y  PE+    R   + A V+S G++L +++ G
Sbjct: 180 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 56/197 (28%), Positives = 87/197 (44%), Gaps = 22/197 (11%)
Query: 783 IGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFD---AEIGTLGRIRHKNLVTLIG 838
           +G G +G  +K      G L AVK+ S+  F+G +      AE+G+  ++        + 
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
               E  +  +   L G +L+    +  G  +  + +     D   ALA+LH      +V
Sbjct: 124 QAWEEGGILYLQTELCGPSLQQHC-EAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLV 179
Query: 899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE-----YATTCR 953
           H D+KP+NI L       L DFGL  L+E+    A     G   Y+APE     Y T   
Sbjct: 180 HLDVKPANIFLGPRGRCKLGDFGL--LVELGTAGAGEVQEGDPRYMAPELLQGSYGTA-- 235
Query: 954 VSDKADVYSFGVVLLEL 970
               ADV+S G+ +LE+
Sbjct: 236 ----ADVFSLGLTILEV 248

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/220 (22%), Positives = 97/220 (44%), Gaps = 27/220 (12%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA------ELVPGYLVAVKKLS-IGRFQGIQQFDAEIGTL 825
           A    ++   +G G FG  Y+       +  P   VA+K ++     +   +F  E   +
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH--------K 877
                 ++V L+G         ++   ++ G+L++++     +     V+         +
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 136
Query: 878 IAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDV 937
           +A +IA  +AYL+ +   + VHRD+   N ++ E+    + DFG+ R  ++ ET      
Sbjct: 137 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR-- 189
Query: 938 AGTFG-----YVAPEYATTCRVSDKADVYSFGVVLLELIS 972
            G  G     +++PE       +  +DV+SFGVVL E+ +
Sbjct: 190 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 66/151 (43%), Gaps = 11/151 (7%)
Query: 546 GSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIP-SQFGHLI 604
            S+ AG+      Q L L  N+++   P     L  LK + LG N L G +P   F  L 
Sbjct: 32  ASVPAGIPT--NAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLT 88
Query: 605 SLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNL 664
            L VLDL  N LT    A   +   L+ LF+  N+L+ E+P     L +L+ L L  N L
Sbjct: 89  QLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL 147
Query: 665 SGHIPH-----LQHLDCIAFKGNKYLASCPD 690
              IPH     L  L      GN +   C D
Sbjct: 148 KS-IPHGAFDRLSSLTHAYLFGNPWDCECRD 177

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 102/233 (43%), Gaps = 38/233 (16%)
Query: 771 VRATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGI---QQFDAEIGTLG 826
           V    N+ I++LIG G +G  Y A +      VA+KK++   F+ +   ++   EI  L 
Sbjct: 22  VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN-RMFEDLIDCKRILREITILN 80
Query: 827 RIRHKNLVTLIGYYVGEA-----EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAID 881
           R++   ++ L    + +      E+++V         + F   K+   +    I  I  +
Sbjct: 81  RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLF---KTPIFLTEEHIKTILYN 137
Query: 882 IAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS-ETHATTDVAG- 939
           +     ++H S    I+HRD+KP+N LL+++ +  + DFGLAR +    +T+   D+   
Sbjct: 138 LLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194
Query: 940 -------------------TFGYVAPEYATTCRVSDKA-DVYSFGVVLLELIS 972
                              T  Y APE         K+ D++S G +  EL++
Sbjct: 195 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 91/208 (43%), Gaps = 23/208 (11%)
Query: 783 IGTGGFGSTYKA---ELVPGYL---VAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
           +G G FG  Y+    +++ G     VAVK ++     +   +F  E   +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHK----------KSGKKIQWSVIHKIAIDIAQA 885
           L+G         +V   ++ G+L++++            +    +Q  +  ++A +IA  
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI--QMAAEIADG 142
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LLEVSETHATTDVAGTFGYV 944
           +AYL+     + VHRD+   N ++  +    + DFG+ R + E               ++
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 199
Query: 945 APEYATTCRVSDKADVYSFGVVLLELIS 972
           APE       +  +D++SFGVVL E+ S
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/166 (24%), Positives = 77/166 (46%), Gaps = 27/166 (16%)
Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGK----KIQWSVIHKI------- 878
           H+N+V L+G       ++L++ +   G+L  ++  K  K    +I++    ++       
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 879 ----------AIDIAQALAYLHY-SCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR-LL 926
                     A  +A+ + +L + SCV    HRD+   N+L+       + DFGLAR ++
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKSCV----HRDLAARNVLVTHGKVVKICDFGLARDIM 223
Query: 927 EVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS 972
             S      +      ++APE       + K+DV+S+G++L E+ S
Sbjct: 224 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/220 (22%), Positives = 96/220 (43%), Gaps = 27/220 (12%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA------ELVPGYLVAVKKLS-IGRFQGIQQFDAEIGTL 825
           A    ++   +G G FG  Y+       +  P   VA+K ++     +   +F  E   +
Sbjct: 13  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 72
Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH--------K 877
                 ++V L+G         ++   ++ G+L++++           V+         +
Sbjct: 73  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 132
Query: 878 IAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDV 937
           +A +IA  +AYL+ +   + VHRD+   N ++ E+    + DFG+ R  ++ ET      
Sbjct: 133 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR-- 185
Query: 938 AGTFG-----YVAPEYATTCRVSDKADVYSFGVVLLELIS 972
            G  G     +++PE       +  +DV+SFGVVL E+ +
Sbjct: 186 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 96/221 (43%), Gaps = 37/221 (16%)
Query: 777 FSIRNLIGTGGFGSTYKA--ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKN-- 832
           +SI   IG+GG    ++   E    Y +    L     Q +  +  EI  L +++  +  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLE--TFIHKKSG-----KKIQWSVIHKIAIDIAQA 885
           ++ L  Y + +  +++V   +  GN++  +++ KK       +K  W        ++ +A
Sbjct: 118 IIRLYDYEITDQYIYMV---MECGNIDLNSWLKKKKSIDPWERKSYWK-------NMLEA 167
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYV 944
           +  +H      IVH D+KP+N L+ + +   L DFG+A  ++   T    D   GT  Y+
Sbjct: 168 VHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 223
Query: 945 APEYATTCRVSDK-----------ADVYSFGVVLLELISGK 974
            PE       S +           +DV+S G +L  +  GK
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 95/212 (44%), Gaps = 31/212 (14%)
Query: 783 IGTGGFGSTYKA---ELVPGYL---VAVKKLS-IGRFQGIQQFDAEIGTLGRIRHKNLVT 835
           +G G FG  Y+    +++ G     VAVK ++     +   +F  E   +      ++V 
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHK----------KSGKKIQWSVIHKIAIDIAQA 885
           L+G         +V   ++ G+L++++            +    +Q  +  ++A +IA  
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI--QMAAEIADG 141
Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFG--- 942
           +AYL+     + VHRD+   N ++  +    + DFG+ R  ++ ET       G  G   
Sbjct: 142 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYR--KGGKGLLP 194
Query: 943 --YVAPEYATTCRVSDKADVYSFGVVLLELIS 972
             ++APE       +  +D++SFGVVL E+ S
Sbjct: 195 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/220 (22%), Positives = 97/220 (44%), Gaps = 27/220 (12%)
Query: 773 ATGNFSIRNLIGTGGFGSTYKA------ELVPGYLVAVKKLS-IGRFQGIQQFDAEIGTL 825
           A    ++   +G G FG  Y+       +  P   VA+K ++     +   +F  E   +
Sbjct: 45  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 104
Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH--------K 877
                 ++V L+G         ++   ++ G+L++++     +     V+         +
Sbjct: 105 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 164
Query: 878 IAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDV 937
           +A +IA  +AYL+ +   + VHRD+   N ++ E+    + DFG+ R  ++ ET      
Sbjct: 165 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR-- 217
Query: 938 AGTFG-----YVAPEYATTCRVSDKADVYSFGVVLLELIS 972
            G  G     +++PE       +  +DV+SFGVVL E+ +
Sbjct: 218 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 83/182 (45%), Gaps = 27/182 (14%)
Query: 827  RIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQAL 886
            R +H    +LI  YV   +  ++Y  L+  ++  +I+                 ++ +AL
Sbjct: 117  RDQHSKTPSLIFEYVNNTDFKVLYPTLTDYDIRYYIY-----------------ELLKAL 159
Query: 887  AYLHYSCVPRIVHRDIKPSNILLDEELNA-YLSDFGLARLLEVSETHATTDVAGTFGYVA 945
             Y H      I+HRD+KP N+++D EL    L D+GLA      + +    VA  + +  
Sbjct: 160  DYCHSQG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRY-FKG 214
Query: 946  PEYATTCRVSDKA-DVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSS 1004
            PE     +  D + D++S G +   +I  K   +P F  + N   +V  AK+L  +G ++
Sbjct: 215  PELLVDLQDYDYSLDMWSLGCMFAGMIFRK---EPFFYGHDNHDQLVKIAKVLGTDGLNA 271
Query: 1005 EL 1006
             L
Sbjct: 272  YL 273
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	1052
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-132
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-116
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-116
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-105
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	7e-97
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-77
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-69
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-19
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-70
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-68
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-64
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-54
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-54
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-34
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-33
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-12
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-65
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-51
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-38
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-32
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	9e-22
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-14
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-61
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	9e-48
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-43
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-38
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-09
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-60
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-58
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-31
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-20
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-60
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-59
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	7e-08
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-57
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-38
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-10
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-56
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-55
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-55
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	9e-53
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-52
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-52
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-49
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	8e-49
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-48
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-48
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	7e-48
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-47
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-47
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	5e-47
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	7e-44
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-36
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-09
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-43
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	9e-30
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-18
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-39
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	8e-39
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-38
1o6v_A	466	Internalin A; bacterial infection, extracellular r	7e-38
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-32
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-31
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-29
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-16
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-37
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-37
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-37
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-36
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-33
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-30
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-15
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-13
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-36
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-36
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-35
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-35
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-35
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-35
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	5e-35
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	9e-35
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	6e-34
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	6e-34
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	7e-34
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-33
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-33
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-33
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-32
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-25
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-15
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	7e-10
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-33
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-33
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-33
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	6e-33
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	7e-33
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	7e-33
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-32
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-32
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-32
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	5e-32
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	7e-32
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	7e-32
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-31
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-31
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-31
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-31
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-31
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-31
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-31
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-31
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-31
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-31
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	4e-31
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-31
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	6e-31
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-30
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-30
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-30
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-30
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-30
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-30
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-30
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-30
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-30
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-30
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	6e-30
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	7e-30
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	9e-30
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-29
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-29
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-29
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-25
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	9e-25
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	8e-24
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-23
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-22
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-22
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-21
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-20
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-20
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-19
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-10
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-29
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-29
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-29
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-29
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-29
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-29
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-29
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-29
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-29
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-29
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	9e-28
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	6e-26
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	5e-24
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-21
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-15
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-06
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-29
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-29
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-28
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-28
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-24
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-20
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-20
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-15
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-29
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-29
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-29
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	5e-29
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	6e-29
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	7e-29
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	9e-29
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-28
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-28
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-28
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-28
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-28
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-28
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-28
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-28
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-28
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-28
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	6e-28
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	7e-28
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-28
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	7e-28
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	7e-28
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	9e-28
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-27
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-27
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-27
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-27
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-27
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-27
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-27
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-27
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-27
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	6e-27
3aln_A	327	Dual specificity mitogen-activated protein kinase;	6e-27
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	7e-27
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	9e-27
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-26
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-26
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-26
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-26
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-26
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-26
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-26
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	7e-26
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	6e-22
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	5e-20
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	5e-19
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-17
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	9e-17
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	6e-08
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	8e-26
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-25
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	9e-25
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	9e-18
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	5e-16
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-25
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-24
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-20
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	7e-16
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-25
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-25
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	5e-25
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	6e-25
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	7e-25
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	7e-25
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	8e-25
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	9e-25
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-24
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	9e-20
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-18
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	9e-17
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-16
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	6e-14
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	5e-10
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-24
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-24
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-24
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	5e-24
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	9e-24
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-23
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-23
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-23
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-14
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	7e-14
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-04
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-23
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-23
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-23
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-23
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-23
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-23
4aoj_A	329	High affinity nerve growth factor receptor; transf	5e-23
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	7e-23
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	8e-23
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	8e-23
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	9e-23
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	7e-21
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	8e-18
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	6e-14
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-10
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-06
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-22
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-22
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-22
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-22
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-22
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-22
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-22
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-22
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-22
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-22
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-22
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	6e-22
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-22
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	7e-22
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	7e-22
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	8e-22
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-21
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-19
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-17
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	5e-12
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-21
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-21
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-21
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-21
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-21
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-14
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-10
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-04
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-21
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-20
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-18
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-17
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-16
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-15
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-12
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-05
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-21
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-21
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-21
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	6e-21
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	8e-21
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-20
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-20
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-16
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-16
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	4e-15
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	8e-13
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-12
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	8e-12
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-20
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-20
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-20
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-20
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-20
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-20
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	8e-20
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-19
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-15
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-15
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	9e-10
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-09
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-07
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	8e-06
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-05
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-19
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-19
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-18
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	9e-16
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-14
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	9e-14
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-12
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	9e-12
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	4e-09
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-07
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-19
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-19
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	7e-19
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-18
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-18
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-16
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-16
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-15
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-14
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	6e-12
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-10
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-05
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-19
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	4e-19
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-16
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-12
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-11
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	6e-11
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	4e-07
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-06
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	8e-05
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-19
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	6e-19
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-17
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	5e-17
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-15
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	7e-13
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	6e-12
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	8e-12
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	9e-06
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	8e-19
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	8e-19
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-18
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-18
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-18
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-16
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-14
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-11
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	5e-09
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-08
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-08
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-04
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-04
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-18
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	6e-18
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-14
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-14
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	7e-10
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	7e-09
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	5e-18
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-15
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-11
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-10
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	8e-08
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	5e-07
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-17
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-17
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-17
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-17
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-17
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-15
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-13
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-10
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-05
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-17
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-17
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	5e-17
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	4e-13
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	9e-11
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	7e-07
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	5e-05
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-04
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	5e-17
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	9e-16
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	8e-13
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-12
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-11
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-11
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-11
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-08
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-07
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	5e-06
3rp9_A	458	Mitogen-activated protein kinase; structural genom	6e-17
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	8e-17
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	9e-17
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	9e-17
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	9e-17
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-15
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	7e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	5e-08
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-06
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-16
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-16
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-16
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	8e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-11
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-08
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-05
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-04
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-04
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-16
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-16
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-16
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-16
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	7e-16
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-15
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-13
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-12
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-06
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	5e-05
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	8e-16
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-15
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-15
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-13
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-11
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-05
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-04
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	9e-15
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-11
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-11
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	4e-06
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-05
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-05
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	7e-05
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	7e-04
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-14
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-14
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-14
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-14
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-14
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-14
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	6e-14
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-13
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	5e-06
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-05
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	6e-14
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	7e-14
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-13
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-13
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	5e-11
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	6e-11
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-10
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-10
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-09
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-05
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-05
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-04
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-13
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-11
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-09
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-08
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-07
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	5e-06
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	4e-04
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-13
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-13
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-13
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-12
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	5e-11
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-09
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-07
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	3e-13
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	5e-13
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	5e-07
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-13
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	9e-05
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	5e-13
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-10
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-09
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-09
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	4e-06
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-05
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	9e-13
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-12
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-12
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-12
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-10
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	5e-10
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	5e-09
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-08
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	8e-08
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	7e-07
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-06
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-05
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-12
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	8e-12
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	9e-12
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-11
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-11
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	9e-11
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-10
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-10
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-06
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	4e-06
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-05
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-11
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	5e-11
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-10
3m19_A	251	Variable lymphocyte receptor A diversity region; a	4e-10
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-09
3m19_A	251	Variable lymphocyte receptor A diversity region; a	4e-07
3m19_A	251	Variable lymphocyte receptor A diversity region; a	7e-06
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	4e-10
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	6e-10
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-09
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	8e-09
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-05
3e6j_A	229	Variable lymphocyte receptor diversity region; var	9e-10
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-09
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	9e-10
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-05
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-09
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	5e-08
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-05
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-05
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	8e-05
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-09
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	4e-09
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	4e-06
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	5e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	7e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	7e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	8e-05
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	7e-09
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	9e-09
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-08
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	4e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-05
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	4e-08
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	5e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	6e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	6e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	6e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	2e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	3e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	3e-04
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	6e-04
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	6e-07
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	7e-04
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	1e-06
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	4e-06
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	1e-04
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	3e-06
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	4e-05
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	8e-04
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	9e-06
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	1e-05
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	1e-05
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	1e-05
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	2e-05
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	9e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  418 bits (1077), Expect = e-132
 Identities = 176/630 (27%), Positives = 278/630 (44%), Gaps = 94/630 (14%)

Query: 48  TDSASLLSFKASISRDPSNLLATWNSSTDHCTWHGVTCDHFTGRVTALRITGKATPWPSK 107
            +   L+SFK  +     NLL  W+S+ + CT+ GVTC     +VT++ ++         
Sbjct: 12  REIHQLISFKDVL--PDKNLLPDWSSNKNPCTFDGVTCR--DDKVTSIDLSS------KP 61

Query: 108 SSVISGTLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIP--Y 165
            +V    +S+S+  LT L +L + ++  +G +  G      L  L+L  N+ SG +    
Sbjct: 62  LNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLT 120

Query: 166 QMSNLERLRVLNLSFNSFSGEVPRGLIGN-GELSVIDMSSNRLSGGL--AIDSSSECEFL 222
            + +   L+ LN+S N+               L V+D+S+N +SG        S  C  L
Sbjct: 121 SLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGEL 180

Query: 223 TYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTD 282
            +L +S N ++  +   + +C NL+ L +  N     IP  +G  S L+ LD+S N L+ 
Sbjct: 181 KHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSG 237

Query: 283 RIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANL 342
                ++ C++L +L +++        N       F G +P   L  +SL+ L       
Sbjct: 238 DFSRAISTCTELKLLNISS--------NQ------FVGPIPPLPL--KSLQYLSLAENKF 281

Query: 343 GGRLPDNWSESC-SLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQL--P 399
            G +PD  S +C +L  L+L  N   GAVP   G C  L  L LS NN  G LPM     
Sbjct: 282 TGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLK 341

Query: 400 VPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGN 459
           +  +   ++S N  +G LP                       + ++S     +  D S N
Sbjct: 342 MRGLKVLDLSFNEFSGELP---------------------ESLTNLSASLLTL--DLSSN 378

Query: 460 KFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLL 519
            F G +    +         +    L L NN F G +P   +S C++L S   +LS    
Sbjct: 379 NFSGPILPN-LCQNPKNTLQE----LYLQNNGFTGKIPPT-LSNCSELVSL--HLS---- 426

Query: 520 SGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKL 579
                                 N +SG+I + +G L KL+ L L  N + G +P EL  +
Sbjct: 427 ---------------------FNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYV 465

Query: 580 KFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNR 639
           K L+ ++L  N+LTGEIPS   +  +L  + LS+N LTG IP  + +   L  L L++N 
Sbjct: 466 KTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNS 525

Query: 640 LSGEIPVSFSTLVNLSALDLSFNNLSGHIP 669
            SG IP       +L  LDL+ N  +G IP
Sbjct: 526 FSGNIPAELGDCRSLIWLDLNTNLFNGTIP 555

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  374 bits (963), Expect = e-116
 Identities = 160/600 (26%), Positives = 241/600 (40%), Gaps = 92/600 (15%)

Query: 111 ISGTLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMS-N 169
           +SG  S +I+  TEL+ L++  N F G IP     L+ L+ L L  N F+G+IP  +S  
Sbjct: 235 LSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGA 292

Query: 170 LERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSD 229
            + L  L+LS N F G VP        L  + +SSN  SG L +D+  +   L  L LS 
Sbjct: 293 CDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSF 352

Query: 230 NFLTESIPKEIGKCR-NLKNLLLDGNILEGSIPKEIG--TISELKVLDVSRNSLTDRIPV 286
           N  +  +P+ +     +L  L L  N   G I   +     + L+ L +  N  T +IP 
Sbjct: 353 NEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPP 412

Query: 287 ELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRL 346
            L++CS+L  L L+         N         G +P  L     L  L      L G +
Sbjct: 413 TLSNCSELVSLHLSF--------NY------LSGTIPSSLGSLSKLRDLKLWLNMLEGEI 458

Query: 347 PDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYF 406
           P       +L+ L L  N L G +P  L  C NL ++ LS N L G +P  +        
Sbjct: 459 PQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWI-------- 510

Query: 407 NVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLP 466
                   G L                L                      S N F G++P
Sbjct: 511 --------GRLEN--------------LAIL-----------------KLSNNSFSGNIP 531

Query: 467 LFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEA 526
              +G        +    L LN N+FNG++P         +   S  ++AN ++G  Y  
Sbjct: 532 A-ELG------DCRSLIWLDLNTNLFNGTIPAA-------MFKQSGKIAANFIAGKRY-V 576

Query: 527 FLLDCVQLVEFEAANN--QISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKW 584
           ++ +     E   A N  +  G  +  + +L      ++      G           + +
Sbjct: 577 YIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMF 636

Query: 585 ILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEI 644
           + +  N L+G IP + G +  L +L+L HN ++GSIP  +     L  L L+ N+L G I
Sbjct: 637 LDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRI 696

Query: 645 PVSFSTLVNLSALDLSFNNLSGHIP---HLQHLDCIAFKGNK-----YLASCPDTNATAP 696
           P + S L  L+ +DLS NNLSG IP     +      F  N       L  C  +NA   
Sbjct: 697 PQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADGY 756

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  360 bits (926), Expect = e-116
 Identities = 113/307 (36%), Positives = 177/307 (57%), Gaps = 15/307 (4%)

Query: 758  FADTPAE------------LTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVK 805
            F D PAE             +   +  A+ NFS +N++G GGFG  YK  L  G LVAVK
Sbjct: 1    FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK 60

Query: 806  KLSIGRFQGIQ-QFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHK 864
            +L   R QG + QF  E+  +    H+NL+ L G+ +   E  LVY +++ G++ + + +
Sbjct: 61   RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120

Query: 865  KSGKKIQ--WSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGL 922
            +   +    W    +IA+  A+ LAYLH  C P+I+HRD+K +NILLDEE  A + DFGL
Sbjct: 121  RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180

Query: 923  ARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFS 982
            A+L++  +TH TT V GT G++APEY +T + S+K DV+ +GV+LLELI+G+R+ D +  
Sbjct: 181  AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240

Query: 983  EYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVK 1042
               +   ++ W K L+KE +   L   +L      E +  ++++A  CT  +   RP + 
Sbjct: 241  ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS 300

Query: 1043 QVLIKLK 1049
            +V+  L+
Sbjct: 301  EVVRMLE 307

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  331 bits (851), Expect = e-105
 Identities = 103/287 (35%), Positives = 153/287 (53%), Gaps = 8/287 (2%)

Query: 766  TYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTL 825
               ++  AT NF  + LIG G FG  YK  L  G  VA+K+ +    QGI++F+ EI TL
Sbjct: 30   PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETL 89

Query: 826  GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQ--WSVIHKIAIDIA 883
               RH +LV+LIG+     EM L+Y ++  GNL+  ++      +   W    +I I  A
Sbjct: 90   SFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAA 149

Query: 884  QALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARL-LEVSETHATTDVAGTFG 942
            + L YLH      I+HRD+K  NILLDE     ++DFG+++   E+ +TH +T V GT G
Sbjct: 150  RGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLG 206

Query: 943  YVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGR 1002
            Y+ PEY    R+++K+DVYSFGVVL E++  + ++  S        N+  WA      G+
Sbjct: 207  YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR--EMVNLAEWAVESHNNGQ 264

Query: 1003 SSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLK 1049
              ++  P L +    E+L      A  C   +   RPS+  VL KL+
Sbjct: 265  LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  308 bits (791), Expect = 7e-97
 Identities = 96/298 (32%), Positives = 154/298 (51%), Gaps = 21/298 (7%)

Query: 766  TYDNVVRATGNFS------IRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGR----FQGI 815
            ++  +   T NF         N +G GGFG  YK  +     VAVKKL+        +  
Sbjct: 16   SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELK 74

Query: 816  QQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK-IQWSV 874
            QQFD EI  + + +H+NLV L+G+     ++ LVY ++  G+L   +    G   + W +
Sbjct: 75   QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134

Query: 875  IHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV-SETHA 933
              KIA   A  + +LH +     +HRDIK +NILLDE   A +SDFGLAR  E  ++T  
Sbjct: 135  RCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191

Query: 934  TTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSW 993
            T+ + GT  Y+APE      ++ K+D+YSFGVVLLE+I+G  ++D           ++  
Sbjct: 192  TSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP----QLLLDI 246

Query: 994  AKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051
             + +  E ++ E ++ +        ++  M  +AS C  E  + RP +K+V   L+++
Sbjct: 247  KEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  264 bits (678), Expect = 5e-77
 Identities = 93/637 (14%), Positives = 194/637 (30%), Gaps = 90/637 (14%)

Query: 59  SISRDPSNLLATWNSSTDHCTWH---GVTCDHFTGRVTALRITGKATPWPSKSSVISGTL 115
           S     +   A WN + +   W    GV+ +   GRVT L + G            SG +
Sbjct: 48  SQQGFGTQPGANWNFNKELDMWGAQPGVSLNS-NGRVTGLSLEGFG---------ASGRV 97

Query: 116 SASIAKLTELRTLSVPHNSFSG----EIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLE 171
             +I +LTEL  L++  +          P G+      E  +    ++           +
Sbjct: 98  PDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPRED 157

Query: 172 --RLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSS-SECEFLTYLKLS 228
              L    ++ +     + +      + + I   SN ++    +  +      L    + 
Sbjct: 158 FSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF---VSKAVMRLTKLRQFYMG 214

Query: 229 DNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVEL 288
           ++        E  +  N +           +   +   + +L  ++V       ++P  L
Sbjct: 215 NSPFVAENICEAWENENSEYAQQ-----YKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFL 269

Query: 289 ADCSKLSVLVLTNIDASLDLDN--SRGEFSAFDGGVPYELLLSRSLEVLWAPRANL-GGR 345
               ++ ++ +          N    GE    D     +  +   +++++    NL    
Sbjct: 270 KALPEMQLINVAC--------NRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFP 321

Query: 346 LPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPC--M 403
           +  +  +   L +L    N L+G    + G    L  L+L+ N +   +P         +
Sbjct: 322 VETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITE-IPANFCGFTEQV 379

Query: 404 VYFNVSQNNITGVLPRFENVSCDN--HFGFQDLQYANVPVMGSISDENFVIIHDFSGNKF 461
              + + N +  +   F+  S        F   +      +GS+  +NF  +        
Sbjct: 380 ENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNE------IGSVDGKNFDPLDPTPFK-- 431

Query: 462 LGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSG 521
             ++                   + L+NN  +        S  + L S  +NL  N+L+ 
Sbjct: 432 GINV-----------------SSINLSNNQISKFPKEL-FSTGSPLSS--INLMGNMLTE 471

Query: 522 MSYEAF------LLDCVQLVEFEAANNQISGSIAA-GVGKLMKLQRLDLRGNRVSGSLPD 574
           +   +         +   L   +   N+++          L  L  +DL  N  S   P 
Sbjct: 472 IPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPT 530

Query: 575 ELGKLKFLKWI------LLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKAT 628
           +      LK           GN    E P       SL  L +  N +   +   +T   
Sbjct: 531 QPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKIT--P 587

Query: 629 KLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLS 665
            +  L +  N             +      L ++   
Sbjct: 588 NISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  244 bits (624), Expect = 1e-69
 Identities = 83/596 (13%), Positives = 166/596 (27%), Gaps = 110/596 (18%)

Query: 127 TLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSG- 185
             +   + +  +    +     +  L L+G   SG++P  +  L  L VL L  +     
Sbjct: 61  NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN 120

Query: 186 ---EVPRGLIGNGELSVIDMSSNRLSGG-LAIDSSSECEFLTYLKLSDNFLTESIPKEIG 241
                P+G+  N                 +  D   +   L    ++ +   +SI K   
Sbjct: 121 ERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR 180

Query: 242 KCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTN 301
                  +    N +   + K +  +++L+   +  +        E  +           
Sbjct: 181 ITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYK 239

Query: 302 IDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNL 361
                  D                      L  +         +LP        ++++N+
Sbjct: 240 T-----EDLKWDNLK--------------DLTDVEVYNCPNLTKLPTFLKALPEMQLINV 280

Query: 362 GQNSLKGA--------VPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPC-------MVYF 406
             N                   +   +  + +  NNL+       PV         +   
Sbjct: 281 ACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKT-----FPVETSLQKMKKLGML 335

Query: 407 NVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENF--VIIHDFSGNKFLGS 464
               N + G LP F +           L   N+         N    I  +F G      
Sbjct: 336 ECLYNQLEGKLPAFGS--------EIKLASLNL-------AYNQITEIPANFCGF--TEQ 378

Query: 465 LPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSY 524
           +                   L   +N              + +   +++ S N +  +  
Sbjct: 379 V-----------------ENLSFAHNKLKYIPNIFDAKSVSVMS--AIDFSYNEIGSVDG 419

Query: 525 EAF------LLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSG-------S 571
           + F          + +     +NNQIS            L  ++L GN ++         
Sbjct: 420 KNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKD 479

Query: 572 LPDELGKLKFLKWILLGGNNLTGEIPS-QFGHLISLVVLDLSHNALTGSIPASLTKATKL 630
             +       L  I L  N LT      +   L  LV +DLS+N+ +   P     ++ L
Sbjct: 480 ENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTL 538

Query: 631 ESLFL------AHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIP-----HLQHLD 675
           +   +        NR   E P   +   +L+ L +  N++   +      ++  LD
Sbjct: 539 KGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKITPNISVLD 593

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 92.0 bits (229), Expect = 3e-19
 Identities = 32/187 (17%), Positives = 67/187 (35%), Gaps = 21/187 (11%)

Query: 111 ISGTLSASIAKLTELRTLSVPHNSFSG-------EIPAGVGELRLLEVLELQGNNFSGKI 163
           IS       +  + L ++++  N  +        +         LL  ++L+ N  +  +
Sbjct: 445 ISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-L 503

Query: 164 P--YQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVI------DMSSNRLSGGLAIDS 215
              ++ + L  L  ++LS+NSFS   P   + +  L         D   NR       + 
Sbjct: 504 SDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWP-EG 561

Query: 216 SSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDV 275
            + C  LT L++  N +   + ++I    N+  L +  N         +    E  +  +
Sbjct: 562 ITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYML 618

Query: 276 SRNSLTD 282
             +   D
Sbjct: 619 FYDKTQD 625

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  237 bits (607), Expect = 1e-70
 Identities = 78/315 (24%), Positives = 131/315 (41%), Gaps = 30/315 (9%)

Query: 760  DTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFD 819
             +  +L  +N+   +    +  +   G FG  +KA+ +    VAVK   I   Q   Q +
Sbjct: 9    SSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQS-WQNE 66

Query: 820  AEIGTLGRIRHKNLVTLIGY----YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVI 875
             E+ +L  ++H+N++  IG        + +++L+  F   G+L  F+       + W+ +
Sbjct: 67   YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNEL 123

Query: 876  HKIAIDIAQALAYLH-------YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV 928
              IA  +A+ LAYLH           P I HRDIK  N+LL   L A ++DFGLA   E 
Sbjct: 124  CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183

Query: 929  SETHA-TTDVAGTFGYVAPEYA-----TTCRVSDKADVYSFGVVLLELISGKRSLDPSFS 982
             ++   T    GT  Y+APE              + D+Y+ G+VL EL S   + D    
Sbjct: 184  GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243

Query: 983  EYGNGFNIVSWAKLLIKEGRSSELF------LPELWEAGPQENLLGMMRLASTCTVETLS 1036
            EY   F         +++ +   +       L + W+      +  +      C      
Sbjct: 244  EYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQ--KHAGMAMLCETIEECWDHDAE 301

Query: 1037 TRPSVKQVLIKLKQL 1051
             R S   V  ++ Q+
Sbjct: 302  ARLSAGCVGERITQM 316

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  242 bits (621), Expect = 1e-68
 Identities = 117/612 (19%), Positives = 196/612 (32%), Gaps = 103/612 (16%)

Query: 111 ISGTLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNL 170
           +S     + A  T L  L +  NS          + + L  L+L  N  S         L
Sbjct: 85  LSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQL 144

Query: 171 ERLRVLNLSFNSFSGEVPR--GLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLS 228
           E L+ L LS N           +  N  L  +++SSN++    +         L  L L+
Sbjct: 145 ENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKE-FSPGCFHAIGRLFGLFLN 203

Query: 229 DNFLTESIPKEIG---KCRNLKNLLLDGNILEGSIPKEIG--TISELKVLDVSRNSLTDR 283
           +  L  S+ +++       +++NL L  + L  +          + L +LD+S N+L   
Sbjct: 204 NVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVV 263

Query: 284 IPVELADCSKLSVLVLTNIDASLDLDNS-RGEFSAFDGGVP--YELLLSRSLEVLWAPRA 340
                A   +L    L          N+ +  FS    G+     L L RS        A
Sbjct: 264 GNDSFAWLPQLEYFFLEY--------NNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLA 315

Query: 341 NLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLE-----GYLP 395
           +L      ++     L+ LN+  N + G          NL YL LS +            
Sbjct: 316 SLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETF 375

Query: 396 MQLPVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHD 455
           + L    +   N+++N I+                              I  + F     
Sbjct: 376 VSLAHSPLHILNLTKNKIS-----------------------------KIESDAF----- 401

Query: 456 FSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLS 515
                +LG L                   L L  N     + G+      ++    + LS
Sbjct: 402 ----SWLGHL-----------------EVLDLGLNEIGQELTGQEWRGLENIFE--IYLS 438

Query: 516 ANLLSGMSYEAFLLDCVQLVEFEAANNQISG--SIAAGVGKLMKLQRLDLRGNRVSGSLP 573
            N    ++  +F      L         +    S  +    L  L  LDL  N ++    
Sbjct: 439 YNKYLQLTRNSFA-LVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANIND 497

Query: 574 DELGKLKFLKWILLGGNNLT--------GEIPSQFGHLISLVVLDLSHNALTGSIPASLT 625
           D L  L+ L+ + L  NNL         G        L  L +L+L  N           
Sbjct: 498 DMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFK 557

Query: 626 KATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIP--------HLQHLDCI 677
              +L+ + L  N L+      F+  V+L +L+L  N ++            +L  LD  
Sbjct: 558 DLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELD-- 615

Query: 678 AFKGNKYLASCP 689
             + N +  +C 
Sbjct: 616 -MRFNPFDCTCE 626

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  231 bits (591), Expect = 1e-64
 Identities = 120/581 (20%), Positives = 188/581 (32%), Gaps = 89/581 (15%)

Query: 122 LTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFN 181
            T +  L++ HN       A       L  L++  N  S   P     L  L+VLNL  N
Sbjct: 24  PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83

Query: 182 SFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIG 241
             S    +       L+ + + SN +   +  +   + + L  L LS N L+ +      
Sbjct: 84  ELSQLSDKTFAFCTNLTELHLMSNSIQ-KIKNNPFVKQKNLITLDLSHNGLSSTKLGTQV 142

Query: 242 KCRNLKNLLLDGNILEGSIPKEIGTI--SELKVLDVSRNSLTDRIPVELADCSKLSVLVL 299
           +  NL+ LLL  N ++    +E+     S LK L++S N + +  P       +L  L L
Sbjct: 143 QLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFL 202

Query: 300 TNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESC---SL 356
                      +  +            L + S+  L    + L     +         +L
Sbjct: 203 -----------NNVQLGPSLTEKLCLELANTSIRNLSLSNSQLST-TSNTTFLGLKWTNL 250

Query: 357 KVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNITGV 416
            +L+L  N+L      S      L Y  L                         NNI  +
Sbjct: 251 TMLDLSYNNLNVVGNDSFAWLPQLEYFFL-----------------------EYNNIQHL 287

Query: 417 LPR-FENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFL 475
                  +        + L         SIS  +   I DFS    L  L          
Sbjct: 288 FSHSLHGLF-----NVRYLNLKRSFTKQSISLASLPKIDDFSFQW-LKCL---------- 331

Query: 476 AAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLS--GMSYEAFL-LDCV 532
                    L + +N   G       +   +L+    +LS +  S   ++ E F+ L   
Sbjct: 332 -------EHLNMEDNDIPGIKSNM-FTGLINLKYL--SLSNSFTSLRTLTNETFVSLAHS 381

Query: 533 QLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLP-DELGKLKFLKWILLGGNN 591
            L       N+IS   +     L  L+ LDL  N +   L   E   L+ +  I L  N 
Sbjct: 382 PLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNK 441

Query: 592 LTGEIPSQFGHLISLVVLDLSHNALTG--SIPASLTKATKLESLFLAHNRLSGEIPVSFS 649
                 + F  + SL  L L   AL    S P+       L  L L++N ++        
Sbjct: 442 YLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLE 501

Query: 650 TLVNLSALDLSFNNLS---------------GHIPHLQHLD 675
            L  L  LDL  NNL+                 + HL  L+
Sbjct: 502 GLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILN 542

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  200 bits (512), Expect = 2e-54
 Identities = 97/531 (18%), Positives = 172/531 (32%), Gaps = 76/531 (14%)

Query: 172 RLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNF 231
              V + S    + +VP  L  N  ++V++++ N+L   L   + +    LT L +  N 
Sbjct: 5   SHEVADCSHLKLT-QVPDDLPTN--ITVLNLTHNQLR-RLPAANFTRYSQLTSLDVGFNT 60

Query: 232 LTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADC 291
           +++  P+   K   LK L L  N L     K     + L  L +  NS+           
Sbjct: 61  ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120

Query: 292 SKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWS 351
             L  L L++        N     S+   G   +L    +L+ L      +     +   
Sbjct: 121 KNLITLDLSH--------NG---LSSTKLGTQVQL---ENLQELLLSNNKIQALKSEELD 166

Query: 352 ESC--SLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPC----MVY 405
                SLK L L  N +K   P        L  L L+   L   L  +L +      +  
Sbjct: 167 IFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRN 226

Query: 406 FNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSL 465
            ++S + ++                F  L++ N+ ++            D S N      
Sbjct: 227 LSLSNSQLSTTSNTT----------FLGLKWTNLTML------------DLSYNN----- 259

Query: 466 PLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQS-------FSVNLSANL 518
            L  +G+   A   +  Y   L  N          +    +++           ++S   
Sbjct: 260 -LNVVGNDSFAWLPQLEY-FFLEYNNIQHLFSHS-LHGLFNVRYLNLKRSFTKQSISLAS 316

Query: 519 LSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELG- 577
           L  +   +F      L      +N I G  +     L+ L+ L L  +  S         
Sbjct: 317 LPKIDDFSF-QWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETF 375

Query: 578 ---KLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPAS-LTKATKLESL 633
                  L  + L  N ++      F  L  L VLDL  N +   +          +  +
Sbjct: 376 VSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEI 435

Query: 634 FLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSG---------HIPHLQHLD 675
           +L++N+       SF+ + +L  L L    L            + +L  LD
Sbjct: 436 YLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILD 486

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  199 bits (508), Expect = 7e-54
 Identities = 93/576 (16%), Positives = 159/576 (27%), Gaps = 101/576 (17%)

Query: 111 ISGTLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRL--LEVLELQGNNFSGKIPYQMS 168
           +S T   +  +L  L+ L + +N         +       L+ LEL  N      P    
Sbjct: 133 LSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFH 192

Query: 169 NLERLRVLNLSFNSFSGEVPRGL---IGNGELSVIDMSSNRLSGGLAIDSSSECEF--LT 223
            + RL  L L+       +   L   + N  +  + +S+++LS   +  +    ++  LT
Sbjct: 193 AIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLST-TSNTTFLGLKWTNLT 251

Query: 224 YLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRN----- 278
            L LS N L             L+   L+ N ++      +  +  ++ L++ R+     
Sbjct: 252 MLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQS 311

Query: 279 ----SLTDRIPVELADCSKLSVLVL-----TNIDAS----------LDLDNSRGEFSAFD 319
               SL             L  L +       I ++          L L NS        
Sbjct: 312 ISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLT 371

Query: 320 GGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRN 379
                 L  S                          L +LNL +N +      +     +
Sbjct: 372 NETFVSLAHS-------------------------PLHILNLTKNKISKIESDAFSWLGH 406

Query: 380 LTYLDLSLNNLEGYLPMQLPVPC--MVYFNVSQNNITGVLPRFENVSCDNHF-GFQDLQY 436
           L  LDL LN +   L  Q       +    +S N    +          N F     LQ 
Sbjct: 407 LEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTR--------NSFALVPSLQR 458

Query: 437 ANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSV 496
                                           +               L L+NN      
Sbjct: 459 L-----------------MLRRVALKNVDSSPSPFQPLRNLTI-----LDLSNNNIANIN 496

Query: 497 PGERISKCNDLQSFSVNLSANLLSGMSYEAF-------LLDCVQLVEFEAANNQISGSIA 549
               +     L+   ++L  N L+ +   A        L     L      +N       
Sbjct: 497 DDM-LEGLEKLEI--LDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPV 553

Query: 550 AGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGH-LISLVV 608
                L +L+ +DL  N ++            LK + L  N +T      FG    +L  
Sbjct: 554 EVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTE 613

Query: 609 LDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEI 644
           LD+  N    +  +       +         LS   
Sbjct: 614 LDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHY 649

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  139 bits (353), Expect = 3e-34
 Identities = 71/352 (20%), Positives = 125/352 (35%), Gaps = 42/352 (11%)

Query: 353 SCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQL-PVPCMVYFNVSQN 411
           + S +V +     L   VP  L    N+T L+L+ N L             +   +V  N
Sbjct: 3   TVSHEVADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFN 59

Query: 412 NITGVLPRFENVSCDNHF-GFQDLQY---ANVPVMGSISDENFVIIH-----DFSGNKFL 462
            I+ + P                L+     +   +  +SD+ F             N  +
Sbjct: 60  TISKLEP--------ELCQKLPMLKVLNLQHNE-LSQLSDKTFAFCTNLTELHLMSNS-I 109

Query: 463 GSLPLFAIGD-GFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSG 521
             +          L         L L++N  + +  G    +  +LQ   + LS N +  
Sbjct: 110 QKIKNNPFVKQKNLI-------TLDLSHNGLSSTKLGT-QVQLENLQ--ELLLSNNKIQA 159

Query: 522 MSYEAF-LLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELG--- 577
           +  E   +     L + E ++NQI          + +L  L L   ++  SL ++L    
Sbjct: 160 LKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLEL 219

Query: 578 KLKFLKWILLGGNNLTGEIPSQFGHL--ISLVVLDLSHNALTGSIPASLTKATKLESLFL 635
               ++ + L  + L+    + F  L   +L +LDLS+N L      S     +LE  FL
Sbjct: 220 ANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFL 279

Query: 636 AHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIP--HLQHLDCIAFKGNKYL 685
            +N +      S   L N+  L+L  +     I    L  +D  +F+  K L
Sbjct: 280 EYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCL 331

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  135 bits (343), Expect = 6e-33
 Identities = 83/431 (19%), Positives = 135/431 (31%), Gaps = 63/431 (14%)

Query: 269 ELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLL 328
             +V D S   LT ++P +L           TNI   L+L +++                
Sbjct: 5   SHEVADCSHLKLT-QVPDDL----------PTNI-TVLNLTHNQ-----LRRLPAANFTR 47

Query: 329 SRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLN 388
              L  L      +    P+   +   LKVLNL  N L     K+   C NLT L L  N
Sbjct: 48  YSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSN 107

Query: 389 NLEGYLPMQL-PVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISD 447
           +++            ++  ++S N ++         +       Q+L             
Sbjct: 108 SIQKIKNNPFVKQKNLITLDLSHNGLSSTKLG----TQVQLENLQEL------------- 150

Query: 448 ENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDL 507
                    S NK           +           +L L++N      PG        L
Sbjct: 151 -------LLSNNKIQALKS-----EELDIFANSSLKKLELSSNQIKEFSPGC-FHAIGRL 197

Query: 508 QSFSVNLSANLLSGMSYEAFLLDC--VQLVEFEAANNQISGSIAAGVG--KLMKLQRLDL 563
               + L+   L     E   L+     +     +N+Q+S +        K   L  LDL
Sbjct: 198 F--GLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDL 255

Query: 564 RGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHN--------- 614
             N ++    D    L  L++  L  NN+          L ++  L+L  +         
Sbjct: 256 SYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLA 315

Query: 615 ALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPHLQHL 674
           +L      S      LE L +  N + G     F+ L+NL  L LS +  S      +  
Sbjct: 316 SLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETF 375

Query: 675 DCIAFKGNKYL 685
             +A      L
Sbjct: 376 VSLAHSPLHIL 386

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 69.6 bits (171), Expect = 4e-12
 Identities = 24/128 (18%), Positives = 45/128 (35%), Gaps = 5/128 (3%)

Query: 108 SSVISGTLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQM 167
                G     +  L+ L  L++  N F         +L  L++++L  NN +       
Sbjct: 521 KHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVF 580

Query: 168 SNLERLRVLNLSFNSFSGEVPRGLIGN-GELSVIDMSSNRLSGGLAIDSSSECEFLTYLK 226
           +N   L+ LNL  N  +    +        L+ +DM  N           S   F+ ++ 
Sbjct: 581 NNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDC----TCESIAWFVNWIN 636

Query: 227 LSDNFLTE 234
            +   + E
Sbjct: 637 ETHTNIPE 644

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  230 bits (588), Expect = 5e-65
 Identities = 95/568 (16%), Positives = 168/568 (29%), Gaps = 90/568 (15%)

Query: 125 LRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFS 184
            + L +  N               L+VL+L              +L  L  L L+ N   
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89

Query: 185 GEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCR 244
             +  G                               L  L   +  L       IG  +
Sbjct: 90  S-LALGAFSG------------------------LSSLQKLVAVETNLASLENFPIGHLK 124

Query: 245 NLKNLLLDGN-ILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNID 303
            LK L +  N I    +P+    ++ L+ LD+S N +      +L    ++ +L L    
Sbjct: 125 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL---- 180

Query: 304 ASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQ 363
            SLDL                                N    +     +   L  L L  
Sbjct: 181 -SLDLSL------------------------------NPMNFIQPGAFKEIRLHKLTLRN 209

Query: 364 NSLKGAVPK-SLGMCRNLTYLDLSLNNLEGYLPMQLPVPC----MVYFNVSQNNITGVLP 418
           N     V K  +     L    L L        ++         +    + +  +   L 
Sbjct: 210 NFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY-LD 268

Query: 419 RFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAK 478
            + +   D      ++   +      +       + DFS N     L L     G     
Sbjct: 269 YYLDDIIDLFNCLTNVSSFS------LVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTL 322

Query: 479 YKPHYRLL-LNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLL-DCVQLVE 536
                + L   +N    +           L+   ++LS N LS     +        L  
Sbjct: 323 KLKSLKRLTFTSNKGGNAFS---EVDLPSLE--FLDLSRNGLSFKGCCSQSDFGTTSLKY 377

Query: 537 FEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDE-LGKLKFLKWILLGGNNLTGE 595
            + + N +   +++    L +L+ LD + + +           L+ L ++ +   +    
Sbjct: 378 LDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVA 436

Query: 596 IPSQFGHLISLVVLDLSHNALTGSI-PASLTKATKLESLFLAHNRLSGEIPVSFSTLVNL 654
               F  L SL VL ++ N+   +  P   T+   L  L L+  +L    P +F++L +L
Sbjct: 437 FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSL 496

Query: 655 SALDLSFNNLSGHIP-------HLQHLD 675
             L++S NN              LQ LD
Sbjct: 497 QVLNMSHNNFFSLDTFPYKCLNSLQVLD 524

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  190 bits (485), Expect = 2e-51
 Identities = 95/572 (16%), Positives = 171/572 (29%), Gaps = 83/572 (14%)

Query: 111 ISGTLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNF-SGKIPYQMSN 169
           I      + + L+ L+ L     + +      +G L+ L+ L +  N   S K+P   SN
Sbjct: 88  IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147

Query: 170 LERLRVLNLSFNSFSGEVPRGLIGNGELSV----IDMSSNRLSGGLAIDSSSECEFLTYL 225
           L  L  L+LS N         L    ++ +    +D+S N ++       + +   L  L
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF--IQPGAFKEIRLHKL 205

Query: 226 KLSDNFLTESIPKE-IGKCRNLKNLLLDGNILEGSIPKE---IGTISELKVLDVSRNSLT 281
            L +NF + ++ K  I     L+   L           E      +  L  L +    L 
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265

Query: 282 ------DRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVL 335
                 D I       + +S   L +         +      F           + LE++
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVS--------VTIERVKDFSY-----NFGWQHLELV 312

Query: 336 WAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNL--EGY 393
                   G+ P    +S  LK L    N        S     +L +LDLS N L  +G 
Sbjct: 313 N----CKFGQFPTLKLKS--LKRLTFTSNKGGN--AFSEVDLPSLEFLDLSRNGLSFKGC 364

Query: 394 LPMQL-PVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVI 452
                     + Y ++S N +  +   F         G + L++                
Sbjct: 365 CSQSDFGTTSLKYLDLSFNGVITMSSNF--------LGLEQLEHL--------------- 401

Query: 453 IHDFSGNKFLGSLPLFAIGD-GFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFS 511
             DF  +                L         L +++     +  G   +  + L+   
Sbjct: 402 --DFQHSNLKQMSEFSVFLSLRNL-------IYLDISHTHTRVAFNGI-FNGLSSLEVL- 450

Query: 512 VNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGS 571
             ++ N            +   L   + +  Q+          L  LQ L++  N     
Sbjct: 451 -KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSL 509

Query: 572 LPDELGKLKFLKWILLGGNNLTGEIPSQFGHLI-SLVVLDLSHNALTGSIPAS--LTKAT 628
                  L  L+ +    N++      +  H   SL  L+L+ N    +      L    
Sbjct: 510 DTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIK 569

Query: 629 KLESLFLAHNRLSGEIPVSFSTLVNLSALDLS 660
               L +   R+    P        +  L L+
Sbjct: 570 DQRQLLVEVERMECATPSDKQ---GMPVLSLN 598

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  151 bits (384), Expect = 2e-38
 Identities = 91/469 (19%), Positives = 144/469 (30%), Gaps = 75/469 (15%)

Query: 227 LSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPV 286
             +      IP  +    + KNL L  N L         +  EL+VLD+SR  +      
Sbjct: 14  CMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70

Query: 287 ELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRL 346
                S LS L+LT         N                    SL+ L A   NL    
Sbjct: 71  AYQSLSHLSTLILTG--------NP------IQSLALGAFSGLSSLQKLVAVETNLASLE 116

Query: 347 PDNWSESCSLKVLNLGQNSLKGA-VPKSLGMCRNLTYLDLSLNNLEGYLP------MQLP 399
                   +LK LN+  N ++   +P+      NL +LDLS N ++           Q+P
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP 176

Query: 400 VPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGN 459
           +   +  ++S N +  + P                        G+  +     +     N
Sbjct: 177 LL-NLSLDLSLNPMNFIQP------------------------GAFKEIRLHKL-TLRNN 210

Query: 460 KFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSV---NLSA 516
               ++                 +RL+L      G++     S    L + ++    L+ 
Sbjct: 211 FDSLNVM----KTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266

Query: 517 NLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDEL 576
                            +  F   +  I              Q L+L   +       +L
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKL 324

Query: 577 GKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALT--GSIPASLTKATKLESLF 634
             LK L +      +  G        L SL  LDLS N L+  G    S    T L+ L 
Sbjct: 325 KSLKRLTF-----TSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379

Query: 635 LAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPH--------LQHLD 675
           L+ N +   +  +F  L  L  LD   +NL              L +LD
Sbjct: 380 LSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD 427

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  133 bits (337), Expect = 2e-32
 Identities = 59/315 (18%), Positives = 105/315 (33%), Gaps = 27/315 (8%)

Query: 106 SKSSVISGTLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPY 165
           +        +      LT + + S+   +               + LEL    F      
Sbjct: 265 AYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTL 322

Query: 166 QMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSG-GLAIDSSSECEFLTY 224
           ++ +L+RL   +    +         +    L  +D+S N LS  G    S      L Y
Sbjct: 323 KLKSLKRLTFTSNKGGN-----AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKY 377

Query: 225 LKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEI-GTISELKVLDVSRNSLTDR 283
           L LS N +  ++         L++L    + L+      +  ++  L  LD+S       
Sbjct: 378 LDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVA 436

Query: 284 IPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLS-RSLEVLWAPRANL 342
                   S L VL +          NS      F      ++    R+L  L   +  L
Sbjct: 437 FNGIFNGLSSLEVLKMAG--------NS------FQENFLPDIFTELRNLTFLDLSQCQL 482

Query: 343 GGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPC 402
               P  ++   SL+VLN+  N+             +L  LD SLN++      +L    
Sbjct: 483 EQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFP 542

Query: 403 --MVYFNVSQNNITG 415
             + + N++QN+   
Sbjct: 543 SSLAFLNLTQNDFAC 557

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  100 bits (250), Expect = 9e-22
 Identities = 41/243 (16%), Positives = 75/243 (30%), Gaps = 48/243 (19%)

Query: 484 RLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQ 543
            L L+         G      + L +  + L+ N +  ++  AF      L +  A    
Sbjct: 56  VLDLSRCEIQTIEDGA-YQSLSHLST--LILTGNPIQSLALGAFS-GLSSLQKLVAVETN 111

Query: 544 ISGSIAAGVGKLMKLQRLDLRGNR-VSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGH 602
           ++      +G L  L+ L++  N   S  LP+    L  L+ + L  N +     +    
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV 171

Query: 603 LISL----VVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIP------------- 645
           L  +    + LDLS N +    P +  K  +L  L L +N  S  +              
Sbjct: 172 LHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVH 230

Query: 646 ---------------VSFSTLVNL----------SALDLSFNNLSGHIPHLQHLDCIAFK 680
                             S L  L          + LD   +++      L ++   +  
Sbjct: 231 RLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLV 290

Query: 681 GNK 683
              
Sbjct: 291 SVT 293

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 75.5 bits (186), Expect = 5e-14
 Identities = 23/97 (23%), Positives = 34/97 (35%), Gaps = 10/97 (10%)

Query: 586 LLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIP 645
                N   +IP       S   LDLS N L      S     +L+ L L+   +     
Sbjct: 13  QCMELNFY-KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69

Query: 646 VSFSTLVNLSALDLSFNNLSGHIP-------HLQHLD 675
            ++ +L +LS L L+ N +             LQ L 
Sbjct: 70  GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  210 bits (538), Expect = 3e-61
 Identities = 73/277 (26%), Positives = 117/277 (42%), Gaps = 32/277 (11%)

Query: 48  TDSASLLSFKASISRDPSNLLATWNSSTDHC--TWHGVTCDHFT--GRVTALRITGK--- 100
            D  +LL  K  +    +  L++W  +TD C  TW GV CD  T   RV  L ++G    
Sbjct: 6   QDKQALLQIKKDLGNPTT--LSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP 63

Query: 101 -ATPWP--------------SKSSVISGTLSASIAKLTELRTLSVPHNSFSGEIPAGVGE 145
              P P                 + + G +  +IAKLT+L  L + H + SG IP  + +
Sbjct: 64  KPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ 123

Query: 146 LRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELS-VIDMSS 204
           ++ L  L+   N  SG +P  +S+L  L  +    N  SG +P       +L   + +S 
Sbjct: 124 IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISR 183

Query: 205 NRLSGGL--AIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPK 262
           NRL+G +     + +    L ++ LS N L        G  +N + + L  N L   +  
Sbjct: 184 NRLTGKIPPTFANLN----LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG- 238

Query: 263 EIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVL 299
           ++G    L  LD+  N +   +P  L     L  L +
Sbjct: 239 KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNV 275

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  172 bits (438), Expect = 9e-48
 Identities = 68/334 (20%), Positives = 119/334 (35%), Gaps = 65/334 (19%)

Query: 341 NLGGRLPDNWSESCSLKVLNLGQNSLKG--AVPKSLGMCRNLTYLDLSLNNLEGYLPMQL 398
              G L D  +++  +  L+L   +L     +P SL     L +L +             
Sbjct: 37  TWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIG------------ 84

Query: 399 PVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSG 458
                       NN+ G +P                     P +  ++  +++     + 
Sbjct: 85  ----------GINNLVGPIP---------------------PAIAKLTQLHYL---YITH 110

Query: 459 NKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANL 518
               G++P F +       + K    L  + N  +G++P   IS   +L         N 
Sbjct: 111 TNVSGAIPDF-LS------QIKTLVTLDFSYNALSGTLPPS-ISSLPNLVGI--TFDGNR 160

Query: 519 LSGMSYEAFLLDCVQLVEF-EAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELG 577
           +SG +         +L      + N+++G I      L  L  +DL  N + G      G
Sbjct: 161 ISG-AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFG 218

Query: 578 KLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAH 637
             K  + I L  N+L  ++    G   +L  LDL +N + G++P  LT+   L SL ++ 
Sbjct: 219 SDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277

Query: 638 NRLSGEIPVSFSTLVNLSALDLSFNNL--SGHIP 669
           N L GEIP   + L        + N       +P
Sbjct: 278 NNLCGEIPQGGN-LQRFDVSAYANNKCLCGSPLP 310

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  160 bits (407), Expect = 1e-43
 Identities = 55/229 (24%), Positives = 87/229 (37%), Gaps = 18/229 (7%)

Query: 455 DFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVP-GERISKCNDLQSFSVN 513
           D     +LG L         +         L L+        P    ++    L    + 
Sbjct: 32  DCCNRTWLGVLCDTDTQTYRVNN-------LDLSGLNLPKPYPIPSSLANLPYLNFLYIG 84

Query: 514 LSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLP 573
              N L G      +    QL      +  +SG+I   + ++  L  LD   N +SG+LP
Sbjct: 85  -GINNLVG-PIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLP 142

Query: 574 DELGKLKFLKWILLGGNNLTGEIPSQFGHLISLV-VLDLSHNALTGSIPASLTKATKLES 632
             +  L  L  I   GN ++G IP  +G    L   + +S N LTG IP +      L  
Sbjct: 143 PSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAF 201

Query: 633 LFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIP------HLQHLD 675
           + L+ N L G+  V F +  N   + L+ N+L+  +       +L  LD
Sbjct: 202 VDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLD 250

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  145 bits (369), Expect = 1e-38
 Identities = 75/400 (18%), Positives = 122/400 (30%), Gaps = 129/400 (32%)

Query: 227 LSDNFLTESIPKEIGKCRNLKNLLLDGNILEGS--IPKEIGTISELKVLDVS-RNSLTDR 283
             +      +     +   + NL L G  L     IP  +  +  L  L +   N+L   
Sbjct: 33  CCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGP 92

Query: 284 IPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLG 343
           IP  +A  ++L  L +T+         +        G +P  L                 
Sbjct: 93  IPPAIAKLTQLHYLYITH--------TN------VSGAIPDFL----------------- 121

Query: 344 GRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQL--PVP 401
            ++        +L  L+   N+L G +P S+    NL  +    N + G +P        
Sbjct: 122 SQIK-------TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSK 174

Query: 402 CMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKF 461
                 +S+N +TG +P                         + ++ N   + D S N  
Sbjct: 175 LFTSMTISRNRLTGKIPP------------------------TFANLNLAFV-DLSRNML 209

Query: 462 LGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSG 521
            G                                          + Q   ++L+ N L+ 
Sbjct: 210 EGDAS--------------------------------VLFGSDKNTQ--KIHLAKNSLAF 235

Query: 522 MSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKF 581
                                 +       VG    L  LDLR NR+ G+LP  L +LKF
Sbjct: 236 ---------------------DLG-----KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKF 269

Query: 582 LKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIP 621
           L  + +  NNL GEIP   G+L    V   ++N      P
Sbjct: 270 LHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 58.7 bits (143), Expect = 3e-09
 Identities = 20/77 (25%), Positives = 32/77 (41%), Gaps = 10/77 (12%)

Query: 609 LDLSHNALTGSIPASLTKATKLESLFLAHNRLSGE--IPVSFSTLVNLSALDLS-FNNLS 665
            D  +    G +  + T+  ++ +L L+   L     IP S + L  L+ L +   NNL 
Sbjct: 31  TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90

Query: 666 GHIP-------HLQHLD 675
           G IP        L +L 
Sbjct: 91  GPIPPAIAKLTQLHYLY 107

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  222 bits (567), Expect = 2e-60
 Identities = 105/665 (15%), Positives = 203/665 (30%), Gaps = 148/665 (22%)

Query: 59  SISRDPSNLLATWNSSTDHCTWH---GVTCDHFTGRVTALRITGKATPWPSKSSVISGTL 115
           S + + +     WN + +   W    GV  D+  GRVT L + G             G +
Sbjct: 290 SGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFG---------AKGRV 339

Query: 116 SASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPY-QMSNLERLR 174
             +I +LTEL+ LS   +S +        E    ++ E + +          +   +RL 
Sbjct: 340 PDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLN 399

Query: 175 VLNLSFNSFS-----GEVPRGLIGNGELSVIDMSSNRLSGGLAIDSS-SECEFLTYLKLS 228
           + +L  ++ +       + +    + + + I   +NR++    I  +      L  +  +
Sbjct: 400 LSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF---ISKAIQRLTKLQIIYFA 456

Query: 229 DNFLT-------------------ESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISE 269
           ++  T                   E+        ++L ++ L        +P  +  + E
Sbjct: 457 NSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPE 516

Query: 270 LKVLDVSRNSLTD---------RIPVELADCSKLSVLVL-----TNIDASLDLDNSRGEF 315
           L+ L+++ N             R+  +     K+ +  +         AS  L       
Sbjct: 517 LQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMV--- 573

Query: 316 SAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLG 375
                                                   L +L+   N ++    ++ G
Sbjct: 574 ---------------------------------------KLGLLDCVHNKVR--HLEAFG 592

Query: 376 MCRNLTYLDLSLNNLEGYLPMQL--PVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQD 433
               LT L L  N +E  +P         +     S N +  +   F   S         
Sbjct: 593 TNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYV------ 645

Query: 434 LQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFN 493
           +                    DFS NK +GS     I       K      + L+ N   
Sbjct: 646 MGSV-----------------DFSYNK-IGSEGR-NISCSMDDYKGINASTVTLSYNEIQ 686

Query: 494 GSVPGERISKCNDLQSFSVNLSANLLSGMSYEAF------LLDCVQLVEFEAANNQISG- 546
              P E  +  + +   ++ LS NL++ +   +         +   L   +   N+++  
Sbjct: 687 K-FPTELFATGSPIS--TIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSL 743

Query: 547 SIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWI------LLGGNNLTGEIPSQF 600
           S       L  L  +D+  N  S S P +      LK           GN +  + P+  
Sbjct: 744 SDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGI 802

Query: 601 GHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLS 660
               SL+ L +  N +   +   LT   +L  L +A N        S    +      L 
Sbjct: 803 TTCPSLIQLQIGSNDIR-KVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLL 859

Query: 661 FNNLS 665
           ++   
Sbjct: 860 YDKTQ 864

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  216 bits (552), Expect = 2e-58
 Identities = 75/594 (12%), Positives = 155/594 (26%), Gaps = 108/594 (18%)

Query: 127 TLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGE 186
             +   + +  +    +     +  L L G    G++P  +  L  L+VL+   +S +  
Sbjct: 303 NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVS 362

Query: 187 VPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTE-----SIPKEIG 241
                       + +   +R+            + L    L  + +        I K+  
Sbjct: 363 GRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSR 422

Query: 242 KCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTN 301
                  +    N +   I K I  +++L+++  + +  T        + +         
Sbjct: 423 ISLKDTQIGNLTNRIT-FISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE 481

Query: 302 IDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNL 361
                                       + L  +         +LPD   +   L+ LN+
Sbjct: 482 N-------------------EELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNI 522

Query: 362 GQNSLKG---------AVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPC-------MVY 405
             N              +         +    +  NNLE       P          +  
Sbjct: 523 ACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE-----FPASASLQKMVKLGL 577

Query: 406 FNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSL 465
            +   N +   L  F             L          +       I +     F   +
Sbjct: 578 LDCVHNKVR-HLEAFGT--NVK------LTDLK------LDYNQIEEIPEDFCA-FTDQV 621

Query: 466 PLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYE 525
                              L  ++N                +   SV+ S N +      
Sbjct: 622 -----------------EGLGFSHNKLKYIPNIFNAKSVYVMG--SVDFSYNKIGSEGRN 662

Query: 526 AF----LLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVS-------GSLPD 574
                     +       + N+I             +  + L  N ++            
Sbjct: 663 ISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDG 722

Query: 575 ELGKLKFLKWILLGGNNLTGEIPS--QFGHLISLVVLDLSHNALTGSIPASLTKATKLES 632
                  L  I L  N LT  +    +   L  L  +D+S+N  + S P     +++L++
Sbjct: 723 NYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKA 780

Query: 633 LFLAH------NRLSGEIPVSFSTLVNLSALDLSFNNLSGHIP-----HLQHLD 675
             + H      NR+  + P   +T  +L  L +  N++   +       L  LD
Sbjct: 781 FGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKLTPQLYILD 833

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  132 bits (333), Expect = 2e-31
 Identities = 64/423 (15%), Positives = 120/423 (28%), Gaps = 85/423 (20%)

Query: 273 LDVSRNSLTD--RIPVELADCSKLS--VLVLTNIDASLDLDNSRGEFSAFDGGVPYELLL 328
             V  N LT    +P++L + ++       L  I  +LD  N R      +        L
Sbjct: 244 FTVIDNKLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTIN---NTIHSL 300

Query: 329 SRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLN 388
           + +           G +   +   +  +  L+L     KG VP ++G    L  L    +
Sbjct: 301 NWNFN---KELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTH 357

Query: 389 NLEGYLPMQLPVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDE 448
           +      +                                FG ++L          +S+E
Sbjct: 358 SETVSGRL--------------------------------FGDEELT-------PDMSEE 378

Query: 449 NFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQ 508
               I       FL       + D           +  +N N     +  +      D Q
Sbjct: 379 RKHRIRMHYKKMFLDYDQRLNLSDLL---------QDAINRNPEMKPIKKDSRISLKDTQ 429

Query: 509 SFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRV 568
              +    N ++ +S    +    +L     AN+  +          +  +  +    + 
Sbjct: 430 ---IGNLTNRITFISKA--IQRLTKLQIIYFANSPFTYDN-----IAVDWEDANSDYAKQ 479

Query: 569 SGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTG---------S 619
             +       LK L  + L       ++P     L  L  L+++ N              
Sbjct: 480 YENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTR 539

Query: 620 IPASLTKATKLESLFLAHNRLSGEIPVS--FSTLVNLSALDLSFNNLS-----GHIPHLQ 672
           +        K++  ++ +N L  E P S     +V L  LD   N +      G    L 
Sbjct: 540 LADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVRHLEAFGTNVKLT 598

Query: 673 HLD 675
            L 
Sbjct: 599 DLK 601

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 97.3 bits (242), Expect = 1e-20
 Identities = 27/218 (12%), Positives = 61/218 (27%), Gaps = 30/218 (13%)

Query: 485 LLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQI 544
           L L      G VP   I +  +L+    +   +  +         +    +  E  +   
Sbjct: 328 LSLAGFGAKGRVPDA-IGQLTELKVL--SFGTHSETVSGRLFGDEELTPDMSEERKHRIR 384

Query: 545 SGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWI------LLGGNNLTGEIPS 598
                  +    +L   DL  + ++ +   E+  +K    I      +    N    I  
Sbjct: 385 MHYKKMFLDYDQRLNLSDLLQDAINRNP--EMKPIKKDSRISLKDTQIGNLTNRITFISK 442

Query: 599 QFGHLISLVVLDLSHNALTG-------------------SIPASLTKATKLESLFLAHNR 639
               L  L ++  +++  T                    +   S +    L  + L +  
Sbjct: 443 AIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCP 502

Query: 640 LSGEIPVSFSTLVNLSALDLSFNNLSGHIPHLQHLDCI 677
              ++P     L  L +L+++ N              +
Sbjct: 503 NMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRL 540

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  217 bits (554), Expect = 2e-60
 Identities = 106/594 (17%), Positives = 199/594 (33%), Gaps = 76/594 (12%)

Query: 126 RTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSG 185
           +T +  +   + EIP  +      E LE   N          S L  L  L+L+      
Sbjct: 15  KTYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW 71

Query: 186 EVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRN 245
                      L  + +++N L   +A  + S  + L +L      ++      +   + 
Sbjct: 72  IHEDTFQSQHRLDTLVLTANPLIF-MAETALSGPKALKHLFFIQTGISSIDFIPLHNQKT 130

Query: 246 LKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVL------ 299
           L++L L  N +      +     +LKVLD   N++      +++   + + L L      
Sbjct: 131 LESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGND 190

Query: 300 -TNIDA---------SLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDN 349
              I+          SL+   ++     F G     +              ++   + + 
Sbjct: 191 IAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEG 250

Query: 350 WSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQL-PVPCMVYFNV 408
             E  S++ +NL ++        +      L  LDL+  +L   LP  L  +  +    +
Sbjct: 251 LCEM-SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVL 308

Query: 409 SQNNITGVLPR-FENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPL 467
           S N    +      N        F  L +                     GN     L  
Sbjct: 309 SANKFENLCQISASN--------FPSLTHL-----------------SIKGNTKRLELGT 343

Query: 468 FAIGD-GFLAAKYKPHYRLLLNNNMFNGSVPGER-ISKCNDLQSFSVNLSANLLSGMSYE 525
             + +   L         L L+++    S      +   + LQS  +NLS N    +  E
Sbjct: 344 GCLENLENLR-------ELDLSHDDIETSDCCNLQLRNLSHLQS--LNLSYNEPLSLKTE 394

Query: 526 AFLLDCVQLVEFEAANNQISGSIAAGV-GKLMKLQRLDLRGNRVSGSLPDELGKLKFLKW 584
           AF  +C QL   + A  ++    A      L  L+ L+L  + +  S       L  L+ 
Sbjct: 395 AFK-ECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQH 453

Query: 585 ILLGGNNLTGEI---PSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLS 641
           + L GN+         +    L  L +L LS   L+     + T    +  + L+HNRL+
Sbjct: 454 LNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLT 513

Query: 642 GEIPVSFSTLVNLSALDLSFNNLSG-------HIPHLQHLDCIAFKGNKYLASC 688
                + S L  +  L+L+ N++S         +   + ++    + N    +C
Sbjct: 514 SSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTIN---LRQNPLDCTC 563

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  214 bits (548), Expect = 1e-59
 Identities = 101/568 (17%), Positives = 186/568 (32%), Gaps = 63/568 (11%)

Query: 111 ISGTLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNL 170
           +    + + ++L  L  L +                  L+ L L  N         +S  
Sbjct: 45  LPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGP 104

Query: 171 ERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDN 230
           + L+ L       S      L     L  + + SN +S  + +      E L  L   +N
Sbjct: 105 KALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHIS-SIKLPKGFPTEKLKVLDFQNN 163

Query: 231 FLTESIPKEIGKCRNLKNLLLD--GNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVEL 288
            +     +++   +   NL L+  GN +   I       +  + L+         I   L
Sbjct: 164 AIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGL 222

Query: 289 ADCS--KLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRL 346
            + +   L +          D+D+     + F+G      L   S+E +   +      +
Sbjct: 223 KNSTIQSLWLGTF------EDMDDEDISPAVFEG------LCEMSVESINLQKHYFFN-I 269

Query: 347 PDNWSESC-SLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQL-PVPCMV 404
             N       L+ L+L    L   +P  L     L  L LS N  E    +     P + 
Sbjct: 270 SSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLT 328

Query: 405 YFNVSQNNITGVLPRFENVSCDNHF-GFQDLQYANVPVMGSISDENFVIIHDFSGNKF-- 461
           + ++  N     L               ++L+  ++         + +   D    +   
Sbjct: 329 HLSIKGNTKRLELG-------TGCLENLENLRELDL-------SHDDIETSDCCNLQLRN 374

Query: 462 LGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSG 521
           L  L                   L L+ N    S+  E   +C  L+   ++L+   L  
Sbjct: 375 LSHL-----------------QSLNLSYNEPL-SLKTEAFKECPQLE--LLDLAFTRLKV 414

Query: 522 MSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNR---VSGSLPDELGK 578
              ++   +   L     +++ +  S       L  LQ L+L+GN     +    + L  
Sbjct: 415 KDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQT 474

Query: 579 LKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHN 638
           L  L+ ++L   +L+      F  L  +  +DLSHN LT S   +L+    +  L LA N
Sbjct: 475 LGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASN 533

Query: 639 RLSGEIPVSFSTLVNLSALDLSFNNLSG 666
            +S  +P     L     ++L  N L  
Sbjct: 534 HISIILPSLLPILSQQRTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 55.4 bits (134), Expect = 7e-08
 Identities = 25/127 (19%), Positives = 46/127 (36%), Gaps = 12/127 (9%)

Query: 109 SVISGTLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMS 168
              +   + S+  L  L  L +     S         L+++  ++L  N  +      +S
Sbjct: 462 PKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALS 521

Query: 169 NLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECE---FLTYL 225
           +L+ +  LNL+ N  S  +P  L    +   I++  N L           C    FL + 
Sbjct: 522 HLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC--------TCSNIYFLEWY 572

Query: 226 KLSDNFL 232
           K +   L
Sbjct: 573 KENMQKL 579

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  208 bits (532), Expect = 2e-57
 Identities = 86/562 (15%), Positives = 171/562 (30%), Gaps = 54/562 (9%)

Query: 111 ISGTLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNL 170
           +    S S +  +EL+ L +               L  L  L L GN      P   S L
Sbjct: 44  LKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGL 103

Query: 171 ERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDN 230
             L  L       +      +     L  ++++ N +         S    L ++ LS N
Sbjct: 104 TSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN 163

Query: 231 FLTESIPKEIGKCRNLKNLL----LDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPV 286
           ++      ++   R    +     +  N ++  I  +     +L  L +  N  +  I  
Sbjct: 164 YIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMK 222

Query: 287 E-LADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGR 345
             L + + L V  L   +   + +    E S  +G      L   +++       N    
Sbjct: 223 TCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEG------LCDVTIDEFRLTYTNDFSD 276

Query: 346 LPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVY 405
               +    ++  ++L   S+K    + +        L +    L+ +  + LP   +  
Sbjct: 277 DIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQFPTLDLP--FLKS 332

Query: 406 FNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSL 465
             ++ N  +                   L Y                  D S N      
Sbjct: 333 LTLTMNKGSISF---------KKVALPSLSYL-----------------DLSRNA----- 361

Query: 466 PLFAIGDGFLAAKYKPHYRLL-LNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSY 524
            L   G    +       R L L+ N     +         +LQ   ++   + L  ++ 
Sbjct: 362 -LSFSGCCSYSDLGTNSLRHLDLSFNGA--IIMSANFMGLEELQH--LDFQHSTLKRVTE 416

Query: 525 EAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDE-LGKLKFLK 583
            +  L   +L+  + +              L  L  L + GN    +           L 
Sbjct: 417 FSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLT 476

Query: 584 WILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGE 643
           ++ L    L       F  L  L +L++SHN L     +   +   L +L  + NR+   
Sbjct: 477 FLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETS 536

Query: 644 IPVSFSTLVNLSALDLSFNNLS 665
             +      +L+  +L+ N+++
Sbjct: 537 KGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  150 bits (380), Expect = 6e-38
 Identities = 90/474 (18%), Positives = 148/474 (31%), Gaps = 54/474 (11%)

Query: 223 TYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTD 282
              +  D  L+  +P +I    + KN+ L  N L+          SEL+ LD+SR  +  
Sbjct: 14  ITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIET 70

Query: 283 RIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANL 342
                      LS L+LT         N      +F  G    L    SLE L A    L
Sbjct: 71  IEDKAWHGLHHLSNLILTG--------NP---IQSFSPGSFSGL---TSLENLVAVETKL 116

Query: 343 GGRLPDNWSESCSLKVLNLGQNSLKGA-VPKSLGMCRNLTYLDLSLNNLEGYLPMQLPV- 400
                    +  +LK LN+  N +    +P       NL ++DLS N ++      L   
Sbjct: 117 ASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFL 176

Query: 401 ----PCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVI---- 452
                  +  ++S N I  +                +L         +I           
Sbjct: 177 RENPQVNLSLDMSLNPIDFIQD-----QAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGL 231

Query: 453 -IHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFS 511
            +H     +F     L       +                 + S    +     ++ +  
Sbjct: 232 HVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAM- 290

Query: 512 VNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGS 571
            +L+   +  +          +         Q+          L  L+ L L  N+  GS
Sbjct: 291 -SLAGVSIKYLEDVPKHF---KWQSLSIIRCQLKQFPTLD---LPFLKSLTLTMNK--GS 341

Query: 572 LPDELGKLKFLKWILLGGNNLTGEIPSQFGHL--ISLVVLDLSHNALTGSIPASLTKATK 629
           +  +   L  L ++ L  N L+      +  L   SL  LDLS N     + A+     +
Sbjct: 342 ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEE 400

Query: 630 LESLFLAHNRLSGEIPVS-FSTLVNLSALDLSFNNLSG-------HIPHLQHLD 675
           L+ L   H+ L      S F +L  L  LD+S+ N           +  L  L 
Sbjct: 401 LQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLK 454

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 62.4 bits (152), Expect = 5e-10
 Identities = 28/132 (21%), Positives = 45/132 (34%), Gaps = 11/132 (8%)

Query: 106 SKSSVISGTLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPY 165
           + +S    TLS   A  T L  L +               L  L++L +  NN       
Sbjct: 456 AGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSS 515

Query: 166 QMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECE---FL 222
             + L  L  L+ SFN               L+  ++++N +        +  CE   FL
Sbjct: 516 HYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV--------ACICEHQKFL 567

Query: 223 TYLKLSDNFLTE 234
            ++K    FL  
Sbjct: 568 QWVKEQKQFLVN 579

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  197 bits (503), Expect = 2e-56
 Identities = 70/321 (21%), Positives = 112/321 (34%), Gaps = 39/321 (12%)

Query: 764  ELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIG 823
            E           N  +  LIG G +G+ YK  L     VAVK  S    Q        I 
Sbjct: 2    EAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFANRQNFINE-KNIY 59

Query: 824  TLGRIRHKNLVTLIGY-----YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKI 878
             +  + H N+   I         G  E  LV  +   G+L  ++   +     W    ++
Sbjct: 60   RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRL 116

Query: 879  AIDIAQALAYLH------YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS--- 929
            A  + + LAYLH          P I HRD+   N+L+  +    +SDFGL+  L  +   
Sbjct: 117  AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176

Query: 930  ----ETHATTDVAGTFGYVAPEYA-------TTCRVSDKADVYSFGVVLLELISGKRSLD 978
                E +A     GT  Y+APE                + D+Y+ G++  E+      L 
Sbjct: 177  RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236

Query: 979  P--SFSEYGNGFNIVSWAKLLIKEGRSSELF------LPELWEAGPQENLLGMMRLASTC 1030
            P  S  EY   F          ++ +            PE W+      +  +      C
Sbjct: 237  PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLA-VRSLKETIEDC 295

Query: 1031 TVETLSTRPSVKQVLIKLKQL 1051
              +    R + +    ++ +L
Sbjct: 296  WDQDAEARLTAQXAEERMAEL 316

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  194 bits (494), Expect = 1e-55
 Identities = 78/290 (26%), Positives = 133/290 (45%), Gaps = 38/290 (13%)

Query: 777  FSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQG-------IQQFDAEIGTLGRI 828
                  IG GGFG  +K  LV    +VA+K L +G  +G        Q+F  E+  +  +
Sbjct: 21   IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80

Query: 829  RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
             H N+V L G         +V  F+  G+L   +  K+   I+WSV  ++ +DIA  + Y
Sbjct: 81   NHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEY 137

Query: 889  LHYSCVPRIVHRDIKPSNILLDEELNAY-----LSDFGLARLLEVSETHATTDVAGTFGY 943
            +  +  P IVHRD++  NI L            ++DFGL++       H+ + + G F +
Sbjct: 138  MQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQW 192

Query: 944  VAPE--YATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEG 1001
            +APE   A     ++KAD YSF ++L  +++G+    P F EY  G   + +  ++ +EG
Sbjct: 193  MAPETIGAEEESYTEKADTYSFAMILYTILTGEG---P-FDEYSYGK--IKFINMIREEG 246

Query: 1002 RSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051
                   P +    P++    +  +   C       RP    ++ +L +L
Sbjct: 247  LR-----PTI----PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  194 bits (496), Expect = 1e-55
 Identities = 79/276 (28%), Positives = 133/276 (48%), Gaps = 23/276 (8%)

Query: 779  IRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQG--IQQFDAEIGTLGRIRHKNLVTL 836
            I+  IG G FG+ ++AE   G  VAVK L    F    + +F  E+  + R+RH N+V  
Sbjct: 41   IKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99

Query: 837  IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGK-KIQWSVIHKIAIDIAQALAYLHYSCVP 895
            +G       + +V  +LS G+L   +HK   + ++       +A D+A+ + YLH +  P
Sbjct: 100  MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNP 158

Query: 896  RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVS 955
             IVHR++K  N+L+D++    + DFGL+R L+ S   ++   AGT  ++APE       +
Sbjct: 159  PIVHRNLKSPNLLVDKKYTVKVCDFGLSR-LKASTFLSSKSAAGTPEWMAPEVLRDEPSN 217

Query: 956  DKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAG 1015
            +K+DVYSFGV+L EL + +    P    +    N       +  + +       E+    
Sbjct: 218  EKSDVYSFGVILWELATLQ---QP----W-GNLNPAQVVAAVGFKCKR-----LEI---- 260

Query: 1016 PQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051
            P+     +  +   C       RPS   ++  L+ L
Sbjct: 261  PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  186 bits (474), Expect = 9e-53
 Identities = 71/278 (25%), Positives = 122/278 (43%), Gaps = 27/278 (9%)

Query: 777  FSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTL 836
              +  ++G G FG   KA+      VA+K++        + F  E+  L R+ H N+V L
Sbjct: 10   IEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIVKL 66

Query: 837  IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGK-KIQWSVIHKIAIDIAQALAYLHYSCVP 895
             G  +    + LV  +  GG+L   +H          +      +  +Q +AYLH     
Sbjct: 67   YGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124

Query: 896  RIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV 954
             ++HRD+KP N+LL        + DFG A  +        T+  G+  ++APE       
Sbjct: 125  ALIHRDLKPPNLLLVAGGTVLKICDFGTACDI----QTHMTNNKGSAAWMAPEVFEGSNY 180

Query: 955  SDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEA 1014
            S+K DV+S+G++L E+I+ ++   P F E G     + WA  +    R      P L   
Sbjct: 181  SEKCDVFSWGIILWEVITRRK---P-FDEIGGPAFRIMWA--VHNGTR------PPL--- 225

Query: 1015 GPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQLK 1052
              +     +  L + C  +  S RPS+++++  +  L 
Sbjct: 226  -IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  183 bits (467), Expect = 3e-52
 Identities = 75/285 (26%), Positives = 126/285 (44%), Gaps = 36/285 (12%)

Query: 779  IRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQ----GIQQFDAEIGTLGRIRHKNLV 834
            +  +IG GGFG  Y+A  + G  VAVK       +     I+    E      ++H N++
Sbjct: 11   LEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69

Query: 835  TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
             L G  + E  + LV  F  GG L   +  K   +I   ++   A+ IA+ + YLH   +
Sbjct: 70   ALRGVCLKEPNLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAI 126

Query: 895  PRIVHRDIKPSNILLDEELNAY--------LSDFGLARLLEVSETHATTDVAGTFGYVAP 946
              I+HRD+K SNIL+ +++           ++DFGLAR    +        AG + ++AP
Sbjct: 127  VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---KMSAAGAYAWMAP 183

Query: 947  EYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSEL 1006
            E       S  +DV+S+GV+L EL++G+    P    +  G + ++ A  +     +   
Sbjct: 184  EVIRASMFSKGSDVWSYGVLLWELLTGE---VP----F-RGIDGLAVAYGVAMNKLA--- 232

Query: 1007 FLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051
                +    P        +L   C      +RPS   +L +L  +
Sbjct: 233  --LPI----PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  183 bits (466), Expect = 4e-52
 Identities = 54/282 (19%), Positives = 113/282 (40%), Gaps = 32/282 (11%)

Query: 778  SIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQG--IQQFDAEIGTLGRIRHKNLVT 835
            +    +     G  +K     G  + VK L +  +     + F+ E   L    H N++ 
Sbjct: 13   NFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71

Query: 836  LIGYYVG--EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
            ++G           L+ +++  G+L   +H+ +   +  S   K A+D+A+ +A+LH + 
Sbjct: 72   VLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TL 130

Query: 894  VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE---YAT 950
             P I    +   ++++DE++ A +S   +    +      +        +VAPE      
Sbjct: 131  EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPEALQKKP 184

Query: 951  TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
                   AD++SF V+L EL++ +    P F+      + +     +  EG       P 
Sbjct: 185  EDTNRRSADMWSFAVLLWELVTRE---VP-FA----DLSNMEIGMKVALEGLR-----PT 231

Query: 1011 LWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQLK 1052
            +    P      + +L   C  E  + RP    ++  L++++
Sbjct: 232  I----PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  176 bits (449), Expect = 4e-49
 Identities = 61/299 (20%), Positives = 108/299 (36%), Gaps = 34/299 (11%)

Query: 779  IRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
            +   IG G +G  +  +   G  VAVK             + EI     +RH+N++  I 
Sbjct: 41   MVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEAS-WFRETEIYQTVLMRHENILGFIA 98

Query: 839  Y----YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH---- 890
                      +++L+ ++   G+L  ++       +    + K+A      L +LH    
Sbjct: 99   ADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIF 155

Query: 891  -YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH---ATTDVAGTFGYVAP 946
                 P I HRD+K  NIL+ +     ++D GLA                  GT  Y+ P
Sbjct: 156  STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215

Query: 947  E------YATTCRVSDKADVYSFGVVLLELISGKRSLD-------PSFSEYGNGFNIVSW 993
            E           +    AD+YSFG++L E+     S         P      +  +    
Sbjct: 216  EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDM 275

Query: 994  AKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQLK 1052
             +++  +        P  W     E L  M +L + C     ++R +  +V   L ++ 
Sbjct: 276  REIVCIKKLR--PSFPNRWS--SDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  174 bits (443), Expect = 8e-49
 Identities = 64/204 (31%), Positives = 106/204 (51%), Gaps = 17/204 (8%)

Query: 779 IRNLIGTGGFGSTYKAELVPGYL--VAVKKLSIGRFQG--IQQFDAEIGTLGRIRHKNLV 834
           +   IG+G FG+ YK +    +   VAVK L++       +Q F  E+G L + RH N++
Sbjct: 28  VGQRIGSGSFGTVYKGK----WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83

Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
             +GY     ++ +V  +  G +L   +H     K +   +  IA   A+ + YLH    
Sbjct: 84  LFMGY-STAPQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLH---A 138

Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLL-EVSETHATTDVAGTFGYVAPE---YAT 950
             I+HRD+K +NI L E+    + DFGLA      S +H    ++G+  ++APE      
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198

Query: 951 TCRVSDKADVYSFGVVLLELISGK 974
           +   S ++DVY+FG+VL EL++G+
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQ 222

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  172 bits (439), Expect = 7e-48
 Identities = 48/213 (22%), Positives = 87/213 (40%), Gaps = 26/213 (12%)

Query: 779 IRNLIGTGGFGSTYKAELVPGYL--VAVKKLSIGRFQG--IQQFDAEIGTLGRIRHKNLV 834
           I  LIG G FG  Y       +   VA++ + I R     ++ F  E+    + RH+N+V
Sbjct: 37  IGELIGKGRFGQVYHGR----WHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVV 92

Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
             +G  +    + ++ +   G  L + +       +  +   +IA +I + + YLH    
Sbjct: 93  LFMGACMSPPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHA--- 148

Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV----SETHATTDVAGTFGYVAPE--- 947
             I+H+D+K  N+  D      ++DFGL  +  V              G   ++APE   
Sbjct: 149 KGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207

Query: 948 ------YATTCRVSDKADVYSFGVVLLELISGK 974
                        S  +DV++ G +  EL + +
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  171 bits (436), Expect = 1e-47
 Identities = 70/291 (24%), Positives = 115/291 (39%), Gaps = 40/291 (13%)

Query: 779  IRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLI 837
               ++G G FG   K      G ++ +K+L     +  + F  E+  +  + H N++  I
Sbjct: 14   HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73

Query: 838  GYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
            G    +  +  +  ++ GG L   I      +  WS     A DIA  +AYLH      I
Sbjct: 74   GVLYKDKRLNFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSM---NI 129

Query: 898  VHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT-------------TDVAGTFGYV 944
            +HRD+   N L+ E  N  ++DFGLARL+   +T                  V G   ++
Sbjct: 130  IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189

Query: 945  APEYATTCRVSDKADVYSFGVVLLELISGKRS---LDPSFSEYGNGFNIVSWAKLLIKEG 1001
            APE        +K DV+SFG+VL E+I    +     P   ++G          L ++  
Sbjct: 190  APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG----------LNVRGF 239

Query: 1002 RSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQLK 1052
               + + P      P         +   C       RPS  ++   L+ L+
Sbjct: 240  L--DRYCPPNC---PPS----FFPITVRCCDLDPEKRPSFVKLEHWLETLR 281

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  171 bits (435), Expect = 1e-47
 Identities = 63/298 (21%), Positives = 118/298 (39%), Gaps = 34/298 (11%)

Query: 779  IRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
            +   +G G +G  ++     G  VAVK  S    +   + + E+     +RH+N++  I 
Sbjct: 12   LLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFR-ETELYNTVMLRHENILGFIA 69

Query: 839  Y----YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH---- 890
                      +++L+ ++   G+L  ++       +      +I + IA  LA+LH    
Sbjct: 70   SDMTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIF 126

Query: 891  -YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH---ATTDVAGTFGYVAP 946
                 P I HRD+K  NIL+ +     ++D GLA +   S            GT  Y+AP
Sbjct: 127  GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186

Query: 947  E------YATTCRVSDKADVYSFGVVLLELISGKRSLD-------PSFSEYGNGFNIVSW 993
            E               + D+++FG+VL E+     S         P +    N  +    
Sbjct: 187  EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDM 246

Query: 994  AKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051
             K++  + +     +P  W + P   L  + +L   C  +  S R +  ++   L ++
Sbjct: 247  RKVVCVDQQR--PNIPNRWFSDP--TLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  171 bits (434), Expect = 5e-47
 Identities = 66/299 (22%), Positives = 122/299 (40%), Gaps = 34/299 (11%)

Query: 779  IRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
            ++  IG G FG  ++ +   G  VAVK  S    +     +AEI     +RH+N++  I 
Sbjct: 46   LQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIA 103

Query: 839  ----YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH---- 890
                      +++LV ++   G+L  ++++     +    + K+A+  A  LA+LH    
Sbjct: 104  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIV 160

Query: 891  -YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH---ATTDVAGTFGYVAP 946
                 P I HRD+K  NIL+ +     ++D GLA   + +      A     GT  Y+AP
Sbjct: 161  GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220

Query: 947  E------YATTCRVSDKADVYSFGVVLLELISGKRSLD-------PSFSEYGNGFNIVSW 993
            E               +AD+Y+ G+V  E+               P +    +  ++   
Sbjct: 221  EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 280

Query: 994  AKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQLK 1052
             K++ ++       +P  W++     L  M ++   C     + R +  ++   L QL 
Sbjct: 281  RKVVCEQKLR--PNIPNRWQSCEA--LRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  167 bits (425), Expect = 7e-44
 Identities = 95/589 (16%), Positives = 180/589 (30%), Gaps = 101/589 (17%)

Query: 123 TELRTLSVPHNSFSGEIPAGV-GELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFN 181
              + L +  N     + +        L+VL+L              +L  L  L L+ N
Sbjct: 28  FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86

Query: 182 SFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTE-SIPKEI 240
                      G   L  +      L+  L        + L  L ++ N +    +P+  
Sbjct: 87  PIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYF 145

Query: 241 GKCRNLKNLLLDGNILEGSIPKEIGTISELKV----LDVSRNSLTDRIPVELADCSKLSV 296
               NL++L L  N ++     ++  + ++ +    LD+S N +   I        +L  
Sbjct: 146 SNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHK 204

Query: 297 LVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSL 356
           L L N   SL++                                     +         L
Sbjct: 205 LTLRNNFDSLNV-------------------------------------MKTCIQGLAGL 227

Query: 357 KVLNLGQNSLKGA---VPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNI 413
           +V  L     +               L  L +    L              Y +   ++I
Sbjct: 228 EVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA-------------YLDYYLDDI 274

Query: 414 TGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDG 473
             +     NVS  +                 +       + DFS N     L L     G
Sbjct: 275 IDLFNCLTNVSSFS-----------------LVSVTIERVKDFSYNFGWQHLELVNCKFG 317

Query: 474 FLAAKYKPH-YRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLD-C 531
                      RL   +N    +     +     L+   ++LS N LS     +      
Sbjct: 318 QFPTLKLKSLKRLTFTSNKGGNAFSEVDLPS---LE--FLDLSRNGLSFKGCCSQSDFGT 372

Query: 532 VQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDE--LGKLKFLKWILLGG 589
             L   + + N +  ++++    L +L+ LD + + +   + +      L+ L ++ +  
Sbjct: 373 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISH 430

Query: 590 NNLTGEIPSQFGHLISLVVLDLSHNALTGSIPA-SLTKATKLESLFLAHNRLSGEIPVSF 648
            +        F  L SL VL ++ N+   +      T+   L  L L+  +L    P +F
Sbjct: 431 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 490

Query: 649 STLVNLSALDLSFNNLS-------GHIPHLQHLDCIAFKGNKYLASCPD 690
           ++L +L  L+++ N L          +  LQ +       N +  SCP 
Sbjct: 491 NSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIW---LHTNPWDCSCPR 536

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  144 bits (366), Expect = 2e-36
 Identities = 93/573 (16%), Positives = 159/573 (27%), Gaps = 81/573 (14%)

Query: 111 ISGTLSASIAKLTELRTLSVPHNSFSGEIPAGV-GELRLLEVLELQGNNFSGKIPYQMSN 169
           +    S S     EL+ L +        I  G    L  L  L L GN          S 
Sbjct: 40  LRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG 98

Query: 170 LERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSD 229
           L  L+ L     + +      +     L  ++++ N +      +  S    L +L LS 
Sbjct: 99  LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS 158

Query: 230 NFLTESIPKEIGKCRNLKNLL----LDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIP 285
           N +      ++     +  L     L  N +   I         L  L +  N  +  + 
Sbjct: 159 NKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVM 217

Query: 286 VELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGR 345
                   L+ L +  +      +        FD      L      E   A        
Sbjct: 218 KTC--IQGLAGLEVHRLVLGEFRNEGN--LEKFDKSALEGLCNLTIEEFRLAYLDYYLDD 273

Query: 346 LPDNWSESCSLKVLNLGQNSLKGAVPKS-LGMCRNLTYLDLSLNNLEGYLPMQLPVPCMV 404
           + D ++   ++   +L   +++     S     ++L  ++             L      
Sbjct: 274 IIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLK----- 328

Query: 405 YFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNK--FL 462
               + N               N F   DL              +   + D S N   F 
Sbjct: 329 RLTFTSNKGG------------NAFSEVDLP-------------SLEFL-DLSRNGLSFK 362

Query: 463 GSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGM 522
           G       G   L         L L+ N    ++          L+   ++   + L  M
Sbjct: 363 GCCSQSDFGTTSL-------KYLDLSFNGVI-TMSSN-FLGLEQLE--HLDFQHSNLKQM 411

Query: 523 SYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFL 582
           S  +  L                         L  L  LD+       +       L  L
Sbjct: 412 SEFSVFL------------------------SLRNLIYLDISHTHTRVAFNGIFNGLSSL 447

Query: 583 KWILLGGNNLTGEIPSQ-FGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLS 641
           + + + GN+         F  L +L  LDLS   L    P +    + L+ L +A N+L 
Sbjct: 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK 507

Query: 642 GEIPVSFSTLVNLSALDLSFNNLSGHIPHLQHL 674
                 F  L +L  + L  N      P + +L
Sbjct: 508 SVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYL 540

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 60.1 bits (146), Expect = 2e-09
 Identities = 23/96 (23%), Positives = 35/96 (36%), Gaps = 10/96 (10%)

Query: 587 LGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPV 646
               N   +IP       S   LDLS N L      S     +L+ L L+   +      
Sbjct: 14  CMELNFY-KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70

Query: 647 SFSTLVNLSALDLSFNNLS-------GHIPHLQHLD 675
           ++ +L +LS L L+ N +          +  LQ L 
Sbjct: 71  AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  170 bits (432), Expect = 1e-43
 Identities = 136/698 (19%), Positives = 230/698 (32%), Gaps = 99/698 (14%)

Query: 122 LTELRTLSVPHNSFSGEIPAGV-GELRLLEVLELQGNNFSGKIPYQM-SNLERLRVLNLS 179
           L     L +  N     + A     L  L++LEL        I  +   NL  LR+L+L 
Sbjct: 23  LNTTERLLLSFNYIR-TVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG 81

Query: 180 FNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSS-SECEFLTYLKLSDNFLTE-SIP 237
            +      P    G   L  + +    LS  +  D      + LT L LS N +    + 
Sbjct: 82  SSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLH 141

Query: 238 KEIGKCRNLKNLLLDGNILEGSIPKEIGTIS--ELKVLDVSRNSLTDRIPVELADC-SKL 294
              GK  +LK++    N +      E+  +    L    ++ NSL  R+ V+   C +  
Sbjct: 142 PSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPF 201

Query: 295 SVLVLTNIDAS---LDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWS 351
             +VL  +D S     +D +    +A      + L+L+  +        N+     + ++
Sbjct: 202 RNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFA 261

Query: 352 ESC--SLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQL-PVPCMVYFNV 408
                S++ L+L    +     +     ++L  L+L+ N +          +  +   N+
Sbjct: 262 GLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNL 321

Query: 409 SQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLF 468
           S N +         +   N +G   + Y                  D   N       + 
Sbjct: 322 SYNLLG-------ELYSSNFYGLPKVAY-----------------IDLQKNH------IA 351

Query: 469 AIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSF-SVNLSANLLSGMSYEAF 527
            I D       K    L L +N          ++  + + S   + LS N L  +     
Sbjct: 352 IIQDQTFKFLEKLQT-LDLRDN---------ALTTIHFIPSIPDIFLSGNKLVTLPKINL 401

Query: 528 LLDCVQLVEFEAANNQISG-SIAAGVGKLMKLQRLDLRGNRVSGSLPDEL-GKLKFLKWI 585
             + + L     + N++    I   + ++  LQ L L  NR S    D+   +   L+ +
Sbjct: 402 TANLIHL-----SENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQL 456

Query: 586 LLGGNNLTGEIPSQ-----FGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRL 640
            LG N L     ++     F  L  L VL L+HN L    P   +  T L  L L  NRL
Sbjct: 457 FLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRL 516

Query: 641 SGEIPVSFSTLVNLSALDLSFNNLSGHIP-HLQHLDCIAFKGNKYLASCP---------- 689
           +           NL  LD+S N L    P     L  +    NK++  C           
Sbjct: 517 TVLSHNDLPA--NLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECELSTFINWLNH 574

Query: 690 --------------DTNATAPEKPPVQLD-EKLQNGKRSKVFIIAVVTSASAVLLIFLVI 734
                             +        L  E     +  K    ++    +  L +FL+ 
Sbjct: 575 TNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLTLFLMT 634

Query: 735 IFVILRRRKFGRIASLRGQVMVTF----ADTPAELTYD 768
           I  + + R F  I     Q +V         P    YD
Sbjct: 635 ILTVTKFRGFCFICYKTAQRLVFKDHPQGTEPDMYKYD 672

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  126 bits (318), Expect = 9e-30
 Identities = 104/553 (18%), Positives = 172/553 (31%), Gaps = 100/553 (18%)

Query: 150 EVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSG 209
            +   +  N + ++P     L     L LSFN              +L ++++ S     
Sbjct: 7   RIAFYRFCNLT-QVP---QVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPL 62

Query: 210 GLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSI--PKEIGTI 267
            +  ++      L  L L  + +    P       +L  L L    L  ++        +
Sbjct: 63  TIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNL 122

Query: 268 SELKVLDVSRNSLTD-RIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYEL 326
             L  LD+S+N +    +       + L  +                            L
Sbjct: 123 KALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDF--------------------SSNQIFL 162

Query: 327 LLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRN------L 380
           +    LE L                +  +L   +L  NSL   V    G C N      L
Sbjct: 163 VCEHELEPL----------------QGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVL 206

Query: 381 TYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNITGVLP---RFENVSCDNHFGFQDLQYA 437
             LD+S N     +                N I+          +      FGF +++  
Sbjct: 207 EILDVSGNGWTVDIT-----------GNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDP 255

Query: 438 NVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVP 497
           +      ++  +   + D S         +F++              L L  N  N  + 
Sbjct: 256 DQNTFAGLARSSVRHL-DLSHGF------VFSLNSRVFETLKDLKV-LNLAYNKIN-KIA 306

Query: 498 GERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGV-GKLM 556
            E     ++LQ   +NLS NLL  +    F     ++   +   N I+  I       L 
Sbjct: 307 DEAFYGLDNLQ--VLNLSYNLLGELYSSNF-YGLPKVAYIDLQKNHIA-IIQDQTFKFLE 362

Query: 557 KLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNAL 616
           KLQ LDLR N ++      +  +  +  I L GN L   +P      ++  ++ LS N L
Sbjct: 363 KLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLV-TLPKIN---LTANLIHLSENRL 413

Query: 617 TG-SIPASLTKATKLESLFLAHNRLSG-EIPVSFSTLVNLSALDLSFNNLSG-------- 666
               I   L +   L+ L L  NR S      + S   +L  L L  N L          
Sbjct: 414 ENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCW 473

Query: 667 ----HIPHLQHLD 675
                + HLQ L 
Sbjct: 474 DVFEGLSHLQVLY 486

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 89.5 bits (222), Expect = 2e-18
 Identities = 70/312 (22%), Positives = 110/312 (35%), Gaps = 42/312 (13%)

Query: 121 KLTELRTLSVPHNSFSGEIPAGV-GELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLS 179
             + +R L + H      + + V   L+ L+VL L  N  +         L+ L+VLNLS
Sbjct: 264 ARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLS 322

Query: 180 FNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKE 239
           +N           G  +++ ID+  N ++  +   +    E L  L L DN LT      
Sbjct: 323 YNLLGELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFKFLEKLQTLDLRDNALT-----T 376

Query: 240 IGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTD-RIPVELADCSKLSVLV 298
           I    ++ ++ L GN L  ++PK         ++ +S N L +  I   L     L +L+
Sbjct: 377 IHFIPSIPDIFLSGNKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILI 432

Query: 299 LTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGG-RLPDNWSESC--- 354
           L          +     S            + SLE L      LG   L   W       
Sbjct: 433 LNQ--NRFSSCSGDQTPS-----------ENPSLEQL-----FLGENMLQLAWETELCWD 474

Query: 355 ------SLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNV 408
                  L+VL L  N L    P        L  L L+ N L   L        +   ++
Sbjct: 475 VFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLPANLEILDI 533

Query: 409 SQNNITGVLPRF 420
           S+N +    P  
Sbjct: 534 SRNQLLAPNPDV 545

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  147 bits (374), Expect = 5e-39
 Identities = 67/280 (23%), Positives = 119/280 (42%), Gaps = 39/280 (13%)

Query: 776  NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKN 832
             +     IG G FG     +    G    +K+++I R   +  ++   E+  L  ++H N
Sbjct: 25   KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84

Query: 833  LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
            +V     +     +++V ++  GG+L   I+ + G   Q   I    + I  AL ++H  
Sbjct: 85   IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR 144

Query: 893  CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
               +I+HRDIK  NI L ++    L DFG+AR+L  +   A     GT  Y++PE     
Sbjct: 145  ---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA-CIGTPYYLSPEICENK 200

Query: 953  RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSEL---FLP 1009
              ++K+D+++ G VL EL + K     +F       ++ +   L I  G    +   +  
Sbjct: 201  PYNNKSDIWALGCVLYELCTLK----HAF----EAGSMKN-LVLKIISGSFPPVSLHYSY 251

Query: 1010 ELWEAGPQENLLGMMRLASTCTVETLST----RPSVKQVL 1045
            +L       +L+  +                 RPSV  +L
Sbjct: 252  DLR------SLVSQL----------FKRNPRDRPSVNSIL 275

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  145 bits (367), Expect = 8e-39
 Identities = 73/279 (26%), Positives = 125/279 (44%), Gaps = 28/279 (10%)

Query: 776  NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKN 832
            ++ +   IGTG +G   K      G ++  K+L  G       Q   +E+  L  ++H N
Sbjct: 7    DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66

Query: 833  LVTLIGYYVGEA--EMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAY 888
            +V      +      +++V  +  GG+L + I    K  + +    + ++   +  AL  
Sbjct: 67   IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126

Query: 889  LHYSCVP--RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAP 946
             H        ++HRD+KP+N+ LD + N  L DFGLAR+L    + A T V GT  Y++P
Sbjct: 127  CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSP 185

Query: 947  EYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSEL 1006
            E       ++K+D++S G +L EL +      P F      F+    A   I+EG+    
Sbjct: 186  EQMNRMSYNEKSDIWSLGCLLYELCALM----PPF----TAFSQKELAG-KIREGKFR-- 234

Query: 1007 FLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVL 1045
             +P  +     E +  M+ L           RPSV+++L
Sbjct: 235  RIPYRYSDELNEIITRMLNLKD-------YHRPSVEEIL 266

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  143 bits (362), Expect = 5e-38
 Identities = 56/225 (24%), Positives = 96/225 (42%), Gaps = 22/225 (9%)

Query: 779 IRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKNLVT 835
               IG G F + YK  +      VA  +L   +      Q+F  E   L  ++H N+V 
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89

Query: 836 LIGYYVGEAEMFLVYNF----LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
               +    +           ++ G L+T++ +   K ++  V+      I + L +LH 
Sbjct: 90  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLH- 146

Query: 892 SCVPRIVHRDIKPSNILLDEEL-NAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
           +  P I+HRD+K  NI +     +  + D GLA L   S       V GT  ++APE   
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMYE 203

Query: 951 TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNG---FNIVS 992
             +  +  DVY+FG+ +LE+ + +      +SE  N    +  V+
Sbjct: 204 E-KYDESVDVYAFGMCMLEMATSE----YPYSECQNAAQIYRRVT 243

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  147 bits (373), Expect = 7e-38
 Identities = 87/541 (16%), Positives = 174/541 (32%), Gaps = 109/541 (20%)

Query: 125 LRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFS 184
           L + ++  ++   +I      L       L   N +  +    ++L+++  L        
Sbjct: 3   LGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIK 59

Query: 185 GEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCR 244
                G+     L+ I+ S+N+L+    I        L  + +++N + +  P  +    
Sbjct: 60  S--IDGVEYLNNLTQINFSNNQLTD---ITPLKNLTKLVDILMNNNQIADITP--LANLT 112

Query: 245 NLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDA 304
           NL  L L  N +    P  +  ++ L  L++S N+++D     L+  + L          
Sbjct: 113 NLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQ--------- 159

Query: 305 SLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQN 364
            L   N   +                               L        +L+ L++  N
Sbjct: 160 QLSFGNQVTDLKPLAN-------------------------LT-------TLERLDISSN 187

Query: 365 SLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNITGVLPRFENVS 424
            +       L    NL  L  + N +    P+ + +  +   +++ N +   +    +  
Sbjct: 188 KVSD--ISVLAKLTNLESLIATNNQISDITPLGI-LTNLDELSLNGNQLKD-IGTLAS-- 241

Query: 425 CDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYR 484
                   +L   +      +++     +   SG   L                      
Sbjct: 242 ------LTNLTDLD------LANNQISNLAPLSGLTKL--------------------TE 269

Query: 485 LLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQI 544
           L L  N  +   P   ++    L +    L+ N L  +S    + +   L       N I
Sbjct: 270 LKLGANQISNISP---LAGLTALTNL--ELNENQLEDIS---PISNLKNLTYLTLYFNNI 321

Query: 545 SGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLI 604
           S      V  L KLQRL    N+VS      L  L  + W+  G N ++   P    +L 
Sbjct: 322 SDIS--PVSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLT 375

Query: 605 SLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNL 664
            +  L L+  A T +        +   ++      L    P + S   + +  D+++N  
Sbjct: 376 RITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLP 433

Query: 665 S 665
           S
Sbjct: 434 S 434

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  130 bits (329), Expect = 4e-32
 Identities = 93/528 (17%), Positives = 168/528 (31%), Gaps = 85/528 (16%)

Query: 118 SIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLN 177
           +   L E     +   + +  +     +L  +  L+             +  L  L  +N
Sbjct: 19  TDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQIN 74

Query: 178 LSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIP 237
            S N  +   P  L    +L  I M++N+++    I   +    LT L L +N +T+  P
Sbjct: 75  FSNNQLTDITP--LKNLTKLVDILMNNNQIAD---ITPLANLTNLTGLTLFNNQITDIDP 129

Query: 238 KEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVL 297
             +    NL  L L  N +       +  ++ L+ L    N +TD  P  LA+ + L  L
Sbjct: 130 --LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERL 182

Query: 298 VLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLK 357
            +++        N   + S              +LE L A    +            +L 
Sbjct: 183 DISS--------NKVSDISVLAK--------LTNLESLIATNNQISD--ITPLGILTNLD 224

Query: 358 VLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNITGVL 417
            L+L  N LK     +L    NLT LDL+ N +    P+   +  +    +  N I+ + 
Sbjct: 225 ELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLS-GLTKLTELKLGANQISNIS 281

Query: 418 PRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAA 477
           P               L          +++     I   S  K L               
Sbjct: 282 P-LAG--------LTALTNLE------LNENQLEDISPISNLKNL--------------- 311

Query: 478 KYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEF 537
                  L L  N  +   P   +S    LQ        N +S +S    L +   +   
Sbjct: 312 -----TYLTLYFNNISDISP---VSSLTKLQRL--FFYNNKVSDVS---SLANLTNINWL 358

Query: 538 EAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIP 597
            A +NQIS      +  L ++ +L L     + +  +    +     +      L    P
Sbjct: 359 SAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--AP 414

Query: 598 SQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIP 645
           +      S    D++ N  +          ++  ++       SG + 
Sbjct: 415 ATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVT 461

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  128 bits (325), Expect = 1e-31
 Identities = 90/495 (18%), Positives = 153/495 (30%), Gaps = 140/495 (28%)

Query: 196 ELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNI 255
           E     +    ++      S ++ + +T L+     +       +    NL  +    N 
Sbjct: 25  EKMKTVLGKTNVTD---TVSQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQ 79

Query: 256 LEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVL-----TNIDASLDLDN 310
           L    P  +  +++L  + ++ N + D  P  LA+ + L+ L L     T+ID   +L N
Sbjct: 80  LTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDPLKNLTN 135

Query: 311 SRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAV 370
                                                        L  L L  N++    
Sbjct: 136 ---------------------------------------------LNRLELSSNTISD-- 148

Query: 371 PKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNITGVLPRFENVSCDNHFG 430
             +L    +L  L                           N +T + P   N        
Sbjct: 149 ISALSGLTSLQQLSFG------------------------NQVTDLKP-LAN-------- 175

Query: 431 FQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNN 490
              L+  +      IS      I   +    L                      L+  NN
Sbjct: 176 LTTLERLD------ISSNKVSDISVLAKLTNL--------------------ESLIATNN 209

Query: 491 MFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAA 550
             +   P   +    +L     +L+ N L  +     L     L + + ANNQIS     
Sbjct: 210 QISDITP---LGILTNLDEL--SLNGNQLKDIG---TLASLTNLTDLDLANNQISNLA-- 259

Query: 551 GVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLD 610
            +  L KL  L L  N++S      L  L  L  + L  N L    P    +L +L  L 
Sbjct: 260 PLSGLTKLTELKLGANQISNI--SPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLT 315

Query: 611 LSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIP- 669
           L  N ++   P  ++  TKL+ LF  +N++S     S + L N++ L    N +S   P 
Sbjct: 316 LYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTPL 371

Query: 670 -HLQHLDCIAFKGNK 683
            +L  +  +      
Sbjct: 372 ANLTRITQLGLNDQA 386

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  122 bits (308), Expect = 2e-29
 Identities = 80/467 (17%), Positives = 152/467 (32%), Gaps = 91/467 (19%)

Query: 213 IDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKV 272
           I + +         L    +T+++         +  L  D   +       +  ++ L  
Sbjct: 17  IFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQ 72

Query: 273 LDVSRNSLTDRIPVELADCSKLSVLVL-----TNIDASLDLDNSRGEFSAFDGGVPYELL 327
           ++ S N LTD  P  L + +KL  +++      +I    +L N                 
Sbjct: 73  INFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTN----------------- 113

Query: 328 LSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSL 387
               L  L      +     D      +L  L L  N++      +L    +L  L    
Sbjct: 114 ----LTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG- 164

Query: 388 NNLEGYLPMQLPVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISD 447
           N +    P+   +  +   ++S N ++  +               +L+            
Sbjct: 165 NQVTDLKPLA-NLTTLERLDISSNKVSD-ISVLAK--------LTNLESLIA-------T 207

Query: 448 ENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDL 507
            N   I D +    L +L                   L LN N          ++   +L
Sbjct: 208 NNQ--ISDITPLGILTNL-----------------DELSLNGNQLKDIGT---LASLTNL 245

Query: 508 QSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNR 567
                +L+ N +S ++    L    +L E +   NQIS      +  L  L  L+L  N+
Sbjct: 246 TDL--DLANNQISNLA---PLSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQ 298

Query: 568 VSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKA 627
           +       +  LK L ++ L  NN++   P     L  L  L   +N ++    +SL   
Sbjct: 299 LED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANL 352

Query: 628 TKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPHLQHL 674
           T +  L   HN++S   P   + L  ++ L L+    +    + +  
Sbjct: 353 TNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKAN 397

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 83.1 bits (206), Expect = 1e-16
 Identities = 27/134 (20%), Positives = 54/134 (40%), Gaps = 11/134 (8%)

Query: 541 NNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQF 600
           +  I+         L +  +  L    V+ ++      L  +  +      +        
Sbjct: 11  DTPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGV 64

Query: 601 GHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLS 660
            +L +L  ++ S+N LT   P  L   TKL  + + +N+++   P   + L NL+ L L 
Sbjct: 65  EYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLF 120

Query: 661 FNNLSGHIPHLQHL 674
            N ++  I  L++L
Sbjct: 121 NNQIT-DIDPLKNL 133

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  142 bits (360), Expect = 2e-37
 Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 15/208 (7%)

Query: 775 GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQG----IQQFDAEIGTLGRIR 829
           G + +R L+G GG G  Y+AE  V   +VA+K +S            +   E  T GR++
Sbjct: 34  GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMS-ETLSSDPVFRTRMQREARTAGRLQ 92

Query: 830 HKNLVTLIGYYVGEAE--MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALA 887
             ++V +  +  GE +  +++    ++G +L   + ++       +V   I   I  AL 
Sbjct: 93  EPHVVPI--HDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAV--AIVRQIGSALD 148

Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE 947
             H +      HRD+KP NIL+  +  AYL DFG+A      +     +  GT  Y+APE
Sbjct: 149 AAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPE 205

Query: 948 YATTCRVSDKADVYSFGVVLLELISGKR 975
             +    + +AD+Y+   VL E ++G  
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGSP 233

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  141 bits (357), Expect = 2e-37
 Identities = 67/295 (22%), Positives = 126/295 (42%), Gaps = 57/295 (19%)

Query: 772  RATGNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRH 830
            R   +F    LIG+GGFG  +KA+  + G    +K++        ++ + E+  L ++ H
Sbjct: 8    RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDH 63

Query: 831  KNLVTLIGYYVGEAEM----------------FLVYNFLSGGNLETFIHKKSGKKIQWSV 874
             N+V   G + G                    F+   F   G LE +I K+ G+K+   +
Sbjct: 64   VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123

Query: 875  IHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT 934
              ++   I + + Y+H     ++++RD+KPSNI L +     + DFGL   L+       
Sbjct: 124  ALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR 180

Query: 935  TDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWA 994
            +   GT  Y++PE  ++     + D+Y+ G++L EL+        +F          +  
Sbjct: 181  S--KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD---TAF----ETSKFFT-- 229

Query: 995  KLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLST----RPSVKQVL 1045
               +++G  S++F  +       + LL  +          LS     RP+  ++L
Sbjct: 230  --DLRDGIISDIFDKKE------KTLLQKL----------LSKKPEDRPNTSEIL 266

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  141 bits (357), Expect = 3e-37
 Identities = 71/285 (24%), Positives = 121/285 (42%), Gaps = 41/285 (14%)

Query: 775  GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRF---QGIQQFDAEIGTLGRIRH 830
             NF I   IG G F   Y+A  L+ G  VA+KK+ I      +       EI  L ++ H
Sbjct: 32   ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 831  KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAY 888
             N++     ++ + E+ +V      G+L   I   KK  + I    + K  + +  AL +
Sbjct: 92   PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 889  LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
            +H     R++HRDIKP+N+ +       L D GL R      T A + + GT  Y++PE 
Sbjct: 152  MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPER 207

Query: 949  ATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGR----SS 1004
                  + K+D++S G +L E+ + +    P + +  N +++       I++       S
Sbjct: 208  IHENGYNFKSDIWSLGCLLYEMAALQS---PFYGDKMNLYSLC----KKIEQCDYPPLPS 260

Query: 1005 ELFLPELWEAGPQENLLGMMRLASTCTVETLST----RPSVKQVL 1045
            + +  EL        L+ M           ++     RP V  V 
Sbjct: 261  DHYSEELR------QLVNMC----------INPDPEKRPDVTYVY 289

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  145 bits (367), Expect = 2e-36
 Identities = 88/584 (15%), Positives = 177/584 (30%), Gaps = 108/584 (18%)

Query: 122 LTELRTLSVPHNSFSGEIPAGV-GELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSF 180
              +++L +  N  +  I  G       L+VL L+ +  +        +L  L  L+LS 
Sbjct: 25  TAAMKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSD 83

Query: 181 NSFSGEVPRGLIGN-GELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKE 239
           N  S  +     G    L  +++  N                L  L++ +      I + 
Sbjct: 84  NHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRI 142

Query: 240 -IGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLV 298
                 +L  L +    L     + + +I ++  L +  +     + +     S +  L 
Sbjct: 143 DFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLE 202

Query: 299 LTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKV 358
           L + + +             +   P + L  R   +       L  +L     E   ++ 
Sbjct: 203 LRDTNLA---RFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELL-KLLRYILELSEVEF 258

Query: 359 LNLGQNSLKGAVPKSLGMCRNLTYLD-LSLNNLEGYLPMQLPVPCMVYFNVSQNNITGVL 417
            +   N L    P    +   L  ++ +++  L                ++ Q  +   L
Sbjct: 259 DDCTLNGLGDFNPSESDVVSELGKVETVTIRRL----------------HIPQFYLFYDL 302

Query: 418 PRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAA 477
                                                 +S  + +               
Sbjct: 303 STV-----------------------------------YSLLEKV--------------- 312

Query: 478 KYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLS--GMSYEAFLLDCVQLV 535
                 R+ + N+     VP         L+   ++LS NL+    +   A       L 
Sbjct: 313 -----KRITVENSKVF-LVPCSFSQHLKSLEF--LDLSENLMVEEYLKNSACKGAWPSLQ 364

Query: 536 EFEAANNQIS--GSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLT 593
               + N +         +  L  L  LD+  N     +PD     + ++++ L    + 
Sbjct: 365 TLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR 423

Query: 594 GEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVN 653
             + +      +L VLD+S+N L  S    L +   L+ L+++ N+L   +P   S    
Sbjct: 424 -VVKT--CIPQTLEVLDVSNNNLD-SFSLFLPR---LQELYISRNKLK-TLP-DASLFPV 474

Query: 654 LSALDLSFNNLS-------GHIPHLQHLDCIAFKGNKYLASCPD 690
           L  + +S N L          +  LQ +       N +  SCP 
Sbjct: 475 LLVMKISRNQLKSVPDGIFDRLTSLQKIW---LHTNPWDCSCPR 515

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  134 bits (340), Expect = 4e-33
 Identities = 91/495 (18%), Positives = 164/495 (33%), Gaps = 60/495 (12%)

Query: 197 LSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNIL 256
             V D  S   +   +I S      +  L LS N +T     ++  C NL+ L+L  + +
Sbjct: 7   SGVCDGRSRSFT---SIPSGL-TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI 62

Query: 257 EGSIPKEI-GTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEF 315
             +I  +   ++  L+ LD+S N L+          S L  L L               F
Sbjct: 63  N-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGN--PYQTLGVTSLF 119

Query: 316 SAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNW-SESCSLKVLNLGQNSLKGAVPKSL 374
                          +L+ L          +     +   SL  L +   SL+    +SL
Sbjct: 120 PNL-----------TNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSL 168

Query: 375 GMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDL 434
              R++ +L L L+        +      ++ ++  +       R+  +   N   FQ  
Sbjct: 169 KSIRDIHHLTLHLS--------ESAFLLEIFADILSSV------RYLELRDTNLARFQFS 214

Query: 435 QYANVPVMGSISDENF--VIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMF 492
                 V   +    F   ++ D S N       L  +    L           LN    
Sbjct: 215 PLPVDEVSSPMKKLAFRGSVLTDESFN------ELLKLLRYILELSEVEFDDCTLNGLGD 268

Query: 493 NGSVPGERISKCNDLQSFSV---NLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIA 549
                 + +S+   +++ ++   ++    L       +     ++      N+++   + 
Sbjct: 269 FNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYS-LLEKVKRITVENSKVF-LVP 326

Query: 550 AGVGKLMK-LQRLDLRGNR---VSGSLPDELGKLKFLKWILLGGNNLT--GEIPSQFGHL 603
               + +K L+ LDL  N             G    L+ ++L  N+L    +       L
Sbjct: 327 CSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTL 386

Query: 604 ISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNN 663
            +L  LD+S N     +P S     K+  L L+   +     V       L  LD+S NN
Sbjct: 387 KNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV---VKTCIPQTLEVLDVSNNN 442

Query: 664 L---SGHIPHLQHLD 675
           L   S  +P LQ L 
Sbjct: 443 LDSFSLFLPRLQELY 457

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  127 bits (320), Expect = 1e-30
 Identities = 75/535 (14%), Positives = 162/535 (30%), Gaps = 78/535 (14%)

Query: 116 SASIAKLTELRTLSVPHNSFSGEIPAGV-GELRLLEVLELQGNNFSGKIPYQM-SNLERL 173
              +     L+ L +  +  +  I       L  LE L+L  N+ S  +       L  L
Sbjct: 43  HGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSL 100

Query: 174 RVLNLSFNSFSGEVPRGLIGN-GELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFL 232
           + LNL  N +       L  N   L  + + +      +     +    L  L++    L
Sbjct: 101 KYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSL 160

Query: 233 TESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCS 292
                + +   R++ +L L  +     +      +S ++ L++   +L       L    
Sbjct: 161 RNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDE 220

Query: 293 KLSVLVLTNIDASLDLDNSRGEFSAFDGGVPY----ELLLSRSLEVLWAPRANLGGRLPD 348
             S +       S+  D S  E       +      E        +     +        
Sbjct: 221 VSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSEL 280

Query: 349 NWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLP--VPCMVYF 406
              E+ +++ L++ Q  L   +     +   +  + +  + +   +P      +  + + 
Sbjct: 281 GKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFL 339

Query: 407 NVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLP 466
           ++S+N +                                       + + +      SL 
Sbjct: 340 DLSENLMV-----------------------------------EEYLKNSACKGAWPSL- 363

Query: 467 LFAIGDGFLAAKYKPHYRLLLNNNMFNG-SVPGERISKCNDLQSFSVNLSANLLSGMSYE 525
                             L+L+ N        GE +    +L   S+++S N    M   
Sbjct: 364 ----------------QTLVLSQNHLRSMQKTGEILLTLKNLT--SLDISRNTFHPMPDS 405

Query: 526 AFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWI 585
               +  ++     ++  I   +   +     L+ LD+  N +  S    L +L+ L   
Sbjct: 406 CQWPE--KMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSLFLPRLQELY-- 457

Query: 586 LLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRL 640
            +  N L   +P        L+V+ +S N L         + T L+ ++L  N  
Sbjct: 458 -ISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 79.8 bits (197), Expect = 2e-15
 Identities = 53/331 (16%), Positives = 111/331 (33%), Gaps = 51/331 (15%)

Query: 114 TLSASIAKLTELRTLSVPHNSFSGEIPAGV-GELRLLEVLELQGNNFSGKIPYQMSNLER 172
            +++    LT L+TL + +     EI       L  L  LE++  +        + ++  
Sbjct: 114 GVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRD 173

Query: 173 LRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFL 232
           +  L L  +  +  +         +  +++    L+           E  + +K      
Sbjct: 174 IHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLA-RFQFSPLPVDEVSSPMKKLAFRG 232

Query: 233 TE----------SIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISE--------LKVLD 274
           +            + + I +   ++      N L    P E   +SE        ++ L 
Sbjct: 233 SVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLH 292

Query: 275 VSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEV 334
           + +  L   +    +   K+           + ++NS+             L   +SLE 
Sbjct: 293 IPQFYLFYDLSTVYSLLEKVKR---------ITVENSK--VFLVPCSFSQHL---KSLEF 338

Query: 335 LWAPRANLGG-RLPDNWSESC-------SLKVLNLGQNSLKGAVPKSLGMC---RNLTYL 383
           L     +L    + + + ++        SL+ L L QN L+ ++ K+  +    +NLT L
Sbjct: 339 L-----DLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSL 392

Query: 384 DLSLNNLEGYLPMQLPVPCMVYFNVSQNNIT 414
           D+S N              M + N+S   I 
Sbjct: 393 DISRNTFHPMPDSCQWPEKMRFLNLSSTGIR 423

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 74.0 bits (182), Expect = 1e-13
 Identities = 54/352 (15%), Positives = 109/352 (30%), Gaps = 71/352 (20%)

Query: 111 ISGTLSASIAKLTELRTLSVPHNSFSGEIPAGV-GELRLLEVLELQGNNFSGKIPYQMSN 169
            S       A LT L  L +   S      +     +R +  L L  +  +  +      
Sbjct: 136 FSEIRRIDFAGLTSLNELEIKALSLR-NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADI 194

Query: 170 LERLRVLNLSFNSFSG----------------------------------EVPRGLIGNG 195
           L  +R L L   + +                                   ++ R ++   
Sbjct: 195 LSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELS 254

Query: 196 ELSVIDMSSNRL-------SGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKN 248
           E+   D + N L       S  ++     E   +  L +   +L   +         +K 
Sbjct: 255 EVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKR 314

Query: 249 LLLDGNILEGSIPKEIGT-ISELKVLDVSRNSLTDRI---PVELADCSKLSVLVLTN--I 302
           + ++ + +   +P      +  L+ LD+S N + +              L  LVL+   +
Sbjct: 315 ITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHL 373

Query: 303 DASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLG 362
                +  +                  ++L  L   R      +PD+      ++ LNL 
Sbjct: 374 R---SMQKTGEILLTL-----------KNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLS 418

Query: 363 QNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNIT 414
              ++  V   +   + L  LD+S NNL+    + L  P +    +S+N + 
Sbjct: 419 STGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSLFL--PRLQELYISRNKLK 464

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  138 bits (350), Expect = 3e-36
 Identities = 57/253 (22%), Positives = 107/253 (42%), Gaps = 36/253 (14%)

Query: 776  NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKNL 833
             +SI   IG+GG    ++       + A+K +++     Q +  +  EI  L +++  + 
Sbjct: 29   IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88

Query: 834  --VTLIGYYVGEAEMFLV--YNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
              + L  Y + +  +++V         +L +++ KK  K I          ++ +A+  +
Sbjct: 89   KIIRLYDYEITDQYIYMVMEC---GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTI 143

Query: 890  HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPE- 947
            H      IVH D+KP+N L+ +     L DFG+A  ++   T    D   GT  Y+ PE 
Sbjct: 144  HQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199

Query: 948  ----------YATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLL 997
                        +  ++S K+DV+S G +L  +  GK      F +  N       +KL 
Sbjct: 200  IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK----TPFQQIIN-----QISKLH 250

Query: 998  IKEGRSSELFLPE 1010
                 + E+  P+
Sbjct: 251  AIIDPNHEIEFPD 263

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  136 bits (346), Expect = 5e-36
 Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 12/204 (5%)

Query: 775 GNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRH 830
            +F I   +G G FG+ Y A E    +++A+K   K  + +     Q   E+     +RH
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            N++ L GY+     ++L+  +   G +  +   +   K           ++A AL+Y H
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTV--YRELQKLSKFDEQRTATYITELANALSYCH 126

Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
                R++HRDIKP N+LL       ++DFG +     S         GT  Y+ PE   
Sbjct: 127 SK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDL--CGTLDYLPPEMIE 180

Query: 951 TCRVSDKADVYSFGVVLLELISGK 974
                +K D++S GV+  E + GK
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGK 204

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  137 bits (346), Expect = 1e-35
 Identities = 53/220 (24%), Positives = 88/220 (40%), Gaps = 27/220 (12%)

Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
           ++     +G GGF      E L  G+  A+K++     Q  ++   E        H N++
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89

Query: 835 TLIGYYV----GEAEMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAY 888
            L+ Y +     + E +L+  F   G L   I   K  G  +    I  + + I + L  
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149

Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVA--------GT 940
           +H        HRD+KP+NILL +E    L D G      +    +   +          T
Sbjct: 150 IHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206

Query: 941 FGYVAPE------YATTCRVSDKADVYSFGVVLLELISGK 974
             Y APE      +   C + ++ DV+S G VL  ++ G+
Sbjct: 207 ISYRAPELFSVQSH---CVIDERTDVWSLGCVLYAMMFGE 243

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  139 bits (351), Expect = 1e-35
 Identities = 56/254 (22%), Positives = 106/254 (41%), Gaps = 36/254 (14%)

Query: 775  GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKN 832
              +SI   IG+GG    ++       + A+K +++     Q +  +  EI  L +++  +
Sbjct: 56   RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115

Query: 833  L--VTLIGYYVGEAEMFLV--YNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
               + L  Y + +  +++V         +L +++ KK  K I          ++ +A+  
Sbjct: 116  DKIIRLYDYEITDQYIYMVMEC---GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHT 170

Query: 889  LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPE 947
            +H      IVH D+KP+N L+ +     L DFG+A  ++   T    D   G   Y+ PE
Sbjct: 171  IHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226

Query: 948  -----------YATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKL 996
                         +  ++S K+DV+S G +L  +  GK      F +  N       +KL
Sbjct: 227  AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK----TPFQQIIN-----QISKL 277

Query: 997  LIKEGRSSELFLPE 1010
                  + E+  P+
Sbjct: 278  HAIIDPNHEIEFPD 291

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  136 bits (344), Expect = 1e-35
 Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 15/204 (7%)

Query: 779 IRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQG----IQQFDAEIGTLGRIRHKNL 833
           I + +G GG  + Y AE  +    VA+K + I   +     +++F+ E+    ++ H+N+
Sbjct: 15  IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFI-PPREKEETLKRFEREVHNSSQLSHQNI 73

Query: 834 VTLIGYYVGEAE--MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
           V++    V E +   +LV  ++ G  L  +I       +           I   + + H 
Sbjct: 74  VSM--IDVDEEDDCYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHD 129

Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT 951
               RIVHRDIKP NIL+D      + DFG+A+ L  +    T  V GT  Y +PE A  
Sbjct: 130 M---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG 186

Query: 952 CRVSDKADVYSFGVVLLELISGKR 975
               +  D+YS G+VL E++ G+ 
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEP 210

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  137 bits (346), Expect = 2e-35
 Identities = 57/253 (22%), Positives = 107/253 (42%), Gaps = 36/253 (14%)

Query: 776  NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKNL 833
             +SI   IG+GG    ++       + A+K +++     Q +  +  EI  L +++  + 
Sbjct: 10   IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69

Query: 834  --VTLIGYYVGEAEMFLV--YNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
              + L  Y + +  +++V         +L +++ KK  K I          ++ +A+  +
Sbjct: 70   KIIRLYDYEITDQYIYMVMEC---GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTI 124

Query: 890  HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFGYVAPE- 947
            H      IVH D+KP+N L+ +     L DFG+A  ++   T    D   GT  Y+ PE 
Sbjct: 125  HQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180

Query: 948  ----------YATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLL 997
                        +  ++S K+DV+S G +L  +  GK      F +  N       +KL 
Sbjct: 181  IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK----TPFQQIIN-----QISKLH 231

Query: 998  IKEGRSSELFLPE 1010
                 + E+  P+
Sbjct: 232  AIIDPNHEIEFPD 244

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  134 bits (340), Expect = 5e-35
 Identities = 58/231 (25%), Positives = 97/231 (41%), Gaps = 35/231 (15%)

Query: 772 RATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRH 830
           R   +F    ++G G FG   KA   +     A+KK+     + +    +E+  L  + H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNH 61

Query: 831 KNLVTLIGYYVGEAE-------------MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHK 877
           + +V     ++                 +F+   +   G L   IH +     Q     +
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWR 120

Query: 878 IAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE---------- 927
           +   I +AL+Y+H      I+HRD+KP NI +DE  N  + DFGLA+ +           
Sbjct: 121 LFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177

Query: 928 ----VSETHATTDVAGTFGYVAPE-YATTCRVSDKADVYSFGVVLLELISG 973
                S  + T+ + GT  YVA E    T   ++K D+YS G++  E+I  
Sbjct: 178 QNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  133 bits (338), Expect = 9e-35
 Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 17/220 (7%)

Query: 780 RNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           R ++G G +G  Y   +L     +A+K++     +  Q    EI     ++HKN+V  +G
Sbjct: 27  RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG 86

Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGK-KIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
            +     + +    + GG+L   +  K G  K     I      I + L YLH +   +I
Sbjct: 87  SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QI 143

Query: 898 VHRDIKPSNILLDEEL-NAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE--YATTCRV 954
           VHRDIK  N+L++       +SDFG ++ L        T   GT  Y+APE         
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGY 202

Query: 955 SDKADVYSFGVVLLELISGKRSLDPSFSEYGNG----FNI 990
              AD++S G  ++E+ +GK    P F E G      F +
Sbjct: 203 GKAADIWSLGCTIIEMATGK----PPFYELGEPQAAMFKV 238

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  132 bits (333), Expect = 6e-34
 Identities = 56/261 (21%), Positives = 98/261 (37%), Gaps = 26/261 (9%)

Query: 775  GNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQG-IQQFDAEIGTLGRIRHKN 832
              + + +++G G   + ++      G L A+K  +   F   +     E   L ++ HKN
Sbjct: 9    HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 833  LVTLIGYY--VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYL 889
            +V L             L+  F   G+L T + +  +   +  S    +  D+   + +L
Sbjct: 69   IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 890  HYSCVPRIVHRDIKPSNILL----DEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
              +    IVHR+IKP NI+     D +    L+DFG AR LE  E   +  + GT  Y+ 
Sbjct: 129  REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLH 183

Query: 946  PEYATTCRVSD--------KADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLL 997
            P+      +            D++S GV      +G       F  +            +
Sbjct: 184  PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS----LPFRPFEGPRRNKEVMYKI 239

Query: 998  IKEGRSSELFLPELWEAGPQE 1018
            I    S  +   +  E GP +
Sbjct: 240  ITGKPSGAISGVQKAENGPID 260

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  135 bits (341), Expect = 6e-34
 Identities = 65/287 (22%), Positives = 106/287 (36%), Gaps = 46/287 (16%)

Query: 776  NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRI-RHKNLV 834
            +F  ++++G G  G+     +     VAVK++    F    +   E+  L     H N++
Sbjct: 25   SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR---EVQLLRESDEHPNVI 81

Query: 835  TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
                        ++    L    L+ ++ +K    +    I  +       LA+LH    
Sbjct: 82   RYFCTEKDRQFQYIAIE-LCAATLQEYVEQKDFAHLGLEPIT-LLQQTTSGLAHLHSL-- 137

Query: 895  PRIVHRDIKPSNILLDE-----ELNAYLSDFGLARLLEV--SETHATTDVAGTFGYVAPE 947
              IVHRD+KP NIL+       ++ A +SDFGL + L V        + V GT G++APE
Sbjct: 138  -NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196

Query: 948  Y---ATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSS 1004
                      +   D++S G V   +IS        F +           +  I  G  S
Sbjct: 197  MLSEDCKENPTYTVDIFSAGCVFYYVISEGS---HPFGK-------SLQRQANILLGACS 246

Query: 1005 ELFLPELWEAGPQE--NLLGMMRLASTCTVETLST----RPSVKQVL 1045
             L      +        L+  M          ++     RPS K VL
Sbjct: 247  -LDCLHPEKHEDVIARELIEKM----------IAMDPQKRPSAKHVL 282

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  130 bits (330), Expect = 7e-34
 Identities = 51/204 (25%), Positives = 88/204 (43%), Gaps = 12/204 (5%)

Query: 775 GNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRH 830
            +F I   +G G FG+ Y A E    +++A+K   K  + +     Q   EI     +RH
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            N++ +  Y+     ++L+  F   G  E +   +   +           ++A AL Y H
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRG--ELYKELQKHGRFDEQRSATFMEELADALHYCH 131

Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
                +++HRDIKP N+L+  +    ++DFG +          T    GT  Y+ PE   
Sbjct: 132 ER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR-TM--CGTLDYLPPEMIE 185

Query: 951 TCRVSDKADVYSFGVVLLELISGK 974
                +K D++  GV+  E + G 
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGM 209

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  130 bits (330), Expect = 2e-33
 Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 21/210 (10%)

Query: 779 IRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQG----IQQFDAEIGTLGRIRHKNL 833
           +  ++G GG    + A  L     VAVK L             +F  E      + H  +
Sbjct: 16  LGEILGFGGMSEVHLARDLRDHRDVAVKVLRA-DLARDPSFYLRFRREAQNAAALNHPAI 74

Query: 834 VTLIGYYVGEAEM------FLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALA 887
           V +  Y  GEAE       ++V  ++ G  L   +H +    +      ++  D  QAL 
Sbjct: 75  VAV--YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALN 130

Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD--VAGTFGYVA 945
           + H +    I+HRD+KP+NI++       + DFG+AR +  S    T    V GT  Y++
Sbjct: 131 FSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187

Query: 946 PEYATTCRVSDKADVYSFGVVLLELISGKR 975
           PE A    V  ++DVYS G VL E+++G+ 
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  134 bits (338), Expect = 2e-33
 Identities = 63/196 (32%), Positives = 102/196 (52%), Gaps = 5/196 (2%)

Query: 777 FSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTL 836
             +   +G G FG  +         VA+K L  G     + F  E   + ++RH+ LV L
Sbjct: 186 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL 244

Query: 837 IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPR 896
               V E  +++V  ++S G+L  F+  ++GK ++   +  +A  IA  +AY+       
Sbjct: 245 YAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---N 300

Query: 897 IVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD 956
            VHRD++ +NIL+ E L   ++DFGLARL+E +E  A         + APE A   R + 
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 360

Query: 957 KADVYSFGVVLLELIS 972
           K+DV+SFG++L EL +
Sbjct: 361 KSDVWSFGILLTELTT 376

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  133 bits (338), Expect = 2e-33
 Identities = 89/557 (15%), Positives = 167/557 (29%), Gaps = 118/557 (21%)

Query: 118 SIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLN 177
                T L+      ++ + E+P     ++         + +    P        + V  
Sbjct: 6   RNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSR 64

Query: 178 LSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIP 237
           L                     +++++  LS             L  L  S N LT  +P
Sbjct: 65  LRDCLDRQ-----------AHELELNNLGLS-----SLPELPPHLESLVASCNSLT-ELP 107

Query: 238 KEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVL 297
           +     ++L     +   L    P        L+ L VS N L   +P EL + S L ++
Sbjct: 108 ELPQSLKSLLVDNNNLKALSDLPPL-------LEYLGVSNNQLEK-LP-ELQNSSFLKII 158

Query: 298 V-----LTNIDASL----DLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPD 348
                 L  +         +     +          EL     L  ++A   +L  +LPD
Sbjct: 159 DVDNNSLKKLPDLPPSLEFIAAGNNQLEELP-----ELQNLPFLTAIYADNNSL-KKLPD 212

Query: 349 NWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNV 408
                 SL+ +  G N L+      L     LT +    N L+  LP     P +   NV
Sbjct: 213 ---LPLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLP--PSLEALNV 264

Query: 409 SQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLF 468
             N +T +    ++++        +  ++ +                    +   +L   
Sbjct: 265 RDNYLTDLPELPQSLT---FLDVSENIFSGLS-------------------ELPPNL--- 299

Query: 469 AIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFL 528
                         Y L  ++N    S+     S    L+    N+S N L  +      
Sbjct: 300 --------------YYLNASSNEIR-SLCDLPPS----LEEL--NVSNNKLIELPAL--- 335

Query: 529 LDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLG 588
               +L    A+ N ++  +         L++L +  N +    PD    ++ L+     
Sbjct: 336 --PPRLERLIASFNHLA-EVPELPQ---NLKQLHVEYNPLR-EFPDIPESVEDLRM---- 384

Query: 589 GNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSF 648
            N+   E+P       +L  L +  N L    P        +E L +   R+      + 
Sbjct: 385 -NSHLAEVPELPQ---NLKQLHVETNPLR-EFPDIP---ESVEDLRMNSERVVDPYEFAH 436

Query: 649 STLVNLSALDLSFNNLS 665
            T   L       ++  
Sbjct: 437 ETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  130 bits (329), Expect = 3e-32
 Identities = 101/541 (18%), Positives = 181/541 (33%), Gaps = 126/541 (23%)

Query: 140 PAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSV 199
           P  V    L E L    +N + ++P +  N++       +++ +    P G     E++V
Sbjct: 5   PRNVSNTFLQEPL-RHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62

Query: 200 IDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGS 259
             +                      L+L++  L+ S+P+      +L++L+   N L   
Sbjct: 63  SRLRDCLDRQ------------AHELELNNLGLS-SLPELPP---HLESLVASCNSLT-E 105

Query: 260 IPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFD 319
           +P+   ++  L V + +  +L+D  P        L  L ++N        N   +     
Sbjct: 106 LPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSN--------NQLEKLP--- 147

Query: 320 GGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRN 379
                EL  S  L+++     N   +LPD      SL+ +  G N L+      L     
Sbjct: 148 -----ELQNSSFLKIIDV-DNNSLKKLPD---LPPSLEFIAAGNNQLE--ELPELQNLPF 196

Query: 380 LTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANV 439
           LT +    N+L+  LP       +       N +   LP  +N+          L     
Sbjct: 197 LTAIYADNNSLK-KLPDLP--LSLESIVAGNNILE-ELPELQNLPF--------LTTIYA 244

Query: 440 PVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGE 499
                              N  L +LP        L         L + +N     +P  
Sbjct: 245 -----------------DNNL-LKTLPDLP---PSLE-------ALNVRDNYLT-DLPEL 275

Query: 500 RISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQ 559
                  L     ++S N+ SG+S          L    A++N+I             L+
Sbjct: 276 -PQSLTFL-----DVSENIFSGLSELP-----PNLYYLNASSNEIRSLC----DLPPSLE 320

Query: 560 RLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGS 619
            L++  N++   LP    +L+ L   +   N+L  E+P       +L  L + +N L   
Sbjct: 321 ELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVPELPQ---NLKQLHVEYNPLR-E 371

Query: 620 IPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIP----HLQHLD 675
            P        L      ++ L+ E+P       NL  L +  N L    P     ++ L 
Sbjct: 372 FPDIPESVEDLRM----NSHLA-EVP---ELPQNLKQLHVETNPLR-EFPDIPESVEDLR 422

Query: 676 C 676
            
Sbjct: 423 M 423

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  108 bits (273), Expect = 4e-25
 Identities = 66/307 (21%), Positives = 107/307 (34%), Gaps = 47/307 (15%)

Query: 114 TLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERL 173
            L      L  L   +    + S   P       LLE L +  N    K+P ++ N   L
Sbjct: 105 ELPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFL 155

Query: 174 RVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLT 233
           +++++  NS   ++P        L  I   +N+L     +       FLT +   +N L 
Sbjct: 156 KIIDVDNNSLK-KLPDLP---PSLEFIAAGNNQLE---ELPELQNLPFLTAIYADNNSLK 208

Query: 234 ESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSK 293
             +P       +L++++   NIL      E+  +  L  +    N L   +P        
Sbjct: 209 -KLPDLPL---SLESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEA 261

Query: 294 LSVL--VLTNIDASL----DLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLP 347
           L+V    LT++         LD S   FS           L  +L  L A    +   L 
Sbjct: 262 LNVRDNYLTDLPELPQSLTFLDVSENIFSGLSE-------LPPNLYYLNASSNEI-RSLC 313

Query: 348 DNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFN 407
           D      SL+ LN+  N L   +P        L  L  S N+L   +P       +   +
Sbjct: 314 DLPP---SLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPELP--QNLKQLH 363

Query: 408 VSQNNIT 414
           V  N + 
Sbjct: 364 VEYNPLR 370

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 77.7 bits (192), Expect = 5e-15
 Identities = 38/204 (18%), Positives = 58/204 (28%), Gaps = 41/204 (20%)

Query: 114 TLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERL 173
            L      LT L       +  S   P        L  L    N     +     +LE  
Sbjct: 271 DLPELPQSLTFLDVSENIFSGLSELPPN-------LYYLNASSNEIR-SLCDLPPSLE-- 320

Query: 174 RVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLT 233
             LN+S N    E+P        L  +  S N L+     +     + L  L +  N L 
Sbjct: 321 -ELNVSNNKLI-ELPALP---PRLERLIASFNHLA-----EVPELPQNLKQLHVEYNPLR 370

Query: 234 ESIPKEIGK----------------CRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSR 277
              P                      +NLK L ++ N L    P    +   ++ L ++ 
Sbjct: 371 -EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPES---VEDLRMNS 425

Query: 278 NSLTDRIPVELADCSKLSVLVLTN 301
             + D          KL   V  +
Sbjct: 426 ERVVDPYEFAHETTDKLEDDVFEH 449

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 61.6 bits (150), Expect = 7e-10
 Identities = 28/167 (16%), Positives = 59/167 (35%), Gaps = 22/167 (13%)

Query: 115 LSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLR 174
           + +       L  L+V +N    E+PA    L   E L    N+ + ++P    NL   +
Sbjct: 309 IRSLCDLPPSLEELNVSNNKLI-ELPALPPRL---ERLIASFNHLA-EVPELPQNL---K 360

Query: 175 VLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTE 234
            L++ +N    E P       +L +    ++ L+     +     + L  L +  N L  
Sbjct: 361 QLHVEYNPLR-EFPDIPESVEDLRM----NSHLA-----EVPELPQNLKQLHVETNPLR- 409

Query: 235 SIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLT 281
             P       ++++L ++   +         T  +L+      +   
Sbjct: 410 EFPDIPE---SVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  129 bits (326), Expect = 3e-33
 Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 11/205 (5%)

Query: 775 GNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRH 830
            +F + NL+G G F   Y+A  +  G  VA+K   K ++ +   +Q+   E+    +++H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70

Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +++ L  Y+     ++LV      G +  ++  +     +    H +   I   + YLH
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH-QIITGMLYLH 129

Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV-SETHATTDVAGTFGYVAPEYA 949
                 I+HRD+  SN+LL   +N  ++DFGLA  L++  E H T    GT  Y++PE A
Sbjct: 130 SH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL--CGTPNYISPEIA 184

Query: 950 TTCRVSDKADVYSFGVVLLELISGK 974
           T      ++DV+S G +   L+ G+
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIGR 209

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  128 bits (325), Expect = 4e-33
 Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 13/206 (6%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRH 830
           +      +G G FGS       P     G +VAVKKL     + ++ F+ EI  L  ++H
Sbjct: 11  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 70

Query: 831 KNLVTLIG--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
            N+V   G  Y  G   + L+  +L  G+L  ++ +K  ++I    + +    I + + Y
Sbjct: 71  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEY 129

Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF--GYVAP 946
           L      R +HRD+   NIL++ E    + DFGL ++L   +        G     + AP
Sbjct: 130 LGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAP 186

Query: 947 EYATTCRVSDKADVYSFGVVLLELIS 972
           E  T  + S  +DV+SFGVVL EL +
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  133 bits (336), Expect = 6e-33
 Identities = 53/197 (26%), Positives = 99/197 (50%), Gaps = 5/197 (2%)

Query: 777 FSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
            ++++ +G G +G  Y+         VAVK L     + +++F  E   +  I+H NLV 
Sbjct: 222 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQ 280

Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
           L+G    E   +++  F++ GNL  ++ + + +++   V+  +A  I+ A+ YL      
Sbjct: 281 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK--- 337

Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVS 955
             +HR++   N L+ E     ++DFGL+RL+      A         + APE     + S
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 397

Query: 956 DKADVYSFGVVLLELIS 972
            K+DV++FGV+L E+ +
Sbjct: 398 IKSDVWAFGVLLWEIAT 414

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  128 bits (325), Expect = 6e-33
 Identities = 66/285 (23%), Positives = 103/285 (36%), Gaps = 54/285 (18%)

Query: 776  NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRI-RHK 831
            +F   + +G G +G  +K      G L AVK+        +   +  AE+G+  ++ +H 
Sbjct: 58   SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 832  NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
              V L   +     ++L    L G +L+    +  G  +  + +     D   ALA+LH 
Sbjct: 118  CCVRLEQAWEEGGILYLQ-TELCGPSLQQHC-EAWGASLPEAQVWGYLRDTLLALAHLHS 175

Query: 892  SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE---- 947
                 +VH D+KP+NI L       L DFGL   L      A     G   Y+APE    
Sbjct: 176  Q---GLVHLDVKPANIFLGPRGRCKLGDFGLLVEL--GTAGAGEVQEGDPRYMAPELLQG 230

Query: 948  -YATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSEL 1006
             Y         ADV+S G+ +LE+                      W +L          
Sbjct: 231  SY------GTAADVFSLGLTILEVACNM----ELP------HGGEGWQQLRQGY------ 268

Query: 1007 FLPELWEAGPQE--NLLGMMRLASTCTVETL----STRPSVKQVL 1045
              PE       E  ++L MM          L      R + + +L
Sbjct: 269  LPPEFTAGLSSELRSVLVMM----------LEPDPKLRATAEALL 303

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  133 bits (337), Expect = 7e-33
 Identities = 63/196 (32%), Positives = 102/196 (52%), Gaps = 5/196 (2%)

Query: 777 FSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTL 836
             +   +G G FG  +         VA+K L  G     + F  E   + ++RH+ LV L
Sbjct: 269 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQL 327

Query: 837 IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPR 896
               V E  +++V  ++S G+L  F+  ++GK ++   +  +A  IA  +AY+       
Sbjct: 328 YAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---N 383

Query: 897 IVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD 956
            VHRD++ +NIL+ E L   ++DFGLARL+E +E  A         + APE A   R + 
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 443

Query: 957 KADVYSFGVVLLELIS 972
           K+DV+SFG++L EL +
Sbjct: 444 KSDVWSFGILLTELTT 459

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  129 bits (326), Expect = 7e-33
 Identities = 49/202 (24%), Positives = 82/202 (40%), Gaps = 16/202 (7%)

Query: 780 RNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIG 838
           +  +G G FG  ++  +   G+  AVKK+ +  F+       E+     +    +V L G
Sbjct: 63  QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYG 117

Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV 898
                  + +    L GG+L   I  K    +             + L YLH     RI+
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLHTR---RIL 172

Query: 899 HRDIKPSNILLDEE-LNAYLSDFGLARLLEVSETHATT----DVAGTFGYVAPEYATTCR 953
           H D+K  N+LL  +   A L DFG A  L+      +      + GT  ++APE      
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 232

Query: 954 VSDKADVYSFGVVLLELISGKR 975
              K D++S   ++L +++G  
Sbjct: 233 CDAKVDIWSSCCMMLHMLNGCH 254

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  128 bits (324), Expect = 1e-32
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 13/206 (6%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRH 830
           +      +G G FGS       P     G +VAVKKL     + ++ F+ EI  L  ++H
Sbjct: 42  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 101

Query: 831 KNLVTLIG--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
            N+V   G  Y  G   + L+  +L  G+L  ++ +K  ++I    + +    I + + Y
Sbjct: 102 DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEY 160

Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF--GYVAP 946
           L      R +HRD+   NIL++ E    + DFGL ++L   + +      G     + AP
Sbjct: 161 LGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAP 217

Query: 947 EYATTCRVSDKADVYSFGVVLLELIS 972
           E  T  + S  +DV+SFGVVL EL +
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFT 243

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  130 bits (328), Expect = 1e-32
 Identities = 56/260 (21%), Positives = 98/260 (37%), Gaps = 26/260 (10%)

Query: 776  NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQG-IQQFDAEIGTLGRIRHKNL 833
             + + +++G G   + ++      G L A+K  +   F   +     E   L ++ HKN+
Sbjct: 10   LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI 69

Query: 834  VTLIGYY--VGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIAQALAYLH 890
            V L             L+  F   G+L T + +  +   +  S    +  D+   + +L 
Sbjct: 70   VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129

Query: 891  YSCVPRIVHRDIKPSNILL----DEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAP 946
             +    IVHR+IKP NI+     D +    L+DFG AR LE  E   +  + GT  Y+ P
Sbjct: 130  EN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHP 184

Query: 947  EYATTCRVSD--------KADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLI 998
            +      +            D++S GV      +G       F  +            +I
Sbjct: 185  DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS----LPFRPFEGPRRNKEVMYKII 240

Query: 999  KEGRSSELFLPELWEAGPQE 1018
                S  +   +  E GP +
Sbjct: 241  TGKPSGAISGVQKAENGPID 260

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  126 bits (318), Expect = 4e-32
 Identities = 52/226 (23%), Positives = 98/226 (43%), Gaps = 29/226 (12%)

Query: 772 RATGNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQ-GIQQFDAEIGTLGRIR 829
           R   +F     +G GGFG  ++A+  V     A+K++ +   +   ++   E+  L ++ 
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61

Query: 830 HKNLVTLIGYYVGEAEM------------FLVYNFLSGGNLETFIHKKSGKK-IQWSVIH 876
           H  +V     ++ +               ++        NL+ +++ +   +  + SV  
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 877 KIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD 936
            I + IA+A+ +LH      ++HRD+KPSNI    +    + DFGL   ++  E   T  
Sbjct: 122 HIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178

Query: 937 VA-----------GTFGYVAPEYATTCRVSDKADVYSFGVVLLELI 971
                        GT  Y++PE       S K D++S G++L EL+
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  128 bits (323), Expect = 5e-32
 Identities = 54/201 (26%), Positives = 89/201 (44%), Gaps = 9/201 (4%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL-VAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNL 833
           +  +   IG G FG  +   L      VAVK            +F  E   L +  H N+
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNI 174

Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
           V LIG    +  +++V   + GG+  TF+ +  G +++   + ++  D A  + YL    
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLESK- 232

Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGY--VAPEYATT 951
               +HRD+   N L+ E+    +SDFG++R       +A +           APE    
Sbjct: 233 --CCIHRDLAARNCLVTEKNVLKISDFGMSREEA-DGVYAASGGLRQVPVKWTAPEALNY 289

Query: 952 CRVSDKADVYSFGVVLLELIS 972
            R S ++DV+SFG++L E  S
Sbjct: 290 GRYSSESDVWSFGILLWETFS 310

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  125 bits (316), Expect = 7e-32
 Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 14/221 (6%)

Query: 759 ADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVP-GYLVAVK---KLSIGRFQG 814
           A    E+  D   R+   +     +G GGF   ++        + A K   K  + +   
Sbjct: 1   AKEIPEVLVDP--RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQ 58

Query: 815 IQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSV 874
            ++   EI     + H+++V   G++     +F+V       +L      K  K +    
Sbjct: 59  REKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPE 116

Query: 875 IHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV-SETHA 933
                  I     YLH +   R++HRD+K  N+ L+E+L   + DFGLA  +E   E   
Sbjct: 117 ARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK 173

Query: 934 TTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
                GT  Y+APE  +    S + DV+S G ++  L+ GK
Sbjct: 174 VL--CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  127 bits (320), Expect = 7e-32
 Identities = 35/220 (15%), Positives = 68/220 (30%), Gaps = 24/220 (10%)

Query: 776 NFSIRNLIGTGGFGSTYKAE------LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIR 829
              + +L+G G F   Y+A               +K                +  L    
Sbjct: 66  LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSM 125

Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKK---SGKKIQWSVIHKIAIDIAQAL 886
               +     ++ +    LV    S G L   I+       K +   ++   A+ +   +
Sbjct: 126 QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMI 185

Query: 887 AYLHYSCVPRIVHRDIKPSNILL-----------DEELNAYLSDFGLARLLEV-SETHAT 934
             +H      I+H DIKP N +L           D      L D G +  +++  +    
Sbjct: 186 EQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242

Query: 935 TDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
           T    T G+   E  +    + + D +     +  ++ G 
Sbjct: 243 TAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  126 bits (318), Expect = 1e-31
 Identities = 48/223 (21%), Positives = 89/223 (39%), Gaps = 25/223 (11%)

Query: 776 NFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIR-HKNL 833
              +R ++  GGF   Y+A+ +  G   A+K+L     +  +    E+  + ++  H N+
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88

Query: 834 VTLIGYYV--------GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
           V               G+AE  L+     G  +E     +S   +    + KI     +A
Sbjct: 89  VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148

Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVA------- 938
           + ++H    P I+HRD+K  N+LL  +    L DFG A  +     ++ +          
Sbjct: 149 VQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207

Query: 939 ----GTFGYVAPE---YATTCRVSDKADVYSFGVVLLELISGK 974
                T  Y  PE     +   + +K D+++ G +L  L   +
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  124 bits (314), Expect = 1e-31
 Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 20/208 (9%)

Query: 779 IRNLIGTGGFGSTYKAELVPGY---LVAVKKLSIG-RFQGIQQFDAEIGTLGRIRHKNLV 834
               +G G FGS  +           VA+K L  G      ++   E   + ++ +  +V
Sbjct: 14  ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73

Query: 835 TLIGYYVGEAE-MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL---H 890
            LIG  V +AE + LV     GG L  F+     ++I  S + ++   ++  + YL   +
Sbjct: 74  RLIG--VCQAEALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKN 130

Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF--GYVAPEY 948
           +      VHRD+   N+LL     A +SDFGL++ L   +++ T   AG +   + APE 
Sbjct: 131 F------VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 184

Query: 949 ATTCRVSDKADVYSFGVVLLELIS-GKR 975
               + S ++DV+S+GV + E +S G++
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALSYGQK 212

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  125 bits (317), Expect = 1e-31
 Identities = 51/205 (24%), Positives = 87/205 (42%), Gaps = 12/205 (5%)

Query: 775 GNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRH 830
             +     +G GGF   ++  +     + A K   K  + +    ++   EI     + H
Sbjct: 41  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100

Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
           +++V   G++     +F+V       +L      K  K +           I     YLH
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARYYLRQIVLGCQYLH 158

Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV-SETHATTDVAGTFGYVAPEYA 949
            +   R++HRD+K  N+ L+E+L   + DFGLA  +E   E        GT  Y+APE  
Sbjct: 159 RN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVL 213

Query: 950 TTCRVSDKADVYSFGVVLLELISGK 974
           +    S + DV+S G ++  L+ GK
Sbjct: 214 SKKGHSFEVDVWSIGCIMYTLLVGK 238

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  128 bits (323), Expect = 1e-31
 Identities = 54/196 (27%), Positives = 98/196 (50%), Gaps = 5/196 (2%)

Query: 777 FSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTL 836
             +   +G G FG  + A       VAVK +  G    ++ F AE   +  ++H  LV L
Sbjct: 190 LKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKL 248

Query: 837 IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPR 896
               V +  ++++  F++ G+L  F+    G K     +   +  IA+ +A++       
Sbjct: 249 HAV-VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---N 304

Query: 897 IVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD 956
            +HRD++ +NIL+   L   ++DFGLAR++E +E  A         + APE       + 
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 364

Query: 957 KADVYSFGVVLLELIS 972
           K+DV+SFG++L+E+++
Sbjct: 365 KSDVWSFGILLMEIVT 380

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  125 bits (316), Expect = 1e-31
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 13/206 (6%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRH 830
           +    + +G G FGS       P     G LVAVK+L        + F  EI  L  +  
Sbjct: 24  HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS 83

Query: 831 KNLVTLIG--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
             +V   G  Y  G   + LV  +L  G L  F+ ++   ++  S +   +  I + + Y
Sbjct: 84  DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICKGMEY 142

Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF--GYVAP 946
           L      R VHRD+   NIL++ E +  ++DFGLA+LL + + +      G     + AP
Sbjct: 143 LGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAP 199

Query: 947 EYATTCRVSDKADVYSFGVVLLELIS 972
           E  +    S ++DV+SFGVVL EL +
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFT 225

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  131 bits (330), Expect = 2e-31
 Identities = 54/214 (25%), Positives = 86/214 (40%), Gaps = 32/214 (14%)

Query: 775 GNFSIRNLIGTGGFGSTYKAE--LVPGYLVAVKKLSIGRFQG----IQQFDAEIGTLGRI 828
           G + ++  I  GG G  Y A    V G  V +K L      G         AE   L  +
Sbjct: 80  GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGL---VHSGDAEAQAMAMAERQFLAEV 136

Query: 829 RHKNLVTLIGYYVGEAE-------MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAID 881
            H ++V +  +   E          ++V  ++ G +L+       G+K+  +      ++
Sbjct: 137 VHPSIVQI--FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK----GQKLPVAEAIAYLLE 190

Query: 882 IAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF 941
           I  AL+YLH      +V+ D+KP NI+L EE    L D G    +      +   + GT 
Sbjct: 191 ILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN-----SFGYLYGTP 241

Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELISGKR 975
           G+ APE   T   +   D+Y+ G  L  L     
Sbjct: 242 GFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLP 274

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  130 bits (329), Expect = 2e-31
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 23/219 (10%)

Query: 772 RATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK----KLSIGRFQGIQQFDAEIGTLG 826
           +  G + ++  +GTGGFG   +      G  VA+K    +LS    +       EI  + 
Sbjct: 11  QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL---EIQIMK 67

Query: 827 RIRHKNLVTLI------GYYVGEAEMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIA 879
           ++ H N+V+                  L   +  GG+L  ++++  +   ++   I  + 
Sbjct: 68  KLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLL 127

Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY---LSDFGLARLLEVSETHATTD 936
            DI+ AL YLH +   RI+HRD+KP NI+L          + D G A+ L+      T  
Sbjct: 128 SDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEF 183

Query: 937 VAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKR 975
           V GT  Y+APE     + +   D +SFG +  E I+G R
Sbjct: 184 V-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  124 bits (313), Expect = 2e-31
 Identities = 59/209 (28%), Positives = 89/209 (42%), Gaps = 15/209 (7%)

Query: 783 IGTGGFGSTYKAELVP-----GYLVAVKKLSIG-RFQGIQQFDAEIGTLGRIRHKNLVTL 836
           +G G FG        P     G  VAVK L        I     EI  L  + H+N+V  
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88

Query: 837 IG--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
            G     G   + L+  FL  G+L+ ++  K+  KI      K A+ I + + YL     
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYLGSR-- 145

Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF--GYVAPEYATTC 952
            + VHRD+   N+L++ E    + DFGL + +E  + + T          + APE     
Sbjct: 146 -QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS 204

Query: 953 RVSDKADVYSFGVVLLELIS-GKRSLDPS 980
           +    +DV+SFGV L EL++       P 
Sbjct: 205 KFYIASDVWSFGVTLHELLTYCDSDSSPM 233

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  126 bits (319), Expect = 4e-31
 Identities = 59/245 (24%), Positives = 96/245 (39%), Gaps = 38/245 (15%)

Query: 777 FSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRI-RHKNLVT 835
                ++G G  G+        G  VAVK++ I           EI  L     H N++ 
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM---EIKLLTESDDHPNVIR 73

Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKS-----GKKIQWSVIHKIAIDIAQALAYLH 890
                  +  +++    L   NL+  +  K+      K  +      +   IA  +A+LH
Sbjct: 74  YYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132

Query: 891 YSCVPRIVHRDIKPSNILLD-------------EELNAYLSDFGLARLL---EVSETHAT 934
                +I+HRD+KP NIL+              E L   +SDFGL + L   + S     
Sbjct: 133 SL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189

Query: 935 TDVAGTFGYVAPE-------YATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNG 987
            + +GT G+ APE         T  R++   D++S G V   ++S  +   P   +Y   
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK--HPFGDKYSRE 247

Query: 988 FNIVS 992
            NI+ 
Sbjct: 248 SNIIR 252

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  122 bits (309), Expect = 4e-31
 Identities = 56/199 (28%), Positives = 100/199 (50%), Gaps = 9/199 (4%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
              +   +G G FG  +         VAVK L  G       F AE   + +++H+ LV 
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVR 72

Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
           L    V +  ++++  ++  G+L  F+   SG K+  + +  +A  IA+ +A++      
Sbjct: 73  LYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--- 128

Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGY--VAPEYATTCR 953
             +HRD++ +NIL+ + L+  ++DFGLARL+E  +   T      F     APE      
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIE--DNEYTAREGAKFPIKWTAPEAINYGT 186

Query: 954 VSDKADVYSFGVVLLELIS 972
            + K+DV+SFG++L E+++
Sbjct: 187 FTIKSDVWSFGILLTEIVT 205

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  123 bits (311), Expect = 4e-31
 Identities = 59/217 (27%), Positives = 93/217 (42%), Gaps = 30/217 (13%)

Query: 772 RATGNFS----IRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLG 826
             T N         ++G+G F   +   + + G L A+K +           + EI  L 
Sbjct: 2   MQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLK 61

Query: 827 RIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-------KIA 879
           +I+H+N+VTL   Y      +LV   +SGG L   I ++                   + 
Sbjct: 62  KIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG---------VYTEKDASLVI 112

Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILL---DEELNAYLSDFGLARLLEVSETHATTD 936
             +  A+ YLH +    IVHRD+KP N+L    +E     ++DFGL+++    +    + 
Sbjct: 113 QQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME---QNGIMST 166

Query: 937 VAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
             GT GYVAPE       S   D +S GV+   L+ G
Sbjct: 167 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  125 bits (316), Expect = 4e-31
 Identities = 57/245 (23%), Positives = 91/245 (37%), Gaps = 26/245 (10%)

Query: 749 SLRGQVMVTFADTPAELTYDNVVRATGN-----------------FSIRNLIGTGGFGST 791
              G  +    D P    YD                         + I   +G+G FG  
Sbjct: 8   HHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVV 67

Query: 792 YKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVY 850
           ++  E   G +   K ++            EI  + ++ H  L+ L   +  + EM L+ 
Sbjct: 68  HRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127

Query: 851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLD 910
            FLSGG L   I  +   K+  + +        + L ++H      IVH DIKP NI+ +
Sbjct: 128 EFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCE 183

Query: 911 EELNAYL--SDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLL 968
            +  + +   DFGLA  L             T  + APE      V    D+++ GV+  
Sbjct: 184 TKKASSVKIIDFGLATKLN--PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGY 241

Query: 969 ELISG 973
            L+SG
Sbjct: 242 VLLSG 246

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  125 bits (314), Expect = 6e-31
 Identities = 31/272 (11%), Positives = 73/272 (26%), Gaps = 44/272 (16%)

Query: 740 RRRKFGRIASLRGQVMVTFADTPAELTYDNVV-RATGNFSIRNLIGTGGFGSTYKA-ELV 797
           R       A++   V  T     AE T D+++ +      +   +  G     +   ++ 
Sbjct: 26  REEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVE 85

Query: 798 PGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKNLVTLIGYY-------------- 840
                A+K  ++G       +++         R+  ++                      
Sbjct: 86  RLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQ 145

Query: 841 ------VGEAEMFLVYNF-----LSGGNLETFIHK-----KSGKKIQWSVIHKIAIDIAQ 884
                     + + V N+      +  +LE                    +H +   + +
Sbjct: 146 PPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIR 205

Query: 885 ALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYV 944
             A L       +VH    P N+ +  +    L D                  +    Y 
Sbjct: 206 LAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALW----KVGTRGPASSVPVTYA 258

Query: 945 APEY--ATTCRVSDKADVYSFGVVLLELISGK 974
             E+  A+T   +   + +  G+ +  +    
Sbjct: 259 PREFLNASTATFTHALNAWQLGLSIYRVWCLF 290

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  122 bits (308), Expect = 1e-30
 Identities = 59/225 (26%), Positives = 102/225 (45%), Gaps = 19/225 (8%)

Query: 759 ADTPAELTYDNVVRATGN----FSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSI---- 809
           A +P +     +     +    F+    IG G FG  +K  +     +VA+K + +    
Sbjct: 2   AHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE 61

Query: 810 GRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK 869
              + IQQ   EI  L +     +    G Y+ + +++++  +L GG+    +       
Sbjct: 62  DEIEDIQQ---EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG---P 115

Query: 870 IQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS 929
           +  + I  I  +I + L YLH     + +HRDIK +N+LL E     L+DFG+A  L  +
Sbjct: 116 LDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172

Query: 930 ETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
           +    T   GT  ++APE         KAD++S G+  +EL  G+
Sbjct: 173 QIKRNT-FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 216

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  121 bits (307), Expect = 1e-30
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 22/205 (10%)

Query: 783 IGTGGFGSTYKAELVPGYL---VAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKNLVTLI 837
           +G+G FG+  K       +   VAVK L           +  AE   + ++ +  +V +I
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84

Query: 838 GYYVGEAE-MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL---HYSC 893
           G  + EAE   LV      G L  ++  +  + ++   I ++   ++  + YL   ++  
Sbjct: 85  G--ICEAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEESNF-- 138

Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF--GYVAPEYATT 951
               VHRD+   N+LL  +  A +SDFGL++ L   E +      G +   + APE    
Sbjct: 139 ----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 194

Query: 952 CRVSDKADVYSFGVVLLELIS-GKR 975
            + S K+DV+SFGV++ E  S G++
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQK 219

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  126 bits (319), Expect = 2e-30
 Identities = 58/224 (25%), Positives = 93/224 (41%), Gaps = 13/224 (5%)

Query: 757 TFADTPAELTYDNVVRATGNFS----IRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGR 811
              D   +     V     +      I   +GTG FG  ++  E   G   A K +    
Sbjct: 135 YVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH 194

Query: 812 FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQ 871
               +    EI T+  +RH  LV L   +  + EM ++Y F+SGG L   +  +  K  +
Sbjct: 195 ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE 254

Query: 872 WSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYL--SDFGLARLLEVS 929
              +      + + L ++H +     VH D+KP NI+   + +  L   DFGL   L+  
Sbjct: 255 DEAVE-YMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310

Query: 930 ETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
           ++       GT  + APE A    V    D++S GV+   L+SG
Sbjct: 311 QS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  120 bits (303), Expect = 2e-30
 Identities = 53/206 (25%), Positives = 88/206 (42%), Gaps = 22/206 (10%)

Query: 777 FSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
           +++ N IG G +G    A +       A KK+     + + +F  EI  +  + H N++ 
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70

Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
           L   +    +++LV    +GG L   +  K  +  + S   +I  D+  A+AY H     
Sbjct: 71  LYETFEDNTDIYLVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKL--- 125

Query: 896 RIVHRDIKPSNILL---DEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE----- 947
            + HRD+KP N L      +    L DFGLA   +           GT  YV+P+     
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK--PGKMMRTKVGTPYYVSPQVLEGL 183

Query: 948 YATTCRVSDKADVYSFGVVLLELISG 973
           Y        + D +S GV++  L+ G
Sbjct: 184 Y------GPECDEWSAGVMMYVLLCG 203

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  121 bits (306), Expect = 3e-30
 Identities = 57/218 (26%), Positives = 90/218 (41%), Gaps = 17/218 (7%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIR 829
                  +G G FG        P     G +VAVK L      Q    +  EI  L  + 
Sbjct: 32  YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLY 91

Query: 830 HKNLVTLIG--YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALA 887
           H++++   G     G A + LV  ++  G+L  ++ +     I  + +   A  I + +A
Sbjct: 92  HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMA 148

Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF--GYVA 945
           YLH       +HRD+   N+LLD +    + DFGLA+ +     +      G     + A
Sbjct: 149 YLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 205

Query: 946 PEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFS 982
           PE     +    +DV+SFGV L EL++    S  P   
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK 243

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  122 bits (308), Expect = 3e-30
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 15/203 (7%)

Query: 777 FSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSI----GRFQGIQQFDAEIGTLGRIRHK 831
           F   + +G G  G  +K    P G ++A K + +         I +   E+  L      
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR---ELQVLHECNSP 91

Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
            +V   G +  + E+ +    + GG+L+  +  K   +I   ++ K++I + + L YL  
Sbjct: 92  YIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLRE 149

Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT 951
               +I+HRD+KPSNIL++      L DFG++  L   ++ A +   GT  Y++PE    
Sbjct: 150 KH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANS-FVGTRSYMSPERLQG 204

Query: 952 CRVSDKADVYSFGVVLLELISGK 974
              S ++D++S G+ L+E+  G+
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGR 227

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  120 bits (304), Expect = 3e-30
 Identities = 54/199 (27%), Positives = 106/199 (53%), Gaps = 8/199 (4%)

Query: 777 FSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
           ++    IG G  G+ Y A ++  G  VA++++++ +    +    EI  +   ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
            +  Y+   E+++V  +L+GG+L   + +    + Q   I  +  +  QAL +LH +   
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ---IAAVCRECLQALEFLHSN--- 135

Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVS 955
           +++HRDIK  NILL  + +  L+DFG    +   ++  +T + GT  ++APE  T     
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYG 194

Query: 956 DKADVYSFGVVLLELISGK 974
            K D++S G++ +E+I G+
Sbjct: 195 PKVDIWSLGIMAIEMIEGE 213

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  120 bits (303), Expect = 4e-30
 Identities = 53/210 (25%), Positives = 85/210 (40%), Gaps = 15/210 (7%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL----VAVKKLSIGRFQGIQQFDA---EIGTLGRI 828
           +  +   +G G FG   + E          VAVK L        +  D    E+  +  +
Sbjct: 19  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 78

Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
            H+NL+ L G  +    M +V      G+L   + K  G       + + A+ +A+ + Y
Sbjct: 79  DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGY 136

Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGY--VAP 946
           L      R +HRD+   N+LL       + DFGL R L  ++ H          +   AP
Sbjct: 137 LESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 193

Query: 947 EYATTCRVSDKADVYSFGVVLLELIS-GKR 975
           E   T   S  +D + FGV L E+ + G+ 
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  120 bits (304), Expect = 5e-30
 Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 10/203 (4%)

Query: 774 TGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSI-GRFQGIQQFDAEIGTLGRIRHK 831
              F +   +G G +GS YKA     G +VA+K++ +    Q I +   EI  + +    
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIK---EISIMQQCDSP 84

Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
           ++V   G Y    ++++V  +   G++ + I +   K +    I  I     + L YLH+
Sbjct: 85  HVVKYYGSYFKNTDLWIVMEYCGAGSV-SDIIRLRNKTLTEDEIATILQSTLKGLEYLHF 143

Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT 951
               R +HRDIK  NILL+ E +A L+DFG+A  L  +     T + GT  ++APE    
Sbjct: 144 M---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQE 199

Query: 952 CRVSDKADVYSFGVVLLELISGK 974
              +  AD++S G+  +E+  GK
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGK 222

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  119 bits (301), Expect = 5e-30
 Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 16/206 (7%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
             +    IG+G FG  +    +    VA+K +  G     + F  E   + ++ H  LV 
Sbjct: 9   ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQ 67

Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL---HYS 892
           L G  + +A + LV  F+  G L  ++ +          +  + +D+ + +AYL      
Sbjct: 68  LYGVCLEQAPICLVTEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLEEACV- 125

Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGY--VAPEYAT 950
                +HRD+   N L+ E     +SDFG+ R +   +   T+     F     +PE  +
Sbjct: 126 -----IHRDLAARNCLVGENQVIKVSDFGMTRFVL--DDQYTSSTGTKFPVKWASPEVFS 178

Query: 951 TCRVSDKADVYSFGVVLLELIS-GKR 975
             R S K+DV+SFGV++ E+ S GK 
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKI 204

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  119 bits (300), Expect = 6e-30
 Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 15/202 (7%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
             ++   +G+G FG     +    Y VAVK +  G      +F  E  T+ ++ H  LV 
Sbjct: 9   EITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLVK 67

Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL---HYS 892
             G    E  +++V  ++S G L  ++ +  GK ++ S + ++  D+ + +A+L    + 
Sbjct: 68  FYGVCSKEYPIYIVTEYISNGCLLNYL-RSHGKGLEPSQLLEMCYDVCEGMAFLESHQF- 125

Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGY--VAPEYAT 950
                +HRD+   N L+D +L   +SDFG+ R +   +    + V   F     APE   
Sbjct: 126 -----IHRDLAARNCLVDRDLCVKVSDFGMTRYVL--DDQYVSSVGTKFPVKWSAPEVFH 178

Query: 951 TCRVSDKADVYSFGVVLLELIS 972
             + S K+DV++FG+++ E+ S
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFS 200

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  119 bits (301), Expect = 7e-30
 Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 23/209 (11%)

Query: 777 FSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQG-IQQFDAEIGTLGRIRHKNLV 834
           F  +  +G+G FG  +   E   G    +K ++  R Q  ++Q +AEI  L  + H N++
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83

Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS--VIHKIAIDIAQALAYLHYS 892
            +   +     M++V     GG L   I     +    S   + ++   +  ALAY H  
Sbjct: 84  KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143

Query: 893 CVPRIVHRDIKPSNILL---DEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE-- 947
               +VH+D+KP NIL           + DFGLA L +  E    T+ AGT  Y+APE  
Sbjct: 144 ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TNAAGTALYMAPEVF 198

Query: 948 ---YATTCRVSDKADVYSFGVVLLELISG 973
                     + K D++S GVV+  L++G
Sbjct: 199 KRDV------TFKCDIWSAGVVMYFLLTG 221

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  120 bits (303), Expect = 9e-30
 Identities = 46/225 (20%), Positives = 85/225 (37%), Gaps = 31/225 (13%)

Query: 775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLS-----------------IGRFQGIQQ 817
            ++ I   +  G F      E       A+KK                   I        
Sbjct: 31  NDYRIIRTLNQGKFNKIILCEKD-NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 818 FDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS---- 873
           F  E+  +  I+++  +T  G      E++++Y ++   ++  F          ++    
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149

Query: 874 --VIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET 931
             VI  I   +  + +Y+H      I HRD+KPSNIL+D+     LSDFG +  +   + 
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207

Query: 932 HATTDVAGTFGYVAPE--YATTCRVSDKADVYSFGVVLLELISGK 974
              +   GT+ ++ PE     +     K D++S G+ L  +    
Sbjct: 208 K-GS--RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  124 bits (313), Expect = 1e-29
 Identities = 52/199 (26%), Positives = 91/199 (45%), Gaps = 17/199 (8%)

Query: 783 IGTGGFGSTYKAELVPG---YLVAVKKLSIGRFQGIQQ-FDAEIGTLGRIRHKNLVTLIG 838
           +G G FGS  +           VA+K L  G  +   +    E   + ++ +  +V LIG
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL---HYSCVP 895
                  + LV     GG L  F+     ++I  S + ++   ++  + YL   ++    
Sbjct: 404 V-CQAEALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNF---- 457

Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGY--VAPEYATTCR 953
             VHR++   N+LL     A +SDFGL++ L   +++ T   AG +     APE     +
Sbjct: 458 --VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515

Query: 954 VSDKADVYSFGVVLLELIS 972
            S ++DV+S+GV + E +S
Sbjct: 516 FSSRSDVWSYGVTMWEALS 534

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  118 bits (299), Expect = 1e-29
 Identities = 55/200 (27%), Positives = 100/200 (50%), Gaps = 9/200 (4%)

Query: 776 NFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
           + ++++ +G G +G  Y+         VAVK L     + +++F  E   +  I+H NLV
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 72

Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
            L+G    E   +++  F++ GNL  ++ + + +++   V+  +A  I+ A+ YL     
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK-- 130

Query: 895 PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGY--VAPEYATTC 952
              +HRD+   N L+ E     ++DFGL+RL+      A       F     APE     
Sbjct: 131 -NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG--AKFPIKWTAPESLAYN 187

Query: 953 RVSDKADVYSFGVVLLELIS 972
           + S K+DV++FGV+L E+ +
Sbjct: 188 KFSIKSDVWAFGVLLWEIAT 207

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  120 bits (303), Expect = 1e-29
 Identities = 75/445 (16%), Positives = 137/445 (30%), Gaps = 101/445 (22%)

Query: 222 LTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLT 281
              L      + +  P            +L    +   +      +  +  L V+   + 
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57

Query: 282 DRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRAN 341
             I   +   + L  L L          N   + S                         
Sbjct: 58  S-IQ-GIEYLTNLEYLNLNG--------NQITDISPL----------------------- 84

Query: 342 LGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPM-QLPV 400
               L         L  L +G N +      +L    NL  L L+ +N+    P+  L  
Sbjct: 85  --SNLV-------KLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNISDISPLANLT- 132

Query: 401 PCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNK 460
             M   N+  N+    L    N           L Y  V        E+   + D +   
Sbjct: 133 -KMYSLNLGANHNLSDLSPLSN--------MTGLNYLTV-------TESK--VKDVTPIA 174

Query: 461 FLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLS 520
            L  L                 Y L LN N      P   ++    L  F      N ++
Sbjct: 175 NLTDL-----------------YSLSLNYNQIEDISP---LASLTSLHYF--TAYVNQIT 212

Query: 521 GMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLK 580
            ++    + +  +L   +  NN+I+      +  L +L  L++  N++S    + +  L 
Sbjct: 213 DIT---PVANMTRLNSLKIGNNKITDLS--PLANLSQLTWLEIGTNQISD--INAVKDLT 265

Query: 581 FLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRL 640
            LK + +G N ++    S   +L  L  L L++N L       +   T L +LFL+ N +
Sbjct: 266 KLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHI 323

Query: 641 SGEIPVSFSTLVNLSALDLSFNNLS 665
           +   P   ++L  + + D +   + 
Sbjct: 324 TDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  107 bits (270), Expect = 3e-25
 Identities = 58/296 (19%), Positives = 108/296 (36%), Gaps = 33/296 (11%)

Query: 119 IAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNL 178
           ++ L +L  L +  N  +    + +  L  L  L L  +N S   P  ++NL ++  LNL
Sbjct: 84  LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNL 139

Query: 179 SFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPK 238
             N         L     L+ + ++ +++     +   +    L  L L+ N + +  P 
Sbjct: 140 GANHNLS-DLSPLSNMTGLNYLTVTESKVKD---VTPIANLTDLYSLSLNYNQIEDISP- 194

Query: 239 EIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLV 298
            +    +L       N +    P  +  ++ L  L +  N +TD  P  LA+ S+L+ L 
Sbjct: 195 -LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLE 249

Query: 299 LTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKV 358
           +          N   + +A              L++L      +        +    L  
Sbjct: 250 IGT--------NQISDINAVKD--------LTKLKMLNVGSNQISD--ISVLNNLSQLNS 291

Query: 359 LNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNIT 414
           L L  N L     + +G   NLT L LS N++    P+   +  M   + +   I 
Sbjct: 292 LFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLA-SLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  106 bits (266), Expect = 9e-25
 Identities = 70/331 (21%), Positives = 122/331 (36%), Gaps = 55/331 (16%)

Query: 355 SLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNIT 414
           +L+ LNL  N +       L     LT L +  N +     +Q  +  +    ++++NI+
Sbjct: 67  NLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKITDISALQ-NLTNLRELYLNEDNIS 123

Query: 415 GVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGF 474
            + P   N           +   N+         N   + D S    +  L         
Sbjct: 124 DISP-LAN--------LTKMYSLNL-------GANH-NLSDLSPLSNMTGL--------- 157

Query: 475 LAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQL 534
                     L +  +      P   I+   DL S   +L+ N +  +S    L     L
Sbjct: 158 --------NYLTVTESKVKDVTP---IANLTDLYSL--SLNYNQIEDIS---PLASLTSL 201

Query: 535 VEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTG 594
             F A  NQI+      V  + +L  L +  N+++      L  L  L W+ +G N ++ 
Sbjct: 202 HYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDL--SPLANLSQLTWLEIGTNQISD 257

Query: 595 EIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNL 654
              +    L  L +L++  N ++    + L   ++L SLFL +N+L  E       L NL
Sbjct: 258 --INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNL 313

Query: 655 SALDLSFNNLSGHIP--HLQHLDCIAFKGNK 683
           + L LS N+++   P   L  +D   F    
Sbjct: 314 TTLFLSQNHITDIRPLASLSKMDSADFANQV 344

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  103 bits (258), Expect = 8e-24
 Identities = 75/446 (16%), Positives = 138/446 (30%), Gaps = 102/446 (22%)

Query: 149 LEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLS 208
              L       +   P   ++L       L   S +  V +  + +  ++ + ++  +++
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVTQEELES--ITKLVVAGEKVA 57

Query: 209 GGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTIS 268
               I        L YL L+ N +T+  P  +     L NL +  N +  +    +  ++
Sbjct: 58  S---IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLT 110

Query: 269 ELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLL 328
            L+ L ++ ++++D  P  LA+ +K+  L L                             
Sbjct: 111 NLRELYLNEDNISDISP--LANLTKMYSLNLGA--------------------------- 141

Query: 329 SRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLN 388
                       N         S    L  L + ++ +K   P  +    +L  L L+ N
Sbjct: 142 ------------NHNLSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYN 187

Query: 389 NLEGYLPM-QLPVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISD 447
            +E   P+  L    + YF    N IT  +    N           L    +        
Sbjct: 188 QIEDISPLASLTS--LHYFTAYVNQITD-ITPVAN--------MTRLNSLKI-------G 229

Query: 448 ENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDL 507
            N   I D S    L  L                   L +  N  +  +    +     L
Sbjct: 230 NNK--ITDLSPLANLSQL-----------------TWLEIGTNQIS-DINA--VKDLTKL 267

Query: 508 QSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNR 567
           +    N+ +N +S +S    L +  QL      NNQ+       +G L  L  L L  N 
Sbjct: 268 KML--NVGSNQISDIS---VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH 322

Query: 568 VSGSLPDELGKLKFLKWILLGGNNLT 593
           ++   P  L  L  +         + 
Sbjct: 323 ITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  102 bits (257), Expect = 1e-23
 Identities = 56/327 (17%), Positives = 102/327 (31%), Gaps = 60/327 (18%)

Query: 355 SLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNIT 414
                 L + S+      +     ++T L ++   +     ++     + Y N++ N IT
Sbjct: 23  EGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVASIQGIEYL-TNLEYLNLNGNQIT 79

Query: 415 GVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGF 474
            + P   N           L          I       I        L +L         
Sbjct: 80  DISP-LSN--------LVKLTNLY------IGTNKITDISALQN---LTNL--------- 112

Query: 475 LAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQL 534
                     L LN +  +   P   ++    + S   NL AN        + L +   L
Sbjct: 113 --------RELYLNEDNISDISP---LANLTKMYSL--NLGANHNLSDL--SPLSNMTGL 157

Query: 535 VEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTG 594
                  +++       +  L  L  L L  N++       L  L  L +     N +T 
Sbjct: 158 NYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDI--SPLASLTSLHYFTAYVNQITD 213

Query: 595 EIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNL 654
             P    ++  L  L + +N +T   P  L   ++L  L +  N++S  I  +   L  L
Sbjct: 214 ITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD-IN-AVKDLTKL 267

Query: 655 SALDLSFNNLS-----GHIPHLQHLDC 676
             L++  N +S      ++  L  L  
Sbjct: 268 KMLNVGSNQISDISVLNNLSQLNSLFL 294

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 99.5 bits (249), Expect = 1e-22
 Identities = 67/316 (21%), Positives = 114/316 (36%), Gaps = 41/316 (12%)

Query: 118 SIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLN 177
           +  +L  +  L V     +  I  G+  L  LE L L GN  +   P  +SNL +L  L 
Sbjct: 39  TQEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLY 94

Query: 178 LSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIP 237
           +  N  +      L     L  + ++ + +S    I   +    +  L L  N    S  
Sbjct: 95  IGTNKITD--ISALQNLTNLRELYLNEDNISD---ISPLANLTKMYSLNLGANHNL-SDL 148

Query: 238 KEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVL 297
             +     L  L +  + ++   P  I  +++L  L ++ N + D  P  LA  + L   
Sbjct: 149 SPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYF 204

Query: 298 VL-----TNIDA--------SLDLDNSR-GEFSAFDGGVPYELLLSRSLEVLWAPRANLG 343
                  T+I          SL + N++  + S           LS  L  L      + 
Sbjct: 205 TAYVNQITDITPVANMTRLNSLKIGNNKITDLSPLAN-------LS-QLTWLEIGTNQIS 256

Query: 344 GRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQL-PVPC 402
               +   +   LK+LN+G N +       L     L  L L+ N L       +  +  
Sbjct: 257 D--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTN 312

Query: 403 MVYFNVSQNNITGVLP 418
           +    +SQN+IT + P
Sbjct: 313 LTTLFLSQNHITDIRP 328

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 98.0 bits (245), Expect = 5e-22
 Identities = 48/316 (15%), Positives = 107/316 (33%), Gaps = 41/316 (12%)

Query: 118 SIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLN 177
             A L E     +   S +  +     EL  +  L + G   +  I   +  L  L  LN
Sbjct: 17  PDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLN 72

Query: 178 LSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIP 237
           L+ N  +   P  L    +L+ + + +N+++    I +      L  L L+++ +++  P
Sbjct: 73  LNGNQITDISP--LSNLVKLTNLYIGTNKITD---ISALQNLTNLRELYLNEDNISDISP 127

Query: 238 KEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVL 297
             +     + +L L  N    S    +  ++ L  L V+ + + D  P  +A+ + L  L
Sbjct: 128 --LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSL 182

Query: 298 VL-----TNIDA--------SLDLDNSR-GEFSAFDGGVPYELLLSRSLEVLWAPRANLG 343
            L      +I                ++  + +           ++  L  L      + 
Sbjct: 183 SLNYNQIEDISPLASLTSLHYFTAYVNQITDITPVAN-------MT-RLNSLKIGNNKIT 234

Query: 344 GRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCM 403
                  +    L  L +G N +      ++     L  L++  N +   + +   +  +
Sbjct: 235 D--LSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD-ISVLNNLSQL 289

Query: 404 VYFNVSQNNITGVLPR 419
               ++ N +      
Sbjct: 290 NSLFLNNNQLGNEDME 305

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 95.7 bits (239), Expect = 3e-21
 Identities = 41/202 (20%), Positives = 85/202 (42%), Gaps = 19/202 (9%)

Query: 484 RLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQ 543
           +L++       S+ G  I    +L+   +NL+ N ++ +S    L + V+L       N+
Sbjct: 48  KLVVAGEKVA-SIQG--IEYLTNLEY--LNLNGNQITDIS---PLSNLVKLTNLYIGTNK 99

Query: 544 ISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHL 603
           I+    + +  L  L+ L L  + +S      L  L  +  + LG N+   ++     ++
Sbjct: 100 IT--DISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLSP-LSNM 154

Query: 604 ISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNN 663
             L  L ++ + +    P  +   T L SL L +N++    P   ++L +L       N 
Sbjct: 155 TGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQ 210

Query: 664 LSGHIP--HLQHLDCIAFKGNK 683
           ++   P  ++  L+ +    NK
Sbjct: 211 ITDITPVANMTRLNSLKIGNNK 232

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 92.6 bits (231), Expect = 3e-20
 Identities = 48/274 (17%), Positives = 95/274 (34%), Gaps = 54/274 (19%)

Query: 118 SIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLN 177
            +A LT++ +L++  N    ++   +  +  L  L +  +      P  ++NL  L  L+
Sbjct: 127 PLANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLS 183

Query: 178 LSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIP 237
           L++N      P  L     L       N+++    I   +    L  LK+ +N +T+  P
Sbjct: 184 LNYNQIEDISP--LASLTSLHYFTAYVNQITD---ITPVANMTRLNSLKIGNNKITDLSP 238

Query: 238 KEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVL 297
             +     L  L +  N +       +  +++LK+L+V  N ++D     ++  + LS  
Sbjct: 239 --LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD-----ISVLNNLS-- 287

Query: 298 VLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLK 357
                                             L  L+     LG    +      +L 
Sbjct: 288 ---------------------------------QLNSLFLNNNQLGNEDMEVIGGLTNLT 314

Query: 358 VLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLE 391
            L L QN +    P  L     +   D +   ++
Sbjct: 315 TLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 91.8 bits (229), Expect = 5e-20
 Identities = 33/188 (17%), Positives = 74/188 (39%), Gaps = 13/188 (6%)

Query: 114 TLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERL 173
           +  + ++ +T L  L+V  +      P  +  L  L  L L  N      P  +++L  L
Sbjct: 146 SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSL 201

Query: 174 RVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLT 233
                  N  +   P  +     L+ + + +N+++    +   +    LT+L++  N ++
Sbjct: 202 HYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD---LSPLANLSQLTWLEIGTNQIS 256

Query: 234 ESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSK 293
           +     +     LK L +  N +       +  +S+L  L ++ N L +     +   + 
Sbjct: 257 D--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTN 312

Query: 294 LSVLVLTN 301
           L+ L L+ 
Sbjct: 313 LTTLFLSQ 320

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 89.9 bits (224), Expect = 2e-19
 Identities = 30/147 (20%), Positives = 64/147 (43%), Gaps = 10/147 (6%)

Query: 528 LLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILL 587
             D  + +        ++  +     +L  + +L + G +V+ S+   +  L  L+++ L
Sbjct: 18  DADLAEGIRAVLQKASVTDVV--TQEELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNL 73

Query: 588 GGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVS 647
            GN +T   P    +L+ L  L +  N +T    ++L   T L  L+L  + +S   P  
Sbjct: 74  NGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISDISP-- 127

Query: 648 FSTLVNLSALDLSFNNLSGHIPHLQHL 674
            + L  + +L+L  N+    +  L ++
Sbjct: 128 LANLTKMYSLNLGANHNLSDLSPLSNM 154

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 63.3 bits (155), Expect = 1e-10
 Identities = 24/117 (20%), Positives = 48/117 (41%), Gaps = 7/117 (5%)

Query: 118 SIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLN 177
            +A L++L  L +  N  S      V +L  L++L +  N  S      ++NL +L  L 
Sbjct: 238 PLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISDISV--LNNLSQLNSLF 293

Query: 178 LSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTE 234
           L+ N    E    + G   L+ + +S N ++    I   +    +     ++  + +
Sbjct: 294 LNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD---IRPLASLSKMDSADFANQVIKK 347

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  118 bits (299), Expect = 1e-29
 Identities = 56/226 (24%), Positives = 96/226 (42%), Gaps = 34/226 (15%)

Query: 772 RATGNFS----IRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDA------ 820
            +T  F      + ++G G      +          AVK + +         +       
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69

Query: 821 ---EIGTLGRI-RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKK---SGKKIQWS 873
              E+  L ++  H N++ L   Y      FLV++ +  G L  ++ +K   S K+ +  
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR-- 127

Query: 874 VIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA 933
              KI   + + +  LH      IVHRD+KP NILLD+++N  L+DFG +  L+      
Sbjct: 128 ---KIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEK 179

Query: 934 TTDVAGTFGYVAPE------YATTCRVSDKADVYSFGVVLLELISG 973
             +V GT  Y+APE               + D++S GV++  L++G
Sbjct: 180 LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  118 bits (298), Expect = 1e-29
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 24/209 (11%)

Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQG--IQQFDAEIGTLGRIRHKN 832
            ++I  ++G G FG   K  + +     AVK ++    +         E+  L ++ H N
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN 82

Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           ++ L       +  ++V    +GG L   I K+  K+       +I   +   + Y+H  
Sbjct: 83  IMKLFEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKH 140

Query: 893 CVPRIVHRDIKPSNILL---DEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE-- 947
               IVHRD+KP NILL   +++ +  + DFGL+      +     D  GT  Y+APE  
Sbjct: 141 ---NIVHRDLKPENILLESKEKDCDIKIIDFGLST--CFQQNTKMKDRIGTAYYIAPEVL 195

Query: 948 ---YATTCRVSDKADVYSFGVVLLELISG 973
              Y       +K DV+S GV+L  L+SG
Sbjct: 196 RGTY------DEKCDVWSAGVILYILLSG 218

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  118 bits (298), Expect = 2e-29
 Identities = 49/202 (24%), Positives = 97/202 (48%), Gaps = 15/202 (7%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
           + +    +GTG FG     +    Y VA+K +  G      +F  E   +  + H+ LV 
Sbjct: 25  DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQ 83

Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL---HYS 892
           L G    +  +F++  +++ G L  ++ ++   + Q   + ++  D+ +A+ YL    + 
Sbjct: 84  LYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLESKQF- 141

Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGY--VAPEYAT 950
                +HRD+   N L++++    +SDFGL+R +   +   T+ V   F      PE   
Sbjct: 142 -----LHRDLAARNCLVNDQGVVKVSDFGLSRYVL--DDEYTSSVGSKFPVRWSPPEVLM 194

Query: 951 TCRVSDKADVYSFGVVLLELIS 972
             + S K+D+++FGV++ E+ S
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYS 216

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  120 bits (302), Expect = 2e-29
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 27/208 (12%)

Query: 777 FSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
           F + + +G G     Y+  +       A+K   + +    +    EIG L R+ H N++ 
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALK--VLKKTVDKKIVRTEIGVLLRLSHPNIIK 112

Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-------KIAIDIAQALAY 888
           L   +    E+ LV   ++GG L   I +K          +            I +A+AY
Sbjct: 113 LKEIFETPTEISLVLELVTGGELFDRIVEKG---------YYSERDAADAVKQILEAVAY 163

Query: 889 LHYSCVPRIVHRDIKPSNILL---DEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
           LH +    IVHRD+KP N+L      +    ++DFGL++++E         V GT GY A
Sbjct: 164 LHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE--HQVLMKTVCGTPGYCA 218

Query: 946 PEYATTCRVSDKADVYSFGVVLLELISG 973
           PE    C    + D++S G++   L+ G
Sbjct: 219 PEILRGCAYGPEVDMWSVGIITYILLCG 246

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  119 bits (300), Expect = 2e-29
 Identities = 48/208 (23%), Positives = 95/208 (45%), Gaps = 13/208 (6%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVPG-----YLVAVKKLSIGRFQG-IQQFDAEIGTLGRIR 829
            F    ++G+G FG+ YK   +P        VA+K+L         ++   E   +  + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75

Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           + ++  L+G     + + L+   +  G L  ++ ++    I    +    + IA+ + YL
Sbjct: 76  NPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 133

Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT-FGYVAPEY 948
                 R+VHRD+   N+L+    +  ++DFGLA+LL   E     +       ++A E 
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190

Query: 949 ATTCRVSDKADVYSFGVVLLELIS-GKR 975
                 + ++DV+S+GV + EL++ G +
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  120 bits (303), Expect = 2e-29
 Identities = 58/221 (26%), Positives = 94/221 (42%), Gaps = 15/221 (6%)

Query: 762 PAELTYDNVVRATGNFS------IRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQG 814
           PA   +  V    G  +         ++G G FG  +K  E   G  +A K +     + 
Sbjct: 70  PAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD 129

Query: 815 IQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSV 874
            ++   EI  + ++ H NL+ L   +  + ++ LV  ++ GG L   I  +S    +   
Sbjct: 130 KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDT 189

Query: 875 IHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYL--SDFGLARLLEVSETH 932
           I      I + + ++H      I+H D+KP NIL        +   DFGLAR  +  E  
Sbjct: 190 IL-FMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK- 244

Query: 933 ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
                 GT  ++APE      VS   D++S GV+   L+SG
Sbjct: 245 -LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  122 bits (307), Expect = 2e-29
 Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 15/200 (7%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
              +   IG G FG     +   G  VAVK +        Q F AE   + ++RH NLV 
Sbjct: 194 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 250

Query: 836 LIGYYV---GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           L+G  V    +  +++V  +++ G+L  ++  +    +    + K ++D+ +A+ YL  +
Sbjct: 251 LLG--VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308

Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
                VHRD+   N+L+ E+  A +SDFGL +    ++      V  T    APE     
Sbjct: 309 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREK 361

Query: 953 RVSDKADVYSFGVVLLELIS 972
           + S K+DV+SFG++L E+ S
Sbjct: 362 KFSTKSDVWSFGILLWEIYS 381

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  118 bits (298), Expect = 3e-29
 Identities = 55/199 (27%), Positives = 95/199 (47%), Gaps = 8/199 (4%)

Query: 777 FSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
                 IG G  G    A E   G  VAVK + + + Q  +    E+  +   +H N+V 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
           +   Y+   E++++  FL GG L   + +    + Q   I  +   + QALAYLH     
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQ---IATVCEAVLQALAYLHAQ--- 160

Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVS 955
            ++HRDIK  +ILL  +    LSDFG    +        + + GT  ++APE  +    +
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS-LVGTPYWMAPEVISRSLYA 219

Query: 956 DKADVYSFGVVLLELISGK 974
            + D++S G++++E++ G+
Sbjct: 220 TEVDIWSLGIMVIEMVDGE 238

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  118 bits (299), Expect = 3e-29
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVPG----YLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRH 830
              I  +IG+G  G      L         VA+K L  G   +  + F +E   +G+  H
Sbjct: 50  RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDH 109

Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL- 889
            N++ L G         +V  ++  G+L+TF+ +    +     +  +   +   + YL 
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL-RTHDGQFTIMQLVGMLRGVGAGMRYLS 168

Query: 890 --HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGY--VA 945
              Y      VHRD+   N+L+D  L   +SDFGL+R+LE     A T   G       A
Sbjct: 169 DLGY------VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTA 222

Query: 946 PEYATTCRVSDKADVYSFGVVLLELIS-GKR 975
           PE       S  +DV+SFGVV+ E+++ G+R
Sbjct: 223 PEAIAFRTFSSASDVWSFGVVMWEVLAYGER 253

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  118 bits (299), Expect = 3e-29
 Identities = 45/289 (15%), Positives = 93/289 (32%), Gaps = 61/289 (21%)

Query: 114 TLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERL 173
                  +L+ L+ +++       E+P  + +   LE L L  N     +P  +++L RL
Sbjct: 95  QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRL 152

Query: 174 RVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLT 233
           R L++       E+P   + + + S                       L  L+L    + 
Sbjct: 153 RELSIRACPELTELPEP-LASTDAS---------------GEHQGLVNLQSLRLEWTGIR 196

Query: 234 ESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSK 293
             +P  I   +NLK+L +  + L  ++   I  + +L+ LD+   +     P      + 
Sbjct: 197 S-LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAP 254

Query: 294 LSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSES 353
           L  L+L +                                       +    LP +    
Sbjct: 255 LKRLILKD--------------------------------------CSNLLTLPLDIHRL 276

Query: 354 CSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLN---NLEGYLPMQLP 399
             L+ L+L        +P  +        + +  +    L+ + P+  P
Sbjct: 277 TQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARP 325

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  114 bits (287), Expect = 9e-28
 Identities = 41/253 (16%), Positives = 83/253 (32%), Gaps = 14/253 (5%)

Query: 143 VGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDM 202
                  E L  QG+         +S  +R    + +    +         +    +   
Sbjct: 8   HHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIETR 63

Query: 203 SSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPK 262
           +   L     +   +       L+L    L    P +  +  +L+++ +D   L   +P 
Sbjct: 64  TGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPD 121

Query: 263 EIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGV 322
            +   + L+ L ++RN L   +P  +A  ++L  L +       +L        A     
Sbjct: 122 TMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDA----- 175

Query: 323 PYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTY 382
             E     +L+ L      +   LP + +   +LK L +  + L  A+  ++     L  
Sbjct: 176 SGEHQGLVNLQSLRLEWTGI-RSLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEE 233

Query: 383 LDLSLNNLEGYLP 395
           LDL         P
Sbjct: 234 LDLRGCTALRNYP 246

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  109 bits (274), Expect = 6e-26
 Identities = 59/352 (16%), Positives = 102/352 (28%), Gaps = 51/352 (14%)

Query: 329 SRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLN 388
           S   E L+   +       D  S+       +  +         S     N      +  
Sbjct: 11  SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANS----NNPQIETRTGR 66

Query: 389 NLEGYLPM--QLPVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSIS 446
            L+    +      P  V   +    +    P       D  F    LQ+  +       
Sbjct: 67  ALKATADLLEDATQPGRVALELRSVPLP-QFP-------DQAFRLSHLQHMTI------- 111

Query: 447 DENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCND 506
                          L  LP   +       ++     L L  N    ++P   I+  N 
Sbjct: 112 ----------DAAG-LMELPD-TMQ------QFAGLETLTLARNPLR-ALPAS-IASLNR 151

Query: 507 LQSFSVNLSANL------LSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQR 560
           L+  S+     L      L+           V L         I  S+ A +  L  L+ 
Sbjct: 152 LRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKS 210

Query: 561 LDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSH-NALTGS 619
           L +R + +S +L   +  L  L+ + L G       P  FG    L  L L   + L  +
Sbjct: 211 LKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-T 268

Query: 620 IPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPHL 671
           +P  + + T+LE L L        +P   + L     + +  +  +    H 
Sbjct: 269 LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHR 320

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  103 bits (259), Expect = 5e-24
 Identities = 46/299 (15%), Positives = 86/299 (28%), Gaps = 62/299 (20%)

Query: 114 TLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRL--LEVLELQGNNFSGKIPYQMSNLE 171
             +   A     +  +    +        + +        LEL+      + P Q   L 
Sbjct: 47  HSAWRQANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLS 104

Query: 172 RLRVLNLSFNSFSGEVPRGLIGN-GELSVIDMSSNRLSGGLAIDSS-SECEFLTYLKLSD 229
            L+ + +       E+P   +     L  + ++ N L    A+ +S +    L  L +  
Sbjct: 105 HLQHMTIDAAGLM-ELPDT-MQQFAGLETLTLARNPLR---ALPASIASLNRLRELSIRA 159

Query: 230 NFLTESIPKEIGKC---------RNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSL 280
                 +P+ +             NL++L L+   +  S+P  I  +  LK L +  + L
Sbjct: 160 CPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPL 218

Query: 281 TDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRA 340
           +  +   +    KL  L L                                         
Sbjct: 219 S-ALGPAIHHLPKLEELDLRGC-------------------------------------- 239

Query: 341 NLGGRLPDNWSESCSLKVLNL-GQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQL 398
                 P  +     LK L L   ++L   +P  +     L  LDL        LP  +
Sbjct: 240 TALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLI 297

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 96.2 bits (240), Expect = 1e-21
 Identities = 31/198 (15%), Positives = 59/198 (29%), Gaps = 25/198 (12%)

Query: 501 ISKCNDLQSFS------VNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAA-GVG 553
                 L+ +               +         +             +  +       
Sbjct: 19  FQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDA 78

Query: 554 KLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSH 613
                  L+LR   +    PD+  +L  L+ + +    L  E+P        L  L L+ 
Sbjct: 79  TQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLAR 136

Query: 614 NALTGSIPASLTKATKLESLFLAHNRLSGEIPVSF---------STLVNLSALDLSFNNL 664
           N L  ++PAS+    +L  L +       E+P              LVNL +L L +  +
Sbjct: 137 NPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGI 195

Query: 665 S------GHIPHLQHLDC 676
                   ++ +L+ L  
Sbjct: 196 RSLPASIANLQNLKSLKI 213

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 77.7 bits (192), Expect = 2e-15
 Identities = 22/146 (15%), Positives = 39/146 (26%), Gaps = 31/146 (21%)

Query: 558 LQRLDLRGNRVSGSLPDELGKLKF--------------------LKWILLGGNNLTGEIP 597
            + L  +G+       D L + +                      +     G  L     
Sbjct: 14  RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALK-ATA 72

Query: 598 SQFGHLIS--LVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLS 655
                      V L+L    L    P    + + L+ + +    L  E+P +      L 
Sbjct: 73  DLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLE 130

Query: 656 ALDLSFNNLS------GHIPHLQHLD 675
            L L+ N L         +  L+ L 
Sbjct: 131 TLTLARNPLRALPASIASLNRLRELS 156

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 49.9 bits (120), Expect = 2e-06
 Identities = 18/135 (13%), Positives = 29/135 (21%), Gaps = 30/135 (22%)

Query: 570 GSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLD------------------- 610
           GS           + +   G+                   D                   
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE 61

Query: 611 -LSHNALTGSIPASLTKAT--KLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLS-- 665
             +  AL  +    L  AT     +L L    L  + P     L +L  + +    L   
Sbjct: 62  TRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLMEL 119

Query: 666 ----GHIPHLQHLDC 676
                    L+ L  
Sbjct: 120 PDTMQQFAGLETLTL 134

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  119 bits (299), Expect = 3e-29
 Identities = 58/250 (23%), Positives = 88/250 (35%), Gaps = 54/250 (21%)

Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK-----KLSIGRFQGIQQFDAEIGTLGRIR 829
            + ++  IG G +G    A E     + A+K     K+     + +++   E+  + ++ 
Sbjct: 27  KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86

Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH------------- 876
           H N+  L   Y  E  + LV     GG+L   ++           +              
Sbjct: 87  HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146

Query: 877 -------------------------KIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDE 911
                                     I   I  AL YLH      I HRDIKP N L   
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFST 203

Query: 912 ELNAYL--SDFGLARLL---EVSETHATTDVAGTFGYVAPE--YATTCRVSDKADVYSFG 964
             +  +   DFGL++        E +  T  AGT  +VAPE    T      K D +S G
Sbjct: 204 NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263

Query: 965 VVLLELISGK 974
           V+L  L+ G 
Sbjct: 264 VLLHLLLMGA 273

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  119 bits (300), Expect = 3e-29
 Identities = 53/208 (25%), Positives = 86/208 (41%), Gaps = 15/208 (7%)

Query: 777 FSIRNLIGTGGFGSTYKA-ELVPGYLVAVK-----KLSIGRFQGIQQFDAEIGTLGRIRH 830
           + +  +IG G F    +      G   AVK     K +       +    E      ++H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85

Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS--VIHKIAIDIAQALAY 888
            ++V L+  Y  +  +++V+ F+ G +L   I K++     +S  V       I +AL Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145

Query: 889 LHYSCVPRIVHRDIKPSNILL---DEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
            H +    I+HRD+KP  +LL   +      L  FG+A  L            GT  ++A
Sbjct: 146 CHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG-ESGLVAGGRVGTPHFMA 201

Query: 946 PEYATTCRVSDKADVYSFGVVLLELISG 973
           PE           DV+  GV+L  L+SG
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSG 229

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  117 bits (296), Expect = 4e-29
 Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 11/204 (5%)

Query: 777 FSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
           + I   +G G FG  YKA     G L A K +     + ++ +  EI  L    H  +V 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 836 LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
           L+G Y  + +++++  F  GG +   I  +  + +    I  +   + +AL +LH     
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK--- 136

Query: 896 RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVS 955
           RI+HRD+K  N+L+  E +  L+DFG++     +     +   GT  ++APE      + 
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-FIGTPYWMAPEVVMCETMK 195

Query: 956 D-----KADVYSFGVVLLELISGK 974
           D     KAD++S G+ L+E+   +
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIE 219

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  117 bits (294), Expect = 5e-29
 Identities = 53/296 (17%), Positives = 108/296 (36%), Gaps = 55/296 (18%)

Query: 776  NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDA--EIGTLGRI-RHK 831
             F     IG+G FGS +K  + + G + A+K+        + + +A  E+     + +H 
Sbjct: 12   EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71

Query: 832  NLVTLIGYYVGEAEMFLVYNFLSGGNLETFI--HKKSGKKIQWSVIHKIAIDIAQALAYL 889
            ++V     +  +  M +   + +GG+L   I  + +     + + +  + + + + L Y+
Sbjct: 72   HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131

Query: 890  HYSCVPRIVHRDIKPSNILLDEELNAY-------------------LSDFGLARLLEVSE 930
            H      +VH DIKPSNI +                          + D G    +    
Sbjct: 132  HSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI---- 184

Query: 931  THATTDVAGTFGYVAPE-YATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFN 989
            +    +  G   ++A E          KAD+++  + ++     +    P         N
Sbjct: 185  SSPQVEE-GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE----PLP------RN 233

Query: 990  IVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVL 1045
               W +  I++GR     +P++      E L  M+             RPS   ++
Sbjct: 234  GDQWHE--IRQGRLPR--IPQVLSQEFTELLKVMIHPDP-------ERRPSAMALV 278

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  116 bits (294), Expect = 5e-29
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 19/207 (9%)

Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK-----KLSIGRFQGIQQFDAEIGTLGRIR 829
           N+ ++  +G G F    +      G   A K     KLS   FQ +++   E     +++
Sbjct: 7   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EARICRKLQ 63

Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           H N+V L      E+  +LV++ ++GG L   I  +  +    +        I +++AY 
Sbjct: 64  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYC 121

Query: 890 HYSCVPRIVHRDIKPSNILL---DEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAP 946
           H +    IVHR++KP N+LL    +     L+DFGLA   EV+++ A    AGT GY++P
Sbjct: 122 HSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI--EVNDSEAWHGFAGTPGYLSP 176

Query: 947 EYATTCRVSDKADVYSFGVVLLELISG 973
           E       S   D+++ GV+L  L+ G
Sbjct: 177 EVLKKDPYSKPVDIWACGVILYILLVG 203

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  121 bits (305), Expect = 6e-29
 Identities = 54/225 (24%), Positives = 91/225 (40%), Gaps = 14/225 (6%)

Query: 757 TFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQG- 814
               TP           +  +     +G+G +G      + V     A+K +        
Sbjct: 19  DLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS 78

Query: 815 -IQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWS 873
              +   E+  L  + H N++ L  ++  +   +LV     GG L   I  +   K    
Sbjct: 79  SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR--MKFNEV 136

Query: 874 VIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILL---DEELNAYLSDFGLARLLEVSE 930
               I   +   + YLH      IVHRD+KP N+LL   +++    + DFGL+ + E  +
Sbjct: 137 DAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193

Query: 931 THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKR 975
                +  GT  Y+APE     +  +K DV+S GV+L  L++G  
Sbjct: 194 KM--KERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYP 235

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  117 bits (295), Expect = 7e-29
 Identities = 48/201 (23%), Positives = 86/201 (42%), Gaps = 10/201 (4%)

Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
            + I   +G G FG  ++  E         K + + +         EI  L   RH+N++
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNIL 64

Query: 835 TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
            L   +    E+ +++ F+SG ++   I+     ++    I      + +AL +LH    
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSH-- 121

Query: 895 PRIVHRDIKPSNILLDEELNAYL--SDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
             I H DI+P NI+     ++ +   +FG AR L+  +      +     Y APE     
Sbjct: 122 -NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVHQHD 178

Query: 953 RVSDKADVYSFGVVLLELISG 973
            VS   D++S G ++  L+SG
Sbjct: 179 VVSTATDMWSLGTLVYVLLSG 199

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  120 bits (303), Expect = 9e-29
 Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 19/215 (8%)

Query: 770 VVRATGNFS----IRNLIGTGGFGSTYKA-ELVPGYLVAVK---KLSIGRFQGIQQFDAE 821
           V  +T  FS     + ++G G FG      + + G   AVK   K  + +    +    E
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76

Query: 822 IGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAID 881
           +  L ++ H N++ L  ++  +   +LV    +GG L   I  +  K+       +I   
Sbjct: 77  VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQ 134

Query: 882 IAQALAYLHYSCVPRIVHRDIKPSNILL---DEELNAYLSDFGLARLLEVSETHATTDVA 938
           +   + Y+H +   +IVHRD+KP N+LL    ++ N  + DFGL+   E S+     D  
Sbjct: 135 VLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--KDKI 189

Query: 939 GTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
           GT  Y+APE        +K DV+S GV+L  L+SG
Sbjct: 190 GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  116 bits (292), Expect = 1e-28
 Identities = 62/225 (27%), Positives = 107/225 (47%), Gaps = 26/225 (11%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSI----GRFQGIQQFDAEIGTLGRIRH 830
           ++ ++ +IG+G       A   P    VA+K++++         + +   EI  + +  H
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLK---EIQAMSQCHH 72

Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVI---HKIAI---DIAQ 884
            N+V+    +V + E++LV   LSGG++   I     K    S +     IA    ++ +
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132

Query: 885 ALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF-G- 942
            L YLH +     +HRD+K  NILL E+ +  ++DFG++  L          V  TF G 
Sbjct: 133 GLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189

Query: 943 --YVAPEYATTCRVSD-KADVYSFGVVLLELISGKRSLDPSFSEY 984
             ++APE     R  D KAD++SFG+  +EL +G       + +Y
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA----APYHKY 230

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  115 bits (290), Expect = 2e-28
 Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 15/200 (7%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
              +   IG G FG     +   G  VAVK +        Q F AE   + ++RH NLV 
Sbjct: 22  ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 78

Query: 836 LIGYYV---GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           L+G  V    +  +++V  +++ G+L  ++  +    +    + K ++D+ +A+ YL  +
Sbjct: 79  LLG--VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136

Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
                VHRD+   N+L+ E+  A +SDFGL +    ++      V  T    APE     
Sbjct: 137 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREK 189

Query: 953 RVSDKADVYSFGVVLLELIS 972
           + S K+DV+SFG++L E+ S
Sbjct: 190 KFSTKSDVWSFGILLWEIYS 209

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  118 bits (296), Expect = 2e-28
 Identities = 47/227 (20%), Positives = 86/227 (37%), Gaps = 26/227 (11%)

Query: 774 TGNFSIRNLIGTG--GFGSTYKAELVP-GYLVAVKKLSIGR-----FQGIQQFDAEIGTL 825
            G + +  +IG G     +   A   P G  V V+++++          +Q    E+   
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQG---ELHVS 80

Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
               H N+V     ++ + E+++V +F++ G+ +  I       +    I  I   + +A
Sbjct: 81  KLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKA 140

Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYV- 944
           L Y+H+      VHR +K S+IL+  +   YLS       +                 V 
Sbjct: 141 LDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197

Query: 945 -----APEYATTCRV--SDKADVYSFGVVLLELISGKRSLDPSFSEY 984
                +PE           K+D+YS G+   EL +G       F + 
Sbjct: 198 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH----VPFKDM 240

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  117 bits (295), Expect = 2e-28
 Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 29/217 (13%)

Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQG--------IQQFDAEIGTLG 826
            +  +++IG G      +      G+  AVK + +   +          +    E   L 
Sbjct: 95  KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154

Query: 827 RIR-HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKK---SGKKIQWSVIHKIAIDI 882
           ++  H +++TLI  Y   + MFLV++ +  G L  ++ +K   S K+ +      I   +
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETR-----SIMRSL 209

Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFG 942
            +A+++LH +    IVHRD+KP NILLD+ +   LSDFG +  LE        ++ GT G
Sbjct: 210 LEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLE--PGEKLRELCGTPG 264

Query: 943 YVAPE------YATTCRVSDKADVYSFGVVLLELISG 973
           Y+APE        T      + D+++ GV+L  L++G
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  114 bits (289), Expect = 2e-28
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 24/212 (11%)

Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQG------IQQFDAEIGTLGRI 828
           ++ +   +G+G F    K  +   G   A K +   R          ++ + E+  L  I
Sbjct: 6   HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65

Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKK---SGKKIQWSVIHKIAIDIAQA 885
           RH N++TL   +  + ++ L+   +SGG L  F+ +K   +  +       +    I   
Sbjct: 66  RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT-----QFLKQILDG 120

Query: 886 LAYLHYSCVPRIVHRDIKPSNILL---DEELNAY-LSDFGLARLLEVSETHATTDVAGTF 941
           + YLH     RI H D+KP NI+L   +       L DFG+A  +E        ++ GT 
Sbjct: 121 VHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTP 175

Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
            +VAPE      +  +AD++S GV+   L+SG
Sbjct: 176 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  119 bits (299), Expect = 3e-28
 Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 30/212 (14%)

Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQG--IQQFDAEIGTLGRIRHKN 832
            ++I  ++G G FG   K  + +     AVK ++    +         E+  L ++ H N
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN 82

Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKK---SGKKIQWSVIHKIAIDIAQALAYL 889
           ++ L       +  ++V    +GG L   I K+   S          +I   +   + Y+
Sbjct: 83  IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-----RIIKQVFSGITYM 137

Query: 890 HYSCVPRIVHRDIKPSNILL---DEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAP 946
           H      IVHRD+KP NILL   +++ +  + DFGL+   +  +     D  GT  Y+AP
Sbjct: 138 HKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRIGTAYYIAP 192

Query: 947 E-----YATTCRVSDKADVYSFGVVLLELISG 973
           E     Y       +K DV+S GV+L  L+SG
Sbjct: 193 EVLRGTY------DEKCDVWSAGVILYILLSG 218

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  116 bits (293), Expect = 3e-28
 Identities = 57/219 (26%), Positives = 103/219 (47%), Gaps = 13/219 (5%)

Query: 761 TPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQG--IQQ 817
             +E   +   + + N+ ++  +G G F    +      G   A K ++  +      Q+
Sbjct: 15  RGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK 74

Query: 818 FDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHK 877
            + E     +++H N+V L      E+  +LV++ ++GG L   I  +  +    +    
Sbjct: 75  LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASH 132

Query: 878 IAIDIAQALAYLHYSCVPRIVHRDIKPSNILL---DEELNAYLSDFGLARLLEVSETHAT 934
               I +++AY H +    IVHR++KP N+LL    +     L+DFGLA   EV+++ A 
Sbjct: 133 CIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI--EVNDSEAW 187

Query: 935 TDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
              AGT GY++PE       S   D+++ GV+L  L+ G
Sbjct: 188 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  119 bits (299), Expect = 4e-28
 Identities = 61/232 (26%), Positives = 88/232 (37%), Gaps = 39/232 (16%)

Query: 770 VVRATGNFS----IRNLIGTGGFGSTYKA-ELVPGYLVAVKKLS-------------IGR 811
           V +  G           +G+G +G      E       A+K +                 
Sbjct: 27  VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86

Query: 812 FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQ 871
            +  ++   EI  L  + H N++ L   +  +   +LV  F  GG L   I  +   K  
Sbjct: 87  EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR--HKFD 144

Query: 872 WSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILL---DEELNAYLSDFGLARLLEV 928
                 I   I   + YLH      IVHRDIKP NILL   +  LN  + DFGL+     
Sbjct: 145 ECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK 201

Query: 929 SETHATTDVAGTFGYVAPE-----YATTCRVSDKADVYSFGVVLLELISGKR 975
                  D  GT  Y+APE     Y      ++K DV+S GV++  L+ G  
Sbjct: 202 DYKL--RDRLGTAYYIAPEVLKKKY------NEKCDVWSCGVIMYILLCGYP 245

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  116 bits (293), Expect = 4e-28
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 18/211 (8%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVPG----YLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRH 830
           N SI  ++G G FG      L         VA+K L +G   +  + F  E   +G+  H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105

Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL- 889
            N++ L G       + +V  ++  G+L++F+ K   +      +  +   IA  + YL 
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIASGMKYLS 164

Query: 890 --HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGY--VA 945
              Y      VHRD+   NIL++  L   +SDFGL R+LE     A T   G       +
Sbjct: 165 DMGY------VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTS 218

Query: 946 PEYATTCRVSDKADVYSFGVVLLELIS-GKR 975
           PE     + +  +DV+S+G+VL E++S G+R
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  114 bits (288), Expect = 4e-28
 Identities = 58/212 (27%), Positives = 86/212 (40%), Gaps = 18/212 (8%)

Query: 775 GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDA----EIGTLGRIR 829
           G + + +L+G G +G   +          AVK L   + + I   +A    EI  L R+R
Sbjct: 5   GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR 64

Query: 830 HKNLVTLIGYYVGEAE----MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
           HKN++ L    V   E    M++V  +   G  E        K+      H     +   
Sbjct: 65  HKNVIQL--VDVLYNEEKQKMYMVMEYCVCGMQEML-DSVPEKRFPVCQAHGYFCQLIDG 121

Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVA-GTFGYV 944
           L YLH      IVH+DIKP N+LL       +S  G+A  L       T   + G+  + 
Sbjct: 122 LEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178

Query: 945 APEYATTCRVSD--KADVYSFGVVLLELISGK 974
            PE A         K D++S GV L  + +G 
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  117 bits (294), Expect = 6e-28
 Identities = 56/229 (24%), Positives = 101/229 (44%), Gaps = 27/229 (11%)

Query: 764 ELTYDNVVRATGNFS----IRNLIGTGGFGSTYKA-ELVPGYLVAVK-----KLSIGRFQ 813
           +LT D+             +   +G+G  G    A E      VA++     K +IG  +
Sbjct: 120 DLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAR 179

Query: 814 G---IQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKI 870
                   + EI  L ++ H  ++ +  ++    + ++V   + GG L   +     K++
Sbjct: 180 EADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGN--KRL 236

Query: 871 QWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILL---DEELNAYLSDFGLARLLE 927
           + +        +  A+ YLH +    I+HRD+KP N+LL   +E+    ++DFG +++L 
Sbjct: 237 KEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 293

Query: 928 VSETHATTDVAGTFGYVAPE---YATTCRVSDKADVYSFGVVLLELISG 973
             ET     + GT  Y+APE      T   +   D +S GV+L   +SG
Sbjct: 294 --ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  116 bits (292), Expect = 7e-28
 Identities = 35/238 (14%), Positives = 72/238 (30%), Gaps = 43/238 (18%)

Query: 777 FSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIR--- 829
                ++G     +  +A     G    V             I+Q   E+  L  +R   
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 830 -------------------HKNLVTLIGYYVGEAEMFLVYNFL----SGGNLETFI---- 862
                                    +I   + E +M+++  F        NL+TF     
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 863 -HKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFG 921
            H  + K +      ++ + + + LA LH+     +VH  ++P +I+LD+    +L+ F 
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFE 256

Query: 922 LARLLEVSETHATTDVAGTFGYVAPE-----YATTCRVSDKADVYSFGVVLLELISGK 974
                  S               A             ++   D ++ G+ +  +    
Sbjct: 257 HLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  114 bits (288), Expect = 7e-28
 Identities = 47/204 (23%), Positives = 93/204 (45%), Gaps = 12/204 (5%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVPG-----YLVAVKKLSIGRFQG-IQQFDAEIGTLGRIR 829
            F    ++G+G FG+ YK   +P        VA+K+L         ++   E   +  + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75

Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           + ++  L+G     + + L+   +  G L  ++ ++    I    +    + IA+ + YL
Sbjct: 76  NPHVCRLLGI-CLTSTVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 133

Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT-FGYVAPEY 948
                 R+VHRD+   N+L+    +  ++DFGLA+LL   E     +       ++A E 
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190

Query: 949 ATTCRVSDKADVYSFGVVLLELIS 972
                 + ++DV+S+GV + EL++
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMT 214

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  114 bits (288), Expect = 7e-28
 Identities = 48/204 (23%), Positives = 93/204 (45%), Gaps = 12/204 (5%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVPG-----YLVAVKKLSIGR-FQGIQQFDAEIGTLGRIR 829
                 ++G+G FG+ +K   +P        V +K +      Q  Q     +  +G + 
Sbjct: 14  ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD 73

Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           H ++V L+G     + + LV  +L  G+L   + +  G  +   ++    + IA+ + YL
Sbjct: 74  HAHIVRLLGL-CPGSSLQLVTQYLPLGSLLDHVRQHRGA-LGPQLLLNWGVQIAKGMYYL 131

Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT-FGYVAPEY 948
                  +VHR++   N+LL       ++DFG+A LL   +       A T   ++A E 
Sbjct: 132 EEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 188

Query: 949 ATTCRVSDKADVYSFGVVLLELIS 972
               + + ++DV+S+GV + EL++
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMT 212

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  117 bits (294), Expect = 7e-28
 Identities = 53/207 (25%), Positives = 92/207 (44%), Gaps = 18/207 (8%)

Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK-----KLSIGRFQGIQQFDAEIGTLGRIR 829
            + +   +G G F    +  +++ G   A       KLS    Q +++   E      ++
Sbjct: 12  EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLER---EARICRLLK 68

Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           H N+V L      E   +L+++ ++GG L   I  +  +    +        I +A+ + 
Sbjct: 69  HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHC 126

Query: 890 HYSCVPRIVHRDIKPSNILL---DEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAP 946
           H      +VHR++KP N+LL    +     L+DFGLA  +E  E  A    AGT GY++P
Sbjct: 127 HQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWFGFAGTPGYLSP 182

Query: 947 EYATTCRVSDKADVYSFGVVLLELISG 973
           E           D+++ GV+L  L+ G
Sbjct: 183 EVLRKDPYGKPVDLWACGVILYILLVG 209

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  114 bits (287), Expect = 9e-28
 Identities = 60/216 (27%), Positives = 102/216 (47%), Gaps = 22/216 (10%)

Query: 774 TGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSI--GRFQGIQQFDAEIGTLGRI-R 829
            G F +  L+G G +G  YK   +  G L A+K + +     + I+Q   EI  L +   
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ---EINMLKKYSH 79

Query: 830 HKNLVTLIGYYV------GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIA 883
           H+N+ T  G ++       + +++LV  F   G++   I    G  ++   I  I  +I 
Sbjct: 80  HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139

Query: 884 QALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGY 943
           + L++LH     +++HRDIK  N+LL E     L DFG++  L+ +     T   GT  +
Sbjct: 140 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYW 195

Query: 944 VAPEYATTCRVSD-----KADVYSFGVVLLELISGK 974
           +APE        D     K+D++S G+  +E+  G 
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  113 bits (286), Expect = 1e-27
 Identities = 54/213 (25%), Positives = 97/213 (45%), Gaps = 23/213 (10%)

Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVK-----KLSIGRFQG---IQQFDAEIGTLG 826
            + +   +G+G  G    A E      VA+K     K +IG  +        + EI  L 
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70

Query: 827 RIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQAL 886
           ++ H  ++ +  ++    + ++V   + GG L   +     K+++ +        +  A+
Sbjct: 71  KLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAV 127

Query: 887 AYLHYSCVPRIVHRDIKPSNILL---DEELNAYLSDFGLARLLEVSETHATTDVAGTFGY 943
            YLH +    I+HRD+KP N+LL   +E+    ++DFG +++L   ET     + GT  Y
Sbjct: 128 QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTY 182

Query: 944 VAPE---YATTCRVSDKADVYSFGVVLLELISG 973
           +APE      T   +   D +S GV+L   +SG
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  113 bits (285), Expect = 2e-27
 Identities = 48/227 (21%), Positives = 96/227 (42%), Gaps = 18/227 (7%)

Query: 760 DTPAELTYDNVV-RATGNFS-----IRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRF 812
            +  +L  +N+  ++  NF+         +G G F    +      G   A K L   R 
Sbjct: 8   SSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR 67

Query: 813 QG--IQQFDAEIGTLGRIRH-KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK 869
                 +   EI  L   +    ++ L   Y   +E+ L+  + +GG + +    +  + 
Sbjct: 68  GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEM 127

Query: 870 IQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILL---DEELNAYLSDFGLARLL 926
           +  + + ++   I + + YLH +    IVH D+KP NILL       +  + DFG++R +
Sbjct: 128 VSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184

Query: 927 EVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
                    ++ GT  Y+APE      ++   D+++ G++   L++ 
Sbjct: 185 G--HACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  113 bits (284), Expect = 2e-27
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 24/211 (11%)

Query: 777 FSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQG------IQQFDAEIGTLGRIR 829
           + I   +G+G F    K  E   G   A K +   + +        ++ + E+  L ++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73

Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKK---SGKKIQWSVIHKIAIDIAQAL 886
           H N++TL   Y    ++ L+   +SGG L  F+ +K   S ++            I   +
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-----SFIKQILDGV 128

Query: 887 AYLHYSCVPRIVHRDIKPSNILL-DEELNAY---LSDFGLARLLEVSETHATTDVAGTFG 942
            YLH     +I H D+KP NI+L D+ +      L DFGLA  +E  +     ++ GT  
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--DGVEFKNIFGTPE 183

Query: 943 YVAPEYATTCRVSDKADVYSFGVVLLELISG 973
           +VAPE      +  +AD++S GV+   L+SG
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  113 bits (286), Expect = 2e-27
 Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 24/211 (11%)

Query: 777 FSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQG------IQQFDAEIGTLGRIR 829
           + I   +G+G F    K  E   G   A K +   + +        ++ + E+  L ++ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73

Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKK---SGKKIQWSVIHKIAIDIAQAL 886
           H N++TL   Y    ++ L+   +SGG L  F+ +K   S ++            I   +
Sbjct: 74  HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-----SFIKQILDGV 128

Query: 887 AYLHYSCVPRIVHRDIKPSNILL----DEELNAYLSDFGLARLLEVSETHATTDVAGTFG 942
            YLH     +I H D+KP NI+L        +  L DFGLA  +E  +     ++ GT  
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--DGVEFKNIFGTPE 183

Query: 943 YVAPEYATTCRVSDKADVYSFGVVLLELISG 973
           +VAPE      +  +AD++S GV+   L+SG
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  113 bits (285), Expect = 2e-27
 Identities = 56/219 (25%), Positives = 89/219 (40%), Gaps = 34/219 (15%)

Query: 772 RATGNFS----IRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLG 826
           R +  F+    ++  IG G +    +          AVK +   +    +    EI  L 
Sbjct: 15  RNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIEILL 70

Query: 827 R-IRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-------KI 878
           R  +H N++TL   Y     +++V   + GG L   I ++                   +
Sbjct: 71  RYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK---------FFSEREASAV 121

Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILL-DEELNAY---LSDFGLARLLEVSETHAT 934
              I + + YLH      +VHRD+KPSNIL  DE  N     + DFG A+ L  +E    
Sbjct: 122 LFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR-AENGLL 177

Query: 935 TDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISG 973
                T  +VAPE           D++S GV+L  +++G
Sbjct: 178 MTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  112 bits (283), Expect = 3e-27
 Identities = 60/251 (23%), Positives = 105/251 (41%), Gaps = 41/251 (16%)

Query: 780  RNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIR-HKNLVTLI 837
             +++G G          L+     AVK +         +   E+  L + + H+N++ LI
Sbjct: 18   EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77

Query: 838  GYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-------KIAIDIAQALAYLH 890
             ++  E   +LV+  + GG++ + IHK+          H        +  D+A AL +LH
Sbjct: 78   EFFEEEDRFYLVFEKMRGGSILSHIHKRR---------HFNELEASVVVQDVASALDFLH 128

Query: 891  YSCVPRIVHRDIKPSNILL---DEELNAYLSDFGLARLLEVSETHAT------TDVAGTF 941
                  I HRD+KP NIL    ++     + DF L   ++++   +           G+ 
Sbjct: 129  N---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185

Query: 942  GYVAPE----YATTCRVSDKA-DVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKL 996
             Y+APE    ++    + DK  D++S GV+L  L+SG     P F   G   +   W + 
Sbjct: 186  EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY----PPF--VGRCGSDCGWDRG 239

Query: 997  LIKEGRSSELF 1007
                   + LF
Sbjct: 240  EACPACQNMLF 250

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  114 bits (286), Expect = 3e-27
 Identities = 33/239 (13%), Positives = 72/239 (30%), Gaps = 54/239 (22%)

Query: 782 LIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIR-------- 829
           ++G     +  +A +   G    V             I+Q   E+  L  +R        
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 830 -----------------HKNLVTLIGYY--VGEAEMFLVYNFLSGGNLET----FIHKKS 866
                             K ++ +      +     F +Y  +             H  +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 867 GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL 926
            K +      ++ + + + LA LH      +VH  ++P +I+LD+    +L+ F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH-HY--GLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254

Query: 927 EVSETHATTDVAGTFGYVAPEY-----------ATTCRVSDKADVYSFGVVLLELISGK 974
                 A    + + G+  PE                 ++   D ++ G+V+  +    
Sbjct: 255 ---RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  112 bits (283), Expect = 3e-27
 Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 24/211 (11%)

Query: 777 FSIRNLIGTGGFGSTYKA-ELVPGYLVAVK------KLSIGRFQGIQQFDAEIGTLGRIR 829
           +     +G+G F    K  E   G   A K        S  R    +  + E+  L  I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72

Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKK---SGKKIQWSVIHKIAIDIAQAL 886
           H N++TL   Y  + ++ L+   ++GG L  F+ +K   + ++       +    I   +
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-----EFLKQILNGV 127

Query: 887 AYLHYSCVPRIVHRDIKPSNILL---DEELNAY-LSDFGLARLLEVSETHATTDVAGTFG 942
            YLH     +I H D+KP NI+L   +       + DFGLA  ++        ++ GT  
Sbjct: 128 YYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPE 182

Query: 943 YVAPEYATTCRVSDKADVYSFGVVLLELISG 973
           +VAPE      +  +AD++S GV+   L+SG
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  112 bits (281), Expect = 5e-27
 Identities = 54/217 (24%), Positives = 97/217 (44%), Gaps = 24/217 (11%)

Query: 783 IGTGGFGSTYKAELVP-GYLVAVKKLSIGR----FQGIQQFDAEIGTLGR-IRHKNLVTL 836
           +G+G  G  +K      G+++AVK++         + I     ++  + +      +V  
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILM---DLDVVLKSHDCPYIVQC 89

Query: 837 IGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPR 896
            G ++   ++F+    +     +  + K+    I   ++ K+ + I +AL YL       
Sbjct: 90  FGTFITNTDVFIAMELMGTCAEK--LKKRMQGPIPERILGKMTVAIVKALYYLKEK--HG 145

Query: 897 IVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSD 956
           ++HRD+KPSNILLDE     L DFG++  L   +  A    AG   Y+APE       + 
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRL--VDDKAKDRSAGCAAYMAPERIDPPDPTK 203

Query: 957 -----KADVYSFGVVLLELISGKRSLDPSFSEYGNGF 988
                +ADV+S G+ L+EL +G+      +      F
Sbjct: 204 PDYDIRADVWSLGISLVELATGQ----FPYKNCKTDF 236

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  112 bits (281), Expect = 6e-27
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 19/212 (8%)

Query: 776 NFSIRNLIGTGGFGSTYKAEL-----VPGYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIR 829
             + + +IG G FG  YK  L          VA+K L  G   +    F  E G +G+  
Sbjct: 45  CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 104

Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           H N++ L G       M ++  ++  G L+ F+ ++   +     +  +   IA  + YL
Sbjct: 105 HHNIIRLEGVISKYKPMMIITEYMENGALDKFL-REKDGEFSVLQLVGMLRGIAAGMKYL 163

Query: 890 ---HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGY--V 944
              +Y      VHRD+   NIL++  L   +SDFGL+R+LE       T   G       
Sbjct: 164 ANMNY------VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 217

Query: 945 APEYATTCRVSDKADVYSFGVVLLELIS-GKR 975
           APE  +  + +  +DV+SFG+V+ E+++ G+R
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVMTYGER 249

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  112 bits (281), Expect = 6e-27
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 13/201 (6%)

Query: 783 IGTGGFGSTYKAELVP-GYLVAVKKLSI-GRFQGIQQFDAEIGTLGR-IRHKNLVTLIGY 839
           IG G +GS  K    P G ++AVK++      +  +Q   ++  + R      +V   G 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89

Query: 840 YVGEAEMFLVYNFLSGG--NLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
              E + ++    +S        +++      I   ++ KI +   +AL +L  +   +I
Sbjct: 90  LFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KI 147

Query: 898 VHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE----YATTCR 953
           +HRDIKPSNILLD   N  L DFG++  L   ++ A T  AG   Y+APE     A+   
Sbjct: 148 IHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSIAKTRDAGCRPYMAPERIDPSASRQG 205

Query: 954 VSDKADVYSFGVVLLELISGK 974
              ++DV+S G+ L EL +G+
Sbjct: 206 YDVRSDVWSLGITLYELATGR 226

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  110 bits (277), Expect = 7e-27
 Identities = 52/207 (25%), Positives = 92/207 (44%), Gaps = 20/207 (9%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVPG----YLVAVKKLSIG-RFQGIQQFDAEIGTLGRIRH 830
              +   IG G FG  ++   +        VA+K           ++F  E  T+ +  H
Sbjct: 16  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 75

Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL- 889
            ++V LIG  + E  ++++    + G L +F+ +     +  + +   A  ++ ALAYL 
Sbjct: 76  PHIVKLIGV-ITENPVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLE 133

Query: 890 --HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF--GYVA 945
              +      VHRDI   N+L+       L DFGL+R +E S  +  +   G     ++A
Sbjct: 134 SKRF------VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS--KGKLPIKWMA 185

Query: 946 PEYATTCRVSDKADVYSFGVVLLELIS 972
           PE     R +  +DV+ FGV + E++ 
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILM 212

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  110 bits (277), Expect = 9e-27
 Identities = 48/223 (21%), Positives = 81/223 (36%), Gaps = 44/223 (19%)

Query: 776 NFSIRNLIGTGGFGSTYKAEL--------VPGYLVAVKKLSIGRFQGIQQFDAEIGTLGR 827
           +      +G G F   +K           +    V +K L        + F      + +
Sbjct: 9   DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSK 68

Query: 828 IRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALA 887
           + HK+LV   G  V   E  LV  F+  G+L+T++ KK+   I      ++A  +A A+ 
Sbjct: 69  LSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKNCINILWKLEVAKQLAAAMH 127

Query: 888 YL---HYSCVPRIVHRDIKPSNILLDEELNAY--------LSDFGLARLLEVSETHATTD 936
           +L           +H ++   NILL  E +          LSD G++  +   +      
Sbjct: 128 FLEENTL------IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------ 175

Query: 937 VAGTFGY------VAPEYATTCRV-SDKADVYSFGVVLLELIS 972
                        V PE     +  +   D +SFG  L E+ S
Sbjct: 176 -----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  110 bits (277), Expect = 1e-26
 Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 14/201 (6%)

Query: 783 IGTGGFGSTYKAELVP-GYLVAVKKLSI-GRFQGIQQFDAEIGTLGR-IRHKNLVTLIGY 839
           +G G +G   K   VP G ++AVK++      Q  ++   ++    R +     VT  G 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74

Query: 840 YVGEAEMFLVYNFLSGGNLETFIHK--KSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRI 897
              E ++++    +    L+ F  +    G+ I   ++ KIA+ I +AL +LH      +
Sbjct: 75  LFREGDVWICMELMDTS-LDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH--SKLSV 131

Query: 898 VHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE----YATTCR 953
           +HRD+KPSN+L++      + DFG++  L   +  A    AG   Y+APE          
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKDIDAGCKPYMAPERINPELNQKG 189

Query: 954 VSDKADVYSFGVVLLELISGK 974
            S K+D++S G+ ++EL   +
Sbjct: 190 YSVKSDIWSLGITMIELAILR 210

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  111 bits (279), Expect = 1e-26
 Identities = 64/208 (30%), Positives = 95/208 (45%), Gaps = 23/208 (11%)

Query: 777 FSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGR------FQGIQQFDAEIGTLGRIR 829
           FS    IG G FG+ Y A ++    +VA+KK+S         +Q I +   E+  L ++R
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK---EVRFLQKLR 112

Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           H N +   G Y+ E   +LV  +  G   +  + +   K +Q   I  +     Q LAYL
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHGALQGLAYL 170

Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
           H      ++HRD+K  NILL E     L DFG A ++      A +   GT  ++APE  
Sbjct: 171 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANS-FVGTPYWMAPEVI 222

Query: 950 TTCRVSD---KADVYSFGVVLLELISGK 974
                     K DV+S G+  +EL   K
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERK 250

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  109 bits (275), Expect = 2e-26
 Identities = 51/212 (24%), Positives = 96/212 (45%), Gaps = 23/212 (10%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVPG----YLVAVKKLSIG-RFQGIQQFDAEIGTLGRIRH 830
           +  +  ++G G FG  Y+            VAVK           ++F +E   +  + H
Sbjct: 13  DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH 72

Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL- 889
            ++V LIG  + E   +++      G L  ++ +++   ++   +   ++ I +A+AYL 
Sbjct: 73  PHIVKLIGI-IEEEPTWIIMELYPYGELGHYL-ERNKNSLKVLTLVLYSLQICKAMAYLE 130

Query: 890 --HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT---FGYV 944
             +       VHRDI   NIL+       L DFGL+R +E  + +  +    T     ++
Sbjct: 131 SINC------VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS---VTRLPIKWM 181

Query: 945 APEYATTCRVSDKADVYSFGVVLLELIS-GKR 975
           +PE     R +  +DV+ F V + E++S GK+
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQ 213

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  109 bits (274), Expect = 3e-26
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 23/208 (11%)

Query: 779 IRNLIGTGGFGSTYKAELVPGY----LVAVKKLSIG-RFQGIQQFDAEIGTLGRIRHKNL 833
              +IG G FG  Y  E +         A+K LS     Q ++ F  E   +  + H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84

Query: 834 VTLIGYYV---GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL- 889
           + LIG  +    E    ++  ++  G+L  FI +   +      +    + +A+ + YL 
Sbjct: 85  LALIG--IMLPPEGLPHVLLPYMCHGDLLQFI-RSPQRNPTVKDLISFGLQVARGMEYLA 141

Query: 890 --HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYV--- 944
              +      VHRD+   N +LDE     ++DFGLAR +   E ++          V   
Sbjct: 142 EQKF------VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT 195

Query: 945 APEYATTCRVSDKADVYSFGVVLLELIS 972
           A E   T R + K+DV+SFGV+L EL++
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELLT 223

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  109 bits (275), Expect = 4e-26
 Identities = 68/251 (27%), Positives = 100/251 (39%), Gaps = 48/251 (19%)

Query: 783  IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIR-HKNLVTLIGYY 840
            +G G F    K          AVK +S       Q+   EI  L     H N+V L   +
Sbjct: 19   LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVF 75

Query: 841  VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-------KIAIDIAQALAYLHYSC 893
              +   FLV   L+GG L   I KK          H        I   +  A++++H   
Sbjct: 76   HDQLHTFLVMELLNGGELFERIKKKK---------HFSETEASYIMRKLVSAVSHMHDV- 125

Query: 894  VPRIVHRDIKPSNILL---DEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE--- 947
               +VHRD+KP N+L    ++ L   + DFG ARL    +         T  Y APE   
Sbjct: 126  --GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP-PDNQPLKTPCFTLHYAAPELLN 182

Query: 948  ---YATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLL--IKEGR 1002
               Y  +C      D++S GV+L  ++SG+      F  +       S  +++  IK+G 
Sbjct: 183  QNGYDESC------DLWSLGVILYTMLSGQ----VPFQSHDRSLTCTSAVEIMKKIKKGD 232

Query: 1003 SSELFLPELWE 1013
             S  F  E W+
Sbjct: 233  FS--FEGEAWK 241

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  108 bits (273), Expect = 4e-26
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 19/207 (9%)

Query: 778 SIRNLIGTGGFGSTYKAELVPGY----LVAVKKL-SIGRFQGIQQFDAEIGTLGRIRHKN 832
               +IG G FG  Y   L+         AVK L  I     + QF  E   +    H N
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87

Query: 833 LVTLIGY-YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL-- 889
           +++L+G     E    +V  ++  G+L  FI +          +    + +A+ + YL  
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYLAS 146

Query: 890 -HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYV---A 945
             +      VHRD+   N +LDE+    ++DFGLAR +   E ++  +  G    V   A
Sbjct: 147 KKF------VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 200

Query: 946 PEYATTCRVSDKADVYSFGVVLLELIS 972
            E   T + + K+DV+SFGV+L EL++
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMT 227

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  113 bits (283), Expect = 7e-26
 Identities = 66/286 (23%), Positives = 102/286 (35%), Gaps = 49/286 (17%)

Query: 122 LTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFN 181
              + TL +P N+ +  +PA   ELR    LE+ GN  +  +P     L  L + +    
Sbjct: 60  PAHITTLVIPDNNLT-SLPALPPELR---TLEVSGNQLT-SLPVLPPGLLELSIFSNPLT 114

Query: 182 SFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIG 241
                    L     L  + +  N+L+             L  L +SDN L  S+P    
Sbjct: 115 HLPA-----LPSG--LCKLWIFGNQLT-----SLPVLPPGLQELSVSDNQLA-SLPALPS 161

Query: 242 KCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVL--VL 299
               L  L    N L  S+P        L+ L VS N L   +P   ++  KL      L
Sbjct: 162 ---ELCKLWAYNNQLT-SLPMLPSG---LQELSVSDNQLAS-LPTLPSELYKLWAYNNRL 213

Query: 300 TNIDAS------LDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSES 353
           T++ A       L +  +R         +P        L+ L      L   LP      
Sbjct: 214 TSLPALPSGLKELIVSGNRLT------SLPVLP---SELKELMVSGNRLT-SLPM---LP 260

Query: 354 CSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLP 399
             L  L++ +N L   +P+SL    + T ++L  N L     +Q  
Sbjct: 261 SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQAL 304

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  100 bits (251), Expect = 6e-22
 Identities = 84/454 (18%), Positives = 137/454 (30%), Gaps = 123/454 (27%)

Query: 219 CEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRN 278
                 L + ++ LT ++P  +    ++  L++  N L  S+P       EL+ L+VS N
Sbjct: 39  NNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPP---ELRTLEVSGN 91

Query: 279 SLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAP 338
            LT  +PV      +LS+             N      A                     
Sbjct: 92  QLTS-LPVLPPGLLELSIF-----------SNPLTHLPA--------------------- 118

Query: 339 RANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQL 398
                  LP        L  L +  N L  ++P        L  L +S N L   LP   
Sbjct: 119 -------LPSG------LCKLWIFGNQLT-SLPVLPP---GLQELSVSDNQLAS-LPALP 160

Query: 399 PVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSG 458
               +       N +T +      +        Q+L                      S 
Sbjct: 161 S--ELCKLWAYNNQLTSLPMLPSGL--------QEL--------------------SVSD 190

Query: 459 NKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANL 518
           N+ L SLP     +  L        +L   NN    S+P    S   +L      +S N 
Sbjct: 191 NQ-LASLPT-LPSE--LY-------KLWAYNNRLT-SLPAL-PSGLKEL-----IVSGNR 232

Query: 519 LSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGK 578
           L+ +          +L E   + N+++ S+      L     L +  N+++  LP+ L  
Sbjct: 233 LTSLPVL-----PSELKELMVSGNRLT-SLPMLPSGL---LSLSVYRNQLT-RLPESLIH 282

Query: 579 LKFLKWILLGGNNLTGEIPSQFGHLISLVVLD---LSHNALTGSIPASLTKATKLESLFL 635
           L     + L GN L+         + S        +  +    S P          + +L
Sbjct: 283 LSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWL 342

Query: 636 AHNRLSG----EIPVSFSTLVNLSALDLSFNNLS 665
              R       +    F    N  A  L  + LS
Sbjct: 343 VPAREGEPAPADRWHMFGQEDNADAFSLFLDRLS 376

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 94.6 bits (235), Expect = 5e-20
 Identities = 77/335 (22%), Positives = 125/335 (37%), Gaps = 56/335 (16%)

Query: 339 RANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQL 398
           RA +  ++    +      VLN+G++ L   +P  L    ++T L +  NNL   LP   
Sbjct: 27  RAAVVQKMRACLNNG--NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPALP 80

Query: 399 PVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSG 458
           P   +    VS N +T +      +   + F         +P            +    G
Sbjct: 81  P--ELRTLEVSGNQLTSLPVLPPGLLELSIFSNPLTHLPALP-------SGLCKL-WIFG 130

Query: 459 NKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANL 518
           N+ L SLP                  L +++N    S+P    S+   L         N 
Sbjct: 131 NQ-LTSLP----------VLPPGLQELSVSDNQLA-SLPAL-PSELCKL-----WAYNNQ 172

Query: 519 LSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGK 578
           L+ +           L E   ++NQ++ S+     +L    +L    NR++ SLP     
Sbjct: 173 LTSLPML-----PSGLQELSVSDNQLA-SLPTLPSEL---YKLWAYNNRLT-SLPALPSG 222

Query: 579 LKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHN 638
           LK L    + GN LT  +P     L  L    +S N LT S+P   +    L SL +  N
Sbjct: 223 LKELI---VSGNRLT-SLPVLPSELKEL---MVSGNRLT-SLPMLPSG---LLSLSVYRN 271

Query: 639 RLSGEIPVSFSTLVNLSALDLSFNNLSGHIPHLQH 673
           +L+  +P S   L + + ++L  N LS        
Sbjct: 272 QLT-RLPESLIHLSSETTVNLEGNPLSERTLQALR 305

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 91.5 bits (227), Expect = 5e-19
 Identities = 41/193 (21%), Positives = 74/193 (38%), Gaps = 29/193 (15%)

Query: 484 RLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQ 543
            L++ +N    S+P     +   L      +S N L+ +         ++L  F      
Sbjct: 65  TLVIPDNNLT-SLP-ALPPELRTL-----EVSGNQLTSLPVL--PPGLLELSIFSNPLTH 115

Query: 544 ISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHL 603
           +    +        L +L + GN+++ SLP     L+ L    +  N L   +P+    L
Sbjct: 116 LPALPSG-------LCKLWIFGNQLT-SLPVLPPGLQELS---VSDNQLA-SLPALPSEL 163

Query: 604 ISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNN 663
             L      +N LT S+P   +    L+ L ++ N+L+  +P   S L  L A +    +
Sbjct: 164 CKL---WAYNNQLT-SLPMLPSG---LQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTS 215

Query: 664 LSGHIPHLQHLDC 676
           L      L+ L  
Sbjct: 216 LPALPSGLKELIV 228

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 85.7 bits (212), Expect = 3e-17
 Identities = 53/254 (20%), Positives = 96/254 (37%), Gaps = 25/254 (9%)

Query: 114 TLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERL 173
           +L A  ++L +L      +N  +  +P        L+ L +  N  +  +P   S L +L
Sbjct: 155 SLPALPSELCKLWAY---NNQLT-SLPM---LPSGLQELSVSDNQLA-SLPTLPSELYKL 206

Query: 174 RVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLT 233
              N    S        L     L  + +S NRL+             L  L +S N LT
Sbjct: 207 WAYNNRLTSLPA-----LPSG--LKELIVSGNRLT-----SLPVLPSELKELMVSGNRLT 254

Query: 234 ESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSK 293
            S+P        L +L +  N L   +P+ +  +S    +++  N L++R    L + + 
Sbjct: 255 -SLPMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITS 309

Query: 294 LSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSES 353
                   I   +   ++  E  A        L+ +R  E   A R ++ G+  +  + S
Sbjct: 310 APGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFS 369

Query: 354 CSLKVLNLGQNSLK 367
             L  L+  +N +K
Sbjct: 370 LFLDRLSETENFIK 383

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 84.2 bits (208), Expect = 9e-17
 Identities = 65/318 (20%), Positives = 111/318 (34%), Gaps = 72/318 (22%)

Query: 361 LGQNSLKGAVPKSLGMC--RNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNITGVLP 418
             ++  + AV + +  C       L++  + L   LP  LP   +    +  NN+T +  
Sbjct: 21  AEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP-AHITTLVIPDNNLTSLPA 78

Query: 419 RFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAK 478
                          L+   V                 SGN+ L SLP+   G   L+  
Sbjct: 79  LPPE-----------LRTLEV-----------------SGNQ-LTSLPVLPPGLLELS-- 107

Query: 479 YKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFE 538
                  + +N +               L +    L    + G    +  +    L E  
Sbjct: 108 -------IFSNPL-------------THLPALPSGLCKLWIFGNQLTSLPVLPPGLQELS 147

Query: 539 AANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPS 598
            ++NQ++ S+ A      +L +L    N+++ SLP     L+ L    +  N L   +P+
Sbjct: 148 VSDNQLA-SLPALPS---ELCKLWAYNNQLT-SLPMLPSGLQELS---VSDNQLA-SLPT 198

Query: 599 QFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALD 658
               L     L   +N LT S+PA     + L+ L ++ NRL+  +PV  S L  L    
Sbjct: 199 LPSELYK---LWAYNNRLT-SLPALP---SGLKELIVSGNRLT-SLPVLPSELKELMVSG 250

Query: 659 LSFNNLSGHIPHLQHLDC 676
               +L      L  L  
Sbjct: 251 NRLTSLPMLPSGLLSLSV 268

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 55.7 bits (134), Expect = 6e-08
 Identities = 18/82 (21%), Positives = 32/82 (39%), Gaps = 10/82 (12%)

Query: 605 SLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNL 664
              VL++  + LT ++P  L     + +L +  N L+  +P        L  L++S N L
Sbjct: 41  GNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPP---ELRTLEVSGNQL 93

Query: 665 S---GHIPHLQHLDCIAFKGNK 683
           +      P L  L   +     
Sbjct: 94  TSLPVLPPGLLELSIFSNPLTH 115

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  108 bits (271), Expect = 8e-26
 Identities = 54/237 (22%), Positives = 97/237 (40%), Gaps = 49/237 (20%)

Query: 775 GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDA------------- 820
             +++++ IG G +G    A         A+K LS  +      F               
Sbjct: 13  NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72

Query: 821 -------------EIGTLGRIRHKNLVTLIGYYV----GEAEMFLVYNFLSGGNLETFIH 863
                        EI  L ++ H N+V L    V     E  +++V+  ++ G +     
Sbjct: 73  CIQPRGPIEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVPT 130

Query: 864 KKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLA 923
               K +          D+ + + YLHY    +I+HRDIKPSN+L+ E+ +  ++DFG++
Sbjct: 131 L---KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVS 184

Query: 924 RLLEVSETHATTDVAGTFGYVAPEYATTCRVSDK------ADVYSFGVVLLELISGK 974
              + S+   +    GT  ++APE   +   + K       DV++ GV L   + G+
Sbjct: 185 NEFKGSDALLSN-TVGTPAFMAPE---SLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  111 bits (278), Expect = 1e-25
 Identities = 65/509 (12%), Positives = 143/509 (28%), Gaps = 85/509 (16%)

Query: 122 LTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFN 181
               +   V  +S    + +       ++ L+L GN  S      ++   +L +LNLS N
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 182 SFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIG 241
                    L     L  +D+++N +              +  L  ++N ++  +    G
Sbjct: 69  VLYE--TLDLESLSTLRTLDLNNNYVQ------ELLVGPSIETLHAANNNIS-RVSCSRG 119

Query: 242 KCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTD-RIPVELADCSKLSVLVL- 299
             +  KN+ L  N +      + G  S ++ LD+  N +         A    L  L L 
Sbjct: 120 --QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177

Query: 300 ----TNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGG----RLPDNWS 351
                ++   +                         L+ L     +L       +   + 
Sbjct: 178 YNFIYDVKGQVVF---------------------AKLKTL-----DLSSNKLAFMGPEFQ 211

Query: 352 ESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQN 411
            +  +  ++L  N L   + K+L   +NL + DL  N                   V++ 
Sbjct: 212 SAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270

Query: 412 NITGV-LPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAI 470
            +  +     E  +      +      ++P                    F   L     
Sbjct: 271 TVKKLTGQNEEECTVPTLGHYGAYCCEDLP------------------APFADRLIAL-- 310

Query: 471 GDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLD 530
                    +  + LL         +  ER ++    +   ++        +  +  L  
Sbjct: 311 --------KRKEHALLSGQGSETERLECERENQ-ARQR--EIDALKEQYRTVIDQVTLR- 358

Query: 531 CVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSG--SLPDELGKLKFLKWILLG 588
               +  E     +   ++ G     +L     +           +E   L+ L+   + 
Sbjct: 359 KQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLR--AIV 416

Query: 589 GNNLTGEIPSQFGHLISLVVLDLSHNALT 617
                  +  Q     ++   D+  +  T
Sbjct: 417 KRYEEMYVEQQSVQNNAIRDWDMYQHKET 445

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  108 bits (271), Expect = 9e-25
 Identities = 76/473 (16%), Positives = 132/473 (27%), Gaps = 73/473 (15%)

Query: 222 LTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLT 281
               K++D+ L +++        N+K L L GN L      ++   ++L++L++S N L 
Sbjct: 12  YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY 71

Query: 282 DRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRAN 341
                E  D   LS L       +LDL+N+         G         S+E L A   N
Sbjct: 72  -----ETLDLESLSTLR------TLDLNNNY--VQELLVG--------PSIETLHAANNN 110

Query: 342 LGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVP 401
           +              K + L  N +        G    + YLDL LN ++     +L   
Sbjct: 111 ISRVSCSRGQ---GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAAS 167

Query: 402 C--MVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGN 459
              + + N+  N I  V              F  L+                   D S N
Sbjct: 168 SDTLEHLNLQYNFIYDV---------KGQVVFAKLKT-----------------LDLSSN 201

Query: 460 KFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLL 519
           K      L  +G  F          + L NN     +    +    +L+    +L  N  
Sbjct: 202 K------LAFMGPEF--QSAAGVTWISLRNNKLV-LIEKA-LRFSQNLE--HFDLRGNGF 249

Query: 520 SGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKL 579
              +   F     ++     A   +         +                       +L
Sbjct: 250 HCGTLRDFFSKNQRVQTV--AKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRL 307

Query: 580 KFLKW----ILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFL 635
             LK     +L G  + T  +  +  +      +D         I     +     +L  
Sbjct: 308 IALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQ 367

Query: 636 AHNRLSGEIPVSFSTLVNLSAL---DLSFNNLSGHIPHLQHLDCIAFKGNKYL 685
               L  ++         L       +    L         L  +     +Y 
Sbjct: 368 KKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYE 420

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 86.8 bits (215), Expect = 9e-18
 Identities = 21/123 (17%), Positives = 44/123 (35%), Gaps = 11/123 (8%)

Query: 557 KLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNAL 616
           + +   +  + +  +L         +K + L GN L+    +       L +L+LS N L
Sbjct: 11  RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70

Query: 617 TGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLS----GHIPHLQ 672
                  L   + L +L L +N +            ++  L  + NN+S          +
Sbjct: 71  YE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSRGQGKK 123

Query: 673 HLD 675
           ++ 
Sbjct: 124 NIY 126

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 81.0 bits (200), Expect = 5e-16
 Identities = 27/113 (23%), Positives = 45/113 (39%), Gaps = 3/113 (2%)

Query: 571 SLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKL 630
           ++ +        K   +  ++L   + S      ++  LDLS N L+    A L   TKL
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 631 ESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPHLQHLDCIAFKGNK 683
           E L L+ N L  E      +L  L  LDL+ N +   +     ++ +    N 
Sbjct: 61  ELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYVQ-ELLVGPSIETLHAANNN 110

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  111 bits (279), Expect = 1e-25
 Identities = 94/537 (17%), Positives = 170/537 (31%), Gaps = 75/537 (13%)

Query: 175 VLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTE 234
           +++ S N     VP+ L      +++++S N +S  L          L  L +S N +  
Sbjct: 4   LVDRSKNGLI-HVPKDLSQK--TTILNISQNYISE-LWTSDILSLSKLRILIISHNRIQY 59

Query: 235 SIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKL 294
                    + L+ L L  N L   I         LK LD+S N+        L  C + 
Sbjct: 60  LDISVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDA-----LPICKEF 111

Query: 295 SVLV-LTNIDASLDLDN---SRGEFSAFDG-GVPYELLLSRSLEVLWAPRANLGGRLPDN 349
             +  L      L L      +          +   LL+             L       
Sbjct: 112 GNMSQLK----FLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGL------- 160

Query: 350 WSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVS 409
                     +L            +      T  +L L+N++  L        +      
Sbjct: 161 ----QDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKL 216

Query: 410 QNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFA 469
           Q N         N+    +   + LQ               V     S  K  G L    
Sbjct: 217 QTNPKLSNLTLNNIETTWNSFIRILQLVW---------HTTVWYFSISNVKLQGQLDFRD 267

Query: 470 IGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISK-------CNDLQSFSVNLSANLLSGM 522
                 + K    ++++ +   F  S   E  S         +  +   +   + +    
Sbjct: 268 FDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKI---- 323

Query: 523 SYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELG---KL 579
                       +  + +NN ++ ++    G L +L+ L L+ N++   L        ++
Sbjct: 324 ---------SPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQM 373

Query: 580 KFLKWILLGGNNLT-GEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHN 638
           K L+ + +  N+++  E         SL+ L++S N LT +I   L    +++ L L  N
Sbjct: 374 KSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSN 431

Query: 639 RLSGEIPVSFSTLVNLSALDLSFNNLSGHIPH-----LQHLDCIAFKGNKYLASCPD 690
           ++   IP     L  L  L+++ N L   +P      L  L  I    N +  SCP 
Sbjct: 432 KIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPR 486

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  107 bits (269), Expect = 2e-24
 Identities = 105/536 (19%), Positives = 174/536 (32%), Gaps = 80/536 (14%)

Query: 139 IPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLI-GNGEL 197
           +P  +   +   +L +  N  S      + +L +LR+L +S N     +   +   N EL
Sbjct: 15  VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQEL 71

Query: 198 SVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTE-SIPKEIGKCRNLKNLLLDGNIL 256
             +D+S N+L   ++   +     L +L LS N      I KE G    LK L L    L
Sbjct: 72  EYLDLSHNKLV-KISCHPTVN---LKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHL 127

Query: 257 EGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFS 316
           E S    I  ++  KVL V   +  ++   E      L      ++      +       
Sbjct: 128 EKSSVLPIAHLNISKVLLVLGETYGEKEDPEG-----LQDFNTESLHIVFPTNKEFHFIL 182

Query: 317 AFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGM 376
                    L LS    VL   + +    +      +  L  L L            +  
Sbjct: 183 DVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQ 242

Query: 377 C---RNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQD 433
                 + Y  +S   L+G L  +        F+ S  ++                    
Sbjct: 243 LVWHTTVWYFSISNVKLQGQLDFRD-------FDYSGTSLKA------------------ 277

Query: 434 LQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFN 493
                            + IH    + F    P   I + F     K      ++     
Sbjct: 278 -----------------LSIHQVVSDVF--GFPQSYIYEIFSNMNIK---NFTVSGTRMV 315

Query: 494 GSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVG 553
             +     SK +      ++ S NLL+   +E       +L       NQ+   ++    
Sbjct: 316 HMLC---PSKISPFL--HLDFSNNLLTDTVFENC-GHLTELETLILQMNQLK-ELSKIAE 368

Query: 554 ---KLMKLQRLDLRGNRVSGSLPDEL-GKLKFLKWILLGGNNLTGEIPSQFGHLISLVVL 609
              ++  LQ+LD+  N VS           K L  + +  N LT  I         + VL
Sbjct: 369 MTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVL 426

Query: 610 DLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPV-SFSTLVNLSALDLSFNNL 664
           DL  N +  SIP  + K   L+ L +A N+L   +P   F  L +L  + L  N  
Sbjct: 427 DLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 94.2 bits (234), Expect = 4e-20
 Identities = 84/496 (16%), Positives = 169/496 (34%), Gaps = 62/496 (12%)

Query: 111 ISGTLSASIAKLTELRTLSVPHNSFSGEIPAGV-GELRLLEVLELQGNNFSGKIPYQMSN 169
           IS   ++ I  L++LR L + HN     +   V    + LE L+L  N    KI      
Sbjct: 33  ISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHNKLV-KISCH--P 88

Query: 170 LERLRVLNLSFNSFSGEVPRGLIGN-GELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLS 228
              L+ L+LSFN+F         GN  +L  + +S+  L     +  +        L L 
Sbjct: 89  TVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLG 148

Query: 229 DNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVEL 288
           + +  +  P+ +   ++     L            I  +S   V ++  +++   +    
Sbjct: 149 ETYGEKEDPEGL---QDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNK 205

Query: 289 ADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPD 348
                  +  L       +L  +  E +        +L+   ++         L G+L  
Sbjct: 206 CSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDF 265

Query: 349 NWSESC-----SLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCM 403
              +       +L +  +  +           +  N+   + +++         + + C 
Sbjct: 266 RDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTR-----MVHMLCP 320

Query: 404 ------VYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFS 457
                 ++ + S N +T       +   +N     +L+                      
Sbjct: 321 SKISPFLHLDFSNNLLT-------DTVFENCGHLTELETL-----------------ILQ 356

Query: 458 GNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSAN 517
            N+ L  L   A     +  + K   +L ++ N  +        S    L S   N+S+N
Sbjct: 357 MNQ-LKELSKIA----EMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSL--NMSSN 409

Query: 518 LLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDE-L 576
           +L+   +        ++   +  +N+I  SI   V KL  LQ L++  N++  S+PD   
Sbjct: 410 ILTDTIFRCLP---PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIF 464

Query: 577 GKLKFLKWILLGGNNL 592
            +L  L+ I L  N  
Sbjct: 465 DRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 81.1 bits (200), Expect = 7e-16
 Identities = 52/303 (17%), Positives = 109/303 (35%), Gaps = 26/303 (8%)

Query: 95  LRITGKATPWPSKSSVISGTLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEV--- 151
           ++   +        S+++   +        L  +    NSF   I   V    +      
Sbjct: 197 IKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFI-RILQLVWHTTVWYFSIS 255

Query: 152 -LELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGG 210
            ++LQG        Y  ++L+ L +  +  + F             +++ + + +     
Sbjct: 256 NVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRM- 314

Query: 211 LAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTI--- 267
           + +   S+     +L  S+N LT+++ +  G    L+ L+L  N L+  + K        
Sbjct: 315 VHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQM 373

Query: 268 SELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELL 327
             L+ LD+S+NS++         CS    L+      SL++ ++    + F         
Sbjct: 374 KSLQQLDISQNSVSYDEKKGD--CSWTKSLL------SLNMSSNILTDTIFRC------- 418

Query: 328 LSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSL 387
           L   ++VL      +   +P    +  +L+ LN+  N LK           +L  + L  
Sbjct: 419 LPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHT 477

Query: 388 NNL 390
           N  
Sbjct: 478 NPW 480

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  108 bits (271), Expect = 1e-25
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 27/212 (12%)

Query: 775 GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVK-----KLSIGRFQGIQQFDAEIGTLGRI 828
           GN+ +   IG G F     A  ++ G  VA+K     +L+    Q + +   E+  +  +
Sbjct: 15  GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR---EVRIMKIL 71

Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
            H N+V L      E  ++L+  + SGG +  ++      +++          I  A+ Y
Sbjct: 72  NHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQY 129

Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE- 947
            H      IVHRD+K  N+LLD ++N  ++DFG +    V          G   Y APE 
Sbjct: 130 CHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF--CGAPPYAAPEL 184

Query: 948 -----YATTCRVSDKADVYSFGVVLLELISGK 974
                Y        + DV+S GV+L  L+SG 
Sbjct: 185 FQGKKYDGP-----EVDVWSLGVILYTLVSGS 211

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  106 bits (267), Expect = 3e-25
 Identities = 48/218 (22%), Positives = 92/218 (42%), Gaps = 28/218 (12%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVPGY----LVAVKKLSIGRF--QGIQQFDAEIGTLGRIR 829
            F++  ++G G FGS  +A+L         VAVK L         I++F  E   +    
Sbjct: 24  QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD 83

Query: 830 HKNLVTLIG------YYVGEAEMFLVYNFLSGGNLETFI----HKKSGKKIQWSVIHKIA 879
           H ++  L+G               ++  F+  G+L  F+      ++   +    + +  
Sbjct: 84  HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFM 143

Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG 939
           +DIA  + YL        +HRD+   N +L E++   ++DFGL+R +   + +      G
Sbjct: 144 VDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY----RQG 196

Query: 940 TFGYV-----APEYATTCRVSDKADVYSFGVVLLELIS 972
               +     A E       +  +DV++FGV + E+++
Sbjct: 197 CASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  107 bits (268), Expect = 5e-25
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 19/207 (9%)

Query: 778 SIRNLIGTGGFGSTYKAELVPG----YLVAVKKLSIG-RFQGIQQFDAEIGTLGRIRHKN 832
               +IG G FG  Y   L+         AVK L+       + QF  E   +    H N
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151

Query: 833 LVTLIGY-YVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL-- 889
           +++L+G     E    +V  ++  G+L  FI +          +    + +A+ + +L  
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFLAS 210

Query: 890 -HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYV---A 945
             +      VHRD+   N +LDE+    ++DFGLAR +   E  +  +  G    V   A
Sbjct: 211 KKF------VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 264

Query: 946 PEYATTCRVSDKADVYSFGVVLLELIS 972
            E   T + + K+DV+SFGV+L EL++
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMT 291

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  106 bits (266), Expect = 6e-25
 Identities = 55/215 (25%), Positives = 87/215 (40%), Gaps = 28/215 (13%)

Query: 775 GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVK--------KLSIGRFQGIQQFDAEIGTL 825
             +S  + +G+G FG  + A        V VK        +        + +   EI  L
Sbjct: 24  QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83

Query: 826 GRIRHKNLVTLIGYYVGEAEMFLVY-NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQ 884
            R+ H N++ ++  +  +    LV     SG +L  FI +    ++   +   I   +  
Sbjct: 84  SRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVS 141

Query: 885 ALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYV 944
           A+ YL       I+HRDIK  NI++ E+    L DFG A  LE  +   T    GT  Y 
Sbjct: 142 AVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF--CGTIEYC 196

Query: 945 APE------YATTCRVSDKADVYSFGVVLLELISG 973
           APE      Y        + +++S GV L  L+  
Sbjct: 197 APEVLMGNPYR-----GPELEMWSLGVTLYTLVFE 226

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  104 bits (262), Expect = 7e-25
 Identities = 64/212 (30%), Positives = 104/212 (49%), Gaps = 26/212 (12%)

Query: 775 GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRH 830
           G++ + + +G G FG     E  + G+ VAVK   +  I     + +   EI  L   RH
Sbjct: 11  GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH 70

Query: 831 KNLVTLIGYYVGE--AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
            +++ L  Y V     + F+V  ++SGG L  +I K    +++     ++   I  A+ Y
Sbjct: 71  PHIIKL--YQVISTPTDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDY 126

Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE- 947
            H      +VHRD+KP N+LLD  +NA ++DFGL+ ++   E   T+   G+  Y APE 
Sbjct: 127 CHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEV 181

Query: 948 -----YATTCRVSDKADVYSFGVVLLELISGK 974
                YA       + D++S GV+L  L+ G 
Sbjct: 182 ISGRLYA-----GPEVDIWSCGVILYALLCGT 208

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  105 bits (264), Expect = 7e-25
 Identities = 49/220 (22%), Positives = 97/220 (44%), Gaps = 33/220 (15%)

Query: 776 NFSIRNLIGTGGFGSTYKAELV----PGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIR 829
              +  ++G G FGS  +  L         VAVK + +     + I++F +E   +    
Sbjct: 35  LLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS 94

Query: 830 HKNLVTLIG-----YYVGEAEMFLVYNFLSGGNLETFI----HKKSGKKIQWSVIHKIAI 880
           H N++ L+G        G  +  ++  F+  G+L T++     +   K I    + K  +
Sbjct: 95  HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMV 154

Query: 881 DIAQALAYL---HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDV 937
           DIA  + YL   ++      +HRD+   N +L +++   ++DFGL++ +   + +     
Sbjct: 155 DIALGMEYLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----R 204

Query: 938 AGTFGYV-----APEYATTCRVSDKADVYSFGVVLLELIS 972
            G    +     A E       + K+DV++FGV + E+ +
Sbjct: 205 QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  109 bits (275), Expect = 8e-25
 Identities = 51/206 (24%), Positives = 90/206 (43%), Gaps = 18/206 (8%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVPGY----LVAVKKLSIG-RFQGIQQFDAEIGTLGRIRH 830
              +   IG G FG  ++   +        VA+K           ++F  E  T+ +  H
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 450

Query: 831 KNLVTLIGYYVGEAE-MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
            ++V LIG  V     ++++    + G L +F+  +    +  + +   A  ++ ALAYL
Sbjct: 451 PHIVKLIG--VITENPVWIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAYL 507

Query: 890 ---HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAP 946
               +      VHRDI   N+L+       L DFGL+R +E S  +  +       ++AP
Sbjct: 508 ESKRF------VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 561

Query: 947 EYATTCRVSDKADVYSFGVVLLELIS 972
           E     R +  +DV+ FGV + E++ 
Sbjct: 562 ESINFRRFTSASDVWMFGVCMWEILM 587

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  105 bits (264), Expect = 9e-25
 Identities = 48/281 (17%), Positives = 94/281 (33%), Gaps = 50/281 (17%)

Query: 122 LTELRTLSVPHNSFSGEIPAGVGE-LRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSF 180
               +   V  +S   +  A + +    ++ L+L GN  S      ++   +L +LNLS 
Sbjct: 9   GNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67

Query: 181 NSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEI 240
           N    E    L     L  +D+++N +              +  L  ++N ++  +    
Sbjct: 68  NVLY-ETL-DLESLSTLRTLDLNNNYVQ------ELLVGPSIETLHAANNNIS-RVSCSR 118

Query: 241 GKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTD-RIPVELADCSKLSVLVL 299
           G  +  KN+ L  N +      + G  S ++ LD+  N +         A    L  L L
Sbjct: 119 G--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176

Query: 300 -----TNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGG----RLPDNW 350
                 ++   +                         L+ L     +L       +   +
Sbjct: 177 QYNFIYDVKGQVVF---------------------AKLKTL-----DLSSNKLAFMGPEF 210

Query: 351 SESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLE 391
             +  +  ++L  N L   + K+L   +NL + DL  N   
Sbjct: 211 QSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH 250

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  104 bits (261), Expect = 2e-24
 Identities = 57/313 (18%), Positives = 97/313 (30%), Gaps = 75/313 (23%)

Query: 355 SLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNIT 414
             K+  +  +SLK A+        N+  LDLS                        N ++
Sbjct: 11  RYKIEKVTDSSLKQALASLRQSAWNVKELDLS-----------------------GNPLS 47

Query: 415 GVLPR-FENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDG 473
            +               F  L+  N      +S        D      L +L        
Sbjct: 48  QISAADLAP--------FTKLELLN------LSSNVLYETLDLES---LSTL-------- 82

Query: 474 FLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQ 533
                      L LNNN        + +     +++  ++ + N +S +S          
Sbjct: 83  ---------RTLDLNNNYV------QELLVGPSIET--LHAANNNISRVSCSRG----QG 121

Query: 534 LVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSG-SLPDELGKLKFLKWILLGGNNL 592
                 ANN+I+       G   ++Q LDL+ N +   +  +       L+ + L  N +
Sbjct: 122 KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181

Query: 593 TGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLV 652
             ++  Q      L  LDLS N L   +      A  +  + L +N+L   I  +     
Sbjct: 182 Y-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQ 237

Query: 653 NLSALDLSFNNLS 665
           NL   DL  N   
Sbjct: 238 NLEHFDLRGNGFH 250

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 90.4 bits (225), Expect = 9e-20
 Identities = 31/171 (18%), Positives = 65/171 (38%), Gaps = 19/171 (11%)

Query: 513 NLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSL 572
            ++ + L              + E + + N +S   AA +    KL+ L+L  N +    
Sbjct: 16  KVTDSSLKQALASLRQ-SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ET 73

Query: 573 PDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLES 632
            D L  L  L+ + L  N +      +     S+  L  ++N ++  +  S       ++
Sbjct: 74  LD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR--GQGKKN 124

Query: 633 LFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLS--------GHIPHLQHLD 675
           ++LA+N+++    +       +  LDL  N +              L+HL+
Sbjct: 125 IYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 86.2 bits (214), Expect = 2e-18
 Identities = 21/125 (16%), Positives = 44/125 (35%), Gaps = 11/125 (8%)

Query: 555 LMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHN 614
             + +   +  + +  +L         +K + L GN L+    +       L +L+LS N
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 615 ALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLS----GHIPH 670
            L       L   + L +L L +N +            ++  L  + NN+S         
Sbjct: 69  VLY-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSRGQG 121

Query: 671 LQHLD 675
            +++ 
Sbjct: 122 KKNIY 126

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 81.6 bits (202), Expect = 9e-17
 Identities = 28/107 (26%), Positives = 44/107 (41%), Gaps = 4/107 (3%)

Query: 571 SLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKL 630
           ++ +        K   +  ++L   + S      ++  LDLS N L+    A L   TKL
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 631 ESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLS--GHIPHLQHLD 675
           E L L+ N L  E      +L  L  LDL+ N +      P ++ L 
Sbjct: 61  ELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYVQELLVGPSIETLH 105

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 79.6 bits (197), Expect = 4e-16
 Identities = 39/240 (16%), Positives = 79/240 (32%), Gaps = 37/240 (15%)

Query: 169 NLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLS 228
           N  R ++  ++ +S    +         +  +D+S N LS  ++    +    L  L LS
Sbjct: 8   NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKLELLNLS 66

Query: 229 DNFLTESIP-----------------KEIGKCRNLKNLLLDGNILEGSIPKEIGTISELK 271
            N L E++                  +E+    +++ L    N +   +    G     K
Sbjct: 67  SNVLYETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNIS-RVSCSRGQ--GKK 123

Query: 272 VLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRS 331
            + ++ N +T    ++    S++           LDL  +       +           +
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQY---------LDLKLNE--IDTVNFAELAASS--DT 170

Query: 332 LEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLE 391
           LE L      +   +      +  LK L+L  N L   +         +T++ L  N L 
Sbjct: 171 LEHLNLQYNFI-YDVKGQVVFA-KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 73.1 bits (180), Expect = 6e-14
 Identities = 37/217 (17%), Positives = 80/217 (36%), Gaps = 28/217 (12%)

Query: 222 LTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLT 281
               K++D+ L +++        N+K L L GN L      ++   ++L++L++S N L 
Sbjct: 12  YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY 71

Query: 282 DRIPVELADCSKLSVLVL-----TNIDA-----SLDLDN---SRGEFSAFDGGVPYELLL 328
           +    +L   S L  L L       +       +L   N   SR   S            
Sbjct: 72  E-TL-DLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRG---------- 119

Query: 329 SRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKG-AVPKSLGMCRNLTYLDLSL 387
            +  + ++     +      +      ++ L+L  N +      +       L +L+L  
Sbjct: 120 -QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY 178

Query: 388 NNLEGYLPMQLPVPCMVYFNVSQNNITGVLPRFENVS 424
           N +   +  Q+    +   ++S N +  + P F++ +
Sbjct: 179 NFIYD-VKGQVVFAKLKTLDLSSNKLAFMGPEFQSAA 214

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 61.2 bits (149), Expect = 5e-10
 Identities = 66/406 (16%), Positives = 122/406 (30%), Gaps = 92/406 (22%)

Query: 235 SIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKL 294
           +I +        K   +  + L+ ++     +   +K LD+S N L+     +LA  +KL
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 295 SVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESC 354
            +L L++        N   E    +           +L  L     +L            
Sbjct: 61  ELLNLSS--------NVLYETLDLESL--------STLRTL-----DLNNNYVQELLVGP 99

Query: 355 SLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQL-PVPCMVYFNVSQNNI 413
           S++ L+   N++   V  S G  +    + L+ N +     +       + Y ++  N I
Sbjct: 100 SIETLHAANNNIS-RVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI 156

Query: 414 TGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDG 473
             V       S D       L++ N+         NF  I+D  G      L        
Sbjct: 157 DTVNFAELAASSDT------LEHLNL-------QYNF--IYDVKGQVVFAKL-------- 193

Query: 474 FLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQ 533
                      L L++N     +  E       +   S+                     
Sbjct: 194 ---------KTLDLSSNKLA-FMGPE-FQSAAGVTWISLR-------------------- 222

Query: 534 LVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVS-GSLPDELGKLKFLKWILLGGNNL 592
                  NN++   I   +     L+  DLRGN    G+L D   K + ++ +       
Sbjct: 223 -------NNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK- 273

Query: 593 TGEIPSQFGHLISLVVLDLSHNALTGSIPA-SLTKATKLESLFLAH 637
             ++  Q     ++  L          +PA    +   L      H
Sbjct: 274 --KLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALGHHHHHH 317

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  104 bits (261), Expect = 3e-24
 Identities = 49/203 (24%), Positives = 87/203 (42%), Gaps = 20/203 (9%)

Query: 780 RNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRI-RHKNLVTLI 837
           + ++G G  G   +      G   A+K   +      +Q   E+    +     ++V ++
Sbjct: 34  KQVLGLGVNGKVLECFHRRTGQKCALK--LLYDSPKARQ---EVDHHWQASGGPHIVCIL 88

Query: 838 GYY----VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
             Y     G+  + ++   + GG L + I ++  +        +I  DI  A+ +LH   
Sbjct: 89  DVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH- 147

Query: 894 VPRIVHRDIKPSNILL-DEELNAYL--SDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
              I HRD+KP N+L   +E +A L  +DFG A+       +A      T  YVAPE   
Sbjct: 148 --NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET---TQNALQTPCYTPYYVAPEVLG 202

Query: 951 TCRVSDKADVYSFGVVLLELISG 973
             +     D++S GV++  L+ G
Sbjct: 203 PEKYDKSCDMWSLGVIMYILLCG 225

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  104 bits (260), Expect = 3e-24
 Identities = 46/225 (20%), Positives = 85/225 (37%), Gaps = 21/225 (9%)

Query: 759 ADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQF 818
               A+L +  +VR    +               +               +     +   
Sbjct: 55  VKALAKLEHPGIVRYFNAWLETP------PEKWQEEMDEIWLKDESTDWPLSSPSPMDAP 108

Query: 819 DAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQ-WSVIHK 877
             +I  +     KN V  +     +  +++        NL+ +++++   + +   V   
Sbjct: 109 SVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLH 168

Query: 878 IAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT--- 934
           I I IA+A+ +LH      ++HRD+KPSNI    +    + DFGL   ++  E   T   
Sbjct: 169 IFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225

Query: 935 --------TDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELI 971
                   T   GT  Y++PE       S K D++S G++L EL+
Sbjct: 226 PMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  104 bits (261), Expect = 5e-24
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 16/208 (7%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVP-GYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
           +F I   IG G FG     +      + A+K   K        ++    E+  +  + H 
Sbjct: 16  HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHP 75

Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIH-KKSGKKIQWSVIHKIAIDIAQALAYLH 890
            LV L   +  E +MF+V + L GG+L    H +++    + +V   I  ++  AL YL 
Sbjct: 76  FLVNLWYSFQDEEDMFMVVDLLLGGDL--RYHLQQNVHFKEETVKLFIC-ELVMALDYLQ 132

Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
                RI+HRD+KP NILLDE  + +++DF +A    +      T +AGT  Y+APE  +
Sbjct: 133 NQ---RIIHRDMKPDNILLDEHGHVHITDFNIAA--MLPRETQITTMAGTKPYMAPEMFS 187

Query: 951 TCRVS--DKA-DVYSFGVVLLELISGKR 975
           + + +    A D +S GV   EL+ G+R
Sbjct: 188 SRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  101 bits (255), Expect = 9e-24
 Identities = 52/225 (23%), Positives = 95/225 (42%), Gaps = 38/225 (16%)

Query: 776 NFSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIR 829
           +  ++  +G G FG  + AE           LVAVK L        + F  E   L  ++
Sbjct: 16  DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQ 75

Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETF--------------IHKKSGKKIQWSVI 875
           H+++V   G       + +V+ ++  G+L  F                +++  ++  S +
Sbjct: 76  HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135

Query: 876 HKIAIDIAQALAYL---HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH 932
             IA  IA  + YL   H+      VHRD+   N L+   L   + DFG++R +  ++ +
Sbjct: 136 LHIASQIASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY 189

Query: 933 ATTDVAGTFGYV-----APEYATTCRVSDKADVYSFGVVLLELIS 972
                 G    +      PE     + + ++DV+SFGV+L E+ +
Sbjct: 190 R----VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  101 bits (254), Expect = 1e-23
 Identities = 52/219 (23%), Positives = 96/219 (43%), Gaps = 24/219 (10%)

Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ-GIQQFDA--EIGTLGRIRHK 831
            +     IG G +G+ +KA       +VA+K++ +     G+    A  EI  L  ++HK
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVP-SSALREICLLKELKHK 61

Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
           N+V L      + ++ LV+ F    +L+ +        +   ++      + + L + H 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYF-DSCNGDLDPEIVKSFLFQLLKGLGFCHS 119

Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE---- 947
                ++HRD+KP N+L++      L++FGLAR   +     + +V  T  Y  P+    
Sbjct: 120 R---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFG 175

Query: 948 ---YATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSE 983
              Y+T+       D++S G +  EL +  R L P    
Sbjct: 176 AKLYSTSI------DMWSAGCIFAELANAGRPLFPGNDV 208

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  101 bits (253), Expect = 2e-23
 Identities = 56/209 (26%), Positives = 91/209 (43%), Gaps = 22/209 (10%)

Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDA--EIGTLGRIRHKN 832
            +     IG G +G  +K      G +VA+KK        + +  A  EI  L +++H N
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN 63

Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           LV L+  +  +  + LV+ +     +   +  +  + +   ++  I     QA+ + H  
Sbjct: 64  LVNLLEVFRRKRRLHLVFEYCDH-TVLHEL-DRYQRGVPEHLVKSITWQTLQAVNFCHKH 121

Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE----- 947
                +HRD+KP NIL+ +     L DFG ARLL     +   +VA T  Y +PE     
Sbjct: 122 ---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPELLVGD 177

Query: 948 --YATTCRVSDKADVYSFGVVLLELISGK 974
             Y          DV++ G V  EL+SG 
Sbjct: 178 TQYGPP------VDVWAIGCVFAELLSGV 200

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  104 bits (262), Expect = 2e-23
 Identities = 104/538 (19%), Positives = 192/538 (35%), Gaps = 96/538 (17%)

Query: 173 LRVLNLSFNSFSGEVPRGLIGN-GELSVIDMSSNRLSGGLAIDSSS--ECEFLTYLKLSD 229
            + L+LS NS S E+    I    EL V+ +S NR+    ++D       + L YL +S 
Sbjct: 54  TKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIR---SLDFHVFLFNQDLEYLDVSH 109

Query: 230 NFLTESIPKEIGKCRNLKNLLLDGNILEGSIP--KEIGTISELKVLDVSRNSLTDRIPVE 287
           N L  +I        +L++L L  N  +  +P  KE G +++L  L +S      ++ + 
Sbjct: 110 NRLQ-NIS--CCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFR-QLDLL 164

Query: 288 LADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLP 347
                 LS ++L  +   +      GE  +        L L      L++ + N+     
Sbjct: 165 PVAHLHLSCILLDLVSYHI----KGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSV--- 217

Query: 348 DNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPV------P 401
            N      L  + L   + +  +     + R  T L+++L ++E      + +       
Sbjct: 218 -NALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPR 276

Query: 402 CMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKF 461
            + Y N+    IT  +              ++  Y+   +         ++I       F
Sbjct: 277 PVEYLNIYNLTITERID------------REEFTYSETAL-------KSLMIEHVKNQVF 317

Query: 462 LGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSG 521
                  A+   F     K    L +++  F   V        +      +N + N+ + 
Sbjct: 318 --LFSKEALYSVFAEMNIK---MLSISDTPFIHMVC---PPSPSSFTF--LNFTQNVFTD 367

Query: 522 MSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLP---DELGK 578
             ++                             L +LQ L L+ N +  +          
Sbjct: 368 SVFQGC-------------------------STLKRLQTLILQRNGLK-NFFKVALMTKN 401

Query: 579 LKFLKWILLGGNNLT-GEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAH 637
           +  L+ + +  N+L             S++VL+LS N LTGS+   L    K++ L L +
Sbjct: 402 MSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHN 459

Query: 638 NRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPH-----LQHLDCIAFKGNKYLASCPD 690
           NR+   IP   + L  L  L+++ N L   +P      L  L  I    N +  +CP 
Sbjct: 460 NRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCPG 515

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 76.4 bits (188), Expect = 2e-14
 Identities = 93/501 (18%), Positives = 162/501 (32%), Gaps = 96/501 (19%)

Query: 121 KLTELRTLSVPHNSFSGEIPAGV-GELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLS 179
            L+ELR L + HN     +   V    + LE L++  N     I      +  LR L+LS
Sbjct: 74  FLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDLS 129

Query: 180 FNSFSGEVPRGLIGN-GELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLT----- 233
           FN F         GN  +L+ + +S+ +           +   + +L LS   L      
Sbjct: 130 FNDFDVLPVCKEFGNLTKLTFLGLSAAKFR-------QLDLLPVAHLHLSCILLDLVSYH 182

Query: 234 -ESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLT-------DRIP 285
            +    E  +  N   L L  +       +   +++ L  L +S   L            
Sbjct: 183 IKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFL 242

Query: 286 VELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGR 345
            EL     L  + L +I+ +        +F              R +E L      +  R
Sbjct: 243 SELTRGPTLLNVTLQHIETTWKCSVKLFQF-----------FWPRPVEYLNIYNLTITER 291

Query: 346 LPDNWSESC-----SLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPV 400
           +             SL + ++       +      +   +    LS+++        + +
Sbjct: 292 IDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTP-----FIHM 346

Query: 401 PC------MVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIH 454
            C        + N +QN  T  + +     C      + LQ                   
Sbjct: 347 VCPPSPSSFTFLNFTQNVFTDSVFQ----GCST---LKRLQT-----------------L 382

Query: 455 DFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSV-N 513
               N  L +          +A   K    L   +   N          C   +S  V N
Sbjct: 383 ILQRNG-LKNFFK-------VALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLN 434

Query: 514 LSANLLSGMSYEAFLLDC--VQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGS 571
           LS+N+L+       +  C   ++   +  NN+I  SI   V  L  LQ L++  N++  S
Sbjct: 435 LSSNMLT-----GSVFRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-S 487

Query: 572 LPDE-LGKLKFLKWILLGGNN 591
           +PD    +L  L++I L  N 
Sbjct: 488 VPDGVFDRLTSLQYIWLHDNP 508

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 74.9 bits (184), Expect = 7e-14
 Identities = 63/422 (14%), Positives = 127/422 (30%), Gaps = 58/422 (13%)

Query: 259 SIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAF 318
            +PK++      K L +S+NS+++   + + D S LS L +      L L ++R    + 
Sbjct: 45  HVPKDLPP--RTKALSLSQNSISE---LRMPDISFLSELRV------LRLSHNR--IRSL 91

Query: 319 DGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCR 378
           D  V                                 L+ L++  N L+  +        
Sbjct: 92  DFHVFLFN---------------------------QDLEYLDVSHNRLQ-NIS--CCPMA 121

Query: 379 NLTYLDLSLNNLEGYLPMQLPVPCMV---YFNVSQNNITGV-LPRFENVSCDNHFGFQDL 434
           +L +LDLS N+ +  LP+      +    +  +S      + L    ++           
Sbjct: 122 SLRHLDLSFNDFDV-LPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVS 180

Query: 435 QYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLN-NNMFN 493
            +       S+   N  ++H       L S+ +        A  +     + LN  N   
Sbjct: 181 YHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVN---MSVNALGHLQLSNIKLNDENCQR 237

Query: 494 GSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVG 553
                  +++   L + ++                     +      N  I+  I     
Sbjct: 238 LMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEF 297

Query: 554 -----KLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVV 608
                 L  L    ++      S          +   +L  ++             S   
Sbjct: 298 TYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTF 357

Query: 609 LDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHI 668
           L+ + N  T S+    +   +L++L L  N L            N+S+L+    +L+   
Sbjct: 358 LNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLN 416

Query: 669 PH 670
            H
Sbjct: 417 SH 418

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 43.7 bits (103), Expect = 3e-04
 Identities = 22/78 (28%), Positives = 32/78 (41%), Gaps = 10/78 (12%)

Query: 605 SLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNL 664
              ++D S+  LT  +P  L   TK  +L L+ N +S       S L  L  L LS N +
Sbjct: 32  LESMVDYSNRNLT-HVPKDLPPRTK--ALSLSQNSISELRMPDISFLSELRVLRLSHNRI 88

Query: 665 S-------GHIPHLQHLD 675
                        L++LD
Sbjct: 89  RSLDFHVFLFNQDLEYLD 106

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  101 bits (253), Expect = 2e-23
 Identities = 62/209 (29%), Positives = 104/209 (49%), Gaps = 23/209 (11%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQ-GIQQFDA--EIGTLGRIRHKN 832
            +     +G G +G  YKA+   G +VA+K++ +     GI    A  EI  L  + H N
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIP-STAIREISLLKELHHPN 80

Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V+LI     E  + LV+ F+   +L+  +  ++   +Q S I      + + +A+ H  
Sbjct: 81  IVSLIDVIHSERCLTLVFEFMEK-DLKKVL-DENKTGLQDSQIKIYLYQLLRGVAHCHQH 138

Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE----- 947
              RI+HRD+KP N+L++ +    L+DFGLAR   +     T +V  T  Y AP+     
Sbjct: 139 ---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGS 194

Query: 948 --YATTCRVSDKADVYSFGVVLLELISGK 974
             Y+T+       D++S G +  E+I+GK
Sbjct: 195 KKYSTS------VDIWSIGCIFAEMITGK 217

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  101 bits (253), Expect = 3e-23
 Identities = 46/217 (21%), Positives = 93/217 (42%), Gaps = 27/217 (12%)

Query: 776 NFSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSIG-RFQGIQQFDAEIGTLGRI 828
             ++   +G G FG  Y+          P   VA+K ++     +   +F  E   +   
Sbjct: 26  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 85

Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSV--------IHKIAI 880
              ++V L+G         ++   ++ G+L++++           V        + ++A 
Sbjct: 86  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145

Query: 881 DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT 940
           +IA  +AYL+ +   + VHRD+   N ++ E+    + DFG+ R +  ++ +      G 
Sbjct: 146 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKGG 198

Query: 941 FGYV-----APEYATTCRVSDKADVYSFGVVLLELIS 972
            G +     +PE       +  +DV+SFGVVL E+ +
Sbjct: 199 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  102 bits (256), Expect = 3e-23
 Identities = 51/200 (25%), Positives = 85/200 (42%), Gaps = 19/200 (9%)

Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRI-RHKNLVTLIGYY 840
           +G G  G   +          A+K   +      ++   E+    R  +  ++V ++  Y
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALK--MLQDCPKARR---EVELHWRASQCPHIVRIVDVY 124

Query: 841 ----VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPR 896
                G   + +V   L GG L + I  +  +        +I   I +A+ YLH      
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---N 181

Query: 897 IVHRDIKPSNILL-DEELNAYL--SDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCR 953
           I HRD+KP N+L   +  NA L  +DFG A+  E +  ++ T    T  YVAPE     +
Sbjct: 182 IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEK 239

Query: 954 VSDKADVYSFGVVLLELISG 973
                D++S GV++  L+ G
Sbjct: 240 YDKSCDMWSLGVIMYILLCG 259

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  101 bits (253), Expect = 3e-23
 Identities = 58/220 (26%), Positives = 93/220 (42%), Gaps = 33/220 (15%)

Query: 776 NFSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSIG-RFQGIQQFDAEIGTLGRI 828
           N ++   +G G FG  Y+ ++           VAVK L      Q    F  E   + + 
Sbjct: 31  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 90

Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-----KIAIDIA 883
            H+N+V  IG  +     F++   ++GG+L++F+ +   +  Q S +       +A DIA
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150

Query: 884 QALAYL---HYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSETHATTDV 937
               YL   H+      +HRDI   N LL        A + DFG+AR +  +  +     
Sbjct: 151 CGCQYLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR---- 200

Query: 938 AGTFGYV-----APEYATTCRVSDKADVYSFGVVLLELIS 972
            G    +      PE       + K D +SFGV+L E+ S
Sbjct: 201 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =   99 bits (250), Expect = 3e-23
 Identities = 59/213 (27%), Positives = 91/213 (42%), Gaps = 19/213 (8%)

Query: 770 VVRATGNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQG-IQQFDAEIGTLGR 827
            V    ++ +   +G G +G    A   V    VAVK + + R     +    EI     
Sbjct: 2   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM 61

Query: 828 IRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALA 887
           + H+N+V   G+       +L   + SGG  E F   +    +      +    +   + 
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVV 119

Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVA-GTFGYVAP 946
           YLH      I HRDIKP N+LLDE  N  +SDFGLA +   +      +   GT  YVAP
Sbjct: 120 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 947 E------YATTCRVSDKADVYSFGVVLLELISG 973
           E      +      ++  DV+S G+VL  +++G
Sbjct: 177 ELLKRREFH-----AEPVDVWSCGIVLTAMLAG 204

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  104 bits (260), Expect = 4e-23
 Identities = 62/203 (30%), Positives = 96/203 (47%), Gaps = 9/203 (4%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLS---IGRFQGIQQFDAEIGTLGRIRHK 831
            F    ++G GGFG     ++   G + A KKL    I + +G      E   L ++  +
Sbjct: 185 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 244

Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
            +V+L   Y  +  + LV   ++GG+L+  I+         +     A +I   L  LH 
Sbjct: 245 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR 304

Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT 951
               RIV+RD+KP NILLD+  +  +SD GLA    V E        GT GY+APE    
Sbjct: 305 E---RIVYRDLKPENILLDDHGHIRISDLGLAV--HVPEGQTIKGRVGTVGYMAPEVVKN 359

Query: 952 CRVSDKADVYSFGVVLLELISGK 974
            R +   D ++ G +L E+I+G+
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQ 382

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  100 bits (251), Expect = 5e-23
 Identities = 51/224 (22%), Positives = 92/224 (41%), Gaps = 37/224 (16%)

Query: 776 NFSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIR 829
           +  ++  +G G FG  + AE           LVAVK L        Q F  E   L  ++
Sbjct: 42  DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQ 101

Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETF-------------IHKKSGKKIQWSVIH 876
           H+++V   G       + +V+ ++  G+L  F                 +   +    + 
Sbjct: 102 HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 161

Query: 877 KIAIDIAQALAYL---HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA 933
            +A  +A  + YL   H+      VHRD+   N L+ + L   + DFG++R +  ++ + 
Sbjct: 162 AVASQVAAGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 215

Query: 934 TTDVAGTFGYV-----APEYATTCRVSDKADVYSFGVVLLELIS 972
                G    +      PE     + + ++DV+SFGVVL E+ +
Sbjct: 216 ----VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 99.7 bits (249), Expect = 7e-23
 Identities = 52/218 (23%), Positives = 84/218 (38%), Gaps = 32/218 (14%)

Query: 775 GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVK------KLSIGRFQGIQQFDAEIGTLGR 827
             + +  L+G GGFG+ +    L     VA+K       L             E+  L +
Sbjct: 31  AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90

Query: 828 IR----HKNLVTLIGYYVGEAEMFLVYNF-LSGGNLETFIHKKSGKKIQWSVIHKIAIDI 882
           +     H  ++ L+ ++  +    LV    L   +L  +I +K    +           +
Sbjct: 91  VGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQV 148

Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVSETHATTDVAGTF 941
             A+ + H      +VHRDIK  NIL+D       L DFG   LL         D  GT 
Sbjct: 149 VAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYT-DFD--GTR 202

Query: 942 GYVAPEYATTCRVSDK------ADVYSFGVVLLELISG 973
            Y  PE+     +S        A V+S G++L +++ G
Sbjct: 203 VYSPPEW-----ISRHQYHALPATVWSLGILLYDMVCG 235

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  102 bits (255), Expect = 8e-23
 Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 22/210 (10%)

Query: 775 GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRH 830
           G++ + + +G G FG     +  + G+ VAVK   +  I     + +   EI  L   RH
Sbjct: 16  GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH 75

Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +++ L       +++F+V  ++SGG L  +I K    ++      ++   I   + Y H
Sbjct: 76  PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCH 133

Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE--- 947
                 +VHRD+KP N+LLD  +NA ++DFGL+ ++   E   T+   G+  Y APE   
Sbjct: 134 RH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVIS 188

Query: 948 ---YATTCRVSDKADVYSFGVVLLELISGK 974
              YA       + D++S GV+L  L+ G 
Sbjct: 189 GRLYA-----GPEVDIWSSGVILYALLCGT 213

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  103 bits (257), Expect = 9e-23
 Identities = 71/435 (16%), Positives = 150/435 (34%), Gaps = 98/435 (22%)

Query: 235 SIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVE-LADCSK 293
            I   +       ++ +D    +     E  T++  K++    +++  ++P   L    +
Sbjct: 18  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 76

Query: 294 LSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSES 353
           + +L         +L++ +                   +E +                  
Sbjct: 77  VELL---------NLNDLQ-------------------IEEI---DTYAFAYAH------ 99

Query: 354 CSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQL--PVPCMVYFNVSQN 411
            +++ L +G N+++   P        LT L L  N+L   LP  +    P +   ++S N
Sbjct: 100 -TIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNN 157

Query: 412 NITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIG 471
           N+  +              FQ                +   +   S N+ L  + L  I 
Sbjct: 158 NLERIEDDT----------FQATT-------------SLQNL-QLSSNR-LTHVDLSLIP 192

Query: 472 DGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDC 531
              L       +   ++ N+         ++    ++    + S N ++ +         
Sbjct: 193 S--L-------FHANVSYNLL------STLAIPIAVEEL--DASHNSINVVRGPVN---- 231

Query: 532 VQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDE-LGKLKFLKWILLGGN 590
           V+L   +  +N ++   A  +     L  +DL  N +   +      K++ L+ + +  N
Sbjct: 232 VELTILKLQHNNLT-DTAWLLN-YPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNN 288

Query: 591 NLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFST 650
            L   +      + +L VLDLSHN L   +  +  +  +LE+L+L HN +     +  ST
Sbjct: 289 RLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV---TLKLST 343

Query: 651 LVNLSALDLSFNNLS 665
              L  L LS N+  
Sbjct: 344 HHTLKNLTLSHNDWD 358

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 97.3 bits (242), Expect = 7e-21
 Identities = 59/333 (17%), Positives = 113/333 (33%), Gaps = 66/333 (19%)

Query: 355 SLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQL--PVPCMVYFNVSQNN 412
           + K++    ++++      L   R +  L+L+   +E  +          +    +  N 
Sbjct: 52  NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNA 110

Query: 413 ITGVLPRFENVSCDNHF-GFQDLQYANVPVMGSISDENFVIIHDFSGNKF--LGSLPLFA 469
           I  + P        + F     L    +       + N   +       F     L    
Sbjct: 111 IRYLPP--------HVFQNVPLLTVLVL-------ERND--LSSLPRGIFHNTPKL---- 149

Query: 470 IGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLL 529
                          L ++NN     +  +       LQ+  + LS+N L+ +       
Sbjct: 150 -------------TTLSMSNNNLE-RIEDDTFQATTSLQN--LQLSSNRLTHVDLSLI-- 191

Query: 530 DCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGG 589
               L     + N +S      +   + ++ LD   N ++  +   +     L  + L  
Sbjct: 192 --PSLFHANVSYNLLST-----LAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQH 241

Query: 590 NNLTGEIPSQFGHLISLVVLDLSHNALTGSIPA-SLTKATKLESLFLAHNRLSGEIPVSF 648
           NNLT +      +   LV +DLS+N L   I      K  +LE L++++NRL   + +  
Sbjct: 242 NNLT-DTAW-LLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYG 297

Query: 649 STLVNLSALDLSFNNLS------GHIPHLQHLD 675
             +  L  LDLS N+L            L++L 
Sbjct: 298 QPIPTLKVLDLSHNHLLHVERNQPQFDRLENLY 330

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 87.3 bits (216), Expect = 8e-18
 Identities = 37/202 (18%), Positives = 75/202 (37%), Gaps = 17/202 (8%)

Query: 487 LNNNMFNGSVPGERISKCNDLQSFSVNLSANL-LSGMSYEAFL----LDCVQLVEFEAAN 541
           +         P +   KC D       +  ++ +   + + +     +           N
Sbjct: 1   VGGQQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKN 60

Query: 542 NQISGSIAAGV-GKLMKLQRLDLRGNRVSGSLPDE-LGKLKFLKWILLGGNNLTGEIPSQ 599
           + +   + A +     +++ L+L   ++   +          ++ + +G N +    P  
Sbjct: 61  STMR-KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHV 118

Query: 600 FGHLISLVVLDLSHNALTGSIPASL-TKATKLESLFLAHNRLSGEIPVS-FSTLVNLSAL 657
           F ++  L VL L  N L+ S+P  +     KL +L +++N L   I    F    +L  L
Sbjct: 119 FQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNL 176

Query: 658 DLSFNNLS----GHIPHLQHLD 675
            LS N L+      IP L H +
Sbjct: 177 QLSSNRLTHVDLSLIPSLFHAN 198

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 75.0 bits (184), Expect = 6e-14
 Identities = 48/275 (17%), Positives = 102/275 (37%), Gaps = 32/275 (11%)

Query: 131 PHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRG 190
           P       I + +    +   + +          ++   L   +++    ++   ++P  
Sbjct: 11  PRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAA 69

Query: 191 LIGN-GELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEI-GKCRNLKN 248
           L+ +  ++ +++++  ++   +   + +    +  L +  N +   +P  +      L  
Sbjct: 70  LLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTV 127

Query: 249 LLLDGNILEGSIPKEI-GTISELKVLDVSRNSLTDRIPVE-LADCSKLSVLVL-----TN 301
           L+L+ N L  S+P+ I     +L  L +S N+L  RI  +     + L  L L     T+
Sbjct: 128 LVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH 185

Query: 302 IDASL-----DLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSL 356
           +D SL       + S    S              ++E L A   ++   +      +  L
Sbjct: 186 VDLSLIPSLFHANVSYNLLSTLAI--------PIAVEELDASHNSI-NVVRGP--VNVEL 234

Query: 357 KVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLE 391
            +L L  N+L       L     L  +DLS N LE
Sbjct: 235 TILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELE 267

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 63.0 bits (153), Expect = 3e-10
 Identities = 42/261 (16%), Positives = 86/261 (32%), Gaps = 11/261 (4%)

Query: 122 LTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFN 181
             EL  L + HN+ + +    +     L  ++L  N     + +    ++RL  L +S N
Sbjct: 231 NVELTILKLQHNNLT-DTAWLLN-YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNN 288

Query: 182 SFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSS-SECEFLTYLKLSDNFLTESIPKEI 240
                +         L V+D+S N L     ++ +  + + L  L L  N +  ++   +
Sbjct: 289 RLV-ALNLYGQPIPTLKVLDLSHNHLL---HVERNQPQFDRLENLYLDHNSIV-TLK--L 341

Query: 241 GKCRNLKNLLLDGNILEGSIPKEIGT-ISELKVLDVSRNSLTDRIPVELADCSKLSVLVL 299
                LKNL L  N  + +  + +   ++   V D  ++   D        C +     L
Sbjct: 342 STHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYL 401

Query: 300 TNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVL 359
             +   + L +   +     G       ++    +        G  L  N      +  L
Sbjct: 402 DRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNEL 461

Query: 360 NLGQNSLKGAVPKSLGMCRNL 380
                 L     +   + + L
Sbjct: 462 RAEVQQLTNEQIQQEQLLQGL 482

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 51.5 bits (123), Expect = 1e-06
 Identities = 30/181 (16%), Positives = 60/181 (33%), Gaps = 15/181 (8%)

Query: 114 TLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERL 173
            L+     +  L+ L + HN     +     +   LE L L  N+    +   +S    L
Sbjct: 292 ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTL 347

Query: 174 RVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECE---------FLTY 224
           + L LS N +     R L  N     +D +         ++    C+          L Y
Sbjct: 348 KNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQY 407

Query: 225 LKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRI 284
           + L+   + E + +  G+C     +    ++      +    +   + L+   N L   +
Sbjct: 408 IALTS--VVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEV 465

Query: 285 P 285
            
Sbjct: 466 Q 466

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =   99 bits (250), Expect = 1e-22
 Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 25/212 (11%)

Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQ---FDA--EIGTLGRIR 829
            +   + +G G F + YKA +     +VA+KK+ +G     +      A  EI  L  + 
Sbjct: 11  RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 70

Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           H N++ L+  +  ++ + LV++F+   +LE  I K +   +  S I    +   Q L YL
Sbjct: 71  HPNIIGLLDAFGHKSNISLVFDFMET-DLEVII-KDNSLVLTPSHIKAYMLMTLQGLEYL 128

Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE-- 947
           H      I+HRD+KP+N+LLDE     L+DFGLA+         T  V  T  Y APE  
Sbjct: 129 HQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TRWYRAPELL 184

Query: 948 -----YATTCRVSDKADVYSFGVVLLELISGK 974
                Y          D+++ G +L EL+   
Sbjct: 185 FGARMYGVG------VDMWAVGCILAELLLRV 210

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 98.7 bits (247), Expect = 1e-22
 Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 23/209 (11%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQ-GIQQFDA--EIGTLGRIRHKN 832
            +     IG G +G  YKA+   G   A+KK+ + +   GI       EI  L  ++H N
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIP-STTIREISILKELKHSN 61

Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +V L      +  + LV+  L   +L+  +    G  ++        + +   +AY H  
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHDR 119

Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE----- 947
              R++HRD+KP N+L++ E    ++DFGLAR   +     T ++  T  Y AP+     
Sbjct: 120 ---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGS 175

Query: 948 --YATTCRVSDKADVYSFGVVLLELISGK 974
             Y+TT       D++S G +  E+++G 
Sbjct: 176 KKYSTT------IDIWSVGCIFAEMVNGT 198

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 99.3 bits (248), Expect = 1e-22
 Identities = 59/213 (27%), Positives = 91/213 (42%), Gaps = 19/213 (8%)

Query: 770 VVRATGNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQG-IQQFDAEIGTLGR 827
            V    ++ +   +G G +G    A   V    VAVK + + R     +    EI     
Sbjct: 2   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKM 61

Query: 828 IRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALA 887
           + H+N+V   G+       +L   + SGG  E F   +    +      +    +   + 
Sbjct: 62  LNHENVVKFYGHRREGNIQYLFLEYCSGG--ELFDRIEPDIGMPEPDAQRFFHQLMAGVV 119

Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVA-GTFGYVAP 946
           YLH      I HRDIKP N+LLDE  N  +SDFGLA +   +      +   GT  YVAP
Sbjct: 120 YLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 947 E------YATTCRVSDKADVYSFGVVLLELISG 973
           E      +      ++  DV+S G+VL  +++G
Sbjct: 177 ELLKRREFH-----AEPVDVWSCGIVLTAMLAG 204

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 98.8 bits (247), Expect = 2e-22
 Identities = 55/212 (25%), Positives = 104/212 (49%), Gaps = 24/212 (11%)

Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDA--EIGTLGRIRHKN 832
            F     +G G + + YK      G  VA+K++ +   +G     A  EI  +  ++H+N
Sbjct: 6   QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTP-STAIREISLMKELKHEN 64

Query: 833 LVTLIGYYVGEAEMFLVYNFLS---GGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           +V L      E ++ LV+ F+       +++     + + ++ +++      + Q LA+ 
Sbjct: 65  IVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124

Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE-- 947
           H +   +I+HRD+KP N+L+++     L DFGLAR   +     +++V  T  Y AP+  
Sbjct: 125 HEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAPDVL 180

Query: 948 -----YATTCRVSDKADVYSFGVVLLELISGK 974
                Y+T+       D++S G +L E+I+GK
Sbjct: 181 MGSRTYSTS------IDIWSCGCILAEMITGK 206

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 98.6 bits (246), Expect = 2e-22
 Identities = 50/217 (23%), Positives = 87/217 (40%), Gaps = 30/217 (13%)

Query: 775 GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKL------SIGRFQGIQQFDAEIGTLGR 827
             + +  L+G+GGFGS Y    +     VA+K +        G      +   E+  L +
Sbjct: 43  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102

Query: 828 IRHK--NLVTLIGYYVGEAEMFLVYNFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQ 884
           +      ++ L+ ++       L+        +L  FI ++    +Q  +       + +
Sbjct: 103 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLE 160

Query: 885 ALAYLHYSCVPRIVHRDIKPSNILLDEE-LNAYLSDFGLARLLEVSETHATTDVAGTFGY 943
           A+ + H      ++HRDIK  NIL+D       L DFG   LL+ +      D  GT  Y
Sbjct: 161 AVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT---DFDGTRVY 214

Query: 944 VAPE------YATTCRVSDKADVYSFGVVLLELISGK 974
             PE      Y         A V+S G++L +++ G 
Sbjct: 215 SPPEWIRYHRYHGR-----SAAVWSLGILLYDMVCGD 246

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 98.4 bits (246), Expect = 2e-22
 Identities = 60/217 (27%), Positives = 93/217 (42%), Gaps = 20/217 (9%)

Query: 772 RATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ-GIQQFDA----EIGTL 825
            AT  +     IG G +G+ YKA +   G+ VA+K + +     G          E+  L
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65

Query: 826 GRIR---HKNLVTLIGYYVG-----EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHK 877
            R+    H N+V L+          E ++ LV+  +   +L T++ K     +    I  
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKD 124

Query: 878 IAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDV 937
           +     + L +LH +    IVHRD+KP NIL+       L+DFGLAR+        T  V
Sbjct: 125 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL-TPVV 180

Query: 938 AGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
             T  Y APE       +   D++S G +  E+   K
Sbjct: 181 V-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 98.0 bits (245), Expect = 2e-22
 Identities = 52/224 (23%), Positives = 92/224 (41%), Gaps = 39/224 (17%)

Query: 778 SIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSIG-RFQGIQQFDAEIGTLGRIRH 830
                +G   FG  YK  L           VA+K L         ++F  E     R++H
Sbjct: 12  RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 71

Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKS--------------GKKIQWSVIH 876
            N+V L+G    +  + +++++ S G+L  F+  +S                 ++     
Sbjct: 72  PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131

Query: 877 KIAIDIAQALAYL---HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA 933
            +   IA  + YL   H       VH+D+   N+L+ ++LN  +SD GL R +  ++ + 
Sbjct: 132 HLVAQIAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYY- 184

Query: 934 TTDVAGTFGYV-----APEYATTCRVSDKADVYSFGVVLLELIS 972
                     +     APE     + S  +D++S+GVVL E+ S
Sbjct: 185 ---KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 98.4 bits (246), Expect = 3e-22
 Identities = 57/209 (27%), Positives = 90/209 (43%), Gaps = 22/209 (10%)

Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDA--EIGTLGRIRHKN 832
            +    L+G G +G   K      G +VA+KK        + +  A  EI  L ++RH+N
Sbjct: 26  KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHEN 85

Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           LV L+     +   +LV+ F+    +   + +     + + V+ K    I   + + H  
Sbjct: 86  LVNLLEVCKKKKRWYLVFEFVDH-TILDDL-ELFPNGLDYQVVQKYLFQIINGIGFCHSH 143

Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE----- 947
               I+HRDIKP NIL+ +     L DFG AR L         +VA T  Y APE     
Sbjct: 144 ---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPELLVGD 199

Query: 948 --YATTCRVSDKADVYSFGVVLLELISGK 974
             Y          DV++ G ++ E+  G+
Sbjct: 200 VKYGKA------VDVWAIGCLVTEMFMGE 222

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  102 bits (255), Expect = 3e-22
 Identities = 57/210 (27%), Positives = 93/210 (44%), Gaps = 22/210 (10%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFDAEIGTLG--RI---- 828
           +FS+  +IG GGFG  Y       G + A+K L   R   I+    E   L    +    
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR---IKMKQGETLALNERIMLSLV 246

Query: 829 ---RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
                  +V +   +    ++  + + ++GG+L   + +           +  A +I   
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY--AAEIILG 304

Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
           L ++H      +V+RD+KP+NILLDE  +  +SD GLA      + HA     GT GY+A
Sbjct: 305 LEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA---SVGTHGYMA 358

Query: 946 PEYATTCRVSDKA-DVYSFGVVLLELISGK 974
           PE        D + D +S G +L +L+ G 
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 99.0 bits (247), Expect = 3e-22
 Identities = 58/220 (26%), Positives = 93/220 (42%), Gaps = 33/220 (15%)

Query: 776 NFSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSIG-RFQGIQQFDAEIGTLGRI 828
           N ++   +G G FG  Y+ ++           VAVK L      Q    F  E   + + 
Sbjct: 72  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 131

Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH-----KIAIDIA 883
            H+N+V  IG  +     F++   ++GG+L++F+ +   +  Q S +       +A DIA
Sbjct: 132 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191

Query: 884 QALAYL---HYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLEVSETHATTDV 937
               YL   H+      +HRDI   N LL        A + DFG+AR +  +  +     
Sbjct: 192 CGCQYLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR---- 241

Query: 938 AGTFGYV-----APEYATTCRVSDKADVYSFGVVLLELIS 972
            G    +      PE       + K D +SFGV+L E+ S
Sbjct: 242 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 98.1 bits (245), Expect = 3e-22
 Identities = 53/209 (25%), Positives = 96/209 (45%), Gaps = 23/209 (11%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFDA--EIGTLGRIRHKN 832
            +   + +G G + + YK +      LVA+K++ +   +G     A  E+  L  ++H N
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAP-CTAIREVSLLKDLKHAN 61

Query: 833 LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +VTL      E  + LV+ +L   +L+ ++    G  I    +      + + LAY H  
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLDK-DLKQYL-DDCGNIINMHNVKLFLFQLLRGLAYCH-- 117

Query: 893 CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE----- 947
              +++HRD+KP N+L++E     L+DFGLAR   +       +V  T  Y  P+     
Sbjct: 118 -RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLGS 175

Query: 948 --YATTCRVSDKADVYSFGVVLLELISGK 974
             Y+T        D++  G +  E+ +G+
Sbjct: 176 TDYSTQI------DMWGVGCIFYEMATGR 198

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 97.4 bits (243), Expect = 6e-22
 Identities = 51/226 (22%), Positives = 99/226 (43%), Gaps = 36/226 (15%)

Query: 776 NFSIRNLIGTGGFGSTYKAELV--------PGYLVAVKKLSIG-RFQGIQQFDAEIGTLG 826
             ++   +G G FG    AE V            VAVK L      + +    +E+  + 
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 95

Query: 827 RI-RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETF--------------IHKKSGKKIQ 871
            I +HKN++ L+G    +  ++++  + S GNL  +              I++   +++ 
Sbjct: 96  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155

Query: 872 WSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET 931
           +  +      +A+ + YL      + +HRD+   N+L+ E     ++DFGLAR +   + 
Sbjct: 156 FKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY 212

Query: 932 HATTDVAGTFGYV-----APEYATTCRVSDKADVYSFGVVLLELIS 972
           +       T G +     APE       + ++DV+SFGV++ E+ +
Sbjct: 213 Y----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 98.7 bits (246), Expect = 6e-22
 Identities = 51/219 (23%), Positives = 92/219 (42%), Gaps = 41/219 (18%)

Query: 783 IGTGGFGSTYKA---ELVPGYLVAVKKLSIGRFQGIQQFDA-EIGTLGRIRHKNLVTLIG 838
           +G G +G  YKA   +       A+K++      GI      EI  L  ++H N+++L  
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQI---EGTGISMSACREIALLRELKHPNVISLQK 85

Query: 839 YYVGEAEM--FLVYNFLSGGNLETFIH-------KKSGKKIQWSVIHKIAIDIAQALAYL 889
            ++  A+   +L++++    +L   I         K   ++   ++  +   I   + YL
Sbjct: 86  VFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144

Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAY----LSDFGLARLLEV---SETHATTDVAGTFG 942
           H +    ++HRD+KP+NIL+  E        ++D G ARL              V  TF 
Sbjct: 145 HAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFW 200

Query: 943 YVAPE-------YATTCRVSDKADVYSFGVVLLELISGK 974
           Y APE       Y          D+++ G +  EL++ +
Sbjct: 201 YRAPELLLGARHYTKAI------DIWAIGCIFAELLTSE 233

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 96.9 bits (242), Expect = 7e-22
 Identities = 46/222 (20%), Positives = 88/222 (39%), Gaps = 36/222 (16%)

Query: 772 RATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGR------FQGIQQFDAEIGT 824
            +   +     +G G +G  YKA + V    VA+K++ +           I+    E+  
Sbjct: 31  TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR----EVSL 86

Query: 825 LGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQ 884
           L  ++H+N++ L         + L++ +    +L+ ++       +   VI      +  
Sbjct: 87  LKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMD--KNPDVSMRVIKSFLYQLIN 143

Query: 885 ALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-----LSDFGLARLLEVSETHATTDVAG 939
            + + H     R +HRD+KP N+LL     +      + DFGLAR   +     T ++  
Sbjct: 144 GVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII- 199

Query: 940 TFGYVAPE-------YATTCRVSDKADVYSFGVVLLELISGK 974
           T  Y  PE       Y+T        D++S   +  E++   
Sbjct: 200 TLWYRPPEILLGSRHYST------SVDIWSIACIWAEMLMKT 235

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 97.3 bits (243), Expect = 7e-22
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 23/210 (10%)

Query: 775 GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRH 830
           G + IR  +G G FG    A        VA+K   +  + +     + + EI  L  +RH
Sbjct: 9   GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRH 68

Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +++ L        ++ +V  + +GG L  +I +K  K++      +    I  A+ Y H
Sbjct: 69  PHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCH 125

Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE--- 947
                +IVHRD+KP N+LLD+ LN  ++DFGL+ ++       T+   G+  Y APE   
Sbjct: 126 RH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVIN 180

Query: 948 ---YATTCRVSDKADVYSFGVVLLELISGK 974
              YA       + DV+S G+VL  ++ G+
Sbjct: 181 GKLYA-----GPEVDVWSCGIVLYVMLVGR 205

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 96.5 bits (241), Expect = 8e-22
 Identities = 51/226 (22%), Positives = 84/226 (37%), Gaps = 36/226 (15%)

Query: 776 NFSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSIG-RFQGIQQFDAEIGTLGRI 828
             S    +G G FG   +A             VAVK L         +   +E+  L  +
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83

Query: 829 -RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETF----------------IHKKSGKKIQ 871
             H N+V L+G         ++  +   G+L  F                I +     + 
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 872 WSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET 931
              +   +  +A+ +A+L        +HRD+   NILL       + DFGLAR ++    
Sbjct: 144 LEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200

Query: 932 HATTDVAGTFGYV-----APEYATTCRVSDKADVYSFGVVLLELIS 972
           +    V      +     APE    C  + ++DV+S+G+ L EL S
Sbjct: 201 Y----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 98.6 bits (246), Expect = 1e-21
 Identities = 77/525 (14%), Positives = 150/525 (28%), Gaps = 149/525 (28%)

Query: 149 LEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLS 208
                                L  L  L+   +S + ++  G+     L+ +  +SN ++
Sbjct: 20  FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT 77

Query: 209 GGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTIS 268
               +D S     LTYL    N LT ++   +     L  L  D N L   +   +    
Sbjct: 78  ---TLDLSQ-NTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLD--VSQNP 127

Query: 269 ELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLL 328
            L  L+ +RN+LT+   ++++  ++L+ L          LD +                 
Sbjct: 128 LLTYLNCARNTLTE---IDVSHNTQLTELDCHLNKKITKLDVT----------------- 167

Query: 329 SRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLN 388
                                      L  L+   N +       +   + L  L+   N
Sbjct: 168 -----------------------PQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTN 201

Query: 389 NLEGYLPMQLPV---PCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSI 445
           N+      +L +     + + + S N +T +                             
Sbjct: 202 NIT-----KLDLNQNIQLTFLDCSSNKLTEI----------------------------- 227

Query: 446 SDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCN 505
                    D +    L                         + N     +    +S  +
Sbjct: 228 ---------DVTPLTQL--------------------TYFDCSVNPLT-ELD---VSTLS 254

Query: 506 DLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRG 565
            L +  ++     L  +     L    QL+ F+A   +    +   V    +L  LD + 
Sbjct: 255 KLTT--LHCIQTDLLEID----LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQA 306

Query: 566 NRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLT 625
             ++  L   L +   L ++ L    LT E+     H   L  L   +  +      S+ 
Sbjct: 307 AGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFS-SVG 358

Query: 626 KATKLESLFLAHNRLSGEIPVSFSTL-----VNLSALDLSFNNLS 665
           K   L + F A  +       + +       V+   LD   N ++
Sbjct: 359 KIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMN 403

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 90.9 bits (226), Expect = 3e-19
 Identities = 77/444 (17%), Positives = 141/444 (31%), Gaps = 106/444 (23%)

Query: 245 NLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTN--I 302
           N  + +     ++ +       ++ L  LD   +S+TD +   +   + L+ L+ T+  I
Sbjct: 19  NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNI 76

Query: 303 DASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLG 362
             +LDL  +                                           +L  L   
Sbjct: 77  T-TLDLSQNT------------------------------------------NLTYLACD 93

Query: 363 QNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNIT----GVLP 418
            N L       +     LTYL+   N L      Q P+  + Y N ++N +T        
Sbjct: 94  SNKLTN---LDVTPLTKLTYLNCDTNKLTKLDVSQNPL--LTYLNCARNTLTEIDVSHNT 148

Query: 419 RFENVSCDNHFGFQDLQYANVPVMGSIS-DENFVIIHDFSGNKFLGSLPLFAIGDGFLAA 477
           +   + C  +     L       + ++    N +   D S NK L  L            
Sbjct: 149 QLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKITELDVSQNKLLNRL------------ 196

Query: 478 KYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEF 537
                     + N     +    +++   L     + S+N L+ +     +    QL  F
Sbjct: 197 --------NCDTNNIT-KLD---LNQNIQLTFL--DCSSNKLTEID----VTPLTQLTYF 238

Query: 538 EAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIP 597
           + + N ++  +   V  L KL  L      +   +   L     L +    G     E+ 
Sbjct: 239 DCSVNPLT-EL--DVSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELD 292

Query: 598 SQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSAL 657
               H   L +LD     +T  +   L++  KL  L+L +  L+ E+ VS      L +L
Sbjct: 293 --VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELDVSH--NTKLKSL 344

Query: 658 DLSFNNLS-----GHIPHLQHLDC 676
                ++      G IP L +   
Sbjct: 345 SCVNAHIQDFSSVGKIPALNNNFE 368

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 85.1 bits (211), Expect = 3e-17
 Identities = 60/310 (19%), Positives = 111/310 (35%), Gaps = 50/310 (16%)

Query: 118 SIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLN 177
            +++ T L  L+   N  +  +   V  L  L  L    N  + K+   +S    L  LN
Sbjct: 80  DLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLN 133

Query: 178 LSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIP 237
            + N+ + E+   +  N +L+ +D   N+    L +   +    LT L  S N +TE   
Sbjct: 134 CARNTLT-EID--VSHNTQLTELDCHLNKKITKLDV---TPQTQLTTLDCSFNKITEL-- 185

Query: 238 KEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVL 297
            ++ + + L  L  D N +   +   +    +L  LD S N LT+   +++   ++L+  
Sbjct: 186 -DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTE---IDVTPLTQLTYF 238

Query: 298 VL-----TNIDASL-----DLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLP 347
                  T +D S       L   + +    D      L  +  L    A        L 
Sbjct: 239 DCSVNPLTELDVSTLSKLTTLHCIQTDLLEID------LTHNTQLIYFQAEGCRKIKEL- 291

Query: 348 DNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPV---PCMV 404
            + + +  L +L+     +       L     L YL L+   L      +L V     + 
Sbjct: 292 -DVTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT-----ELDVSHNTKLK 342

Query: 405 YFNVSQNNIT 414
             +    +I 
Sbjct: 343 SLSCVNAHIQ 352

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 68.2 bits (167), Expect = 5e-12
 Identities = 29/184 (15%), Positives = 52/184 (28%), Gaps = 20/184 (10%)

Query: 118 SIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLN 177
            + +  +L  L    N  + EI   V  L  L   +   N  +      +S L  L  + 
Sbjct: 207 DLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQ 263

Query: 178 LSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIP 237
                        L  N +L        R    L +   +    L  L      +T  + 
Sbjct: 264 TDLLEID------LTHNTQLIYFQAEGCRKIKELDV---THNTQLYLLDCQAAGIT-ELD 313

Query: 238 KEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVL 297
             + +   L  L L+   L   +   +   ++LK L      + D     +     L+  
Sbjct: 314 --LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQD-FS-SVGKIPALNNN 366

Query: 298 VLTN 301
               
Sbjct: 367 FEAE 370

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 99.5 bits (248), Expect = 1e-21
 Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 10/205 (4%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLS---IGRFQGIQQFDAEIGTLGRIRHK 831
            F    ++G GGFG  +  ++   G L A KKL+   + + +G Q    E   L ++  +
Sbjct: 186 WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSR 245

Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKI--AIDIAQALAYL 889
            +V+L   +  + ++ LV   ++GG++   I+        +     I     I   L +L
Sbjct: 246 FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305

Query: 890 HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
           H      I++RD+KP N+LLD++ N  +SD GLA  L+  +T      AGT G++APE  
Sbjct: 306 HQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG-YAGTPGFMAPELL 361

Query: 950 TTCRVSDKADVYSFGVVLLELISGK 974
                    D ++ GV L E+I+ +
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAAR 386

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 96.6 bits (241), Expect = 1e-21
 Identities = 52/232 (22%), Positives = 90/232 (38%), Gaps = 52/232 (22%)

Query: 776 NFSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSIG-RFQGIQQFDAEIGTLGRI 828
           N      +G G FG   +A             VAVK L         +   +E+  +  +
Sbjct: 47  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 106

Query: 829 -RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKS------------GKKIQWSVI 875
            +H+N+V L+G       + ++  +   G+L  F+ +KS                    +
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166

Query: 876 HKIAIDIAQALAYL---HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH 932
              +  +AQ +A+L   +       +HRD+   N+LL     A + DFGLAR        
Sbjct: 167 LHFSSQVAQGMAFLASKNC------IHRDVAARNVLLTNGHVAKIGDFGLAR-------- 212

Query: 933 ATTDVAGTFGYV------------APEYATTCRVSDKADVYSFGVVLLELIS 972
              D+     Y+            APE    C  + ++DV+S+G++L E+ S
Sbjct: 213 ---DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 96.2 bits (240), Expect = 1e-21
 Identities = 52/231 (22%), Positives = 95/231 (41%), Gaps = 41/231 (17%)

Query: 776 NFSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSIG-RFQGIQQFDAEIGTLGRI 828
           N  +   +G G FG   KA             VAVK L        ++   +E   L ++
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV 83

Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETF----------------------IHKKS 866
            H +++ L G    +  + L+  +   G+L  F                      +    
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143

Query: 867 GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL 926
            + +    +   A  I+Q + YL  + + ++VHRD+   NIL+ E     +SDFGL+R +
Sbjct: 144 ERALTMGDLISFAWQISQGMQYL--AEM-KLVHRDLAARNILVAEGRKMKISDFGLSRDV 200

Query: 927 EVSETHATTDVAGTFGYV-----APEYATTCRVSDKADVYSFGVVLLELIS 972
              +++    V  + G +     A E       + ++DV+SFGV+L E+++
Sbjct: 201 YEEDSY----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 95.8 bits (239), Expect = 1e-21
 Identities = 55/227 (24%), Positives = 92/227 (40%), Gaps = 39/227 (17%)

Query: 776 NFSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSIG-RFQGIQQFDAEIGTLGRI 828
              +   +G G FG   +A+            VAVK L  G      +   +E+  L  I
Sbjct: 28  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 87

Query: 829 -RHKNLVTLIGYYV---GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSV---------- 874
             H N+V L+G          + ++  F   GNL T++  K  + + + V          
Sbjct: 88  GHHLNVVNLLG--ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145

Query: 875 ----IHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE 930
               +   +  +A+ + +L      + +HRD+   NILL E+    + DFGLAR +    
Sbjct: 146 TLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 202

Query: 931 THATTDVAGTFGYV-----APEYATTCRVSDKADVYSFGVVLLELIS 972
            +    V      +     APE       + ++DV+SFGV+L E+ S
Sbjct: 203 DY----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 97.1 bits (242), Expect = 3e-21
 Identities = 88/481 (18%), Positives = 145/481 (30%), Gaps = 111/481 (23%)

Query: 222 LTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEI-GTISELKVLDVSRNSL 280
           + Y+ LS N + E       + ++L+ L ++       I       +S L +L +  N  
Sbjct: 32  VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91

Query: 281 TDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRA 340
              +     +   L+ L +      L L                  L    L        
Sbjct: 92  LQ-LETGAFN--GLANLEV------LTLTQCN--------------LDGAVL------SG 122

Query: 341 NLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSL--GMCRNLTYLDLSLNNLEGYLPMQL 398
           N    L        SL++L L  N++K   P S    M R    LDL+ N +        
Sbjct: 123 NFFKPLT-------SLEMLVLRDNNIKKIQPASFFLNM-RRFHVLDLTFNKV-------- 166

Query: 399 PVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSG 458
                                             + Q  +  ++   S      + D + 
Sbjct: 167 -------------------------KSICEEDLLNFQGKHFTLLRLSSIT----LQDMNE 197

Query: 459 NKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANL 518
                        +  +         L L+ N F  S+           +  S+ LS + 
Sbjct: 198 YWLGWEKCGNPFKNTSI-------TTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSY 250

Query: 519 LSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDEL-G 577
             G S+            F+                   ++  DL  +++  +L   +  
Sbjct: 251 NMGSSFGHTNFKDPDNFTFKGLEAS-------------GVKTCDLSKSKIF-ALLKSVFS 296

Query: 578 KLKFLKWILLGGNNLTGEIPSQ-FGHLISLVVLDLSHNALTGSIPA-SLTKATKLESLFL 635
               L+ + L  N +  +I    F  L  L+ L+LS N L  SI +       KLE L L
Sbjct: 297 HFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDL 354

Query: 636 AHNRLSGEIPV-SFSTLVNLSALDLSFNNLSGHIPH-----LQHLDCIAFKGNKYLASCP 689
           ++N +   +   SF  L NL  L L  N L   +P      L  L  I    N +  SCP
Sbjct: 355 SYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 412

Query: 690 D 690
            
Sbjct: 413 R 413

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 76.7 bits (189), Expect = 1e-14
 Identities = 29/143 (20%), Positives = 52/143 (36%), Gaps = 10/143 (6%)

Query: 558 LQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQ-FGHLISLVVLDLSHNAL 616
           +  +DL  N ++        +L+ L+++ +        I +  F  L SL++L L +N  
Sbjct: 32  VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91

Query: 617 TGSIPAS-LTKATKLESLFLAHNRL-SGEIPV-SFSTLVNLSALDLSFNNLSGHIPH--- 670
              +          LE L L    L    +    F  L +L  L L  NN+    P    
Sbjct: 92  L-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150

Query: 671 --LQHLDCIAFKGNKYLASCPDT 691
             ++    +    NK  + C + 
Sbjct: 151 LNMRRFHVLDLTFNKVKSICEED 173

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 62.5 bits (152), Expect = 4e-10
 Identities = 42/284 (14%), Positives = 90/284 (31%), Gaps = 21/284 (7%)

Query: 149 LEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGN-GELSVIDMSSNRL 207
           +  ++L  N+ +       S L+ L+ L +   +    +          L ++ +  N+ 
Sbjct: 32  VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91

Query: 208 SGGLAIDSSSECEFLTYLKLSDNFLTES-IPKEI-GKCRNLKNLLLDGNILEGSIPKEI- 264
              L   + +    L  L L+   L  + +         +L+ L+L  N ++   P    
Sbjct: 92  L-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150

Query: 265 GTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPY 324
             +    VLD++ N +      +L +       +L     +L  D +         G P+
Sbjct: 151 LNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITL-QDMNEYWLGWEKCGNPF 209

Query: 325 ------ELLLS----RSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSL 374
                  L LS    +         A  G ++      +      + G  + K     + 
Sbjct: 210 KNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTF 269

Query: 375 G--MCRNLTYLDLSLNNLEGYLPMQLPV--PCMVYFNVSQNNIT 414
                  +   DLS + +   L   +      +    ++QN I 
Sbjct: 270 KGLEASGVKTCDLSKSKIFA-LLKSVFSHFTDLEQLTLAQNEIN 312

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 43.6 bits (103), Expect = 3e-04
 Identities = 25/89 (28%), Positives = 36/89 (40%), Gaps = 6/89 (6%)

Query: 120 AKLTELRTLSVPHNSFSGEIPAGV-GELRLLEVLELQGNNFSGKIPYQM-SNLERLRVLN 177
             LT L  L++  N     I + +   L  LEVL+L  N+    +  Q    L  L+ L 
Sbjct: 320 WGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRA-LGDQSFLGLPNLKELA 377

Query: 178 LSFNSFSGEVPRGLIGN-GELSVIDMSSN 205
           L  N     VP G+      L  I + +N
Sbjct: 378 LDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 96.3 bits (240), Expect = 3e-21
 Identities = 59/333 (17%), Positives = 113/333 (33%), Gaps = 66/333 (19%)

Query: 355 SLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQL--PVPCMVYFNVSQNN 412
           + K++    ++++      L   R +  L+L+   +E  +          +    +  N 
Sbjct: 46  NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNA 104

Query: 413 ITGVLPRFENVSCDNHF-GFQDLQYANVPVMGSISDENFVIIHDFSGNKF--LGSLPLFA 469
           I  + P        + F     L    +       + N   +       F     L    
Sbjct: 105 IRYLPP--------HVFQNVPLLTVLVL-------ERND--LSSLPRGIFHNTPKL---- 143

Query: 470 IGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLL 529
                          L ++NN     +  +       LQ+  + LS+N L+ +       
Sbjct: 144 -------------TTLSMSNNNLE-RIEDDTFQATTSLQN--LQLSSNRLTHVDLSLI-- 185

Query: 530 DCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGG 589
               L     + N +S      +   + ++ LD   N ++  +   +     L  + L  
Sbjct: 186 --PSLFHANVSYNLLST-----LAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQH 235

Query: 590 NNLTGEIPSQFGHLISLVVLDLSHNALTGSIPA-SLTKATKLESLFLAHNRLSGEIPVSF 648
           NNLT +      +   LV +DLS+N L   I      K  +LE L++++NRL   + +  
Sbjct: 236 NNLT-DTAW-LLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYG 291

Query: 649 STLVNLSALDLSFNNLS------GHIPHLQHLD 675
             +  L  LDLS N+L            L++L 
Sbjct: 292 QPIPTLKVLDLSHNHLLHVERNQPQFDRLENLY 324

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 94.3 bits (235), Expect = 1e-20
 Identities = 81/436 (18%), Positives = 148/436 (33%), Gaps = 100/436 (22%)

Query: 235 SIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVE-LADCSK 293
            I   +       ++ +D    +     E  T++  K++    +++  ++P   L    +
Sbjct: 12  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 70

Query: 294 LSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSES 353
           + +         L+L++ +      D           +++ L+    N    LP +  ++
Sbjct: 71  VEL---------LNLNDLQ--IEEIDTYAFAYA---HTIQKLYM-GFNAIRYLPPHVFQN 115

Query: 354 C-SLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQL--PVPCMVYFNVSQ 410
              L VL L +N L             LT L +S NNLE  +          +    +S 
Sbjct: 116 VPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSS 174

Query: 411 NNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAI 470
           N +T V                 L +ANV         N   +   +    +        
Sbjct: 175 NRLTHVDLS----------LIPSLFHANV-------SYNL--LSTLAIPIAV-------- 207

Query: 471 GDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLD 530
                         L  ++N  N  V G       +L    + L  N L+  +   +LL+
Sbjct: 208 ------------EELDASHNSIN-VVRGP---VNVELT--ILKLQHNNLTDTA---WLLN 246

Query: 531 CVQLVEFEAANNQISGSIAAGV-GKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGG 589
              LVE + + N++   I      K+ +L+RL +  NR+                     
Sbjct: 247 YPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-------------------- 285

Query: 590 NNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFS 649
                 +      + +L VLDLSHN L   +  +  +  +LE+L+L HN +   +    S
Sbjct: 286 -----ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LS 336

Query: 650 TLVNLSALDLSFNNLS 665
           T   L  L LS N+  
Sbjct: 337 THHTLKNLTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 87.8 bits (218), Expect = 2e-18
 Identities = 35/172 (20%), Positives = 69/172 (40%), Gaps = 13/172 (7%)

Query: 513 NLSANLLSGMSYEAF-LLDCVQLVEFEAANNQISGSIAAGV-GKLMKLQRLDLRGNRVSG 570
           ++  ++ +   Y  F  +           N+ +   + A +     +++ L+L   ++  
Sbjct: 25  DVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE- 82

Query: 571 SLPDE-LGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASL-TKAT 628
            +          ++ + +G N +    P  F ++  L VL L  N L+ S+P  +     
Sbjct: 83  EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTP 141

Query: 629 KLESLFLAHNRLSGEIPVS-FSTLVNLSALDLSFNNLS----GHIPHLQHLD 675
           KL +L +++N L   I    F    +L  L LS N L+      IP L H +
Sbjct: 142 KLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHAN 192

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 85.1 bits (211), Expect = 2e-17
 Identities = 55/316 (17%), Positives = 112/316 (35%), Gaps = 36/316 (11%)

Query: 117 ASIAKLTELRTLSVPHNSFSGEIPAGVGELRL--LEVLELQGNNFSGKIPYQMSNLERLR 174
           +++        + +   +   ++  G  ++ L   +++  + +         + +  ++ 
Sbjct: 15  SNLQYDCVFYDVHIDMQTQ--DVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72

Query: 175 VLNLSFNSFSGEVPRG-LIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLT 233
           +LNL+      E+          +  + M  N +   L          LT L L  N L+
Sbjct: 73  LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS 130

Query: 234 ESIPKEI-GKCRNLKNLLLDGNILEGSIPKEIGT-ISELKVLDVSRNSLTDRIPVELADC 291
            S+P+ I      L  L +  N LE  I  +     + L+ L +S N LT    V+L+  
Sbjct: 131 -SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH---VDLSLI 185

Query: 292 SKLSVLVL-----TNIDA-----SLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRAN 341
             L    +     + +        LD  ++    +   G       ++  L +L     N
Sbjct: 186 PSLFHANVSYNLLSTLAIPIAVEELDASHNS--INVVRGP------VNVELTILKLQHNN 237

Query: 342 LGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQL-PV 400
           L             L  ++L  N L+  +       + L  L +S N L   L +   P+
Sbjct: 238 L--TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPI 294

Query: 401 PCMVYFNVSQNNITGV 416
           P +   ++S N++  V
Sbjct: 295 PTLKVLDLSHNHLLHV 310

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 80.1 bits (198), Expect = 5e-16
 Identities = 71/470 (15%), Positives = 151/470 (32%), Gaps = 105/470 (22%)

Query: 139 IPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGN-GEL 197
           I + +    +   + +          ++   L   +++    ++   ++P  L+ +  ++
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71

Query: 198 SVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEI-GKCRNLKNLLLDGNIL 256
            +++++  ++   +   + +    +  L +  N +   +P  +      L  L+L+ N L
Sbjct: 72  ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 129

Query: 257 EGSIPKEI-GTISELKVLDVSRNSLTDRIPVE-LADCSKLSVLVLTNIDASLDLDN--SR 312
             S+P+ I     +L  L +S N+L  RI  +     + L  L L++        N  + 
Sbjct: 130 S-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSS--------NRLTH 179

Query: 313 GEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPK 372
            + S              SL        N+   L    +   +++ L+   NS+   V  
Sbjct: 180 VDLSLI-----------PSLFHA-----NVSYNLLSTLAIPIAVEELDASHNSIN-VVRG 222

Query: 373 SLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQ 432
              +   LT L L  NNL       L  P +V  ++S N +  ++               
Sbjct: 223 --PVNVELTILKLQHNNLTD-TAWLLNYPGLVEVDLSYNELEKIMY-------------- 265

Query: 433 DLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMF 492
                                H F   + L                     RL ++NN  
Sbjct: 266 ---------------------HPFVKMQRL--------------------ERLYISNNRL 284

Query: 493 NGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGV 552
             ++          L+   ++LS N L  +       D  +L      +N I  ++    
Sbjct: 285 V-ALNLY-GQPIPTLK--VLDLSHNHLLHVERNQPQFD--RLENLYLDHNSIV-TLKLST 337

Query: 553 GKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGH 602
                L+ L L  N    +    L   + +    +   +   +I  Q  H
Sbjct: 338 --HHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEH 383

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 77.8 bits (192), Expect = 3e-15
 Identities = 41/166 (24%), Positives = 70/166 (42%), Gaps = 15/166 (9%)

Query: 118 SIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLN 177
           ++A    +  L   HNS +  +   V     L +L+LQ NN +      + N   L  ++
Sbjct: 200 TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTA-WLLNYPGLVEVD 254

Query: 178 LSFNSFSGEVPRG-LIGNGELSVIDMSSNRLSGGLAIDSS-SECEFLTYLKLSDNFLTES 235
           LS+N    ++     +    L  + +S+NRL    A++        L  L LS N L   
Sbjct: 255 LSYNELE-KIMYHPFVKMQRLERLYISNNRLV---ALNLYGQPIPTLKVLDLSHNHLL-H 309

Query: 236 IPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLT 281
           + +   +   L+NL LD N +  ++   + T   LK L +S N   
Sbjct: 310 VERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 68.9 bits (169), Expect = 3e-12
 Identities = 20/136 (14%), Positives = 43/136 (31%), Gaps = 7/136 (5%)

Query: 547 SIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISL 606
            I + +        + +           E   L   K +    + +     +       +
Sbjct: 12  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71

Query: 607 VVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLS- 665
            +L+L+   +      +   A  ++ L++  N +    P  F  +  L+ L L  N+LS 
Sbjct: 72  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 131

Query: 666 ------GHIPHLQHLD 675
                  + P L  L 
Sbjct: 132 LPRGIFHNTPKLTTLS 147

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 45.8 bits (109), Expect = 5e-05
 Identities = 21/106 (19%), Positives = 36/106 (33%), Gaps = 4/106 (3%)

Query: 114 TLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERL 173
            L+     +  L+ L + HN     +     +   LE L L  N+    +   +S    L
Sbjct: 286 ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTL 341

Query: 174 RVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSEC 219
           + L LS N +     R L  N     +D +         ++    C
Sbjct: 342 KNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCC 387

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 96.2 bits (240), Expect = 4e-21
 Identities = 59/232 (25%), Positives = 99/232 (42%), Gaps = 28/232 (12%)

Query: 760 DTPAELTYDNVVRATGNFSIRN------LIGTGGFGSTYKAELVPGYLVAVKKLSI-GRF 812
           D P ++                      +IG G FG  ++A+LV    VA+KK+    RF
Sbjct: 19  DDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF 78

Query: 813 QGIQQFDAEIGTLGRIRHKNLVTLIGYYV------GEAEMFLVYNFLSGGNLETFI--HK 864
           +       E+  +  ++H N+V L  ++        E  + LV  ++    +      + 
Sbjct: 79  KNR-----ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYA 132

Query: 865 KSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLA 923
           K  + +   +I      + ++LAY+H      I HRDIKP N+LLD       L DFG A
Sbjct: 133 KLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSA 189

Query: 924 RLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA-DVYSFGVVLLELISGK 974
           ++L   E +  + +  +  Y APE            D++S G V+ EL+ G+
Sbjct: 190 KILIAGEPN-VSYIC-SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 94.2 bits (235), Expect = 4e-21
 Identities = 51/213 (23%), Positives = 90/213 (42%), Gaps = 28/213 (13%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVP-GYLVAVK---KLSIGRFQGIQQFDAEIGTLGRIRHK 831
           +F    ++G G F +   A  +      A+K   K  I +   +     E   + R+ H 
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90

Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIH-KKSGKKIQWSVIHKIAIDIAQ------ 884
             V L   +  + +++   ++   G  E   + +K G                +      
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNG--ELLKYIRKIGS---------FDETCTRFYTAEI 139

Query: 885 --ALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLA-RLLEVSETHATTDVAGTF 941
             AL YLH      I+HRD+KP NILL+E+++  ++DFG A  L   S+        GT 
Sbjct: 140 VSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 196

Query: 942 GYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
            YV+PE  T       +D+++ G ++ +L++G 
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 95.1 bits (237), Expect = 5e-21
 Identities = 51/229 (22%), Positives = 98/229 (42%), Gaps = 42/229 (18%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVPGY--------LVAVKKLSIG-RFQGIQQFDAEIGTLG 826
             ++   +G G FG    AE V            VAVK L      + +    +E+  + 
Sbjct: 82  KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 141

Query: 827 RI-RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETF--------------IHKKSGKKIQ 871
            I +HKN++ L+G    +  ++++  + S GNL  +              I++   +++ 
Sbjct: 142 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201

Query: 872 WSVIHKIAIDIAQALAYL---HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV 928
           +  +      +A+ + YL           +HRD+   N+L+ E     ++DFGLAR +  
Sbjct: 202 FKDLVSCTYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLARDINN 255

Query: 929 SETHATTDVAGTFGYV-----APEYATTCRVSDKADVYSFGVVLLELIS 972
            + +       T G +     APE       + ++DV+SFGV++ E+ +
Sbjct: 256 IDYY----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 94.2 bits (235), Expect = 6e-21
 Identities = 59/223 (26%), Positives = 95/223 (42%), Gaps = 26/223 (11%)

Query: 768 DNVVRATGNFSIRNLIGTGGFGSTYKA--ELVPGYLVAVKKLSIGRFQ------GIQQFD 819
           D + RA   +     IG G +G  +KA      G  VA+K++ +   +       I+   
Sbjct: 4   DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR--- 60

Query: 820 AEIGTLGRIR---HKNLVTLI-----GYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQ 871
            E+  L  +    H N+V L           E ++ LV+  +   +L T++ K     + 
Sbjct: 61  -EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVP 118

Query: 872 WSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET 931
              I  +   + + L +LH     R+VHRD+KP NIL+       L+DFGLAR+      
Sbjct: 119 TETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA 175

Query: 932 HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
             T+ V  T  Y APE       +   D++S G +  E+   K
Sbjct: 176 L-TSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 95.5 bits (238), Expect = 8e-21
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 31/215 (14%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFDA-----EIGTLGRIR 829
           +++   +IG G FG  Y+A+L   G LVA+KK        + Q D      E+  + ++ 
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--------VLQ-DKRFKNRELQIMRKLD 105

Query: 830 HKNLVTLIGYYVGEAEMF------LVYNFLSGGNLETFIHKKSGKKIQWSVIH-KIAI-D 881
           H N+V L  ++    E        LV +++    +       S  K    VI+ K+ +  
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQ 164

Query: 882 IAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVSETHATTDVAGT 940
           + ++LAY+H      I HRDIKP N+LLD +     L DFG A+ L   E +  + +  +
Sbjct: 165 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSYIC-S 219

Query: 941 FGYVAPEYATTCRVSDKA-DVYSFGVVLLELISGK 974
             Y APE          + DV+S G VL EL+ G+
Sbjct: 220 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 94.0 bits (234), Expect = 1e-20
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 27/211 (12%)

Query: 777 FSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDA-----EIGTLGRIRH 830
           +     IG+G  G    A + +    VA+KKLS   FQ   Q  A     E+  +  + H
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQ--NQTHAKRAYRELVLMKCVNH 83

Query: 831 KNLVTLIGYYVGEA------EMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDIA 883
           KN++ L+  +  +       ++++V   +   NL   I  +   +++ +     +   + 
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSY-----LLYQML 137

Query: 884 QALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGY 943
             + +LH S    I+HRD+KPSNI++  +    + DFGLAR      +   T    T  Y
Sbjct: 138 CGIKHLH-SA--GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 192

Query: 944 VAPEYATTCRVSDKADVYSFGVVLLELISGK 974
            APE        +  D++S G ++ E+I G 
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 96.2 bits (239), Expect = 1e-20
 Identities = 52/315 (16%), Positives = 100/315 (31%), Gaps = 48/315 (15%)

Query: 114 TLSASIAKLTELRTLSVPHN--SFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLE 171
           ++   I     L   S  +       +  +   +     +     N     +      + 
Sbjct: 2   SIMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLK--ECLIN 59

Query: 172 RLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNF 231
           +   L L+  + S  +P  L     ++V++++ N L    ++        L YL   DN 
Sbjct: 60  QFSELQLNRLNLS-SLPDNLPPQ--ITVLEITQNALI---SLPELPAS--LEYLDACDNR 111

Query: 232 LTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADC 291
           L+ ++P+      +LK+L +D N L   +P+       L+ ++   N LT  +P      
Sbjct: 112 LS-TLPELPA---SLKHLDVDNNQLT-MLPELPAL---LEYINADNNQLT-MLPELP--- 159

Query: 292 SKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWS 351
           + L VL + N        N                 L  SLE L     NL   LP    
Sbjct: 160 TSLEVLSVRN--------NQLTFLPE----------LPESLEALDV-STNLLESLPAVPV 200

Query: 352 ESCSLK----VLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFN 407
            +   +         +N +   +P+++        + L  N L   +   L         
Sbjct: 201 RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDY 259

Query: 408 VSQNNITGVLPRFEN 422
                   +    +N
Sbjct: 260 HGPRIYFSMSDGQQN 274

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 83.5 bits (206), Expect = 1e-16
 Identities = 48/319 (15%), Positives = 94/319 (29%), Gaps = 57/319 (17%)

Query: 120 AKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRV---- 175
             + +   L +   + S  +P  +     + VLE+  N     +P   ++LE L      
Sbjct: 56  CLINQFSELQLNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPASLEYLDACDNR 111

Query: 176 -------------LNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLS------GGLAIDSS 216
                        L++  N  +  +P  L     L  I+  +N+L+        L + S 
Sbjct: 112 LSTLPELPASLKHLDVDNNQLT-MLPE-LPAL--LEYINADNNQLTMLPELPTSLEVLSV 167

Query: 217 SECEF---------LTYLKLSDNFLTESIPKEIGKCRNLKNLL----LDGNILEGSIPKE 263
              +          L  L +S N L  S+P    +  + +          N +   IP+ 
Sbjct: 168 RNNQLTFLPELPESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPEN 225

Query: 264 IGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVP 323
           I ++     + +  N L+ RI   L+  +         I  S+               V 
Sbjct: 226 ILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVT 285

Query: 324 YELLLSRSLEV--LWAPRANLGGRLPDNWSESCSLKVLNLGQN-----SLKGAVPKSLGM 376
                ++  +V  +W    +         + S  L  L+   +       +  V   L  
Sbjct: 286 AWFPENKQSDVSQIW----HAFEHEEHANTFSAFLDRLSDTVSARNTSGFREQVAAWLEK 341

Query: 377 CRNLTYLDLSLNNLEGYLP 395
                 L      +     
Sbjct: 342 LSASAELRQQSFAVAADAT 360

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 83.5 bits (206), Expect = 1e-16
 Identities = 37/187 (19%), Positives = 71/187 (37%), Gaps = 28/187 (14%)

Query: 495 SVPGERISKCNDLQSFSV--NLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGV 552
               +  S  +  +  ++        +S +  E  +    Q  E +     +S S+   +
Sbjct: 24  GTYADYFSAWDKWEKQALPGENRNEAVSLLK-ECLI---NQFSELQLNRLNLS-SLPDNL 78

Query: 553 GKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLS 612
               ++  L++  N +  SLP+    L++L       N L+  +P       SL  LD+ 
Sbjct: 79  PP--QITVLEITQNALI-SLPELPASLEYLD---ACDNRLS-TLPELPA---SLKHLDVD 128

Query: 613 HNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSG---HIP 669
           +N LT  +P        LE +   +N+L+  +P       +L  L +  N L+       
Sbjct: 129 NNQLT-MLPELPAL---LEYINADNNQLT-MLP---ELPTSLEVLSVRNNQLTFLPELPE 180

Query: 670 HLQHLDC 676
            L+ LD 
Sbjct: 181 SLEALDV 187

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 78.9 bits (194), Expect = 4e-15
 Identities = 35/142 (24%), Positives = 57/142 (40%), Gaps = 18/142 (12%)

Query: 533 QLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNL 592
            L   +  NNQ++  +      L   + ++   N+++  LP+    L+ L    +  N L
Sbjct: 121 SLKHLDVDNNQLT-MLPELPALL---EYINADNNQLT-MLPELPTSLEVLS---VRNNQL 172

Query: 593 TGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLES----LFLAHNRLSGEIPVSF 648
           T  +P       SL  LD+S N L  S+PA   +    E          NR++  IP + 
Sbjct: 173 T-FLPEL---PESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENI 226

Query: 649 STLVNLSALDLSFNNLSGHIPH 670
            +L     + L  N LS  I  
Sbjct: 227 LSLDPTCTIILEDNPLSSRIRE 248

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 71.2 bits (174), Expect = 8e-13
 Identities = 29/138 (21%), Positives = 49/138 (35%), Gaps = 16/138 (11%)

Query: 542 NQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFG 601
           +       +   K  K        N     L +    +     + L   NL+  +P    
Sbjct: 23  SGTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLINQFSELQLNRLNLS-SLPDNLP 79

Query: 602 HLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSF 661
               + VL+++ NAL  S+P        LE L    NRLS  +P       +L  LD+  
Sbjct: 80  P--QITVLEITQNALI-SLPELPAS---LEYLDACDNRLS-TLP---ELPASLKHLDVDN 129

Query: 662 NNLS---GHIPHLQHLDC 676
           N L+        L++++ 
Sbjct: 130 NQLTMLPELPALLEYINA 147

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 70.4 bits (172), Expect = 2e-12
 Identities = 53/391 (13%), Positives = 108/391 (27%), Gaps = 79/391 (20%)

Query: 294 LSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSES 353
           +S+++  N + SL  ++     S                 +    R      L +     
Sbjct: 1   MSIMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQ 60

Query: 354 CSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNI 413
                L L + +L  ++P +L     +T L+++ N L   LP       + Y +   N +
Sbjct: 61  --FSELQLNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPA--SLEYLDACDNRL 112

Query: 414 TGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKF------LGSLPL 467
           + +     ++        + L                    D   N+          L  
Sbjct: 113 STLPELPASL--------KHL--------------------DVDNNQLTMLPELPALL-- 142

Query: 468 FAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAF 527
                            +  +NN     +P         L+    ++  N L+ +     
Sbjct: 143 ---------------EYINADNNQLT-MLP----ELPTSLEVL--SVRNNQLTFLPE--- 177

Query: 528 LLDCVQLVEFEAANNQISGSIAAGVGKLMKLQR----LDLRGNRVSGSLPDELGKLKFLK 583
           L +   L   + + N +  S+ A   +    +        R NR++  +P+ +  L    
Sbjct: 178 LPE--SLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTC 233

Query: 584 WILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGE 643
            I+L  N L+  I        +           + S     T    L     A       
Sbjct: 234 TIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAW--FPEN 291

Query: 644 IPVSFSTLVNLSALDLSFNNLSGHIPHLQHL 674
                S + +    +   N  S  +  L   
Sbjct: 292 KQSDVSQIWHAFEHEEHANTFSAFLDRLSDT 322

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 68.1 bits (166), Expect = 8e-12
 Identities = 24/132 (18%), Positives = 41/132 (31%), Gaps = 8/132 (6%)

Query: 547 SIAAGVGKLMKLQRLDLRGN--RVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLI 604
           SI   +     L +                   K +         N     +      + 
Sbjct: 2   SIMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLIN 59

Query: 605 SLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNL 664
               L L+   L+ S+P +L    ++  L +  N L   +P   ++L  L A D   + L
Sbjct: 60  QFSELQLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPELPASLEYLDACDNRLSTL 115

Query: 665 SGHIPHLQHLDC 676
                 L+HLD 
Sbjct: 116 PELPASLKHLDV 127

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 93.1 bits (232), Expect = 1e-20
 Identities = 56/224 (25%), Positives = 96/224 (42%), Gaps = 40/224 (17%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVPGYL---VAVKKL-SIGRFQGIQQFDAEIGTLGRI-RH 830
           +   +++IG G FG   KA +    L    A+K++         + F  E+  L ++  H
Sbjct: 26  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 85

Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKK--------------SGKKIQWSVIH 876
            N++ L+G       ++L   +   GNL  F+ K               +   +    + 
Sbjct: 86  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145

Query: 877 KIAIDIAQALAYL---HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA 933
             A D+A+ + YL    +      +HRD+   NIL+ E   A ++DFGL+R  EV     
Sbjct: 146 HFAADVARGMDYLSQKQF------IHRDLAARNILVGENYVAKIADFGLSRGQEVY---- 195

Query: 934 TTDVAGTFGYV-----APEYATTCRVSDKADVYSFGVVLLELIS 972
              V  T G +     A E       +  +DV+S+GV+L E++S
Sbjct: 196 ---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 93.1 bits (232), Expect = 2e-20
 Identities = 51/238 (21%), Positives = 91/238 (38%), Gaps = 55/238 (23%)

Query: 776 NFSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSIG-RFQGIQQFDAEIGTLGRI 828
           N     ++G+G FG    A             VAVK L         +   +E+  + ++
Sbjct: 46  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 105

Query: 829 -RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIH----------- 876
             H+N+V L+G       ++L++ +   G+L  ++  K  K  +  + +           
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165

Query: 877 ----------KIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL 926
                       A  +A+ + +L +      VHRD+   N+L+       + DFGLAR  
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLAR-- 220

Query: 927 EVSETHATTDVAGTFGYV------------APEYATTCRVSDKADVYSFGVVLLELIS 972
                    D+     YV            APE       + K+DV+S+G++L E+ S
Sbjct: 221 ---------DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 94.0 bits (234), Expect = 2e-20
 Identities = 51/226 (22%), Positives = 96/226 (42%), Gaps = 36/226 (15%)

Query: 776 NFSIRNLIGTGGFGSTYKAELV--------PGYLVAVKKLSIG-RFQGIQQFDAEIGTLG 826
              +   +G G FG    AE +            VAVK L      + +    +E+  + 
Sbjct: 70  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 129

Query: 827 RI-RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETF--------------IHKKSGKKIQ 871
            I +HKN++ L+G    +  ++++  + S GNL  +                    +++ 
Sbjct: 130 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 189

Query: 872 WSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET 931
              +   A  +A+ + YL      + +HRD+   N+L+ E+    ++DFGLAR +   + 
Sbjct: 190 SKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 246

Query: 932 HATTDVAGTFGYV-----APEYATTCRVSDKADVYSFGVVLLELIS 972
           +       T G +     APE       + ++DV+SFGV+L E+ +
Sbjct: 247 Y----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 93.5 bits (233), Expect = 2e-20
 Identities = 55/240 (22%), Positives = 95/240 (39%), Gaps = 30/240 (12%)

Query: 752 GQVMVTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIG 810
           G +M   A   A+   +   +    F +  + G G FG+    +    G  VA+KK+   
Sbjct: 3   GSMMSLNAAAAAD---ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV--- 56

Query: 811 RFQGIQQFDA-----EIGTLGRIRHKNLVTLIGYYVGEAE-------MFLVYNFLSGGNL 858
             Q             +  L  + H N+V L  Y+    E       + +V  ++    L
Sbjct: 57  -IQ--DPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTL 112

Query: 859 ETFIHKKSGKKIQWSVIHK--IAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY 916
                    +++    I        + +++  LH   V  + HRDIKP N+L++E     
Sbjct: 113 HRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTL 171

Query: 917 -LSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA-DVYSFGVVLLELISGK 974
            L DFG A+ L  SE +    +   + Y APE     +    A D++S G +  E++ G+
Sbjct: 172 KLCDFGSAKKLSPSEPN-VAYICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 93.7 bits (233), Expect = 3e-20
 Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 21/211 (9%)

Query: 776 NFSIRNLIGTGGFGSTYKAELV----PGYLVAVKKLS---IGRFQGIQQFDAEIGTLGRI 828
           +F I  +IG G FG   +  +V       + A+K L+   + +      F  E   L   
Sbjct: 75  DFEILKVIGRGAFG---EVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG 131

Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGK-KIQWSVIHKIAIDIAQALA 887
             K + TL   +  +  ++LV ++  GG+L T + K   +   + +  +    ++  A+ 
Sbjct: 132 DSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY--LAEMVIAID 189

Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE 947
            +H       VHRDIKP NIL+D   +  L+DFG    L    T  ++   GT  Y++PE
Sbjct: 190 SVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 246

Query: 948 YATTCRVSDK-----ADVYSFGVVLLELISG 973
                           D +S GV + E++ G
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 92.0 bits (229), Expect = 4e-20
 Identities = 55/234 (23%), Positives = 91/234 (38%), Gaps = 47/234 (20%)

Query: 776 NFSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSIG-RFQGIQQFDAEIGTLGRI 828
           N      IG G FG  ++A         P  +VAVK L           F  E   +   
Sbjct: 48  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 107

Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSV-------------- 874
            + N+V L+G       M L++ +++ G+L  F+   S   +                  
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167

Query: 875 --------IHKIAIDIAQALAYL---HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLA 923
                      IA  +A  +AYL    +      VHRD+   N L+ E +   ++DFGL+
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLS 221

Query: 924 RLLEVSETHATTDVAGTFGYV-----APEYATTCRVSDKADVYSFGVVLLELIS 972
           R +  ++ +     A     +      PE     R + ++DV+++GVVL E+ S
Sbjct: 222 RNIYSADYY----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 93.0 bits (231), Expect = 8e-20
 Identities = 50/210 (23%), Positives = 91/210 (43%), Gaps = 25/210 (11%)

Query: 777 FSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDA-----EIGTLGRIRH 830
           +     IG+G  G    A + V    VA+KKLS   FQ   Q  A     E+  +  + H
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQ--NQTHAKRAYRELVLMKCVNH 120

Query: 831 KNLVTLI------GYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQ 884
           KN+++L+             +++LV   +     +  + +    ++    +  +   +  
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYLLYQMLC 175

Query: 885 ALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYV 944
            + +LH + +   +HRD+KPSNI++  +    + DFGLAR      +   T    T  Y 
Sbjct: 176 GIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 230

Query: 945 APEYATTCRVSDKADVYSFGVVLLELISGK 974
           APE        +  D++S G ++ E++  K
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 87.3 bits (217), Expect = 1e-19
 Identities = 25/156 (16%), Positives = 54/156 (34%), Gaps = 8/156 (5%)

Query: 511 SVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSG 570
            + L+   ++ ++    +     + +    N   +      +  L  L+RL + G  V+ 
Sbjct: 48  YITLANINVTDLT---GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTS 102

Query: 571 SLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKL 630
                L  L  L  + +  +     I ++   L  +  +DLS+N     I   L    +L
Sbjct: 103 DKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPEL 161

Query: 631 ESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSG 666
           +SL +  + +             L+ L      + G
Sbjct: 162 KSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 75.4 bits (186), Expect = 1e-15
 Identities = 25/122 (20%), Positives = 50/122 (40%), Gaps = 4/122 (3%)

Query: 553 GKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLS 612
            ++  L  + L    V+  L   +     +K + +   + T    +    L +L  L + 
Sbjct: 41  AQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIM 96

Query: 613 HNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPHLQ 672
              +T     +L+  T L  L ++H+     I    +TL  ++++DLS+N     I  L+
Sbjct: 97  GKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLK 156

Query: 673 HL 674
            L
Sbjct: 157 TL 158

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 74.2 bits (183), Expect = 4e-15
 Identities = 19/143 (13%), Positives = 47/143 (32%), Gaps = 8/143 (5%)

Query: 501 ISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQR 560
           I   ++++   + ++    +  +    +     L         ++      +  L  L  
Sbjct: 62  IEYAHNIKD--LTINNIHATNYN---PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116

Query: 561 LDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSI 620
           LD+  +    S+  ++  L  +  I L  N    +I      L  L  L++  + +    
Sbjct: 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYR 175

Query: 621 PASLTKATKLESLFLAHNRLSGE 643
              +    KL  L+     + G+
Sbjct: 176 G--IEDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 58.4 bits (142), Expect = 9e-10
 Identities = 22/136 (16%), Positives = 48/136 (35%), Gaps = 6/136 (4%)

Query: 119 IAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNL 178
           I     ++ L++ +   +      +  L  LE L + G + +      +S L  L +L++
Sbjct: 62  IEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119

Query: 179 SFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPK 238
           S ++    +   +    +++ ID+S N       I        L  L +  + + +    
Sbjct: 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITD--IMPLKTLPELKSLNIQFDGVHDYRG- 176

Query: 239 EIGKCRNLKNLLLDGN 254
            I     L  L     
Sbjct: 177 -IEDFPKLNQLYAFSQ 191

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 56.9 bits (138), Expect = 3e-09
 Identities = 20/135 (14%), Positives = 50/135 (37%), Gaps = 6/135 (4%)

Query: 167 MSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLK 226
            + +  L  + L+  + +     G+     +  + +++   +     +  S    L  L+
Sbjct: 40  EAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNIHATN---YNPISGLSNLERLR 94

Query: 227 LSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPV 286
           +    +T      +    +L  L +  +  + SI  +I T+ ++  +D+S N     I  
Sbjct: 95  IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM- 153

Query: 287 ELADCSKLSVLVLTN 301
            L    +L  L +  
Sbjct: 154 PLKTLPELKSLNIQF 168

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 51.5 bits (124), Expect = 2e-07
 Identities = 30/223 (13%), Positives = 67/223 (30%), Gaps = 49/223 (21%)

Query: 168 SNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKL 227
           S  +      L  +S +      +     L+ I +++  ++    +        +  L +
Sbjct: 20  STFKAYLNGLLGQSSTANITEAQMNS---LTYITLANINVTD---LTGIEYAHNIKDLTI 73

Query: 228 SDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVE 287
           ++   T   P  I    NL+ L + G  +       +  ++ L +LD+S ++  D I  +
Sbjct: 74  NNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131

Query: 288 LADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLP 347
           +    K++ + L+         N                     +  L      L     
Sbjct: 132 INTLPKVNSIDLSY--------NGA----------------ITDIMPL----KTLP---- 159

Query: 348 DNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNL 390
                   LK LN+  + +       +     L  L      +
Sbjct: 160 -------ELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTI 193

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 46.9 bits (112), Expect = 8e-06
 Identities = 20/99 (20%), Positives = 41/99 (41%), Gaps = 3/99 (3%)

Query: 111 ISGTLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNL 170
           ++     +++ LT L  L + H++    I   +  L  +  ++L  N     I   +  L
Sbjct: 100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTL 158

Query: 171 ERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSG 209
             L+ LN+ F+       RG+    +L+ +   S  + G
Sbjct: 159 PELKSLNIQFDGVHD--YRGIEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 46.1 bits (110), Expect = 2e-05
 Identities = 19/87 (21%), Positives = 37/87 (42%), Gaps = 7/87 (8%)

Query: 589 GNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSF 648
           G + T  I      + SL  + L++  +T  +   +  A  ++ L + +   +   P   
Sbjct: 31  GQSSTANI--TEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATNYNP--I 84

Query: 649 STLVNLSALDLSFNNLSG-HIPHLQHL 674
           S L NL  L +   +++   IP+L  L
Sbjct: 85  SGLSNLERLRIMGKDVTSDKIPNLSGL 111

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 90.4 bits (225), Expect = 2e-19
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 19/205 (9%)

Query: 776 NFSIRNLIGTGGFGSTYKAELV----PGYLVAVKKLSIGRFQGIQQFD---AEIGTLGRI 828
            F     +GTG FG   +  LV     G   A+K L   +   ++Q +    E   L  +
Sbjct: 42  QFDRIKTLGTGSFG---RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98

Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
               LV L   +   + +++V  +++GG  E F H +   +         A  I     Y
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGG--EMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156

Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
           LH      +++RD+KP N+L+D++    ++DFG A+   V     T  + GT   +APE 
Sbjct: 157 LHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGR--TWTLCGTPEALAPEI 209

Query: 949 ATTCRVSDKADVYSFGVVLLELISG 973
             +   +   D ++ GV++ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 88.8 bits (220), Expect = 3e-19
 Identities = 48/206 (23%), Positives = 67/206 (32%), Gaps = 18/206 (8%)

Query: 485 LLLNNNMFNGSVPGERISKCN-DLQSFSV-NLSANLLSGMSYEAFLLDCVQLVEFEAANN 542
           L L N    G+ P   +     DL   ++ N+S         E        L     A  
Sbjct: 100 LTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQA 159

Query: 543 QISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDE----LGKLKFLKWILLGGNNLT---GE 595
                    V     L  LDL  N   G           K   L+ + L    +    G 
Sbjct: 160 HSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGV 219

Query: 596 IPSQFGHLISLVVLDLSHNALTGSIPASL-TKATKLESLFLAHNRLSGEIPVSFSTLVNL 654
             +     + L  LDLSHN+L  +  A      ++L SL L+   L     V       L
Sbjct: 220 CSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ---VPKGLPAKL 276

Query: 655 SALDLSFNNLSG-----HIPHLQHLD 675
           S LDLS+N L        +P + +L 
Sbjct: 277 SVLDLSYNRLDRNPSPDELPQVGNLS 302

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 86.1 bits (213), Expect = 3e-18
 Identities = 37/168 (22%), Positives = 55/168 (32%), Gaps = 12/168 (7%)

Query: 122 LTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKI-------PYQMSNLERLR 174
              L+ LS+            V     L  L+L  N   G+        P +   L+ L 
Sbjct: 148 KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLA 207

Query: 175 VLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTE 234
           + N    + SG          +L  +D+S N L       S      L  L LS   L  
Sbjct: 208 LRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK- 266

Query: 235 SIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTD 282
            +PK +     L  L L  N L+   P     + ++  L +  N   D
Sbjct: 267 QVPKGLP--AKLSVLDLSYNRLD-RNPS-PDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 78.4 bits (193), Expect = 9e-16
 Identities = 37/209 (17%), Positives = 61/209 (29%), Gaps = 17/209 (8%)

Query: 484 RLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSY-EAFLLDCVQLVEFEAANN 542
           RL +        +    +          + L    ++G +           L      N 
Sbjct: 72  RLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNV 131

Query: 543 QISGSIAA----GVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEI-- 596
             +   A            L+ L +          +++     L  + L  N   GE   
Sbjct: 132 SWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGL 191

Query: 597 -----PSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPV-SFST 650
                P +F  L  L + +      +G   A      +L+ L L+HN L       S   
Sbjct: 192 ISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDW 251

Query: 651 LVNLSALDLSFNNLS----GHIPHLQHLD 675
              L++L+LSF  L     G    L  LD
Sbjct: 252 PSQLNSLNLSFTGLKQVPKGLPAKLSVLD 280

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 74.5 bits (183), Expect = 2e-14
 Identities = 52/285 (18%), Positives = 85/285 (29%), Gaps = 28/285 (9%)

Query: 144 GELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLI---GNGELSVI 200
           G   L  +L+             +     L+ L +        +  G +   G   L  +
Sbjct: 41  GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100

Query: 201 DMSSNRLSG-GLAIDSSSECEFLTYLKLSDNFLT--ESIPKEIGKC--RNLKNLLLDGNI 255
            + +  ++G        +    L  L L +      ++   E+ +     LK L +    
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160

Query: 256 LEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADC----SKLSVLVLTNIDASLDLDNS 311
                 +++     L  LD+S N       +  A C      L VL L N          
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNA--------- 211

Query: 312 RGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPD-NWSESCSLKVLNLGQNSLKGAV 370
                   G           L+ L     +L       +      L  LNL    LK  V
Sbjct: 212 --GMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QV 268

Query: 371 PKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNITG 415
           PK L     L+ LDLS N L+   P    +P +   ++  N    
Sbjct: 269 PKGLP--AKLSVLDLSYNRLDR-NPSPDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 72.6 bits (178), Expect = 9e-14
 Identities = 57/305 (18%), Positives = 86/305 (28%), Gaps = 45/305 (14%)

Query: 374 LGMCRNLTYLDLSLNNLEGYLPMQLPVPCM--VYFNVSQNNITGVLPRFENVSCDNHFGF 431
            G  R+L YL   ++           +  +      V    I   +  F  +      G 
Sbjct: 39  YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRIL-FGALRVLGISGL 97

Query: 432 QDLQYANVPVMGSISDENFVIIH------DFSGNKFLGSLPLFAIGDGFLAAKYKPHYRL 485
           Q+L   N+ V G+                +     +       A    +L    K    L
Sbjct: 98  QELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLK---VL 154

Query: 486 LLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQIS 545
            +       +   E++     L +  ++LS N   G                     +  
Sbjct: 155 SIAQAHSL-NFSCEQVRVFPALST--LDLSDNPELG---------------------ERG 190

Query: 546 GSIAAGVGKLMKLQRLDLRGNR---VSGSLPDELGKLKFLKWILLGGNNLTGEIP-SQFG 601
              A    K   LQ L LR       SG           L+ + L  N+L          
Sbjct: 191 LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCD 250

Query: 602 HLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSF 661
               L  L+LS   L   +P  L    KL  L L++NRL    P S   L  +  L L  
Sbjct: 251 WPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLD-RNP-SPDELPQVGNLSLKG 305

Query: 662 NNLSG 666
           N    
Sbjct: 306 NPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 69.2 bits (169), Expect = 1e-12
 Identities = 34/132 (25%), Positives = 50/132 (37%), Gaps = 10/132 (7%)

Query: 108 SSVISGTLSASIAKLTELRTLSVPHN---SFSGEIPAGVGELRLLEVLELQGNNFSGKIP 164
                   +    K   L+ L++ +    + SG   A       L+ L+L  N+      
Sbjct: 186 LGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245

Query: 165 YQM-SNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLT 223
                   +L  LNLSF     +VP+GL     LSV+D+S NRL       S  E   + 
Sbjct: 246 APSCDWPSQLNSLNLSFTGLK-QVPKGLPAK--LSVLDLSYNRLDR---NPSPDELPQVG 299

Query: 224 YLKLSDNFLTES 235
            L L  N   +S
Sbjct: 300 NLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 66.5 bits (162), Expect = 9e-12
 Identities = 39/251 (15%), Positives = 73/251 (29%), Gaps = 18/251 (7%)

Query: 177 NLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESI 236
           + +FN           G   L  +    +  +         +   L  L +    +   I
Sbjct: 25  SSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRI 84

Query: 237 PKEIGKCRN---LKNLLLDGNILEGSIPKEIG--TISELKVLDVSRNSLTDRIPVELADC 291
                +      L+ L L+   + G+ P  +   T  +L +L++   S        LA+ 
Sbjct: 85  LFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAEL 143

Query: 292 SKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELL----LSRSLEVLWAPRANLGGRLP 347
            +     L      L +  +     + +    +  L    LS +       R  +    P
Sbjct: 144 QQWLKPGLK----VLSIAQAHSLNFSCEQVRVFPALSTLDLSDNP--ELGERGLISALCP 197

Query: 348 DNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPM--QLPVPCMVY 405
             +     L + N G  +  G           L  LDLS N+L              +  
Sbjct: 198 LKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNS 257

Query: 406 FNVSQNNITGV 416
            N+S   +  V
Sbjct: 258 LNLSFTGLKQV 268

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 58.4 bits (141), Expect = 4e-09
 Identities = 28/158 (17%), Positives = 51/158 (32%), Gaps = 9/158 (5%)

Query: 537 FEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKL---KFLKWILLGGNNLT 593
            +  + +        + K + L+RL +R  R+   +     ++     L+ + L    +T
Sbjct: 49  LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108

Query: 594 GEIPSQFG--HLISLVVLDLSHNALTGSIPASLT----KATKLESLFLAHNRLSGEIPVS 647
           G  P          L +L+L + +                  L+ L +A           
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ 168

Query: 648 FSTLVNLSALDLSFNNLSGHIPHLQHLDCIAFKGNKYL 685
                 LS LDLS N   G    +  L  + F   + L
Sbjct: 169 VRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVL 206

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 53.7 bits (129), Expect = 1e-07
 Identities = 50/271 (18%), Positives = 73/271 (26%), Gaps = 61/271 (22%)

Query: 355 SLKVLNLGQNSLKGAVPKSLGMC--RNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNN 412
            L+ L L    + G  P  L      +L  L+L   +          +   +   +   +
Sbjct: 96  GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLS 155

Query: 413 ITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGD 472
           I        N SC+    F  L                    D S N  LG   L     
Sbjct: 156 IAQA--HSLNFSCEQVRVFPALSTL-----------------DLSDNPELGERGLI---- 192

Query: 473 GFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLL--D 530
                           + +     P         LQ     L    +   S     L   
Sbjct: 193 ----------------SALCPLKFP--------TLQVL--ALRNAGMETPSGVCSALAAA 226

Query: 531 CVQLVEFEAANNQISGSIAAGVGKLM-KLQRLDLRGNRVSGSLPDELG-KLKFLKWILLG 588
            VQL   + ++N +  +  A       +L  L+L    +   +P  L  KL  L    L 
Sbjct: 227 RVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPAKLSVLD---LS 282

Query: 589 GNNLTGEIPSQFGHLISLVVLDLSHNALTGS 619
            N L    PS    L  +  L L  N    S
Sbjct: 283 YNRLD-RNPS-PDELPQVGNLSLKGNPFLDS 311

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 90.5 bits (225), Expect = 3e-19
 Identities = 53/210 (25%), Positives = 84/210 (40%), Gaps = 17/210 (8%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLS---IGRFQGIQQFDAEIGTLGRIRHK 831
           +F I  +IG G F      ++   G + A+K ++   + +   +  F  E   L     +
Sbjct: 62  DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRR 121

Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIH-KKSGKKIQWSVIHKIAIDIAQALAYLH 890
            +  L   +  E  ++LV  +  GG+L       K G++I   +      +I  A+  +H
Sbjct: 122 WITQLHFAFQDENYLYLVMEYYVGGDL--LTLLSKFGERIPAEMARFYLAEIVMAIDSVH 179

Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
                  VHRDIKP NILLD   +  L+DFG    L    T  +    GT  Y++PE   
Sbjct: 180 RL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQ 236

Query: 951 TCRVSDKADVY-------SFGVVLLELISG 973
                     Y       + GV   E+  G
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYG 266

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 90.9 bits (226), Expect = 3e-19
 Identities = 46/202 (22%), Positives = 81/202 (40%), Gaps = 17/202 (8%)

Query: 484 RLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQ 543
            L L +N     +P    +  ++L    +++S N +  +    F  D   L   E  +N 
Sbjct: 84  TLGLRSNRLK-LIPLGVFTGLSNLTK--LDISENKIVILLDYMFQ-DLYNLKSLEVGDND 139

Query: 544 ISGSIAAGV-GKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQ-FG 601
           +   I+      L  L++L L    ++    + L  L  L  + L   N+   I    F 
Sbjct: 140 LV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFK 197

Query: 602 HLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIP-VSFSTLVNLSALDLS 660
            L  L VL++SH     ++  +      L SL + H  L+  +P ++   LV L  L+LS
Sbjct: 198 RLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLS 256

Query: 661 FNNLS-------GHIPHLQHLD 675
           +N +S         +  LQ + 
Sbjct: 257 YNPISTIEGSMLHELLRLQEIQ 278

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 90.2 bits (224), Expect = 7e-19
 Identities = 65/317 (20%), Positives = 119/317 (37%), Gaps = 46/317 (14%)

Query: 355 SLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQL--PVPCMVYFNVSQNN 412
            L+ L L +N +    P +     NL  L L  N L+  +P+ +   +  +   ++S+N 
Sbjct: 57  HLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENK 115

Query: 413 ITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHD--FSGNKFLGSLPLFAI 470
           I  +L             FQDL   N+  +  + D + V I    FSG   L SL     
Sbjct: 116 IVILLDYM----------FQDLY--NLKSL-EVGDNDLVYISHRAFSG---LNSLE---- 155

Query: 471 GDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLD 530
                        +L L       S+P E +S  + L      L    ++ +   +F   
Sbjct: 156 -------------QLTLEKCNLT-SIPTEALSHLHGLIVL--RLRHLNINAIRDYSFK-R 198

Query: 531 CVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDE-LGKLKFLKWILLGG 589
             +L   E ++     ++       + L  L +    ++ ++P   +  L +L+++ L  
Sbjct: 199 LYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSY 257

Query: 590 NNLTGEIPSQ-FGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSF 648
           N ++  I       L+ L  + L    L    P +      L  L ++ N+L+      F
Sbjct: 258 NPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVF 316

Query: 649 STLVNLSALDLSFNNLS 665
            ++ NL  L L  N L+
Sbjct: 317 HSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 88.2 bits (219), Expect = 3e-18
 Identities = 42/174 (24%), Positives = 69/174 (39%), Gaps = 16/174 (9%)

Query: 513 NLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGV-GKLMKLQRLDLRGNRVSGS 571
           +L  N +  ++ + F      L E E   N +S ++  G    L  L+ L LR NR+   
Sbjct: 38  DLGKNRIKTLNQDEFA-SFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLK-L 94

Query: 572 LPDE-LGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPA-SLTKATK 629
           +P      L  L  + +  N +   +   F  L +L  L++  N L   I   + +    
Sbjct: 95  IPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNS 153

Query: 630 LESLFLAHNRLSGEIPV-SFSTLVNLSALDLSFNNLS-------GHIPHLQHLD 675
           LE L L    L+  IP  + S L  L  L L   N++         +  L+ L+
Sbjct: 154 LEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLE 206

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 87.5 bits (217), Expect = 5e-18
 Identities = 54/257 (21%), Positives = 95/257 (36%), Gaps = 23/257 (8%)

Query: 138 EIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGEL 197
            +P G+       +L+L  N        + ++   L  L L+ N  S   P        L
Sbjct: 25  AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNL 82

Query: 198 SVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEI-GKCRNLKNLLLDGNIL 256
             + + SNRL   + +   +    LT L +S+N +   +   +     NLK+L +  N L
Sbjct: 83  RTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDL 140

Query: 257 EGSIPKEI-GTISELKVLDVSRNSLTDRIPVE-LADCSKLSVLVLTNIDASLDLDNSRGE 314
              I       ++ L+ L + + +LT  IP E L+    L VL L +         +   
Sbjct: 141 V-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRH--------LN--- 187

Query: 315 FSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSL 374
            +A        L     L+VL          +  N     +L  L++   +L      ++
Sbjct: 188 INAIRDYSFKRL---YRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAV 244

Query: 375 GMCRNLTYLDLSLNNLE 391
                L +L+LS N + 
Sbjct: 245 RHLVYLRFLNLSYNPIS 261

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 82.1 bits (203), Expect = 2e-16
 Identities = 63/274 (22%), Positives = 93/274 (33%), Gaps = 25/274 (9%)

Query: 123 TELRTLSVPHNSFSGEIPAGV-GELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFN 181
           TE R L +  N     +          LE LEL  N  S   P   +NL  LR L L  N
Sbjct: 32  TETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90

Query: 182 SFSGEVPRG-LIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEI 240
                +P G   G   L+ +D+S N++   L      +   L  L++ DN L   I    
Sbjct: 91  RLK-LIPLGVFTGLSNLTKLDISENKIVI-LLDYMFQDLYNLKSLEVGDNDLV-YISHRA 147

Query: 241 -GKCRNLKNLLLDGNILEGSIPKEI-GTISELKVLDVSRNSLTDRIPVELADCSKLSVLV 298
                +L+ L L+   L  SIP E    +  L VL +   ++            +L VL 
Sbjct: 148 FSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLE 206

Query: 299 LTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDN-WSESCSLK 357
           +++      +  +        G          +L  L     NL   +P         L+
Sbjct: 207 ISHWPYLDTMTPN-----CLYG---------LNLTSLSITHCNLT-AVPYLAVRHLVYLR 251

Query: 358 VLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLE 391
            LNL  N +       L     L  + L    L 
Sbjct: 252 FLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA 285

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 81.7 bits (202), Expect = 4e-16
 Identities = 52/277 (18%), Positives = 92/277 (33%), Gaps = 51/277 (18%)

Query: 120 AKLTELRTLSVPHNSFSGEIPAGV-GELRLLEVLELQGNNFSGKIPYQM-SNLERLRVLN 177
             L+ L  L +  N     +   +  +L  L+ LE+  N+    I ++  S L  L  L 
Sbjct: 101 TGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLT 158

Query: 178 LSFNSFSGEVPRG-LIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESI 236
           L   + +  +P   L     L V+ +    ++  +   S      L  L++S     +++
Sbjct: 159 LEKCNLT-SIPTEALSHLHGLIVLRLRHLNINA-IRDYSFKRLYRLKVLEISHWPYLDTM 216

Query: 237 PKEIGKCRNLKNLLLDGNILEGSIPKE-IGTISELKVLDVSRNSLTDRIPVELADCSKLS 295
                   NL +L +    L  ++P   +  +  L+ L++S N ++      L +  +L 
Sbjct: 217 TPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQ 275

Query: 296 VLVLTNIDASLDLDN--SRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSES 353
            + L             +  E  AF G                         L       
Sbjct: 276 EIQLVG--------GQLAVVEPYAFRG-------------------------LN------ 296

Query: 354 CSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNL 390
             L+VLN+  N L            NL  L L  N L
Sbjct: 297 -YLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 79.0 bits (195), Expect = 2e-15
 Identities = 58/281 (20%), Positives = 89/281 (31%), Gaps = 33/281 (11%)

Query: 120 AKLTELRTLSVPHNSFSGEIPAGV-GELRLLEVLELQGNNFSGKIPYQM-SNLERLRVLN 177
           A    L  L +  N  S  +  G    L  L  L L+ N     IP  + + L  L  L+
Sbjct: 53  ASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLD 110

Query: 178 LSFNSFSGEVPRGL-IGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESI 236
           +S N     +   +      L  +++  N L   ++  + S    L  L L    LT SI
Sbjct: 111 ISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVY-ISHRAFSGLNSLEQLTLEKCNLT-SI 167

Query: 237 PKEI-GKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLS 295
           P E       L  L L    +          +  LKVL++S     D +         L+
Sbjct: 168 PTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLT 227

Query: 296 VLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGG----RLPDNWS 351
            L +T+              +A        L     L  L     NL       +  +  
Sbjct: 228 SLSITH--------C---NLTAVPYLAVRHL---VYLRFL-----NLSYNPISTIEGSML 268

Query: 352 ESC-SLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLE 391
                L+ + L    L    P +      L  L++S N L 
Sbjct: 269 HELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT 309

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 76.7 bits (189), Expect = 1e-14
 Identities = 32/127 (25%), Positives = 53/127 (41%), Gaps = 11/127 (8%)

Query: 558 LQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQ-FGHLISLVVLDLSHNAL 616
            + LDL  NR+     DE      L+ + L  N ++  +    F +L +L  L L  N L
Sbjct: 34  TRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRL 92

Query: 617 TGSIPA-SLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLS-------GHI 668
              IP    T  + L  L ++ N++   +   F  L NL +L++  N+L          +
Sbjct: 93  K-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGL 151

Query: 669 PHLQHLD 675
             L+ L 
Sbjct: 152 NSLEQLT 158

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 68.2 bits (167), Expect = 6e-12
 Identities = 28/126 (22%), Positives = 55/126 (43%), Gaps = 14/126 (11%)

Query: 559 QRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTG 618
           + +     R   ++P+ +      + + LG N +      +F     L  L+L+ N ++ 
Sbjct: 14  RAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS- 69

Query: 619 SIPA-SLTKATKLESLFLAHNRLSGEIPV-SFSTLVNLSALDLSFNNLS-------GHIP 669
           ++   +      L +L L  NRL   IP+  F+ L NL+ LD+S N +          + 
Sbjct: 70  AVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLY 128

Query: 670 HLQHLD 675
           +L+ L+
Sbjct: 129 NLKSLE 134

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 64.0 bits (156), Expect = 1e-10
 Identities = 40/250 (16%), Positives = 70/250 (28%), Gaps = 48/250 (19%)

Query: 172 RLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNF 231
             R+L+L  N               L  ++++ N +S  +   + +    L  L L  N 
Sbjct: 33  ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSA-VEPGAFNNLFNLRTLGLRSNR 91

Query: 232 LTESIPKEI-GKCRNLKNLLLDGNILEGSIPKEI-GTISELKVLDVSRNSLTDRIPVE-L 288
           L   IP  +     NL  L +  N +   +   +   +  LK L+V  N L   I     
Sbjct: 92  LK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-YISHRAF 148

Query: 289 ADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPD 348
           +  + L  L L                                              +P 
Sbjct: 149 SGLNSLEQLTLEK---------------------------------------CNLTSIPT 169

Query: 349 NWSESC-SLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPC-MVYF 406
                   L VL L   ++      S      L  L++S       +         +   
Sbjct: 170 EALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSL 229

Query: 407 NVSQNNITGV 416
           +++  N+T V
Sbjct: 230 SITHCNLTAV 239

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 47.4 bits (113), Expect = 2e-05
 Identities = 25/94 (26%), Positives = 43/94 (45%), Gaps = 6/94 (6%)

Query: 118 SIAKLTELRTLSVPHNSFSGEIPAGV-GELRLLEVLELQGNNFSGKIPYQM-SNLERLRV 175
           ++  L  LR L++ +N  S  I   +  EL  L+ ++L G   +  +       L  LRV
Sbjct: 243 AVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRV 300

Query: 176 LNLSFNSFSGEVPRGLI-GNGELSVIDMSSNRLS 208
           LN+S N  +  +   +    G L  + + SN L+
Sbjct: 301 LNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 89.3 bits (222), Expect = 4e-19
 Identities = 52/213 (24%), Positives = 82/213 (38%), Gaps = 22/213 (10%)

Query: 770 VVRATGNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRI 828
           ++  +  +     IG+G FG        +   LVAVK +  G     +    EI     +
Sbjct: 15  IMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID-ENVQREIINHRSL 73

Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
           RH N+V      +    + ++  + SGG L   I      +            +   ++Y
Sbjct: 74  RHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSY 131

Query: 889 LHYSCVPRIVHRDIKPSNILLDE--ELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAP 946
            H     +I HRD+K  N LLD        + DFG ++   +     +T   GT  Y+AP
Sbjct: 132 CHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAP 186

Query: 947 E------YATTCRVSDKADVYSFGVVLLELISG 973
           E      Y         ADV+S GV L  ++ G
Sbjct: 187 EVLLRQEYD-----GKIADVWSCGVTLYVMLVG 214

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 87.7 bits (218), Expect = 4e-19
 Identities = 52/203 (25%), Positives = 83/203 (40%), Gaps = 18/203 (8%)

Query: 484 RLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQ 543
           R+ L+ N  +  VP      C +L    + L +N+L+ +   AF      L + + ++N 
Sbjct: 36  RIFLHGNRIS-HVPAASFRACRNLTI--LWLHSNVLARIDAAAFT-GLALLEQLDLSDNA 91

Query: 544 ISGSIAAGV-GKLMKLQRLDLRGNRVSGSLPDE-LGKLKFLKWILLGGNNLTGEIPSQ-F 600
              S+       L +L  L L    +   L       L  L+++ L  N L   +P   F
Sbjct: 92  QLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTF 149

Query: 601 GHLISLVVLDLSHNALTGSIPA-SLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDL 659
             L +L  L L  N ++ S+P  +      L+ L L  NR++   P +F  L  L  L L
Sbjct: 150 RDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208

Query: 660 SFNNLS-------GHIPHLQHLD 675
             NNLS         +  LQ+L 
Sbjct: 209 FANNLSALPTEALAPLRALQYLR 231

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 37/128 (28%), Positives = 49/128 (38%), Gaps = 12/128 (9%)

Query: 558 LQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQ-FGHLISLVVLDLSHNAL 616
            QR+ L GNR+S          + L  + L  N L   I +  F  L  L  LDLS NA 
Sbjct: 34  SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQ 92

Query: 617 TGSIPAS-LTKATKLESLFLAHNRLSGEIPV-SFSTLVNLSALDLSFNNLS-------GH 667
             S+  +      +L +L L    L  E+    F  L  L  L L  N L          
Sbjct: 93  LRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151

Query: 668 IPHLQHLD 675
           + +L HL 
Sbjct: 152 LGNLTHLF 159

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 68.9 bits (169), Expect = 1e-12
 Identities = 40/183 (21%), Positives = 62/183 (33%), Gaps = 33/183 (18%)

Query: 485 LLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQI 544
           L L++N    SV          L +  ++L    L  +    F      L      +N +
Sbjct: 85  LDLSDNAQLRSVDPATFHGLGRLHT--LHLDRCGLQELGPGLFR-GLAALQYLYLQDNAL 141

Query: 545 SGSIAAGV-GKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHL 603
             ++       L  L  L L GNR+S S+P+                         F  L
Sbjct: 142 Q-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERA-----------------------FRGL 176

Query: 604 ISLVVLDLSHNALTGSIPA-SLTKATKLESLFLAHNRLSGEIPVS-FSTLVNLSALDLSF 661
            SL  L L  N +   +   +     +L +L+L  N LS  +P    + L  L  L L+ 
Sbjct: 177 HSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLND 234

Query: 662 NNL 664
           N  
Sbjct: 235 NPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 64.6 bits (158), Expect = 2e-11
 Identities = 32/167 (19%), Positives = 55/167 (32%), Gaps = 8/167 (4%)

Query: 138 EIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGEL 197
            +P G+      + + L GN  S            L +L L  N  +        G   L
Sbjct: 25  AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 198 SVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEI-GKCRNLKNLLLDGNIL 256
             +D+S N     +   +      L  L L    L   +   +      L+ L L  N L
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL 141

Query: 257 EGSIPKEI-GTISELKVLDVSRNSLTDRIPVE-LADCSKLSVLVLTN 301
           + ++P +    +  L  L +  N ++  +P         L  L+L  
Sbjct: 142 Q-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQ 186

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 63.5 bits (155), Expect = 6e-11
 Identities = 33/164 (20%), Positives = 57/164 (34%), Gaps = 10/164 (6%)

Query: 122 LTELRTLSVPHNSFSGEIPAGV-GELRLLEVLELQGNNFSGKIPYQM-SNLERLRVLNLS 179
           L  L  L +  N+    +       L  L  L L       ++   +   L  L+ L L 
Sbjct: 79  LALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQ 137

Query: 180 FNSFSGEVPRGLIGN-GELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPK 238
            N+    +P     + G L+ + +  NR+S  +   +      L  L L  N +   +  
Sbjct: 138 DNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA-HVHP 194

Query: 239 EI-GKCRNLKNLLLDGNILEGSIPKEI-GTISELKVLDVSRNSL 280
                   L  L L  N L  ++P E    +  L+ L ++ N  
Sbjct: 195 HAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 51.5 bits (124), Expect = 4e-07
 Identities = 30/113 (26%), Positives = 44/113 (38%), Gaps = 5/113 (4%)

Query: 120 AKLTELRTLSVPHNSFSGEIPAGV-GELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNL 178
             L  L+ L +  N+    +P     +L  L  L L GN  S         L  L  L L
Sbjct: 126 RGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL 184

Query: 179 SFNSFSGEVPRG-LIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDN 230
             N  +  V        G L  + + +N LS  L  ++ +    L YL+L+DN
Sbjct: 185 HQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 50.4 bits (121), Expect = 1e-06
 Identities = 21/95 (22%), Positives = 31/95 (32%), Gaps = 11/95 (11%)

Query: 589 GNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSF 648
              L   +P       +   + L  N ++    AS      L  L+L  N L+     +F
Sbjct: 20  QQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAF 76

Query: 649 STLVNLSALDLSFNNLSGHIP--------HLQHLD 675
           + L  L  LDLS N     +          L  L 
Sbjct: 77  TGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 45.0 bits (107), Expect = 8e-05
 Identities = 33/172 (19%), Positives = 53/172 (30%), Gaps = 41/172 (23%)

Query: 222 LTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEI-GTISELKVLDVSRNSL 280
              + L  N ++         CRNL  L L  N+L   I       ++ L+ LD+S N+ 
Sbjct: 34  SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQ 92

Query: 281 TDRIPVE-LADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPR 339
              +         +L          +L LD           G+   L             
Sbjct: 93  LRSVDPATFHGLGRLH---------TLHLDRCG--LQELGPGLFRGLA------------ 129

Query: 340 ANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLE 391
                          +L+ L L  N+L+     +     NLT+L L  N + 
Sbjct: 130 ---------------ALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS 166

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 88.8 bits (221), Expect = 5e-19
 Identities = 57/226 (25%), Positives = 96/226 (42%), Gaps = 36/226 (15%)

Query: 772 RATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQ-GIQQFDA--EIGTLGR 827
                +     IG G FG  +KA     G  VA+KK+ +   + G     A  EI  L  
Sbjct: 14  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP-ITALREIKILQL 72

Query: 828 IRHKNLVTLIGYYVGEAE--------MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
           ++H+N+V LI     +A         ++LV++F    +L   +      K   S I ++ 
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNV-LVKFTLSEIKRVM 130

Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA----TT 935
             +   L Y+H +   +I+HRD+K +N+L+  +    L+DFGLAR   +++       T 
Sbjct: 131 QMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 187

Query: 936 DVAGTFGYVAPE-------YATTCRVSDKADVYSFGVVLLELISGK 974
            V  T  Y  PE       Y          D++  G ++ E+ +  
Sbjct: 188 RVV-TLWYRPPELLLGERDYGPPI------DLWGAGCIMAEMWTRS 226

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 87.8 bits (218), Expect = 6e-19
 Identities = 43/175 (24%), Positives = 70/175 (40%), Gaps = 15/175 (8%)

Query: 513 NLSANLLSGMSYEAFLLDCVQLVEFEAANNQIS-GSIAAGV-GKLMKLQRLDLRGNRVSG 570
            L +N L  + +  F     QL +   ++N +S     +        L+ LDL  N V  
Sbjct: 34  ELESNKLQSLPHGVFD-KLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI- 91

Query: 571 SLPDELGKLKFLKWILLGGNNLTGEIPSQ--FGHLISLVVLDLSHNALTGSIPASLTKAT 628
           ++      L+ L+ +    +NL  ++     F  L +L+ LD+SH     +        +
Sbjct: 92  TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 150

Query: 629 KLESLFLAHNRLSGEI-PVSFSTLVNLSALDLSFNNLS-------GHIPHLQHLD 675
            LE L +A N       P  F+ L NL+ LDLS   L          +  LQ L+
Sbjct: 151 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 205

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 83.5 bits (207), Expect = 2e-17
 Identities = 36/143 (25%), Positives = 55/143 (38%), Gaps = 14/143 (9%)

Query: 558 LQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLT-GEIPSQ-FGHLISLVVLDLSHNA 615
             RL+L  N++         KL  L  + L  N L+     SQ      SL  LDLS N 
Sbjct: 30  ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89

Query: 616 LTGSIPASLTKATKLESLFLAHNRLSGEIPVS-FSTLVNLSALDLSFNNLS-------GH 667
           +  ++ ++     +LE L   H+ L      S F +L NL  LD+S  +           
Sbjct: 90  VI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 148

Query: 668 IPHLQHLDCIAFKGNKYLASCPD 690
           +  L+ L      GN +  +   
Sbjct: 149 LSSLEVLK---MAGNSFQENFLP 168

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 82.4 bits (204), Expect = 5e-17
 Identities = 31/157 (19%), Positives = 60/157 (38%), Gaps = 6/157 (3%)

Query: 513 NLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGV-GKLMKLQRLDLRGNRVSGS 571
           +   + L  MS  +  L    L+  + ++         G+   L  L+ L + GN    +
Sbjct: 107 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQEN 165

Query: 572 LPDE-LGKLKFLKWILLGGNNLTGEIPSQ-FGHLISLVVLDLSHNALTGSIPASLTKATK 629
              +   +L+ L ++ L    L  ++    F  L SL VL++SHN               
Sbjct: 166 FLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNS 224

Query: 630 LESLFLAHNRLSGEIPVSFSTLV-NLSALDLSFNNLS 665
           L+ L  + N +             +L+ L+L+ N+ +
Sbjct: 225 LQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 77.7 bits (192), Expect = 1e-15
 Identities = 57/267 (21%), Positives = 94/267 (35%), Gaps = 41/267 (15%)

Query: 138 EIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFN--SFSGEVPRGLIGNG 195
            +P G+        LEL+ N            L +L  L+LS N  SF G   +   G  
Sbjct: 21  SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78

Query: 196 ELSVIDMSSNRLSGGLAIDSS-SECEFLTYLKLSDNFLTESIPKEI-GKCRNLKNLLLDG 253
            L  +D+S N +     + S+    E L +L    + L +     +    RNL  L +  
Sbjct: 79  SLKYLDLSFNGVI---TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 135

Query: 254 NILEGSIPKEI-GTISELKVLDVSRNSLTDRIPVE-LADCSKLSVLVL-----TNIDASL 306
                     I   +S L+VL ++ NS  +    +   +   L+ L L       +    
Sbjct: 136 THTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP-- 192

Query: 307 DLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESC-SLKVLNLGQNS 365
                    +AF+           SL+VL     N    L     +   SL+VL+   N 
Sbjct: 193 ---------TAFNS--------LSSLQVLNMSHNNF-FSLDTFPYKCLNSLQVLDYSLNH 234

Query: 366 LKGAVPKSL--GMCRNLTYLDLSLNNL 390
           +     K        +L +L+L+ N+ 
Sbjct: 235 IM-TSKKQELQHFPSSLAFLNLTQNDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 69.7 bits (171), Expect = 7e-13
 Identities = 51/296 (17%), Positives = 85/296 (28%), Gaps = 68/296 (22%)

Query: 353 SCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQ---LPVPCMVYFNVS 409
             S   L L  N L+            LT L LS N L               + Y ++S
Sbjct: 27  PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86

Query: 410 QNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFA 469
            N +  +   F         G + L++                  DF  +  L  +  F+
Sbjct: 87  FNGVITMSSNFL--------GLEQLEHL-----------------DFQHSN-LKQMSEFS 120

Query: 470 IGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLL 529
           +        Y     L +++                            + +G+S      
Sbjct: 121 VFLSLRNLIY-----LDISHT---------HTR----------VAFNGIFNGLS------ 150

Query: 530 DCVQLVEFEAANNQISGSIAAGV-GKLMKLQRLDLRGNRVSGSLPDE-LGKLKFLKWILL 587
               L   + A N    +    +  +L  L  LDL   ++   L       L  L+ + +
Sbjct: 151 ---SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNM 206

Query: 588 GGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKA--TKLESLFLAHNRLS 641
             NN        +  L SL VLD S N +  +      +   + L  L L  N  +
Sbjct: 207 SHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 66.6 bits (163), Expect = 6e-12
 Identities = 36/173 (20%), Positives = 68/173 (39%), Gaps = 10/173 (5%)

Query: 114 TLSASIAKLTELRTLSVPHNSFSGEIPAGV-GELRLLEVLELQGNNFSGKIPYQM-SNLE 171
           T+S++   L +L  L   H++        V   LR L  L++   +        + + L 
Sbjct: 92  TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLS 150

Query: 172 RLRVLNLSFNSFSGEVPRGLIGN-GELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDN 230
            L VL ++ NSF       +      L+ +D+S  +L   L+  + +    L  L +S N
Sbjct: 151 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHN 209

Query: 231 FLTESIPKEI-GKCRNLKNLLLDGNILEGSIPKEI--GTISELKVLDVSRNSL 280
               S+         +L+ L    N +  +  K+      S L  L++++N  
Sbjct: 210 NFF-SLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 66.6 bits (163), Expect = 8e-12
 Identities = 29/127 (22%), Positives = 46/127 (36%), Gaps = 14/127 (11%)

Query: 559 QRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALT- 617
             +      ++ S+P  +        + L  N L       F  L  L  L LS N L+ 
Sbjct: 10  TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66

Query: 618 GSIPA-SLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLS--------GHI 668
               + S    T L+ L L+ N +   +  +F  L  L  LD   +NL           +
Sbjct: 67  KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 125

Query: 669 PHLQHLD 675
            +L +LD
Sbjct: 126 RNLIYLD 132

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 47.7 bits (114), Expect = 9e-06
 Identities = 31/180 (17%), Positives = 49/180 (27%), Gaps = 48/180 (26%)

Query: 222 LTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGN-ILEGSIPKEIGT-ISELKVLDVSRNS 279
            T L+L  N L         K   L  L L  N +       +     + LK LD+S N 
Sbjct: 30  ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89

Query: 280 LTDRIPVELADCSKLSVLVLTNIDASLDLDNSR----GEFSAFDGGVPYELLLSRSLEVL 335
           +   +        +L           LD  +S      EFS F                 
Sbjct: 90  VI-TMSSNFLGLEQL---------EHLDFQHSNLKQMSEFSVFLS--------------- 124

Query: 336 WAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLP 395
                     L        +L  L++     + A         +L  L ++ N+ +    
Sbjct: 125 ----------LR-------NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 167

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 88.5 bits (220), Expect = 8e-19
 Identities = 55/217 (25%), Positives = 87/217 (40%), Gaps = 28/217 (12%)

Query: 777 FSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQ------QFDA-----EIGTL 825
           ++++  I +G +G+        G  VA+K++      G         F       EI  L
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83

Query: 826 GRIRHKNLVTLIGYYVGEA-----EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHK--I 878
               H N++ L   +V        +++LV   +   +L   IH +   +I  S  H    
Sbjct: 84  NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQ---RIVISPQHIQYF 139

Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVA 938
              I   L  LH      +VHRD+ P NILL +  +  + DF LAR  E +     T   
Sbjct: 140 MYHILLGLHVLH-EA--GVVHRDLHPGNILLADNNDITICDFNLAR--EDTADANKTHYV 194

Query: 939 GTFGYVAPEYATTCRVSDKA-DVYSFGVVLLELISGK 974
               Y APE     +   K  D++S G V+ E+ + K
Sbjct: 195 THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 89.4 bits (222), Expect = 8e-19
 Identities = 50/215 (23%), Positives = 88/215 (40%), Gaps = 34/215 (15%)

Query: 777 FSIRNLIGTGGFGSTYKAELV----PGYLVAVKKLS---IGRFQGIQQFDAEIGTLGRIR 829
           + +  +IG G FG   + +LV       + A+K LS   + +      F  E   +    
Sbjct: 71  YEVVKVIGRGAFG---EVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 127

Query: 830 HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGK-KIQWSVIHKIAIDIAQALAY 888
              +V L   +  +  +++V  ++ GG+L       +     +W+  +    ++  AL  
Sbjct: 128 SPWVVQLFYAFQDDRYLYMVMEYMPGGDL--VNLMSNYDVPEKWARFY--TAEVVLALDA 183

Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE- 947
           +H       +HRD+KP N+LLD+  +  L+DFG    +            GT  Y++PE 
Sbjct: 184 IHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 240

Query: 948 ---------YATTCRVSDKADVYSFGVVLLELISG 973
                    Y   C      D +S GV L E++ G
Sbjct: 241 LKSQGGDGYYGREC------DWWSVGVFLYEMLVG 269

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 87.7 bits (218), Expect = 1e-18
 Identities = 60/213 (28%), Positives = 107/213 (50%), Gaps = 30/213 (14%)

Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDA-----EIGTLGRIR 829
            +     +G+G +GS   A +   G  VA+KKLS   FQ   +  A     E+  L  ++
Sbjct: 25  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-RPFQ--SEIFAKRAYRELLLLKHMQ 81

Query: 830 HKNLVTLIGYYVGEA------EMFLVYNFLSGGNLETFIHKK-SGKKIQWSVIHKIAIDI 882
           H+N++ L+  +   +      + +LV  F+   +L+  +  K S +KIQ+ V       +
Sbjct: 82  HENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLKFSEEKIQYLVYQ-----M 135

Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFG 942
            + L Y+H +    +VHRD+KP N+ ++E+    + DFGLAR    ++   T  V  T  
Sbjct: 136 LKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVV-TRW 188

Query: 943 YVAPEYATTCRVSDKA-DVYSFGVVLLELISGK 974
           Y APE   +    ++  D++S G ++ E+++GK
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 87.7 bits (218), Expect = 2e-18
 Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 29/215 (13%)

Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDA-----EIGTLGRIR 829
            ++  + IG G +G    A + +    VA+KK  I  F+   Q        EI  L R R
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKK--ISPFE--HQTYCQRTLREIKILLRFR 83

Query: 830 HKNLVTLIGYYVGEA-----EMFLVYNFLSGGNLETFIHKK--SGKKIQWSVIHKIAIDI 882
           H+N++ +             ++++V + +   +L   +  +  S   I + +       I
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQ-----I 137

Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT--TDVAGT 940
            + L Y+H S    ++HRD+KPSN+LL+   +  + DFGLAR+ +    H    T+   T
Sbjct: 138 LRGLKYIH-SA--NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194

Query: 941 FGYVAPEYATTCRVSDKA-DVYSFGVVLLELISGK 974
             Y APE     +   K+ D++S G +L E++S +
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 88.3 bits (219), Expect = 2e-18
 Identities = 55/230 (23%), Positives = 90/230 (39%), Gaps = 39/230 (16%)

Query: 484 RLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQ 543
            L L+ N     +          L+   + LS N +  +   AF      L   E  +N+
Sbjct: 68  LLNLHENQIQ-IIKVNSFKHLRHLEI--LQLSRNHIRTIEIGAFN-GLANLNTLELFDNR 123

Query: 544 ISGSIAAGV-GKLMKLQRLDLRGNR---VSGSLPDELGKLKF------------------ 581
           ++ +I  G    L KL+ L LR N    +     + +  L+                   
Sbjct: 124 LT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFE 182

Query: 582 ----LKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAH 637
               L+++ L   NL  EIP+    LI L  LDLS N L+   P S      L+ L++  
Sbjct: 183 GLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQ 240

Query: 638 NRLSGEIPVSFSTLVNLSALDLSFNNLSGHIP-----HLQHLDCIAFKGN 682
           +++      +F  L +L  ++L+ NNL+  +P      L HL+ I    N
Sbjct: 241 SQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 81.3 bits (201), Expect = 3e-16
 Identities = 34/127 (26%), Positives = 60/127 (47%), Gaps = 12/127 (9%)

Query: 558 LQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQ-FGHLISLVVLDLSHNAL 616
            + L+L  N++     +    L+ L+ + L  N++   I    F  L +L  L+L  N L
Sbjct: 66  TRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRL 124

Query: 617 TGSIPA-SLTKATKLESLFLAHNRLSGEIPV-SFSTLVNLSALDLSFNNLSGHIPHLQHL 674
           T +IP  +    +KL+ L+L +N +   IP  +F+ + +L  LDL           L ++
Sbjct: 125 T-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELK------RLSYI 176

Query: 675 DCIAFKG 681
              AF+G
Sbjct: 177 SEGAFEG 183

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 76.7 bits (189), Expect = 1e-14
 Identities = 36/155 (23%), Positives = 60/155 (38%), Gaps = 8/155 (5%)

Query: 513 NLSANLLSGMSYEAFLLDCVQLVEFE-AANNQISGSIAAGV-GKLMKLQRLDLRGNRVSG 570
            L  N +  +   AF      L   +     ++S  I+ G    L  L+ L+L    +  
Sbjct: 142 WLRNNPIESIPSYAFN-RIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLR- 198

Query: 571 SLPDELGKLKFLKWILLGGNNLTGEIPSQ-FGHLISLVVLDLSHNALTGSIPASLTKATK 629
            +P+ L  L  L  + L GN+L+  I    F  L+ L  L +  + +      +      
Sbjct: 199 EIPN-LTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQS 256

Query: 630 LESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNL 664
           L  + LAHN L+      F+ L +L  + L  N  
Sbjct: 257 LVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 67.1 bits (164), Expect = 1e-11
 Identities = 55/274 (20%), Positives = 89/274 (32%), Gaps = 52/274 (18%)

Query: 123 TELRTLSVPHNSFSGEIPAGV-GELRLLEVLELQGNNFSGKIPYQM-SNLERLRVLNLSF 180
           T  R L++  N     I       LR LE+L+L  N+    I     + L  L  L L  
Sbjct: 64  TNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFD 121

Query: 181 NSFSGEVPRG-LIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKE 239
           N  +  +P G  +   +L  + + +N +   +   + +    L  L L +      I + 
Sbjct: 122 NRLT-TIPNGAFVYLSKLKELWLRNNPIES-IPSYAFNRIPSLRRLDLGELKRLSYISEG 179

Query: 240 I-GKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVE-LADCSKLSVL 297
                 NL+ L L    L   IP  +  + +L  LD+S N L+  I          L  L
Sbjct: 180 AFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKL 236

Query: 298 VLT-NIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSL 356
            +  +    ++ +       AFD                          L        SL
Sbjct: 237 WMIQSQIQVIERN-------AFDN-------------------------LQ-------SL 257

Query: 357 KVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNL 390
             +NL  N+L            +L  + L  N  
Sbjct: 258 VEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 58.6 bits (142), Expect = 5e-09
 Identities = 31/138 (22%), Positives = 56/138 (40%), Gaps = 8/138 (5%)

Query: 120 AKLTELRTLSVPHNSFSGEIPAGV-GELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNL 178
            ++  LR L +        I  G    L  L  L L   N   +IP  ++ L +L  L+L
Sbjct: 157 NRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDL 214

Query: 179 SFNSFSGEVPRGLIGN-GELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIP 237
           S N  S  +  G       L  + M  +++   +  ++    + L  + L+ N LT  +P
Sbjct: 215 SGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT-LLP 271

Query: 238 KEI-GKCRNLKNLLLDGN 254
            ++     +L+ + L  N
Sbjct: 272 HDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 57.5 bits (139), Expect = 1e-08
 Identities = 53/266 (19%), Positives = 89/266 (33%), Gaps = 57/266 (21%)

Query: 129 SVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVP 188
            VP       I           +L L  N           +L  L +L LS N       
Sbjct: 57  EVPDG-----ISTN------TRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEI 105

Query: 189 RGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEI-GKCRNLK 247
               G   L+ +++  NRL+  +   +      L  L L +N +  SIP     +  +L+
Sbjct: 106 GAFNGLANLNTLELFDNRLTT-IPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLR 163

Query: 248 NL-LLDGNILEGSIPKEI-GTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDAS 305
            L L +   L   I +     +S L+ L+++  +L   IP  L    KL  L L+     
Sbjct: 164 RLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSG---- 216

Query: 306 LDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNS 365
               N     SA   G    L+                            L+ L + Q+ 
Sbjct: 217 ----N---HLSAIRPGSFQGLM---------------------------HLQKLWMIQSQ 242

Query: 366 LKGAVPKSLGMCRNLTYLDLSLNNLE 391
           ++     +    ++L  ++L+ NNL 
Sbjct: 243 IQVIERNAFDNLQSLVEINLAHNNLT 268

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 56.7 bits (137), Expect = 2e-08
 Identities = 23/101 (22%), Positives = 40/101 (39%), Gaps = 10/101 (9%)

Query: 582 LKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLS 641
              ++    NL  E+P       +  +L+L  N +      S      LE L L+ N + 
Sbjct: 45  FSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR 101

Query: 642 GEIPVSFSTLVNLSALDLSFNNLSG-------HIPHLQHLD 675
                +F+ L NL+ L+L  N L+        ++  L+ L 
Sbjct: 102 TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELW 142

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 44.0 bits (104), Expect = 2e-04
 Identities = 46/244 (18%), Positives = 76/244 (31%), Gaps = 47/244 (19%)

Query: 355 SLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQL--PVPCMVYFNVSQNN 412
            L++L L +N ++     +     NL  L+L  N L   +P      +  +    +  N 
Sbjct: 89  HLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNP 147

Query: 413 ITGVLPR-FENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIG 471
           I  +    F  +        + L    +  +  IS+        F G   L +L      
Sbjct: 148 IESIPSYAFNRIP-----SLRRLDLGELKRLSYISE------GAFEG---LSNL------ 187

Query: 472 DGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSV-NLSANLLSGMSYEAFLLD 530
                        L L             I     L      +LS N LS +   +F   
Sbjct: 188 -----------RYLNLAMCNLR------EIPNLTPLIKLDELDLSGNHLSAIRPGSF-QG 229

Query: 531 CVQLVEFEAANNQISGSIAAGV-GKLMKLQRLDLRGNRVSGSLPDE-LGKLKFLKWILLG 588
            + L +     +QI   I       L  L  ++L  N ++  LP +    L  L+ I L 
Sbjct: 230 LMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLH 287

Query: 589 GNNL 592
            N  
Sbjct: 288 HNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 44.0 bits (104), Expect = 2e-04
 Identities = 21/90 (23%), Positives = 35/90 (38%), Gaps = 4/90 (4%)

Query: 118 SIAKLTELRTLSVPHNSFSGEIPAGV-GELRLLEVLELQGNNFSGKIPYQMSNLERLRVL 176
           ++  L +L  L +  N  S  I  G    L  L+ L +  +           NL+ L  +
Sbjct: 202 NLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEI 260

Query: 177 NLSFNSFSGEVPRGLI-GNGELSVIDMSSN 205
           NL+ N+ +  +P  L      L  I +  N
Sbjct: 261 NLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 85.8 bits (213), Expect = 4e-18
 Identities = 39/185 (21%), Positives = 69/185 (37%), Gaps = 16/185 (8%)

Query: 484 RLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQ 543
           +L ++ N     +P    S   +L      +  N +  +    F      +   E   N 
Sbjct: 106 KLYISKNHLV-EIPPNLPSSLVEL-----RIHDNRIRKVPKGVFS-GLRNMNCIEMGGNP 158

Query: 544 I-SGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQ-FG 601
           + +     G    +KL  L +   +++  +P +L   + L  + L  N +   I  +   
Sbjct: 159 LENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ-AIELEDLL 214

Query: 602 HLISLVVLDLSHNALTGSIPA-SLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLS 660
               L  L L HN +   I   SL+    L  L L +N+LS  +P     L  L  + L 
Sbjct: 215 RYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLH 272

Query: 661 FNNLS 665
            NN++
Sbjct: 273 TNNIT 277

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 85.5 bits (212), Expect = 6e-18
 Identities = 60/344 (17%), Positives = 114/344 (33%), Gaps = 70/344 (20%)

Query: 353 SCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLP-VPCMVYFNVSQN 411
            C L+V+      LK AVPK +    + T LDL  N++          +  +    +  N
Sbjct: 32  HCHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNN 88

Query: 412 NITGVLPR-FENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLP--LF 468
            I+ +  + F  +          LQ   +                 S N  L  +P  L 
Sbjct: 89  KISKIHEKAFSPLR--------KLQKLYI-----------------SKNH-LVEIPPNLP 122

Query: 469 AIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFL 528
                           L +++N     VP    S   ++    + +  N L    +E   
Sbjct: 123 -----------SSLVELRIHDNRIR-KVPKGVFSGLRNMNC--IEMGGNPLENSGFEPGA 168

Query: 529 LDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDE-LGKLKFLKWILL 587
            D ++L     +  +++  I   +     L  L L  N++  ++  E L +   L  + L
Sbjct: 169 FDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGL 224

Query: 588 GGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVS 647
           G N +          L +L  L L +N L+  +PA L     L+ ++L  N ++ ++ V+
Sbjct: 225 GHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVN 282

Query: 648 -------FSTLVNLSALDLSFNNLSG---------HIPHLQHLD 675
                         + + L  N +            +     + 
Sbjct: 283 DFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQ 326

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 75.1 bits (185), Expect = 2e-14
 Identities = 53/259 (20%), Positives = 91/259 (35%), Gaps = 33/259 (12%)

Query: 138 EIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGEL 197
            +P  +       +L+LQ N+ S         L+ L  L L  N  S    +      +L
Sbjct: 47  AVPKEISPD--TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKL 104

Query: 198 SVIDMSSNRLSGGLAIDSSSECEF--LTYLKLSDNFLTESIPKEI-GKCRNLKNLLLDGN 254
             + +S N L     I  +       L  L++ DN +   +PK +    RN+  + + GN
Sbjct: 105 QKLYISKNHLV---EIPPNL---PSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGN 157

Query: 255 -ILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRG 313
            +             +L  L +S   LT  IP +L             ++  L LD+++ 
Sbjct: 158 PLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL----------PETLN-ELHLDHNK- 204

Query: 314 EFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESC-SLKVLNLGQNSLKGAVPK 372
              A +            L  L      +   + +       +L+ L+L  N L   VP 
Sbjct: 205 -IQAIELEDLLRY---SKLYRLGLGHNQI-RMIENGSLSFLPTLRELHLDNNKLS-RVPA 258

Query: 373 SLGMCRNLTYLDLSLNNLE 391
            L   + L  + L  NN+ 
Sbjct: 259 GLPDLKLLQVVYLHTNNIT 277

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 74.7 bits (184), Expect = 2e-14
 Identities = 58/288 (20%), Positives = 93/288 (32%), Gaps = 53/288 (18%)

Query: 123 TELRTLSVPHNSFSGEIPAGV-GELRLLEVLELQGNNFSGKIPYQM-SNLERLRVLNLSF 180
            +   L + +N  S E+       L+ L  L L  N  S KI  +  S L +L+ L +S 
Sbjct: 54  PDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISK 111

Query: 181 NSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTES-IPKE 239
           N    E+P  L  +  L  + +  NR+   +     S    +  +++  N L  S     
Sbjct: 112 NHLV-EIPPNLPSS--LVELRIHDNRIRK-VPKGVFSGLRNMNCIEMGGNPLENSGFEPG 167

Query: 240 IGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVE-LADCSKLSVLV 298
                 L  L +    L   IPK       L  L +  N +   I +E L   SKL  L 
Sbjct: 168 AFDGLKLNYLRISEAKLT-GIPK--DLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLG 223

Query: 299 L-----TNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGG----RLPDN 349
           L       I+             +          L  +L  L     +L      R+P  
Sbjct: 224 LGHNQIRMIENG-----------SLSF-------LP-TLREL-----HLDNNKLSRVPAG 259

Query: 350 WSESCSLKVLNLGQNSLKG------AVPKSLGMCRNLTYLDLSLNNLE 391
             +   L+V+ L  N++                      + L  N + 
Sbjct: 260 LPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 60.8 bits (148), Expect = 7e-10
 Identities = 60/296 (20%), Positives = 95/296 (32%), Gaps = 54/296 (18%)

Query: 355 SLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNIT 414
            L  L L  N +     K+    R L  L +S N+L   +P  LP   +V   +  N I 
Sbjct: 79  HLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP-SSLVELRIHDNRIR 136

Query: 415 GVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDG- 473
            V              F  L              N   I    GN     L       G 
Sbjct: 137 KVPKG----------VFSGL-------------RNMNCIE-MGGNP----LENSGFEPGA 168

Query: 474 FLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQ 533
           F   K      L ++       +P +     N+L     +L  N +  +  E  L    +
Sbjct: 169 FDGLKLN---YLRISEAKLT-GIPKDLPETLNEL-----HLDHNKIQAIELEDLL-RYSK 218

Query: 534 LVEFEAANNQISGSIAAGV-GKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNL 592
           L      +NQI   I  G    L  L+ L L  N++S  +P  L  LK L+ + L  NN+
Sbjct: 219 LYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNI 276

Query: 593 TGEIPSQ-------FGHLISLVVLDLSHNALT-GSIPASL-TKATKLESLFLAHNR 639
           T ++                   + L +N +    +  +     T   ++   + +
Sbjct: 277 T-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 57.7 bits (140), Expect = 7e-09
 Identities = 28/144 (19%), Positives = 45/144 (31%), Gaps = 16/144 (11%)

Query: 122 LTELRTLSVPHNSFSGEIPAGV-GELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSF 180
              L  L + HN     I          L  L L  N         +S L  LR L+L  
Sbjct: 192 PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDN 250

Query: 181 NSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEF--------LTYLKLSDNFL 232
           N  S  VP GL     L V+ + +N ++    +  +  C             + L +N +
Sbjct: 251 NKLS-RVPAGLPDLKLLQVVYLHTNNIT---KVGVNDFCPVGFGVKRAYYNGISLFNNPV 306

Query: 233 T-ESIPKEIGKC-RNLKNLLLDGN 254
               +     +C  +   +     
Sbjct: 307 PYWEVQPATFRCVTDRLAIQFGNY 330

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 87.1 bits (216), Expect = 5e-18
 Identities = 52/231 (22%), Positives = 92/231 (39%), Gaps = 41/231 (17%)

Query: 484 RLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQ 543
            L L  N     +  +     + L+   + L  N +  +   AF      L   E  +N 
Sbjct: 79  YLNLMENNIQ-MIQADTFRHLHHLEV--LQLGRNSIRQIEVGAFN-GLASLNTLELFDNW 134

Query: 544 ISGSIAAGV-GKLMKLQRLDLRGNRVSGSLPDE----LGKLKF----------------- 581
           ++  I +G    L KL+ L LR N +  S+P      +  L                   
Sbjct: 135 LT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAF 192

Query: 582 -----LKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLA 636
                LK++ LG  N+  ++P+    L+ L  L++S N      P S    + L+ L++ 
Sbjct: 193 EGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVM 250

Query: 637 HNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIP-----HLQHLDCIAFKGN 682
           ++++S     +F  L +L  L+L+ NNLS  +P      L++L  +    N
Sbjct: 251 NSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 78.6 bits (194), Expect = 3e-15
 Identities = 38/155 (24%), Positives = 62/155 (40%), Gaps = 8/155 (5%)

Query: 513 NLSANLLSGMSYEAFLLDCVQLVEFE-AANNQISGSIAAGV-GKLMKLQRLDLRGNRVSG 570
            L  N +  +   AF      L+  +     ++   I+ G    L  L+ L+L    +  
Sbjct: 153 WLRNNPIESIPSYAFN-RVPSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIK- 209

Query: 571 SLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKL 630
            +P+ L  L  L+ + + GN+     P  F  L SL  L + ++ ++     +      L
Sbjct: 210 DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASL 268

Query: 631 ESLFLAHNRLSGEIPVS-FSTLVNLSALDLSFNNL 664
             L LAHN LS  +P   F+ L  L  L L  N  
Sbjct: 269 VELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 67.1 bits (164), Expect = 1e-11
 Identities = 31/128 (24%), Positives = 49/128 (38%), Gaps = 14/128 (10%)

Query: 557 KLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNAL 616
           +  ++      +S  +P  +      +++ L  NN+       F HL  L VL L  N++
Sbjct: 55  QFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111

Query: 617 TGSIPA-SLTKATKLESLFLAHNRLSGEIPV-SFSTLVNLSALDLSFNNLS-------GH 667
              I   +      L +L L  N L+  IP  +F  L  L  L L  N +          
Sbjct: 112 R-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNR 169

Query: 668 IPHLQHLD 675
           +P L  LD
Sbjct: 170 VPSLMRLD 177

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 62.8 bits (153), Expect = 3e-10
 Identities = 54/272 (19%), Positives = 89/272 (32%), Gaps = 51/272 (18%)

Query: 124 ELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSF 183
           +   +       S E+P G+        L L  NN          +L  L VL L  NS 
Sbjct: 55  QFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111

Query: 184 SGEVPRG-LIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEI-G 241
             ++  G   G   L+ +++  N L+  +   +      L  L L +N +  SIP     
Sbjct: 112 R-QIEVGAFNGLASLNTLELFDNWLTV-IPSGAFEYLSKLRELWLRNNPIE-SIPSYAFN 168

Query: 242 KCRNLKNL-LLDGNILEGSIPKEI-GTISELKVLDVSRNSLTDRIPVELADCSKLSVLVL 299
           +  +L  L L +   LE  I +     +  LK L++   ++ D +P  L     L  L +
Sbjct: 169 RVPSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEM 225

Query: 300 TNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVL 359
           +         N                            R      L        SLK L
Sbjct: 226 SG--------NH-----------------------FPEIRPGSFHGLS-------SLKKL 247

Query: 360 NLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLE 391
            +  + +      +     +L  L+L+ NNL 
Sbjct: 248 WVMNSQVSLIERNAFDGLASLVELNLAHNNLS 279

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 55.1 bits (133), Expect = 8e-08
 Identities = 53/275 (19%), Positives = 87/275 (31%), Gaps = 57/275 (20%)

Query: 353 SCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQL--PVPCMVYFNVSQ 410
             + + LNL +N+++     +     +L  L L  N++   + +     +  +    +  
Sbjct: 74  PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFD 132

Query: 411 NNITGVLPR-FENVSC-------DNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFL 462
           N +T +    FE +S        +N                SI    F           +
Sbjct: 133 NWLTVIPSGAFEYLSKLRELWLRNNPIE-------------SIPSYAF---------NRV 170

Query: 463 GSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGM 522
            SL                  RL L        +         +L+   +NL    +  M
Sbjct: 171 PSL-----------------MRLDLGELKKLEYISEGAFEGLFNLKY--LNLGMCNIKDM 211

Query: 523 SYEAFLLDCVQLVEFEAANNQISGSIAAGV-GKLMKLQRLDLRGNRVSGSLPDELGKLKF 581
                L   V L E E + N     I  G    L  L++L +  ++VS    +    L  
Sbjct: 212 PN---LTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLAS 267

Query: 582 LKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNAL 616
           L  + L  NNL+      F  L  LV L L HN  
Sbjct: 268 LVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 52.4 bits (126), Expect = 5e-07
 Identities = 29/112 (25%), Positives = 47/112 (41%), Gaps = 5/112 (4%)

Query: 120 AKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLS 179
             L  L+ L++   +   ++P     L  LE LE+ GN+F    P     L  L+ L + 
Sbjct: 193 EGLFNLKYLNLGMCNIK-DMPNLTP-LVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVM 250

Query: 180 FNSFSGEVPRG-LIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDN 230
            +  S  + R    G   L  ++++ N LS  L  D  +   +L  L L  N
Sbjct: 251 NSQVS-LIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 83.6 bits (207), Expect = 1e-17
 Identities = 25/209 (11%), Positives = 56/209 (26%), Gaps = 47/209 (22%)

Query: 775 GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIG-----RFQGIQQFDAEIGTLGRI 828
           G + +    G       ++A        VA+  +             Q+  +    L RI
Sbjct: 31  GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVL--QETLSRTLRLSRI 88

Query: 829 RHKNLVTLIGYYVGEAE--MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQAL 886
               +  +    V        +V  ++ GG+L+      +      ++  +    +A A 
Sbjct: 89  DKPGVARV--LDVVHTRAGGLVVAEWIRGGSLQEVAD--TSPSPVGAI--RAMQSLAAAA 142

Query: 887 AYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAP 946
              H +    +      PS + +  +        G   L                  +  
Sbjct: 143 DAAHRA---GVALSIDHPSRVRVSID--------GDVVL-------------AYPATMPD 178

Query: 947 EYATTCRVSDKADVYSFGVVLLELISGKR 975
                   + + D+   G  L  L+  + 
Sbjct: 179 -------ANPQDDIRGIGASLYALLVNRW 200

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 85.1 bits (211), Expect = 1e-17
 Identities = 50/223 (22%), Positives = 92/223 (41%), Gaps = 32/223 (14%)

Query: 775 GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKL-SIGRFQGIQQFDAEIGTLGRIR--- 829
             + +   +G G F + + A+ +V    VA+K +     +   +  + EI  L R+    
Sbjct: 19  ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT--EAAEDEIKLLQRVNDAD 76

Query: 830 --------HKNLVTLIG--YYVGEAE--MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHK 877
                     +++ L+    + G     + +V+  L G NL   I K   + I    + +
Sbjct: 77  NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ 135

Query: 878 IAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY------LSDFGLARLLEVSET 931
           I+  +   L Y+H  C   I+H DIKP N+L++   +        ++D G A      + 
Sbjct: 136 ISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW---YDE 190

Query: 932 HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
           H T  +     Y +PE          AD++S   ++ ELI+G 
Sbjct: 191 HYTNSIQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 84.2 bits (209), Expect = 1e-17
 Identities = 50/215 (23%), Positives = 93/215 (43%), Gaps = 19/215 (8%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIR-HKNL 833
           ++ +   +G G +   ++A  +     V VK L   + + I++   EI  L  +R   N+
Sbjct: 37  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR---EIKILENLRGGPNI 93

Query: 834 VTLIGYYVGEAEM--FLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
           +TL             LV+  ++  + +      +   I+   +++I     +AL Y H 
Sbjct: 94  ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIR-FYMYEIL----KALDYCH- 147

Query: 892 SCVPRIVHRDIKPSNILLDEELNA-YLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
           S    I+HRD+KP N+++D E     L D+GLA      + +    VA +  +  PE   
Sbjct: 148 SM--GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRVA-SRYFKGPELLV 203

Query: 951 TCRVSDKA-DVYSFGVVLLELISGKRSLDPSFSEY 984
             ++ D + D++S G +L  +I  K         Y
Sbjct: 204 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 238

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 83.1 bits (206), Expect = 2e-17
 Identities = 43/200 (21%), Positives = 73/200 (36%), Gaps = 40/200 (20%)

Query: 783 IGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRI-RHKNLVTLIGYY 840
           +G G  G   +          A+K   +      ++   E+    R  +  ++V ++  Y
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALK--MLQDCPKARR---EVELHWRASQCPHIVRIVDVY 80

Query: 841 ----VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPR 896
                G   + +V   L GG L + I  +  +        +I   I +A+ YLH      
Sbjct: 81  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---N 137

Query: 897 IVHRDIKPSNILL---DEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCR 953
           I HRD+KP N+L           L+DFG A+  E +             Y          
Sbjct: 138 IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTGE----------KY---------- 175

Query: 954 VSDKADVYSFGVVLLELISG 973
                D++S GV++  L+ G
Sbjct: 176 -DKSCDMWSLGVIMYILLCG 194

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 83.5 bits (207), Expect = 2e-17
 Identities = 66/351 (18%), Positives = 115/351 (32%), Gaps = 70/351 (19%)

Query: 353 SCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLP-VPCMVYFNVSQN 411
            C L+V+      L+  VPK L    +   LDL  N +          +  +    +  N
Sbjct: 30  QCHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINN 86

Query: 412 NITGVLPR-FENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLP--LF 468
            I+ + P  F  +          L+                     S N+ L  LP  + 
Sbjct: 87  KISKISPGAFAPLV--------KLERL-----------------YLSKNQ-LKELPEKMP 120

Query: 469 AIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLL--SGMSYEA 526
                 L         L ++ N     V     +  N +    V L  N L  SG+   A
Sbjct: 121 KT----LQ-------ELRVHENEIT-KVRKSVFNGLNQMIV--VELGTNPLKSSGIENGA 166

Query: 527 FLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDE-LGKLKFLKWI 585
           F     +L     A+  I+ +I  G+     L  L L GN+++  +    L  L  L  +
Sbjct: 167 FQ-GMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT-KVDAASLKGLNNLAKL 221

Query: 586 LLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIP 645
            L  N+++        +   L  L L++N L   +P  L     ++ ++L +N +S  I 
Sbjct: 222 GLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIG 279

Query: 646 VS-------FSTLVNLSALDLSFNNLSGH-IP-----HLQHLDCIAFKGNK 683
            +        +   + S + L  N +    I       +     +     K
Sbjct: 280 SNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 77.0 bits (190), Expect = 4e-15
 Identities = 57/283 (20%), Positives = 101/283 (35%), Gaps = 42/283 (14%)

Query: 123 TELRTLSVPHNSFSGEIPAGV-GELRLLEVLELQGNNFSGKIPYQM-SNLERLRVLNLSF 180
            +   L + +N  + EI  G    L+ L  L L  N  S KI     + L +L  L LS 
Sbjct: 52  PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSK 109

Query: 181 NSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTES-IPKE 239
           N    E+P  +     L  + +  N ++  +     +    +  ++L  N L  S I   
Sbjct: 110 NQLK-ELPEKMPKT--LQELRVHENEITK-VRKSVFNGLNQMIVVELGTNPLKSSGIENG 165

Query: 240 I-GKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLV 298
                + L  + +    +  +IP+  G    L  L +  N +T    V+ A    L+ L 
Sbjct: 166 AFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITK---VDAASLKGLNNL- 218

Query: 299 LTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGG----RLPDNWSESC 354
                A L L  +    SA D G          L  L     +L      ++P   ++  
Sbjct: 219 -----AKLGLSFNS--ISAVDNGSLANT---PHLREL-----HLNNNKLVKVPGGLADHK 263

Query: 355 SLKVLNLGQNSLKG------AVPKSLGMCRNLTYLDLSLNNLE 391
            ++V+ L  N++          P       + + + L  N ++
Sbjct: 264 YIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 70.4 bits (173), Expect = 5e-13
 Identities = 48/260 (18%), Positives = 94/260 (36%), Gaps = 34/260 (13%)

Query: 138 EIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGEL 197
           ++P  +       +L+LQ N  +        NL+ L  L L  N  S   P       +L
Sbjct: 45  KVPKDLPPD--TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 102

Query: 198 SVIDMSSNRLSGGLAIDSSSECEF--LTYLKLSDNFLTESIPKEI-GKCRNLKNLLLDGN 254
             + +S N+L     +          L  L++ +N +T  + K +      +  + L  N
Sbjct: 103 ERLYLSKNQLK---ELPEKM---PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTN 155

Query: 255 -ILEGSIPKEI-GTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSR 312
            +    I       + +L  + ++  ++T  IP  L            ++   L LD ++
Sbjct: 156 PLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL----------PPSL-TELHLDGNK 203

Query: 313 GEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDN-WSESCSLKVLNLGQNSLKGAVP 371
              +  D      L    +L  L     ++   + +   + +  L+ L+L  N L   VP
Sbjct: 204 --ITKVDAASLKGL---NNLAKLGLSFNSI-SAVDNGSLANTPHLRELHLNNNKLV-KVP 256

Query: 372 KSLGMCRNLTYLDLSLNNLE 391
             L   + +  + L  NN+ 
Sbjct: 257 GGLADHKYIQVVYLHNNNIS 276

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 63.1 bits (154), Expect = 1e-10
 Identities = 32/144 (22%), Positives = 54/144 (37%), Gaps = 16/144 (11%)

Query: 122 LTELRTLSVPHNSFSGEIPAGV-GELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSF 180
              L  L +  N  + ++ A     L  L  L L  N+ S      ++N   LR L+L+ 
Sbjct: 191 PPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNN 249

Query: 181 NSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEF--------LTYLKLSDNFL 232
           N    +VP GL  +  + V+ + +N +S   AI S+  C           + + L  N +
Sbjct: 250 NKLV-KVPGGLADHKYIQVVYLHNNNIS---AIGSNDFCPPGYNTKKASYSGVSLFSNPV 305

Query: 233 T-ESIPKEIGKC-RNLKNLLLDGN 254
               I     +C      + L   
Sbjct: 306 QYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 47.3 bits (113), Expect = 1e-05
 Identities = 17/97 (17%), Positives = 37/97 (38%), Gaps = 9/97 (9%)

Query: 118 SIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSG------KIPYQMSNLE 171
           S+A    LR L + +N    ++P G+ + + ++V+ L  NN S         P   +   
Sbjct: 235 SLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKA 293

Query: 172 RLRVLNLSFNSFS-GEVPRGL-IGNGELSVIDMSSNR 206
               ++L  N     E+           + + + + +
Sbjct: 294 SYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 83.5 bits (207), Expect = 3e-17
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 31/213 (14%)

Query: 777 FSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFDA-----EIGTLGRIRH 830
           +   + +G+G +GS   A     G  VAVKKLS   FQ      A     E+  L  ++H
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQ--SIIHAKRTYRELRLLKHMKH 87

Query: 831 KNLVTLI------GYYVGEAEMFLVYNFLSGGNLETFIHKK--SGKKIQWSVIHKIAIDI 882
           +N++ L+             +++LV + + G +L   +  +  +   +Q+     +   I
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQF-----LIYQI 141

Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFG 942
            + L Y+H S    I+HRD+KPSN+ ++E+    + DFGLAR          T    T  
Sbjct: 142 LRGLKYIH-SA--DIIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGYVATRW 194

Query: 943 YVAPEYATTCRVSDKA-DVYSFGVVLLELISGK 974
           Y APE        ++  D++S G ++ EL++G+
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 82.6 bits (205), Expect = 4e-17
 Identities = 59/209 (28%), Positives = 102/209 (48%), Gaps = 27/209 (12%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFD---AEIGTLGRIRHK 831
           +F I   +GTG FG  +       G   A+K L       ++Q +    E   L  + H 
Sbjct: 7   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 66

Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIH-KKSGK------KIQWSVIHKIAIDIAQ 884
            ++ + G +    ++F++ +++ GG  E F   +KS +      K         A ++  
Sbjct: 67  FIIRMWGTFQDAQQIFMIMDYIEGG--ELFSLLRKSQRFPNPVAKF-------YAAEVCL 117

Query: 885 ALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYV 944
           AL YLH      I++RD+KP NILLD+  +  ++DFG A+   V +   T  + GT  Y+
Sbjct: 118 ALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAK--YVPDV--TYTLCGTPDYI 170

Query: 945 APEYATTCRVSDKADVYSFGVVLLELISG 973
           APE  +T   +   D +SFG+++ E+++G
Sbjct: 171 APEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 81.7 bits (202), Expect = 5e-17
 Identities = 51/172 (29%), Positives = 70/172 (40%), Gaps = 16/172 (9%)

Query: 513 NLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSL 572
           +LS NLL   S    +    +L +      +++  +    G L  L  LDL  N++  SL
Sbjct: 37  HLSENLLYTFSLATLM-PYTRLTQLNLDRAELT-KLQVD-GTLPVLGTLDLSHNQLQ-SL 92

Query: 573 PDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASL-TKATKLE 631
           P     L  L  + +  N LT         L  L  L L  N L  ++P  L T   KLE
Sbjct: 93  PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLE 151

Query: 632 SLFLAHNRLSGEIPVS-FSTLVNLSALDLSFNNLSGHIPH-------LQHLD 675
            L LA+N L+ E+P    + L NL  L L  N+L   IP        L    
Sbjct: 152 KLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAF 201

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 70.1 bits (172), Expect = 4e-13
 Identities = 50/185 (27%), Positives = 74/185 (40%), Gaps = 20/185 (10%)

Query: 484 RLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQ 543
            L L+ N+   +     +     L    +NL    L+ +  +  L     L   + ++NQ
Sbjct: 35  ILHLSENLL-YTFSLATLMPYTRLTQ--LNLDRAELTKLQVDGTL---PVLGTLDLSHNQ 88

Query: 544 ISGSIAAGVGKLMKLQRLDLRGNRVSGSLP----DELGKLKFLKWILLGGNNLTGEIPSQ 599
           +  S+      L  L  LD+  NR++ SLP      LG+L+ L    L GN L   +P  
Sbjct: 89  LQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQEL---YLKGNELK-TLPPG 142

Query: 600 -FGHLISLVVLDLSHNALTGSIPASL-TKATKLESLFLAHNRLSGEIPVSFSTLVNLSAL 657
                  L  L L++N LT  +PA L      L++L L  N L   IP  F     L   
Sbjct: 143 LLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFA 200

Query: 658 DLSFN 662
            L  N
Sbjct: 201 FLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 63.2 bits (154), Expect = 9e-11
 Identities = 30/128 (23%), Positives = 46/128 (35%), Gaps = 19/128 (14%)

Query: 558 LQRLDLRGNR---VSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHN 614
              ++        +   LP +   L       L  N L     +       L  L+L   
Sbjct: 12  HLEVNCDKRNLTALPPDLPKDTTILH------LSENLLYTFSLATLMPYTRLTQLNLDRA 65

Query: 615 ALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSG-------H 667
            LT  +         L +L L+HN+L   +P+   TL  L+ LD+SFN L+         
Sbjct: 66  ELT-KLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRG 122

Query: 668 IPHLQHLD 675
           +  LQ L 
Sbjct: 123 LGELQELY 130

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 51.3 bits (123), Expect = 7e-07
 Identities = 45/178 (25%), Positives = 72/178 (40%), Gaps = 25/178 (14%)

Query: 129 SVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSG-EV 187
           ++P +     +P          +L L  N         +    RL  LNL     +  +V
Sbjct: 24  ALPPD-----LPKD------TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV 72

Query: 188 PRGLIGNGELSVIDMSSNRL-SGGLAIDSSSECEFLTYLKLSDNFLTESIPKEI-GKCRN 245
              L     L  +D+S N+L S  L   +      LT L +S N LT S+P         
Sbjct: 73  DGTL---PVLGTLDLSHNQLQSLPLLGQTLPA---LTVLDVSFNRLT-SLPLGALRGLGE 125

Query: 246 LKNLLLDGNILEGSIPKEI-GTISELKVLDVSRNSLTDRIPVELADC-SKLSVLVLTN 301
           L+ L L GN L+ ++P  +     +L+ L ++ N+LT  +P  L +    L  L+L  
Sbjct: 126 LQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQE 181

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 45.5 bits (108), Expect = 5e-05
 Identities = 23/92 (25%), Positives = 35/92 (38%), Gaps = 12/92 (13%)

Query: 605 SLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNL 664
           S + ++     LT ++P  L K T    L L+ N L      +      L+ L+L    L
Sbjct: 11  SHLEVNCDKRNLT-ALPPDLPKDT--TILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67

Query: 665 S-----GHIPHLQHLDCIAFKGNKYLASCPDT 691
           +     G +P L  LD      +  L S P  
Sbjct: 68  TKLQVDGTLPVLGTLDL----SHNQLQSLPLL 95

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 44.3 bits (105), Expect = 1e-04
 Identities = 26/88 (29%), Positives = 39/88 (44%), Gaps = 5/88 (5%)

Query: 120 AKLTELRTLSVPHNSFSGEIPAGV-GELRLLEVLELQGNNFSGKIPYQM-SNLERLRVLN 177
             L EL+ L +  N     +P G+      LE L L  NN + ++P  + + LE L  L 
Sbjct: 121 RGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLL 178

Query: 178 LSFNSFSGEVPRGLIGNGELSVIDMSSN 205
           L  NS    +P+G  G+  L    +  N
Sbjct: 179 LQENSLYT-IPKGFFGSHLLPFAFLHGN 205

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 82.0 bits (203), Expect = 5e-17
 Identities = 39/198 (19%), Positives = 79/198 (39%), Gaps = 23/198 (11%)

Query: 484 RLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQ 543
           ++    +    +V     +  + + +   +     ++ +     +     L+  E  +NQ
Sbjct: 23  KIAAGKSNVTDTVT---QADLDGITTL--SAFGTGVTTIE---GVQYLNNLIGLELKDNQ 74

Query: 544 ISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHL 603
           I+  +A  +  L K+  L+L GN +       +  L+ +K + L    +T   P     L
Sbjct: 75  IT-DLA-PLKNLTKITELELSGNPLKN--VSAIAGLQSIKTLDLTSTQITDVTP--LAGL 128

Query: 604 ISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNN 663
            +L VL L  N +T +I   L   T L+ L + + ++S   P   + L  L+ L    N 
Sbjct: 129 SNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNK 184

Query: 664 LS-----GHIPHLQHLDC 676
           +S       +P+L  +  
Sbjct: 185 ISDISPLASLPNLIEVHL 202

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 78.6 bits (194), Expect = 9e-16
 Identities = 36/181 (19%), Positives = 78/181 (43%), Gaps = 20/181 (11%)

Query: 501 ISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQR 560
           +   N+L    + L  N ++ ++    L +  ++ E E + N +  +++  +  L  ++ 
Sbjct: 59  VQYLNNLIG--LELKDNQITDLA---PLKNLTKITELELSGNPLK-NVS-AIAGLQSIKT 111

Query: 561 LDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSI 620
           LDL   +++      L  L  L+ + L  N +T  I      L +L  L + +  ++  +
Sbjct: 112 LDLTSTQITD--VTPLAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVS-DL 166

Query: 621 PASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLS-----GHIPHLQHLD 675
              L   +KL +L    N++S +I    ++L NL  + L  N +S      +  +L  + 
Sbjct: 167 TP-LANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQISDVSPLANTSNLFIVT 223

Query: 676 C 676
            
Sbjct: 224 L 224

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 69.7 bits (171), Expect = 8e-13
 Identities = 32/165 (19%), Positives = 64/165 (38%), Gaps = 15/165 (9%)

Query: 501 ISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQR 560
           +     +      LS N L  +S    +     +   +  + QI+      +  L  LQ 
Sbjct: 81  LKNLTKITEL--ELSGNPLKNVS---AIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQV 133

Query: 561 LDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSI 620
           L L  N+++ ++   L  L  L+++ +G   ++   P    +L  L  L    N ++  I
Sbjct: 134 LYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS-DI 188

Query: 621 PASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLS 665
              L     L  + L +N++S   P   +   NL  + L+   ++
Sbjct: 189 SP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT 230

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 67.8 bits (166), Expect = 3e-12
 Identities = 27/147 (18%), Positives = 56/147 (38%), Gaps = 12/147 (8%)

Query: 539 AANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPS 598
                I+  +      L    ++    + V+         L  +  +   G  +T  I  
Sbjct: 4   TQPTAIN--VIFPDPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG 58

Query: 599 QFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALD 658
              +L +L+ L+L  N +T  +   L   TK+  L L+ N L   +  + + L ++  LD
Sbjct: 59  -VQYLNNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLD 113

Query: 659 LSFNNLSG--HIPHLQHLDCIAFKGNK 683
           L+   ++    +  L +L  +    N+
Sbjct: 114 LTSTQITDVTPLAGLSNLQVLYLDLNQ 140

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 47/311 (15%), Positives = 99/311 (31%), Gaps = 54/311 (17%)

Query: 355 SLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNIT 414
           +   +  G++++   V         +T L      +     +Q  +  ++   +  N IT
Sbjct: 20  NAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTIEGVQY-LNNLIGLELKDNQIT 76

Query: 415 GVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGF 474
            + P  +N           +    +         N   + + S    L S+         
Sbjct: 77  DLAP-LKN--------LTKITELEL-------SGNP--LKNVSAIAGLQSI--------- 109

Query: 475 LAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQL 534
                     L L +       P   ++  ++LQ   + L  N ++ +S    L     L
Sbjct: 110 --------KTLDLTSTQITDVTP---LAGLSNLQ--VLYLDLNQITNIS---PLAGLTNL 153

Query: 535 VEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTG 594
                 N Q+S  +   +  L KL  L    N++S  +   L  L  L  + L  N ++ 
Sbjct: 154 QYLSIGNAQVS-DL-TPLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISD 209

Query: 595 EIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNL 654
             P    +  +L ++ L++  +T               +           P + S     
Sbjct: 210 VSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPI--APATISDNGTY 265

Query: 655 SALDLSFNNLS 665
           ++ +L++N  S
Sbjct: 266 ASPNLTWNLTS 276

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 43/184 (23%), Positives = 74/184 (40%), Gaps = 15/184 (8%)

Query: 118 SIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLN 177
           + A L  + TLS      +  I  GV  L  L  LEL+ N  +  +   + NL ++  L 
Sbjct: 36  TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQIT-DLA-PLKNLTKITELE 91

Query: 178 LSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIP 237
           LS N         + G   +  +D++S +++    +   +    L  L L  N +T   P
Sbjct: 92  LSGNPLK--NVSAIAGLQSIKTLDLTSTQITD---VTPLAGLSNLQVLYLDLNQITNISP 146

Query: 238 KEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVL 297
             +    NL+ L +    +   +   +  +S+L  L    N ++D I   LA    L  +
Sbjct: 147 --LAGLTNLQYLSIGNAQVS-DLT-PLANLSKLTTLKADDNKISD-IS-PLASLPNLIEV 200

Query: 298 VLTN 301
            L N
Sbjct: 201 HLKN 204

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 65.1 bits (159), Expect = 3e-11
 Identities = 34/188 (18%), Positives = 75/188 (39%), Gaps = 15/188 (7%)

Query: 119 IAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNL 178
           +  LT++  L +  N     +   +  L+ ++ L+L     +   P  ++ L  L+VL L
Sbjct: 81  LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYL 136

Query: 179 SFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPK 238
             N  +  +   L G   L  + + + ++S    +   +    LT LK  DN ++  I  
Sbjct: 137 DLNQIT-NIS-PLAGLTNLQYLSIGNAQVSD---LTPLANLSKLTTLKADDNKIS-DIS- 189

Query: 239 EIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLV 298
            +    NL  + L  N +    P  +   S L ++ ++  ++T++      +   +   V
Sbjct: 190 PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNN--LVVPNV 245

Query: 299 LTNIDASL 306
           +     + 
Sbjct: 246 VKGPSGAP 253

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 56.6 bits (137), Expect = 2e-08
 Identities = 51/256 (19%), Positives = 82/256 (32%), Gaps = 50/256 (19%)

Query: 168 SNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKL 227
             L     +    ++ +  V +  +    ++ +      ++    I+       L  L+L
Sbjct: 16  PALANAIKIAAGKSNVTDTVTQADLDG--ITTLSAFGTGVT---TIEGVQYLNNLIGLEL 70

Query: 228 SDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVE 287
            DN +T  +   +     +  L L GN L       I  +  +K LD++   +TD  P  
Sbjct: 71  KDNQIT-DLA-PLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTP-- 124

Query: 288 LADCSKLSVLVL-----TNIDASLDLDNSRGEFSAFDGGVPYELLLS----RSLEVLWAP 338
           LA  S L VL L     TNI     L N +             L +       L  L   
Sbjct: 125 LAGLSNLQVLYLDLNQITNISPLAGLTNLQ------------YLSIGNAQVSDLTPL--- 169

Query: 339 RANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQL 398
            ANL             L  L    N +    P  L    NL  + L  N +    P+  
Sbjct: 170 -ANLS-----------KLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLA- 214

Query: 399 PVPCMVYFNVSQNNIT 414
               +    ++   IT
Sbjct: 215 NTSNLFIVTLTNQTIT 230

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 52.0 bits (125), Expect = 4e-07
 Identities = 49/310 (15%), Positives = 103/310 (33%), Gaps = 54/310 (17%)

Query: 355 SLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNIT 414
            +  L+     +     + +    NL  L+L  N +   L     +  +    +S N + 
Sbjct: 42  GITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITD-LAPLKNLTKITELELSGNPLK 98

Query: 415 GVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGF 474
                   ++     G Q ++  ++             I D +    L +L         
Sbjct: 99  ----NVSAIA-----GLQSIKTLDL-------TSTQ--ITDVTPLAGLSNLQ-------- 132

Query: 475 LAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQL 534
                     L L+ N      P   ++   +LQ    ++    +S ++    L +  +L
Sbjct: 133 ---------VLYLDLNQITNISP---LAGLTNLQYL--SIGNAQVSDLT---PLANLSKL 175

Query: 535 VEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTG 594
              +A +N+IS  I + +  L  L  + L+ N++S   P  L     L  + L    +T 
Sbjct: 176 TTLKADDNKIS-DI-SPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231

Query: 595 EIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLS--GEIPVSFSTLV 652
           +      +L+      +   +     PA+++      S  L  N  S    +  +F+  V
Sbjct: 232 QPVFYNNNLVVP--NVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVSYTFNQSV 289

Query: 653 NLSALDLSFN 662
                 + F+
Sbjct: 290 TFKNTTVPFS 299

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 48.9 bits (117), Expect = 5e-06
 Identities = 39/223 (17%), Positives = 84/223 (37%), Gaps = 30/223 (13%)

Query: 196 ELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNI 255
               I    + ++      + ++ + +T L      +T +I   +    NL  L L  N 
Sbjct: 20  NAIKIAAGKSNVTD---TVTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQ 74

Query: 256 LEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEF 315
           +   +   +  ++++  L++S N L + +   +A    +  L LT+            + 
Sbjct: 75  IT-DLA-PLKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTS--------TQITDV 122

Query: 316 SAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLG 375
           +   G       LS +L+VL+     +        +   +L+ L++G   +    P  L 
Sbjct: 123 TPLAG-------LS-NLQVLYLDLNQI--TNISPLAGLTNLQYLSIGNAQVSDLTP--LA 170

Query: 376 MCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNITGVLP 418
               LT L    N +    P+   +P ++  ++  N I+ V P
Sbjct: 171 NLSKLTTLKADDNKISDISPLA-SLPNLIEVHLKNNQISDVSP 212

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 84.1 bits (208), Expect = 6e-17
 Identities = 54/250 (21%), Positives = 108/250 (43%), Gaps = 55/250 (22%)

Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDA-----EIGTLGRIR 829
            + IR+LIGTG +G   +A + +   +VA+KK+    F+     D      EI  L R+ 
Sbjct: 54  RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-RVFE--DLIDCKRILREIAILNRLN 110

Query: 830 HKNLVTLIGYYVGEA-----EMFLVYNFLSGGNLETFIHK--KSGKKIQWSVIHK--IAI 880
           H ++V ++   + +      E+++V         ++   K  ++   +  + +H   +  
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIA-----DSDFKKLFRTPVYL--TELHIKTLLY 163

Query: 881 DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT 940
           ++   + Y+H +    I+HRD+KP+N L++++ +  + DFGLAR ++  E   +      
Sbjct: 164 NLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISP 220

Query: 941 F--------------------GYV------APEYATTCRVSDKA-DVYSFGVVLLELISG 973
                                G+V      APE         +A DV+S G +  EL++ 
Sbjct: 221 REDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280

Query: 974 KRSLDPSFSE 983
            +      ++
Sbjct: 281 IKENVAYHAD 290

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 82.4 bits (204), Expect = 8e-17
 Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 31/216 (14%)

Query: 774 TGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDA-----EIGTLGR 827
              +     +G+G +G+   A +   G  VA+KKL    FQ   +  A     E+  L  
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-RPFQ--SELFAKRAYRELRLLKH 80

Query: 828 IRHKNLVTLIGYYVGEA------EMFLVYNFLSGGNLETFIHKK--SGKKIQWSVIHKIA 879
           +RH+N++ L+  +  +       + +LV  F+ G +L   +  +     +IQ+ V     
Sbjct: 81  MRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQ--- 136

Query: 880 IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG 939
             + + L Y+H +    I+HRD+KP N+ ++E+    + DFGLAR    +++  T  V  
Sbjct: 137 --MLKGLRYIH-AA--GIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMTGYVV- 187

Query: 940 TFGYVAPEYATTCRVSDKA-DVYSFGVVLLELISGK 974
           T  Y APE         +  D++S G ++ E+I+GK
Sbjct: 188 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 81.8 bits (203), Expect = 9e-17
 Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 26/212 (12%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVP----GYLVAVK---KLSIGRFQGIQQFDAEIGT---- 824
            F +  ++G G FG  +  + +       L A+K   K ++       +           
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL-----KVRDRVRTKMERDI 79

Query: 825 LGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIH-KKSGK-KIQWSVIHKIAIDI 882
           L  + H  +V L   +  E +++L+ +FL GG+L  F    K      +    +    ++
Sbjct: 80  LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFY--LAEL 135

Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFG 942
           A AL +LH      I++RD+KP NILLDEE +  L+DFGL++   +          GT  
Sbjct: 136 ALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVE 191

Query: 943 YVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
           Y+APE       +  AD +SFGV++ E+++G 
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 82.3 bits (204), Expect = 9e-17
 Identities = 57/222 (25%), Positives = 98/222 (44%), Gaps = 38/222 (17%)

Query: 777 FSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDA-----EIGTLGRIRH 830
           F +++L+G G +G    A     G +VA+KK+    F   +   A     EI  L   +H
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--FD--KPLFALRTLREIKILKHFKH 68

Query: 831 KNLVTLIG-YYVGEAEMF----LVYNFLSGGNLETFIHKK-SGKKIQWSVIHK--IAIDI 882
           +N++T+         E F    ++   +     +T +H+  S + +  S  H        
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQML--SDDHIQYFIYQT 121

Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF- 941
            +A+  LH      ++HRD+KPSN+L++   +  + DFGLAR+++ S    +        
Sbjct: 122 LRAVKVLH-GS--NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178

Query: 942 --GYV------APEYATTCRVSDKA-DVYSFGVVLLELISGK 974
              +V      APE   T     +A DV+S G +L EL   +
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 82.2 bits (203), Expect = 9e-17
 Identities = 37/158 (23%), Positives = 62/158 (39%), Gaps = 11/158 (6%)

Query: 513 NLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGV-GKLMKLQRLDLRGNRVSGS 571
           +LS N LS +  E        L     ++N ++  I++     +  L+ LDL  N +  +
Sbjct: 45  DLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-T 102

Query: 572 LPDE-LGKLKFLKWILLGGNNLTGEIPS-QFGHLISLVVLDLSHNALTGSIPA----SLT 625
           L +     L+ L+ +LL  N++   +    F  +  L  L LS N ++   P        
Sbjct: 103 LDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGN 160

Query: 626 KATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNN 663
           K  KL  L L+ N+L          L       L  +N
Sbjct: 161 KLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 78.7 bits (194), Expect = 1e-15
 Identities = 39/133 (29%), Positives = 56/133 (42%), Gaps = 19/133 (14%)

Query: 558 LQRLDLRGNRVSGSLPDE--LGKLKFLKWILLGGNNLTGEIPSQ-FGHLISLVVLDLSHN 614
              LDL  N +S  L  E    +L  L  +LL  N+L   I S+ F  + +L  LDLS N
Sbjct: 41  TALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSN 98

Query: 615 ALTGSIPA-SLTKATKLESLFLAHNRLSGEIPV-SFSTLVNLSALDLSFNNLS------- 665
            L  ++     +    LE L L +N +   +   +F  +  L  L LS N +S       
Sbjct: 99  HLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELI 156

Query: 666 ---GHIPHLQHLD 675
                +P L  LD
Sbjct: 157 KDGNKLPKLMLLD 169

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 73.3 bits (180), Expect = 7e-14
 Identities = 35/139 (25%), Positives = 61/139 (43%), Gaps = 15/139 (10%)

Query: 541 NNQISGSIAAGV--GKLMKLQRLDLRGNRVSGSLPDE-LGKLKFLKWILLGGNNLTGEIP 597
           +N +S  + A     +L  L  L L  N ++  +  E    +  L+++ L  N+L   + 
Sbjct: 48  HNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLD 104

Query: 598 SQ-FGHLISLVVLDLSHNALTGSIPA-SLTKATKLESLFLAHNRLSGEIP----VSFSTL 651
              F  L +L VL L +N +   +   +     +L+ L+L+ N++S   P       + L
Sbjct: 105 EFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKL 162

Query: 652 VNLSALDLSFNNLSGHIPH 670
             L  LDLS N L   +P 
Sbjct: 163 PKLMLLDLSSNKLK-KLPL 180

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 55.2 bits (133), Expect = 5e-08
 Identities = 31/97 (31%), Positives = 42/97 (43%), Gaps = 15/97 (15%)

Query: 589 GNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKA--TKLESLFLAHNRLSGEIPV 646
              L   +P          +LDLSHN L+  + A  T    T L SL L+HN L+  I  
Sbjct: 27  KQQLP-NVPQ--SLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISS 81

Query: 647 -SFSTLVNLSALDLSFNNLSG-------HIPHLQHLD 675
            +F  + NL  LDLS N+L          +  L+ L 
Sbjct: 82  EAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLL 118

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 51.0 bits (122), Expect = 1e-06
 Identities = 35/170 (20%), Positives = 60/170 (35%), Gaps = 29/170 (17%)

Query: 121 KLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQM-SNLERLRVLNLS 179
            L+ LR       + +         L  L  L L  N+ +  I  +    +  LR L+LS
Sbjct: 50  NLSRLR----AEWTPTR--------LTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLS 96

Query: 180 FNSFSGEVPRG-LIGNGELSVIDMSSNRLSGGLAIDSS--SECEFLTYLKLSDNFLTESI 236
            N     +          L V+ + +N +     +D +   +   L  L LS N ++   
Sbjct: 97  SNHLH-TLDEFLFSDLQALEVLLLYNNHIV---VVDRNAFEDMAQLQKLYLSQNQIS-RF 151

Query: 237 PKEI----GKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTD 282
           P E+     K   L  L L  N L+  +P     + +L     +   L +
Sbjct: 152 PVELIKDGNKLPKLMLLDLSSNKLK-KLPL--TDLQKLPAWVKNGLYLHN 198

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 81.5 bits (202), Expect = 1e-16
 Identities = 50/227 (22%), Positives = 93/227 (40%), Gaps = 46/227 (20%)

Query: 777 FSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDA-----EIGTLGRIRH 830
           +     +G GG G  + A +      VA+KK+                  EI  + R+ H
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---LT--DPQSVKHALREIKIIRRLDH 67

Query: 831 KNLVTLI--------------GYYVGEAEMFLVYNFLSGGNLETFIHK--KSGKKIQWSV 874
            N+V +               G       +++V  ++     ET +    + G       
Sbjct: 68  DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQG---PLLE 119

Query: 875 IHK--IAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLS--DFGLARLLEVSE 930
            H       + + L Y+H S    ++HRD+KP+N+ ++ E +  L   DFGLAR+++   
Sbjct: 120 EHARLFMYQLLRGLKYIH-SA--NVLHRDLKPANLFINTE-DLVLKIGDFGLARIMDPHY 175

Query: 931 THAT--TDVAGTFGYVAPEYATTCRVSDKA-DVYSFGVVLLELISGK 974
           +H    ++   T  Y +P    +     KA D+++ G +  E+++GK
Sbjct: 176 SHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 81.4 bits (202), Expect = 1e-16
 Identities = 54/209 (25%), Positives = 101/209 (48%), Gaps = 18/209 (8%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVP----GYLVAVKKLS----IGRFQGIQQFDAEIGTLGR 827
            F +  ++G GG+G  ++   V     G + A+K L     +   +      AE   L  
Sbjct: 18  CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEE 77

Query: 828 IRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIH-KKSGK-KIQWSVIHKIAIDIAQA 885
           ++H  +V LI  +    +++L+  +LSGG L  F+  ++ G      +  +    +I+ A
Sbjct: 78  VKHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFY--LAEISMA 133

Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
           L +LH      I++RD+KP NI+L+ + +  L+DFGL +   + +   T    GT  Y+A
Sbjct: 134 LGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFCGTIEYMA 189

Query: 946 PEYATTCRVSDKADVYSFGVVLLELISGK 974
           PE       +   D +S G ++ ++++G 
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 83.7 bits (206), Expect = 1e-16
 Identities = 43/327 (13%), Positives = 93/327 (28%), Gaps = 34/327 (10%)

Query: 378 RNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYA 437
               ++      L       L V   +   +   +   +   +      N      L   
Sbjct: 245 LCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDL 304

Query: 438 NVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVP 497
               +     ++   +     +     + L    + +               ++   +V 
Sbjct: 305 PAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVL 364

Query: 498 GERISKCNDLQSFSVNLSANLLSGMSYEAFL------------------LDCVQLVEFEA 539
              +  C +LQ         LL+ +     L                  +D ++    + 
Sbjct: 365 QSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDD 424

Query: 540 ANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQ 599
             ++     +    +   ++ L L    ++  L   L +L  +  + L  N L   +P  
Sbjct: 425 LRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPA 481

Query: 600 FGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSG-EIPVSFSTLVNLSALD 658
              L  L VL  S NAL  ++   +    +L+ L L +NRL          +   L  L+
Sbjct: 482 LAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLN 539

Query: 659 LSFNNLS----------GHIPHLQHLD 675
           L  N+L             +P +  + 
Sbjct: 540 LQGNSLCQEEGIQERLAEMLPSVSSIL 566

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 71.3 bits (174), Expect = 8e-13
 Identities = 33/169 (19%), Positives = 60/169 (35%), Gaps = 18/169 (10%)

Query: 118 SIAKLTELRTL--------SVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSN 169
           ++   + L+ +            + F  E      E   + VL L   + +  + + +  
Sbjct: 404 TLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH-LEQ 461

Query: 170 LERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSD 229
           L  +  L+LS N     +P  L     L V+  S N L     +D  +    L  L L +
Sbjct: 462 LLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE---NVDGVANLPRLQELLLCN 517

Query: 230 NFLTE-SIPKEIGKCRNLKNLLLDGN---ILEGSIPKEIGTISELKVLD 274
           N L + +  + +  C  L  L L GN     EG   +    +  +  + 
Sbjct: 518 NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 566

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 67.1 bits (163), Expect = 2e-11
 Identities = 35/189 (18%), Positives = 69/189 (36%), Gaps = 20/189 (10%)

Query: 119 IAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNL 178
           +    EL+ L   +      I   +  L  L   +     FS         L+ +  +  
Sbjct: 368 LESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFS--------TLKAVDPMRA 419

Query: 179 SF-----NSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLT 233
           ++     + F  E     +   ++ V+ ++   L+    +    +   +T+L LS N L 
Sbjct: 420 AYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT---VLCHLEQLLLVTHLDLSHNRLR 476

Query: 234 ESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTD-RIPVELADCS 292
            ++P  +   R L+ L    N LE ++   +  +  L+ L +  N L        L  C 
Sbjct: 477 -ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCP 533

Query: 293 KLSVLVLTN 301
           +L +L L  
Sbjct: 534 RLVLLNLQG 542

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 57.5 bits (138), Expect = 2e-08
 Identities = 31/144 (21%), Positives = 52/144 (36%), Gaps = 6/144 (4%)

Query: 103 PWPSKSSVISGTLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGK 162
                 S      S    +  ++R L + H   +  +   + +L L+  L+L  N     
Sbjct: 421 YLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-A 477

Query: 163 IPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFL 222
           +P  ++ L  L VL  S N+    V  G+     L  + + +NRL    AI     C  L
Sbjct: 478 LPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRL 535

Query: 223 TYLKLSDNFLTESIPKEIGKCRNL 246
             L L  N L +       +   +
Sbjct: 536 VLLNLQGNSLCQ-EEGIQERLAEM 558

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 46.7 bits (110), Expect = 3e-05
 Identities = 35/204 (17%), Positives = 65/204 (31%), Gaps = 22/204 (10%)

Query: 213 IDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKV 272
              S+  E L   +LS    T  +  E+  C+ L+ L  +      +I   +  +  L  
Sbjct: 342 CRDSATDEQLFRCELSVEKSTV-LQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400

Query: 273 LDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSL 332
              +    +                 L  +D  +         S F        +    +
Sbjct: 401 EKETLQYFST----------------LKAVD-PMRAAYLDDLRSKFLLENSVLKMEYADV 443

Query: 333 EVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEG 392
            VL     +L   +  +  +   +  L+L  N L+ A+P +L   R L  L  S N LE 
Sbjct: 444 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE- 499

Query: 393 YLPMQLPVPCMVYFNVSQNNITGV 416
            +     +P +    +  N +   
Sbjct: 500 NVDGVANLPRLQELLLCNNRLQQS 523

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 45.1 bits (106), Expect = 1e-04
 Identities = 30/212 (14%), Positives = 61/212 (28%), Gaps = 15/212 (7%)

Query: 478 KYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEF 537
           +    +   L     N  +P                          +        QL   
Sbjct: 295 RPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRC 354

Query: 538 EAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKW---ILLGGNNLTG 594
           E +  + +  + + +    +LQ L+        ++   +  L  L +    L   + L  
Sbjct: 355 ELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKA 413

Query: 595 EIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNL 654
             P +  +L          +           +   +  L LAH  L+  +      L+ +
Sbjct: 414 VDPMRAAYLDD------LRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLC-HLEQLLLV 465

Query: 655 SALDLSFNNLS---GHIPHLQHLDCIAFKGNK 683
           + LDLS N L      +  L+ L+ +    N 
Sbjct: 466 THLDLSHNRLRALPPALAALRCLEVLQASDNA 497

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 43.6 bits (102), Expect = 3e-04
 Identities = 49/338 (14%), Positives = 91/338 (26%), Gaps = 54/338 (15%)

Query: 54  LSFKASISRDPSNLLATWNSSTDHCTWHGVTCDHFTGRVTALRITGKATPWPSKSSVISG 113
            S   ++      LL   + +     W      +    V    +   +            
Sbjct: 261 FSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLN-DQLPQHTFR 319

Query: 114 TLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERL 173
            +        E   L      +  +          L   EL     S  +  ++ + + L
Sbjct: 320 VIWTGSDSQKECVLLKDRPECWCRDS----ATDEQLFRCEL-SVEKSTVLQSELESCKEL 374

Query: 174 RVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLT 233
           + L          +   +     L     +    S   A+D         YL    +   
Sbjct: 375 QELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMR----AAYLDDLRSKFL 430

Query: 234 ESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSK 293
                   +  +++ L L    L   +   +  +  +  LD+S N L   +P  LA    
Sbjct: 431 LENSVLKMEYADVRVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRA-LPPALAALRC 487

Query: 294 LSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSES 353
           L VL            ++  E                +++ +          LP      
Sbjct: 488 LEVL---------QASDNALE----------------NVDGV--------ANLP------ 508

Query: 354 CSLKVLNLGQNSLKG-AVPKSLGMCRNLTYLDLSLNNL 390
             L+ L L  N L+  A  + L  C  L  L+L  N+L
Sbjct: 509 -RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 81.2 bits (201), Expect = 2e-16
 Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 20/212 (9%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVP----GYLVAVKKLS----IGRFQGIQQFDAEIGTLGR 827
           NF +  ++GTG +G  +    +     G L A+K L     + + +  +    E   L  
Sbjct: 55  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 114

Query: 828 IRHKN-LVTLIGYYVGEAEMFLVYNFLSGGNLETFIH-KKSGK-KIQWSVIHKIAIDIAQ 884
           IR    LVTL   +  E ++ L+ ++++GG L  F H  +  +       I+    +I  
Sbjct: 115 IRQSPFLVTLHYAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHEVQIY--VGEIVL 170

Query: 885 ALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYV 944
           AL +LH      I++RDIK  NILLD   +  L+DFGL++     ET    D  GT  Y+
Sbjct: 171 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 227

Query: 945 APEYATTCRVS-DKA-DVYSFGVVLLELISGK 974
           AP+         DKA D +S GV++ EL++G 
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 82.1 bits (203), Expect = 2e-16
 Identities = 53/244 (21%), Positives = 101/244 (41%), Gaps = 50/244 (20%)

Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDA-----EIGTLGRIR 829
           N+ I++LIG G +G  Y A +      VA+KK++   F+     D      EI  L R++
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN-RMFE--DLIDCKRILREITILNRLK 83

Query: 830 HKNLVTLIGYYVGEA-----EMFLVYNFLSGGNLETFIHK--KSGKKIQWSVIHK--IAI 880
              ++ L    + +      E+++V         ++ + K  K+   +  +  H   I  
Sbjct: 84  SDYIIRLYDLIIPDDLLKFDELYIVLEIA-----DSDLKKLFKTPIFL--TEEHIKTILY 136

Query: 881 DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT 940
           ++     ++H      I+HRD+KP+N LL+++ +  + DFGLAR +   +     +    
Sbjct: 137 NLLLGENFIH-ES--GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEE 193

Query: 941 F---------------GYV------APEYATTCRVSDKA-DVYSFGVVLLELISGKRSLD 978
                            +V      APE         K+ D++S G +  EL++  +S  
Sbjct: 194 NEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253

Query: 979 PSFS 982
              +
Sbjct: 254 NDPT 257

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 81.3 bits (201), Expect = 2e-16
 Identities = 55/245 (22%), Positives = 87/245 (35%), Gaps = 59/245 (24%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFDA----EIGTLGRIRH 830
            +S+   +GTG FG   +   +  G   A+KK        + Q       E+  +  + H
Sbjct: 8   KYSLGKTLGTGSFGIVCEVFDIESGKRFALKK--------VLQDPRYKNRELDIMKVLDH 59

Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVI--------------- 875
            N++ L+ Y+    +           + +             SVI               
Sbjct: 60  VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119

Query: 876 -----HKIAID-------------------IAQALAYLHYSCVPRIVHRDIKPSNILLDE 911
                HK+                      + +A+ ++H      I HRDIKP N+L++ 
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNS 176

Query: 912 ELNAY-LSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKA-DVYSFGVVLLE 969
           + N   L DFG A+ L  SE      +   F Y APE          + D++S G V  E
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPS-VAYICSRF-YRAPELMLGATEYTPSIDLWSIGCVFGE 234

Query: 970 LISGK 974
           LI GK
Sbjct: 235 LILGK 239

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 81.3 bits (201), Expect = 4e-16
 Identities = 53/212 (25%), Positives = 84/212 (39%), Gaps = 27/212 (12%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFD------AEIGTLGRI 828
            F    L+G G FG     +    G   A+K L   + + I   D       E   L   
Sbjct: 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKIL---KKEVIVAKDEVAHTLTENRVLQNS 205

Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKI------AIDI 882
           RH  L  L   +     +  V  + +GG L  F H      +    +           +I
Sbjct: 206 RHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFH------LSRERVFSEDRARFYGAEI 257

Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFG 942
             AL YLH      +V+RD+K  N++LD++ +  ++DFGL +   + +        GT  
Sbjct: 258 VSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPE 314

Query: 943 YVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
           Y+APE           D +  GVV+ E++ G+
Sbjct: 315 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 78.1 bits (193), Expect = 7e-16
 Identities = 46/178 (25%), Positives = 70/178 (39%), Gaps = 20/178 (11%)

Query: 513 NLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGV-GKLMKLQRLDLRGNRVSGS 571
           +LS   +  +   A+      L       N I  S+A G    L  LQ+L      ++ S
Sbjct: 58  DLSRCEIQTIEDGAYQ-SLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-S 114

Query: 572 LPDEL-GKLKFLKWILLGGNNLTG-EIPSQFGHLISLVVLDLSHNALTGSIPA----SLT 625
           L +   G LK LK + +  N +   ++P  F +L +L  LDLS N +  SI       L 
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLH 173

Query: 626 KATKLE-SLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLS-------GHIPHLQHLD 675
           +   L  SL L+ N ++  I       + L  L L  N L          +  LQ + 
Sbjct: 174 QMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIW 230

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 76.5 bits (189), Expect = 2e-15
 Identities = 37/138 (26%), Positives = 53/138 (38%), Gaps = 16/138 (11%)

Query: 541 NNQISGSIAAGV-GKLMKLQRLDLRGNRVSGSLP----DELGKLKFLKWILLGGNNLTGE 595
            N +   + +       +LQ LDL    +  ++       L  L  L    L GN +   
Sbjct: 37  FNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLI---LTGNPIQ-S 90

Query: 596 IPSQ-FGHLISLVVLDLSHNALTGSIPASL-TKATKLESLFLAHNRL-SGEIPVSFSTLV 652
           +    F  L SL  L      L  S+          L+ L +AHN + S ++P  FS L 
Sbjct: 91  LALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149

Query: 653 NLSALDLSFNNLSGHIPH 670
           NL  LDLS N +   I  
Sbjct: 150 NLEHLDLSSNKIQ-SIYC 166

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 37/161 (22%), Positives = 59/161 (36%), Gaps = 19/161 (11%)

Query: 513 NLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGV-GKLMKLQRLDLRGNRVSGS 571
            L+ N +  ++  AF      L +  A    ++ S+     G L  L+ L++  N +  S
Sbjct: 82  ILTGNPIQSLALGAFS-GLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-S 138

Query: 572 LP-----DELGKLKFLKWILLGGNNLTGEIPSQ-FGHLISLVV----LDLSHNALTGSIP 621
                    L  L+ L    L  N +   I       L  + +    LDLS N +   I 
Sbjct: 139 FKLPEYFSNLTNLEHLD---LSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQ 193

Query: 622 ASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFN 662
               K  +L+ L L  N+L       F  L +L  + L  N
Sbjct: 194 PGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 24/128 (18%), Positives = 45/128 (35%), Gaps = 12/128 (9%)

Query: 558 LQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQ-FGHLISLVVLDLSHNAL 616
            + LDL  N +             L+ + L    +   I    +  L  L  L L+ N +
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPI 88

Query: 617 TGSIPASL-TKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLS--------GH 667
             S+     +  + L+ L      L+         L  L  L+++ N +          +
Sbjct: 89  Q-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147

Query: 668 IPHLQHLD 675
           + +L+HLD
Sbjct: 148 LTNLEHLD 155

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 49.2 bits (118), Expect = 3e-06
 Identities = 37/190 (19%), Positives = 63/190 (33%), Gaps = 19/190 (10%)

Query: 123 TELRTLSVPHNSFSGEIPAGV-GELRLLEVLELQGNNFSGKIPYQM-SNLERLRVLNLSF 180
              + L +  N     + +        L+VL+L        I      +L  L  L L+ 
Sbjct: 28  FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTG 85

Query: 181 N---SFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIP 237
           N   S +     GL     L  +      L+  L        + L  L ++ N +     
Sbjct: 86  NPIQSLALGAFSGL---SSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKL 141

Query: 238 KEI-GKCRNLKNLLLDGNILEGSIPKEI-GTISELKV----LDVSRNSLTDRIPVELADC 291
            E      NL++L L  N ++ SI       + ++ +    LD+S N +   I       
Sbjct: 142 PEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKE 199

Query: 292 SKLSVLVLTN 301
            +L  L L  
Sbjct: 200 IRLKELALDT 209

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 45.3 bits (108), Expect = 5e-05
 Identities = 24/95 (25%), Positives = 35/95 (36%), Gaps = 12/95 (12%)

Query: 589 GNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVS- 647
             N   +IP       S   LDLS N L      S     +L+ L L+   +   I    
Sbjct: 16  ELNFY-KIPD--NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGA 71

Query: 648 FSTLVNLSALDLSFNNLS-------GHIPHLQHLD 675
           + +L +LS L L+ N +          +  LQ L 
Sbjct: 72  YQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 78.8 bits (195), Expect = 8e-16
 Identities = 56/212 (26%), Positives = 85/212 (40%), Gaps = 28/212 (13%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFD------AEIGTLGRI 828
           +F    L+G G FG          G   A+K L   R + I   D       E   L   
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKIL---RKEVIIAKDEVAHTVTESRVLQNT 62

Query: 829 RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKI------AIDI 882
           RH  L  L   +     +  V  + +GG L  F H      +    +           +I
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFH------LSRERVFTEERARFYGAEI 114

Query: 883 AQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFG 942
             AL YLH      +V+RDIK  N++LD++ +  ++DFGL +   +S+        GT  
Sbjct: 115 VSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPE 170

Query: 943 YVAPEYATTCRVSDKADVYSFGVVLLELISGK 974
           Y+APE           D +  GVV+ E++ G+
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 78.6 bits (194), Expect = 2e-15
 Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 20/208 (9%)

Query: 777 FSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKL-SIGRFQGIQQFDAEIGTLGRIRHK--- 831
           + +  +IG G FG   KA        VA+K + +  RF   +Q   EI  L  +R +   
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFH--RQAAEEIRILEHLRKQDKD 156

Query: 832 ---NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
              N++ ++  +     + + +  LS  NL   I K   +     ++ K A  I Q L  
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDA 215

Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAY--LSDFGLARLLEVSETHATTDVAGTFGYVAP 946
           LH +   RI+H D+KP NILL ++  +   + DFG +      +    T +   F Y AP
Sbjct: 216 LHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCY--EHQRV-YTYIQSRF-YRAP 268

Query: 947 EYATTCRVSDKADVYSFGVVLLELISGK 974
           E     R     D++S G +L EL++G 
Sbjct: 269 EVILGARYGMPIDMWSLGCILAELLTGY 296

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 75.8 bits (187), Expect = 4e-15
 Identities = 52/190 (27%), Positives = 86/190 (45%), Gaps = 21/190 (11%)

Query: 513 NLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGV-GKLMKLQRLDLRGNRVSGS 571
           +L +N LS +  +AF     +L      +N++  ++ AG+  +L  L+ L +  N++  +
Sbjct: 43  DLQSNKLSSLPSKAFH-RLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-A 99

Query: 572 LP----DELGKLKFLKWILLGGNNLTGEIPSQ-FGHLISLVVLDLSHNALTGSIPASL-T 625
           LP    D+L  L  L+   L  N L   +P + F  L  L  L L +N L  S+P  +  
Sbjct: 100 LPIGVFDQLVNLAELR---LDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFD 154

Query: 626 KATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPH-----LQHLDCIAFK 680
           K T L+ L L +N+L      +F  L  L  L L  N L   +P      L+ L  +  +
Sbjct: 155 KLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKR-VPEGAFDSLEKLKMLQLQ 213

Query: 681 GNKYLASCPD 690
            N +  +C  
Sbjct: 214 ENPWDCTCNG 223

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 71.5 bits (176), Expect = 1e-13
 Identities = 48/159 (30%), Positives = 71/159 (44%), Gaps = 17/159 (10%)

Query: 512 VNLSANLLSGMSYEAFLLDC-VQLVEFEAANNQISGSIAAGV-GKLMKLQRLDLRGNRVS 569
           + L+ N L  +    F       L      +N++  ++  GV  +L+ L  L L  N++ 
Sbjct: 66  LYLNDNKLQTLPAGIF--KELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK 122

Query: 570 GSLP----DELGKLKFLKWILLGGNNLTGEIPSQ-FGHLISLVVLDLSHNALTGSIPASL 624
            SLP    D L KL +L    LG N L   +P   F  L SL  L L +N L   +P   
Sbjct: 123 -SLPPRVFDSLTKLTYLS---LGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGA 176

Query: 625 -TKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFN 662
             K T+L++L L +N+L      +F +L  L  L L  N
Sbjct: 177 FDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 65.4 bits (160), Expect = 1e-11
 Identities = 34/129 (26%), Positives = 58/129 (44%), Gaps = 15/129 (11%)

Query: 558 LQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQ-FGHLISLVVLDLSHNAL 616
            ++LDL+ N++S        +L  L+ + L  N L   +P+  F  L +L  L ++ N L
Sbjct: 39  TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKL 97

Query: 617 TGSIPASL-TKATKLESLFLAHNRLSGEIPVS-FSTLVNLSALDLSFNNLSGHIPH---- 670
             ++P  +  +   L  L L  N+L   +P   F +L  L+ L L +N L   +P     
Sbjct: 98  Q-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFD 154

Query: 671 ----LQHLD 675
               L+ L 
Sbjct: 155 KLTSLKELR 163

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 46.9 bits (112), Expect = 1e-05
 Identities = 49/189 (25%), Positives = 76/189 (40%), Gaps = 21/189 (11%)

Query: 123 TELRTLSVPHNSFSGEIPAGV-GELRLLEVLELQGNNFSGKIPYQM-SNLERLRVLNLSF 180
            + + L +  N  S  +P+     L  L +L L  N     +P  +   L+ L  L ++ 
Sbjct: 37  ADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTD 94

Query: 181 NSFSGEVPRGLIGN-GELSVIDMSSNRLSGGLAIDSSSECEF-----LTYLKLSDNFLTE 234
           N     +P G+      L+ + +  N+L       S     F     LTYL L  N L  
Sbjct: 95  NKLQ-ALPIGVFDQLVNLAELRLDRNQLK------SLPPRVFDSLTKLTYLSLGYNELQ- 146

Query: 235 SIPKEI-GKCRNLKNLLLDGNILEGSIPKEIGT-ISELKVLDVSRNSLTDRIPVELADCS 292
           S+PK +  K  +LK L L  N L+  +P+     ++ELK L +  N L            
Sbjct: 147 SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLE 205

Query: 293 KLSVLVLTN 301
           KL +L L  
Sbjct: 206 KLKMLQLQE 214

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 42.7 bits (101), Expect = 4e-04
 Identities = 25/78 (32%), Positives = 33/78 (42%), Gaps = 5/78 (6%)

Query: 589 GNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVS- 647
              LT  IPS          LDL  N L+     +  + TKL  L+L  N+L   +P   
Sbjct: 25  SKKLT-AIPS--NIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGI 80

Query: 648 FSTLVNLSALDLSFNNLS 665
           F  L NL  L ++ N L 
Sbjct: 81  FKELKNLETLWVTDNKLQ 98

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 73.9 bits (182), Expect = 9e-15
 Identities = 40/201 (19%), Positives = 79/201 (39%), Gaps = 17/201 (8%)

Query: 484 RLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANL-LSGMSYEAFLLDCVQLVEFEAANN 542
            L L       ++P    S   ++    + +S ++ L  +   +F  +  ++   E  N 
Sbjct: 35  TLKLIETHLR-TIPSHAFSNLPNISR--IYVSIDVTLQQLESHSFY-NLSKVTHIEIRNT 90

Query: 543 QISGSIAAGV-GKLMKLQRLDLRGNRVSGSLPDE--LGKLKFLKWILLGGNNLTGEIPSQ 599
           +    I      +L  L+ L +    +    PD   +        + +  N     IP  
Sbjct: 91  RNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVN 149

Query: 600 -FGHLIS-LVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPV-SFSTLVN-LS 655
            F  L +  + L L +N  T S+       TKL++++L  N+    I   +F  + +  S
Sbjct: 150 AFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPS 208

Query: 656 ALDLSFNNLSGHIPH--LQHL 674
            LD+S  +++  +P   L+HL
Sbjct: 209 LLDVSQTSVT-ALPSKGLEHL 228

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 35/193 (18%), Positives = 70/193 (36%), Gaps = 12/193 (6%)

Query: 116 SASIAKLTELRTLSVPHNSFSGEIPAGV-GELRLLEVLELQGNNFSGKIPYQM-SNLERL 173
           S + + L  +  + V  +    ++ +     L  +  +E++       I       L  L
Sbjct: 48  SHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLL 107

Query: 174 RVLNLSFNSFSGEVP--RGLIGNGELSVIDMSSNRLSGGLAIDS-SSECEFLTYLKLSDN 230
           + L +         P    +       +++++ N     + +++    C     LKL +N
Sbjct: 108 KFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNN 166

Query: 231 FLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEI--GTISELKVLDVSRNSLTDRIPVEL 288
             T S+         L  + L+ N     I K+   G  S   +LDVS+ S+T  +P + 
Sbjct: 167 GFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKG 224

Query: 289 ADCSKLSVLVLTN 301
                L  L+  N
Sbjct: 225 --LEHLKELIARN 235

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 63.5 bits (155), Expect = 3e-11
 Identities = 18/116 (15%), Positives = 38/116 (32%), Gaps = 5/116 (4%)

Query: 558 LQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQ-FGHLISLVVLDLSHNAL 616
            Q L L    +          L  +  I +  +    ++ S  F +L  +  +++ +   
Sbjct: 33  TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRN 92

Query: 617 TGSIPAS-LTKATKLESLFLAHNRLSGEIP--VSFSTLVNLSALDLSFNNLSGHIP 669
              I    L +   L+ L + +  L    P      +      L+++ N     IP
Sbjct: 93  LTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIP 147

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 48.1 bits (115), Expect = 4e-06
 Identities = 26/142 (18%), Positives = 51/142 (35%), Gaps = 14/142 (9%)

Query: 120 AKLTELRTLSVPHNSFSGEIPAG--VGELRLLEVLELQGNNFSGKIPYQ----MSNLERL 173
            +L  L+ L + +       P    V    +  +LE+  N +   IP      + N    
Sbjct: 102 KELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNE--T 158

Query: 174 RVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDS-SSECEFLTYLKLSDNFL 232
             L L  N F+  V        +L  + ++ N+    +  D+        + L +S   +
Sbjct: 159 LTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSV 217

Query: 233 TESIPKEIGKCRNLKNLLLDGN 254
           T ++P +     +LK L+    
Sbjct: 218 T-ALPSKG--LEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 46.5 bits (111), Expect = 1e-05
 Identities = 35/250 (14%), Positives = 71/250 (28%), Gaps = 71/250 (28%)

Query: 149 LEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGL-IGNGELSVIDMSSNRL 207
            + L+L   +      +  SNL  +  + +S +    ++         +++ I++ + R 
Sbjct: 33  TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRN 92

Query: 208 SGGLAIDSSSECEFLTYLKLSDNFLTESIPKE--IGKCRNLKNLLLDGNILEGSIPKEI- 264
              +  D+  E   L +L + +  L    P    +        L +  N    SIP    
Sbjct: 93  LTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAF 151

Query: 265 -GTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVP 323
            G  +E   L +  N                     T++              AF+G   
Sbjct: 152 QGLCNETLTLKLYNNG-------------------FTSVQGY-----------AFNG--- 178

Query: 324 YELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSL--GMCRNLT 381
                                           L  + L +N     + K    G+    +
Sbjct: 179 ------------------------------TKLDAVYLNKNKYLTVIDKDAFGGVYSGPS 208

Query: 382 YLDLSLNNLE 391
            LD+S  ++ 
Sbjct: 209 LLDVSQTSVT 218

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 26/155 (16%), Positives = 51/155 (32%), Gaps = 9/155 (5%)

Query: 484 RLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQ 543
            + + N      +  + + +   L+   + +    L        +         E  +N 
Sbjct: 84  HIEIRNTRNLTYIDPDALKELPLLKF--LGIFNTGLKMFPDLTKVYSTDIFFILEITDNP 141

Query: 544 ISGSIAAGV--GKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQ-F 600
              SI      G   +   L L  N  + S+         L  + L  N     I    F
Sbjct: 142 YMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAF 200

Query: 601 GHLIS-LVVLDLSHNALTGSIPA-SLTKATKLESL 633
           G + S   +LD+S  ++T ++P+  L    +L + 
Sbjct: 201 GGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIAR 234

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 44.6 bits (106), Expect = 7e-05
 Identities = 16/95 (16%), Positives = 38/95 (40%), Gaps = 13/95 (13%)

Query: 589 GNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPA-SLTKATKLESLFLAHNRLSGEIPV- 646
             ++   IPS      S   L L    L  +IP+ + +    +  ++++ +    ++   
Sbjct: 20  CKDIQ-RIPSL---PPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESH 74

Query: 647 SFSTLVNLSALDLSFNNLSGHIPHLQHLDCIAFKG 681
           SF  L  ++ +++          +L ++D  A K 
Sbjct: 75  SFYNLSKVTHIEIRNTR------NLTYIDPDALKE 103

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 41.5 bits (98), Expect = 7e-04
 Identities = 23/135 (17%), Positives = 49/135 (36%), Gaps = 10/135 (7%)

Query: 484 RLLLNNNMFNGSVPGERISKCNDLQS-FSVNLSANL-LSGMSYEAFLLDCVQLVEFEAAN 541
            L + N       P   ++K       F + ++ N  ++ +   AF   C + +  +  N
Sbjct: 109 FLGIFNTGLK-MFPD--LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYN 165

Query: 542 NQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDEL--GKLKFLKWILLGGNNLTGEIPSQ 599
           N  + S+        KL  + L  N+    +  +   G       + +   ++T  +PS+
Sbjct: 166 NGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSK 223

Query: 600 -FGHLISLVVLDLSH 613
              HL  L+  +   
Sbjct: 224 GLEHLKELIARNTWT 238

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 76.3 bits (188), Expect = 1e-14
 Identities = 52/211 (24%), Positives = 91/211 (43%), Gaps = 18/211 (8%)

Query: 774 TGNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKL-SIGRFQGIQQFDAEIGTLGRIRH- 830
              + I +LIG G FG   KA   V    VA+K + +   F    Q   E+  L  +   
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL--NQAQIEVRLLELMNKH 110

Query: 831 -----KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
                  +V L  +++    + LV+  LS  NL   +   + + +  ++  K A  +  A
Sbjct: 111 DTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTA 169

Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAY--LSDFGLARLLEVSETHATTDVAGTFGY 943
           L +L  +    I+H D+KP NILL     +   + DFG +   ++ +      +   F Y
Sbjct: 170 LLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRI-YQYIQSRF-Y 224

Query: 944 VAPEYATTCRVSDKADVYSFGVVLLELISGK 974
            +PE           D++S G +L+E+ +G+
Sbjct: 225 RSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 77.0 bits (189), Expect = 2e-14
 Identities = 55/209 (26%), Positives = 99/209 (47%), Gaps = 21/209 (10%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFDAEIGTLG--RI---- 828
           +F+   ++G G FG    +E      L AVK L   +   + Q D    T+   R+    
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKIL---KKDVVIQDDDVECTMVEKRVLALP 398

Query: 829 -RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIH-KKSGK-KIQWSVIHKIAIDIAQA 885
            +   L  L   +     ++ V  +++GG+L    H ++ G+ K   +V +  A +IA  
Sbjct: 399 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFY--AAEIAIG 454

Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
           L +L       I++RD+K  N++LD E +  ++DFG+ +   + +   T    GT  Y+A
Sbjct: 455 LFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTPDYIA 510

Query: 946 PEYATTCRVSDKADVYSFGVVLLELISGK 974
           PE           D ++FGV+L E+++G+
Sbjct: 511 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 75.4 bits (186), Expect = 2e-14
 Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 21/209 (10%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFDAEIGTLG-------R 827
           +F    +IG G FG    A         AVK L   + + I +   E   +         
Sbjct: 39  DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVL---QKKAILKKKEEKHIMSERNVLLKN 95

Query: 828 IRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIH-KKSGK-KIQWSVIHKIAIDIAQA 885
           ++H  LV L   +    +++ V ++++GG L  F H ++        +  +  A +IA A
Sbjct: 96  VKHPFLVGLHFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFY--AAEIASA 151

Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
           L YLH      IV+RD+KP NILLD + +  L+DFGL +   +     T+   GT  Y+A
Sbjct: 152 LGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTPEYLA 207

Query: 946 PEYATTCRVSDKADVYSFGVVLLELISGK 974
           PE           D +  G VL E++ G 
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 74.6 bits (184), Expect = 3e-14
 Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 21/209 (10%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFD------AEIGTLGRI 828
           +F+   ++G G FG    +E      L AVK L   +   + Q D       E   L   
Sbjct: 21  DFNFLMVLGKGSFGKVMLSERKGTDELYAVKIL---KKDVVIQDDDVECTMVEKRVLALP 77

Query: 829 -RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIH-KKSGK-KIQWSVIHKIAIDIAQA 885
            +   L  L   +     ++ V  +++GG+L    H ++ G+ K   +V +  A +IA  
Sbjct: 78  GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFY--AAEIAIG 133

Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
           L +L       I++RD+K  N++LD E +  ++DFG+ +   + +   T    GT  Y+A
Sbjct: 134 LFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTPDYIA 189

Query: 946 PEYATTCRVSDKADVYSFGVVLLELISGK 974
           PE           D ++FGV+L E+++G+
Sbjct: 190 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 75.1 bits (185), Expect = 3e-14
 Identities = 61/232 (26%), Positives = 103/232 (44%), Gaps = 48/232 (20%)

Query: 777 FSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDA-----EIGTLGRIR- 829
           + +   +G G +G  +K+ +   G +VAVKK+    FQ     DA     EI  L  +  
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-DAFQ--NSTDAQRTFREIMILTELSG 67

Query: 830 HKNLVTLIGYYVGEA--EMFLVYNFLSGGNLETFIHK--KSGKKIQWSVIHK--IAIDIA 883
           H+N+V L+     +   +++LV++++     ET +H   ++        +HK  +   + 
Sbjct: 68  HENIVNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIRANI---LEPVHKQYVVYQLI 119

Query: 884 QALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTF-- 941
           + + YLH S    ++HRD+KPSNILL+ E +  ++DFGL+R                   
Sbjct: 120 KVIKYLH-SG--GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176

Query: 942 ------------GYV------APEYATTCRVSDKA-DVYSFGVVLLELISGK 974
                        YV      APE         K  D++S G +L E++ GK
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 73.8 bits (182), Expect = 4e-14
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 17/206 (8%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFDAEIGTLG--RI---- 828
           +F +  ++G G FG  + AE        A+K L   +   +   D    T+   R+    
Sbjct: 18  DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKAL---KKDVVLMDDDVECTMVEKRVLSLA 74

Query: 829 -RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALA 887
             H  L  +   +  +  +F V  +L+GG+L   I       +  +  +  A +I   L 
Sbjct: 75  WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFY--AAEIILGLQ 132

Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE 947
           +LH      IV+RD+K  NILLD++ +  ++DFG+ +   +     T    GT  Y+APE
Sbjct: 133 FLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGDAKTNTFCGTPDYIAPE 188

Query: 948 YATTCRVSDKADVYSFGVVLLELISG 973
                + +   D +SFGV+L E++ G
Sbjct: 189 ILLGQKYNHSVDWWSFGVLLYEMLIG 214

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 71.2 bits (175), Expect = 6e-14
 Identities = 35/127 (27%), Positives = 52/127 (40%), Gaps = 15/127 (11%)

Query: 559 QRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQ-FGHLISLVVLDLSHNALT 617
             + L  N +    P      K L+ I L  N ++ E+    F  L SL  L L  N +T
Sbjct: 35  TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT 93

Query: 618 GSIPASL-TKATKLESLFLAHNRLSGEIPV-SFSTLVNLSALDLSFNNLSGHIPH----- 670
             +P SL      L+ L L  N+++  + V +F  L NL+ L L  N L   I       
Sbjct: 94  -ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSP 150

Query: 671 ---LQHL 674
              +Q +
Sbjct: 151 LRAIQTM 157

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 38/129 (29%), Positives = 54/129 (41%), Gaps = 14/129 (10%)

Query: 541 NNQISGSIAAGV-GKLMKLQRLDLRGNRVSGSLP----DELGKLKFLKWILLGGNNLTGE 595
            N I   I  G      KL+R+DL  N++S  L       L  L  L    L GN +T E
Sbjct: 41  QNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLV---LYGNKIT-E 94

Query: 596 IPSQ-FGHLISLVVLDLSHNALTGSIPA-SLTKATKLESLFLAHNRLSGEIPVSFSTLVN 653
           +P   F  L SL +L L+ N +   +   +      L  L L  N+L      +FS L  
Sbjct: 95  LPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRA 153

Query: 654 LSALDLSFN 662
           +  + L+ N
Sbjct: 154 IQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 47.7 bits (114), Expect = 5e-06
 Identities = 30/133 (22%), Positives = 52/133 (39%), Gaps = 8/133 (6%)

Query: 484 RLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQ 543
            + L  N     +P    S    L+   ++LS N +S ++ +AF      L       N+
Sbjct: 36  EIRLEQNTIK-VIPPGAFSPYKKLRR--IDLSNNQISELAPDAFQ-GLRSLNSLVLYGNK 91

Query: 544 ISGSIAAGV-GKLMKLQRLDLRGNRVSGSLPDEL-GKLKFLKWILLGGNNLTGEIPSQFG 601
           I+  +   +   L  LQ L L  N+++  L  +    L  L  + L  N L       F 
Sbjct: 92  IT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFS 149

Query: 602 HLISLVVLDLSHN 614
            L ++  + L+ N
Sbjct: 150 PLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 46.9 bits (112), Expect = 1e-05
 Identities = 18/76 (23%), Positives = 35/76 (46%), Gaps = 9/76 (11%)

Query: 608 VLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPV-SFSTLVNLSALDLSFNNLS- 665
            + L  N +    P + +   KL  + L++N++S E+   +F  L +L++L L  N ++ 
Sbjct: 36  EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITE 94

Query: 666 ------GHIPHLQHLD 675
                   +  LQ L 
Sbjct: 95  LPKSLFEGLFSLQLLL 110

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 73.4 bits (181), Expect = 6e-14
 Identities = 50/204 (24%), Positives = 95/204 (46%), Gaps = 11/204 (5%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVP-GYLVAVK---KLSIGRFQGIQQFDAEIGTLGRI-RH 830
           +F +  +IG G +       L     + A+K   K  +   + I     E     +   H
Sbjct: 10  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 69

Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
             LV L   +  E+ +F V  +++GG+L   + ++     + +  +  + +I+ AL YLH
Sbjct: 70  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY--SAEISLALNYLH 127

Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
                 I++RD+K  N+LLD E +  L+D+G+ +   +     T+   GT  Y+APE   
Sbjct: 128 ER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEILR 183

Query: 951 TCRVSDKADVYSFGVVLLELISGK 974
                   D ++ GV++ E+++G+
Sbjct: 184 GEDYGFSVDWWALGVLMFEMMAGR 207

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 73.9 bits (182), Expect = 7e-14
 Identities = 49/204 (24%), Positives = 95/204 (46%), Gaps = 11/204 (5%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVP-GYLVAVK---KLSIGRFQGIQQFDAEIGTLGRI-RH 830
           +F +  +IG G +       L     + A++   K  +   + I     E     +   H
Sbjct: 53  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNH 112

Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
             LV L   +  E+ +F V  +++GG+L   + ++     + +  +  + +I+ AL YLH
Sbjct: 113 PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY--SAEISLALNYLH 170

Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
                 I++RD+K  N+LLD E +  L+D+G+ +   +     T+   GT  Y+APE   
Sbjct: 171 ER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEILR 226

Query: 951 TCRVSDKADVYSFGVVLLELISGK 974
                   D ++ GV++ E+++G+
Sbjct: 227 GEDYGFSVDWWALGVLMFEMMAGR 250

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 72.7 bits (179), Expect = 1e-13
 Identities = 62/209 (29%), Positives = 92/209 (44%), Gaps = 21/209 (10%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFD------AEIGTLGRI 828
           NF    ++G G FG    A +   G L AVK L   +   I Q D       E   L   
Sbjct: 24  NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVL---KKDVILQDDDVECTMTEKRILSLA 80

Query: 829 -RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIH-KKSGK-KIQWSVIHKIAIDIAQA 885
             H  L  L   +     +F V  F++GG+L    H +KS +     +  +  A +I  A
Sbjct: 81  RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFY--AAEIISA 136

Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
           L +LH      I++RD+K  N+LLD E +  L+DFG+ +   +     T    GT  Y+A
Sbjct: 137 LMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATFCGTPDYIA 192

Query: 946 PEYATTCRVSDKADVYSFGVVLLELISGK 974
           PE           D ++ GV+L E++ G 
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 73.5 bits (181), Expect = 1e-13
 Identities = 86/499 (17%), Positives = 147/499 (29%), Gaps = 107/499 (21%)

Query: 194 NGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLT----ESIPKEIGKCRNLKNL 249
           + ++  +D+    LS     +     +    ++L D  LT    + I   +     L  L
Sbjct: 2   SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 61

Query: 250 LLDGNILEGSIPKEIGTI-----SELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNID- 303
            L  N L       +         +++ L +    LT       A C  LS  + T    
Sbjct: 62  NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTG------AGCGVLSSTLRTLPTL 115

Query: 304 ASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQ 363
             L L ++       D G+    LL   L                     C L+ L L  
Sbjct: 116 QELHLSDNLLG----DAGLQ---LLCEGLL-----------------DPQCRLEKLQLEY 151

Query: 364 NSLK----GAVPKSLGMCRNLTYLDLSLNNLEG----YLPMQLPVPC--MVYFNVSQNNI 413
            SL       +   L    +   L +S N++       L   L      +    +    +
Sbjct: 152 CSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGV 211

Query: 414 TGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIH-DFSGNKFLGSLPLFAIGD 472
           T                 +DL          I      +       NK LG + +  +  
Sbjct: 212 T-------------SDNCRDL--------CGIVASKASLRELALGSNK-LGDVGMAELCP 249

Query: 473 GFLAAKYKPHYRL----LLNNNMFNGSVP--GERISKCNDLQSFSVNLSANLL--SGMSY 524
           G L     P  RL    +    +           +     L+    +L+ N L   G   
Sbjct: 250 GLL----HPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKEL--SLAGNELGDEGARL 303

Query: 525 --EAFLLDCVQLVEFEAANNQISG----SIAAGVGKLMKLQRLDLRGNRVSGS----LPD 574
             E  L    QL      +   +       ++ + +   L  L +  NR+  +    L  
Sbjct: 304 LCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQ 363

Query: 575 ELGK-LKFLKWILLGGNNLTGE----IPSQFGHLISLVVLDLSHNALTGSIPASLTKA-- 627
            LG+    L+ + L   +++      + +      SL  LDLS+N L  +    L ++  
Sbjct: 364 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVR 423

Query: 628 ---TKLESLFLAHNRLSGE 643
                LE L L     S E
Sbjct: 424 QPGCLLEQLVLYDIYWSEE 442

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 65.4 bits (160), Expect = 5e-11
 Identities = 53/301 (17%), Positives = 90/301 (29%), Gaps = 63/301 (20%)

Query: 123 TELRTLSVPHNSFSGEIPAGVGEL----RLLEVLELQGNNFSGK-----IPYQMSNLERL 173
             L  L + + S S      +  +       + L +  N+ +             +  +L
Sbjct: 142 CRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQL 201

Query: 174 RVLNLSFNSFSGE----VPRGLIGNGELSVIDMSSNRLSGG----LAIDSSSECEFLTYL 225
             L L     + +    +   +     L  + + SN+L       L          L  L
Sbjct: 202 EALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTL 261

Query: 226 KLSDNFLTE----SIPKEIGKCRNLKNLLLDGNILEGSIPKEIG-----TISELKVLDVS 276
            + +  +T      + + +    +LK L L GN L     + +         +L+ L V 
Sbjct: 262 WIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVK 321

Query: 277 RNSLTDRIPVELADCSKLSVLVLTNID-ASLDL-DNSRGEFSAFDGGVPYELLLSRSLEV 334
             S T       A CS  S ++  N     L + +N        D GV     L + L  
Sbjct: 322 SCSFTA------ACCSHFSSVLAQNRFLLELQISNNRLE-----DAGV---RELCQGLG- 366

Query: 335 LWAPRANLGGRLPDNWSESCSLKVLNLGQNSL--KGAVP--KSLGMCRNLTYLDLSLNNL 390
                                L+VL L    +          +L    +L  LDLS N L
Sbjct: 367 ----------------QPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 410

Query: 391 E 391
            
Sbjct: 411 G 411

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 65.0 bits (159), Expect = 6e-11
 Identities = 47/312 (15%), Positives = 93/312 (29%), Gaps = 69/312 (22%)

Query: 115 LSASIAKLTELRTLSVPHNSFSGEIPAGVGEL-------RLLEVLELQGNNFSGK----- 162
            +  +  L + + + +     +    A   ++         L  L L+ N          
Sbjct: 20  WAELLPLLQQCQVVRLDDCGLT---EARCKDISSALRVNPALAELNLRSNELGDVGVHCV 76

Query: 163 IPYQMSNLERLRVLNLSFNSFSGE----VPRGLIGNGELSVIDMSSNRLSGG----LAID 214
           +    +   +++ L+L     +G     +   L     L  + +S N L       L   
Sbjct: 77  LQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEG 136

Query: 215 SSSECEFLTYLKLSDNFLTESIPKEIGK----CRNLKNLLLDGNILEGSIPKEIGTI--- 267
                  L  L+L    L+ +  + +        + K L +  N +  +  + +      
Sbjct: 137 LLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKD 196

Query: 268 --SELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNID-ASLDL-DNSRGEFSAFDGGVP 323
              +L+ L +    +T        +C  L  +V +      L L  N  G     D G+ 
Sbjct: 197 SPCQLEALKLESCGVTS------DNCRDLCGIVASKASLRELALGSNKLG-----DVGM- 244

Query: 324 YELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSL--KGAVP--KSLGMCRN 379
               L   L                    S  L+ L + +  +  KG     + L    +
Sbjct: 245 --AELCPGLL-----------------HPSSRLRTLWIWECGITAKGCGDLCRVLRAKES 285

Query: 380 LTYLDLSLNNLE 391
           L  L L+ N L 
Sbjct: 286 LKELSLAGNELG 297

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 64.2 bits (157), Expect = 1e-10
 Identities = 78/465 (16%), Positives = 146/465 (31%), Gaps = 99/465 (21%)

Query: 244 RNLKNLLLDGNIL-EGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNI 302
            ++++L +    L +    + +  + + +V+ +    LT+      A C  +S  +  N 
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTE------ARCKDISSALRVNP 56

Query: 303 D-ASLDLDNSR-GEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLN 360
             A L+L ++  G     D GV     + + L+                 + SC ++ L+
Sbjct: 57  ALAELNLRSNELG-----DVGV---HCVLQGLQ-----------------TPSCKIQKLS 91

Query: 361 LGQNSLK----GAVPKSLGMCRNLTYLDLSLNNLEG----YLPMQLPVPCMV--YFNVSQ 410
           L    L     G +  +L     L  L LS N L       L   L  P        +  
Sbjct: 92  LQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEY 151

Query: 411 NNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIH-DFSGNKFLGSLPLFA 469
            +++                 + L         S+            S N  +    +  
Sbjct: 152 CSLS-------------AASCEPL--------ASVLRAKPDFKELTVSNND-INEAGVRV 189

Query: 470 IGDGFLAAKYKPHYRLLLNNNMFNG---SVPGERISKCNDLQSFSVNLSANLL--SGMSY 524
           +  G   +  +    L L +              ++    L+     L +N L   GM+ 
Sbjct: 190 LCQGLKDSPCQLEA-LKLESCGVTSDNCRDLCGIVASKASLREL--ALGSNKLGDVGMAE 246

Query: 525 --EAFLLDCVQLVEFEAANNQIS----GSIAAGVGKLMKLQRLDLRGNRVSGS----LPD 574
                L    +L         I+    G +   +     L+ L L GN +       L +
Sbjct: 247 LCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE 306

Query: 575 ELGK-LKFLKWILLGGNNLTGE----IPSQFGHLISLVVLDLSHNALTGSIPASLTKA-- 627
            L +    L+ + +   + T        S       L+ L +S+N L  +    L +   
Sbjct: 307 TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLG 366

Query: 628 ---TKLESLFLAHNRLSGE----IPVSFSTLVNLSALDLSFNNLS 665
              + L  L+LA   +S      +  +     +L  LDLS N L 
Sbjct: 367 QPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 63.8 bits (156), Expect = 2e-10
 Identities = 44/265 (16%), Positives = 87/265 (32%), Gaps = 53/265 (20%)

Query: 149 LEVLELQGNNFSGK-IPYQMSNLERLRVLNLSFNSFSGE----VPRGLIGNGELSVIDMS 203
           ++ L++Q    S       +  L++ +V+ L     +      +   L  N  L+ +++ 
Sbjct: 5   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64

Query: 204 SNRLSG----GLAIDSSSECEFLTYLKLSDNFLTE----SIPKEIGKCRNLKNLLLDGNI 255
           SN L       +     +    +  L L +  LT      +   +     L+ L L  N+
Sbjct: 65  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 124

Query: 256 LEGSIPKEIGTI-----SELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNID-ASLDLD 309
           L  +  + +          L+ L +   SL+       A C  L+ ++    D   L + 
Sbjct: 125 LGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSA------ASCEPLASVLRAKPDFKELTVS 178

Query: 310 NSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSL--K 367
           N+    +  + GV    +L + L+                    C L+ L L    +   
Sbjct: 179 NND--IN--EAGVR---VLCQGLK-----------------DSPCQLEALKLESCGVTSD 214

Query: 368 GAVP--KSLGMCRNLTYLDLSLNNL 390
                   +    +L  L L  N L
Sbjct: 215 NCRDLCGIVASKASLRELALGSNKL 239

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 61.1 bits (149), Expect = 1e-09
 Identities = 57/302 (18%), Positives = 93/302 (30%), Gaps = 65/302 (21%)

Query: 123 TELRTLSVPHNSFSGE----IPAGVGELRLLEVLELQGNNFSGKIPYQMSNLER-----L 173
            +++ LS+ +   +G     + + +  L  L+ L L  N         +          L
Sbjct: 85  CKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRL 144

Query: 174 RVLNLSFNSFSGE----VPRGLIGNGELSVIDMSSNRLS--GGLAI---DSSSECEFLTY 224
             L L + S S      +   L    +   + +S+N ++  G   +      S C+ L  
Sbjct: 145 EKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQ-LEA 203

Query: 225 LKLSDNFLTE----SIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTI-----SELKVLDV 275
           LKL    +T      +   +    +L+ L L  N L      E+        S L+ L +
Sbjct: 204 LKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWI 263

Query: 276 SRNSLTDRIPVELADCSKLSVLVLTNID-ASLDL-DNSRGEFSAFDGGVPYELLLSRSLE 333
               +T         C  L  ++        L L  N  G     D G     LL  +L 
Sbjct: 264 WECGITA------KGCGDLCRVLRAKESLKELSLAGNELG-----DEGA---RLLCETLL 309

Query: 334 VLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKG----AVPKSLGMCRNLTYLDLSLNN 389
                               C L+ L +   S            L   R L  L +S N 
Sbjct: 310 -----------------EPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNR 352

Query: 390 LE 391
           LE
Sbjct: 353 LE 354

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 48.0 bits (115), Expect = 1e-05
 Identities = 53/278 (19%), Positives = 87/278 (31%), Gaps = 59/278 (21%)

Query: 125 LRTLSVPHNSFSGE----IPAGVGELRLLEVLELQGNNFSGK-----IPYQMSNLERLRV 175
           L  L +     + +    +   V     L  L L  N           P  +    RLR 
Sbjct: 201 LEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRT 260

Query: 176 LNLSFNSFSGE----VPRGLIGNGELSVIDMSSNRL--SGGLAIDSS--SECEFLTYLKL 227
           L +     + +    + R L     L  + ++ N L   G   +  +       L  L +
Sbjct: 261 LWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWV 320

Query: 228 SDNFLT----ESIPKEIGKCRNLKNLLLDGNILEGSIPKEIG-----TISELKVLDVSRN 278
                T          + + R L  L +  N LE +  +E+        S L+VL ++  
Sbjct: 321 KSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADC 380

Query: 279 SLTDRIPVELADCSKLSVLVLTNID-ASLDL-DNSRGEFSAFDGGVPYELLLSRSLEVLW 336
            ++D      + CS L+  +L N     LDL +N  G     D G+   L L  S+    
Sbjct: 381 DVSD------SSCSSLAATLLANHSLRELDLSNNCLG-----DAGI---LQLVESVRQP- 425

Query: 337 APRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSL 374
                            C L+ L L        +   L
Sbjct: 426 ----------------GCLLEQLVLYDIYWSEEMEDRL 447

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 47.6 bits (114), Expect = 2e-05
 Identities = 45/220 (20%), Positives = 80/220 (36%), Gaps = 31/220 (14%)

Query: 115 LSASIAKLTELRTLSVPHNSFSGE-----IPAGVGELRLLEVLELQGNNFSGK----IPY 165
           L   +A    LR L++  N           P  +     L  L +     + K    +  
Sbjct: 219 LCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCR 278

Query: 166 QMSNLERLRVLNLSFNSFSGEVPRGLI-----GNGELSVIDMSSNRLS--GGLAIDSS-S 217
            +   E L+ L+L+ N    E  R L         +L  + + S   +        S  +
Sbjct: 279 VLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLA 338

Query: 218 ECEFLTYLKLSDNFLTESIPKEIGK-----CRNLKNLLLDGNIL--EG--SIPKEIGTIS 268
           +  FL  L++S+N L ++  +E+ +        L+ L L    +      S+   +    
Sbjct: 339 QNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANH 398

Query: 269 ELKVLDVSRNSLTDRIPVELAD-----CSKLSVLVLTNID 303
            L+ LD+S N L D   ++L +        L  LVL +I 
Sbjct: 399 SLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIY 438

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 44.6 bits (106), Expect = 1e-04
 Identities = 32/202 (15%), Positives = 62/202 (30%), Gaps = 37/202 (18%)

Query: 511 SVNLSANLLSGMSYEAF---LLDCVQLVEFEAANNQISGSIAAGVGKLMK-----LQRLD 562
            V L    L+    +     L     L E    +N++       V + ++     +Q+L 
Sbjct: 32  VVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLS 91

Query: 563 LRGNRVS----GSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLI-----SLVVLDLSH 613
           L+   ++    G L   L  L  L+ + L  N L           +      L  L L +
Sbjct: 92  LQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEY 151

Query: 614 NALTGSIPASLTKA----TKLESLFLAHNRLSGE-----IPVSFSTLVNLSALDLSFNNL 664
            +L+ +    L          + L +++N ++             +   L AL L    +
Sbjct: 152 CSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGV 211

Query: 665 S-----------GHIPHLQHLD 675
           +                L+ L 
Sbjct: 212 TSDNCRDLCGIVASKASLRELA 233

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 73.6 bits (180), Expect = 2e-13
 Identities = 33/147 (22%), Positives = 61/147 (41%), Gaps = 11/147 (7%)

Query: 528 LLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILL 587
                + ++       ++ ++     +L  + ++    + +  S+   +  L  +  + L
Sbjct: 17  DDAFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFL 72

Query: 588 GGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVS 647
            GN LT +I     +L +L  L L  N +   +  SL    KL+SL L HN +S +I   
Sbjct: 73  NGNKLT-DI-KPLTNLKNLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGIS-DIN-G 126

Query: 648 FSTLVNLSALDLSFNNLSGHIPHLQHL 674
              L  L +L L  N ++  I  L  L
Sbjct: 127 LVHLPQLESLYLGNNKIT-DITVLSRL 152

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 67.8 bits (165), Expect = 1e-11
 Identities = 32/183 (17%), Positives = 70/183 (38%), Gaps = 15/183 (8%)

Query: 119 IAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNL 178
                E    ++   S +  +     EL  ++ +    ++    +   +  L  +  L L
Sbjct: 17  DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFL 72

Query: 179 SFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPK 238
           + N  +   P  L     L  + +  N++     + S  + + L  L L  N +++    
Sbjct: 73  NGNKLTDIKP--LTNLKNLGWLFLDENKIK---DLSSLKDLKKLKSLSLEHNGISDING- 126

Query: 239 EIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLV 298
            +     L++L L  N +  +    +  +++L  L +  N ++D I   LA  +KL  L 
Sbjct: 127 -LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQNLY 181

Query: 299 LTN 301
           L+ 
Sbjct: 182 LSK 184

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 59.7 bits (144), Expect = 3e-09
 Identities = 43/316 (13%), Positives = 95/316 (30%), Gaps = 62/316 (19%)

Query: 356 LKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNITG 415
           +         +K   P            +L   ++      Q  +  +     + ++I  
Sbjct: 1   MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTD-AVTQNELNSIDQIIANNSDIK- 56

Query: 416 VLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFL 475
                + +         ++          ++      + D      L +L          
Sbjct: 57  ---SVQGIQ-----YLPNVTKLF------LNGNK---LTDIKPLTNLKNL---------- 89

Query: 476 AAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFS----VNLSANLLSGMSYEAFLLDC 531
                    L L+ N         +I   + L+       ++L  N +S ++    L+  
Sbjct: 90  -------GWLFLDEN---------KIKDLSSLKDLKKLKSLSLEHNGISDIN---GLVHL 130

Query: 532 VQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNN 591
            QL      NN+I+  I   + +L KL  L L  N++S  +   L  L  L+ + L  N+
Sbjct: 131 PQLESLYLGNNKIT-DIT-VLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNH 186

Query: 592 LTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTL 651
           ++ ++      L +L VL+L             +      ++      L    P   S  
Sbjct: 187 IS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIISDD 242

Query: 652 VNLSALDLSFNNLSGH 667
            +    ++ ++     
Sbjct: 243 GDYEKPNVKWHLPEFT 258

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 57.0 bits (137), Expect = 2e-08
 Identities = 38/221 (17%), Positives = 71/221 (32%), Gaps = 56/221 (25%)

Query: 196 ELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNI 255
           E    ++    ++      + +E   +  +  +++ +  S+ + I    N+  L L+GN 
Sbjct: 22  ETIKDNLKKKSVTD---AVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNK 76

Query: 256 LEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTN--IDASLDLDNSRG 313
           L   I K +  +  L  L +  N + D     L D  KL  L L +  I           
Sbjct: 77  LT-DI-KPLTNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGI----------- 121

Query: 314 EFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKS 373
                             +  L                    L+ L LG N +       
Sbjct: 122 ----------------SDINGL---------------VHLPQLESLYLGNNKIT--DITV 148

Query: 374 LGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNIT 414
           L     L  L L  N +   +P+   +  +    +S+N+I+
Sbjct: 149 LSRLTKLDTLSLEDNQISDIVPLA-GLTKLQNLYLSKNHIS 188

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 54.7 bits (131), Expect = 1e-07
 Identities = 39/157 (24%), Positives = 65/157 (41%), Gaps = 10/157 (6%)

Query: 118 SIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLN 177
           S+  L +L++LS+ HN  S +I  G+  L  LE L L  N  +      +S L +L  L+
Sbjct: 104 SLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLS 159

Query: 178 LSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIP 237
           L  N  S  VP  L G  +L  + +S N +S    + + +  + L  L+L          
Sbjct: 160 LEDNQISDIVP--LAGLTKLQNLYLSKNHIS---DLRALAGLKNLDVLELFSQECLNKPI 214

Query: 238 KEIGKCRNLKNL-LLDGNILEGSIPKEIGTISELKVL 273
                      +   DG+++   I  + G   +  V 
Sbjct: 215 NHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVK 251

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 49.3 bits (117), Expect = 5e-06
 Identities = 11/100 (11%), Positives = 36/100 (36%), Gaps = 11/100 (11%)

Query: 582 LKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLS 641
           +   +     +  +I          +  +L   ++T ++     +   ++ +   ++ + 
Sbjct: 1   MGETITVSTPIK-QI-FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56

Query: 642 GEIPVSFSTLVNLSALDLSFNNLS-----GHIPHLQHLDC 676
             +      L N++ L L+ N L+      ++ +L  L  
Sbjct: 57  -SVQ-GIQYLPNVTKLFLNGNKLTDIKPLTNLKNLGWLFL 94

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 43.2 bits (101), Expect = 4e-04
 Identities = 40/280 (14%), Positives = 82/280 (29%), Gaps = 58/280 (20%)

Query: 355 SLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNIT 414
           S+  +    + +K    + +    N+T L L+ N L    P+   +  + +  + +N I 
Sbjct: 44  SIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKPLT-NLKNLGWLFLDENKIK 100

Query: 415 GVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGF 474
                  ++        + L+  ++       + N   I D +G   L  L         
Sbjct: 101 ----DLSSLK-----DLKKLKSLSL-------EHNG--ISDINGLVHLPQL--------- 133

Query: 475 LAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFS----VNLSANLLSGMSYEAFLLD 530
                     L L NN         +I+    L   +    ++L  N +S +     L  
Sbjct: 134 --------ESLYLGNN---------KITDITVLSRLTKLDTLSLEDNQISDIV---PLAG 173

Query: 531 CVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGN 590
             +L     + N IS  +   +  L  L  L+L          +    L     +     
Sbjct: 174 LTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDG 231

Query: 591 NLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKL 630
           +L    P            ++  +    +   S      +
Sbjct: 232 SL--VTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPV 269

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 72.1 bits (177), Expect = 2e-13
 Identities = 27/181 (14%), Positives = 55/181 (30%), Gaps = 21/181 (11%)

Query: 513 NLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGV-GKLMKLQRLDLRGNRVSGS 571
           NL  N    +   +      +L      N      I       L  L+ L++  + +  S
Sbjct: 130 NLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-S 188

Query: 572 LPDE-LGKLKFLKWILLGGNNLTGEIPSQ-FGHLISLVVLDLSHNALTG----SIPA--- 622
              + L  ++ +  ++L        +         S+  L+L    L       +     
Sbjct: 189 YEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGET 247

Query: 623 -SLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSG-------HIPHLQHL 674
            SL K     ++ +    L  ++    + +  L  L+ S N L          +  LQ +
Sbjct: 248 NSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKI 306

Query: 675 D 675
            
Sbjct: 307 W 307

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 71.3 bits (175), Expect = 3e-13
 Identities = 51/273 (18%), Positives = 93/273 (34%), Gaps = 35/273 (12%)

Query: 129 SVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVP 188
           S+P       +         ++ L+L  N  +      +     L+ L L+ N  +  + 
Sbjct: 45  SIPSG-----LTEA------VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIE 92

Query: 189 RGL-IGNGELSVIDMSSNRLSGGLAIDSSSECEF-----LTYLKLSDNFLTESIPKEI-G 241
                  G L  +D+S N LS    + SS    F     LT+L L  N         +  
Sbjct: 93  EDSFSSLGSLEHLDLSYNYLS---NLSSSW---FKPLSSLTFLNLLGNPYKTLGETSLFS 146

Query: 242 KCRNLKNLLLDGNILEGSIPKEI-GTISELKVLDVSRNSLTDRIPVE-LADCSKLSVLVL 299
               L+ L +        I ++    ++ L+ L++  + L      + L     +S L+L
Sbjct: 147 HLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLIL 205

Query: 300 TNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVL 359
                 L L+         D     E L  R  ++     + L     ++  +  + + +
Sbjct: 206 HMKQHILLLEI------FVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNV 259

Query: 360 NLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEG 392
            +   SL   V K L     L  L+ S N L+ 
Sbjct: 260 KITDESLF-QVMKLLNQISGLLELEFSRNQLKS 291

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 70.9 bits (174), Expect = 4e-13
 Identities = 37/235 (15%), Positives = 79/235 (33%), Gaps = 50/235 (21%)

Query: 484 RLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQ 543
            L L+NN     +    + +C +LQ+  + L++N ++ +  ++F      L   + + N 
Sbjct: 56  SLDLSNNRIT-YISNSDLQRCVNLQA--LVLTSNGINTIEEDSFS-SLGSLEHLDLSYNY 111

Query: 544 ISGSIAAGV-GKLMKLQRLDLRGNRVSGSLPDE--------------------------- 575
           +S ++++     L  L  L+L GN    +L +                            
Sbjct: 112 LS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKD 169

Query: 576 LGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPA-SLTKATKLESLF 634
              L FL+ + +  ++L    P     + ++  L L        +    +   + +E L 
Sbjct: 170 FAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLE 228

Query: 635 LAHNRLSG----EIPV----SFSTLVNLSALDLSFNNLS------GHIPHLQHLD 675
           L    L      E+      S         + ++  +L         I  L  L+
Sbjct: 229 LRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELE 283

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 69.0 bits (169), Expect = 2e-12
 Identities = 30/192 (15%), Positives = 61/192 (31%), Gaps = 17/192 (8%)

Query: 484 RLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQ 543
            L L  N +         S    LQ   V  + +  + +  + F      L E E   + 
Sbjct: 128 FLNLLGNPYKTLGETSLFSHLTKLQILRV-GNMDTFTKIQRKDFA-GLTFLEELEIDASD 185

Query: 544 ISGSIAAGV-GKLMKLQRLDLRGNRVSGSLPDEL-GKLKFLKWILLGGNNLTG----EIP 597
           +  S        +  +  L L   +    L +        ++ + L   +L      E+ 
Sbjct: 186 LQ-SYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELS 243

Query: 598 S----QFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVS-FSTLV 652
           +          +   + ++  +L   +   L + + L  L  + N+L   +P   F  L 
Sbjct: 244 TGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLT 301

Query: 653 NLSALDLSFNNL 664
           +L  + L  N  
Sbjct: 302 SLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 64.4 bits (157), Expect = 5e-11
 Identities = 44/297 (14%), Positives = 97/297 (32%), Gaps = 51/297 (17%)

Query: 355 SLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQL--PVPCMVYFNVSQNN 412
           ++K L+L  N +       L  C NL  L L+ N +   +       +  + + ++S N 
Sbjct: 53  AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNY 111

Query: 413 ITGVLPR-FENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIG 471
           ++ +    F+ +S         L + N      +    +  + + S    L  L      
Sbjct: 112 LSNLSSSWFKPLS--------SLTFLN------LLGNPYKTLGETSLFSHLTKL------ 151

Query: 472 DGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDC 531
                        L + N      +  +  +    L+   + + A+ L     ++     
Sbjct: 152 -----------QILRVGNMDTFTKIQRKDFAGLTFLEE--LEIDASDLQSYEPKSLK-SI 197

Query: 532 VQLVEFEAANNQISGSIAAGV-GKLMKLQRLDLRGNRVSG----SLP----DELGKLKFL 582
             +        Q    +          ++ L+LR   +       L     + L K    
Sbjct: 198 QNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTF 256

Query: 583 KWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPAS-LTKATKLESLFLAHN 638
           + + +   +L  ++      +  L+ L+ S N L  S+P     + T L+ ++L  N
Sbjct: 257 RNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 60.5 bits (147), Expect = 1e-09
 Identities = 27/111 (24%), Positives = 41/111 (36%), Gaps = 9/111 (8%)

Query: 587 LGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPA-SLTKATKLESLFLAHNRLSGEIP 645
           L  N +T    S     ++L  L L+ N +  +I   S +    LE L L++N LS  + 
Sbjct: 59  LSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLS 116

Query: 646 VS-FSTLVNLSALDLSFNNLS-----GHIPHLQHLDCIAFKGNKYLASCPD 690
            S F  L +L+ L+L  N            HL  L  +             
Sbjct: 117 SSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQR 167

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 31/95 (32%), Positives = 47/95 (49%), Gaps = 12/95 (12%)

Query: 589 GNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPV-S 647
             +L   IPS  G   ++  LDLS+N +T    + L +   L++L L  N ++  I   S
Sbjct: 40  SGSLN-SIPS--GLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDS 95

Query: 648 FSTLVNLSALDLSFNNLSG-------HIPHLQHLD 675
           FS+L +L  LDLS+N LS         +  L  L+
Sbjct: 96  FSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLN 130

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 68.9 bits (169), Expect = 3e-13
 Identities = 26/127 (20%), Positives = 45/127 (35%), Gaps = 14/127 (11%)

Query: 559 QRLDLRGNRVSGSLPD-ELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALT 617
             L L  N  +         KL  L+ I    N +T      F     +  + L+ N L 
Sbjct: 35  AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE 94

Query: 618 GSIPASL-TKATKLESLFLAHNRLSGEIPV-SFSTLVNLSALDLSFNNLSGHIPH----- 670
            ++   +      L++L L  NR++  +   SF  L ++  L L  N ++  +       
Sbjct: 95  -NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDT 151

Query: 671 ---LQHL 674
              L  L
Sbjct: 152 LHSLSTL 158

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 68.5 bits (168), Expect = 5e-13
 Identities = 33/130 (25%), Positives = 60/130 (46%), Gaps = 14/130 (10%)

Query: 541 NNQISGSIAAGV-GKLMKLQRLDLRGNRVSGSLP----DELGKLKFLKWILLGGNNLTGE 595
           NN+ +   A G+  KL +L++++   N+++  +     +    +  +   LL  N L   
Sbjct: 41  NNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEI---LLTSNRLE-N 95

Query: 596 IPSQ-FGHLISLVVLDLSHNALTGSIPA-SLTKATKLESLFLAHNRLSGEIPVSFSTLVN 653
           +  + F  L SL  L L  N +T  +   S    + +  L L  N+++   P +F TL +
Sbjct: 96  VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHS 154

Query: 654 LSALDLSFNN 663
           LS L+L   N
Sbjct: 155 LSTLNL-LAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 50.8 bits (122), Expect = 5e-07
 Identities = 34/135 (25%), Positives = 57/135 (42%), Gaps = 7/135 (5%)

Query: 484 RLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQ 543
            L LNNN F          K   L+   +N S N ++ +   AF      + E    +N+
Sbjct: 36  ELRLNNNEFTVLEATGIFKKLPQLRK--INFSNNKITDIEEGAFE-GASGVNEILLTSNR 92

Query: 544 ISGSIAAGV-GKLMKLQRLDLRGNRVSGSLPDEL-GKLKFLKWILLGGNNLTGEIPSQFG 601
           +  ++   +   L  L+ L LR NR++  + ++    L  ++ + L  N +T   P  F 
Sbjct: 93  LE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFD 150

Query: 602 HLISLVVLDLSHNAL 616
            L SL  L+L  N  
Sbjct: 151 TLHSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 14/78 (17%), Positives = 32/78 (41%), Gaps = 12/78 (15%)

Query: 608 VLDLSHNALTGSIP--ASLTKATKLESLFLAHNRLSGEIPV-SFSTLVNLSALDLSFNNL 664
            L L++N  T  +       K  +L  +  ++N+++ +I   +F     ++ + L+ N L
Sbjct: 36  ELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRL 93

Query: 665 SG-------HIPHLQHLD 675
                     +  L+ L 
Sbjct: 94  ENVQHKMFKGLESLKTLM 111

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 73.0 bits (178), Expect = 4e-13
 Identities = 95/599 (15%), Positives = 189/599 (31%), Gaps = 171/599 (28%)

Query: 35  MLSGGANA-----ESVPTTDSASLLSFKASISRDPSNLLATWNSSTDHCTWHGVT--CDH 87
           +LS          E V   +   L+S   +  R PS +   +    D   ++       +
Sbjct: 71  LLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDR-LYNDNQVFAKY 129

Query: 88  FTGR---VTALRITGKATPWPSKSSVISG-------TLSASIAKLTELRTLSVPHNSFSG 137
              R      LR        P+K+ +I G        ++  +       +  V       
Sbjct: 130 NVSRLQPYLKLR-QALLELRPAKNVLIDGVLGSGKTWVALDV-----CLSYKV-QCKMDF 182

Query: 138 EIP-AGVGELR----LLEVLE----------LQGNNFSGKIPYQMSNL-ERLR------- 174
           +I    +        +LE+L+             ++ S  I  ++ ++   LR       
Sbjct: 183 KIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKP 242

Query: 175 ------VL-NLS----FNSFSGEVPRGLIGNGELSVID---------MSSNRLSGGLAID 214
                 VL N+     +N+F+    + L+      V D         +S +  S  L  D
Sbjct: 243 YENCLLVLLNVQNAKAWNAFNLSC-KILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPD 301

Query: 215 SSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLD 274
                  L YL        + +P+E+          L  N      P+ +  I+E     
Sbjct: 302 EVKSL-LLKYLDCR----PQDLPREV----------LTTN------PRRLSIIAESIRDG 340

Query: 275 VSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAF-----DGGVPYELLLS 329
           ++       +     +C KL+ ++ ++++  L+    R  F           +P  LL  
Sbjct: 341 LATWDNWKHV-----NCDKLTTIIESSLNV-LEPAEYRKMFDRLSVFPPSAHIPTILL-- 392

Query: 330 RSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNN 389
               ++W            +  +S  + V+N            SL   +      +S+ +
Sbjct: 393 ---SLIWF-----------DVIKSDVMVVVNKLHK-------YSLVEKQPKEST-ISIPS 430

Query: 390 LEGYLPMQLPVPCMVYFN---VSQNNI-------TGVLPRFENVSCDNHFGF---QDLQY 436
           +  YL +++ +      +   V   NI         + P  +     +H G         
Sbjct: 431 I--YLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFY-SHIGHHLKNIEHP 487

Query: 437 ANVPVMGSI-SDENFV---IIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMF 492
             + +   +  D  F+   I HD +     GS+ L  +        YKP+  +  N+  +
Sbjct: 488 ERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSI-LNTLQQ---LKFYKPY--ICDNDPKY 541

Query: 493 NGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQL-------VEFEAANNQI 544
                 ER+   N +  F   +  NL+          D +++         FE A+ Q+
Sbjct: 542 ------ERL--VNAILDFLPKIEENLICSKY-----TDLLRIALMAEDEAIFEEAHKQV 587

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 62.6 bits (151), Expect = 6e-10
 Identities = 97/662 (14%), Positives = 195/662 (29%), Gaps = 205/662 (30%)

Query: 186 EVPRGLIGNGELSVIDMSSNRLSG-----GLAIDSSSEC--EFL-TYLKLSDNFLTESIP 237
           ++P+ ++   E+  I MS + +SG        +    E   +F+   L+++  FL   I 
Sbjct: 40  DMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIK 99

Query: 238 KE-IGKCRNLKNLLLDGNILEGSIPKEI-GTISELKVLDVSRNSLTDRIPVE------LA 289
            E        +  +   + L           +S L+     R +L +  P +      + 
Sbjct: 100 TEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVL 159

Query: 290 DCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDN 349
              K + + L   D  L                 Y++      ++ W             
Sbjct: 160 GSGK-TWVAL---DVCLS----------------YKVQCKMDFKIFW------------- 186

Query: 350 WSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTY-LDLSLNNLEGYLPMQLPVPCMVYFNV 408
                    LNL   +    V   L M + L Y +D +  +   +    + +        
Sbjct: 187 ---------LNLKNCNSPETV---LEMLQKLLYQIDPNWTSRSDH-SSNIKLRI------ 227

Query: 409 SQNNITGVLPRFENVSCDNHFGFQDLQYANV-PVMGSISDENFVIIHDFSGN-KFLGSLP 466
             ++I   L R            +   Y N   V+ ++ +      + F+ + K L +  
Sbjct: 228 --HSIQAELRRL----------LKSKPYENCLLVLLNVQNAK--AWNAFNLSCKILLTTR 273

Query: 467 LFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEA 526
              + D FL+A    H  L  ++       P E             +L    L     + 
Sbjct: 274 FKQVTD-FLSAATTTHISLDHHSMTLT---PDE-----------VKSLLLKYL-DCRPQ- 316

Query: 527 FLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWIL 586
                  L   E      +    + + + ++                D L       W  
Sbjct: 317 ------DLPR-EVL--TTNPRRLSIIAESIR----------------DGLATWDN--WKH 349

Query: 587 LGGNNLTGEIPSQFGHL---------ISLVVLDLSHNALTGSIPASLTKATKLESLFLAH 637
           +  + LT  I S    L           L V   S +     IP  L     L  ++   
Sbjct: 350 VNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAH-----IPTIL-----LSLIWF-- 397

Query: 638 NRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPHLQ-------------HLDCIAFKGNKY 684
           + +  ++ V  + L   S ++      +  IP +              H   +    + Y
Sbjct: 398 DVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIV----DHY 453

Query: 685 -LASCPDTNATAPEKPPVQLD-----------EKLQNGKRSKVFIIAVVTSASAVLLIFL 732
            +    D++    +  P  LD           + +++ +R  +F            ++FL
Sbjct: 454 NIPKTFDSD----DLIPPYLDQYFYSHIGHHLKNIEHPERMTLF-----------RMVFL 498

Query: 733 VIIFVILRRRKFGRIASLRGQVMVTFAD--------TPAELTYDNVVRATGNFSIR---N 781
              F+  + R      +  G ++ T              +  Y+ +V A  +F  +   N
Sbjct: 499 DFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEEN 558

Query: 782 LI 783
           LI
Sbjct: 559 LI 560

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 45.6 bits (107), Expect = 9e-05
 Identities = 88/574 (15%), Positives = 161/574 (28%), Gaps = 175/574 (30%)

Query: 573  PDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLV--VLDLSHNALTGSIPASLTKATKL 630
             D +     L W LL       E+  +F      V  VL +++  L   I     + + +
Sbjct: 58   KDAVSGTLRLFWTLLSKQE---EMVQKF------VEEVLRINYKFLMSPIKTEQRQPSMM 108

Query: 631  ESLFL-AHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPHLQHLDCIAFKGNKYLASCP 689
              +++   +RL  +  V F+   N+S L   +  L   +  L+    +   G   +    
Sbjct: 109  TRMYIEQRDRLYNDNQV-FAKY-NVSRLQP-YLKLRQALLELRPAKNVLIDG---VLGSG 162

Query: 690  DTNATAPEKPPVQLDEKLQNGKRSKVFIIAV--VTSASAVLLIFLVIIFVI---LRRRKF 744
             T         V L  K+Q     K+F + +    S   VL +   +++ I      R  
Sbjct: 163  KTWVAL----DVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSD 218

Query: 745  G------RIASLRGQVMVTFADTPAE---LTYDNV-----VRA----------TGNFSIR 780
                   RI S++ ++       P E   L   NV       A          T    + 
Sbjct: 219  HSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVT 278

Query: 781  NLIGTG------------GFGSTYKAELVPGYL-VAVKKLS-------------IGRFQG 814
            + +                        L+  YL    + L              I     
Sbjct: 279  DFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAES-- 336

Query: 815  IQQFDAEIGTLGRIRHKNLVTLI-------------GYYVGEAEMFLVYNFLSGGN---- 857
            I+   A       +    L T+I               +    +   V  F    +    
Sbjct: 337  IRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMF----DRLSV--FPPSAHIPTI 390

Query: 858  -LETF---------------IHKKS-----GKKIQWSVIHKIAIDI---AQALAYLHYSC 893
             L                  +HK S      K+   S I  I +++    +    LH S 
Sbjct: 391  LLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTIS-IPSIYLELKVKLENEYALHRSI 449

Query: 894  VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCR 953
            V          S+ L+   L+ Y                         G+    +     
Sbjct: 450  VDHYNIPKTFDSDDLIPPYLDQYFYSH--------------------IGH----HLKNIE 485

Query: 954  VSDKADVYSFGVVLLEL--ISGK-RSLDPSFSEYGNGFNIVS----WAKLLIK-----EG 1001
              ++  +  F +V L+   +  K R    +++  G+  N +     +   +       E 
Sbjct: 486  HPERMTL--FRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYER 543

Query: 1002 RSSEL--FLPELWEAGPQENLLGMMRLASTCTVE 1033
              + +  FLP       +ENL+       T  + 
Sbjct: 544  LVNAILDFLP-----KIEENLI---CSKYTDLLR 569

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 69.7 bits (171), Expect = 5e-13
 Identities = 38/165 (23%), Positives = 67/165 (40%), Gaps = 16/165 (9%)

Query: 501 ISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQR 560
             + + +Q+F  N   + +  ++    +     L E   ++NQIS  ++  +  L KL+ 
Sbjct: 37  QKELSGVQNF--NGDNSNIQSLA---GMQFFTNLKELHLSHNQIS-DLS-PLKDLTKLEE 89

Query: 561 LDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSI 620
           L +  NR+          L  L    L  N L         HL +L +L + +N L  SI
Sbjct: 90  LSVNRNRLKNLNGIPSACLSRLF---LDNNELRD--TDSLIHLKNLEILSIRNNKLK-SI 143

Query: 621 PASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLS 665
              L   +KLE L L  N ++       + L  ++ +DL+     
Sbjct: 144 V-MLGFLSKLEVLDLHGNEIT-NTG-GLTRLKKVNWIDLTGQKCV 185

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 61.2 bits (149), Expect = 3e-10
 Identities = 30/134 (22%), Positives = 49/134 (36%), Gaps = 12/134 (8%)

Query: 541 NNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQF 600
              I+  +      L    + +L    V+  +     +L  ++      +N+   +    
Sbjct: 6   PTPIN-QVF-PDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAG-M 59

Query: 601 GHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLS 660
               +L  L LSHN ++  +   L   TKLE L +  NRL     ++      LS L L 
Sbjct: 60  QFFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKN---LNGIPSACLSRLFLD 114

Query: 661 FNNLSGHIPHLQHL 674
            N L      L HL
Sbjct: 115 NNELR-DTDSLIHL 127

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 36/190 (18%), Positives = 74/190 (38%), Gaps = 20/190 (10%)

Query: 118 SIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLN 177
           S  +L+ ++  +  +++    +  G+     L+ L L  N  S  +   + +L +L  L+
Sbjct: 36  SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQIS-DLS-PLKDLTKLEELS 91

Query: 178 LSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIP 237
           ++ N          I +  LS + + +N L      DS    + L  L + +N L  SI 
Sbjct: 92  VNRNRLKNLNG---IPSACLSRLFLDNNELRD---TDSLIHLKNLEILSIRNNKLK-SIV 144

Query: 238 KEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVL 297
             +G    L+ L L GN +  +    +  + ++  +D++     +              L
Sbjct: 145 -MLGFLSKLEVLDLHGNEIT-NT-GGLTRLKKVNWIDLTGQKCVN------EPVKYQPEL 195

Query: 298 VLTNIDASLD 307
            +TN     D
Sbjct: 196 YITNTVKDPD 205

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 58.1 bits (141), Expect = 3e-09
 Identities = 39/164 (23%), Positives = 63/164 (38%), Gaps = 14/164 (8%)

Query: 501 ISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQR 560
           +    +L+   ++LS N +S +S    L D  +L E     N++  ++         L R
Sbjct: 59  MQFFTNLKE--LHLSHNQISDLS---PLKDLTKLEELSVNRNRLK-NLNGI--PSACLSR 110

Query: 561 LDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSI 620
           L L  N +     D L  LK L+ + +  N L   I    G L  L VLDL  N +T + 
Sbjct: 111 LFLDNNELRD--TDSLIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEIT-NT 165

Query: 621 PASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNL 664
              LT+  K+  + L   +   E       L   + +       
Sbjct: 166 G-GLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW 208

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 48.5 bits (116), Expect = 4e-06
 Identities = 26/136 (19%), Positives = 45/136 (33%), Gaps = 16/136 (11%)

Query: 168 SNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKL 227
             L      NL   S +  V         +   +  ++ +    ++        L  L L
Sbjct: 16  PGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ---SLAGMQFFTNLKELHL 70

Query: 228 SDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISE--LKVLDVSRNSLTDRIP 285
           S N +++  P  +     L+ L ++ N L     K +  I    L  L +  N L D   
Sbjct: 71  SHNQISDLSP--LKDLTKLEELSVNRNRL-----KNLNGIPSACLSRLFLDNNELRDTDS 123

Query: 286 VELADCSKLSVLVLTN 301
             L     L +L + N
Sbjct: 124 --LIHLKNLEILSIRN 137

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 46.2 bits (110), Expect = 3e-05
 Identities = 37/195 (18%), Positives = 73/195 (37%), Gaps = 32/195 (16%)

Query: 222 LTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLT 281
                L    +T+ +     +   ++N   D + ++ S+   +   + LK L +S N ++
Sbjct: 21  AVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSHNQIS 76

Query: 282 DRIPVELADCSKLSVLVLTN--IDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPR 339
           D  P  L D +KL  L +    +    +L+                 + S  L  L+   
Sbjct: 77  DLSP--LKDLTKLEELSVNRNRLK---NLNG----------------IPSACLSRLFLDN 115

Query: 340 ANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLP 399
             L  R  D+     +L++L++  N LK  V   LG    L  LDL  N +     +   
Sbjct: 116 NEL--RDTDSLIHLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEITNTGGLT-R 170

Query: 400 VPCMVYFNVSQNNIT 414
           +  + + +++     
Sbjct: 171 LKKVNWIDLTGQKCV 185

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 42.7 bits (101), Expect = 3e-04
 Identities = 13/80 (16%), Positives = 30/80 (37%), Gaps = 9/80 (11%)

Query: 602 HLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSF 661
            L + V  +L   ++T  +     + + +++    ++ +   +        NL  L LS 
Sbjct: 17  GLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSH 72

Query: 662 NNLS-----GHIPHLQHLDC 676
           N +S       +  L+ L  
Sbjct: 73  NQISDLSPLKDLTKLEELSV 92

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 70.3 bits (172), Expect = 9e-13
 Identities = 57/272 (20%), Positives = 94/272 (34%), Gaps = 70/272 (25%)

Query: 774 TGNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIR--- 829
            G + +   +G G F + + +  +     VA+K +        +    EI  L  +R   
Sbjct: 36  NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSD 94

Query: 830 -----HKNLVTLIGY--YVGEAE--MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI 880
                 + +V L+      G     + +V+  L G +L  +I K + + +    + KI  
Sbjct: 95  PNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQ 153

Query: 881 DIAQALAYLHYSCVPRIVHRDIKPSNILL------------------------------- 909
            + Q L YLH  C  RI+H DIKP NILL                               
Sbjct: 154 QVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211

Query: 910 ------------------DEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT 951
                              E+L   ++D G A    V +    T+   T  Y + E    
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW--VHKHF--TEDIQTRQYRSLEVLIG 267

Query: 952 CRVSDKADVYSFGVVLLELISGKRSLDPSFSE 983
              +  AD++S   +  EL +G    +P   E
Sbjct: 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGE 299

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 69.4 bits (170), Expect = 2e-12
 Identities = 29/184 (15%), Positives = 62/184 (33%), Gaps = 34/184 (18%)

Query: 775 GNFSIRNLIGTGGFGSTYKAE---------LVPGYLVAVK-----------KLSIGRFQG 814
             + +++       G  Y+A                 ++K           +    R   
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101

Query: 815 IQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLS----GGNLETFIHKKSGKKI 870
             Q +     L       + T +G+ V + +    Y FL     G +L++ +       +
Sbjct: 102 PLQVNKWK-KLYSTPLLAIPTCMGFGVHQDK----YRFLVLPSLGRSLQSALDVSPKHVL 156

Query: 871 QWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILL--DEELNAYLSDFGLARLLEV 928
               + ++A  +  AL +LH +     VH ++   NI +  +++    L+ +G A     
Sbjct: 157 SERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP 213

Query: 929 SETH 932
           S  H
Sbjct: 214 SGKH 217

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 67.4 bits (165), Expect = 4e-12
 Identities = 49/213 (23%), Positives = 80/213 (37%), Gaps = 22/213 (10%)

Query: 775 GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNL 833
             + +   IG+G FG  Y    +  G  VA+K   +       Q   E      ++    
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVG 66

Query: 834 VTLIGYYVGEAEMF--LVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
           +  I  + G    +  +V   L G +LE  +     +K     +  +A  +   + Y+H 
Sbjct: 67  IPTI-RWCGAEGDYNVMVMELL-GPSLED-LFNFCSRKFSLKTVLLLADQMISRIEYIHS 123

Query: 892 SCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETH------ATTDVAGTFG 942
                 +HRD+KP N L+         Y+ DFGLA+    + TH         ++ GT  
Sbjct: 124 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 180

Query: 943 YVAPEYATTCRV-SDKADVYSFGVVLLELISGK 974
           Y A          S + D+ S G VL+    G 
Sbjct: 181 Y-ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 67.0 bits (164), Expect = 4e-12
 Identities = 32/154 (20%), Positives = 61/154 (39%), Gaps = 15/154 (9%)

Query: 528 LLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILL 587
                + ++       ++ ++     +L  + ++    + +  S+   +  L  +  + L
Sbjct: 20  DDAFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFL 75

Query: 588 GGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVS 647
            GN LT +I     +L +L  L L  N +   +  SL    KL+SL L HN +S +I   
Sbjct: 76  NGNKLT-DI-KPLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS-DIN-G 129

Query: 648 FSTLVNLSALDLSFNNLS-----GHIPHLQHLDC 676
              L  L +L L  N ++       +  L  L  
Sbjct: 130 LVHLPQLESLYLGNNKITDITVLSRLTKLDTLSL 163

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 61.6 bits (150), Expect = 3e-10
 Identities = 32/183 (17%), Positives = 70/183 (38%), Gaps = 15/183 (8%)

Query: 119 IAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNL 178
                E    ++   S +  +     EL  ++ +    ++    +   +  L  +  L L
Sbjct: 20  DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFL 75

Query: 179 SFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPK 238
           + N  +   P  L     L  + +  N++     + S  + + L  L L  N +++    
Sbjct: 76  NGNKLTDIKP--LANLKNLGWLFLDENKVK---DLSSLKDLKKLKSLSLEHNGISDING- 129

Query: 239 EIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLV 298
            +     L++L L  N +  +    +  +++L  L +  N ++D I   LA  +KL  L 
Sbjct: 130 -LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQNLY 184

Query: 299 LTN 301
           L+ 
Sbjct: 185 LSK 187

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 60.8 bits (148), Expect = 5e-10
 Identities = 40/188 (21%), Positives = 80/188 (42%), Gaps = 15/188 (7%)

Query: 119 IAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNL 178
           I  L  +  L +  N  + +I   +  L+ L  L L  N     +   + +L++L+ L+L
Sbjct: 64  IQYLPNVTKLFLNGNKLT-DIK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSL 119

Query: 179 SFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPK 238
             N  S ++  GL+   +L  + + +N+++    I   S    L  L L DN ++  I  
Sbjct: 120 EHNGIS-DIN-GLVHLPQLESLYLGNNKITD---ITVLSRLTKLDTLSLEDNQIS-DIV- 172

Query: 239 EIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLV 298
            +     L+NL L  N +   + + +  +  L VL++      ++     ++    +   
Sbjct: 173 PLAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPN--T 228

Query: 299 LTNIDASL 306
           + N D SL
Sbjct: 229 VKNTDGSL 236

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 57.8 bits (140), Expect = 5e-09
 Identities = 38/169 (22%), Positives = 68/169 (40%), Gaps = 14/169 (8%)

Query: 119 IAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNL 178
           +A L  L  L +  N    ++   + +L+ L+ L L+ N  S  I   + +L +L  L L
Sbjct: 86  LANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYL 141

Query: 179 SFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPK 238
             N  +      L    +L  + +  N++S    I   +    L  L LS N +++   +
Sbjct: 142 GNNKITD--ITVLSRLTKLDTLSLEDNQIS---DIVPLAGLTKLQNLYLSKNHISD--LR 194

Query: 239 EIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVE 287
            +   +NL  L L        + K I   S L V +  +N+    +  E
Sbjct: 195 ALAGLKNLDVLELFSQEC---LNKPINHQSNLVVPNTVKNTDGSLVTPE 240

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 56.2 bits (136), Expect = 2e-08
 Identities = 32/167 (19%), Positives = 63/167 (37%), Gaps = 13/167 (7%)

Query: 499 ERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKL 558
             +     L+S   +L  N +S ++    L+   QL      NN+I+  I   + +L KL
Sbjct: 106 SSLKDLKKLKSL--SLEHNGISDIN---GLVHLPQLESLYLGNNKIT-DIT-VLSRLTKL 158

Query: 559 QRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTG 618
             L L  N++S  +   L  L  L+ + L  N+++ ++      L +L VL+L       
Sbjct: 159 DTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLN 214

Query: 619 SIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLS 665
                 +      ++      L    P   S   +    ++ ++   
Sbjct: 215 KPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLPE 259

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 54.3 bits (131), Expect = 8e-08
 Identities = 55/309 (17%), Positives = 109/309 (35%), Gaps = 54/309 (17%)

Query: 356 LKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNITG 415
               NL + S+  AV        ++  +  + ++++    +Q  +P +    ++ N +T 
Sbjct: 26  TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQ-YLPNVTKLFLNGNKLT- 81

Query: 416 VLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFL 475
                + ++       ++L +  +       DEN   + D S  K L  L          
Sbjct: 82  ---DIKPLA-----NLKNLGWLFL-------DEN--KVKDLSSLKDLKKL---------- 114

Query: 476 AAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLV 535
                    L L +N  +  + G  +     L+  S+ L  N ++ ++    L    +L 
Sbjct: 115 -------KSLSLEHNGIS-DING--LVHLPQLE--SLYLGNNKITDIT---VLSRLTKLD 159

Query: 536 EFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGE 595
                +NQIS  I   +  L KLQ L L  N +S  L   L  LK L  + L       +
Sbjct: 160 TLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNK 215

Query: 596 IPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHN--RLSGEIPVSFSTLVN 653
             +   +L+    +  +  +L    P  ++     E   +  +    + E+   F   V 
Sbjct: 216 PINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVT 273

Query: 654 LSALDLSFN 662
           +      F+
Sbjct: 274 IGKAKARFH 282

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 51.2 bits (123), Expect = 7e-07
 Identities = 38/156 (24%), Positives = 66/156 (42%), Gaps = 10/156 (6%)

Query: 118 SIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLN 177
           S+  L +L++LS+ HN  S +I  G+  L  LE L L  N  +  I   +S L +L  L+
Sbjct: 107 SLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKIT-DIT-VLSRLTKLDTLS 162

Query: 178 LSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIP 237
           L  N  S ++   L G  +L  + +S N +S    + + +  + L  L+L          
Sbjct: 163 LEDNQIS-DIV-PLAGLTKLQNLYLSKNHISD---LRALAGLKNLDVLELFSQECLNKPI 217

Query: 238 KEIGKCRNLKNL-LLDGNILEGSIPKEIGTISELKV 272
                      +   DG+++   I  + G   +  V
Sbjct: 218 NHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNV 253

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 49.3 bits (118), Expect = 3e-06
 Identities = 40/223 (17%), Positives = 78/223 (34%), Gaps = 31/223 (13%)

Query: 168 SNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKL 227
                    NL   S +  V +  + +  +  I  +++ +    ++        +T L L
Sbjct: 21  DAFAETIKDNLKKKSVTDAVTQNELNS--IDQIIANNSDIK---SVQGIQYLPNVTKLFL 75

Query: 228 SDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVE 287
           + N LT+  P  +   +NL  L LD N ++  +   +  + +LK L +  N ++D     
Sbjct: 76  NGNKLTDIKP--LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGISDING-- 129

Query: 288 LADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLP 347
           L    +L  L L N        N   + +               L+ L      +     
Sbjct: 130 LVHLPQLESLYLGN--------NKITDITVLSR--------LTKLDTLSLEDNQI--SDI 171

Query: 348 DNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNL 390
              +    L+ L L +N +     ++L   +NL  L+L     
Sbjct: 172 VPLAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQEC 212

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 47.4 bits (113), Expect = 1e-05
 Identities = 39/221 (17%), Positives = 73/221 (33%), Gaps = 56/221 (25%)

Query: 196 ELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNI 255
           E    ++    ++      + +E   +  +  +++ +  S+ + I    N+  L L+GN 
Sbjct: 25  ETIKDNLKKKSVTD---AVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNK 79

Query: 256 LEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTN--IDASLDLDNSRG 313
           L   I K +  +  L  L +  N + D     L D  KL  L L +  I           
Sbjct: 80  LT-DI-KPLANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGI----------- 124

Query: 314 EFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKS 373
                             +  L     +L             L+ L LG N +       
Sbjct: 125 ----------------SDINGL----VHL-----------PQLESLYLGNNKITD--ITV 151

Query: 374 LGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNIT 414
           L     L  L L  N +   +P+   +  +    +S+N+I+
Sbjct: 152 LSRLTKLDTLSLEDNQISDIVPLA-GLTKLQNLYLSKNHIS 191

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 67.8 bits (166), Expect = 4e-12
 Identities = 40/180 (22%), Positives = 66/180 (36%), Gaps = 29/180 (16%)

Query: 775 GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNL 833
             + +   IG+GGFG  Y A         A   + +   Q      +E+    R+  K+ 
Sbjct: 37  NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEY-QENGPLFSELKFYQRVAKKDC 95

Query: 834 VTLIG-------------YYVGEAEM------FLVYNFLSGGNLETFIHKKSGKKIQWSV 874
           +                 Y  G  E       F+V   L G +L+           + S 
Sbjct: 96  IKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKIS--GQNGTFKKST 152

Query: 875 IHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLD--EELNAYLSDFGLARLLEVSETH 932
           + ++ I +   L Y+H +     VH DIK +N+LL        YL+D+GL+     +  H
Sbjct: 153 VLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 67.0 bits (164), Expect = 8e-12
 Identities = 54/238 (22%), Positives = 87/238 (36%), Gaps = 52/238 (21%)

Query: 774 TGNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKL-SIGRFQGIQQFDAEIGTLGRIRH- 830
              F +   +G G FG     + +      AVK + +I ++   +    E   L +I++ 
Sbjct: 34  NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYT--RSAKIEADILKKIQND 91

Query: 831 ----KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKK-IQWSVIHKIAIDIAQA 885
                N+V   G ++    M L++  L G +L   I  ++         I    I+I +A
Sbjct: 92  DINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEII-TRNNYNGFHIEDIKLYCIEILKA 149

Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGT----- 940
           L YL       + H D+KP NILLD+    +       R +   +         T     
Sbjct: 150 LNYLR-KM--SLTHTDLKPENILLDD--PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204

Query: 941 -FG-----------------YVAPE------YATTCRVSDKADVYSFGVVLLELISGK 974
            FG                 Y APE      +  +       D++SFG VL EL +G 
Sbjct: 205 DFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSS------DMWSFGCVLAELYTGS 256

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 66.2 bits (162), Expect = 9e-12
 Identities = 41/173 (23%), Positives = 69/173 (39%), Gaps = 18/173 (10%)

Query: 768 DNVVRATGNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLG 826
           +NVV    ++ +   IG G FG  ++   L+    VA+K           Q   E  T  
Sbjct: 5   NNVVG--VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYK 60

Query: 827 RIRHKNLVTLIGYYVGEAEMF--LVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQ 884
            +     +  + YY G+  +   LV + L G +LE  +    G+K     +   A  +  
Sbjct: 61  LLAGCTGIPNV-YYFGQEGLHNVLVIDLL-GPSLED-LLDLCGRKFSVKTVAMAAKQMLA 117

Query: 885 ALAYLHYSCVPRIVHRDIKPSNILLDEELNA-----YLSDFGLARLLEVSETH 932
            +  +H      +V+RDIKP N L+    +      Y+ DFG+ +      T 
Sbjct: 118 RVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 167

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 66.3 bits (162), Expect = 1e-11
 Identities = 38/180 (21%), Positives = 65/180 (36%), Gaps = 26/180 (14%)

Query: 775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQ--QFDAEIGTLGRIRHKN 832
             + +   IG GGFG  Y A++     V      + + +         E+    R     
Sbjct: 35  AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94

Query: 833 LVTLIG-------------YYVG-EAEMFLVYNFLS----GGNLETFIHKKSGKKIQWSV 874
            +                 +  G   +    Y F+     G +L+  I++ + K+     
Sbjct: 95  QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQK-IYEANAKRFSRKT 153

Query: 875 IHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLD--EELNAYLSDFGLARLLEVSETH 932
           + ++++ I   L Y+H       VH DIK SN+LL+       YL D+GLA        H
Sbjct: 154 VLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 66.5 bits (162), Expect = 1e-11
 Identities = 32/127 (25%), Positives = 53/127 (41%), Gaps = 12/127 (9%)

Query: 851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLD 910
             LS    E          +    +   +  +A+ + +L      + +HRD+   NILL 
Sbjct: 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS 227

Query: 911 EELNAYLSDFGLARLLEVSETHATTDVAGTFGYV-----APEYATTCRVSDKADVYSFGV 965
           E+    + DFGLAR +     +    V      +     APE       + ++DV+SFGV
Sbjct: 228 EKNVVKICDFGLARDIYKDPDY----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 283

Query: 966 VLLELIS 972
           +L E+ S
Sbjct: 284 LLWEIFS 290

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 66.0 bits (161), Expect = 2e-11
 Identities = 20/128 (15%), Positives = 43/128 (33%), Gaps = 12/128 (9%)

Query: 558 LQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQ-FGHLISLVVLDLSH-NA 615
              L     ++             L+ I +  N++   I +  F +L  L  + +   N 
Sbjct: 32  AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 91

Query: 616 LTGSIPAS-LTKATKLESLFLAHNRLSGEIP-VSFSTLVNLSALDLSFNNLSGHIPHLQH 673
           L   I          L+ L +++  +   +P V     +    LD+  N       ++  
Sbjct: 92  LL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNI------NIHT 143

Query: 674 LDCIAFKG 681
           ++  +F G
Sbjct: 144 IERNSFVG 151

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 63.7 bits (155), Expect = 9e-11
 Identities = 33/162 (20%), Positives = 57/162 (35%), Gaps = 17/162 (10%)

Query: 541 NNQISGSIAAGV-GKLMKLQRLDLRGNRVSGSLP----DELGKLKFLKWILLGGNNLTGE 595
             ++   I  G       L+++++  N V   +       L KL  +   +   NNL   
Sbjct: 39  LTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEI--RIEKANNLLYI 95

Query: 596 IPSQFGHLISLVVLDLSHNALTGSIPA-SLTKATKLESLFLAHNRLSGEIPV-SFSTL-V 652
            P  F +L +L  L +S+  +   +P      + +   L +  N     I   SF  L  
Sbjct: 96  NPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSF 154

Query: 653 NLSALDLSFNNLSGHIP----HLQHLDCIAFKGNKYLASCPD 690
               L L+ N +   I     +   LD +    N  L   P+
Sbjct: 155 ESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPN 195

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 62.9 bits (153), Expect = 1e-10
 Identities = 41/198 (20%), Positives = 73/198 (36%), Gaps = 11/198 (5%)

Query: 120 AKLTELRTLSVPHNSFSGEIPAGV-GELRLLEVLELQGNNFSGKIPYQM-SNLERLRVLN 177
           +   +L  + +  N     I A V   L  L  + ++  N    I  +   NL  L+ L 
Sbjct: 51  SGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL 110

Query: 178 LSFNSFSGEVPRGL-IGNGELSVIDMSSNRLSGGLAIDSSSECEF-LTYLKLSDNFLTES 235
           +S       +P    I + +  ++D+  N     +  +S     F    L L+ N +   
Sbjct: 111 ISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-E 168

Query: 236 IPKEI-GKCRNLKNLLLDGNILEGSIPKEI-GTISELKVLDVSRNSLTDRIPVE-LADCS 292
           I        +  +  L D N LE  +P ++    S   +LD+SR  +   +P   L +  
Sbjct: 169 IHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLK 226

Query: 293 KLSVLVLTNIDASLDLDN 310
           KL      N+     L+ 
Sbjct: 227 KLRARSTYNLKKLPTLEK 244

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 62.2 bits (151), Expect = 3e-10
 Identities = 33/202 (16%), Positives = 62/202 (30%), Gaps = 17/202 (8%)

Query: 484 RLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQ 543
           ++ ++ N     +  +  S    L    +   AN L  ++ EAF  +   L     +N  
Sbjct: 58  KIEISQNDVLEVIEADVFSNLPKLHEIRI-EKANNLLYINPEAFQ-NLPNLQYLLISNTG 115

Query: 544 ISGSIAAGV-GKLMKLQRLDLRGNRVSGSLPDEL--GKLKFLKWILLGGNNLTGEIPSQ- 599
           I   +        ++   LD++ N    ++      G       + L  N +  EI +  
Sbjct: 116 IK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSA 173

Query: 600 FGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPV-SFSTLVNLSALD 658
           F       +    +N L          A+    L ++  R+   +P      L  L A  
Sbjct: 174 FNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARS 232

Query: 659 LSFNNLSG-----HIPHLQHLD 675
               NL        +  L    
Sbjct: 233 T--YNLKKLPTLEKLVALMEAS 252

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 49.8 bits (119), Expect = 2e-06
 Identities = 52/315 (16%), Positives = 95/315 (30%), Gaps = 96/315 (30%)

Query: 355 SLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQ----LPVPCMVYFNVSQ 410
           +   L      L+     +     +L  +++S N++   +       LP    +    + 
Sbjct: 31  NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA- 89

Query: 411 NNITGVLPR-FENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFA 469
           NN+  + P  F+N+         +LQY        IS+     + D      + SL    
Sbjct: 90  NNLLYINPEAFQNLP--------NLQYL------LISNTGIKHLPDVH---KIHSLQKV- 131

Query: 470 IGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLL 529
                          L + +N               ++ +   N    L           
Sbjct: 132 --------------LLDIQDN--------------INIHTIERNSFVGL----------- 152

Query: 530 DCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGG 589
              + V      N I   I        +L  L+L  N                       
Sbjct: 153 -SFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDN----------------------- 187

Query: 590 NNLTGEIPSQ-FGHLISLVVLDLSHNALTGSIPA-SLTKATKLESLFLAHNRLSGEIPVS 647
           NNL  E+P+  F      V+LD+S   +  S+P+  L    KL +    + +   ++P +
Sbjct: 188 NNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK---KLP-T 241

Query: 648 FSTLVNLSALDLSFN 662
              LV L    L++ 
Sbjct: 242 LEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 49.1 bits (117), Expect = 4e-06
 Identities = 21/99 (21%), Positives = 38/99 (38%), Gaps = 12/99 (12%)

Query: 585 ILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPA-SLTKATKLESLFLAHNRLSGE 643
            L   + +T EIPS      + + L      L   I   + +    LE + ++ N +   
Sbjct: 14  FLCQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEV 69

Query: 644 IPVS-FSTLVNLSALDLSFNNLSGHIPHLQHLDCIAFKG 681
           I    FS L  L  + +   N      +L +++  AF+ 
Sbjct: 70  IEADVFSNLPKLHEIRIEKAN------NLLYINPEAFQN 102

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 47.1 bits (112), Expect = 2e-05
 Identities = 39/245 (15%), Positives = 73/245 (29%), Gaps = 44/245 (17%)

Query: 150 EVLELQGNNFSGKIPYQMSNL-ERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLS 208
            V   Q +  + +IP   S+L      L                G G+L  I++S N + 
Sbjct: 12  RVFLCQESKVT-EIP---SDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVL 67

Query: 209 GGLAIDSSSECEFLTYLKLSDNFLTESIPKEI-GKCRNLKNLLLDGNILEGSIPKEIGTI 267
             +  D  S    L  +++        I  E      NL+ LL+    ++  +P      
Sbjct: 68  EVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIH 126

Query: 268 S-ELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYEL 326
           S +  +LD+  N     I                               ++F G      
Sbjct: 127 SLQKVLLDIQDNINIHTIER-----------------------------NSFVG------ 151

Query: 327 LLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLS 386
            LS    +LW  +  +       ++ +   ++     N+L+               LD+S
Sbjct: 152 -LSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDIS 210

Query: 387 LNNLE 391
              + 
Sbjct: 211 RTRIH 215

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 64.7 bits (158), Expect = 3e-11
 Identities = 37/165 (22%), Positives = 63/165 (38%), Gaps = 14/165 (8%)

Query: 775 GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNL 833
            NF +   IG G FG     + L     VA+K           Q   E     ++   + 
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEP--MKSRAPQLHLEYRFYKQLGSGDG 66

Query: 834 VTLIGYYVGEAEM-FLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
           +  + Y+    +   +V   L G +LE  +     +      +  IAI +   + Y+H  
Sbjct: 67  IPQVYYFGPCGKYNAMVLELL-GPSLED-LFDLCDRTFSLKTVLMIAIQLISRMEYVHSK 124

Query: 893 CVPRIVHRDIKPSNILLDEELNA-----YLSDFGLARLLEVSETH 932
               +++RD+KP N L+    N      ++ DF LA+     ET 
Sbjct: 125 N---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 65.8 bits (160), Expect = 3e-11
 Identities = 50/215 (23%), Positives = 84/215 (39%), Gaps = 26/215 (12%)

Query: 775 GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNL 833
             F +   IG+G FG  Y    +     VA+K  ++       Q   E      ++    
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLLYESKIYRILQGGTG 64

Query: 834 VTLIGYYVGEAEMFLVYNF----LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
           +  + ++  E +    YN     L G +LE  +     +K+    +  +A  +   + ++
Sbjct: 65  IPNVRWFGVEGD----YNVLVMDLLGPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFV 119

Query: 890 HYSCVPRIVHRDIKPSNILLDEELNA---YLSDFGLARLLEVSETH------ATTDVAGT 940
           H       +HRDIKP N L+     A   Y+ DFGLA+    + TH         ++ GT
Sbjct: 120 HSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 176

Query: 941 FGYVAPEYATTCRV-SDKADVYSFGVVLLELISGK 974
             Y A          S + D+ S G VL+  + G 
Sbjct: 177 ARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 64.7 bits (158), Expect = 5e-11
 Identities = 52/235 (22%), Positives = 87/235 (37%), Gaps = 50/235 (21%)

Query: 774 TGNFSIRNLIGTGGFGSTYKA--ELVPGYLVAVKKL-SIGRFQGIQQFDAEIGTLGRIRH 830
              + I   +G G FG   +          VA+K + ++G+++  +    EI  L +I+ 
Sbjct: 18  QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYR--EAARLEINVLKKIKE 75

Query: 831 K------NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQ 884
           K        V +  ++     M + +  L G N   F+ + + +      +  +A  +  
Sbjct: 76  KDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCH 134

Query: 885 ALAYLHYSCVPRIVHRDIKPSNILLDEELNAY-------------------LSDFGLARL 925
           AL +LH +   ++ H D+KP NIL                           ++DFG A  
Sbjct: 135 ALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA-- 189

Query: 926 LEVSETHATTDVAGTFGYVAPE------YATTCRVSDKADVYSFGVVLLELISGK 974
               E H T     T  Y  PE      +A  C      DV+S G +L E   G 
Sbjct: 190 TFDHEHHTTIVA--TRHYRPPEVILELGWAQPC------DVWSIGCILFEYYRGF 236

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 62.7 bits (153), Expect = 2e-10
 Identities = 54/235 (22%), Positives = 91/235 (38%), Gaps = 50/235 (21%)

Query: 774 TGNFSIRNLIGTGGFGSTYKA--ELVPGYLVAVKKL-SIGRFQGIQQFDAEIGTLGRIRH 830
           +  + I + +G G FG   +       G  VAVK + ++ R+   +   +EI  L  +  
Sbjct: 13  SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYC--EAARSEIQVLEHLNT 70

Query: 831 K------NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQ 884
                    V ++ ++     + +V+  L G +   FI +      +   I K+A  I +
Sbjct: 71  TDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICK 129

Query: 885 ALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLS-------------------DFGLARL 925
           ++ +LH S   ++ H D+KP NIL  +                          DFG A  
Sbjct: 130 SVNFLH-SN--KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA-- 184

Query: 926 LEVSETHATTDVAGTFGYVAPE------YATTCRVSDKADVYSFGVVLLELISGK 974
               E H+T     T  Y APE      ++  C      DV+S G +L+E   G 
Sbjct: 185 TYDDEHHSTLVS--TRHYRAPEVILALGWSQPC------DVWSIGCILIEYYLGF 231

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 60.5 bits (147), Expect = 4e-10
 Identities = 51/156 (32%), Positives = 71/156 (45%), Gaps = 14/156 (8%)

Query: 514 LSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGV-GKLMKLQRLDLRGNRVSGSL 572
           L +  L+ +S   F     +L       NQ+  +++AGV   L +L  L L  N+++ SL
Sbjct: 42  LQSTGLATLSDATFR-GLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA-SL 98

Query: 573 P----DELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASL-TKA 627
           P    D L +L  L    LGGN L       F  L  L  L L+ N L  SIPA    K 
Sbjct: 99  PLGVFDHLTQLDKLY---LGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKL 154

Query: 628 TKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNN 663
           T L++L L+ N+L      +F  L  L  + L F N
Sbjct: 155 TNLQTLSLSTNQLQSVPHGAFDRLGKLQTITL-FGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 37/127 (29%), Positives = 53/127 (41%), Gaps = 13/127 (10%)

Query: 559 QRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTG 618
           ++LDL+   ++         L  L W+ L  N L       F  L  L  L L++N L  
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA- 96

Query: 619 SIPASL-TKATKLESLFLAHNRLSGEIPVS-FSTLVNLSALDLSFNNLSGHIPH------ 670
           S+P  +    T+L+ L+L  N+L   +P   F  L  L  L L+ N L   IP       
Sbjct: 97  SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKL 154

Query: 671 --LQHLD 675
             LQ L 
Sbjct: 155 TNLQTLS 161

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 51.6 bits (124), Expect = 4e-07
 Identities = 52/162 (32%), Positives = 75/162 (46%), Gaps = 18/162 (11%)

Query: 484 RLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQ 543
           +L L +     ++          L    +NL  N L  +S   F  D  +L     ANNQ
Sbjct: 39  KLDLQSTGLA-TLSDATFRGLTKLTW--LNLDYNQLQTLSAGVFD-DLTELGTLGLANNQ 94

Query: 544 ISGSIAAGV-GKLMKLQRLDLRGNRVSGSLP----DELGKLKFLKWILLGGNNLTGEIPS 598
           ++ S+  GV   L +L +L L GN++  SLP    D L KLK L+   L  N L   IP+
Sbjct: 95  LA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELR---LNTNQLQ-SIPA 148

Query: 599 -QFGHLISLVVLDLSHNALTGSIPA-SLTKATKLESLFLAHN 638
             F  L +L  L LS N L  S+P  +  +  KL+++ L  N
Sbjct: 149 GAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 47.8 bits (114), Expect = 7e-06
 Identities = 48/179 (26%), Positives = 74/179 (41%), Gaps = 24/179 (13%)

Query: 129 SVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVP 188
           SVP       IPA        E L+LQ    +         L +L  LNL +N     + 
Sbjct: 28  SVPSG-----IPADT------EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LS 75

Query: 189 RGLIGN-GELSVIDMSSNRLSG--GLAIDSSSECEFLTYLKLSDNFLTESIPKEI-GKCR 244
            G+  +  EL  + +++N+L+       D  ++   L  L L  N L  S+P  +  +  
Sbjct: 76  AGVFDDLTELGTLGLANNQLASLPLGVFDHLTQ---LDKLYLGGNQLK-SLPSGVFDRLT 131

Query: 245 NLKNLLLDGNILEGSIPKEI-GTISELKVLDVSRNSLTDRIPVELAD-CSKLSVLVLTN 301
            LK L L+ N L+ SIP      ++ L+ L +S N L   +P    D   KL  + L  
Sbjct: 132 KLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFG 188

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 60.8 bits (148), Expect = 4e-10
 Identities = 50/181 (27%), Positives = 70/181 (38%), Gaps = 42/181 (23%)

Query: 532 VQLVEFEAANNQISGSIAAGV-GKLMKLQRLDLRGNRVSGSLP----DELGKLKFLKWIL 586
             +       N++          +L  L  L L GN++  SLP    D+L  LK L    
Sbjct: 63  PNVRYLALGGNKLH---DISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELV--- 115

Query: 587 LGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASL-TKATKLESLFLAHNRLSGEIP 645
           L  N L       F  L +L  L+L+HN L  S+P  +  K T L  L L++N+L   +P
Sbjct: 116 LVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLP 173

Query: 646 VS-FSTLVNLSALDLSFNNLSGHIPH--------LQHL-------DCIAFKGNKYLASCP 689
              F  L  L  L L  N L   +P         LQ++       DC          +CP
Sbjct: 174 EGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDNPWDC----------TCP 222

Query: 690 D 690
            
Sbjct: 223 G 223

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 50/176 (28%), Positives = 71/176 (40%), Gaps = 22/176 (12%)

Query: 511 SVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSG 570
             NL    ++         +   + +  A N+ I      G+  L  ++ L L GN++  
Sbjct: 23  KANLKKKSVT--DAVTQN-ELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLH- 76

Query: 571 SLP--DELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASL-TKA 627
            +    EL  L +L    L GN L       F  L +L  L L  N L  S+P  +  K 
Sbjct: 77  DISALKELTNLTYLI---LTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKL 132

Query: 628 TKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPH--------LQHLD 675
           T L  L LAHN+L       F  L NL+ LDLS+N L   +P         L+ L 
Sbjct: 133 TNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQS-LPEGVFDKLTQLKDLR 187

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 58.5 bits (142), Expect = 6e-10
 Identities = 27/138 (19%), Positives = 53/138 (38%), Gaps = 14/138 (10%)

Query: 549 AAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVV 608
           AA     ++ + LDLRG ++   + +    L     I    N +  ++   F  L  L  
Sbjct: 12  AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKT 68

Query: 609 LDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSF-STLVNLSALDLSFNNLS-- 665
           L +++N +             L  L L +N L     +   ++L +L+ L +  N ++  
Sbjct: 69  LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK 128

Query: 666 --------GHIPHLQHLD 675
                     +P ++ LD
Sbjct: 129 KHYRLYVIYKVPQVRVLD 146

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 57.4 bits (139), Expect = 1e-09
 Identities = 28/148 (18%), Positives = 54/148 (36%), Gaps = 8/148 (5%)

Query: 141 AGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVI 200
           A          L+L+G      I    + L++   ++ S N        G      L  +
Sbjct: 13  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTL 69

Query: 201 DMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTE-SIPKEIGKCRNLKNLLLDGNI---L 256
            +++NR+   +          LT L L++N L E      +   ++L  L +  N     
Sbjct: 70  LVNNNRIC-RIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK 128

Query: 257 EGSIPKEIGTISELKVLDVSRNSLTDRI 284
           +      I  + +++VLD  +  L +R 
Sbjct: 129 KHYRLYVIYKVPQVRVLDFQKVKLKERQ 156

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 55.4 bits (134), Expect = 8e-09
 Identities = 20/114 (17%), Positives = 41/114 (35%), Gaps = 8/114 (7%)

Query: 574 DELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESL 633
            +       + + L G  +   I +    L     +D S N +   +        +L++L
Sbjct: 13  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTL 69

Query: 634 FLAHNRLSGEIPVSFSTLVNLSALDLSFNNLS-----GHIPHLQHLDCIAFKGN 682
            + +NR+          L +L+ L L+ N+L        +  L+ L  +    N
Sbjct: 70  LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 24/122 (19%), Positives = 47/122 (38%), Gaps = 8/122 (6%)

Query: 499 ERISKCNDLQSFSV-NLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMK 557
           E+ ++  +       +L    +  +  E       Q    + ++N+I   +  G   L +
Sbjct: 10  EQAAQYTNAVRDRELDLRGYKIPVI--ENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRR 65

Query: 558 LQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLT--GEIPSQFGHLISLVVLDLSHNA 615
           L+ L +  NR+          L  L  ++L  N+L   G++      L SL  L +  N 
Sbjct: 66  LKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRNP 124

Query: 616 LT 617
           +T
Sbjct: 125 VT 126

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 28/137 (20%), Positives = 42/137 (30%), Gaps = 29/137 (21%)

Query: 166 QMSNLERLRVLNLSFNSFSGEVPRGLIGN-GELSVIDMSSNRLSGGLAIDSSSECEFLTY 224
           Q +N  R R L+L        V   L     +   ID S N +     +D       L  
Sbjct: 14  QYTNAVRDRELDLRGYKI--PVIENLGATLDQFDAIDFSDNEIR---KLDGFPLLRRLKT 68

Query: 225 LKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRI 284
           L +++N +            +L  L+L  N            + EL  LD          
Sbjct: 69  LLVNNNRICRIGEGLDQALPDLTELILTNNS-----------LVELGDLD---------- 107

Query: 285 PVELADCSKLSVLVLTN 301
              LA    L+ L +  
Sbjct: 108 --PLASLKSLTYLCILR 122

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 59.3 bits (144), Expect = 9e-10
 Identities = 45/148 (30%), Positives = 61/148 (41%), Gaps = 29/148 (19%)

Query: 559 QRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTG 618
           Q L L  N+++   P     L  LK + LG N L       F  L  L VLDL  N LT 
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT- 101

Query: 619 SIPASL-TKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPH------- 670
            +P+++  +   L+ LF+  N+L+ E+P     L +L+ L L  N L   IPH       
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKS-IPHGAFDRLS 159

Query: 671 -LQHL-------DCIAFKGNKYLASCPD 690
            L H        DC           C D
Sbjct: 160 SLTHAYLFGNPWDC----------ECRD 177

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 46/172 (26%), Positives = 66/172 (38%), Gaps = 28/172 (16%)

Query: 541 NNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLP----DELGKLKFLKWILLGGNNLTGEI 596
           +NQI+         L+ L+ L L  N++  +LP    D L +L  L    LG N LT   
Sbjct: 49  DNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLD---LGTNQLTVLP 104

Query: 597 PSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSA 656
            + F  L+ L  L +  N LT  +P  + + T L  L L  N+L      +F  L +L+ 
Sbjct: 105 SAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTH 163

Query: 657 LDLSFNN-----------LSGHIPHLQHLDCIAFKGNKYL-----ASCPDTN 692
             L F N           L   +    H         K +     A C  TN
Sbjct: 164 AYL-FGNPWDCECRDIMYLRNWVA--DHTSIAMRWDGKAVNDPDSAKCAGTN 212

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 57.4 bits (139), Expect = 9e-10
 Identities = 31/132 (23%), Positives = 53/132 (40%), Gaps = 14/132 (10%)

Query: 557 KLQRLDLRGNRVS-GSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNA 615
            ++ L L  +R + G L     + + L+++      LT  I +    L  L  L+LS N 
Sbjct: 18  DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNR 75

Query: 616 LTGSIPASLTKATKLESLFLAHNRLSG-EIPVSFSTLVNLSALDLSFNNLS--------- 665
           ++G +     K   L  L L+ N++           L NL +LDL    ++         
Sbjct: 76  VSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENV 135

Query: 666 -GHIPHLQHLDC 676
              +P L +LD 
Sbjct: 136 FKLLPQLTYLDG 147

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 51.2 bits (123), Expect = 1e-07
 Identities = 28/137 (20%), Positives = 53/137 (38%), Gaps = 8/137 (5%)

Query: 121 KLTELRTLSVPHNSFS-GEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLS 179
             ++++ L + ++  + G++     E   LE L       +  I   +  L +L+ L LS
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELS 72

Query: 180 FNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESI--- 236
            N  SG +         L+ +++S N++     I+   + E L  L L +  +T      
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYR 132

Query: 237 PKEIGKCRNLKNLLLDG 253
                    L    LDG
Sbjct: 133 ENVFKLLPQLT--YLDG 147

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 49.3 bits (118), Expect = 5e-07
 Identities = 30/106 (28%), Positives = 45/106 (42%), Gaps = 3/106 (2%)

Query: 513 NLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSL 572
            L  +  +    E    +  +L      N  ++ SIA  + KL KL++L+L  NRVSG L
Sbjct: 23  VLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELSDNRVSGGL 80

Query: 573 PDELGKLKFLKWILLGGNNLTG-EIPSQFGHLISLVVLDLSHNALT 617
                K   L  + L GN +           L +L  LDL +  +T
Sbjct: 81  EVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 43.1 bits (102), Expect = 7e-05
 Identities = 30/116 (25%), Positives = 54/116 (46%), Gaps = 6/116 (5%)

Query: 168 SNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKL 227
           S+++ L + N   N   G++        EL  +   +  L+   +I +  +   L  L+L
Sbjct: 17  SDVKELVLDNSRSNE--GKLEGLTDEFEELEFLSTINVGLT---SIANLPKLNKLKKLEL 71

Query: 228 SDNFLTESIPKEIGKCRNLKNLLLDGN-ILEGSIPKEIGTISELKVLDVSRNSLTD 282
           SDN ++  +     KC NL +L L GN I + S  + +  +  LK LD+    +T+
Sbjct: 72  SDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTN 127

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 60.1 bits (146), Expect = 2e-09
 Identities = 37/254 (14%), Positives = 82/254 (32%), Gaps = 56/254 (22%)

Query: 167 MSNLERLRVLNLSFNSFSGE----VPRGLIGNGELSVIDMSSNRLS--GGLAI-DSSSEC 219
           M+    +   +L  ++ + E    V   L+ +  +  I +S N +       + ++ +  
Sbjct: 1   MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59

Query: 220 EFLTYLKLSDNFL----------TESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTI-- 267
           + L   + SD F              + + + KC  L  + L  N    +  + +     
Sbjct: 60  KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLS 119

Query: 268 --SELKVLDVSRNSLTD----RIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGG 321
             + L+ L +  N L      +I   L + +            S+    +R E    +G 
Sbjct: 120 KHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLE----NGS 175

Query: 322 VPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSL-----KGAVPKSLGM 376
           +      +++ +                      L  + + QN +     +  + + L  
Sbjct: 176 MKE---WAKTFQS------------------HRLLHTVKMVQNGIRPEGIEHLLLEGLAY 214

Query: 377 CRNLTYLDLSLNNL 390
           C+ L  LDL  N  
Sbjct: 215 CQELKVLDLQDNTF 228

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 55.5 bits (134), Expect = 5e-08
 Identities = 52/325 (16%), Positives = 102/325 (31%), Gaps = 82/325 (25%)

Query: 115 LSASIAKLTELRTLSVPHNSFSGE----IPAGVGELRLLEVLELQGNNFSGKIPYQ---- 166
           + A + +   ++ + +  N+   E    +   +   + LE+ E   + F+G++  +    
Sbjct: 24  VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF-SDIFTGRVKDEIPEA 82

Query: 167 -------MSNLERLRVLNLSFNSFSGE----VPRGLIGNGELSVIDMSSNRLS--GGLAI 213
                  +    +L  + LS N+F       +   L  +  L  + + +N L    G  I
Sbjct: 83  LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 142

Query: 214 ----------DSSSECEFLTYLKLSDNFLTE----SIPKEIGKCRNLKNLLLDGNIL--- 256
                       +     L  +    N L         K     R L  + +  N +   
Sbjct: 143 ARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 202

Query: 257 --EGSIPKEIGTISELKVLDVSRNSLTDR----IPVELADCSKLSVLVLTNIDASLDLDN 310
             E  + + +    ELKVLD+  N+ T      + + L     L  L L         D 
Sbjct: 203 GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLN--------DC 254

Query: 311 SRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAV 370
                     G      +  +   L                E+  L+ L L  N ++   
Sbjct: 255 LLS-----ARGA---AAVVDAFSKL----------------ENIGLQTLRLQYNEIELDA 290

Query: 371 PKSLGM-----CRNLTYLDLSLNNL 390
            ++L         +L +L+L+ N  
Sbjct: 291 VRTLKTVIDEKMPDLLFLELNGNRF 315

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 47.8 bits (114), Expect = 1e-05
 Identities = 52/330 (15%), Positives = 99/330 (30%), Gaps = 61/330 (18%)

Query: 355 SLKVLNLGQNSL--KGAVP--KSLGMCRNLTYLDLSLNNL--EG--YLPMQLPV-PCMVY 405
           S++  +L  +++  +        L    ++  + LS N +  E   +L   +     +  
Sbjct: 5   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64

Query: 406 FNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIH-DFSGNKFLGS 464
              S      V               +D     + ++     +   +     S N F G 
Sbjct: 65  AEFSDIFTGRV---------------KDEIPEALRLLLQALLKCPKLHTVRLSDNAF-GP 108

Query: 465 LPLFAIGDGFLAAKYKPHYRLLLNNNMFN---GSVPGERISKCNDLQSFSVN-------L 514
                + D    +K+ P   L L+NN      G+     + +    +             
Sbjct: 109 TAQEPLIDFL--SKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIIC 166

Query: 515 SANLLSGMSYEAF---LLDCVQLVEFEAANNQI-----SGSIAAGVGKLMKLQRLDLRGN 566
             N L   S + +         L   +   N I        +  G+    +L+ LDL+ N
Sbjct: 167 GRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDN 226

Query: 567 RVSG----SLPDELGKLKFLKWILLGGNNLTGE----IPS--QFGHLISLVVLDLSHNAL 616
             +     +L   L     L+ + L    L+      +         I L  L L +N +
Sbjct: 227 TFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEI 286

Query: 617 TG----SIPASL-TKATKLESLFLAHNRLS 641
                 ++   +  K   L  L L  NR S
Sbjct: 287 ELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 47.4 bits (113), Expect = 2e-05
 Identities = 42/242 (17%), Positives = 76/242 (31%), Gaps = 42/242 (17%)

Query: 115 LSASIAKLTELRTLSVPHNSFSGEIPAGVGEL----------------RLLEVLELQGNN 158
           L   ++K T L  L + +N      P    ++                  L  +    N 
Sbjct: 114 LIDFLSKHTPLEHLYLHNNGLG---PQAGAKIARALQELAVNKKAKNAPPLRSIICGRNR 170

Query: 159 FSGK----IPYQMSNLERLRVLNLSFNSFSGE-----VPRGLIGNGELSVIDMSSNRLS- 208
                         +   L  + +  N    E     +  GL    EL V+D+  N  + 
Sbjct: 171 LENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTH 230

Query: 209 -GGLAI-DSSSECEFLTYLKLSDNFLT----ESIPKEIGKCRN--LKNLLLDGNILEGSI 260
            G  A+  +      L  L L+D  L+     ++     K  N  L+ L L  N +E   
Sbjct: 231 LGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDA 290

Query: 261 PKEIGT-----ISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEF 315
            + + T     + +L  L+++ N  ++   V        S      +D   D++    E 
Sbjct: 291 VRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDMEELTDEE 350

Query: 316 SA 317
             
Sbjct: 351 EE 352

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 45.1 bits (107), Expect = 8e-05
 Identities = 29/159 (18%), Positives = 51/159 (32%), Gaps = 35/159 (22%)

Query: 541 NNQISGSIAAGVGKLMK----LQRLDLRGNRVSG----SLPDELGKLKFLKWILLGGN-- 590
            + I+      V  ++     ++ + L GN +       L + +   K L+         
Sbjct: 13  LDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFT 72

Query: 591 -NLTGEIPSQFGHLI-------SLVVLDLSHNALTG----SIPASLTKATKLESLFLAHN 638
             +  EIP     L+        L  + LS NA        +   L+K T LE L+L +N
Sbjct: 73  GRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNN 132

Query: 639 RLSGE-------------IPVSFSTLVNLSALDLSFNNL 664
            L  +             +         L ++    N L
Sbjct: 133 GLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL 171

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 58.7 bits (141), Expect = 3e-09
 Identities = 35/248 (14%), Positives = 64/248 (25%), Gaps = 64/248 (25%)

Query: 756 VTFADTPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIG----- 810
           V F+            +          IG G FG  ++        VA+K ++I      
Sbjct: 11  VPFSHCLPTEKLQRCEK----------IGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLV 59

Query: 811 ---RFQGIQQFDAEIGTL---------GRIRHKNLVTLIGYYV----------------- 841
                +  ++   EI               R +  + L   +                  
Sbjct: 60  NGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYN 119

Query: 842 -------------GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
                         + ++F+V  F  GG     + +   K    +    I   +  +LA 
Sbjct: 120 STKGSANDRPDFFKDDQLFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAV 176

Query: 889 LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
              S   R  HRD+   N+LL +     L      +   +  +         +     E 
Sbjct: 177 AEASL--RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTI-PSCGLQVSIIDYTLSRLER 233

Query: 949 ATTCRVSD 956
                  D
Sbjct: 234 DGIVVFCD 241

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 56.6 bits (137), Expect = 4e-09
 Identities = 33/162 (20%), Positives = 66/162 (40%), Gaps = 24/162 (14%)

Query: 532 VQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNN 591
            + VE       I   + A +  L   + L L  N +   +   L  ++ L+ + LG N 
Sbjct: 25  AEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNL 81

Query: 592 LTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSF-ST 650
           +  +I +      +L  L +S+N +  S+ + + K   L  L++++N+++    +   + 
Sbjct: 82  IK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEIDKLAA 138

Query: 651 LVNLSALDLSFNNLSG-----------------HIPHLQHLD 675
           L  L  L L+ N L                    +P+L+ LD
Sbjct: 139 LDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 40/177 (22%), Positives = 67/177 (37%), Gaps = 40/177 (22%)

Query: 121 KLTELRTLSVPHNSFSG--EIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLE---RLRV 175
             TE   + + H       ++ A +  L+  + L L  NN       ++S+L     LR+
Sbjct: 21  VATEAEKVEL-HGMIPPIEKMDATLSTLKACKHLALSTNNIE-----KISSLSGMENLRI 74

Query: 176 LNLSFNSFSGEVPRGLIGNGE-----LSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDN 230
           L+L  N          I N +     L  + +S N+++   ++    +   L  L +S+N
Sbjct: 75  LSLGRNLIKK------IENLDAVADTLEELWISYNQIA---SLSGIEKLVNLRVLYMSNN 125

Query: 231 FLTESIPKEIGKCRNLKNL---LLDGNILEGSIPKE----------IGTISELKVLD 274
            +T     EI K   L  L   LL GN L     +           +  +  LK LD
Sbjct: 126 KITN--WGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 32/145 (22%), Positives = 61/145 (42%), Gaps = 15/145 (10%)

Query: 115 LSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLR 174
           + A+++ L   + L++  N+   +I + +  +  L +L L  N    KI    +  + L 
Sbjct: 40  MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96

Query: 175 VLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTE 234
            L +S+N        G+     L V+ MS+N+++    ID  +  + L  L L+ N L  
Sbjct: 97  ELWISYNQI--ASLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154

Query: 235 SIPKE----------IGKCRNLKNL 249
              +           + +  NLK L
Sbjct: 155 DYKENNATSEYRIEVVKRLPNLKKL 179

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 47.8 bits (114), Expect = 4e-06
 Identities = 33/148 (22%), Positives = 57/148 (38%), Gaps = 17/148 (11%)

Query: 145 ELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSS 204
           E   +E L         K+   +S L+  + L LS N+   E    L G   L ++ +  
Sbjct: 24  EAEKVE-LHGMIPPIE-KMDATLSTLKACKHLALSTNNI--EKISSLSGMENLRILSLGR 79

Query: 205 NRLS--GGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPK 262
           N +     L     +  + L  L +S N +  S+   I K  NL+ L +  N +      
Sbjct: 80  NLIKKIENL----DAVADTLEELWISYNQI-ASL-SGIEKLVNLRVLYMSNNKITN--WG 131

Query: 263 EIGTISE---LKVLDVSRNSLTDRIPVE 287
           EI  ++    L+ L ++ N L +     
Sbjct: 132 EIDKLAALDKLEDLLLAGNPLYNDYKEN 159

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 36/142 (25%), Positives = 60/142 (42%), Gaps = 30/142 (21%)

Query: 485 LLLNNNMFNGSVPGERISKCNDLQSFS----VNLSANLLSGMSYEAFLLDCVQLVEFEAA 540
           L L+ N          I K + L        ++L  NL+  +     + D   L E   +
Sbjct: 53  LALSTN---------NIEKISSLSGMENLRILSLGRNLIKKIENLDAVAD--TLEELWIS 101

Query: 541 NNQISGSIAAGVGKLMKLQRLDLRGNRVS--GSLPDELGKLKFLKWILLGGNNLTGEIPS 598
            NQI+ S++ G+ KL+ L+ L +  N+++  G + D+L  L  L+ +LL GN L  +   
Sbjct: 102 YNQIA-SLS-GIEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGNPLYNDYKE 158

Query: 599 QFG----------HLISLVVLD 610
                         L +L  LD
Sbjct: 159 NNATSEYRIEVVKRLPNLKKLD 180

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 58.2 bits (140), Expect = 5e-09
 Identities = 21/88 (23%), Positives = 33/88 (37%), Gaps = 4/88 (4%)

Query: 555 LMKLQRLDLRGNRVSGSLPDE-LGKLKFLKWILLGGNNLTGEIPSQ-FGHLISLVVLDLS 612
              L  L +   +    L    L  L  L+ + +  + L   +    F     L  L+LS
Sbjct: 30  AENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLS 88

Query: 613 HNALTGSIPASLTKATKLESLFLAHNRL 640
            NAL  S+     +   L+ L L+ N L
Sbjct: 89  FNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 57.8 bits (139), Expect = 7e-09
 Identities = 22/99 (22%), Positives = 35/99 (35%), Gaps = 6/99 (6%)

Query: 595 EIPSQFGHLISLVVLDLSHNALTGSIPA-SLTKATKLESLFLAHNRLSGEIPVSFSTLVN 653
           +         +L  L + +      +    L    +L +L +  + L    P +F     
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81

Query: 654 LSALDLSFNNLS----GHIPHLQHLDCIAFKGNKYLASC 688
           LS L+LSFN L       +  L  L  +   GN    SC
Sbjct: 82  LSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPLHCSC 119

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 54.7 bits (131), Expect = 7e-08
 Identities = 20/113 (17%), Positives = 34/113 (30%), Gaps = 12/113 (10%)

Query: 566 NRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQ-FGHLISLVVLDLSHNALTGSIPA-S 623
              +      L   + L  + +        +  +    L  L  L +  + L   +   +
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDA 75

Query: 624 LTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPHLQHLDC 676
                +L  L L+ N L      +   L +L  L LS N L        H  C
Sbjct: 76  FHFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPL--------HCSC 119

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 51.3 bits (122), Expect = 1e-06
 Identities = 18/91 (19%), Positives = 29/91 (31%), Gaps = 2/91 (2%)

Query: 118 SIAKLTELRTLSVPHNSFSGEIPAGV-GELRLLEVLELQGNNFSGKIPYQMSNLERLRVL 176
            +     L  L + +      +       L  L  L +  +      P       RL  L
Sbjct: 26  HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL 85

Query: 177 NLSFNSFSGEVPRGLIGNGELSVIDMSSNRL 207
           NLSFN+    +    +    L  + +S N L
Sbjct: 86  NLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 47.0 bits (111), Expect = 2e-05
 Identities = 19/99 (19%), Positives = 31/99 (31%), Gaps = 7/99 (7%)

Query: 138 EIPAGVGELRLLEVLELQGNNFSGKIP-YQMSNLERLRVLNLSFNSFSGEVPRGLIGNGE 196
           +    +     L  L ++       +    +  L  LR L +  +      P        
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81

Query: 197 LSVIDMSSNRLSG--GLAIDSSSECEFLTYLKLSDNFLT 233
           LS +++S N L       +   S    L  L LS N L 
Sbjct: 82  LSRLNLSFNALESLSWKTVQGLS----LQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 45.1 bits (106), Expect = 8e-05
 Identities = 11/71 (15%), Positives = 19/71 (26%), Gaps = 8/71 (11%)

Query: 613 HNALTGSIPASLTKATKLESLFLAHNRLSGEIP-VSFSTLVNLSALDLSFNNLS------ 665
                      L  A  L  L++ + +    +       L  L  L +  + L       
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75

Query: 666 -GHIPHLQHLD 675
               P L  L+
Sbjct: 76  FHFTPRLSRLN 86

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 55.8 bits (135), Expect = 7e-09
 Identities = 44/149 (29%), Positives = 58/149 (38%), Gaps = 30/149 (20%)

Query: 559 QRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTG 618
             LDL  N +         +L  L  + LGGN L       F  L SL  L+LS N L  
Sbjct: 31  TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ- 89

Query: 619 SIPASL-TKATKLESLFLAHNRLSGEIPV-SFSTLVNLSALDLSFNNLSGHIPH------ 670
           S+P  +  K T+L+ L L  N+L   +P   F  L  L  L L  N L   +P       
Sbjct: 90  SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRL 147

Query: 671 --LQHL-------DCIAFKGNKYLASCPD 690
             LQ++       DC          +CP 
Sbjct: 148 TSLQYIWLHDNPWDC----------TCPG 166

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 55.4 bits (134), Expect = 9e-09
 Identities = 33/107 (30%), Positives = 47/107 (43%), Gaps = 6/107 (5%)

Query: 559 QRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTG 618
             L L GN+ +  +P EL   K L  I L  N ++      F ++  L+ L LS+N L  
Sbjct: 34  TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR- 91

Query: 619 SIPASLT-KATKLESLFLAHNRLSGEIPV-SFSTLVNLSALDLSFNN 663
            IP         L  L L  N +S  +P  +F+ L  LS L +   N
Sbjct: 92  CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAI-GAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 54.2 bits (131), Expect = 2e-08
 Identities = 31/107 (28%), Positives = 51/107 (47%), Gaps = 21/107 (19%)

Query: 587 LGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASL-TKATKLESLFLAHNRLSGEIP 645
           L GN  T  +P +  +   L ++DLS+N ++ ++     +  T+L +L L++NRL   IP
Sbjct: 38  LDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR-CIP 94

Query: 646 V-SFSTLVNLSALDLSFNNLSGHIPH--------LQHL-------DC 676
             +F  L +L  L L  N++S  +P         L HL        C
Sbjct: 95  PRTFDGLKSLRLLSLHGNDISV-VPEGAFNDLSALSHLAIGANPLYC 140

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 44.6 bits (106), Expect = 4e-05
 Identities = 24/76 (31%), Positives = 33/76 (43%), Gaps = 10/76 (13%)

Query: 608 VLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGH 667
            L L  N  T  +P  L+    L  + L++NR+S     SFS +  L  L LS+N L   
Sbjct: 35  ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRC- 92

Query: 668 IPH--------LQHLD 675
           IP         L+ L 
Sbjct: 93  IPPRTFDGLKSLRLLS 108

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 54.0 bits (130), Expect = 2e-08
 Identities = 29/132 (21%), Positives = 50/132 (37%), Gaps = 16/132 (12%)

Query: 557 KLQRLDLRGNRVSGSLPDELG-KLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNA 615
            ++ L L   + +    + L  +   L+++ L    L   + S    L  L  L+LS N 
Sbjct: 25  AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENR 82

Query: 616 LTGSIPASLTKATKLESLFLAHNRLS--GEIPVSFSTLVNLSALDLSFNNLS-------- 665
           + G +     K   L  L L+ N+L     +      L  L +LDL    ++        
Sbjct: 83  IFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNCEVTNLNDYRES 141

Query: 666 --GHIPHLQHLD 675
               +P L +LD
Sbjct: 142 VFKLLPQLTYLD 153

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 48.6 bits (116), Expect = 1e-06
 Identities = 28/107 (26%), Positives = 41/107 (38%), Gaps = 5/107 (4%)

Query: 513 NLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSL 572
            L     +    E    + V L      N  +     + + KL KL++L+L  NR+ G L
Sbjct: 30  VLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI--SVSNLPKLPKLKKLELSENRIFGGL 87

Query: 573 PDELGKLKFLKWILLGGNNLT--GEIPSQFGHLISLVVLDLSHNALT 617
                KL  L  + L GN L     +      L  L  LDL +  +T
Sbjct: 88  DMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNCEVT 133

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 44.7 bits (106), Expect = 3e-05
 Identities = 29/135 (21%), Positives = 49/135 (36%), Gaps = 7/135 (5%)

Query: 118 SIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLN 177
           + A + EL  L    ++  G+I     E   LE L L        +   +  L +L+ L 
Sbjct: 22  TPAAVREL-VLDNCKSN-DGKIEGLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLKKLE 77

Query: 178 LSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESI- 236
           LS N   G +         L+ +++S N+L     ++   + E L  L L +  +T    
Sbjct: 78  LSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLND 137

Query: 237 --PKEIGKCRNLKNL 249
                      L  L
Sbjct: 138 YRESVFKLLPQLTYL 152

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 53.5 bits (129), Expect = 4e-08
 Identities = 30/108 (27%), Positives = 50/108 (46%), Gaps = 6/108 (5%)

Query: 559 QRLDLRGNRVSGSLPDE--LGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNAL 616
             L L  N +   +  +   G+L  L  + L  N LTG  P+ F     +  L L  N +
Sbjct: 32  TELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKI 90

Query: 617 TGSIPASL-TKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNN 663
              I   +     +L++L L  N++S  +P SF  L +L++L+L  +N
Sbjct: 91  K-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNL-ASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 50.4 bits (121), Expect = 5e-07
 Identities = 32/109 (29%), Positives = 43/109 (39%), Gaps = 23/109 (21%)

Query: 587 LGGNNLTGEIPSQ--FGHLISLVVLDLSHNALTGSIPASL-TKATKLESLFLAHNRLSGE 643
           L  N L   I S   FG L  LV L+L  N LT  I  +    A+ ++ L L  N++  E
Sbjct: 36  LNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK-E 92

Query: 644 IPV-SFSTLVNLSALDLSFNNLSGHIPH--------LQHL-------DC 676
           I    F  L  L  L+L  N +S  +          L  L       +C
Sbjct: 93  ISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLASNPFNC 140

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 44.2 bits (105), Expect = 6e-05
 Identities = 29/107 (27%), Positives = 45/107 (42%), Gaps = 10/107 (9%)

Query: 513 NLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGV-GKLMKLQRLDLRGNRVSGS 571
            L+ N L  +S +        LV+ E   NQ++  I          +Q L L  N++   
Sbjct: 35  LLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK-E 92

Query: 572 LP----DELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHN 614
           +       L +LK L    L  N ++  +P  F HL SL  L+L+ N
Sbjct: 93  ISNKMFLGLHQLKTLN---LYDNQISCVMPGSFEHLNSLTSLNLASN 136

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 51.9 bits (123), Expect = 6e-07
 Identities = 26/159 (16%), Positives = 50/159 (31%), Gaps = 20/159 (12%)

Query: 501 ISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQR 560
           +     L +  +  + NL    S        ++ +E  +     S         L  L++
Sbjct: 168 LDAMPLLNNLKIKGTNNL----SIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEK 223

Query: 561 LDL---RGNRVSGSLPDEL------GKLKFLKWILLGGNNLTGEIPSQFGH---LISLVV 608
           L L     +       +         +   LKW+ +        +   F     L  L  
Sbjct: 224 LVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLET 283

Query: 609 LDLSHNALTGS----IPASLTKATKLESLFLAHNRLSGE 643
           +D+S   LT      +   + K   L+ + + +N LS E
Sbjct: 284 MDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 51.9 bits (123), Expect = 6e-07
 Identities = 26/160 (16%), Positives = 56/160 (35%), Gaps = 17/160 (10%)

Query: 115 LSASIAKLTELRTLSVPHNSFSGEIPAGVGELRL--LEVLEL--QGNNFSGKIP------ 164
           LS        L++L +        +   +    L  LE L L     ++           
Sbjct: 185 LSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRP 244

Query: 165 -YQMSNLERLRVLNLSFNSFSGEVPRGLIG---NGELSVIDMSSNRLS--GGLAI-DSSS 217
            +       L+ L +        V    +      +L  +D+S+  L+  G   + D   
Sbjct: 245 LFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVD 304

Query: 218 ECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILE 257
           + + L ++ +  N+L++ + KE+ K   +K  + D    +
Sbjct: 305 KIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVSDSQEYD 344

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 47.3 bits (111), Expect = 2e-05
 Identities = 25/168 (14%), Positives = 53/168 (31%), Gaps = 17/168 (10%)

Query: 146 LRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNG-----ELSVI 200
           L  + +L       +  +         L+ L +        V   ++G+      +L + 
Sbjct: 168 LDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227

Query: 201 DMSSNRLSGGLAID-----SSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNL---LLD 252
               +    G         S      L +L + D      + +   +   L  L    + 
Sbjct: 228 VGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDIS 287

Query: 253 GNIL--EG--SIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSV 296
             +L  EG   +   +  I  LK +++  N L+D +  EL     + +
Sbjct: 288 AGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKI 335

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 46.9 bits (110), Expect = 3e-05
 Identities = 24/217 (11%), Positives = 65/217 (29%), Gaps = 23/217 (10%)

Query: 467 LFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEA 526
           L  I  G    + +    +                    D+      +S      +S   
Sbjct: 109 LKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLS--P 166

Query: 527 FLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKF--LKW 584
            L     L   +        +++ G      L+ L++    +  S+ +++       L+ 
Sbjct: 167 VLDAMPLLNNLKIKGTN---NLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEK 223

Query: 585 --ILLGGNNLTGEIPSQF-------GHLISLVVLDLSHNALTGSIPASLTKA---TKLES 632
             + +G  +   +                +L  L +        +     ++    +LE+
Sbjct: 224 LVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLET 283

Query: 633 LFLAHNRLSGE----IPVSFSTLVNLSALDLSFNNLS 665
           + ++   L+ E    +      + +L  +++ +N LS
Sbjct: 284 MDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 43.4 bits (101), Expect = 3e-04
 Identities = 12/82 (14%), Positives = 30/82 (36%), Gaps = 7/82 (8%)

Query: 553 GKLMKLQRLDLRGNRVSGSLPDELGK---LKFLKWILLGGNNLTGE----IPSQFGHLIS 605
            +   L+ L +        + +   +   L  L+ + +    LT E    +      +  
Sbjct: 249 DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKH 308

Query: 606 LVVLDLSHNALTGSIPASLTKA 627
           L  +++ +N L+  +   L K+
Sbjct: 309 LKFINMKYNYLSDEMKKELQKS 330

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 42.2 bits (98), Expect = 6e-04
 Identities = 23/171 (13%), Positives = 47/171 (27%), Gaps = 32/171 (18%)

Query: 534 LVEFEAANNQIS----GSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGG 589
             + +    +IS      ++  +  +  L  L ++G             LK L+   +  
Sbjct: 146 WGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLE---IIS 202

Query: 590 NNLTGEIPSQFG--HLISLVVLDL---SHNALTGSIPASLTKA------TKLESLFLAHN 638
             L   +        L +L  L L     +                     L+ L +   
Sbjct: 203 GGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDA 262

Query: 639 RLSGEIP---VSFSTLVNLSALDLSFNNLS-----------GHIPHLQHLD 675
                +    +    L  L  +D+S   L+             I HL+ ++
Sbjct: 263 EEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFIN 313

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 52.3 bits (125), Expect = 6e-07
 Identities = 49/292 (16%), Positives = 93/292 (31%), Gaps = 27/292 (9%)

Query: 115 LSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLR 174
           L         L ++ V       E+         LE       N    +P +  NL   R
Sbjct: 212 LETIARNCRSLVSVKVGDFEIL-ELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPR 270

Query: 175 VLNLSFNSFSG--EVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFL 232
            L     S+ G  E+P       ++  +D+    L          +C  L  L+  +   
Sbjct: 271 KLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIG 330

Query: 233 TESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISE------------LKVLDVSRNSL 280
              +      C+ LK L ++    E  +  E G +S+            L+ + V  + +
Sbjct: 331 DRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDI 390

Query: 281 TDRIPVELAD-CSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLE--VLWA 337
           T+     +      L    L  +D    + +        D GV   L+  + L     + 
Sbjct: 391 TNESLESIGTYLKNLCDFRLVLLDREERITD-----LPLDNGVRSLLIGCKKLRRFAFYL 445

Query: 338 PRANLGGRLPDNWSESC-SLKVLNLG--QNSLKGAVPKSLGMCRNLTYLDLS 386
            +  L         +   +++ + LG    S +G + +    C NL  L++ 
Sbjct: 446 RQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEG-LMEFSRGCPNLQKLEMR 496

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 42.6 bits (100), Expect = 7e-04
 Identities = 49/301 (16%), Positives = 92/301 (30%), Gaps = 37/301 (12%)

Query: 115 LSASIAKLTELRTLSVPHNSFSGEIPAGVGEL----RLLEVLELQGNNFSG----KIPYQ 166
           L + +    +++TL +  +SFS +    + EL      LEVL      F+      +   
Sbjct: 156 LLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETI 215

Query: 167 MSNLERLRVLNLSFNSFS--GEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTY 224
             N   L  + +            +      E     ++ + +       +      L  
Sbjct: 216 ARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNED-IGMPEKYMNLVFPRKLCR 274

Query: 225 LKLSDNFLTESIPKEIGKCRNLKNL-LLDGNILEGSIPKEIGTISELKVLDVSRNSLTDR 283
           L LS       +P        ++ L LL   +        I     L+VL+  RN + DR
Sbjct: 275 LGLSY-MGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLET-RNVIGDR 332

Query: 284 IPVELAD-CSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANL 342
               LA  C +L  L +        +++  G  S    G+       + LE +      +
Sbjct: 333 GLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVS--QRGLIALAQGCQELEYM-----AV 385

Query: 343 GGR---------LPDNWSESCSLKVLNLGQNSLKGAVPKSLGM------CRNLTYLDLSL 387
                       +       C  +++ L +      +P   G+      C+ L      L
Sbjct: 386 YVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYL 445

Query: 388 N 388
            
Sbjct: 446 R 446

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 50.9 bits (122), Expect = 1e-06
 Identities = 49/282 (17%), Positives = 93/282 (32%), Gaps = 49/282 (17%)

Query: 149 LEVLELQGNNFSGKIPYQM-----SNLERLRVLNLSFNSFSGEVPRGLI-----GNGELS 198
           +  L+L  NN       ++     +    +  LNLS NS   +    L+         ++
Sbjct: 24  VTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVT 83

Query: 199 VIDMSSNRLS--GGLAIDS--SSECEFLTYLKLSDNFLTESIPKEIGK-----CRNLKNL 249
            +++S N LS      +    ++    +T L L  N  +     E  +       ++ +L
Sbjct: 84  SLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSL 143

Query: 250 LLDGNILEGSIPKEIGTI-----SELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDA 304
            L GN L      E+  I     + +  L++  N+L  +   ELA         +T    
Sbjct: 144 NLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVT---- 199

Query: 305 SLDLDNSR-GEFSAFDGGVPY--ELLLS--RSLEVLWAPRANLGG----RLPDNWSESCS 355
           SLDL  +  G              +  S    +  L      L G     L         
Sbjct: 200 SLDLSANLLG-----LKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKH 254

Query: 356 LKVLNLGQNSLKG-------AVPKSLGMCRNLTYLDLSLNNL 390
           L+ + L  + +K        A+  +    + +  +D +   +
Sbjct: 255 LQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEI 296

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 49.3 bits (118), Expect = 4e-06
 Identities = 35/217 (16%), Positives = 73/217 (33%), Gaps = 41/217 (18%)

Query: 123 TELRTLSVPHNSFSGEIPAGVGEL--------RLLEVLELQGNNFSGK-IPYQMSNLER- 172
             +  L +  N FS        E           +  L L+GN+   K     +  L   
Sbjct: 109 FTITVLDLGWNDFS---SKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAI 165

Query: 173 ---LRVLNLSFNSFSGEVPRGL-----IGNGELSVIDMSSNRL--SGGLAIDS--SSECE 220
              +  LNL  N+ + +    L          ++ +D+S+N L       +    SS   
Sbjct: 166 PANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPN 225

Query: 221 FLTYLKLSDNFLTESIPKEIG----KCRNLKNLLLDGNILEGSIPKEIGTISE------- 269
            +  L L  N L     + +       ++L+ + LD +I++    ++   +         
Sbjct: 226 HVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQK 285

Query: 270 LKVLDVSRNSLTDRIPVELAD-----CSKLSVLVLTN 301
           + ++D +   +     + +++       K  V  L N
Sbjct: 286 IILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLN 322

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 44.7 bits (106), Expect = 1e-04
 Identities = 49/305 (16%), Positives = 93/305 (30%), Gaps = 65/305 (21%)

Query: 123 TELRTLSVPHNSFSGEIPAGVGEL--------RLLEVLELQGNNFSGK-IPYQMSNLER- 172
             + +L++  N  S +      EL          + VL+L  N+FS K            
Sbjct: 80  ANVTSLNLSGNFLSYK---SSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNL 136

Query: 173 ---LRVLNLSFNSFSGEVPRGLIG-----NGELSVIDMSSNRLS--GGLAIDS--SSECE 220
              +  LNL  N    +    LI         ++ +++  N L+      +    +S   
Sbjct: 137 PASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPA 196

Query: 221 FLTYLKLSDNFLTESIPKEIGKC-----RNLKNLLLDGNILEGSIPKEIGTISE----LK 271
            +T L LS N L      E+         ++ +L L  N L G   + +  + +    L+
Sbjct: 197 SVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQ 256

Query: 272 VLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRS 331
            + +  + + +       +  K       NI   + +D +  E           + +S  
Sbjct: 257 TVYLDYDIVKN----MSKEQCKALGAAFPNIQKIILVDKNGKEIH--PSHS---IPISNL 307

Query: 332 LEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAV-----PKSLGMCRNLTYLDLS 386
           +  L                 S    V +L    L  A       + L +   L     +
Sbjct: 308 IREL-----------------SGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQT 350

Query: 387 LNNLE 391
              L 
Sbjct: 351 CKPLL 355

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 49.9 bits (119), Expect = 3e-06
 Identities = 40/175 (22%), Positives = 68/175 (38%), Gaps = 13/175 (7%)

Query: 146 LRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNG--ELSVIDMS 203
              L+ L L+G   S  I   ++    L  LNLS  S   E     + +    L  +++S
Sbjct: 117 CSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLS 176

Query: 204 SNRL--SGGLAIDSSSECEFLTYLKLSD--NFLTESIPKEIGK-CRNLKNLLLDG--NIL 256
                    + +  +   E +T L LS     L +S    + + C NL +L L     + 
Sbjct: 177 WCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLK 236

Query: 257 EGSIPKEIGTISELKVLDVSR-NSLTDRIPVELADCSKLSVLVLTNI--DASLDL 308
                +E   ++ L+ L +SR   +     +EL +   L  L +  I  D +L L
Sbjct: 237 NDCF-QEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQL 290

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 46.0 bits (109), Expect = 4e-05
 Identities = 45/253 (17%), Positives = 85/253 (33%), Gaps = 32/253 (12%)

Query: 147 RLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVP-RGLIGNGELSVIDMSSN 205
            L + L+L G N    +      L    V+         + P         +  +D+S++
Sbjct: 47  SLWQTLDLTGKNLHPDVT---GRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNS 103

Query: 206 RLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDG--NILEGSIPKE 263
            +         S+C  L  L L    L++ I   + K  NL  L L G     E ++   
Sbjct: 104 VIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTL 163

Query: 264 IGTISELKVLDVSR-NSLTDR-IPVELAD-CSKLSVLVLTNIDASLDLDNSRGEFSAFDG 320
           + + S L  L++S     T++ + V +A     ++ L L+    +L              
Sbjct: 164 LSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQ-----------KS 212

Query: 321 GVPYELLLSRSLEVLWAPRANLGG--RLPDNW----SESCSLKVLNL-GQNSLKGAVPKS 373
            +   +    +L  L     +L     L ++      +   L+ L+L     +       
Sbjct: 213 DLSTLVRRCPNLVHL-----DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLE 267

Query: 374 LGMCRNLTYLDLS 386
           LG    L  L + 
Sbjct: 268 LGEIPTLKTLQVF 280

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 41.8 bits (98), Expect = 8e-04
 Identities = 37/234 (15%), Positives = 72/234 (30%), Gaps = 42/234 (17%)

Query: 484 RLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQ 543
           + ++        +        +  +   ++LS +++   +    L  C +L        +
Sbjct: 70  QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLR 129

Query: 544 ISGSIAAGVGKLMKLQRLDLRG---------NRVSGSLP---------------DELGKL 579
           +S  I   + K   L RL+L G           +  S                   +   
Sbjct: 130 LSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVA 189

Query: 580 -----KFLKWILLGG--NNLTGE-IPSQFGHLISLVVLDLSH-NALTGSIPASLTKATKL 630
                + +  + L G   NL    + +      +LV LDLS    L         +   L
Sbjct: 190 VAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYL 249

Query: 631 ESLFLAH-NRLSGEIPVSFSTLVNLSALDLS-------FNNLSGHIPHLQHLDC 676
           + L L+    +  E  +    +  L  L +           L   +PHLQ ++C
Sbjct: 250 QHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ-INC 302

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 46.5 bits (111), Expect = 9e-06
 Identities = 34/110 (30%), Positives = 48/110 (43%), Gaps = 11/110 (10%)

Query: 559 QRLDLRGNRVSGSLP----DELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHN 614
            RL+L  N++  SLP    D+L +L  L    L  N +       F  L  L +L L  N
Sbjct: 31  TRLELESNKLQ-SLPHGVFDKLTQLTKLS---LSQNQIQSLPDGVFDKLTKLTILYLHEN 86

Query: 615 ALTGSIPASL-TKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNN 663
            L  S+P  +  K T+L+ L L  N+L       F  L +L  + L   N
Sbjct: 87  KLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWL-HTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 45.7 bits (109), Expect = 1e-05
 Identities = 36/121 (29%), Positives = 44/121 (36%), Gaps = 30/121 (24%)

Query: 587 LGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASL-TKATKLESLFLAHNRLSGEIP 645
           L  N L       F  L  L  L LS N +  S+P  +  K TKL  L+L  N+L   +P
Sbjct: 35  LESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ-SLP 92

Query: 646 VS-FSTLVNLSALDLSFNNLSGHIPH--------LQHL-------DCIAFKGNKYLASCP 689
              F  L  L  L L  N L   +P         LQ +       DC          SCP
Sbjct: 93  NGVFDKLTQLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTNPWDC----------SCP 141

Query: 690 D 690
            
Sbjct: 142 R 142

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 48.4 bits (115), Expect = 1e-05
 Identities = 41/295 (13%), Positives = 97/295 (32%), Gaps = 31/295 (10%)

Query: 115 LSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQG------NNFSGKIPYQMS 168
           L   + +   L++L +       ++   +     LE L   G       +    +   +S
Sbjct: 203 LERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALS 262

Query: 169 NLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLS 228
             + LR L+  +++    +P        L+ +++S   +     +    +C  L  L + 
Sbjct: 263 GCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVL 322

Query: 229 DNFLTESIPKEIGKCRNLKNLLLDG----------NILEGSIPKEIGTISELKVLDVSRN 278
           D      +      C++L+ L +             + E  +        +L+ +     
Sbjct: 323 DYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCR 382

Query: 279 SLTDRIPVELAD-CSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWA 337
            +T+   + +A     ++   L  I+     D    E    D G    +   + L  L  
Sbjct: 383 QMTNAALITIARNRPNMTRFRLCIIE-PKAPDYLTLEPL--DIGFGAIVEHCKDLRRL-- 437

Query: 338 PRANLGGRLPDN-----WSESCSLKVLNLGQNSLKGAVPKSLGM-CRNLTYLDLS 386
              +L G L D       + +  +++L++            +   C +L  L++ 
Sbjct: 438 ---SLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIR 489

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 48.0 bits (114), Expect = 1e-05
 Identities = 72/514 (14%), Positives = 153/514 (29%), Gaps = 105/514 (20%)

Query: 172 RLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNF 231
           ++R + L           G     + +++               SS   +L  ++L    
Sbjct: 67  KVRSVELK----------GKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMV 116

Query: 232 LTESIPKEIGK-CRNLKNLLLDG--NILEGSIPKEIGTISELKVLDVSRNSLTDRIPVEL 288
           +T+   + I K  +N K L+L          +     T   LK LD+  + + D     L
Sbjct: 117 VTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWL 176

Query: 289 AD----CSKLSVLVLTNIDA------------------SLDLDNSRGEFSAFDGGVPYEL 326
           +      + L  L ++ + +                  SL L+ +          +   L
Sbjct: 177 SHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVP-----LEKLATLL 231

Query: 327 LLSRSLEVL------WAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNL 380
             +  LE L         R ++   L    S    L+ L+   +++   +P    +C  L
Sbjct: 232 QRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRL 291

Query: 381 TYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNITGVLPRFENVSCDNHFG---------- 430
           T L+LS   +                +     +    P+ + +   ++            
Sbjct: 292 TTLNLSYATV---------------QSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLAST 336

Query: 431 FQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNN 490
            +DL+   V        E  V + +           L ++      +   P    +L   
Sbjct: 337 CKDLRELRVFPSEPFVMEPNVALTEQG---------LVSV------SMGCPKLESVL--- 378

Query: 491 MFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQIS-GSIA 549
                        C  + + ++   A     M    F L  ++    +    +       
Sbjct: 379 -----------YFCRQMTNAALITIARNRPNM--TRFRLCIIEPKAPDYLTLEPLDIGFG 425

Query: 550 AGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGE-IPSQFGHLISLVV 608
           A V     L+RL L G              K ++ + +     +   +        SL  
Sbjct: 426 AIVEHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRK 485

Query: 609 LDLSH-NALTGSIPASLTKATKLESLFLAHNRLS 641
           L++        ++ A+ +K   + SL+++   +S
Sbjct: 486 LEIRDCPFGDKALLANASKLETMRSLWMSSCSVS 519

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 47.4 bits (113), Expect = 2e-05
 Identities = 45/298 (15%), Positives = 93/298 (31%), Gaps = 48/298 (16%)

Query: 122 LTELRTLSVPHNSFSGEIPAGVGEL--------RLLEVLELQGNNFSGK-IPYQMSNLER 172
           L+ LR L++     +   P     +          L+ + L         +   +    R
Sbjct: 71  LSSLRQLNLAGVRMT---PVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLR 127

Query: 173 LRVLNLSFNSFSGE----VPRGLIGNG-ELSVIDMSSNRL--SGGLAI-DSSSECEFLTY 224
            R L L  NS   E    +   L+ +  +++ + +S+N L  +G   + +  +    +T+
Sbjct: 128 ARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTH 187

Query: 225 LKLSDNFLTESIPKEIGK----CRNLKNLLLDGNILEGSIPKEIGTI----SELKVLDVS 276
           L L    L +   + +       R L+ L +  N    +    +         L++L + 
Sbjct: 188 LSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLY 247

Query: 277 RNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLW 336
            N L+      L D    +      +  SL    +  E+ +        ++LS       
Sbjct: 248 FNELSSEGRQVLRDLGGAAE-GGARVVVSLTEGTAVSEYWS--------VILSEVQR--- 295

Query: 337 APRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLG----MCRNLTYLDLSLNNL 390
               NL             L + +L  +      P        +   +  L   L + 
Sbjct: 296 ----NLNSWDRARVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSS 349

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 42.0 bits (99), Expect = 9e-04
 Identities = 27/174 (15%), Positives = 55/174 (31%), Gaps = 19/174 (10%)

Query: 511 SVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMK-----LQRLDLRG 565
            ++         +          L +   A  +++      V  ++      L  ++L  
Sbjct: 51  LLDHLFFHYEFQNQRFSAEVLSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLAS 110

Query: 566 NRVSGSLPDELGK-LKFLKWILLGGNNLTGEIPSQFGHLI-----SLVVLDLSHNALTGS 619
            ++  +    L       + + L  N+L  E       L+      +  L LS+N LT +
Sbjct: 111 CQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAA 170

Query: 620 ----IPASLTKATKLESLFLAHNRLSGE----IPVSFSTLVNLSALDLSFNNLS 665
               +   L   T +  L L H  L  E    +         L  L++++N   
Sbjct: 171 GVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAG 224

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

No hit with probability above 80.00

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	1052
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	6e-66
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	6e-62
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-58
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	9e-58
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	9e-58
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-57
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	6e-57
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-55
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-55
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-54
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	5e-54
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	5e-54
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-53
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-53
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-52
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-52
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	5e-52
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-52
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-52
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-51
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-50
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-50
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-50
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-50
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-50
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-50
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	6e-50
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-49
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-48
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-47
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-47
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-45
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-44
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-44
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-44
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	8e-44
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-43
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-43
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	7e-43
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	8e-43
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-42
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-42
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-42
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-41
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	9e-41
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-40
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-40
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-39
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-39
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-39
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-39
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	6e-39
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-37
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-37
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-36
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-35
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-35
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-32
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-31
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-31
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-29
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	9e-28
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-22
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-22
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-16
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	4e-12
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-08
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-07
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	4e-06
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	4e-05
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-21
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	9e-19
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-17
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	4e-10
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-10
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-04
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	9e-15
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	8e-13
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-12
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	6e-12
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-11
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-09
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	6e-09
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-08
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-06
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	6e-13
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	7e-13
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-10
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	7e-09
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-08
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	9e-05
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	0.003
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-12
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-10
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	4e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.001
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.003
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-10
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	8e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	9e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.004
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	4e-10
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	6e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.001
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	5e-09
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	6e-09
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	6e-07
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	5e-08
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	6e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	5e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	7e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-07
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.002
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.002
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.004
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.004
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-07
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	4e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	6e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	7e-07
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.002
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	4e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.001
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.003
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	1e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	2e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	3e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.001
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.003
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.004

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (564), Expect = 6e-66
 Identities = 78/282 (27%), Positives = 130/282 (46%), Gaps = 22/282 (7%)

Query: 775  GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
            G  ++   IG+G FG+ YK +      V +  ++    Q +Q F  E+G L + RH N++
Sbjct: 8    GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 835  TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
              +GY     ++ +V  +  G +L   +H     K +   +  IA   AQ + YLH    
Sbjct: 68   LFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHA--- 122

Query: 895  PRIVHRDIKPSNILLDEELNAYLSDFGLARLL-EVSETHATTDVAGTFGYVAPEYATT-- 951
              I+HRD+K +NI L E+L   + DFGLA +    S +H    ++G+  ++APE      
Sbjct: 123  KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182

Query: 952  -CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
                S ++DVY+FG+VL EL++G+              N       ++  G  S   L +
Sbjct: 183  KNPYSFQSDVYAFGIVLYELMTGQLPYS--------NINNRDQIIFMVGRGYLSP-DLSK 233

Query: 1011 LWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQLK 1052
            +    P+     M RL + C  +    RP   Q+L  ++ L 
Sbjct: 234  VRSNCPKA----MKRLMAECLKKKRDERPLFPQILASIELLA 271

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (534), Expect = 6e-62
 Identities = 67/274 (24%), Positives = 122/274 (44%), Gaps = 22/274 (8%)

Query: 776  NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
               +   +G G FG  +         VAVK L  G       F AE   + +++H+ LV 
Sbjct: 14   TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVR 72

Query: 836  LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
            L      E  ++++  ++  G+L  F+   SG K+  + +  +A  IA+ +A++      
Sbjct: 73   LYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN-- 129

Query: 896  RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVS 955
              +HRD++ +NIL+ + L+  ++DFGLARL+E +E  A         + APE       +
Sbjct: 130  -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188

Query: 956  DKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAG 1015
             K+DV+SFG++L E+++  R   P  +      N+    +++  +    EL+        
Sbjct: 189  IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY-------- 240

Query: 1016 PQENLLGMMRLASTCTVETLSTRPSVKQVLIKLK 1049
                     +L   C  E    RP+   +   L+
Sbjct: 241  ---------QLMRLCWKERPEDRPTFDYLRSVLE 265

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 2e-58
 Identities = 71/276 (25%), Positives = 121/276 (43%), Gaps = 22/276 (7%)

Query: 776  NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
            +  +   +G G FG  +         VA+K L  G     + F  E   + ++RH+ LV 
Sbjct: 18   SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQ 76

Query: 836  LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
            L      E  +++V  ++S G+L  F+  ++GK ++   +  +A  IA  +AY+      
Sbjct: 77   LYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---M 132

Query: 896  RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVS 955
              VHRD++ +NIL+ E L   ++DFGLARL+E +E  A         + APE A   R +
Sbjct: 133  NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 192

Query: 956  DKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAG 1015
             K+DV+SFG++L EL +  R   P                  ++ G     +        
Sbjct: 193  IKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVERG-----YRMPCPPEC 239

Query: 1016 PQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051
            P+     +  L   C  +    RP+ + +   L+  
Sbjct: 240  PES----LHDLMCQCWRKEPEERPTFEYLQAFLEDY 271

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (508), Expect = 9e-58
 Identities = 54/210 (25%), Positives = 99/210 (47%), Gaps = 9/210 (4%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRHKNL 833
           +F   + +G G  G  +K    P G ++A K + +     I  Q   E+  L       +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66

Query: 834 VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
           V   G +  + E+ +    + GG+L+  + K    +I   ++ K++I + + L YL    
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH 124

Query: 894 VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCR 953
             +I+HRD+KPSNIL++      L DFG++  L            GT  Y++PE      
Sbjct: 125 --KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPERLQGTH 179

Query: 954 VSDKADVYSFGVVLLELISGKRSLDPSFSE 983
            S ++D++S G+ L+E+  G+  + P  ++
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (503), Expect = 9e-58
 Identities = 59/276 (21%), Positives = 118/276 (42%), Gaps = 22/276 (7%)

Query: 776  NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
              +    IG+G FG  +    +    VA+K +  G     + F  E   + ++ H  LV 
Sbjct: 6    ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQ 64

Query: 836  LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
            L G  + +A + LV+ F+  G L  ++  +         +  + +D+ + +    Y    
Sbjct: 65   LYGVCLEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGM---AYLEEA 120

Query: 896  RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVS 955
             ++HRD+   N L+ E     +SDFG+ R +   +  ++T       + +PE  +  R S
Sbjct: 121  CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180

Query: 956  DKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAG 1015
             K+DV+SFGV++ E+ S  +    + S      +I +  +L      S+ ++        
Sbjct: 181  SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVY-------- 232

Query: 1016 PQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051
                     ++ + C  E    RP+  ++L +L ++
Sbjct: 233  ---------QIMNHCWKERPEDRPAFSRLLRQLAEI 259

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 4e-57
 Identities = 57/276 (20%), Positives = 118/276 (42%), Gaps = 22/276 (7%)

Query: 776  NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
            + +    +GTG FG     +    Y VA+K +  G      +F  E   +  + H+ LV 
Sbjct: 5    DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQ 63

Query: 836  LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
            L G    +  +F++  +++ G L  ++ +   +  Q   + ++  D+ +A+ YL      
Sbjct: 64   LYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLES---K 119

Query: 896  RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVS 955
            + +HRD+   N L++++    +SDFGL+R +   E  ++        +  PE     + S
Sbjct: 120  QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179

Query: 956  DKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAG 1015
             K+D+++FGV++ E+ S  +     F+      +I    +L      S +++        
Sbjct: 180  SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVY-------- 231

Query: 1016 PQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051
                      +  +C  E    RP+ K +L  +  +
Sbjct: 232  ---------TIMYSCWHEKADERPTFKILLSNILDV 258

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 6e-57
 Identities = 66/299 (22%), Positives = 120/299 (40%), Gaps = 26/299 (8%)

Query: 775  GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
                ++  IG G FG  ++ +   G  VAVK  S  R +     +AEI     +RH+N++
Sbjct: 3    RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS-REERSWFREAEIYQTVMLRHENIL 60

Query: 835  TLIGYYVGE----AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
              I     +     +++LV ++   G+L  ++++     +    + K+A+  A  LA+LH
Sbjct: 61   GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLH 117

Query: 891  YSCV-----PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH---ATTDVAGTFG 942
               V     P I HRD+K  NIL+ +     ++D GLA   + +      A     GT  
Sbjct: 118  MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177

Query: 943  YVAPEYATTC------RVSDKADVYSFGVVLLELISGKR--SLDPSFSEYGNGFNIVSWA 994
            Y+APE               +AD+Y+ G+V  E+        +   +            +
Sbjct: 178  YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237

Query: 995  KLLIKEGRSSELFLPELWEAG-PQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQLK 1052
               +++    +   P +       E L  M ++   C     + R +  ++   L QL 
Sbjct: 238  VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (485), Expect = 2e-55
 Identities = 67/278 (24%), Positives = 118/278 (42%), Gaps = 28/278 (10%)

Query: 776  NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVT 835
               +   IG G FG     +   G  VAVK +        Q F AE   + ++RH NLV 
Sbjct: 8    ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 64

Query: 836  LIGYYV-GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
            L+G  V  +  +++V  +++ G+L  ++  +    +    + K ++D+ +A+ YL     
Sbjct: 65   LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG--- 121

Query: 895  PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV 954
               VHRD+   N+L+ E+  A +SDFGL +    ++            + APE     + 
Sbjct: 122  NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----GKLPVKWTAPEALREKKF 177

Query: 955  SDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEA 1014
            S K+DV+SFG++L E+ S  R   P          +    K+   +G    ++       
Sbjct: 178  STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY------- 230

Query: 1015 GPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQLK 1052
                       +   C     + RPS  Q+  +L+ +K
Sbjct: 231  ----------EVMKNCWHLDAAMRPSFLQLREQLEHIK 258

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 4e-55
 Identities = 69/279 (24%), Positives = 122/279 (43%), Gaps = 28/279 (10%)

Query: 776  NFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKN 832
            ++ +   IGTG +G   K      G ++  K+L  G       Q   +E+  L  ++H N
Sbjct: 5    DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 833  LVTLIGYYVGEAE--MFLVYNFLSGGNLETFIHK--KSGKKIQWSVIHKIAIDIAQALAY 888
            +V      +      +++V  +  GG+L + I K  K  + +    + ++   +  AL  
Sbjct: 65   IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 889  LHY--SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAP 946
             H        ++HRD+KP+N+ LD + N  L DFGLAR+L    + A     GT  Y++P
Sbjct: 125  CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSP 183

Query: 947  EYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSEL 1006
            E       ++K+D++S G +L EL +      P F+     F+    A   I+EG+    
Sbjct: 184  EQMNRMSYNEKSDIWSLGCLLYELCALM----PPFT----AFSQKELAG-KIREGK---- 230

Query: 1007 FLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVL 1045
                +      E    +  + +         RPSV+++L
Sbjct: 231  -FRRIPYRYSDE----LNEIITRMLNLKDYHRPSVEEIL 264

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  189 bits (481), Expect = 2e-54
 Identities = 70/277 (25%), Positives = 127/277 (45%), Gaps = 22/277 (7%)

Query: 776  NFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
            + ++++ +G G +G  Y+         VAVK L     + +++F  E   +  I+H NLV
Sbjct: 18   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 76

Query: 835  TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
             L+G    E   +++  F++ GNL  ++ + + +++   V+  +A  I+ A+ YL     
Sbjct: 77   QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK--- 133

Query: 895  PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV 954
               +HRD+   N L+ E     ++DFGL+RL+      A         + APE     + 
Sbjct: 134  KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 193

Query: 955  SDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEA 1014
            S K+DV++FGV+L E+ +   S  P       G ++    +LL K+ R       E  E 
Sbjct: 194  SIKSDVWAFGVLLWEIATYGMSPYP-------GIDLSQVYELLEKDYR------MERPEG 240

Query: 1015 GPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051
             P++    +  L   C     S RPS  ++    + +
Sbjct: 241  CPEK----VYELMRACWQWNPSDRPSFAEIHQAFETM 273

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  188 bits (478), Expect = 5e-54
 Identities = 66/304 (21%), Positives = 120/304 (39%), Gaps = 39/304 (12%)

Query: 766  TYDNVVRATGNFS---------IRNLIGTGGFGSTYKAELVP----GYLVAVKKLSIGRF 812
            T+++   A   F+         I  +IG G FG      L         VA+K L  G  
Sbjct: 8    TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67

Query: 813  -QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQ 871
             +  + F +E   +G+  H N++ L G       + ++  F+  G+L++F+ +  G+   
Sbjct: 68   EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ-FT 126

Query: 872  WSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET 931
               +  +   IA  + YL        VHRD+   NIL++  L   +SDFGL+R LE   +
Sbjct: 127  VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183

Query: 932  HATT----DVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNG 987
              T            + APE     + +  +DV+S+G+V+ E++S        +      
Sbjct: 184  DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE---RPYW----D 236

Query: 988  FNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047
                     + ++ R             P      + +L   C  +  + RP   Q++  
Sbjct: 237  MTNQDVINAIEQDYR------LPPPMDCPSA----LHQLMLDCWQKDRNHRPKFGQIVNT 286

Query: 1048 LKQL 1051
            L ++
Sbjct: 287  LDKM 290

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (477), Expect = 5e-54
 Identities = 70/288 (24%), Positives = 120/288 (41%), Gaps = 30/288 (10%)

Query: 767  YDNVVRATG---NFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFDAEI 822
            Y++V R       + I   +G G FG  YKA+      L A K +     + ++ +  EI
Sbjct: 1    YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60

Query: 823  GTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDI 882
              L    H N+V L+  +  E  ++++  F +GG ++  + +   + +  S I  +    
Sbjct: 61   DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQT 119

Query: 883  AQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFG 942
              AL YLH +   +I+HRD+K  NIL   + +  L+DFG++     +     +   GT  
Sbjct: 120  LDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-FIGTPY 175

Query: 943  YVAPEYATTCRVSD-----KADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLL 997
            ++APE        D     KADV+S G+ L+E+   +    P   E  N   ++    L 
Sbjct: 176  WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE----PPHHEL-NPMRVL----LK 226

Query: 998  IKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVL 1045
            I +     L  P  W                 C  + +  R +  Q+L
Sbjct: 227  IAKSEPPTLAQPSRW---SSN----FKDFLKKCLEKNVDARWTTSQLL 267

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 4e-53
 Identities = 67/271 (24%), Positives = 112/271 (41%), Gaps = 31/271 (11%)

Query: 783  IGTGGFGSTYKAELVP-GYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKNLVTLIGY 839
            IG G F + YK         VA  +L   +      Q+F  E   L  ++H N+V     
Sbjct: 17   IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76

Query: 840  YV----GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
            +     G+  + LV   ++ G L+T++ +   K ++  V+      I + L +LH    P
Sbjct: 77   WESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRT-P 133

Query: 896  RIVHRDIKPSNILLDEELN-AYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV 954
             I+HRD+K  NI +        + D GLA L           V GT  ++APE     + 
Sbjct: 134  PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEMYEE-KY 189

Query: 955  SDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEA 1014
             +  DVY+FG+ +LE+ + +      +SE  N   I       +K     ++ +PE+ E 
Sbjct: 190  DESVDVYAFGMCMLEMATSE----YPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE- 244

Query: 1015 GPQENLLGMMRLASTCTVETLSTRPSVKQVL 1045
                       +   C  +    R S+K +L
Sbjct: 245  -----------IIEGCIRQNKDERYSIKDLL 264

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 6e-53
 Identities = 69/285 (24%), Positives = 118/285 (41%), Gaps = 32/285 (11%)

Query: 776  NFSIRNLIGTGGFGSTYKAELVP----GYLVAVKKLSIGRFQG-IQQFDAEIGTLGRIRH 830
            +F+   +IG G FG  Y   L+         AVK L+     G + QF  E   +    H
Sbjct: 30   HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87

Query: 831  KNLVTLIGYYV-GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
             N+++L+G  +  E    +V  ++  G+L  FI  +         +    + +A+ +   
Sbjct: 88   PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGM--- 143

Query: 890  HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE---THATTDVAGTFGYVAP 946
             +    + VHRD+   N +LDE+    ++DFGLAR +   E    H  T       ++A 
Sbjct: 144  KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203

Query: 947  EYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSEL 1006
            E   T + + K+DV+SFGV+L EL++      P         N       L++  R   L
Sbjct: 204  ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP-------DVNTFDITVYLLQGRR---L 253

Query: 1007 FLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051
              PE     P      +  +   C       RPS  +++ ++  +
Sbjct: 254  LQPEYC---PDP----LYEVMLKCWHPKAEMRPSFSELVSRISAI 291

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (464), Expect = 3e-52
 Identities = 66/283 (23%), Positives = 116/283 (40%), Gaps = 29/283 (10%)

Query: 776  NFSIRNL-IGTGGFGSTYKAELVP---GYLVAVKKLSIGRFQG-IQQFDAEIGTLGRIRH 830
            N  I ++ +G G FGS  +           VA+K L  G  +   ++   E   + ++ +
Sbjct: 9    NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 68

Query: 831  KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
              +V LIG    E  + LV     GG L  F+  K  + I  S + ++   ++  + YL 
Sbjct: 69   PYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLE 126

Query: 891  YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH--ATTDVAGTFGYVAPEY 948
                   VHRD+   N+LL     A +SDFGL++ L   +++  A +       + APE 
Sbjct: 127  E---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183

Query: 949  ATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFL 1008
                + S ++DV+S+GV + E +S  +     + +              I++G+      
Sbjct: 184  INFRKFSSRSDVWSYGVTMWEALSYGQ---KPYKKMKG-----PEVMAFIEQGK-----R 230

Query: 1009 PELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051
             E     P E    +  L S C +     RP    V  +++  
Sbjct: 231  MECPPECPPE----LYALMSDCWIYKWEDRPDFLTVEQRMRAC 269

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 5e-52
 Identities = 65/273 (23%), Positives = 122/273 (44%), Gaps = 24/273 (8%)

Query: 774  TGNFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKN 832
               ++    IG G  G+ Y A  V  G  VA++++++ +    +    EI  +   ++ N
Sbjct: 19   KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 833  LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
            +V  +  Y+   E+++V  +L+GG+L   + +     +    I  +  +  QAL +LH +
Sbjct: 79   IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN 135

Query: 893  CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
               +++HRDIK  NILL  + +  L+DFG    +   ++  +T V GT  ++APE  T  
Sbjct: 136  ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRK 191

Query: 953  RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012
                K D++S G++ +E+I G+    P +       N +    L+   G        +L 
Sbjct: 192  AYGPKVDIWSLGIMAIEMIEGE----PPYL----NENPLRALYLIATNGTPELQNPEKLS 243

Query: 1013 EAGPQENLLGMMRLASTCTVETLSTRPSVKQVL 1045
                           + C    +  R S K++L
Sbjct: 244  AI--------FRDFLNRCLDMDVEKRGSAKELL 268

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  183 bits (465), Expect = 5e-52
 Identities = 75/276 (27%), Positives = 111/276 (40%), Gaps = 34/276 (12%)

Query: 777  FSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQG---IQQFDAEIGTLGRIRHKN 832
            FS    IG G FG+ Y A  V    +VA+KK+S    Q     Q    E+  L ++RH N
Sbjct: 17   FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 833  LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
             +   G Y+ E   +LV  +  G   +     K  K +Q   I  +     Q LAYLH  
Sbjct: 77   TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH 134

Query: 893  CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
                ++HRD+K  NILL E     L DFG A ++            GT  ++APE     
Sbjct: 135  ---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANSFVGTPYWMAPEVILAM 186

Query: 953  ---RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009
               +   K DV+S G+  +EL   K  L  + +     ++I       ++ G  SE F  
Sbjct: 187  DEGQYDGKVDVWSLGITCIELAERKPPL-FNMNAMSALYHIAQNESPALQSGHWSEYFR- 244

Query: 1010 ELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVL 1045
                               +C  +    RP+ + +L
Sbjct: 245  ---------------NFVDSCLQKIPQDRPTSEVLL 265

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  182 bits (463), Expect = 5e-52
 Identities = 67/306 (21%), Positives = 118/306 (38%), Gaps = 50/306 (16%)

Query: 776  NFSIRNLIGTGGFGSTYKAEL------VPGYLVAVKKLSIGRFQGIQ-QFDAEIGTLGRI 828
            N      IG G FG  ++A         P  +VAVK L       +Q  F  E   +   
Sbjct: 14   NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73

Query: 829  RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSG--------------------- 867
             + N+V L+G       M L++ +++ G+L  F+   S                      
Sbjct: 74   DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133

Query: 868  -KKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL 926
               +  +    IA  +A  +AYL      + VHRD+   N L+ E +   ++DFGL+R +
Sbjct: 134  PPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNI 190

Query: 927  EVSE-THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYG 985
              ++   A  + A    ++ PE     R + ++DV+++GVVL E+ S         +   
Sbjct: 191  YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH-- 248

Query: 986  NGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVL 1045
                        +++G      +    E  P E    +  L   C  +  + RPS   + 
Sbjct: 249  ------EEVIYYVRDGN-----ILACPENCPLE----LYNLMRLCWSKLPADRPSFCSIH 293

Query: 1046 IKLKQL 1051
              L+++
Sbjct: 294  RILQRM 299

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 6e-52
 Identities = 66/275 (24%), Positives = 105/275 (38%), Gaps = 25/275 (9%)

Query: 775  GNFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKN 832
             ++ +   +G G +G    A        VAVK + + R     +    EI     + H+N
Sbjct: 5    EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 833  LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
            +V   G+       +L   + SGG L   I       +      +    +   + YLH  
Sbjct: 65   VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG- 121

Query: 893  CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV-SETHATTDVAGTFGYVAPEYATT 951
                I HRDIKP N+LLDE  N  +SDFGLA +    +       + GT  YVAPE    
Sbjct: 122  --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179

Query: 952  CRVSD-KADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
                    DV+S G+VL  +++G+   D             S +     + +  + +L  
Sbjct: 180  REFHAEPVDVWSCGIVLTAMLAGELPWDQP-----------SDSCQEYSDWKEKKTYLNP 228

Query: 1011 LWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVL 1045
             W+          + L     VE  S R ++  + 
Sbjct: 229  -WKKIDSA----PLALLHKILVENPSARITIPDIK 258

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 2e-51
 Identities = 67/274 (24%), Positives = 109/274 (39%), Gaps = 31/274 (11%)

Query: 776  NFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRF---QGIQQFDAEIGTLGRIRHK 831
            +F I   +G G FG+ Y A      +++A+K L   +        Q   E+     +RH 
Sbjct: 7    DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66

Query: 832  NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
            N++ L GY+     ++L+  +   G +   + K    K           ++A AL+Y H 
Sbjct: 67   NILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS 124

Query: 892  SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT 951
                R++HRDIKP N+LL       ++DFG +     S       + GT  Y+ PE    
Sbjct: 125  K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMIEG 178

Query: 952  CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPEL 1011
                +K D++S GV+  E + GK             F   ++ +   K     E   P+ 
Sbjct: 179  RMHDEKVDLWSLGVLCYEFLVGKPP-----------FEANTYQETY-KRISRVEFTFPDF 226

Query: 1012 WEAGPQENLLGMMRLASTCTVETLSTRPSVKQVL 1045
                      G   L S       S RP +++VL
Sbjct: 227  VTE-------GARDLISRLLKHNPSQRPMLREVL 253

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  180 bits (458), Expect = 1e-50
 Identities = 66/287 (22%), Positives = 114/287 (39%), Gaps = 27/287 (9%)

Query: 762  PAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFDA 820
            P E+ +D+V+    ++ I   +GTG FG  ++      G   A K +        +    
Sbjct: 16   PVEIKHDHVL---DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRK 72

Query: 821  EIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI 880
            EI T+  +RH  LV L   +  + EM ++Y F+SGG L   +  +  K +      +   
Sbjct: 73   EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMR 131

Query: 881  DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAY--LSDFGLARLLEVSETHATTDVA 938
             + + L ++H +     VH D+KP NI+   + +    L DFGL   L+  ++   T   
Sbjct: 132  QVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--T 186

Query: 939  GTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLI 998
            GT  + APE A    V    D++S GV+   L+SG              F   +  + L 
Sbjct: 187  GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP-----------FGGENDDETLR 235

Query: 999  KEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVL 1045
                         +    ++             +   +TR ++ Q L
Sbjct: 236  NVKSCDWNMDDSAFSGISED----GKDFIRKLLLADPNTRMTIHQAL 278

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 1e-50
 Identities = 62/281 (22%), Positives = 110/281 (39%), Gaps = 27/281 (9%)

Query: 776  NFSIRNLIGTGGFGSTYKAELV----PGYLVAVKKLSIGRFQGI-QQFDAEIGTLGRIRH 830
               +   IG G FG  ++   +    P   VA+K         + ++F  E  T+ +  H
Sbjct: 8    RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67

Query: 831  KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
             ++V LIG    E  ++++    + G L +F+  +    +  + +   A  ++ ALAYL 
Sbjct: 68   PHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLE 125

Query: 891  YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
                 R VHRDI   N+L+       L DFGL+R +E S  +  +       ++APE   
Sbjct: 126  S---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182

Query: 951  TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010
              R +  +DV+ FGV + E++                  I +  +L +       L+   
Sbjct: 183  FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY--- 239

Query: 1011 LWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051
                           L + C     S RP   ++  +L  +
Sbjct: 240  --------------SLMTKCWAYDPSRRPRFTELKAQLSTI 266

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 1e-50
 Identities = 66/295 (22%), Positives = 115/295 (38%), Gaps = 41/295 (13%)

Query: 776  NFSIRNLIGTGGFGSTYKAELVPG---YLVAVKKLS-IGRFQGIQQFDAEIGTLGRI-RH 830
            +   +++IG G FG   KA +         A+K++         + F  E+  L ++  H
Sbjct: 11   DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70

Query: 831  KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKK--------------SGKKIQWSVIH 876
             N++ L+G       ++L   +   GNL  F+ K               +   +    + 
Sbjct: 71   PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130

Query: 877  KIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD 936
              A D+A+ +    Y    + +HRD+   NIL+ E   A ++DFGL+R  EV      T 
Sbjct: 131  HFAADVARGM---DYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KTM 185

Query: 937  VAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKL 996
                  ++A E       +  +DV+S+GV+L E++S        +     G       + 
Sbjct: 186  GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG---TPY----CGMTCAELYEK 238

Query: 997  LIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051
            L +  R       E       E    +  L   C  E    RPS  Q+L+ L ++
Sbjct: 239  LPQGYR------LEKPLNCDDE----VYDLMRQCWREKPYERPSFAQILVSLNRM 283

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 2e-50
 Identities = 69/301 (22%), Positives = 114/301 (37%), Gaps = 44/301 (14%)

Query: 776  NFSIRNLIGTGGFGSTYKAELVP------GYLVAVKKLSIGRFQG-IQQFDAEIGTLGRI 828
              S    +G G FG   +A             VAVK L         +   +E+  L  +
Sbjct: 24   RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83

Query: 829  -RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGK----------------KIQ 871
              H N+V L+G         ++  +   G+L  F+ +K                    + 
Sbjct: 84   GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 872  WSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET 931
               +   +  +A+ +A+L        +HRD+   NILL       + DFGLAR ++    
Sbjct: 144  LEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200

Query: 932  HA-TTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
            +    +      ++APE    C  + ++DV+S+G+ L EL S   S  P       G  +
Sbjct: 201  YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP-------GMPV 253

Query: 991  VSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQ 1050
             S    +IKEG     F     E  P E    M  +  TC       RP+ KQ++  +++
Sbjct: 254  DSKFYKMIKEG-----FRMLSPEHAPAE----MYDIMKTCWDADPLKRPTFKQIVQLIEK 304

Query: 1051 L 1051
             
Sbjct: 305  Q 305

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 3e-50
 Identities = 67/277 (24%), Positives = 110/277 (39%), Gaps = 30/277 (10%)

Query: 781  NLIGTGGFGSTYKAELVP---GYLVAVKKLSIGRFQG--IQQFDAEIGTLGRIRHKNLVT 835
              +G+G FG+  K           VAVK L           +  AE   + ++ +  +V 
Sbjct: 13   KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 836  LIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVP 895
            +IG    E    LV      G L  ++ +   + ++   I ++   ++  + YL  S   
Sbjct: 73   MIGICEAE-SWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES--- 126

Query: 896  RIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH--ATTDVAGTFGYVAPEYATTCR 953
              VHRD+   N+LL  +  A +SDFGL++ L   E +  A T       + APE     +
Sbjct: 127  NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186

Query: 954  VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWE 1013
             S K+DV+SFGV++ E  S  +     +     G        +L K  R           
Sbjct: 187  FSSKSDVWSFGVLMWEAFSYGQ---KPYR----GMKGSEVTAMLEKGER------MGCPA 233

Query: 1014 AGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQ 1050
              P+E    M  L + C    +  RP    V ++L+ 
Sbjct: 234  GCPRE----MYDLMNLCWTYDVENRPGFAAVELRLRN 266

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 4e-50
 Identities = 61/321 (19%), Positives = 116/321 (36%), Gaps = 54/321 (16%)

Query: 762  PAELTYDN---VVRATGNFSIRNLIGTGGFGSTYKA------ELVPGYLVAVKKLSIGRF 812
              E  YD      R   N     ++G+G FG    A      +      VAVK L     
Sbjct: 23   FREYEYDLKWEFPRE--NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD 80

Query: 813  QG-IQQFDAEIGTLGRI-RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGK-- 868
                +   +E+  + ++  H+N+V L+G       ++L++ +   G+L  ++  K  K  
Sbjct: 81   SSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFS 140

Query: 869  -------------------KIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILL 909
                                + +  +   A  +A+ + +L +      VHRD+   N+L+
Sbjct: 141  EDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLV 197

Query: 910  DEELNAYLSDFGLARLLEVSETHAT-TDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLL 968
                   + DFGLAR +     +    +      ++APE       + K+DV+S+G++L 
Sbjct: 198  THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLW 257

Query: 969  ELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLAS 1028
            E+ S   +  P      N + ++               F  +      +E    +  +  
Sbjct: 258  EIFSLGVNPYPGIPVDANFYKLI------------QNGFKMDQPFYATEE----IYIIMQ 301

Query: 1029 TCTVETLSTRPSVKQVLIKLK 1049
            +C       RPS   +   L 
Sbjct: 302  SCWAFDSRKRPSFPNLTSFLG 322

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 6e-50
 Identities = 70/284 (24%), Positives = 118/284 (41%), Gaps = 29/284 (10%)

Query: 776  NFSIRNLIGTGGFGSTYKAELVPG-----YLVAVKKLSIGRFQG-IQQFDAEIGTLGRIR 829
              + + +IG G FG  YK  L          VA+K L  G  +     F  E G +G+  
Sbjct: 8    CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67

Query: 830  HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
            H N++ L G       M ++  ++  G L+ F+ +K G+      +  +   IA   A +
Sbjct: 68   HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIA---AGM 123

Query: 890  HYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE--VSETHATTDVAGTFGYVAPE 947
             Y      VHRD+   NIL++  L   +SDFGL+R+LE     T+ T+       + APE
Sbjct: 124  KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183

Query: 948  YATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELF 1007
              +  + +  +DV+SFG+V+ E+++         S +             I +G     F
Sbjct: 184  AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--------EVMKAINDG-----F 230

Query: 1008 LPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051
                    P      + +L   C  +  + RP    ++  L +L
Sbjct: 231  RLPTPMDCPSA----IYQLMMQCWQQERARRPKFADIVSILDKL 270

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 3e-49
 Identities = 65/286 (22%), Positives = 108/286 (37%), Gaps = 30/286 (10%)

Query: 776  NFSIRNLIGTGGFGSTYKAELVP----GYLVAVKKLS---IGRFQGIQQFDAEIGTLGRI 828
            +  +   +G G FG   + E          VAVK L    + + + +  F  E+  +  +
Sbjct: 9    DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68

Query: 829  RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
             H+NL+ L G  +    M +V      G+L   + K  G       + + A+ +A+ + Y
Sbjct: 69   DHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGY 126

Query: 889  LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH--ATTDVAGTFGYVAP 946
            L      R +HRD+   N+LL       + DFGL R L  ++ H          F + AP
Sbjct: 127  LES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

Query: 947  EYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSEL 1006
            E   T   S  +D + FGV L E+ +  +           G N       + KEG     
Sbjct: 184  ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI-------GLNGSQILHKIDKEGER--- 233

Query: 1007 FLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQLK 1052
                  E  PQ+    +  +   C       RP+   +   L + +
Sbjct: 234  --LPRPEDCPQD----IYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 3e-48
 Identities = 56/290 (19%), Positives = 122/290 (42%), Gaps = 30/290 (10%)

Query: 770  VVRATGNFSIRNLIGTGGFGSTYKAELVP-----GYLVAVKKLS-IGRFQGIQQFDAEIG 823
            +++ T  F    ++G+G FG+ YK   +P        VA+K+L      +  ++   E  
Sbjct: 5    ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63

Query: 824  TLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIA 883
             +  + + ++  L+G  +  + + L+   +  G L  ++ +     I    +    + IA
Sbjct: 64   VMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIA 121

Query: 884  QALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTD-VAGTFG 942
            + + YL      R+VHRD+   N+L+    +  ++DFGLA+LL   E     +       
Sbjct: 122  KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178

Query: 943  YVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGR 1002
            ++A E       + ++DV+S+GV + EL++        +    +G      + +L K  R
Sbjct: 179  WMALESILHRIYTHQSDVWSYGVTVWELMTFGS---KPY----DGIPASEISSILEKGER 231

Query: 1003 SSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQLK 1052
                           +    +  +   C +    +RP  ++++I+  ++ 
Sbjct: 232  ------LPQPPICTID----VYMIMVKCWMIDADSRPKFRELIIEFSKMA 271

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 4e-47
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 10/205 (4%)

Query: 776 NFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRF---QGIQQFDAEIGTLGRIRHK 831
           +F    ++G G F +   A EL      A+K L          +     E   + R+ H 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
             V L   +  + +++   ++   G L  +I K        +       +I  AL YLH 
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG 126

Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV-SETHATTDVAGTFGYVAPEYAT 950
                I+HRD+KP NILL+E+++  ++DFG A++L   S+        GT  YV+PE  T
Sbjct: 127 ---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183

Query: 951 TCRVSDKADVYSFGVVLLELISGKR 975
                  +D+++ G ++ +L++G  
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLP 208

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  169 bits (430), Expect = 5e-47
 Identities = 63/287 (21%), Positives = 105/287 (36%), Gaps = 27/287 (9%)

Query: 762  PAELTYDNVVRATGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQGIQQFDA 820
            P E+   +V      + I   +G+G FG  ++  E   G +   K ++            
Sbjct: 19   PVEVKQGSVY---DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN 75

Query: 821  EIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAI 880
            EI  + ++ H  L+ L   +  + EM L+  FLSGG L   I  +   K+  + +     
Sbjct: 76   EISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMR 134

Query: 881  DIAQALAYLHYSCVPRIVHRDIKPSNILLD--EELNAYLSDFGLARLLEVSETHATTDVA 938
               + L ++H      IVH DIKP NI+ +  +  +  + DFGLA  L  +         
Sbjct: 135  QACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL--NPDEIVKVTT 189

Query: 939  GTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLI 998
             T  + APE      V    D+++ GV+   L+SG              F      + L 
Sbjct: 190  ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP-----------FAGEDDLETLQ 238

Query: 999  KEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVL 1045
               R    F  + + +   E              +    R +V   L
Sbjct: 239  NVKRCDWEFDEDAFSSVSPE----AKDFIKNLLQKEPRKRLTVHDAL 281

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  162 bits (411), Expect = 7e-45
 Identities = 72/274 (26%), Positives = 113/274 (41%), Gaps = 27/274 (9%)

Query: 777  FSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQ-FDAEIGTLGRIRHKNLV 834
            +  R+++GTG F     AE      LVA+K ++    +G +   + EI  L +I+H N+V
Sbjct: 11   YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70

Query: 835  TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
             L   Y     ++L+   +SGG L   I +K           ++   +  A+ YLH    
Sbjct: 71   ALDDIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLG- 127

Query: 895  PRIVHRDIKPSNILL---DEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT 951
              IVHRD+KP N+L    DE+    +SDFGL+++         +   GT GYVAPE    
Sbjct: 128  --IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGYVAPEVLAQ 183

Query: 952  CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPEL 1011
               S   D +S GV+   L+ G              F   + AKL  +  ++   F    
Sbjct: 184  KPYSKAVDCWSIGVIAYILLCGYPP-----------FYDENDAKLFEQILKAEYEFDSPY 232

Query: 1012 WEAGPQENLLGMMRLASTCTVETLSTRPSVKQVL 1045
            W+                   +    R + +Q L
Sbjct: 233  WDDISDS----AKDFIRHLMEKDPEKRFTCEQAL 262

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 2e-44
 Identities = 56/293 (19%), Positives = 110/293 (37%), Gaps = 36/293 (12%)

Query: 776  NFSIRNLIGTGGFGSTYKAEL------VPGYLVAVKKLS-IGRFQGIQQFDAEIGTLGRI 828
              ++   +G G FG  Y+          P   VA+K ++     +   +F  E   +   
Sbjct: 21   KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80

Query: 829  RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIH--------KKSGKKIQWSVIHKIAI 880
               ++V L+G         ++   ++ G+L++++                  S + ++A 
Sbjct: 81   NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140

Query: 881  DIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL-EVSETHATTDVAG 939
            +IA  +AYL+ +   + VHRD+   N ++ E+    + DFG+ R + E            
Sbjct: 141  EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197

Query: 940  TFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIK 999
               +++PE       +  +DV+SFGVVL E+ +         S               + 
Sbjct: 198  PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--------EQVLRFVM 249

Query: 1000 EGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQLK 1052
            EG      L +  +  P      +  L   C       RPS  +++  +K+  
Sbjct: 250  EGG-----LLDKPDNCPDM----LFELMRMCWQYNPKMRPSFLEIISSIKEEM 293

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  159 bits (403), Expect = 3e-44
 Identities = 65/302 (21%), Positives = 116/302 (38%), Gaps = 39/302 (12%)

Query: 761  TPAELTYDNVVRATGNFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQG---IQ 816
            TP+ L+          + +  ++G GG    + A  +     VAVK L     +      
Sbjct: 1    TPSHLSDR--------YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYL 52

Query: 817  QFDAEIGTLGRIRHKNLVTLIGYYVGEAE----MFLVYNFLSGGNLETFIHKKSGKKIQW 872
            +F  E      + H  +V +      E       ++V  ++ G  L   +H +    +  
Sbjct: 53   RFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTP 110

Query: 873  SVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH 932
                ++  D  QAL + H      I+HRD+KP+NI++       + DFG+AR +  S   
Sbjct: 111  KRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 167

Query: 933  A--TTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
               T  V GT  Y++PE A    V  ++DVYS G VL E+++G+    P        F  
Sbjct: 168  VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP---P--------FTG 216

Query: 991  VSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRP-SVKQVLIKLK 1049
             S   +  +  R   +      E    +    +  +      +    R  +  ++   L 
Sbjct: 217  DSPVSVAYQHVREDPIPPSARHEGLSAD----LDAVVLKALAKNPENRYQTAAEMRADLV 272

Query: 1050 QL 1051
            ++
Sbjct: 273  RV 274

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 6e-44
 Identities = 66/300 (22%), Positives = 109/300 (36%), Gaps = 43/300 (14%)

Query: 776  NFSIRNLIGTGGFGSTYKA------ELVPGYLVAVKKLSIGRFQG-IQQFDAEIGTLGRI 828
               +   +G G FG   +A      +      VAVK L  G      +   +E+  L  I
Sbjct: 14   RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73

Query: 829  RHKNLVTLIGYYVGEAE--MFLVYNFLSGGNLETFIHKKSGK--------------KIQW 872
             H   V  +     +    + ++  F   GNL T++  K  +               +  
Sbjct: 74   GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133

Query: 873  SVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH 932
              +   +  +A+ + +L      + +HRD+   NILL E+    + DFGLAR +     +
Sbjct: 134  EHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190

Query: 933  A-TTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIV 991
                D      ++APE       + ++DV+SFGV+L E+ S   S  P       G  I 
Sbjct: 191  VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP-------GVKID 243

Query: 992  SWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051
                  +KEG              P      M +    C     S RP+  +++  L  L
Sbjct: 244  EEFCRRLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 8e-44
 Identities = 65/301 (21%), Positives = 122/301 (40%), Gaps = 45/301 (14%)

Query: 776  NFSIRNLIGTGGFGSTYKAELVP--------GYLVAVKKLSIGRFQ-GIQQFDAEIGTLG 826
               +   +G G FG    AE +            VAVK L     +  +    +E+  + 
Sbjct: 14   RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73

Query: 827  RI-RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSG--------------KKIQ 871
             I +HKN++ L+G    +  ++++  + S GNL  ++  +                +++ 
Sbjct: 74   MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133

Query: 872  WSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET 931
               +   A  +A+ + YL      + +HRD+   N+L+ E+    ++DFGLAR +   + 
Sbjct: 134  SKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190

Query: 932  HATTDV-AGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNI 990
            +  T        ++APE       + ++DV+SFGV+L E+ +   S  P           
Sbjct: 191  YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-------- 242

Query: 991  VSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQ 1050
            V     L+KEG        +       E    +  +   C     S RP+ KQ++  L +
Sbjct: 243  VEELFKLLKEGH-----RMDKPSNCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLDR 293

Query: 1051 L 1051
            +
Sbjct: 294  I 294

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  157 bits (398), Expect = 2e-43
 Identities = 55/291 (18%), Positives = 97/291 (33%), Gaps = 27/291 (9%)

Query: 771  VRATGNFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIR 829
            +R    + +   IG+G FG  Y    +  G  VA+K   +       Q   E      ++
Sbjct: 3    LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQ 60

Query: 830  HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
                +  I +   E +  ++   L G +LE  +     +K     +  +A  +   + Y+
Sbjct: 61   GGVGIPTIRWCGAEGDYNVMVMELLGPSLE-DLFNFCSRKFSLKTVLLLADQMISRIEYI 119

Query: 890  HYSCVPRIVHRDIKPSNIL---LDEELNAYLSDFGLARLLEVSETHA------TTDVAGT 940
            H       +HRD+KP N L     +    Y+ DFGLA+    + TH         ++ GT
Sbjct: 120  HSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176

Query: 941  FGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKE 1000
              Y +         S + D+ S G VL+    G        +            K     
Sbjct: 177  ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA-------TKRQKYERIS 229

Query: 1001 GRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051
             +     +  L +  P E         + C       +P    +    + L
Sbjct: 230  EKKMSTPIEVLCKGYPSE----FATYLNFCRSLRFDDKPDYSYLRQLFRNL 276

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  156 bits (396), Expect = 3e-43
 Identities = 63/287 (21%), Positives = 109/287 (37%), Gaps = 39/287 (13%)

Query: 776  NFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGI---------QQFDAEIGTL 825
            N+  + ++G G      +    P     AVK + +               +    E+  L
Sbjct: 4    NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 826  GRIR-HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQ 884
             ++  H N++ L   Y      FLV++ +  G L  ++ +K    +      KI   + +
Sbjct: 64   RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLE 121

Query: 885  ALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYV 944
             +  LH      IVHRD+KP NILLD+++N  L+DFG +  L+        +V GT  Y+
Sbjct: 122  VICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLREVCGTPSYL 176

Query: 945  APEYATTCRV------SDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLI 998
            APE               + D++S GV++  L++G              F       +L 
Sbjct: 177  APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-----------FWHRKQMLMLR 225

Query: 999  KEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVL 1045
                 +  F    W+         +  L S   V     R + ++ L
Sbjct: 226  MIMSGNYQFGSPEWDDYSDT----VKDLVSRFLVVQPQKRYTAEEAL 268

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 7e-43
 Identities = 56/273 (20%), Positives = 104/273 (38%), Gaps = 25/273 (9%)

Query: 776  NFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
             + I   +G G FG  ++            K + + +         EI  L   RH+N++
Sbjct: 6    KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNIL 64

Query: 835  TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
             L   +    E+ +++ F+SG ++   I+     ++    I      + +AL +LH    
Sbjct: 65   HLHESFESMEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHS--- 120

Query: 895  PRIVHRDIKPSNILLDEELNAY--LSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
              I H DI+P NI+     ++   + +FG AR L+  +            Y APE     
Sbjct: 121  HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQHD 178

Query: 953  RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012
             VS   D++S G ++  L+SG     P        F   +  +++     +   F  E +
Sbjct: 179  VVSTATDMWSLGTLVYVLLSGIN---P--------FLAETNQQIIENIMNAEYTFDEEAF 227

Query: 1013 EAGPQENLLGMMRLASTCTVETLSTRPSVKQVL 1045
            +    E     M       V+   +R +  + L
Sbjct: 228  KEISIE----AMDFVDRLLVKERKSRMTASEAL 256

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  158 bits (400), Expect = 8e-43
 Identities = 66/264 (25%), Positives = 110/264 (41%), Gaps = 19/264 (7%)

Query: 776  NFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRF---QGIQQFDAE---IGTLGRI 828
            +FS+  +IG GGFG  Y       G + A+K L   R    QG      E   +  +   
Sbjct: 5    DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 829  RHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAY 888
                +V +   +    ++  + + ++GG+L   + +        + +   A +I   L +
Sbjct: 65   DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEH 122

Query: 889  LHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEY 948
            +H      +V+RD+KP+NILLDE  +  +SD GLA      + HA+    GT GY+APE 
Sbjct: 123  MHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEV 176

Query: 949  ATTCRVSD-KADVYSFGVVLLELISGKRSLD-PSFSEYGNGFNIVSWAKLLIKEGRSSEL 1006
                   D  AD +S G +L +L+ G          +      +     + + +  S EL
Sbjct: 177  LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 236

Query: 1007 --FLPELWEAGPQENLLGMMRLAS 1028
               L  L +      L  + R A 
Sbjct: 237  RSLLEGLLQRDVNRRLGCLGRGAQ 260

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  156 bits (394), Expect = 1e-42
 Identities = 53/204 (25%), Positives = 97/204 (47%), Gaps = 13/204 (6%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLS---IGRFQGIQQFDAEIGTLGRIRHK 831
           +F I   +GTG FG  +       G   A+K L    + R + ++  + E   L  + H 
Sbjct: 5   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64

Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
            ++ + G +    ++F++ +++ GG L + + K      Q           A+    L Y
Sbjct: 65  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEY 119

Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT 951
                I++RD+KP NILLD+  +  ++DFG A+ +       T  + GT  Y+APE  +T
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPDYIAPEVVST 175

Query: 952 CRVSDKADVYSFGVVLLELISGKR 975
              +   D +SFG+++ E+++G  
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYT 199

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 1e-42
 Identities = 69/284 (24%), Positives = 113/284 (39%), Gaps = 19/284 (6%)

Query: 776  NFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKN 832
            NF     IG G +G  YKA     G +VA+KK+ +             EI  L  + H N
Sbjct: 3    NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 833  LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
            +V L+     E +++LV+ FL   +L+ F+   +   I   +I      + Q LA+ H  
Sbjct: 63   IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121

Query: 893  CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
                ++HRD+KP N+L++ E    L+DFGLAR   V     T +V   +           
Sbjct: 122  R---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178

Query: 953  RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012
              S   D++S G +  E+++ +  L P  SE    F I        +        +P+  
Sbjct: 179  YYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237

Query: 1013 EAGPQENLLGMMRLASTCTVETL-----------STRPSVKQVL 1045
             + P+       ++      +             + R S K  L
Sbjct: 238  PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 3e-42
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 11/205 (5%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRF---QGIQQFDAEIGTLGR-IRH 830
           +F +  ++G G FG  + AE        A+K L          ++    E   L     H
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 831 KNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH 890
             L  +   +  +  +F V  +L+GG+L   I      K   S     A +I   L +LH
Sbjct: 63  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLH 120

Query: 891 YSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYAT 950
                 IV+RD+K  NILLD++ +  ++DFG+ +   + +    T   GT  Y+APE   
Sbjct: 121 S---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILL 176

Query: 951 TCRVSDKADVYSFGVVLLELISGKR 975
             + +   D +SFGV+L E++ G+ 
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQS 201

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 3e-41
 Identities = 62/276 (22%), Positives = 103/276 (37%), Gaps = 30/276 (10%)

Query: 779  IRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFDAEIGTLGRI-RHKNLVTL 836
               ++G G  G   +          A+K L     Q   +   E+    R  +  ++V +
Sbjct: 16   TSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRI 70

Query: 837  IGYY----VGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
            +  Y     G   + +V   L GG L + I  +  +        +I   I +A+ YLH  
Sbjct: 71   VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 130

Query: 893  CVPRIVHRDIKPSNILLDEELN---AYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYA 949
                I HRD+KP N+L   +       L+DFG A+      +  T     T  YVAPE  
Sbjct: 131  ---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVL 185

Query: 950  TTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009
               +     D++S GV++  L+ G     P F    +G  I    K  I+ G+    F  
Sbjct: 186  GPEKYDKSCDMWSLGVIMYILLCGY----PPFYS-NHGLAISPGMKTRIRMGQYE--FPN 238

Query: 1010 ELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVL 1045
              W    +E    +  L         + R ++ + +
Sbjct: 239  PEWSEVSEE----VKMLIRNLLKTEPTQRMTITEFM 270

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  150 bits (378), Expect = 9e-41
 Identities = 63/283 (22%), Positives = 112/283 (39%), Gaps = 19/283 (6%)

Query: 776  NFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKNL 833
             +     IG G +G  YKA+   G   A+KK+ + +           EI  L  ++H N+
Sbjct: 3    KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 834  VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
            V L      +  + LV+  L     +     +    ++        + +   +AY H   
Sbjct: 63   VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHD-- 118

Query: 894  VPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCR 953
              R++HRD+KP N+L++ E    ++DFGLAR   +     T ++   +         + +
Sbjct: 119  -RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177

Query: 954  VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVS---------WAKL--LIKEGR 1002
             S   D++S G +  E+++G   L P  SE      I           W  +  L K   
Sbjct: 178  YSTTIDIWSVGCIFAEMVNG-TPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236

Query: 1003 SSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVL 1045
            +  ++ P  WE+  +      + L S       + R + KQ L
Sbjct: 237  NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  149 bits (376), Expect = 2e-40
 Identities = 54/289 (18%), Positives = 97/289 (33%), Gaps = 29/289 (10%)

Query: 775  GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNL 833
             ++ +   IG G FG  ++   L+    VA+K     R     Q   E  T   +     
Sbjct: 5    VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTG 62

Query: 834  VTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC 893
            +  + Y+  E    ++   L G +LE  +    G+K     +   A  +   +  +H   
Sbjct: 63   IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEK- 120

Query: 894  VPRIVHRDIKPSNILLDEELN-----AYLSDFGLARLLEVSETHA------TTDVAGTFG 942
               +V+RDIKP N L+    +      Y+ DFG+ +      T          +++GT  
Sbjct: 121  --SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178

Query: 943  YVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGR 1002
            Y++         S + D+ + G V +  + G           G            I E +
Sbjct: 179  YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ------GLKAATNKQKYERIGEKK 232

Query: 1003 SSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051
             S   L EL    P+E      +             P    +     ++
Sbjct: 233  QS-TPLRELCAGFPEE----FYKYMHYARNLAFDATPDYDYLQGLFSKV 276

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 3e-40
 Identities = 72/282 (25%), Positives = 117/282 (41%), Gaps = 24/282 (8%)

Query: 781  NLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQG-----IQQFDAEIGTLGRIRHKNLV 834
            + +G G F + YKA       +VA+KK+ +G          +    EI  L  + H N++
Sbjct: 4    DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 835  TLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCV 894
             L+  +  ++ + LV++F+        I K +   +  S I    +   Q L YLH    
Sbjct: 64   GLLDAFGHKSNISLVFDFMETDLE--VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW- 120

Query: 895  PRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRV 954
              I+HRD+KP+N+LLDE     L+DFGLA+    S   A T    T  Y APE     R+
Sbjct: 121  --ILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVVTRWYRAPELLFGARM 177

Query: 955  SD-KADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE--L 1011
                 D+++ G +L EL+       P  S+      I        +E       LP+   
Sbjct: 178  YGVGVDMWAVGCILAELLLRVP-FLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236

Query: 1012 WEAGPQENLLGMMRLASTCTVETL--------STRPSVKQVL 1045
            +++ P   L  +   A    ++ +          R +  Q L
Sbjct: 237  FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 1e-39
 Identities = 72/295 (24%), Positives = 112/295 (37%), Gaps = 28/295 (9%)

Query: 772  RATGNFSIRNLIGTGGFGSTYKAELVP--GYLVAVKKLSI-----GRFQGIQQFDAEIGT 824
            RA   +     IG G +G  +KA  +   G  VA+K++ +     G      +  A +  
Sbjct: 4    RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63

Query: 825  LGRIRHKNLVTLIGYYV-----GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
            L    H N+V L           E ++ LV+  +       ++ K     +    I  + 
Sbjct: 64   LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT-YLDKVPEPGVPTETIKDMM 122

Query: 880  IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAG 939
              + + L +LH      +VHRD+KP NIL+       L+DFGLAR+   S   A T V  
Sbjct: 123  FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVV 177

Query: 940  TFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIK 999
            T  Y APE       +   D++S G +  E+   K  L    S+      I+    L  +
Sbjct: 178  TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP-LFRGSSDVDQLGKILDVIGLPGE 236

Query: 1000 EGRSSELFLPE----LWEAGPQENLLGMM-----RLASTCTVETLSTRPSVKQVL 1045
            E    ++ LP        A P E  +  +      L   C     + R S    L
Sbjct: 237  EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 1e-39
 Identities = 54/284 (19%), Positives = 101/284 (35%), Gaps = 19/284 (6%)

Query: 776  NFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKN 832
             +     IG G +G+ +KA+      +VA+K++ +             EI  L  ++HKN
Sbjct: 3    KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62

Query: 833  LVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYS 892
            +V L      + ++ LV+ F      + F        +   ++      + + L + H  
Sbjct: 63   IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHS- 119

Query: 893  CVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTC 952
                ++HRD+KP N+L++      L++FGLAR   +     + +V   +           
Sbjct: 120  --RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177

Query: 953  RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012
              S   D++S G +  EL +  R L P          I        +E   S   LP+  
Sbjct: 178  LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237

Query: 1013 EAGPQENLLGMMRLASTCTVETL-----------STRPSVKQVL 1045
                      ++ +                      R S ++ L
Sbjct: 238  PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 2e-39
 Identities = 59/280 (21%), Positives = 108/280 (38%), Gaps = 33/280 (11%)

Query: 777  FSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQG------IQQFDAEIGTLGRIR 829
            +     +G+G F    K  E   G   A K +   R +        +  + E+  L  I+
Sbjct: 12   YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71

Query: 830  HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYL 889
            H N++TL   Y  + ++ L+   ++GG L  F+ +K  + +      +    I   +   
Sbjct: 72   HPNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGV--- 126

Query: 890  HYSCVPRIVHRDIKPSNILLDEE----LNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
            +Y    +I H D+KP NI+L +         + DFGLA   ++   +   ++ GT  +VA
Sbjct: 127  YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIFGTPEFVA 184

Query: 946  PEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005
            PE      +  +AD++S GV+   L+SG              F   +  + L      + 
Sbjct: 185  PEIVNYEPLGLEADMWSIGVITYILLSGASP-----------FLGDTKQETLANVSAVNY 233

Query: 1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVL 1045
             F  E +                   V+    R +++  L
Sbjct: 234  EFEDEYFSNTSAL----AKDFIRRLLVKDPKKRMTIQDSL 269

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 2e-39
 Identities = 66/297 (22%), Positives = 113/297 (38%), Gaps = 35/297 (11%)

Query: 774  TGNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRFQG-IQQFDAEIGTLGRIRHK 831
               ++  + IG G +G    A + V    VA+KK+S    Q   Q+   EI  L R RH+
Sbjct: 7    GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 832  NLVTLIGYYVGEA----EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALA 887
            N++ +            +   +   L G +L   +  +    +    I      I + L 
Sbjct: 67   NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLK 123

Query: 888  YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT--TDVAGTFGYVA 945
            Y+H +    ++HRD+KPSN+LL+   +  + DFGLAR+ +    H    T+   T  Y A
Sbjct: 124  YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 180

Query: 946  PEYATTCRVSD-KADVYSFGVVLLELISGK----------------RSLDPSFSEYGNGF 988
            PE     +      D++S G +L E++S +                  L     E  N  
Sbjct: 181  PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240

Query: 989  NIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVL 1045
              +     L+     +++    L+     +     + L           R  V+Q L
Sbjct: 241  INLKARNYLLSLPHKNKVPWNRLFPNADSK----ALDLLDKMLTFNPHKRIEVEQAL 293

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 6e-39
 Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 17/209 (8%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLV 834
           +++   +IG G FG  Y+A+L   G LVA+KK+     Q  +  + E+  + ++ H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 76

Query: 835 TLIGYYVGEAE------MFLVYNFLSGGNLETFIH-KKSGKKIQWSVIHKIAIDIAQALA 887
            L  ++    E      + LV +++         H  ++ + +    +      + ++LA
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136

Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNAY-LSDFGLARLLEVSETHATTDVAGTFGYVAP 946
           Y+H      I HRDIKP N+LLD +     L DFG A+ L   E + +  +   +     
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAPE 192

Query: 947 EYATTCRVSDKADVYSFGVVLLELISGKR 975
                   +   DV+S G VL EL+ G+ 
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 1e-37
 Identities = 57/260 (21%), Positives = 99/260 (38%), Gaps = 16/260 (6%)

Query: 776  NFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRF---QGIQQFDAEIGTLGRIRHK 831
            +F    L+G G FG          G   A+K L          +     E   L   RH 
Sbjct: 6    DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65

Query: 832  NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
             L  L   +     +  V  + +GG L   + ++     +           A+ ++ L Y
Sbjct: 66   FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSALEY 120

Query: 892  SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT 951
                 +V+RDIK  N++LD++ +  ++DFGL +              GT  Y+APE    
Sbjct: 121  LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEVLED 179

Query: 952  CRVSDKADVYSFGVVLLELISGKRSLDPSFSE-YGNGFNIVSWAKLLIKEGRSSEL--FL 1008
                   D +  GVV+ E++ G+    P +++ +   F ++   ++      S E    L
Sbjct: 180  NDYGRAVDWWGLGVVMYEMMCGRL---PFYNQDHERLFELILMEEIRFPRTLSPEAKSLL 236

Query: 1009 PELWEAGPQENLLGMMRLAS 1028
              L +  P++ L G    A 
Sbjct: 237  AGLLKKDPKQRLGGGPSDAK 256

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 2e-37
 Identities = 59/282 (20%), Positives = 103/282 (36%), Gaps = 43/282 (15%)

Query: 775  GNFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQG------IQQFDAEIGTLGR 827
              + +  L+G+GGFGS Y    V     VA+K +   R           +   E+  L +
Sbjct: 4    SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 828  IR--HKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
            +      ++ L+ ++       L+               + G  +Q  +       + +A
Sbjct: 64   VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEA 122

Query: 886  LAYLHYSCVPRIVHRDIKPSNILLDEE-LNAYLSDFGLARLLEVSETHATTDVAGTFGYV 944
            + + H      ++HRDIK  NIL+D       L DFG   LL   +    TD  GT  Y 
Sbjct: 123  VRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 176

Query: 945  APEYATTCRVSDK-ADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRS 1003
             PE+    R   + A V+S G++L +++ G       F         +   ++  ++  S
Sbjct: 177  PPEWIRYHRYHGRSAAVWSLGILLYDMVCGD----IPF----EHDEEIIRGQVFFRQRVS 228

Query: 1004 SELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVL 1045
            SE                    L   C     S RP+ +++ 
Sbjct: 229  SEC-----------------QHLIRWCLALRPSDRPTFEEIQ 253

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (347), Expect = 2e-36
 Identities = 53/221 (23%), Positives = 92/221 (41%), Gaps = 20/221 (9%)

Query: 770 VVRATGNFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQG--IQQFDAEIGTLG 826
                  +     IG G FG  +KA     G  VA+KK+ +   +         EI  L 
Sbjct: 5   FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ 64

Query: 827 RIRHKNLVTLIG--------YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKI 878
            ++H+N+V LI         Y   +  ++LV++F          +     K   S I ++
Sbjct: 65  LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL--VKFTLSEIKRV 122

Query: 879 AIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET---HATT 935
              +   L  L+Y    +I+HRD+K +N+L+  +    L+DFGLAR   +++    +  T
Sbjct: 123 ---MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 179

Query: 936 DVAGTFGYVAPEYATTCR-VSDKADVYSFGVVLLELISGKR 975
           +   T  Y  PE     R      D++  G ++ E+ +   
Sbjct: 180 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 220

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  136 bits (343), Expect = 2e-35
 Identities = 46/204 (22%), Positives = 88/204 (43%), Gaps = 13/204 (6%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLS---IGRFQGIQQFDAEIGTLGRIRHK 831
            F     +GTG FG     +    G   A+K L    + + + I+    E   L  +   
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101

Query: 832 NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY 891
            LV L   +   + +++V  +++GG + + + +    +         A  I     YLH 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHS 159

Query: 892 SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATT 951
                +++RD+KP N+L+D++    ++DFG A+         T  + GT   +APE   +
Sbjct: 160 L---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILS 212

Query: 952 CRVSDKADVYSFGVVLLELISGKR 975
              +   D ++ GV++ E+ +G  
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYP 236

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 4e-35
 Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 16/211 (7%)

Query: 776 NFSIRNLIGTGGFGSTYKAELVP----GYLVAVKKLS----IGRFQGIQQFDAEIGTLGR 827
           NF +  ++GTG +G  +    +     G L A+K L     + + +  +    E   L  
Sbjct: 25  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84

Query: 828 IRHK-NLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQAL 886
           IR    LVTL   +  E ++ L+ ++++GG L T + ++            + I + + +
Sbjct: 85  IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-----VQIYVGEIV 139

Query: 887 AYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAP 946
             L +     I++RDIK  NILLD   +  L+DFGL++     ET    D  GT  Y+AP
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199

Query: 947 EYATTCRVSD--KADVYSFGVVLLELISGKR 975
           +             D +S GV++ EL++G  
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  126 bits (317), Expect = 3e-32
 Identities = 55/307 (17%), Positives = 109/307 (35%), Gaps = 41/307 (13%)

Query: 767  YDNVVRATGN---FSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGIQQFDAEI 822
            Y++ V   GN   + +   +G G +   ++A  +     V VK L   +    ++   EI
Sbjct: 24   YESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREI 80

Query: 823  GTLGRIR-HKNLVTLIGYYVGEAE--MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
              L  +R   N++TL             LV+  ++  + +        + +    I    
Sbjct: 81   KILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYM 135

Query: 880  IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEE-LNAYLSDFGLARLLEVSETHATTDVA 938
             +I +AL Y H      I+HRD+KP N+++D E     L D+GLA      + +      
Sbjct: 136  YEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRV 190

Query: 939  GTFGYVAPEYATTCRVSD-KADVYSFGVVLLELISGKRSLDPSFSEYG---NGFNIVSWA 994
             +  +  PE     ++ D   D++S G +L  +I  K         Y        ++   
Sbjct: 191  ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 250

Query: 995  KLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLS----------------TR 1038
             L     + +    P   +   + +     R   +     +S                +R
Sbjct: 251  DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 310

Query: 1039 PSVKQVL 1045
             + ++ +
Sbjct: 311  LTAREAM 317

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 2e-31
 Identities = 61/291 (20%), Positives = 116/291 (39%), Gaps = 33/291 (11%)

Query: 777  FSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKNL 833
            +     +G+G +G+   A +   G  VA+KKL          ++   E+  L  +RH+N+
Sbjct: 20   YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79

Query: 834  VTLIGYYVGE------AEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALA 887
            + L+  +  +       + +LV  F+  G     + K   +K+    I  +   + + L 
Sbjct: 80   IGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLR 135

Query: 888  YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE 947
            Y+H + +    HRD+KP N+ ++E+    + DFGLAR     ++  T  V   +      
Sbjct: 136  YIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTGYVVTRWYRAPEV 189

Query: 948  YATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVS---------WAKLLI 998
                 R +   D++S G ++ E+I+G ++L            I+            +L  
Sbjct: 190  ILNWMRYTQTVDIWSVGCIMAEMITG-KTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248

Query: 999  KEGRSSELFLPELWEAGPQENLLGM----MRLASTCTVETLSTRPSVKQVL 1045
             E ++    LPEL +      L       + L     V     R +  + L
Sbjct: 249  DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL 299

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 5e-31
 Identities = 47/209 (22%), Positives = 88/209 (42%), Gaps = 19/209 (9%)

Query: 775 GNFSIRNLIGTGGFGSTYKA-ELVPGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHK 831
             +     IG+G  G    A + V    VA+KKLS         ++   E+  +  + HK
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 832 NLVTLIGYYVGEA------EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQA 885
           N+++L+  +  +       +++LV   +     +    +          +  +   +   
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-----HERMSYLLYQMLCG 131

Query: 886 LAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVA 945
           + +LH +    I+HRD+KPSNI++  +    + DFGLAR      +   T    T  Y A
Sbjct: 132 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRA 186

Query: 946 PEYATTCRVSDKADVYSFGVVLLELISGK 974
           PE        +  D++S G ++ E++  K
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 2e-29
 Identities = 65/291 (22%), Positives = 117/291 (40%), Gaps = 31/291 (10%)

Query: 776  NFSIRNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGRFQGI--QQFDAEIGTLGRIRHKN 832
             +   + +G+G +GS   A     G  VAVKKLS      I  ++   E+  L  ++H+N
Sbjct: 19   RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 78

Query: 833  LVTLIGYYV-----GEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALA 887
            ++ L+  +       E     +   L G +L   +  +   K+    +  +   I + L 
Sbjct: 79   VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLK 135

Query: 888  YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHATTDVAGTFGYVAPE 947
            Y+H      I+HRD+KPSN+ ++E+    + DFGLAR    ++   T  VA  +      
Sbjct: 136  YIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEI 189

Query: 948  YATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVS---------WAKLLI 998
                   +   D++S G ++ EL++G R+L P          I+            K+  
Sbjct: 190  MLNWMHYNQTVDIWSVGCIMAELLTG-RTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248

Query: 999  KEGRSSELFLPELWEAGPQENLLGM----MRLASTCTVETLSTRPSVKQVL 1045
            +  R+    L ++ +       +G     + L     V     R +  Q L
Sbjct: 249  ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 299

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  113 bits (284), Expect = 9e-28
 Identities = 58/290 (20%), Positives = 102/290 (35%), Gaps = 21/290 (7%)

Query: 775  GNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNL 833
              + +   +G G F + + A+ +V    VA+K +  G     +  + EI  L R+   + 
Sbjct: 13   ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADN 71

Query: 834  VTLIG--------------YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIA 879
                               +        ++   + G NL   I K   + I    + +I+
Sbjct: 72   TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131

Query: 880  IDIAQALAYLHYSCVPRIVHRDIKPSNILLDEE-LNAYLSDFGLARL-LEVSETHATTDV 937
              +   L Y+H  C   I+H DIKP N+L++       L    +A L          T+ 
Sbjct: 132  KQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 189

Query: 938  AGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLL 997
              T  Y +PE          AD++S   ++ ELI+G    +P    +    +    A+++
Sbjct: 190  IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD-EGHSYTKDDDHIAQII 248

Query: 998  IKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047
               G      L          N  G++R  S      L    + K    K
Sbjct: 249  ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSK 298

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 94.1 bits (233), Expect = 2e-22
 Identities = 32/160 (20%), Positives = 56/160 (35%), Gaps = 19/160 (11%)

Query: 778 SIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIG----------RFQGIQQFDAEIGTLGR 827
           +I  L+G G   + +           VK   +G          R  G   F        R
Sbjct: 3   AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62

Query: 828 IRHKNLVTLIGYYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALA 887
              + L  L G  V +     VY +     L   I  K   +++     ++   I + +A
Sbjct: 63  NEFRALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVA 117

Query: 888 YLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE 927
             ++     IVH D+   N+L+ EE   ++ DF  +  + 
Sbjct: 118 KFYHRG---IVHGDLSQYNVLVSEE-GIWIIDFPQSVEVG 153

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 96.4 bits (238), Expect = 3e-22
 Identities = 75/305 (24%), Positives = 116/305 (38%), Gaps = 61/305 (20%)

Query: 48  TDSASLLSFKASISRDPSNLLATWNSSTDHC--TWHGVTCD--HFTGRVTALRITGKATP 103
            D  +LL  K  +  +P+ L ++W  +TD C  TW GV CD    T RV  L ++G   P
Sbjct: 6   QDKQALLQIKKDLG-NPTTL-SSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP 63

Query: 104 WPSKSSVISGTLSASIAKLTELRTLSVPHN-SFSGEIPAGVGELRLLEVLELQGNNFSGK 162
            P         + +S+A L  L  L +    +  G IP  + +L  L  L +   N SG 
Sbjct: 64  KP-------YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA 116

Query: 163 IPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFL 222
           IP  +S ++ L  L+ S+N+ SG +P  +     L  I    NR+SG +     S  +  
Sbjct: 117 IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLF 176

Query: 223 TYLKLSDNFLTESIPKEIGKCRNLKNL--------------------------------- 249
           T + +S N LT  IP                                             
Sbjct: 177 TSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD 236

Query: 250 -------------LLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSV 296
                         L  N + G++P+ +  +  L  L+VS N+L   IP +  +  +  V
Sbjct: 237 LGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDV 295

Query: 297 LVLTN 301
               N
Sbjct: 296 SAYAN 300

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 79.4 bits (194), Expect = 2e-16
 Identities = 55/278 (19%), Positives = 97/278 (34%), Gaps = 17/278 (6%)

Query: 348 DNWSESCSLKVLNLGQNSLKGA--VPKSLGMCRNLTYLDLS--LNNLEGYLPMQLPVPCM 403
           D  +++  +  L+L   +L     +P SL     L +L +    N +    P    +  +
Sbjct: 44  DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103

Query: 404 VYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLG 463
            Y  ++  N++G +P F +               +  +  SIS    ++   F GN+  G
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163

Query: 464 SLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMS 523
           ++P        L            N            ++      S ++      +   S
Sbjct: 164 AIPDSYGSFSKLFTSMTISR----NRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGS 219

Query: 524 YEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLK 583
            +      +          ++             L  LDLR NR+ G+LP  L +LKFL 
Sbjct: 220 DKNTQKIHLAKNSLAFDLGKVG--------LSKNLNGLDLRNNRIYGTLPQGLTQLKFLH 271

Query: 584 WILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIP 621
            + +  NNL GEIP   G+L    V   ++N      P
Sbjct: 272 SLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 66.3 bits (160), Expect = 4e-12
 Identities = 24/58 (41%), Positives = 33/58 (56%), Gaps = 3/58 (5%)

Query: 635 LAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIP---HLQHLDCIAFKGNKYLASCP 689
           L +NR+ G +P   + L  L +L++SFNNL G IP   +LQ  D  A+  NK L   P
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 55.9 bits (133), Expect = 1e-08
 Identities = 20/65 (30%), Positives = 35/65 (53%), Gaps = 3/65 (4%)

Query: 154 LQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGN-GELSVIDMSSNRLSGGLA 212
           L+ N   G +P  ++ L+ L  LN+SFN+  GE+P+G  GN     V   ++N+   G  
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG--GNLQRFDVSAYANNKCLCGSP 308

Query: 213 IDSSS 217
           + + +
Sbjct: 309 LPACT 313

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 51.3 bits (121), Expect = 3e-07
 Identities = 19/54 (35%), Positives = 26/54 (48%), Gaps = 1/54 (1%)

Query: 111 ISGTLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIP 164
           I GTL   + +L  L +L+V  N+  GEIP G G L+  +V     N      P
Sbjct: 256 IYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 47.8 bits (112), Expect = 4e-06
 Identities = 16/64 (25%), Positives = 27/64 (42%), Gaps = 2/64 (3%)

Query: 198 SVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILE 257
           + +D+ +NR+ G L     ++ +FL  L +S N L   IP + G  +         N   
Sbjct: 247 NGLDLRNNRIYGTLP-QGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCL 304

Query: 258 GSIP 261
              P
Sbjct: 305 CGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 44.4 bits (103), Expect = 4e-05
 Identities = 53/285 (18%), Positives = 87/285 (30%), Gaps = 29/285 (10%)

Query: 241 GKCRNLKNLLLDGNILEG--SIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLV 298
            +   + NL L G  L     IP  +  +  L               + +   + L   +
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN-------------FLYIGGINNLVGPI 93

Query: 299 LTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKV 358
              I     L       +   G +P  L   ++L  L      L G LP + S   +L  
Sbjct: 94  PPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVG 153

Query: 359 LNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNITGVLP 418
           +    N + GA+P S G    L        N              + F     N+     
Sbjct: 154 ITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDA 213

Query: 419 RFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAK 478
                S  N       + +    +G +     +   D   N+  G+LP      G    +
Sbjct: 214 SVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLP-----QGL--TQ 266

Query: 479 YKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSV-NLSAN-LLSG 521
            K  + L ++ N   G +P     +  +LQ F V   + N  L G
Sbjct: 267 LKFLHSLNVSFNNLCGEIP-----QGGNLQRFDVSAYANNKCLCG 306

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 95.1 bits (235), Expect = 3e-21
 Identities = 65/361 (18%), Positives = 116/361 (32%), Gaps = 67/361 (18%)

Query: 351 SESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEG-----------YLPMQLP 399
           ++   +  L   +  +K      +    NLT ++ S N L              + M   
Sbjct: 41  TDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNN 98

Query: 400 VPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGN 459
               +    +  N+TG+      ++  +                +ISD + +        
Sbjct: 99  QIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQ 158

Query: 460 KFLGSLPLFAIGDGFL------------------AAKYKPHYRLLLNNNMFNGSVPGERI 501
              G+          L                   AK      L+  NN  +   P   +
Sbjct: 159 LSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL 218

Query: 502 SKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRL 561
           +  ++L     +L+ N L  +     L     L + + ANNQIS      +  L KL  L
Sbjct: 219 TNLDEL-----SLNGNQLKDIG---TLASLTNLTDLDLANNQISNLAP--LSGLTKLTEL 268

Query: 562 DLRGNRVSGSLP--------------------DELGKLKFLKWILLGGNNLTGEIPSQFG 601
            L  N++S   P                      +  LK L ++ L  NN++   P    
Sbjct: 269 KLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VS 326

Query: 602 HLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSF 661
            L  L  L  ++N ++    +SL   T +  L   HN++S   P   + L  ++ L L+ 
Sbjct: 327 SLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLND 382

Query: 662 N 662
            
Sbjct: 383 Q 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 87.4 bits (215), Expect = 9e-19
 Identities = 60/391 (15%), Positives = 121/391 (30%), Gaps = 33/391 (8%)

Query: 225 LKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRI 284
             L    +T+++ +       +  L  D   ++ SI   +  ++ L  ++ S N LTD  
Sbjct: 27  TVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLTDIT 82

Query: 285 PVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGG 344
           P  L + +KL  +++ N   +     +             ++     L+ L         
Sbjct: 83  P--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELS 140

Query: 345 RLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMV 404
               +   + S        +                       +N    + +   +  + 
Sbjct: 141 SNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLE 200

Query: 405 YFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGS 464
               + N I+ + P     + D       L    +  +G+++    +   D + N+    
Sbjct: 201 SLIATNNQISDITPLGILTNLDEL----SLNGNQLKDIGTLASLTNLTDLDLANNQISNL 256

Query: 465 LPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSY 524
            PL         +       L L  N  +   P   ++   +L+             +  
Sbjct: 257 APL---------SGLTKLTELKLGANQISNISPLAGLTALTNLELNENQ--------LED 299

Query: 525 EAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKW 584
            + + +   L       N IS      V  L KLQRL    N+VS      L  L  + W
Sbjct: 300 ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINW 355

Query: 585 ILLGGNNLTGEIPSQFGHLISLVVLDLSHNA 615
           +  G N ++   P    +L  +  L L+  A
Sbjct: 356 LSAGHNQISDLTP--LANLTRITQLGLNDQA 384

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 84.3 bits (207), Expect = 1e-17
 Identities = 39/179 (21%), Positives = 67/179 (37%), Gaps = 15/179 (8%)

Query: 123 TELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNS 182
           T L  LS+  N         +  L  L  L+L  N  S   P  +S L +L  L L  N 
Sbjct: 219 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ 274

Query: 183 FSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGK 242
                   +     L+ +       +    I   S  + LTYL L  N +++  P  +  
Sbjct: 275 I-----SNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSS 327

Query: 243 CRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTN 301
              L+ L    N +       +  ++ +  L    N ++D  P  LA+ ++++ L L +
Sbjct: 328 LTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLND 382

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 60.8 bits (146), Expect = 4e-10
 Identities = 44/244 (18%), Positives = 76/244 (31%), Gaps = 71/244 (29%)

Query: 165 YQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTY 224
             ++ L  L  L  + N  S   P G++ N  L  + ++ N+L     I + +    LT 
Sbjct: 191 SVLAKLTNLESLIATNNQISDITPLGILTN--LDELSLNGNQLKD---IGTLASLTNLTD 245

Query: 225 LKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISE--------------- 269
           L L++N ++   P  +     L  L L  N +    P    T                  
Sbjct: 246 LDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPI 303

Query: 270 -----LKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPY 324
                L  L +  N+++D  P  ++  +KL  L   N        N   + S+       
Sbjct: 304 SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFAN--------NKVSDVSSL------ 347

Query: 325 ELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLD 384
                                L        ++  L+ G N +    P  L     +T L 
Sbjct: 348 -------------------ANLT-------NINWLSAGHNQISDLTP--LANLTRITQLG 379

Query: 385 LSLN 388
           L+  
Sbjct: 380 LNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 60.4 bits (145), Expect = 5e-10
 Identities = 67/423 (15%), Positives = 121/423 (28%), Gaps = 62/423 (14%)

Query: 146 LRLLEVLELQGNNFSGKIP-YQMSNLERLRVLNLSFNSFSGEVPRGLIGN-GELSVIDMS 203
           L       L   N +  +    +  +  L+   L   S  G      +     L+ I+ S
Sbjct: 21  LAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG------VEYLNNLTQINFS 74

Query: 204 SNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKE 263
           +N+L+    I        L  + +++N + +  P           L  +       +   
Sbjct: 75  NNQLTD---ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNL 131

Query: 264 IGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVP 323
                     +   +         L   S  + +      A+L         S     + 
Sbjct: 132 TNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDIS 191

Query: 324 YELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYL 383
               L+   E L A    +    P       +L  L+L  N LK     +L    NLT L
Sbjct: 192 VLAKLTNL-ESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDL 246

Query: 384 DLSLNNLEGYLPMQLPVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMG 443
           DL+ N +    P+   +  +    +  N I+ + P     +  N    ++      P+  
Sbjct: 247 DLANNQISNLAPLS-GLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPIS- 304

Query: 444 SISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISK 503
                                               K    L L  N  +   P   +S 
Sbjct: 305 ----------------------------------NLKNLTYLTLYFNNISDISP---VSS 327

Query: 504 CNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDL 563
              LQ      + N +S +S    L +   +    A +NQIS      +  L ++ +L L
Sbjct: 328 LTKLQRL--FFANNKVSDVS---SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGL 380

Query: 564 RGN 566
              
Sbjct: 381 NDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.1 bits (100), Expect = 1e-04
 Identities = 20/85 (23%), Positives = 39/85 (45%), Gaps = 8/85 (9%)

Query: 555 LMKLQRLDLRGNRVSGSLP-DELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSH 613
           L +  +  L    V+ ++   +L ++  L+   LG  ++ G       +L +L  ++ S+
Sbjct: 21  LAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSN 75

Query: 614 NALTGSIPASLTKATKLESLFLAHN 638
           N LT   P  L   TKL  + + +N
Sbjct: 76  NQLTDITP--LKNLTKLVDILMNNN 98

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 74.3 bits (181), Expect = 9e-15
 Identities = 48/324 (14%), Positives = 96/324 (29%), Gaps = 51/324 (15%)

Query: 345 RLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQL-PVPCM 403
           ++P +        +L+L  N +           +NL  L L  N +    P    P+  +
Sbjct: 24  KVPKDLPPD--TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 404 VYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLG 463
               +S+N +  +  +      +      ++      V                      
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFN-------------------- 121

Query: 464 SLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMS 523
                                ++        S   E  +     +   + ++   ++ + 
Sbjct: 122 ---------------GLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIP 166

Query: 524 YEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLK 583
                     L E     N+I+   AA +  L  L +L L  N +S      L     L+
Sbjct: 167 QGLP----PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLR 222

Query: 584 WILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTG------SIPASLTKATKLESLFLAH 637
            + L  N L  ++P        + V+ L +N ++         P   TK      + L  
Sbjct: 223 ELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFS 281

Query: 638 NRLS-GEI-PVSFSTLVNLSALDL 659
           N +   EI P +F  +   +A+ L
Sbjct: 282 NPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 68.1 bits (165), Expect = 8e-13
 Identities = 44/282 (15%), Positives = 84/282 (29%), Gaps = 48/282 (17%)

Query: 138 EIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGEL 197
           ++P  +       +L+LQ N  +        NL+ L  L L  N  S   P       +L
Sbjct: 24  KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 198 SVIDMSSNRLSG--------------------GLAIDSSSECEFLTYLKLSDNFLTES-- 235
             + +S N+L                       +     +    +  ++L  N L  S  
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141

Query: 236 IPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLS 295
                   + L  + +    +  +IP+  G    L  L +  N +T      L   + L+
Sbjct: 142 ENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLA 198

Query: 296 VLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCS 355
            L L+                         L  +  L  L      L    P   ++   
Sbjct: 199 KLGLSFNS--------------ISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKY 243

Query: 356 LKVLNLGQNSLKG------AVPKSLGMCRNLTYLDLSLNNLE 391
           ++V+ L  N++          P       + + + L  N ++
Sbjct: 244 IQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 67.4 bits (163), Expect = 2e-12
 Identities = 41/269 (15%), Positives = 82/269 (30%), Gaps = 19/269 (7%)

Query: 222 LTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLT 281
              L L +N +TE    +    +NL  L+L  N +    P     + +L+ L +S+N L 
Sbjct: 33  TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92

Query: 282 DRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRAN 341
           + +P ++    +              L     E +     V   L     +E L      
Sbjct: 93  E-LPEKMPKTLQE-------------LRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLK 137

Query: 342 LGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVP 401
             G     +     L  + +   ++        G+  +LT L L  N +       L   
Sbjct: 138 SSGIENGAFQGMKKLSYIRIADTNITTIPQ---GLPPSLTELHLDGNKITKVDAASLKGL 194

Query: 402 CMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKF 461
             +       N    +      +  +           V V G ++D  ++ +     N  
Sbjct: 195 NNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNN- 253

Query: 462 LGSLPLFAIGDGFLAAKYKPHYRLLLNNN 490
           + ++            K   +  + L +N
Sbjct: 254 ISAIGSNDFCPPGYNTKKASYSGVSLFSN 282

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 65.8 bits (159), Expect = 6e-12
 Identities = 57/320 (17%), Positives = 101/320 (31%), Gaps = 50/320 (15%)

Query: 353 SCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLP-VPCMVYFNVSQN 411
            C L+V+      L+  VPK L    +   LDL  N +          +  +    +  N
Sbjct: 9   QCHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINN 65

Query: 412 NITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIG 471
            I+ + P                                     F+    L  L L    
Sbjct: 66  KISKISP-----------------------------------GAFAPLVKLERLYLSKNQ 90

Query: 472 DGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDC 531
              L  K     + L  +      V     +  N +    +  +    SG+   AF    
Sbjct: 91  LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ-GM 149

Query: 532 VQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNN 591
            +L     A+  I+ +I  G+     L  L L GN+++      L  L  L  + L  N+
Sbjct: 150 KKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 206

Query: 592 LTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSF--- 648
           ++        +   L  L L++N L   +P  L     ++ ++L +N +S      F   
Sbjct: 207 ISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPP 265

Query: 649 ---STLVNLSALDLSFNNLS 665
              +   + S + L  N + 
Sbjct: 266 GYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 64.7 bits (156), Expect = 1e-11
 Identities = 32/139 (23%), Positives = 51/139 (36%), Gaps = 5/139 (3%)

Query: 541 NNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQF 600
           NN+I+         L  L  L L  N++S   P     L  L+ + L  N L        
Sbjct: 40  NNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMP 99

Query: 601 GHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLS 660
             L  L V +     +  S+   L +   +E L     + SG    +F  +  LS + ++
Sbjct: 100 KTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQGMKKLSYIRIA 158

Query: 661 FNNLS----GHIPHLQHLD 675
             N++    G  P L  L 
Sbjct: 159 DTNITTIPQGLPPSLTELH 177

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 57.7 bits (138), Expect = 2e-09
 Identities = 56/315 (17%), Positives = 96/315 (30%), Gaps = 52/315 (16%)

Query: 379 NLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYAN 438
           +L  +  S   LE  +P  LP P     ++  N IT +          N      L   N
Sbjct: 11  HLRVVQCSDLGLE-KVPKDLP-PDTALLDLQNNKITEIKDG----DFKNLKNLHTLILIN 64

Query: 439 VPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPG 498
             +              F+    L  L L       L  K     + L  +      V  
Sbjct: 65  NKISKISPGA-------FAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRK 117

Query: 499 ERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKL 558
              +  N +    +  +    SG+   AF                           + KL
Sbjct: 118 SVFNGLNQMIVVELGTNPLKSSGIENGAF-------------------------QGMKKL 152

Query: 559 QRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTG 618
             + +    ++ ++P  L     L  + L GN +T    +    L +L  L LS N+++ 
Sbjct: 153 SYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA 209

Query: 619 SIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLS----------GHI 668
               SL     L  L L +N+L  ++P   +    +  + L  NN+S          G+ 
Sbjct: 210 VDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYN 268

Query: 669 PHLQHLDCIAFKGNK 683
                   ++   N 
Sbjct: 269 TKKASYSGVSLFSNP 283

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 56.6 bits (135), Expect = 6e-09
 Identities = 22/99 (22%), Positives = 35/99 (35%), Gaps = 3/99 (3%)

Query: 589 GNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSF 648
              L  ++P          +LDL +N +T            L +L L +N++S   P +F
Sbjct: 19  DLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAF 75

Query: 649 STLVNLSALDLSFNNLSGHIPHLQHLDCIAFKGNKYLAS 687
           + LV L  L LS N L      +             +  
Sbjct: 76  APLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITK 114

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 55.0 bits (131), Expect = 2e-08
 Identities = 26/122 (21%), Positives = 45/122 (36%), Gaps = 2/122 (1%)

Query: 571 SLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKL 630
            +P +L        + L  N +T      F +L +L  L L +N ++   P +     KL
Sbjct: 24  KVPKDLPPD--TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 631 ESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPHLQHLDCIAFKGNKYLASCPD 690
           E L+L+ N+L         TL  L   +     +   + +  +   +   G   L S   
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141

Query: 691 TN 692
            N
Sbjct: 142 EN 143

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 49.7 bits (117), Expect = 1e-06
 Identities = 26/167 (15%), Positives = 53/167 (31%), Gaps = 11/167 (6%)

Query: 121 KLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSF 180
               +  L       SG        ++ L  + +   N +  IP        L  L+L  
Sbjct: 124 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIP--QGLPPSLTELHLDG 180

Query: 181 NSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEI 240
           N  +      L G   L+ + + S      +   S +    L  L L++N L + +P  +
Sbjct: 181 NKITKVDAASLKGLNNLAKLGL-SFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGL 238

Query: 241 GKCRNLKNLLLDGNILEG------SIPKEIGTISELKVLDVSRNSLT 281
              + ++ + L  N +          P      +    + +  N + 
Sbjct: 239 ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.3 bits (165), Expect = 6e-13
 Identities = 49/290 (16%), Positives = 80/290 (27%), Gaps = 16/290 (5%)

Query: 377 CRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQY 436
                        L+  +P+ +P        +  N I+ V         +    +     
Sbjct: 10  NEPKVTTSCPQQGLQ-AVPVGIP-AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNV 67

Query: 437 ANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSV 496
                  + +    +   D S N  L S+                    L  +      +
Sbjct: 68  LARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFH-------GLGRLHTLHLDRCGLQEL 120

Query: 497 PGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLM 556
                     LQ     L  N L  +  + F  D   L       N+IS         L 
Sbjct: 121 GPGLFRGLAALQYL--YLQDNALQALPDDTFR-DLGNLTHLFLHGNRISSVPERAFRGLH 177

Query: 557 KLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNAL 616
            L RL L  NRV+   P     L  L  + L  NNL+         L +L  L L+ N  
Sbjct: 178 SLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237

Query: 617 TGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSG 666
                 +      L+    + + +   +P   +         L+ N+L G
Sbjct: 238 VCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLA---GRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.3 bits (165), Expect = 7e-13
 Identities = 50/264 (18%), Positives = 81/264 (30%), Gaps = 14/264 (5%)

Query: 138 EIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGEL 197
            +P G+      + + L GN  S            L +L L  N  +        G   L
Sbjct: 25  AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 198 SVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILE 257
             +D+S N     +   +      L  L L    L E  P        L+ L L  N L+
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142

Query: 258 GSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSA 317
                    +  L  L +  N ++            L  L+L     +    ++  +   
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202

Query: 318 FDGGVPYELLLSRSLEVLWAPRANLGG-RLPDN-WSESCS-------LKVLNLGQNSLKG 368
                 +   LS       AP   L   RL DN W   C        L+      + +  
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPC 262

Query: 369 AVPKSLGMCRNLTYLDLSLNNLEG 392
           ++P+ L          L+ N+L+G
Sbjct: 263 SLPQRL---AGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.6 bits (145), Expect = 2e-10
 Identities = 37/189 (19%), Positives = 55/189 (29%), Gaps = 5/189 (2%)

Query: 488 NNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGS 547
           ++N    SV          L +  ++                    L      +N +   
Sbjct: 88  SDNAQLRSVDPATFHGLGRLHTLHLD---RCGLQELGPGLFRGLAALQYLYLQDNALQAL 144

Query: 548 IAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLV 607
                  L  L  L L GNR+S         L  L  +LL  N +    P  F  L  L+
Sbjct: 145 PDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLM 204

Query: 608 VLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGH 667
            L L  N L+     +L     L+ L L  N    +          L     S + +   
Sbjct: 205 TLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCS 263

Query: 668 IP-HLQHLD 675
           +P  L   D
Sbjct: 264 LPQRLAGRD 272

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.0 bits (133), Expect = 7e-09
 Identities = 46/210 (21%), Positives = 74/210 (35%), Gaps = 7/210 (3%)

Query: 484 RLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQ 543
           R+ L+ N  +  VP      C +L    ++ +    + +   AF    +      + N Q
Sbjct: 36  RIFLHGNRISH-VPAASFRACRNLTILWLHSNVL--ARIDAAAFTGLALLEQLDLSDNAQ 92

Query: 544 ISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHL 603
           +     A    L +L  L L    +    P     L  L+++ L  N L       F  L
Sbjct: 93  LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDL 152

Query: 604 ISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNN 663
            +L  L L  N ++     +      L+ L L  NR++   P +F  L  L  L L  NN
Sbjct: 153 GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212

Query: 664 LSGHIPHLQ----HLDCIAFKGNKYLASCP 689
           LS            L  +    N ++  C 
Sbjct: 213 LSALPTEALAPLRALQYLRLNDNPWVCDCR 242

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.4 bits (129), Expect = 2e-08
 Identities = 37/163 (22%), Positives = 49/163 (30%), Gaps = 29/163 (17%)

Query: 558 LQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNN-------------------------L 592
            QR+ L GNR+S          + L  + L  N                          L
Sbjct: 34  SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93

Query: 593 TGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLV 652
               P+ F  L  L  L L    L    P        L+ L+L  N L      +F  L 
Sbjct: 94  RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153

Query: 653 NLSALDLSFNNLSGHIP----HLQHLDCIAFKGNKYLASCPDT 691
           NL+ L L  N +S         L  LD +    N+     P  
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHA 196

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.3 bits (100), Expect = 9e-05
 Identities = 36/289 (12%), Positives = 81/289 (28%), Gaps = 56/289 (19%)

Query: 259 SIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAF 318
           ++P  I      + + +  N ++         C  L++L L +   +     +    +  
Sbjct: 25  AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 319 DGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLG---------------- 362
           +             ++  +  A L    P  +     L  L+L                 
Sbjct: 83  E-------------QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLA 129

Query: 363 --------QNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLP-VPCMVYFNVSQNNI 413
                    N+L+     +     NLT+L L  N +          +  +    + QN +
Sbjct: 130 ALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRV 189

Query: 414 TGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDG 473
             V P            +      +     +++    +     + N ++           
Sbjct: 190 AHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARP---- 245

Query: 474 FLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSV-NLSANLLSG 521
            L A  +   +   +++    S+P         L    +  L+AN L G
Sbjct: 246 -LWAWLQ---KFRGSSSEVPCSLPQR-------LAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.3 bits (87), Expect = 0.003
 Identities = 17/70 (24%), Positives = 26/70 (37%), Gaps = 3/70 (4%)

Query: 607 VVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSG 666
           V        L  ++P  +  A+  + +FL  NR+S     SF    NL+ L L  N L+ 
Sbjct: 14  VTTSCPQQGLQ-AVPVGIPAAS--QRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR 70

Query: 667 HIPHLQHLDC 676
                     
Sbjct: 71  IDAAAFTGLA 80

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 67.5 bits (163), Expect = 2e-12
 Identities = 52/326 (15%), Positives = 95/326 (29%), Gaps = 21/326 (6%)

Query: 355 SLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNIT 414
               L L    L  ++P+      +L  L  S N+L   LP       +    V  NN+ 
Sbjct: 39  QAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQ--SLKSLLVDNNNLK 91

Query: 415 GVL---PRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIG 471
            +    P  E +   N+   +  +  N   +  I  +N  +         L  +      
Sbjct: 92  ALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQ 151

Query: 472 DGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDC 531
              L       +   +  +  +     +       + + +  L              +  
Sbjct: 152 LEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYA 211

Query: 532 VQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNN 591
              +     +   S          +       +         +    L  L   L   N 
Sbjct: 212 DNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNA 271

Query: 592 LTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTL 651
            + EI S      SL  L++S+N L   +PA      +LE L  + N L+ E+P      
Sbjct: 272 SSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHLA-EVP---ELP 323

Query: 652 VNLSALDLSFNNLSG---HIPHLQHL 674
            NL  L + +N L         ++ L
Sbjct: 324 QNLKQLHVEYNPLREFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 61.4 bits (147), Expect = 2e-10
 Identities = 52/331 (15%), Positives = 99/331 (29%), Gaps = 21/331 (6%)

Query: 328 LSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSL 387
           L R    L      L   LP+       L+ L    NSL   +P+      +L  L +  
Sbjct: 36  LDRQAHELELNNLGLS-SLPE---LPPHLESLVASCNSLT-ELPELPQ---SLKSLLVDN 87

Query: 388 NNLEG--YLPMQLPVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSI 445
           NNL+    LP  L    +    + +          + +  DN+   +           + 
Sbjct: 88  NNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAA 147

Query: 446 SDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCN 505
            +     + +     FL ++         L         ++  NN+       + +    
Sbjct: 148 GNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLT 207

Query: 506 DLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRL--DL 563
            + + +  L        S EA  +    L +       ++    +        +      
Sbjct: 208 TIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLY 267

Query: 564 RGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPAS 623
             N  S  +         L+ + +  N L  E+P+       L  L  S N L   +P  
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPEL 322

Query: 624 LTKATKLESLFLAHNRLSGEIPVSFSTLVNL 654
                 L+ L + +N L  E P    ++ +L
Sbjct: 323 P---QNLKQLHVEYNPLR-EFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 48.3 bits (113), Expect = 3e-06
 Identities = 19/75 (25%), Positives = 27/75 (36%), Gaps = 9/75 (12%)

Query: 222 LTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLT 281
           L  L +S+N L   +P        L+ L+   N L   +P+       LK L V  N L 
Sbjct: 286 LEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPELPQN---LKQLHVEYNPLR 337

Query: 282 DRIPVELADCSKLSV 296
              P        L +
Sbjct: 338 -EFPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 48.3 bits (113), Expect = 3e-06
 Identities = 20/94 (21%), Positives = 30/94 (31%), Gaps = 10/94 (10%)

Query: 154 LQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAI 213
              N  S +I         L  LN+S N    E+P        L  +  S N L+     
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHLA----- 317

Query: 214 DSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLK 247
           +     + L  L +  N L    P       +L+
Sbjct: 318 EVPELPQNLKQLHVEYNPLR-EFPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 47.9 bits (112), Expect = 4e-06
 Identities = 44/337 (13%), Positives = 93/337 (27%), Gaps = 27/337 (8%)

Query: 270 LKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLS 329
              L+++   L+  +P        L  LV +         NS  E       +   L+ +
Sbjct: 40  AHELELNNLGLSS-LPELP---PHLESLVASC--------NSLTELPELPQSLKSLLVDN 87

Query: 330 RSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNN 389
            +L+ L      L      N       ++ N     +      SL    +L      +  
Sbjct: 88  NNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAA 147

Query: 390 LEGYLPMQLPVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDEN 449
               L     +  + +      +   +    +           +     +P + ++    
Sbjct: 148 GNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLT 207

Query: 450 FVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQS 509
            +   +          P     +            L  +    + S              
Sbjct: 208 TIYADNNLLKTLPDLPPSLEALNVRDNYLTD-LPELPQSLTFLDVSENIFSGLSELPPNL 266

Query: 510 FSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVS 569
           + +N S+N +  +           L E   +NN++   + A   +L   +RL    N ++
Sbjct: 267 YYLNASSNEIRSLCD-----LPPSLEELNVSNNKLI-ELPALPPRL---ERLIASFNHLA 317

Query: 570 GSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISL 606
             +P+    LK L    +  N L  E P     +  L
Sbjct: 318 -EVPELPQNLKQLH---VEYNPLR-EFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 42.5 bits (98), Expect = 2e-04
 Identities = 24/97 (24%), Positives = 37/97 (38%), Gaps = 13/97 (13%)

Query: 132 HNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGL 191
            N+ S EI +       LE L +  N    ++P   +   RL  L  SFN  + EVP   
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHLA-EVPELP 323

Query: 192 IGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLS 228
                L  + +  N L     I  S     +  L+++
Sbjct: 324 ---QNLKQLHVEYNPLREFPDIPES-----VEDLRMN 352

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 40.2 bits (92), Expect = 0.001
 Identities = 47/346 (13%), Positives = 94/346 (27%), Gaps = 37/346 (10%)

Query: 243 CRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIP-----VELADCSKLSVL 297
            R    L L+   L  S+P+       L+ L  S NSLT+ +P     ++       ++ 
Sbjct: 37  DRQAHELELNNLGLS-SLPELPP---HLESLVASCNSLTE-LPELPQSLKSLLVDNNNLK 91

Query: 298 VLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLK 357
            L+++   L+              +                       L        SL+
Sbjct: 92  ALSDLPPLLEYLGVSNNQLEKLPELQN--------SSFLKIIDVDNNSLKKLPDLPPSLE 143

Query: 358 VLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNITGVL 417
            +  G N L+              Y D +       LP+ L         + +      L
Sbjct: 144 FIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNL 203

Query: 418 PRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAA 477
           P    +  DN+               ++ D     + +   +     +            
Sbjct: 204 PFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELP 263

Query: 478 KYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEF 537
               +     N                  L+   +N+S N L  +          +L   
Sbjct: 264 PNLYYLNASSNEIRSL-------CDLPPSLE--ELNVSNNKLIELPAL-----PPRLERL 309

Query: 538 EAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLK 583
            A+ N ++  +         L++L +  N +    PD    ++ L+
Sbjct: 310 IASFNHLA-EVP---ELPQNLKQLHVEYNPLR-EFPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 38.7 bits (88), Expect = 0.003
 Identities = 16/59 (27%), Positives = 30/59 (50%), Gaps = 8/59 (13%)

Query: 222 LTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSL 280
              L+L++  L+ S+P+      +L++L+   N L   +P+   +   LK L V  N+L
Sbjct: 40  AHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQS---LKSLLVDNNNL 90

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.9 bits (148), Expect = 2e-10
 Identities = 18/90 (20%), Positives = 33/90 (36%), Gaps = 5/90 (5%)

Query: 558 LQRLDLRGNRVSGS-LPDELGKLKFLKWILLGGNNLTGE----IPSQFGHLISLVVLDLS 612
           +Q LD++   +S +   + L  L+  + + L    LT      I S      +L  L+L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 613 HNALTGSIPASLTKATKLESLFLAHNRLSG 642
            N L       + +  +  S  +    L  
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.1 bits (125), Expect = 1e-07
 Identities = 18/79 (22%), Positives = 30/79 (37%), Gaps = 9/79 (11%)

Query: 582 LKWILLGGNNLTGE----IPSQFGHLISLVVLDLSHNALTGSIPASLTKA-----TKLES 632
           L+ + L   +++      + +      SL  LDLS+N L  +    L ++       LE 
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430

Query: 633 LFLAHNRLSGEIPVSFSTL 651
           L L     S E+      L
Sbjct: 431 LVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.4 bits (118), Expect = 8e-07
 Identities = 13/68 (19%), Positives = 25/68 (36%), Gaps = 5/68 (7%)

Query: 604 ISLVVLDLSHNALTGSIPASLTKA-TKLESLFLAHNRLSGE----IPVSFSTLVNLSALD 658
           + +  LD+    L+ +  A L     + + + L    L+      I  +      L+ L+
Sbjct: 2   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61

Query: 659 LSFNNLSG 666
           L  N L  
Sbjct: 62  LRSNELGD 69

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.2 bits (115), Expect = 2e-06
 Identities = 16/110 (14%), Positives = 33/110 (30%), Gaps = 20/110 (18%)

Query: 196 ELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNI 255
           ++  +D+    LS     +     +    ++L D  LTE+  K+I     L+        
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSA--LRVN------ 54

Query: 256 LEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDAS 305
                         L  L++  N L D     +    +     +  +   
Sbjct: 55  ------------PALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.2 bits (115), Expect = 2e-06
 Identities = 17/82 (20%), Positives = 26/82 (31%), Gaps = 9/82 (10%)

Query: 597 PSQFGHLISLVVLDLSHNALTG----SIPASLTKATKLESLFLAHNRLSGEIPVSFSTLV 652
                    L VL L+   ++     S+ A+L     L  L L++N L     +     V
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421

Query: 653 -----NLSALDLSFNNLSGHIP 669
                 L  L L     S  + 
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEME 443

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.2 bits (115), Expect = 2e-06
 Identities = 14/92 (15%), Positives = 33/92 (35%), Gaps = 9/92 (9%)

Query: 149 LEVLELQGNNFSGK-IPYQMSNLERLRVLNLSFNSFSGE----VPRGLIGNGELSVIDMS 203
           ++ L++Q    S       +  L++ +V+ L     +      +   L  N  L+ +++ 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 204 SNRLSG----GLAIDSSSECEFLTYLKLSDNF 231
           SN L       +     +    +  L L +  
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.4 bits (113), Expect = 3e-06
 Identities = 23/93 (24%), Positives = 34/93 (36%), Gaps = 8/93 (8%)

Query: 166 QMSNLERLRVLNLSFNSFSGE----VPRGLIGNGELSVIDMSSNRLS--GGLAIDSS--S 217
                  LRVL L+    S      +   L+ N  L  +D+S+N L   G L +  S   
Sbjct: 364 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ 423

Query: 218 ECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLL 250
               L  L L D + +E +   +      K  L
Sbjct: 424 PGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSL 456

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.9 bits (109), Expect = 1e-05
 Identities = 13/83 (15%), Positives = 33/83 (39%), Gaps = 8/83 (9%)

Query: 197 LSVIDMSSNRLS--GGLAIDSS-SECEFLTYLKLSDNFLTESIPKEIGK-----CRNLKN 248
           L V+ ++   +S     ++ ++      L  L LS+N L ++   ++ +        L+ 
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430

Query: 249 LLLDGNILEGSIPKEIGTISELK 271
           L+L        +   +  + + K
Sbjct: 431 LVLYDIYWSEEMEDRLQALEKDK 453

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.1 bits (107), Expect = 2e-05
 Identities = 11/73 (15%), Positives = 23/73 (31%), Gaps = 5/73 (6%)

Query: 124 ELRTLSVPHNSFSGE-IPAGVGELRLLEVLELQGNNFSGK----IPYQMSNLERLRVLNL 178
           ++++L +     S       +  L+  +V+ L     +      I   +     L  LNL
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 179 SFNSFSGEVPRGL 191
             N         +
Sbjct: 63  RSNELGDVGVHCV 75

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.0 bits (99), Expect = 1e-04
 Identities = 15/84 (17%), Positives = 26/84 (30%), Gaps = 10/84 (11%)

Query: 347 PDNWSESCSLKVLNLGQNSLKG----AVPKSLGMCRNLTYLDLSLNNLEGYLPMQL---- 398
                    L+VL L    +      ++  +L    +L  LDLS N L     +QL    
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421

Query: 399 --PVPCMVYFNVSQNNITGVLPRF 420
             P   +    +     +  +   
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDR 445

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.7 bits (98), Expect = 2e-04
 Identities = 19/99 (19%), Positives = 36/99 (36%), Gaps = 13/99 (13%)

Query: 524 YEAFLLDCVQLVEFEAANNQISG----SIAAGVGKLMKLQRLDLRGNRVSGSLPDELGK- 578
            +        L     A+  +S     S+AA +     L+ LDL  N +  +   +L + 
Sbjct: 361 CQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES 420

Query: 579 ----LKFLKWILLGGNNLTGEIPSQFGHLI----SLVVL 609
                  L+ ++L     + E+  +   L     SL V+
Sbjct: 421 VRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 9e-04
 Identities = 18/78 (23%), Positives = 32/78 (41%), Gaps = 9/78 (11%)

Query: 243 CRNLKNLLLDGNILEG----SIPKEIGTISELKVLDVSRNSLTDRIPVELAD-----CSK 293
              L+ L L    +      S+   +     L+ LD+S N L D   ++L +        
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427

Query: 294 LSVLVLTNIDASLDLDNS 311
           L  LVL +I  S ++++ 
Sbjct: 428 LEQLVLYDIYWSEEMEDR 445

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.6 bits (90), Expect = 0.002
 Identities = 18/71 (25%), Positives = 31/71 (43%), Gaps = 9/71 (12%)

Query: 115 LSASIAKLTELRTLSVPHNSFSGEIPAGVGE-----LRLLEVLELQGNNFSGKIPYQMSN 169
           L+A++     LR L + +N         + E       LLE L L    +S ++  ++  
Sbjct: 389 LAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQA 448

Query: 170 LER----LRVL 176
           LE+    LRV+
Sbjct: 449 LEKDKPSLRVI 459

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.4 bits (87), Expect = 0.004
 Identities = 9/42 (21%), Positives = 15/42 (35%), Gaps = 4/42 (9%)

Query: 355 SLKVLNLGQNSLKG----AVPKSLGMCRNLTYLDLSLNNLEG 392
             +V+ L    L       +  +L +   L  L+L  N L  
Sbjct: 28  QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGD 69

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 60.3 bits (144), Expect = 4e-10
 Identities = 52/324 (16%), Positives = 89/324 (27%), Gaps = 23/324 (7%)

Query: 352 ESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLP-----VPCMVYF 406
           E  SLK+  +     K +V   L    ++  + LS N +       L         +   
Sbjct: 6   EGKSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64

Query: 407 NVSQN---NITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLG 463
             S      +   +P    +          L    +            +I   S +  L 
Sbjct: 65  EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 124

Query: 464 SLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGER--ISKCNDLQSFSVNLSANLLSG 521
            L L   G G  A          L  N    + P  R  I   N L++ S+   A     
Sbjct: 125 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 184

Query: 522 MSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKF 581
                 +      +  E   + +   +A      +   + +   +  S +L   L     
Sbjct: 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 244

Query: 582 LKWILLGGNNLTGEIPSQ------FGHLISLVVLDLSHNALTGSIPASLTKA-----TKL 630
           L+ + L    L+    +           I L  L L +N +      +L          L
Sbjct: 245 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDL 304

Query: 631 ESLFLAHNRLSGEIPVSFSTLVNL 654
             L L  NR S E       +  +
Sbjct: 305 LFLELNGNRFSEE-DDVVDEIREV 327

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 41.0 bits (94), Expect = 6e-04
 Identities = 38/295 (12%), Positives = 80/295 (27%), Gaps = 19/295 (6%)

Query: 138 EIPAGVGELRLLEVLELQGNNFSGK----IPYQMSNLERLRVLNLSFNSFSGEVPRGLIG 193
            + A + E   ++ + L GN    +    +   +++ + L +   S              
Sbjct: 22  SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 81

Query: 194 NGELSVIDMSSNRLS--GGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLL 251
              L    +   +L              +      LS +   E +              +
Sbjct: 82  LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 141

Query: 252 DGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNS 311
              + E ++ K+      L+ +   RN L +    E A   +    +L  +    +    
Sbjct: 142 ARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR-LLHTVKMVQNGIRP 200

Query: 312 RGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVP 371
            G       G+ Y   L                 L        +L+ L L    L     
Sbjct: 201 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGA 260

Query: 372 KSLGMC------RNLTYLDLSLNNLEGYLPMQLP------VPCMVYFNVSQNNIT 414
            ++           L  L L  N +E      L       +P +++  ++ N  +
Sbjct: 261 AAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 40.2 bits (92), Expect = 0.001
 Identities = 45/367 (12%), Positives = 102/367 (27%), Gaps = 56/367 (15%)

Query: 222 LTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNIL--EG--SIPKEIGTISELKVLDVSR 277
           L    ++     +S+   + +  ++K ++L GN +  E    + + I +  +L++ + S 
Sbjct: 10  LKLDAITTEDE-KSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68

Query: 278 NSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWA 337
                R+  E+ +  +    +L          ++        G    E L+    +    
Sbjct: 69  IFT-GRVKDEIPEALR----LLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 123

Query: 338 PRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQ 397
               L      + +         + +   + AV K       L  +    N LE     +
Sbjct: 124 EHLYL------HNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKE 177

Query: 398 LPVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFS 457
                  +  +    +     R E +      G    Q   V  +   +  +        
Sbjct: 178 WAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 237

Query: 458 GNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFN--GSVPGERISKCNDLQSFSVNLS 515
             K                         L +  +     +   +  SK  ++   ++ L 
Sbjct: 238 ALKS----------------WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQ 281

Query: 516 ANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVS--GSLP 573
            N +   +                              K+  L  L+L GNR S    + 
Sbjct: 282 YNEIELDAVRTL--------------------KTVIDEKMPDLLFLELNGNRFSEEDDVV 321

Query: 574 DELGKLK 580
           DE+ ++ 
Sbjct: 322 DEIREVF 328

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.3 bits (134), Expect = 5e-09
 Identities = 42/266 (15%), Positives = 86/266 (32%), Gaps = 26/266 (9%)

Query: 174 RVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLT 233
           + L+L+  +   +V   L+  G   VI     R      +        + ++ LS++ + 
Sbjct: 3   QTLDLTGKNLHPDVTGRLLSQG---VIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIE 59

Query: 234 -ESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCS 292
             ++   + +C  L+NL L+G  L   I   +   S L  L++S  S      ++    S
Sbjct: 60  VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSS 119

Query: 293 KLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLS-------------------RSLE 333
              +  L         +       A       +L LS                     + 
Sbjct: 120 CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVH 179

Query: 334 VLWAPRANLGGRLPDNWSESCSLKVLNL-GQNSLKGAVPKSLGMCRNLTYLDLSLNNLEG 392
           +  +    L       + +   L+ L+L     +       LG    L  L +     +G
Sbjct: 180 LDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDG 239

Query: 393 YLPMQLPVPCMVYFNVSQNNITGVLP 418
            L  QL    + +  ++ ++ T +  
Sbjct: 240 TL--QLLKEALPHLQINCSHFTTIAR 263

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.3 bits (134), Expect = 6e-09
 Identities = 25/119 (21%), Positives = 47/119 (39%), Gaps = 3/119 (2%)

Query: 559 QRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTG 618
           Q LDL G  +   +   L     +       + +   +   F     +  +DLS++ +  
Sbjct: 3   QTLDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEV 60

Query: 619 -SIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIPHLQHLDC 676
            ++   L++ +KL++L L   RLS  I  + +   NL  L+LS  +          L  
Sbjct: 61  STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSS 119

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.1 bits (118), Expect = 6e-07
 Identities = 36/277 (12%), Positives = 76/277 (27%), Gaps = 31/277 (11%)

Query: 327 LLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKG-AVPKSLGMCRNLTYLDL 385
           LLS+ +     PR+ +   L +++S    ++ ++L  + ++   +   L  C  L  L L
Sbjct: 20  LLSQGVIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSL 78

Query: 386 SLNNLEGYLPMQLPVPCMVYFNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSI 445
               L   +   L                        ++     GF            ++
Sbjct: 79  EGLRLSDPIVNTL----------------AKNSNLVRLNLSGCSGFS---------EFAL 113

Query: 446 SDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCN 505
                        N               +A   +   +L L+    N            
Sbjct: 114 QTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRR 173

Query: 506 DLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAAN-NQISGSIAAGVGKLMKLQRLDLR 564
                 ++LS +++              L     +    I       +G++  L+ L + 
Sbjct: 174 CPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVF 233

Query: 565 GNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFG 601
           G    G+L      L  L+   +  ++ T       G
Sbjct: 234 GIVPDGTLQLLKEALPHLQ---INCSHFTTIARPTIG 267

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.2 bits (113), Expect = 2e-06
 Identities = 36/224 (16%), Positives = 73/224 (32%), Gaps = 36/224 (16%)

Query: 106 SKSSVISGTLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQG--NNFSGKI 163
           S S +   TL   +++ ++L+ LS+     S  I   + +   L  L L G        +
Sbjct: 54  SNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFAL 113

Query: 164 PYQMSNLERLRVLN------------------------------LSFNSFSGEVPRGLIG 193
              +S+  RL  LN                                 N    ++   +  
Sbjct: 114 QTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRR 173

Query: 194 NGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSD-NFLTESIPKEIGKCRNLKNLLLD 252
              L  +D+S + +          +  +L +L LS    +      E+G+   LK L + 
Sbjct: 174 CPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVF 233

Query: 253 GNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSV 296
           G + +G++         L  L ++ +  T      + +     +
Sbjct: 234 GIVPDGTLQL---LKEALPHLQINCSHFTTIARPTIGNKKNQEI 274

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 50.5 bits (120), Expect = 5e-08
 Identities = 25/120 (20%), Positives = 39/120 (32%), Gaps = 34/120 (28%)

Query: 587 LGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPA---------------------SLT 625
           L   +LT  +      L+ +  LDLSHN L    PA                      + 
Sbjct: 5   LAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVA 62

Query: 626 KATKLESLFLAHNRL-SGEIPVSFSTLVNLSALDLSFNNLSG----------HIPHLQHL 674
              +L+ L L +NRL          +   L  L+L  N+L             +P +  +
Sbjct: 63  NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 47.4 bits (112), Expect = 6e-07
 Identities = 28/129 (21%), Positives = 49/129 (37%), Gaps = 10/129 (7%)

Query: 126 RTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSG 185
           R L + H   +  +   + +L L+  L+L  N      P  ++ L  L VL    +  + 
Sbjct: 1   RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQ--ASDNAL 55

Query: 186 EVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCR- 244
           E   G+     L  + + +NRL    AI     C  L  L L  N L +       +   
Sbjct: 56  ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAE 114

Query: 245 ---NLKNLL 250
              ++ ++L
Sbjct: 115 MLPSVSSIL 123

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 42.0 bits (98), Expect = 5e-05
 Identities = 21/132 (15%), Positives = 42/132 (31%), Gaps = 29/132 (21%)

Query: 151 VLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGG 210
           VL L   + +  +   +  L  +  L+LS N      P        L  +++     +  
Sbjct: 2   VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDNAL 55

Query: 211 LAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISEL 270
             +D  +    L  L L +N L +                        +  + + +   L
Sbjct: 56  ENVDGVANLPRLQELLLCNNRLQQ-----------------------SAAIQPLVSCPRL 92

Query: 271 KVLDVSRNSLTD 282
            +L++  NSL  
Sbjct: 93  VLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 38.5 bits (89), Expect = 7e-04
 Identities = 23/98 (23%), Positives = 31/98 (31%), Gaps = 33/98 (33%)

Query: 608 VLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNL------------- 654
           VL L+H  LT  +   L +   +  L L+HNRL    P + + L  L             
Sbjct: 2   VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58

Query: 655 ---------SALDLSFNNLS--------GHIPHLQHLD 675
                      L L  N L            P L  L+
Sbjct: 59  DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLN 96

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.1 bits (120), Expect = 2e-07
 Identities = 38/248 (15%), Positives = 73/248 (29%), Gaps = 16/248 (6%)

Query: 353 SCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLP-VPCMVYFNVSQN 411
            CS +V    ++ +   +P  L   RN   L   L  L             +    +SQN
Sbjct: 7   HCSNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQN 63

Query: 412 NITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIG 471
           ++  V+      +       +  +  N+  +   + +N   +     +            
Sbjct: 64  DVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNT--------GI 115

Query: 472 DGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDC 531
                       + +L +   N ++     +    L   SV L  N            + 
Sbjct: 116 KHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNG 175

Query: 532 VQLVEFEAANNQISGSIAAGV-GKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGN 590
            QL E   ++N     +   V         LD+   R+       L  LK L+       
Sbjct: 176 TQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLR--ARSTY 233

Query: 591 NLTGEIPS 598
           NL  ++P+
Sbjct: 234 NLK-KLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.7 bits (88), Expect = 0.002
 Identities = 15/89 (16%), Positives = 25/89 (28%), Gaps = 3/89 (3%)

Query: 584 WILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGE 643
            + L  N +       F       +    +N L          A+    L ++  R+   
Sbjct: 157 ILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSL 216

Query: 644 IPVSFSTLVNLSALDLSFNNLSGHIPHLQ 672
                  L  L A      NL   +P L+
Sbjct: 217 PSYGLENLKKLRARST--YNLK-KLPTLE 242

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.7 bits (88), Expect = 0.002
 Identities = 12/59 (20%), Positives = 19/59 (32%)

Query: 581 FLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNR 639
             +  L   NNL       F      V+LD+S   +       L    KL +    + +
Sbjct: 178 LDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.0 bits (86), Expect = 0.004
 Identities = 10/49 (20%), Positives = 19/49 (38%), Gaps = 1/49 (2%)

Query: 132 HNSFSGEIPAGV-GELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLS 179
            N+   E+P  V        +L++          Y + NL++LR  +  
Sbjct: 185 DNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.0 bits (86), Expect = 0.004
 Identities = 14/72 (19%), Positives = 26/72 (36%), Gaps = 3/72 (4%)

Query: 605 SLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNL 664
           S  V     + +T  IP+ L        L     +L      +FS   +L  +++S N++
Sbjct: 9   SNRVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65

Query: 665 SGHIPHLQHLDC 676
              I      + 
Sbjct: 66  LEVIEADVFSNL 77

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.9 bits (120), Expect = 3e-07
 Identities = 32/204 (15%), Positives = 56/204 (27%), Gaps = 24/204 (11%)

Query: 118 SIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLN 177
            ++K+     ++    + +  +P  +   +   +L L  N         +    RL  LN
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 178 LSFNSFSGEVPRGLIGNGELSVIDMSSNRLS--------------------GGLAIDSSS 217
           L     +     G +       +  +  +                        L + +  
Sbjct: 62  LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121

Query: 218 ECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSR 277
               L  L L  N L    P  +     L+ L L  N L       +  +  L  L +  
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181

Query: 278 NSLTDRIPVELADCSKLSVLVLTN 301
           NSL   IP        L    L  
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLHG 204

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.4 bits (111), Expect = 4e-06
 Identities = 40/243 (16%), Positives = 67/243 (27%), Gaps = 43/243 (17%)

Query: 351 SESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQL-PVPCMVYFNVS 409
           S+  S   +N  + +L  A+P  L   ++ T L LS N L  +    L P   +   N  
Sbjct: 7   SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN-- 61

Query: 410 QNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFA 469
                  L R E            L   ++      S               +    L +
Sbjct: 62  -------LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTS 114

Query: 470 IGDGFLAAKYKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLL 529
           +  G L    +     L  N +          +   +  S +                  
Sbjct: 115 LPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLA------------------ 156

Query: 530 DCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGG 589
                      NN ++   A  +  L  L  L L+ N +  ++P        L +  L G
Sbjct: 157 -----------NNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHG 204

Query: 590 NNL 592
           N  
Sbjct: 205 NPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.6 bits (109), Expect = 6e-06
 Identities = 14/72 (19%), Positives = 26/72 (36%), Gaps = 3/72 (4%)

Query: 599 QFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALD 658
           +   + S + ++     LT ++P  L K      L L+ N L      +      L+ L+
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 659 LSFNNLSGHIPH 670
           L    L+     
Sbjct: 62  LDRAELTKLQVD 73

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.8 bits (99), Expect = 1e-04
 Identities = 21/75 (28%), Positives = 28/75 (37%), Gaps = 1/75 (1%)

Query: 566 NRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLT 625
           N +    P  L     L+ + L  NNLT         L +L  L L  N+L  +IP    
Sbjct: 134 NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFF 192

Query: 626 KATKLESLFLAHNRL 640
            +  L   FL  N  
Sbjct: 193 GSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.4 bits (98), Expect = 2e-04
 Identities = 12/63 (19%), Positives = 22/63 (34%), Gaps = 3/63 (4%)

Query: 552 VGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDL 611
           V K+     ++     ++ +LP +L K      + L  N L     +       L  L+L
Sbjct: 6   VSKVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNL 62

Query: 612 SHN 614
              
Sbjct: 63  DRA 65

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.0 bits (97), Expect = 2e-04
 Identities = 15/51 (29%), Positives = 19/51 (37%), Gaps = 3/51 (5%)

Query: 589 GNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNR 639
             NLT  +P          +L LS N L     A+L   T+L  L L    
Sbjct: 19  KRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.9 bits (113), Expect = 7e-07
 Identities = 32/135 (23%), Positives = 52/135 (38%), Gaps = 21/135 (15%)

Query: 557 KLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNAL 616
             Q LDL+G R       +L        +L   +++   +     ++  L+ L+LS+N L
Sbjct: 23  SQQALDLKGLR----SDPDLVAQNIDV-VLNRRSSMAATLRIIEENIPELLSLNLSNNRL 77

Query: 617 TG--SIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSG-------- 666
                + + + KA  L+ L L+ N L  E  +     + L  L L  N+LS         
Sbjct: 78  YRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTY 137

Query: 667 ------HIPHLQHLD 675
                   P L  LD
Sbjct: 138 ISAIRERFPKLLRLD 152

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.5 bits (86), Expect = 0.002
 Identities = 26/155 (16%), Positives = 53/155 (34%), Gaps = 15/155 (9%)

Query: 115 LSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLR 174
           L   ++K  +    ++            +    +  VL  + ++ +  +     N+  L 
Sbjct: 12  LKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRR-SSMAATLRIIEENIPELL 68

Query: 175 VLNLSFNSFSG--EVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFL 232
            LNLS N      ++   +     L ++++S N L          +   L  L L  N L
Sbjct: 69  SLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSL 127

Query: 233 TESIPKE-------IGKCRNLKNLLLDGNILEGSI 260
           +++   +         +   L    LDG+ L   I
Sbjct: 128 SDTFRDQSTYISAIRERFPKLLR--LDGHELPPPI 160

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.0 bits (105), Expect = 2e-05
 Identities = 14/64 (21%), Positives = 25/64 (39%), Gaps = 4/64 (6%)

Query: 597 PSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSA 656
            +   +L  L  L    N ++   P  L     L  + L +N++S   P   +   NL  
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFI 221

Query: 657 LDLS 660
           + L+
Sbjct: 222 VTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.3 bits (103), Expect = 3e-05
 Identities = 13/65 (20%), Positives = 25/65 (38%), Gaps = 4/65 (6%)

Query: 573 PDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLES 632
              L  L  L  +    N ++   P     L +L+ + L +N ++   P  L   + L  
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFI 221

Query: 633 LFLAH 637
           + L +
Sbjct: 222 VTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.9 bits (102), Expect = 4e-05
 Identities = 32/219 (14%), Positives = 63/219 (28%), Gaps = 45/219 (20%)

Query: 120 AKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLS 179
             L     ++   ++ +  +     +L  +  L   G   +  I   +  L  L  L L 
Sbjct: 16  PALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELK 71

Query: 180 FNSFSGEVPRGLIGNGELSVIDMSS--------------------NRLSGGLAIDSSSEC 219
            N  +   P   +       +  +                      +++    +   S  
Sbjct: 72  DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131

Query: 220 EFL-----------------TYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPK 262
           + L                     LS      S    +     L  L  D N +    P 
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190

Query: 263 EIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTN 301
            + ++  L  + +  N ++D  P  LA+ S L ++ LTN
Sbjct: 191 -LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.9 bits (97), Expect = 2e-04
 Identities = 30/229 (13%), Positives = 71/229 (31%), Gaps = 28/229 (12%)

Query: 359 LNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNNITGVLP 418
           +  G++++   V ++      +T L      +     +Q  +  ++   +  N I     
Sbjct: 24  IAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTIEGVQY-LNNLIGLELKDNQI----T 76

Query: 419 RFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAK 478
               +         +L    +  + +I+    +   D +  +     PL           
Sbjct: 77  DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLA---------- 126

Query: 479 YKPHYRLLLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFE 538
              + ++L  +     ++            S            +S    L +  +L   +
Sbjct: 127 GLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNA-------QVSDLTPLANLSKLTTLK 179

Query: 539 AANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILL 587
           A +N+IS      +  L  L  + L+ N++S   P  L     L  + L
Sbjct: 180 ADDNKISDIS--PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.2 bits (90), Expect = 0.001
 Identities = 15/57 (26%), Positives = 25/57 (43%), Gaps = 7/57 (12%)

Query: 624 LTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIP-----HLQHLD 675
           L   +KL +L    N++S   P   ++L NL  + L  N +S   P     +L  + 
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLANTSNLFIVT 223

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.1 bits (87), Expect = 0.003
 Identities = 27/202 (13%), Positives = 54/202 (26%), Gaps = 7/202 (3%)

Query: 196 ELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNI 255
               I    + ++      + ++ + +T L      +T +I   +    NL  L L  N 
Sbjct: 20  NAIKIAAGKSNVTD---TVTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQ 74

Query: 256 LEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEF 315
           +    P +  T      L  +       I    +  +             L   ++    
Sbjct: 75  ITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVL 134

Query: 316 SAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLG 375
                 +     L+    + +    N         +    L  L    N +    P  L 
Sbjct: 135 YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LA 192

Query: 376 MCRNLTYLDLSLNNLEGYLPMQ 397
              NL  + L  N +    P+ 
Sbjct: 193 SLPNLIEVHLKNNQISDVSPLA 214

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.1 bits (95), Expect = 1e-04
 Identities = 13/83 (15%), Positives = 29/83 (34%), Gaps = 4/83 (4%)

Query: 591 NLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFST 650
            L  +   Q+ + +    LDL    +   I        + +++  + N +  ++   F  
Sbjct: 6   ELIEQAA-QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPL 61

Query: 651 LVNLSALDLSFNNLSGHIPHLQH 673
           L  L  L ++ N +      L  
Sbjct: 62  LRRLKTLLVNNNRICRIGEGLDQ 84

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (94), Expect = 2e-04
 Identities = 23/140 (16%), Positives = 47/140 (33%), Gaps = 4/140 (2%)

Query: 116 SASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRV 175
           +A        R L +        I      L   + ++   N    +       L RL+ 
Sbjct: 11  AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKT 67

Query: 176 LNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTES 235
           L ++ N              +L+ + +++N L     +D  +  + LTYL +  N +T  
Sbjct: 68  LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK 127

Query: 236 IPKEIGKCRNLKNL-LLDGN 254
               +     +  + +LD  
Sbjct: 128 KHYRLYVIYKVPQVRVLDFQ 147

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (93), Expect = 3e-04
 Identities = 25/132 (18%), Positives = 48/132 (36%), Gaps = 14/132 (10%)

Query: 555 LMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHN 614
            ++ + LDLRG ++   + +    L     I    N +       F  L  L  L +++N
Sbjct: 17  AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTLLVNNN 73

Query: 615 ALTGSIPASLTKATKLESLFLAHNRLSG-EIPVSFSTLVNLSALDLSFNNLS-------- 665
            +             L  L L +N L         ++L +L+ L +  N ++        
Sbjct: 74  RICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLY 133

Query: 666 --GHIPHLQHLD 675
               +P ++ LD
Sbjct: 134 VIYKVPQVRVLD 145

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.8 bits (89), Expect = 0.001
 Identities = 22/111 (19%), Positives = 41/111 (36%), Gaps = 4/111 (3%)

Query: 582 LKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLS 641
            + + L G  +   I +    L     +D S N +            +L++L + +NR+ 
Sbjct: 20  DRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTLLVNNNRIC 76

Query: 642 GEIPVSFSTLVNLSALDLSFNNLSGHIPHLQHLDCIAFKGNKYLASCPDTN 692
                    L +L+ L L+ N+L   +  L  L  +       +   P TN
Sbjct: 77  RIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN 126

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.6 bits (86), Expect = 0.003
 Identities = 19/139 (13%), Positives = 50/139 (35%), Gaps = 6/139 (4%)

Query: 149 LEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLS 208
              L+L+G      I    + L++   ++ S N         L+    L  + +++NR+ 
Sbjct: 20  DRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFPLLRR--LKTLLVNNNRIC 76

Query: 209 GGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDG---NILEGSIPKEIG 265
                   +  +    +  +++ +       +   ++L  L +        +      I 
Sbjct: 77  RIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIY 136

Query: 266 TISELKVLDVSRNSLTDRI 284
            + +++VLD  +  L +R 
Sbjct: 137 KVPQVRVLDFQKVKLKERQ 155

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.5 bits (96), Expect = 2e-04
 Identities = 8/65 (12%), Positives = 28/65 (43%), Gaps = 4/65 (6%)

Query: 603 LISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFN 662
               +  +L   ++T ++  +  +   ++ +   ++ +     + +  L N++ L L+ N
Sbjct: 23  FAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQGIQY--LPNVTKLFLNGN 78

Query: 663 NLSGH 667
            L+  
Sbjct: 79  KLTDI 83

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.7 bits (86), Expect = 0.004
 Identities = 30/195 (15%), Positives = 65/195 (33%), Gaps = 23/195 (11%)

Query: 122 LTELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFN 181
             E    ++   S +  +     EL  ++ +    ++        +  L  +  L L+ N
Sbjct: 23  FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGN 78

Query: 182 SFSGEVPRGLIGNGELSVIDMSSNR---------------LSGGLAIDSSSECEFLTYLK 226
             +   P   + N     +D +  +               L      D +          
Sbjct: 79  KLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLES 138

Query: 227 LSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPV 286
           L       +    + +   L  L L+ N +   +P  +  +++L+ L +S+N ++D +  
Sbjct: 139 LYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LR- 194

Query: 287 ELADCSKLSVLVLTN 301
            LA    L VL L +
Sbjct: 195 ALAGLKNLDVLELFS 209

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	1052
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	100.0
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	100.0
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	100.0
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	100.0
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	100.0
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.97
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.97
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.96
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.96
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.93
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.93
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.9
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.9
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.9
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.89
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.89
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.87
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.86
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.8
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.79
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.79
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.75
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.72
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.67
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.67
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.65
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.61
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.6
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.58
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	99.14
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	99.0
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.82
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.62
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.29
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	98.1
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.9
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.88
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.79
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.62

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=370.12  Aligned_cols=265  Identities=25%  Similarity=0.410  Sum_probs=220.5

Q ss_pred             CHHHHHHHHCCCCCCEEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEECCC
Q ss_conf             63568875079755303301484489999944-99099999940675101888999999850267785005997886288
Q 001566          766 TYDNVVRATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEA  844 (1052)
Q Consensus       766 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  844 (1052)
                      .++..+...++|++.+.||+|+||+||+|.+. +++.||||+++... ...+++.+|++++++++||||+++++++.+.+
T Consensus         8 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   86 (287)
T d1opja_           8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP   86 (287)
T ss_dssp             TCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CCCCCEECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHCCCCCEECCCCCEEECC
T ss_conf             97651745799398659820888089999999999699999977761-03999999999998679998826775274578


Q ss_pred             EEEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCC
Q ss_conf             16999941599999999835069964589999999999999999876399981637999999798899969995205640
Q 001566          845 EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR  924 (1052)
Q Consensus       845 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~~~kl~Dfgla~  924 (1052)
                      ..++||||+++|+|.+++.......+++..+..++.|++.|++|||++   +|+||||||+|||+++++.+||+|||+|+
T Consensus        87 ~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~  163 (287)
T d1opja_          87 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR  163 (287)
T ss_dssp             SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred             EEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCEE
T ss_conf             547876314676067775303554157999999999999978889878---93057604576899899928983244546


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCC
Q ss_conf             02546763334654455312543327788894015899999999999299999989556799751789999999708866
Q 001566          925 LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSS 1004 (1052)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1052)
                      ..............|++.|+|||++.+..++.++||||+|+++|||++|+.|+....       +.....+ .+..+...
T Consensus       164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~-------~~~~~~~-~i~~~~~~  235 (287)
T d1opja_         164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-------DLSQVYE-LLEKDYRM  235 (287)
T ss_dssp             TCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC-------CHHHHHH-HHHTTCCC
T ss_pred             ECCCCCCEEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC-------HHHHHHH-HHHCCCCC
T ss_conf             537887221035566546669278727999810430217899999986799887742-------5999999-98558888


Q ss_pred             CCCCCHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             32240111189768899999999873546999999999999998505
Q 001566         1005 ELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1005 ~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~i 1051 (1052)
                               ..+...+.++.+|+.+||+.||++|||++|+++.|+.+
T Consensus       236 ---------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~  273 (287)
T d1opja_         236 ---------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  273 (287)
T ss_dssp             ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             ---------CCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             ---------88743309999999997577976893999999999999

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=366.63  Aligned_cols=256  Identities=23%  Similarity=0.375  Sum_probs=214.7

Q ss_pred             CCCCCCEEEECCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEEECC
Q ss_conf             79755303301484489999944990999999406751018889999998502677850059978862881699994159
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLS  854 (1052)
Q Consensus       775 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  854 (1052)
                      ++|++.+.||+|+||+||+|.+.++..||||++.... ...+++.+|++++++++||||++++|++...+..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEECC
T ss_conf             9958888982088829999998899999999987886-768999999999996689975653524315993379998369


Q ss_pred             CCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCCCCC
Q ss_conf             99999998350699645899999999999999998763999816379999997988999699952056400254676333
Q 001566          855 GGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT  934 (1052)
Q Consensus       855 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  934 (1052)
                      +|+|.+++.... ..+++..+..++.|++.|+.|+|++   +|+||||||+||++++++.+||+|||+++..........
T Consensus        84 ~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~  159 (263)
T d1sm2a_          84 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS  159 (263)
T ss_dssp             TCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred             CCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCHHHEEECCCCCEEECCCCHHEECCCCCCEEE
T ss_conf             991899752013-4788999999999999987765316---431044315326666887768655321002368873350


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHCC
Q ss_conf             46544553125433277888940158999999999992999999895567997517899999997088663224011118
Q 001566          935 TDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEA 1014 (1052)
Q Consensus       935 ~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 1014 (1052)
                      ....|++.|+|||++.+..++.++||||||+++|||+|++.|+...       ....+....+. .+...         .
T Consensus       160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~-------~~~~~~~~~i~-~~~~~---------~  222 (263)
T d1sm2a_         160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-------RSNSEVVEDIS-TGFRL---------Y  222 (263)
T ss_dssp             -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS-------CCHHHHHHHHH-HTCCC---------C
T ss_pred             CCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCC-------CCHHHHHHHHH-HCCCC---------C
T ss_conf             4300176667857860799984033210599999998789888778-------99999999998-06888---------9


Q ss_pred             CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf             97688999999998735469999999999999985059
Q 001566         1015 GPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQLK 1052 (1052)
Q Consensus      1015 ~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~i~ 1052 (1052)
                      .|..++.++.+++.+||+.||++|||++|+++.|++|+
T Consensus       223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~  260 (263)
T d1sm2a_         223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA  260 (263)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf             95436799999999976579768919999999999998

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=360.66  Aligned_cols=249  Identities=24%  Similarity=0.388  Sum_probs=210.7

Q ss_pred             CCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEEEC
Q ss_conf             7975530330148448999994-499099999940675101888999999850267785005997886288169999415
Q 001566          775 GNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFL  853 (1052)
Q Consensus       775 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  853 (1052)
                      ++|++.+.||+|+||+||+|.. .+|+.||+|++........+.+.+|++++++++||||+++++++.+++..|+||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
T ss_conf             05388789812858299999998999899999984301727999999999998679998805857798899989999703


Q ss_pred             CCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCCCC
Q ss_conf             99999999835069964589999999999999999876399981637999999798899969995205640025467633
Q 001566          854 SGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA  933 (1052)
Q Consensus       854 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  933 (1052)
                      ++|+|.+++...   .+++.++..++.|++.|+.|||++   ||+||||||+|||++.++.+||+|||+|+..... ...
T Consensus       100 ~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~-~~~  172 (293)
T d1yhwa1         100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSK  172 (293)
T ss_dssp             TTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST-TCC
T ss_pred             CCCCHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHHEEECCC-CCC
T ss_conf             798089886415---999999999999999999999987---9722677688868878996864251564132136-664


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHC
Q ss_conf             34654455312543327788894015899999999999299999989556799751789999999708866322401111
Q 001566          934 TTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWE 1013 (1052)
Q Consensus       934 ~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1013 (1052)
                      .....||+.|+|||++.+..++.++||||+||++|||++|+.||....        ..+........+....        
T Consensus       173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--------~~~~~~~~~~~~~~~~--------  236 (293)
T d1yhwa1         173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN--------PLRALYLIATNGTPEL--------  236 (293)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHHCSCCC--------
T ss_pred             CCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHHCCCCCC--------
T ss_conf             444444777368266447998801203137299999804889989979--------9999999985799988--------


Q ss_pred             CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             897688999999998735469999999999999
Q 001566         1014 AGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1014 ~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ..+...+..+.+++.+||+.||++|||+.|+++
T Consensus       237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             885537999999999986699668909999964

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=367.18  Aligned_cols=257  Identities=26%  Similarity=0.431  Sum_probs=214.0

Q ss_pred             HHCCCCCCEEEECCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEEE
Q ss_conf             50797553033014844899999449909999994067510188899999985026778500599788628816999941
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       773 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  852 (1052)
                      ..++|++.+.||+|+||+||+|.+.++..||||++.... ...+.+.+|++++++++||||++++|++. ++..++||||
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey   88 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY   88 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred             CHHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEC-CCCEEEEEEE
T ss_conf             889938867981079828999999999999999986476-88899999999998679998857873104-5976999995


Q ss_pred             CCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCCC
Q ss_conf             59999999983506996458999999999999999987639998163799999979889996999520564002546763
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      +++|+|.+++.......+++..+..++.|++.|+.|||++   +|+||||||+||++++++.+||+|||+|+........
T Consensus        89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~  165 (272)
T d1qpca_          89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (272)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             CCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEEECCCCEEECCCCCEEECCCCCCC
T ss_conf             7898288887514789887889999999999999999748---9546756422515620244042341014773588644


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHH
Q ss_conf             33465445531254332778889401589999999999929999998955679975178999999970886632240111
Q 001566          933 ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012 (1052)
Q Consensus       933 ~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1012 (1052)
                      ......|++.|+|||++.+..++.++||||||+++|||+||+.|+.....       ..+....+ ..+...        
T Consensus       166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-------~~~~~~~i-~~~~~~--------  229 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-------NPEVIQNL-ERGYRM--------  229 (272)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HHHHHHHH-HTTCCC--------
T ss_pred             CCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCC-------HHHHHHHH-HHCCCC--------
T ss_conf             20356774444582898379998245645257999999968988888889-------99999999-706888--------


Q ss_pred             CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             189768899999999873546999999999999998505
Q 001566         1013 EAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1013 ~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~i 1051 (1052)
                       ..|...+.++.+++.+||+.||++|||++|+++.|+++
T Consensus       230 -~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         230 -VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             -89655719999999997588976893999999986113

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=362.36  Aligned_cols=255  Identities=25%  Similarity=0.425  Sum_probs=209.2

Q ss_pred             CCCCCCEEEECCCCEEEEEEEECC-C---CEEEEEEECCCCC-CCHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
Q ss_conf             797553033014844899999449-9---0999999406751-0188899999985026778500599788628816999
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELVP-G---YLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLV  849 (1052)
Q Consensus       775 ~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  849 (1052)
                      ++|++.+.||+|+||+||+|.... +   ..||||++..... ...+.|.+|++++++++||||++++|++...+..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             HHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf             04278569802788299999995799788999999978445989999999999999857998886189999628877999


Q ss_pred             EEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCC
Q ss_conf             94159999999983506996458999999999999999987639998163799999979889996999520564002546
Q 001566          850 YNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS  929 (1052)
Q Consensus       850 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  929 (1052)
                      |||+++|+|.+++.... ..+++.++..++.|++.|+.|||++   +|+||||||+|||++.++.+||+|||+|+.....
T Consensus       106 ~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  181 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  181 (299)
T ss_dssp             EECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEECCCCCCEEEECCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCCEECCCC
T ss_conf             97227985300210456-7999999999999999988988527---9835761504489889991998884431575677


Q ss_pred             CCC----CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCC
Q ss_conf             763----3346544553125433277888940158999999999992-99999989556799751789999999708866
Q 001566          930 ETH----ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSS 1004 (1052)
Q Consensus       930 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1052)
                      ...    ......+++.|||||.+.+..++.++||||||+++|||+| |+.||....        ..+....+ ..+...
T Consensus       182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~--------~~~~~~~i-~~~~~~  252 (299)
T d1jpaa_         182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT--------NQDVINAI-EQDYRL  252 (299)
T ss_dssp             --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHH-HTTCCC
T ss_pred             CCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC--------HHHHHHHH-HCCCCC
T ss_conf             776536502566688300387888369978612144535789999867999999999--------99999999-737889


Q ss_pred             CCCCCHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             32240111189768899999999873546999999999999998505
Q 001566         1005 ELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1005 ~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~i 1051 (1052)
                               ..+..++..+.+|+.+||+.||++|||+.|+++.|+++
T Consensus       253 ---------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~  290 (299)
T d1jpaa_         253 ---------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM  290 (299)
T ss_dssp             ---------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ---------CCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             ---------99742269999999997587976892999999999998

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=364.47  Aligned_cols=261  Identities=30%  Similarity=0.479  Sum_probs=210.3

Q ss_pred             HHHCCCCCCEEEECCCCEEEEEEEECCCCEEEEEEECCCC--CCCHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
Q ss_conf             7507975530330148448999994499099999940675--10188899999985026778500599788628816999
Q 001566          772 RATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGR--FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLV  849 (1052)
Q Consensus       772 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  849 (1052)
                      ...++|++.+.||+|+||+||+|++.  ..||||+++...  .+..+.+.+|++++++++||||+++++++. .+..++|
T Consensus         5 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv   81 (276)
T d1uwha_           5 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIV   81 (276)
T ss_dssp             CCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             CCCCCEEEEEEEEECCCCEEEEEEEC--CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEEEE
T ss_conf             15451899889830788589999999--98999999734699899999999999998479987864567971-5589999


Q ss_pred             EEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCC
Q ss_conf             94159999999983506996458999999999999999987639998163799999979889996999520564002546
Q 001566          850 YNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS  929 (1052)
Q Consensus       850 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  929 (1052)
                      |||+++|+|.+++.... ..+++..+..++.|++.|++|||++   +|+||||||+|||++.++.+||+|||+|+.....
T Consensus        82 ~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          82 TQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW  157 (276)
T ss_dssp             EECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred             EECCCCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCHHHEEECCCCCEEECCCCCEEECCCC
T ss_conf             96589988899985235-7899999999999999998887509---9951614789979818997887500221333556


Q ss_pred             C-CCCCCCCCCCCCCCCCCCCCC---CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCC
Q ss_conf             7-633346544553125433277---888940158999999999992999999895567997517899999997088663
Q 001566          930 E-THATTDVAGTFGYVAPEYATT---CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005 (1052)
Q Consensus       930 ~-~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1052)
                      . ........||+.|||||++.+   ..++.++||||||+++|||+||+.||.....        ..........+....
T Consensus       158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~--------~~~~~~~~~~~~~~p  229 (276)
T d1uwha_         158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--------RDQIIFMVGRGYLSP  229 (276)
T ss_dssp             --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--------HHHHHHHHHHTSCCC
T ss_pred             CCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHHCCCCCC
T ss_conf             776312566557431799999505689999531516359999999978899899896--------999999996588898


Q ss_pred             CCCCHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf             22401111897688999999998735469999999999999985059
Q 001566         1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQLK 1052 (1052)
Q Consensus      1006 ~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~i~ 1052 (1052)
                      . .+    ..+..++..+.+++.+||+.||++|||++|+++.|+.++
T Consensus       230 ~-~~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~  271 (276)
T d1uwha_         230 D-LS----KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA  271 (276)
T ss_dssp             C-GG----GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             C-CH----HCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf             6-00----036555499999999975889768929999999999999

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=355.88  Aligned_cols=254  Identities=23%  Similarity=0.399  Sum_probs=216.2

Q ss_pred             CCCCCCEEEECCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEEECC
Q ss_conf             79755303301484489999944990999999406751018889999998502677850059978862881699994159
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLS  854 (1052)
Q Consensus       775 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~  854 (1052)
                      ++|++.++||+|+||+||+|.++++..||||+++.... ..+++.+|+.++++++||||++++|++.++...++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECCC
T ss_conf             99799689820788399999988998999999874757-78999999999996689860158899850781699997048


Q ss_pred             CCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCCCCC
Q ss_conf             99999998350699645899999999999999998763999816379999997988999699952056400254676333
Q 001566          855 GGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHAT  934 (1052)
Q Consensus       855 ~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~  934 (1052)
                      +|++.+++.... ..+++..+.+++.|+++|+.|||++   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        83 ~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  158 (258)
T d1k2pa_          83 NGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS  158 (258)
T ss_dssp             TEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred             CCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCCEEE
T ss_conf             993888641024-6776899999999999999987546---843466541358876998479886144202357872252


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHC
Q ss_conf             46544553125433277888940158999999999992-99999989556799751789999999708866322401111
Q 001566          935 TDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWE 1013 (1052)
Q Consensus       935 ~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1013 (1052)
                      ....+++.|+|||.+.+..++.++||||||+++|||+| |+.||...        ...+.... +..+...         
T Consensus       159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~--------~~~~~~~~-i~~~~~~---------  220 (258)
T d1k2pa_         159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF--------TNSETAEH-IAQGLRL---------  220 (258)
T ss_dssp             CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS--------CHHHHHHH-HHTTCCC---------
T ss_pred             CCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCC--------CHHHHHHH-HHHCCCC---------
T ss_conf             46578877578078637998852103364324673975599998899--------99999999-9807978---------


Q ss_pred             CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             89768899999999873546999999999999998505
Q 001566         1014 AGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1014 ~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~i 1051 (1052)
                      ..|...+..+.+++.+||+.||++|||+.|+++.|.+|
T Consensus       221 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCC
T ss_conf             99654659999999997668976893999999874188

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=358.43  Aligned_cols=251  Identities=25%  Similarity=0.375  Sum_probs=208.2

Q ss_pred             CCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEEEC
Q ss_conf             7975530330148448999994-499099999940675101888999999850267785005997886288169999415
Q 001566          775 GNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFL  853 (1052)
Q Consensus       775 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  853 (1052)
                      +.|++.+.||+|+||+||+|.. .++..||+|++........+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
T ss_conf             37598479930778199999999999399999987289999999999999998679999884988980099589999627


Q ss_pred             CCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCCCC
Q ss_conf             99999999835069964589999999999999999876399981637999999798899969995205640025467633
Q 001566          854 SGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA  933 (1052)
Q Consensus       854 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  933 (1052)
                      ++|+|.+++.... ..+++.++..++.|++.|+.|||++   +|+||||||+|||++.++.+||+|||+|...... ...
T Consensus        92 ~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-~~~  166 (288)
T d2jfla1          92 AGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQR  166 (288)
T ss_dssp             TTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-HHH
T ss_pred             CCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEECCHHHEEECCCCCEEEEECHHHHCCCCC-CCC
T ss_conf             9981889998628-9999999999999999999999988---9887140700314878999899716123035778-641


Q ss_pred             CCCCCCCCCCCCCCCCC-----CCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCC
Q ss_conf             34654455312543327-----7888940158999999999992999999895567997517899999997088663224
Q 001566          934 TTDVAGTFGYVAPEYAT-----TCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFL 1008 (1052)
Q Consensus       934 ~~~~~~~~~y~aPE~~~-----~~~~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1052)
                      .....|++.|+|||++.     +..++.++||||+||++|||++|+.||......        +....+.... ....  
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~--------~~~~~i~~~~-~~~~--  235 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM--------RVLLKIAKSE-PPTL--  235 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG--------GHHHHHHHSC-CCCC--
T ss_pred             CCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHCCC-CCCC--
T ss_conf             0010256264799998320257888880665787899999982088999998999--------9999997079-9877--


Q ss_pred             CHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             01111897688999999998735469999999999999
Q 001566         1009 PELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1009 ~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                           ..+...+.++.+|+.+||+.||++|||++|+++
T Consensus       236 -----~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         236 -----AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             -----SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             -----765669999999999976699668919999962

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=0  Score=356.02  Aligned_cols=253  Identities=24%  Similarity=0.312  Sum_probs=210.2

Q ss_pred             HCCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEEE
Q ss_conf             07975530330148448999994-49909999994067510188899999985026778500599788628816999941
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       774 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  852 (1052)
                      -++|++.+.||+|+||.||+|.. .+|+.||+|++........+.+.+|+.++++++||||+++++++.+++..|+||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf             65758988984076819999998899989999998452431699999999999867997999299999989999999985


Q ss_pred             CCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC--CCCEEEEEECCCCCCCCCC
Q ss_conf             59999999983506996458999999999999999987639998163799999979889--9969995205640025467
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDE--ELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~--~~~~kl~Dfgla~~~~~~~  930 (1052)
                      +++|+|.+++.... ..+++..+..++.|++.|+.|||++   ||+||||||+|||++.  ++.+||+|||+|+..... 
T Consensus       105 ~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-  179 (350)
T d1koaa2         105 MSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-  179 (350)
T ss_dssp             CCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-
T ss_pred             CCCCCHHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHC---CCEEEEECHHHEEECCCCCCEEEEEECCHHEECCCC-
T ss_conf             79988999997623-7899999999999999999999756---976000154673641688986999545210442565-


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCH
Q ss_conf             63334654455312543327788894015899999999999299999989556799751789999999708866322401
Q 001566          931 THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010 (1052)
Q Consensus       931 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1052)
                       .......||+.|||||++.+..++.++||||+||++|||++|+.||...        +..+....+.......   .+.
T Consensus       180 -~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~--------~~~~~~~~i~~~~~~~---~~~  247 (350)
T d1koaa2         180 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE--------NDDETLRNVKSCDWNM---DDS  247 (350)
T ss_dssp             -SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHTCCCS---CCG
T ss_pred             -CCCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHHCCCCC---CCC
T ss_conf             -4320006862421889975899872676554659999998598998997--------9999999998478898---942


Q ss_pred             HHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             1118976889999999987354699999999999999
Q 001566         1011 LWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus      1011 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                      ....    .+..+.+|+.+|++.||++|||++|+++.
T Consensus       248 ~~~~----~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         248 AFSG----ISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             GGGG----CCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             CCCC----CCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             2358----99999999999756896679089998629

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=0  Score=353.40  Aligned_cols=252  Identities=22%  Similarity=0.279  Sum_probs=209.3

Q ss_pred             HCCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEEE
Q ss_conf             07975530330148448999994-49909999994067510188899999985026778500599788628816999941
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       774 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  852 (1052)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++..........+.+|++++++++||||+++++++.++...|+||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf             40359989993177829999999899979999998872646799999999999867997989199999989999999982


Q ss_pred             CCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCEEEEEECCCCCCCCCC
Q ss_conf             5999999998350699645899999999999999998763999816379999997988--99969995205640025467
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLD--EELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~--~~~~~kl~Dfgla~~~~~~~  930 (1052)
                      +++|+|.+++.... ..+++.++..++.|++.|+.|||++   ||+||||||+|||++  .++.+||+|||+|...... 
T Consensus       108 ~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-  182 (352)
T d1koba_         108 LSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-  182 (352)
T ss_dssp             CCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred             CCCCHHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCC-
T ss_conf             89980888898638-9989999999999999999999977---926513144553113467884899525630343788-


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCH
Q ss_conf             63334654455312543327788894015899999999999299999989556799751789999999708866322401
Q 001566          931 THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010 (1052)
Q Consensus       931 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1052)
                       .......|++.|+|||++.+..++.++||||+||++|||++|+.||....        ..+....+......   +.+.
T Consensus       183 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------~~~~~~~i~~~~~~---~~~~  250 (352)
T d1koba_         183 -EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED--------DLETLQNVKRCDWE---FDED  250 (352)
T ss_dssp             -SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHHCCCC---CCSS
T ss_pred             -CCEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHHCCCC---CCCC
T ss_conf             -72010047645348999747998976333898999999996889989979--------99999999847889---8930


Q ss_pred             HHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             111897688999999998735469999999999999
Q 001566         1011 LWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1011 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      .+..    .+.++.+|+.+|++.||.+|||+.|+++
T Consensus       251 ~~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         251 AFSS----VSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             TTTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CCCC----CCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             0247----9999999999975699668918999960

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=356.78  Aligned_cols=266  Identities=23%  Similarity=0.363  Sum_probs=205.7

Q ss_pred             HHCCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEEECCCCC-CCHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf             507975530330148448999994-4990999999406751-01888999999850267785005997886288169999
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       773 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      ..++|++.+.||+|+||+||+|.. .+|+.||+|+++.... ....++.+|+.++++++||||+++++++.+.+..|+||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf             75688897897127780999999989996999999875409789999999999998679999994999999899999999


Q ss_pred             EECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCC
Q ss_conf             41599999999835069964589999999999999999876-39998163799999979889996999520564002546
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY-SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS  929 (1052)
Q Consensus       851 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  929 (1052)
                      ||+++|+|.+++.+.  ..+++..+..++.|++.|+.|||+ .   +|+||||||+|||++.++.+||+|||+|+.....
T Consensus        84 Ey~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  158 (322)
T d1s9ja_          84 EHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  158 (322)
T ss_dssp             ECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             ECCCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEECCCCCEEEEECCCCCCCCCC
T ss_conf             767998689987424--99999999999999999999999859---9971445779946878998999548776256788


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCC-------CCCHHHHH--------
Q ss_conf             763334654455312543327788894015899999999999299999989556799-------75178999--------
Q 001566          930 ETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGN-------GFNIVSWA--------  994 (1052)
Q Consensus       930 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~elltg~~p~~~~~~~~~~-------~~~~~~~~--------  994 (1052)
                         .....+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.......       ........        
T Consensus       159 ---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (322)
T d1s9ja_         159 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  235 (322)
T ss_dssp             ---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred             ---CCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCC
T ss_conf             ---62111377141194687589989488899899999999988899899887899999988751775457742123332


Q ss_pred             --HHHHHHCCCCCCC---CCHHHCC----C-CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             --9999708866322---4011118----9-7688999999998735469999999999999
Q 001566          995 --KLLIKEGRSSELF---LPELWEA----G-PQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus       995 --~~~~~~~~~~~~~---~~~l~~~----~-~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                        .............   .......    . ......++.+++.+|+..||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             21111222354134778876650268766764448999999999986899467908999960

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=354.98  Aligned_cols=257  Identities=22%  Similarity=0.350  Sum_probs=209.6

Q ss_pred             HHCCCCCCEEEECCCCEEEEEEEECC------CCEEEEEEECCCC-CCCHHHHHHHHHHHHCC-CCCCEEEEEEEEECCC
Q ss_conf             50797553033014844899999449------9099999940675-10188899999985026-7785005997886288
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAELVP------GYLVAVKKLSIGR-FQGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEA  844 (1052)
Q Consensus       773 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  844 (1052)
                      ..++|++.++||+|+||+||+|....      ...||+|.+.... ......+.+|+.++.++ +||||+++++++.+.+
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC
T ss_conf             78993970198307881999999857885542049999996633587899999999999997158996868778886299


Q ss_pred             EEEEEEEECCCCCHHHHHHHCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCC
Q ss_conf             16999941599999999835069---------------------964589999999999999999876399981637999
Q 001566          845 EMFLVYNFLSGGNLETFIHKKSG---------------------KKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIK  903 (1052)
Q Consensus       845 ~~~lv~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik  903 (1052)
                      ..++||||+++|+|.++++....                     ..+++..+..++.|++.|++|||++   +|+|||||
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlK  191 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA  191 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred             EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCC
T ss_conf             589999727999599999862577751022100001222001257789999999999999999999739---90505270


Q ss_pred             CCCEEECCCCCEEEEEECCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCC
Q ss_conf             99979889996999520564002546763-3346544553125433277888940158999999999992-999999895
Q 001566          904 PSNILLDEELNAYLSDFGLARLLEVSETH-ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSF  981 (1052)
Q Consensus       904 ~~Nill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~ellt-g~~p~~~~~  981 (1052)
                      |+||+++.++.+||+|||+|+........ ......||+.|||||++.+..++.++||||+||++|||+| |+.||....
T Consensus       192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~  271 (325)
T d1rjba_         192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  271 (325)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             HHCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCCC
T ss_conf             32144345982898514222204577861562343578765783887279999633030003999999838999999989


Q ss_pred             CCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf             56799751789999999708866322401111897688999999998735469999999999999985
Q 001566          982 SEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLK 1049 (1052)
Q Consensus       982 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~ 1049 (1052)
                      ..        +........+...         ..|..++.++.+|+.+||+.||++|||++|+++.|.
T Consensus       272 ~~--------~~~~~~~~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         272 VD--------ANFYKLIQNGFKM---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CS--------HHHHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HH--------HHHHHHHHCCCCC---------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf             89--------9999998569989---------988767899999999975889668939999999974

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=352.68  Aligned_cols=245  Identities=27%  Similarity=0.419  Sum_probs=206.1

Q ss_pred             CCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEEECCCC---CCCHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf             7975530330148448999994-499099999940675---101888999999850267785005997886288169999
Q 001566          775 GNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       775 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      ++|++.+.||+|+||+||+|.. .+++.||+|++....   ......+.+|++++++++||||+++++++.+++..|+||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf             37699889851778589999998999499999981688567689999999999998568888885999999899989998


Q ss_pred             EECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCC
Q ss_conf             41599999999835069964589999999999999999876399981637999999798899969995205640025467
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       851 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  930 (1052)
                      ||+++|+|.+++...  ..+++..+..++.|++.|++|||++   +|+||||||+|||++.++.+||+|||+|...... 
T Consensus        86 Ey~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-  159 (263)
T d2j4za1          86 EYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-  159 (263)
T ss_dssp             ECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred             EECCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCCCEECCCCCEEECCCCEEEECCCC-
T ss_conf             504798589887504--8999999999999999999999988---9465220234414668998711555633544888-


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCH
Q ss_conf             63334654455312543327788894015899999999999299999989556799751789999999708866322401
Q 001566          931 THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010 (1052)
Q Consensus       931 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1052)
                        ......||+.|||||++.+..++.++||||+||++|||++|+.||...        +..+....+. ....       
T Consensus       160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~--------~~~~~~~~i~-~~~~-------  221 (263)
T d2j4za1         160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN--------TYQETYKRIS-RVEF-------  221 (263)
T ss_dssp             --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHH-TTCC-------
T ss_pred             --CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCC--------CHHHHHHHHH-CCCC-------
T ss_conf             --523557887634999975899893144046759999983299998889--------9999999997-1899-------


Q ss_pred             HHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             111897688999999998735469999999999999
Q 001566         1011 LWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1011 l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                         ..|...+.++.+++.+|++.||++|||++|+++
T Consensus       222 ---~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         222 ---TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             ---998668999999999976479768909999971

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=350.82  Aligned_cols=256  Identities=26%  Similarity=0.419  Sum_probs=209.9

Q ss_pred             CCCCCCEEEECCCCEEEEEEEECCC-----CEEEEEEECCCCCC-CHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEE
Q ss_conf             7975530330148448999994499-----09999994067510-18889999998502677850059978862881699
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELVPG-----YLVAVKKLSIGRFQ-GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFL  848 (1052)
Q Consensus       775 ~~~~~~~~lg~G~~g~V~~~~~~~~-----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  848 (1052)
                      +.|++.++||+|+||+||+|.+...     ..||||++.....+ ...++.+|++++++++||||++++|++.+....++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEE
T ss_conf             99686159811779099999996899878799999998844596899999999999985689878323677833880389


Q ss_pred             EEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCC
Q ss_conf             99415999999998350699645899999999999999998763999816379999997988999699952056400254
Q 001566          849 VYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV  928 (1052)
Q Consensus       849 v~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  928 (1052)
                      |+||+.++++.+++.... ..+++.++..++.|++.|+.|||++   +|+||||||+|||++.++.+||+|||+|+....
T Consensus        87 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          87 ITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             EEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEEECCCCCCHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHCCCC---CCCCCCCCCCEEEECCCCEEEECCCCHHHCCCC
T ss_conf             997213574022210234-5420899999999999854121212---342576564427888998499845510300357


Q ss_pred             CCC--CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCC
Q ss_conf             676--333465445531254332778889401589999999999929999998955679975178999999970886632
Q 001566          929 SET--HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSEL 1006 (1052)
Q Consensus       929 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      ...  .......|++.|+|||++.+..++.++||||||+++|||++++.|+....       ...+..+. +..+...  
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~-------~~~~~~~~-i~~~~~~--  232 (283)
T d1mqba_         163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-------SNHEVMKA-INDGFRL--  232 (283)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-------CHHHHHHH-HHTTCCC--
T ss_pred             CCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCC-------CHHHHHHH-HHCCCCC--
T ss_conf             8765267426777734348888704999973556344898999996798865568-------99999999-8635789--


Q ss_pred             CCCHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             240111189768899999999873546999999999999998505
Q 001566         1007 FLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1007 ~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~i 1051 (1052)
                             ..+..++..+.+|+.+||+.||++||++.|+++.|+++
T Consensus       233 -------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l  270 (283)
T d1mqba_         233 -------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL  270 (283)
T ss_dssp             -------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -------CCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             -------98504579999999997767976893999999999998

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=354.79  Aligned_cols=252  Identities=27%  Similarity=0.373  Sum_probs=206.1

Q ss_pred             HCCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEEECCCCC-CCHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEE
Q ss_conf             07975530330148448999994-4990999999406751-018889999998502677850059978862881699994
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYN  851 (1052)
Q Consensus       774 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  851 (1052)
                      .++|++.+.||+|+||+||+|.. .+++.||+|++..... +..+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEE
T ss_conf             74608998972174809999999999979999998456641279999999999985799888469654046743679886


Q ss_pred             ECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCC-
Q ss_conf             1599999999835069964589999999999999999876399981637999999798899969995205640025467-
Q 001566          852 FLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE-  930 (1052)
Q Consensus       852 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~-  930 (1052)
                      |+++|+|.+++...  ..+++.++..++.|++.|++|||++   +|+||||||+|||+++++.+||+|||+|+...... 
T Consensus        84 y~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          84 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             CCCCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCC
T ss_conf             45898089997537--9999999999999999999999975---983575468997887899879832314224046886


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCC-CCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCC
Q ss_conf             633346544553125433277888-9401589999999999929999998955679975178999999970886632240
Q 001566          931 THATTDVAGTFGYVAPEYATTCRV-SDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009 (1052)
Q Consensus       931 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                      .......+||+.|||||++.+..+ +.++||||+|+++|||++|+.||......       ....... .......    
T Consensus       159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~-------~~~~~~~-~~~~~~~----  226 (271)
T d1nvra_         159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-------CQEYSDW-KEKKTYL----  226 (271)
T ss_dssp             ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT-------SHHHHHH-HTTCTTS----
T ss_pred             CCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHH-HCCCCCC----
T ss_conf             531113255747428728618999997101617379999998299788889859-------9999998-6388878----


Q ss_pred             HHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             1111897688999999998735469999999999999
Q 001566         1010 ELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1010 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ..+    ...+.++.+|+.+||+.||++|||++|+++
T Consensus       227 ~~~----~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         227 NPW----KKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             TTG----GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCC----CCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             864----469999999999976799668909999961

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=353.39  Aligned_cols=256  Identities=28%  Similarity=0.429  Sum_probs=214.6

Q ss_pred             HCCCCCCEEEECCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEEEC
Q ss_conf             07975530330148448999994499099999940675101888999999850267785005997886288169999415
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFL  853 (1052)
Q Consensus       774 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~  853 (1052)
                      .++|++.+.||+|+||+||+|....+..||||+++... ...+.+.+|+.++++++|+||+++++++. ++..++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred             HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCCEEEEEEEC
T ss_conf             79979846993079809999999999999999988044-88899999999998666678868999982-39759999944


Q ss_pred             CCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCCCC
Q ss_conf             99999999835069964589999999999999999876399981637999999798899969995205640025467633
Q 001566          854 SGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETHA  933 (1052)
Q Consensus       854 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~~  933 (1052)
                      ++|++..++.......+++.++..++.|++.|++|||++   +|+||||||+|||++.++.+||+|||+|+.........
T Consensus        94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~  170 (285)
T d1fmka3          94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  170 (285)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHHH---HEECCCCCCEEEEECCCCCEEECCCCHHHHCCCCCCEE
T ss_conf             799435420000355305999999999999999987541---14335312307999899929984425554256887335


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHC
Q ss_conf             34654455312543327788894015899999999999299999989556799751789999999708866322401111
Q 001566          934 TTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWE 1013 (1052)
Q Consensus       934 ~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1013 (1052)
                      .....|++.|+|||++.+..++.++||||||+++|||++|+.|+....       ...+....+ ..+...         
T Consensus       171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~-------~~~~~~~~i-~~~~~~---------  233 (285)
T d1fmka3         171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-------VNREVLDQV-ERGYRM---------  233 (285)
T ss_dssp             -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-------CHHHHHHHH-HTTCCC---------
T ss_pred             ECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCC-------CHHHHHHHH-HHCCCC---------
T ss_conf             245455665458089837998917741323589999986899999888-------899999999-826899---------


Q ss_pred             CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             89768899999999873546999999999999998505
Q 001566         1014 AGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1014 ~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~i 1051 (1052)
                      ..+..++.++.+++.+||+.||++||++.++++.|+++
T Consensus       234 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~  271 (285)
T d1fmka3         234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  271 (285)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred             CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             99832379999999997566975891999999987666

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=353.32  Aligned_cols=253  Identities=25%  Similarity=0.407  Sum_probs=205.9

Q ss_pred             CCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEEECCCCC--CCHHHHHHHHHHHHCCCCCCEEEEEEEEEC--CCEEEEE
Q ss_conf             7975530330148448999994-4990999999406751--018889999998502677850059978862--8816999
Q 001566          775 GNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKNLVTLIGYYVG--EAEMFLV  849 (1052)
Q Consensus       775 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  849 (1052)
                      ++|++.+.||+|+||+||+|.. .+|+.||+|.+.....  ...+.+.+|++++++++||||+++++++.+  ....|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
T ss_conf             33799679830889199999999999799999987465797999999999999997789998248999991789989999


Q ss_pred             EEECCCCCHHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCEEECCCCCCCEEECCCCCEEEEEECCCCC
Q ss_conf             9415999999998350--6996458999999999999999987639--99816379999997988999699952056400
Q 001566          850 YNFLSGGNLETFIHKK--SGKKIQWSVIHKIAIDIAQALAYLHYSC--VPRIVHRDIKPSNILLDEELNAYLSDFGLARL  925 (1052)
Q Consensus       850 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~iiH~Dik~~Nill~~~~~~kl~Dfgla~~  925 (1052)
                      |||+++|+|.+++...  ....+++..++.++.|++.|+.|||++.  ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEEE
T ss_conf             95689993899998515457899999999999999999999997167788788586765425747888579800100032


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCC
Q ss_conf             25467633346544553125433277888940158999999999992999999895567997517899999997088663
Q 001566          926 LEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005 (1052)
Q Consensus       926 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1052)
                      ..... .......||+.|||||++.+..++.++||||+|+++|||++|+.||...        +..+....+ ..+... 
T Consensus       164 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~--------~~~~~~~~i-~~~~~~-  232 (269)
T d2java1         164 LNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF--------SQKELAGKI-REGKFR-  232 (269)
T ss_dssp             C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHH-HHTCCC-
T ss_pred             CCCCC-CCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCC--------CHHHHHHHH-HCCCCC-
T ss_conf             24577-7556677882327999983999993898875278999980188998998--------999999999-718998-


Q ss_pred             CCCCHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             22401111897688999999998735469999999999999
Q 001566         1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1006 ~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                          .    .+...+.++.+++.+||+.||++|||++|+++
T Consensus       233 ----~----~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         233 ----R----IPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             ----C----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----C----CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             ----8----97435999999999976799557918999972

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=351.09  Aligned_cols=254  Identities=26%  Similarity=0.408  Sum_probs=207.1

Q ss_pred             CCCCCCEE-EECCCCEEEEEEEEC---CCCEEEEEEECCCCC-CCHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
Q ss_conf             79755303-301484489999944---990999999406751-0188899999985026778500599788628816999
Q 001566          775 GNFSIRNL-IGTGGFGSTYKAELV---PGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLV  849 (1052)
Q Consensus       775 ~~~~~~~~-lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  849 (1052)
                      ++|.+.+. ||+|+||+||+|.+.   .+..||||+++.... ...+++.+|++++++++||||++++|++.. +..|+|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             CCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEEE
T ss_conf             4718878487306080999999960897689999998820397899999999999986799888068656036-807999


Q ss_pred             EEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCC
Q ss_conf             94159999999983506996458999999999999999987639998163799999979889996999520564002546
Q 001566          850 YNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS  929 (1052)
Q Consensus       850 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  929 (1052)
                      |||+++|+|.+++.... ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+|+.....
T Consensus        87 mE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEECCCCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEECCCCCEEECCCHHHHCCCCC
T ss_conf             98078996899752125-6999999999999999987899868---8105767646604546885420331342115543


Q ss_pred             CC--CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCC
Q ss_conf             76--33346544553125433277888940158999999999992-9999998955679975178999999970886632
Q 001566          930 ET--HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSEL 1006 (1052)
Q Consensus       930 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      ..  .......|++.|+|||++.+..++.++||||||+++|||+| |+.||....        ..+... .+..+...  
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~--------~~~~~~-~i~~~~~~--  231 (285)
T d1u59a_         163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--------GPEVMA-FIEQGKRM--  231 (285)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--------THHHHH-HHHTTCCC--
T ss_pred             CCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCC--------HHHHHH-HHHCCCCC--
T ss_conf             4321135621137433586887279999541232201789999938999999979--------999999-99818999--


Q ss_pred             CCCHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             240111189768899999999873546999999999999998505
Q 001566         1007 FLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1007 ~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~i 1051 (1052)
                             ..|..++.++.+|+.+||+.||++||++.++.+.|+.+
T Consensus       232 -------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         232 -------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             -------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             -------99976789999999997577976890999999999999

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=353.44  Aligned_cols=252  Identities=27%  Similarity=0.397  Sum_probs=207.1

Q ss_pred             HHCCCCCCEEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCC-CHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf             5079755303301484489999944-9909999994067510-1888999999850267785005997886288169999
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRFQ-GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       773 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      ..+.|++.+.||+|+||+||+|... +++.||+|++...... ....+.+|+.++++++||||+++++++.+++..|+||
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf             76666998899406583999999999998999999815773128999999999998679989991989999899888988


Q ss_pred             EECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCEEEEEECCCCCCC
Q ss_conf             415999999998350699645899999999999999998763999816379999997988---99969995205640025
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLD---EELNAYLSDFGLARLLE  927 (1052)
Q Consensus       851 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~---~~~~~kl~Dfgla~~~~  927 (1052)
                      ||+++|+|.+++...  ..+++..+..++.|++.|++|||++   +|+||||||+||++.   +++.+||+|||+|+...
T Consensus        87 E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          87 QLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             CCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             ECCCCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHC---EEEEEEECCCCEEECCCCCCCEEEEECCCEEEECC
T ss_conf             526898488865303--6788789999999999998752413---05568704630011046888249983154358725


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCC
Q ss_conf             46763334654455312543327788894015899999999999299999989556799751789999999708866322
Q 001566          928 VSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELF 1007 (1052)
Q Consensus       928 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1052)
                      ..  .......||+.|||||++.+..++.++||||+||++|||++|+.||....        ..+....+..... .  +
T Consensus       162 ~~--~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~~~~i~~~~~-~--~  228 (307)
T d1a06a_         162 PG--SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN--------DAKLFEQILKAEY-E--F  228 (307)
T ss_dssp             -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHTTCC-C--C
T ss_pred             CC--CEEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHCCCC-C--C
T ss_conf             89--70440032842259188737999807873451599999985979999989--------9999999861687-7--7


Q ss_pred             CCHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             401111897688999999998735469999999999999
Q 001566         1008 LPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1008 ~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ....+.    ..+..+.+++.+|+..||++|||++|+++
T Consensus       229 ~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         229 DSPYWD----DISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             CTTTTT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCCCC----CCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             876666----78999999999976089757918999862

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=343.60  Aligned_cols=248  Identities=23%  Similarity=0.292  Sum_probs=207.4

Q ss_pred             HCCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEEECCCC---CCCHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
Q ss_conf             07975530330148448999994-499099999940675---10188899999985026778500599788628816999
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLV  849 (1052)
Q Consensus       774 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  849 (1052)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++....   ....+.+.+|+.++++++||||+++++++.+....|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf             47428988983176849999999899989999998156544979999999999999867999887787640356421110


Q ss_pred             EEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCC
Q ss_conf             94159999999983506996458999999999999999987639998163799999979889996999520564002546
Q 001566          850 YNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS  929 (1052)
Q Consensus       850 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  929 (1052)
                      |||+++|+|.+++...  ..+++..+..++.|++.|++|+|++   +|+||||||+|||++.++.+||+|||+|+.....
T Consensus        84 ~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          84 MEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             EECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             EECCCCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEEEECCCCCCCCCC
T ss_conf             0035798605555325--6775999999999996521134315---9622464777847658998888205652003567


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCC
Q ss_conf             76333465445531254332778889401589999999999929999998955679975178999999970886632240
Q 001566          930 ETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009 (1052)
Q Consensus       930 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                       .......+||+.|+|||++.+..++.++||||+||++|||++|++||....        ..+..+... .+..      
T Consensus       159 -~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~--------~~~~~~~i~-~~~~------  222 (337)
T d1o6la_         159 -GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HERLFELIL-MEEI------  222 (337)
T ss_dssp             -TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHH-HCCC------
T ss_pred             -CCCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCC--------HHHHHHHHH-CCCC------
T ss_conf             -862055100889966665048988833310223067889987899999969--------999999985-2899------


Q ss_pred             HHHCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf             1111897688999999998735469999999-----999999
Q 001566         1010 ELWEAGPQENLLGMMRLASTCTVETLSTRPS-----VKQVLI 1046 (1052)
Q Consensus      1010 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt-----~~eil~ 1046 (1052)
                      .    .|...+.++.+|+.+|+..||.+|++     +.|+++
T Consensus       223 ~----~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         223 R----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             C----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             C----CCCCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHC
T ss_conf             8----9866899999999866638934422565234999972

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=350.42  Aligned_cols=247  Identities=23%  Similarity=0.378  Sum_probs=206.5

Q ss_pred             CCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEEECCCC---CCCHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf             7975530330148448999994-499099999940675---101888999999850267785005997886288169999
Q 001566          775 GNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       775 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      ++|++.+.||+|+||.||+|.. .+++.||+|++....   ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf             87789889850879099999998999799999986577557778999999999998768888617999999899889999


Q ss_pred             EECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCC
Q ss_conf             41599999999835069964589999999999999999876399981637999999798899969995205640025467
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       851 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  930 (1052)
                      ||+++|+|.+++...  ..+++..+..++.|++.|++|||++   +|+||||||+||++++++.+||+|||+|+......
T Consensus        88 Ey~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~  162 (288)
T d1uu3a_          88 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  162 (288)
T ss_dssp             CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             ECCCCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCCCCCCCCCCCEEEECCCCCCEECCCCC
T ss_conf             704898777765315--9999999999999999999762165---08847677412366888538860321024225677


Q ss_pred             -CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCC
Q ss_conf             -6333465445531254332778889401589999999999929999998955679975178999999970886632240
Q 001566          931 -THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009 (1052)
Q Consensus       931 -~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                       ........||+.|+|||++.+..++.++||||+||++|||++|+.||...        +..+....+.. +..      
T Consensus       163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~--------~~~~~~~~i~~-~~~------  227 (288)
T d1uu3a_         163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG--------NEYLIFQKIIK-LEY------  227 (288)
T ss_dssp             -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHT-TCC------
T ss_pred             CCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHC-CCC------
T ss_conf             643335556775525844002689896662304569999980388998995--------99999999971-899------


Q ss_pred             HHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHH
Q ss_conf             111189768899999999873546999999999999
Q 001566         1010 ELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVL 1045 (1052)
Q Consensus      1010 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil 1045 (1052)
                      .    .|...+.++.+|+.+||+.||++|||++|++
T Consensus       228 ~----~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         228 D----FPEKFFPKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             C----CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             C----CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHC
T ss_conf             9----9854799999999998557976891978973

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=343.52  Aligned_cols=252  Identities=23%  Similarity=0.332  Sum_probs=207.6

Q ss_pred             HHCCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEEECCCCC------CCHHHHHHHHHHHHCCCCCCEEEEEEEEECCCE
Q ss_conf             507975530330148448999994-4990999999406751------018889999998502677850059978862881
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRF------QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAE  845 (1052)
Q Consensus       773 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  845 (1052)
                      ..++|++.+.||+|+||.||+|.. .+|+.||+|++.....      ...+.+.+|+.++++++||||+++++++.+...
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   87 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCE
T ss_conf             55677982798117895999999999998999999875663213406899999999999986799899938899997998


Q ss_pred             EEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC----CEEEEEEC
Q ss_conf             69999415999999998350699645899999999999999998763999816379999997988999----69995205
Q 001566          846 MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEEL----NAYLSDFG  921 (1052)
Q Consensus       846 ~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~----~~kl~Dfg  921 (1052)
                      .|+||||+++|+|.+++...  ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++    .+|++|||
T Consensus        88 ~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          88 VILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEECCCCCCCCCHHCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEEECCCCCCCCEEECCHH
T ss_conf             99999867786431001035--6421557899999999998766625---422113330127982589866646964334


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHC
Q ss_conf             64002546763334654455312543327788894015899999999999299999989556799751789999999708
Q 001566          922 LARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEG 1001 (1052)
Q Consensus       922 la~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1052)
                      +|......  .......|++.|+|||++.+..++.++||||+|+++|||++|+.||....        ..+....+... 
T Consensus       163 ~a~~~~~~--~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~~~~i~~~-  231 (293)
T d1jksa_         163 LAHKIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANVSAV-  231 (293)
T ss_dssp             TCEECTTS--CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHTT-
T ss_pred             HHHHCCCC--CCCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCC--------HHHHHHHHHHC-
T ss_conf             42105777--63122477774309999818999976652214099999970889988999--------99999999816-


Q ss_pred             CCCCCCCCHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             866322401111897688999999998735469999999999999
Q 001566         1002 RSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1002 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ..  .+.+..+...+    ..+.+++.+||+.||++|||++|+++
T Consensus       232 ~~--~~~~~~~~~~s----~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         232 NY--EFEDEYFSNTS----ALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             CC--CCCHHHHTTSC----HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CC--CCCCHHCCCCC----HHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             88--88701047889----99999999986389668919999961

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=347.49  Aligned_cols=245  Identities=29%  Similarity=0.376  Sum_probs=201.0

Q ss_pred             CCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEEECCCCCC---CHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf             7975530330148448999994-49909999994067510---1888999999850267785005997886288169999
Q 001566          775 GNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQ---GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       775 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      ..|+..+.||+|+||+||+|.. .+++.||||++......   ..+.+.+|++++++++||||+++++++.+++..|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf             85676279701888099999998999399999984444358899999999999999778999823899999899889999


Q ss_pred             EECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCC
Q ss_conf             41599999999835069964589999999999999999876399981637999999798899969995205640025467
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       851 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  930 (1052)
                      ||+++|++..+....  ..+++.++..++.|++.|+.|||++   ||+||||||+|||++.++.+||+|||+|.....  
T Consensus        95 E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~--  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--  167 (309)
T ss_dssp             ECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred             EECCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCCCEEEECCCCCEEEEECCCCCCCCC--
T ss_conf             806999457899737--9999999999999999999999868---976667884217987999789844365334677--


Q ss_pred             CCCCCCCCCCCCCCCCCCCCC---CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCC
Q ss_conf             633346544553125433277---88894015899999999999299999989556799751789999999708866322
Q 001566          931 THATTDVAGTFGYVAPEYATT---CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELF 1007 (1052)
Q Consensus       931 ~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1052)
                         .....||+.|||||++.+   ..|+.++||||+||++|||++|..||...        ...+.......... ... 
T Consensus       168 ---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~--------~~~~~~~~i~~~~~-~~~-  234 (309)
T d1u5ra_         168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--------NAMSALYHIAQNES-PAL-  234 (309)
T ss_dssp             ---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--------CHHHHHHHHHHSCC-CCC-
T ss_pred             ---CCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHHCCC-CCC-
T ss_conf             ---87313476636889983467888672145455899999998788999997--------99999999982899-988-


Q ss_pred             CCHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             401111897688999999998735469999999999999
Q 001566         1008 LPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1008 ~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                             .+...+..+.+|+.+||+.||++|||++|+++
T Consensus       235 -------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         235 -------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             -------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             -------87888999999999977379657918999971

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=345.66  Aligned_cols=247  Identities=26%  Similarity=0.382  Sum_probs=201.9

Q ss_pred             EEEECCCCEEEEEEEEC---CCCEEEEEEECCCCC--CCHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEEECCC
Q ss_conf             03301484489999944---990999999406751--0188899999985026778500599788628816999941599
Q 001566          781 NLIGTGGFGSTYKAELV---PGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNFLSG  855 (1052)
Q Consensus       781 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  855 (1052)
                      +.||+|+||+||+|.+.   .++.||||+++....  ...+++.+|++++++++||||++++|++.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCCC
T ss_conf             7834587829999998169738599999988010898999999999999986799898527777505-977999974788


Q ss_pred             CCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCCC--C
Q ss_conf             99999983506996458999999999999999987639998163799999979889996999520564002546763--3
Q 001566          856 GNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH--A  933 (1052)
Q Consensus       856 gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~--~  933 (1052)
                      |+|.++++..  ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+|++|||+++........  .
T Consensus        92 g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  166 (277)
T d1xbba_          92 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  166 (277)
T ss_dssp             EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred             CCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCCCC
T ss_conf             9689997522--5789999999999999997668747---9556777611310235675123413453313432344322


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHH
Q ss_conf             346544553125433277888940158999999999992-9999998955679975178999999970886632240111
Q 001566          934 TTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELW 1012 (1052)
Q Consensus       934 ~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1012 (1052)
                      .....|++.|+|||.+.+..++.++||||||+++|||++ |+.||...        ...+... .+..+...        
T Consensus       167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~--------~~~~~~~-~i~~~~~~--------  229 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--------KGSEVTA-MLEKGERM--------  229 (277)
T ss_dssp             ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC--------CHHHHHH-HHHTTCCC--------
T ss_pred             CCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCC--------CHHHHHH-HHHCCCCC--------
T ss_conf             445677842039166537999843443034031328965899999998--------9999999-99828999--------


Q ss_pred             CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             189768899999999873546999999999999998505
Q 001566         1013 EAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1013 ~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~i 1051 (1052)
                       ..|..++.++.+|+.+||+.||++|||++++.+.|+.+
T Consensus       230 -~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         230 -GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCH
T ss_conf             -99865679999999997588976890989999985288

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=342.70  Aligned_cols=247  Identities=25%  Similarity=0.391  Sum_probs=198.1

Q ss_pred             CCC-CCCEEEECCCCEEEEEEEE-CCCCEEEEEEECCCC--CCCHHHHHHHHHHHHCCCCCCEEEEEEEEEC----CCEE
Q ss_conf             797-5530330148448999994-499099999940675--1018889999998502677850059978862----8816
Q 001566          775 GNF-SIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGR--FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG----EAEM  846 (1052)
Q Consensus       775 ~~~-~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~  846 (1052)
                      ++| ++.+.||+|+||+||+|.. .++..||+|++....  ....+.+.+|++++++++||||+++++++..    ....
T Consensus         8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~   87 (270)
T d1t4ha_           8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI   87 (270)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             CCEEEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEE
T ss_conf             87788516970082849999999999959999998512279899999999999998579998506999984033458889


Q ss_pred             EEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCC--EEECCCCCCCEEEC-CCCCEEEEEECCC
Q ss_conf             99994159999999983506996458999999999999999987639998--16379999997988-9996999520564
Q 001566          847 FLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPR--IVHRDIKPSNILLD-EELNAYLSDFGLA  923 (1052)
Q Consensus       847 ~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--iiH~Dik~~Nill~-~~~~~kl~Dfgla  923 (1052)
                      |+||||+++|+|.+++...  ..+++..+..++.|++.|++|||++   +  |+||||||+|||++ .++.+||+|||+|
T Consensus        88 ~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla  162 (270)
T d1t4ha_          88 VLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  162 (270)
T ss_dssp             EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EEEEECCCCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEECCCCHHHCEEECCCCCEEEEECCCC
T ss_conf             9999578989489997513--5546999999999999999999978---9979968767435116679998898005765


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCC
Q ss_conf             00254676333465445531254332778889401589999999999929999998955679975178999999970886
Q 001566          924 RLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRS 1003 (1052)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1052)
                      +....   .......||+.|||||++.+ .++.++||||+||++|||++|+.||....       ......+ .+..+..
T Consensus       163 ~~~~~---~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~-------~~~~~~~-~i~~~~~  230 (270)
T d1t4ha_         163 TLKRA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-------NAAQIYR-RVTSGVK  230 (270)
T ss_dssp             GGCCT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-------SHHHHHH-HHTTTCC
T ss_pred             EECCC---CCCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCC-------CHHHHHH-HHHCCCC
T ss_conf             42368---76677553813008988478-99986711007999999987889998765-------5999999-9973899


Q ss_pred             CCCCCCHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             6322401111897688999999998735469999999999999
Q 001566         1004 SELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1004 ~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ..    .+....++    ++.+++.+||..||++|||++|+++
T Consensus       231 ~~----~~~~~~~~----~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         231 PA----SFDKVAIP----EVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             CG----GGGGCCCH----HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CC----CCCCCCCH----HHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             86----56755789----9999999976379758929999967

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=346.22  Aligned_cols=264  Identities=25%  Similarity=0.358  Sum_probs=215.3

Q ss_pred             HHHHHHHCCCCCCEEEECCCCEEEEEEEEC------CCCEEEEEEECCCCCC-CHHHHHHHHHHHHCCCCCCEEEEEEEE
Q ss_conf             568875079755303301484489999944------9909999994067510-188899999985026778500599788
Q 001566          768 DNVVRATGNFSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSIGRFQ-GIQQFDAEIGTLGRIRHKNLVTLIGYY  840 (1052)
Q Consensus       768 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~  840 (1052)
                      ..++...++|++.+.||+|+||+||+|+..      +++.||||++...... ..+++.+|++++++++|||++++++++
T Consensus         6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_           6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             HHCCCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEE
T ss_conf             31138988938867982078839999998887657788299999988210857999999999999966899765524666


Q ss_pred             ECCCEEEEEEEECCCCCHHHHHHHCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEE
Q ss_conf             62881699994159999999983506----------------------99645899999999999999998763999816
Q 001566          841 VGEAEMFLVYNFLSGGNLETFIHKKS----------------------GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIV  898 (1052)
Q Consensus       841 ~~~~~~~lv~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ii  898 (1052)
                      ......++++||+++|+|.+++....                      ...+++..+..++.|++.|++|||++   +|+
T Consensus        86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iv  162 (301)
T d1lufa_          86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV  162 (301)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred             CCCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCC---CEE
T ss_conf             05980389998158992999998527554210000111001210346788989999999999999985541357---868


Q ss_pred             ECCCCCCCEEECCCCCEEEEEECCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCC-C
Q ss_conf             379999997988999699952056400254676-33346544553125433277888940158999999999992999-9
Q 001566          899 HRDIKPSNILLDEELNAYLSDFGLARLLEVSET-HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKR-S  976 (1052)
Q Consensus       899 H~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~elltg~~-p  976 (1052)
                      ||||||+||+++.++.+||+|||+|+....... .......+++.|+|||.+.+..++.++||||||+++|||++|.. |
T Consensus       163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p  242 (301)
T d1lufa_         163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  242 (301)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             EEEECCCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCCC
T ss_conf             54884011689899928983314421136776411157777676767989972688980563025236299998068999


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf             9989556799751789999999708866322401111897688999999998735469999999999999985059
Q 001566          977 LDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQLK 1052 (1052)
Q Consensus       977 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~i~ 1052 (1052)
                      |...        ...+.... +..+...         ..+...+.++.+|+.+||+.||++||||.|+++.|++|+
T Consensus       243 ~~~~--------~~~e~~~~-v~~~~~~---------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         243 YYGM--------AHEEVIYY-VRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TTTS--------CHHHHHHH-HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCC--------CHHHHHHH-HHCCCCC---------CCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHC
T ss_conf             9998--------99999999-9739978---------887325299999999974889657939999999999842

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=343.55  Aligned_cols=254  Identities=22%  Similarity=0.413  Sum_probs=206.5

Q ss_pred             CCCCCCEEEECCCCEEEEEEEEC-CCC----EEEEEEECCCC-CCCHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEE
Q ss_conf             79755303301484489999944-990----99999940675-1018889999998502677850059978862881699
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGY----LVAVKKLSIGR-FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFL  848 (1052)
Q Consensus       775 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  848 (1052)
                      ++|++.++||+|+||+||+|.+. +|+    +||+|+++... .+..+++.+|++++++++||||++++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CEEE
T ss_conf             999783198208992999999958998898999999965134979999999999999867998881589999619-8369


Q ss_pred             EEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCC
Q ss_conf             99415999999998350699645899999999999999998763999816379999997988999699952056400254
Q 001566          849 VYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV  928 (1052)
Q Consensus       849 v~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  928 (1052)
                      ++|++.+++|.+++.... ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+|+....
T Consensus        88 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             EEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             EEEECCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCHHHCCEECCCCCEEEECCCCCEECCC
T ss_conf             998426874010111334-5799999999999999999999876---950476212031167998758602552223354


Q ss_pred             CCCC-CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCC
Q ss_conf             6763-3346544553125433277888940158999999999992-9999998955679975178999999970886632
Q 001566          929 SETH-ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSEL 1006 (1052)
Q Consensus       929 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1052)
                      .... ......|++.|+|||++.+..++.++||||||+++|||+| |.+||.....        .+... .+..+...  
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~--------~~~~~-~i~~~~~~--  232 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------SEISS-ILEKGERL--  232 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG--------GGHHH-HHHHTCCC--
T ss_pred             CCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCH--------HHHHH-HHHCCCCC--
T ss_conf             44532236510586446708874699983565440799999999779999999998--------99999-99759989--


Q ss_pred             CCCHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             240111189768899999999873546999999999999998505
Q 001566         1007 FLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1007 ~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~i 1051 (1052)
                             ..|..++..+.+|+.+||+.||++|||+.|+++.|+++
T Consensus       233 -------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         233 -------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             -------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             -------99855689999999984789934691999999999998

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=343.81  Aligned_cols=255  Identities=24%  Similarity=0.381  Sum_probs=210.2

Q ss_pred             HCCCCCCEEEECCCCEEEEEEEECC----CCEEEEEEECCCCCC-CHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEE
Q ss_conf             0797553033014844899999449----909999994067510-18889999998502677850059978862881699
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELVP----GYLVAVKKLSIGRFQ-GIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFL  848 (1052)
Q Consensus       774 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  848 (1052)
                      .++|++.+.||+|+||.||+|.+..    +..||+|.++..... ..+.+.+|++++++++||||+++++++. ++..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEEE
T ss_conf             8996987799307882999999936996449999999365668799999999999998689999856988995-374799


Q ss_pred             EEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCC
Q ss_conf             99415999999998350699645899999999999999998763999816379999997988999699952056400254
Q 001566          849 VYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEV  928 (1052)
Q Consensus       849 v~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~~~kl~Dfgla~~~~~  928 (1052)
                      ||||+++|++.+++.... ..+++..+..++.|++.|+.|||++   +|+||||||+||+++.++.+||+|||+|+....
T Consensus        85 v~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             EEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEEECCCCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCHHHEEECCCCCEEECCCHHHEECCC
T ss_conf             998406980776542247-8999999999999998775230226---744141026553206789678765034213367


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCC
Q ss_conf             67633346544553125433277888940158999999999992-99999989556799751789999999708866322
Q 001566          929 SETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELF 1007 (1052)
Q Consensus       929 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1052)
                      ..........|++.|+|||++.+..++.++||||+|+++|||++ |.+||......        +.... +..+...   
T Consensus       161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--------~~~~~-i~~~~~~---  228 (273)
T d1mp8a_         161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--------DVIGR-IENGERL---  228 (273)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--------GHHHH-HHTTCCC---
T ss_pred             CCCEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHH--------HHHHH-HHCCCCC---
T ss_conf             76233054005831032667516998874524442478999982699998889999--------99999-9818999---


Q ss_pred             CCHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             40111189768899999999873546999999999999998505
Q 001566         1008 LPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1008 ~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~i 1051 (1052)
                            ..+...+..+.+|+.+||+.||++|||+.|+++.|+++
T Consensus       229 ------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i  266 (273)
T d1mp8a_         229 ------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  266 (273)
T ss_dssp             ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             ------89877799999999997687976892999999999999

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=338.96  Aligned_cols=244  Identities=21%  Similarity=0.316  Sum_probs=205.3

Q ss_pred             CCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEEECCCC---CCCHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf             7975530330148448999994-499099999940675---101888999999850267785005997886288169999
Q 001566          775 GNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGR---FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       775 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      ++|++.+.||+|+||.||+|.. .+|+.||+|++....   ....+.+.+|+++++.++||||+++++++......++|+
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf             37089889611768089999998999899999982677458899999999999999748772740344443222223222


Q ss_pred             EECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCC
Q ss_conf             41599999999835069964589999999999999999876399981637999999798899969995205640025467
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       851 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  930 (1052)
                      ||+.+|+|..++...  ..+++..+..++.|++.|+.|||++   +|+||||||+|||++.++.+||+|||+|+..... 
T Consensus       121 e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             ECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             CCCCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHCCCCCCCCEEEEECEEEEECCCC-
T ss_conf             233466226667515--8989999999999999989999859---9861767999936077897886101033322566-


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCH
Q ss_conf             63334654455312543327788894015899999999999299999989556799751789999999708866322401
Q 001566          931 THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010 (1052)
Q Consensus       931 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1052)
                         .....|++.|||||++.+..++.++||||+||++|||++|+.||...        +.......+... ...      
T Consensus       195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~--------~~~~~~~~i~~~-~~~------  256 (350)
T d1rdqe_         195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--------QPIQIYEKIVSG-KVR------  256 (350)
T ss_dssp             ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHC-CCC------
T ss_pred             ---CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHCC-CCC------
T ss_conf             ---64336763567889971799885331145007899997588998995--------999999998617-988------


Q ss_pred             HHCCCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH
Q ss_conf             11189768899999999873546999999-----9999999
Q 001566         1011 LWEAGPQENLLGMMRLASTCTVETLSTRP-----SVKQVLI 1046 (1052)
Q Consensus      1011 l~~~~~~~~~~~l~~Li~~cl~~dP~~RP-----t~~eil~ 1046 (1052)
                          .+...+.++.+++.+|+..||.+|+     +++|+++
T Consensus       257 ----~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         257 ----FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ----CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----CCCCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHC
T ss_conf             ----9766899999999998340998606553454999971

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=337.41  Aligned_cols=252  Identities=21%  Similarity=0.277  Sum_probs=208.0

Q ss_pred             HHCCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEE
Q ss_conf             507975530330148448999994-4990999999406751018889999998502677850059978862881699994
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYN  851 (1052)
Q Consensus       773 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  851 (1052)
                      ..++|++.+.||+|+||+||+|.. .+++.||+|.++....+ ...+.+|++++++++||||+++++++.+++..|+|||
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCCC-HHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEE
T ss_conf             701058878983177839999999899969999997578665-9999999999985799798909899988998899995


Q ss_pred             ECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC--CCEEEEEECCCCCCCCC
Q ss_conf             1599999999835069964589999999999999999876399981637999999798899--96999520564002546
Q 001566          852 FLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEE--LNAYLSDFGLARLLEVS  929 (1052)
Q Consensus       852 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~--~~~kl~Dfgla~~~~~~  929 (1052)
                      |+++|+|.+++.... ..+++.++..++.|++.|+.|||++   ||+||||||+|||++.+  ..+||+|||++......
T Consensus        82 ~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          82 FISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCCC
T ss_conf             389980889987538-9999999999999999999999876---997513554443443788518997644111003467


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCC
Q ss_conf             76333465445531254332778889401589999999999929999998955679975178999999970886632240
Q 001566          930 ETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009 (1052)
Q Consensus       930 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                        .......+++.|+|||...+..++.++||||+||++|+|++|..||....        ..+....+.....   .+..
T Consensus       158 --~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~--------~~~~~~~i~~~~~---~~~~  224 (321)
T d1tkia_         158 --DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--------NQQIIENIMNAEY---TFDE  224 (321)
T ss_dssp             --CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHTCC---CCCH
T ss_pred             --CCCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHHCCC---CCCH
T ss_conf             --75321223322234021048777840113027999999982899999989--------9999999983899---9880


Q ss_pred             HHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             1111897688999999998735469999999999999
Q 001566         1010 ELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1010 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ..+...+.    ++.+++.+|+..||++|||+.|+++
T Consensus       225 ~~~~~~s~----~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         225 EAFKEISI----EAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHHTTSCH----HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHCCCCCH----HHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             22367899----9999999986699668909999963

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=0  Score=338.25  Aligned_cols=244  Identities=27%  Similarity=0.421  Sum_probs=205.1

Q ss_pred             CCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEEECCC---CCCCHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf             7975530330148448999994-49909999994067---5101888999999850267785005997886288169999
Q 001566          775 GNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIG---RFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       775 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      ++|++.+.||+|+||+||+|.. .+|+.||+|++...   .....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf             47088889720768089999998999799999984577548899999999999998636967533035685288005676


Q ss_pred             EECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCC
Q ss_conf             41599999999835069964589999999999999999876399981637999999798899969995205640025467
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSE  930 (1052)
Q Consensus       851 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~  930 (1052)
                      ||+++|++..++...  ..+++..+..++.|++.|+.|||++   +|+||||||+|||++.++.+||+|||+|+..... 
T Consensus        84 E~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-  157 (316)
T d1fota_          84 DYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  157 (316)
T ss_dssp             CCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             EECCCCCCCCCCCCC--CCCCCCHHHHHHHHHHHHHHHHCCC---CEECCCCCCHHEEECCCCCEEEECCCCCEEECCC-
T ss_conf             503786322343222--2111007999999998765541247---6770556810503868998898317521671245-


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCH
Q ss_conf             63334654455312543327788894015899999999999299999989556799751789999999708866322401
Q 001566          931 THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010 (1052)
Q Consensus       931 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1052)
                         .....|++.|||||++.+..++.++||||+||++|||++|+.||...        +..+....+... ..       
T Consensus       158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~--------~~~~~~~~i~~~-~~-------  218 (316)
T d1fota_         158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS--------NTMKTYEKILNA-EL-------  218 (316)
T ss_dssp             ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHHHC-CC-------
T ss_pred             ---CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCC--------CHHHHHHHHHCC-CC-------
T ss_conf             ---64345763435999983899980430465333689997598999996--------999999999708-98-------


Q ss_pred             HHCCCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH
Q ss_conf             11189768899999999873546999999-----9999999
Q 001566         1011 LWEAGPQENLLGMMRLASTCTVETLSTRP-----SVKQVLI 1046 (1052)
Q Consensus      1011 l~~~~~~~~~~~l~~Li~~cl~~dP~~RP-----t~~eil~ 1046 (1052)
                         ..|...+.++.+++.+|+..||.+|+     +++++++
T Consensus       219 ---~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         219 ---RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---CCCCCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHC
T ss_conf             ---89977899999999999544997666431021999981

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=345.49  Aligned_cols=251  Identities=26%  Similarity=0.427  Sum_probs=207.0

Q ss_pred             HCCCCCCEEEECCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEC-CCEEEEEEEE
Q ss_conf             079755303301484489999944990999999406751018889999998502677850059978862-8816999941
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG-EAEMFLVYNF  852 (1052)
Q Consensus       774 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~E~  852 (1052)
                      .++|++.+.||+|+||.||+|.+. |+.||||+++...  ..+.+.+|++++++++||||++++|++.+ .+..++||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHEEEEEEEECCCCEEEEEEEEC-CEEEEEEEECCHH--HHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEC
T ss_conf             899488579820798089999999-9099999988577--7999999999998678989854987887238928999963


Q ss_pred             CCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCCC
Q ss_conf             59999999983506996458999999999999999987639998163799999979889996999520564002546763
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      +++|+|.+++.......+++..+.+++.|++.|+.|||+.   +|+||||+|+||+++.++.+|++|||.++.....   
T Consensus        83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---  156 (262)
T d1byga_          83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  156 (262)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCC---CEECCCCCHHHHEECCCCCEEECCCCCCEECCCC---
T ss_conf             6999899998745788889999999999998523211337---6553666567601468997763245600344787---


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHH
Q ss_conf             3346544553125433277888940158999999999992-999999895567997517899999997088663224011
Q 001566          933 ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPEL 1011 (1052)
Q Consensus       933 ~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1011 (1052)
                       .....++..|+|||++.+..++.++||||||+++|||+| |++||.....        .+.... +..+...       
T Consensus       157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~--------~~~~~~-i~~~~~~-------  219 (262)
T d1byga_         157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVPR-VEKGYKM-------  219 (262)
T ss_dssp             ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--------GGHHHH-HTTTCCC-------
T ss_pred             -CCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCH--------HHHHHH-HHCCCCC-------
T ss_conf             -76556664677817872798885887775799999999789999999999--------999999-9808999-------


Q ss_pred             HCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf             11897688999999998735469999999999999985059
Q 001566         1012 WEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQLK 1052 (1052)
Q Consensus      1012 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~i~ 1052 (1052)
                        ..+...+.++.+++.+||+.||.+|||+.|+++.|+++|
T Consensus       220 --~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         220 --DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf             --997657999999999975669768939999999999998

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=0  Score=338.00  Aligned_cols=249  Identities=24%  Similarity=0.353  Sum_probs=198.6

Q ss_pred             HCCCCCCEEEECCCCEEEEEEEEC-CCCEEEEEEECCCCC---CCHHHHH---HHHHHHHCCCCCCEEEEEEEEECCCEE
Q ss_conf             079755303301484489999944-990999999406751---0188899---999985026778500599788628816
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAELV-PGYLVAVKKLSIGRF---QGIQQFD---AEIGTLGRIRHKNLVTLIGYYVGEAEM  846 (1052)
Q Consensus       774 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~  846 (1052)
                      -++|++.+.||+|+||.||+|... +|+.||+|++.....   .....+.   .++.+++.++||||+++++++.+.+..
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEE
T ss_conf             77685101884288909999999999979999998458754266799999999999998508998588999999989988


Q ss_pred             EEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCC
Q ss_conf             99994159999999983506996458999999999999999987639998163799999979889996999520564002
Q 001566          847 FLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL  926 (1052)
Q Consensus       847 ~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~~~kl~Dfgla~~~  926 (1052)
                      |+||||+++|+|.+++...  ..+++..+..++.|++.|+.|||++   +|+||||||+|||++.++.+||+|||+|+..
T Consensus        83 ~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEEECCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCEEECCCEEEECCCCCEEEEEECEEEEC
T ss_conf             9999914898389998732--5532789999999999999999977---9622044422167858896798220102333


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCC
Q ss_conf             5467633346544553125433277-888940158999999999992999999895567997517899999997088663
Q 001566          927 EVSETHATTDVAGTFGYVAPEYATT-CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSE 1005 (1052)
Q Consensus       927 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1052)
                      ...   ......||+.|+|||++.. ..++.++||||+||++|||++|+.||......     ....    .........
T Consensus       158 ~~~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-----~~~~----~~~~~~~~~  225 (364)
T d1omwa3         158 SKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DKHE----IDRMTLTMA  225 (364)
T ss_dssp             SSS---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS-----CHHH----HHHHSSSCC
T ss_pred             CCC---CCCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHH-----HHHH----HHHHCCCCC
T ss_conf             788---6433113455421687603899984410467789999998599988889989-----9999----998604688


Q ss_pred             CCCCHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf             22401111897688999999998735469999999-----999999
Q 001566         1006 LFLPELWEAGPQENLLGMMRLASTCTVETLSTRPS-----VKQVLI 1046 (1052)
Q Consensus      1006 ~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt-----~~eil~ 1046 (1052)
                         ...    +...+.++.+|+.+||..||++||+     +.|+++
T Consensus       226 ---~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         226 ---VEL----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             ---CCC----CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             ---CCC----CCCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHC
T ss_conf             ---878----877899999999998566988808874357999974

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=339.37  Aligned_cols=264  Identities=25%  Similarity=0.327  Sum_probs=208.3

Q ss_pred             HHHHHHHCCCCCCEEEECCCCEEEEEEEEC------CCCEEEEEEECCCCC-CCHHHHHHHHHHHHCC-CCCCEEEEEEE
Q ss_conf             568875079755303301484489999944------990999999406751-0188899999985026-77850059978
Q 001566          768 DNVVRATGNFSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRI-RHKNLVTLIGY  839 (1052)
Q Consensus       768 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~  839 (1052)
                      ++.+...++|++.+.||+|+||.||+|...      +++.||+|+++.... ...+.+.+|...+.++ +|+|++.++++
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~   85 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   85 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEE
T ss_conf             25261679979844984167839999998677755578399999986001717899999999998861499849974115


Q ss_pred             EECC-CEEEEEEEECCCCCHHHHHHHCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCC
Q ss_conf             8628-81699994159999999983506--------------99645899999999999999998763999816379999
Q 001566          840 YVGE-AEMFLVYNFLSGGNLETFIHKKS--------------GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKP  904 (1052)
Q Consensus       840 ~~~~-~~~~lv~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~  904 (1052)
                      +... ...++||||+++|+|.++++...              ...+++.++..++.|++.|+.|||++   +|+||||||
T Consensus        86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp  162 (299)
T d1ywna1          86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA  162 (299)
T ss_dssp             ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCG
T ss_pred             ECCCCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCC
T ss_conf             40479757999984589929999985366666532220233214689999999999999999988737---971786773


Q ss_pred             CCEEECCCCCEEEEEECCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCC-CCCCCCC
Q ss_conf             997988999699952056400254676-33346544553125433277888940158999999999992999-9998955
Q 001566          905 SNILLDEELNAYLSDFGLARLLEVSET-HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKR-SLDPSFS  982 (1052)
Q Consensus       905 ~Nill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~elltg~~-p~~~~~~  982 (1052)
                      +|||+++++.+||+|||+|+....... .......||+.|+|||++.+..++.++||||+|+++|||+++.. ||.....
T Consensus       163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~  242 (299)
T d1ywna1         163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  242 (299)
T ss_dssp             GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred             CCEEECCCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCH
T ss_conf             10657799828984575200113566522247516672102036864688996632213678999998688999989998


Q ss_pred             CCCCCCCHHHHHHHHHHHCCCCCCCCCHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             679975178999999970886632240111189768899999999873546999999999999998505
Q 001566          983 EYGNGFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus       983 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~i 1051 (1052)
                              .+........+....         .+...+.++.+++.+||+.||++|||++|+++.|+++
T Consensus       243 --------~~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         243 --------DEEFCRRLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             --------SHHHHHHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------HHHHHHHHHCCCCCC---------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             --------999999996389888---------8865789999999997677966791999999999799

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=0  Score=336.89  Aligned_cols=259  Identities=24%  Similarity=0.335  Sum_probs=211.7

Q ss_pred             HHCCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEEECCCCC---CCHHHHHHHHHHHHCCCCCCEEEEEEEEECCC----
Q ss_conf             507975530330148448999994-4990999999406751---01888999999850267785005997886288----
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRF---QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEA----  844 (1052)
Q Consensus       773 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  844 (1052)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|+++....   .....+.+|++++++++||||+++++++....    
T Consensus         5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~   84 (277)
T d1o6ya_           5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   84 (277)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred             CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCC
T ss_conf             06206986899608992999999999998999999855664698999999999999985699988731143543268876


Q ss_pred             EEEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCC
Q ss_conf             16999941599999999835069964589999999999999999876399981637999999798899969995205640
Q 001566          845 EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR  924 (1052)
Q Consensus       845 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~~~kl~Dfgla~  924 (1052)
                      ..|+||||+++++|.+++...  ..+++.++..++.|++.|++|||++   ||+||||||+||+++.++..+++|||.+.
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEEECCCCCEEHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCEEEHHHHHH
T ss_conf             699999778898710112035--8999999999999999999999857---95276346755665754320100344432


Q ss_pred             CCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCC
Q ss_conf             025467--633346544553125433277888940158999999999992999999895567997517899999997088
Q 001566          925 LLEVSE--THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGR 1002 (1052)
Q Consensus       925 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1052)
                      ......  ........|++.|+|||++.+..++.++||||+|+++|||+||+.||...        +..+..........
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~--------~~~~~~~~~~~~~~  231 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD--------SPVSVAYQHVREDP  231 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHHCCC
T ss_pred             HHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCC--------CHHHHHHHHHHCCC
T ss_conf             2123544333346425762436999983999996632026528999997697998996--------99999999984699


Q ss_pred             CCCCCCCHHHCCCCHHHHHHHHHHHHHCCCCCCCCCC-CHHHHHHHHHCC
Q ss_conf             6632240111189768899999999873546999999-999999998505
Q 001566         1003 SSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRP-SVKQVLIKLKQL 1051 (1052)
Q Consensus      1003 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RP-t~~eil~~L~~i 1051 (1052)
                      ...   ...+..    .+.++.+++.+|++.||++|| +++++.+.|.++
T Consensus       232 ~~~---~~~~~~----~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         232 IPP---SARHEG----LSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             CCG---GGTSSS----CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             CCC---CHHCCC----CCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHH
T ss_conf             997---100347----8999999999986679767773999999999997

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=339.04  Aligned_cols=254  Identities=26%  Similarity=0.413  Sum_probs=206.4

Q ss_pred             CCCCCCEEEECCCCEEEEEEEEC-CCC--EEEEEEECCCC-CCCHHHHHHHHHHHHCC-CCCCEEEEEEEEECCCEEEEE
Q ss_conf             79755303301484489999944-990--99999940675-10188899999985026-778500599788628816999
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV-PGY--LVAVKKLSIGR-FQGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGEAEMFLV  849 (1052)
Q Consensus       775 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  849 (1052)
                      ++|++.++||+|+||+||+|.+. ++.  .||||++.... .+..+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
T ss_conf             99688779820788289999998999699999999782338579999999999998622899883678888418736999


Q ss_pred             EEECCCCCHHHHHHHC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCE
Q ss_conf             9415999999998350--------------69964589999999999999999876399981637999999798899969
Q 001566          850 YNFLSGGNLETFIHKK--------------SGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNA  915 (1052)
Q Consensus       850 ~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~~~  915 (1052)
                      |||+++|+|.++++..              ....+++..+.+++.|++.|+.|+|++   +|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred             EEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCCCE
T ss_conf             980289869999864035555512310123457899999999999999998766308---95455505204898688763


Q ss_pred             EEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCC-CCCCCCCCCCCCCHHHHH
Q ss_conf             9952056400254676333465445531254332778889401589999999999929999-998955679975178999
Q 001566          916 YLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRS-LDPSFSEYGNGFNIVSWA  994 (1052)
Q Consensus       916 kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~elltg~~p-~~~~~~~~~~~~~~~~~~  994 (1052)
                      ||+|||+++.....  .......|+..|+|||.+.+..++.++||||||+++|||++|..| |..        .+..+..
T Consensus       167 kl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~--------~~~~~~~  236 (309)
T d1fvra_         167 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG--------MTCAELY  236 (309)
T ss_dssp             EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT--------CCHHHHH
T ss_pred             EECCCCCCCCCCCC--CCCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCC--------CCHHHHH
T ss_conf             87434432244422--3455301377555538752699996221531388999998368999999--------9999999


Q ss_pred             HHHHHHCCCCCCCCCHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             999970886632240111189768899999999873546999999999999998505
Q 001566          995 KLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus       995 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~i 1051 (1052)
                      ..+ ..+...         ..+...+.++.+|+.+||+.||++||++.|+++.|+++
T Consensus       237 ~~i-~~~~~~---------~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i  283 (309)
T d1fvra_         237 EKL-PQGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  283 (309)
T ss_dssp             HHG-GGTCCC---------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHH-HHCCCC---------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             999-826888---------88766789999999997678966894999999999999

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=338.40  Aligned_cols=261  Identities=25%  Similarity=0.363  Sum_probs=212.3

Q ss_pred             HHHCCCCCCEEEECCCCEEEEEEEEC------CCCEEEEEEECCCCC-CCHHHHHHHHHHHHCC-CCCCEEEEEEEEECC
Q ss_conf             75079755303301484489999944------990999999406751-0188899999985026-778500599788628
Q 001566          772 RATGNFSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRI-RHKNLVTLIGYYVGE  843 (1052)
Q Consensus       772 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  843 (1052)
                      ...++|++.++||+|+||.||+|.+.      .+..||||+++.... .....+.+|+.+++++ +||||+++++++.+.
T Consensus        20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~   99 (311)
T d1t46a_          20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (311)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEEC
T ss_conf             77899698549820688299999980664477886999999874248779999999999987626999887899898319


Q ss_pred             CEEEEEEEECCCCCHHHHHHHCC----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCE
Q ss_conf             81699994159999999983506----------------99645899999999999999998763999816379999997
Q 001566          844 AEMFLVYNFLSGGNLETFIHKKS----------------GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNI  907 (1052)
Q Consensus       844 ~~~~lv~E~~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Ni  907 (1052)
                      ...++||||+++|+|.++++...                ...+++..+..++.|++.|++|||++   +++||||||+||
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NI  176 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI  176 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             CEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCC
T ss_conf             97899997379987999998535665444445332223345889999999999999999988757---926662410210


Q ss_pred             EECCCCCEEEEEECCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf             98899969995205640025467-63334654455312543327788894015899999999999299999989556799
Q 001566          908 LLDEELNAYLSDFGLARLLEVSE-THATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGN  986 (1052)
Q Consensus       908 ll~~~~~~kl~Dfgla~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~elltg~~p~~~~~~~~~~  986 (1052)
                      +++.++.++++|||.++...... ........|++.|+|||++.+..++.++||||||+++|||+|++.|+......   
T Consensus       177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~---  253 (311)
T d1t46a_         177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV---  253 (311)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS---
T ss_pred             CCCCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCH---
T ss_conf             00025752102340102336788615862013596876778861799997400102589999998589988778998---


Q ss_pred             CCCHHHHHHHHHHHCCCCCCCCCHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             75178999999970886632240111189768899999999873546999999999999998505
Q 001566          987 GFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus       987 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~i 1051 (1052)
                          .+........+....         .+...+..+.+|+.+||+.||++|||+.|+++.|+++
T Consensus       254 ----~~~~~~~i~~~~~~~---------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         254 ----DSKFYKMIKEGFRML---------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             ----SHHHHHHHHHTCCCC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----HHHHHHHHHCCCCCC---------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             ----999999986689889---------8543659999999997577965792999999999876

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=337.11  Aligned_cols=252  Identities=26%  Similarity=0.427  Sum_probs=205.0

Q ss_pred             CCEEEECCCCEEEEEEEECC----CCEEEEEEECCC-CCCCHHHHHHHHHHHHCCCCCCEEEEEEEEEC-CCEEEEEEEE
Q ss_conf             53033014844899999449----909999994067-51018889999998502677850059978862-8816999941
Q 001566          779 IRNLIGTGGFGSTYKAELVP----GYLVAVKKLSIG-RFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVG-EAEMFLVYNF  852 (1052)
Q Consensus       779 ~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~E~  852 (1052)
                      ..++||+|+||+||+|.+..    ...||||++... .....+++.+|++++++++||||++++|++.. ++..++||||
T Consensus        31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~  110 (311)
T d1r0pa_          31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY  110 (311)
T ss_dssp             EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred             CCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEE
T ss_conf             66698136880999999977998799999999884369789999999999998678999867867898069943899987


Q ss_pred             CCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCC-
Q ss_conf             5999999998350699645899999999999999998763999816379999997988999699952056400254676-
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET-  931 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~-  931 (1052)
                      +++|+|.+++.... ...++..+.+++.|++.|+.|+|+.   +|+||||||+|||+++++.+||+|||+++....... 
T Consensus       111 ~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         111 MKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             CTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             EECCCHHHHHCCCC-CCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCCC
T ss_conf             40674144210134-5404899999999988765200336---7625776687576779998899106523225566555


Q ss_pred             --CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCC
Q ss_conf             --333465445531254332778889401589999999999929999998955679975178999999970886632240
Q 001566          932 --HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009 (1052)
Q Consensus       932 --~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                        .......|++.|+|||.+.+..++.++||||||+++|||++|+.||......       .++...+. .+...     
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-------~~~~~~i~-~g~~~-----  253 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-------FDITVYLL-QGRRL-----  253 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHHHH-TTCCC-----
T ss_pred             CCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCH-------HHHHHHHH-CCCCC-----
T ss_conf             310025655564556768874379997457466199999999789999888999-------99999998-08988-----


Q ss_pred             HHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             111189768899999999873546999999999999998505
Q 001566         1010 ELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1010 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~i 1051 (1052)
                          ..|..++..+.+++.+||+.||++||++.|+++.|+++
T Consensus       254 ----~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i  291 (311)
T d1r0pa_         254 ----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  291 (311)
T ss_dssp             ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             ----99644759999999997688976893999999999999

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=335.07  Aligned_cols=269  Identities=25%  Similarity=0.313  Sum_probs=203.8

Q ss_pred             CCCCCCEEEECCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEECCC----EEEEEE
Q ss_conf             7975530330148448999994499099999940675101888999999850267785005997886288----169999
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEA----EMFLVY  850 (1052)
Q Consensus       775 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  850 (1052)
                      .+|.+.+.||+|+||.||+|+.. |+.||||++...... ......|+..+..++||||+++++++.+.+    ..++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             CEEEEEEEEEECCCEEEEEEEEC-CEEEEEEEECCCCHH-HHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEEE
T ss_conf             68999889820788199999999-989999998720046-7999999999962799868326889983798604899999


Q ss_pred             EECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCEEECCCCCCCEEECCCCCEEEEEECCCCC
Q ss_conf             4159999999983506996458999999999999999987639-----99816379999997988999699952056400
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC-----VPRIVHRDIKPSNILLDEELNAYLSDFGLARL  925 (1052)
Q Consensus       851 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~iiH~Dik~~Nill~~~~~~kl~Dfgla~~  925 (1052)
                      ||+++|+|.+++++.   .+++..+.+++.|++.|+.|+|+..     .++|+||||||+|||++.++.+||+|||++..
T Consensus        81 Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~  157 (303)
T d1vjya_          81 DYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             ECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             ECCCCCCHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCC
T ss_conf             646698989998658---99989999999999999999887665204689866153173135786887768876386623


Q ss_pred             CCCCCC---CCCCCCCCCCCCCCCCCCCCCC------CCCCHHHHHHHHHHHHHHHCCCCCCCCCCCC------CCCCCH
Q ss_conf             254676---3334654455312543327788------8940158999999999992999999895567------997517
Q 001566          926 LEVSET---HATTDVAGTFGYVAPEYATTCR------VSDKADVYSFGVVLLELISGKRSLDPSFSEY------GNGFNI  990 (1052)
Q Consensus       926 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~------~~~~sDv~slG~il~elltg~~p~~~~~~~~------~~~~~~  990 (1052)
                      ......   .......|++.|+|||++.+..      ++.++||||||+++|||+||..|+.......      ......
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T d1vjya_         158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             CCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCH
T ss_conf             46777620013552503547678221056545467776750122015999999962899887663112410122556430


Q ss_pred             HHHHHHHHHHCCCCCCCCCHHHCC-CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf             899999997088663224011118-97688999999998735469999999999999985059
Q 001566          991 VSWAKLLIKEGRSSELFLPELWEA-GPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQLK 1052 (1052)
Q Consensus       991 ~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~i~ 1052 (1052)
                      .+........+..    .|.+... .+.+....+.+++.+||+.||++|||+.|+++.|++|+
T Consensus       238 ~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~  296 (303)
T d1vjya_         238 VEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             HHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHCCCC----CCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf             9999998750246----8887765577689999999999976069858959999999999888

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=336.60  Aligned_cols=252  Identities=23%  Similarity=0.303  Sum_probs=199.0

Q ss_pred             HCCCCCCE-EEECCCCEEEEEEEE-CCCCEEEEEEECCCCCCCHHHHHHHHHHHHCC-CCCCEEEEEEEEEC----CCEE
Q ss_conf             07975530-330148448999994-49909999994067510188899999985026-77850059978862----8816
Q 001566          774 TGNFSIRN-LIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRI-RHKNLVTLIGYYVG----EAEM  846 (1052)
Q Consensus       774 ~~~~~~~~-~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~  846 (1052)
                      .++|++.+ .||+|+||.||+|.. .+++.||+|+++.     ...+.+|++++.++ +||||+++++++++    +...
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEE
T ss_conf             14879810796545486999999889998999999897-----4779999999998669999782989995034689789


Q ss_pred             EEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCEEEEEECCC
Q ss_conf             99994159999999983506996458999999999999999987639998163799999979889---996999520564
Q 001566          847 FLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDE---ELNAYLSDFGLA  923 (1052)
Q Consensus       847 ~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~---~~~~kl~Dfgla  923 (1052)
                      |+||||++||+|.+++.......+++.++..++.|++.|++|||++   +|+||||||+||+++.   .+.+||+|||+|
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCEE
T ss_conf             9999778998499999862787757999999999999999999976---9864441002201135555663113545512


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCC
Q ss_conf             00254676333465445531254332778889401589999999999929999998955679975178999999970886
Q 001566          924 RLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRS 1003 (1052)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1052)
                      +.....  .......|++.|+|||++.+..++.++||||+||++|+|+||+.||.......     ........+..+. 
T Consensus       162 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~-----~~~~~~~~i~~~~-  233 (335)
T d2ozaa1         162 KETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-----ISPGMKTRIRMGQ-  233 (335)
T ss_dssp             EECCCC--CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------CCCSCS-
T ss_pred             EECCCC--CCCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHH-----HHHHHHHHHHCCC-
T ss_conf             333688--86432267756379277748988888888764516778865889988988778-----8999999985388-


Q ss_pred             CCCCCCHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             6322401111897688999999998735469999999999999
Q 001566         1004 SELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1004 ~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                       ..+....+    ...+.++.+|+.+|+..||++|||+.|+++
T Consensus       234 -~~~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         234 -YEFPNPEW----SEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             -SSCCTTHH----HHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -CCCCCCCC----CCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             -88898543----469999999999975699657909999970

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=335.79  Aligned_cols=262  Identities=21%  Similarity=0.352  Sum_probs=212.3

Q ss_pred             HHHHHHCCCCCCEEEECCCCEEEEEEEEC------CCCEEEEEEECCCCC-CCHHHHHHHHHHHHCCCCCCEEEEEEEEE
Q ss_conf             68875079755303301484489999944------990999999406751-01888999999850267785005997886
Q 001566          769 NVVRATGNFSIRNLIGTGGFGSTYKAELV------PGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYV  841 (1052)
Q Consensus       769 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~  841 (1052)
                      +.+...++|++.+.||+|+||+||+|.+.      +++.||||+++.... +....+.+|++++++++||||+++++++.
T Consensus        14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~   93 (308)
T d1p4oa_          14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   93 (308)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             CEEECHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE
T ss_conf             00426899188359820788189999987864477896899999870128689999999999999769998841254784


Q ss_pred             CCCEEEEEEEECCCCCHHHHHHHCC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC
Q ss_conf             2881699994159999999983506--------99645899999999999999998763999816379999997988999
Q 001566          842 GEAEMFLVYNFLSGGNLETFIHKKS--------GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEEL  913 (1052)
Q Consensus       842 ~~~~~~lv~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~  913 (1052)
                      .....++||||+++|+|.+++....        ...+++..+.+++.|++.|+.|||++   +|+||||||+|||+++++
T Consensus        94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~  170 (308)
T d1p4oa_          94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF  170 (308)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred             CCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECEECCCCEEECCCC
T ss_conf             28810677760489988999875033211344468879999999999999999987647---965432867754035996


Q ss_pred             CEEEEEECCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCC-CCCCCCCCCCCCCCCHH
Q ss_conf             699952056400254676-3334654455312543327788894015899999999999299-99998955679975178
Q 001566          914 NAYLSDFGLARLLEVSET-HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGK-RSLDPSFSEYGNGFNIV  991 (1052)
Q Consensus       914 ~~kl~Dfgla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~elltg~-~p~~~~~~~~~~~~~~~  991 (1052)
                      .+||+|||+|+....... .......+++.|+|||.+.+..++.++||||||+++|||+||+ +||.        .....
T Consensus       171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~--------~~~~~  242 (308)
T d1p4oa_         171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ--------GLSNE  242 (308)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTT--------TSCHH
T ss_pred             EEEEEECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCC--------CCCHH
T ss_conf             4999424542023577630313402316323788887369988333444378999999968999999--------98999


Q ss_pred             HHHHHHHHHCCCCCCCCCHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             999999970886632240111189768899999999873546999999999999998505
Q 001566          992 SWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus       992 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~i 1051 (1052)
                      ++...+. .+....         .+..++..+.+++.+||+.||++|||+.++++.|++.
T Consensus       243 ~~~~~i~-~~~~~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         243 QVLRFVM-EGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             HHHHHHH-TTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             HHHHHHH-HCCCCC---------CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             9999998-088888---------8633539999999997577965893999999997876

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=336.00  Aligned_cols=247  Identities=25%  Similarity=0.349  Sum_probs=202.0

Q ss_pred             CCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEEECCCC---CCCHHHHHHHHHHHH-CCCCCCEEEEEEEEECCCEEEEE
Q ss_conf             7975530330148448999994-499099999940675---101888999999850-26778500599788628816999
Q 001566          775 GNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGR---FQGIQQFDAEIGTLG-RIRHKNLVTLIGYYVGEAEMFLV  849 (1052)
Q Consensus       775 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv  849 (1052)
                      ++|++.+.||+|+||+||+|.. .+++.||+|+++...   ....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf             97188658940878289999999999899999980555338489999999999999847999687898897049831677


Q ss_pred             EEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCC
Q ss_conf             94159999999983506996458999999999999999987639998163799999979889996999520564002546
Q 001566          850 YNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVS  929 (1052)
Q Consensus       850 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~  929 (1052)
                      |||+++|+|.+++...  ..+++.++..++.|++.|+.|||++   +|+||||||+|||++.++.+||+|||.++.....
T Consensus        82 mEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~  156 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  156 (320)
T ss_dssp             EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEECCCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCEEECCCCCEECCCCCHHHHCCCC
T ss_conf             7503798089986404--7899999999999999999999868---9340347654044448996301555302323566


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCC
Q ss_conf             76333465445531254332778889401589999999999929999998955679975178999999970886632240
Q 001566          930 ETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLP 1009 (1052)
Q Consensus       930 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1052)
                       ........|++.|+|||++.+..++.++||||+||++|||++|+.||....        ..+....+ ..+..      
T Consensus       157 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~--------~~~~~~~i-~~~~~------  220 (320)
T d1xjda_         157 -DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD--------EEELFHSI-RMDNP------  220 (320)
T ss_dssp             -TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHH-HHCCC------
T ss_pred             -CCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHH-HCCCC------
T ss_conf             -533454578777689999827998832320112278989873889999989--------99999999-71899------


Q ss_pred             HHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHH-HHHH
Q ss_conf             111189768899999999873546999999999-9999
Q 001566         1010 ELWEAGPQENLLGMMRLASTCTVETLSTRPSVK-QVLI 1046 (1052)
Q Consensus      1010 ~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~-eil~ 1046 (1052)
                      .    .|...+.++.+|+.+|+..||++||++. |+++
T Consensus       221 ~----~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         221 F----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             C----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             C----CCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf             8----975679999999999654489878388999980

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=338.74  Aligned_cols=256  Identities=25%  Similarity=0.383  Sum_probs=208.6

Q ss_pred             CCCCCCEEEECCCCEEEEEEEECC--C--CEEEEEEECCCC---CCCHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEE
Q ss_conf             797553033014844899999449--9--099999940675---101888999999850267785005997886288169
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELVP--G--YLVAVKKLSIGR---FQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMF  847 (1052)
Q Consensus       775 ~~~~~~~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  847 (1052)
                      ++|++.+.||+|+||+||+|....  +  ..||+|++....   .+..+++.+|++++++++||||++++|++.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCHH
T ss_conf             891997898038883999999988999079999999983555798999999999999986899998789877740-1001


Q ss_pred             EEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCC
Q ss_conf             99941599999999835069964589999999999999999876399981637999999798899969995205640025
Q 001566          848 LVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLE  927 (1052)
Q Consensus       848 lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~~~kl~Dfgla~~~~  927 (1052)
                      +|+||+++|++.+++.... ..+++..+..++.|++.|+.|||++   +|+||||||+||+++.++.+||+|||+++...
T Consensus        87 lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEEECCCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECHHHHCCCCCCCEEECCCHHHHHCC
T ss_conf             1465423861254442126-8999999999999999999875217---87520566888156556543325611555303


Q ss_pred             CCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCC
Q ss_conf             46763--3346544553125433277888940158999999999992-99999989556799751789999999708866
Q 001566          928 VSETH--ATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSS 1004 (1052)
Q Consensus       928 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1004 (1052)
                      .....  ......++..|+|||.+.+..++.++||||||+++|||+| |+.||...        +..+....+...+...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~--------~~~~~~~~i~~~~~~~  234 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL--------NGSQILHKIDKEGERL  234 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHHHHHHHTSCCCC
T ss_pred             CCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCC--------CHHHHHHHHHHCCCCC
T ss_conf             58875265476325731079999837999942156614899999996899999996--------9999999998479999


Q ss_pred             CCCCCHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf             322401111897688999999998735469999999999999985059
Q 001566         1005 ELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQLK 1052 (1052)
Q Consensus      1005 ~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~i~ 1052 (1052)
                           .    .+...+..+.+|+.+||+.||++|||+.|+.+.|++.+
T Consensus       235 -----~----~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~  273 (273)
T d1u46a_         235 -----P----RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  273 (273)
T ss_dssp             -----C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             -----C----CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHCC
T ss_conf             -----9----85445399999999976889667929999999999649

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=333.97  Aligned_cols=258  Identities=25%  Similarity=0.420  Sum_probs=210.3

Q ss_pred             HHCCCCCCEEEECCCCEEEEEEEECC--------CCEEEEEEECCCCC-CCHHHHHHHHHHHHCC-CCCCEEEEEEEEEC
Q ss_conf             50797553033014844899999449--------90999999406751-0188899999985026-77850059978862
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAELVP--------GYLVAVKKLSIGRF-QGIQQFDAEIGTLGRI-RHKNLVTLIGYYVG  842 (1052)
Q Consensus       773 ~~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  842 (1052)
                      ..++|++.+.||+|+||.||+|+...        +..||+|+++.... ....++.+|...+.++ +||||++++++|.+
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCC
T ss_conf             58996970098516782899999857875556675499999988112868899999999999981399969734652201


Q ss_pred             CCEEEEEEEECCCCCHHHHHHHCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEE
Q ss_conf             881699994159999999983506--------------996458999999999999999987639998163799999979
Q 001566          843 EAEMFLVYNFLSGGNLETFIHKKS--------------GKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNIL  908 (1052)
Q Consensus       843 ~~~~~lv~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nil  908 (1052)
                      ++..++||||+++|+|.+++....              ...+++.++..++.|++.|++|||+.   +|+||||||+|||
T Consensus        91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiL  167 (299)
T d1fgka_          91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL  167 (299)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred             CCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCCEE
T ss_conf             8868999973699909999986067764322233457434679999999999999999876637---9786302210224


Q ss_pred             ECCCCCEEEEEECCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH-CCCCCCCCCCCCCC
Q ss_conf             88999699952056400254676-33346544553125433277888940158999999999992-99999989556799
Q 001566          909 LDEELNAYLSDFGLARLLEVSET-HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELIS-GKRSLDPSFSEYGN  986 (1052)
Q Consensus       909 l~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~ellt-g~~p~~~~~~~~~~  986 (1052)
                      ++.++.+||+|||.++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |.+||....     
T Consensus       168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~-----  242 (299)
T d1fgka_         168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-----  242 (299)
T ss_dssp             ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----
T ss_pred             ECCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCC-----
T ss_conf             547897676221110113555554314667888466326675179888255547758888874017989899999-----


Q ss_pred             CCCHHHHHHHHHHHCCCCCCCCCHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             75178999999970886632240111189768899999999873546999999999999998505
Q 001566          987 GFNIVSWAKLLIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus       987 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~i 1051 (1052)
                         ... ....+..+....         .+...+.++.+|+.+||+.||++|||+.|+++.|++|
T Consensus       243 ---~~~-~~~~i~~~~~~~---------~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i  294 (299)
T d1fgka_         243 ---VEE-LFKLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  294 (299)
T ss_dssp             ---HHH-HHHHHHTTCCCC---------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HHH-HHHHHHCCCCCC---------CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             ---999-999997288889---------8743529999999997667976793999999999888

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=0  Score=328.85  Aligned_cols=252  Identities=23%  Similarity=0.321  Sum_probs=205.6

Q ss_pred             HCCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEEECCCCCC---------CHHHHHHHHHHHHCCC-CCCEEEEEEEEEC
Q ss_conf             07975530330148448999994-49909999994067510---------1888999999850267-7850059978862
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQ---------GIQQFDAEIGTLGRIR-HKNLVTLIGYYVG  842 (1052)
Q Consensus       774 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  842 (1052)
                      .++|++.+.||+|+||+||+|.. .+++.||+|++......         ..+.+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf             66388852884176849999999999989999999624464114788899999999999999985079974799762146


Q ss_pred             CCEEEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECC
Q ss_conf             88169999415999999998350699645899999999999999998763999816379999997988999699952056
Q 001566          843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGL  922 (1052)
Q Consensus       843 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~~~kl~Dfgl  922 (1052)
                      .+..|+||||+++|+|.++++..  ..+++.++..++.|++.|++|||++   ||+||||||+||+++.++.+||+|||.
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             CCCEEEEEECCCCCHHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCHH
T ss_conf             76059999768986689999865--9999999999999999999999875---994323462548986899838712403


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHH
Q ss_conf             40025467633346544553125433277------888940158999999999992999999895567997517899999
Q 001566          923 ARLLEVSETHATTDVAGTFGYVAPEYATT------CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKL  996 (1052)
Q Consensus       923 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  996 (1052)
                      ++.....  .......|++.|+|||.+.+      ..++.++||||+|+++|||++|+.||....        .....+.
T Consensus       157 a~~~~~~--~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~--------~~~~~~~  226 (277)
T d1phka_         157 SCQLDPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--------QMLMLRM  226 (277)
T ss_dssp             CEECCTT--CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHH
T ss_pred             EEECCCC--CCEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCC--------HHHHHHH
T ss_conf             1672688--72134524678889888605344567889923318565602310322888988999--------9999999


Q ss_pred             HHHHCCCCCCCCCHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             997088663224011118976889999999987354699999999999999
Q 001566          997 LIKEGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus       997 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                      +.......   ....    ....+.++.+++.+|+.+||++||+++|+++.
T Consensus       227 i~~~~~~~---~~~~----~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         227 IMSGNYQF---GSPE----WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             HHHTCCCC---CTTT----GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHCCCCC---CCCC----CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             98189888---9854----34689999999999765896689199999739

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=327.42  Aligned_cols=264  Identities=28%  Similarity=0.407  Sum_probs=205.7

Q ss_pred             CCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEEECCCCC--CCHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEE
Q ss_conf             7975530330148448999994-4990999999406751--018889999998502677850059978862881699994
Q 001566          775 GNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYN  851 (1052)
Q Consensus       775 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  851 (1052)
                      ++|++.+.||+|+||+||+|.. .+++.||+|+++....  ...+++.+|++++++++||||+++++++.+.+..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf             99776517723768099999999999799999980222575899999999999986799838874453322432037886


Q ss_pred             ECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCC
Q ss_conf             15999999998350699645899999999999999998763999816379999997988999699952056400254676
Q 001566          852 FLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET  931 (1052)
Q Consensus       852 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  931 (1052)
                      |+. +.+.+++.......+++..+..++.|++.|+.|||++   +|+||||||+|||++.++.+||+|||.|+..... .
T Consensus        82 ~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~-~  156 (298)
T d1gz8a_          82 FLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-V  156 (298)
T ss_dssp             CCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC-S
T ss_pred             ECC-CCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCHHEEECCCCCCEECCCCCCEECCCC-C
T ss_conf             237-7445554420256888899999999999999986528---8992135711401134676210357861343688-6


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCH
Q ss_conf             3334654455312543327788-894015899999999999299999989556799751789999999708866322401
Q 001566          932 HATTDVAGTFGYVAPEYATTCR-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE 1010 (1052)
Q Consensus       932 ~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1052)
                      .......|++.|+|||++.... ++.++||||+|+++|+|++|+.||.....       ...+.......+.......+.
T Consensus       157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~  229 (298)
T d1gz8a_         157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-------IDQLFRIFRTLGTPDEVVWPG  229 (298)
T ss_dssp             BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHHHCCCCTTTSTT
T ss_pred             CCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCH-------HHHHHHHHHHCCCCCHHHCCC
T ss_conf             4100103652154112213665777422103333134279668799898899-------999999998328983331444


Q ss_pred             HHC------------CC-----CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHC
Q ss_conf             111------------89-----76889999999987354699999999999999--850
Q 001566         1011 LWE------------AG-----PQENLLGMMRLASTCTVETLSTRPSVKQVLIK--LKQ 1050 (1052)
Q Consensus      1011 l~~------------~~-----~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~--L~~ 1050 (1052)
                      ...            ..     ......++.+|+.+|+..||++|||+.|+++.  |++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~  288 (298)
T d1gz8a_         230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD  288 (298)
T ss_dssp             GGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred             CCCCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf             22242124345432222044416678999999999976399557918999967870146

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=327.69  Aligned_cols=255  Identities=25%  Similarity=0.326  Sum_probs=195.6

Q ss_pred             CCEEEECCCCEEEEEEEE-CCCCEEEEEEECCCCCCC-----HHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEEE
Q ss_conf             530330148448999994-499099999940675101-----88899999985026778500599788628816999941
Q 001566          779 IRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQG-----IQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       779 ~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  852 (1052)
                      ..++||+|+||+||+|.. .+|+.||+|+++......     ...+.+|+.++++++||||+++++++..++..|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             CCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHH
T ss_conf             56385127282999999999996999999842021245679999999999999867999986898542258740220455


Q ss_pred             CCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCCC
Q ss_conf             59999999983506996458999999999999999987639998163799999979889996999520564002546763
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      +.++++..+....  ..+++..+..++.|++.|++|||++   ||+||||||+||+++.++.+||+|||.|+...... .
T Consensus        82 ~~~~~~~~~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-~  155 (299)
T d1ua2a_          82 METDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-R  155 (299)
T ss_dssp             CSEEHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-C
T ss_pred             HCCHHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCC-C
T ss_conf             3450776554126--6778999999999999999886316---35503577625885377841146576100057875-5


Q ss_pred             CCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCHH
Q ss_conf             33465445531254332778-88940158999999999992999999895567997517899999997088663224011
Q 001566          933 ATTDVAGTFGYVAPEYATTC-RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPEL 1011 (1052)
Q Consensus       933 ~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1011 (1052)
                      .....+|++.|+|||++.+. .++.++||||+||++|||++|.+||......       ..........+.......+..
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~-------~~l~~i~~~~~~~~~~~~~~~  228 (299)
T d1ua2a_         156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-------DQLTRIFETLGTPTEEQWPDM  228 (299)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHHHCCCCTTTSSST
T ss_pred             CCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHH-------HHHHHHHHHCCCCCHHHCCCH
T ss_conf             4330204733363999726778880564363042899998596999999999-------999999985189972545210


Q ss_pred             -----------HCCCC-----HHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             -----------11897-----688999999998735469999999999999
Q 001566         1012 -----------WEAGP-----QENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1012 -----------~~~~~-----~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                                 ....+     ......+.+|+.+|+..||++|||++|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         229 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             HCCCHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             002134430347898867856568999999999976389456908999967

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=0  Score=322.90  Aligned_cols=298  Identities=30%  Similarity=0.457  Sum_probs=206.4

Q ss_pred             CCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCC--CCCCEEEECCC--CCEEEEEECCCCCCCCCCCCCCCC--CCCH
Q ss_conf             99922499999999865679988656778999999--87703730699--964899982578899998764343--2432
Q 001566           44 SVPTTDSASLLSFKASISRDPSNLLATWNSSTDHC--TWHGVTCDHFT--GRVTALRITGKATPWPSKSSVISG--TLSA  117 (1052)
Q Consensus        44 ~~~~~d~~~ll~~k~~~~~~~~~~l~~W~~~~~~C--~w~gV~C~~~~--~~v~~l~l~~~~~~~~~~~~~~~g--~l~~  117 (1052)
                      -|.++|++||++||++++ ||. .+++|..++|||  .|.||+|+..+  +||+.+++.+..         ++|  .+|+
T Consensus         2 ~c~~~e~~aLl~~k~~~~-~~~-~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~---------l~g~~~lp~   70 (313)
T d1ogqa_           2 LCNPQDKQALLQIKKDLG-NPT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLN---------LPKPYPIPS   70 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTT-CCG-GGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCC---------CSSCEECCG
T ss_pred             CCCHHHHHHHHHHHHHCC-CCC-CCCCCCCCCCCCCCCCCCEEEECCCCCEEEEEEECCCCC---------CCCCCCCCH
T ss_conf             989899999999999779-998-677889999998894889697489994798899898998---------888887984


Q ss_pred             HHCCCCCCCEEEECC-CCCEECCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCC
Q ss_conf             100788878557037-9820028987358787648981375033358932438777885852234363358822339999
Q 001566          118 SIAKLTELRTLSVPH-NSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGE  196 (1052)
Q Consensus       118 ~l~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  196 (1052)
                      ++++|++|++|+|++ |++.|.+|..|+++++|++|+|++|++.+..+..+..+.+|+.+++++|.+.+.+|..+..++.
T Consensus        71 ~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~  150 (313)
T d1ogqa_          71 SLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPN  150 (313)
T ss_dssp             GGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTT
T ss_pred             HHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHCCCCC
T ss_conf             78467533520202654333002431145420011020356434433222220111001111224555568512206740


Q ss_pred             CCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECC
Q ss_conf             86798568744675566787545777779824786887778124799999989757982433423210079998799942
Q 001566          197 LSVIDMSSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVS  276 (1052)
Q Consensus       197 L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~  276 (1052)
                      ++.+++++|.+.+.+|.........++.+++++|++++..+..+..+. ...+++..+...+.+|..+..+++++.++++
T Consensus       151 L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~-~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~  229 (313)
T d1ogqa_         151 LVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLA  229 (313)
T ss_dssp             CCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECC
T ss_pred             CCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             000002355335620312144311232310224643533243322222-2233333343322222222222221112222


Q ss_pred             CCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCC
Q ss_conf             79897777712103799980321566555667887786544468986222202478287568997875589644489874
Q 001566          277 RNSLTDRIPVELADCSKLSVLVLTNIDASLDLDNSRGEFSAFDGGVPYELLLSRSLEVLWAPRANLGGRLPDNWSESCSL  356 (1052)
Q Consensus       277 ~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~l~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L  356 (1052)
                      +|.+.+                                                              .++ .+..+++|
T Consensus       230 ~~~l~~--------------------------------------------------------------~~~-~~~~~~~L  246 (313)
T d1ogqa_         230 KNSLAF--------------------------------------------------------------DLG-KVGLSKNL  246 (313)
T ss_dssp             SSEECC--------------------------------------------------------------BGG-GCCCCTTC
T ss_pred             CCCCCC--------------------------------------------------------------CCC-CCCCCCCC
T ss_conf             222222--------------------------------------------------------------222-22245544


Q ss_pred             CEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCC-CCCC
Q ss_conf             29967999453347823203489989968799476789988777874467112670-2235
Q 001566          357 KVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVYFNVSQNN-ITGV  416 (1052)
Q Consensus       357 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~l~l~~N~-l~~~  416 (1052)
                      +.|+|++|+++|.+|..++.+++|++|+|++|+++|.+|....+.+|+.+++++|+ +.|.
T Consensus       247 ~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~  307 (313)
T d1ogqa_         247 NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS  307 (313)
T ss_dssp             CEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEEST
T ss_pred             CCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCC
T ss_conf             4444765706660876884799999897958835166898666799897886889500198

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=0  Score=322.52  Aligned_cols=259  Identities=23%  Similarity=0.312  Sum_probs=203.5

Q ss_pred             CCCCCCEEEECCCCEEEEEEEECCCCEEEEEEECCCCC--CCHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEEE
Q ss_conf             79755303301484489999944990999999406751--0188899999985026778500599788628816999941
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYNF  852 (1052)
Q Consensus       775 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~  852 (1052)
                      ++|++.++||+|+||+||+|...+++.||+|++.....  ...+++.+|+.++++++||||+++++++..++..++++|+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEE
T ss_conf             99634318722778189999968999999999812326858999999999999867998687660120467731589974


Q ss_pred             CCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCCC
Q ss_conf             59999999983506996458999999999999999987639998163799999979889996999520564002546763
Q 001566          853 LSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSETH  932 (1052)
Q Consensus       853 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~~  932 (1052)
                      +.++.+..+....  ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+|++|||.+....... .
T Consensus        82 ~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~  155 (286)
T d1ob3a_          82 LDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-R  155 (286)
T ss_dssp             CSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             EHHHHHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHCCC---CEEECCCCCCEEEECCCCCEEECCCCCCEECCCCC-C
T ss_conf             0045678998604--7751445689999999999986057---48826787750568689978732366430114676-5


Q ss_pred             CCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCH-
Q ss_conf             33465445531254332778-8894015899999999999299999989556799751789999999708866322401-
Q 001566          933 ATTDVAGTFGYVAPEYATTC-RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRSSELFLPE- 1010 (1052)
Q Consensus       933 ~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 1010 (1052)
                      ......+++.|+|||.+.+. .++.++||||+|+++|||++|+.||......       ....+.....+.......+. 
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~  228 (286)
T d1ob3a_         156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA-------DQLMRIFRILGTPNSKNWPNV  228 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHHHCCCCTTTSTTG
T ss_pred             CCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHH-------HHHHHHHHHHCCCCHHHCCCH
T ss_conf             4101024311013788717888884100211175899997797998988989-------999999986389971104212


Q ss_pred             ----------------HHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             ----------------111897688999999998735469999999999999
Q 001566         1011 ----------------LWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1011 ----------------l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                                      -+..........+.+++.+|+..||++|||+.|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             3332214333335676466651258999999999986689668909999856

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=322.05  Aligned_cols=263  Identities=26%  Similarity=0.307  Sum_probs=197.2

Q ss_pred             HHHCCCCCCEEEECCCCEEEEEEEE-CC-CCEEEEEEECCCCC--CCHHHHHHHHHHHHCC---CCCCEEEEEEEEEC--
Q ss_conf             7507975530330148448999994-49-90999999406751--0188899999985026---77850059978862--
Q 001566          772 RATGNFSIRNLIGTGGFGSTYKAEL-VP-GYLVAVKKLSIGRF--QGIQQFDAEIGTLGRI---RHKNLVTLIGYYVG--  842 (1052)
Q Consensus       772 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~--  842 (1052)
                      +..++|++.+.||+|+||+||+|.. .+ ++.||+|+++....  .....+.+|+.+++.+   +||||+++++++..  
T Consensus         4 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~   83 (305)
T d1blxa_           4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   83 (305)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CCCCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCC
T ss_conf             87589798889921558699999998889989999998023245167999999999999874258988023663221466


Q ss_pred             ---CCEEEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEE
Q ss_conf             ---88169999415999999998350699645899999999999999998763999816379999997988999699952
Q 001566          843 ---EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSD  919 (1052)
Q Consensus       843 ---~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~~~kl~D  919 (1052)
                         ....++++|++.++.+.... ......+++..+..++.|++.|++|||++   +|+||||||+|||++..+.+||+|
T Consensus        84 ~~~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d  159 (305)
T d1blxa_          84 TDRETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD  159 (305)
T ss_dssp             CSSEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred             CCCCCEEEEEEEECCCCCHHHHH-HCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEECCCCCEEECC
T ss_conf             66674699999740587144444-30378999899999999999999999758---898357986278985899754210


Q ss_pred             ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf             05640025467633346544553125433277888940158999999999992999999895567997517899999997
Q 001566          920 FGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIK  999 (1052)
Q Consensus       920 fgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  999 (1052)
                      ||.+.....  ........||+.|+|||++.+..++.++||||+||++|||++|+.||......       .........
T Consensus       160 fg~~~~~~~--~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-------~~~~~i~~~  230 (305)
T d1blxa_         160 FGLARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-------DQLGKILDV  230 (305)
T ss_dssp             CCSCCCCCG--GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHH
T ss_pred             HHHHHHHCC--CCCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHHH
T ss_conf             001011002--34577765485114831001798881110003289999998787998998989-------999999984


Q ss_pred             HCCCCCCCCC---------------HHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             0886632240---------------11118976889999999987354699999999999999
Q 001566         1000 EGRSSELFLP---------------ELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus      1000 ~~~~~~~~~~---------------~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                      .+.......+               .............+.+|+.+|+..||++|||++|+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         231 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HCCCCHHCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             079961105321111033302234564544044589999999999874896679189999669

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=322.72  Aligned_cols=240  Identities=24%  Similarity=0.379  Sum_probs=196.1

Q ss_pred             HCCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEEECCCCCC------CHHHHHHHHHHHHCCC--CCCEEEEEEEEECCC
Q ss_conf             07975530330148448999994-49909999994067510------1888999999850267--785005997886288
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQ------GIQQFDAEIGTLGRIR--HKNLVTLIGYYVGEA  844 (1052)
Q Consensus       774 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~  844 (1052)
                      .++|++.+.||+|+||+||+|.. .+++.||+|++......      ...++.+|+.++++++  ||||+++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf             88379967984087839999999999979999998568844334556799999999999974358988127999983099


Q ss_pred             EEEEEEEECCC-CCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-CCCEEEEEECC
Q ss_conf             16999941599-99999983506996458999999999999999987639998163799999979889-99699952056
Q 001566          845 EMFLVYNFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDE-ELNAYLSDFGL  922 (1052)
Q Consensus       845 ~~~lv~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~-~~~~kl~Dfgl  922 (1052)
                      ..++||||+.+ +++.+++...  ..+++.++..++.|++.|++|||++   +|+||||||+||+++. ++.+||+|||.
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEEEECCCCCHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEEECCCCEEEECCCCC
T ss_conf             6899998336862289998615--8999999999999999999999877---9755667611147744788489775465


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHC
Q ss_conf             40025467633346544553125433277888-94015899999999999299999989556799751789999999708
Q 001566          923 ARLLEVSETHATTDVAGTFGYVAPEYATTCRV-SDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEG 1001 (1052)
Q Consensus       923 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1052)
                      |.....   .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||...              .......
T Consensus       158 a~~~~~---~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~--------------~~i~~~~  220 (273)
T d1xwsa_         158 GALLKD---TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD--------------EEIIRGQ  220 (273)
T ss_dssp             CEECCS---SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH--------------HHHHHCC
T ss_pred             CEECCC---CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCC--------------HHHHHCC
T ss_conf             353244---45566565877479999848997886533255403453675688998873--------------6776154


Q ss_pred             CCCCCCCCHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             866322401111897688999999998735469999999999999
Q 001566         1002 RSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1002 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      .       .+....    +.++.+++.+|+..||++|||++|+++
T Consensus       221 ~-------~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         221 V-------FFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             C-------CCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             C-------CCCCCC----CHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             4-------778779----999999999976089758939999853

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=315.73  Aligned_cols=258  Identities=24%  Similarity=0.311  Sum_probs=198.5

Q ss_pred             HHCCCCCCEEEECCCCEEEEEEE-ECCCCEEEEEEECCCCC-CCHHHHHHHHHHHHCCCCCCEEEEEEEEECCC----EE
Q ss_conf             50797553033014844899999-44990999999406751-01888999999850267785005997886288----16
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAE-LVPGYLVAVKKLSIGRF-QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEA----EM  846 (1052)
Q Consensus       773 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~  846 (1052)
                      .+++|++.+.||+|+||+||+|. ..+|+.||||++..... ...+++.+|++++++++|||++++++++....    ..
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCE
T ss_conf             38985997899406480999999999994999999803109589999999999999768989885888995056455414


Q ss_pred             EEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCC
Q ss_conf             99994159999999983506996458999999999999999987639998163799999979889996999520564002
Q 001566          847 FLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLL  926 (1052)
Q Consensus       847 ~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~~~kl~Dfgla~~~  926 (1052)
                      +++++++.+|+|.+++...   .+++..+..++.|++.|++|||++   ||+||||||+|||++.++.+||+|||+|...
T Consensus        86 ~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEEECCCCHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCEEEC
T ss_conf             9999962598656644058---999999999999999999999978---9867778764378879997787545705650


Q ss_pred             CCCCC--CCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCC
Q ss_conf             54676--33346544553125433277-8889401589999999999929999998955679975178999999970886
Q 001566          927 EVSET--HATTDVAGTFGYVAPEYATT-CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRS 1003 (1052)
Q Consensus       927 ~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1052)
                      .....  .......|++.|+|||++.. ..++.++||||+|+++|||++|+.||......       .............
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~-------~~~~~~~~~~~~~  232 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL-------DQLNHILGILGSP  232 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHHHCSC
T ss_pred             CCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHH-------HHHHHHHHHCCCC
T ss_conf             477764101011026520003878604788874101004670133776697997888889-------9999876520699


Q ss_pred             C-----------------------CCCCCHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             6-----------------------3224011118976889999999987354699999999999999
Q 001566         1004 S-----------------------ELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus      1004 ~-----------------------~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                      .                       .........    ....++.+|+.+|+..||++|||+.|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFP----NADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHCC----CCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             756642343322220244677557787778378----999999999999764895679089998619

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=315.35  Aligned_cols=261  Identities=20%  Similarity=0.269  Sum_probs=200.5

Q ss_pred             HHCCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCC-EEEEEEEEECCCEEEEEE
Q ss_conf             507975530330148448999994-499099999940675101888999999850267785-005997886288169999
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKN-LVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       773 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~  850 (1052)
                      ..++|++.+.||+|+||.||+|.. .+++.||||.+......  .++..|+++++.++|++ ++.+.+++.+.+..++||
T Consensus         5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm   82 (299)
T d1ckia_           5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   82 (299)
T ss_dssp             ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             ECCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCCC--HHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEE
T ss_conf             888899968985078809999999889989999997210058--889999999997038996017999995198778999


Q ss_pred             EECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCEEEEEECCCCCCC
Q ss_conf             4159999999983506996458999999999999999987639998163799999979889---9969995205640025
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDE---ELNAYLSDFGLARLLE  927 (1052)
Q Consensus       851 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~---~~~~kl~Dfgla~~~~  927 (1052)
                      ||+ ++++.+.+.... ..+++..+..++.|++.|++|||++   +|+||||||+||+++.   +..++++|||+|+.+.
T Consensus        83 e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          83 ELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             ECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             EEC-CCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHCCCCCCCCCCEEEEECCCCCEECC
T ss_conf             873-871333244306-8876899999999999999999979---94426678766064335777615650467513425


Q ss_pred             CCCC------CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHC
Q ss_conf             4676------3334654455312543327788894015899999999999299999989556799751789999999708
Q 001566          928 VSET------HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEG 1001 (1052)
Q Consensus       928 ~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1001 (1052)
                      ....      .......||+.|||||.+.+..++.++||||+|+++|||++|+.||........ ......+......  
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~-~~~~~~~~~~~~~--  234 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK-RQKYERISEKKMS--  234 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHHHHHH--
T ss_pred             CCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHH-HHHHHHHHCCCCC--
T ss_conf             5445541000135776787353299999189989832188617789999849876655305779-9999985235678--


Q ss_pred             CCCCCCCCHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             86632240111189768899999999873546999999999999998505
Q 001566         1002 RSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1002 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~i 1051 (1052)
                      .    ..+.+....|    .++.+++.+||+.+|++||++.++.+.|+.+
T Consensus       235 ~----~~~~~~~~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         235 T----PIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             S----CHHHHTTTSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             C----CHHHHCCCCC----HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             9----8357534788----9999999998439955791999999999999

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=314.96  Aligned_cols=257  Identities=23%  Similarity=0.343  Sum_probs=199.2

Q ss_pred             HHCCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEEECCCCC--CCHHHHHHHHHHHHCCCCCCEEEEEEEEECCC-----
Q ss_conf             507975530330148448999994-4990999999406751--01888999999850267785005997886288-----
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEA-----  844 (1052)
Q Consensus       773 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  844 (1052)
                      ..++|++.+.||+|+||+||+|.. .+|+.||+|+++....  ...+.+.+|+++++.++|||++++++++...+     
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf             47718998898017781999999999998999999852225969999999999999866898754799986357655554


Q ss_pred             -EEEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCC
Q ss_conf             -1699994159999999983506996458999999999999999987639998163799999979889996999520564
Q 001566          845 -EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLA  923 (1052)
Q Consensus       845 -~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~~~kl~Dfgla  923 (1052)
                       ..|+||||+ +.++..+.+.   ..+++..+..++.|++.|+.|||++   ||+||||||+|||++.++.+|++|||.|
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             CEEEEEEECC-CCCHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCHHHCCCCCCCCCCCCCCE
T ss_conf             1599998405-5218999874---0226999999999999999998737---8764566851111210012211343102


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCC
Q ss_conf             00254676333465445531254332778-88940158999999999992999999895567997517899999997088
Q 001566          924 RLLEVSETHATTDVAGTFGYVAPEYATTC-RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGR 1002 (1052)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1002 (1052)
                      .....    ......|++.|+|||++.+. .++.++||||+||++|||++|+.||......       ..........+.
T Consensus       169 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~-------~~~~~~~~~~~~  237 (346)
T d1cm8a_         169 RQADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-------DQLKEIMKVTGT  237 (346)
T ss_dssp             EECCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHHHCC
T ss_pred             ECCCC----CCCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHH-------HHHHHHHHCCCC
T ss_conf             20687----6310245533358899817878996501030038999999786998889768-------999999850378


Q ss_pred             CCCC-------------------CCCHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             6632-------------------24011118976889999999987354699999999999999
Q 001566         1003 SSEL-------------------FLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus      1003 ~~~~-------------------~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                      ....                   ....-+..........+.+|+.+|+..||++|||+.|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCHHHHHHHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             8488886530003443311578666556677556899999999999772995579299999639

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=315.45  Aligned_cols=255  Identities=24%  Similarity=0.315  Sum_probs=190.6

Q ss_pred             CCCCCEEEECCCCEEEEEEEE-CCCCEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCCEEEEEEEEECC------CEEEE
Q ss_conf             975530330148448999994-49909999994067510188899999985026778500599788628------81699
Q 001566          776 NFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNLVTLIGYYVGE------AEMFL  848 (1052)
Q Consensus       776 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l  848 (1052)
                      +|+..++||+|+||+||+|.. .+++.||+|++.....    ...+|++++++++|+||+++++++...      ...++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH----HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf             76751698217683999999999997999999881606----89999999986689898738789974476577318999


Q ss_pred             EEEECCCCCHHHHHHH-CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEEEEECCCCCC
Q ss_conf             9941599999999835-0699645899999999999999998763999816379999997988999-6999520564002
Q 001566          849 VYNFLSGGNLETFIHK-KSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEEL-NAYLSDFGLARLL  926 (1052)
Q Consensus       849 v~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~-~~kl~Dfgla~~~  926 (1052)
                      ||||++++.+..+... .....+++.++..++.|++.|++|||++   ||+||||||+|||++.++ .+||+|||++...
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEEECCCCCEEEECCCCHHHC
T ss_conf             984168860788886310368999999999999999999999866---87645788603787358971167336605440


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCC--
Q ss_conf             5467633346544553125433277-8889401589999999999929999998955679975178999999970886--
Q 001566          927 EVSETHATTDVAGTFGYVAPEYATT-CRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRS-- 1003 (1052)
Q Consensus       927 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 1003 (1052)
                      ....  ......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||......       ..........+..  
T Consensus       174 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~-------~~l~~i~~~~g~~~~  244 (350)
T d1q5ka_         174 VRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-------DQLVEIIKVLGTPTR  244 (350)
T ss_dssp             CTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-------HHHHHHHHHHCCCCH
T ss_pred             CCCC--CCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHH-------HHHHHHHHHHCCCHH
T ss_conf             4776--5320025555568277640468882100024652778550287998987999-------999999997489817


Q ss_pred             ---------------CCCCCCHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             ---------------6322401111897688999999998735469999999999999
Q 001566         1004 ---------------SELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1004 ---------------~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                                     ..................++.+|+.+|+..||++|||+.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             7654306210110355445674444315689999999999976589557929999966

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=311.13  Aligned_cols=262  Identities=22%  Similarity=0.267  Sum_probs=197.8

Q ss_pred             HCCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEEECCCCC--CCHHHHHHHHHHHHCCCCCCEEEEEEEEEC--------
Q ss_conf             07975530330148448999994-4990999999406751--018889999998502677850059978862--------
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKNLVTLIGYYVG--------  842 (1052)
Q Consensus       774 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  842 (1052)
                      .++|++.+.||+|+||+||+|.. .+|+.||||++.....  ....++.+|++++++++|+|++++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf             27988999972274829999999899979999998422246378999999999999835999660676540246544445


Q ss_pred             CCEEEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECC
Q ss_conf             88169999415999999998350699645899999999999999998763999816379999997988999699952056
Q 001566          843 EAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGL  922 (1052)
Q Consensus       843 ~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~~~kl~Dfgl  922 (1052)
                      ....++|||++.++.+..+...  ...+++..+..++.|++.|+.|||++   ||+||||||+||+++.++.+|++|||+
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEECCCCCCCCHHHHC--CCCCCCHHHHHHHHHHHHHHHHHCCC---CEEECCCCCHHEEECCCCCEEEEECCE
T ss_conf             7638999853578741012220--34433089999999999999885229---988567672220366899687631350


Q ss_pred             CCCCCCCC---CCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf             40025467---6333465445531254332778-8894015899999999999299999989556799751789999999
Q 001566          923 ARLLEVSE---THATTDVAGTFGYVAPEYATTC-RVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLI  998 (1052)
Q Consensus       923 a~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  998 (1052)
                      +.......   ........||+.|+|||++.+. .++.++||||+|+++|||++|+.||.....       .........
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~-------~~~~~~i~~  236 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE-------QHQLALISQ  236 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHH
T ss_pred             EEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCH-------HHHHHHHHH
T ss_conf             0223554443211356602497874289970799989178700678646617448799899899-------999999998


Q ss_pred             HHCCCCCCCCCHHH-----------CCC--C-------HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             70886632240111-----------189--7-------6889999999987354699999999999999
Q 001566          999 KEGRSSELFLPELW-----------EAG--P-------QENLLGMMRLASTCTVETLSTRPSVKQVLIK 1047 (1052)
Q Consensus       999 ~~~~~~~~~~~~l~-----------~~~--~-------~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~ 1047 (1052)
                      ..+...........           ...  +       ......+.+|+.+|+..||++|||+.|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             HHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             418998255344320344433201334455503340444599899999999873896589099999749

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=0  Score=308.42  Aligned_cols=261  Identities=18%  Similarity=0.230  Sum_probs=205.6

Q ss_pred             HHCCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEEECCCCCCCHHHHHHHHHHHHCCCC-CCEEEEEEEEECCCEEEEEE
Q ss_conf             507975530330148448999994-4990999999406751018889999998502677-85005997886288169999
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRH-KNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       773 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~  850 (1052)
                      ..++|++.+.||+|+||+||+|.. .+++.||+|++.....  ...+.+|++.++.+.| +|++.+++++......++||
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm   80 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   80 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC--CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEE
T ss_conf             89806997998417882999999988997999999750258--2999999999999648999877999960188117999


Q ss_pred             EECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-----CCCEEEEEECCCCC
Q ss_conf             4159999999983506996458999999999999999987639998163799999979889-----99699952056400
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDE-----ELNAYLSDFGLARL  925 (1052)
Q Consensus       851 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~-----~~~~kl~Dfgla~~  925 (1052)
                      |++ +++|.+++.... ..++..++..++.|++.|++|+|++   ||+||||||+||+++.     ++.+||+|||+|+.
T Consensus        81 e~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          81 DLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             ECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEC-CCCHHHHHHHHC-CCHHHHHHHHHHHHHHHHHHHHHHC---CCEECCCCCCCEEECCCCCCCCCCEEECCCCEEEE
T ss_conf             964-888799997520-3110689999999999999999977---96626677131523475434479568723660577


Q ss_pred             CCCCCC------CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf             254676------33346544553125433277888940158999999999992999999895567997517899999997
Q 001566          926 LEVSET------HATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIK  999 (1052)
Q Consensus       926 ~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  999 (1052)
                      ......      .......||+.|||||.+.+..++.++||||+|+++|||++|+.||......     ...+..+....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~-----~~~~~~~~i~~  230 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA-----TNKQKYERIGE  230 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC-----CHHHHHHHHHH
T ss_pred             CCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCH-----HHHHHHHHHHH
T ss_conf             1467665411102467627751026798964888886999898319999998698767885302-----19999999970


Q ss_pred             HCCCCCCCCCHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             0886632240111189768899999999873546999999999999998505
Q 001566         1000 EGRSSELFLPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLIKLKQL 1051 (1052)
Q Consensus      1000 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~~L~~i 1051 (1052)
                      ....  ...+.+....|    .++.+++..|+..+|++||+++.+.+.|+++
T Consensus       231 ~~~~--~~~~~l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~  276 (293)
T d1csna_         231 KKQS--TPLRELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKV  276 (293)
T ss_dssp             HHHH--SCHHHHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             CCCC--CCHHHHCCCCC----HHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
T ss_conf             5679--99589657998----9999999998439930085999999999999

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=311.46  Aligned_cols=252  Identities=26%  Similarity=0.386  Sum_probs=204.3

Q ss_pred             CCCCCCEEEECCCCEEEEEEEEC----CCCEEEEEEECCCC----CCCHHHHHHHHHHHHCCCC-CCEEEEEEEEECCCE
Q ss_conf             79755303301484489999944----99099999940675----1018889999998502677-850059978862881
Q 001566          775 GNFSIRNLIGTGGFGSTYKAELV----PGYLVAVKKLSIGR----FQGIQQFDAEIGTLGRIRH-KNLVTLIGYYVGEAE  845 (1052)
Q Consensus       775 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~  845 (1052)
                      ++|++.+.||+|+||+||+|...    +|+.||+|++....    ....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf             02599989832878399999987658879489999983677210168999999999999864679839996200024873


Q ss_pred             EEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCC
Q ss_conf             69999415999999998350699645899999999999999998763999816379999997988999699952056400
Q 001566          846 MFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARL  925 (1052)
Q Consensus       846 ~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~~~kl~Dfgla~~  925 (1052)
                      .++++||+.+|+|.+++...  ..+++..+..++.|++.|+.|+|++   +|+||||||+||+++.++.+||+|||++..
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             EEEEEECCCCCHHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCCCCEEECCCCCEEEEECCCHHH
T ss_conf             00123123411799998730--4543788888899999999885149---989654773201246999888741320222


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCC
Q ss_conf             2546763334654455312543327788--89401589999999999929999998955679975178999999970886
Q 001566          926 LEVSETHATTDVAGTFGYVAPEYATTCR--VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRS 1003 (1052)
Q Consensus       926 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1052)
                      +............|++.|++||.+.+..  ++.++||||+||++|||++|+.||......    .......+..... ..
T Consensus       179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~----~~~~~i~~~~~~~-~~  253 (322)
T d1vzoa_         179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK----NSQAEISRRILKS-EP  253 (322)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC----CCHHHHHHHHHHC-CC
T ss_pred             HCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHHHCCCC-CC
T ss_conf             034444322122233333106876057768871325177779999997689998888777----7999999833568-99


Q ss_pred             CCCCCCHHHCCCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH
Q ss_conf             632240111189768899999999873546999999-----9999999
Q 001566         1004 SELFLPELWEAGPQENLLGMMRLASTCTVETLSTRP-----SVKQVLI 1046 (1052)
Q Consensus      1004 ~~~~~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RP-----t~~eil~ 1046 (1052)
                                ..+...+.++.+++.+|+.+||.+||     +++|+++
T Consensus       254 ----------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         254 ----------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             ----------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ----------CCCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHC
T ss_conf             ----------88654799999999997445898819997450999974

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=305.88  Aligned_cols=259  Identities=22%  Similarity=0.296  Sum_probs=203.4

Q ss_pred             CCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEEECCCCC--CCHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEE
Q ss_conf             7975530330148448999994-4990999999406751--018889999998502677850059978862881699994
Q 001566          775 GNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGEAEMFLVYN  851 (1052)
Q Consensus       775 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E  851 (1052)
                      ++|++.+.||+|+||+||+|.. .+++.||||+++....  ....++.+|+.+++.++||||+++++++.+....++++|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf             99786269712868199999999999699999980321786899999999999985675788821354444431158863


Q ss_pred             ECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCC
Q ss_conf             15999999998350699645899999999999999998763999816379999997988999699952056400254676
Q 001566          852 FLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLARLLEVSET  931 (1052)
Q Consensus       852 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~~~kl~Dfgla~~~~~~~~  931 (1052)
                      ++.++++..+....  ..+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+|++|||.+....... 
T Consensus        82 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~-  155 (292)
T d1unla_          82 FCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-  155 (292)
T ss_dssp             CCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-
T ss_pred             ECCCCCCCCCCCCC--CCCCHHHHHHHHHHHHHHHHHHHCC---CEEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCC-
T ss_conf             02332221121235--6540367899999999998774339---98600146761211337826652046011046887-


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHH-HCCCCCCCCC
Q ss_conf             3334654455312543327788-8940158999999999992999999895567997517899999997-0886632240
Q 001566          932 HATTDVAGTFGYVAPEYATTCR-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIK-EGRSSELFLP 1009 (1052)
Q Consensus       932 ~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 1009 (1052)
                      .......+++.|+|||.+.+.. ++.++||||+||++|||++|+.||....       +..+....... .+.......+
T Consensus       156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~~~  228 (292)
T d1unla_         156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-------DVDDQLKRIFRLLGTPTEEQWP  228 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS-------SHHHHHHHHHHHHCCCCTTTCT
T ss_pred             CCCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCC-------CHHHHHHHHHHHCCCCCHHHHH
T ss_conf             510010344310146675069888804440265418899851899998899-------9999999998611899735513


Q ss_pred             H-----------------HHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             1-----------------111897688999999998735469999999999999
Q 001566         1010 E-----------------LWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1010 ~-----------------l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      .                 ............+.+|+.+|++.||++|||++|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHHCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             443222113344454431043306568999999999986499668909999964

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=0  Score=308.58  Aligned_cols=256  Identities=20%  Similarity=0.275  Sum_probs=195.3

Q ss_pred             CCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEEECCCCCCCHHHHHHHHHHHHCCC-CCCEEEEEEEEEC--CCEEEEEE
Q ss_conf             7975530330148448999994-499099999940675101888999999850267-7850059978862--88169999
Q 001566          775 GNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIR-HKNLVTLIGYYVG--EAEMFLVY  850 (1052)
Q Consensus       775 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~  850 (1052)
                      ++|++.++||+|+||+||+|.. .+++.||+|+++...   .+++.+|+++++.++ ||||+++++++..  ....++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEE
T ss_conf             67189789831748199999988999799999988899---999999999998515799876799999816877126888


Q ss_pred             EECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEEEEECCCCCCCCC
Q ss_conf             415999999998350699645899999999999999998763999816379999997988999-6999520564002546
Q 001566          851 NFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEEL-NAYLSDFGLARLLEVS  929 (1052)
Q Consensus       851 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~-~~kl~Dfgla~~~~~~  929 (1052)
                      ||+.+++|..+.     +.+++..+..++.|++.||.|||++   ||+||||||+|||++.++ .+||+|||.|......
T Consensus       112 e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         112 EHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             ECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             EECCCCCHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEECCCCCCEECCCC
T ss_conf             631798589974-----6899999999999999999887643---34434564412377489983664156542664688


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHH--------HHHHH
Q ss_conf             763334654455312543327788-894015899999999999299999989556799751789999--------99970
Q 001566          930 ETHATTDVAGTFGYVAPEYATTCR-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAK--------LLIKE 1000 (1052)
Q Consensus       930 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~--------~~~~~ 1000 (1052)
                        .......+++.|+|||.+.+.. ++.++||||+|+++|||++|+.||........   ......+        .....
T Consensus       184 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~---~~~~i~~~~g~~~~~~~~~~  258 (328)
T d3bqca1         184 --QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD---QLVRIAKVLGTEDLYDYIDK  258 (328)
T ss_dssp             --CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH---HHHHHHHHHCHHHHHHHHHH
T ss_pred             --CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHH---HHHHHHHHHCCCHHHHHHHH
T ss_conf             --7444322486424761026888888452323354555876048899988760189---99999998788415555542


Q ss_pred             CCCC--CCC------------CCHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             8866--322------------401111897688999999998735469999999999999
Q 001566         1001 GRSS--ELF------------LPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1001 ~~~~--~~~------------~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ....  ..+            ..............++.+|+.+|+..||++|||++|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             254447430000033343311211552112448999999999986699568908999964

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=307.87  Aligned_cols=263  Identities=23%  Similarity=0.265  Sum_probs=197.7

Q ss_pred             HCCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEEECCCCC--CCHHHHHHHHHHHHCCCCCCEEEEEEEEEC------CC
Q ss_conf             07975530330148448999994-4990999999406751--018889999998502677850059978862------88
Q 001566          774 TGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKNLVTLIGYYVG------EA  844 (1052)
Q Consensus       774 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~  844 (1052)
                      .++|++.++||+|+||+||+|.. .+|+.||||++.....  ....++.+|+.++++++||||+++++++..      ..
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCC
T ss_conf             37759988962175859999999999989999998823369799999999999998648987648998970256434576


Q ss_pred             EEEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCC
Q ss_conf             16999941599999999835069964589999999999999999876399981637999999798899969995205640
Q 001566          845 EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR  924 (1052)
Q Consensus       845 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~~~kl~Dfgla~  924 (1052)
                      ..|+||||+.++ +.+.+.    ..+++..+..++.|++.|+.|||++   ||+||||||+|||++.++.++++|||.+.
T Consensus        96 ~~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          96 DVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             EEEEEEECCCHH-HHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCEEEECHHHHH
T ss_conf             269998414467-787650----3899999999999999999886522---11245677632113654431320102321


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCC--------------CCH
Q ss_conf             025467633346544553125433277888940158999999999992999999895567997--------------517
Q 001566          925 LLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNG--------------FNI  990 (1052)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~--------------~~~  990 (1052)
                      ....  ........+|+.|+|||++.+..++.++||||+||++|||++|+.||..........              ...
T Consensus       168 ~~~~--~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (355)
T d2b1pa1         168 TAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_dssp             ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred             CCCC--CCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHH
T ss_conf             1466--65533221465555813314777787743335662578986598998889778899999972058987999876


Q ss_pred             HHHHHHHHHHCC-CCCCCCC-----HHHCCC---CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             899999997088-6632240-----111189---7688999999998735469999999999999
Q 001566          991 VSWAKLLIKEGR-SSELFLP-----ELWEAG---PQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus       991 ~~~~~~~~~~~~-~~~~~~~-----~l~~~~---~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ............ ....-.+     ......   .......+.+|+.+|+..||++|||++|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             56677776417543566642126433354321013337999999999987699457908999966

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=307.63  Aligned_cols=253  Identities=24%  Similarity=0.331  Sum_probs=197.0

Q ss_pred             HHCCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEEECCCCC--CCHHHHHHHHHHHHCCCCCCEEEEEEEEECC-----C
Q ss_conf             507975530330148448999994-4990999999406751--0188899999985026778500599788628-----8
Q 001566          773 ATGNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRF--QGIQQFDAEIGTLGRIRHKNLVTLIGYYVGE-----A  844 (1052)
Q Consensus       773 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~  844 (1052)
                      ..++|++.+.||+|+||+||+|.. .+|+.||||++.....  ...+++.+|++++++++|||++++++++...     .
T Consensus        16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~   95 (348)
T d2gfsa1          16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   95 (348)
T ss_dssp             EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred             CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCC
T ss_conf             89871888898317883999999999997999999882002868999999999999866898742599999634645668


Q ss_pred             EEEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCC
Q ss_conf             16999941599999999835069964589999999999999999876399981637999999798899969995205640
Q 001566          845 EMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLSDFGLAR  924 (1052)
Q Consensus       845 ~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~~~kl~Dfgla~  924 (1052)
                      ..+++++++.+|+|.+++..   ..+++..+..++.|++.|++|||++   ||+||||||+||+++.++.+|++|||.+.
T Consensus        96 ~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          96 NDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             CEEEEEEEECCCCHHHHCCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCCCHHC
T ss_conf             64999996258862320022---4530999999999999999999738---87651667763345543220013210001


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCC
Q ss_conf             02546763334654455312543327788-89401589999999999929999998955679975178999999970886
Q 001566          925 LLEVSETHATTDVAGTFGYVAPEYATTCR-VSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVSWAKLLIKEGRS 1003 (1052)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1003 (1052)
                      ...    .......|++.|+|||...+.. ++.++||||+|+++|+|++|+.||......       ..........+..
T Consensus       170 ~~~----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~-------~~~~~i~~~~~~~  238 (348)
T d2gfsa1         170 HTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-------DQLKLILRLVGTP  238 (348)
T ss_dssp             CCT----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHHHCCC
T ss_pred             CCC----CCCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHHHCCCC
T ss_conf             257----54444345435558355337756785512432058999997688997889889-------9999999730799


Q ss_pred             CCCC-----------------------CCHHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             6322-----------------------401111897688999999998735469999999999999
Q 001566         1004 SELF-----------------------LPELWEAGPQENLLGMMRLASTCTVETLSTRPSVKQVLI 1046 (1052)
Q Consensus      1004 ~~~~-----------------------~~~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~eil~ 1046 (1052)
                      ....                       .....    ......+.+|+.+|+..||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         239 GAELLKKISSESARNYIQSLTQMPKMNFANVF----IGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             CHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHS----TTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CHHHHHHCCCHHHHHHHHHCCCCCCCCHHHHC----CCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             75773200102445444303557875556626----789999999999977588345938999855

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=0  Score=278.29  Aligned_cols=264  Identities=20%  Similarity=0.240  Sum_probs=192.8

Q ss_pred             CCCCCCEEEECCCCEEEEEEEE-CCCCEEEEEEECCCCCCCHHHHHHHHHHHHCCC-----------CCCEEEEEEEEEC
Q ss_conf             7975530330148448999994-499099999940675101888999999850267-----------7850059978862
Q 001566          775 GNFSIRNLIGTGGFGSTYKAEL-VPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIR-----------HKNLVTLIGYYVG  842 (1052)
Q Consensus       775 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~  842 (1052)
                      ++|++.++||+|+||.||+|.. .+|+.||||+++.... ..+.+.+|+.+++.+.           |+|++++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf             857998997507781899999999997999999834313-3689999999999840145555542276764789987631


Q ss_pred             C--CEEEEEEEECCC-CCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCCC-----
Q ss_conf             8--816999941599-999999835069964589999999999999999876-3999816379999997988999-----
Q 001566          843 E--AEMFLVYNFLSG-GNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHY-SCVPRIVHRDIKPSNILLDEEL-----  913 (1052)
Q Consensus       843 ~--~~~~lv~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dik~~Nill~~~~-----  913 (1052)
                      .  ...++++++... +.............+++..+..++.|++.|+.|||+ .   ||+||||||+|||++.++     
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTE
T ss_pred             CCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEEECCCCCCCC
T ss_conf             256520234320003542000001223467868999999999999988876405---86465677057056305765644


Q ss_pred             -CEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHH
Q ss_conf             -6999520564002546763334654455312543327788894015899999999999299999989556799751789
Q 001566          914 -NAYLSDFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLLELISGKRSLDPSFSEYGNGFNIVS  992 (1052)
Q Consensus       914 -~~kl~Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~elltg~~p~~~~~~~~~~~~~~~~  992 (1052)
                       .++++|||.+....    .......|++.|+|||++.+..++.++||||+|+++++|++|+.||.+...... ......
T Consensus       169 ~~~kl~dfg~s~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~-~~~~~~  243 (362)
T d1q8ya_         169 IQIKIADLGNACWYD----EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY-TKDDDH  243 (362)
T ss_dssp             EEEEECCCTTCEETT----BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----------CHHHH
T ss_pred             CEEEEEECCCCCCCC----CCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCC-CCHHHH
T ss_conf             305675314421234----454223665210571321466777643201237899999878899898755432-102689


Q ss_pred             HHHHHHHHCCCCCCCC----------------C--------------HHHCCCCHHHHHHHHHHHHHCCCCCCCCCCCHH
Q ss_conf             9999997088663224----------------0--------------111189768899999999873546999999999
Q 001566          993 WAKLLIKEGRSSELFL----------------P--------------ELWEAGPQENLLGMMRLASTCTVETLSTRPSVK 1042 (1052)
Q Consensus       993 ~~~~~~~~~~~~~~~~----------------~--------------~l~~~~~~~~~~~l~~Li~~cl~~dP~~RPt~~ 1042 (1052)
                      .......-+.......                .              ......+......+.+|+.+|+..||.+|||++
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHH
T ss_conf             99999983799878862453220001320122024323577644421000156743589999999998779945790899


Q ss_pred             HHHHH
Q ss_conf             99999
Q 001566         1043 QVLIK 1047 (1052)
Q Consensus      1043 eil~~ 1047 (1052)
                      |+++.
T Consensus       324 e~L~H  328 (362)
T d1q8ya_         324 GLVNH  328 (362)
T ss_dssp             HHHTC
T ss_pred             HHHCC
T ss_conf             99669

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=100.00  E-value=2.8e-38  Score=224.15  Aligned_cols=124  Identities=26%  Similarity=0.350  Sum_probs=91.4

Q ss_pred             CCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEE
Q ss_conf             27675199755850133563235899977799754985889996000597448689758983597682111189778699
Q 001566          530 DCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVL  609 (1052)
Q Consensus       530 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  609 (1052)
                      .+++|+++++++|++++..+  +..++.++.++++.|++++  ...+..+++++.|++++|++++..  .+..+++|+.|
T Consensus       261 ~~~~L~~L~l~~~~l~~~~~--~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L  334 (384)
T d2omza2         261 GLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRL  334 (384)
T ss_dssp             TCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEE
T ss_pred             CCCCCCEEECCCCCCCCCCC--CCCCCCCCCCCCCCCCCCC--CCCCCHHCCCCEEECCCCCCCCCC--CCCCCCCCCEE
T ss_conf             54668775456744578773--2356522223323233333--221000024676777788778984--53668988989


Q ss_pred             ECCCCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEECCCCC
Q ss_conf             858997899883111023421200134864788777433344435812122464
Q 001566          610 DLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNN  663 (1052)
Q Consensus       610 ~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~  663 (1052)
                      ++++|++++ ++ .+.++++|+.|++++|++++..|  +.++++|+.|++++|.
T Consensus       335 ~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~Na  384 (384)
T d2omza2         335 FFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA  384 (384)
T ss_dssp             ECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCEE
T ss_pred             ECCCCCCCC-CH-HHCCCCCCCEEECCCCCCCCCHH--HCCCCCCCEEECCCCC
T ss_conf             898998999-74-67089999989897995899800--0039999996397895

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=5.1e-39  Score=228.20  Aligned_cols=37  Identities=27%  Similarity=0.443  Sum_probs=12.8

Q ss_pred             CCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf             7429967999453347823203489989968799476
Q 001566          355 SLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLE  391 (1052)
Q Consensus       355 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  391 (1052)
                      .|+.+++++|.+.+.+|..+..++.|+.+++++|.+.
T Consensus       126 ~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~  162 (313)
T d1ogqa_         126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRIS  162 (313)
T ss_dssp             TCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCE
T ss_pred             HHCCCCCCCCCCCCCCCHHHCCCCCCCEEECCCCCCC
T ss_conf             1001111224555568512206740000002355335

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=100.00  E-value=6.2e-36  Score=211.21  Aligned_cols=100  Identities=22%  Similarity=0.351  Sum_probs=66.5

Q ss_pred             CCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEE
Q ss_conf             76751997558501335632358999777997549858899960005974486897589835976821111897786998
Q 001566          531 CVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLD  610 (1052)
Q Consensus       531 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  610 (1052)
                      +..++.++++.|++.+.  ..+..+++++.|++++|++++. + .+..+++|+.|++++|++++ ++ .+.++++|++|+
T Consensus       284 ~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~  357 (384)
T d2omza2         284 LTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLS  357 (384)
T ss_dssp             CTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCC-G-GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEE
T ss_pred             CCCCCCCCCCCCCCCCC--CCCCHHCCCCEEECCCCCCCCC-C-CCCCCCCCCEEECCCCCCCC-CH-HHCCCCCCCEEE
T ss_conf             65222233232333332--2100002467677778877898-4-53668988989898998999-74-670899999898


Q ss_pred             CCCCCCCCCCCHHHHCCCCCCEEECCCC
Q ss_conf             5899789988311102342120013486
Q 001566          611 LSHNALTGSIPASLTKATKLESLFLAHN  638 (1052)
Q Consensus       611 ls~N~l~~~~p~~~~~l~~L~~L~l~~N  638 (1052)
                      +++|++++..|  +.++++|+.|++++|
T Consensus       358 l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         358 AGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             CCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             CCCCCCCCCHH--HCCCCCCCEEECCCC
T ss_conf             97995899800--003999999639789

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=5.7e-34  Score=200.37  Aligned_cols=88  Identities=20%  Similarity=0.274  Sum_probs=39.3

Q ss_pred             CCCCCCCCCCEEEECCCCCEEEEEECCCCCCCCCCCCCCCCCCCHHHCCCCCCCEEEECCCCCEECCCCCCCCCCCCCEE
Q ss_conf             99999987703730699964899982578899998764343243210078887855703798200289873587876489
Q 001566           73 SSTDHCTWHGVTCDHFTGRVTALRITGKATPWPSKSSVISGTLSASIAKLTELRTLSVPHNSFSGEIPAGVGELRLLEVL  152 (1052)
Q Consensus        73 ~~~~~C~w~gV~C~~~~~~v~~l~l~~~~~~~~~~~~~~~g~l~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L  152 (1052)
                      +..+-|.|.+|.|++..                     ++ .+|..+  .+.+++|+|++|+++...+..|.++++|+.|
T Consensus         5 p~~c~c~~~~~~C~~~~---------------------L~-~lP~~l--~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L   60 (305)
T d1xkua_           5 PFRCQCHLRVVQCSDLG---------------------LE-KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTL   60 (305)
T ss_dssp             CTTCEEETTEEECTTSC---------------------CC-SCCCSC--CTTCCEEECCSSCCCCBCTTTTTTCTTCCEE
T ss_pred             CCCCEECCCEEEECCCC---------------------CC-CCCCCC--CCCCCEEECCCCCCCCCCHHHHHCCCCCCCC
T ss_conf             99889559999855999---------------------88-519888--9997989784991898696576046565231


Q ss_pred             ECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf             81375033358932438777885852234363
Q 001566          153 ELQGNNFSGKIPYQMSNLERLRVLNLSFNSFS  184 (1052)
Q Consensus       153 ~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~  184 (1052)
                      ++++|.+....|..|..+++|+.|++++|.++
T Consensus        61 ~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~   92 (305)
T d1xkua_          61 ILINNKISKISPGAFAPLVKLERLYLSKNQLK   92 (305)
T ss_dssp             ECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS
T ss_pred             CCCCCCCCCCCHHHHHCCCCCCEECCCCCCCC
T ss_conf             12344344523566527985578315687567

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.8e-32  Score=191.10  Aligned_cols=85  Identities=24%  Similarity=0.324  Sum_probs=31.6

Q ss_pred             CCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEEC
Q ss_conf             97779975498588999600059744868975898359768211118977869985899789988311102342120013
Q 001566          556 MKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFL  635 (1052)
Q Consensus       556 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l  635 (1052)
                      ++|+.|++++|.++...+..|.+++.+++|++++|.+++..+..|.++++|++|+|++|.++ .+|.+|..+++|+.|++
T Consensus       171 ~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~L  249 (305)
T d1xkua_         171 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL  249 (305)
T ss_dssp             TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEEC
T ss_pred             CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC-CCCCCCCCCCCCCEEEC
T ss_conf             76678989788677888267641341330154455332223454334433224302554002-46311033467898989


Q ss_pred             CCCCCC
Q ss_conf             486478
Q 001566          636 AHNRLS  641 (1052)
Q Consensus       636 ~~N~l~  641 (1052)
                      ++|+|+
T Consensus       250 s~N~i~  255 (305)
T d1xkua_         250 HNNNIS  255 (305)
T ss_dssp             CSSCCC
T ss_pred             CCCCCC
T ss_conf             898657

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-32  Score=192.09  Aligned_cols=85  Identities=28%  Similarity=0.273  Sum_probs=34.9

Q ss_pred             CCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECC
Q ss_conf             75199755850133563235899977799754985889996000597448689758983597682111189778699858
Q 001566          533 QLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLS  612 (1052)
Q Consensus       533 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls  612 (1052)
                      .|++|++++|+++++.+..|.++++|+.+++++|++++..|..|.++++|++|++++|++.+..+..|.++++|++|+++
T Consensus       154 ~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~  233 (284)
T d1ozna_         154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLN  233 (284)
T ss_dssp             TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECC
T ss_pred             CHHHCCCCCCCCCCCCHHHHCCCCCCCHHHHHHCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEC
T ss_conf             05022314176566256665465634131421143466281676653200023333352210000023554656889811


Q ss_pred             CCCCC
Q ss_conf             99789
Q 001566          613 HNALT  617 (1052)
Q Consensus       613 ~N~l~  617 (1052)
                      +|.+.
T Consensus       234 ~N~l~  238 (284)
T d1ozna_         234 DNPWV  238 (284)
T ss_dssp             SSCEE
T ss_pred             CCCCC
T ss_conf             99887

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-32  Score=190.47  Aligned_cols=48  Identities=27%  Similarity=0.264  Sum_probs=22.1

Q ss_pred             CCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf             589644489874299679994533478232034899899687994767
Q 001566          345 RLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEG  392 (1052)
Q Consensus       345 ~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  392 (1052)
                      ..|..|..+++|++|++++|.+.+..+..+..+++|+.|++++|.+..
T Consensus       192 i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C  239 (284)
T d1ozna_         192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC  239 (284)
T ss_dssp             ECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred             CCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC
T ss_conf             281676653200023333352210000023554656889811998878

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=4.4e-30  Score=178.98  Aligned_cols=135  Identities=26%  Similarity=0.203  Sum_probs=67.9

Q ss_pred             CCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECC
Q ss_conf             75199755850133563235899977799754985889996000597448689758983597682111189778699858
Q 001566          533 QLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLS  612 (1052)
Q Consensus       533 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls  612 (1052)
                      +|++|++++|+++. .+..+..+++|+.|++++|.+.+..+..+..+.+++.|++++|.++...+..+..++.|+.++++
T Consensus        78 ~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~  156 (266)
T d1p9ag_          78 VLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLA  156 (266)
T ss_dssp             TCCEEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred             CCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHCCCC
T ss_conf             32111112222211-11121222222222222231101100112222111122124342102212333221110000000


Q ss_pred             CCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCC
Q ss_conf             997899883111023421200134864788777433344435812122464668889
Q 001566          613 HNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIP  669 (1052)
Q Consensus       613 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~  669 (1052)
                      +|++++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.++|++|++.+.+.
T Consensus       157 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~  212 (266)
T d1p9ag_         157 NNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE  212 (266)
T ss_dssp             TSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred             CCCCCCCCCCCCCCCCCCCEEECCCCCCC-CCCHHHCCCCCCCEEEECCCCCCCCCC
T ss_conf             15652237200134212423430139785-568667778889999836999878864

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.9e-29  Score=173.72  Aligned_cols=80  Identities=25%  Similarity=0.194  Sum_probs=28.1

Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCC
Q ss_conf             99755850133563235899977799754985889996000597448689758983597682111189778699858997
Q 001566          536 EFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNA  615 (1052)
Q Consensus       536 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~  615 (1052)
                      +|++++|.++.+.+..+..+++++.+++++|++++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|.
T Consensus       128 ~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np  206 (266)
T d1p9ag_         128 ELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNP  206 (266)
T ss_dssp             EEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCC
T ss_pred             CCCCCCCCCCEECCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC-CCCHHHCCCCCCCEEEECCCC
T ss_conf             2212434210221233322111000000015652237200134212423430139785-568667778889999836999


Q ss_pred             C
Q ss_conf             8
Q 001566          616 L  616 (1052)
Q Consensus       616 l  616 (1052)
                      +
T Consensus       207 ~  207 (266)
T d1p9ag_         207 W  207 (266)
T ss_dssp             B
T ss_pred             C
T ss_conf             8

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.96  E-value=1.1e-25  Score=154.83  Aligned_cols=138  Identities=22%  Similarity=0.280  Sum_probs=77.6

Q ss_pred             CCCCEEEECCCCCEECCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf             88785570379820028987358787648981375033358932438777885852234363358822339999867985
Q 001566          123 TELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDM  202 (1052)
Q Consensus       123 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  202 (1052)
                      .++++|+|++++++ .+|+.   .++|++|+|++|+++ .+|..+   .+|+.|++++|.++ .++..   .+.|+.|++
T Consensus        38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L  105 (353)
T d1jl5a_          38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGV  105 (353)
T ss_dssp             HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred             CCCCEEEECCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCCCH---HHHHHHHHHHCCCC-HHHHH---CCCCCCCCC
T ss_conf             69989993799988-78898---789888989999796-336203---32033266551432-03210---221111133


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCC
Q ss_conf             6874467556678754577777982478688777812479999998975798243342321007999879994279897
Q 001566          203 SSNRLSGGLAIDSSSECEFLTYLKLSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLT  281 (1052)
Q Consensus       203 s~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  281 (1052)
                      ++|.+.. ++  ....++.|++|++++|.+.. .+.   ....+..+.+..+...  ....+..++.++.++++.|...
T Consensus       106 ~~n~l~~-lp--~~~~l~~L~~L~l~~~~~~~-~~~---~~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~  175 (353)
T d1jl5a_         106 SNNQLEK-LP--ELQNSSFLKIIDVDNNSLKK-LPD---LPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK  175 (353)
T ss_dssp             CSSCCSS-CC--CCTTCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCS
T ss_pred             CCCCCCC-CC--CHHHHCCCEEECCCCCCCCC-CCC---CCCCCCCHHHCCCCCC--CCCCCCCCCCCEECCCCCCCCC
T ss_conf             4554322-21--00110131231135651001-322---3333210000122222--3332000122200111233443

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.96  E-value=2.4e-25  Score=152.90  Aligned_cols=135  Identities=27%  Similarity=0.356  Sum_probs=82.2

Q ss_pred             CCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf             87648981375033358932438777885852234363358822339999867985687446755667875457777798
Q 001566          147 RLLEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSFSGEVPRGLIGNGELSVIDMSSNRLSGGLAIDSSSECEFLTYLK  226 (1052)
Q Consensus       147 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~  226 (1052)
                      .+++.|||++|.++ .+|..   +++|++|++++|.|+ .+|..   ..+|+.|++++|++.. ++    .-.+.|++|+
T Consensus        38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~~-l~----~lp~~L~~L~  104 (353)
T d1jl5a_          38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLKA-LS----DLPPLLEYLG  104 (353)
T ss_dssp             HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CC----SCCTTCCEEE
T ss_pred             CCCCEEEECCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCCC---HHHHHHHHHHHCCCCH-HH----HHCCCCCCCC
T ss_conf             69989993799988-78898---789888989999796-33620---3320332665514320-32----1022111113


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEECCCC
Q ss_conf             2478688777812479999998975798243342321007999879994279897777712103799980321566
Q 001566          227 LSDNFLTESIPKEIGKCRNLKNLLLDGNILEGSIPKEIGTISELKVLDVSRNSLTDRIPVELADCSKLSVLVLTNI  302 (1052)
Q Consensus       227 Ls~N~l~~~~~~~l~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~n  302 (1052)
                      +++|.+.. +|. ++.+++|+.|++++|.+.. .+..   ...+..+.+..+....  +..+..++.++.+.++++
T Consensus       105 L~~n~l~~-lp~-~~~l~~L~~L~l~~~~~~~-~~~~---~~~l~~l~~~~~~~~~--~~~l~~l~~l~~L~l~~n  172 (353)
T d1jl5a_         105 VSNNQLEK-LPE-LQNSSFLKIIDVDNNSLKK-LPDL---PPSLEFIAAGNNQLEE--LPELQNLPFLTAIYADNN  172 (353)
T ss_dssp             CCSSCCSS-CCC-CTTCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSS--CCCCTTCTTCCEEECCSS
T ss_pred             CCCCCCCC-CCC-HHHHCCCEEECCCCCCCCC-CCCC---CCCCCCHHHCCCCCCC--CCCCCCCCCCEECCCCCC
T ss_conf             34554322-210-0110131231135651001-3223---3332100001222223--332000122200111233

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=1.8e-28  Score=170.10  Aligned_cols=61  Identities=18%  Similarity=0.238  Sum_probs=26.4

Q ss_pred             CCCEEEECCCCCEEC-CCCCCCCCCCCCEEECCCCCCCC----CCCCCCCCCCCCCEEECCCCCCC
Q ss_conf             878557037982002-89873587876489813750333----58932438777885852234363
Q 001566          124 ELRTLSVPHNSFSGE-IPAGVGELRLLEVLELQGNNFSG----KIPYQMSNLERLRVLNLSFNSFS  184 (1052)
Q Consensus       124 ~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~Ls~n~l~~----~~p~~~~~l~~L~~L~Ls~N~l~  184 (1052)
                      .|+.||+++|++++. +.+-+..+++++.|+|++|.++.    .+...+..+++|++|||++|.++
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~   68 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG   68 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCH
T ss_pred             CCCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCC
T ss_conf             877798208958868999999767799999828999988999999999853999888979598597

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=3e-26  Score=157.85  Aligned_cols=171  Identities=15%  Similarity=0.131  Sum_probs=120.2

Q ss_pred             CCCCEEEECCCCEEEEEEEECCCCEEEEEEECCCCCC------------------CHHHHHHHHHHHHCCCCCCEEEEEE
Q ss_conf             7553033014844899999449909999994067510------------------1888999999850267785005997
Q 001566          777 FSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQ------------------GIQQFDAEIGTLGRIRHKNLVTLIG  838 (1052)
Q Consensus       777 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~h~niv~l~~  838 (1052)
                      +.+.++||+|+||+||+|...+|+.||+|+++.....                  .......|...+.++.|.+++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             CHHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEE
T ss_conf             02277802485659999997999999999986044346665565630008889999997789999999816999144998


Q ss_pred             EEECCCEEEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEE
Q ss_conf             88628816999941599999999835069964589999999999999999876399981637999999798899969995
Q 001566          839 YYVGEAEMFLVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSCVPRIVHRDIKPSNILLDEELNAYLS  918 (1052)
Q Consensus       839 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dik~~Nill~~~~~~kl~  918 (1052)
                      +..    .+++||++++..+.         .++......++.|++.++.|||++   ||+||||||+|||++++ .++++
T Consensus        82 ~~~----~~lvme~~~~~~~~---------~l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          82 WEG----NAVLMELIDAKELY---------RVRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             EET----TEEEEECCCCEEGG---------GCCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred             ECC----CEEEEEEECCCCCC---------CHHHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHEEEECC-CEEEE
T ss_conf             628----88999950456542---------001578999999999999998268---88983689036114289-89998


Q ss_pred             EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf             20564002546763334654455312543327788894015899999999
Q 001566          919 DFGLARLLEVSETHATTDVAGTFGYVAPEYATTCRVSDKADVYSFGVVLL  968 (1052)
Q Consensus       919 Dfgla~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~  968 (1052)
                      |||.|...........-  ...... ..+ +..+.|+.++|+||..--+.
T Consensus       145 DFG~a~~~~~~~~~~~l--~rd~~~-~~~-~f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         145 DFPQSVEVGEEGWREIL--ERDVRN-IIT-YFSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             CCTTCEETTSTTHHHHH--HHHHHH-HHH-HHHHHHCCCCCHHHHHHHHH
T ss_pred             ECCCCCCCCCCCCHHHH--HHHHHH-HHH-HHCCCCCCCCCHHHHHHHHH
T ss_conf             77884308998709999--877999-999-97578998446899999874

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=5.4e-29  Score=172.96  Aligned_cols=111  Identities=19%  Similarity=0.250  Sum_probs=61.3

Q ss_pred             CCCEEECCCCCCCCCC-CCCCCCCCCCCEEECCCCCCCC----CCCCCCCCCCCCCEEECCCCCCCCCCC---CCCC-CC
Q ss_conf             7648981375033358-9324387778858522343633----588223399998679856874467556---6787-54
Q 001566          148 LLEVLELQGNNFSGKI-PYQMSNLERLRVLNLSFNSFSG----EVPRGLIGNGELSVIDMSSNRLSGGLA---IDSS-SE  218 (1052)
Q Consensus       148 ~L~~L~Ls~n~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~-~~  218 (1052)
                      +|+.||+++|++++.. ...+..+++++.|+|++|.++.    .+...+...++|+.|+|++|+++....   ...+ ..
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~   82 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   82 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             CCCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHCC
T ss_conf             87779820895886899999976779999982899998899999999985399988897959859728999999998437


Q ss_pred             CCCCCEEECCCCCCCCC----CCCCCCCCCCCCEEECCCCCCCC
Q ss_conf             57777798247868877----78124799999989757982433
Q 001566          219 CEFLTYLKLSDNFLTES----IPKEIGKCRNLKNLLLDGNILEG  258 (1052)
Q Consensus       219 l~~L~~L~Ls~N~l~~~----~~~~l~~l~~L~~L~l~~N~l~~  258 (1052)
                      ..+|++|++++|.+++.    ++..+..+++|++|++++|.++.
T Consensus        83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~  126 (460)
T d1z7xw1          83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD  126 (460)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred             CCCCCEEECCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCHH
T ss_conf             88778877888775432210121100003432002444332023

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=2e-22  Score=136.76  Aligned_cols=84  Identities=17%  Similarity=0.141  Sum_probs=32.6

Q ss_pred             CCCEEEECCCCCEECCCCCCCCCCCCCEEECCCCCCCCCC-CCCCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCEEE
Q ss_conf             8785570379820028987358787648981375033358-93243877788585223-436335882233999986798
Q 001566          124 ELRTLSVPHNSFSGEIPAGVGELRLLEVLELQGNNFSGKI-PYQMSNLERLRVLNLSF-NSFSGEVPRGLIGNGELSVID  201 (1052)
Q Consensus       124 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~-p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~  201 (1052)
                      .+++|++++|.++...+..|.++++|++|++++|.+...+ +..+.++++++++++.. |.+....+..+.++++|+.++
T Consensus        30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~  109 (242)
T d1xwdc1          30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL  109 (242)
T ss_dssp             CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEE
T ss_pred             CCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             88999876991896496686146432321102211242010011222222222111112343222222122222222223


Q ss_pred             CCCCCC
Q ss_conf             568744
Q 001566          202 MSSNRL  207 (1052)
Q Consensus       202 Ls~N~l  207 (1052)
                      +++|++
T Consensus       110 l~~~~l  115 (242)
T d1xwdc1         110 ISNTGI  115 (242)
T ss_dssp             EESCCC
T ss_pred             CCHHHH
T ss_conf             421111

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.90  E-value=7.5e-24  Score=144.64  Aligned_cols=133  Identities=23%  Similarity=0.224  Sum_probs=66.6

Q ss_pred             CCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEE
Q ss_conf             27675199755850133563235899977799754985889996000597448689758983597682111189778699
Q 001566          530 DCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVL  609 (1052)
Q Consensus       530 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  609 (1052)
                      .+++|++|++++|++....+..+..+++|++|+|++|+|+.+.+..|.++++|++|+|++|+|++..++.|.++++|++|
T Consensus        52 ~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l  131 (192)
T d1w8aa_          52 RLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSL  131 (192)
T ss_dssp             GCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEE
T ss_pred             CCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCC
T ss_conf             87627213013632212121222112222101003553443497998079746552457745353597785687533420


Q ss_pred             ECCCCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEECCCCCCCC
Q ss_conf             858997899883111023421200134864788777433344435812122464668
Q 001566          610 DLSHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSG  666 (1052)
Q Consensus       610 ~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~  666 (1052)
                      +|++|.+....+ ...-...++.+.+..|.++...|..+   ..++.++++.|.+.+
T Consensus       132 ~L~~N~~~~~~~-~~~~~~~l~~~~l~~~~~~c~~p~~l---~~~~l~~L~~n~l~C  184 (192)
T d1w8aa_         132 NLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSEFKC  184 (192)
T ss_dssp             ECTTCCBCCSGG-GHHHHHHHHHHCCSGGGCBBCSSTTT---TTSBGGGSCTTTCCC
T ss_pred             CCCCCCCCCCCC-HHHHHHHHHHHCCCCCCEEECCCHHH---CCCEEEECCHHHCCC
T ss_conf             003644343530-27776423540356898276898433---698861448755758

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.90  E-value=6.7e-23  Score=139.41  Aligned_cols=156  Identities=21%  Similarity=0.255  Sum_probs=81.7

Q ss_pred             CCCEEECCCCCCCC-CCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEEC
Q ss_conf             75199755850133-56323589997779975498588999600059744868975898359768211118977869985
Q 001566          533 QLVEFEAANNQISG-SIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDL  611 (1052)
Q Consensus       533 ~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l  611 (1052)
                      ++++|++++|+|+. ..+..|..+++|+.|+|++|.+....+..|..+++|+.|+|++|+++...+..|.++++|++|+|
T Consensus        30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L  109 (192)
T d1w8aa_          30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL  109 (192)
T ss_dssp             TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred             CCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCHHHHHCCCCCCCCCC
T ss_conf             87889848987755302002578762721301363221212122211222210100355344349799807974655245


Q ss_pred             CCCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCC
Q ss_conf             8997899883111023421200134864788777433344435812122464668889-76445432213970245789
Q 001566          612 SHNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLSFNNLSGHIP-HLQHLDCIAFKGNKYLASCP  689 (1052)
Q Consensus       612 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~-~~~~l~~~~~~~n~~~~~~~  689 (1052)
                      ++|+|++..|..|..+++|+.|+|++|.+...... ..-...++.+.+..|.+.+..| .+..++...+..|.+.|.++
T Consensus       110 ~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~-~~~~~~l~~~~l~~~~~~c~~p~~l~~~~l~~L~~n~l~C~~~  187 (192)
T d1w8aa_         110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL-AWFAEWLRKKSLNGGAARCGAPSKVRDVQIKDLPHSEFKCSSE  187 (192)
T ss_dssp             CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG-HHHHHHHHHHCCSGGGCBBCSSTTTTTSBGGGSCTTTCCCCCC
T ss_pred             CCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCH-HHHHHHHHHHCCCCCCEEECCCHHHCCCEEEECCHHHCCCCCC
T ss_conf             77453535977856875334200036443435302-7776423540356898276898433698861448755758998

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=1.2e-22  Score=137.97  Aligned_cols=35  Identities=14%  Similarity=0.040  Sum_probs=12.3

Q ss_pred             CCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf             64898137503335893243877788585223436
Q 001566          149 LEVLELQGNNFSGKIPYQMSNLERLRVLNLSFNSF  183 (1052)
Q Consensus       149 L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l  183 (1052)
                      +++|++++|+++...+..|.++++|++|++++|.+
T Consensus        31 l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~   65 (242)
T d1xwdc1          31 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV   65 (242)
T ss_dssp             CSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTT
T ss_pred             CCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCC
T ss_conf             89998769918964966861464323211022112

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.89  E-value=6.5e-22  Score=133.96  Aligned_cols=190  Identities=23%  Similarity=0.249  Sum_probs=0.0

Q ss_pred             HHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCE
Q ss_conf             22024782875689978755896444898742996799945334782320348998996879947678998877787446
Q 001566          326 LLLSRSLEVLWAPRANLGGRLPDNWSESCSLKVLNLGQNSLKGAVPKSLGMCRNLTYLDLSLNNLEGYLPMQLPVPCMVY  405 (1052)
Q Consensus       326 l~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~  405 (1052)
                      +..+.+|+.|++.+|++...  +.+..+++|+.|++++|.+++..|  +..+++|+.+++++|.++ .++....++.|+.
T Consensus        37 ~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~~l~~l~~L~~  111 (227)
T d1h6ua2          37 QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVSAIAGLQSIKT  111 (227)
T ss_dssp             HHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCGGGTTCTTCCE
T ss_pred             HHHCCCCCEEECCCCCCCCC--HHHHCCCCCCEEECCCCEEECCCC--CCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCC
T ss_conf             87848868997779999766--457448888376357853202543--112334320121112222-2222222222212


Q ss_pred             EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCHHHHH
Q ss_conf             71126702235899875556766674445212235456534531368752268833466676545653112454224884
Q 001566          406 FNVSQNNITGVLPRFENVSCDNHFGFQDLQYANVPVMGSISDENFVIIHDFSGNKFLGSLPLFAIGDGFLAAKYKPHYRL  485 (1052)
Q Consensus       406 l~l~~N~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~n~~~~~~p~~~~~~~~~~~~~~~~~~l  485 (1052)
                      ++++++...+..+                                                                   
T Consensus       112 l~l~~~~~~~~~~-------------------------------------------------------------------  124 (227)
T d1h6ua2         112 LDLTSTQITDVTP-------------------------------------------------------------------  124 (227)
T ss_dssp             EECTTSCCCCCGG-------------------------------------------------------------------
T ss_pred             CCCCCCCCCCCCH-------------------------------------------------------------------
T ss_conf             2122244331100-------------------------------------------------------------------


Q ss_pred             HCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCHHHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf             40597456788973212368875227755752135756588973276751997558501335632358999777997549
Q 001566          486 LLNNNMFNGSVPGERISKCNDLQSFSVNLSANLLSGMSYEAFLLDCVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRG  565 (1052)
Q Consensus       486 ~l~~n~~~~~~p~~~~~~~~~l~~~~l~l~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~  565 (1052)
                                                                +...+.+..+.++++.+....+  +...++|+.|++++
T Consensus       125 ------------------------------------------~~~~~~~~~l~~~~~~~~~~~~--~~~~~~L~~L~l~~  160 (227)
T d1h6ua2         125 ------------------------------------------LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGN  160 (227)
T ss_dssp             ------------------------------------------GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCS
T ss_pred             ------------------------------------------HCCCCCHHHHHCHHHHHCHHHH--HCCCCCCCCCCCCC
T ss_conf             ------------------------------------------0002301222000000000000--01021110023333


Q ss_pred             CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCC
Q ss_conf             858899960005974486897589835976821111897786998589978998831110234212001348
Q 001566          566 NRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAH  637 (1052)
Q Consensus       566 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~  637 (1052)
                      |.+....+  +.++++|+.|++++|++++..+  +.++++|++|++++|++++..|  +.++++|+.|++++
T Consensus       161 n~~~~~~~--l~~l~~L~~L~Ls~n~l~~l~~--l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~lsn  226 (227)
T d1h6ua2         161 AQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN  226 (227)
T ss_dssp             SCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEE
T ss_pred             CCCCCCHH--HCCCCCCEECCCCCCCCCCCHH--HCCCCCCCEEECCCCCCCCCCC--CCCCCCCCEEEEEC
T ss_conf             33331001--0564633564458884177853--4479999989795996899802--03699989897129

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.87  E-value=1.5e-21  Score=132.01  Aligned_cols=118  Identities=30%  Similarity=0.416  Sum_probs=52.4

Q ss_pred             CCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECC
Q ss_conf             75199755850133563235899977799754985889996000597448689758983597682111189778699858
Q 001566          533 QLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLS  612 (1052)
Q Consensus       533 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls  612 (1052)
                      +|+.|++++|+++++.  .+..+++|+.|++++|.+.. + ..+..+++++.+++++|.+++  +..+..+++|+.++++
T Consensus        91 ~L~~L~l~~n~i~~l~--~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~  164 (210)
T d1h6ta2          91 NLGWLFLDENKVKDLS--SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLE  164 (210)
T ss_dssp             TCCEEECCSSCCCCGG--GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECC
T ss_pred             CCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCC-C-CCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCC
T ss_conf             2120143333321222--12122211122345653221-1-220111112221122233345--4310001332100134


Q ss_pred             CCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEECC
Q ss_conf             997899883111023421200134864788777433344435812122
Q 001566          613 HNALTGSIPASLTKATKLESLFLAHNRLSGEIPVSFSTLVNLSALDLS  660 (1052)
Q Consensus       613 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~  660 (1052)
                      +|++++ ++ .+.++++|+.|++++|+++. +| .+..+++|+.|+++
T Consensus       165 ~n~l~~-i~-~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls  208 (210)
T d1h6ta2         165 DNQISD-IV-PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF  208 (210)
T ss_dssp             SSCCCC-CG-GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred             CCCCCC-CC-CCCCCCCCCEEECCCCCCCC-CH-HHCCCCCCCEEECC
T ss_conf             643025-64-53678989999897998998-72-11699998999711

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.86  E-value=1.8e-20  Score=126.01  Aligned_cols=14  Identities=36%  Similarity=0.484  Sum_probs=4.4

Q ss_pred             CCCCCEEECCCCCC
Q ss_conf             34212001348647
Q 001566          627 ATKLESLFLAHNRL  640 (1052)
Q Consensus       627 l~~L~~L~l~~N~l  640 (1052)
                      +++|+.|++++|++
T Consensus       171 l~~L~~L~ls~N~i  184 (199)
T d2omxa2         171 LTTLERLDISSNKV  184 (199)
T ss_dssp             CTTCCEEECCSSCC
T ss_pred             CCCCCEEECCCCCC
T ss_conf             99899997879979

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.80  E-value=7e-20  Score=122.78  Aligned_cols=39  Identities=18%  Similarity=0.267  Sum_probs=13.7

Q ss_pred             CCCCCCCCEEECCCC-CCCCCCCHHHCCCCCCCEEECCCC
Q ss_conf             059744868975898-359768211118977869985899
Q 001566          576 LGKLKFLKWILLGGN-NLTGEIPSQFGHLISLVVLDLSHN  614 (1052)
Q Consensus       576 ~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~ls~N  614 (1052)
                      +..+++|++|++++| .+++.....++.+++|+.|+++++
T Consensus       196 l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         196 FFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             GGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             HCCCCCCCEEECCCCCCCCHHHHHHHHCCCCCCEEEEECC
T ss_conf             2135768779899999787378999726999898964488

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.79  E-value=4e-20  Score=124.12  Aligned_cols=12  Identities=25%  Similarity=0.257  Sum_probs=3.9

Q ss_pred             CCCCCCCEEECC
Q ss_conf             034899899687
Q 001566          375 GMCRNLTYLDLS  386 (1052)
Q Consensus       375 ~~l~~L~~L~L~  386 (1052)
                      ..+++|+.|+++
T Consensus       222 ~~~~~L~~L~l~  233 (284)
T d2astb2         222 GEIPTLKTLQVF  233 (284)
T ss_dssp             GGCTTCCEEECT
T ss_pred             HCCCCCCEEEEE
T ss_conf             269998989644

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.79  E-value=5.1e-21  Score=129.04  Aligned_cols=11  Identities=36%  Similarity=0.449  Sum_probs=4.0

Q ss_pred             CCEEECCCCCC
Q ss_conf             86998589978
Q 001566          606 LVVLDLSHNAL  616 (1052)
Q Consensus       606 L~~L~ls~N~l  616 (1052)
                      |+.|++++|++
T Consensus       275 L~~L~ls~N~i  285 (344)
T d2ca6a1         275 LQTLRLQYNEI  285 (344)
T ss_dssp             CCEEECCSSCC
T ss_pred             CCEEECCCCCC
T ss_conf             89898989869

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.75  E-value=3.8e-20  Score=124.20  Aligned_cols=38  Identities=18%  Similarity=0.234  Sum_probs=15.9

Q ss_pred             CCCCEEECCCCCCCCC----CCHHH-CCCCCCCEEECCCCCCC
Q ss_conf             4486897589835976----82111-18977869985899789
Q 001566          580 KFLKWILLGGNNLTGE----IPSQF-GHLISLVVLDLSHNALT  617 (1052)
Q Consensus       580 ~~L~~L~L~~N~l~~~----~p~~~-~~l~~L~~L~ls~N~l~  617 (1052)
                      +.|++|++++|+++..    +...+ .++++|+.|++++|++.
T Consensus       273 ~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~  315 (344)
T d2ca6a1         273 IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS  315 (344)
T ss_dssp             CCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred             CCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCC
T ss_conf             8889898989869808999999999703899998978798089

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.72  E-value=7.2e-18  Score=111.66  Aligned_cols=123  Identities=20%  Similarity=0.189  Sum_probs=55.6

Q ss_pred             CCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEE
Q ss_conf             76751997558501335632358999777997549858899960005974486897589835976821111897786998
Q 001566          531 CVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLD  610 (1052)
Q Consensus       531 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  610 (1052)
                      ..++++|++++|+|+.+ +..+..+++|+.|+|++|+|+. ++ .|..+++|+.|++++|+++...+..+..+++|+.|+
T Consensus        17 ~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~   93 (162)
T d1a9na_          17 AVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI   93 (162)
T ss_dssp             TTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred             CCCCCEEECCCCCCCCC-CCCCCCCCCCCEEECCCCCCCC-CC-CCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCE
T ss_conf             57484897889978865-7620041459989897997876-47-744576130643102134577763223345344342


Q ss_pred             CCCCCCCCCCC--HHHHCCCCCCEEECCCCCCCCCCCC----CCCCCCCCCCEE
Q ss_conf             58997899883--1110234212001348647887774----333444358121
Q 001566          611 LSHNALTGSIP--ASLTKATKLESLFLAHNRLSGEIPV----SFSTLVNLSALD  658 (1052)
Q Consensus       611 ls~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~~p~----~~~~l~~L~~l~  658 (1052)
                      +++|+++. ++  ..+..+++|+.|++++|+++ ..|.    .+..+|+|+.||
T Consensus        94 L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          94 LTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             CCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred             ECCCCCCC-CCCCCCCCCCCCCCHHHCCCCCCC-CCCCHHHHHHHHCCCCCEEC
T ss_conf             03000166-542110013653206640799634-56106999998789958337

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.67  E-value=1.7e-16  Score=104.16  Aligned_cols=62  Identities=31%  Similarity=0.431  Sum_probs=21.6

Q ss_pred             CCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCC
Q ss_conf             89997779975498588999600059744868975898359768211118977869985899789
Q 001566          553 GKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALT  617 (1052)
Q Consensus       553 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~  617 (1052)
                      +.+++|++|++++|+|+ .+|..|..+++|+.|++++|.++ .+| .+..+++|+.|++++|+++
T Consensus        17 ~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~i~   78 (124)
T d1dcea3          17 EQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQ   78 (124)
T ss_dssp             GGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSCCC
T ss_pred             CCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCC-CCC-CCCCCCCCCEEECCCCCCC
T ss_conf             05898898979787168-65215655431354532432112-357-4123355576888898658

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.67  E-value=2.4e-16  Score=103.33  Aligned_cols=101  Identities=28%  Similarity=0.381  Sum_probs=44.7

Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCC
Q ss_conf             99754985889996000597448689758983597682111189778699858997899883111023421200134864
Q 001566          560 RLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNR  639 (1052)
Q Consensus       560 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~  639 (1052)
                      .|+|++|+++ .++ .+..+++|++|++++|.++ .+|..+..+++|+.|++++|+++. +| .+..+++|+.|++++|+
T Consensus         2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~   76 (124)
T d1dcea3           2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR   76 (124)
T ss_dssp             EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred             EEECCCCCCC-CCC-CCCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCCC-CC-CCCCCCCCCEEECCCCC
T ss_conf             8986899898-871-0105898898979787168-652156554313545324321123-57-41233555768888986


Q ss_pred             CCCCCC-CCCCCCCCCCCEECCCCCCC
Q ss_conf             788777-43334443581212246466
Q 001566          640 LSGEIP-VSFSTLVNLSALDLSFNNLS  665 (1052)
Q Consensus       640 l~~~~p-~~~~~l~~L~~l~l~~N~l~  665 (1052)
                      ++.... ..+..+++|+.+++++|+++
T Consensus        77 i~~~~~~~~l~~~~~L~~L~l~~N~i~  103 (124)
T d1dcea3          77 LQQSAAIQPLVSCPRLVLLNLQGNSLC  103 (124)
T ss_dssp             CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             CCCCCCCHHHCCCCCCCEEECCCCCCC
T ss_conf             588888256537999999989799688

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.65  E-value=7.4e-16  Score=100.58  Aligned_cols=107  Identities=20%  Similarity=0.103  Sum_probs=59.7

Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCCEEECCCC-CCCCCCCHHHCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCC
Q ss_conf             9975498588999600059744868975898-359768211118977869985899789988311102342120013486
Q 001566          560 RLDLRGNRVSGSLPDELGKLKFLKWILLGGN-NLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHN  638 (1052)
Q Consensus       560 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N  638 (1052)
                      .++.+++.+. ..|..+.++++|++|++++| .++...+..|.++++|+.|++++|+|+.+.|..|..+++|+.|+|++|
T Consensus        12 ~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N   90 (156)
T d2ifga3          12 GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN   90 (156)
T ss_dssp             CEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred             EEEECCCCCC-CCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCC
T ss_conf             6985289976-586002576565743168986644369212256666672162021247742011124554333322678


Q ss_pred             CCCCCCCCCCCCCCCCCCEECCCCCCCCCC
Q ss_conf             478877743334443581212246466888
Q 001566          639 RLSGEIPVSFSTLVNLSALDLSFNNLSGHI  668 (1052)
Q Consensus       639 ~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~  668 (1052)
                      +|+...+..|..+ +|+.|+|++|+|.+.+
T Consensus        91 ~l~~l~~~~~~~~-~l~~L~L~~Np~~C~C  119 (156)
T d2ifga3          91 ALESLSWKTVQGL-SLQELVLSGNPLHCSC  119 (156)
T ss_dssp             CCSCCCSTTTCSC-CCCEEECCSSCCCCCG
T ss_pred             CCCCCCHHHHCCC-CCCCCCCCCCCCCCCC
T ss_conf             7851574563353-2124335798633881

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.61  E-value=5.5e-18  Score=112.31  Aligned_cols=104  Identities=24%  Similarity=0.284  Sum_probs=34.7

Q ss_pred             CCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEE
Q ss_conf             76751997558501335632358999777997549858899960005974486897589835976821111897786998
Q 001566          531 CVQLVEFEAANNQISGSIAAGVGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLD  610 (1052)
Q Consensus       531 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  610 (1052)
                      +++|++|++++|+|+.+ + .+..+++|+.|+|++|+|+ .++..+..+++|++|++++|+++. + ..+..+++|+.|+
T Consensus        47 L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l~~L~~L~  121 (198)
T d1m9la_          47 LKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKLVNLRVLY  121 (198)
T ss_dssp             TTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHHHHSSEEE
T ss_pred             CCCCCEEECCCCCCCCC-C-CCCCCCCCCCHHHCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCC-C-CCCCCCCCCCCCC
T ss_conf             60461519944689986-4-4247825357341353432-100003322123333333322222-2-2222222341112


Q ss_pred             CCCCCCCCCCC--HHHHCCCCCCEEECCCCCC
Q ss_conf             58997899883--1110234212001348647
Q 001566          611 LSHNALTGSIP--ASLTKATKLESLFLAHNRL  640 (1052)
Q Consensus       611 ls~N~l~~~~p--~~~~~l~~L~~L~l~~N~l  640 (1052)
                      +++|+++. ++  ..+..+++|+.|++++|++
T Consensus       122 L~~N~i~~-~~~~~~l~~l~~L~~L~L~~N~l  152 (198)
T d1m9la_         122 MSNNKITN-WGEIDKLAALDKLEDLLLAGNPL  152 (198)
T ss_dssp             ESEEECCC-HHHHHHHTTTTTCSEEEECSSHH
T ss_pred             CCCCHHCC-CCCCCCCCCCCCCCEEECCCCCC
T ss_conf             34102125-54221236777630234279843

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.60  E-value=1.1e-17  Score=110.60  Aligned_cols=108  Identities=22%  Similarity=0.282  Sum_probs=41.9

Q ss_pred             CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCHHHHCCCCCC
Q ss_conf             58999777997549858899960005974486897589835976821111897786998589978998831110234212
Q 001566          552 VGKLMKLQRLDLRGNRVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALTGSIPASLTKATKLE  631 (1052)
Q Consensus       552 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~  631 (1052)
                      +..+++|+.|+|++|+|+. ++ .+.++++|+.|++++|+++ .++..+..+++|+.|++++|+++. + ..+..+++|+
T Consensus        44 l~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l~~L~  118 (198)
T d1m9la_          44 LSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKLVNLR  118 (198)
T ss_dssp             HHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHHHHSS
T ss_pred             HHCCCCCCEEECCCCCCCC-CC-CCCCCCCCCCHHHCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCC-C-CCCCCCCCCC
T ss_conf             7626046151994468998-64-4247825357341353432-100003322123333333322222-2-2222222341


Q ss_pred             EEECCCCCCCCCCC-CCCCCCCCCCCEECCCCCC
Q ss_conf             00134864788777-4333444358121224646
Q 001566          632 SLFLAHNRLSGEIP-VSFSTLVNLSALDLSFNNL  664 (1052)
Q Consensus       632 ~L~l~~N~l~~~~p-~~~~~l~~L~~l~l~~N~l  664 (1052)
                      .|++++|+++.... ..+..+++|+.|++++|++
T Consensus       119 ~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l  152 (198)
T d1m9la_         119 VLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPL  152 (198)
T ss_dssp             EEEESEEECCCHHHHHHHTTTTTCSEEEECSSHH
T ss_pred             CCCCCCCHHCCCCCCCCCCCCCCCCEEECCCCCC
T ss_conf             1123410212554221236777630234279843

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.58  E-value=4.7e-15  Score=96.16  Aligned_cols=105  Identities=19%  Similarity=0.168  Sum_probs=51.9

Q ss_pred             CEEECCCCCCCCCCCCCCCCCCCCCEEECCCC-CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCC
Q ss_conf             19975585013356323589997779975498-58899960005974486897589835976821111897786998589
Q 001566          535 VEFEAANNQISGSIAAGVGKLMKLQRLDLRGN-RVSGSLPDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSH  613 (1052)
Q Consensus       535 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~  613 (1052)
                      +.++.+++++. ..|..+..+++|++|++++| .++.+.+..|.++++|+.|+|++|+|+.+.+.+|.++++|++|+|++
T Consensus        11 ~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~   89 (156)
T d2ifga3          11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (156)
T ss_dssp             SCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             CEEEECCCCCC-CCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCC
T ss_conf             96985289976-58600257656574316898664436921225666667216202124774201112455433332267


Q ss_pred             CCCCCCCCHHHHCCCCCCEEECCCCCCC
Q ss_conf             9789988311102342120013486478
Q 001566          614 NALTGSIPASLTKATKLESLFLAHNRLS  641 (1052)
Q Consensus       614 N~l~~~~p~~~~~l~~L~~L~l~~N~l~  641 (1052)
                      |+++. +|........|+.|+|++|.+.
T Consensus        90 N~l~~-l~~~~~~~~~l~~L~L~~Np~~  116 (156)
T d2ifga3          90 NALES-LSWKTVQGLSLQELVLSGNPLH  116 (156)
T ss_dssp             SCCSC-CCSTTTCSCCCCEEECCSSCCC
T ss_pred             CCCCC-CCHHHHCCCCCCCCCCCCCCCC
T ss_conf             87851-5745633532124335798633

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=99.14  E-value=4.2e-10  Score=68.86  Aligned_cols=149  Identities=11%  Similarity=0.006  Sum_probs=101.3

Q ss_pred             HHHHHHCCCCCCEEEECCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHCCC-CCCEEEEEEEEECCCEEE
Q ss_conf             6887507975530330148448999994499099999940675101888999999850267-785005997886288169
Q 001566          769 NVVRATGNFSIRNLIGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIR-HKNLVTLIGYYVGEAEMF  847 (1052)
Q Consensus       769 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  847 (1052)
                      ++....+.|+..+..+.+..+.||+.... +..+++|+...........+.+|...+..+. +--+.+++.+...++..+
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHHHHCEEEEECCCCCCCCCEEEEEEC-CCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEE
T ss_conf             99975135279976789987718999908-98699998488765325569999999998760699872899975089649


Q ss_pred             EEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCC----------------------------------
Q ss_conf             9994159999999983506996458999999999999999987639----------------------------------
Q 001566          848 LVYNFLSGGNLETFIHKKSGKKIQWSVIHKIAIDIAQALAYLHYSC----------------------------------  893 (1052)
Q Consensus       848 lv~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----------------------------------  893 (1052)
                      +||++++|.++.+.....       .....++.+++..+..+|+..                                  
T Consensus        87 lv~~~l~G~~~~~~~~~~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T d1j7la_          87 LLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEEECCSSEEHHHHTTTC-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred             EEEEECCCCCCCCCCCCC-------CCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCC
T ss_conf             999860433435433440-------2699999989999999855684214357644656555778998776555543033


Q ss_pred             ----------------------CCCEEECCCCCCCEEECCCCCEEEEEECCCCC
Q ss_conf             ----------------------99816379999997988999699952056400
Q 001566          894 ----------------------VPRIVHRDIKPSNILLDEELNAYLSDFGLARL  925 (1052)
Q Consensus       894 ----------------------~~~iiH~Dik~~Nill~~~~~~kl~Dfgla~~  925 (1052)
                                            .+.++|+|+.+.||+++++..+.++||+.+..
T Consensus       160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             CCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf             232005799999999844986781789860047642364996599960231441

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.00  E-value=4.6e-12  Score=79.71  Aligned_cols=66  Identities=30%  Similarity=0.251  Sum_probs=25.4

Q ss_pred             CCCCCCCEEECCCCCCCCCC--CHHHCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCCCCC
Q ss_conf             59744868975898359768--2111189778699858997899883111023421200134864788
Q 001566          577 GKLKFLKWILLGGNNLTGEI--PSQFGHLISLVVLDLSHNALTGSIPASLTKATKLESLFLAHNRLSG  642 (1052)
Q Consensus       577 ~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~  642 (1052)
                      ..+++|++|+|++|+|+...  +..+..+++|+.|++++|.++...+-.+....+|+.|++++|++..
T Consensus        62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~  129 (162)
T d1koha1          62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSD  129 (162)
T ss_dssp             HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred             HHCCCCCEEECCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHCCCCCEEECCCCCCCC
T ss_conf             74878788637776666773158898658856100043572134234422203310426648997676

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.82  E-value=1.6e-10  Score=71.15  Aligned_cols=63  Identities=29%  Similarity=0.221  Sum_probs=25.2

Q ss_pred             CCCCCEEECCCCCCCCCC--CCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCC
Q ss_conf             997779975498588999--600059744868975898359768211118977869985899789
Q 001566          555 LMKLQRLDLRGNRVSGSL--PDELGKLKFLKWILLGGNNLTGEIPSQFGHLISLVVLDLSHNALT  617 (1052)
Q Consensus       555 l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~  617 (1052)
                      +++|++|+|++|+|+...  +..+..+++|+.|+|++|.++...+-.+.....|+.|++++|.+.
T Consensus        64 ~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~  128 (162)
T d1koha1          64 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS  128 (162)
T ss_dssp             CTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred             CCCCCEEECCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHCCCCCEEECCCCCCC
T ss_conf             87878863777666677315889865885610004357213423442220331042664899767

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.62  E-value=1.9e-07  Score=54.20  Aligned_cols=132  Identities=14%  Similarity=0.128  Sum_probs=83.9

Q ss_pred             EEEECCCC-EEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHCCCC--CCEEEEEEEEECCCEEEEEEEECCCCC
Q ss_conf             03301484-489999944990999999406751018889999998502677--850059978862881699994159999
Q 001566          781 NLIGTGGF-GSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRH--KNLVTLIGYYVGEAEMFLVYNFLSGGN  857 (1052)
Q Consensus       781 ~~lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~E~~~~gs  857 (1052)
                      +.+..|.. +.||+....++..+++|.......   ..+..|...++.+..  -.+.+++++..+.+..+++|++++|.+
T Consensus        16 ~~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~   92 (255)
T d1nd4a_          16 AQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD   92 (255)
T ss_dssp             EECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred             EECCCCCCCCEEEEEEECCCCEEEEEECCCCCH---HHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCC
T ss_conf             876786547758999938987899995896677---68999999999998659998861322245661599987441355


Q ss_pred             HHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHH-----------------------------------------------
Q ss_conf             999983506996458999999999999999987-----------------------------------------------
Q 001566          858 LETFIHKKSGKKIQWSVIHKIAIDIAQALAYLH-----------------------------------------------  890 (1052)
Q Consensus       858 L~~~l~~~~~~~l~~~~~~~i~~~i~~~l~~LH-----------------------------------------------  890 (1052)
                      +.+..       ....   ..+.+++..+..||                                               
T Consensus        93 ~~~~~-------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (255)
T d1nd4a_          93 LLSSH-------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  162 (255)
T ss_dssp             TTTSC-------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             CCCCC-------CCHH---HHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHH
T ss_conf             43221-------2689---9999999999987368854488755412468899999987541101134011213799999


Q ss_pred             ----HCC----CCCEEECCCCCCCEEECCCCCEEEEEECCCCC
Q ss_conf             ----639----99816379999997988999699952056400
Q 001566          891 ----YSC----VPRIVHRDIKPSNILLDEELNAYLSDFGLARL  925 (1052)
Q Consensus       891 ----~~~----~~~iiH~Dik~~Nill~~~~~~kl~Dfgla~~  925 (1052)
                          ...    .+.++|+|+.+.||+++++..+.|+||+.+..
T Consensus       163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf             9998718765795678678887635773796589998533265

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.29  E-value=5.8e-06  Score=46.07  Aligned_cols=76  Identities=16%  Similarity=0.009  Sum_probs=48.3

Q ss_pred             CEEEECCCCEEEEEEEECC-CCEEEEEEECCCC-------CCCHHHHHHHHHHHHCCC-C--CCEEEEEEEEECCCEEEE
Q ss_conf             3033014844899999449-9099999940675-------101888999999850267-7--850059978862881699
Q 001566          780 RNLIGTGGFGSTYKAELVP-GYLVAVKKLSIGR-------FQGIQQFDAEIGTLGRIR-H--KNLVTLIGYYVGEAEMFL  848 (1052)
Q Consensus       780 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~l  848 (1052)
                      .+.||.|....||++.... ++.+++|.-....       .....+...|.+.++.+. +  ..+.+++.+.  ....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEEC--CCCCEE
T ss_conf             998079852768999957998489996177130346777888778999999999986505798855289985--988779


Q ss_pred             EEEECCCCC
Q ss_conf             994159999
Q 001566          849 VYNFLSGGN  857 (1052)
Q Consensus       849 v~E~~~~gs  857 (1052)
                      |||++.+..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEECCCCCC
T ss_conf             871357765

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=98.10  E-value=9.8e-07  Score=50.34  Aligned_cols=112  Identities=14%  Similarity=0.131  Sum_probs=0.0

Q ss_pred             CCCCCCCEEECCC-CCCC----CCCCCCCCCCCCCCEEECCCCCCCC---CCCCCCCCCCCCCCEEECCCCCCC----CC
Q ss_conf             3877788585223-4363----3588223399998679856874467---556678754577777982478688----77
Q 001566          168 SNLERLRVLNLSF-NSFS----GEVPRGLIGNGELSVIDMSSNRLSG---GLAIDSSSECEFLTYLKLSDNFLT----ES  235 (1052)
Q Consensus       168 ~~l~~L~~L~Ls~-N~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~---~~~~~~~~~l~~L~~L~Ls~N~l~----~~  235 (1052)
                      .+.++|++|+|++ +.+.    ..+...+...+.|+.|++++|.+..   ......+...+.|+.|++++|.++    ..
T Consensus        12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~   91 (167)
T d1pgva_          12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR   91 (167)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred             HCCCCCCEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEHHHCCHHHHHH
T ss_conf             28999819782799998989999999997637764540120156215679887531000234330033010214599999


Q ss_pred             CCCCCCCCCCCCEEECCCCCCCCC-------CCHHHCCCCCCCEEECCCCC
Q ss_conf             781247999999897579824334-------23210079998799942798
Q 001566          236 IPKEIGKCRNLKNLLLDGNILEGS-------IPKEIGTISELKVLDVSRNS  279 (1052)
Q Consensus       236 ~~~~l~~l~~L~~L~l~~N~l~~~-------~p~~l~~l~~L~~L~L~~N~  279 (1052)
                      +...+...++|++|++++|.+...       +...+...+.|+.|+++.+.
T Consensus        92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~  142 (167)
T d1pgva_          92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS  142 (167)
T ss_dssp             HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred             HHHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf             999998489389877887768886579999999999729985386486888

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.90  E-value=4.9e-05  Score=40.97  Aligned_cols=73  Identities=14%  Similarity=0.068  Sum_probs=48.5

Q ss_pred             CEEEECCCCEEEEEEEECC--------CCEEEEEEECCCCCCCHHHHHHHHHHHHCCC-CCCEEEEEEEEECCCEEEEEE
Q ss_conf             3033014844899999449--------9099999940675101888999999850267-785005997886288169999
Q 001566          780 RNLIGTGGFGSTYKAELVP--------GYLVAVKKLSIGRFQGIQQFDAEIGTLGRIR-HKNLVTLIGYYVGEAEMFLVY  850 (1052)
Q Consensus       780 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  850 (1052)
                      .+.|+.|-.-.+|++....        ...|.+++.. .. .......+|..+++.+. +.-..++++++.+    ..|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECC-CC-CHHHHHHHHHHHHHHHHHCCCCCEEEEECCC----CEEE
T ss_conf             9991785334348999688775445789817999659-96-1165899999999999757999808998189----5699


Q ss_pred             EECCCCCH
Q ss_conf             41599999
Q 001566          851 NFLSGGNL  858 (1052)
Q Consensus       851 E~~~~gsL  858 (1052)
                      ||++|..+
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEECCCCC
T ss_conf             97345548

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.88  E-value=5.7e-05  Score=40.59  Aligned_cols=137  Identities=15%  Similarity=0.098  Sum_probs=77.0

Q ss_pred             CCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCCE--EEEE-----EEEECCCEEEEEEEECCCCCH
Q ss_conf             484489999944990999999406751018889999998502677850--0599-----788628816999941599999
Q 001566          786 GGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNL--VTLI-----GYYVGEAEMFLVYNFLSGGNL  858 (1052)
Q Consensus       786 G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~E~~~~gsL  858 (1052)
                      +.--.||+++..+|..+++|...... ...+++..|...+..+....+  +..+     ......+..+.++++++|..+
T Consensus        33 s~EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~  111 (325)
T d1zyla1          33 SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF  111 (325)
T ss_dssp             CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred             CCCCEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCC
T ss_conf             61202699983899979999847877-88999999999999998559987875206898056653479999865277688


Q ss_pred             -----HHHH---------HH----CC---CCC-------------------CCHH---HHHHHHHHHHHHHHHHH-HCCC
Q ss_conf             -----9998---------35----06---996-------------------4589---99999999999999987-6399
Q 001566          859 -----ETFI---------HK----KS---GKK-------------------IQWS---VIHKIAIDIAQALAYLH-YSCV  894 (1052)
Q Consensus       859 -----~~~l---------~~----~~---~~~-------------------l~~~---~~~~i~~~i~~~l~~LH-~~~~  894 (1052)
                           ..+-         +.    ..   ...                   ++..   .....+..+...+...- +...
T Consensus       112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p  191 (325)
T d1zyla1         112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT  191 (325)
T ss_dssp             CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCC
T ss_conf             99999999998999999886303578655677897887665689998747699889899999999999999984545687


Q ss_pred             CCEEECCCCCCCEEECCCCCEEEEEECCCCC
Q ss_conf             9816379999997988999699952056400
Q 001566          895 PRIVHRDIKPSNILLDEELNAYLSDFGLARL  925 (1052)
Q Consensus       895 ~~iiH~Dik~~Nill~~~~~~kl~Dfgla~~  925 (1052)
                      .+++|+|+.+.||+++++  ..++||+-+..
T Consensus       192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             CEEECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf             120247888042878389--35886520146

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.79  E-value=1.4e-05  Score=43.91  Aligned_cols=159  Identities=14%  Similarity=0.083  Sum_probs=82.4

Q ss_pred             CCCHHHHHHHHCCCCCCEE-----EECCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCCE--EEE
Q ss_conf             6563568875079755303-----301484489999944990999999406751018889999998502677850--059
Q 001566          764 ELTYDNVVRATGNFSIRNL-----IGTGGFGSTYKAELVPGYLVAVKKLSIGRFQGIQQFDAEIGTLGRIRHKNL--VTL  836 (1052)
Q Consensus       764 ~~~~~~~~~~~~~~~~~~~-----lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l  836 (1052)
                      .++.+++.....+|.+++.     |..|.--+.|+.+...|+ +++|++......  +++..|.+.+..+...++  ...
T Consensus         2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~--~~l~~~~~~l~~L~~~g~pvp~p   78 (316)
T d2ppqa1           2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEK--NDLPFFLGLMQHLAAKGLSCPLP   78 (316)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---C--CHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             CCCHHHHHHHHHHCCCCCCEEEECCCCCCCCCEEEEEECCCC-EEEEECCCCCCH--HHHHHHHHHHHHHHHCCCCCCCC
T ss_conf             889999999998679998568523788852673899978972-899980789998--89999999987543025554556


Q ss_pred             EE------EEECCCEEEEEEEECCCCCHH-----HH---------HHHC----C----CC-----------------CCC
Q ss_conf             97------886288169999415999999-----99---------8350----6----99-----------------645
Q 001566          837 IG------YYVGEAEMFLVYNFLSGGNLE-----TF---------IHKK----S----GK-----------------KIQ  871 (1052)
Q Consensus       837 ~~------~~~~~~~~~lv~E~~~~gsL~-----~~---------l~~~----~----~~-----------------~l~  871 (1052)
                      +.      +.........++.+..+....     ..         ++..    .    ..                 ...
T Consensus        79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (316)
T d2ppqa1          79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  158 (316)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             CEECCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHC
T ss_conf             41048976213412550245311465533320467888889987645444320245310111012002456777765311


Q ss_pred             HHHHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCCCCEEEEEECCCCC
Q ss_conf             89999999999999999876-3999816379999997988999699952056400
Q 001566          872 WSVIHKIAIDIAQALAYLHY-SCVPRIVHRDIKPSNILLDEELNAYLSDFGLARL  925 (1052)
Q Consensus       872 ~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dik~~Nill~~~~~~kl~Dfgla~~  925 (1052)
                      .......+......+..... ....|++|+|+.+.|++++.+...-++||+.+..
T Consensus       159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf             4127999999987642048554545033378636564020454126742221236

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.62  E-value=6.7e-06  Score=45.73  Aligned_cols=115  Identities=17%  Similarity=0.155  Sum_probs=0.0

Q ss_pred             HHHHHCCCCCCEEECCC-CCCCCCCCCCCC----CCCCCCEEECCCCCCCC----CCCCCCCCCCCCCEEECCCCCCC--
Q ss_conf             88973276751997558-501335632358----99977799754985889----99600059744868975898359--
Q 001566          525 EAFLLDCVQLVEFEAAN-NQISGSIAAGVG----KLMKLQRLDLRGNRVSG----SLPDELGKLKFLKWILLGGNNLT--  593 (1052)
Q Consensus       525 ~~~~~~~~~L~~L~l~~-n~l~~~~~~~~~----~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~--  593 (1052)
                      .....+.+.|++|++++ +.++......+.    ..++|+.|++++|.++.    .+...+...+.++.+++++|.++  
T Consensus        10 ~~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~   89 (166)
T d1io0a_          10 KRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGS   89 (166)
T ss_dssp             HHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHH
T ss_pred             HHHHHCCCCCCEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCHHHHHCCCCCCCH
T ss_conf             99995599986887689999898999999988841982574301589611778999998775212210121025432201


Q ss_pred             --CCCCHHHCCCCCCCE--EECCCCCCCC----CCCHHHHCCCCCCEEECCCCC
Q ss_conf             --768211118977869--9858997899----883111023421200134864
Q 001566          594 --GEIPSQFGHLISLVV--LDLSHNALTG----SIPASLTKATKLESLFLAHNR  639 (1052)
Q Consensus       594 --~~~p~~~~~l~~L~~--L~ls~N~l~~----~~p~~~~~l~~L~~L~l~~N~  639 (1052)
                        ..+...+...++|+.  |++++|.+..    .+...+...+.|+.|+++.+.
T Consensus        90 g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~  143 (166)
T d1io0a_          90 GILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ  143 (166)
T ss_dssp             HHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred             HHHHHHHHHHHCCCCCEEEECCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf             478899999848652477321677867679999999999849984788581898